Citrus Sinensis ID: 005040
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 717 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.980 | 0.696 | 0.383 | 1e-134 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.967 | 0.673 | 0.379 | 1e-126 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.984 | 0.688 | 0.391 | 1e-121 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.973 | 0.712 | 0.351 | 1e-109 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.952 | 0.582 | 0.349 | 1e-107 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.945 | 0.542 | 0.329 | 1e-100 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.963 | 0.551 | 0.324 | 6e-99 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.947 | 0.569 | 0.332 | 8e-92 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.952 | 0.598 | 0.313 | 1e-89 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.963 | 0.577 | 0.314 | 1e-87 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 481 bits (1237), Expect = e-134, Method: Compositional matrix adjust.
Identities = 282/736 (38%), Positives = 440/736 (59%), Gaps = 33/736 (4%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G+IP +++N + L L + N+ +G IP TFGN+ +L +L L N+L ++SS FL
Sbjct: 273 GSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSR--DLEFL 329
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+SLTNC L L + N LGG LP I N SA L + + GSIP +IGNL L
Sbjct: 330 TSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQK 389
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L L N L+G +PTS+G L L+ + N L G +P + ++ L L+LS N G +
Sbjct: 390 LILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIV 449
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P L + + L L++ NKL+ ++P + ++ +LR+++S NSL G+LP +I L L
Sbjct: 450 PTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGT 509
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
L L N+LS +P T+G +E+L L GN F G IP+ G L+ ++ +D SNN+LSG I
Sbjct: 510 LSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSI 568
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPR-LQVPPCKQDN 360
P+ + S L+ N+S N LEG++PVKG F++ + S GN LCG Q+ PC
Sbjct: 569 PEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQA 628
Query: 361 ----RKRTNKVAPIVLQY-ILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRR 415
+K ++++ +V+ + ++L + + + ++++R R ++ + +
Sbjct: 629 PSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHE 688
Query: 416 RTSYLDIRRATDEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDSEC 474
+ SY D+R AT+ F+ N++G+G FG+VYK L++ VA+K+ N+Q A +SF +EC
Sbjct: 689 KISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAEC 748
Query: 475 EILRNVRHRNLLKILGSCSNLD-----FKALVLEFMPNGSLEKWLYSHNY--------FL 521
E L+++RHRNL+K+L +CS++D F+AL+ EFMPNGSL+ WL+ L
Sbjct: 749 ESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTL 808
Query: 522 DILQRLNIMIDVGSALEYLH-HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580
+L+RLNI IDV S L+YLH HCH PI HCDLKP+N+LLD+++ AHVSDFG+++LL +
Sbjct: 809 TLLERLNIAIDVASVLDYLHVHCHE--PIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLK 866
Query: 581 -GEDSVIQTMTMA----TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFT 635
E+S ++ A TIGY APEYG G S DVYS+G+LL+E FT K+PT+E+F
Sbjct: 867 FDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFG 926
Query: 636 GEMSLRRWVKESLPHRLTEVVDANLVR-EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH 694
G +L + K +LP R+ ++VD +++ + ++CL + ++ L CC ++P R+
Sbjct: 927 GNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLA 986
Query: 695 MTDAAAKLRKIKAKFL 710
+ +L I+ +F
Sbjct: 987 TSIVVKELISIRERFF 1002
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-126, Method: Compositional matrix adjust.
Identities = 280/737 (37%), Positives = 417/737 (56%), Gaps = 43/737 (5%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP ++ N + L D+ N SG IP +FG LR+L L + N+L SSS + F+
Sbjct: 280 GAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLE--FI 337
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
++ NC L L + N LGG LP I N S +L +++ + + G+IP +IGNL L
Sbjct: 338 GAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQE 397
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
LSL N L+G +P S G L LQ + N + G +P ++ RL L+L+ N G I
Sbjct: 398 LSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRI 457
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
PQ L L L++ +N+L+ ++P + + + I+LS+N L G P + KL +L+
Sbjct: 458 PQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVG 517
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
L S N+LS +P IG ++E L + GN F G IP+ + L+SL+++DFSNNNLSG+I
Sbjct: 518 LGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRI 576
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPR-LQVPPCKQDN 360
P+ L +L L+ N+S N+ EG +P G F++ +A S FGN +CG R +Q+ PC
Sbjct: 577 PRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQA 636
Query: 361 RKRTNK---VAPIVLQYILPSILSTVLLVIII----IMYVRCRNRSTKHLDHEDFLPPAT 413
R K V V+ I I S +L++I+ M + +N ++ +
Sbjct: 637 SPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMF 696
Query: 414 RRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDS 472
+ SY ++ AT F+ NL+G+G FG+V+KG L + VA+K+ NL A +SF +
Sbjct: 697 HEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMA 756
Query: 473 ECEILRNVRHRNLLKILGSCSNL-----DFKALVLEFMPNGSLEKWLY--------SHNY 519
ECE + +RHRNL+K++ CS+L DF+ALV EFMP GSL+ WL H+
Sbjct: 757 ECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSR 816
Query: 520 FLDILQRLNIMIDVGSALEYLH-HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578
L ++LNI IDV SALEYLH HCH P+ HCD+KP+NILLD+++ AHVSDFG+++LL
Sbjct: 817 SLTPAEKLNIAIDVASALEYLHVHCHD--PVAHCDIKPSNILLDDDLTAHVSDFGLAQLL 874
Query: 579 GE-GEDSVIQTMTMA----TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
+ +S + + A TIGY APEYG G S + DVYS+G+LL+E F+ KKPTDE
Sbjct: 875 YKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDES 934
Query: 634 FTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI 693
F G+ +L + K S+ T +N + E L ++ + + C + P R+
Sbjct: 935 FAGDYNLHSYTK-SILSGCTSSGGSNAIDE---------GLRLVLQVGIKCSEEYPRDRM 984
Query: 694 HMTDAAAKLRKIKAKFL 710
+A +L I++KF
Sbjct: 985 RTDEAVRELISIRSKFF 1001
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1120), Expect = e-121, Method: Compositional matrix adjust.
Identities = 290/740 (39%), Positives = 421/740 (56%), Gaps = 34/740 (4%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
GTIP +++N + L LD+ N +G IP +FG R ++L L +NN + + S+ FL
Sbjct: 288 GTIPETLSNISSLRQLDIPSNHLTGKIPLSFG--RLQNLLLLGLNNNSLGNYSSGDLDFL 345
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+LTNC L L + N LGG LP I N S L + + GSIP IGNL L
Sbjct: 346 GALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQT 405
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L LG N L G +P S+G L +L+ + N L G +P L ++ L L L N G+I
Sbjct: 406 LDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSI 465
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P L S + L L L +NKL+ S+P L L ++ +N+S N L G L +I KL L+
Sbjct: 466 PSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLA 525
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
LD+S N+LS IP T+ +LE L L GN F GPIP+ G L L LD S NNLSG I
Sbjct: 526 LDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTI 584
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGP-PRLQVPPCKQDN 360
P+ + S L+ N+S N +G +P +G F++ SA S FGN LCG P LQ+ PC +
Sbjct: 585 PEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVEL 644
Query: 361 RKRTNKVAPIVLQYI--LPSILSTVLLVIIIIMYVRCRNRSTKHLDHED---FLPPAT-R 414
+R + V I+ + + + L + L ++ + + + R +S + ++E+ F P +
Sbjct: 645 PRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFY 704
Query: 415 RRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSE 473
+ SY ++ + T F+ NL+G+G FG+V+KG L S VAIK+ NL A +SF +E
Sbjct: 705 EKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAE 764
Query: 474 CEILRNVRHRNLLKILGSCSNL-----DFKALVLEFMPNGSLEKWLY--------SHNYF 520
CE L +RHRNL+K++ CS+ DF+ALV EFMPNG+L+ WL+ + +
Sbjct: 765 CEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRT 824
Query: 521 LDILQRLNIMIDVGSALEYLH-HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579
L + RLNI IDV SAL YLH +CH+ PI HCD+KP+NILLD+++ AHVSDFG+++LL
Sbjct: 825 LGLFARLNIAIDVASALVYLHTYCHN--PIAHCDIKPSNILLDKDLTAHVSDFGLAQLLL 882
Query: 580 EGEDSVIQTM-----TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMF 634
+ + TIGY APEYG G S DVYS+G++L+E FT K+PT+++F
Sbjct: 883 KFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLF 942
Query: 635 TGEMSLRRWVKESLPHRLT-EVVDANLVREEQAFSDKM-DCLFSIMDLALDCCMDTPHKR 692
++L + K +L R ++ D ++R A M +CL + + + C ++P R
Sbjct: 943 VDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNR 1002
Query: 693 IHMTDAAAKLRKIKAKFLDD 712
I M +A +KL I+ F D
Sbjct: 1003 ISMAEAISKLVSIRESFFRD 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 397 bits (1020), Expect = e-109, Method: Compositional matrix adjust.
Identities = 267/760 (35%), Positives = 409/760 (53%), Gaps = 62/760 (8%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPN-TFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
GT+P+S++N+T L +DL N SG +P+ + L L L N+ + +++ + F
Sbjct: 205 GTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPF 264
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+SL N +L L LA N LGG + + + S +L I+ + ++ GSIP EI NL L
Sbjct: 265 FASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLT 324
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
+L+L N L+G IP + L +L+ Y+ N+L G +P +L + RL +L++S N LSG+
Sbjct: 325 LLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGS 384
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLW---SLEYI---------------------- 215
IP +L+ LR L L N LS ++P SL +LE +
Sbjct: 385 IPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNL 444
Query: 216 -LRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
L +NLSSN L G +P + K+++++ +DLS N+LS IP +G+ LE L+L+ N F
Sbjct: 445 KLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFS 504
Query: 275 GPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDF 334
+P S+G L L+ LD S N L+G IP S + S LK N S N L G + KGSF
Sbjct: 505 STLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKL 564
Query: 335 SAQSYFGNYALCGPPRLQVPPCKQDNRKRTNK--------VAPIVLQYILPSILSTVLLV 386
+ +S+ G+ LCG + + CK+ ++ + P++ + P + +
Sbjct: 565 TIESFLGDSLLCGSIK-GMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGK 623
Query: 387 IIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKG 446
+ + Y + + + D P R SY + AT FN +L+G+G FG VYKG
Sbjct: 624 NLTV-YAKEEVEDEEKQNQNDPKYP----RISYQQLIAATGGFNASSLIGSGRFGHVYKG 678
Query: 447 TLSDGTNVAIKIFNLQLERAFR-SFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505
L + T VA+K+ + + F SF EC+IL+ RHRNL++I+ +CS F ALVL M
Sbjct: 679 VLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLM 738
Query: 506 PNGSLEKWLYSHNYF---LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD 562
PNGSLE+ LY Y LD++Q +NI DV + YLHH +S ++HCDLKP+NILLD
Sbjct: 739 PNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH-YSPVKVVHCDLKPSNILLD 797
Query: 563 ENMVAHVSDFGISKLLGEGEDSV----------IQTMTMATIGYMAPEYGSEGIVSTKCD 612
+ M A V+DFGIS+L+ E++V + ++GY+APEYG ST D
Sbjct: 798 DEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGD 857
Query: 613 VYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR-EEQAFSDKM 671
VYS+GVLL+E + ++PTD + SL ++K P L +++ L R + Q +K
Sbjct: 858 VYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKC 917
Query: 672 DCLF-----SIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706
+ L+ +++L L C P R M D A ++ ++K
Sbjct: 918 EKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLK 957
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1005), Expect = e-107, Method: Compositional matrix adjust.
Identities = 275/786 (34%), Positives = 420/786 (53%), Gaps = 103/786 (13%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP+SI+N T L LDL N +G IP FG + +L+ +S+ N+ T E
Sbjct: 398 GPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHFTGE--------IP 448
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+ NC NL L++A N L G L PLIG L+ + L G IP+EIGNL+ L +
Sbjct: 449 DDIFNCSNLETLSVADNNLTGTLKPLIGKLQK-LRILQVSYNSLTGPIPREIGNLKDLNI 507
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L L N G IP + L LQG + N+L+G +P ++ ++ L++L+LS NK SG I
Sbjct: 508 LYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQI 567
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYI-------------------------- 215
P + L SL L LQ NK + S+P+SL SL +
Sbjct: 568 PALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQ 627
Query: 216 LRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETL--------- 266
L +N S+N L GT+P + KL ++ ++DLS N S IP ++ KN+ TL
Sbjct: 628 LYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSG 687
Query: 267 ----------------SLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSH 310
+L+ N F G IP+S GN+ L SLD S+NNL+G+IP+SL LS
Sbjct: 688 HIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLST 747
Query: 311 LKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPC--KQDNRKRTNKVA 368
LK ++ N L+G +P G FK+ +A GN LCG + + PC KQ + + +
Sbjct: 748 LKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTR 806
Query: 369 PIVLQYILPSILSTVLLVIIIIMYVRC-------RNRSTKHLDHEDFLPPATRRRTSYLD 421
I++ IL S + +L+++++++ C N S L D +R +
Sbjct: 807 VILI--ILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSL--PDLDSALKLKRFEPKE 862
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAF--RSFDSECEILRN 479
+ +ATD FN N++G+ +VYKG L DGT +A+K+ NL+ A + F +E + L
Sbjct: 863 LEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQ 922
Query: 480 VRHRNLLKILG-SCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILQRLNIMIDVGSAL 537
++HRNL+KILG + + KALVL FM NG+LE ++ S +L+++++ + + S +
Sbjct: 923 LKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGI 982
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA---TI 594
+YLH + PI+HCDLKP NILLD + VAHVSDFG +++LG ED T A TI
Sbjct: 983 DYLHSGY-GFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTI 1041
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPT--DEMFTGEMSLRRWVKESLPH-- 650
GY+APE+ V+TK DV+S+G+++ME T+++PT ++ + +M+LR+ V++S+ +
Sbjct: 1042 GYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGR 1101
Query: 651 -RLTEVVDANL------VREEQAFSDKMD-CLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702
+ V+D L +++E+A D + CLF C P R M + L
Sbjct: 1102 KGMVRVLDMELGDSIVSLKQEEAIEDFLKLCLF--------CTSSRPEDRPDMNEILTHL 1153
Query: 703 RKIKAK 708
K++ K
Sbjct: 1154 MKLRGK 1159
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 366 bits (939), Expect = e-100, Method: Compositional matrix adjust.
Identities = 246/747 (32%), Positives = 380/747 (50%), Gaps = 69/747 (9%)
Query: 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
+G +P S+ N +L LDL N SG IP++FG L+ L L L N+L Q +
Sbjct: 493 VGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSL--------QGNL 544
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
SL + RNL + L+ N L G + PL G S+S + IP E+GN + L
Sbjct: 545 PDSLISLRNLTRINLSHNRLNGTIHPLCG--SSSYLSFDVTNNGFEDEIPLELGNSQNLD 602
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L LG N L G IP ++G +++L + N L G +P L ++L ++L+ N LSG
Sbjct: 603 RLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGP 662
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
IP L L+ L L L SN+ SLP+ L++ +L ++L NSL G++P I L L
Sbjct: 663 IPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALN 722
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLES-LDFSNNNLSG 299
L+L +NQ S +P +G L L L L+ N G IP +G L L+S LD S NN +G
Sbjct: 723 VLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTG 782
Query: 300 KIPKSLEALSHLKQFNVSHNRLEGEIP----------------------VKGSFKDFSAQ 337
IP ++ LS L+ ++SHN+L GE+P +K F + A
Sbjct: 783 DIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPAD 842
Query: 338 SYFGNYALCGPPRLQVPPCKQDNRKRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRN 397
S+ GN LCG P + + +N+++ +V+ + ++ + L++++I ++ + R+
Sbjct: 843 SFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRH 902
Query: 398 RSTKHLDHED-----------------FLPPATRRRTSYLDIRRATDEFNECNLLGTGGF 440
K + H F A++ + DI AT +E ++G+GG
Sbjct: 903 DFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGS 962
Query: 441 GSVYKGTLSDGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLD--F 497
G VYK L +G VA+K + + + +SF E + L +RHR+L+K++G CS+
Sbjct: 963 GKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGL 1022
Query: 498 KALVLEFMPNGSLEKWLYS-------HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550
L+ E+M NGS+ WL+ LD RL I + + +EYLHH PI+
Sbjct: 1023 NLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHH-DCVPPIV 1081
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM--ATIGYMAPEYGSEGIVS 608
H D+K +N+LLD NM AH+ DFG++K+L E D+ + T + GY+APEY +
Sbjct: 1082 HRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKAT 1141
Query: 609 TKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP---HRLTEVVDANLVREEQ 665
K DVYS G++LME T K PTD +F EM + RWV+ L +++D L +
Sbjct: 1142 EKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKL-KPLL 1200
Query: 666 AFSDKMDCLFSIMDLALDCCMDTPHKR 692
F + C ++++AL C +P +R
Sbjct: 1201 PFEEDAAC--QVLEIALQCTKTSPQER 1225
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 362 bits (929), Expect = 6e-99, Method: Compositional matrix adjust.
Identities = 245/756 (32%), Positives = 378/756 (50%), Gaps = 65/756 (8%)
Query: 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
+G IP S+ N ++ +DL N SG IP++FG L L + + N+L Q +
Sbjct: 494 VGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSL--------QGNL 545
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
SL N +NL + +SN G + PL G S+S + E G IP E+G L
Sbjct: 546 PDSLINLKNLTRINFSSNKFNGSISPLCG--SSSYLSFDVTENGFEGDIPLELGKSTNLD 603
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L LG N G IP + G + +L + N+L G +P +L ++L ++L+ N LSG
Sbjct: 604 RLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGV 663
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
IP L L L L L SNK SLP+ ++SL IL + L NSL G++P I L L
Sbjct: 664 IPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALN 723
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLES-LDFSNNNLSG 299
L+L NQLS +PSTIG L L L L+ N G IP +G L L+S LD S NN +G
Sbjct: 724 ALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTG 783
Query: 300 KIPKSLEALSHLKQFNVSHNRLEGEIP----------------------VKGSFKDFSAQ 337
+IP ++ L L+ ++SHN+L GE+P +K F + A
Sbjct: 784 RIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQAD 843
Query: 338 SYFGNYALCGPPRLQVPPCKQDNRKRTNKVAP--IVLQYILPSILSTVLLVIIIIMYVRC 395
++ GN LCG P + C + K ++P +V+ + S+ + L+V++II++ +
Sbjct: 844 AFVGNAGLCGSP---LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQ 900
Query: 396 RNRSTKHLDHED--------------FLPPATRRRTSYLDIRRATDEFNECNLLGTGGFG 441
+ K + + F + + DI AT NE ++G+GG G
Sbjct: 901 NHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSG 960
Query: 442 SVYKGTLSDGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFK 498
VYK L +G +A+K + + + +SF+ E + L +RHR+L+K++G CS+
Sbjct: 961 KVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLN 1020
Query: 499 ALVLEFMPNGSLEKWLYSH-----NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
L+ E+M NGS+ WL+++ L RL I + + +EYLH+ PI+H D
Sbjct: 1021 LLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHY-DCVPPIVHRD 1079
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM--ATIGYMAPEYGSEGIVSTKC 611
+K +N+LLD N+ AH+ DFG++K+L D+ ++ TM + GY+APEY + K
Sbjct: 1080 IKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKS 1139
Query: 612 DVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE--QAFSD 669
DVYS G++LME T K PT+ MF E + RWV+ L L+ E
Sbjct: 1140 DVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPC 1199
Query: 670 KMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+ + + ++++AL C P +R A+ L +
Sbjct: 1200 EEEAAYQVLEIALQCTKSYPQERPSSRQASEYLLNV 1235
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (867), Expect = 8e-92, Method: Compositional matrix adjust.
Identities = 251/756 (33%), Positives = 368/756 (48%), Gaps = 77/756 (10%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G +P I NA L L L N +G IP G L LSVL+L N Q
Sbjct: 462 GYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMF--------QGKIP 513
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPK---------- 111
L +C +L L L SN L G +P I A LQ + L GSIP
Sbjct: 514 VELGDCTSLTTLDLGSNNLQGQIPDKITAL-AQLQCLVLSYNNLSGSIPSKPSAYFHQIE 572
Query: 112 --EIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNI 169
++ L+ + L +N L+G IP +G L + N+L G +P L L L I
Sbjct: 573 MPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTI 632
Query: 170 LNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTL 229
L+LSGN L+G+IP+ + + L+ L L +N+L+ +P S L ++++NL+ N L G +
Sbjct: 633 LDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPV 692
Query: 230 PSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLES 289
P+++ L L +DLS N LS ++ S + T++ L L + N+F G IP +GNL LE
Sbjct: 693 PASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEY 752
Query: 290 LDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPP 349
LD S N LSG+IP + L +L+ N++ N L GE+P G +D S GN LCG
Sbjct: 753 LDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCG-- 810
Query: 350 RLQVPPCKQDNRKRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHED-- 407
R+ CK + K + I +L ++V + + +R R TK + D
Sbjct: 811 RVVGSDCKIEGTKLRSAWG------IAGLMLGFTIIVFVFVFSLR-RWAMTKRVKQRDDP 863
Query: 408 -----------------FLPPATRR---------------RTSYLDIRRATDEFNECNLL 435
FL + R + DI ATD F++ N++
Sbjct: 864 ERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNII 923
Query: 436 GTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNL 495
G GGFG+VYK L VA+K + + R F +E E L V+H NL+ +LG CS
Sbjct: 924 GDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFS 983
Query: 496 DFKALVLEFMPNGSLEKWLYSHNYFLDIL---QRLNIMIDVGSALEYLHHCHSSAPIIHC 552
+ K LV E+M NGSL+ WL + L++L +RL I + L +LHH IIH
Sbjct: 984 EEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPH-IIHR 1042
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCD 612
D+K +NILLD + V+DFG+++L+ E S + T+ T GY+ PEYG +TK D
Sbjct: 1043 DIKASNILLDGDFEPKVADFGLARLISACE-SHVSTVIAGTFGYIPPEYGQSARATTKGD 1101
Query: 613 VYSYGVLLMETFTEKKPTDEMFTGEM--SLRRWVKESLPH-RLTEVVDANLVREEQAFSD 669
VYS+GV+L+E T K+PT F +L W + + + +V+D LV S
Sbjct: 1102 VYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQ 1161
Query: 670 KMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
++ +A+ C +TP KR +M D L++I
Sbjct: 1162 -----LRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (849), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 230/734 (31%), Positives = 371/734 (50%), Gaps = 51/734 (6%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G+IP +I+N + L+ L L N SG IP+ G L L++ N L + S
Sbjct: 360 GSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQL--------EGSIP 411
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFS-ASLQNIYAFECKLGGSIPKEIGNLRGLI 120
L +C +L L L+ N L G +P G F +L + L G IP+EIGN L+
Sbjct: 412 PGLADCTDLQALDLSRNSLTGTIPS--GLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLV 469
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L LGFN + G IP+ IG+L+++ N L G VP ++ L +++LS N L G+
Sbjct: 470 RLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGS 529
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
+P ++SL+ L+ L + +N+ S +P+SL L + ++ LS N G++P+++ + L
Sbjct: 530 LPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQ 589
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLE-TLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG 299
LDL N+LS +IPS +G ++NLE L+L+ N+ G IP + +L L LD S+N L G
Sbjct: 590 LLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEG 649
Query: 300 KIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQD 359
+ L + +L N+S+N G +P F+ S Q GN LC + C
Sbjct: 650 DL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQ---DSCFLT 705
Query: 360 NRK-----------RTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDF 408
RK RT K+ + I ++ VL+++ + +R R D E
Sbjct: 706 YRKGNGLGDDGDASRTRKLRLTLALLITLTV---VLMILGAVAVIRARRNIDNERDSE-L 761
Query: 409 LPPATRRRTSYLDIRRATDEFNEC----NLLGTGGFGSVYKGTLSDGTNVAIKIF----- 459
+ T + + + D+ C N++G G G VY+ + +G +A+K
Sbjct: 762 GETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMV 821
Query: 460 ----NLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLY 515
+ + + SF +E + L +RH+N+++ LG C N + + L+ ++MPNGSL L+
Sbjct: 822 NGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH 881
Query: 516 SH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574
LD R I++ L YLHH PI+H D+K NIL+ + +++DFG+
Sbjct: 882 ERRGSSLDWDLRYRILLGAAQGLAYLHH-DCLPPIVHRDIKANNILIGLDFEPYIADFGL 940
Query: 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMF 634
+KL+ EG+ + GY+APEYG ++ K DVYSYGV+++E T K+P D
Sbjct: 941 AKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTV 1000
Query: 635 TGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH 694
+ L WV+++ EV+D+ L +A +D+M ++ AL C +P +R
Sbjct: 1001 PEGIHLVDWVRQN--RGSLEVLDSTLRSRTEAEADEM---MQVLGTALLCVNSSPDERPT 1055
Query: 695 MTDAAAKLRKIKAK 708
M D AA L++IK +
Sbjct: 1056 MKDVAAMLKEIKQE 1069
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 251/797 (31%), Positives = 378/797 (47%), Gaps = 106/797 (13%)
Query: 2 GTIPNSITN-ATKLIGLDLGLNSFSGHI-PNTFGNLRH-LSVLSLMMNNLTTESSSADQW 58
G +P S+TN + L+ LDL N+FSG I PN N ++ L L L N T +
Sbjct: 379 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK------- 431
Query: 59 SFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRG 118
+L+NC L +L L+ N L G +P +G+ S L+++ + L G IP+E+ ++
Sbjct: 432 -IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKT 489
Query: 119 LIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS 178
L L L FNDL G IP+ + L + N L G +P + LE L IL LS N S
Sbjct: 490 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 549
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSL-------------------------- 212
G IP L SL L L +N + ++P++++
Sbjct: 550 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKEC 609
Query: 213 --------------EYILRI------NLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSD 252
E + R+ N++S G ++ LD+S N LS
Sbjct: 610 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 669
Query: 253 IPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLK 312
IP IG++ L L+L N G IP+ VG+L L LD S+N L G+IP+++ AL+ L
Sbjct: 670 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 729
Query: 313 QFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQD--------NRKRT 364
+ ++S+N L G IP G F+ F + N LCG P + P D + +R
Sbjct: 730 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHGRRP 789
Query: 365 NKVAPIVLQYILPSILSTVLLVII--------------IIMYVRCRNRSTKH-------- 402
+A V +L S + L+++ + MY S
Sbjct: 790 ASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWK 849
Query: 403 ---------LDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTN 453
++ F P R+ ++ D+ +AT+ F+ +L+G+GGFG VYK L DG+
Sbjct: 850 LTGVKEALSINLAAFEKPL--RKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSA 907
Query: 454 VAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKW 513
VAIK + R F +E E + ++HRNL+ +LG C D + LV EFM GSLE
Sbjct: 908 VAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDV 967
Query: 514 LY---SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570
L+ L+ R I I L +LHH + S IIH D+K +N+LLDEN+ A VS
Sbjct: 968 LHDPKKAGVKLNWSTRRKIAIGSARGLAFLHH-NCSPHIIHRDMKSSNVLLDENLEARVS 1026
Query: 571 DFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPT 630
DFG+++L+ + + + T GY+ PEY STK DVYSYGV+L+E T K+PT
Sbjct: 1027 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPT 1086
Query: 631 DEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPH 690
D G+ +L WVK+ R+++V D L++E+ A + L + +A+ C D
Sbjct: 1087 DSPDFGDNNLVGWVKQHAKLRISDVFDPELMKEDPALEIE---LLQHLKVAVACLDDRAW 1143
Query: 691 KRIHMTDAAAKLRKIKA 707
+R M A ++I+A
Sbjct: 1144 RRPTMVQVMAMFKEIQA 1160
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 717 | ||||||
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.986 | 0.666 | 0.591 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.988 | 0.651 | 0.572 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.986 | 0.693 | 0.563 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.979 | 0.645 | 0.575 | 0.0 | |
| 359497186 | 1140 | PREDICTED: LRR receptor-like serine/thre | 0.981 | 0.617 | 0.543 | 0.0 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.981 | 0.572 | 0.539 | 0.0 | |
| 359483688 | 1197 | PREDICTED: LRR receptor-like serine/thre | 0.981 | 0.588 | 0.546 | 0.0 | |
| 147852480 | 1229 | hypothetical protein VITISV_039533 [Viti | 0.981 | 0.572 | 0.536 | 0.0 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.980 | 0.483 | 0.538 | 0.0 | |
| 147776333 | 1205 | hypothetical protein VITISV_000078 [Viti | 0.981 | 0.584 | 0.540 | 0.0 |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/713 (59%), Positives = 533/713 (74%), Gaps = 6/713 (0%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP+SI NA+KLI LDL NSFSG IP+ GNLR+L L+L N LT++S ++ L
Sbjct: 346 GPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRSELSF-L 404
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
SSL+NCR+LA L NPL G LP IGN SASL+ +YAF+C++ G+IP+ IGNL LI
Sbjct: 405 SSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIGNIPRGIGNLSNLIG 464
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L L N+L G IP+ IG L+ LQ F + N LQG++P+++CHLERL+ L L N SG++
Sbjct: 465 LILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSL 524
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P CL+++TSLR LYL SN+ +S +P++ WSL+ +L+INLS NSL GTLP I L V+
Sbjct: 525 PACLSNITSLRELYLGSNRFTS-IPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTV 583
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
+D S NQLS DIP++I L+NL SL+ N+ QGPIP S G+L+SLE LD S N+LSG I
Sbjct: 584 IDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAI 643
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNR 361
PKSLE L HLK FNVS NRL+GEI G F +FS +S+ N ALCGP R+QVPPCK +
Sbjct: 644 PKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSIST 703
Query: 362 KRTNKVA-PIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYL 420
R +K V++YI+P+I +L++ + ++ R R+ K ED LPPAT R+ SY
Sbjct: 704 HRQSKRPREFVIRYIVPAIAFIILVLALAVIIFR-RSHKRKLSTQEDPLPPATWRKISYH 762
Query: 421 DIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV 480
++ RAT+ FNE NLLGTG GSVYKGTLSDG +A+K+F+LQLE FDSECE+LR +
Sbjct: 763 ELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRML 822
Query: 481 RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
RHRNL+KI+ SC NLDFKAL+LEF+P+GSLEKWLYSHNY+LDILQRLNIMIDV SALEYL
Sbjct: 823 RHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYL 882
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE 600
HH + P++HCDLKP+N+L++E+MVAHVSDFGIS+LLGEG D+V QT+T+ATIGYMAPE
Sbjct: 883 HHG-CTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEG-DAVTQTLTLATIGYMAPE 940
Query: 601 YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660
YG EGIVS K DVYSYG+ LMETFT KKPTD+MF GEMSL+ WVK+SLP +TEV+DANL
Sbjct: 941 YGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANL 1000
Query: 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713
+ EE+ F K DC+ SI++LAL+C D P +RI M D L KIK K+ DV
Sbjct: 1001 LIEEEHFVAKKDCITSILNLALECSADLPGERICMRDVLPALEKIKLKYKKDV 1053
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/714 (57%), Positives = 532/714 (74%), Gaps = 5/714 (0%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP+ I+NA+KL L+L NSF+G IP++ G+LR+L L L N L+++ +S + +
Sbjct: 375 GPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTS-QELTIF 433
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
SSL NC+NL L L+ NPL G LP +GN S SL++ A + + GS+ + IGNL L
Sbjct: 434 SSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTR 493
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L+LG NDL G IPT+IGTL+ LQG Y+ N+L G +P +LC L L L L+GNKLSG+I
Sbjct: 494 LNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSI 553
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P C ++LTSLR+L+L SN+ S++ S+LW+L+ IL++NL+SN L G+LPS I+ L +
Sbjct: 554 PTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYM 613
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
+++S+NQLS +IP +IG L++L L L+GN+ QGPIP+SVG++ SLE LD S+NNLSG I
Sbjct: 614 INISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMI 673
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNR 361
PKSL+ L +LK FNVS N L+GEIP GSF +FSAQS+ GN ALCG RLQV PCK DN
Sbjct: 674 PKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNS 733
Query: 362 KRTNKV-APIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYL 420
+ T + IVL+Y+LP+I+ V ++ +IM R R K +DFL T RR SY
Sbjct: 734 RATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYH 793
Query: 421 DIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV 480
+++ AT+ F E N LG G FGSVYKGTLSDGT +A K+FNLQLERAF+SFD+ECE+LRN+
Sbjct: 794 ELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNL 853
Query: 481 RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
RHRNL+KI+ SCS +FKALVLEFMPN SLEKWLYS +YFL+ LQRLNIM+DV S LEYL
Sbjct: 854 RHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYL 913
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE 600
HH + + P+ HCD+KP+N+LL+E+MVA ++DFGISKLLGE E SV+QTMT+ATIGYMAPE
Sbjct: 914 HHGY-TIPMAHCDIKPSNVLLNEDMVAFLADFGISKLLGE-EGSVMQTMTLATIGYMAPE 971
Query: 601 YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660
YGSEGIVS + DVYSYGVLLMETFT+KKPTD+MFT ++SL+ WV++SL +T+V+DANL
Sbjct: 972 YGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANL 1031
Query: 661 VR-EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713
+ EE + K DC+ SI+ LAL C D PH RI M L+KIK KFL D+
Sbjct: 1032 LGIEEDHLAAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDI 1085
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2019), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/712 (56%), Positives = 520/712 (73%), Gaps = 5/712 (0%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G++P + N ++L LDL N +G++ FGNLR L VLSL N+ T SS +F+
Sbjct: 306 GSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSS-QTLNFI 364
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+SLTN R L L + NPL G+LP +GN S+ L Y + KL G+IP EIGNL LIV
Sbjct: 365 TSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIV 424
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
LSL N L G IPT++G L+++Q Y+ +NNL G +P D+C RL + L+ N LSG I
Sbjct: 425 LSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEI 484
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P C+ +LTSLR+LYL N LSS++P +LWSL+ +L +NL SN L G+LPS + ++ I
Sbjct: 485 PSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIG 544
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
+ LS NQLS +IPSTIG+L+NL SL+ N FQG IPE+ G L+SLE LD S NNLSG+I
Sbjct: 545 IRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEI 604
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNR 361
PKSLEAL +L+ F+VS N L+GEIP G F +F+A+S+ N LCGP RLQVPPC ++R
Sbjct: 605 PKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESR 664
Query: 362 KRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLD 421
K + K +L++ LP++ S +L+V I + + CR R K E A +RR SYL+
Sbjct: 665 KDS-KTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLE 723
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
+ AT+EF+E NLLG G FGSVY+G L DG NVA+KIFNLQL+RAFRSFD+ECEI+RN+R
Sbjct: 724 LLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIR 783
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
HRNL+KI+ SCSNLDFKALVLE+MP GSLEKWLYSHNY LDI+QR+NIMIDV SALEYLH
Sbjct: 784 HRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLH 843
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
H + S P++HCDLKP+N+LLDE+MVAHV DFGI+KLLGE E S QT T+ATIGYMAPEY
Sbjct: 844 HGYPS-PVVHCDLKPSNVLLDEDMVAHVCDFGIAKLLGENE-SFAQTRTLATIGYMAPEY 901
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
G +G+VSTK DVYS+G++LME T K+PTDEMF GEMSL+R VKESLP + ++VD+N++
Sbjct: 902 GLDGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNML 961
Query: 662 REEQAFSDKMD-CLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712
+S K + C+ SIM+LAL C ++P +R+ M + A+L+ IKA+FL D
Sbjct: 962 NRGDGYSVKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRD 1013
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1997), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/709 (57%), Positives = 521/709 (73%), Gaps = 7/709 (0%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP+SI NA+KL LD G N +G IP+ G+LR L L+L +NNL ES + SFL
Sbjct: 379 GIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESY-IQELSFL 437
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+SLTNC+ L L L+ NPL GILP IGN S SLQ A CKL G+IP EIGNL L +
Sbjct: 438 TSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYL 497
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
LSL NDL GTIP SIG LQ+LQG Y+P N LQG +P+D+C L L L L+ N+LSG+I
Sbjct: 498 LSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSI 557
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P CL LT LR LYL SNKL+S++PS+LWSL +IL +++SSN L G LPS++ L VL+
Sbjct: 558 PACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVK 617
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
+DLSRNQLS +IPS IG L++L +LSLA N+F+GPI S NL SLE +D S+N L G+I
Sbjct: 618 IDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEI 677
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNR 361
PKSLE L +LK +VS N L GEIP +G F +FSA+S+ N ALCG PRL++PPC+ R
Sbjct: 678 PKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTR 737
Query: 362 KRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLD 421
T ++ ++L+YILP+ILST+L + +I ++ RCR R+ + L AT RR SY +
Sbjct: 738 WSTT-ISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQE 796
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
I +AT+ F+ NLLG G GSVY+GTLSDG N AIK+FNLQ E AF+SFD+ECE++ ++R
Sbjct: 797 IFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIR 856
Query: 482 HRNLLKILGSCSN--LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
HRNL+KI+ SCSN +DFKALVLE++PNGSLE+WLYSHNY LDILQRLNIMIDV A+EY
Sbjct: 857 HRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEY 916
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
LHH S P++HCDLKP+NILLDE+ HV DFGI+KLL E E+S+ +T T+ATIGYMAP
Sbjct: 917 LHH-GCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLRE-EESIRETQTLATIGYMAP 974
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659
+Y S GIV+T DVYSYG++LMETFT ++PTDE+F+ EMS++ WV + L +TEVVDAN
Sbjct: 975 KYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDAN 1034
Query: 660 LVR-EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707
L+R E++ F K C+ I+ LA+DC D+P +RI M D L+KIK
Sbjct: 1035 LLRGEDEQFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIKT 1083
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1937), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/710 (54%), Positives = 507/710 (71%), Gaps = 6/710 (0%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP SI+N +KL L L NSF+G++P GNL L VL L N LT E A + FL
Sbjct: 435 GIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHV-ASEVGFL 493
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+SLTNC+ L NL + + P G LP +GN +L++ A C+ G+IP IGNL LI
Sbjct: 494 TSLTNCKFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGNLTNLIR 553
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L LG NDL G+IPT++G LQ+LQ Y+ N ++G +P+DLCHL+ L L LS NKLSG+I
Sbjct: 554 LDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSSNKLSGSI 613
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P C L +L+ L+L SN L+ ++P+SLWSL +L +NLSSN L G LP + + +
Sbjct: 614 PSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVGNMKSITT 673
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
LDLS+N +S IPS +G L++L TLSL+ N+ QGPIP G+L+SLESLD S NNLSG I
Sbjct: 674 LDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQNNLSGTI 733
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNR 361
PKSLEAL +LK NVS N+L+GEIP G F +F+A+S+ N ALCG P QV C ++NR
Sbjct: 734 PKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNR 793
Query: 362 KRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLD 421
++ K +L+YIL + S V LV+ I++++R R+ + +L P T + S+
Sbjct: 794 TQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWL-PGTHEKISHQQ 852
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
+ AT++F E NL+G G G VYKG LS+G VAIK+FNL+ + A RSFDSECE+++ +R
Sbjct: 853 LLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIR 912
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
HRNL++I+ CSNLDFKALVLE+MPNGSLEKWLYSHNYFLD++QRLNIMIDV SALEYLH
Sbjct: 913 HRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLH 972
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
H SS ++HCDLKP N+LLD++MVAHV+DFGI+KLL + E S+ QT T+ TIGYMAPE+
Sbjct: 973 HDCSSL-VVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTE-SMQQTKTLGTIGYMAPEH 1030
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
GS+GIVSTK DVYSYG+LLME F+ KKP DEMFTG ++L+ WV ESL + + +VVDANL+
Sbjct: 1031 GSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWV-ESLSNSVIQVVDANLL 1089
Query: 662 -REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710
RE++ + K+ CL SIM LAL C ++P KR++M DA +L+K K K L
Sbjct: 1090 RREDEDLATKLSCLSSIMALALACTTNSPEKRLNMKDAVVELKKSKMKLL 1139
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 749 bits (1934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/710 (53%), Positives = 507/710 (71%), Gaps = 6/710 (0%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP SI+N +KL L L NSF+G++P GNL L VL L N LT E A + FL
Sbjct: 524 GIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHV-ASEVGFL 582
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+SLTNC+ L NL + +NP G LP +GN +L++ A C+ G+IP IGNL LI
Sbjct: 583 TSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTRIGNLTNLIW 642
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L LG NDL G+IPT++G L++LQ ++ N L+G +P+DLCHL+ L L+LS NKLSG+I
Sbjct: 643 LDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSI 702
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P C L +L+ L+L SN L+ ++P+SLWSL +L +NLSSN L G LP + + +
Sbjct: 703 PSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITT 762
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
LDLS+N +S IP +G +NL LSL+ N+ QGPIP G+L+SLESLD S NNLSG I
Sbjct: 763 LDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTI 822
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNR 361
PKSLEAL +LK NVS N+L+GEIP G F +F+A+S+ N ALCG P QV C ++NR
Sbjct: 823 PKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNR 882
Query: 362 KRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLD 421
++ K +L+YIL + S V LV+ I++++R R+ + +L P T + S+
Sbjct: 883 TQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWL-PGTHEKISHQQ 941
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
+ AT++F E NL+G G G VYKG LS+G VAIK+FNL+ + A RSFDSECE+++ +R
Sbjct: 942 LLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIR 1001
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
HRNL++I+ CSNLDFKALVLE+MPNGSLEKWLYSHNYFLD++QRLNIMIDV SALEYLH
Sbjct: 1002 HRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLH 1061
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
H SS ++HCDLKP N+LLD++MVAHV+DFGI+KLL + E S+ QT T+ TIGYMAPE+
Sbjct: 1062 HDCSSL-VVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTE-SMQQTKTLGTIGYMAPEH 1119
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
GS+GIVSTK DVYSYG+LLME F+ KKP DEMFTG+++L+ WV ESL + + +VVDANL+
Sbjct: 1120 GSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDANLL 1178
Query: 662 -REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710
RE++ + K+ CL SIM LAL C D+P +R++M DA +L+K + K L
Sbjct: 1179 RREDEDLATKLSCLSSIMALALACTTDSPEERLNMKDAVVELKKSRMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483688|ref|XP_003633002.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FLS2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/710 (54%), Positives = 504/710 (70%), Gaps = 6/710 (0%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP SI+N +KLI L + NSF+G++P GNL L VL+L N LT E A SFL
Sbjct: 492 GIIPMSISNMSKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLANNQLTDEHL-ASGVSFL 550
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+SLTNC+ L L + NPL G LP +GN +L++ A+ C+ G+IP IGNL LI+
Sbjct: 551 TSLTNCKFLRTLWIGYNPLKGTLPNSLGNLPIALESFNAYACQFRGTIPTGIGNLTNLIM 610
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L LG NDL G+IPT++G LQ+LQ + N ++G +P+DLCHL+ L L LS NKLSG+
Sbjct: 611 LHLGANDLTGSIPTTLGQLQKLQALSIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGST 670
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P C L +LR L+L SN L+ ++P+SLWSL +L +NLSSN L G LP + + +I
Sbjct: 671 PSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKYIIT 730
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
LDLS+N +S IPS +G L+NL TLSL+ N+ QGPIP G+L+SLESLD S NNLS I
Sbjct: 731 LDLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVECGDLVSLESLDLSQNNLSRII 790
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNR 361
PKSLEAL +LK NVS N+L+GEIP G F +F+A+S+ N ALCG P QV C ++NR
Sbjct: 791 PKSLEALIYLKYLNVSFNKLQGEIPNGGPFVNFNAESFMFNEALCGAPHFQVMACDKNNR 850
Query: 362 KRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLD 421
++ K +L+YIL + STV LV+ I++++R R+ +L P T + S+
Sbjct: 851 TQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIASWL-PGTHEKISHQQ 909
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
+ AT++F E NL+G G G VYKG LS+G VAIK+FNL+ +RA RSFDSECE+++ +R
Sbjct: 910 LLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQRALRSFDSECEVMQGIR 969
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
HRNL++I+ CSNLDFKALVLE+MPNGSLEKWLYSHNYFLD++QRLNIMI V SALEYLH
Sbjct: 970 HRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIYVASALEYLH 1029
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
H SS ++HCDLKP+N+LLD+NMVAHV+DFGI+KLL E E S+ QT T+ TIGYMAPE+
Sbjct: 1030 HDCSSL-VVHCDLKPSNVLLDDNMVAHVADFGIAKLLTETE-SMQQTKTLGTIGYMAPEH 1087
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
GS GIVSTK DVYSY +LLME F KKP DEMFTG+++L+ WV ESL + + +VVD NL+
Sbjct: 1088 GSAGIVSTKSDVYSYEILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLL 1146
Query: 662 -REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710
RE++ K+ CL SIM LAL C D+P +RI M D +L+K + K L
Sbjct: 1147 RREDEDLGTKLSCLSSIMALALACTTDSPKERIDMKDVVVELKKSRIKLL 1196
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852480|emb|CAN78527.1| hypothetical protein VITISV_039533 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/710 (53%), Positives = 506/710 (71%), Gaps = 6/710 (0%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP SI+N +KL LD+ NSF G++P GNL L VL+L N T E A + SFL
Sbjct: 524 GIIPVSISNMSKLTQLDVSRNSFIGNVPKDLGNLTKLEVLNLAGNQFTNEHL-ASEVSFL 582
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+SLTNC+ L NL + +NP G LP +GN +L++ A C+ G+IP IGNL LI
Sbjct: 583 TSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGNLTNLIW 642
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L LG NDL G+IPT +G L++LQ ++ N L+G +P+DLCHL+ L L+LS NKLSG+I
Sbjct: 643 LDLGANDLTGSIPTILGRLKKLQRLHIAGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSI 702
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P C L +L+ L+L SN L+ ++P+SLWSL +L +NLSSN L G LP + + +
Sbjct: 703 PSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITT 762
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
LDLS+N +S IP +G +NL LSL+ N+ QGPIP G+L+SLESLD S NNLSG I
Sbjct: 763 LDLSKNLVSGYIPRRMGEQQNLAKLSLSQNRLQGPIPVEFGDLVSLESLDLSQNNLSGTI 822
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNR 361
PKSLEAL +LK NVS N+L+GEIP G F +F+A+S+ N ALCG P QV C ++NR
Sbjct: 823 PKSLEALIYLKYLNVSSNKLQGEIPNGGPFVNFTAESFMFNEALCGAPHFQVMACDKNNR 882
Query: 362 KRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLD 421
++ K +L+YIL + ST+ LV+ I++++R R+ + +L P T + S+
Sbjct: 883 TQSWKTKSFILKYILLPVGSTITLVVFIVLWIRRRDNMEIPTPIDSWL-PGTHEKISHQR 941
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
+ AT++F E NL+G G G VYKG LS+G VAIK+FNL+ + A RSFDSECE+++ +R
Sbjct: 942 LLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIR 1001
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
HRNL++I+ CSNLDFKALVL++MPNGSLEKWLYSHNYFLD++QRLNIMIDV SALEYLH
Sbjct: 1002 HRNLVRIITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLH 1061
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
H SS ++HCDLKP+N+LLD++MVAHV+DFGI+KLL + E S+ QT T+ TIGYMAPE+
Sbjct: 1062 HDCSSL-VVHCDLKPSNVLLDDDMVAHVADFGITKLLTKTE-SMQQTKTLGTIGYMAPEH 1119
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
GS+GIVSTK DVYSYG+LLME F KKP DEMFTG+++L+ WV ESL + + +VVD NL+
Sbjct: 1120 GSDGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLL 1178
Query: 662 -REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710
RE++ + K+ CL SIM LAL C D+P +R+ M DA +L+K + K L
Sbjct: 1179 RREDEDLATKLSCLSSIMALALACTNDSPEERLDMKDAVVELKKSRMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 742 bits (1915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/711 (53%), Positives = 501/711 (70%), Gaps = 8/711 (1%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP SI+N ++L LD+ N F+G +P GNLR L L+L N LT E S A + FL
Sbjct: 749 GIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTDEHS-ASEVGFL 807
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+SLTNC L L + NPL GILP +GN S SL++ A C+ G+IP IGNL LI
Sbjct: 808 TSLTNCNFLRTLWIEDNPLKGILPNSLGNLSISLESFDASACQFRGTIPTGIGNLTSLIS 867
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L LG NDL G IPT++G L++LQ + N L+G +P+DLC L+ L L LS N+L+G+I
Sbjct: 868 LELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYLFLSSNQLTGSI 927
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P CL L LR LYL SN L+S++P SLW+L +L +NLSSN L G LP + + +
Sbjct: 928 PSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLPPEVGNIKSIRT 987
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
LDLS+NQ+S IP T+G L+NLE LSL+ N+ QGPIP G+L+SL+ LD S NNLSG I
Sbjct: 988 LDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVI 1047
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNR 361
PKSL+AL++LK NVS N+L+GEIP G F +F+A+S+ N ALCG P QV C + R
Sbjct: 1048 PKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACDKSTR 1107
Query: 362 KRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLD 421
R+ + +L+YILP ++S + LV+ +++++R R + +L P + + S+
Sbjct: 1108 SRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRKNLEVPTPIDSWL-PGSHEKISHQQ 1166
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
+ AT+ F E NL+G G VYKG LS+G VA+K+FNL+ + AFRSFDSECE+++++R
Sbjct: 1167 LLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIR 1226
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
HRNL+KI+ CSNLDFKALVLE+MP GSL+KWLYSHNYFLD++QRLNIMIDV SALEYLH
Sbjct: 1227 HRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLH 1286
Query: 542 H-CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE 600
H C S ++HCDLKP NILLD++MVAHV DFGI++LL E E S+ QT T+ TIGYMAPE
Sbjct: 1287 HDCPSL--VVHCDLKPNNILLDDDMVAHVGDFGIARLLTETE-SMQQTKTLGTIGYMAPE 1343
Query: 601 YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660
YGS+GIVSTK DV+SYG++LME F KKP DEMF G+++L+ WV ESL + EVVDANL
Sbjct: 1344 YGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWV-ESLADSMIEVVDANL 1402
Query: 661 V-REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710
+ RE++ F+ K+ CL SIM LAL C D+P +RI M D L+KIK + L
Sbjct: 1403 LRREDEDFATKLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/710 (54%), Positives = 503/710 (70%), Gaps = 6/710 (0%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
GTIP SI+N +KL L L NSF+G++P NL L L+L N LT E A FL
Sbjct: 500 GTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLKFLNLAHNQLTDEHL-ASGVGFL 558
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+SLTNC+ L L + NPL G LP +GN +L++ A+ C+ G+IP IGNL LI
Sbjct: 559 TSLTNCKFLRYLWIGYNPLKGTLPNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIW 618
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L LG NDL G+IPT++G LQ+LQ ++ N ++G +P+DLCHL+ L L LS NKLSG+
Sbjct: 619 LDLGANDLTGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGST 678
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P C L +LR L+L SN L+ ++P+SLWSL +L +NLSSN L G LP + + +
Sbjct: 679 PSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITT 738
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
LDLS+N +S IPS +G L+ L TLSL+ N+ QGPI G+L+SLESLD S+NNLSG I
Sbjct: 739 LDLSKNLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTI 798
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNR 361
PKSLEAL +LK NVS N+L+GEIP G F F+A+S+ N ALCG P QV C ++NR
Sbjct: 799 PKSLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNR 858
Query: 362 KRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLD 421
++ K +L+YIL + STV LV+ I++++R R+ + +L T + S+
Sbjct: 859 TQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWL-LGTHEKISHQQ 917
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
+ AT++F E NL+G G G VYKG LS+G NVAIK+FNL+ + A RSFDSECE+++ +R
Sbjct: 918 LLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIR 977
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
HRNL++I+ CSNLDFKALVLE+MPNGSLEKWLYSHNYFLD++QRLNIMIDV SALEYLH
Sbjct: 978 HRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLH 1037
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
H S+ ++HCDLKP+N+LLD++MVAHV+DFGI+KLL E E S+ QT T+ TIGYMAPE+
Sbjct: 1038 H-DCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLTETE-SMQQTKTLGTIGYMAPEH 1095
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
GS GIVSTK DVYSYG+LLME F KKP DEMFTG+++L+ WV ESL + + +VVD NL+
Sbjct: 1096 GSAGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLL 1154
Query: 662 -REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710
RE++ + K+ CL SIM LAL C D+P +RI M DA +L+K + K L
Sbjct: 1155 RREDEDLATKLSCLSSIMALALACTTDSPKERIDMKDAVVELKKSRIKLL 1204
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 717 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.711 | 0.504 | 0.359 | 3.8e-127 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.712 | 0.498 | 0.373 | 1.9e-121 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.723 | 0.503 | 0.353 | 3.2e-119 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.907 | 0.635 | 0.404 | 1.6e-118 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.711 | 0.504 | 0.332 | 7.3e-118 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.958 | 0.585 | 0.326 | 3.1e-90 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.916 | 0.670 | 0.345 | 4.1e-88 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.796 | 0.565 | 0.346 | 6.9e-86 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.847 | 0.612 | 0.317 | 8.3e-81 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.405 | 0.259 | 0.369 | 1.4e-80 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 794 (284.6 bits), Expect = 3.8e-127, Sum P(2) = 3.8e-127
Identities = 189/526 (35%), Positives = 290/526 (55%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G+IP +++N + L L + N+ +G IP TFGN+ +L +L L N+L ++SS FL
Sbjct: 273 GSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSR--DLEFL 329
Query: 62 SSLTNCRXXXXXXXXXXPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+SLTNC LGG LP I N SA L + + GSIP +IGNL L
Sbjct: 330 TSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQK 389
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L L N L+G +PTS+G L L+ + N L G +P + ++ L L+LS N G +
Sbjct: 390 LILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIV 449
Query: 182 PQCLASLTSLRSLYXXXXXXXXXXXXXXXXXEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P L + + L L+ + +LR+++S NSL G+LP +I L L
Sbjct: 450 PTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGT 509
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
L L N+LS +P T+G +E+L L GN F G IP+ G L+ ++ +D SNN+LSG I
Sbjct: 510 LSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSI 568
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPR-LQVPPCKQDN 360
P+ + S L+ N+S N LEG++PVKG F++ + S GN LCG Q+ PC
Sbjct: 569 PEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQA 628
Query: 361 ----RKRTNKVAPIVLQYXXXXXXXXXXXXXXXXM-YVRCRNRSTKHLDHEDFLPPATRR 415
+K ++++ +V+ + ++R R ++ + +
Sbjct: 629 PSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHE 688
Query: 416 RTSYLDIRRATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSEC 474
+ SY D+R AT+ F+ N++G+G FG+VYK L ++ VA+K+ N+Q A +SF +EC
Sbjct: 689 KISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAEC 748
Query: 475 EILRNVRHRNLLKILGSCSNLDF-----KALVLEFMPNGSLEKWLY 515
E L+++RHRNL+K+L +CS++DF +AL+ EFMPNGSL+ WL+
Sbjct: 749 ESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 782 (280.3 bits), Expect = 1.9e-121, Sum P(2) = 1.9e-121
Identities = 197/527 (37%), Positives = 275/527 (52%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
GTIP +++N + L LD+ N +G IP +FG L++L +L L N+L SS FL
Sbjct: 288 GTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSG--DLDFL 345
Query: 62 SSLTNCRXXXXXXXXXXPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+LTNC LGG LP I N S L + + GSIP IGNL L
Sbjct: 346 GALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQT 405
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L LG N L G +P S+G L +L+ + N L G +P L ++ L L L N G+I
Sbjct: 406 LDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSI 465
Query: 182 PQCLASLTSLRSLYXXXXXXXXXXXXXXXXXEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P L S + L L ++ +N+S N L G L +I KL L+
Sbjct: 466 PSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLA 525
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
LD+S N+LS IP T+ +LE L L GN F GPIP+ G L L LD S NNLSG I
Sbjct: 526 LDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTI 584
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGP-PRLQVPPCKQDN 360
P+ + S L+ N+S N +G +P +G F++ SA S FGN LCG P LQ+ PC +
Sbjct: 585 PEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVEL 644
Query: 361 RKRTNKVAPIVLQYXXXXXXXXXXXXX--XXXMYVRCRNRSTKHLDHED---FLPPAT-R 414
+R + V I+ + + R +S + ++E+ F P +
Sbjct: 645 PRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFY 704
Query: 415 RRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSE 473
+ SY ++ + T F+ NL+G+G FG+V+KG L S VAIK+ NL A +SF +E
Sbjct: 705 EKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAE 764
Query: 474 CEILRNVRHRNLLKILGSCSNLDF-----KALVLEFMPNGSLEKWLY 515
CE L +RHRNL+K++ CS+ DF +ALV EFMPNG+L+ WL+
Sbjct: 765 CEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 3.2e-119, Sum P(2) = 3.2e-119
Identities = 191/541 (35%), Positives = 282/541 (52%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP ++ N + L D+ N SG IP +FG LR+L L + N+L SSS + F+
Sbjct: 280 GAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLE--FI 337
Query: 62 SSLTNCRXXXXXXXXXXPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
++ NC LGG LP I N S +L +++ + + G+IP +IGNL L
Sbjct: 338 GAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQE 397
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
LSL N L+G +P S G L LQ + N + G +P ++ RL L+L+ N G I
Sbjct: 398 LSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRI 457
Query: 182 PQCLASLTSLRSLYXXXXXXXXXXXXXXXXXEYILRINLSSNSLKGTLPSNIQKLNVLID 241
PQ L L L+ + I+LS+N L G P + KL +L+
Sbjct: 458 PQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVG 517
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
L S N+LS +P IG ++E L + GN F G IP+ + L+SL+++DFSNNNLSG+I
Sbjct: 518 LGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRI 576
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPR-LQVPPC--KQ 358
P+ L +L L+ N+S N+ EG +P G F++ +A S FGN +CG R +Q+ PC +
Sbjct: 577 PRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQA 636
Query: 359 DNRKRT-----NKVAPIVLQYXXXXXXXXXXXXXXXXMYVRCRNRSTKHLDHEDFLPPAT 413
RKR KV + M + +N ++ +
Sbjct: 637 SPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMF 696
Query: 414 RRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDS 472
+ SY ++ AT F+ NL+G+G FG+V+KG L + VA+K+ NL A +SF +
Sbjct: 697 HEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMA 756
Query: 473 ECEILRNVRHRNLLKILGSCSNLD-----FKALVLEFMPNGSLEKWLYSHNYFLDILQRL 527
ECE + +RHRNL+K++ CS+LD F+ALV EFMP GSL+ WL L+ L+R+
Sbjct: 757 ECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ-----LEDLERV 811
Query: 528 N 528
N
Sbjct: 812 N 812
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1167 (415.9 bits), Expect = 1.6e-118, P = 1.6e-118
Identities = 277/685 (40%), Positives = 388/685 (56%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP S+ NA+ L + + N FSG I + FG LR+L+ L L N T D W F+
Sbjct: 287 GKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQ--DDWGFI 344
Query: 62 SSLTNCRXXXXXXXXXXPLGGILPPLIGNFSASLQNIYAFEC-KLGGSIPKEIGNLRGLI 120
S LTNC LGG+LP N S SL + A E K+ GSIPK+IGNL GL
Sbjct: 345 SDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSL-SFLALELNKITGSIPKDIGNLIGLQ 403
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L L N+ G++P+S+G L+ L ENNL G +P + +L LNIL L NK SG
Sbjct: 404 HLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGW 463
Query: 181 IPQCLASLTSLRSLYXXXXXXXXXXXXXXXXXEYI-LRINLSSNSLKGTLPSNIQKLNVL 239
IP L++LT+L SL + + + IN+S N+L+G++P I L L
Sbjct: 464 IPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNL 523
Query: 240 IDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG 299
++ N+LS IP+T+G + L L L N G IP ++G L LE+LD S+NNLSG
Sbjct: 524 VEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSG 583
Query: 300 KIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGP-PRLQVPPCKQ 358
+IP SL ++ L N+S N GE+P G+F S S GN LCG P L +P C
Sbjct: 584 QIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCP 643
Query: 359 --DNRKRTNKVAPIVLQYXXXXXXXXXXXXXXXXMYVRCRNRSTKHLDHEDFLPPATRRR 416
+NRK V PI + + + R+ K +
Sbjct: 644 LLENRKHF-PVLPISVSLAAALAILSSLY-----LLITWHKRTKKGAPSRTSMKG--HPL 695
Query: 417 TSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEI 476
SY + +ATD F NLLG+G FGSVYKG L+ +VA+K+ L+ +A +SF +ECE
Sbjct: 696 VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEA 755
Query: 477 LRNVRHRNLLKILGSCSNLD-----FKALVLEFMPNGSLEKWLY------SHNYFLDILQ 525
LRN+RHRNL+KI+ CS++D FKA+V +FMPNGSLE W++ + L++ +
Sbjct: 756 LRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHR 815
Query: 526 RLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585
R+ I++DV AL+YLH H P++HCD+K +N+LLD +MVAHV DFG++++L +G S+
Sbjct: 816 RVTILLDVACALDYLHR-HGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGT-SL 873
Query: 586 IQTMT-----MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL 640
IQ T + TIGY APEYG I ST D+YSYG+L++E T K+PTD F ++ L
Sbjct: 874 IQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGL 933
Query: 641 RRWVKESLPHRLTEVVDANLVREEQ 665
R++V+ L R+T+VVD L+ + +
Sbjct: 934 RQYVELGLHGRVTDVVDTKLILDSE 958
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 718 (257.8 bits), Expect = 7.3e-118, Sum P(2) = 7.3e-118
Identities = 176/529 (33%), Positives = 266/529 (50%)
Query: 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
+G IP +++N + L + N +G I FG + L L L N L S + F
Sbjct: 272 VGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLG--SYTFGDLEF 329
Query: 61 LSSLTNCRXXXXXXXXXXPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ SLTNC LGG LP I N S L ++ GSIP++IGNL GL
Sbjct: 330 IDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQ 389
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L LG N L G +PTS+G L +L + N + G +P + +L +L IL LS N G
Sbjct: 390 RLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGI 449
Query: 181 IPQCLASLTSLRSLYXXXXXXXXXXXXXXXXXEYILRINLSSNSLKGTLPSNIQKLNVLI 240
+P L + + L ++ +++ NSL G+LP++I L L+
Sbjct: 450 VPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLV 509
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK 300
L L N+ S +P T+G +E L L GN F G IP ++ L+ + +D SNN+LSG
Sbjct: 510 KLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVRRVDLSNNDLSGS 568
Query: 301 IPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCG--------PPRLQ 352
IP+ S L+ N+S N G++P KG+F++ + FGN LCG P Q
Sbjct: 569 IPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQ 628
Query: 353 VPPCKQDNRKRTNKVAPIVLQYXXXXXXXXXXXXXXXXMYVRCRNRSTKHLDHEDFLPPA 412
PP + + KVA +V R +N+ T +L
Sbjct: 629 EPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKL--EI 686
Query: 413 TRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFD 471
+ SY D+R AT+ F+ N++G+G FG+V+K L ++ VA+K+ N+Q A +SF
Sbjct: 687 FHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFM 746
Query: 472 SECEILRNVRHRNLLKILGSCSNLDF-----KALVLEFMPNGSLEKWLY 515
+ECE L++ RHRNL+K+L +C++ DF +AL+ E++PNGS++ WL+
Sbjct: 747 AECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLH 795
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 900 (321.9 bits), Expect = 3.1e-90, P = 3.1e-90
Identities = 240/735 (32%), Positives = 383/735 (52%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP+ I N + L L + N+ +G + G L+ L +L + N+LT
Sbjct: 445 GEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPR------- 497
Query: 62 SSLTNCRXXXXXXXXXXPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+ N + G +P + N + LQ + + L G IP+E+ +++ L V
Sbjct: 498 -EIGNLKDLNILYLHSNGFTGRIPREMSNLTL-LQGLRMYSNDLEGPIPEEMFDMKLLSV 555
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L L N +G IP L+ L + N G +P L L LN ++S N L+G I
Sbjct: 556 LDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTI 615
Query: 182 P-QCLASLTSLRSLYXXXXXXXXXXXX--XXXXXEYILRINLSSNSLKGTLPSNIQKLNV 238
P + LASL +++ LY E + I+LS+N G++P ++Q
Sbjct: 616 PGELLASLKNMQ-LYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKN 674
Query: 239 LIDLDLSRNQLSSDIPSTIGT-LKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNL 297
+ LD S+N LS IP + + + +L+L+ N F G IP+S GN+ L SLD S+NNL
Sbjct: 675 VFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNL 734
Query: 298 SGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPC- 356
+G+IP+SL LS LK ++ N L+G +P G FK+ +A GN LCG + + PC
Sbjct: 735 TGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCT 793
Query: 357 -KQDNR---KRTNKVAPIVLQYXXXXXXXXXXXXXXXXMYVRCRNRSTKHLDH--EDFLP 410
KQ + KRT +V I+L + + C + K +++ E LP
Sbjct: 794 IKQKSSHFSKRT-RVILIIL-----GSAAALLLVLLLVLILTCCKKKEKKIENSSESSLP 847
Query: 411 P---ATR-RRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERA 466
A + +R ++ +ATD FN N++G+ +VYKG L DGT +A+K+ NL+ E +
Sbjct: 848 DLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLK-EFS 906
Query: 467 FRS---FDSECEILRNVRHRNLLKILG-SCSNLDFKALVLEFMPNGSLEKWLYSHNYFL- 521
S F +E + L ++HRNL+KILG + + KALVL FM NG+LE ++ +
Sbjct: 907 AESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIG 966
Query: 522 DILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581
+L+++++ + + S ++YLH + PI+HCDLKP NILLD + VAHVSDFG +++LG
Sbjct: 967 SLLEKIDLCVHIASGIDYLHSGYGF-PIVHCDLKPANILLDSDRVAHVSDFGTARILGFR 1025
Query: 582 EDSVIQTMTMA---TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPT--DEMFTG 636
ED T A TIGY+APE+ V+TK DV+S+G+++ME T+++PT ++ +
Sbjct: 1026 EDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQ 1085
Query: 637 EMSLRRWVKESLPHR---LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI 693
+M+LR+ V++S+ + + V+D L + + + + + L L C P R
Sbjct: 1086 DMTLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQE-EAIEDFLKLCLFCTSSRPEDRP 1144
Query: 694 HMTDAAAKLRKIKAK 708
M + L K++ K
Sbjct: 1145 DMNEILTHLMKLRGK 1159
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
Identities = 245/710 (34%), Positives = 358/710 (50%)
Query: 2 GTIPNS-ITNATKLIGLDLGLNSFSGHIPNT-----FGNLRH---LSVLSLMMNNLTTES 52
G +P+ I+ +L L L N F H NT F +L + L L L N+L E
Sbjct: 229 GELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEI 288
Query: 53 SSADQWSFLSSLTNCRXXXXXXXXXXPLGGILPPLIGNF-SASLQNIYAFECKLGGSIPK 111
+S+ + LS N + G +PP I N + +L N+ + L G IP+
Sbjct: 289 TSSVR--HLS--VNL---VQIHLDQNRIHGSIPPEISNLLNLTLLNLSSN--LLSGPIPR 339
Query: 112 EIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILN 171
E+ L L + L N L G IP +G + +L V NNL G +P +L +L L
Sbjct: 340 ELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLL 399
Query: 172 LSGNKLSGAIPQCLASLTSLR--SLYXXXXXXXXXXXXXXXXXEYILRINLSSNSLKGTL 229
L GN LSG +PQ L +L L L +NLSSN L G +
Sbjct: 400 LYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPI 459
Query: 230 PSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLES 289
P + K+++++ +DLS N+LS IP +G+ LE L+L+ N F +P S+G L L+
Sbjct: 460 PLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKE 519
Query: 290 LDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPP 349
LD S N L+G IP S + S LK N S N L G + KGSF + +S+ G+ LCG
Sbjct: 520 LDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSI 579
Query: 350 RLQVPPCKQDNRKRTNKVAPIVLQYXXXXXX--------XXXXXXXXXXMYVRCRNRSTK 401
+ + CK+ + K + + P++L +Y + +
Sbjct: 580 K-GMQACKKKH-KYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEE 637
Query: 402 HLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNL 461
+ D P R SY + AT FN +L+G+G FG VYKG L + T VA+K+ +
Sbjct: 638 KQNQNDPKYP----RISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDP 693
Query: 462 QLERAFR-SFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF 520
+ F SF EC+IL+ RHRNL++I+ +CS F ALVL MPNGSLE+ LY Y
Sbjct: 694 KTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYS 753
Query: 521 ---LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577
LD++Q +NI DV + YLHH +S ++HCDLKP+NILLD+ M A V+DFGIS+L
Sbjct: 754 SKNLDLIQLVNICSDVAEGIAYLHH-YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRL 812
Query: 578 LGEGEDSVIQT-----------MTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTE 626
+ +G + + T + ++GY+APEYG ST DVYS+GVLL+E +
Sbjct: 813 V-QGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSG 871
Query: 627 KKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR-EEQAFSDKMDCLF 675
++PTD + SL ++K P L +++ L R + Q +K + L+
Sbjct: 872 RRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLW 921
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 859 (307.4 bits), Expect = 6.9e-86, P = 6.9e-86
Identities = 207/597 (34%), Positives = 313/597 (52%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP ++ N + L +G N +G I FG L +L L L N+L S S +FL
Sbjct: 273 GAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLG--SYSFGDLAFL 330
Query: 62 SSLTNCRXXXXXXXXXXPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+LTNC LGG LP I N S L + + GSIP +IGNL GL
Sbjct: 331 DALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQS 390
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L L N L G +PTS+G L L + N G +P + +L +L L LS N G +
Sbjct: 391 LLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIV 450
Query: 182 PQCLASLTSLRSLYXXXXXXXXXXXXXXXXXEYILRINLSSNSLKGTLPSNIQKLNVLID 241
P L + + L ++ +N+ SNSL G+LP++I +L L++
Sbjct: 451 PPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVE 510
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
L L N LS +P T+G ++E + L N F G IP+ G L+ ++++D SNNNLSG I
Sbjct: 511 LLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSGSI 569
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPR-LQVPPCKQD- 359
+ E S L+ N+S N EG +P +G F++ + S FGN LCG + L++ PC
Sbjct: 570 SEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQA 629
Query: 360 ---NRKRTNKVAPIVLQYXXXXXXXXXXXXXXXXMYVRCRNRSTKHLDHEDFLPPATRRR 416
+ + + + + + + +N K + F +
Sbjct: 630 PPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQ-KINNSAPFTLEIFHEK 688
Query: 417 TSYLDIRRATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECE 475
SY D+R ATD F+ N++G+G FG+V+K L ++ VA+K+ N+Q A +SF +ECE
Sbjct: 689 LSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECE 748
Query: 476 ILRNVRHRNLLKILGSCSNLDF-----KALVLEFMPNGSLEKWLYSHNYFLDILQR---- 526
L+++RHRNL+K+L +C+++DF +AL+ EFMPNGSL+KWL+ ++ + R
Sbjct: 749 SLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEE--VEEIHRPSRT 806
Query: 527 LNIMIDVGSALEYLH-----HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578
L ++ + A++ H H PI HCDLKP+NILLD+++ AHVSDFG+++LL
Sbjct: 807 LTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLL 863
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 712 (255.7 bits), Expect = 8.3e-81, Sum P(2) = 8.3e-81
Identities = 207/651 (31%), Positives = 307/651 (47%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G +P SI N T+L D+ N+ +G +P + L ++S +N+ D +
Sbjct: 282 GKLPESIGNLTELRNFDVSQNNLTGELPE---KIAALQLISFNLNDNFFTGGLPDVVALN 338
Query: 62 SSLTNCRXXXXXXXXXXPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+L + G LP +G FS + + G +P + R L
Sbjct: 339 PNLVEFKIFNNSFT------GTLPRNLGKFS-EISEFDVSTNRFSGELPPYLCYRRKLQK 391
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLE--RLNILNLSGNKLSG 179
+ N L+G IP S G L + +N L G VP L RL + N N+L G
Sbjct: 392 IITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELAN--NNQLQG 449
Query: 180 AIPQCLASLTSLRSLYXXXXXXXXXXXXXXXXXEYILRINLSSNSLKGTLPSNIQKLNVL 239
+IP ++ L L + I+LS NS G++PS I KL L
Sbjct: 450 SIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNL 509
Query: 240 IDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG 299
+++ N L +IPS++ + L L+L+ N+ +G IP +G+L L LD SNN L+G
Sbjct: 510 ERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTG 569
Query: 300 KIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQD 359
+IP L L L QFNVS N+L G+IP G +D S+ GN LC P + PC+
Sbjct: 570 EIPAELLRLK-LNQFNVSDNKLYGKIP-SGFQQDIFRPSFLGNPNLCAPNLDPIRPCR-- 625
Query: 360 NRKRTNKVAPI-VLQYXXXXXXXXXXXXXXXXMYVRCRNRSTKHLDHEDFLPPATRRRTS 418
+++ T + PI +L ++ R R+ K + R
Sbjct: 626 SKRETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTNKITIFQ---------RVG 676
Query: 419 YLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRS---FDSECE 475
+ + + E N++G+GG G VY+ L G +A+K + + S F SE E
Sbjct: 677 FTE-EDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVE 735
Query: 476 ILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYS---HNYF--LDILQRLNIM 530
L VRH N++K+L C+ +F+ LV EFM NGSL L+S H LD R +I
Sbjct: 736 TLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIA 795
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590
+ L YLHH S PI+H D+K NILLD M V+DFG++K L ++ + ++
Sbjct: 796 VGAAQGLSYLHH-DSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVS 854
Query: 591 MATI----GYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
M+ + GY+APEYG V+ K DVYS+GV+L+E T K+P D F GE
Sbjct: 855 MSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSF-GE 904
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 1.4e-80, Sum P(3) = 1.4e-80
Identities = 112/303 (36%), Positives = 166/303 (54%)
Query: 421 DIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV 480
D+ AT+ F+ +G+GGFG VYK L DG VAIK + R F +E E + +
Sbjct: 799 DLVEATNGFHIACQIGSGGFGDVYKAQLKDGKVVAIKKLIHVSGQGDREFTAEMETIGKI 858
Query: 481 RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF---LDILQRLNIMIDVGSAL 537
+HRNL+ +LG C + + LV ++M GSLE L+ L+ R I + L
Sbjct: 859 KHRNLVPLLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWEARRKIAVGAARGL 918
Query: 538 EYLHHCHSSAP-IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIG 595
+LHH + P IIH D+K +N+L+DE + A VSDFG+++L+ D+ + T+A T G
Sbjct: 919 AFLHH--NCIPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSV-VDTHLSVSTLAGTPG 975
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE-MSLRRWVKESLPHRLTE 654
Y+ PEY +TK DVYSYGV+L+E T K PTD GE +L WVK+ ++T+
Sbjct: 976 YVPPEYYQSFRCTTKGDVYSYGVVLLELLTGKPPTDSADFGEDNNLVGWVKQHTKLKITD 1035
Query: 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDVA 714
V D L++E+ S +++ L + +A C D P +R M A ++I+A D
Sbjct: 1036 VFDPELLKEDP--SVELE-LLEHLKIACACLDDRPSRRPTMLKVMAMFKEIQAGSTVDSK 1092
Query: 715 ASS 717
SS
Sbjct: 1093 TSS 1095
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 717 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-77 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-48 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-47 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.003 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.003 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 2e-77
Identities = 208/703 (29%), Positives = 322/703 (45%), Gaps = 50/703 (7%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP SI + KLI LDL NS SG IP L++L +L L NN T + A L
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA-----L 328
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI---GNLRG 118
+SL L L L SN G +P +G + +L + L G IP+ + GNL
Sbjct: 329 TSLPR---LQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
Query: 119 LIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS 178
LI+ S N L G IP S+G + L+ + +N+ G +P + L + L++S N L
Sbjct: 385 LILFS---NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ 441
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV 238
G I + SL+ L L NK LP S S + + ++LS N G +P + L+
Sbjct: 442 GRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSE 500
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
L+ L LS N+LS +IP + + K L +L L+ NQ G IP S + L LD S N LS
Sbjct: 501 LMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560
Query: 299 GKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQ-VPPCK 357
G+IPK+L + L Q N+SHN L G +P G+F +A + GN LCG +PPCK
Sbjct: 561 GEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK 620
Query: 358 QDNRKRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHED------FLPP 411
R R + L + L L+ + N K +++ED F
Sbjct: 621 ---RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDS 677
Query: 412 ATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSF 470
+ + DI + E N++ G G+ YKG ++ +G +K N + S
Sbjct: 678 KVSKSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSE 733
Query: 471 DSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIM 530
++ + ++H N++K++G C + L+ E++ +L + L + L +R I
Sbjct: 734 IAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIA 786
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590
I + AL +L HC S ++ +L P I++D H+ L T
Sbjct: 787 IGIAKALRFL-HCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKC 838
Query: 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH 650
+ Y+APE ++ K D+Y +G++L+E T K P D F S+ W +
Sbjct: 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD 898
Query: 651 -RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKR 692
L +D ++ + +++ +M+LAL C P R
Sbjct: 899 CHLDMWIDPSIRGDVSVNQNEI---VEVMNLALHCTATDPTAR 938
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 3e-51
Identities = 129/350 (36%), Positives = 179/350 (51%), Gaps = 34/350 (9%)
Query: 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
+G IPNS+TN T L L L N G IP G ++ L + L NNL+ E +
Sbjct: 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY--EIGG 234
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
L+SL + L L N L G +P +GN +LQ ++ ++ KL G IP I +L+ LI
Sbjct: 235 LTSLNH------LDLVYNNLTGPIPSSLGNLK-NLQYLFLYQNKLSGPIPPSIFSLQKLI 287
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L L N L+G IP + LQ L+ ++ NN G +P L L RL +L L NK SG
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK-------------- 226
IP+ L +L L L +N L+ +P L S + ++ L SNSL+
Sbjct: 348 IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR 407
Query: 227 ----------GTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP 276
G LPS KL ++ LD+S N L I S + +L+ LSLA N+F G
Sbjct: 408 RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467
Query: 277 IPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
+P+S G+ LE+LD S N SG +P+ L +LS L Q +S N+L GEIP
Sbjct: 468 LPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 9e-48
Identities = 72/192 (37%), Positives = 99/192 (51%), Gaps = 10/192 (5%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSC 492
LG GGFG+VY G VAIKI + E EIL+ + H N++K+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552
+ + LV+E+ GSL+ L + L + L I++ + LEYLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN----GIIHR 116
Query: 553 DLKPTNILLDE-NMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE-YGSEGIVSTK 610
DLKP NILLD N ++DFG+SKLL + + + T YMAPE +G S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEK 174
Query: 611 CDVYSYGVLLME 622
D++S GV+L E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 2e-47
Identities = 126/325 (38%), Positives = 175/325 (53%), Gaps = 13/325 (4%)
Query: 2 GTIPN-SITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
G+IP SI N L LDL N SG IPN G+ L VL L N L + +
Sbjct: 132 GSIPRGSIPN---LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN------ 182
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
SLTN +L L LASN L G +P +G SL+ IY L G IP EIG L L
Sbjct: 183 --SLTNLTSLEFLTLASNQLVGQIPRELGQMK-SLKWIYLGYNNLSGEIPYEIGGLTSLN 239
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L L +N+L G IP+S+G L+ LQ ++ +N L G +P + L++L L+LS N LSG
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
IP+ + L +L L+L SN + +P +L SL + + L SN G +P N+ K N L
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK 300
LDLS N L+ +IP + + NL L L N +G IP+S+G SL + +N+ SG+
Sbjct: 360 VLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419
Query: 301 IPKSLEALSHLKQFNVSHNRLEGEI 325
+P L + ++S+N L+G I
Sbjct: 420 LPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 9e-45
Identities = 118/326 (36%), Positives = 176/326 (53%), Gaps = 12/326 (3%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIP-NTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
G I ++I + ++L N SG IP + F L L+L NN T
Sbjct: 83 GKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG----S 138
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ NL L L++N L G +P IG+FS SL+ + L G IP + NL L
Sbjct: 139 IP------NLETLDLSNNMLSGEIPNDIGSFS-SLKVLDLGGNVLVGKIPNSLTNLTSLE 191
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L+L N L G IP +G ++ L+ Y+ NNL G +P+++ L LN L+L N L+G
Sbjct: 192 FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP 251
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
IP L +L +L+ L+L NKLS +P S++SL+ ++ ++LS NSL G +P + +L L
Sbjct: 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLE 311
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK 300
L L N + IP + +L L+ L L N+F G IP+++G +L LD S NNL+G+
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 301 IPKSLEALSHLKQFNVSHNRLEGEIP 326
IP+ L + +L + + N LEGEIP
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 81/269 (30%), Positives = 120/269 (44%), Gaps = 26/269 (9%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLER--AFRSFDSECEILRNVRHRNLLKILGS 491
LG+G FG+VYK G VA+KI + E+ ++ E ILR + H N+++++ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 492 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIH 551
+ D LV+E+ G L +L + I + + LEYLH S IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH----SNGIIH 121
Query: 552 CDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--YGSEGIVST 609
DLKP NILLDEN V ++DFG++K L S + T T YMAPE G G
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGY-GP 178
Query: 610 KCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSD 669
K DV+S GV+L E+ TG+ + ++ L +E +S
Sbjct: 179 KVDVWSLGVILY----------ELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS 228
Query: 670 KMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
+ ++ C P KR +
Sbjct: 229 GSEEAKDLIK---KCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 6e-44
Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 433 NLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFR-SFDSECEILRNVRHRNLLKILG 490
LG G FG VY G VAIK+ + + R E +IL+ ++H N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550
+ D LV+E+ G L L + + + SALEYLH I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLHSKG----IV 119
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGYMAPEYGSEGIVST 609
H DLKP NILLDE+ ++DFG+++ L GE + T T YMAPE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGE----KLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 610 KCDVYSYGVLLMETFTEKKPTDEMFTGE 637
D++S GV+L E+ TG+
Sbjct: 176 AVDIWSLGVILY----------ELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 81/275 (29%), Positives = 122/275 (44%), Gaps = 31/275 (11%)
Query: 435 LGTGGFGSVYKGTLSD-----GTNVAIKIFNL-QLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FG VYKG L VA+K E+ F E I+R + H N++K+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
LG C+ + +V+E+M G L +L + L + L+ + + +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE----SKN 122
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVS 608
IH DL N L+ EN+V +SDFG+S+ L + D + I +MAPE EG +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 609 TKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667
+K DV+S+GVLL E FT ++P M + E + +
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGM--------------SNEEVLEYLKNGYRLPQPP- 226
Query: 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702
+C + DL L C + P R ++ L
Sbjct: 227 ----NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 8e-43
Identities = 69/197 (35%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 435 LGTGGFGSVYKGTL-----SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKI 488
LG G FG VYKGTL T VA+K E F E I++ + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
LG C+ + +V E+MP G L +L H L + L + + + +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE----SKN 122
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVS 608
+H DL N L+ EN+V +SDFG+S+ + E + + I +MAPE +G +
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 609 TKCDVYSYGVLLMETFT 625
+K DV+S+GVLL E FT
Sbjct: 183 SKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 3e-42
Identities = 74/207 (35%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 435 LGTGGFGSVYKGTLSDG-----TNVAIKIFNL-QLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FG VYKGTL VA+K E+ F E I+R + H N++K+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWL-YSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
LG C+ + +V+E+MP G L +L + L + L+ + + +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SK 122
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV 607
IH DL N L+ EN+V +SDFG+S+ L + D I +MAPE EG
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 608 STKCDVYSYGVLLMETFT-EKKPTDEM 633
++K DV+S+GVLL E FT ++P M
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGM 208
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 79/286 (27%), Positives = 126/286 (44%), Gaps = 39/286 (13%)
Query: 433 NLLGTGGFGSVYKGTLSDGTN----VAIKIFNLQLERAFRS-FDSECEILRNVRHRNLLK 487
LG G FG VYKG L VA+K R F E +++ + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSH--------NYFLDILQRLNIMIDVGSALEY 539
+LG C+ + LVLE+M G L +L L + L+ I + +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
L S +H DL N L+ E++V +SDFG+S+ + + + +T I +MAP
Sbjct: 121 LA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTE-KKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658
E +GI ++K DV+S+GVLL E FT P + E+ ++++ +RL
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--LEYLRK--GYRL------ 226
Query: 659 NLVREEQAFSDKMD-CLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703
K + C + +L L C P R ++ +L
Sbjct: 227 ----------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 6e-37
Identities = 108/309 (34%), Positives = 158/309 (51%), Gaps = 23/309 (7%)
Query: 48 LTTESSSAD--QWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKL 105
L+ +SSAD W ++ N + ++ L+ + G + I +Q I +L
Sbjct: 48 LSNWNSSADVCLWQGITC-NNSSRVVSIDLSGKNISGKISSAIFRLP-YIQTINLSNNQL 105
Query: 106 GGSIPKEIGNL-RGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHL 164
G IP +I L L+L N+ G+IP G++ L+ + N L G +P+D+
Sbjct: 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF 163
Query: 165 ERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNS 224
L +L+L GN L G IP L +LTSL L L SN+L +P L ++ + I L N+
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223
Query: 225 LKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNL 284
L G +P I L L LDL N L+ IPS++G LKNL+ L L N+ GPIP S+ +L
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 285 ISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYA 344
L SLD S+N+LSG+IP+ + L +L+ ++ N G+IPV A
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV----------------A 327
Query: 345 LCGPPRLQV 353
L PRLQV
Sbjct: 328 LTSLPRLQV 336
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 433 NLLGTGGFGSVYKGTLSD-GTNVAIK--IFNLQLERAFRSFDSECEILRNVRHRNLLKIL 489
LLG G FGSVY D G +A+K + E + + E IL +++H N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 490 GSCSNLDFKAL--VLEFMPNGSLEKWLYS---------HNYFLDILQRLNIMIDVGSALE 538
GS + + L LE++ GSL L Y IL+ L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE----------GLA 115
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
YLH S I+H D+K NIL+D + V ++DFG +K LG+ E T +MA
Sbjct: 116 YLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
PE D++S G ++E T K P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 81/291 (27%), Positives = 126/291 (43%), Gaps = 44/291 (15%)
Query: 435 LGTGGFGSVYKGTLS------DGTNVAIKIF-NLQLERAFRSFDSECEILRNVRHRNLLK 487
LG G FG V+ G D VA+K A + F+ E E+L N +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL-------------QRLNIMIDVG 534
G C+ D +V E+M +G L K+L SH L Q L I + +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATI 594
S + YL +S +H DL N L+ ++V + DFG+S+ + + + TM I
Sbjct: 133 SGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLT 653
+M PE +T+ DV+S+GV+L E FT K+P W S +
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYGLS-NEEVI 234
Query: 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704
E + + + C + D+ L C P +RI++ D +L+K
Sbjct: 235 ECITQGRLLQRPR-----TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 8/216 (3%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHR 483
R +EF LG+G FG V++G + VAIKI + F E + L+ +RH+
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYS-HNYFLDILQRLNIMIDVGSALEYLHH 542
+L+ + CS + ++ E M GSL +L S L + +++ V + YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYG 602
+ IH DL NIL+ E++V V+DFG+++L+ ED + + + APE
Sbjct: 123 QN----SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAA 176
Query: 603 SEGIVSTKCDVYSYGVLLMETFTEKK-PTDEMFTGE 637
S G STK DV+S+G+LL E FT + P M E
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 69/193 (35%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 434 LLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFR-SFDSECEILRNVRHRNLLKILGSC 492
+G G FG VYKG L T VA+K L + F E EIL+ H N++K++G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552
+V+E +P GSL +L L + + L + +D + +EYL S IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHR 117
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCD 612
DL N L+ EN V +SDFG+S+ G +V + I + APE + G +++ D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 613 VYSYGVLLMETFT 625
V+SYG+LL ETF+
Sbjct: 178 VWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 68/196 (34%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
+G GGFG VYK G VAIK+ L+ + +E +IL+ +H N++K GS
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
D +V+EF GSL+ L S N L Q + ++ LEYLH S IIH D
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNGIIHRD 123
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
+K NILL + + DFG+S L + + TM + T +MAPE + K D+
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTM-VGTPYWMAPEVINGKPYDYKADI 180
Query: 614 YSYGVLLMETFTEKKP 629
+S G+ +E K P
Sbjct: 181 WSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 65/193 (33%), Positives = 99/193 (51%), Gaps = 12/193 (6%)
Query: 434 LLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
+G G FG V G G VA+K A ++F +E ++ +RH NL+++LG
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 494 NLDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552
+ +V E+M GSL +L S + + Q+L +DV +EYL +H
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFVHR 126
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCD 612
DL N+L+ E++VA VSDFG++K E S Q + + APE E STK D
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSD 181
Query: 613 VYSYGVLLMETFT 625
V+S+G+LL E ++
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 69/195 (35%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 434 LLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFR-SFDSECEILRNVRHRNLLKILGSC 492
LLG G FG V+KGTL D T VA+K L + + F SE IL+ H N++K++G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552
+ +V+E +P G +L L Q + +D + + YL S IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHR 117
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT--MTMATIGYMAPEYGSEGIVSTK 610
DL N L+ EN V +SDFG+S+ + +D + + + I + APE + G S++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 611 CDVYSYGVLLMETFT 625
DV+SYG+LL ETF+
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 34/212 (16%)
Query: 433 NLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQ--LERAFRSFDSECEILRNVRHRNLLKIL 489
+L+G G FG VYKG L G VAIK +L+ E A +S E ++L+N++H N++K +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHN---------YFLDILQRLNIMIDVGSALEYL 540
GS D ++LE+ NGSL + + Y +LQ L YL
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ----------GLAYL 115
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS-KL--LGEGEDSVIQTMTMATIGYM 597
H +IH D+K NIL ++ V ++DFG++ KL + + + SV+ T +M
Sbjct: 116 H----EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-----GTPYWM 166
Query: 598 APEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
APE ST D++S G ++E T P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
+G G FG+V +G + G VA+K N++ + ++F E ++ + H+NL+++LG +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 495 LDFKALVLEFMPNGSLEKWLYSHNYFL-DILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
+V+E M G+L +L + L ++Q L +DV +EYL S ++H D
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRD 125
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
L NIL+ E+ VA VSDFG++++ G D+ + + + APE S+K DV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEALKHKKFSSKSDV 180
Query: 614 YSYGVLLMETFT-EKKPTDEMFTGEMS 639
+SYGVLL E F+ + P +M E+
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 433 NLLGTGGFGSVYKGT---LSDGTN--VAIKIFNLQLERAFRS-FDSECEILRNVRHRNLL 486
LG G FG V L D T VA+K N E RS F+ E EILR + H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 487 KILGSCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
K G C ++ L++E++P+GSL +L H +++ + L + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-SVIQTMTMATIGYMAPEYGS 603
IH DL NIL++ + +SDFG++K+L E +D ++ + I + APE
Sbjct: 130 ----YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKPT 630
S+ DV+S+GV L E FT P+
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 1e-25
Identities = 73/216 (33%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 428 EFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLER---AFRSFDSECEILRNVRH-R 483
+ LG G FG VY D VA+K+ +LE F E +IL ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILQRLNIMIDVGSALEYLH 541
N++K+ + LV+E++ GSLE L L + L I+ + SALEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 542 HCHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGEDSVIQTMTMA----TIGY 596
S IIH D+KP NILLD + V + DFG++KLL + + + T GY
Sbjct: 119 ----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 597 MAPEY---GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
MAPE S S+ D++S G+ L E T P
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 67/222 (30%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 433 NLLGTGGFGSVYKGT-LSDGTNVAIKIFNL------QLERAFRSFDSECEILRNVRHRNL 485
+G G FG VY SDG +K +L + E A E +IL+ + H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL---QRLNIMIDVGSALEYLHH 542
+K S +V+E+ G L + + Q L+ + + AL+YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGYMAPE- 600
S I+H D+KP NI L N + + DFGISK+L +V T+ T Y++PE
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSPEL 174
Query: 601 -----YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
Y + K D++S G +L E T K P F GE
Sbjct: 175 CQNKPY------NYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 12/219 (5%)
Query: 428 EFNECNLLGTGGFGSVYKGT-LSDGTN----VAIKIFNLQLER-AFRSFDSECEILRNVR 481
E + +LG+G FG+VYKG + +G VAIK+ + A + E ++ +V
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
H +++++LG C + L+ + MP G L ++ +H + LN + + + YL
Sbjct: 68 HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
++H DL N+L+ ++DFG++KLL E I +MA E
Sbjct: 127 EKR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 602 GSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639
I + K DV+SYGV + E T KP + + E+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 63/195 (32%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIF---NLQLERAFRSFDSECEILRNVRHRNLLKILGS 491
LG G FG V+ GT + T VA+K + E +F E +I++ +RH L+++
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE----AFLQEAQIMKKLRHDKLVQLYAV 69
Query: 492 CSNLDFKALVLEFMPNGSLEKWLYS-HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550
CS + +V E+M GSL +L S L + Q +++ + + YL S I
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE----SRNYI 125
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTK 610
H DL NIL+ EN+V ++DFG+++L+ + E + + I + APE + G + K
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP-IKWTAPEAANYGRFTIK 184
Query: 611 CDVYSYGVLLMETFT 625
DV+S+G+LL E T
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 50/218 (22%)
Query: 435 LGTGGFGSVYKGTLSDGTN--VAIKIFNLQLERAFRS-FDSECEILRNVRHRNLLKILGS 491
LG G G VYK T A+K ++ + FR E + LR+ ++K
Sbjct: 9 LGQGSSGVVYKVRH-KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK---- 63
Query: 492 CSNLDFK----ALVLEFMPNGSLEKWLYSHNYFLDILQRLN---------IMIDVGSALE 538
C +K ++VLE+M GSL D+L+++ I + L+
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILKGLD 113
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT-MATIGYM 597
YLH IIH D+KP+N+L++ ++DFGISK+L E+++ Q T + T+ YM
Sbjct: 114 YLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYM 167
Query: 598 APE------YGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+PE Y S D++S G+ L+E K P
Sbjct: 168 SPERIQGESY------SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 13/216 (6%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRS---FDSECEILRNVRHR 483
E +G+G FG V+ G + VAIK + S F E +++ + H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIK----TIREGAMSEEDFIEEAQVMMKLSHP 59
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
L+++ G C+ LV EFM +G L +L + L + +DV + YL
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE-- 117
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS 603
S+ +IH DL N L+ EN V VSDFG+++ + + + + T T + + +PE S
Sbjct: 118 --SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFS 174
Query: 604 EGIVSTKCDVYSYGVLLMETFTE-KKPTDEMFTGEM 638
S+K DV+S+GVL+ E F+E K P + E+
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 71/279 (25%), Positives = 130/279 (46%), Gaps = 31/279 (11%)
Query: 433 NLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLK 487
++G G FG V +G L +VAIK ++ F +E I+ H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+ G + ++ E+M NGSL+K+L ++ + Q + ++ + S ++YL S
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL----SEM 125
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV 607
+H DL NIL++ N+V VSDFG+S+ L + E + I + APE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 608 STKCDVYSYGVLLME--TFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665
++ DV+S+G+++ E ++ E +P +M + + +V+ A V +
Sbjct: 186 TSASDVWSFGIVMWEVMSYGE-RPYWDM-SNQ----------------DVIKA--VEDGY 225
Query: 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704
MDC ++ L LDC ++R + + L K
Sbjct: 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 44/291 (15%)
Query: 435 LGTGGFGSVYKGTL------SDGTNVAIKIFNLQLERAFRS-FDSECEILRNVRHRNLLK 487
LG G FG VYKG L T+VAIK E + F E E++ +++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMID 532
+LG C+ ++ E++ +G L ++L ++ LD L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
+ + +EYL SS +H DL N L+ E + +SDFG+S+ + + +Q+ ++
Sbjct: 133 IAAGMEYL----SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652
+ +M PE G +T+ D++S+GV+L E F+ F+ +
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------------- 233
Query: 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703
EV+ ++R Q DC + L ++C + P +R D +LR
Sbjct: 234 -EVI--EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 433 NLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLER--AFRSFDSECEILRNVRHRNLLKIL 489
N +G G FG VY L G +A+K +Q + E ++L ++H NL+K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD--ILQRLNIMIDVGSALEYLHHCHSSA 547
G + + + +E+ G+LE+ L H LD +++ + + G L YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEG--LAYLHSHG--- 119
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM--TMATIGYMAPEYGSEG 605
I+H D+KP NI LD N V + DFG + L ++ + + T YMAPE + G
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 606 IVSTK---CDVYSYGVLLMETFTEKKPTDEM 633
D++S G +++E T K+P E+
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRS--FDSECEILRNVRHRNLLKILGSC 492
LG+G FG V+ G +VAIK+ E A F E +++ + H NL+++ G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552
+ +V E+M NG L +L L L++ DV A+EYL S IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHR 124
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCD 612
DL N L+ E+ V VSDFG+++ + + + T + + PE S+K D
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 613 VYSYGVLLMETFTEKKPTDEMFT 635
V+S+GVL+ E F+E K E F+
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 4e-23
Identities = 68/211 (32%), Positives = 93/211 (44%), Gaps = 23/211 (10%)
Query: 435 LGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFD---SECEILRNVRHRNLLK 487
LG G FG V K T G A+K+ + + + +E IL + H ++K
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+ + + LVLE+ P G L L F + R ++ ALEYLH S
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH----SL 112
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGYMAPEYGSEGI 606
II+ DLKP NILLD + ++DFG++K E +T T T Y+APE
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTNTFCGTPEYLAPEVLLGKG 169
Query: 607 VSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
D +S GVLL E T K P F E
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPP----FYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 8e-23
Identities = 81/288 (28%), Positives = 129/288 (44%), Gaps = 29/288 (10%)
Query: 434 LLGTGGFGSVYK---GTLSDGTN--VAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FGSV L D T VA+K R F+ E EIL++++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 489 LGSC-----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
G C NL LV+E++P GSL +L H LD + L + +EYL
Sbjct: 71 KGVCYSAGRRNL---RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL--- 124
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS-VIQTMTMATIGYMAPEYG 602
S +H DL NIL++ + DFG++K+L + ++ ++ + I + APE
Sbjct: 125 -GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 603 SEGIVSTKCDVYSYGVLLMETFT----EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658
+E S DV+S+GV+L E FT P E F M + + + H +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHLI------ 236
Query: 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706
L++ C I + +C + P +R ++ A ++ I+
Sbjct: 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 9e-23
Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 36/282 (12%)
Query: 434 LLGTGGFGSVYKGTL--SDGTNVAIKIFNLQ---LERAFRSFDSECEILRNVRHRNLLKI 488
++G G FG V++G L VA+ I L+ E+ + F SE I+ H N++++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
G + ++ E+M NG+L+K+L H+ Q + ++ + + ++YL S
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL----SDMN 127
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA----TIGYMAPEYGSE 604
+H DL NIL++ N+ VSDFG+S++L ED T T + I + APE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 605 GIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663
++ DV+S+G+++ E + ++P +M EV+ A + +
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----------------HEVMKA--IND 225
Query: 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
MDC ++ L L C +R D L K+
Sbjct: 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 434 LLGTGGFGSVYKGTLS--DGT--NVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLK 487
+LG G FGSV +G LS DG+ VA+K L + F SE +++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 488 ILGSCSNLDFKA------LVLEFMPNGSLEKWLYSHN-----YFLDILQRLNIMIDVGSA 536
++G C ++L FM +G L +L L + L M+D+
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT-MTMATIG 595
+EYL S+ IH DL N +L E+M V+DFG+SK + G D Q + +
Sbjct: 126 MEYL----SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPVK 180
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
++A E ++ + ++K DV+++GV + E T
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 18/195 (9%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
+G G FG V G G VA+K ++ + ++F +E ++ +RH NL+++LG
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68
Query: 495 LDFKA---LVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550
++ K +V E+M GSL +L S L L +DV A+EYL + +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFV 124
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTK 610
H DL N+L+ E+ VA VSDFG++K E S Q + + APE E STK
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 611 CDVYSYGVLLMETFT 625
DV+S+G+LL E ++
Sbjct: 180 SDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 3e-22
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
LGTG FG V G +VAIK+ + + F E +++ + H L+++ G C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 495 LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDL 554
+V E+M NG L +L H Q L + DV + YL S IH DL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDL 126
Query: 555 KPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT---IGYMAPEYGSEGIVSTKC 611
N L+D+ VSDFG+S+ + + E T ++ + + + PE S+K
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 612 DVYSYGVLLMETFTEKKPTDEMFT 635
DV+++GVL+ E ++ K E F
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 435 LGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRS-FDSECEILRNVRHRNLLKILGSC 492
+G G FG V+ G L +D T VA+K L ++ F E IL+ H N+++++G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH--HCHSSAPII 550
+ +V+E + G +L + L + + + ++ + + +EYL HC I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC------I 116
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTK 610
H DL N L+ E V +SDFG+S+ +G + M + + APE + G S++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 611 CDVYSYGVLLMETFT 625
DV+S+G+LL E F+
Sbjct: 177 SDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 435 LGTGGFGSVYKGTLS------DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FG V+ D VA+K E A + F E E+L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL--------------QRLNIMIDVG 534
G C+ +V E+M +G L ++L SH IL Q L I +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATI 594
S + YL H +H DL N L+ + +V + DFG+S+ + + + TM I
Sbjct: 133 SGMVYLASLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKK 628
+M PE +T+ D++S+GV+L E FT K
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 68/229 (29%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFN---LQLERAFRSFDSECEIL-RNVR 481
D+F ++G G F +V AIKI + L E+ + E E+L R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 482 HRNLLKILGSC---SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALE 538
H ++K+ + NL F VLE+ PNG L +++ LD ++ ALE
Sbjct: 61 HPGIIKLYYTFQDEENLYF---VLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALE 116
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE------------DSVI 586
YLH S IIH DLKP NILLD++M ++DFG +K+L DS I
Sbjct: 117 YLH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 587 QTMT------MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+ + T Y++PE +E D+++ G ++ + T K P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 75/284 (26%), Positives = 121/284 (42%), Gaps = 43/284 (15%)
Query: 435 LGTGGFGSVYKGT------LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FG V+ D VA+K A + F E E+L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILQRLNIMIDV 533
G C + D +V E+M +G L K+L +H L + Q L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT 593
S + YL H +H DL N L+ N++ + DFG+S+ + + + TM
Sbjct: 133 ASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 594 IGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLT 653
I +M PE +T+ DV+S+GV+L E FT K + W + S +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLS-NTEVI 235
Query: 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTD 697
E + V E C + D+ L C P +R+++ +
Sbjct: 236 ECITQGRVLERPRV-----CPKEVYDIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 433 NLLGTGGFGSVYKGTLSD-GTNVAIKIF---NLQLERAFRSFDSECEILRNVRHRNLLKI 488
+ LG G +G VY+G VA+K +++E F E +++ ++H NL+++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHPNLVQL 67
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSA 547
LG C+ ++ EFM G+L +L N ++ + L + + SA+EYL +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV 607
IH DL N L+ EN + V+DFG+S+L+ G+ I + APE +
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 608 STKCDVYSYGVLLMETFT 625
S K DV+++GVLL E T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 30/279 (10%)
Query: 434 LLGTGGFGSVYKGTLS----DGTNVAIKIFNL-QLERAFRSFDSECEILRNVRHRNLLKI 488
++G G FG V G L VAIK E+ R F SE I+ H N++ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
G + +V E+M NGSL+ +L H+ ++Q + ++ + S ++YL S
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL----SDMG 126
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM-TMATIGYMAPEYGSEGIV 607
+H DL NIL++ N+V VSDFG+S++L + ++ T I + APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 608 STKCDVYSYGVLLMETFTE-KKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666
++ DV+SYG+++ E + ++P EM +V+ A + E
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSN-----------------QDVIKA--IEEGYR 227
Query: 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
MDC ++ L LDC ++R + L K+
Sbjct: 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 25/213 (11%)
Query: 434 LLGTGGFGSVYKG-TLSDGTNVAIKIFNL-----QLERAFRS----FDSECEILRNVRHR 483
L+G+G FGSVY G S G +A+K L + RS E +L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
N+++ LGS + D + LE++P GS+ L ++ F + L R N + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT-------MATIGY 596
+ IIH D+K NIL+D +SDFGISK L E + + T T ++ +
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGARPSLQGSVFW 178
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
MAPE + + K D++S G L++E T K P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 433 NLLGTGGFGSVYKGTLS-DGT--NVAIKIFN-LQLERAFRSFDSECEILRNV-RHRNLLK 487
+++G G FG V + + DG N AIK+ E R F E E+L + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILQRLNIMID 532
+LG+C N + + +E+ P G+L +L L Q L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
V + ++YL S IH DL N+L+ EN+ + ++DFG+S+ GE E V +TM
Sbjct: 128 VATGMQYL----SEKQFIHRDLAARNVLVGENLASKIADFGLSR--GE-EVYVKKTMGRL 180
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHR 651
+ +MA E + + +TK DV+S+GVLL E + P M E+ E LP
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------EKLPQG 234
Query: 652 LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
R E+ +C + +L C D P++R + +L ++
Sbjct: 235 Y---------RMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 8/195 (4%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
LG G FG V+ GT + T VAIK + +F E ++++ +RH L+++ S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 495 LDFKALVLEFMPNGSLEKWLY-SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
+V E+M GSL +L +L + Q +++ + S + Y+ + +H D
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 127
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
L+ NIL+ EN+V V+DFG+++L+ + E + Q I + APE G + K DV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 614 YSYGVLLMETFTEKK 628
+S+G+LL E T+ +
Sbjct: 187 WSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
LG G FG V++G ++ T VA+K + F +E +I++ +RH L+++ C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 495 LDFKALVLEFMPNGSLEKWLY-SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
+ +V E M GSL ++L L + Q +++ V S + YL + IH D
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE----AQNYIHRD 128
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
L N+L+ EN + V+DFG+++++ E + I + APE S K DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 614 YSYGVLLMETFT 625
+S+G+LL E T
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 434 LLGTGGFGSVYKG-TLSDGTNVAIKIFNL-----QLERAFRSFDSECEILRNVRHRNLLK 487
LLG+G FGSVY+G L DG A+K +L + A + + E +L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL---NIMIDVGSALEYLHHCH 544
LG+ D + LE +P GSL K L + F + + RL I+ LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN 122
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG---YMAPEY 601
+H D+K NIL+D N V ++DFG++K + E + + G +MAPE
Sbjct: 123 ----TVHRDIKGANILVDTNGVVKLADFGMAKQVVE------FSFAKSFKGSPYWMAPEV 172
Query: 602 -GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+G D++S G ++E T K P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 73/282 (25%), Positives = 130/282 (46%), Gaps = 34/282 (12%)
Query: 434 LLGTGGFGSVYKGTLS----DGTNVAIKIFNL-QLERAFRSFDSECEILRNVRHRNLLKI 488
++G G FG V +G L VAIK E+ R F SE I+ H N++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
G + ++ EFM NG+L+ +L ++ ++Q + ++ + + ++YL S
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL----SEMN 126
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA---TIGYMAPEYGSEG 605
+H DL NIL++ N+V VSDFG+S+ L + T ++ I + APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 606 IVSTKCDVYSYGVLLME--TFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663
++ DV+SYG+++ E ++ E+ D MS + +V++A + +
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWD------MSNQ------------DVINA--IEQ 226
Query: 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+ MDC ++ L LDC + R + L K+
Sbjct: 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 66/206 (32%), Positives = 93/206 (45%), Gaps = 13/206 (6%)
Query: 435 LGTGGFGSVYKGT--LSDGT--NVAIKIF-NLQLERAFRSFDSECEILRNVRHRNLLKIL 489
LG G FGSV KG + G VA+K + + F E ++ + H +++++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
G C LV+E P G L K+L + V + YL H
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVS-DLKELAHQVAMGMAYLESKH----F 116
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV-IQTMTMATIGYMAPEYGSEGIVS 608
+H DL N+LL A +SDFG+S+ LG G D T + + APE + G S
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 609 TKCDVYSYGVLLMETFTE-KKPTDEM 633
+K DV+SYGV L E F+ KP EM
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 74/262 (28%), Positives = 111/262 (42%), Gaps = 61/262 (23%)
Query: 433 NLLGTGGFGSVYKGT-LSDGTNVAIK-IFN-----LQLERAFRSFDSECEILRNVRHRNL 485
+G+G +G V G VAIK I N + +R R E ++LR++RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 486 LK---ILGSCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
+ IL S DF + V E M L K + S L + + L+YL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP-LTDDHIQYFLYQILRGLKYL 119
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIGYMA 598
H SA +IH DLKP+NIL++ N + DFG+++ + ED +T + T Y A
Sbjct: 120 H----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK-GFLTEYVVTRWYRA 174
Query: 599 PE-------YGSEGIVSTKCDVYSYGVLLMETFTEK--------------------KPTD 631
PE Y ++ I D++S G + E T K P++
Sbjct: 175 PELLLSSSRY-TKAI-----DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 632 EMFTGEMSL--RRWVKESLPHR 651
E S R ++K SLP +
Sbjct: 229 EDLKFITSEKARNYLK-SLPKK 249
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 67/217 (30%), Positives = 112/217 (51%), Gaps = 22/217 (10%)
Query: 434 LLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFR----------SFDSECEILRNVRH 482
L+G G +G VY ++ G +A+K L A R + SE E L+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
N+++ LG + ++ ++ LE++P GS+ L ++ F + L R V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPE- 600
S I+H DLK N+L+D + + +SDFGISK + D+ Q M+M ++ +MAPE
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND-QNMSMQGSVFWMAPEV 181
Query: 601 -YGSEGIVSTKCDVYSYGVLLMETFTEKKP--TDEMF 634
+ S K D++S G +++E F ++P +E
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 38/216 (17%)
Query: 428 EFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
+ E LG G +GSVYK G VAIK+ + E + E IL+ ++
Sbjct: 6 DILEK--LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIV 61
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLN----------IMIDVGSA 536
K GS +V+E+ GS DI++ N I+
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG- 595
LEYLH S IH D+K NILL+E A ++DFG+S G+ D++ + T+ IG
Sbjct: 112 LEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVS---GQLTDTMAKRNTV--IGT 162
Query: 596 --YMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+MAPE E + K D++S G+ +E E KP
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMA-EGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 78/310 (25%), Positives = 120/310 (38%), Gaps = 81/310 (26%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLER------AFRSFDSECEILRNVRHRNLLK 487
+G G +G VYK G VA+K ++ E+ A R E ++L+ +RH N+++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 488 IL--------GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
+ GS +V E+M + L L S Q M + L+Y
Sbjct: 63 LKEIVTSKGKGSIY------MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
LH I+H D+K +NIL++ + V ++DFG+++ +S T + T+ Y P
Sbjct: 116 LHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPP 170
Query: 600 E-------YGSEGIVSTKCDVYSYGVLLMETFTEK--------------------KPTDE 632
E YG + D++S G +L E F K PTDE
Sbjct: 171 ELLLGATRYG------PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDE 224
Query: 633 MFTGEMSLRRW----VKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDT 688
+ G L + K+ RL E + DK+ L LD
Sbjct: 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKL--------LTLD----- 271
Query: 689 PHKRIHMTDA 698
P KRI A
Sbjct: 272 PKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 435 LGTGGFGSVYKGTLSD------GTNVAIKIFNLQLERA----FRSFDSECEILRNVRHRN 484
LG G FG VY+G T VAIK N E A F +E +++ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH------NYFLDILQRLNIM---IDVGS 535
++++LG S +V+E M G L+ +L S N L + ++
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
+ YL +H DL N ++ E++ + DFG+++ + E + + +
Sbjct: 131 GMAYLAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+MAPE +G+ +TK DV+S+GV+L E T
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 40/276 (14%)
Query: 435 LGTGGFGSVYKGTL------SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FG V+ D VA+K + A + F E E+L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHN------------YFLDILQRLNIMIDVGSA 536
G C D +V E+M +G L K+L +H L Q L+I + +
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
+ YL H +H DL N L+ EN++ + DFG+S+ + + + TM I +
Sbjct: 133 MVYLASQH----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656
M PE +T+ DV+S GV+L E FT K + W + S EV+
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQLS----NNEVI 232
Query: 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKR 692
+ + + + C + DL L C PH R
Sbjct: 233 EC--ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 433 NLLGTGGFGSVYKGTLSD----GTN---VAIKIFNL-QLERAFRSFDSECEILRNVRHRN 484
N LG+G FG VY+GT +D G+ VA+K ++ + F E ++ N H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYS------HNYFLDILQRLNIMIDVGSALE 538
++K+LG C + + +++E M G L +L L + + L+I +DV
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDE-----NMVAHVSDFGISKLLGEGEDSVIQTMTMAT 593
YL H IH DL N L+ E + V + DFG+++ + + + + +
Sbjct: 121 YLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 594 IGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE +G +T+ DV+S+GVL+ E T
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 70/268 (26%), Positives = 103/268 (38%), Gaps = 33/268 (12%)
Query: 434 LLGTGGFGSVYKGT----LSDGTNVAIKIF-NLQLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FG V +G VA+K + +L F E I+ ++ H NL+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 489 LGSCSNLDFKA-LVLEFMPNGSL-EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
G L +V E P GSL ++ I + + + + + YL S
Sbjct: 62 YGVV--LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE----S 115
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT-IGYMAPEYGSEG 605
IH DL NILL + + DFG+ + L + ED + + + APE
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 606 IVSTKCDVYSYGVLLMETFTEKKPTDEMFT-GEMSLRRWVKESLPHRLTEVVDANLVREE 664
S DV+ +GV L EMFT GE W S L + +D R E
Sbjct: 176 TFSHASDVWMFGVTLW----------EMFTYGEEP---WAGLSGSQIL-KKIDKEGERLE 221
Query: 665 QAFSDKMDCLFSIMDLALDCCMDTPHKR 692
+ C I ++ L C P R
Sbjct: 222 RP----EACPQDIYNVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 9e-20
Identities = 83/294 (28%), Positives = 129/294 (43%), Gaps = 47/294 (15%)
Query: 433 NLLGTGGFGSVYKGTLS-DG--TNVAIKIFN-LQLERAFRSFDSECEILRNV-RHRNLLK 487
+++G G FG V K + DG + AIK + R F E E+L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILQRLNIMID 532
+LG+C + + L +E+ P+G+L +L L Q L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
V ++YL S IH DL NIL+ EN VA ++DFG+S+ G+ E V +TM
Sbjct: 121 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRL 173
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHR 651
+ +MA E + + +T DV+SYGVLL E + P M E+ E LP
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQG 227
Query: 652 LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
R E+ ++C + DL C + P++R L ++
Sbjct: 228 Y---------RLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 8/195 (4%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
LG G FG V+ GT + T VAIK +F E +I++ +RH L+ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 495 LDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
+V EFM GSL +L + +L + Q +++ + + Y+ + IH D
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN----YIHRD 127
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
L+ NIL+ +N+V ++DFG+++L+ + E + Q I + APE G + K DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 614 YSYGVLLMETFTEKK 628
+S+G+LL E T+ +
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 433 NLLGTGGFGSVYKGT-LSDGTNVAIK-IFNLQLER--------AFRSFDSECEILRNVRH 482
LG G + VYK G VAIK I + + A R E ++L+ ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLLQELKH 61
Query: 483 RN---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
N LL + G SN++ LV EFM LEK + + L + M+ LEY
Sbjct: 62 PNIIGLLDVFGHKSNIN---LVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
LH I+H DLKP N+L+ + V ++DFG+++ G + T + T Y AP
Sbjct: 118 LHSNW----ILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVVTRWYRAP 171
Query: 600 E--YGSEGIVSTKCDVYSYGVLLME 622
E +G+ D++S G + E
Sbjct: 172 ELLFGAR-HYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 433 NLLGTGGFGSVYKGTLSDGTNV-AIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKI 488
++G G FG V D + A+K N Q + + R+ +E IL+ + H L+ +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
S + + LV++ + G L L F + + + ++ ALEYLH S
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLH----SKG 120
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVS 608
IIH D+KP NILLDE H++DF I+ + + T T T GYMAPE S
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 609 TKCDVYSYGVLLMETFTEKKP 629
D +S GV E K+P
Sbjct: 178 VAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
LG G FG V+ GT + T VA+K + SF E +I++ +RH L+++ S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 495 LDFKALVLEFMPNGSLEKWLYS-HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
+V E+M GSL +L L + +++ V + + Y+ + IH D
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN----YIHRD 127
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
L+ NIL+ + +V ++DFG+++L+ + E + Q I + APE G + K DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 614 YSYGVLLMETFTEKK 628
+S+G+LL E T+ +
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 435 LGTGGFGSVYKGTLSDGTN--VAIKIFNLQLERA-FRSFDSECEILRNVRHRNLLKILGS 491
LG G G V K L T +A+K L++ A + E +IL ++ G+
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 492 CSNLDFKALVLEFMPNGSLEKWL--YSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
N ++ +E+M GSL+K L IL + I + V L YLH H I
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK---I 122
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG---YMAPEYGSEGI 606
IH D+KP+NIL++ + DFG+S L + ++ +G YMAPE
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-------VNSLAKTFVGTSSYMAPERIQGND 175
Query: 607 VSTKCDVYSYGVLLMETFTEKKP 629
S K D++S G+ L+E T + P
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 433 NLLGTGGFGSVYKGTL-SDG--TNVAIK-IFNLQLERAFRSFDSECEIL-RNVRHRNLLK 487
+++G G FG V K + DG + AIK + + R F E E+L + H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILQRLNIMID 532
+LG+C + + L +E+ P+G+L +L L Q L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
V ++YL S IH DL NIL+ EN VA ++DFG+S+ G+ E V +TM
Sbjct: 133 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRL 185
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLME 622
+ +MA E + + +T DV+SYGVLL E
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 435 LGTGGFGSV----YKGTLSDGTN--VAIKIFNLQLERAFRS-FDSECEILRNVRHRNLLK 487
LG G FG V Y +DGT VA+K + + S + E IL+ + H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 488 ILGSCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
G CS K L++E++P GSL +L H L++ Q L + + YLH H
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQH- 127
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV-IQTMTMATIGYMAPEYGSE 604
IH DL N+LLD + + + DFG++K + EG + ++ + + + A E E
Sbjct: 128 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 605 GIVSTKCDVYSYGVLLMETFT 625
S DV+S+GV L E T
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 71/222 (31%), Positives = 104/222 (46%), Gaps = 58/222 (26%)
Query: 427 DEFNECNLLGTGGFGSV----YKGTLSDGTNVAIKIFNL-------QLERAFRSFDSECE 475
D+F LGTG FG V +KG+ G A+KI + Q+E +E
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVL----NEKR 53
Query: 476 ILRNVRHRNLLKILGS---CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMI- 531
IL+++RH L+ + GS SNL LV+E++P G L +SH L R +
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNL---YLVMEYVPGGEL----FSH---LRKSGRFPEPVA 103
Query: 532 -----DVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586
V ALEYLH I++ DLKP N+LLD + ++DFG +K +
Sbjct: 104 RFYAAQVVLALEYLHSLD----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----- 154
Query: 587 QTMTM-ATIGYMAPEYGSEGIVSTK-----CDVYSYGVLLME 622
T T+ T Y+APE I+ +K D ++ G+L+ E
Sbjct: 155 -TYTLCGTPEYLAPE-----IILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 44/217 (20%)
Query: 427 DEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNL 485
+++ +G+G +G VYK ++ G VAIK+ L+ F E +L+ RH N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLN----------IMIDVGS 535
+ GS D +V+E+ GSL+ DI Q + +
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLK 112
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT-- 593
L YLH IH D+K NILL E+ ++DFG+S L T T+A
Sbjct: 113 GLAYLHETG----KIHRDIKGANILLTEDGDVKLADFGVSAQL---------TATIAKRK 159
Query: 594 --IG---YMAPEYGSE---GIVSTKCDVYSYGVLLME 622
IG +MAPE + G KCD+++ G+ +E
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 72/230 (31%), Positives = 106/230 (46%), Gaps = 32/230 (13%)
Query: 420 LDIRRATDEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDSECEILR 478
L+ DE E +LG G +G VY LS +AIK + R + E +
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 479 NVRHRNLLKILGSCSNLDFKALVLEFMPNGSLE-----KW--LYSHN-----YFLDILQR 526
++HRN+++ LGS S F + +E +P GSL KW L + Y IL+
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE- 119
Query: 527 LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEGEDSV 585
L+YLH I+H D+K N+L++ + V +SDFG SK L G +
Sbjct: 120 ---------GLKYLH----DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPC 165
Query: 586 IQTMTMATIGYMAPEYGSEGI--VSTKCDVYSYGVLLMETFTEKKPTDEM 633
+T T T+ YMAPE +G D++S G ++E T K P E+
Sbjct: 166 TETFT-GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 19/218 (8%)
Query: 428 EFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQ------LERAFRSFDSECEILRNVR 481
E+ + +LG G +G+VY G + G +A+K L E+ + E ++L++++
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI-LQRLNIMIDVGSALEYL 540
H N+++ LG+C + + ++ +EF+P GS+ L + + I G A YL
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--YL 118
Query: 541 H-HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG----EGEDSVIQTMTMATIG 595
H +C ++H D+K N++L N + + DFG ++ L G S + T
Sbjct: 119 HNNC-----VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
+MAPE +E K D++S G + E T K P M
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 434 LLGTGGFGSVYKGTLSD-GTNVAIKIFNL-----QLERAFRSFDSECEILRNVRHRNLLK 487
LLG G FG VY D G +A+K + ++ + + E ++L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
G + + ++ +E+MP GS++ L ++ + + R + +EYLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSNM--- 124
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLL------GEGEDSVIQTMTMATIGYMAPEY 601
I+H D+K NIL D + DFG SK L G G SV T +M+PE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-----GTPYWMSPEV 178
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
S K DV+S G ++E TEK P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 32/201 (15%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQ---LERAFRSFDSECEILRNVRHRNLLKILG 490
+G G G VYK T + G VAIK L+ E E I+++ +H N++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYD 82
Query: 491 SCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
S L L V+E+M GSL + + ++ Q + +V LEYLH S
Sbjct: 83 S--YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQN 136
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPE------Y 601
+IH D+K NILL ++ ++DFG + L + + + ++ T +MAPE Y
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDY 193
Query: 602 GSEGIVSTKCDVYSYGVLLME 622
G K D++S G++ +E
Sbjct: 194 G------PKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 72/291 (24%), Positives = 124/291 (42%), Gaps = 44/291 (15%)
Query: 435 LGTGGFGSVYKGTL-----SDGTNVAIKIF-NLQLERAFRSFDSECEILRNVRHRNLLKI 488
LG FG +YKG L VAIK ++ + + F E ++ + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHN----------------YFLDILQRLNIMID 532
LG + ++ E++ G L ++L + LD L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
+ + +EYL SS +H DL NIL+ E + +SD G+S+ + + +Q ++
Sbjct: 133 IAAGMEYL----SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652
I +M PE G S+ D++S+GV+L E F+ F+ +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------------- 233
Query: 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703
EV++ +VR+ Q DC + L +C + P +R D +LR
Sbjct: 234 -EVIE--MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 78/287 (27%), Positives = 128/287 (44%), Gaps = 38/287 (13%)
Query: 435 LGTGGFGSVYKGTLSDGTN---VAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKIL 489
LG G FGSV +G L+ + VA+K + + F SE ++ H N+++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 490 GSC----SNLDFKA--LVLEFMPNGSLEKWL-YSH----NYFLDILQRLNIMIDVGSALE 538
G C + + + ++L FM +G L +L YS +L + M D+ S +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
YL SS IH DL N +L+ENM V+DFG+SK + G+ + + ++A
Sbjct: 127 YL----SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658
E ++ + +TK DV+S+GV + E T + + G V+ S E+ D
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP---YPG-------VENS------EIYD- 225
Query: 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+R+ DCL + L C + P R +L K
Sbjct: 226 -YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 435 LGTGGFGSVYKGTL---SDGTNVAIKIFNLQLERAFR-SFDSECEILRNVRHRNLLKILG 490
LG+G FG V KG +VAIK+ + E++ R E EI+ + + +++++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550
C LV+E G L K+L + + + +M V ++YL +
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE----GKNFV 117
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT--IGYMAPEYGSEGIVS 608
H DL N+LL A +SDFG+SK LG +DS + + + + APE + S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 609 TKCDVYSYGVLLMETFT-EKKPTDEM 633
++ DV+SYG+ + E F+ +KP +M
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 75/305 (24%), Positives = 124/305 (40%), Gaps = 54/305 (17%)
Query: 435 LGTGGFGSVYKGT------LSDGTNVAIKIFNLQLERA-FRSFDSECEILRNVRHRNLLK 487
LG G FG V K T + T VA+K+ + R SE +L+ V H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWL-----------------YSHNYFLDILQRLNIM 530
+ G+CS L++E+ GSL +L S + L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 531 I------DVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584
+ ++YL + ++H DL N+L+ E +SDFG+S+ + E +
Sbjct: 128 DLISFAWQISRGMQYL----AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRW 643
V ++ + +MA E + I +T+ DV+S+GVLL E T P + G R +
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP----YPGIAPERLF 239
Query: 644 VKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703
NL++ +C + +L L C P KR D + +L
Sbjct: 240 ---------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
Query: 704 KIKAK 708
K+ K
Sbjct: 285 KMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 428 EFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFD--------SECEILR 478
++ +G G FG+V K SDG + K E + + SE ILR
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWK------EIDYGNMTEKEKQQLVSEVNILR 54
Query: 479 NVRHRNLLKILGSCSNLDFKAL--VLEFMPNGSLEKWL---YSHNYFLDILQRLNIMIDV 533
++H N+++ + + L V+E+ G L + + +++ I+ +
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 534 GSALEYLHHCHSSAP----IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
A L+ CH+ + ++H DLKP NI LD N + DFG++K+L G DS
Sbjct: 115 LLA---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFAKT 169
Query: 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLME 622
+ T YM+PE + K D++S G L+ E
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 12/230 (5%)
Query: 428 EFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLE-----RAFRSFDSECEILRNVR 481
EF + +LG+G FG+VYKG + +G V I + +L +A + E ++ +V
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
+ ++ ++LG C + L+ + MP G L ++ H + LN + + + YL
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
++H DL N+L+ ++DFG++KLLG E I +MA E
Sbjct: 127 ERR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 602 GSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPH 650
I + + DV+SYGV + E T KP D + E+S E LP
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 80/293 (27%), Positives = 118/293 (40%), Gaps = 51/293 (17%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLE------RAFRSFDSECEILRNVRHRNLLK 487
+G G +G VYK G VAIK L+ E A R E ++L+ + H N++K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+L + LV EFM + L K + L + + + L + H S
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SH 117
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--YGSEG 605
I+H DLKP N+L++ V ++DFG+++ G T + T Y APE G +G
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 606 IVSTKCDVYSYGVLLMETFTEK--------------------KPTDEMFTGEMSLRRWVK 645
ST D++S G + E + + P E++ SL R K
Sbjct: 176 -YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 646 ESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
S P + L + S + L S M L D PHKRI A
Sbjct: 235 FSFPKK----AGMPLPKLFPNASPQALDLLSQM-LHYD-----PHKRITAEQA 277
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 433 NLLGTGGFGSVYKGTLS--DGTN----VAIKIFNLQLERAFRS-FDSECEILRNVRHRNL 485
LG G FG VY+G DG VA+K S F E I+ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILQRLNIMIDVGSALEY 539
++++G + ++LE M G L+ +L L + L DV +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 540 LHHCHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
L H IH D+ N LL VA ++DFG+++ + M I +
Sbjct: 132 LEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
M PE +GI ++K DV+S+GVLL E F+
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-17
Identities = 41/103 (39%), Positives = 65/103 (63%), Gaps = 1/103 (0%)
Query: 218 INLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI 277
+ L + L+G +P++I KL L ++LS N + +IP ++G++ +LE L L+ N F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 278 PESVGNLISLESLDFSNNNLSGKIPKSLEA-LSHLKQFNVSHN 319
PES+G L SL L+ + N+LSG++P +L L H FN + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 435 LGTGGFGSVYKGTL-SDGTNVAIK------IFNLQLERAFRSFDSECEILRNVRHRNLLK 487
LG GGFG V + S A+K I + S E EIL H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNI--MIDVGSALEYLHHCHS 545
+ + + + +++E+ G L L F + R I ++ A EYLH+
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHNRG- 113
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEYGSE 604
II+ DLKP N+LLD N + DFG +K L G+ +T T T Y+APE
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPE---- 162
Query: 605 GIVSTK-----CDVYSYGVLLMETFTEKKPTDEMFTGE 637
I+ K D +S G+LL E T + P F +
Sbjct: 163 -IILNKGYDFSVDYWSLGILLYELLTGRPP----FGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTL----SDGTNVAIKIFNLQLERAFRS-FDSECEI 476
I+R C +G G FG VY+G ++ VA+K + R F E I
Sbjct: 3 IQREDITLGRC--IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 477 LRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSA 536
+R H +++K++G + + +V+E P G L +L + Y LD+ + + +A
Sbjct: 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
L YL S +H D+ N+L+ + DFG+S+ L E E + I +
Sbjct: 120 LAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKW 174
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTE-KKP 629
MAPE + ++ DV+ +GV + E KP
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 70/207 (33%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 434 LLGTGGFGSVYK-GTLSDGTNVAIKIFNLQLERAFRSFDS--ECEILRNVRHRNLLKILG 490
LG G +GSVYK LSD A+K +L D+ E IL +V H N+ I
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI--ISY 64
Query: 491 SCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILQR---LNIMIDVGSALEYLHHCHS 545
+ LD L V+E+ P G L K + ++ I I + L+ LH
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---- 120
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG---YMAPEYG 602
I+H DLK NILL N + + D GISK+L + M IG YMAPE
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLK-------KNMAKTQIGTPHYMAPEVW 173
Query: 603 SEGIVSTKCDVYSYGVLLMETFTEKKP 629
S K D++S G LL E T P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 65/198 (32%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAF--RSFDSECEILRNVRHRNLLKILGSC 492
LG+G FG V+ G VAIK N E A F E +++ + H L+++ G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFL--DILQRLNIMIDVGSALEYLHHCHSSAPII 550
+ +V EFM NG L +L L D+L L++ DV +EYL I
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLER----NSFI 122
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTK 610
H DL N L+ V VSDFG+++ + + E + + + PE + S+K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 611 CDVYSYGVLLMETFTEKK 628
DV+S+GVL+ E FTE K
Sbjct: 182 SDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 8e-17
Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 12/241 (4%)
Query: 428 EFNECNLLGTGGFGSVYKGT-LSDGTN----VAIKIFNLQL-ERAFRSFDSECEILRNVR 481
E +LG+G FG+VYKG + +G VAIKI N +A F E I+ ++
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
H +L+++LG C + + LV + MP+G L +++ H + LN + + + YL
Sbjct: 68 HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
++H DL N+L+ ++DFG+++LL E I +MA E
Sbjct: 127 E----RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 602 GSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660
+ + DV+SYGV + E T KP D + T E+ E LP +D +
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242
Query: 661 V 661
V
Sbjct: 243 V 243
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-16
Identities = 43/117 (36%), Positives = 68/117 (58%), Gaps = 4/117 (3%)
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
L L L IP+ I L++L++++L+GN +G IP S+G++ SLE LD S N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIP--VKGSFKDFSAQSYFGNYALCGPPRLQVPPC 356
P+SL L+ L+ N++ N L G +P + G ++ ++ N LCG P L C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RAC 537
|
Length = 623 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 47/219 (21%)
Query: 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNL--------QLERAFRSFDSECEIL 477
++ E + LG G GSV K L + G A+K Q+ R E EI
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-------ELEIN 53
Query: 478 RNVRHRNLLKILGSC-----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR------ 526
++ + ++K G+ S++ + +E+ GSL+ +Y + +R
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSI---GIAMEYCEGGSLDS-IYK-----KVKKRGGRIGE 104
Query: 527 ---LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583
I V L YLH S IIH D+KP+NILL + DFG+S GE +
Sbjct: 105 KVLGKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVN 157
Query: 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLME 622
S+ T T T YMAPE S DV+S G+ L+E
Sbjct: 158 SLAGTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 64/248 (25%), Positives = 110/248 (44%), Gaps = 28/248 (11%)
Query: 431 ECNLLGTGGFGSVY----KGTLSDGTN--VAIKIFN-LQLERAFRSFDSECEILRNVRHR 483
E LG G FG V+ KG +G V +K + E F E ++ R + H+
Sbjct: 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL--------QRLNIMIDVGS 535
N++++LG C + ++LE+ G L+++L + + L Q++ + +
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
+++L S+A +H DL N L+ VS +SK + E ++ + +
Sbjct: 129 GMDHL----SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN-ALIPLR 183
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLLMETFT------EKKPTDEMFTG--EMSLRRWVKES 647
++APE E STK DV+S+GVL+ E FT +E+ L V E
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243
Query: 648 LPHRLTEV 655
P RL ++
Sbjct: 244 CPSRLYKL 251
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 40/220 (18%)
Query: 428 EFNECNLLGTGGFGSVYKGT-LSDGTNVAIK-IFNLQLERAFRSFDSECEILRNVRHRNL 485
E N +G+G G+VYK G A+K I+ + R E EILR+V H N+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
+K + ++LEFM GSLE + FL + R + S + YLH H
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-----QILSGIAYLHRRH- 188
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM-----TMATIGYMAPE 600
I+H D+KP+N+L++ ++DFG+S++L QTM ++ TI YM+PE
Sbjct: 189 ---IVHRDIKPSNLLINSAKNVKIADFGVSRILA-------QTMDPCNSSVGTIAYMSPE 238
Query: 601 Y-----------GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
G G D++S GV ++E + + P
Sbjct: 239 RINTDLNHGAYDGYAG------DIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 433 NLLGTGGFGSVYKGTLSDG----TNVAIKIFN--LQLERAFRSFDSECEILRNVRHRNLL 486
++G G FG VY GTL D + A+K N LE F E I+++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV-EQFLKEGIIMKDFSHPNVL 59
Query: 487 KILGSCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
+LG C + LV L +M +G L ++ S + + + + V +EYL +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL----A 115
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT--IGYMAPEYGS 603
S +H DL N +LDE+ V+DFG+++ + + E + T A + +MA E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKP 629
+TK DV+S+GVLL E T P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 14/210 (6%)
Query: 428 EFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQ-LERAFRSFD-SECEILRNVRHRN 484
+F N +G G FG V+K +D A+K +L + R R E +L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHN---YFLDILQRLNIMIDVGSALEYLH 541
+++ S + +V+E+ NG L K L D + R I I +G L +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--LAHLH 118
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
S I+H D+K N+ LD + D G++KLL +++ + T Y++PE
Sbjct: 119 ----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPEL 172
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTD 631
+ + K DV++ GV+L E T K P D
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 50/225 (22%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEI--------- 476
+ F +G G FG VYK VAIK+ +L+ ++E EI
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--------EAEDEIEDIQQEIQF 52
Query: 477 LRNVRHRNLLKILGSC---SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQ--RLN--- 528
L R + K GS S L +++E+ GS LD+L+ +L+
Sbjct: 53 LSQCRSPYITKYYGSFLKGSKL---WIIMEYCGGGSC----------LDLLKPGKLDETY 99
Query: 529 ---IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585
I+ +V LEYLH IH D+K NILL E ++DFG+S G+ ++
Sbjct: 100 IAFILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVS---GQLTSTM 152
Query: 586 IQTMTMA-TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+ T T +MAPE + K D++S G+ +E + P
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 434 LLGTGGFGSVYKGTL--SDGT--NVAIKIFNLQLERA--FRSFDSECEILRNVRHRNLLK 487
+LG G FGSV + L DG+ VA+K+ + + F E ++ H N++K
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 488 ILG------SCSNLDFKALVLEFMPNGSLEKWLY----SHNYFLDILQRL-NIMIDVGSA 536
++G + L ++L FM +G L +L F LQ L MID+ S
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
+EYL SS IH DL N +L+ENM V+DFG+SK + G+ + + +
Sbjct: 126 MEYL----SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+A E ++ + +T DV+++GV + E T
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 25/203 (12%)
Query: 438 GGFGSVYKG-TLSDGTNVAIKIFN---LQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
G +G V+ S G AIK+ + + +E +IL + ++K+ S
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
LV+E++P G L L + + + R + ++ ALEYLH IIH D
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHSNG----IIHRD 118
Query: 554 LKPTNILLDENMVAHVSDFGISKL------LGEGEDSVIQTMTMATIGYMAPEYGSEGIV 607
LKP NIL+D N ++DFG+SK+ + +D + T Y+APE ++
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-----VI 173
Query: 608 -----STKCDVYSYGVLLMETFT 625
S D +S G +L E
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 51/195 (26%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
LG G FG V+ G ++ T VA+K + ++F E +++ ++H L+++ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 495 LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL-NIMIDVGSALEYLHHCHSSAPIIHCD 553
+ ++ E+M GSL +L S +L +L + + + Y+ + IH D
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 128
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
L+ N+L+ E+++ ++DFG+++++ + E + + I + APE + G + K DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDV 187
Query: 614 YSYGVLLMETFTEKK 628
+S+G+LL E T K
Sbjct: 188 WSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTN----VAIK-IFNLQLERAFRSFDSECEILRN 479
E + LLG+G FG+V+KG + +G + VAIK I + + F+ + +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 480 VRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
+ H ++++LG C + LV + P GSL + H LD + LN + + + Y
Sbjct: 66 LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 540 LH-HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
L H ++H +L NILL + + ++DFG++ LL + + I +MA
Sbjct: 125 LEEHR-----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFT 625
E G + + DV+SYGV + E +
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 16/177 (9%)
Query: 469 SFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR-- 526
F E +IL + N+ ++LG C+ +++E+M NG L ++L H L
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 527 --------LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578
L + + S + YL S +H DL N L+ +N ++DFG+S+ L
Sbjct: 125 KSLSFSTLLYMATQIASGMRYL----ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT--EKKPTDEM 633
+ +Q I +MA E G +TK DV+++GV L E T ++P + +
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 53/192 (27%), Positives = 97/192 (50%), Gaps = 8/192 (4%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
LG G FG V+ G + T VAIK Q + +F +E +++ ++H L+++ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 495 LDFKALVLEFMPNGSLEKWL-YSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
++ E+M NGSL +L L I + +++ + + ++ + IH D
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY----IHRD 127
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
L+ NIL+ E + ++DFG+++L+ E + + I + APE + G + K DV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 614 YSYGVLLMETFT 625
+S+G+LL E T
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 434 LLGTGGFGSVYKGTLSD------GTNVAIKIFNLQ-LERAFRSFDSECEILRNV-RHRNL 485
LG G FG V K + VA+K+ E+ SE E+++ + +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSH-------NYFLDILQRLNIMI------- 531
+ +LG C+ +V+E+ +G+L +L + + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 532 -DVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590
V +E+L +S IH DL N+L+ E+ V ++DFG+++ + + T
Sbjct: 139 YQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + + + DV+S+GVLL E FT
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 428 EFNECNL-----LGTGGFGSVYKGTL-----SDGT-NVAIKIFNLQLERAFR-SFDSECE 475
EF NL LG G FG V + T SD VA+K+ + R + SE +
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 476 ILRNV-RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNY-FLDILQRLNIMIDV 533
I+ ++ H N++ +LG+C+ ++ E+ G L +L FL + L+ V
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT 593
+ +L +S IH DL N+LL + + DFG+++ + + V++
Sbjct: 151 AKGMAFL----ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 594 IGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + + DV+SYG+LL E F+
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 30/212 (14%)
Query: 434 LLGTGGFGSVY--KGTLSDGTNVAIKIFNL-QLERAFR-SFDSECEILRNVRHRNLLKIL 489
++G G FG V+ + +D V IK + Q+ + R + +EC++L+ + H N+++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 490 GSCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY-------L 540
+ L+ KAL V+E+ P G+L ++ I +R N ++D + L + L
Sbjct: 66 ENF--LEDKALMIVMEYAPGGTLAEY---------IQKRCNSLLDEDTILHFFVQILLAL 114
Query: 541 HHCHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
HH H+ I+H DLK NILLD++ MV + DFGISK+L + + T Y++P
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISP 170
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTEKKPTD 631
E + K D+++ G +L E + K+ +
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 75/231 (32%), Positives = 113/231 (48%), Gaps = 41/231 (17%)
Query: 423 RRATDEFNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLER------AFRSFDSECE 475
+R D+F+ +G G +G VYK D G VA+K L E+ A R E +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIK 58
Query: 476 ILRNVRHRNLLKILGSCSN----LDFKA------LVLEFMPN---GSLEKWL--YSHNYF 520
ILR + HRN++ + ++ LDFK LV E+M + G LE L +S ++
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 521 LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580
+++L LE L++CH +H D+K +NILL+ ++DFG+++L
Sbjct: 119 KSFMKQL---------LEGLNYCHKKN-FLHRDIKCSNILLNNKGQIKLADFGLARLY-N 167
Query: 581 GEDSVIQTMTMATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
E+S T + T+ Y PE G E DV+S G +L E FT KKP
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 435 LGTGGFGSVY-------KGTLSDGTN--------VAIKIFNLQLERAFRS-FDSECEILR 478
LG G FG V+ L +G VA+K+ + + R+ F E +I+
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 479 NVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWL--------YSHNYFLDILQRLNIM 530
+++ N++++LG C + D ++ E+M NG L ++L ++H + + N++
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 531 ---IDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587
+ + S ++YL +S +H DL N L+ + ++DFG+S+ L G+ IQ
Sbjct: 133 YMAVQIASGMKYL----ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ I +MA E G +T DV+++GV L E FT
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 434 LLGTGGFGSVYKGTLSD-GTNVAIK--IFNLQLERAFRSFDS-ECEI--LRNVRHRNLLK 487
LLG G FG VY +D G +A+K F+ + + ++ ECEI L+N+RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 488 ILGSCSNLDFKALVL--EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
G + + K L + E+MP GS++ L ++ + + R + + YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---- 123
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG---------Y 596
S I+H D+K NIL D + DFG SK IQT+ M+ G +
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKR--------IQTICMSGTGIKSVTGTPYW 175
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDE 632
M+PE S K DV+S ++E TEK P E
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 62/230 (26%), Positives = 112/230 (48%), Gaps = 15/230 (6%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
LG G FG V+ T + T VA+K + +F +E +++ ++H L+K L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVK-LHAVVT 71
Query: 495 LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL-NIMIDVGSALEYLHHCHSSAPIIHCD 553
+ ++ EFM GSL +L S L +L + + + ++ + IH D
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRD 127
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
L+ NIL+ ++V ++DFG+++++ E + + I + APE + G + K DV
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 614 YSYGVLLMETFTE-KKPTDEMFTGEM--SLRRWVK----ESLPHRLTEVV 656
+S+G+LLME T + P M E+ +L R + E+ P L ++
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 20/233 (8%)
Query: 425 ATDEFNECNLLGTGGFGSVY----KGTLSDG--TNVAIKIFNLQLERAFR-SFDSECEIL 477
A ++ LG G FG VY KG + D T VAIK N R F +E ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYS-----HNYFLDILQRLNIMI- 531
+ +++++LG S +++E M G L+ +L S N + L MI
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 532 ---DVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT 588
++ + YL ++ +H DL N ++ E+ + DFG+++ + E +
Sbjct: 124 MAGEIADGMAYL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 589 MTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR 641
+ + +M+PE +G+ +T DV+S+GV+L E T + + + E LR
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 35/231 (15%)
Query: 435 LGTGGFGSVY--------KGTLSDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRN 484
LG G FG V K + T VA+K+ E+ SE E+++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWL---------YSHN------YFLDILQRLNI 529
++ +LG+C+ +++E+ G+L ++L Y +N L ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
V +EYL +S IH DL N+L+ E+ V ++DFG+++ + + T
Sbjct: 146 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT------EKKPTDEMF 634
+ +MAPE + I + + DV+S+GVLL E FT P +E+F
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 39/291 (13%)
Query: 435 LGTGGFGSVY------KGTLSDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLK 487
LG G FG V +G + G VA+K + E EILRN+ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 488 ILGSCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
G C+ L++EF+P+GSL+++L + +++ Q+L + + ++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL----G 126
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-SVIQTMTMATIGYMAPEYGSE 604
S +H DL N+L++ + DFG++K + ++ ++ + + + APE +
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 605 GIVSTKCDVYSYGVLLMETFT----EKKPTDEMFT------GEMSLRRWVKESLPHRLTE 654
DV+S+GV L E T E P G+M++ R V+
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR--------- 237
Query: 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
++ E + +C + L C P KR + I
Sbjct: 238 -----VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/291 (22%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 435 LGTGGFGSVYKGTLSDGT------NVAIKIFNLQLERAFRS-FDSECEILRNVRHRNLLK 487
LG FG VYKG L VAIK + E R F E + ++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR---------------LNIMID 532
+LG + +++ + + L ++L + D+ ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
+ + +E+L SS ++H DL N+L+ + + +SD G+ + + + + ++
Sbjct: 133 IAAGMEFL----SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652
I +M+PE G S D++SYGV+L E F+ L+ + S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YGLQPYCGYS----N 232
Query: 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703
+V++ ++R Q DC + L L+C + P +R D ++LR
Sbjct: 233 QDVIE--MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 434 LLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLE-----RAFRSFDSECEILRNVRHRNLLK 487
LLG G FG VY D G +A K E + + + E ++L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 488 ILGSCSNLDFKALV--LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
G + K L +E+MP GS++ L ++ + + R + + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---- 123
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG---------Y 596
S I+H D+K NIL D + DFG SK L QT+ M+ G +
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICMSGTGIRSVTGTPYW 175
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDE 632
M+PE S K DV+S G ++E TEK P E
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQ------LERAFRSFDSECEILRNVRHRNLL 486
LGTG F S Y+ + GT +A+K E + E ++ + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
++LG+ L +E+M GS+ L + F + + +N + L YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-INYTEQLLRGLSYLHENQ-- 123
Query: 547 APIIHCDLKPTNILLDEN-MVAHVSDFGI-----SKLLGEGEDSVIQTMTMATIGYMAPE 600
IIH D+K N+L+D ++DFG +K G GE Q + TI +MAPE
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE---FQGQLLGTIAFMAPE 178
Query: 601 ------YGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
YG CDV+S G +++E T K P
Sbjct: 179 VLRGEQYGRS------CDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
LG G FG VYK G A KI ++ E F E +IL +H N++ + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
+ +++EF G+L+ + L Q + + AL +LH S +IH D
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHRD 128
Query: 554 LKPTNILLDENMVAHVSDFGIS-KLLGEGE--DSVIQTMTMATIGYMAPEY-----GSEG 605
LK NILL + ++DFG+S K + D+ I T +MAPE +
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEVVACETFKDN 183
Query: 606 IVSTKCDVYSYGVLLMETFTEKKPTDEM 633
K D++S G+ L+E + P E+
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 33/185 (17%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQL------ERAFRSFDSECEILRNVRHRNLLK 487
+G G G V+K G VA+K L+ +A R E + L+ +H ++K
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63
Query: 488 IL-----GSCSNLDFKALVLEFMPNGSLEKWL--YSHNYFLDILQRLNIMIDVGSALEYL 540
+L GS LV+E+MP L + L ++ M+ L+ +
Sbjct: 64 LLDVFPHGSGF-----VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML-----LKGV 112
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE 600
+ H++ I+H DLKP N+L+ + V ++DFG+++L E E + + +AT Y APE
Sbjct: 113 AYMHANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQVATRWYRAPE 170
Query: 601 --YGS 603
YG+
Sbjct: 171 LLYGA 175
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 60/231 (25%), Positives = 109/231 (47%), Gaps = 35/231 (15%)
Query: 435 LGTGGFGSVY--------KGTLSDGTNVAIKIF-NLQLERAFRSFDSECEILRNV-RHRN 484
LG G FG V K + VA+K+ + E+ SE E+++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDILQ----------RLNI 529
++ +LG+C+ +++E+ G+L ++L + Y DI + ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
V +EYL +S IH DL N+L+ EN V ++DFG+++ + + T
Sbjct: 143 TYQVARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT------EKKPTDEMF 634
+ +MAPE + + + + DV+S+GVL+ E FT P +E+F
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 454 VAIKIFNLQLERAFRS-FDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEK 512
VA+K+ + R+ F E +I+ ++ N++++L C D ++ E+M NG L +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 513 WLYSHNY----------FLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD 562
+L H + + + + S ++YL SS +H DL N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL----SSLNFVHRDLATRNCLVG 164
Query: 563 ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLME 622
+N ++DFG+S+ L G+ IQ + I +M+ E G +T DV+++GV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 623 TFT--EKKP----TDEMF---TGE 637
T +++P +DE TGE
Sbjct: 225 ILTLCKEQPYSQLSDEQVIENTGE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 54/157 (34%), Positives = 82/157 (52%), Gaps = 18/157 (11%)
Query: 502 LEFMPNGSLEKW---LYSHNYFL--DILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKP 556
+E M + SL+K+ +Y + DIL + I + + ALEYLH S +IH D+KP
Sbjct: 79 MEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLH---SKLSVIHRDVKP 132
Query: 557 TNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY----GSEGIVSTKCD 612
+N+L++ N + DFGIS G DSV +T+ YMAPE ++ K D
Sbjct: 133 SNVLINRNGQVKLCDFGIS---GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSD 189
Query: 613 VYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649
V+S G+ ++E T + P D T L++ V+E P
Sbjct: 190 VWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR------HRNLLK 487
+G G VY L + VAIK +L E+ S D E+ + V+ H N++K
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVD---ELRKEVQAMSQCNHPNVVK 63
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNI---MIDVGSALEYLH-HC 543
S D LV+ ++ GSL + +Y L I + +V LEYLH +
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIGYMAPEY 601
IH D+K NILL E+ ++DFG+S L +G D + + T +MAPE
Sbjct: 123 Q-----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 602 GSEGIVST-KCDVYSYGVLLMETFTEKKP 629
+ K D++S+G+ +E T P
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 434 LLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLE-----RAFRSFDSECEILRNVRHRNLLK 487
LLG G FG VY +D G +A+K E + + + E ++L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 488 ILGSCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLD-ILQRLNIMIDVGSALEYLHHCH 544
G + + L +E MP GS++ L S+ + + ++ I LE + + H
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL------GEGEDSVIQTMTMATIGYMA 598
S+ I+H D+K NIL D + DFG SK L G G SV T +M+
Sbjct: 124 SNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-----TGTPYWMS 177
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDE 632
PE S K D++S G ++E TEK P E
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 435 LGTGGFGSVYK-GTLSDGTNVAIKIFNLQLERAFR-SFDSECEILRNVRHRNLLKILGSC 492
LG G GSV K + GT +A K+ ++ + + R E +I+ R ++ G+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYF-LDILQRLNIMIDVGSALEYLHHCHSSAPIIH 551
N + + +EFM GSL++ ++IL + I + V L YL++ H I+H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR---IMH 127
Query: 552 CDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKC 611
D+KP+NIL++ + DFG+S GE +S+ T + T YM+PE G + K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTYMSPERIQGGKYTVKS 183
Query: 612 DVYSYGVLLMETFTEKKPTDE 632
DV+S G+ ++E K P
Sbjct: 184 DVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 87/317 (27%), Positives = 132/317 (41%), Gaps = 85/317 (26%)
Query: 433 NLLGTGGFGSVYKGT-LSDGTNVAIKI---FNLQL--ERAFRSFDSECEILRNVRHRNLL 486
+ +G G +G V T G VAIK F Q +R R E +ILR +H N++
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66
Query: 487 KILGSCSNLDFKA-----LVLEFMPNGSLEKWLYSHN-------YFL-DILQRLNIMIDV 533
IL F++ +V E M L K + + + YFL IL+
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------- 117
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ-TMTMA 592
L+Y+H SA ++H DLKP+N+LL+ N + DFG++++ D T +A
Sbjct: 118 --GLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 593 TIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEK--------------------KPT 630
T Y APE S+G + D++S G +L E + + P+
Sbjct: 172 TRWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230
Query: 631 DEMFTGEMSLR-RWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMD-LALD----- 683
E +SLR R +SLP + + ++ LF D ALD
Sbjct: 231 QEDLNCIISLRARNYIKSLPF-----------KPKVPWNK----LFPNADPKALDLLDKM 275
Query: 684 CCMDTPHKRIHMTDAAA 700
+ PHKRI + +A A
Sbjct: 276 LTFN-PHKRITVEEALA 291
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 435 LGTGGFGSVY----KGTLSDGTNVAIKIFN----LQLERAFRSFDSECEILRNVRHRNLL 486
LGTG +G V+ G G A+K+ +Q + +E ++L VR L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 487 KILGSCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
L D K L+L+++ G L LY +F + R+ I ++ AL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ--- 123
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY--GS 603
II+ D+K NILLD ++DFG+SK E+ + TI YMAPE G
Sbjct: 124 -LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRGG 181
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKP 629
G D +S GVL E T P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVA---IKIFNLQLERAFRSFDSECEILRNVRHRNLLKILG 490
+G G F VYK L DG VA ++IF + +A + E ++L+ + H N++K L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 491 SCSNLDFKALVLEFMPNGSLE---KWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
S + +VLE G L K + + + SALE++H S
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----SK 125
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT----MATIGYMAPEYGS 603
I+H D+KP N+ + V + D G+ + +T + T YM+PE
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS------KTTAAHSLVGTPYYMSPERIH 179
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE-MSL 640
E + K D++S G LL E + P F G+ M+L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 28/239 (11%)
Query: 434 LLGTGGFGSVYK--GTLSDGTNVAIKIFNL----------QLERAFRSFDSECEILR-NV 480
LG+G FG VYK + +A+K N+ + +++ SE I++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 481 RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYS----HNYFLDILQRL-NIMIDVGS 535
RH N+++ + D +V++ + L + S F + +R+ NI + +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
AL YLH I+H DL P NI+L E+ ++DFG++K T + TI
Sbjct: 125 ALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTIL 178
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP--TDEMFTGEMSLRRWVKESLPHRL 652
Y PE K DV+++G +L + T + P + M + + V E LP +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 429 FNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFD-----SECEILRNVRH 482
+ L+G G +G+VY+G + G VA+KI NL D E +L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQ 58
Query: 483 ---RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
N+ K GS +++E+ GS+ + + + I+ +V AL+Y
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVALKY 116
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
+H +IH D+K NIL+ + DFG++ LL + S T T +MAP
Sbjct: 117 IHK----VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFV-GTPYWMAP 170
Query: 600 EYGSEGIV-STKCDVYSYGVLLMETFTEKKP 629
E +EG TK D++S G+ + E T P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 427 DEFNECNLLGTGGFGSVY--KGTLSDGTNVAIKIFNL-------QLERAFRSFDSECEIL 477
D+ +GTG FG V+ + +S A+K+ + Q + +E +L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIRLKQEQHV----HNEKRVL 55
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
+ V H ++++ + + F +++E++P G L +L + F + ++ AL
Sbjct: 56 KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCAL 114
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGY 596
EYLH S I++ DLKP NILLD+ ++DFG +K L +T T+ T Y
Sbjct: 115 EYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEY 164
Query: 597 MAPE-YGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+APE S+G + D ++ G+L+ E P
Sbjct: 165 LAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 34/79 (43%), Positives = 49/79 (62%)
Query: 153 LQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSL 212
L+G++P+D+ L L +NLSGN + G IP L S+TSL L L N + S+P SL L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 213 EYILRINLSSNSLKGTLPS 231
+ +NL+ NSL G +P+
Sbjct: 490 TSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 435 LGTGGFGS--VYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILG 490
LG G FG +Y+ T D + V K NL E+ R +E IL ++H N++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 491 SCSNLDFKALV--LEFMPNGSL-EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+D L+ +E+ G+L +K + + L + + SA+ Y+H A
Sbjct: 67 HF--MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH----KA 120
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV 607
I+H D+K NI L + + + DFGISK+LG E S+ +T+ + T YM+PE
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETV-VGTPYYMSPELCQGVKY 178
Query: 608 STKCDVYSYGVLLMETFTEKK 628
+ K D+++ G +L E T K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 429 FNECNLLGTGGFGSVYKGTLSDGTN--VAIKIFNLQ-LERAFRSFDSECEILRNVRHRNL 485
F + +G G FG V+KG + + T VAIKI +L+ E E +L +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
K GS +++E++ GS L + + D Q ++ ++ L+YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---- 118
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT-MATIGYMAPEYGSE 604
S IH D+K N+LL E ++DFG++ G+ D+ I+ T + T +MAPE +
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 605 GIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
+K D++S G+ +E + P +M
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 72/231 (31%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 434 LLGTGGFGSVY---KGTLSD-GTNVAIKIF---NLQLERAFRSFDSECEILRNVRHRNLL 486
+LG G FG V+ K T D G A+K+ L++ R+ E +IL V H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
K+ + L+L+F+ G L L F + + + ++ AL++LH S
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH----S 116
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEYGSEG 605
II+ DLKP NILLDE ++DFG+SK E D + + T+ YMAPE +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 606 IVSTKCDVYSYGVLLMETFTEKKP---TDEMFTGEMSLRRWVKESLPHRLT 653
+ D +S+GVL+ E T P D T M L+ K +P L+
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--AKLGMPQFLS 222
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 38/222 (17%)
Query: 435 LGTGGFGSVYKGTL------SDGTNVAIKIF----NLQLERAFRSFDSECEILRNVRHRN 484
+G G FG V++ T VA+K+ + ++ F E ++ H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA---DFQREAALMAEFDHPN 69
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWL--------------------YSHNYF-LDI 523
++K+LG C+ L+ E+M G L ++L N L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 524 LQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583
++L I V + + YL S +H DL N L+ ENMV ++DFG+S+ + +
Sbjct: 130 TEQLCIAKQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
I +M PE +T+ DV++YGV+L E F+
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 429 FNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSEC--EI--LRNVRHR 483
+ + LG G +G VYK G VA+K ++L+ S EI L+ ++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK--IRLDNEEEGIPSTALREISLLKELKHP 58
Query: 484 N---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
N LL ++ + L LV E+ L+K+L L +IM + L Y
Sbjct: 59 NIVKLLDVIHTERKL---YLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIGYMA 598
H S I+H DLKP NIL++ + V ++DFG+++ G ++T T + T+ Y A
Sbjct: 115 H----SHRILHRDLKPQNILINRDGVLKLADFGLARAFG----IPLRTYTHEVVTLWYRA 166
Query: 599 PEYGSEGIVSTKCDVYSYGV 618
PE + YS V
Sbjct: 167 PE------ILLGSKHYSTAV 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 435 LGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
LG G FG VYK + G A K+ + E + E EIL H ++K+LG+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
+++EF P G+++ + + L Q I + AL+YLH S IIH D
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRD 135
Query: 554 LKPTNILLDENMVAHVSDFGIS----KLLGEGEDSVIQTMTMATIGYMAPE-YGSEGIVS 608
LK N+LL + ++DFG+S K L + DS I T +MAPE E +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFI-----GTPYWMAPEVVMCETMKD 189
Query: 609 T----KCDVYSYGVLLMETFTEKKPTDEM 633
T K D++S G+ L+E + P E+
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 435 LGTGGFGSVYKG---TLSDGTNVAIKIF-NLQLERAFR-SFDSECEILRNVRHRNLLKIL 489
LG+G FG+V KG VA+KI N + A + E +++ + + +++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
G C + LV+E G L K+L N + ++ V ++YL +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEETN----F 116
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV-IQTMTMATIGYMAPEYGSEGIVS 608
+H DL N+LL A +SDFG+SK LG E+ +T + + APE + S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 609 TKCDVYSYGVLLMETFTE-KKPTDEMFTGEMS 639
+K DV+S+GVL+ E F+ +KP M E++
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 41/120 (34%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 194 LYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDI 253
L L + L +P+ + L ++ INLS NS++G +P ++ + L LDLS N + I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 254 PSTIGTLKNLETLSLAGNQFQGPIPESVGN-LISLESLDFSNN-NLSGKIPKSLEALSHL 311
P ++G L +L L+L GN G +P ++G L+ S +F++N L G IP HL
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IPGLRACGPHL 541
|
Length = 623 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 55/189 (29%), Positives = 94/189 (49%), Gaps = 25/189 (13%)
Query: 454 VAIKIFNLQLERAFRS-FDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEK 512
VA+KI + R+ F E +IL ++ N++++LG C + D ++ E+M NG L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 513 WLYSHNYFLDILQR-------------------LNIMIDVGSALEYLHHCHSSAPIIHCD 553
+L S ++ D + L++ + + S ++YL SS +H D
Sbjct: 109 FL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL----SSLNFVHRD 163
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
L N L+ EN+ ++DFG+S+ L G+ IQ + I +MA E G +T DV
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 614 YSYGVLLME 622
+++GV L E
Sbjct: 224 WAFGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 420 LDIRRATDEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDSECEILR 478
L R ++F +G+G +G VYK ++ G AIK+ L+ F E +++
Sbjct: 2 LSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMK 61
Query: 479 NVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALE 538
+ +H N++ GS D + +EF GSL+ +Y + L I L+
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IY---HVTGPLSESQIAYVSRETLQ 117
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT----I 594
L++ HS +H D+K NILL +N ++DFG+S + T T+A I
Sbjct: 118 GLYYLHSKGK-MHRDIKGANILLTDNGHVKLADFGVSAQI---------TATIAKRKSFI 167
Query: 595 G---YMAPEYGS---EGIVSTKCDVYSYGVLLMETFTEKKP 629
G +MAPE + +G + CD+++ G+ +E E +P
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 428 EFNECNLLGTGGFGSVYKGT-LSDGTN----VAIKIFNLQLE-RAFRSFDSECEILRNVR 481
E + +LG+G FG+VYKG + DG N VAIK+ +A + E ++ V
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
+ ++LG C + LV + MP G L ++ + + LN + + + YL
Sbjct: 68 SPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
++H DL N+L+ ++DFG+++LL E I +MA E
Sbjct: 127 EVR----LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 602 GSEGIVSTKCDVYSYGVLLMETFT-EKKPTD 631
+ + DV+SYGV + E T KP D
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 39/210 (18%)
Query: 434 LLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLER---------AFRSFDSECEILRNVRHR 483
L+G G +G V K + G VAIK F LE A R E +L+ +RH
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMR----EIRMLKQLRHE 60
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
NL+ ++ LV EF+ + L+ L + LD + + + +E+ H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH-- 117
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL-GEGEDSVIQTMTMATIGYMAPE-- 600
S IIH D+KP NIL+ ++ V + DFG ++ L GE + T +AT Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELL 172
Query: 601 -----YGSEGIVSTKCDVYSYGVLLMETFT 625
YG D+++ G L+ E T
Sbjct: 173 VGDTKYGR------AVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIK---IFNLQLERAFRSFDSECEILRNVRHRNLLKILG 490
+G G F VY+ T L DG VA+K IF+L +A E ++L+ + H N++K
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNI---MIDVGSALEYLHHCHSSA 547
S + +VLE G L + + ++ + + + SALE++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----SR 125
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG---YMAPEYGSE 604
++H D+KP N+ + V + D G+ + S T + +G YM+PE E
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERIHE 180
Query: 605 GIVSTKCDVYSYGVLLMETFTEKKP 629
+ K D++S G LL E + P
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 35/88 (39%), Positives = 50/88 (56%)
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L L L G IP I L+ LQ + N+++G +P L + L +L+LS N +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSL 209
P+ L LTSLR L L N LS +P++L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 58/231 (25%), Positives = 108/231 (46%), Gaps = 35/231 (15%)
Query: 435 LGTGGFGSVY--------KGTLSDGTNVAIKIF-NLQLERAFRSFDSECEILRNV-RHRN 484
LG G FG V K + VA+K+ + ++ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDILQRLNIMI-------- 531
++ +LG+C+ +++E+ G+L ++L + +Y D + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 532 --DVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
V +EYL +S IH DL N+L+ E+ V ++DFG+++ + + T
Sbjct: 140 AYQVARGMEYL----ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKK------PTDEMF 634
+ +MAPE + + + + DV+S+GVLL E FT P +E+F
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
+G G G+VY ++ G VAIK NLQ + +E ++R +H N++ L S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
D +V+E++ GSL + +D Q + + ALE+LH S +IH D
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRD 140
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
+K NILL + ++DFG + E S TM + T +MAPE + K D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 198
Query: 614 YSYGVLLMETFTEKKP 629
+S G++ +E + P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 62/173 (35%), Positives = 99/173 (57%), Gaps = 7/173 (4%)
Query: 165 ERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNS 224
L L+LS NK+ ++P L +L +L++L L N LS LP L +L + ++LS N
Sbjct: 140 SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNK 197
Query: 225 LKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNL 284
+ LP I+ L+ L +LDLS N + + S++ LKNL L L+ N+ + +PES+GNL
Sbjct: 198 IS-DLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLE-DLPESIGNL 254
Query: 285 ISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQ 337
+LE+LD SNN +S SL +L++L++ ++S N L +P+
Sbjct: 255 SNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLEL 305
|
Length = 394 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 56/237 (23%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNV-AIKIFN--LQLERAFRSFD-SECEILRNVRH 482
D+F ++G G FG V+ D V A+K+ ++R + +E +IL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNI--MIDVGSALEYL 540
++K+ S + + LV+E+MP G L L + F + R I ++ AL+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV---LALDSV 117
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVI------------ 586
H IH D+KP NIL+D + H+ +DFG+ K + + +D
Sbjct: 118 HKLG----FIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 587 ----------QTMTMA--TIG---YMAPE------YGSEGIVSTKCDVYSYGVLLME 622
Q A T+G Y+APE YG +CD +S GV+L E
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG------LECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 429 FNECNLLGTGGFGSVYKGTLSDGTN--VAIKIFNLQ-LERAFRSFDSECEILRNVRHRNL 485
F + +G G FG V+KG + + T VAIKI +L+ E E +L +
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
K GS +++E++ GS L LD Q I+ ++ L+YLH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---- 118
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
S IH D+K N+LL E+ ++DFG++ L + + + + + T +MAPE +
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQS 176
Query: 606 IVSTKCDVYSYGVLLMETFTEKKPTDEM 633
+K D++S G+ +E + P E+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 19/151 (12%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-------HRNLL 486
LG G FGSVY G VAIK ++++ F S++ EC LR V+ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNY-FLDILQRLNIMIDVGSALEYLHHCHS 545
K+ D V E+M G+L + + +I+ + L ++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG- 119
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISK 576
H DLKP N+L+ V ++DFG+++
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 429 FNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLER------AFRSFDSECEILRNVR 481
F + +G G +G VYK G VA+K L E A R E +L+ +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMID-VGSALEYL 540
H N++K+L + LV EF+ + L+K F+D I + + S L L
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQL 109
Query: 541 HH----CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
CHS ++H DLKP N+L++ ++DFG+++ G + T + T+ Y
Sbjct: 110 LQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 166
Query: 597 MAPE--YGSEGIVSTKCDVYSYGVLLMETFTEK 627
APE G + ST D++S G + E T +
Sbjct: 167 RAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 50/227 (22%)
Query: 435 LGTGGFGSVYKG--TLSDGTNVAIKIFNLQLERAF-------RSFDSECEILRNVRHRN- 484
+G+G +G V T S G VAIK ++ AF R+ E +ILR+ +H N
Sbjct: 13 IGSGAYGVVCSAIDTRS-GKKVAIK----KIPHAFDVPTLAKRTL-RELKILRHFKHDNI 66
Query: 485 --LLKILGSCSNLDFKA--LVLEFMPNGSLEKWLYSH--------NYFLDILQRLNIMID 532
+ IL DFK +V++ M + L ++S YFL L R
Sbjct: 67 IAIRDILRPPGA-DFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR------ 118
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT-- 590
L+Y+H SA +IH DLKP+N+L++E+ + DFG+++ L MT
Sbjct: 119 ---GLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 591 MATIGYMAPEYG-SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG 636
+AT Y APE S +T D++S G + E + ++F G
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 12/200 (6%)
Query: 435 LGTGGFGSVYKGTLSD-GTNVAIKIFN---LQLERAFRSFDSECEILRNVRHRNLLKILG 490
LG GGFG V + G A K + L+ + + +E +IL V R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYF-LDILQRLNIMIDVGSALEYLHHCHSSAPI 549
+ D LV+ M G L+ +Y+ + + + LE+LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR----I 116
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVST 609
++ DLKP N+LLD++ +SD G++ L G+ T GYMAPE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGTPGYMAPEVLQGEVYDF 173
Query: 610 KCDVYSYGVLLMETFTEKKP 629
D ++ G L E + P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 66/265 (24%), Positives = 119/265 (44%), Gaps = 29/265 (10%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIK---IFNLQLERAFRSFDSECEILRNVRHRNLLKILG 490
+G G F VY+ T L D VA+K IF + +A + E ++L+ + H N++K L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNI---MIDVGSALEYLHHCHSSA 547
S + +VLE G L + + ++ + + + SA+E++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH----SR 125
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV 607
++H D+KP N+ + V + D G+ + + + ++ + T YM+PE E
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSL-VGTPYYMSPERIHENGY 183
Query: 608 STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667
+ K D++S G LL E + P + +M+L SL ++ + L E +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSP---FYGDKMNLF-----SLCQKIEQCDYPPLPTEH--Y 233
Query: 668 SDKMDCLFSIMDLALDCCMDTPHKR 692
S+K+ L S+ C P +R
Sbjct: 234 SEKLRELVSM------CIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-12
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 26/226 (11%)
Query: 451 GTNVAIKIF---NLQLERAFRSFDSECEILRNVRHRNLLKIL--GSCSNLDFKALVLEFM 505
G VAIK+ + E F E + + H N++ +L G V E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61
Query: 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---D 562
P +L + L + L + +M+ V L+ L H+ I+H DLKP NI++
Sbjct: 62 PGRTLREVLAADGA-LPAGETGRLMLQV---LDALACAHNQG-IVHRDLKPQNIMVSQTG 116
Query: 563 ENMVAHVSDFGISKLLGEGEDSVIQTMTMAT--IG---YMAPEYGSEGIVSTKCDVYSYG 617
A V DFGI LL D+ + T+T T +G Y APE V+ D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 618 VLLMETFTEKKPTDEMFTGEMSLRRW--VKESLP-----HRLTEVV 656
++ +E T ++ E+ ++ V SLP H L +V+
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVL 222
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNV--AIKIFNLQLERA-FRSFDSECEILRNVRHR 483
DE + LG G +GSVYK L T V A+K L+L+ + F E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSP 59
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFL-----DILQRLNIMIDVGSALE 538
++ G+ + +E+M GSL+K LY+ D+L+R+ + G L+
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKG--LK 116
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG--- 595
+L H+ IIH D+KPTN+L++ N + DFG+S G S+ +T IG
Sbjct: 117 FLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKT----NIGCQS 166
Query: 596 YMAPEYGSEG------IVSTKCDVYSYGVLLME 622
YMAPE G + + DV+S G+ ++E
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 434 LLGTGGFGSVYKGTLSDGTNVAIKIFNLQ-LERA--FRS------FDSECEILRNVRHRN 484
+LG GG+G V++ G + KIF ++ L++A R+ +E IL V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTG-KIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++ ++ + L+LE++ G L L F++ + ++ ALE+LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-YLSEISLALEHLHQ-- 118
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE 604
II+ DLKP NILLD ++DFG+ K E +V T TI YMAPE
Sbjct: 119 --QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFC-GTIEYMAPEILMR 174
Query: 605 GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
D +S G L+ + T P FT E
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPP----FTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDS--ECEILRNV 480
R+ EF + N +G G +G VY+ + G VA+K + ER S E +L N+
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 481 RHRNL--LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALE 538
RH N+ LK + +LD LV+E+ L L + Q +M+ + L+
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIGY 596
YLH IIH DLK +N+LL + ++DFG+++ G + MT + T+ Y
Sbjct: 123 YLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYG----LPAKPMTPKVVTLWY 174
Query: 597 MAPE--YGSEGIVSTKCDVYSYGVLLMETFTEK 627
APE G +T D+++ G +L E K
Sbjct: 175 RAPELLLGCT-TYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 67/229 (29%), Positives = 98/229 (42%), Gaps = 43/229 (18%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSD-GTNVAIK------------IFNLQLERAFRSFDSE 473
++ + +G G FG+V K GT +A+K + L+ RS S+
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS--SD 61
Query: 474 CEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLN----- 528
C + V+ L G C + +E M + SL+K Y + Y + +
Sbjct: 62 CPYI--VKFYGALFREGDC------WICMELM-DISLDK-FYKYVY-EVLKSVIPEEILG 110
Query: 529 -IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587
I + AL YL IIH D+KP+NILLD N + DFGIS G+ DS+ +
Sbjct: 111 KIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAK 164
Query: 588 TMTMATIGYMAPE----YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDE 632
T YMAPE +G + DV+S G+ L E T K P +
Sbjct: 165 TRDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 50/195 (25%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 434 LLGTGGFGSVYKGTLSDGTN----VAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKI 488
+LGTG FG + +G L + VAI ++ R F +E L H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
G + + +V E+M NG+L+ +L H L Q + ++ + S ++YL S
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL----SEMG 127
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG-YMAPEYGSEGIV 607
+H L +L++ ++V +S F +L + +++ TM+ + + APE
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 608 STKCDVYSYGVLLME 622
S+ DV+S+G+++ E
Sbjct: 186 SSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 30/206 (14%)
Query: 434 LLGTGGFGSVYKGTLSD-GTNVAIKIF------NLQLERAFRSFDSECEILRNVRHRNLL 486
++G G +G V K G VAIK F + A R E ++LR +RH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----EVKVLRQLRHENIV 63
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
+ + LV E++ LE L + L + + + A+ +CHS
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAI---AYCHSH 119
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE------ 600
IIH D+KP NIL+ E+ V + DFG ++ L S + T +AT Y APE
Sbjct: 120 N-IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLVGDT 177
Query: 601 -YGSEGIVSTKCDVYSYGVLLMETFT 625
YG DV++ G ++ E
Sbjct: 178 NYGKP------VDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 28/256 (10%)
Query: 421 DIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRN 479
D R D F + +G G G V T G VA+K +L+ ++ +E I+R+
Sbjct: 19 DPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRD 75
Query: 480 VRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
H N++ + S D +V+EF+ G+L + +H ++ Q + + V AL Y
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIATVCLSVLRALSY 133
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
LH + +IH D+K +ILL + +SDFG + ++ + + T +MAP
Sbjct: 134 LH----NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKSLVGTPYWMAP 187
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR--RWVKESLPHRLTEV-- 655
E S T+ D++S G++++E + P + E L+ R ++++LP R+ +
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDNLPPRVKDSHK 243
Query: 656 --------VDANLVRE 663
+D LVRE
Sbjct: 244 VSSVLRGFLDLMLVRE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 36/207 (17%)
Query: 438 GGFGSVYKG-TLSDGTNVAIKIF------------NLQLERAFRSFDSECEILRNVRHR- 483
G FGSVY S G AIK+ N++ ERA I+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERA---------IMMIQGESP 57
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
+ K+ S + D+ LV+E++ G + + + + + +V +E LH
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH-- 114
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS 603
IIH D+KP N+L+D+ ++DFG+S+ E + V T Y+APE
Sbjct: 115 --QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPET-I 165
Query: 604 EGIVSTK-CDVYSYGVLLMETFTEKKP 629
G+ K D +S G ++ E P
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 435 LGTGGFGSVYKGTLSD------GTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLK 487
LG G FG VY+G D T VA+K N R F +E +++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYS-----HNYFLDILQRLNIMI----DVGSALE 538
+LG S +V+E M +G L+ +L S N L MI ++ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
YL ++ +H DL N ++ + + DFG+++ + E + + + +MA
Sbjct: 134 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFT 625
PE +G+ +T D++S+GV+L E +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 41/236 (17%)
Query: 433 NLLGTGGFGSV----YKGTLSDGTNVAIKIFNLQLERAFRSFD---SECEILRNVRHRNL 485
LGTG FG V +KGT G AIK + + E IL + H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
+ ++ S + + +LEF+ G L L F + + + ++ A EYLH
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLHSKD- 138
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEYGSE 604
II+ DLKP N+LLD V+DFG +K + + +T T+ T Y+APE
Sbjct: 139 ---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPE---- 185
Query: 605 GIVSTK-----CDVYSYGVLLME------TFTEKKPT---DEMFTGEMSLRRWVKE 646
++ +K D ++ GVLL E F + P +++ G + W
Sbjct: 186 -VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
|
Length = 329 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 435 LGTGGFGSVYKGTLSDGTNVA-IKIFNLQLERAFR---SFDSECEILRNVRHRNLLKILG 490
+G G FG V G G + A + + L+ F E + R + H N+L+ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFL------DILQRLNIMIDVGSALEYLHHCH 544
C LVLEF P G L+ +L S+ + D+LQR+ +V S L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQAD 120
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT-IGYMAPE--- 600
IH DL N L ++ + D+G++ L ED I A + ++APE
Sbjct: 121 ----FIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 601 -YGSEGIV---STKCDVYSYGVLLMETFT 625
G + + + K +++S GV + E FT
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 429 FNECNLLGTGGFGSVYKGTLSDGTNV-AIKIFNLQ-LERAFRSFDSECEILRNVRHRNLL 486
F + +G G FG VYKG + V AIKI +L+ E E +L +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 487 KILGSCSNLDFKALVLEFMPNGS----LEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
+ GS +++E++ GS L+ Y IL+ ++ L+YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH- 118
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT-MATIGYMAPEY 601
S IH D+K N+LL E ++DFG++ G+ D+ I+ T + T +MAPE
Sbjct: 119 ---SERKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
+ K D++S G+ +E + P ++
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 58/229 (25%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLE------RAFRSFDSECEILRN 479
D + + +G+G +G V + G VAIK + + R +R E +L++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKH 70
Query: 480 VRHRNLLKILG----SCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLN----- 528
+ H N++ +L + S DF+ LV M L + Q+L+
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQ 121
Query: 529 -IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587
++ + L+Y+H SA IIH DLKP+NI ++E+ + DFG+++ +
Sbjct: 122 FLVYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD------- 170
Query: 588 TMT--MATIGYMAPE-------YGSEGIVSTKCDVYSYGVLLMETFTEK 627
MT +AT Y APE Y + D++S G ++ E T K
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 435 LGTGGFGSVYKGTL----SDGTNVAIKIFNLQ--LERAFRSFDSECEILRNVRHRNLLKI 488
+G G +G V +L +DG IK NL+ R ++ + E ++L ++H N++
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 489 LGSCSNLD-FKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSS 546
S D +V+ F G L L L Q + + + AL+YLH H
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGI 606
I+H DLK N+ L + V D GI+++L E + + T+ + T YM+PE S
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTL-IGTPYYMSPELFSNKP 178
Query: 607 VSTKCDVYSYGVLLMETFTEK 627
+ K DV++ G + E T K
Sbjct: 179 YNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 40/239 (16%)
Query: 433 NLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDS--------------ECEIL 477
LG G +G V K G VAIK + + D E +I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
++H N++ ++ DF LV++ M L+K + L Q I++ + + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG----EGEDSVIQTMT--- 590
LH + +H DL P NI ++ + ++DFG+++ G S +TM
Sbjct: 133 NVLHKWY----FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 591 -----MATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRR 642
+ T+ Y APE G+E D++S G + E T K +F GE + +
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFA-VDMWSVGCIFAELLTGKP----LFPGENEIDQ 242
|
Length = 335 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 72/238 (30%), Positives = 109/238 (45%), Gaps = 24/238 (10%)
Query: 429 FNECNLLGTGGFGSVY---KGTLSD-GTNVAIKIFN----LQLERAFRSFDSECEILRNV 480
F +LGTG +G V+ K + D G A+K+ +Q + +E ++L ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 481 RHRNLLKILGSCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMI-DVGSALE 538
R L L D K L+L+++ G L L F + Q + I ++ ALE
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALE 119
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
+LH II+ D+K NILLD N ++DFG+SK E E + TI YMA
Sbjct: 120 HLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEYMA 174
Query: 599 PEY--GSEGIVSTKCDVYSYGVLLMETFTEKKP----TDEMFTGEMSLRRWVKESLPH 650
P+ G +G D +S GVL+ E T P ++ E+S RR +K P+
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS-RRILKSEPPY 231
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 64/227 (28%), Positives = 112/227 (49%), Gaps = 31/227 (13%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFD----SECEILR 478
R+ DE+ + N + G +G VY+ G VA+K L++E+ F E IL
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILL 59
Query: 479 NVRHRNLLKI----LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVG 534
++H N++ + +GS NLD +V+E++ + L+ + + + +M+ +
Sbjct: 60 KLQHPNIVTVKEVVVGS--NLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MA 592
S + +LH I+H DLK +N+LL+ + + DFG+++ G S ++ T +
Sbjct: 117 SGVAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYG----SPLKPYTQLVV 168
Query: 593 TIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
T+ Y APE G ST D++S G + E T KKP +F G+
Sbjct: 169 TLWYRAPELLLG-AKEYSTAIDMWSVGCIFAELLT-KKP---LFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 435 LGTGGFGSVYKGTLSDGTNVA-IKIFNLQLERAF---RSFDSECEILRNVRHRNLLKILG 490
+G G FG V G ++ G A + + L++ + F E + R+++H NLL+ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYS----HNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
C+ + LV+EF P G L+ +L S D + ++ L +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE-----Y 601
IH DL N LL ++ + D+G+S + + V + ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 602 GSEGIV--STKCDVYSYGVLLMETF 624
G+ +V + + +V+S GV + E F
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 13/219 (5%)
Query: 405 HEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL 463
HE F A + D R D F + +G G G V T S G VA+K +L+
Sbjct: 1 HEQF-RAALQLVVDPGDPRSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRK 56
Query: 464 ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 523
++ +E I+R+ +H N++++ S D +V+EF+ G+L + +H ++
Sbjct: 57 QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTR-MNE 114
Query: 524 LQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583
Q + + V AL +LH + +IH D+K +ILL + +SDFG + ++
Sbjct: 115 EQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKE 168
Query: 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLME 622
+ + T +MAPE S T+ D++S G++++E
Sbjct: 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 4e-11
Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 42/224 (18%)
Query: 434 LLGTGGFGSV-YKGTLSDGTNVAIKIFNLQ--LERAFRSFDSECEILRNVRHRNLLKILG 490
+LG+G G+V +SDG A+K+ +++ E +E L N +++K
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95
Query: 491 SC------------SNLDFKALVLEFMPNGSLEKWLYS----------HNYFLDILQRLN 528
C N+ ALVL++ G L + + S H L +Q
Sbjct: 96 -CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ--- 151
Query: 529 IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDSVIQ 587
L +HH HS +IH D+K NILL N + + DFG SK+ D V +
Sbjct: 152 -------VLLAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR 203
Query: 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTD 631
T T Y+APE S K D++S GVLL E T K+P D
Sbjct: 204 TFC-GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 4/93 (4%)
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
V +E+L +S IH DL NILL EN V + DFG+++ + + D V +
Sbjct: 182 VARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + +T+ DV+S+GVLL E F+
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 65/225 (28%), Positives = 89/225 (39%), Gaps = 45/225 (20%)
Query: 425 ATDEFNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNV-RH 482
T F ++G G +G VYK G VAIKI ++ + E ILR H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNH 62
Query: 483 RNLLKILGSCSNLDFKA------LVLEFMPNGS---LEKWLYSHNYFLDILQRLN----- 528
N+ G+ + LV+E GS L K L +RL
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG------KRLKEEWIA 116
Query: 529 -IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS--DFGISKLLGEGEDSV 585
I+ + L YLH +IH D+K NILL +N A V DFG+S L DS
Sbjct: 117 YILRETLRGLAYLHENK----VIHRDIKGQNILLTKN--AEVKLVDFGVSAQL----DST 166
Query: 586 IQTMTMATIG---YMAPE-----YGSEGIVSTKCDVYSYGVLLME 622
+ IG +MAPE + + DV+S G+ +E
Sbjct: 167 LGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 35/241 (14%)
Query: 435 LGTGGFGSVYKGTLSD-GTNVAIKIFNLQL-----ERAFRSFDSECEILRNVRHRNLLKI 488
+G GG+G V+ D G VA+K L E R +E +IL + L+K+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTERDILTTTKSEWLVKL 66
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNI--MIDVGSALEYLHHCHSS 546
L + + ++ L +E++P G L + + R + M + AL L + H
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHR- 125
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--YGSE 604
DLKP N L+D + ++DFG+SK + +SV+ + YMAPE G
Sbjct: 126 ------DLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRGKG 174
Query: 605 GIVSTKCDVYSYGVLLMETFTEKKP-----TDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659
D +S G +L E P +E + +L+ W KE+L + + N
Sbjct: 175 --YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETLQRPVYDDPRFN 228
Query: 660 L 660
L
Sbjct: 229 L 229
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 428 EFNECNLLGTGGFGSVY---KGTLSD-GTNVAIKIFN----LQLERAFRSFDSECEILRN 479
F +LGTG +G V+ K T D G A+K+ +Q + +E +L +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 480 VRHRNLLKILGSCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALE 538
VR L L + K L+L+++ G + LY + F + R G +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVR----FYSGEIIL 116
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
L H H I++ D+K NILLD ++DFG+SK E + TI YMA
Sbjct: 117 ALEHLHKLG-IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMA 174
Query: 599 PE-YGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
PE +G D +S G+L+ E T P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
+G G G+V+ ++ G VAIK NLQ + +E +++ +++ N++ L S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
D +V+E++ GSL + +D Q + + ALE+LH + +IH D
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH----ANQVIHRD 140
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
+K N+LL + ++DFG + E S TM + T +MAPE + K D+
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 198
Query: 614 YSYGVLLMETFTEKKP 629
+S G++ +E + P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 70/222 (31%), Positives = 103/222 (46%), Gaps = 43/222 (19%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLER------AFRSFDSECEILRNVRHRN--- 484
+G G +G VYKG G VA+K L+ E A R E +L+ ++H N
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH-- 542
L +L S L L+ EF+ + L+K +LD L +D YL+
Sbjct: 64 LQDVLMQESRL---YLIFEFL-SMDLKK-------YLDSL-PKGQYMDAELVKSYLYQIL 111
Query: 543 -----CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597
CHS ++H DLKP N+L+D V ++DFG+++ G + T + T+ Y
Sbjct: 112 QGILFCHSRR-VLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYR 168
Query: 598 APE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
APE GS ST D++S G + E T KKP +F G+
Sbjct: 169 APEVLLGSP-RYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
+G G G+VY ++ G VAIK NLQ + +E ++R ++ N++ L S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
D +V+E++ GSL + +D Q + + AL++LH S +IH D
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH----SNQVIHRD 140
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
+K NILL + ++DFG + E S TM + T +MAPE + K D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 198
Query: 614 YSYGVLLMETFTEKKP 629
+S G++ +E + P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 42/219 (19%)
Query: 433 NLLGTGGFGSVYKGTLSDGTN-----VAIKIFN-----LQLERAFRSFDSECEILRNVRH 482
+LL G FG ++ G L D V +K +Q+ E +L + H
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL----LLQESCLLYGLSH 67
Query: 483 RNLLKILGSCSNLDFKALVLE-FMPNGSLEKWLYSHNYF-------LDILQRLNIMIDVG 534
+N+L IL C VL +M G+L+ +L L Q +++ I +
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK--------LLGEGEDSVI 586
+ YLH +IH D+ N ++DE + ++D +S+ LG+ E+ +
Sbjct: 128 CGMSYLH----KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MA E S+ DV+S+GVLL E T
Sbjct: 184 K--------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 63/203 (31%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 435 LGTGGFGSVYKGTLS-DGTNVAIKIFNL---QLERAFRSFDSECEILRNVRHRNLLKILG 490
+G G FG+VY VAIK + Q ++ E L+ +RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 491 SCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
C + A LV+E+ GS L H L ++ I L YLH S
Sbjct: 83 -CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHER 136
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY---GSEGI 606
IH D+K NILL E ++DFG + L+ V T +MAPE EG
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQ 190
Query: 607 VSTKCDVYSYGVLLMETFTEKKP 629
K DV+S G+ +E E+KP
Sbjct: 191 YDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 48/222 (21%)
Query: 429 FNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERA------FRSFDSECEILRNVR 481
+ E +G G +G+VYK L+ G VA+K + L R E +L+ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLE 56
Query: 482 ---HRNLLKILGSCSNLDFK-----ALVLEFM-----------PNGSLEKWLYSHNYFLD 522
H N++++L C LV E + P L
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE--------- 107
Query: 523 ILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582
++M + +++LH H I+H DLKP NIL+ + ++DFG++++
Sbjct: 108 --TIKDLMRQLLRGVDFLH-SHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--SF 159
Query: 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETF 624
+ + T + T+ Y APE + +T D++S G + E F
Sbjct: 160 EMAL-TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 41/119 (34%), Positives = 56/119 (47%), Gaps = 10/119 (8%)
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATI 594
AL YL H +IH D+KP+NILLD + + DFGIS G DS +T +
Sbjct: 125 KALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCA 178
Query: 595 GYMAPEY----GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649
YMAPE + DV+S G+ L+E T + P T L + ++E P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
+G G G+VY ++ G VAI+ NLQ + +E ++R ++ N++ L S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
D +V+E++ GSL + +D Q + + ALE+LH S +IH D
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH----SNQVIHRD 141
Query: 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDV 613
+K NILL + ++DFG + + ++ + T +MAPE + K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 614 YSYGVLLMETFTEKKP 629
+S G++ +E + P
Sbjct: 200 WSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 33/84 (39%), Positives = 46/84 (54%)
Query: 105 LGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHL 164
L G IP +I LR L ++L N + G IP S+G++ L+ + N+ G +P L L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 165 ERLNILNLSGNKLSGAIPQCLASL 188
L ILNL+GN LSG +P L
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAF-RSFDSECEILRNVRHRNLLKILGSC 492
LG G G+VYK L +A+K+ L + + SE EIL ++ G+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 493 SNLDFKALVLEFMPNGSLEKW--LYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550
+ ++ EFM GSL+ + + H +L R I + V L YL S I+
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEH-----VLGR--IAVAVVKGLTYLW----SLKIL 117
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTK 610
H D+KP+N+L++ + DFG+S L I + T YMAPE S
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIH 173
Query: 611 CDVYSYGVLLMETFTEKKPTDEMFTGEMSL 640
DV+S G+ ME + P ++ + SL
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSL 203
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 52/216 (24%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 435 LGTGGFGSVYKGTL--------SDGTNVAIKIF-NLQLERAFRSFDSECEILRNV-RHRN 484
LG G FG V + VA+K+ + ++ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDILQR----------LNI 529
++ +LG C+ +++E+ G+L ++L + +Y DI + ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
V +EYL S IH DL N+L+ E+ V ++DFG+++ + + + +
Sbjct: 140 AYQVARGMEYL----ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + + + DV+S+G+L+ E FT
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 423 RRATDEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
R ++ +G+G +G VYK L G A+KI L+ F E +++ +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
H N++ GS + + + +E+ GSL+ +Y L LQ + + L YLH
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT----IG-- 595
S +H D+K NILL +N ++DFG++ + T T+A IG
Sbjct: 124 ----SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI---------TATIAKRKSFIGTP 170
Query: 596 -YMAPEYGS---EGIVSTKCDVYSYGVLLME 622
+MAPE + G + CD+++ G+ +E
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 74/232 (31%), Positives = 111/232 (47%), Gaps = 61/232 (26%)
Query: 435 LGTGGFGSVYKGTLSD---GTNVAIK-IFNLQLERAFR-SFDSECEILRNVRHRNLLKIL 489
LG G +G V+K D VA+K IF+ AFR + D++ R R L+ L
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFD-----AFRNATDAQ----RTFREIMFLQEL 63
Query: 490 GSCSN----LD-FKA-------LVLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVG 534
G N L+ KA LV E+M E L++ N D+ +R IM +
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLL 117
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV---IQTMTM 591
AL+Y+H S +IH DLKP+NILL+ + ++DFG+++ L E E++ + T +
Sbjct: 118 KALKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 592 ATIGYMAPE-------YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG 636
AT Y APE Y ++G+ D++S G +L E K +F G
Sbjct: 174 ATRWYRAPEILLGSTRY-TKGV-----DMWSVGCILGEMLLGKP----LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 57/235 (24%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIK-IFN-----LQLERAFRSFDSECEILR 478
T+ + + +G G FG V G NVAIK I + +R +R E ++L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR----ELKLLK 64
Query: 479 NVRHRNLLKILGS-CSNLDFKALVLEFM--------PNGSLEKWLYSHNYFLDILQRLNI 529
++RH N++ + S L+ V E + + LEK YFL + R
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILR--- 119
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
L+Y+H SA ++H DLKP+NIL++EN + DFG++++ +D + T
Sbjct: 120 ------GLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQM-TG 164
Query: 590 TMATIGYMAPE-------YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
++T Y APE Y E D++S G + E E KP +F G+
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEML-EGKP---LFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 60/194 (30%), Positives = 85/194 (43%), Gaps = 45/194 (23%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGT--NVAIKIF-------NLQLERAFRSFDSECEIL 477
++FN LGTG FG V T + VAIK F Q++ F SE +IL
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF----SERKIL 85
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGS-- 535
+ H + + GS + + LVLEF+ G +L + F + DVG
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---------DVGCFY 136
Query: 536 ------ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
EYL S I++ DLKP N+LLD++ ++DFG +K V+ T
Sbjct: 137 AAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTR 184
Query: 590 TMATIG---YMAPE 600
T G Y+APE
Sbjct: 185 TYTLCGTPEYIAPE 198
|
Length = 340 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 47/228 (20%)
Query: 435 LGTGGFGSV----YKGTLSDGTNVAIK----IFN--LQLERAFRSFDSECEILRNVR-HR 483
LG G +G V T S+ VAIK +F+ + +RA R E ++LR+ R H+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHK 62
Query: 484 NL-----LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD------ILQRLNIMID 532
N+ + I+ N + L E M L + + S D I Q L
Sbjct: 63 NITCLYDMDIVFP-GNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL----- 115
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT-- 590
L+Y+H SA ++H DLKP N+L++ + + DFG+++ E MT
Sbjct: 116 --CGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 591 MATIGYMAPEYG-SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
+AT Y APE S + DV+S G +L E +KP +F G+
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 56/175 (32%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEI-------LRNVRHRNLL 486
+G G FG V +DG A+K+ ++A + I L+NV+H L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQ---KKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
+ S D VL+++ G L L F + R ++ SAL YLH S
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH----S 114
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPE 600
II+ DLKP NILLD ++DFG+ K EG + T T T Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 435 LGTGGFGSVYKGTLSDGTN--VAIKIFNL---QLERAFRSFDSECEILRNVRHRNLLKIL 489
+G G FG+VY T S TN VA+K + Q ++ E + L+ ++H N ++
Sbjct: 29 IGHGSFGAVYFATNSH-TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 490 GSCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
G C + A LV+E+ GS L H LQ + I AL+ L + HS
Sbjct: 88 G-CYLKEHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY---GSEG 605
+IH D+K NILL E ++DFG + V T +MAPE EG
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEG 195
Query: 606 IVSTKCDVYSYGVLLMETFTEKKP 629
K DV+S G+ +E E+KP
Sbjct: 196 QYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 40/222 (18%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLER------AFRSFDSECEILRNVRHRN--- 484
+G G +G VYK G VA+K L+ E A R E +L+ + H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF-LDILQRLNIMIDVGSALEYLHHC 543
LL ++ S + L LV EF+ + L+K++ S LD + + + + Y C
Sbjct: 63 LLDVVHSENKL---YLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY---C 115
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIGYMAPE- 600
HS ++H DLKP N+L+D ++DFG+++ G ++T T + T+ Y APE
Sbjct: 116 HSHR-VLHRDLKPQNLLIDREGALKLADFGLARAFG----VPVRTYTHEVVTLWYRAPEI 170
Query: 601 -YGSEGIVSTKCDVYSYGVLLMETFTEKKP-------TDEMF 634
GS ST D++S G + E ++P D++F
Sbjct: 171 LLGSR-QYSTPVDIWSIGCIFAEMVN-RRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 435 LGTGGFGSVY--KGTLSDGTNVAIKIFNLQLERAFRSFDSECEI--LRNVRHRNLLKILG 490
+G G FG +Y K SD + IK +L S+ E+ L ++H N++
Sbjct: 8 IGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 491 SCSNLDFKALVLEFMPNGSLEKWL-YSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
S +V+E+ G L K + Q L+ + + L+++H I
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKI 122
Query: 550 IHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVS 608
+H D+K NI L +N MVA + DFGI++ L + + + + T Y++PE +
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYN 180
Query: 609 TKCDVYSYGVLLMETFTEKKP 629
K D++S G +L E T K P
Sbjct: 181 NKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 52/280 (18%)
Query: 435 LGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKI----- 488
LG G G V+ SD VA+K L ++ + E +I+R + H N++K+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 489 ---------LGSCSNLDFKALVLEFMPNG---SLEKWLYSHNYFLDILQRLNIMIDVGSA 536
+GS + L+ +V E+M LE+ S + RL M +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLRG 126
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLG-EGEDSVIQTMTMATI 594
L+Y+H SA ++H DLKP N+ ++ E++V + DFG+++++ + + T
Sbjct: 127 LKYIH----SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 595 GYMAPEYGSEGIVSTKC-DVYSYGVLLMETFTEKKPTDEMFTG--EMSLRRWVKESLPHR 651
Y +P TK D+++ G + E T K +F G E+ + + ES+P
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLILESVP-- 236
Query: 652 LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHK 691
+VREE D+ + L +++ + P +
Sbjct: 237 --------VVREE----DR-NELLNVIPSFVRNDGGEPRR 263
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 71/249 (28%), Positives = 111/249 (44%), Gaps = 30/249 (12%)
Query: 429 FNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLER-AFRSFDS----ECEILRNVRH 482
F + +LG GGFG V + + G A K L+ +R R +S E +IL V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--RLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLH 541
+ ++ + + D LVL M G L+ +Y+ N + + L ++ LE LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
++ DLKP NILLD+ +SD G++ + EGE I+ + T+GYMAPE
Sbjct: 120 R----ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRG-RVGTVGYMAPEV 172
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
+ + D + G L+ E + P F G KE + E VD ++
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP----FRGR-------KEKVKR---EEVDRRVL 218
Query: 662 REEQAFSDK 670
E+ +S K
Sbjct: 219 ETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 4/93 (4%)
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
V +E+L +S IH DL NILL EN V + DFG+++ + + D V +
Sbjct: 183 VARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + +T+ DV+S+GVLL E F+
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 61/235 (25%), Positives = 115/235 (48%), Gaps = 18/235 (7%)
Query: 421 DIRRATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRN 479
D R D F + +G G G V T+ S G VA+K +L+ ++ +E I+R+
Sbjct: 17 DPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 73
Query: 480 VRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
+H N++++ S D +V+EF+ G+L + +H ++ Q + + V AL
Sbjct: 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLKALSV 131
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
LH + +IH D+K +ILL + +SDFG + ++ + + T +MAP
Sbjct: 132 LH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAP 185
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR--RWVKESLPHRL 652
E S + D++S G++++E + P + E L+ + ++++LP +L
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPKL 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRS-FDSECEILRNVRHRN 484
D+F + + LG G G V+K + G +A K+ +L+++ A R+ E ++L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILQRLNIMIDVGSALEYLHHC 543
++ G+ + ++ +E M GSL++ L + IL +++I + G L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 122
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS 603
H I+H D+KP+NIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 123 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQ 175
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKP 629
S + D++S G+ L+E + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 435 LGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
LG G FG VYK + G A K+ + + E + E +IL + H N++K+L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
+ +++EF G+++ + L Q + AL YLH IIH D
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH----ENKIIHRD 128
Query: 554 LKPTNILLDENMVAHVSDFGIS---KLLGEGEDSVIQTMTMATIGYMAPEY-----GSEG 605
LK NIL + ++DFG+S + DS I T +MAPE +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKDR 183
Query: 606 IVSTKCDVYSYGVLLMETFTEKKPTDEM 633
K DV+S G+ L+E + P E+
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 434 LLGTGGFGSV-YKGTLSDGTNVAIKIFNLQLERAFRSFD---SECEILRNVRHRNLLKIL 489
LLG G FG V + G A+KI ++ A +E +L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
S D V+E++ G L L F + R ++ SAL+YLH S I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH----SGKI 116
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDSVIQTMTMATIGYMAPEYGSEGIVS 608
++ DLK N++LD++ ++DFG+ K EG D+ T Y+APE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 609 TKCDVYSYGVLLMETFTEKKP 629
D + GV++ E + P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 69/249 (27%), Positives = 109/249 (43%), Gaps = 30/249 (12%)
Query: 429 FNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLER-AFRSFDS----ECEILRNVRH 482
F +LG GGFG V + + G A K L+ +R R ++ E IL V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLH 541
R ++ + + D LVL M G L+ +Y+ N D + + ++ LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
I++ DLKP NILLD+ +SD G++ + EGE + T+GYMAPE
Sbjct: 120 R----ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV---RGRVGTVGYMAPEV 172
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
+ + D + G L+ EM G+ R+ KE + E VD +
Sbjct: 173 INNEKYTFSPDWWGLGCLIY----------EMIQGQSPFRKR-KERVKR---EEVDRRVK 218
Query: 662 REEQAFSDK 670
+++ +S+K
Sbjct: 219 EDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 429 FNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLER-AFRSFDS----ECEILRNVRH 482
F + +LG GGFG V + + G A K L+ +R R +S E +IL V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLH 541
R ++ + + D LVL M G L+ +Y + + + ++ LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIGYMAP 599
I++ DLKP NILLD++ +SD G++ + EG QT+ + T+GYMAP
Sbjct: 120 Q----ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTIKGRVGTVGYMAP 170
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
E + D ++ G LL E + P
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 32/206 (15%)
Query: 435 LGTGGFGSVYKGTLSDGTN--VAIKIFNLQLER-----AFRSFDSECEILRNVRHRNLLK 487
LG G + +VYKG + T VA+K +L E A R E +++ ++H N+++
Sbjct: 8 LGEGTYATVYKG-RNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELKHENIVR 62
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF--LDILQRLNIMIDVGSALEYLHHCHS 545
+ + LV E+M + L+K++ +H LD + + L+ + CH
Sbjct: 63 LHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHE 118
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA----TIGYMAPE- 600
+ ++H DLKP N+L+++ ++DFG+++ G I T + T+ Y AP+
Sbjct: 119 NR-VLHRDLKPQNLLINKRGELKLADFGLARAFG------IPVNTFSNEVVTLWYRAPDV 171
Query: 601 -YGSEGIVSTKCDVYSYGVLLMETFT 625
GS ST D++S G ++ E T
Sbjct: 172 LLGSR-TYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 59/232 (25%), Positives = 109/232 (46%), Gaps = 16/232 (6%)
Query: 451 GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510
G VA+K+ +L+ ++ +E I+R+ +H+N++++ S + +++EF+ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570
+ L+ Q + V AL YLH S +IH D+K +ILL + +S
Sbjct: 106 TDIVSQTR--LNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLS 159
Query: 571 DFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP- 629
DFG + + D + + T +MAPE S T+ D++S G++++E + P
Sbjct: 160 DFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
Query: 630 -TDEMFTGEMSLRRWVKESLP--HRLTEV----VDANLVREEQAFSDKMDCL 674
+D LR L H+++ V ++ L RE Q + + L
Sbjct: 218 FSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 73/314 (23%), Positives = 123/314 (39%), Gaps = 68/314 (21%)
Query: 427 DEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLER------AFRSFDSECEILRN 479
D + + +G G +G VYK + G VA+K L+++ A R E +L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQM 56
Query: 480 VRHRNLLKILGSCSNLDFKA------LVLEFMPNGSLEKWLYSHNYFL------DILQRL 527
+ + L +++ K LV E++ + L+K++ S+ ++
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 528 NIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDSVI 586
+ G A HCH ++H DLKP N+L+D + + ++D G+ + S
Sbjct: 116 MYQLLKGVA-----HCHKHG-VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY- 168
Query: 587 QTMTMATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEK----------------- 627
T + T+ Y APE GS ST D++S G + E ++
Sbjct: 169 -THEIVTLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226
Query: 628 ---KPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDC 684
PT++++ G LR W H + +L R S + L M L D
Sbjct: 227 LLGTPTEQVWPGVSKLRDW------HEFPQWKPQDLSRAVPDLSPEGLDLLQKM-LRYD- 278
Query: 685 CMDTPHKRIHMTDA 698
P KRI A
Sbjct: 279 ----PAKRISAKAA 288
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 68/229 (29%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECE----ILRNV 480
TD + +G G +G VYK T DG+ A+KI + D E E IL+++
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSL 75
Query: 481 -RHRNLLKILGSCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILQRLN---IMI 531
H N++K G D LVLE GS+ + + L QRL+ I
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISY 132
Query: 532 DVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM 591
+ AL L H H++ IIH D+K NILL + DFG+S L + + ++
Sbjct: 133 ILYGALLGLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSV 189
Query: 592 ATIGYMAPE-------YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
T +MAPE Y +CDV+S G+ +E P +M
Sbjct: 190 GTPFWMAPEVIACEQQYDYS--YDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
V +E+L +S IH DL NILL EN V + DFG+++ + + D V +
Sbjct: 188 VAKGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + + + DV+S+GVLL E F+
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 427 DEFNECNLLGTGGFGSVYK-GTLSDGTNVAIKIFNLQLERAFRS-FDSECEILRNVRHRN 484
D+F + LG G G V K G +A K+ +L+++ A R+ E ++L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF-LDILQRLNIMIDVGSALEYLHHC 543
++ G+ + ++ +E M GSL++ L +IL +++I + G L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG--LAYLREK 122
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS 603
H I+H D+KP+NIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 123 HQ---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQ 175
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKP 629
S + D++S G+ L+E + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 427 DEFNECNLLGTGGFGSV-YKGTLSDGTNVAIKIF------NLQLERAFRSFDSECEILRN 479
D + + +G+G +G+V G VAIK L +RA+R E +L++
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKH 70
Query: 480 VRHRN---LLKILGSCSNLD-FKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533
++H N LL + +LD F LV+ FM L K + D +Q L +
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLK 129
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT 593
G L+Y+H +A IIH DLKP N+ ++E+ + DFG+++ DS + T + T
Sbjct: 130 G--LKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEM-TGYVVT 178
Query: 594 IGYMAPEYGSEGIVSTK-CDVYSYGVLLMETFTEK 627
Y APE + T+ D++S G ++ E T K
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 429 FNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNL---QLERAFRSFDSECEILRNVRHRN 484
F++ +G G FG+VY + + VAIK + Q ++ E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++ G LV+E+ GS L H LQ + I AL+ L + H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH 132
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY--- 601
S +IH D+K NILL E + + DFG + ++ V T +MAPE
Sbjct: 133 SHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILA 185
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
EG K DV+S G+ +E E+KP
Sbjct: 186 MDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 435 LGTGGFGSVYKGTL-SDGTNVAIKIFN---LQLERAFRSFDSECEILRNVRHRNLLKILG 490
LG GGFG V + + G A K N L+ + + E IL V R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+ LV+ M G L +Y+ N + + S LE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ----R 116
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGYMAPEY--GSE 604
II+ DLKP N+LLD + +SD G++ L +G+ +T A T G+MAPE G E
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQGEE 173
Query: 605 GIVSTKCDVYSYGVLLMETFTEKKP 629
S D ++ GV L E + P
Sbjct: 174 YDFSV--DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 52/227 (22%)
Query: 417 TSYLDIRRATDEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERA--FRSFDSE 473
TSYL++ + LG G + +VYKG + +G VA+K+ +++ E F + E
Sbjct: 5 TSYLNLEK----------LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-RE 53
Query: 474 CEILRNVRHRNLL---KILGSCSNLDFKALVLEFM-----------PNGSLEKWLYSHNY 519
+L+ ++H N++ I+ + L F V E+M P G L+ +N
Sbjct: 54 ASLLKGLKHANIVLLHDIIHTKETLTF---VFEYMHTDLAQYMIQHPGG-----LHPYNV 105
Query: 520 FLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579
L + Q L L Y+H H I+H DLKP N+L+ ++DFG+++
Sbjct: 106 RLFMFQLLR-------GLAYIHGQH----ILHRDLKPQNLLISYLGELKLADFGLAR--A 152
Query: 580 EGEDSVIQTMTMATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETF 624
+ S + + T+ Y P+ G+ S+ D++ G + +E
Sbjct: 153 KSIPSQTYSSEVVTLWYRPPDVLLGATD-YSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 65/214 (30%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 434 LLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSEC-----EILRNVRHRNLLK 487
+LG G FG V L G A+K+ L+ + + D EC IL R+ L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 488 ILGSC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
L C D V+EF+ G L + F + R ++ SAL +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH----D 114
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEYGSEG 605
II+ DLK N+LLD ++DFG+ K EG + T T T Y+APE E
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 606 IVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
+ D ++ GVLL E P D++F
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 434 LLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEIL-RNVRHRNLLKI 488
++G G FG V DG A+K+ ++ + + +E +L +NV+H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
S + VL+F+ G L L F + R ++ SAL YLH S
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH----SIN 116
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEYGSEGIV 607
I++ DLKP NILLD ++DFG+ K EG T T T Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 608 STKCDVYSYGVLLMETFTEKKPTDEMFTGEM 638
D + G +L E P EM
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 41/210 (19%)
Query: 435 LGTGGFGSVYKGTLSD-GTNVAIKIF-----NLQLER-AFRSFDSECEILRNVRHRNLLK 487
+G G +G V+K + G VAIK F + +++ A R E +L+ ++H NL+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 488 ILGSCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
++ F+ LV E+ + L + L + + I+ A+ +
Sbjct: 65 LIEV-----FRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNF--- 115
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE-- 600
CH IH D+KP NIL+ + + DFG +++L D T +AT Y APE
Sbjct: 116 CHKHN-CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELL 172
Query: 601 -----YGSEGIVSTKCDVYSYGVLLMETFT 625
YG DV++ G + E T
Sbjct: 173 VGDTQYG------PPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 51/168 (30%), Positives = 75/168 (44%), Gaps = 29/168 (17%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQ-------LERAFRSFDSECE 475
F + LLG G G V+ KGT G A+K+ + + ++R +E E
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVL----TEQE 53
Query: 476 ILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWL--YSHNYFLDILQRLNIMIDV 533
IL + H L + S + LV+++ P G L + L + + R +V
Sbjct: 54 ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EV 112
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLG 579
ALEYLH I++ DLKP NILL E+ H+ SDF +SK
Sbjct: 113 LLALEYLH----LLGIVYRDLKPENILLHES--GHIMLSDFDLSKQSD 154
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 429 FNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFD-----SECEILRNVRH 482
F +LG GGFG V + + G A K L+ +R + +E +IL V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKQILEKVNS 59
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYS-HNYFLDILQRLNIMIDVGSALEYLH 541
R ++ + + D LVL M G L+ +Y+ N D + + ++ LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
I++ DLKP NILLD+ +SD G++ + EGE I+ + T+GYMAPE
Sbjct: 120 ----RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRG-RVGTVGYMAPEV 172
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+ D + G L+ E K P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTN-VAIKIF--NLQLERAFRSFDSECEILRNVRHR 483
++F ++G G +G V K + VAIK F + + E + E ++LR ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 484 NLLKILGSCSNLDFKALVLEF-----------MPNGSLEKWLYSHNYFLDILQRLNIMID 532
N++++ + LV E+ MPNG + + S+ Y L
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
++ +H CH + I+H D+KP N+L+ N V + DFG ++ L EG ++ T +A
Sbjct: 110 ----IKAIHWCHKND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVA 163
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLME------TFTEKKPTDEMFT 635
T Y +PE D++S G +L E F + D++FT
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 434 LLGTGGFGSVYKGTL-SDGTNVAIKIFN----LQLERAFRSFDSECEILRNVRHRNLLKI 488
++G G FG V SDG+ A+K+ L+ + +L+N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
S + VL+++ G L L FL+ R +V SA+ YLH S
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH----SLN 116
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEYGSEGIV 607
II+ DLKP NILLD ++DFG+ K E E++ T T T Y+APE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---TSTFCGTPEYLAPEVLRKEPY 173
Query: 608 STKCDVYSYGVLLME 622
D + G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 37/140 (26%), Positives = 57/140 (40%), Gaps = 12/140 (8%)
Query: 438 GGFGSVYKGTLSDGTNVAIKIFNL--QLERAFRSFDSECEILRNVRHRNLLKILGSCSNL 495
+ K T VA+K NL + + E R ++H N+L + S
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRL---NIMIDVGSALEYLHHCHSSAPIIHC 552
+V M GS E L +H F + L L I+ DV +AL+Y+H IH
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG----FIHR 125
Query: 553 DLKPTNILLDENMVAHVSDF 572
+K ++ILL + +S
Sbjct: 126 SVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 26/237 (10%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFN---LQLERAFRSFDSECEILRN 479
+F+ +L+G G FG V K T G A+K+ L + F+ E +IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 480 VRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
+ ++ + + D LV+E+ P G L L N + D + +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLA 114
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
+H H +H D+KP N+L+D ++DFG + L V + + T Y+AP
Sbjct: 115 IHSVHQMG-YVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAP 172
Query: 600 EY------GSEGIVSTKCDVYSYGVLLMETFTEKKPTDE-----MFTGEMSLRRWVK 645
E +G +CD +S GV+ E + P E + M+ +R++K
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 4/105 (3%)
Query: 521 LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580
LD L+ V + +L +S IH DL NILL + + DFG+++ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ V++ + +MAPE + + + DV+SYG+LL E F+
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 32/105 (30%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 521 LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580
L L L+ V +E+L +S +H DL N+LL + + + DFG+++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFL----ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH 289
Query: 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ V + T + +MAPE + + +T DV+SYG+LL E F+
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 25/244 (10%)
Query: 398 RSTKHLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNV-AI 456
R K++D +FL D+R +++ ++G G FG V V A+
Sbjct: 16 RKNKNID--NFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 73
Query: 457 KIFNLQLERAFRS----FDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEK 512
K+ + + E RS F E +I+ ++++ + + + +V+E+MP G L
Sbjct: 74 KLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 132
Query: 513 WLYSHNYFLDILQRLN--IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570
+ NY D+ ++ +V AL+ +H S IH D+KP N+LLD++ ++
Sbjct: 133 LM--SNY--DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLA 184
Query: 571 DFGISKLLGEGEDSVIQTMT-MATIGYMAPEY----GSEGIVSTKCDVYSYGVLLMETFT 625
DFG + ++ +++ T + T Y++PE G +G +CD +S GV L E
Sbjct: 185 DFGTC--MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 626 EKKP 629
P
Sbjct: 243 GDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 40/213 (18%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNV--AIKIFNLQLERAFRSFDSECEILRNVRHRN 484
D+F + LG G G V K L + + A K+ +L+++ A R+ +I+R
Sbjct: 1 DDFEKLGELGAGNGGVVTK-VLHRPSGLIMARKLIHLEIKPAIRN-----QIIRE----- 49
Query: 485 LLKILGSCSN---LDFK---------ALVLEFMPNGSLEKWLYSHNYF-LDILQRLNIMI 531
LK+L C++ + F ++ +E M GSL++ L +IL +++I +
Sbjct: 50 -LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 532 DVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM 591
G L YL H I+H D+KP+NIL++ + DFG+S G+ DS+ + +
Sbjct: 109 LRG--LTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-V 159
Query: 592 ATIGYMAPE--YGSEGIVSTKCDVYSYGVLLME 622
T YM+PE G+ V + D++S G+ L+E
Sbjct: 160 GTRSYMSPERLQGTHYTVQS--DIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDS----ECEILRNVRH 482
D++ + +G G +G VYK TN I + ++LE+ S E +L+ ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKAR-DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
N++++ + LV E++ + L+K + S F RL I + L + +
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKN-PRL-IKTYLYQILRGIAY 117
Query: 543 CHSSAPIIHCDLKPTNILLDENMVA-HVSDFGISKLLGEGEDSVIQTMT--MATIGYMAP 599
CHS ++H DLKP N+L+D A ++DFG+++ G ++T T + T+ Y AP
Sbjct: 118 CHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFG----IPVRTFTHEVVTLWYRAP 172
Query: 600 E--YGSEGIVSTKCDVYSYGVLLMETFTEK 627
E GS ST D++S G + E +K
Sbjct: 173 EILLGSRH-YSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 429 FNECNLLGTGGFGSVY-KGTLSDGTNVAIKIFNL---QLERAFRSFDSECEILRNVRHRN 484
F + +G G FG+VY + VAIK + Q ++ E + L+ ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++ G LV+E+ GS L H LQ + I AL+ L + H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH 142
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY--- 601
S +IH D+K NILL E ++DFG + + V T +MAPE
Sbjct: 143 SHN-MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILA 195
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
EG K DV+S G+ +E E+KP
Sbjct: 196 MDEGQYDGKVDVWSLGITCIE-LAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 56/244 (22%), Positives = 104/244 (42%), Gaps = 36/244 (14%)
Query: 442 SVYKGTLSDGTNVAIKIF---NLQLERAFRSFDSECEILRNVRHRNLLKILG----SCSN 494
S+YKG + V I+ F + + ++E + LR + N+LKI G +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 495 LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDL 554
L +L+LE+ G L + L L +L++ ID L L+ +++ P + +L
Sbjct: 94 LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYK-YTNKP--YKNL 149
Query: 555 KPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVST----- 609
+ L+ EN K++ G + ++ + + +M Y S +++
Sbjct: 150 TSVSFLVTEN--------YKLKIICHGLEKILSSPPFKNVNFMV--YFSYKMLNDIFSEY 199
Query: 610 --KCDVYSYGVLLMETFTEKKPTDEMFTGE---MSLRRWVKESL----PHRLTEVVDANL 660
K D+YS GV+L E FT K P + + T E + + + L P + +V+A
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259
Query: 661 VREE 664
+
Sbjct: 260 SHDS 263
|
Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLER------AFRSFDSECEILRNVRHRNLLK 487
+G G FG V+K VA+K ++ E+ A R E +IL+ ++H N++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 75
Query: 488 ILGSCSNL-----DFKA---LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
++ C +K LV EF + L L + N + + +M + + L Y
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIGYM 597
+H I+H D+K NIL+ ++ + ++DFG+++ ++S T + T+ Y
Sbjct: 135 IH----RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 598 APE-------YGSEGIVSTKCDVYSYGVLLMETFT 625
PE YG D++ G ++ E +T
Sbjct: 191 PPELLLGERDYG------PPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 71/301 (23%), Positives = 114/301 (37%), Gaps = 63/301 (20%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDSECEI-----LRNVRHRNLLKI 488
+G G +G+VYK G VA+K +Q + E+ L H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 489 LGSCSNL-----------------DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMI 531
+ C+ D + + + P G L ++M
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG------------LPAETIKDLMR 115
Query: 532 DVGSALEYLH-HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590
L++LH +C I+H DLKP NIL+ ++DFG++++ + T
Sbjct: 116 QFLRGLDFLHANC-----IVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPV 167
Query: 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK----E 646
+ T+ Y APE + +T D++S G + E F +KP +F G + K
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGNSEADQLGKIFDLI 223
Query: 647 SLPHRLTEVVDANLVREEQAFSDK-----MDCLFSI----MDLALDCCMDTPHKRIHMTD 697
LP D L R AFS + + I L L+ PHKRI
Sbjct: 224 GLPPEDDWPRDVTLPR--GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR 281
Query: 698 A 698
A
Sbjct: 282 A 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 434 LLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEIL-RNV-----RHRNLLK 487
+LG G FG V+ L GTN I L+ + D EC ++ + V H L
Sbjct: 2 MLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+ + + V+E++ G L + S + F D+ + ++ L++LH S
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLH----SK 115
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISK--LLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
I++ DLK NILLD + ++DFG+ K +LG+ + T Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEILLGQ 171
Query: 606 IVSTKCDVYSYGVLLMETFTEKKP 629
+T D +S+GVLL E + P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 68/263 (25%), Positives = 115/263 (43%), Gaps = 40/263 (15%)
Query: 434 LLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKIL--G 490
++G GGFG VY +D G A+K + + R + E L + R +L ++ G
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54
Query: 491 SCSNL----------DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
C + D +L+ M G L L H F + R ++ LE++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE 600
H+ +++ DLKP NILLDE+ +SD G++ + + ++ T GYMAPE
Sbjct: 114 HNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPE 165
Query: 601 YGSEGIV-STKCDVYSYGVLLME------TFTEKKPTDEMFTGEMSLRRWVK--ESLPHR 651
+G + D +S G +L + F + K D+ M+L V+ +S
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPE 225
Query: 652 LTEVVDANLVREEQAFSDKMDCL 674
L +++ L R+ S ++ CL
Sbjct: 226 LKSLLEGLLQRD---VSKRLGCL 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 32/210 (15%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDS--------------ECEILRNV 480
LG GGFG V A+++ N A + D E EIL V
Sbjct: 1 LGKGGFGEV----------CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV 50
Query: 481 RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYS-HNYFLDILQRLNIMIDVGSALEY 539
++ + + + LV+ M G L+ +Y+ L++ + ++ + + +
Sbjct: 51 NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
LH S I++ D+KP N+LLD+ +SD G++ L +G+ T T GYMAP
Sbjct: 111 LH----SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAP 163
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
E E S D ++ G + E + P
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 434 LLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFD---SECEILRNVRHRNLL 486
LLG G FG V K T G A+KI ++ A +E +L+N RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
+ S D V+E+ G L L F + R ++ SAL+YLH S
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH---SE 114
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDSVIQTMTMATIGYMAPEYGSEG 605
+++ DLK N++LD++ ++DFG+ K EG +D T Y+APE +
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 606 IVSTKCDVYSYGVLLMETFTEKKP 629
D + GV++ E + P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 53/220 (24%)
Query: 435 LGTGGFGSVYKGTLSD-GTNVAIK-IFN-----LQLERAFRSFDSECEILRNVRHRNLLK 487
+G G +G V S+ VAIK I N + +R R E ++LR++ H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68
Query: 488 ---ILGSCSNLDFKA--LVLEFMPNGSLEKWLYS-------H-NYFLDILQRLNIMIDVG 534
I+ F +V E M + L + + S H YFL L R
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------- 119
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATI 594
L+Y+H SA ++H DLKP+N+LL+ N + DFG+++ E D T + T
Sbjct: 120 -GLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTR 172
Query: 595 GYMAPE-------YGSEGIVSTKCDVYSYGVLLMETFTEK 627
Y APE Y T DV+S G + E K
Sbjct: 173 WYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 434 LLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFD---SECEILRNVRHRNLL 486
LLG G FG V K T G A+KI ++ A +E +L+N RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
+ + D V+E+ G L L F + R ++ SALEYLH S
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH----S 113
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDSVIQTMTMATIGYMAPEYGSEG 605
+++ D+K N++LD++ ++DFG+ K EG D T Y+APE +
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 606 IVSTKCDVYSYGVLLMETFTEKKP 629
D + GV++ E + P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSF------DSECEILRNV 480
+ + + +G+G +GSV + T +++ +L R F+S E +L+++
Sbjct: 17 ERYQNLSPVGSGAYGSVCA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73
Query: 481 RHRNLLKILGSCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LQRLN--- 528
+H N++ +L F P SLE+ +L +H D+ Q+L
Sbjct: 74 KHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 121
Query: 529 ---IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585
++ + L+Y+H SA IIH DLKP+N+ ++E+ + DFG+++ +
Sbjct: 122 VQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 173
Query: 586 IQTMTMATIGYMAPEYGSEGI-VSTKCDVYSYGVLLMETFT 625
T +AT Y APE + + D++S G ++ E T
Sbjct: 174 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 39/244 (15%)
Query: 406 EDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNV-AIKIFNLQLE 464
++FL + +R ++F+ ++G G FG V V A+K+ + + E
Sbjct: 22 DNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFE 80
Query: 465 RAFRS----FDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL---------- 510
RS F E +I+ + ++++ + + + +V+E+MP G L
Sbjct: 81 MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIP 140
Query: 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570
EKW R +V AL+ +H S IH D+KP N+LLD++ ++
Sbjct: 141 EKW-----------ARFYTA-EVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLA 184
Query: 571 DFGISKLLGEGEDSVIQTMT-MATIGYMAPEY----GSEGIVSTKCDVYSYGVLLMETFT 625
DFG + + +++ T + T Y++PE G +G +CD +S GV L E
Sbjct: 185 DFGTCMKM--DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 626 EKKP 629
P
Sbjct: 243 GDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFN--LQLE----RAFRSFDSECEILRNVRHRN-- 484
+G+G +GSV G VAIK + Q E RA+R E +L++++H N
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVI 77
Query: 485 -LLKILGSCSNL----DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
LL + S + DF LV+ +M L+K + H D +Q L + G L+Y
Sbjct: 78 GLLDVFTSAVSGDEFQDF-YLVMPYMQT-DLQK-IMGHPLSEDKVQYLVYQMLCG--LKY 132
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIGYM 597
+H SA IIH DLKP N+ ++E+ + DFG+++ MT + T Y
Sbjct: 133 IH----SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYR 181
Query: 598 APEYGSEGIVSTK-CDVYSYGVLLMETFTEK 627
APE + + D++S G ++ E T K
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 14/211 (6%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFN----LQLERAFRSFDSECEILRNVRHRNLLKI 488
++G G FG V ++ A+K+ L+ + +L+NV+H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
S D VL+++ G L L FL+ R ++ SAL YLH S
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH----SLN 116
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEYGSEGIV 607
I++ DLKP NILLD ++DFG+ K E + T T T Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 608 STKCDVYSYGVLLMETFTEKKPTDEMFTGEM 638
D + G +L E P T EM
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 53/239 (22%)
Query: 425 ATDEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLER------AFRSFDSECEIL 477
++ LG G FG VYK + G VA+K + E+ A R E +IL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKIL 61
Query: 478 RNVRHRNLLKILG-----SCSNLDFKALVLEFMP------NGSLEKWLYSHNYFLDILQR 526
+ ++H N++ ++ + + V P +G LE + + L Q
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE----NPSVKLTESQI 117
Query: 527 LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL-------- 578
M+ + + YLH H I+H D+K NIL+D + ++DFG+++
Sbjct: 118 KCYMLQLLEGINYLHENH----ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 579 -GEGEDSVIQTMTMATIGYMAPE-------YGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
G G + T + T Y PE Y T D++ G + E FT ++P
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYT------TAVDIWGIGCVFAEMFT-RRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 51/162 (31%), Positives = 85/162 (52%), Gaps = 5/162 (3%)
Query: 163 HLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSL--PSSLWSLEYILRINL 220
+LE + + L+ N S + +SL+ L SL L S SSL +L +L + ++L
Sbjct: 41 NLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDL 100
Query: 221 SSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPES 280
+ N L+ S + +L L LDL N ++ P NL+ L L+ N+ + +P
Sbjct: 101 NLNRLRS-NISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSP 158
Query: 281 VGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
+ NL +L++LD S N+LS +PK L LS+L ++S N++
Sbjct: 159 LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
|
Length = 394 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 24/201 (11%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIK----IFN--LQLERAFRSFDSECEILRNVRHRNLLK 487
+G G FG V+ T DG VA+K +F + +R FR E ++L +H N+L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVLS 63
Query: 488 ILG--SCSNLDF--KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
L ++D + V+ + L K + S ++ + + L+YLH
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH-- 120
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--Y 601
SA I+H D+KP N+L++ N V + DFG+++ + E ++S T + T Y APE
Sbjct: 121 --SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEILM 177
Query: 602 GSEGIVSTKCDVYSYGVLLME 622
GS ++ D++S G + E
Sbjct: 178 GSRH-YTSAVDIWSVGCIFAE 197
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 45/219 (20%)
Query: 434 LLGTGGFGSV--YKGTLSDGTNVAIKIFNLQLE------RAFRSFDSECEILRNVRHRNL 485
++G G +G V T + G VAIK N E R R E ++LR +RH ++
Sbjct: 7 VIGKGSYGVVCSAIDTHT-GEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDI 61
Query: 486 LK---ILGSCSNLDFKAL--VLEFM---------PNGSLEKWLYSHNYFLDILQRLNIMI 531
++ I+ S +FK + V E M N L H +FL L R
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP--EHHQFFLYQLLR----- 114
Query: 532 DVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL-LGEGEDSVIQTMT 590
AL+Y+H +A + H DLKP NIL + + + DFG++++ + ++ T
Sbjct: 115 ----ALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 591 MATIGYMAPEY-GS-EGIVSTKCDVYSYGVLLMETFTEK 627
+AT Y APE GS + D++S G + E T K
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 58/242 (23%), Positives = 92/242 (38%), Gaps = 37/242 (15%)
Query: 406 EDFLPPATRRRTSYLDIRRATD-------EFNECNLLGTGGFGSVYKGTL---SDGTNVA 455
E+ L P T + ++D ++N + L G G V+ T V
Sbjct: 64 EESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVI 123
Query: 456 IKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLY 515
+K ++ E +IL+ + HR ++ ++ + K+ V MP Y
Sbjct: 124 VKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPK-------Y 168
Query: 516 SHNYF--LDILQRLN----IMIDVG--SALEYLHHCHSSAPIIHCDLKPTNILLDENMVA 567
+ F +D L I I AL YLH IIH D+K NI LDE A
Sbjct: 169 KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENA 224
Query: 568 HVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEK 627
+ DFG + L D+ T+ +PE + K D++S G++L E +
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
Query: 628 KP 629
Sbjct: 285 VT 286
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNV-AIKIFNL--QLERAFRS-FDSECEILRNVRH 482
++F ++G G FG V L + V A+KI N L+RA + F E ++L N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
+ + + + + + LV+++ G L L L + ++ A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS-KLLGEGEDSVIQTMTMATIGYMAPEY 601
H +H D+KP NIL+D N ++DFG KL+ +G +V ++ + T Y++PE
Sbjct: 121 LH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEI 174
Query: 602 -----GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+G +CD +S GV + E + P
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 23/227 (10%)
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNV 480
+R F L+G G +G VYKG + G AIK+ ++ + E +L+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKY 59
Query: 481 -RHRNLLKILGSC-----SNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533
HRN+ G+ +D + LV+EF GS+ + N + L+ I
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYIC 117
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI--QTMTM 591
L L H H +IH D+K N+LL EN + DFG+S L D + + +
Sbjct: 118 REILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFI 172
Query: 592 ATIGYMAPEY-----GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
T +MAPE + K D++S G+ +E P +M
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 29/210 (13%)
Query: 434 LLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGS- 491
++G GGFG VY +D G A+K + + R + E L + R +L ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54
Query: 492 ------CSNLDFK-----ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
C + F + +L+ M G L L H F + R ++ LE++
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHM 113
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE 600
H + +++ DLKP NILLDE+ +SD G++ + + ++ T GYMAPE
Sbjct: 114 H----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPE 165
Query: 601 YGSEGIV-STKCDVYSYGVLLMETFTEKKP 629
+G+ + D +S G +L + P
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 33/236 (13%)
Query: 435 LGTGGFGSVYKGTL---SDGTN--------VAIKIFNLQLERAFRSFDSECEILRNVRHR 483
LG G F ++YKG L SD V +K+ R +F ++ + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
+L+K+ G C + +V E++ G L+ +L+ + + +L++ + SAL YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 544 HSSAPIIHCDLKPTNILL-----DENMV--AHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
++H ++ NIL+ +E V +SD GI + E+ V + I +
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPW 170
Query: 597 MAPEYGSEGIVSTK--CDVYSYGVLLMETFTE-KKPTDEMFTGEMSLRRWVKESLP 649
+APE G S D +S+G L+E + ++P + + E + LP
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 61/243 (25%), Positives = 110/243 (45%), Gaps = 23/243 (9%)
Query: 398 RSTKHLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNV-AI 456
R K++D +FL + ++ ++++ ++G G FG V V A+
Sbjct: 16 RKNKNID--NFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAM 73
Query: 457 KIFNLQLERAFRS----FDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEK 512
K+ + + E RS F E +I+ ++++ + + + +V+E+MP G L
Sbjct: 74 KLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN 132
Query: 513 WLYSHNYFLDILQRLN--IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570
+ NY D+ ++ +V AL+ +H S +IH D+KP N+LLD++ ++
Sbjct: 133 LM--SNY--DVPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLA 184
Query: 571 DFGISKLLGEGEDSVIQTMTMATIGYMAPEY----GSEGIVSTKCDVYSYGVLLMETFTE 626
DFG + E V + T Y++PE G +G +CD +S GV L E
Sbjct: 185 DFGTCMKMDE-TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
Query: 627 KKP 629
P
Sbjct: 244 DTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 38/159 (23%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565
P + L + + L + + V + +E+L +S +H DL N+L+ E
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFL----ASKNCVHRDLAARNVLICEGK 276
Query: 566 VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ + DFG+++ + + + + T + +MAPE + +T DV+S+G+LL E FT
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
Query: 626 ------EKKPTDEMFTGEMSLRRWVKESLP-HRLTEVVD 657
+ P +E F +++R + + P H E+ +
Sbjct: 337 LGGTPYPELPMNEQFYN--AIKRGYRMAKPAHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 23/214 (10%)
Query: 434 LLGTGGFGSVYKGTLSDGTNV-AIKIFNLQLERAFRSFDSEC-----EILRNVRHRNLLK 487
+LG G FG V L V AIK+ L+ + + D +C IL L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 488 ILGSC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
L C D V+E++ G L + F + R +V AL +LH H
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHR-HG- 116
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEYGSEG 605
+I+ DLK NILLD ++DFG+ K EG + + T T T Y+APE E
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 606 IVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
D ++ GVL+ E + P D++F
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 33/145 (22%), Positives = 61/145 (42%), Gaps = 14/145 (9%)
Query: 431 ECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL--KI 488
LL G VY D +KI + + A R + E IL+ + + L K+
Sbjct: 2 SIKLLKGGLTNRVYLLGTKDED-YVLKINPSREKGADR--EREVAILQLLARKGLPVPKV 58
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
L S + + L++E++ +L++ + ++ +I + L LH
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQ-LPLLV 109
Query: 549 IIHCDLKPTNILLDENMVAHVSDFG 573
+ H DL P NIL+D+ + + D+
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 31/105 (29%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 521 LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580
LD+ L V +++L +S IH D+ N+LL + VA + DFG+++ +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL----ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ V++ + +MAPE + + + + DV+SYG+LL E F+
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 429 FNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLL 486
F ++G G +G VYKG + G AIK+ ++ E E +L+ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76
Query: 487 KILGS------CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
G+ + D LV+EF GS+ + N + L+ I L L
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGL 134
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI--QTMTMATIGYMA 598
H H+ +IH D+K N+LL EN + DFG+S L D + + + T +MA
Sbjct: 135 AHLHAHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMA 189
Query: 599 PEY-----GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
PE + + D++S G+ +E P +M
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 434 LLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEIL-RNV-----RHRNLLK 487
+LG G FG V L GTN I L+ + D EC ++ R V H L
Sbjct: 2 VLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+ + + V+E++ G L + S F + R ++ L++LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLH----KK 115
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISK--LLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
II+ DLK N+LLD++ ++DFG+ K + GEG+ S T Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF----CGTPDYIAPEILKGQ 171
Query: 606 IVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
+ D +S+GVLL E + P DE+F
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 64/254 (25%), Positives = 98/254 (38%), Gaps = 43/254 (16%)
Query: 434 LLGTGGFGSVYKG-TLSDGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKIL 489
L+G GG G VY VA+K L + F E +I ++ H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 490 GSCSNLDFKALVLEFMP--NGSLEKWLYSHNYFLDILQR-----------LNIMIDVGSA 536
CS+ D V MP G K L + + L + L+I + +
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-----------SV 585
+EY+H S ++H DLKP NILL + D+G + E+
Sbjct: 126 IEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 586 IQTMT-----MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL 640
+MT + T YMAPE S D+Y+ GV+L + T P ++S
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241
Query: 641 RRWV---KESLPHR 651
R + E P+R
Sbjct: 242 RDVILSPIEVAPYR 255
|
Length = 932 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 64/220 (29%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 434 LLGTGGFGSV----YKGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EILRNVRHRN 484
+LG G FG V KGT A+K+ L+ + + D EC +L
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHP 56
Query: 485 LLKILGSC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
L L SC L F V+E++ G L + F D + ++ L++L
Sbjct: 57 FLTQLHSCFQTKDRLFF---VMEYVNGGDLMFHIQRSGRF-DEPRARFYAAEIVLGLQFL 112
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAP 599
H II+ DLK N+LLD ++DFG+ K EG + T T T Y+AP
Sbjct: 113 H----ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAP 165
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
E S D ++ GVLL E + P DE+F
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 427 DEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERA--FRSFDSECEILRNVRHR 483
D + + LG G + +VYKG + +G VA+K+ LQ E F + E +L+ ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHA 63
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
N++ + + LV E++ + L +++ H L + + L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--Y 601
+ I+H DLKP N+L+ + ++DFG+++ + S + + T+ Y P+
Sbjct: 123 Y----ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 602 GSEGIVSTKCDVYSYGVLLME 622
GS ST D++ G + +E
Sbjct: 177 GSTE-YSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 27/200 (13%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLE------RAFRSFDSECEILRNVRHRN--- 484
+G G +G+V+K VA+K L + A R E +L+ ++H+N
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
L +L S L LV E+ + L+K+ S N +D + M + L+ L CH
Sbjct: 64 LYDVLHSDKKL---TLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQL---LKGLAFCH 116
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--YG 602
S ++H DLKP N+L+++N ++DFG+++ G + + T+ Y P+ +G
Sbjct: 117 SHN-VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFG 173
Query: 603 SEGIVSTKCDVYSYGVLLME 622
++ ST D++S G + E
Sbjct: 174 AKL-YSTSIDMWSAGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 428 EFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EILR 478
+FN +LG G FG V KGT AIKI L+ + + D EC +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKI--LKKDVVIQDDDVECTMVEKRVLA 55
Query: 479 NVRHRNLLKILGSC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
L L SC +D V+E++ G L + F + Q + ++ L
Sbjct: 56 LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGL 114
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATI--- 594
+LH II+ DLK N++LD ++DFG+ K + ++ +T T
Sbjct: 115 FFLHR----RGIIYRDLKLDNVMLDSEGHIKIADFGMCK------EHMVDGVTTRTFCGT 164
Query: 595 -GYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMFTGEM 638
Y+APE + D ++YGVLL E + P DE+F M
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 21/205 (10%)
Query: 434 LLGTGGFGSVY----KGTLSDGTNVAIKIFN----LQLERAFRSFDSECEILRNVRHRNL 485
LLG G FG V K T G A+KI + + + +E +L+N RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFL 57
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
+ S D V+E+ G L L F + R ++ SAL YLH C
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLHSCD- 115
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEYGSE 604
+++ DLK N++LD++ ++DFG+ K EG T T Y+APE +
Sbjct: 116 ---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 605 GIVSTKCDVYSYGVLLMETFTEKKP 629
D + GV++ E + P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 435 LGTGGFGSVYKGTLSDGTN-VAIKIFNLQLER-----AFRSFDSECEILRNVRHRNLLKI 488
LG G + +V+KG N VA+K L+ E A R E +L+N++H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
LV E++ + L+++L + +++ N+ I + L L +CH
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHKRK- 123
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--YGSEGI 606
I+H DLKP N+L++E ++DFG+++ + + + + T+ Y P+ GS
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTE- 180
Query: 607 VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL 648
ST D++ G +L E T + MF G VKE L
Sbjct: 181 YSTPIDMWGVGCILYEMATGRP----MFPGST-----VKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 426 TDEFNECNLLGTGGFGSVYK-GTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HR 483
+D + +G G +G V+K +G+ A+KI + + ++E IL+ + H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHP 75
Query: 484 NLLKILGSCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILQRLN---IMIDVGS 535
N++K G D K LVLE GS+ + FL +R+ I +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHE 132
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
AL L H H + IH D+K NILL + DFG+S L + + ++ T
Sbjct: 133 ALMGLQHLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPF 189
Query: 596 YMAPEYGS-----EGIVSTKCDVYSYGVLLME 622
+MAPE + + +CDV+S G+ +E
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 34/235 (14%)
Query: 434 LLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRN------VRHRNLLK 487
+LG G FG V L G + L+ + D EC ++ + L
Sbjct: 2 VLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+ + + V+EF+ G L + F D+ + ++ L++LH S
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLH----SK 115
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISK--LLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
II+ DLK N++LD + ++DFG+ K + G+ S T Y+APE
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQGL 171
Query: 606 IVSTKCDVYSYGVLLMETFTEKKP-----TDEMFTGEMSLR-------RWV-KES 647
+ D +S+GVLL E + P DE+F S+R RW+ KES
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE---SIRVDTPHYPRWITKES 223
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 66/229 (28%), Positives = 98/229 (42%), Gaps = 33/229 (14%)
Query: 428 EFNECNLLGTGGFGSVYKGTLSD--GTN--VAIKIFNLQLERAFRSFDSECEILRNVRHR 483
+FN +LG G FG V L++ GT+ AIKI L+ + + D EC + V R
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKI--LKKDVVIQDDDVECTM---VEKR 52
Query: 484 NL--------LKILGSC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVG 534
L L L SC +D V+E++ G L + F + + ++
Sbjct: 53 VLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP-HAVFYAAEIA 111
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATI 594
L +LH S II+ DLK N++LD ++DFG+ K D V T
Sbjct: 112 IGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMFTGEM 638
Y+APE + D +++GVLL E + P DE+F M
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 435 LGTGGFGSVYKG-TLSDGTN-VAIKIFNLQLERAFRSFDS--ECEILRNVR---HRNLLK 487
+G G +G V+K L +G VA+K +Q + E +LR++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 488 ILGSC--SNLDFKA---LVLEFMPNGSLEKWL-YSHNYFLDILQRLNIMIDVGSALEYLH 541
+ C S D + LV E + + L +L + ++M + L++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
S ++H DLKP NIL+ + ++DFG++++ + T + T+ Y APE
Sbjct: 128 ----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEV 180
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEK 627
+ +T D++S G + E F K
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 40/182 (21%), Positives = 76/182 (41%), Gaps = 23/182 (12%)
Query: 473 ECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMID 532
E +L+NV H +++++ + + +VL + L +L + L I Q L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM- 591
+ L YLH + IIH D+K NI +++ + D G ++ V+ +
Sbjct: 166 ILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF------PVVAPAFLG 215
Query: 592 --ATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKK---------PTDEMFTGEMSL 640
T+ APE + ++K D++S G++L E P + + + L
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275
Query: 641 RR 642
+
Sbjct: 276 LK 277
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 43/211 (20%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFD-----SECEILRNVR-HRNLLK 487
+G G F V K + G AIK +++ F+S + E + LR + H N+L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 488 IL--------GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
++ G ALV E M + +L + + L + + M + +L++
Sbjct: 63 LIEVLFDRKTGRL------ALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ----TMTMATIG 595
+H I H D+KP NIL+ ++++ ++DFG + + T ++T
Sbjct: 116 MHRNG----IFHRDIKPENILIKDDIL-KLADFGSCR-------GIYSKPPYTEYISTRW 163
Query: 596 YMAPE-YGSEGIVSTKCDVYSYGVLLMETFT 625
Y APE ++G K D+++ G + E +
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNV-AIKIFNL--QLERAFRS-FDSECEILRNVRH 482
D+F ++G G FG V + + A+KI N L+RA + F E +L N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
+ + + + + ++ LV+++ G L L + F D L + + +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ-TMTMATIGYMAPE- 600
H +H D+KP N+LLD N ++DFG L +D +Q ++ + T Y++PE
Sbjct: 118 IHQLH-YVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 601 ----------YGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
YG E CD +S GV + E + P
Sbjct: 175 LQAMEDGMGKYGPE------CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 71/270 (26%), Positives = 125/270 (46%), Gaps = 39/270 (14%)
Query: 398 RSTKHLDHEDFLPPATR------RRTSYLDIRRATDE-FNECNLLGTGGFGSVYKGTLSD 450
+ K LD E+ + DI R+ ++ + N++G G FG VY+ D
Sbjct: 30 MNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICID 89
Query: 451 GT-NVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA--------LV 501
+ VAIK ++ + + + E I++N+ H N++ + FK +V
Sbjct: 90 TSEKVAIK----KVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 502 LEFMPNGSLEKWL--YS-HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTN 558
+EF+P ++ K++ Y+ +N+ L + + AL Y+H S I H DLKP N
Sbjct: 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQN 200
Query: 559 ILLDENM-VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--YGSEGIVSTKCDVYS 615
+L+D N + DFG +K L G+ SV + + Y APE G+ +T D++S
Sbjct: 201 LLIDPNTHTLKLCDFGSAKNLLAGQRSV---SYICSRFYRAPELMLGATN-YTTHIDLWS 256
Query: 616 YGVLLMETFTEKKPTDEMFTGEMSLRRWVK 645
G ++ E +F+G+ S+ + V+
Sbjct: 257 LGCIIAEMILGYP----IFSGQSSVDQLVR 282
|
Length = 440 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 48/232 (20%)
Query: 435 LGTGGFGSV---YKGTLSDGTNVAIKIFNLQLE------RAFRSFDSECEILRNVRHRNL 485
+G+G G V Y L NVAIK + + RA+R E +++ V H+N+
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 78
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKW--LYSHNYFLD--ILQRLNIMIDVGSALEYL- 540
+ +L F P SLE++ +Y +D + Q + + +D + YL
Sbjct: 79 ISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYLL 125
Query: 541 -------HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT 593
H HS A IIH DLKP+NI++ + + DFG+++ G S + T + T
Sbjct: 126 YQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 181
Query: 594 IGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK 645
Y APE D++S G ++ E K +F G + +W K
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 75/275 (27%), Positives = 112/275 (40%), Gaps = 57/275 (20%)
Query: 435 LGTGGFGSVYKGTLSDGTNV-AIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
+G G FG VY+ D + A+K+ + + A + E+ + RN+L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILV----RT 50
Query: 494 NLD-----------FKA-----LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
LD F+ LV ++M G L L F + + I ++ AL
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLAL 109
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597
E+LH I++ DLKP NILLD + DFG+SK D+ T Y+
Sbjct: 110 EHLH----KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 598 APEYGSEGIVSTK-CDVYSYGVLLMETFTEKKP-----TDEMF-----------TGEMSL 640
APE + TK D +S GVL+ E P T +M+ +S
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSD 223
Query: 641 --RRWVKESL----PHRLTEVVDANLVREEQAFSD 669
R++VK L HRL DA ++E F+D
Sbjct: 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 53/151 (35%), Positives = 70/151 (46%), Gaps = 12/151 (7%)
Query: 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNI 559
LVL F+ G L L F R ++ ALE LH +I+ DLKP NI
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH----KFNVIYRDLKPENI 124
Query: 560 LLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEYGSEGIVSTKC-DVYSYG 617
LLD + DFG+ KL + +D +T T T Y+APE G TK D ++ G
Sbjct: 125 LLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLL-GHGYTKAVDWWTLG 180
Query: 618 VLLMETFTEKKPTDEMFTGEMSLRRWVKESL 648
VLL E T P + EM R+ ++E L
Sbjct: 181 VLLYEMLTGLPPFYDENVNEM-YRKILQEPL 210
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRN------VRHRNLLKI 488
+G G FG V + T VA + ++ +A S + E L+ ++H N+L+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVV--VKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF-----LDILQRLNIMIDVGSALEYLHHC 543
LG C LV E+ G L+ +L + L +LQR+ I G + H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI-QTMTMATIGYMAPEYG 602
+H DL N L ++ V D+GI ED + + + ++APE
Sbjct: 120 -----FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 603 SE---GIVSTK----CDVYSYGVLLMETF 624
E G+++ + +V++ GV L E F
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 22/200 (11%)
Query: 435 LGTGGFGSVYKGTLSDGTNVA---------IKIFNLQLERAFRSFDSECEILRNVRHRNL 485
LG G FG+VY + D VA I + L ++ + E ++L + H +
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAI 64
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL---QRLNIMIDVGSALEYLHH 542
+K S D ++ E+ L+ L + L Q I + + Y+H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYG 602
I+H DLK NI L N++ + DFG+S+LL D + T T YM+PE
Sbjct: 125 ----RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177
Query: 603 SEGIVSTKCDVYSYGVLLME 622
+K D++S G +L E
Sbjct: 178 KHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 35/165 (21%)
Query: 434 LLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRS---FDSECEI--------LR 478
L+G GGFG VY KI NL+ E +++ +I +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 479 NVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL---------NI 529
N+ H + K G C + + F+ LEK + + +I +R+ NI
Sbjct: 79 NIDHLGIPKYYG-CGSFKRCRMYYRFI---LLEKLVENTK---EIFKRIKCKNKKLIKNI 131
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574
M D+ + LEY+H I H D+KP NI++D N ++ D+GI
Sbjct: 132 MKDMLTTLEYIH----EHGISHGDIKPENIMVDGNNRGYIIDYGI 172
|
Length = 294 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 48/232 (20%)
Query: 435 LGTGGFGSV---YKGTLSDGTNVAIKIFNLQLE------RAFRSFDSECEILRNVRHRNL 485
+G+G G V Y L NVAIK + + RA+R E +++ V H+N+
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKW--LYSHNYFLD--ILQRLNIMIDVGSALEYL- 540
+ +L F P SLE++ +Y +D + Q + + +D + YL
Sbjct: 86 IGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYLL 132
Query: 541 -------HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT 593
H HS A IIH DLKP+NI++ + + DFG+++ G S + T + T
Sbjct: 133 YQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 594 IGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK 645
Y APE D++S G ++ E +F G + +W K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 61/220 (27%), Positives = 87/220 (39%), Gaps = 27/220 (12%)
Query: 429 FNECNLLGTGGFGSV----YKGTLSDGTNVAIKIFNLQ--LER-AFRSFDSECEILRNV- 480
F +LG G FG V YK T G AIK + R S E I
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 481 --RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALE 538
RH L+ + D V+E+ G L ++ H + + V L+
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQ 115
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYM 597
YLH I++ DLK N+LLD ++DFG+ K EG +T T T ++
Sbjct: 116 YLH----ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFL 168
Query: 598 APEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
APE +E + D + GVL+ E + P F G+
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 52/200 (26%), Positives = 98/200 (49%), Gaps = 22/200 (11%)
Query: 435 LGTGGFGSVYKG--TLSDGTNVAIKIFNLQLER-----AFRSFDSECEILRNVRHRNLLK 487
LG G + +VYKG L+D VA+K L+ E A R E +L++++H N++
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+ LV E++ + L+++L + + N+ + + L L++CH
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--YGSEG 605
++H DLKP N+L++E ++DFG+++ + + + + T+ Y P+ GS
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTD 181
Query: 606 IVSTKCDVYSYGVLLMETFT 625
ST+ D++ G + E T
Sbjct: 182 -YSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 55/219 (25%)
Query: 451 GTNVAIKI----FNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504
G NVAIK F +RA+R +++ V H+N++ +L F
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYREL----VLMKLVNHKNIIGLLNV------------F 84
Query: 505 MPNGSLEKW--LYSHNYFLD--ILQRLNIMIDVGSALEYL--------HHCHSSAPIIHC 552
P SLE++ +Y +D + Q + + +D + YL H HS A IIH
Sbjct: 85 TPQKSLEEFQDVYLVMELMDANLCQVIQMDLD-HERMSYLLYQMLCGIKHLHS-AGIIHR 142
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE------YGSEGI 606
DLKP+NI++ + + DFG+++ G S + T + T Y APE Y
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGY----- 194
Query: 607 VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK 645
D++S G ++ E +F G + +W K
Sbjct: 195 -KENVDIWSVGCIMGEMIRGTV----LFPGTDHIDQWNK 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 51/188 (27%), Positives = 73/188 (38%), Gaps = 25/188 (13%)
Query: 454 VAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKW 513
V K L ER SE L H ++K + D L++E+ G L K
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK- 154
Query: 514 LYSHNYFLDILQRLN------------IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL 561
I QRL + + AL+ +H S ++H DLK NI L
Sbjct: 155 --------QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH----SRKMMHRDLKSANIFL 202
Query: 562 DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLM 621
+ + DFG SK + + + T Y+APE S K D++S GV+L
Sbjct: 203 MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILY 262
Query: 622 ETFTEKKP 629
E T +P
Sbjct: 263 ELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 69/237 (29%), Positives = 99/237 (41%), Gaps = 49/237 (20%)
Query: 428 EFNECNLLGTGGFGSVYKGTLSD--GTN--VAIKIFNLQLERAFRSFDSECEILRNVRHR 483
+FN +LG G FG V L++ GT+ AIKI L+ + + D EC + V R
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKI--LKKDVIIQDDDVECTM---VEKR 52
Query: 484 NL--------LKILGSC-SNLDFKALVLEFMPNGSLE-------KWLYSHNYFLDILQRL 527
L L L SC +D V+E++ G L K+ H F
Sbjct: 53 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------ 106
Query: 528 NIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587
++ L +LH S II+ DLK N++LD ++DFG+ K E
Sbjct: 107 --AAEIAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKT 157
Query: 588 TMTM-ATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMFTGEM 638
T T T Y+APE + D +++GVLL E + P DE+F M
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 56/220 (25%)
Query: 435 LGTGGFGSV---YKGTLSDGTNVAIKIFNLQLERAFRSF------DSECEILRNVRHRNL 485
+G+G +GSV Y L VA+K +L R F+S E +L++++H N+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL-----------QRLN------ 528
+ +L F P S+E ++ Y + L Q+L+
Sbjct: 77 IGLLDV------------FTPATSIEN--FNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122
Query: 529 IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT 588
++ + L+Y+H SA IIH DLKP+N+ ++E+ + DFG+++ + +D + T
Sbjct: 123 LIYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--T 173
Query: 589 MTMATIGYMAPEYGSEGI-VSTKCDVYSYGVLLMETFTEK 627
+AT Y APE + + D++S G ++ E K
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 49/192 (25%), Positives = 95/192 (49%), Gaps = 12/192 (6%)
Query: 435 LGTGGFGSVYKGTLSDGTN-VAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSC 492
LG G + +V+KG N VA+K L+ E A + E +L++++H N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552
LV E++ + L++++ +I+ N+ I + L L +CH ++H
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK-VLHR 128
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--YGSEGIVSTK 610
DLKP N+L++E ++DFG+++ + + + + T+ Y P+ GS ST+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSE-YSTQ 185
Query: 611 CDVYSYGVLLME 622
D++ G + E
Sbjct: 186 IDMWGVGCIFFE 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 5e-06
Identities = 19/60 (31%), Positives = 32/60 (53%)
Query: 262 NLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRL 321
NL++L L+ N+ + L +L+ LD S NNL+ P++ L L+ ++S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 435 LGTGGFG-SVYKGTLSDGTNVAIKIFNL------QLERAFRSFDSECEILRNVRHRNLLK 487
+G G FG ++ + DG IK N+ + E + + E +L N++H N+++
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK----EVAVLSNMKHPNIVQ 63
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFL-DILQRLNIMIDVGSALEYLHHCHSS 546
S +V+++ G L K + + L Q L+ + + AL+++H
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH----D 119
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA--TIG---YMAPEY 601
I+H D+K NI L ++ + DFGI+++L T+ +A IG Y++PE
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-------STVELARTCIGTPYYLSPEI 172
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEK 627
+ K D+++ G +L E T K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 29/78 (37%), Positives = 46/78 (58%), Gaps = 5/78 (6%)
Query: 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNI 559
LV+E++ G ++ L+ + YF + + I +V AL+YLH H IIH DLKP N+
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHR-HG---IIHRDLKPDNM 135
Query: 560 LLDENMVAHVSDFGISKL 577
L+ ++DFG+SK+
Sbjct: 136 LISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 68/294 (23%), Positives = 116/294 (39%), Gaps = 45/294 (15%)
Query: 17 LDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALA 76
LDL N +P+ NL +L L L N+L+ L+N NL NL L+
Sbjct: 145 LDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS---------DLPKLLSNLSNLNNLDLS 194
Query: 77 SNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTS 136
N + +P EI L L L L N + + +S
Sbjct: 195 GNKI--------------------------SDLPPEIELLSALEELDLSNNSII-ELLSS 227
Query: 137 IGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYL 196
+ L+ L G + NN +P + +L L L+LS N++S L SLT+LR L L
Sbjct: 228 LSNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDL 284
Query: 197 QSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPST 256
N LS++LP L +L + L+ L + + + ++ N +S P
Sbjct: 285 SGNSLSNALPLIA-LLLLLLELLLNLLLTLKALELKLNSILLNNNIL--SNGETS-SPEA 340
Query: 257 IGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSH 310
+ L++L L N + + + ++ + + + + LE +++
Sbjct: 341 LSILESLNNLWTLDNALD-ESNLNRYIVKNPNAIGSLLDLVKKHVNQLLEKVNY 393
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-05
Identities = 26/59 (44%), Positives = 31/59 (52%)
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNL 297
L LDLS N+L+ L NL+ L L+GN PE+ L SL SLD S NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 23/152 (15%)
Query: 435 LGTGGFGSVYKGTLSDGTN--VAIKIFNLQLER-----AFRSFDSECEILRNVRHRN--- 484
LG G + +VYKG S T VA+K L+ E A R E +L++++H N
Sbjct: 13 LGEGSYATVYKGR-SKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVT 67
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
L I+ + L LV E++ + L++++ L N+ + + L L +CH
Sbjct: 68 LHDIIHTKKTL---TLVFEYL-DTDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCH 120
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576
++H DLKP N+L+ E ++DFG+++
Sbjct: 121 QRR-VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNV-AIKIFNL--QLERAFRS-FDSECEILRNVRH 482
D+F ++G G FG V + + V A+KI N L+RA + F E ++L N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR------LNIMIDVGSA 536
R + + + + + LV+++ G L L + F D L L M+ A
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMV---LA 114
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS-KLLGEGEDSVIQTMTMATIG 595
++ +H +H D+KP N+LLD+N ++DFG +LL +G +V + + T
Sbjct: 115 IDSVHQLG----YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGTPD 168
Query: 596 YMAPEY-----GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
Y++PE +G +CD +S GV + E + P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 15/202 (7%)
Query: 435 LGTGGFGSVYKGT---LSDG-----TNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
LG G F ++KG + D T V +K+ + SF ++ + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
G C D +V E++ GSL+ +L + ++I +L + + AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE----D 118
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT--IGYMAPEYGSE 604
+ H ++ N+LL + KL G + + I ++ PE
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178
Query: 605 G-IVSTKCDVYSYGVLLMETFT 625
+S D +S+G L E F+
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 55/199 (27%), Positives = 80/199 (40%), Gaps = 56/199 (28%)
Query: 436 GTGGFGSVYKG---TLSDGTNVAIKIFNLQLER-------AFRSFDSECEILRNVRHRNL 485
G G +G VYK DG AIK F E+ A R E +LR ++H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKHENV 64
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWL---YSHNYFLDIL----QRLNIMID---VGS 535
+ LV F+ + +L Y+ + I+ Q + I V S
Sbjct: 65 VS------------LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 536 A----LEYLHHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGE------G 581
L +H+ HS+ ++H DLKP NIL+ E V + D G+++L
Sbjct: 113 LLWQILNGVHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 582 EDSVIQTMTMATIGYMAPE 600
D V+ TI Y APE
Sbjct: 172 LDPVV-----VTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 2e-05
Identities = 19/60 (31%), Positives = 30/60 (50%)
Query: 166 RLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSL 225
L L+LS N+L+ L +L+ L L N L+S P + L + ++LS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 39/190 (20%)
Query: 451 GTNVAIKIF------NLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504
G NVA+K +RA+R E +L+ V H+N++ +L F
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR----ELVLLKCVNHKNIISLLNV------------F 89
Query: 505 MPNGSLEKW--LYSHNYFLD--ILQRLNIMIDVGSALEYL--------HHCHSSAPIIHC 552
P SLE++ +Y +D + Q +++ +D + YL H HS A IIH
Sbjct: 90 TPQKSLEEFQDVYLVMELMDANLCQVIHMELD-HERMSYLLYQMLCGIKHLHS-AGIIHR 147
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCD 612
DLKP+NI++ + + DFG+++ + + T + T Y APE D
Sbjct: 148 DLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVD 204
Query: 613 VYSYGVLLME 622
++S G ++ E
Sbjct: 205 IWSVGCIMGE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 41/245 (16%)
Query: 419 YLDIRRATDEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC 474
Y D +E+ +G G FG V+ K T AI L+ ER E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEV 63
Query: 475 EILRNVRHRNLLKILGSCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILQRLNIMID 532
++R ++H+N+++ + N + L ++EF G L + + ++ I+
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 533 VGSALEYLHHCHS--SAP----IIHCDLKPTNILLDENM-----------------VAHV 569
L L +CH+ P ++H DLKP NI L + +A +
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 570 SDFGISKLLGEGEDSVIQTMTMATIG---YMAPEYGSEGIVS--TKCDVYSYGVLLMETF 624
DFG+SK +G I++M + +G Y +PE S K D+++ G ++ E
Sbjct: 184 GDFGLSKNIG------IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 625 TEKKP 629
+ K P
Sbjct: 238 SGKTP 242
|
Length = 1021 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 21/52 (40%), Positives = 27/52 (51%), Gaps = 1/52 (1%)
Query: 151 NNLQGYVPHDLCH-LERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKL 201
NN +P L L +L+LSGN L+ P+ + L SLRSL L N L
Sbjct: 9 NNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 57/224 (25%), Positives = 87/224 (38%), Gaps = 40/224 (17%)
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNF--SASLQNIYAFECKLGGSIPKEIG---- 114
L LT L L L+ N LG ++ + S+SLQ + LG + +
Sbjct: 74 LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK 133
Query: 115 -NLRGLIVLSLGFNDLNGTIPT-------SIGTLQQLQGFYVPENNLQG----YVPHDLC 162
L L LG N L G + L++L + N + + L
Sbjct: 134 DLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELN---LANNGIGDAGIRALAEGLK 190
Query: 163 HLERLNILNLSGNKL----SGAIPQCLASLTSLRSLYLQSNKLS--------SSLPSSLW 210
L +L+L+ N L + A+ + LASL SL L L N L+ S+L S
Sbjct: 191 ANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNI 250
Query: 211 SLEYILRINLSSNSLK----GTLPSNIQKLNVLIDLDLSRNQLS 250
SL L ++LS N + L + + L++LDL N+
Sbjct: 251 SL---LTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 56/240 (23%), Positives = 93/240 (38%), Gaps = 42/240 (17%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNV-AIKIF---NLQLERAFRSFDSECEILRNVRH 482
++F ++G G FG V D +V A+KI ++ + +E +IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
++K+ S + L++EF+P G + L + + + I V A++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LAIDSIHQ 119
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE--------------DSVIQT 588
IH D+KP N+LLD +SDFG+ L + D Q
Sbjct: 120 LG----FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 589 M-------------------TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
M T+ T Y+APE + + CD +S GV++ E P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 5e-05
Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 24/170 (14%)
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
+ N +K+ S + L L+++++ +G L L L + I+ + AL LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126
Query: 542 HCHSSAPIIHCDLKPTNILLDENMV-AHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE 600
IIH D+K N+L D ++ D+G+ K+ G S T+ Y +P
Sbjct: 127 ----KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPSCYD----GTLDYFSP- 175
Query: 601 YGSEGIVSTKCDV----YSYGVLLMETFTEKKP----TDEMFTGEMSLRR 642
E I DV ++ GVL E T K P DE E L+R
Sbjct: 176 ---EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR 222
|
Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 58/241 (24%), Positives = 94/241 (39%), Gaps = 44/241 (18%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNV-AIKIFN----LQLERAFRSFDSECEILRNVR 481
D+F ++G G FG V D ++ A+KI L+ E+ +E +IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQV-AHIRAERDILVEAD 59
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
++K+ S + L++EF+P G + L + + + I V A++ +H
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-LAIDAIH 118
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE--------------DSVIQ 587
IH D+KP N+LLD +SDFG+ L + D Q
Sbjct: 119 QLG----FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 588 TM-------------------TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKK 628
M T+ T Y+APE + + CD +S GV++ E
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 629 P 629
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 23/54 (42%), Positives = 32/54 (59%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSA 55
G IP S+ + T L LDL NSF+G IP + G L L +L+L N+L+ +A
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 50/168 (29%)
Query: 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNI 559
L++EF+P G L L ++ F + + R M + A+E +H IH D+KP NI
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVH----KLGFIHRDIKPDNI 132
Query: 560 LLDENMVAHVSDFGIS------------KLLGEGE--------------DSVIQTMT--- 590
L+D +SDFG+S + L +G+ DS+ TM+
Sbjct: 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKD 192
Query: 591 -----------MA--TIG---YMAPEYGSEGIVSTKCDVYSYGVLLME 622
MA T+G Y+APE + +CD +S G ++ E
Sbjct: 193 QIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 43/177 (24%), Positives = 68/177 (38%), Gaps = 49/177 (27%)
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553
NL F V++++P G + L F + L R I ++ A+E +H IH D
Sbjct: 75 NLYF---VMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH----KMGFIHRD 126
Query: 554 LKPTNILLDENMVAHVSDFGI---------SKLLGEGEDSVIQTMT-------------- 590
+KP NIL+D + ++DFG+ SK +G+ +M
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 591 ------------------MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+ T Y+APE + CD +S GV+L E + P
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 9/150 (6%)
Query: 429 FNECNLLGTGGFGSVYKGTLSD-GTNVAIKIF---NLQLERAFRSFDSECEILRNVRHRN 484
F + LG G FG V D A+K ++ L +E +IL +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++++ S + D V++++P G + L F + L R I ++ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGI 574
IH D+KP NIL+D + ++DFG+
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 27/164 (16%)
Query: 472 SECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILQRLNIM 530
+E ILR + H +++++ G+ + F L+L P + + Y + + I L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS---------KLLGEG 581
V A++YLH IIH D+K NI ++ + DFG + K G
Sbjct: 189 RSVLRAIQYLH----ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
TI APE + D++S G++L E T
Sbjct: 245 ----------GTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 6e-04
Identities = 20/57 (35%), Positives = 28/57 (49%)
Query: 217 RINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQF 273
++LS+N L + L L LDLS N L+S P L +L +L L+GN
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 29/88 (32%), Positives = 40/88 (45%), Gaps = 8/88 (9%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IPN I+ L ++L NS G+IP + G++ L VL L N+ S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG--------SIP 483
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIG 89
SL +L L L N L G +P +G
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 33/106 (31%), Positives = 47/106 (44%), Gaps = 29/106 (27%)
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL--------LGEGEDSV-- 585
ALEYLH + I+H DLKP N+L+ ++DFG+SK+ L EG
Sbjct: 113 ALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 586 ---IQTMTMATIGYMAPE------YGSEGIVSTKCDVYSYGVLLME 622
+ T Y+APE YG D ++ G++L E
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGK------PVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 40/165 (24%), Positives = 62/165 (37%), Gaps = 53/165 (32%)
Query: 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNI 559
L++E++P G + L + F + R I + A++ +H IH D+KP N+
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-LAIDSIH----KLGYIHRDIKPDNL 132
Query: 560 LLDENMVAHVSDFGISK-----------------LLGEGEDSVIQTM------------- 589
LLD +SDFG+ L D + + M
Sbjct: 133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNR 192
Query: 590 ------TMATIGYMAPE------YGSEGIVSTKCDVYSYGVLLME 622
T+ T Y+APE Y E CD +S GV++ E
Sbjct: 193 RALAYSTVGTPDYIAPEVFLQTGYNKE------CDWWSLGVIMYE 231
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 60/250 (24%), Positives = 99/250 (39%), Gaps = 54/250 (21%)
Query: 429 FNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQ--LER-AFRSFDSECEILRNVRHRN 484
F + LG G FG V D A+K + L R +E +IL +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++K+ S + D V++++P G + L F ++L R I ++ A+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGI---------SKLLGEG----EDSV------ 585
IH D+KP NIL+D + ++DFG+ SK +G +DS+
Sbjct: 119 -KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 586 -----------IQTMT---------------MATIGYMAPEYGSEGIVSTKCDVYSYGVL 619
++T+ + T Y+APE + CD +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 620 LMETFTEKKP 629
L E + P
Sbjct: 238 LFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 15/41 (36%), Positives = 21/41 (51%)
Query: 287 LESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327
++ L N L G IP + L HL+ N+S N + G IP
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPP 460
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 19/60 (31%), Positives = 23/60 (38%)
Query: 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKL 177
L L L N L + L L+ + NNL P L L L+LSGN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL-LGEGEDSVIQTMTMATI 594
AL +LH II+ DLK N+LLD + ++D+G+ K LG G+ + + T
Sbjct: 108 ALNFLHE----RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTP 160
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTD 631
Y+APE D ++ GVL+ E + P D
Sbjct: 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 41/110 (37%), Positives = 60/110 (54%), Gaps = 7/110 (6%)
Query: 163 HLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLP--SSLWSLEYILRINL 220
E L L + G+KL + + SLT LR++ L+ +K +P S +LE + L
Sbjct: 609 RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLE---TLKL 664
Query: 221 SSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAG 270
S S LPS+IQ LN L DLD+SR + +P+ I LK+L L+L+G
Sbjct: 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSG 713
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 47/188 (25%), Positives = 68/188 (36%), Gaps = 46/188 (24%)
Query: 408 FLPPATRR-RTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERA 466
L P R S+ D+F LG G FG VYK +L + + K L++A
Sbjct: 117 VLAPLEGLFRPSF-----KKDDFVLGKKLGEGAFGVVYKASLVN--KQSKKEGKYVLKKA 169
Query: 467 FRSFDSECEILRNVRHRNLLKILGSCSNLDFKA---------------LVLEFMPNGSLE 511
+ EI N R R SC+ DF LV + +L
Sbjct: 170 --TEYGAVEIWMNERVRRACP--NSCA--DFVYGFLEPVSSKKEDEYWLVWRYEGESTLA 223
Query: 512 KWLYSHNY--------FLDI------LQRLNIMID--VGSALEYLHHCHSSAPIIHCDLK 555
+ S + + L+R N +I + L L HS+ I+H D+K
Sbjct: 224 DLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-IVHRDVK 282
Query: 556 PTNILLDE 563
P NI+ E
Sbjct: 283 PQNIIFSE 290
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 717 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.47 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.45 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.45 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.32 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.31 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.3 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.3 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.28 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.28 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.28 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.03 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.02 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.96 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.93 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.91 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.87 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.73 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.68 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.66 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.49 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-82 Score=761.22 Aligned_cols=674 Identities=29% Similarity=0.463 Sum_probs=479.8
Q ss_pred CCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCc
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
+.+|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.++...+. .+.++++|++|++++|.+.
T Consensus 250 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~--------~~~~l~~L~~L~l~~n~~~ 321 (968)
T PLN00113 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE--------LVIQLQNLEILHLFSNNFT 321 (968)
T ss_pred cccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCCh--------hHcCCCCCcEEECCCCccC
Confidence 35677777777777777777777777777777777777777777777654322 2444555555555555555
Q ss_pred ccCCcchhccc-----------------------cccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCcccc
Q 005040 82 GILPPLIGNFS-----------------------ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIG 138 (717)
Q Consensus 82 ~~~~~~~~~l~-----------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 138 (717)
+..|..+..++ ++|+.|++++|++.+.+|..+..+++|+.|++++|++.+..|..+.
T Consensus 322 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~ 401 (968)
T PLN00113 322 GKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401 (968)
T ss_pred CcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHh
Confidence 44444444441 3344444444444444444444445555555555555555555555
Q ss_pred ccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeE
Q 005040 139 TLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRI 218 (717)
Q Consensus 139 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 218 (717)
.+++|+.|++++|++++..|..|.++++|+.|+|++|.+++.++..+..+++|+.|+|++|++.+.+|..+ ..++|+.|
T Consensus 402 ~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L 480 (968)
T PLN00113 402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENL 480 (968)
T ss_pred CCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEE
Confidence 56666666666666665566666666666666666666666666555666666666666666666555544 45678888
Q ss_pred EccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCC
Q 005040 219 NLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 219 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 298 (717)
++++|++++..|..+..+++|+.|+|++|.+.+.+|..+..+++|++|+|++|.+++.+|..+.++++|+.|+|++|+++
T Consensus 481 ~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 560 (968)
T PLN00113 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560 (968)
T ss_pred ECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccc
Confidence 88888888888888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccccccEEEccCCcccccccccccccccccccccCCccccCCC-CCCCCCCCCCCccCcCCccceeeeehhh
Q 005040 299 GKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPP-RLQVPPCKQDNRKRTNKVAPIVLQYILP 377 (717)
Q Consensus 299 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~-~~~~~~c~~~~~~~~~~~~~~~~~~~~~ 377 (717)
+.+|..+..+++|+.|++++|++.+.+|..+.+..+....+.||+.+|++. ....++|.... ....+ +.+++.
T Consensus 561 ~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~---~~~~~---~~~~~~ 634 (968)
T PLN00113 561 GEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR---KTPSW---WFYITC 634 (968)
T ss_pred ccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc---cccee---eeehhH
Confidence 999999999999999999999999999998888888888899999999864 33455674321 11111 111222
Q ss_pred hhhHHHHHHHHHhhhhhcccCCC---CCCCCCC--CCCCccc-CCCCHHHHHHHhccCCccccccccccEEEEEEEe-cC
Q 005040 378 SILSTVLLVIIIIMYVRCRNRST---KHLDHED--FLPPATR-RRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTL-SD 450 (717)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~ 450 (717)
.++++++++++++.++++|+|+. ++...+. ....... ..............|...+.||+|+||.||+|.. .+
T Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~ 714 (968)
T PLN00113 635 TLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKN 714 (968)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCC
Confidence 22222222222222222222211 1111111 0000000 0011123344456678888999999999999997 48
Q ss_pred CCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHH
Q 005040 451 GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIM 530 (717)
Q Consensus 451 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~ 530 (717)
++.||||++..... ...+|++.+++++|||||+++|++.+.+..++||||+++|+|.++++. ++|..+..++
T Consensus 715 ~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~ 786 (968)
T PLN00113 715 GMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIA 786 (968)
T ss_pred CcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHH
Confidence 89999998864322 123468899999999999999999999999999999999999999964 7899999999
Q ss_pred HHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcc
Q 005040 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTK 610 (717)
Q Consensus 531 ~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 610 (717)
.|+++|++|||+.+ +++|+|||+||+||+++.++.+++. ||....... .....+|++|+|||+..+..++.+
T Consensus 787 ~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~ 858 (968)
T PLN00113 787 IGIAKALRFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEK 858 (968)
T ss_pred HHHHHHHHHhccCC-CCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcc
Confidence 99999999999654 5689999999999999999988876 665543321 122357899999999999999999
Q ss_pred cchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC-chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCC
Q 005040 611 CDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH-RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTP 689 (717)
Q Consensus 611 ~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P 689 (717)
+|||||||++|||+||+.||+..........+|....... .....+|+.+.... ....+...++.+++.+||+.||
T Consensus 859 sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P 935 (968)
T PLN00113 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV---SVNQNEIVEVMNLALHCTATDP 935 (968)
T ss_pred cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC---CccHHHHHHHHHHHHhhCcCCc
Confidence 9999999999999999999976656666777787654433 23444555443221 1123445678899999999999
Q ss_pred CCCCCHHHHHHHHHHhHHhh
Q 005040 690 HKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 690 ~~Rpt~~ev~~~L~~~~~~~ 709 (717)
++||||.||++.|+++.+..
T Consensus 936 ~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 936 TARPCANDVLKTLESASRSS 955 (968)
T ss_pred hhCcCHHHHHHHHHHhhccc
Confidence 99999999999999986643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=423.61 Aligned_cols=289 Identities=45% Similarity=0.702 Sum_probs=247.7
Q ss_pred ccCCCCHHHHHHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeee
Q 005040 413 TRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSC 492 (717)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 492 (717)
....++|.+++.+|++|...+.||+|+||+||+|..++|+.||||++.....+..++|..|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45678999999999999999999999999999999999999999988765433145599999999999999999999999
Q ss_pred ecCC-eeEEEEEccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 005040 493 SNLD-FKALVLEFMPNGSLEKWLYSHNY-FLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570 (717)
Q Consensus 493 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 570 (717)
.+.+ +.++|||||++|+|.++++.... .++|.+|.+|+.++|+||+|||+.+ .++|+|||||++|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~-~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC-PPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC-CCCEecCCCCHHHeeECCCCCEEcc
Confidence 9988 59999999999999999997665 7999999999999999999999866 5589999999999999999999999
Q ss_pred eeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccc-cCcchHHHHHHhhCC
Q 005040 571 DFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMF-TGEMSLRRWVKESLP 649 (717)
Q Consensus 571 Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~ 649 (717)
|||+|+......... .....||.+|+|||+...+..+.|+|||||||+++|++||+.|.+... .++..+..|+.....
T Consensus 220 DFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 999996654311111 111179999999999999999999999999999999999999987643 345568999877666
Q ss_pred C-chhhhccccchh-hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 650 H-RLTEVVDANLVR-EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 650 ~-~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
. .+.+++|+.+.. .+. ..+....+..++.+|++.+|.+||+|.||++.|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~----~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYP----DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCC----hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 5 688999999873 221 11455668999999999999999999999999976644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=380.32 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=212.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC-eeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD-FKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~ 502 (717)
..+.+..+.||+|..|+||++.++ +++.+|+|++.... ....+++.+|++++++.+||+||+++|.|.... ..+++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 346667789999999999999987 78889999995444 345578999999999999999999999999988 499999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|||++|+|.+++...+ .+++.....++.+|++||.|||+ +++|+||||||+|||++..|+|||||||.+..+...
T Consensus 158 EYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~---~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE---ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh---ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999998764 48999999999999999999995 478999999999999999999999999999887543
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
......||..|||||.+.+..|+.++||||||++++|+.+|+.||....+.... +.+.++.-..+
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~------------~~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD------------IFELLCAIVDE 297 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC------------HHHHHHHHhcC
Confidence 446678999999999999999999999999999999999999999764121111 11222222222
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+.+..+.. .+++++.+++..|+++||.+||+++|+++.
T Consensus 298 ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 298 PPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22222222 478889999999999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=389.68 Aligned_cols=262 Identities=30% Similarity=0.475 Sum_probs=215.2
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC-eeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD-FKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e 503 (717)
.++...+.+|+|+||+||+|.++....||||++.... ....+.|.+|+.+|++++|||||+++|+|.+.. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3444556699999999999999644449999997654 222568999999999999999999999998887 7899999
Q ss_pred ccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCC-eEecCCCCCCeeeCCCC-cEEEeeeccccccCC
Q 005040 504 FMPNGSLEKWLYS-HNYFLDILQRLNIMIDVGSALEYLHHCHSSAP-IIHCDLKPTNILLDENM-VAHVSDFGISKLLGE 580 (717)
Q Consensus 504 ~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~ 580 (717)
|+++|+|.++++. ....+++..+..++.|||+|+.||| +.+ |||||||++|||++.++ ++||+|||+++....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH----~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH----SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999998 4677999999999999999999999 566 99999999999999998 999999999987653
Q ss_pred CCCceeeeccccCccccCCCccC--CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGS--EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
.. ...+...||..|||||++. ...|+.|+|||||||++|||+||+.||..... ......+.....
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~--------- 263 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGL--------- 263 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCC---------
Confidence 22 2223467999999999999 67999999999999999999999999987644 222222111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
.. ..+..|+..+..++.+||..||+.||++.+++..|+.+...+..+
T Consensus 264 --Rp-----~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 264 --RP-----PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred --CC-----CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 00 011126677889999999999999999999999999998876653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=386.47 Aligned_cols=258 Identities=31% Similarity=0.515 Sum_probs=218.4
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
+.+..++.||+|.||.||.|.++....||+|.++... -..++|.+|+++|++|+|++||+++|+|..++.+|||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 3455678999999999999999877799999987652 233678899999999999999999999999889999999999
Q ss_pred CCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 507 NGSLEKWLYS-HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 507 ~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
.|+|.+|++. .+..+...+...++.|||+|++||+ ++++|||||.++||||+++..+||+|||+|+...... ..
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe----s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~ 359 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE----SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YT 359 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH----hCCccchhhhhhheeeccCceEEEcccccccccCCCc-ee
Confidence 9999999997 5667899999999999999999999 7899999999999999999999999999999554333 33
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......-+..|.|||.+..+.++.|||||||||+||||+| |+.||..+...+ ..+.++...
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------------v~~~le~Gy---- 421 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------------VLELLERGY---- 421 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------------HHHHHhccC----
Confidence 3344445888999999999999999999999999999999 888987753221 112222222
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
..+.+..|+.++.++|..||+.+|++|||++.+...|+.+....
T Consensus 422 -Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 422 -RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 23455679999999999999999999999999999999876544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=383.59 Aligned_cols=247 Identities=25% Similarity=0.352 Sum_probs=211.3
Q ss_pred ccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.+|...+.||+|+|+.||.++. ..|..||+|++.+.. ....+.+.+|+++.++|+|||||+++++|++..++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 789999999998754 455678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|.|.+++|..+++ ..+.+++..++.++.||+.||.||| +.+|+|||||..|++++++.+|||+|||+|..+...+
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH----~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH----SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH----hcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999988 4556999999999999999999999 7889999999999999999999999999999886443
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. .....+|||.|.|||++.....+..+||||+|||||-|+.|++||+...-. ..+.+. + .
T Consensus 173 E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-ety~~I-k----------------~ 232 (592)
T KOG0575|consen 173 E--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-ETYNKI-K----------------L 232 (592)
T ss_pred c--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-HHHHHH-H----------------h
Confidence 2 234568999999999999999999999999999999999999999762110 011110 0 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+.-+...+.++.+||.++|+.||.+|||+++|+.
T Consensus 233 --~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 233 --NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011112245667889999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=364.37 Aligned_cols=200 Identities=33% Similarity=0.534 Sum_probs=182.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQ--LERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
..+|...+.||+|+||+||+|+++ ++..||||.+.+. ..+..+....|+++|+.++|||||++++++.+.+..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468888899999999999999976 7899999999766 3556677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC------CcEEEeeecccc
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN------MVAHVSDFGISK 576 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfgl~~ 576 (717)
|||.||||.+|++..+. +++.++..++.|+|.||++|| +++||||||||.|||++.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~----~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH----ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999998764 899999999999999999999 6889999999999999865 568999999999
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~ 633 (717)
.+.+.. .....+|++-|||||++...+|+.|+|+||+|+++|||++|+.||+..
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 986432 335668999999999999999999999999999999999999999863
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=365.30 Aligned_cols=253 Identities=29% Similarity=0.385 Sum_probs=206.1
Q ss_pred HhccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhH-------HHHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLE-------RAFRSFDSECEILRNVRHRNLLKILGSCSNLD 496 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 496 (717)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+... .....+.+|+++|++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346788889999999999999985 4899999999976541 12234678999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeec
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN---MVAHVSDFG 573 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg 573 (717)
..||||||++||+|.+++-.++. +.+.....+++|++.|+.||| ++||+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH----~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH----SQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH----HcCcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999987654 777778889999999999999 7899999999999999866 789999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccCCCCc---CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV---STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
+|+..++.. .....+||+.|.|||++.++.+ ..+.|+||+||++|-+++|.+||.+..... .+.+.+..
T Consensus 325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI~~---- 396 (475)
T KOG0615|consen 325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQILK---- 396 (475)
T ss_pred hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHHhc----
Confidence 999886433 2356789999999999877653 347899999999999999999998743322 12222211
Q ss_pred chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 651 RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.++.-. ...+.+.+++..++|..||..||++|||+.|+++
T Consensus 397 -------G~y~f~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 -------GRYAFG---PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -------Cccccc---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111000 0223456778999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=349.54 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=207.9
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeee-e-ecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGS-C-SNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~-~-~~~~~~~l 500 (717)
..+|++.++||+|.||+||++.. .+|..||.|.+.-.. .+..++..+|+.+|++|+|||||+++++ + ++.+.+++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35788899999999999999984 599999999887443 4556788999999999999999999993 3 44455899
Q ss_pred EEEccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 501 VLEFMPNGSLEKWLY---SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 501 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
|||+|.+|||.++++ +.++.+++..+|+++.|++.||.++|..-...-|.||||||.||+++.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999997 45677999999999999999999999522123399999999999999999999999999998
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
+... .......+|||.||+||.+.+..|+.||||||+||++|||+.-++||.+. .-..+.+-+.+ .
T Consensus 178 l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~q--------g-- 243 (375)
T KOG0591|consen 178 LSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQ--------G-- 243 (375)
T ss_pred hcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHc--------C--
Confidence 8543 23345678999999999999999999999999999999999999999763 11111111111 0
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
+.+. ..+..++.++..+|.-|+.+||+.||+.-..++.+.
T Consensus 244 -----d~~~-~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 -----DYPP-LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -----CCCC-CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1110 112467788999999999999999998655544443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=351.06 Aligned_cols=243 Identities=28% Similarity=0.338 Sum_probs=203.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+++.+ +++.+|+|++++.. ....+...+|..+|.+++||.||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 578999999999999999999865 78999999998765 33457788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
+||+.||.|..+|++++. +++..+.-++..|+.||.||| +.+|||||+||+|||+|.+|+++|+|||+++.....
T Consensus 104 ld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH----~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH----SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999997765 788888889999999999999 789999999999999999999999999999865333
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. .....+||+.|||||++.+..|+..+|+||+|+++|||++|.+||.+... .+++....... ..
T Consensus 179 ~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~I~~~k--------~~ 243 (357)
T KOG0598|consen 179 GD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDKILKGK--------LP 243 (357)
T ss_pred CC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHHHhcCc--------CC
Confidence 22 23457899999999999999999999999999999999999999976321 12222111111 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH 694 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt 694 (717)
..+.-.+.+..+++.+.+..||++|..
T Consensus 244 ------~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 244 ------LPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ------CCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 001113456789999999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=337.37 Aligned_cols=265 Identities=22% Similarity=0.267 Sum_probs=206.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|+...++|+|+||+||+++.+ +|+.||||++....+ ...+-.++|+++|++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999987 799999999965442 233456899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
||+. ++.+-++......+...+.+++.|+++|+.|+| +++++||||||+|||++.+|.+||||||+|+.+....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH----k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH----KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh----hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 9986 666667766666899999999999999999999 7899999999999999999999999999999886432
Q ss_pred ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh---CCCchhhhcccc
Q 005040 584 SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES---LPHRLTEVVDAN 659 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 659 (717)
..++..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+. ++.+....+... ...+-..++...
T Consensus 156 -d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~--SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 156 -DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR--SDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc--chHHHHHHHHHHHcccCHHHHHHhccC
Confidence 23455678999999998776 78999999999999999999999988653 222222222111 111112222110
Q ss_pred -------chh---hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 -------LVR---EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 -------~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
++. ..+........+..+.+++..|++.||++|++.+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 000 00000111223446889999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=381.05 Aligned_cols=263 Identities=29% Similarity=0.471 Sum_probs=221.8
Q ss_pred HhccCCccccccccccEEEEEEEec------CCCeEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeeEeeeeecCCe
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSCSNLDF 497 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 497 (717)
...+....+.||+|+||.||+|+.. +...||||.++...+. ..++|.+|+++++.++|||||+++|.|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3455566789999999999999853 4566999999877755 77899999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC
Q 005040 498 KALVLEFMPNGSLEKWLYSH-------------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN 564 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~ 564 (717)
++||+|||..|||.+||+.. +.+++..+...||.|||.|+.||- ++.+|||||.++|+||.++
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs----~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS----SHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCcccccchhhhhceeccc
Confidence 99999999999999999842 123788999999999999999999 6779999999999999999
Q ss_pred CcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHH
Q 005040 565 MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRW 643 (717)
Q Consensus 565 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~ 643 (717)
..|||+|||+++.+-..++........-+++|||||.+..+.||.+||||||||+|||+++ |+.||.+....+. .+.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--Ie~ 717 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--IEC 717 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--HHH
Confidence 9999999999998766555554445556899999999999999999999999999999999 9999877433211 111
Q ss_pred HHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 644 VKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
++ . ....+.+..|+.++++||..||+..|++||+++|+-..|+...+.-+
T Consensus 718 i~-----------~------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 718 IR-----------A------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred HH-----------c------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 11 1 11234556899999999999999999999999999999998865433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=355.58 Aligned_cols=267 Identities=24% Similarity=0.275 Sum_probs=209.0
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHH-HHHHHHHHHHhcC-CCceeeEeeeeecCC-eeEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFR-SFDSECEILRNVR-HRNLLKILGSCSNLD-FKAL 500 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-hpniv~~~~~~~~~~-~~~l 500 (717)
..++|..+++||.|.||.||+|+.. +|..||||.++..-..+.+ .=.+|++.|++++ |||||++.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4578999999999999999999965 7899999999766533322 2357999999998 999999999998888 9999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
|||||+ .+|++.++.+++.+++..+..|+.||++||+|+| .+|+.|||+||+|||+.....+||+|||+|+.+..
T Consensus 88 VfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH----k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH----KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH----hcCcccccCChhheEecccceeEeccccccccccc
Confidence 999996 5999999988999999999999999999999999 78999999999999999999999999999998754
Q ss_pred CCCceeeeccccCccccCCCc-cCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc----hh--
Q 005040 581 GEDSVIQTMTMATIGYMAPEY-GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR----LT-- 653 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~-~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~-- 653 (717)
. ..++..+.|.+|+|||+ +..+.|+.+.|+||+|||++|+.+-++-|.+..+-+ ++.+ +.+.+-.. +.
T Consensus 163 k---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~K-Ic~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 163 K---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYK-ICEVLGTPDKDSWPEG 237 (538)
T ss_pred C---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHH-HHHHhCCCccccchhH
Confidence 3 33466678999999996 567889999999999999999999999887632211 1111 11111110 10
Q ss_pred ----hhccccchhhhh--hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 654 ----EVVDANLVREEQ--AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 654 ----~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+.-++....+ -..-...++.++.++|.+|+++||.+||||+|+++.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111100000 000011356788999999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=322.69 Aligned_cols=267 Identities=25% Similarity=0.333 Sum_probs=209.5
Q ss_pred ccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.+|...+++|+|.||.||+|+. .+|+.||||.++... +.......+|++.|+.++||||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677888999999999999985 489999999997654 2223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
||+. +|+..++.....++..++..++.++++|++||| ++.|+|||+||.|+|++++|.+||+|||+++.++....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H----~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH----SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH----hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9975 999999998888999999999999999999999 78899999999999999999999999999999876554
Q ss_pred ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC---CCchhhh---c
Q 005040 584 SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL---PHRLTEV---V 656 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~---~ 656 (717)
.. ...+.|.+|+|||.+.+ +.|+...|+||.||++.||+-|.+-|.+. .+-.++........ ++.+.++ -
T Consensus 157 ~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 IQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHHHHHHHHHcCCCCcccCccccccc
Confidence 33 33378999999997766 56999999999999999999988776552 12222222222211 1112221 1
Q ss_pred cccchhhhhh---hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 657 DANLVREEQA---FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 657 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
|..-....+. ..--..++.++.+++..|+..||.+|++++|+++.
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1100000000 00112345667999999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=355.74 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=211.1
Q ss_pred HHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCe
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDF 497 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~ 497 (717)
++...+|...+.||+|+|++|++|+.. .++.+|||++.+.. +...+.+..|-.+|.+| .||.|++++..|+|...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 455678999999999999999999865 79999999997653 33345567799999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
+|+|+||+++|+|.++|++.+. +++...+.++.+|+.||+||| +.|||||||||+|||+|.+++++|+|||.|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH----~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH----SNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999998754 899999999999999999999 89999999999999999999999999999998
Q ss_pred cCCCCCc---------ee--eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh
Q 005040 578 LGEGEDS---------VI--QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 578 ~~~~~~~---------~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 646 (717)
+.+.... .. ....+||..|.+||++..+..+..+|+|+||||+|+|+.|++||.+..+ +..+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yliF--- 296 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLIF--- 296 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHHH---
Confidence 7643221 11 1447899999999999999999999999999999999999999976321 1111
Q ss_pred hCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+++-.+ .-+..+++.+.+|+.+.|..||.+|+|++|+.+.
T Consensus 297 ------qkI~~l~y-------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 ------QKIQALDY-------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------HHHHHhcc-------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11111110 1112445678899999999999999999887764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=351.69 Aligned_cols=266 Identities=27% Similarity=0.336 Sum_probs=209.9
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--CeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~l 500 (717)
.+.|+.+.+||+|.||.||+|+. .+|+.||+|++.... .+......+|+.+|++|.||||+++.+...+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35677888999999999999985 489999999987665 34445667899999999999999999998776 78999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
|+|||+. ||..++...+..+++.++..+++|++.||+|+| +++|+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH----~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH----SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh----hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999987 999999988778999999999999999999999 78999999999999999999999999999998865
Q ss_pred CCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHH------------HHHhh
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRR------------WVKES 647 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~------------~~~~~ 647 (717)
... ...+..+.|.+|+|||.+.+ ..|+.+.|+||.|||+.||++|++.|.+..+ -.++.. |-...
T Consensus 271 ~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 SGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHhCCCChhcccccc
Confidence 432 33567788999999997665 5699999999999999999999999876321 112222 22111
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.|. ...+.+.-.-...-......++...++|+..+|..||.+|.||.++++
T Consensus 349 LP~--~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPH--ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCc--ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 001110000000001112345567889999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=357.84 Aligned_cols=263 Identities=24% Similarity=0.425 Sum_probs=213.0
Q ss_pred HHhccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
+..+++.+...||+|.||+||+|+|- ..||||++.... .+..+.|+.|+.++++-+|.||+-|.|||..... .+|
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred cCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 34466778889999999999999984 359999997654 4577899999999999999999999999998887 999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
+.||+|.+|+.+++-....++..+.+.|++|||+|+.||| .++|+|||||..||++++++.|||+|||++..-..-
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH----AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH----AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh----hhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 9999999999999977777999999999999999999999 789999999999999999999999999998754322
Q ss_pred CCceeeeccccCccccCCCccCC---CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSE---GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
..........|..-|||||++.. ..|++.+||||||+++|||+||..||.....+. +--++..
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--------------IifmVGr 607 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--------------IIFMVGR 607 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--------------eEEEecc
Confidence 11122223356778999998754 469999999999999999999999997532221 1111111
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.+... +.......|++++.+|+..||..++++||.+.+++..|+++...
T Consensus 608 G~l~p-d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 608 GYLMP-DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cccCc-cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 11100 01122346788999999999999999999999999999988764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=344.85 Aligned_cols=256 Identities=29% Similarity=0.399 Sum_probs=204.5
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC--eeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLD--FKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e 503 (717)
.+|...+.||+|+||+||++... +|...|||..........+.+.+|+++|++++|||||+++|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777889999999999999975 58999999887664333667889999999999999999999855554 5899999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeeccccccCC-C
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGE-G 581 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~-~ 581 (717)
|+++|+|.+++...+..+++..+...+.||++||+||| +++|+||||||+|||++. ++.+||+|||++..... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH----s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH----SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999987657999999999999999999999 789999999999999999 79999999999987753 1
Q ss_pred CCceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
..........||+.|||||++..+ ....++||||+||++.||+||++||... .. ...+.-.... ....
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~---~~~~~~~ig~-------~~~~ 241 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE---EAEALLLIGR-------EDSL 241 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc---hHHHHHHHhc-------cCCC
Confidence 112223346799999999998864 3345999999999999999999999763 11 1111110000 0000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
+.. +...+.++.+++.+|+..+|++||||.++++.--
T Consensus 242 ----P~i--p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 242 ----PEI--PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----CCC--CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 011 1134567889999999999999999999998654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=367.83 Aligned_cols=269 Identities=27% Similarity=0.476 Sum_probs=225.7
Q ss_pred CCCCHHHHHHHhc---------cCCccccccccccEEEEEEEec----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc
Q 005040 415 RRTSYLDIRRATD---------EFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV 480 (717)
Q Consensus 415 ~~~~~~~~~~~~~---------~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l 480 (717)
..++|+|.-.+.. ...+.++||.|.||.||+|+++ ....||||.++... ++++++|..|..||.+.
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 4555665433333 3345688999999999999975 34569999998765 55678899999999999
Q ss_pred CCCceeeEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 481 RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 481 ~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
.||||+++-|+......+++|+|||++|+|..||+.+...+.+.+...+.++||.|++||. +.++|||||.++|||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs----dm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS----DMNYVHRDLAARNIL 763 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh----hcCchhhhhhhhhee
Confidence 9999999999999999999999999999999999998888999999999999999999999 689999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccc--cCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCc
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTM--ATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGE 637 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~ 637 (717)
++.+..+|++|||+++.+.++.. ...+... -+..|.|||.+....+|.+||||||||+|||.++ |.+||.++.+.+
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred eccceEEEeccccceeecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 99999999999999998754432 1122222 2688999999999999999999999999999888 999998754321
Q ss_pred chHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 638 MSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
. ...++ +....+.+++|+..+.+|+..||++|-.+||.+.|++..|.++.+
T Consensus 843 V--------------IkaIe-----~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 843 V--------------IKAIE-----QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred H--------------HHHHH-----hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1 11111 122457788999999999999999999999999999999999855
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=351.31 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=211.2
Q ss_pred ccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
..|+...+||+|+.|.||.|.. .+++.||||++........+-+..|+.+|+..+|+|||.+++.|...+...+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 5777888999999999999984 478999999998887666778899999999999999999999998889999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
+||+|.+.+.... +++.++..|+..+++||+||| .++|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH----~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH----ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH----hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 9999999998755 899999999999999999999 78999999999999999999999999999988765432
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHH-H-HHhhCCCchhhhccccchhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRR-W-VKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~ 663 (717)
.....+||+.|||||+.....|++|.||||||+|++||+.|.+||-.. ..+.. | +....+ +
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~PlrAlyLIa~ng~--------P----- 487 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRALYLIATNGT--------P----- 487 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChHHHHHHHhhcCC--------C-----
Confidence 345668999999999999999999999999999999999999998531 11111 1 111111 1
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
........+..+.+|+.+||..||++|++++|+++.
T Consensus 488 --~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 --KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 112233456778999999999999999999999863
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=318.90 Aligned_cols=237 Identities=27% Similarity=0.359 Sum_probs=200.7
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|+..+.||.|+||+|.+++.+ +|..+|+|++.+.. -.+.+....|..+|+.+.||.++++++.+.+....||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 68899999999999999999976 78899999998765 344567788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||++||.|..++++.++ +++..++-++.+|+.|++||| +.+|++||+||+|||+|.+|++||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH----~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH----SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH----hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999998765 899999999999999999999 788999999999999999999999999999987432
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
....||||.|+|||.+..+.|..++|+|||||++|||+.|.+||.+..+ + ..+- .++...+.
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~--~iY~---------KI~~~~v~- 259 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--I--QIYE---------KILEGKVK- 259 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--H--HHHH---------HHHhCccc-
Confidence 3456899999999999999999999999999999999999999976332 1 1111 11111111
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCC
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRI 693 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 693 (717)
+ +.-++.++.+|+...+++|-.+|.
T Consensus 260 ----f--P~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 260 ----F--PSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred ----C--CcccCHHHHHHHHHHHhhhhHhhh
Confidence 1 113345678999999999998883
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=332.44 Aligned_cols=260 Identities=25% Similarity=0.314 Sum_probs=213.2
Q ss_pred ccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|+....||.|..++||+|.. +.+..||||++..+. ....+.+.+|+..|+.++||||++++..|..+..+++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 6889999999999999999985 478999999998665 33468899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|.+|++.+.++.. ...+++..+..|.+++++||.||| .+|.+|||||+.|||++.+|.|||+|||.+..+.....
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH----~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH----QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH----hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999853 344899999999999999999999 68999999999999999999999999999876654332
Q ss_pred -ceee-eccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 584 -SVIQ-TMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 584 -~~~~-~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.... ....||+.|||||++.. ..|+.|+||||||++..||.+|..||....+-++.+...-.. .|.-.....+
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~-pp~~~t~~~~-- 258 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND-PPTLLTSGLD-- 258 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-CCCcccccCC--
Confidence 1222 45689999999998543 469999999999999999999999998876555444433221 1111111111
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......+...+.+++..|+..||++|||++++++
T Consensus 259 -------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 259 -------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1223345567999999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=342.93 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=206.4
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
...++|+.++.||+|+||.||+|+-+ +|..+|+|++++.. ....+.+++|-.+|....+|+||+++..|++.+++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35689999999999999999999865 79999999998775 556678899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
|||||++|||+..+|...+. +++..+...+.+++-|+..+| ..||+||||||+|+|||..|++||+|||++.-+.
T Consensus 218 LiMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH----~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH----QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH----HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999987654 888899999999999999999 6899999999999999999999999999985331
Q ss_pred CC----------------------CCc----e-------------------eeeccccCccccCCCccCCCCcCcccchh
Q 005040 580 EG----------------------EDS----V-------------------IQTMTMATIGYMAPEYGSEGIVSTKCDVY 614 (717)
Q Consensus 580 ~~----------------------~~~----~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw 614 (717)
.. +.. . .....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 0 01124799999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC
Q 005040 615 SYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH 694 (717)
Q Consensus 615 s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt 694 (717)
|+|||+|||+.|.+||....+ ...|.+-. . .+..-.++....++.++.+||.+|+. ||+.|..
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp----~~T~rkI~---------n---wr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETP----QETYRKIV---------N---WRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCH----HHHHHHHH---------H---HhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999976432 22222211 0 00001123333455778999999999 9999996
Q ss_pred ---HHHHH
Q 005040 695 ---MTDAA 699 (717)
Q Consensus 695 ---~~ev~ 699 (717)
++||.
T Consensus 436 ~~G~~EIK 443 (550)
T KOG0605|consen 436 SKGAEEIK 443 (550)
T ss_pred cccHHHHh
Confidence 44443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=354.05 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=205.4
Q ss_pred HhccCCccccccccccEEEEEEEe------cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC-
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL- 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~- 495 (717)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+++++.+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346899999999999999999974 245679999987543 23346788999999999 899999999988654
Q ss_pred CeeEEEEEccCCCCHHHHHhhCC---------------------------------------------------------
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHN--------------------------------------------------------- 518 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 518 (717)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 45789999999999999997531
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCc
Q 005040 519 ----YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATI 594 (717)
Q Consensus 519 ----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~ 594 (717)
..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++...............++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23678888999999999999999 6899999999999999999999999999998664332222223334678
Q ss_pred cccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHH
Q 005040 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDC 673 (717)
Q Consensus 595 ~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (717)
.|+|||++.+..++.++|||||||++|||++ |..||......+ ........... . ..+..+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~~--------~---------~~~~~~ 302 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKDGTR--------M---------RAPENA 302 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhcCCC--------C---------CCCCCC
Confidence 8999999999999999999999999999997 999987532211 11111110000 0 001133
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 674 LFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 674 ~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
+.++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4568899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=377.23 Aligned_cols=264 Identities=28% Similarity=0.455 Sum_probs=221.2
Q ss_pred ccCCccccccccccEEEEEEEec--CCC----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS--DGT----NVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
...+..+.||+|+||.||.|... +|. .||+|.++... .+...+|.+|..+|++++|||||+++|++-+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 44556678999999999999864 343 38999887654 556688999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 005040 500 LVLEFMPNGSLEKWLYSH------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 573 (717)
+++|||++|||..||++. ...+.......++.|||+|+.||+ ++++|||||.++|+|++....|||+|||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe----~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE----SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH----hCCCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999977 677899999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCch
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRL 652 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 652 (717)
+|+++-..+.........-+..|||||.+..+.++.|+|||||||++||++| |..||.+...-+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------------- 912 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------------- 912 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---------------
Confidence 9996655444443333345788999999999999999999999999999999 889997643211
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccch
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 713 (717)
++..-+.+ ...+.+..|+..+.++|..||+.+|++||++..+++.+.++.+...+++
T Consensus 913 --v~~~~~~g--gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 913 --VLLDVLEG--GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred --HHHHHHhC--CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 11111111 1345566889999999999999999999999999999999987766543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=348.05 Aligned_cols=249 Identities=27% Similarity=0.346 Sum_probs=205.2
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh----H-HHHHHHHHHHHHHHhcC-CCceeeEeeeeecCC
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL----E-RAFRSFDSECEILRNVR-HRNLLKILGSCSNLD 496 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~ 496 (717)
...++|...+.||+|.||.|+.|.+. +++.||+|++.... . ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999864 78999999876541 2 23456678999999998 999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeeccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGIS 575 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~ 575 (717)
..|+||||+.||+|.+++.+ ...+.+..+..++.|++.|++|+| +++|+||||||+|||++.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H----~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH----SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999999 556889999999999999999999 7899999999999999999 99999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCCC-cC-cccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchh
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGI-VS-TKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLT 653 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 653 (717)
..... ........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||++... ......
T Consensus 169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l~~k------- 234 (370)
T KOG0583|consen 169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNLYRK------- 234 (370)
T ss_pred cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHHHHH-------
Confidence 98731 112235668999999999999877 75 889999999999999999999987211 111110
Q ss_pred hhccccchhhhhhhhhhHHH-HHHHHHHHhhccCCCCCCCCCHHHHH
Q 005040 654 EVVDANLVREEQAFSDKMDC-LFSIMDLALDCCMDTPHKRIHMTDAA 699 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~Rpt~~ev~ 699 (717)
+......++. .+ +.++..++.+|+..+|.+|+|+.+++
T Consensus 235 ------i~~~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 ------IRKGEFKIPS--YLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ------HhcCCccCCC--CcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0000001111 22 56688999999999999999999998
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=351.78 Aligned_cols=259 Identities=29% Similarity=0.437 Sum_probs=213.4
Q ss_pred cCCccccccccccEEEEEEEec--CC--Ce-EEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS--DG--TN-VAIKIFNLQ---LERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
+-...++||+|+||.||+|.++ ++ .. ||||..+.. .......+.+|.++|++++|||||+++|++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 3444589999999999999875 23 23 899998852 2667788999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+|||+|.||+|.++|+..+..++..++..++.+.|.||+||| +++++||||.++|+|++.++.+||+|||+++.-.
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh----~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH----SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH----HCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 999999999999999988777999999999999999999999 7899999999999999999999999999987532
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHH-HhhCCCchhhhcc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWV-KESLPHRLTEVVD 657 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 657 (717)
..........-+..|+|||.+..+.|+.++|||||||++||+++ |..||.+.... ....++ ...++-
T Consensus 314 --~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~------- 382 (474)
T KOG0194|consen 314 --QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRM------- 382 (474)
T ss_pred --ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccC-------
Confidence 11111112345788999999999999999999999999999999 88899874322 333333 211111
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
+.+...+.++..++.+||..+|++||+|.++.+.++.+......
T Consensus 383 ----------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 383 ----------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11113456788999999999999999999999999999877654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=330.21 Aligned_cols=279 Identities=25% Similarity=0.337 Sum_probs=212.3
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhc--CCCceeeEeeeeecCC----eeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV--RHRNLLKILGSCSNLD----FKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~hpniv~~~~~~~~~~----~~~l 500 (717)
...+..+.||+|.||.||+|++. ++.||||++... ..+.|..|-++++.. +|+||++++++-.... .+.+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556678999999999999994 699999999855 346788888888865 8999999999865444 7789
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH-----SSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
|+||.+.|+|.+|+..+. ++|....+|+..+++||+|||+.. ..++|+|||||++|||+..|++..|+|||+|
T Consensus 286 Vt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999999876 899999999999999999999753 3567999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCCCc------CcccchhhHHHHHHHHHhCCCCCCc--cccCcchHHHHHHhh
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV------STKCDVYSYGVLLMETFTEKKPTDE--MFTGEMSLRRWVKES 647 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~------~~~~Dvws~G~il~el~tg~~p~~~--~~~~~~~~~~~~~~~ 647 (717)
..+............+||.+|||||++.+... =.+.||||+|.++|||+++..-+.. ..+-+..+..-+..+
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 98876555444556789999999998876532 1369999999999999997765431 111122222222221
Q ss_pred CCC-chh-hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 648 LPH-RLT-EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 648 ~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
..- ++. -++.++.+...+..+..-.....+.+.+..||..||+.|.|+.=|-+++.++....++
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111 111 1222222222222233334456789999999999999999999999999998766554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=341.08 Aligned_cols=246 Identities=29% Similarity=0.425 Sum_probs=209.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.. ++..+.+.+|+++++.++|||||.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999976 78899999997664 4456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+.| +|..++...+. ++++.+..++.+++.||.||| +.+|.|||+||.|||++.+|.+|+||||+++.+...
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh----s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH----SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-- 153 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH----hcCcccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence 9976 99999997765 999999999999999999999 789999999999999999999999999999987653
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
....+...|||-|||||...++.|+..+|.||+||++||+++|++||-.. .+.+.++....+..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v----------- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPV----------- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCC-----------
Confidence 33445667999999999999999999999999999999999999998541 12222222111110
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+...+..+..++...+..||..|.|..+++.
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 111245567889999999999999999999865
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=317.16 Aligned_cols=266 Identities=24% Similarity=0.307 Sum_probs=205.7
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHH--HHHHHHHHHHHHhcCCCceeeEeeeeec--CCeeE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERA--FRSFDSECEILRNVRHRNLLKILGSCSN--LDFKA 499 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~ 499 (717)
..++|+.++.|++|.||.||+|+++ +++.||+|+++...... --...+|+.+|.+.+|||||.+-.+... -+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3468999999999999999999975 78999999998765321 1235789999999999999999988754 45789
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
||||||+. ||...+..-+..+...++..++.|+++|++||| ...|+|||||++|+|+...|.+||+|||+|+.++
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH----~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH----DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh----hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999987 999999987777999999999999999999999 6789999999999999999999999999999987
Q ss_pred CCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcc-hHHHHHHhh-CCCc--hhh
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM-SLRRWVKES-LPHR--LTE 654 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~--~~~ 654 (717)
.+. ...+..+.|.+|+|||.+.+ ..|+...|+||+|||+.||+++++-|.+. ++. ++.+..... .|.+ +..
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~--sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK--SEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC--chHHHHHHHHHHhCCCccccCCC
Confidence 653 23455678999999997655 66999999999999999999999988663 222 222222211 1111 111
Q ss_pred hccccch------h-----hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLV------R-----EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~------~-----~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+...... . -...+.. ...+..-.+++..++..||++|.||+|.++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~-~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGA-LSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccc-cccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1110000 0 0001111 113466789999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=339.29 Aligned_cols=241 Identities=27% Similarity=0.408 Sum_probs=201.7
Q ss_pred ccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 431 ECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 431 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
..+-||.|+.|.||+|+.. ++.||||+++.-. ..+++-|++|+||||+.|.|+|....-+|+|||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 4568999999999999994 7889999765332 2378889999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeecc
Q 005040 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590 (717)
Q Consensus 511 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 590 (717)
..+++.... +.......|.++||.|+.||| .+.|+|||||.-|||++.+..|||+|||-++...... ..-.+
T Consensus 200 ~~VLka~~~-itp~llv~Wsk~IA~GM~YLH----~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSF 271 (904)
T KOG4721|consen 200 YEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH----LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSF 271 (904)
T ss_pred HHHHhccCc-cCHHHHHHHHHHhhhhhHHHH----HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhh
Confidence 999997654 777788899999999999999 6889999999999999999999999999998765431 23456
Q ss_pred ccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhh
Q 005040 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDK 670 (717)
Q Consensus 591 ~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
+||..|||||++.....++|+|||||||+||||+||..||.+..... +..-+.. ..-..+.+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--------------IIwGVGs----NsL~LpvP 333 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--------------IIWGVGS----NSLHLPVP 333 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--------------eEEeccC----CcccccCc
Confidence 79999999999999999999999999999999999999997632110 0000111 11123455
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 671 MDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
..|+..+.-|++.||+..|..||++.+++..|.-.
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 68889999999999999999999999999988743
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.13 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=200.3
Q ss_pred cccccccccEEEEEEEecCCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeec----CCeeEEEEEc
Q 005040 432 CNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSN----LDFKALVLEF 504 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~ 504 (717)
...||+|++|.||+|.+ +|+.||||++.... ....+.+.+|++++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 68999999987543 2235678899999999999999999999866 4567999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++|+|.+++.+.. .+++.....++.|++.|+.|||. ..+++||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~---~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK---YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh---cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999998754 48899999999999999999994 2478899999999999999999999999988654321
Q ss_pred eeeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 585 VIQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+... . .
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~---~------~---- 239 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLIINK---N------N---- 239 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhc---C------C----
Confidence 23457889999999876 67999999999999999999999999763211 111111000 0 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
....+..++.++.+++.+||+.||++|||++|+++.|+++..
T Consensus 240 ---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 ---SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 001112356678999999999999999999999999998743
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.18 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=204.0
Q ss_pred hccCCccccccccccEEEEEEEecC-----------------CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSD-----------------GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLK 487 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~ 487 (717)
.++|++.+.||+|+||.||+|.+++ +..||+|++.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999997532 3369999987543 334567889999999999999999
Q ss_pred EeeeeecCCeeEEEEEccCCCCHHHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 005040 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHN------------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549 (717)
Q Consensus 488 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i 549 (717)
+++++.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i 159 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS----SLNF 159 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----HCCc
Confidence 9999999999999999999999999986431 23678889999999999999999 6789
Q ss_pred EecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh--CC
Q 005040 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT--EK 627 (717)
Q Consensus 550 vH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t--g~ 627 (717)
+||||||+||+++.++.+||+|||++................++..|+|||+..++.++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999987644332222333456788999999888889999999999999999987 55
Q ss_pred CCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 628 KPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 628 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
.||..... ......+............ ...+..++..+.+++.+||+.||++|||+.|+.+.|++
T Consensus 240 ~p~~~~~~--~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTD--EQVIENAGEFFRDQGRQVY----------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCH--HHHHHHHHHHhhhcccccc----------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 67765321 1122222211111000000 00112345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=389.66 Aligned_cols=337 Identities=36% Similarity=0.549 Sum_probs=278.4
Q ss_pred CCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCc
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
+.+|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+ ..+.++++|++|+|++|.+.
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p--------~~l~~l~~L~~L~Ls~n~l~ 297 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP--------PSIFSLQKLISLDLSDNSLS 297 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCc--------hhHhhccCcCEEECcCCeec
Confidence 4789999999999999999999999999999999999999999999986543 34889999999999999999
Q ss_pred ccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccc
Q 005040 82 GILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL 161 (717)
Q Consensus 82 ~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~ 161 (717)
+..|..+..+ ++|+.|++++|.+.+..|..+.++++|++|+|++|.+.+.+|..+..+++|+.|++++|++.+..|..+
T Consensus 298 ~~~p~~~~~l-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~ 376 (968)
T PLN00113 298 GEIPELVIQL-QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376 (968)
T ss_pred cCCChhHcCC-CCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhH
Confidence 9999999888 679999999999999999999999999999999999998889999999999999999999887777777
Q ss_pred cCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccC------
Q 005040 162 CHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQK------ 235 (717)
Q Consensus 162 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~------ 235 (717)
+.+++|+.|++++|.+.+..|..+..+++|+.|+|++|++++..|..|..+++|+.|++++|.+++.++..+..
T Consensus 377 ~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 456 (968)
T PLN00113 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQM 456 (968)
T ss_pred hCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcE
Confidence 77777777777777766666666666666666666666666656666666666655555555555544443333
Q ss_pred -----------------CCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCC
Q 005040 236 -----------------LNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 236 -----------------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 298 (717)
.++|+.|++++|.+++..|..+..+++|+.|+|++|++.+.+|..+.++++|++|+|++|.++
T Consensus 457 L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 536 (968)
T PLN00113 457 LSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536 (968)
T ss_pred EECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence 355667777777777777888888899999999999999899999999999999999999999
Q ss_pred CCCcccccccccccEEEccCCccccccccc-ccccccccccccCCccccC
Q 005040 299 GKIPKSLEALSHLKQFNVSHNRLEGEIPVK-GSFKDFSAQSYFGNYALCG 347 (717)
Q Consensus 299 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~ 347 (717)
+.+|..+..+++|+.|+|++|++++.+|.. ..+..+..+.+.+|+..+.
T Consensus 537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~ 586 (968)
T PLN00113 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586 (968)
T ss_pred ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence 999999999999999999999999988863 4455666777777776543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.79 Aligned_cols=244 Identities=24% Similarity=0.280 Sum_probs=205.2
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCee
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 498 (717)
...++|...++||+|.||.|++|..+ +++.+|||++++.. ++..+..+.|.+++... +||.++.++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999987 78899999998775 55667888899999988 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|+||||+.|||+..+ .+...+++..+.-++..|+.||.||| +++|+|||||.+|||+|.+|++||+|||+++.-
T Consensus 445 ~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH----~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLH----ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHH----hcCceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999995433 33345999999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
.... ...+..+|||.|||||++.+..|+..+|+|||||+||||+.|..||.+..+. +++|.
T Consensus 519 m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------e~Fds 579 (694)
T KOG0694|consen 519 MGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------EVFDS 579 (694)
T ss_pred CCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHH
Confidence 3222 2346779999999999999999999999999999999999999999863221 22222
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
-+..+ ...+..++.+..+++++++..+|++|..+
T Consensus 580 I~~d~---~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDE---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCC---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22111 12233567789999999999999999976
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.67 Aligned_cols=248 Identities=26% Similarity=0.317 Sum_probs=209.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.. .+..+++.+|+++-+.|+||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 478999999999999999999965 78889999997664 34456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 502 LEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
+||..+|.+...++.. ...+++...+.++.|+|.|+.|+| .++|+||||||+|+|++.++..||+|||-+..-.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h----~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH----LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc----cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999944 345888999999999999999999 7889999999999999999999999999987543
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
.......+||..|.|||+..+..++.+.|+|++|++.||++.|.+||.... .+..+.+..+.. ..++
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~-------~~~p-- 242 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD-------LKFP-- 242 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc-------ccCC--
Confidence 223355689999999999999999999999999999999999999998743 222222222211 1111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
...+.++.++|.+|+..+|.+|.+-.|+++.
T Consensus 243 ----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ----------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2344567899999999999999999998763
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=331.79 Aligned_cols=249 Identities=26% Similarity=0.352 Sum_probs=208.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..|+....||+|.||.||+|... .++.||+|++.... +...+++.+|+.++.+++++||.++|+.+..+..+.++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45677789999999999999965 78999999998765 45567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
|.||++.+.++.... +++..+..++.++..|+.||| ..+.+|||||+.||++..+|.+|++|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH----~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH----SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh----hcceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence 999999999987553 477788889999999999999 67899999999999999999999999999987754332
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
.....+||+.|||||++....|+.|+||||+|++.+||.+|.+|+....+.. ..-.+. +..+
T Consensus 167 -rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr--------------vlflIp---k~~P 228 (467)
T KOG0201|consen 167 -RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR--------------VLFLIP---KSAP 228 (467)
T ss_pred -ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce--------------EEEecc---CCCC
Confidence 2256789999999999998899999999999999999999999997754311 000000 0111
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+.... .+++.+.+++..|+..||++||+|+++++.
T Consensus 229 P~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred Ccccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11122 567779999999999999999999998863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.38 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=204.7
Q ss_pred hccCCccccccccccEEEEEEEe------cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~ 497 (717)
.++|++.+.||+|+||.||+|.+ .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788999999999999999974 246689999986443 23346788999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC-----------------------------------------------------------
Q 005040 498 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 518 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 518 (717)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999997431
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 519 ---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 519 ---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 24788899999999999999999 67899999999999999999999999999987644332
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
........++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+++.......
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~----------- 337 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRML----------- 337 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccCC-----------
Confidence 222223345678999999999999999999999999999998 88888653221 12222222111000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
.+...+.++.+++.+||+.||++||++.|+++.|++
T Consensus 338 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 ------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 001123568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=340.09 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=207.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.+-|+..+.||.|+-|.|-.|++. +|+.+|||++.+.. ......+.+|+-+|+-+.|||++++++++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 356788899999999999999975 89999999997663 22345678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
.||+++|-|.+++-..+. +++..+.+++.||+.|+.|+| ..+|+|||+||+|+|+|..+++||+|||+|..-.++
T Consensus 91 lEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH----~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH----AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh----hhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999987765 888889999999999999999 678999999999999999999999999999864332
Q ss_pred CCceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
. .-...||++.|.|||++.+..| +.++||||+|||||.|+||+.||++. .++......
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlKV------------- 224 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLKV------------- 224 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHHH-------------
Confidence 2 2345689999999999999887 68999999999999999999999852 222221111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
....+.-+...+.++.+|+.+|+.+||+.|.|++||++.
T Consensus 225 --~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 225 --QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 111122233556778899999999999999999999874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=342.54 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=205.4
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~ 497 (717)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.+ +||||+++++++.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 358899999999999999998742 34579999987543 33446788999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC-----------------------------------------------------------
Q 005040 498 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 518 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 518 (717)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986421
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeee
Q 005040 519 ----------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT 588 (717)
Q Consensus 519 ----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 588 (717)
..+++..+.+++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA----SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 23678889999999999999999 6899999999999999999999999999998664332222222
Q ss_pred ccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 589 MTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 589 ~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
...++..|+|||++.+..++.++|||||||++|||++ |+.||....... ........... ..
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~--------~~-------- 335 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQ--------MS-------- 335 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccC--------cc--------
Confidence 3345678999999988999999999999999999997 999997642221 11111111000 00
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
.+...+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 336 -~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 -RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00112456889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=315.39 Aligned_cols=269 Identities=26% Similarity=0.319 Sum_probs=204.6
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEec--hhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec-----CC
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFN--LQLERAFRSFDSECEILRNVRHRNLLKILGSCSN-----LD 496 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~ 496 (717)
....|...+.||+|+||.|+.|..+ +|+.||+|.+. ....-..++..+|+++|+.++|+||+.+.+.+.. ..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456666789999999999999875 89999999887 3334455677889999999999999999998754 45
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..|+|+|+|+ .||.+.++.+.. ++...+..++.|+++||+|+| +-+|+|||+||+|++++.+...||+|||+|+
T Consensus 100 DvYiV~elMe-tDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH----SAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH----SANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh----cccccccccchhheeeccCCCEEecccccee
Confidence 7899999994 599999987654 888999999999999999999 7889999999999999999999999999999
Q ss_pred ccCCCCCceeeeccccCccccCCCc-cCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc----
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEY-GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR---- 651 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~-~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 651 (717)
...........+..+.|.+|+|||. +....|+.+.||||.|||+.||++|++-|.+.. ....-..+.......
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d--~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD--YVHQLQLILELLGTPSEED 251 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc--hHHHHHHHHHhcCCCCHHH
Confidence 8865422223355678999999995 456789999999999999999999999887621 111122222222111
Q ss_pred hhhhcccc---chh-----hhhhh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 652 LTEVVDAN---LVR-----EEQAF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 652 ~~~~~~~~---~~~-----~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+..+-... +.. ....+ .........+.+++.+||..||.+|+|++|+++.
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111000 000 00000 0112344678999999999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=308.98 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=204.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++.|++.+.||+|+|+.||++... +|+.+|+|++.... ....+.+.+|+++-+.|+||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467888899999999999998764 89999999987554 346678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~ 579 (717)
|+|+|++|..-+-.. ...++..+...++||+++|.|+| .++|||||+||+|+++-+ ..-+||+|||++..++
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH----~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH----SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997555443 34788899999999999999999 789999999999999953 4469999999999887
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.+ .......|||+|||||+.+..+|+..+|||+.||++|-++.|+.||.+.. ...+.+.+.+. .
T Consensus 165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I~~g-----------~ 228 (355)
T KOG0033|consen 165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQIKAG-----------A 228 (355)
T ss_pred Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHhcc-----------c
Confidence 32 23456789999999999999999999999999999999999999997621 11222211110 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+... .++....+++..+++++|+..||++|.|+.|++.
T Consensus 229 yd~~---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 YDYP---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cCCC---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 0000 0122345567889999999999999999999874
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=304.59 Aligned_cols=252 Identities=29% Similarity=0.380 Sum_probs=207.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--------HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--------ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL 495 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 495 (717)
-+.|...+.+|.|..++|-++.++ +|+.+|+|++.... .+..+.-.+|+.+|+++ .||+|+++.++|+..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 467788889999999999998865 78999999986432 33445667899999999 699999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
..+++|+|.|+.|.|.+++.+.-. ++++...+|+.|+.+|++||| .+.|||||+||+|||+|++.++||+|||++
T Consensus 96 sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH----a~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH----ARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH----HhhhhhcccChhheeeccccceEEecccee
Confidence 999999999999999999987543 899999999999999999999 788999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccC------CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGS------EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 649 (717)
+.+.++..- ...+|||+|+|||.+. ...|+...|+||+||+||.++.|.+||.. ..++.+.+.+.+.
T Consensus 171 ~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--RkQmlMLR~ImeG-- 243 (411)
T KOG0599|consen 171 CQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RKQMLMLRMIMEG-- 243 (411)
T ss_pred eccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HHHHHHHHHHHhc--
Confidence 998765532 4568999999999543 45688999999999999999999999965 2222222222111
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.+. -..+++.+.+....++|.+|+++||.+|.|++|+++.
T Consensus 244 ---------kyq---F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 ---------KYQ---FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ---------ccc---cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 000 0123445677788999999999999999999999863
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=328.46 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=200.0
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677889999999999999864 79999999987543 22334578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ----RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999999888643 335899999999999999999999 68999999999999999999999999999987543221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.....||..|+|||++.+..++.++||||+||++|||++|+.||........ ... +...... .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~-~~~~~~~------------~ 220 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REE-VDRRVKE------------D 220 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHH-HHHHhhc------------c
Confidence 2334689999999999999999999999999999999999999976322111 001 1100000 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
. ......++.++.+++.+||+.||++||+ ++++++
T Consensus 221 ~--~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 Q--EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred c--ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0 0111234566889999999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=331.66 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=221.1
Q ss_pred HhccCCccccccccccEEEEEEEecCCCeEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
..+...+.++||+|.||.|..++...+..||||+++..+. ....+|.+|+++|.+++||||+.++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3456778899999999999999998889999999987764 345789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 504 FMPNGSLEKWLYSHNYF-LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||++|+|.+|+..+..+ ...+...+|+.||+.|++||. +-++||||+.++|+|+|.++++||+|||+++-+-.++
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe----s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE----SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH----hhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999987433 355667789999999999999 6789999999999999999999999999999776667
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh--CCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT--EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
....+...+-++.|||||.+.-+.++.++|||+||+++||+++ ...||....+. +..+-.....+..-..+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~~~~~----- 764 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQGRQV----- 764 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCCCcce-----
Confidence 7777777778999999999999999999999999999999876 77898764332 22222222222221111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
-.+.+.-|+.++.+++.+||+.+-++||+++++...|.+.
T Consensus 765 -----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 -----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1123346778899999999999999999999999888754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=333.21 Aligned_cols=268 Identities=22% Similarity=0.298 Sum_probs=202.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 789999999875432 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+. ++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH----QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 6899988876666899999999999999999999 6899999999999999999999999999987543221
Q ss_pred ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-CC--chhhh----
Q 005040 584 SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-PH--RLTEV---- 655 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~---- 655 (717)
.......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......+........ +. .+...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 11233467899999998755 55889999999999999999999999764322222221111100 00 00000
Q ss_pred -ccc-cc----hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 656 -VDA-NL----VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 656 -~~~-~~----~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.++ .+ .............+..+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 00 0000000111123356789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.56 Aligned_cols=249 Identities=35% Similarity=0.539 Sum_probs=196.1
Q ss_pred ccccccccccEEEEEEEec-----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 431 ECNLLGTGGFGSVYKGTLS-----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 431 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..+.||+|.||.||+|.+. .+..|+||+++... .+..+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999976 35679999996543 33467899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++|+|.+++... ...+++..+..|+.|+++||+||| +.+++|+||+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh----~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH----SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH----HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987 566899999999999999999999 57899999999999999999999999999987743333
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
............|+|||.+....++.++||||||+++||+++ |+.||..... ......+... .
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~---~----------- 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQG---Q----------- 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTT---E-----------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccc---c-----------
Confidence 333344557888999999988889999999999999999999 6788865311 1111111110 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
.......++..+.+++.+||+.+|++|||+.++++.|
T Consensus 223 ---~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 ---RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0011123456688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=326.22 Aligned_cols=256 Identities=22% Similarity=0.356 Sum_probs=206.1
Q ss_pred hccCCccccccccccEEEEEEEec----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
..+|++.+.||+|+||.||+|.++ .+..||+|+++... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357888999999999999999753 45689999987653 2334678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++......+++..++.++.|++.||+||| +.+++||||||+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS----EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999999876666899999999999999999999 67899999999999999999999999998765422
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
... .......++..|+|||...+..++.++|||||||++||+++ |+.||...... ...+.+....
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~----------- 225 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDGF----------- 225 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC-----------
Confidence 111 11112234678999999999999999999999999999875 99999753221 1111111100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
..+.+..++..+.+++.+||+.+|++||++.|+.+.|+++
T Consensus 226 ------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011224556788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.44 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=206.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||++... ++..||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999976 78899999987653 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++|+|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE---KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhh---cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999998654 48899999999999999999994 2469999999999999999999999999987653321
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc------------
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR------------ 651 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 651 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...........
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCccc
Confidence 22346899999999999999999999999999999999999999653221 1111111100000
Q ss_pred -------------------hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 652 -------------------LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 652 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+..+. +............++.++.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDY-IVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHH-HHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 000000000011345678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=298.01 Aligned_cols=265 Identities=23% Similarity=0.287 Sum_probs=211.7
Q ss_pred HHHhccCCccccccccccEEEEEEE-ecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec-----CC
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN-----LD 496 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~ 496 (717)
....++|++.+.+|+|||+.||.++ ..+++.+|+|++.....+..+..++|++..++++|||+++++++... ..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3345789999999999999999998 45889999999987777777889999999999999999999998743 34
Q ss_pred eeEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 005040 497 FKALVLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 573 (717)
..|++++|...|+|.+.++. .+..+++.++..|+.++++||.+||+.. .+++||||||.||++++.+.+++.|||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~--~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE--PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC--CcccccCCCcceeEecCCCceEEEecc
Confidence 58999999999999999984 3557999999999999999999999643 369999999999999999999999999
Q ss_pred cccccCCCCCce-------eeeccccCccccCCCcc---CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHH
Q 005040 574 ISKLLGEGEDSV-------IQTMTMATIGYMAPEYG---SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRW 643 (717)
Q Consensus 574 l~~~~~~~~~~~-------~~~~~~~t~~y~aPE~~---~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~ 643 (717)
.++...-..... .......|..|+|||.+ .+...++++|||||||++|+|+.|..||+.....+..+.-
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL- 253 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL- 253 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-
Confidence 998654221111 11233568999999965 4456789999999999999999999999764332221111
Q ss_pred HHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 644 VKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
.+....+ .++....+++.+.+++..|+++||.+||++.+++..+..+
T Consensus 254 ----------Av~n~q~-----s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 ----------AVQNAQI-----SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----------eeecccc-----ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111111 1222233677899999999999999999999999998765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.61 Aligned_cols=250 Identities=22% Similarity=0.287 Sum_probs=211.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe-eEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF-KALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-~~lv~ 502 (717)
++|..++++|+|+||.++.++++ +++.+++|.+.... ....+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999876 78889999886554 3444578889999999999999999999988887 99999
Q ss_pred EccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 503 EFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
+|++||++.+.+.+.. ..++++.+..++.|++.|+.||| +..|+|||||+.||+++.++.|||+|||+|+.+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH----~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH----ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998654 77999999999999999999999 678999999999999999999999999999998765
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. ......||+.||.||.+.+..|..|+||||+||++|||++-+++|.+... ...+... ..
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----~~Li~ki------------~~ 220 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----SELILKI------------NR 220 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----HHHHHHH------------hh
Confidence 42 23556899999999999999999999999999999999999999976321 1111111 11
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.. ..+.+..++.++..++..|++.+|+.||++.+++..
T Consensus 221 ~~--~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GL--YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cc--CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 10 012234567789999999999999999999999987
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=330.96 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=200.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999976 78999999987543 234456888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999998654 4889999999999999999999 6899999999999999999999999999998654321
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+... . .
T Consensus 156 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~i~~~---~--------~-- 215 (291)
T cd05612 156 -----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEKILAG---K--------L-- 215 (291)
T ss_pred -----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---C--------c--
Confidence 2346899999999999888999999999999999999999999753211 111111100 0 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAAK 701 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~~ 701 (717)
.+ +..++..+.+++.+||+.||.+||+ ++|+++.
T Consensus 216 ---~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ---EF--PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CC--CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00 0122456789999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=328.95 Aligned_cols=264 Identities=21% Similarity=0.286 Sum_probs=201.5
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|+..+.||+|+||+||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57899999999999999999875 78999999986443 22334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++ |+|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH----KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 97 5999999877666899999999999999999999 68999999999999999999999999999876532221
Q ss_pred eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC----chhhh----
Q 005040 585 VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH----RLTEV---- 655 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~---- 655 (717)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+..... .... .+..+
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFR-LLGTPTEETWPGITSNE 235 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCChHHhhccccch
Confidence 1233457899999998765 568999999999999999999999997532211 1111111 1100 01110
Q ss_pred -----ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 656 -----VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 656 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+..... +........+.++.+++.+|+..||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQ-PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCC-chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00100000 000011123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=333.41 Aligned_cols=259 Identities=25% Similarity=0.431 Sum_probs=207.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCC----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGT----NVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.+|+..+.||+|+||.||+|.+. ++. .||+|+++... ....+.+..|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57899999999999999999864 343 38999986443 34456788999999999999999999998764 5689
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
|+||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999999987667899999999999999999999 68899999999999999999999999999987754
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
...........++..|+|||++.+..++.++||||||+++|||++ |+.||++.... ..........
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~----------- 228 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE----------- 228 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCC-----------
Confidence 333222223335678999999999999999999999999999998 99998753211 1111111100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
..+....++.++.+++.+||+.+|++||++.+++..+.++.+..
T Consensus 229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00111124456889999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.90 Aligned_cols=256 Identities=28% Similarity=0.516 Sum_probs=207.6
Q ss_pred ccCCccccccccccEEEEEEEecC------CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSD------GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
++|+..+.||+|+||.||+|.... ...||+|.+.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 578889999999999999998642 2579999886543 334467889999999999999999999999989999
Q ss_pred EEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC
Q 005040 500 LVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN 564 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~ 564 (717)
++|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS----SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccccceEEEcCC
Confidence 9999999999999997531 34788899999999999999999 6789999999999999999
Q ss_pred CcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHH
Q 005040 565 MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRW 643 (717)
Q Consensus 565 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~ 643 (717)
+.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... .....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~ 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEM 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 9999999999986544332222334456888999999988899999999999999999998 99998753221 11111
Q ss_pred HHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 644 VKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
+.... . ......++.++.+++.+||+.||++||+++|+++.|+++
T Consensus 239 i~~~~-----------~------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IRSRQ-----------L------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcCC-----------c------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11100 0 011224567799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=336.67 Aligned_cols=244 Identities=26% Similarity=0.290 Sum_probs=200.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67899999999999999999976 68999999997553 234466889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH----SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999998754 4788899999999999999999 6899999999999999999999999999998764322
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ....+.+. ... .
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~---~~~--------~-- 232 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIYEKIL---AGR--------L-- 232 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHHHHHh---cCC--------c--
Confidence 234689999999999999999999999999999999999999965211 11111111 000 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
..+ ..++..+.+++.+||+.||++||+ +++++.
T Consensus 233 ---~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 ---KFP--NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---CCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 000 112345789999999999999997 577664
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=334.02 Aligned_cols=241 Identities=23% Similarity=0.261 Sum_probs=195.8
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
+.||+|+||.||+|..+ +|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 78999999997653 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeee
Q 005040 509 SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT 588 (717)
Q Consensus 509 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 588 (717)
+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~ 153 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK 153 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--ccc
Confidence 9999998654 4899999999999999999999 68999999999999999999999999999875422111 123
Q ss_pred ccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhh
Q 005040 589 MTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFS 668 (717)
Q Consensus 589 ~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (717)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. .. ..+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~~~~---~~------~~~-------- 214 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM---EE------IRF-------- 214 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHHHHHc---CC------CCC--------
Confidence 34689999999999999999999999999999999999999965211 111111110 00 000
Q ss_pred hhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 669 DKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 669 ~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
+...+.++.+++.+||+.||++|| ++.++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 112345688999999999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=315.40 Aligned_cols=246 Identities=25% Similarity=0.342 Sum_probs=206.4
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++.. ++..-.+.+|+++|+.|+||||++++.+|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788889999999999999974 689999999998765 44455688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||..+|.|++|+.+.+. +++..+.+++.||..|+.|+| .++++|||||.+|||+|.++++||+|||++..+...
T Consensus 132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH----knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH----KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh----hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999998765 999999999999999999999 689999999999999999999999999999988543
Q ss_pred CCceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
. .-+.++|++-|.+||...+..| ++..|-||+||++|-++.|..||++.. ....+++.-.
T Consensus 207 k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs~----------- 267 (668)
T KOG0611|consen 207 K---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQISR----------- 267 (668)
T ss_pred c---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhhc-----------
Confidence 3 3356789999999999988887 678999999999999999999998731 1122221110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.+..- +-+.++.-+|+-|+.++|++|.|+.++..
T Consensus 268 -GaYrEP----~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 268 -GAYREP----ETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -ccccCC----CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 111000 11234568999999999999999998764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=322.54 Aligned_cols=257 Identities=28% Similarity=0.393 Sum_probs=200.0
Q ss_pred HHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH---------H-----HHHHHHHHHHHHHhcCCCceee
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---------R-----AFRSFDSECEILRNVRHRNLLK 487 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~-----~~~~~~~e~~~l~~l~hpniv~ 487 (717)
++..++|++.+.||+|.||.|-+|... +++.||+|++.+... . ..+.+.+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445689999999999999999999865 899999999976531 0 1247889999999999999999
Q ss_pred EeeeeecC--CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 005040 488 ILGSCSNL--DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565 (717)
Q Consensus 488 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~ 565 (717)
++++..+. +..|||+|||..|.+... ......+++.++++++.++..||+||| .++|+||||||+|+|++++|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH----~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLH----YQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEEcCCC
Confidence 99999764 578999999998877532 222233899999999999999999999 78999999999999999999
Q ss_pred cEEEeeeccccccCCCCCc---eeeeccccCccccCCCccCCCC----cCcccchhhHHHHHHHHHhCCCCCCccccCcc
Q 005040 566 VAHVSDFGISKLLGEGEDS---VIQTMTMATIGYMAPEYGSEGI----VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM 638 (717)
Q Consensus 566 ~~kl~Dfgl~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~----~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~ 638 (717)
+|||+|||.+.....+... ..-....|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-+.+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--- 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--- 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence 9999999999866322111 1112357999999999766532 46789999999999999999999965321
Q ss_pred hHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 639 SLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
+..+ ..++...+ .++...+...++.++|.++|.+||+.|.+..+|....
T Consensus 325 -~~l~---------~KIvn~pL-----~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 -LELF---------DKIVNDPL-----EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -HHHH---------HHHhcCcc-----cCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1111 11111111 1223334556788999999999999999999987543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.18 Aligned_cols=253 Identities=24% Similarity=0.302 Sum_probs=204.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+..|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 68999999997653 233456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH----ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999998654 4889999999999999999999 67899999999999999999999999999986543
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....+... ..... .+...
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~-~~~~~---~~~~~- 223 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWENLKYW-KETLQ---RPVYD- 223 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHHHHhc-ccccc---CCCCC-
Confidence 1234468999999999999999999999999999999999999997532211 11111100 00000 00000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.....++.++.+++.+|+..+|.+||++.++++.
T Consensus 224 -----~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 -----DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -----ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0001345668899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.32 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=209.1
Q ss_pred hccCCccccccccccEEEEEEEec----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|.++ +...||+|+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 367899999999999999999874 24579999887543 3345678889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++++|.+++......+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999999876667899999999999999999999 67899999999999999999999999999987753
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
...........++..|+|||...+..++.++||||||+++|||++ |..||...... ...+.+......
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~--------- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGYRL--------- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCC---------
Confidence 222222222345678999999998899999999999999999998 99998653211 111211111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
+....++..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 228 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 --------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01123456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.44 Aligned_cols=262 Identities=26% Similarity=0.316 Sum_probs=200.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----eeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLD-----FKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~ 499 (717)
.-.|...+++|+|+||.||+|... +++.||||+.....+ .-.+|+++|+.+.|||||++..+|.... ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 346777899999999999999965 678999998764432 2235999999999999999999884422 335
Q ss_pred EEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeeccc
Q 005040 500 LVLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGIS 575 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~ 575 (717)
+|||||+. +|.++++. .+..++...+.-++.|+++||+||| +.+|+||||||.|+|+|.+ |.+||||||.|
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh----~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH----SHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH----hcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 89999975 99999984 2455888888999999999999999 6899999999999999965 99999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
+.+..++.+. ....|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+ ..+..++...++......-.+
T Consensus 174 K~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 174 KVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred eeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHH
Confidence 9987665542 3356889999997766 5699999999999999999999999887 334445555555433221111
Q ss_pred h----------ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 V----------VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+ -.+.+....-..-.....+.++.+++.+++.++|.+|.++.|++.
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1 001111111000011244577899999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.64 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=205.9
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~ 497 (717)
.++|++.+.||+|+||.||+|... .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 468889999999999999999853 23469999997543 334467899999999996 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC-----------------------------------------------------------
Q 005040 498 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 518 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 518 (717)
.|+||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999986421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 005040 519 ------------------------------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD 562 (717)
Q Consensus 519 ------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~ 562 (717)
..+++..+..++.|+++||.||| +.+|+||||||+||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dikp~Nill~ 271 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA----SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHhEEEe
Confidence 23678888999999999999999 67899999999999999
Q ss_pred CCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHH
Q 005040 563 ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLR 641 (717)
Q Consensus 563 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~ 641 (717)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HH
Confidence 999999999999987643322222233456788999999988899999999999999999997 9999875322111 11
Q ss_pred HHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 642 RWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
..+.... . ......++.++.+++.+||+.+|++||++.++.+.|+++.
T Consensus 351 ~~~~~~~----------~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 NKIKSGY----------R-------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHhcCC----------C-------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1111000 0 0111234567889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.52 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=206.1
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
+.|+.++.||.|.-|+||+++.+ ++..+|+|++.+.. +....+...|.+||+.+.||.++.+|+.++.....|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 56778889999999999999986 45889999998775 344556778999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 503 EFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 503 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+||+|....+++ +..+++..++-++..|+-||+||| ..|||+|||||+|||+.++|++-|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH----mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH----MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH----hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999999854 567999999999999999999999 789999999999999999999999999997643110
Q ss_pred ---------------------------------CC---------------------ceeeeccccCccccCCCccCCCCc
Q 005040 582 ---------------------------------ED---------------------SVIQTMTMATIGYMAPEYGSEGIV 607 (717)
Q Consensus 582 ---------------------------------~~---------------------~~~~~~~~~t~~y~aPE~~~~~~~ 607 (717)
.. .......+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 011123478999999999999999
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCC
Q 005040 608 STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMD 687 (717)
Q Consensus 608 ~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 687 (717)
+.++|+|+|||++|||+.|..||.+....+ .+. .++.. ...++.....+..+.+||++.|.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~------------NIv~~-----~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLR------------NIVGQ-----PLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHH------------HHhcC-----CCcCCCCCcchhHHHHHHHHHhcc
Confidence 999999999999999999999998743322 111 11111 112333335567789999999999
Q ss_pred CCCCCCC----HHHHHH
Q 005040 688 TPHKRIH----MTDAAA 700 (717)
Q Consensus 688 ~P~~Rpt----~~ev~~ 700 (717)
||.+|.. |+||.+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999998 777654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.39 Aligned_cols=268 Identities=25% Similarity=0.301 Sum_probs=204.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhcCCCc-eeeEeeeeecCC-----
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNVRHRN-LLKILGSCSNLD----- 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~----- 496 (717)
...|+.+++||+|+||+||+|+.+ +|+.||+|.+....+ .......+|+.+++.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 346777788999999999999965 889999999876643 23455688999999999999 999999997776
Q ss_pred -eeEEEEEccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 005040 497 -FKALVLEFMPNGSLEKWLYSHN---YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDF 572 (717)
Q Consensus 497 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 572 (717)
..++||||++. +|..++.... ..++...+..++.|+++||+||| +++|+||||||.||++++.|.+||+||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H----~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH----SHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCcceEEECCCCcEeeecc
Confidence 78999999965 9999999765 35788899999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHH-hhCC-
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK-ESLP- 649 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~- 649 (717)
|+|+...-+.. ..+...+|.+|+|||++.+. .|+...||||+||+++||+++++-|.+..+-+ ++.+... -..|
T Consensus 165 GlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 165 GLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRLLGTPN 241 (323)
T ss_pred chHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHHcCCCC
Confidence 99997653222 24566789999999987776 79999999999999999999998887643311 1111111 1111
Q ss_pred -Cchhhhcc-ccchhhhhhhh-------hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 650 -HRLTEVVD-ANLVREEQAFS-------DKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 650 -~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+.+..+.. +......+... ..........+++.+|++++|++|.|++.+++.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11222111 00110110000 001111468899999999999999999999875
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=322.40 Aligned_cols=260 Identities=29% Similarity=0.457 Sum_probs=209.8
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
..+|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467889999999999999999742 34568999987655555677899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 005040 500 LVLEFMPNGSLEKWLYSHN------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVA 567 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~ 567 (717)
+||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH----~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcE
Confidence 9999999999999997542 24899999999999999999999 6789999999999999999999
Q ss_pred EEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHh
Q 005040 568 HVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 568 kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 646 (717)
+|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||......+ ....+..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~ 237 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQ 237 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc
Confidence 9999999986643322222233345778999999998899999999999999999998 899986532211 1111111
Q ss_pred hCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
... . .....++.++.+++.+||+.+|.+|||+.++.+.|+++...
T Consensus 238 ~~~-----------~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 GRV-----------L------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCc-----------C------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000 0 00112345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=344.14 Aligned_cols=257 Identities=24% Similarity=0.314 Sum_probs=210.7
Q ss_pred ccCCccccccccccEEEEEEEecCC-CeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeee-ec------CCe
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDG-TNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSC-SN------LDF 497 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~-~~------~~~ 497 (717)
.++++.+.|.+|||+.||.|....+ ..||+|++-...+...+.+.+|+++|++|+ |||||.+++.. .. ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4667889999999999999997655 999999998777778889999999999996 99999999932 11 246
Q ss_pred eEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 498 KALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
++|.||||.||.|-+++... ...+.+.++++|+.|+++|+++||.. ..+|+|||||-+|||++.+++.||||||.+.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 78999999999999999843 33499999999999999999999965 5689999999999999999999999999987
Q ss_pred ccCCCCCce-------eeeccccCccccCCCc---cCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh
Q 005040 577 LLGEGEDSV-------IQTMTMATIGYMAPEY---GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 577 ~~~~~~~~~-------~~~~~~~t~~y~aPE~---~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 646 (717)
..-...... ..-....|+.|+|||+ ..+...++|+||||+||+||-|+....||++.-
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 543222110 0112356999999995 577889999999999999999999999998621
Q ss_pred hCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
...+++..+ .++....++..+.+||+.||++||.+||++.||++.+.++..
T Consensus 263 -----~laIlng~Y-----~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 263 -----KLAILNGNY-----SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -----ceeEEeccc-----cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 112233222 233334677889999999999999999999999999998865
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=317.53 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=203.2
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
++|+..+.||+|+||.||+|.++++..+|+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 5688889999999999999998888899999876432 223568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+|+|.++++.....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||.+........ ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE----RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 99999999865556899999999999999999999 67899999999999999999999999999886533221 11
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....++..|+|||+..+..++.++||||||+++|||++ |+.||..... ......+...... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~~-----~--------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFRL-----Y--------- 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCC-----C---------
Confidence 122235678999999988889999999999999999999 8999865321 1111211111000 0
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
.+...+.++.+++.+||+.+|++||+++++++.|
T Consensus 222 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 ---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0011234688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=323.01 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=205.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCC----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGT----NVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
++|+..+.||+|+||.||+|.+. +++ .|++|.+.... ......+..|+..++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 57888899999999999999864 444 47788775433 3344677888889999999999999998764 45689
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
++||+++|+|.+++......+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE----EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999999877667899999999999999999999 67899999999999999999999999999987644
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
...........++..|+|||+..++.++.++||||||+++||+++ |+.||.+.... ...+++.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~---------- 229 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGER---------- 229 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCc----------
Confidence 332222233456788999999988899999999999999999998 99998764221 11222211000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.+....++.++.+++.+||..+|++|||+.|+++.|..+.+.
T Consensus 230 -------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 -------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 000112345578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=318.34 Aligned_cols=248 Identities=27% Similarity=0.438 Sum_probs=198.9
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
+.||+|+||.||+|... +++.||+|.+.... .+....+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 78999999876433 33456788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeecc
Q 005040 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590 (717)
Q Consensus 511 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 590 (717)
.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE----SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999876666899999999999999999999 688999999999999999999999999998765432211111112
Q ss_pred ccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhh
Q 005040 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSD 669 (717)
Q Consensus 591 ~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (717)
..+..|+|||.+.++.++.++||||||+++|||++ |..||...... ..........+. ..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~~~-----------------~~ 217 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGVRL-----------------PC 217 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCC-----------------CC
Confidence 23567999999998899999999999999999998 88888653211 111111110000 01
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 670 KMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 670 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
+..++..+.+++.+|+..+|++|||+.++.+.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.26 Aligned_cols=267 Identities=21% Similarity=0.225 Sum_probs=201.1
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999976 68899999987543 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|++++.+..+. .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH----KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99987665544 33445899999999999999999999 67899999999999999999999999999987643221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh--hCCCc-hh-------
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE--SLPHR-LT------- 653 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~-~~------- 653 (717)
. ......|++.|+|||++.+..++.++||||+||++|||++|+.||......+ ........ ..+.. ..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 A-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 1223468999999999988889999999999999999999999997632211 11110000 00000 00
Q ss_pred --hhccccchh-hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 654 --EVVDANLVR-EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 654 --~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....+.... ..........++.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 00000001124567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.74 Aligned_cols=237 Identities=25% Similarity=0.251 Sum_probs=191.7
Q ss_pred ccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 435 LGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 435 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 68899999987543 33445678899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeecc
Q 005040 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590 (717)
Q Consensus 511 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 590 (717)
.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 153 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH----KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF 153 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence 99998654 4899999999999999999999 6889999999999999999999999999987543221 112344
Q ss_pred ccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhh
Q 005040 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDK 670 (717)
Q Consensus 591 ~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
.||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........... . ..+
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~--------~-------~~~ 213 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEP--------L-------RFP 213 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCC--------C-------CCC
Confidence 689999999999999999999999999999999999999965311 11111111100 0 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 005040 671 MDCLFSIMDLALDCCMDTPHKRIHMTDA 698 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~P~~Rpt~~ev 698 (717)
..++.++.+++.+||+.||++||++.++
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 1234567899999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.68 Aligned_cols=246 Identities=25% Similarity=0.276 Sum_probs=199.9
Q ss_pred hccCCccccccccccEEEEEEEec--CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|..+ ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 367999999999999999999864 33689999987543 2334567889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999998754 4889999999999999999999 68999999999999999999999999999987643
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
.. ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... ....... .
T Consensus 184 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~---~~i~~~~--------~ 245 (340)
T PTZ00426 184 RT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIY---QKILEGI--------I 245 (340)
T ss_pred Cc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHH---HHHhcCC--------C
Confidence 21 2346899999999998888999999999999999999999999753211 000 0000000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAAK 701 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~~ 701 (717)
.. +...+..+.+++.+|++.||++|+ +++++++.
T Consensus 246 -----~~--p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YF--PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CC--CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 012234577999999999999995 78887653
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=326.37 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=216.9
Q ss_pred HhccCCccccccccccEEEEEEEecC---CC--eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSD---GT--NVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
..+.....++||+|.||.||+|.+.+ |. .||||..+... .+..+.|.+|..+|++++|||||+++|+|.+.. .
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-M 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-e
Confidence 33455567889999999999998632 33 48999887644 445688999999999999999999999998654 6
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
.+|||.++-|.|..|++.+...++......++.||+.||+||| +..+|||||..+|||+.+..-||++|||+++.+
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe----SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE----SKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH----hhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999999999888999999999999999999999 789999999999999999999999999999998
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
........ +...-++.|||||.+.-.+++.++|||.|||.+||++. |..||.+....+ ++-
T Consensus 542 ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------VI~ 603 (974)
T KOG4257|consen 542 EDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------VIG 603 (974)
T ss_pred cccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------eEE
Confidence 76554432 33345788999999999999999999999999999987 999998744332 111
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.- +.....+-+..|+..+..++.+||+++|.+||++.|+...|+.+.+
T Consensus 604 ~i--EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HI--ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred Ee--cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11 1112234556889999999999999999999999999999999866
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=329.69 Aligned_cols=241 Identities=23% Similarity=0.264 Sum_probs=195.2
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999865 78999999997653 234456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeee
Q 005040 509 SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT 588 (717)
Q Consensus 509 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 588 (717)
+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 153 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK 153 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccc
Confidence 9999887654 4899999999999999999999 68999999999999999999999999999875322211 123
Q ss_pred ccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhh
Q 005040 589 MTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFS 668 (717)
Q Consensus 589 ~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (717)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ...... ..+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~---~~~~~~------~~~-------- 214 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFE---LILMEE------IRF-------- 214 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHHH---HHhcCC------CCC--------
Confidence 346899999999999999999999999999999999999999653211 1111 000000 000
Q ss_pred hhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 669 DKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 669 ~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
+..++.++.+++.+||+.||++|| ++.++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 113345678999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=309.17 Aligned_cols=276 Identities=26% Similarity=0.388 Sum_probs=217.1
Q ss_pred CHHHHHHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhc--CCCceeeEeeeeecC
Q 005040 418 SYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV--RHRNLLKILGSCSNL 495 (717)
Q Consensus 418 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~hpniv~~~~~~~~~ 495 (717)
.....+....+....+.||+|.||.||+|.|+ |+.||||+|....+ +.+.+|.++++.. +|+||+.|++.-..+
T Consensus 202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred hhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 34445667788899999999999999999995 89999999975543 5567788888875 999999999875333
Q ss_pred ----CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc----CCCCCeEecCCCCCCeeeCCCCcE
Q 005040 496 ----DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC----HSSAPIIHCDLKPTNILLDENMVA 567 (717)
Q Consensus 496 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----~~~~~ivH~dlk~~Nill~~~~~~ 567 (717)
..++||++|.+.|||.||+.... ++.....+++..+|.||+|||.. .+.+.|.|||||+.|||+..++..
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 25689999999999999999854 88999999999999999999942 346679999999999999999999
Q ss_pred EEeeeccccccCCCCCc--eeeeccccCccccCCCccCCCC----c--CcccchhhHHHHHHHHHhCC----------CC
Q 005040 568 HVSDFGISKLLGEGEDS--VIQTMTMATIGYMAPEYGSEGI----V--STKCDVYSYGVLLMETFTEK----------KP 629 (717)
Q Consensus 568 kl~Dfgl~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~----~--~~~~Dvws~G~il~el~tg~----------~p 629 (717)
.|+|+|+|......... ......+||-+|||||++.... + -..+||||||.++||+..+. .|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99999999887654322 2334568999999999875532 1 13599999999999997532 57
Q ss_pred CCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 630 TDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
|.+..+.+.++.+..+ -+...++....++.+...++...+.++|+.||..+|..|.|+-.+.+.|.++.+
T Consensus 436 yyd~Vp~DPs~eeMrk--------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRK--------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cccCCCCCCCHHHHhc--------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 7665555444433222 122333444444455556778889999999999999999999999999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=321.87 Aligned_cols=256 Identities=31% Similarity=0.487 Sum_probs=206.2
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|.+.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888899999999999999864 3478999998755433 457889999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 005040 499 ALVLEFMPNGSLEKWLYSHN-------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~ 565 (717)
++||||+++++|.+++...+ ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA----SQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeeccccccceEEEcCCC
Confidence 99999999999999997542 34788899999999999999999 67899999999999999999
Q ss_pred cEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHH
Q 005040 566 VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWV 644 (717)
Q Consensus 566 ~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 644 (717)
.++|+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||..... ......+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--~~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--EEVIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH
Confidence 999999999976543322222233345788999999999999999999999999999999 9999865322 1111211
Q ss_pred HhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 645 KESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
...... .....++..+.+++.+||+.||++||++.|+++.|++
T Consensus 238 ~~~~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQGRLL-----------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HcCCcC-----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 110000 0011344668899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.45 Aligned_cols=250 Identities=22% Similarity=0.241 Sum_probs=202.6
Q ss_pred cCCccccccccccEEEEEEEec-C-CCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-D-GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+..|+++++.++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999864 4 6778999776555555567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 506 PNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 506 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..+....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988642 345889999999999999999999 6899999999999999999999999999998765433
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
.........||++|+|||++.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~--------~-- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGK--------Y-- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC--------C--
Confidence 22223445689999999999999999999999999999999999999965211 11111100000 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. +.+..++.++.+++.+||..||++||++.++++
T Consensus 289 --~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 --D--PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --C--CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 001123456889999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=329.86 Aligned_cols=199 Identities=26% Similarity=0.358 Sum_probs=175.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|... ++..+|+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999976 78889999887543 3344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++|+|.+++.... .+++..+..++.|++.|+.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999998654 47899999999999999999994 2479999999999999999999999999987653221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDE 632 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 632 (717)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1234688999999999988999999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=319.54 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=211.2
Q ss_pred HhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
...+|+..+.||+|+||.||+|...+++.+|+|++..........+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45688999999999999999999888999999999866554566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++++|.+++... +..+++..+..++.|++.|++||| +.+++|+||||+||+++.++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE----EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999863 345899999999999999999999 67899999999999999999999999999987643221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. .....++..|+|||...+..++.++||||||+++|+|++ |+.||..... ....+.+......
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~------------ 223 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQITAGYRM------------ 223 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHHhCCcC------------
Confidence 1 123345778999999988899999999999999999998 8999865321 1111111111000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
+....++..+.+++.+||+.||++|||++++++.|+.+
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 -----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11123456688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=317.23 Aligned_cols=255 Identities=22% Similarity=0.414 Sum_probs=207.5
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46889999999999999999998888899999876543 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++|+|.++++.. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE----RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999753 455889999999999999999999 678999999999999999999999999999876432211
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......++..|+|||+..++.++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~-------------- 222 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR-------------- 222 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC--------------
Confidence 1222345678999999988889999999999999999998 99998653211 11221111100
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
.+....++.++.+++.+|+..+|++||+++++.+.|+++
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 ---MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 001112445688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.09 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=207.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999965 78999999875322 334466888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988863 2345789999999999999999999 6799999999999999999999999999988764
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.... ......+++.|+|||...+..++.++|+||+|+++|||++|+.||.............+... . .+.
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~-----~~~ 227 (267)
T cd08228 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC---D-----YPP 227 (267)
T ss_pred chhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC---C-----CCC
Confidence 3221 11234578899999999888899999999999999999999999854222111111111110 0 000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
. ....++..+.+++.+||+.+|++||++.++++.+++++
T Consensus 228 ~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 L--------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C--------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0 01234466889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=321.83 Aligned_cols=270 Identities=27% Similarity=0.430 Sum_probs=206.0
Q ss_pred ccCCccccccccccEEEEEEEe-----cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec--CCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-----SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN--LDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~ 499 (717)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788899999999999999974 2578899999876655566788999999999999999999998643 34678
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+++|+|.+++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG----SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999999876666899999999999999999999 6789999999999999999999999999998764
Q ss_pred CCCCcee-eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC--chhhhc
Q 005040 580 EGEDSVI-QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH--RLTEVV 656 (717)
Q Consensus 580 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 656 (717)
....... .....++..|+|||+..+..++.++||||||+++|||++|..|+..... ...+........ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccchHHHH
Confidence 4322211 1112234569999999888999999999999999999999877543211 011100110000 000000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
+ ........+....++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 237 ~--~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 E--LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred H--HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 0000011122234566799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=328.85 Aligned_cols=242 Identities=24% Similarity=0.286 Sum_probs=196.2
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999865 78999999997653 234466788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeee
Q 005040 509 SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT 588 (717)
Q Consensus 509 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 588 (717)
+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 153 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH----SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK 153 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence 9999887654 4899999999999999999999 6899999999999999999999999999987542211 1123
Q ss_pred ccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhh
Q 005040 589 MTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFS 668 (717)
Q Consensus 589 ~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (717)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... ..+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~~------~~~-------- 214 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMED------IKF-------- 214 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccCC------ccC--------
Confidence 346899999999999999999999999999999999999999652111 1111110000 000
Q ss_pred hhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 005040 669 DKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAAK 701 (717)
Q Consensus 669 ~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~~ 701 (717)
+..++.++.+++.+||+.||++|| ++.|+++.
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112345678999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.29 Aligned_cols=261 Identities=29% Similarity=0.452 Sum_probs=210.5
Q ss_pred ccCCccccccccccEEEEEEEec------CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56888899999999999999742 355689999876655555678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 005040 501 VLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~ 565 (717)
||||+++++|.+++.... ..+++..+..++.|++.|++||| +++++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA----SQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCC
Confidence 999999999999997532 34789999999999999999999 68899999999999999999
Q ss_pred cEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHH
Q 005040 566 VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWV 644 (717)
Q Consensus 566 ~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 644 (717)
.++|+|||++................++..|+|||+..+..++.++||||||+++|||+| |+.||......+ ..+..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~ 238 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECI 238 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 999999999976544332222233456788999999998999999999999999999999 999986532211 11111
Q ss_pred HhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 645 KESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
... .... ....++..+.+++.+||+.+|++||++.+|++.|+++.+..+
T Consensus 239 ~~~---~~~~--------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 239 TQG---RVLE--------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred hCC---CCCC--------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 110 0000 011234568899999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=328.63 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=204.4
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeec-CC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSN-LD 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~-~~ 496 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357899999999999999999642 35789999986443 23345678899999999 89999999998754 45
Q ss_pred eeEEEEEccCCCCHHHHHhhCC----------------------------------------------------------
Q 005040 497 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 518 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 518 (717)
..+++|||+++|+|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999999986421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccc
Q 005040 519 --YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596 (717)
Q Consensus 519 --~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y 596 (717)
..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++..+.............++..|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH----~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 25789999999999999999999 679999999999999999999999999999876433222222334457789
Q ss_pred cCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHH
Q 005040 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLF 675 (717)
Q Consensus 597 ~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (717)
+|||++.+..++.++|||||||++|||++ |..||......+ .+.......... ..+..++.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~-----------------~~~~~~~~ 303 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRM-----------------RAPEYATP 303 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCC-----------------CCCccCCH
Confidence 99999999999999999999999999998 999986532211 111111110000 00112345
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 676 SIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 676 ~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
++.+++.+||+.+|++||++.|+++.|+++.+
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 68899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=329.62 Aligned_cols=266 Identities=22% Similarity=0.284 Sum_probs=196.7
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC-----CeeE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL-----DFKA 499 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~ 499 (717)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999965 78999999986432 22345678899999999999999999987432 3579
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+. ++|.+++.... .+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 69999987654 3899999999999999999999 6789999999999999999999999999997653
Q ss_pred CCCC-ceeeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc----h
Q 005040 580 EGED-SVIQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR----L 652 (717)
Q Consensus 580 ~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~ 652 (717)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+....... .
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHH
Confidence 2221 112234568999999998765 6789999999999999999999999965321 11111111110000 0
Q ss_pred hhhcccc-------chh-hhhhh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 653 TEVVDAN-------LVR-EEQAF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 653 ~~~~~~~-------~~~-~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+.... +.. ..... .....++.++.+++.+||+.||++|||++|+++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 000 00000 0001234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.53 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=203.7
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
++|+..+.||+|+||.||.|..+++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 5788889999999999999998777789999887442 223568889999999999999999999998888999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+|+|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||.++....... ..
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 99999999876556899999999999999999999 67899999999999999999999999999876543221 11
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....++..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+......
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~--------------- 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLRL--------------- 220 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCCC---------------
Confidence 122345678999999988889999999999999999999 99998653211 111111111000
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
......+..+.+++.+||+.+|++||++.++++.|+
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000112456889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=321.28 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=202.9
Q ss_pred HhccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF 497 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 497 (717)
..++|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 35679999886432 2334568899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 005040 498 KALVLEFMPNGSLEKWLYSHN---------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAH 568 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~k 568 (717)
.++||||+++|+|.++++... ...++..+..++.|++.||.||| +.+++||||||+||++++++.++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999997532 23578889999999999999999 67899999999999999999999
Q ss_pred EeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhh
Q 005040 569 VSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKES 647 (717)
Q Consensus 569 l~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 647 (717)
|+|||++................++..|+|||++.++.++.++||||||+++|||++ |..||..... ....+++...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~ 237 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRFVMEG 237 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcC
Confidence 999999876543322222222345788999999998899999999999999999999 7888865321 1111111110
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
. .. .....++..+.+++.+|++.+|++|||+.|+++.|+
T Consensus 238 ---~--------~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 238 ---G--------LL------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---C--------cC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0 00 001123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=334.72 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=197.7
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.|+.++.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999865 78899999997643 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++++||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH----~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH----KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999998654 3788999999999999999999 68999999999999999999999999999754311000
Q ss_pred c---------------------------------------------eeeeccccCccccCCCccCCCCcCcccchhhHHH
Q 005040 584 S---------------------------------------------VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGV 618 (717)
Q Consensus 584 ~---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~ 618 (717)
. .......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0 0012346899999999998888999999999999
Q ss_pred HHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhh--ccCCCCCCCCCHH
Q 005040 619 LLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALD--CCMDTPHKRIHMT 696 (717)
Q Consensus 619 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~P~~Rpt~~ 696 (717)
++|||++|+.||......+. ...... .... + ..+....++.++.+++.+ |+..+|..||++.
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~--~~~~--------~-----~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET-QLKVIN--WENT--------L-----HIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH-HHHHHc--cccc--------c-----CCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999975322111 010000 0000 0 011111234567788887 5566677799999
Q ss_pred HHHHH
Q 005040 697 DAAAK 701 (717)
Q Consensus 697 ev~~~ 701 (717)
|+++.
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=317.63 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=205.9
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|++.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46788999999999999999998778889999987543 22456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++++|.+++.... ..+++..+..++.|++.|+.||| +.+|+||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE----AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999997643 55899999999999999999999 678999999999999999999999999999876532211
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.......+..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~-------------- 222 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYR-------------- 222 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC--------------
Confidence 1111223467999999998899999999999999999999 99998653211 11111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
.+....++..+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00111344668899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=331.42 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=194.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.+|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 46677889999999999999875 78999999986543 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++|+|.+. ...++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLH----RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999998653 22567788899999999999999 67899999999999999999999999999987643221
Q ss_pred eeeeccccCccccCCCccCC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 585 VIQTMTMATIGYMAPEYGSE-----GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ............
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~-------- 292 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMSQ-------- 292 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhccC--------
Confidence 1233468999999998643 334578999999999999999999997422111 111111000000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.......++.++.+++.+||+.||++||++.|+++.
T Consensus 293 ------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112345668899999999999999999999874
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.01 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=204.7
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 78999999997653 234467888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH----KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999876 45899999999999999999999 6899999999999999999999999999998764432
Q ss_pred ---------------------------CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 005040 583 ---------------------------DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFT 635 (717)
Q Consensus 583 ---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~ 635 (717)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00112334689999999999999999999999999999999999999976321
Q ss_pred CcchHHHHHHhh-CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 005040 636 GEMSLRRWVKES-LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-MTDAAAK 701 (717)
Q Consensus 636 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~ev~~~ 701 (717)
. ..+.... .... + ..+....++.++.+++.+|+. ||++||+ ++|+++.
T Consensus 236 ~----~~~~~i~~~~~~--------~-----~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 Q----ETYNKIINWKES--------L-----RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H----HHHHHHhccCCc--------c-----cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 1111000 0000 0 001111245668899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.44 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=207.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCC----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGT----NVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
..+|+..+.||+|+||+||+|.+. +++ .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 367889999999999999999853 444 48999886443 33446788899999999999999999998754 468
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+++||+++|+|.++++.....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999999876666899999999999999999999 6889999999999999999999999999998764
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
............++..|+|||...+..++.++||||||+++|||++ |..||..... .....++......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~-------- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGERL-------- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcC--------
Confidence 3322222222335678999999988899999999999999999998 8899865321 1222222211000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
+....++.++.+++.+||..||++||++.++++.|+.+.+..
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 011234566889999999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=320.53 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=203.8
Q ss_pred ccCCccccccccccEEEEEEEe-----cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-----SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.+|+..+.||+|+||.||+|.. .++..||+|.+.... .+....+.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999984 256789999987433 3344678889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhC----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC
Q 005040 501 VLEFMPNGSLEKWLYSH----------------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN 564 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~ 564 (717)
||||+++++|.+++... ...+++.++..++.|++.||+||| +.+++||||||+||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS----SHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hcCeehhccccceEEEcCC
Confidence 99999999999998632 124788899999999999999999 6789999999999999999
Q ss_pred CcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHH
Q 005040 565 MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRW 643 (717)
Q Consensus 565 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~ 643 (717)
+.+||+|||++................++..|+|||+..+..++.++||||||+++|||++ |..||.+... ......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~ 238 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEM 238 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Confidence 9999999999987644332222233445778999999988889999999999999999998 8889865311 111111
Q ss_pred HHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 644 VKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
+..... .+....++.++.+++.+|++.||++||++.++.+.|.+
T Consensus 239 ~~~~~~-----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQL-----------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCc-----------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111100 00112345668899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.08 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=202.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||+||+|... +++.||+|+++... .+..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999875 78999999998653 234456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH----QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999887566899999999999999999999 6889999999999999999999999999998764332
Q ss_pred CceeeeccccCccccCCCccC------CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 583 DSVIQTMTMATIGYMAPEYGS------EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..........
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~----- 225 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQ----- 225 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCC-----
Confidence 22 223446899999999876 456789999999999999999999999653211 1111100000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ..++.....+.++.+++..|++ +|++|||+.++++
T Consensus 226 --~~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 --RF----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --Cc----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 0011111244568899999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.10 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=200.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 78999999997643 334456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH----KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999998754 4899999999999999999999 6789999999999999999999999999987543211
Q ss_pred Cce------------------------------------eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhC
Q 005040 583 DSV------------------------------------IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTE 626 (717)
Q Consensus 583 ~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg 626 (717)
... ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000 01123589999999999999999999999999999999999
Q ss_pred CCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 005040 627 KKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH---MTDAAA 700 (717)
Q Consensus 627 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~ev~~ 700 (717)
+.||......+ ....+.. .... + ..+....++.++.+++.+|+. +|.+|++ +.|+++
T Consensus 236 ~~Pf~~~~~~~--~~~~i~~-~~~~--------~-----~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQE--TYRKIIN-WKET--------L-----QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHH--HHHHHHc-CCCc--------c-----CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99997532111 1111100 0000 0 001111234567899999997 9999998 888776
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=344.11 Aligned_cols=256 Identities=25% Similarity=0.311 Sum_probs=203.9
Q ss_pred HHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC---
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD--- 496 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--- 496 (717)
+...++|.+.+.||+|+||+||+|... +++.||||++.... ......+.+|+.++..++|+||+++.+.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 334579999999999999999999864 79999999986542 344566788999999999999999988764332
Q ss_pred -----eeEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 005040 497 -----FKALVLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAH 568 (717)
Q Consensus 497 -----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~k 568 (717)
..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH----~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH----SKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEeCCCCEE
Confidence 368999999999999999743 345889999999999999999999 68999999999999999999999
Q ss_pred EeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC
Q 005040 569 VSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 569 l~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 648 (717)
|+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~ 258 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTL 258 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHh
Confidence 999999987643322222334568999999999999999999999999999999999999996531 111111111
Q ss_pred CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 649 PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.... . +.+..++.++.+++.+||+.||.+||++.++++.
T Consensus 259 ~~~~------------~--~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRY------------D--PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCC------------C--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1000 0 0112345668899999999999999999998763
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.73 Aligned_cols=267 Identities=25% Similarity=0.398 Sum_probs=203.8
Q ss_pred CCccccccccccEEEEEEEe-----cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--CeeEE
Q 005040 429 FNECNLLGTGGFGSVYKGTL-----SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFKAL 500 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~l 500 (717)
|+..+.||+|+||+||++.. .+++.||+|++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 367889999987543 23456788899999999999999999987653 45789
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++++|.+++.... +++..+..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 86 v~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH----SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH----HCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999998654 899999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-CCchhhhccc
Q 005040 581 GEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-PHRLTEVVDA 658 (717)
Q Consensus 581 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 658 (717)
..... ......++..|+|||...+..++.++||||||+++|||++|+.|+............+..... .....+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 32211 112234566799999998888999999999999999999999998653221111111100000 0011111111
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
... .+....++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 240 ~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMR-----LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCC-----CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 110 1112245677999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=323.32 Aligned_cols=260 Identities=26% Similarity=0.454 Sum_probs=207.3
Q ss_pred HHhccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL 495 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 495 (717)
...++|+..+.||+|+||.||+|... ....+|+|.+.... .+....+.+|+++++++ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34568899999999999999999864 23679999887543 33446688899999999 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 496 DFKALVLEFMPNGSLEKWLYSH---------------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
+..++||||+++|+|.++++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~Nil 164 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA----SKKCIHRDLAARNVL 164 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCccccccceeeEE
Confidence 9999999999999999999742 345889999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 639 (717)
++.++.+||+|||+++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||...... .
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~ 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--E 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--H
Confidence 99999999999999987654332222222335678999999988899999999999999999998 99998653211 1
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
..+...... . ......++.++.+++.+|++.+|++|||+.|+++.|+.+.
T Consensus 243 ~~~~~~~~~--~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKEGY--R---------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHcCC--c---------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111100 0 0011133456889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=315.63 Aligned_cols=251 Identities=27% Similarity=0.398 Sum_probs=202.4
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
.+|++.+.||+|+||.||+|.++++..+|+|++..... ....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 46888899999999999999987777899998864322 23467889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||+++........ .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 99999999876556899999999999999999999 678999999999999999999999999998765432211 1
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....++..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~---------------- 219 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGYR---------------- 219 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCCc----------------
Confidence 112223567999999988899999999999999999999 88898653221 11111111000
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
...+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus 220 -~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 -LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 001112456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.75 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=193.7
Q ss_pred ccccccccEEEEEEEe----cCCCeEEEEEechhh----HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 433 NLLGTGGFGSVYKGTL----SDGTNVAIKIFNLQL----ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+.||+|+||.||+++. .+++.||+|+++... ......+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357889999997543 22335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH----QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999998654 3788888899999999999999 68899999999999999999999999999875432221
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~~~--------~---- 217 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILKGK--------L---- 217 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC--------C----
Confidence 123346899999999999888999999999999999999999999753211 1111111000 0
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
..+..++.++.+++.+|++.||++|| ++.++++
T Consensus 218 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 ---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 00112345678999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.01 Aligned_cols=201 Identities=25% Similarity=0.373 Sum_probs=175.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|+..+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 68999999997643 233456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH----QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999998654 4899999999999999999999 6899999999999999999999999999987653211
Q ss_pred Cc---------------------------------eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCC
Q 005040 583 DS---------------------------------VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629 (717)
Q Consensus 583 ~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p 629 (717)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 001234689999999999999999999999999999999999999
Q ss_pred CCc
Q 005040 630 TDE 632 (717)
Q Consensus 630 ~~~ 632 (717)
|..
T Consensus 236 f~~ 238 (363)
T cd05628 236 FCS 238 (363)
T ss_pred CCC
Confidence 975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.77 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=205.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.+|+..+.||+|+||.||+|..+ .++.||+|++.... .....+.+|+++++.++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 56888899999999999999875 68899999987543 23466888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++++|.+++... ...+++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999999754 345899999999999999999999 678999999999999999999999999999876432211
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.......+..|+|||+..+..++.++||||||+++|||++ |..||...... ........... .
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~--------~----- 224 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKGYR--------M----- 224 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCC--------C-----
Confidence 1112234668999999988899999999999999999998 89998653211 11111111000 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
.....++.++.+++.+|++.+|++||++.++++.|+.+
T Consensus 225 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.57 Aligned_cols=244 Identities=22% Similarity=0.258 Sum_probs=193.3
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHH---HhcCCCceeeEeeeeecCCeeEEE
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEIL---RNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+..|++++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999875 78999999997553 22345566676655 456799999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++|+|..++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH----~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH----ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999888653 4899999999999999999999 689999999999999999999999999998753222
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~i~~~~--------~- 218 (324)
T cd05589 155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDSIVNDE--------V- 218 (324)
T ss_pred C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC--------C-
Confidence 1 1123456899999999999999999999999999999999999999753211 1111100000 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
..+..++..+.+++.+||+.||.+|| ++.++++
T Consensus 219 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00112345678999999999999999 4555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.81 Aligned_cols=258 Identities=24% Similarity=0.324 Sum_probs=208.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|... +++.+|||.+.... ......+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999964 89999999876432 334467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
||+++++|.+++.. ....+++..++.++.|++.|+.||| +.+++|+||||+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999999874 2345899999999999999999999 6889999999999999999999999999987664
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.... ......++..|+|||+..+..++.++|+||||+++|||++|..||...... ...+.... .....+.
T Consensus 158 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-----~~~~~~~ 227 (267)
T cd08229 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI-----EQCDYPP 227 (267)
T ss_pred cCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh-----hcCCCCC
Confidence 3221 122345888999999998888999999999999999999999998643221 11111110 0000000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
. ....++.++.+++.+||+.+|++|||+.+|++.++++.
T Consensus 228 ~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 L--------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C--------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 01234567889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.58 Aligned_cols=262 Identities=20% Similarity=0.213 Sum_probs=199.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..+|++.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999865 78999999643 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+. ++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH----~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH----ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 95 69999887654 4889999999999999999999 67999999999999999999999999999975432211
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCcccc------CcchHHHHHHhhC------CCch
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFT------GEMSLRRWVKESL------PHRL 652 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~------~~~~~~~~~~~~~------~~~~ 652 (717)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||-.... ....+...+.... +...
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 122345689999999999999999999999999999999999988643211 1111111111110 0000
Q ss_pred hhhccccc----------hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 653 TEVVDANL----------VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 653 ~~~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....+..+ ....+........+.++.+++.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 0000011112244667899999999999999999999985
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=331.81 Aligned_cols=254 Identities=21% Similarity=0.293 Sum_probs=201.5
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3578999999999999999999875 78899999997542 2233557789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999997643 788889999999999999999 68999999999999999999999999999987643
Q ss_pred CCCceeeeccccCccccCCCccCCC----CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEG----IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+....... ..
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~--~~----- 265 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDHK--NS----- 265 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCC--Cc-----
Confidence 221 112345689999999987543 4789999999999999999999999753211 0111110000 00
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHK--RIHMTDAAAK 701 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ev~~~ 701 (717)
..++....++.++.+++.+|++.+|.+ |+++.|+++.
T Consensus 266 --------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 --------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 001111234567889999999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.29 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=207.8
Q ss_pred ccCCccccccccccEEEEEEEec--------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS--------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLD 496 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 496 (717)
++|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+..|+++++.+ +||||+++++++.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 67899999999999999999752 23569999987543 33456788899999999 7999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 005040 497 FKALVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL 561 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill 561 (717)
..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nill 173 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLV 173 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHHheEE
Confidence 9999999999999999998532 24788999999999999999999 6799999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchH
Q 005040 562 DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSL 640 (717)
Q Consensus 562 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~ 640 (717)
+.++.+||+|||.+................++..|+|||+..+..++.++|||||||++|||++ |..||..... ...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~~ 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EEL 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHH
Confidence 9999999999999876543221111122234568999999988889999999999999999998 8888864221 111
Q ss_pred HHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 641 RRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
......... ...+..++.++.+++.+|+..+|++||++.++++.|.++.+...+
T Consensus 252 ~~~~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 252 FKLLKEGHR-----------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred HHHHHcCCC-----------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 111111000 011123456788999999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=317.62 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=205.0
Q ss_pred cCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
+|++.+.||+|+||.||+|... ....+|+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 23568999886543 3344678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCC
Q 005040 501 VLEFMPNGSLEKWLYSHN-----------------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPT 557 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~ 557 (717)
|+||+.+|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~ivH~dikp~ 156 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA----EMKLVHRDLAAR 156 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH----HCCeehhhhhhh
Confidence 999999999999986421 24788999999999999999999 678999999999
Q ss_pred CeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccC
Q 005040 558 NILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTG 636 (717)
Q Consensus 558 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~ 636 (717)
||++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |+.||.+....
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999986543322222233345778999999888889999999999999999999 99998653211
Q ss_pred cchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 637 EMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.+..+..... .. .....++.++.+++.+|++.+|++||+++++++.|+++..
T Consensus 237 --~~~~~~~~~~------------~~-----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 --RLFNLLKTGY------------RM-----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --HHHHHHhCCC------------CC-----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1122211110 00 0112344668899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=327.38 Aligned_cols=243 Identities=22% Similarity=0.257 Sum_probs=195.0
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
+.||+|+||.||++... +++.||+|++.... ......+..|+++++.++||||+++.+++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999865 78999999997653 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeee
Q 005040 509 SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT 588 (717)
Q Consensus 509 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 588 (717)
+|..++.... .+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS---EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence 9999887654 48999999999999999999993 26899999999999999999999999999875432211 122
Q ss_pred ccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhh
Q 005040 589 MTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFS 668 (717)
Q Consensus 589 ~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (717)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. .. ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i~~---~~------~~~-------- 215 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILM---EE------IRF-------- 215 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHHhc---CC------CCC--------
Confidence 346899999999999999999999999999999999999999652211 11111100 00 000
Q ss_pred hhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 005040 669 DKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAAK 701 (717)
Q Consensus 669 ~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~~ 701 (717)
+..++.++.+++.+||+.||++|+ ++.++++.
T Consensus 216 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 -PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 112345678999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.11 Aligned_cols=266 Identities=24% Similarity=0.426 Sum_probs=209.9
Q ss_pred hccCCccccccccccEEEEEEEec--------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL 495 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 495 (717)
.++|.+.+.||+|+||.||+|+.. ....+|+|.+.... ......+.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 368889999999999999999742 34568999887543 33456788899999999 699999999999998
Q ss_pred CeeEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
+..++||||+++|+|.+++.... ..+++.++..++.|++.||.||| +.+++||||||+||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nil 166 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE----SRRCIHRDLAARNVL 166 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeeccccceeEE
Confidence 99999999999999999997532 34788999999999999999999 679999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 639 (717)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~ 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence 99999999999999986643222111122234567999999988899999999999999999999 88888653211 1
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccchh
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDVA 714 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~~ 714 (717)
......... . ......++.++.+++.+|++.+|++||++.|+++.|.++.....++.+
T Consensus 245 ~~~~~~~~~--~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 302 (314)
T cd05099 245 LFKLLREGH--R---------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302 (314)
T ss_pred HHHHHHcCC--C---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCce
Confidence 111111100 0 001123445688999999999999999999999999999876666554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.40 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=204.8
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
..+|+..+.||+|+||.||++... ++..+|+|.+..........+.+|+++++.++||||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788899999999999999632 45679999887665556678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 005040 500 LVLEFMPNGSLEKWLYSHN--------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~ 565 (717)
+||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA----SLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH----HCCeecccccHhhEEEcCCC
Confidence 9999999999999998543 24789999999999999999999 67899999999999999999
Q ss_pred cEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHH
Q 005040 566 VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWV 644 (717)
Q Consensus 566 ~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 644 (717)
.+||+|||++................+++.|+|||+..+..++.++|||||||++|||++ |+.||...... ......
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~ 237 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAIECI 237 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHHHHH
Confidence 999999999876543322222223345788999999998899999999999999999998 89998653221 111111
Q ss_pred HhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 645 KESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
....+ ......++..+.+++.+||+.||++||++.|+.+.|+
T Consensus 238 ~~~~~-----------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 TQGRE-----------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCcc-----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 10000 0011134456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.58 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=197.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999865 78999999986543 234466888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH----~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH----KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999998654 4788999999999999999999 6899999999999999999999999999986432110
Q ss_pred Cc---------------------------------------------eeeeccccCccccCCCccCCCCcCcccchhhHH
Q 005040 583 DS---------------------------------------------VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYG 617 (717)
Q Consensus 583 ~~---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G 617 (717)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCC---CC
Q 005040 618 VLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKR---IH 694 (717)
Q Consensus 618 ~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---pt 694 (717)
|++|||++|+.||...... ..+..... ..... .++....++.++.+++.+|+. +|.+| ++
T Consensus 236 vil~elltG~~Pf~~~~~~-~~~~~i~~--~~~~~-------------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 236 AIMFECLIGWPPFCSENSH-ETYRKIIN--WRETL-------------YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhhcCCCCCCCCCHH-HHHHHHHc--cCCcc-------------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 9999999999999653221 11111100 00000 011111234567899999997 77765 59
Q ss_pred HHHHHHH
Q 005040 695 MTDAAAK 701 (717)
Q Consensus 695 ~~ev~~~ 701 (717)
+.|+++.
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.57 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=205.3
Q ss_pred HHhccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecC
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVR-HRNLLKILGSCSNL 495 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~ 495 (717)
...++|.+.+.||+|+||.||+|.+. .+..||+|+++... ....+.+.+|++++.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34467888999999999999999863 34679999997543 333457889999999997 99999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhCC---------------------------------------------------------
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHN--------------------------------------------------------- 518 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 518 (717)
+..++||||+++|+|.++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999997431
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 005040 519 ----------------------------------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTN 558 (717)
Q Consensus 519 ----------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~N 558 (717)
..+++..+..++.|++.||.||| +.+++||||||+|
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrdlkp~N 269 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA----SKNCVHRDLAARN 269 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCcCcccCCcce
Confidence 13567788899999999999999 6789999999999
Q ss_pred eeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCc
Q 005040 559 ILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGE 637 (717)
Q Consensus 559 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~ 637 (717)
|+++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986543222111223356788999999988889999999999999999998 888986532111
Q ss_pred chHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 638 MSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
.....+... .. ...+..++.++.+++.+||..+|++||+++|+++.|+++.
T Consensus 350 -~~~~~~~~~------------~~-----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 -QFYNAIKRG------------YR-----MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHHHHcC------------CC-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111100 00 0011134567889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.19 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=195.9
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.|+.++.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999865 78899999997543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++|+|.+++.+.+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH----~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999998654 4788899999999999999999 67899999999999999999999999999753211000
Q ss_pred ---------------------------------------------ceeeeccccCccccCCCccCCCCcCcccchhhHHH
Q 005040 584 ---------------------------------------------SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGV 618 (717)
Q Consensus 584 ---------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~ 618 (717)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011236899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC---H
Q 005040 619 LLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH---M 695 (717)
Q Consensus 619 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~ 695 (717)
++|||++|+.||......+. ...... .... . ..+.....+.++.+++.+|+ .+|++|++ +
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~--~~~~--------~-----~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET-QMKVIN--WQTS--------L-----HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH-HHHHHc--cCCC--------c-----CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 99999999999975322111 111000 0000 0 00111123455778888876 49999997 7
Q ss_pred HHHHH
Q 005040 696 TDAAA 700 (717)
Q Consensus 696 ~ev~~ 700 (717)
.|+++
T Consensus 300 ~ei~~ 304 (382)
T cd05625 300 DEIKA 304 (382)
T ss_pred HHHhc
Confidence 77664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.98 Aligned_cols=251 Identities=24% Similarity=0.265 Sum_probs=197.0
Q ss_pred cCCccccccccccEEEEEEEe----cCCCeEEEEEechhh----HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCee
Q 005040 428 EFNECNLLGTGGFGSVYKGTL----SDGTNVAIKIFNLQL----ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 498 (717)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|+++++.+ +||+|+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999875 268899999997543 22345678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH----KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999997654 3889999999999999999999 678999999999999999999999999999865
Q ss_pred CCCCCceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .......... .+
T Consensus 156 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~------~~ 227 (332)
T cd05614 156 LSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK------CD 227 (332)
T ss_pred cccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc------CC
Confidence 3322211 2234689999999988765 478999999999999999999999964322111 1111111000 00
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
+.+ +...+..+.+++.+||+.||++|| +++++++
T Consensus 228 ~~~---------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 PPF---------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCC---------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 000 112345678999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.87 Aligned_cols=244 Identities=24% Similarity=0.290 Sum_probs=194.0
Q ss_pred ccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 435 LGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 435 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
||+|+||+||++... +++.||+|.+.... ....+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 78999999987543 22335677899999999999999999999999999999999999999
Q ss_pred HHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 511 EKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 511 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......... .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~ 154 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH----QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--T 154 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--c
Confidence 988753 2345899999999999999999999 689999999999999999999999999999766433221 2
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ........... .. .
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~--------~~-------~ 218 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILN--------DS-------V 218 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcc--------cC-------C
Confidence 23468999999999999999999999999999999999999996532111 11111111000 00 0
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
..+..++..+.+++.+||+.||++|| +++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11123456688999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.96 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=208.6
Q ss_pred hccCCccccccccccEEEEEEEec--------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL 495 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 495 (717)
..+|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 468888999999999999999741 34579999886543 34456788999999999 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
...++||||+++|+|.+++.... ..+++.++..++.|+++||.||| +.+++||||||+||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nil 169 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA----SQKCIHRDLAARNVL 169 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH----HCCeeecccccceEE
Confidence 99999999999999999998532 34788899999999999999999 679999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 639 (717)
++.++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||...... .
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~ 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--H
Confidence 99999999999999987654332222223345678999999988889999999999999999998 78887643111 1
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
....+..... ......++.++.+++.+||+.+|++||++.|+++.|+++...-.
T Consensus 248 ~~~~~~~~~~-----------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 248 LFKLLKEGHR-----------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHHHHcCCc-----------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 1111111000 00112345678899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.32 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=202.6
Q ss_pred HhccCCccccccccccEEEEEEEecC------CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSD------GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF 497 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 497 (717)
.+++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+..|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35788999999999999999998753 5678999886443 3334568889999999999999999999988889
Q ss_pred eEEEEEccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEE
Q 005040 498 KALVLEFMPNGSLEKWLYSHN------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM---VAH 568 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~---~~k 568 (717)
.++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++ .+|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE----ENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchheEEEeccCCCcceE
Confidence 999999999999999997543 24889999999999999999999 67899999999999998654 699
Q ss_pred EeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhh
Q 005040 569 VSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKES 647 (717)
Q Consensus 569 l~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 647 (717)
|+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~ 237 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFVTGG 237 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC
Confidence 999999987643222211122234568999999998899999999999999999997 99998753221 111111110
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
. . ...+..++..+.+++.+|++.+|++||++.+|++.|.
T Consensus 238 ~--~---------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 G--R---------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred C--c---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0 0011234566889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=311.11 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=208.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|+..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 89999999886422 233567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
||+++|+|.+++.. ....+++..+..++.+++.|+.||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999864 2345789999999999999999999 6799999999999999999999999999987654
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
..... .....++..|+|||...+..++.++||||||+++|+|++|+.||.... ....+.......... +.
T Consensus 158 ~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~-----~~ 227 (267)
T cd08224 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCDY-----PP 227 (267)
T ss_pred CCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCCC-----CC
Confidence 32211 223457889999999988889999999999999999999999985422 122222111100000 00
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
.....++..+.+++.+||..+|++|||+.++++.|+++.
T Consensus 228 --------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 --------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001134556889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.13 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=213.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.+..+.++||-|.||.||.|.|+ -.-.||||.++... -..+.|.+|..+|+.++|||+|+++|+|..+...|+|+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 45567789999999999999997 45569999987553 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
..|+|.+|+++.. ..++......++.||+.|+.||. .+.++||||.++|.|+.++..||++|||+++++..+. .
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE----kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-Y 420 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-Y 420 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH----HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-e
Confidence 9999999999764 34667778899999999999999 6789999999999999999999999999999886543 2
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.......-++.|.|||-+....++.|+|||+|||+|||+.| |-.||.+... .+ .-++++..+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----Sq---------VY~LLEkgy--- 483 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQ---------VYGLLEKGY--- 483 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HH---------HHHHHhccc---
Confidence 23334445888999999999999999999999999999999 7788876321 11 112222222
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
.+..++.|++.+++||+.||+++|.+||++.|+-+.++.+.
T Consensus 484 --RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 --RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 23445689999999999999999999999999999998864
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=346.55 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=205.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999875 68999999987542 233467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 005040 503 EFMPNGSLEKWLYSH----------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDF 572 (717)
Q Consensus 503 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 572 (717)
||++||+|.+++... ....++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH----s~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH----HCCccccCCchheEEEcCCCCEEEEec
Confidence 999999999998642 123567788899999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCC----------------ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccC
Q 005040 573 GISKLLGEGED----------------SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG 636 (717)
Q Consensus 573 gl~~~~~~~~~----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~ 636 (717)
|++........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99986621110 00111246899999999999999999999999999999999999999652211
Q ss_pred cchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhHHh
Q 005040 637 EMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-HMTDAAAKLRKIKAK 708 (717)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ev~~~L~~~~~~ 708 (717)
..... ... .++ .......+++..+.+++.+|++.||++|| +++++++.|+...+.
T Consensus 238 ki~~~----~~i-------~~P------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KISYR----DVI-------LSP------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhh----hhc-------cCh------hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11000 000 000 00011123456688999999999999996 577788888876543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.96 Aligned_cols=240 Identities=24% Similarity=0.276 Sum_probs=190.5
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 68889999997653 22334456677777654 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH----KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 99999998654 4899999999999999999999 6889999999999999999999999999997643222 122
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~~---------~~-------- 214 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFDSILNDR---------PH-------- 214 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC---------CC--------
Confidence 3456899999999999889999999999999999999999999753211 1111111000 00
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMT-DAA 699 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ev~ 699 (717)
.+..++.++.+++.+||+.||++||++. +++
T Consensus 215 -~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 215 -FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0112345678999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.27 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=200.2
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999865 78999999987543 2223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 504 FMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 504 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|+++|+|.+++... ...+++..+..++.|++.|+.||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH----RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999988754 345899999999999999999999 6789999999999999999999999999998754322
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. .....|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ....... .......
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-~~~~~~~-~~~~~~~----------- 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEV-ERRVKED----------- 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-hhHHHHH-HHHhhhc-----------
Confidence 1 1234689999999999888999999999999999999999999975321 1111111 1100000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAAK 701 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~~ 701 (717)
.. .....++..+.+++.+||..||++|| ++.++++.
T Consensus 221 -~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 -QE--EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cc--ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00 01113455688999999999999999 78887553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.07 Aligned_cols=247 Identities=19% Similarity=0.260 Sum_probs=194.4
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..+++.+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999875 78899999998653 23345678899999998 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TT 153 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cc
Confidence 99999887654 4899999999999999999999 68999999999999999999999999999875322111 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccC---cchHHHHHHhhCCCchhhhccccchhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG---EMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
....||+.|+|||++.+..++.++||||+||++|||++|+.||+..... ......+...... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~---- 222 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-------EKQI---- 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-------cCCC----
Confidence 3346899999999999999999999999999999999999999642111 1111122111110 0000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIH------MTDAAA 700 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt------~~ev~~ 700 (717)
. .+..++.++.+++.+|++.||++||+ +.++++
T Consensus 223 -~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 -R--IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -C--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 0 01123456789999999999999998 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.06 Aligned_cols=241 Identities=23% Similarity=0.243 Sum_probs=193.4
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 68899999997653 23345677889999876 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH----RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TT 153 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cc
Confidence 99999987654 4889999999999999999999 67899999999999999999999999999875432221 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.. .. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~i~~---~~--------~------- 213 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFESILH---DD--------V------- 213 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHHHHc---CC--------C-------
Confidence 3446899999999999889999999999999999999999999753211 11111110 00 0
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRI-------HMTDAAA 700 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rp-------t~~ev~~ 700 (717)
..+..++.++.+++.+|++.||++|| +++++++
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 00012345678999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.52 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=195.4
Q ss_pred ccCCccccccccccEEEEEEEec--CCCeEEEEEechhh--HHHHHHHHHHHHHHHhc---CCCceeeEeeeee-----c
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS--DGTNVAIKIFNLQL--ERAFRSFDSECEILRNV---RHRNLLKILGSCS-----N 494 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~hpniv~~~~~~~-----~ 494 (717)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37889999999999999999863 46889999886543 22223456677777766 6999999999874 3
Q ss_pred CCeeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 005040 495 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573 (717)
Q Consensus 495 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 573 (717)
....++||||+. ++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999996 6999999754 344899999999999999999999 6889999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC---CC
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL---PH 650 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~ 650 (717)
++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.... ..+........ +.
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 231 (290)
T ss_pred ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChh
Confidence 998664321 223446899999999998889999999999999999999999999763221 11111111110 00
Q ss_pred chhh-------hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 651 RLTE-------VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 651 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+.. .+...-....... ..+.+..+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKF--VTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHH--ccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000000000000 1134566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=313.38 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=194.7
Q ss_pred ccccccEEEEEEEec-CCCeEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 435 LGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 435 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
||+|+||.||+++.+ +|+.||+|.+..... .....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 799999999865431 1234456799999999999999999999999999999999999999
Q ss_pred HHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeec
Q 005040 511 EKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589 (717)
Q Consensus 511 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 589 (717)
.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH----SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 9888653 335889999999999999999999 6899999999999999999999999999988764322 1233
Q ss_pred cccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhh
Q 005040 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSD 669 (717)
Q Consensus 590 ~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (717)
..|+..|+|||++.+..++.++||||+||++|||++|+.||...... ............. .... .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~--------~~~~------~ 218 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLED--------EVKF------E 218 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhcc--------cccc------c
Confidence 46899999999998888999999999999999999999998653221 1111111111100 0000 0
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 670 KMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 670 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
...++.++.+++.+||+.||++||+++|+++...
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 0124556889999999999999999987764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=323.48 Aligned_cols=241 Identities=23% Similarity=0.268 Sum_probs=193.8
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCC-ceeeEeeeeecCCeeEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHR-NLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hp-niv~~~~~~~~~~~~~lv~ 502 (717)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|.++++.+.|+ +|+.+++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788899999999999999875 67889999997653 23446678899999999765 6888999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999997654 3789999999999999999999 6799999999999999999999999999987532211
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+... . .
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~---~------~---- 218 (324)
T cd05587 156 K--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIMEH---N------V---- 218 (324)
T ss_pred C--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC---C------C----
Confidence 1 123446899999999999999999999999999999999999999753211 111111110 0 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
..+...+.++.+++.+|+..||++|+++
T Consensus 219 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0011234567899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=334.86 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=197.7
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999965 68999999987543 233456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999998754 4788889999999999999999 6899999999999999999999999999975321000
Q ss_pred C-----------------------------------------ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHH
Q 005040 583 D-----------------------------------------SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLM 621 (717)
Q Consensus 583 ~-----------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~ 621 (717)
. ........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 00011246899999999999999999999999999999
Q ss_pred HHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC---CHHHH
Q 005040 622 ETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI---HMTDA 698 (717)
Q Consensus 622 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp---t~~ev 698 (717)
||++|+.||......+. ...+. ..... . ..+....++.++.+++.+|+ .+|.+|+ ++.|+
T Consensus 236 ell~G~~Pf~~~~~~~~--~~~i~-~~~~~--------~-----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 236 EMLVGQPPFLADTPAET--QLKVI-NWETT--------L-----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred ehhhCCCCCCCCCHHHH--HHHHh-ccCcc--------c-----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999976322111 00000 00000 0 00111123455778888876 4999999 88888
Q ss_pred HHH
Q 005040 699 AAK 701 (717)
Q Consensus 699 ~~~ 701 (717)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=316.69 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=206.0
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~ 497 (717)
.++|...+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 467999999999999999999741 35579999887543 33446788999999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
.++||||+.+|+|.++++... ..+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.++++|||++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999998543 34899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (717)
...............++..|+|||.+.+..++.++||||+||++|||++ |..||....... ............
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~----- 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGYRM----- 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCCcC-----
Confidence 6644332222223345778999999998899999999999999999998 999986532211 111111111000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
......+.++.+++.+|+..+|++|||+.|+++.|++.
T Consensus 264 ------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 ------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00012235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.62 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=203.3
Q ss_pred ccCCccccccccccEEEEEEEec------CCCeEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
.+|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45777889999999999999863 257899999975442 33466889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC
Q 005040 500 LVLEFMPNGSLEKWLYSH---------------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN 564 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~ 564 (717)
+++||+.+++|.+++... ...+++..+..++.|++.||.|+| +.+|+||||||+||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH----~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS----SHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HcCccccccchhheEecCC
Confidence 999999999999998632 134788889999999999999999 6789999999999999999
Q ss_pred CcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHH
Q 005040 565 MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRW 643 (717)
Q Consensus 565 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~ 643 (717)
+.+||+|||+++...............+++.|+|||.+.++.++.++||||+|+++|||++ |..||.+.... .....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~ 238 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEM 238 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 9999999999886643332222233346788999999988889999999999999999998 88887653211 11111
Q ss_pred HHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 644 VKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
+... .. .+.+.+++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 239 i~~~---~~--------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNR---QV--------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcC---Cc--------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1110 00 01112456678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=315.75 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=209.8
Q ss_pred HhccCCccccccccccEEEEEEEecC-----CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeec-CCe
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSD-----GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSN-LDF 497 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~ 497 (717)
..++|+..+.||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35688899999999999999999765 6889999886443 3345678889999999999999999998765 567
Q ss_pred eEEEEEccCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 005040 498 KALVLEFMPNGSLEKWLYSHN-------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 570 (717)
.++++||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH----KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCHhhEEEcCCCcEEEC
Confidence 899999999999999997532 45889999999999999999999 6789999999999999999999999
Q ss_pred eeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCC
Q 005040 571 DFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLP 649 (717)
Q Consensus 571 Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 649 (717)
|||+++.+.............++..|+|||+..+..++.++||||||+++||+++ |+.||..... ..+..+......
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~ 237 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYR 237 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCC
Confidence 9999987644332222233346778999999988889999999999999999999 9999865321 222222221110
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
......++.++.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 238 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 -----------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 001112345688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.72 Aligned_cols=237 Identities=24% Similarity=0.280 Sum_probs=191.0
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999975 68899999997643 23445677888888877 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH----~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TT 153 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cc
Confidence 99999988654 4889999999999999999999 68899999999999999999999999999875422211 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+. ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~---~~~~--------------- 213 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAIL---NDEV--------------- 213 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHh---cCCC---------------
Confidence 3346899999999999999999999999999999999999999753211 1111111 0000
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMT 696 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ 696 (717)
..+...+.++.+++.+|++.||++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 00112345678999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.31 Aligned_cols=242 Identities=19% Similarity=0.256 Sum_probs=191.0
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|..+ +++.||+|+++... ......+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 68899999997653 23345677889988877 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TT 153 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cc
Confidence 99999887654 4899999999999999999999 67899999999999999999999999999875322111 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccC---cchHHHHHHhhCCCchhhhccccchhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG---EMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+....... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-------~~~---- 222 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------KQI---- 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-------CCC----
Confidence 3346899999999999999999999999999999999999999642111 11111111111100 000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
..+..++.++.+++.+||+.||++||++
T Consensus 223 ---~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 ---RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0111334567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=306.18 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=211.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
+-|+++.+||+|.||.||+|.++ .|+.+|+|.+... ...+.+.+|+.++++++.|++|++||.|.....+.+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 45677889999999999999976 7999999987654 34578889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
..|+..+.++..++.+++..+..+.+..++||+|||. ..-+|||||+.|||++.+|++||+|||.+..+.. .-.
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~----~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD----LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH----HHHHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 9999999999888889999999999999999999994 5679999999999999999999999999976632 222
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
......||+.|||||++..-.|..++||||+|++..||..|++||.+..+-. .++ .--....+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIF-MIPT~PPP 247 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIF-MIPTKPPP 247 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeE-eccCCCCC
Confidence 3455679999999999999999999999999999999999999997643211 000 00011223
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.+..++..+.++.++++.|+-+.|++|-|+.++++.
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 444555667889999999999999999999988764
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=312.70 Aligned_cols=256 Identities=27% Similarity=0.482 Sum_probs=206.1
Q ss_pred ccCCccccccccccEEEEEEEec-CC---CeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DG---TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.+|++.+.||+|+||.||+|... ++ ..||+|++.... ......+..|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788899999999999999865 33 369999987542 34456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++|+|.+++......+++.++..++.|++.|++||| +.+++|+||||+||+++.++.++++|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH----~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999876666899999999999999999999 678999999999999999999999999998766433
Q ss_pred CCceeeeccc---cCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 582 EDSVIQTMTM---ATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 582 ~~~~~~~~~~---~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
.......... .+..|+|||+..+..++.++||||||+++||+++ |..||..... .....++....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~~-------- 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDYR-------- 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCCc--------
Confidence 2211111111 2457999999999999999999999999999987 9999865322 122222221110
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
.+...+++..+.+++.+||+.+|++||++.+++..|+++
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ---------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011124456688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.86 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=212.7
Q ss_pred cCCccccccccccEEEEEEEec--CCC--eEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS--DGT--NVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
+....++||+|.||.|++|.|+ +|+ .||||.++.... ....+|.+|+.+|.+|+|||++++||.+.+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3445678999999999999985 344 489999987653 367899999999999999999999999987 5678999
Q ss_pred EccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 503 EFMPNGSLEKWLYS-HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 503 e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|.++.|+|.+.+++ ....+.......++.|||.|+.||. ++++|||||.++|+++-..-.|||+|||+.+-++..
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe----skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE----SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999997 4556788889999999999999999 789999999999999999999999999999999876
Q ss_pred CCcee-eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 582 EDSVI-QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 582 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
+..+. ......+..|.|||.+....++.++|||+|||++|||+| |..||-+.... + +-+.+|.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--q------------IL~~iD~- 330 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--Q------------ILKNIDA- 330 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--H------------HHHhccc-
Confidence 65543 233345788999999999999999999999999999999 77888663211 1 1122221
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
....+.+..|++++++++..||...|++|||+.++.+.+-..+++
T Consensus 331 ----~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaq 375 (1039)
T KOG0199|consen 331 ----GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ 375 (1039)
T ss_pred ----cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence 122345568999999999999999999999999998766554443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.07 Aligned_cols=339 Identities=22% Similarity=0.238 Sum_probs=269.2
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
++.||.......+|+.|+|.+|.|+.+..++++.++.|+.||||.|.|+.++... |..-.++++|+|++|.|
T Consensus 114 Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~s--------fp~~~ni~~L~La~N~I 185 (873)
T KOG4194|consen 114 LTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPS--------FPAKVNIKKLNLASNRI 185 (873)
T ss_pred hhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCC--------CCCCCCceEEeeccccc
Confidence 3567877777777888888888888877888888888888888888888877544 66777888888888888
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD 160 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 160 (717)
+......|..+. +|.+|.|+.|+++...+..|.+|++|+.|+|..|+|.-.---+|.+|++|+.|.|..|.|.....+.
T Consensus 186 t~l~~~~F~~ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~ 264 (873)
T KOG4194|consen 186 TTLETGHFDSLN-SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGA 264 (873)
T ss_pred cccccccccccc-hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcc
Confidence 887778888774 7888888888888777777888888888888888887444567788888888888888888777788
Q ss_pred ccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCC
Q 005040 161 LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240 (717)
Q Consensus 161 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 240 (717)
|..|.++++|+|+.|++...-.+++-++++|+.|+||+|.|..+.++.+...++|+.|+|++|+|+...+..|..+..|+
T Consensus 265 Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le 344 (873)
T KOG4194|consen 265 FYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLE 344 (873)
T ss_pred eeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhh
Confidence 88888888888888888877777888888888888888888887888888888888888888888877788888888888
Q ss_pred eEEccCCCCCCCCcccccCCcccccccccCccccCCCC---ccccccCccceEeccCCCCCCCCcccccccccccEEEcc
Q 005040 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP---ESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVS 317 (717)
Q Consensus 241 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~ 317 (717)
+|+|++|.|+.+--..|..+++|++|||+.|.++..+. ..|.++++|+.|.|.+|++..+.-..|.++++|+.|||.
T Consensus 345 ~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~ 424 (873)
T KOG4194|consen 345 ELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLG 424 (873)
T ss_pred hhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCC
Confidence 88888888887666778888888888888888875443 356778889999999999986666788999999999999
Q ss_pred CCccccccccc-ccccccccccccCCccccCCC
Q 005040 318 HNRLEGEIPVK-GSFKDFSAQSYFGNYALCGPP 349 (717)
Q Consensus 318 ~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~ 349 (717)
+|.+...-|.. ... .++.+.+.....+|+..
T Consensus 425 ~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 425 DNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQ 456 (873)
T ss_pred CCcceeecccccccc-hhhhhhhcccceEEecc
Confidence 99887654432 222 45555566666677643
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=316.86 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=205.4
Q ss_pred hccCCccccccccccEEEEEEEecC-----------------CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSD-----------------GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLK 487 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~ 487 (717)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4688999999999999999988642 2458999987553 344567889999999999999999
Q ss_pred EeeeeecCCeeEEEEEccCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCC
Q 005040 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHN----------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPT 557 (717)
Q Consensus 488 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~ 557 (717)
+++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH----~~~i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE----SLNFVHRDLATR 159 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH----HcCccccccchh
Confidence 9999999999999999999999999997643 25899999999999999999999 678999999999
Q ss_pred CeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh--CCCCCCcccc
Q 005040 558 NILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT--EKKPTDEMFT 635 (717)
Q Consensus 558 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t--g~~p~~~~~~ 635 (717)
||+++.++.++|+|||++................++..|+|||+..+..++.++||||||+++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999986544332222334456788999999888889999999999999999998 6677754321
Q ss_pred CcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 636 GEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
....+......... +... .......++.++.+++.+|++.||++|||+.|+++.|+
T Consensus 240 --~~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDD-----GRQI-----YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccc-----cccc-----cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111110000 0000 00111234467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=313.66 Aligned_cols=254 Identities=28% Similarity=0.491 Sum_probs=197.7
Q ss_pred CCccccccccccEEEEEEEecC-CC--eEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC------Ce
Q 005040 429 FNECNLLGTGGFGSVYKGTLSD-GT--NVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL------DF 497 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~~ 497 (717)
|.+.+.||+|+||.||+|.+.+ ++ .||+|.++... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466889999999999999753 33 58999886542 34457788999999999999999999976432 24
Q ss_pred eEEEEEccCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 005040 498 KALVLEFMPNGSLEKWLYS-----HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDF 572 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 572 (717)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS----SKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhheEEcCCCCEEECCC
Confidence 6899999999999998852 2344789999999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCc
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHR 651 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 651 (717)
|++................+++.|+|||+..+..++.++||||||+++|||++ |+.||...... .....+.... .
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~--~ 232 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQGN--R 232 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCC--C
Confidence 99987644332222223345778999999999999999999999999999999 78888653221 1111111100 0
Q ss_pred hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 652 LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
......++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 233 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 ---------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001113445688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.40 Aligned_cols=254 Identities=28% Similarity=0.482 Sum_probs=200.9
Q ss_pred CCccccccccccEEEEEEEec-C---CCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe-----
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-D---GTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF----- 497 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~----- 497 (717)
|.+.+.||+|+||.||+|... + +..||+|+++... ......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999864 2 3679999987542 3345678899999999999999999998865443
Q ss_pred -eEEEEEccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 005040 498 -KALVLEFMPNGSLEKWLYSH-----NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSD 571 (717)
Q Consensus 498 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 571 (717)
.++|+||+++|+|..++... ...+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS----NRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchheEEECCCCeEEECC
Confidence 78999999999999998532 235899999999999999999999 67899999999999999999999999
Q ss_pred eccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCC
Q 005040 572 FGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 572 fgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||.+.... ...++.......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~ 234 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNRL 234 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC
Confidence 999987644332222222335678999999988899999999999999999999 88888653221 111221111000
Q ss_pred chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 651 RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
.....++.++.+++.+||+.||.+||++.|+++.|+++
T Consensus 235 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 -----------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.46 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=203.8
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||+|++|.||+|..+ +++.|++|.+.... ......+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999875 78999999886542 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++++|.++++.. ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999864 456899999999999999999999 67899999999999999999999999999887654322
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
. .....+++.|+|||+..+..++.++|+||||+++|||++|+.||..... ......+......
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~------------- 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKIIRGVFP------------- 219 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCC-------------
Confidence 1 2234578899999999998999999999999999999999999975321 1111111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.. ...++.++.+++.+||+.+|++||++.++++.
T Consensus 220 --~~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 --PV--SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CC--ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 11344668899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=313.15 Aligned_cols=257 Identities=26% Similarity=0.499 Sum_probs=206.3
Q ss_pred hccCCccccccccccEEEEEEEec-CC---CeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DG---TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
..+|+..+.||+|+||.||+|..+ ++ ..+|+|.+.... ....+.+..|++++++++|||++++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999875 33 369999886543 3345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS----DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999876666899999999999999999999 67899999999999999999999999999986643
Q ss_pred CCCcee-eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 581 GEDSVI-QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 581 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
...... ......+..|+|||+..+..++.++||||||+++|||++ |+.||..... ......+....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~~~---------- 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGF---------- 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhcCC----------
Confidence 222111 111223567999999988889999999999999999998 9999865321 11111111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
..+...+++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.54 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=199.7
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3478999999999999999999976 68899999987532 2234557789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH----~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999997653 788999999999999999999 68999999999999999999999999999987643
Q ss_pred CCCceeeeccccCccccCCCccCCC----CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEG----IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ............ .
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~~~~~~i~~~~~--~----- 265 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-VGTYSKIMDHKN--S----- 265 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCc--c-----
Confidence 221 122345699999999987653 378999999999999999999999975321 111111111000 0
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHK--RIHMTDAAAK 701 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ev~~~ 701 (717)
+ ..+.....+..+.+++..|+..+|.+ |+++.|+++.
T Consensus 266 ---~-----~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 ---L-----NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---c-----CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 01112234556788999999855543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=314.07 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=201.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..+|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357999999999999999999964 7889999998765444556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.++++... .+++..+..++.|++.|+.||| +.+|+|||++|+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH----SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999999987654 4799999999999999999999 67899999999999999999999999999986643211
Q ss_pred eeeeccccCccccCCCccC---CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 585 VIQTMTMATIGYMAPEYGS---EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
......++..|+|||.+. ...++.++||||||+++|||++|+.||......+. ...+..... ..+..
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~-------~~~~~- 231 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNF-------QPPKL- 231 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCC-------CCCCC-
Confidence 112345788999999764 45578899999999999999999999854321110 000000000 00000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
......+..+.+++.+||+.+|++||+++++++.+
T Consensus 232 ------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 ------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01112345688999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.76 Aligned_cols=259 Identities=22% Similarity=0.394 Sum_probs=203.1
Q ss_pred HhccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF 497 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 497 (717)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 24579999876443 2233467889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 005040 498 KALVLEFMPNGSLEKWLYSHN---------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAH 568 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~k 568 (717)
.++||||+++|+|.++++... ...++..+..++.|++.||.||| +++|+||||||+||+++.++.++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN----AKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999997521 23467788899999999999999 68999999999999999999999
Q ss_pred EeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhh
Q 005040 569 VSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKES 647 (717)
Q Consensus 569 l~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 647 (717)
|+|||+++...............++..|+|||...++.++.++|||||||++|||++ |..||...... ...+.+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~-- 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFVM-- 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH--
Confidence 999999886543322222222345678999999998899999999999999999998 78888652211 1111111
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
. .... .....++..+.+++.+|++.||++|||+.++++.|++..
T Consensus 236 -~--------~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 -D--------GGYL------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -c--------CCCC------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 0000 001123456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=316.49 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=201.6
Q ss_pred hccCCccccccccccEEEEEEEecC---------------CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSD---------------GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKIL 489 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~ 489 (717)
..+|++.+.||+|+||.||++...+ ...||+|.+.... ......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3588999999999999999987532 2348999987543 33446788999999999999999999
Q ss_pred eeeecCCeeEEEEEccCCCCHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 005040 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHN-----------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTN 558 (717)
Q Consensus 490 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~N 558 (717)
+++......++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+|
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~N 159 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA----SLNFVHRDLATRN 159 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH----hcCeeccccChhh
Confidence 99999999999999999999999997532 23688899999999999999999 6789999999999
Q ss_pred eeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh--CCCCCCccccC
Q 005040 559 ILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT--EKKPTDEMFTG 636 (717)
Q Consensus 559 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t--g~~p~~~~~~~ 636 (717)
|++++++.+||+|||++................++..|+|||+..++.++.++||||||+++|||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999976543322222233345778999999888889999999999999999998 55676542211
Q ss_pred cchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 637 EMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
................... .....++..+.+++.+|++.+|++||++.++++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 --QVIENTGEFFRNQGRQIYL----------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHHhhhhccccccC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111110000000000 0011234568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=311.11 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=203.5
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|++.++||+|+||.||+|...++..||+|++..... ..+.+.+|+++++.++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 357899999999999999999987777899999875322 23568889999999999999999998754 5579999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++|+|.+++... ...+++..+..++.|+++||+||| +.+++||||||+||++++++.++|+|||.+..+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999864 345789999999999999999999 678999999999999999999999999999876443321
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......++..|+|||+..+..++.++||||||+++|||++ |..||......+ .........
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~--------------- 220 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY--------------- 220 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHHHhcCC---------------
Confidence 1123346778999999988889999999999999999999 888886532211 000000000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
..+...+++..+.+++.+|++.+|++||+++++++.|+..
T Consensus 221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011124556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.60 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=205.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCC--eEEEEEechh-hHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGT--NVAIKIFNLQ-LERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv 501 (717)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.. .....+.+.+|+++++++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999875 333 4788887643 233456788999999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 005040 502 LEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV 566 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~ 566 (717)
+||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS----EKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCcCCcceEEECCCCe
Confidence 99999999999997532 24788999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 005040 567 AHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVK 645 (717)
Q Consensus 567 ~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~ 645 (717)
+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |+.||...... ....
T Consensus 158 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~~~ 229 (297)
T cd05089 158 SKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----ELYE 229 (297)
T ss_pred EEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence 999999998643211 11111223567999999988889999999999999999998 99998653221 1111
Q ss_pred hhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccch
Q 005040 646 ESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 713 (717)
.. ... .. ...+..++.++.+++.+|++.+|.+||++.++++.|+.+.+.+...+
T Consensus 230 ~~-~~~--------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 230 KL-PQG--------YR-----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred HH-hcC--------CC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 10 000 00 00112345668899999999999999999999999999987665544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=321.96 Aligned_cols=241 Identities=22% Similarity=0.251 Sum_probs=194.1
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 502 (717)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++..+ +||+|+.+++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999876 67899999997653 22334567788888877 5899999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999987654 3889999999999999999999 6789999999999999999999999999987543221
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... . .
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~~---~--------~-- 218 (323)
T cd05616 156 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEH---N--------V-- 218 (323)
T ss_pred C--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHHHHhC---C--------C--
Confidence 1 12345689999999999999999999999999999999999999975321 1111111110 0 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
..+...+.++.+++.+|++.||++|+++
T Consensus 219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0011234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=321.40 Aligned_cols=241 Identities=23% Similarity=0.259 Sum_probs=194.2
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|..+ +++.||+|+++... ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 68899999998653 23345677899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH----ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TT 153 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cc
Confidence 99999988654 4899999999999999999999 68999999999999999999999999999875322211 11
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.. .. .
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~~---~~--------~------- 213 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSILE---DE--------V------- 213 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHc---CC--------C-------
Confidence 234689999999999999999999999999999999999999965321 111111110 00 0
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHM-----TDAAA 700 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ev~~ 700 (717)
..+..++.++.+++.+||+.||.+||++ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0011234568899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=319.55 Aligned_cols=240 Identities=24% Similarity=0.304 Sum_probs=191.6
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 67899999998653 23345566788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH----SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KT 153 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ce
Confidence 99999998653 4789999999999999999999 68999999999999999999999999999875322211 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.... +.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~~---------~~~------- 215 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMDN---------PCY------- 215 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC---------CCC-------
Confidence 334689999999999998999999999999999999999999975321 11111111100 000
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMT-DAA 699 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ev~ 699 (717)
+ ..++.++.+++.+||+.||++||++. ++.
T Consensus 216 ~--~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 P--RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred C--ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0 12345578999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.34 Aligned_cols=269 Identities=25% Similarity=0.406 Sum_probs=204.3
Q ss_pred cCCccccccccccEEEEEEEe-----cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--CeeE
Q 005040 428 EFNECNLLGTGGFGSVYKGTL-----SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFKA 499 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~ 499 (717)
-|++.+.||+|+||.||+++. .++..||+|.++... ......+.+|+++++.++|||++++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999974 257889999987543 33456788999999999999999999998765 5679
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+++++|.+++.+....+++..+..++.|++.||+||| +++++||||||+||+++.++.++|+|||+++.+.
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 999999999999999876556899999999999999999999 6899999999999999999999999999998765
Q ss_pred CCCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC-chhhhcc
Q 005040 580 EGEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH-RLTEVVD 657 (717)
Q Consensus 580 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 657 (717)
...... ......++..|+|||+..+..++.++||||||+++|||++++.|+...... ..........+ .....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcccccccccHHHHHH
Confidence 433211 112334677899999988888999999999999999999988765321110 00000000000 0000000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
. + ......+....++.++.+++.+|++.+|++||+++++++.++++
T Consensus 238 ~-~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 V-L-EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred H-H-HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 0 00000111224567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=311.92 Aligned_cols=256 Identities=28% Similarity=0.481 Sum_probs=206.3
Q ss_pred ccCCccccccccccEEEEEEEec----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
++|++.+.||+|+||.||+|... .+..+|+|.++... ....+.+..|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999863 23479999886543 33456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999877666899999999999999999999 678999999999999999999999999999876543
Q ss_pred CCcee-eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 582 EDSVI-QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 582 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
..... .....++..|+|||+..+..++.++|+||||+++||+++ |+.||...... .....+.....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~---------- 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYR---------- 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCc----------
Confidence 22111 111223567999999998899999999999999999887 99998653221 11222111100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
.+....++..+.+++.+|++.+|.+||++.++++.|.++
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011123455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=308.95 Aligned_cols=248 Identities=25% Similarity=0.454 Sum_probs=197.1
Q ss_pred cccccccEEEEEEEec---CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCC
Q 005040 434 LLGTGGFGSVYKGTLS---DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGS 509 (717)
Q Consensus 434 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 509 (717)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 45579999987553 3334668899999999999999999998864 56799999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce-eee
Q 005040 510 LEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV-IQT 588 (717)
Q Consensus 510 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~ 588 (717)
|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE----GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999876667899999999999999999999 6789999999999999999999999999998654332211 112
Q ss_pred ccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 589 MTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 589 ~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
...++..|+|||+..+..++.++||||||+++||+++ |+.||...... .....+....+ .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~-----------------~ 217 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGKR-----------------L 217 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCC-----------------C
Confidence 2233578999999888889999999999999999996 99998764221 11111111100 0
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
..+..++.++.+++.+||..+|++||++.++.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 01123456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=319.68 Aligned_cols=240 Identities=22% Similarity=0.284 Sum_probs=191.6
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|+.+ +|+.||+|+++... ....+....|..++... +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 78899999997653 22345566788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+|||+++...... ...
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH----SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRA 153 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cce
Confidence 99999987653 4889999999999999999999 6899999999999999999999999999987532211 122
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.... +.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~---------~~~------- 215 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDT---------PHY------- 215 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC---------CCC-------
Confidence 345689999999999999999999999999999999999999965321 11111111100 000
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMT-DAA 699 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ev~ 699 (717)
+ ..++.++.+++.+||+.||++||++. ++.
T Consensus 216 ~--~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 P--RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C--CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 11345678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.17 Aligned_cols=238 Identities=26% Similarity=0.290 Sum_probs=192.3
Q ss_pred ccccccccEEEEEEEe----cCCCeEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 433 NLLGTGGFGSVYKGTL----SDGTNVAIKIFNLQLE--RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3688999999976542 233456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+|+|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~ 154 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K 154 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--c
Confidence 999999997654 4899999999999999999999 67899999999999999999999999999876543221 1
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (717)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+. ... .
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~i~---~~~--------~------ 215 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMTMIL---KAK--------L------ 215 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHHHHH---cCC--------C------
Confidence 23456899999999998888999999999999999999999999753211 1111110 000 0
Q ss_pred hhhhHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 005040 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMTD 697 (717)
Q Consensus 667 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e 697 (717)
..+..++.++.+++.+||+.||++||++.+
T Consensus 216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 001123456789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=318.46 Aligned_cols=265 Identities=19% Similarity=0.286 Sum_probs=200.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|...+.||+|+||.||+|..+ +++.||+|.++... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57889999999999999999875 78889999987543 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++ +|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 974 899998877666899999999999999999999 68999999999999999999999999999876433221
Q ss_pred eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC----chhhhc---
Q 005040 585 VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH----RLTEVV--- 656 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~--- 656 (717)
......+++.|+|||++.+ ..++.++||||+|+++|||+||+.||......+ ....... .... .+....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFR-LLGTPTEETWPGISSND 236 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-HhCCCCHHHHhhhcchh
Confidence 1223457899999998754 568999999999999999999999997532211 1111111 0000 000000
Q ss_pred ---cccchhh--hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 657 ---DANLVRE--EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 657 ---~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+...... ..........+.++.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 0000111234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=315.40 Aligned_cols=250 Identities=23% Similarity=0.300 Sum_probs=203.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.+|+..+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++|||++++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 58888999999999999999864 78999999987655445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++++|.+++.+. .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH----~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 999999998754 3789999999999999999999 67899999999999999999999999999876543221
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
......+++.|+|||...+..++.++|||||||++|||++|+.||...... ..+.... .... +.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~~~~-~~~~-----~~------ 235 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIA-TNGT-----PE------ 235 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHHHHh-cCCC-----CC------
Confidence 122346888999999998888999999999999999999999999653221 1111110 0000 00
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.......+..+.+++.+||..+|++||++.|+++.
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00111334567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=313.15 Aligned_cols=259 Identities=25% Similarity=0.443 Sum_probs=208.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCC----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGT----NVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
..+|+..+.||+|+||.||+|..+ +|+ .||+|.+.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 367888999999999999999864 333 58999886554 3345678899999999999999999999887 7789
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+++|+|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE----EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999999987666999999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
............++..|+|||......++.++|+||||+++||+++ |+.||..... ......+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~---------- 228 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKGE---------- 228 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCCC----------
Confidence 4332222222334678999999888899999999999999999999 9999875321 11122111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
..+.+..++.++.+++.+||..+|.+||++.++++.|+++.+.
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 -------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0011112345678999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.63 Aligned_cols=253 Identities=27% Similarity=0.463 Sum_probs=203.3
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|||++++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 457889999999999999999988888899999875432 23568899999999999999999998854 5579999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++++|.+++... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE----RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999864 345899999999999999999999 678999999999999999999999999999876433211
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......++..|+|||+..+..++.++||||||+++|||++ |..||...... ...+......+
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~-------------- 221 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGYR-------------- 221 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC--------------
Confidence 1122235678999999888889999999999999999999 88898653211 11111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
.+.+.+++..+.+++.+|+..+|++|||+.++.+.|++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 ---MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112345668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.71 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=202.2
Q ss_pred hccCCccccccccccEEEEEEEe------cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC-C
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL-D 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~-~ 496 (717)
.++|++.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36899999999999999999973 357889999987543 33446788899999999 689999999987654 4
Q ss_pred eeEEEEEccCCCCHHHHHhhCC----------------------------------------------------------
Q 005040 497 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 518 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 518 (717)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999987421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeecc
Q 005040 519 --------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590 (717)
Q Consensus 519 --------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 590 (717)
..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 23678888999999999999999 689999999999999999999999999999865332222222223
Q ss_pred ccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhh
Q 005040 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSD 669 (717)
Q Consensus 591 ~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (717)
.++..|+|||...+..++.++||||||+++|||++ |..||....... .....+...... ..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~-----------------~~ 303 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRM-----------------RA 303 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCCC-----------------CC
Confidence 45678999999988899999999999999999997 899986532211 111111100000 00
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 670 KMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 670 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
+...+.++.+++.+||+.+|++|||+.|+++.|+.+.+
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 01123457899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=307.66 Aligned_cols=247 Identities=33% Similarity=0.498 Sum_probs=199.3
Q ss_pred ccccccccEEEEEEEecCCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCHH
Q 005040 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLE 511 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~ 511 (717)
+.||+|+||.||+|..++++.+|+|.+.... ......+.+|+++++.++||||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998889999999886543 333456888999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccc
Q 005040 512 KWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM 591 (717)
Q Consensus 512 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~ 591 (717)
+++......+++..+..++.|++.||.|+| +.+++||||||+||+++.++.+|++|||++......... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~ 155 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQ 155 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCC
Confidence 999876666899999999999999999999 678999999999999999999999999998754322111 111223
Q ss_pred cCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhh
Q 005040 592 ATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDK 670 (717)
Q Consensus 592 ~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
++..|+|||+..++.++.++||||||+++||+++ |..||...... .....+.... . . ...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~--~------~---------~~~ 216 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGY--R------M---------SCP 216 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCC--C------C---------CCC
Confidence 4677999999988899999999999999999998 99998653221 1111111100 0 0 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 671 MDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
..++.++.+++.+|++.+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 123466889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.58 Aligned_cols=251 Identities=24% Similarity=0.292 Sum_probs=210.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH---HHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---RAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 500 (717)
...|+..+.||+|.||.||+++.+ +|+.+|+|++.+... .....+.+|+++|+++. |||||.+.+.|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467888899999999999999976 599999999977653 24468899999999998 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC----CcEEEeeecccc
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN----MVAHVSDFGISK 576 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~ 576 (717)
|||++.||.|.+.+... . +++..+..++.|++.+++||| +.+|+|||+||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH----~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH----SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH----hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999877 3 899999999999999999999 7899999999999999643 579999999999
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+....+.. .. +.
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-~~------------i~ 251 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-LA------------IL 251 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-HH------------HH
Confidence 8865 22345678999999999999999999999999999999999999999764322111 11 11
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
...+. -........+..+.+++..|+..||.+|+|+.++++.
T Consensus 252 ~~~~~---f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 RGDFD---FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCCCC---CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11110 0112233456778999999999999999999999984
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=312.31 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=204.4
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 468889999999999999999864 23679999986543 23445788899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 005040 499 ALVLEFMPNGSLEKWLYSHN---------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV 569 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl 569 (717)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA----AKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccChheEEEcCCCCEEE
Confidence 99999999999999997432 23678899999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhC
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 648 (717)
+|||+++...............++..|+|||...++.++.++||||||+++||+++ |..||..... ....++.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~ 238 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVIDGG 238 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHhcCC
Confidence 99999886644332222233446788999999988889999999999999999998 8999865321 11222221100
Q ss_pred CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 649 PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
. . ..+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 239 ~-----------~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 H-----------L------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred C-----------C------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 0 001123566889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=309.92 Aligned_cols=248 Identities=26% Similarity=0.412 Sum_probs=200.3
Q ss_pred ccccccccEEEEEEEecC--C--CeEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLSD--G--TNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998642 3 3689999976654 566789999999999999999999999988 888999999999
Q ss_pred CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce-
Q 005040 508 GSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV- 585 (717)
Q Consensus 508 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 585 (717)
++|.+++.+.. ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++..+.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE----SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH----hCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999998765 56899999999999999999999 6899999999999999999999999999998775432221
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......++..|+|||+..+..++.++||||||+++|||++ |+.||...... ...+..... ...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~-~~~------------- 219 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKE-GER------------- 219 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhc-CCc-------------
Confidence 1123356788999999998899999999999999999999 99998653221 111111110 000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
......++..+.+++.+|++.+|++||++.++++.|.
T Consensus 220 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 --LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011134466889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.21 Aligned_cols=248 Identities=33% Similarity=0.515 Sum_probs=200.7
Q ss_pred ccccccccEEEEEEEecCCCeEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCHH
Q 005040 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLE 511 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~ 511 (717)
++||+|+||.||+|...+++.||+|.+..... .....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999998875443 34567889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccc
Q 005040 512 KWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM 591 (717)
Q Consensus 512 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~ 591 (717)
+++......+++..+..++.+++.|+.||| +.+++||||+|+||+++.++.++|+|||++................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999876556889999999999999999999 6789999999999999999999999999998654222111112223
Q ss_pred cCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhh
Q 005040 592 ATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDK 670 (717)
Q Consensus 592 ~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
.+..|+|||...++.++.++|+||||+++|||++ |..||...... .....+.... ....+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~-----------------~~~~~ 217 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY-----------------RMPAP 217 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC-----------------CCCCC
Confidence 4667999999888899999999999999999999 88888653211 1111111100 00111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 671 MDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
..++.++.+++.+|+..+|.+||++.|+++.|.
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=314.60 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=204.8
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 357889999999999999999975 6899999998766555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++......+++..+..++.|++.|+.||| +.+|+|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999999876667999999999999999999999 67899999999999999999999999999876533221
Q ss_pred eeeeccccCccccCCCccC-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 585 VIQTMTMATIGYMAPEYGS-----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
......+++.|+|||++. ...++.++||||||+++|||++|+.||...... .....+.....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~----------- 225 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSEP----------- 225 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcCCC-----------
Confidence 123345789999999764 445788999999999999999999998753211 11111110000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+....+..++.++.+++.+||+.+|++||++.++++.
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -----PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0001112344568899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.36 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=201.2
Q ss_pred HHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 005040 421 DIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD 496 (717)
Q Consensus 421 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 496 (717)
+.+...++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34555689999999999999999999976 78899999986532 233455778999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..++||||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999997653 788889999999999999999 6899999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCC----CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCch
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEG----IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 652 (717)
....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .......... ..
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~--~~- 265 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHK--NS- 265 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC--Cc-
Confidence 7643221 122345689999999987653 3789999999999999999999999753211 0111110000 00
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHK--RIHMTDAAAK 701 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ev~~~ 701 (717)
..++....++..+.+++..|+...+.+ |+++.|+++.
T Consensus 266 ------------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 ------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ------------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 001112234566889999999844433 7788888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=329.36 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=216.0
Q ss_pred cCCccccccccccEEEEEEEe-cCCC----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTL-SDGT----NVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
+....++||+|+||+||+|.+ ..|+ +||+|++.... .+...++.+|+-+|.++.|||+++++|++.... +.+|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 344568999999999999986 3443 58999886543 445678999999999999999999999997665 7899
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
++|++.|+|.+|++.++..+-.+....|..|||+|+.||| .+++|||||.++|||+.+-.++||.|||+++.+...
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe----~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE----EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999999998888999999999999999999999 678999999999999999999999999999998776
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
+.........-++.|||-|.+....|+.++|||||||++||++| |..|+++....+ +.+.+
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------------I~dll---- 913 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------------IPDLL---- 913 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------------hhHHH----
Confidence 65554444455788999999999999999999999999999999 999998743221 11111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
+.....+.+.-|+.++..++.+||..|++.||+++++.+.+.++.+
T Consensus 914 -e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 914 -EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1222355666888999999999999999999999999999988744
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=312.92 Aligned_cols=250 Identities=25% Similarity=0.317 Sum_probs=200.1
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
-|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|||++++++++...+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3577789999999999999976 578889999876555556778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+++|..++......+++..+..++.|+++||.||| +.+++||||||+||+++.++.++++|||++........ .
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH----~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH----ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 99999988765566899999999999999999999 67899999999999999999999999999876532211 1
Q ss_pred eeccccCccccCCCccC-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 587 QTMTMATIGYMAPEYGS-----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.....++..|+|||++. +..++.++|||||||++|||++|+.||......+ ..........+ .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~---------~-- 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPP---------T-- 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCCC---------C--
Confidence 23345889999999873 4557889999999999999999999986532111 11111110000 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...+..++.++.+++.+||+.+|.+||++.++++
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 -----LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011123456889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=308.45 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=196.5
Q ss_pred cccccccEEEEEEEec---CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 434 LLGTGGFGSVYKGTLS---DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 434 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
.||+|+||.||+|.++ ++..+|+|+++... ....+.+.+|+.+++.++||||+++++++.+ +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 67889999986443 3345678899999999999999999998864 4668999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce-ee
Q 005040 509 SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV-IQ 587 (717)
Q Consensus 509 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~ 587 (717)
+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE----ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997654 4899999999999999999999 6789999999999999999999999999998765433221 11
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (717)
....++..|+|||......++.++||||||+++|||++ |+.||..... ......+......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~~~---------------- 217 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGERM---------------- 217 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCCC----------------
Confidence 22234678999999888889999999999999999998 9999975322 1122221110000
Q ss_pred hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 667 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
+.+..++.++.++|.+||+.||++||++.+|++.|+..
T Consensus 218 -~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 -ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01113456688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.79 Aligned_cols=262 Identities=25% Similarity=0.381 Sum_probs=202.2
Q ss_pred ccCCccccccccccEEEEEEEec-----------------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-----------------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKI 488 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~ 488 (717)
++|++.+.||+|+||.||++... ++..||+|++.... ......+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999998532 23468999987543 3345678899999999999999999
Q ss_pred eeeeecCCeeEEEEEccCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 005040 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHN----------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTN 558 (717)
Q Consensus 489 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~N 558 (717)
++++.+.+..++||||+++|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dlkp~N 160 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS----SLNFVHRDLATRN 160 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhe
Confidence 999999999999999999999999997532 23677889999999999999999 6789999999999
Q ss_pred eeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh--CCCCCCccccC
Q 005040 559 ILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT--EKKPTDEMFTG 636 (717)
Q Consensus 559 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t--g~~p~~~~~~~ 636 (717)
|+++.++.++|+|||++..+.............++..|+|||+..++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986643322222223345678999998888889999999999999999998 67787643221
Q ss_pred cchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 637 EMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
+ ................ ..+....++..+.+++.+||+.||++||++.|+++.|++
T Consensus 241 ~--~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q--VIENTGEFFRDQGRQV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H--HHHHHHHHHhhccccc----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111000000000 001112345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.82 Aligned_cols=237 Identities=27% Similarity=0.296 Sum_probs=188.0
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHH-HHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECE-ILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 78999999997543 222234445544 56788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TT 153 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--cc
Confidence 99999998654 4889999999999999999999 67999999999999999999999999999875322211 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~--------~~------ 214 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNKP--------LR------ 214 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCC--------CC------
Confidence 344689999999999999999999999999999999999999965321 11111111000 00
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMT 696 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ 696 (717)
.....+.++.+++.+|++.||++||++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 -LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0012345678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=323.48 Aligned_cols=244 Identities=26% Similarity=0.370 Sum_probs=201.2
Q ss_pred cccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCHHH
Q 005040 434 LLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEK 512 (717)
Q Consensus 434 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~ 512 (717)
++|+|.||+||-|++. +...+|||-+.....+..+.+..|+...++++|.|||+++|++.+.++.-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999975 566799999987777777889999999999999999999999999999999999999999999
Q ss_pred HHhhCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeeccccccCCCCCceeeec
Q 005040 513 WLYSHNYFL--DILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDSVIQTM 589 (717)
Q Consensus 513 ~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 589 (717)
.++..=+++ .+.++.-+.+||++||.||| ...|||||||-.|||++ -.|.+||+|||-++++..-. .....
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH----en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET 735 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH----ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET 735 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh----hcceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence 999654445 66778889999999999999 56799999999999997 68899999999998874322 22345
Q ss_pred cccCccccCCCccCCC--CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 590 TMATIGYMAPEYGSEG--IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 590 ~~~t~~y~aPE~~~~~--~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
..||..|||||++..+ .|+.++|||||||++.||.||++||-+.-.... .++.-.+-+..+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMFkVGmyKvHP-- 798 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMFKVGMYKVHP-- 798 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhhhhcceecCC--
Confidence 5799999999998765 488999999999999999999999976432211 122222222222
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.+.+.+.+...+|.+|+.+||.+||+++++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 223466788999999999999999999999875
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.19 Aligned_cols=251 Identities=26% Similarity=0.320 Sum_probs=202.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
+.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++++.++||||+++++++......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999975 68999999997666666678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++++|..++.+....+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||++....... .
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~ 165 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q 165 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence 999999988766666899999999999999999999 6799999999999999999999999999887543221 1
Q ss_pred eeeccccCccccCCCccC-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 586 IQTMTMATIGYMAPEYGS-----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
......++..|+|||++. ...++.++|||||||++|||++|+.||..... ......+..... +
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~---------~-- 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEP---------P-- 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-HHHHHHHhcCCC---------c--
Confidence 122345788999999874 44578899999999999999999999865321 111111110000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.......++.++.+++.+||+.+|++||++.|+++
T Consensus 234 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 -----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00111233456789999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.09 Aligned_cols=255 Identities=27% Similarity=0.340 Sum_probs=201.3
Q ss_pred HHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
+.+++.+.....||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445566666789999999999999865 6788999988766555667889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeecccccc
Q 005040 502 LEFMPNGSLEKWLYSHNYFL--DILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLL 578 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~ 578 (717)
+||+++++|.+++......+ ++..+..++.|++.|++||| +.+|+||||||+||+++. ++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH----DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999998654445 78888999999999999999 679999999999999986 679999999998765
Q ss_pred CCCCCceeeeccccCccccCCCccCCCC--cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGI--VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
..... ......++..|+|||+..+.. ++.++||||||+++|||++|+.||....... ...+.....
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~~-------- 227 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMF-------- 227 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhhh--------
Confidence 43221 122335788999999876543 7889999999999999999999986532111 111111000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...+. .+..++.++.+++.+||+.+|++|||+.|+++
T Consensus 228 -----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 -----KIHPE--IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -----ccCCC--CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00000 01133456889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.14 Aligned_cols=239 Identities=22% Similarity=0.331 Sum_probs=190.3
Q ss_pred ccccccccEEEEEEEecC-------------CCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 433 NLLGTGGFGSVYKGTLSD-------------GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
+.||+|+||.||+|...+ ...||+|.+..........+.+|+.+++.++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2258999887665555567888999999999999999999999988999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc-------EEEeee
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV-------AHVSDF 572 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~-------~kl~Df 572 (717)
+||||+++|+|..++......+++..+..++.|+++|++||| +.+|+||||||+||+++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE----DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh----hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999876666899999999999999999999 689999999999999987664 899999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCccC-CCCcCcccchhhHHHHHHHHH-hCCCCCCccccCcchHHHHHHhhCCC
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGS-EGIVSTKCDVYSYGVLLMETF-TEKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
|++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.|+......+ ........
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~--- 225 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEGQ--- 225 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhcC---
Confidence 998765321 2235788899999876 567899999999999999998 5888876421111 01100000
Q ss_pred chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 651 RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
. ........++.+++.+||+.||++||++.++++.+
T Consensus 226 ---------~-------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 ---------C-------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---------c-------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 00011234578999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.39 Aligned_cols=249 Identities=27% Similarity=0.360 Sum_probs=205.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
++|+..+.||+|+||.||+|... +++.+|+|.+..... .+.+.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 67899999999999999999976 488999999875533 578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++++|.+++......+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999876677899999999999999999999 67899999999999999999999999999987643321
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
......++..|+|||++.+..++.++||||||+++|||++|+.||........ ......... .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~---------------~ 217 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMIPNKPP---------------P 217 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhhhccCCC---------------C
Confidence 12334578899999999888999999999999999999999999875322110 000000000 0
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.......++.++.+++.+|++.+|++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01112234456889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.34 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=206.3
Q ss_pred hccCCccccccccccEEEEEEEecC----CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSD----GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
..+|.+.+.||+|+||.||+|...+ ...||+|...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999998643 3468999887554 4455678999999999999999999999876 45689
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999999876666899999999999999999999 67899999999999999999999999999876543
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
... .......++..|+|||......++.++||||||+++||+++ |..||...... ....+..... ..
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~--~~------- 227 (270)
T cd05056 160 ESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRIENGE--RL------- 227 (270)
T ss_pred ccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCC--cC-------
Confidence 321 11222234568999999888889999999999999999996 99999754321 1111111100 00
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.....++.++.+++.+|+..+|++|||+.++++.|++++..
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01123456788999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.06 Aligned_cols=248 Identities=30% Similarity=0.527 Sum_probs=204.0
Q ss_pred ccccccccEEEEEEEecC----CCeEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLSD----GTNVAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|.... +..||+|++...... ..+.+.+|+++++.++|+|++++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 888999999765433 367888999999999999999999999999999999999999
Q ss_pred CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 508 GSLEKWLYSH--------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 508 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
++|.+++... ...+++..++.++.|+++||+||| +.+++||||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH----cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999876 466899999999999999999999 6899999999999999999999999999998775
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
............++..|+|||......++.++||||+|+++|||++ |..||..... ....+......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~---------- 224 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRKGY---------- 224 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC----------
Confidence 4432222334457889999999888899999999999999999999 6999876421 11111111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
.......++.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 225 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 -------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00111233567889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.53 Aligned_cols=253 Identities=24% Similarity=0.420 Sum_probs=204.2
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 468899999999999999999988899999999875432 2357888999999999999999999875 45689999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++++|.+++... +..+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE----RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999998753 346899999999999999999999 678999999999999999999999999999766432211
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......++..|+|||+..+..++.++||||||+++||+++ |+.||.+.... ............
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~------------- 222 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRM------------- 222 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCC-------------
Confidence 1223345678999999988889999999999999999999 99999753221 111111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
+....++.++.+++.+|+..+|++||+++++++.|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.20 Aligned_cols=250 Identities=30% Similarity=0.481 Sum_probs=205.4
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|+..+.||.|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999874 88999999976644 4567889999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++++|.+++.... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999998654 35899999999999999999999 68899999999999999999999999999987632211
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
....+..|+|||+..++.++.++||||||+++||+++ |+.||..... .............
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~------------- 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVEKGYRM------------- 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhcCCCC-------------
Confidence 2234667999999988889999999999999999998 9999865311 1111111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
.....++.++.+++.+|+..+|++||++.|+++.|+.+
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 ----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00113456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=316.50 Aligned_cols=257 Identities=30% Similarity=0.490 Sum_probs=202.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCC--eEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGT--NVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 468888999999999999999875 454 45777765432 33456788899999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 005040 501 VLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~ 565 (717)
||||+++|+|.++++... ..+++.++..++.|++.|++||| +.+++||||||+||+++.++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEecCCC
Confidence 999999999999997532 24789999999999999999999 68999999999999999999
Q ss_pred cEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHH
Q 005040 566 VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWV 644 (717)
Q Consensus 566 ~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 644 (717)
.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||+| |..||...... ......
T Consensus 162 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~ 236 (303)
T cd05088 162 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL 236 (303)
T ss_pred cEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHH
Confidence 9999999998643211 11112234667999999888889999999999999999998 99998653211 111111
Q ss_pred HhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 645 KESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.... .. .....++.++.+++.+|++.+|++||++.++++.|+++...
T Consensus 237 ~~~~--~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 237 PQGY--RL---------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred hcCC--cC---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1000 00 00112345688999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.14 Aligned_cols=243 Identities=19% Similarity=0.253 Sum_probs=192.1
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +||+|+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 68899999998653 23445678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|..++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH----ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TT 153 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ce
Confidence 99999887654 4899999999999999999999 68999999999999999999999999999875322111 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccC-cchHHHHHHhhCCCchhhhccccchhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG-EMSLRRWVKESLPHRLTEVVDANLVREEQA 666 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+....... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~------ 220 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-------KPI------ 220 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-------CCC------
Confidence 3456899999999999999999999999999999999999999643221 11111111111000 000
Q ss_pred hhhhHHHHHHHHHHHhhccCCCCCCCCCHH
Q 005040 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMT 696 (717)
Q Consensus 667 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ 696 (717)
..+...+..+.+++.+||+.||++|++++
T Consensus 221 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 -RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 00112345578999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=305.25 Aligned_cols=252 Identities=25% Similarity=0.317 Sum_probs=201.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-----ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
+.|+..+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46889999999999999999864 78999999886432 2234568889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
|+||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999998654 3788999999999999999999 67899999999999999999999999999876543
Q ss_pred CCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
..... ......++..|+|||+..+..++.++||||+|+++|||++|+.||...... ......... ... .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~-~~~------~- 226 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--AAIFKIATQ-PTN------P- 226 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--HHHHHHhcc-CCC------C-
Confidence 22111 112345788999999999988999999999999999999999998653111 000110000 000 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+..++..+.+++.+||..+|.+|||+.|+++.
T Consensus 227 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 --------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111344568899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.91 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=204.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999875 68889999886543 33445688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.++++... .+++..+..++.|+++||.|||+ ..+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999998653 48899999999999999999994 2589999999999999999999999999987653221
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc-------------
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR------------- 651 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 651 (717)
.....++..|+|||+..+..++.++||||||+++|||++|+.||.... ......+........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCC
Confidence 233467899999999888889999999999999999999999986432 112222221110000
Q ss_pred --------hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 652 --------LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 652 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+..+.......+.. ....++.++.+++.+|++.+|++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000000 011245678999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=314.27 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=203.6
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|+..+.||+|+||.||+|..+ ++..||+|++.... ......+.+|+.+++++.||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999863 46789999987543 33446788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCC
Q 005040 499 ALVLEFMPNGSLEKWLYSHN---------------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPT 557 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~ 557 (717)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH----~~~i~H~dl~p~ 159 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS----ERKFVHRDLATR 159 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCeecccccHh
Confidence 99999999999999997431 24678889999999999999999 678999999999
Q ss_pred CeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccC
Q 005040 558 NILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTG 636 (717)
Q Consensus 558 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~ 636 (717)
||+++.++.++|+|||++..+..............+..|+|||...+..++.++|||||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543322211222345677999999888899999999999999999998 88888543211
Q ss_pred cchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 637 EMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
.....+.. .. .. +.+..++.++.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 --~~~~~~~~---~~--------~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EVIYYVRD---GN--------VL------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHHhc---CC--------CC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111110 00 00 0111344668899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.88 Aligned_cols=259 Identities=27% Similarity=0.451 Sum_probs=205.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCC----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGT----NVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 367888899999999999999864 444 47889876543 23334688899999999999999999998754 467
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+++||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE----ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh----hcCeeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999999877666899999999999999999999 6789999999999999999999999999998764
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
............++..|+|||++.+..++.++||||||+++|||++ |+.||.+... .....++.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~--------- 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGER--------- 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC---------
Confidence 3332222223345778999999998899999999999999999998 8999865321 122222221100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
. +....++.++.+++.+||..+|++||++.++++.|+++...
T Consensus 230 -~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 -L-------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00112345678999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=320.34 Aligned_cols=241 Identities=25% Similarity=0.276 Sum_probs=189.0
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHH-HHHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSEC-EILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 67889999997543 12223344444 456788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|.+++.... .+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~ 153 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TT 153 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cc
Confidence 99999998654 3778888889999999999999 68999999999999999999999999999875432211 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.. . ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~---~--------~~------- 213 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILN---K--------PL------- 213 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHHh---C--------Cc-------
Confidence 3446899999999999999999999999999999999999999653211 11111110 0 00
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......+..+.+++.+|++.||.+||++.+.+.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 001123456789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.16 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=201.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|+..+.||+|+||.||+|... +++.||+|+++.........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999864 7889999998766544556678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++...+ .+++.++..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH----SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 99999999987654 4899999999999999999999 67899999999999999999999999999876543211
Q ss_pred eeeeccccCccccCCCccC---CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 585 VIQTMTMATIGYMAPEYGS---EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
......|+..|+|||++. ...++.++||||+||++|||++|+.||....+... .......... .+..
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~-------~~~~- 231 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQ-------PPKL- 231 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCC-------CCcc-
Confidence 123346899999999864 45688999999999999999999999854322111 0000000000 0000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++..+.+++.+|++.+|++||+++++++
T Consensus 232 ------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 ------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 011123455789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.34 Aligned_cols=266 Identities=24% Similarity=0.259 Sum_probs=197.8
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----eeE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD-----FKA 499 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~ 499 (717)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999964 79999999886432 233456888999999999999999999998766 789
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+. ++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 58888886543 4899999999999999999999 6789999999999999999999999999998654
Q ss_pred CCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh---
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV--- 655 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 655 (717)
.... .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+.............+.
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHh
Confidence 3221 11233457899999998776 45799999999999999999999999763221 111111110000000000
Q ss_pred -------ccccc---hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 656 -------VDANL---VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 656 -------~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+.... ...........+.+.++.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 00000000111235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.34 Aligned_cols=248 Identities=29% Similarity=0.430 Sum_probs=200.0
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeee-ecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSC-SNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e~~ 505 (717)
.+|++.+.||+|+||.||+|..+ |+.||+|.+.... ..+.+.+|+.++++++|+|++++++++ .+....++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57888999999999999999874 7889999886443 235688899999999999999999975 4556789999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999998653 34789999999999999999999 6789999999999999999999999999987653322
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
....++..|+|||+..+..++.++||||||+++|||++ |+.||..... .....++....+.
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~------------- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKM------------- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCC-------------
Confidence 12234668999999988889999999999999999998 9999864211 1111111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
.....++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00113456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.56 Aligned_cols=271 Identities=28% Similarity=0.417 Sum_probs=208.4
Q ss_pred ccCCccccccccccEEEEEEEec-----CCCeEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeeEeeeeec--CCee
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-----DGTNVAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSCSN--LDFK 498 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~ 498 (717)
.+|+..+.||+|+||.||+|++. ++..||||++...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46777889999999999999863 3678999999765443 45788999999999999999999999877 5578
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+++++|.+++......+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG----SQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999999877666899999999999999999999 678999999999999999999999999999877
Q ss_pred CCCCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 579 GEGEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 579 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
....... ......++..|+|||...+..++.++||||||+++|||++|+.|+........ .+............+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL---RMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc---cccccccccccHHHHH
Confidence 5332221 11123456679999998888999999999999999999999999754322111 0000000000000000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
..+. .....+....++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHH-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000 0001112234556789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=307.12 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=190.1
Q ss_pred ccccccccEEEEEEEec---CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 433 NLLGTGGFGSVYKGTLS---DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
+.||+|+||.||+|... .+..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 34578999886543 233356888999999999999999999999989999999999999
Q ss_pred CHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 509 SLEKWLYSHN----YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 509 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH----KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999997532 24567788889999999999999 678999999999999999999999999998754332222
Q ss_pred eeeeccccCccccCCCccCCC-------CcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 585 VIQTMTMATIGYMAPEYGSEG-------IVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~-------~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
.......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ ...+... .......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~~~---~~~~~~~ 231 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTVR---EQQLKLP 231 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHhh---cccCCCC
Confidence 222334567889999987542 35789999999999999996 999996532221 1111100 0000111
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
++.+. ...+..+.+++..|+ .+|++|||++||++.|+
T Consensus 232 ~~~~~---------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK---------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC---------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11110 112345778999998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.19 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=202.1
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
++|++...||+|+||.||+|...++..+|+|.+.... ...+.+.+|+++++.++|||++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 5688889999999999999998777789999876432 233568889999999999999999998864 55799999999
Q ss_pred CCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 507 NGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 507 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
+|+|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE----RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999999764 345789999999999999999999 678999999999999999999999999999766433211
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......++..|+|||+..+..++.++||||||+++|||++ |+.||.+.... ....+.......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~-------------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYRM-------------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC--------------
Confidence 1122345678999999988899999999999999999999 89998753221 111111111000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
+...+.+..+.+++.+||..+|++||+++++++.|++
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112345668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.70 Aligned_cols=253 Identities=27% Similarity=0.380 Sum_probs=205.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
++|+..+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999875 67889999998665556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++++|.+++......+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH----ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 999999999876556899999999999999999999 67899999999999999999999999999876543211
Q ss_pred eeeccccCccccCCCccCCC---CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 586 IQTMTMATIGYMAPEYGSEG---IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~---~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
......++..|+|||...+. .++.++||||||+++|||++|+.||........ ........... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~~-------~~--- 225 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFPP-------PK--- 225 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCC-------cc---
Confidence 12234578889999988776 889999999999999999999999865322111 11100000000 00
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.......+.++.+++.+||..+|.+|||+++++.
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 ----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ----ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0111234566889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.52 Aligned_cols=255 Identities=23% Similarity=0.284 Sum_probs=197.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||++... +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999975 68999999997532 233456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++.+....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH----QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999876666899999999999999999999 6889999999999999999999999999987654322
Q ss_pred CceeeeccccCccccCCCccCC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 583 DSVIQTMTMATIGYMAPEYGSE-----GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||..... .+......... ...
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~--~~~- 227 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHK--EHF- 227 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCC--Ccc-
Confidence 2 11223468999999998763 4578899999999999999999999965211 11111110000 000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPH--KRIHMTDAAAK 701 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~--~Rpt~~ev~~~ 701 (717)
.+. .....++.++.+++.+|+..+++ .||++.++++.
T Consensus 228 -~~~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 -QFP------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -cCC------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 00112445678889887765433 37888888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=325.71 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=196.5
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++.+++||+|+++++++.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999875 78999999997543 334466788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++.+.+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH----~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH----QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999998654 3889999999999999999999 6899999999999999999999999999987543211
Q ss_pred Cc---------------------------------eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCC
Q 005040 583 DS---------------------------------VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629 (717)
Q Consensus 583 ~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p 629 (717)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00 001134689999999999999999999999999999999999999
Q ss_pred CCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 005040 630 TDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH---MTDAAA 700 (717)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~ev~~ 700 (717)
|....... ......... ..+ .++.....+.++.+++.+|+. ||.+|++ +.|+++
T Consensus 236 f~~~~~~~-----~~~~i~~~~------~~~-----~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 236 FCSETPQE-----TYRKVMNWK------ETL-----VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCHHH-----HHHHHHcCC------Cce-----ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 97532211 111000000 000 001111234557788888774 9999996 455543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.16 Aligned_cols=241 Identities=23% Similarity=0.261 Sum_probs=193.3
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 502 (717)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+..|.++++.+. |++|+++.+++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999875 78999999997653 233456778889998885 577888999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999997654 3899999999999999999999 6799999999999999999999999999987543221
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+... . .
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i~~~---~--------~-- 218 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQSIMEH---N--------V-- 218 (323)
T ss_pred c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC---C--------C--
Confidence 1 12334689999999999988999999999999999999999999976321 1111111110 0 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
..+..++.++.+++.+|++.+|.+|++.
T Consensus 219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0011234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=303.42 Aligned_cols=248 Identities=29% Similarity=0.464 Sum_probs=198.3
Q ss_pred ccccccccEEEEEEEec--C--CCeEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS--D--GTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|.+. + +..+|+|.+..... ...+.+.+|+++++++.||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 47999999999999753 2 26899999875543 344678899999999999999999998764 467999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee-
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI- 586 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~- 586 (717)
|+|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE----SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh----hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998765 5899999999999999999999 67899999999999999999999999999987644332211
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....++..|+|||...+..++.++||||||+++|||++ |+.||..... .....++....+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~--------------- 217 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL--------------- 217 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC---------------
Confidence 111223567999999988899999999999999999998 9999875322 2222222221100
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
+....++..+.+++.+||..+|++||++.++++.|+++
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11123456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.78 Aligned_cols=264 Identities=22% Similarity=0.228 Sum_probs=196.6
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC------
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL------ 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------ 495 (717)
..++|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999875 68999999986432 23345677899999999999999999988543
Q ss_pred CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH----~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 357999999965 67776653 2788899999999999999999 689999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (717)
+...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...... ......... ......+.
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~-~~~~~~~~ 245 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQ-LGTPSAEF 245 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh-cCCCcHHH
Confidence 7643221 123346799999999999999999999999999999999999999753211 111111111 00000000
Q ss_pred cc-----------c--cch-----hhhh------hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 656 VD-----------A--NLV-----REEQ------AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 656 ~~-----------~--~~~-----~~~~------~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.+ . ... ...+ ........+.++.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0 000 0000 000011124568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.20 Aligned_cols=265 Identities=19% Similarity=0.263 Sum_probs=201.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|+..+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+++++.++||||+++++++.+....++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999875 68899999986443 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++ ++|.+++......+++..+..++.|+++||.||| +.+|+|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 5999999876666899999999999999999999 68999999999999999999999999999876532221
Q ss_pred eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC----chhhhcccc
Q 005040 585 VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH----RLTEVVDAN 659 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 659 (717)
......+++.|+|||+..+ ..++.++||||+|+++|||++|+.||...... .....+...... .+....+..
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhccc
Confidence 1123356889999998755 45788999999999999999999999753221 111111111110 111111100
Q ss_pred ------chhhhhh--hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 ------LVREEQA--FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ------~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....... ......++.++.+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 0011234566889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=307.46 Aligned_cols=239 Identities=23% Similarity=0.335 Sum_probs=189.6
Q ss_pred cccccccEEEEEEEec-------------------------CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeE
Q 005040 434 LLGTGGFGSVYKGTLS-------------------------DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKI 488 (717)
Q Consensus 434 ~lg~G~~g~V~~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~ 488 (717)
+||+|+||.||+|... ....||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999742 113589999976665556678889999999999999999
Q ss_pred eeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---
Q 005040 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM--- 565 (717)
Q Consensus 489 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~--- 565 (717)
++++.+....++||||+++|+|..++......+++..+..++.|+++||+||| +.+|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE----DKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----cCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999876667899999999999999999999 67999999999999997644
Q ss_pred ----cEEEeeeccccccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHH-hCCCCCCccccCcch
Q 005040 566 ----VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETF-TEKKPTDEMFTGEMS 639 (717)
Q Consensus 566 ----~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~-tg~~p~~~~~~~~~~ 639 (717)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 4899999987643221 12346788999998765 56899999999999999985 6999986532211
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
...+..... .+ +. ....++.+++.+||+.+|++|||+.++++.|+
T Consensus 230 ~~~~~~~~~----------~~-------~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYEKKH----------RL-------PE--PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHhcc----------CC-------CC--CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111111100 00 00 11235789999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.39 Aligned_cols=264 Identities=19% Similarity=0.214 Sum_probs=199.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.+|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++||||+++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46899999999999999999976 68889999632 234567999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
. ++|.+++......+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH----GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 5 7999999876667999999999999999999999 6799999999999999999999999999998764332222
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccC------cchHHHHHHhhCC--Cchhhhcc
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG------EMSLRRWVKESLP--HRLTEVVD 657 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~------~~~~~~~~~~~~~--~~~~~~~~ 657 (717)
......||+.|+|||++.+..++.++|||||||++|||++|..|+-..... ...+.+.+..... ........
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 223456899999999999999999999999999999999988764321111 1122222221100 00000000
Q ss_pred ccchhhh--------------hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 658 ANLVREE--------------QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 658 ~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.++.... ...........++.+++.+||+.||++|||+.|+++.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 0000011223468899999999999999999999863
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.49 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=206.1
Q ss_pred HhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..++|++.+.||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3468899999999999999999988888999999875432 235688899999999999999999999988899999999
Q ss_pred cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++++|.+++.... ..+++..+..++.|++.|+.||| +.+++|+||||+||++++++.++++|||++........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE----SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999998643 46899999999999999999999 67899999999999999999999999999887643221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. .......+..|+|||...+..++.++||||+|+++||+++ |+.||...... ...+.+.....
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~------------- 222 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERGYR------------- 222 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence 1 1112234568999999988889999999999999999999 99998653211 11111111000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
.+.+.+++.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=320.22 Aligned_cols=241 Identities=24% Similarity=0.301 Sum_probs=189.4
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHH-HHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECE-ILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 78999999997553 223344555554 56778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TT 153 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cc
Confidence 99999887654 4899999999999999999999 68999999999999999999999999999875322211 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~--------~~~~------ 214 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILH--------KPLV------ 214 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHc--------CCcc------
Confidence 3446899999999999999999999999999999999999999653211 11111100 0000
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....+..+.+++.+|++.+|.+||++.+.++
T Consensus 215 -~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 215 -LRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 00123355779999999999999998864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.93 Aligned_cols=262 Identities=23% Similarity=0.286 Sum_probs=192.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--------C
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNL--------D 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--------~ 496 (717)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999875 78899999885432 2234699999999999999998876332 2
Q ss_pred eeEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeee
Q 005040 497 FKALVLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDF 572 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Df 572 (717)
..++||||++ ++|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH----~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 4679999997 478777753 3456899999999999999999999 68899999999999999665 7999999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR 651 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 651 (717)
|+++.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.... ..+.+.+.......
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC
Confidence 99987643322 123467999999998765 46899999999999999999999999763221 12222211111100
Q ss_pred hhh--hccc--------cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 652 LTE--VVDA--------NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 652 ~~~--~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
... ...+ ......-...-+...+.++.+++.+||..||.+|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 0000 000000000001123467899999999999999999999884
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.89 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=203.3
Q ss_pred ccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++|||++++++++.+.+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999986 478999999987655445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++++|.+++... .+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH----~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH----ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 999999998764 3899999999999999999999 689999999999999999999999999998765432211
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....++..|+|||...+..++.++|||||||++|+|++|+.||........ ...........
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~~~~~~~~-------------- 234 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNGTPE-------------- 234 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCCcc--------------
Confidence 2234678899999999888899999999999999999999999965322111 11111100000
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++..+.++|.+||..||++||++.++++
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0111234456889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.02 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=203.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 478999999999999999999864 7999999998765544456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++.+.. +++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~~~~--~~~~~~~~~~~~l~~~L~~LH----~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999997643 788999999999999999999 678999999999999999999999999998765432211
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
.....+++.|+|||...+..++.++|+||||+++|++++|+.||............+. .. .
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-----~~------------~ 232 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-----NG------------T 232 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-----CC------------C
Confidence 2334678899999999888899999999999999999999999965321110000000 00 0
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+........+..+.+++.+||..+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111233456789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.35 Aligned_cols=265 Identities=21% Similarity=0.198 Sum_probs=200.9
Q ss_pred hccCCccccccccccEEEEEEEec---CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS---DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
..+|++.+.||+|+||.||++... .++.||+|.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 4578999987643 23457999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|++. ++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH----~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 6899998543 45899999999999999999999 6789999999999999999999999999998765443
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc--chHHHHHHhhC--CCchhh----
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE--MSLRRWVKESL--PHRLTE---- 654 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~--~~~~~~---- 654 (717)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ..+...+.... +.....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 3333344578999999999999999999999999999999999999986533221 11111111110 000000
Q ss_pred hccccc-------hhh--hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 655 VVDANL-------VRE--EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 655 ~~~~~~-------~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.+...+ ... .+.......++.++.++|.+|+..||++|||+.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000 00000011234568899999999999999999999864
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.29 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=198.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999864 78999999986543 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|..+. .+++..+..++.|++.|+.||| +.+|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW----SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999997652 3688889999999999999999 6899999999999999999999999999997654322
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchH--HHHHHhhCCCchhhhccccchh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL--RRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
.....++..|+|||++.+..++.++||||||+++|||++|+.||.......... ..+........ .+.+
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-- 220 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL-- 220 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC--
Confidence 233468999999999999899999999999999999999999997533221110 01110000000 0000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.....+.++.+++.+|++.+|++||+++|+++.
T Consensus 221 ------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 ------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011234567899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=303.87 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=200.8
Q ss_pred cCCccccccccccEEEEEEEecCCCeEEEEEechhh------HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL------ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
+|+..+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886431 23345688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
+||+++++|.+++.+.. .+++..+..++.|++.|++||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH----NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999998654 3789999999999999999999 678999999999999999999999999998765321
Q ss_pred CC----ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 582 ED----SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 582 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
.. ........++..|+|||+..+..++.++||||+|+++|||++|+.||....... ... ..... .. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~-~~~~~--~~----~~ 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMF-YIGAH--RG----LM 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHH-Hhhhc--cC----CC
Confidence 11 111223458899999999998889999999999999999999999996532111 110 00000 00 00
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.. ...++.++.+++++||+.+|++||++.|+++
T Consensus 228 ~~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PRL---------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC---------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001 1124456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.92 Aligned_cols=255 Identities=21% Similarity=0.264 Sum_probs=198.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|..++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999975 78889999987532 233455788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH----~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH----QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999876556899999999999999999999 6899999999999999999999999999998764332
Q ss_pred CceeeeccccCccccCCCccCC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 583 DSVIQTMTMATIGYMAPEYGSE-----GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||...... ..........
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~------ 224 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHE------ 224 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----HHHHHHHcCC------
Confidence 2 12233568999999998765 56789999999999999999999999652211 1111100000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHK--RIHMTDAAAK 701 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ev~~~ 701 (717)
.++. .+ ....+.+.++.+++.+|+..++++ |++++++++.
T Consensus 225 ~~~~--~p--~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ERFQ--FP--SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Cccc--CC--CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000 00 001123466889999999866544 4578877653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.49 Aligned_cols=258 Identities=23% Similarity=0.403 Sum_probs=204.5
Q ss_pred ccCCccccccccccEEEEEEEec--------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS--------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLD 496 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 496 (717)
.+|++.+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 12368999887543 33456788999999999 7999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 005040 497 FKALVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL 561 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill 561 (717)
..++|+||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nill 167 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA----SQKCIHRDLAARNVLV 167 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEE
Confidence 9999999999999999997532 24788899999999999999999 6899999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchH
Q 005040 562 DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSL 640 (717)
Q Consensus 562 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~ 640 (717)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 9999999999999986643322221222234567999999999999999999999999999998 8888865321
Q ss_pred HHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 641 RRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
..+......... ......++.++.+++.+|++.+|++||++.|+++.|+++..
T Consensus 243 ~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EELFKLLKEGHR--------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHcCCC--------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111111100000 00111334568899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.36 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=198.1
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+++.+ +++.||+|++.+.. ......+..|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999976 67889999986532 223345788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++.+....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH----~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999876566899999999999999999999 6889999999999999999999999999987653322
Q ss_pred CceeeeccccCccccCCCccC-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 583 DSVIQTMTMATIGYMAPEYGS-----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ............ .
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~-~--- 226 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKE-R--- 226 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCCCc-c---
Confidence 1 1223456899999999875 35688999999999999999999999965311 111111100000 0
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHK--RIHMTDAAAK 701 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ev~~~ 701 (717)
..+. .....++.++.+++.+|+..+|.. |+++.|+++.
T Consensus 227 ~~~p------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQFP------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCC------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 001134566789999988654443 6889988766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.29 Aligned_cols=249 Identities=20% Similarity=0.272 Sum_probs=201.4
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
+|++.+.||+|+||.||++... +++.+|+|.++... ....+.+..|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999975 78899999886432 334567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++|+|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH----EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999998753 445789999999999999999999 68999999999999999999999999999876543221
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......+++.|+|||+..+..++.++|+||||+++|+|++|+.||..... .............
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~----------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQGSYK----------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcCCCC-----------
Confidence 12234688899999999888899999999999999999999999975211 1111111000000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+.+..++..+.+++.+||+.||++||++.+++..
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=302.92 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=202.5
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++|||++++++++.+....++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 47788899999999999999987788999998864432 23568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+++|.+++......+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||.+......... .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~ 157 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE----SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence 99999999876666899999999999999999999 678999999999999999999999999998765432211 1
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....++.+|+|||+..++.++.++||||||+++|||++ |+.||...... .......... ....+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~-----~~~~~------- 223 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGF-----RLYKP------- 223 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCC-----CCCCC-------
Confidence 122335678999999988899999999999999999998 99998653211 1111111000 00000
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 224 -----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 -----RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11235688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.30 Aligned_cols=252 Identities=26% Similarity=0.434 Sum_probs=194.7
Q ss_pred ccccccccEEEEEEEec----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeee-cCCeeEEEEEccC
Q 005040 433 NLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCS-NLDFKALVLEFMP 506 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~ 506 (717)
+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. ..+..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 34579999885432 344567888999999999999999999765 4556789999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce-
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV- 585 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 585 (717)
+|+|.+++.......++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA----SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999999876655788888999999999999999 6789999999999999999999999999987653321111
Q ss_pred -eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhC-CCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 586 -IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTE-KKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 586 -~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......++..|+|||+..+..++.++||||||+++|||++| .+||..... ...........+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~-------------- 220 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQGRR-------------- 220 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCCC--------------
Confidence 11223457789999998888899999999999999999995 555543211 111111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
...+..++..+.+++.+||..+|++||++.|+++.|+++..
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00011234568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=307.66 Aligned_cols=249 Identities=23% Similarity=0.287 Sum_probs=197.9
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
|+..+.||+|+||+||+|... +++.||+|.+.... ......+.+|+++++.++|++|+.+.+++.+.+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999875 78999999986543 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH----RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999988754 345899999999999999999999 68999999999999999999999999999876532211
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.....|+..|+|||++.+..++.++|+||+|+++|||++|+.||....... ....+ ........ ..
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~-~~~~~~~~-----~~---- 223 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEV-DRRVLETE-----EV---- 223 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HHhhhccc-----cc----
Confidence 123468999999999988899999999999999999999999997532211 11111 11100000 00
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
....++.++.+++..|++.||++||+ +.++++
T Consensus 224 -----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 -----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 01123456789999999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=308.13 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=198.8
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|++++.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999875 78999999987543 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH----QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999998643 335899999999999999999999 68999999999999999999999999999876532221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.....|+..|+|||++.+..++.++||||+|+++|||++|+.||....... ..... .. ..+. ...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~--------~~~~-~~~- 222 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ER--------LVKE-VQE- 222 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH-Hh--------hhhh-hhh-
Confidence 123468999999999999999999999999999999999999997532211 00010 00 0000 000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
.....++.++.+++.+||+.||++||| ++|+++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 ----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011134456889999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.73 Aligned_cols=252 Identities=31% Similarity=0.430 Sum_probs=198.7
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhhHHH--HHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERA--FRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
|++.+.||+|+||+||++... +++.||+|++....... ......|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999976 66789999997665322 223456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++++|.+++... ..+++..+..++.|+++||.||| +.+++|+||||+||+++.++.++|+|||.+..... ...
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh----~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH----SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH----HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred cccccccccccc-ccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccc--ccc
Confidence 999999999833 33899999999999999999999 57899999999999999999999999999976421 122
Q ss_pred eeeccccCccccCCCccC-CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 586 IQTMTMATIGYMAPEYGS-EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......++..|+|||+.. +..++.++||||+|+++|+|++|+.||..... ........... .......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~--------~~~~~~~- 222 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKIL--------KRPLPSS- 222 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHH--------HTHHHHH-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcc--------ccccccc-
Confidence 334556899999999988 88899999999999999999999999976410 01111111100 0000000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.........++.+++.+||+.||++||++.++++
T Consensus 223 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 --SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000111267899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.86 Aligned_cols=237 Identities=25% Similarity=0.303 Sum_probs=186.9
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHH-HHHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSEC-EILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 78899999997543 22233455554 467889999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|..++.... .+++..+..++.||++||.||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TT 153 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--cc
Confidence 99998887643 4788889999999999999999 67899999999999999999999999999875322211 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... . ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~--------~-----~~ 215 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHKP--------L-----QL 215 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcCC--------C-----CC
Confidence 344689999999999988999999999999999999999999965311 11111111000 0 00
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMT 696 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ 696 (717)
+...+.++.+++.+|++.||++||++.
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 --PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 012235578999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.32 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=204.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+....++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57888899999999999999865 68899999886543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++...+ .+++..+..++.+++.|+.|||+ ..+++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN---VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH---hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999987654 48999999999999999999995 3579999999999999999999999999986542211
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcc------hHHHHHHhhCCCchhhhccc
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM------SLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 658 (717)
.....++..|+|||++.+..++.++|||||||++||+++|+.||......+. ....+......
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 227 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ--------- 227 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh---------
Confidence 1234688999999998888999999999999999999999999976432210 01111111110
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
...+.. ...+++.++.+++.+|++.||++|||+.|+++..
T Consensus 228 ---~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 228 ---EPPPRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---ccCCCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000000 1113556788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=302.27 Aligned_cols=253 Identities=23% Similarity=0.423 Sum_probs=204.4
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|+..+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+++++.++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788999999999999999998778889999887543 234678889999999999999999999887 7789999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++++|.+++... ....++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999863 445788999999999999999999 578999999999999999999999999998765432211
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......++..|+|||++..+.++.++|+||||+++|++++ |+.||..... .....+.......
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~------------- 222 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRM------------- 222 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCCC-------------
Confidence 1122345677999999988889999999999999999999 8999865321 1222222211100
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
+.....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=308.75 Aligned_cols=265 Identities=25% Similarity=0.309 Sum_probs=197.9
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999975 78999999886543 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSHN--YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
++ ++|.+++.... ..+++..+..++.|+++||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH----SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68999887532 45899999999999999999999 6789999999999999999999999999987654322
Q ss_pred CceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC---ch---hhh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH---RL---TEV 655 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~ 655 (717)
.......+++.|+|||+..+ ..++.++||||||+++|||+||+.||....... ............ .+ ...
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhh
Confidence 11233456889999998765 457899999999999999999999997532211 111111100000 00 000
Q ss_pred cc--ccchhhh--hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 656 VD--ANLVREE--QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 656 ~~--~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+ ....... ........++.++.+++.+||..||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0000000 000011124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.27 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=198.3
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC------
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNL------ 495 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~------ 495 (717)
.+.+.|+..+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678899999999999999999865 688999999865432 235678899999998 699999999998642
Q ss_pred CeeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecc
Q 005040 496 DFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 574 (717)
...++||||+.+++|.+++... ...+++..+..++.|++.|++||| +.+|+|+||+|+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH----~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4679999999999999999864 345899999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccC-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGS-----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 649 (717)
+........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||....... ...... .
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~~~~-~ 230 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALFLIP-R 230 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHHHHh-c
Confidence 876533211 123346889999999875 3468889999999999999999999986532211 111000 0
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. .... ....++.++.+++.+||..+|.+|||+.|+++
T Consensus 231 ~~-----~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NP-----APRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC-----CCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 0000 01123456889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=306.78 Aligned_cols=248 Identities=28% Similarity=0.478 Sum_probs=197.1
Q ss_pred ccccccccEEEEEEEecC-------CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 433 NLLGTGGFGSVYKGTLSD-------GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2578999876443 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-----cEEEeeec
Q 005040 505 MPNGSLEKWLYSH------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-----VAHVSDFG 573 (717)
Q Consensus 505 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg 573 (717)
+++++|.+++... ...+++..+..++.|++.|++||| +.+++|+||||+||+++.++ .++++|||
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH----hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999742 234788999999999999999999 67899999999999999887 89999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCch
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRL 652 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 652 (717)
++................++..|+|||++.++.++.++||||||+++|||++ |+.||..... ......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~---- 230 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTAGG---- 230 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhcCC----
Confidence 9976643332222223345778999999999999999999999999999998 9999864321 11111111000
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
.......++..+.+++.+||..+|.+||+++++++.|+
T Consensus 231 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 -------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00111234566889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.97 Aligned_cols=262 Identities=25% Similarity=0.316 Sum_probs=193.7
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhc---CCCceeeEeeeeec-----CC
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNV---RHRNLLKILGSCSN-----LD 496 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~-----~~ 496 (717)
+|++.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+++++.+ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999876 789999998865321 1223455677777665 69999999998754 34
Q ss_pred eeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
..++||||+. ++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5799999997 5899988754 334899999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-CCC--ch
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES-LPH--RL 652 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~--~~ 652 (717)
........ .....+|..|+|||++.+..++.++||||+||++|||++|++||...... ..+.+..... .+. .+
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhC
Confidence 87643221 12345789999999998889999999999999999999999998653221 1122211111 000 00
Q ss_pred hh-------hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 653 TE-------VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 653 ~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ...+........ ...+++.++.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQS--VVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHH--hCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000000000 01134566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=306.60 Aligned_cols=248 Identities=26% Similarity=0.326 Sum_probs=202.7
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|+..+.||.|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999975 78899999987543 33446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++... .+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999999875 5899999999999999999999 6789999999999999999999999999998775432
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
.......+++.|+|||+..+..++.++||||||+++|||++|+.||....... ....+....+ +.+.
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~--------~~~~--- 219 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNNP--------PSLE--- 219 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcCC--------CCCc---
Confidence 11233467889999999988889999999999999999999999996532111 1100110000 0000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. ..++.++.+++.+||..+|++|||++++++
T Consensus 220 ----~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 ----G-NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ----c-cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 014456889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.23 Aligned_cols=248 Identities=31% Similarity=0.514 Sum_probs=194.8
Q ss_pred ccccccccEEEEEEEec-CCC--eEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGT--NVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|..+ ++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999975 444 46888876432 34456788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 005040 508 GSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDF 572 (717)
Q Consensus 508 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 572 (717)
|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||+++.++.+|++||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccccceEEEcCCCeEEECCC
Confidence 99999997532 24789999999999999999999 679999999999999999999999999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCc
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHR 651 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 651 (717)
|++..... .........+..|+|||+.....++.++||||||+++|||++ |..||...... .......... .
T Consensus 157 gl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~--~ 229 (270)
T cd05047 157 GLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQGY--R 229 (270)
T ss_pred CCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHHHhCCC--C
Confidence 99863221 111112234667999999988889999999999999999997 99998653211 1111110000 0
Q ss_pred hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 652 LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
. .....++.++.+++.+|++.+|.+|||+.++++.|+++.
T Consensus 230 --------~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 --------L-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------C-------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 001123456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=313.51 Aligned_cols=265 Identities=18% Similarity=0.230 Sum_probs=195.5
Q ss_pred cccccccc--ccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 431 ECNLLGTG--GFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 431 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
+.++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 68899999875 78999999997543 334456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999754 334899999999999999999999 678999999999999999999999999875443211110
Q ss_pred -----eeeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCch-----
Q 005040 585 -----VIQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL----- 652 (717)
Q Consensus 585 -----~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 652 (717)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... .......+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhcCCccccccccch
Confidence 01122346778999998865 458999999999999999999999997533221111 11111111000
Q ss_pred --hh--------hccccchh----------h--hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 653 --TE--------VVDANLVR----------E--EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 653 --~~--------~~~~~~~~----------~--~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+ ..+..... . ....+....++.++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 00000000 0 0000111234567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=315.38 Aligned_cols=266 Identities=21% Similarity=0.262 Sum_probs=197.3
Q ss_pred HHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC----
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL---- 495 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~---- 495 (717)
....++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999864 78899999986543 22335577899999999999999999987543
Q ss_pred --CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 005040 496 --DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573 (717)
Q Consensus 496 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 573 (717)
...++++|++ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhhEEECCCCCEEEcCCc
Confidence 3568999988 77999888653 3899999999999999999999 6899999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc-
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR- 651 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 651 (717)
++...... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+..+........
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 237 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSP 237 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCH
Confidence 99865432 123468999999998776 56899999999999999999999999653211 11111111110000
Q ss_pred -hhhhcccc----chhhhhhhhh------hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 652 -LTEVVDAN----LVREEQAFSD------KMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 652 -~~~~~~~~----~~~~~~~~~~------~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
....+... .....+..+. .......+.+++.+|+..||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0000000000 01123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=305.80 Aligned_cols=240 Identities=22% Similarity=0.341 Sum_probs=190.0
Q ss_pred ccccccccEEEEEEEec-C-------CCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 433 NLLGTGGFGSVYKGTLS-D-------GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+.||+|+||.||+|..+ . ...||+|.+........+.+.+|+.+++.+.||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999864 2 234888887665555567788899999999999999999999998899999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc--------EEEeeecccc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV--------AHVSDFGISK 576 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfgl~~ 576 (717)
+++|+|.++++.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++. ++++|||.+.
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE----DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999876666899999999999999999999 689999999999999987765 6999999887
Q ss_pred ccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCC-CCCCccccCcchHHHHHHhhCCCchhh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEK-KPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
..... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...... ........
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~-------- 220 (258)
T cd05078 157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQFYED-------- 220 (258)
T ss_pred ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHHHHHc--------
Confidence 55321 22357888999998876 45799999999999999999995 555432111 00000000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
. ...+ .....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ----~-----~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ----R-----HQLP--APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----c-----ccCC--CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0000 112345789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.44 Aligned_cols=326 Identities=21% Similarity=0.247 Sum_probs=240.2
Q ss_pred ccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcc
Q 005040 8 ITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPL 87 (717)
Q Consensus 8 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 87 (717)
|.++.+|+.++|.+|.++ .+|...+...+|+.|+|.+|.|+.+..+ .+..++.|+.||||.|.|+.+.-+.
T Consensus 98 f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se--------~L~~l~alrslDLSrN~is~i~~~s 168 (873)
T KOG4194|consen 98 FYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSE--------ELSALPALRSLDLSRNLISEIPKPS 168 (873)
T ss_pred HhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHH--------HHHhHhhhhhhhhhhchhhcccCCC
Confidence 344555555555555554 3444333333455555555555554433 2667777788888888887666566
Q ss_pred hhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCC
Q 005040 88 IGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167 (717)
Q Consensus 88 ~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L 167 (717)
|.+- .++++|+|++|+|+...-..|.++.+|.+|.|++|+|+...+..|.+|++|+.|+|..|+|.-.....|.++++|
T Consensus 169 fp~~-~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl 247 (873)
T KOG4194|consen 169 FPAK-VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSL 247 (873)
T ss_pred CCCC-CCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhh
Confidence 6553 468888888888887777888888888888888888887777778888888888888888885556678888888
Q ss_pred CEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCC
Q 005040 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRN 247 (717)
Q Consensus 168 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 247 (717)
+.|.|..|.|.....+.|-.+.++++|+|..|++...-..++.+++.|+.|+||+|.|..+-++.+...++|++|+|++|
T Consensus 248 ~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N 327 (873)
T KOG4194|consen 248 QNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSN 327 (873)
T ss_pred hhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccc
Confidence 88888888888777778888888888888888888777777888888888888888888777888888888888888888
Q ss_pred CCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcc---cccccccccEEEccCCccccc
Q 005040 248 QLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPK---SLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~---~~~~l~~L~~L~l~~N~l~~~ 324 (717)
+|+...+..|..+..|++|+|++|+++..-...|..+.+|+.|||++|.++..+.+ .|.+|++|+.|+|.||++...
T Consensus 328 ~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I 407 (873)
T KOG4194|consen 328 RITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSI 407 (873)
T ss_pred ccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeec
Confidence 88887788888888888888888888877677788888888888888888765543 577788888888888888754
Q ss_pred ccc-cccccccccccccCCc
Q 005040 325 IPV-KGSFKDFSAQSYFGNY 343 (717)
Q Consensus 325 ~p~-~~~~~~~~~~~~~~n~ 343 (717)
... ...++.++.+.+-+|+
T Consensus 408 ~krAfsgl~~LE~LdL~~Na 427 (873)
T KOG4194|consen 408 PKRAFSGLEALEHLDLGDNA 427 (873)
T ss_pred chhhhccCcccceecCCCCc
Confidence 332 2345555555555554
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=316.99 Aligned_cols=262 Identities=20% Similarity=0.209 Sum_probs=195.8
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++.+....++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3468999999999999999999975 6788999975432 23458999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
++. ++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 995 6999999877677999999999999999999999 6789999999999999999999999999987532211
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc-c--------hHHHHHHhh--CCCch
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE-M--------SLRRWVKES--LPHRL 652 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~-~--------~~~~~~~~~--~~~~~ 652 (717)
......||..|+|||++.+..++.++|||||||++|||+++..|+-...+.. . .+.+.+... .+...
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 1223468999999999999999999999999999999999666542221111 0 111111100 00000
Q ss_pred h---------hhcccc-chh-hh--hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 653 T---------EVVDAN-LVR-EE--QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 653 ~---------~~~~~~-~~~-~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. ..++.. ... .. ........++.++.++|.+||+.||++|||+.||++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 0 000000 000 00 000111133455678999999999999999999986
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=307.99 Aligned_cols=269 Identities=21% Similarity=0.289 Sum_probs=199.3
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++++|...+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++.+++.+.+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999864 789999999865432 22235678999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+. +++.+++......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH----GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 7888887765555788889999999999999999 6789999999999999999999999999987643222
Q ss_pred CceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHH-hhCC-----------
Q 005040 583 DSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK-ESLP----------- 649 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~----------- 649 (717)
.. .....+++.|+|||+..+ ..++.++||||||+++|||++|+.||....+....+.+... ...+
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 QT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 11 123356889999998765 45788999999999999999999999754322111111110 0001
Q ss_pred -CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 650 -HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 650 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....+...................+.++.+++.+|+..||++|||++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000000111112456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=301.24 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=203.2
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||.|+||.||.++.. +++.+++|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999854 78899999876442 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++++|.+++... ...+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999865 455899999999999999999999 67899999999999999999999999999987643321
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......+++.|+|||+..+..++.++||||||+++|||++|+.||..... ........... ..
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~--------~~-- 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQGN--------YT-- 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCC--------CC--
Confidence 12334688999999998888899999999999999999999999865221 11111111100 00
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+....++.++.+++.+||..+|++||+++++++.
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0012345668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=304.05 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=188.5
Q ss_pred ccccccccEEEEEEEecC---CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 433 NLLGTGGFGSVYKGTLSD---GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 4568888775443 333456888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 509 SLEKWLYSHN----YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 509 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+|.+++.... ...++.....++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH----hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 9999998643 22467788899999999999999 678999999999999999999999999998754332222
Q ss_pred eeeeccccCccccCCCccC-------CCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 585 VIQTMTMATIGYMAPEYGS-------EGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~-------~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
.......++..|+|||+.. ...++.++|||||||++|||++ |..||......+ .+....... . ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~-~---~~~~ 231 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQ-D---IKLP 231 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhcc-C---ccCC
Confidence 2223334577899999753 3457889999999999999999 778886532211 111111110 0 0000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
.+.. ...++..+.+++..|+ .||++|||++||++.|.
T Consensus 232 ~~~~---------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL---------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc---------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1110 1133455678888998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=311.68 Aligned_cols=246 Identities=27% Similarity=0.344 Sum_probs=202.5
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
..|...+-||+|.||.||-|... +.+.||||.+.... .+.+.++.+|+++|++++|||+|.+-|+|-......+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34566678999999999999864 78889999986443 455688999999999999999999999999888899999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|||- |+-.|.+.-..+++-+..+..|+.+.+.||+||| +.+.+|||||+.|||+++.|.|||+|||.+....+.
T Consensus 106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH----S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH----HhhHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 9995 5888888877777899999999999999999999 789999999999999999999999999999876543
Q ss_pred CceeeeccccCccccCCCcc---CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 583 DSVIQTMTMATIGYMAPEYG---SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
..++|||.|||||++ ..+.|+-|+||||+|++..|+...++|+-.+.. +.-..-+.+..+..+.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQNesPtLq------ 246 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNESPTLQ------ 246 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHhcCCCCCC------
Confidence 456799999999974 458899999999999999999999999754321 1111112222111111
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+.+..+.+++..|+++-|.+|||..+++..
T Consensus 247 ----------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ----------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 12345668999999999999999999998764
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=327.04 Aligned_cols=266 Identities=22% Similarity=0.251 Sum_probs=193.0
Q ss_pred HHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCC------CceeeEeeeeec
Q 005040 422 IRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRH------RNLLKILGSCSN 494 (717)
Q Consensus 422 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------pniv~~~~~~~~ 494 (717)
+....++|++.+.||+|+||+||+|... .++.||||+++... ...+.+..|+++++.++| ++++.+++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999865 68889999986432 223445667777777754 458899998865
Q ss_pred C-CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC--------
Q 005040 495 L-DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-------- 565 (717)
Q Consensus 495 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-------- 565 (717)
. .+.++|||++ +++|.+++...+ .+++..+..++.||+.||.|||. ..+|+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~---~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHT---ELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5788999988 679999887654 48999999999999999999993 25899999999999998765
Q ss_pred --------cEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc
Q 005040 566 --------VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637 (717)
Q Consensus 566 --------~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 637 (717)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||+.....
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~- 351 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL- 351 (467)
T ss_pred cccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-
Confidence 4999999987643221 23457899999999999999999999999999999999999999763221
Q ss_pred chHHHHHHhh---CCCch---------hhhccc------cchhh----hhh--hhhhHHHHHHHHHHHhhccCCCCCCCC
Q 005040 638 MSLRRWVKES---LPHRL---------TEVVDA------NLVRE----EQA--FSDKMDCLFSIMDLALDCCMDTPHKRI 693 (717)
Q Consensus 638 ~~~~~~~~~~---~~~~~---------~~~~~~------~~~~~----~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rp 693 (717)
.....+... .+..+ .++++. ..... ... ..........+.+||.+||+.||++||
T Consensus 352 -~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 352 -EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred -HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 111111110 01000 000000 00000 000 000001134578999999999999999
Q ss_pred CHHHHHH
Q 005040 694 HMTDAAA 700 (717)
Q Consensus 694 t~~ev~~ 700 (717)
|++|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999987
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=317.61 Aligned_cols=265 Identities=22% Similarity=0.233 Sum_probs=197.4
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC------
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL------ 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------ 495 (717)
..++|+..+.||+|+||.||+|... .++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999865 68899999986532 23345677899999999999999999987543
Q ss_pred CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
...++||||+++ ++.+++.. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH----~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999965 77777754 3788899999999999999999 689999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC-----
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH----- 650 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 650 (717)
+...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .....+......
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 8654321 1233468999999999999899999999999999999999999997532111 111111110000
Q ss_pred -----chhhhcccc-------chhhhh------hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 651 -----RLTEVVDAN-------LVREEQ------AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 651 -----~~~~~~~~~-------~~~~~~------~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.....++.. +..... ..........++.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 000000 000011124567899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=303.69 Aligned_cols=253 Identities=25% Similarity=0.302 Sum_probs=204.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|+..+.||+|+||.||+|..+ +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999976 78999999887653 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++++|.+++......+++..+..++.|++.|++||| + .+++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH----EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc----CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999999876566899999999999999999999 5 7999999999999999999999999999876532211
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
....++..|+|||+..+..++.++||||||+++|+|++|+.||.....................
T Consensus 157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 220 (265)
T cd06605 157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------------ 220 (265)
T ss_pred ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------------
Confidence 1156788999999998889999999999999999999999998754222121222211111100
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+..+. ..++.++.++|.+||..+|++|||+.+++.
T Consensus 221 ~~~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 221 PPRLPS-GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCCh-hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 000001 114566889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=309.28 Aligned_cols=266 Identities=22% Similarity=0.283 Sum_probs=198.5
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999975 78999999986542 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++ ++|.+++......+++..+..++.|+++||.||| +.+++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH----SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 96 5899888766566899999999999999999999 678999999999999999999999999999865432211
Q ss_pred eeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc------hhhhcc
Q 005040 585 VIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR------LTEVVD 657 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 657 (717)
.....++..|+|||++.+. .++.++|||||||++|||+||+.|+.........+........... .....+
T Consensus 156 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred --cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 1234568899999987664 4789999999999999999999986432222211111111100000 000000
Q ss_pred cc----chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 AN----LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ......-.......+.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 00000000011134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=339.39 Aligned_cols=255 Identities=20% Similarity=0.284 Sum_probs=197.7
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec--CCee
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN--LDFK 498 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~ 498 (717)
...++|++.+.||+|+||+||+|... ++..||+|++.... ......+..|+.++++++||||++++++|.+ ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999975 67789999886432 3345678899999999999999999998844 4568
Q ss_pred EEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcC---CCCCeEecCCCCCCeeeCC---------
Q 005040 499 ALVLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCH---SSAPIIHCDLKPTNILLDE--------- 563 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~---~~~~ivH~dlk~~Nill~~--------- 563 (717)
|+||||+++|+|.+++... ...+++..++.|+.||+.||.|||... ...+|+||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999753 245899999999999999999999532 0146999999999999964
Q ss_pred --------CCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 005040 564 --------NMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEM 633 (717)
Q Consensus 564 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~ 633 (717)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23589999999987643221 234468999999998753 45889999999999999999999999642
Q ss_pred ccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 634 FTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ....+...... +.+ ....++.++.+||..||..+|.+||++.|++.
T Consensus 247 ~~----~~qli~~lk~~-------p~l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN----FSQLISELKRG-------PDL--------PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc----HHHHHHHHhcC-------CCC--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 11111111000 000 00123456889999999999999999999984
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.28 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=199.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|++.+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999976 78999999886542 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSH--NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
+++++|.+++... ...+++..+..++.|++.|+.|||+ +.+|+||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE---EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999998764 2358999999999999999999994 3589999999999999999999999999987653221
Q ss_pred CceeeeccccCccccCCCccCCC------CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEG------IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
.....++..|+|||.+.+. .++.++|+|||||++|||++|+.||....... .... .. ...
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~-~~--------~~~ 223 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQ-LS--------AIV 223 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHH-HH--------HHh
Confidence 1233578899999987544 35889999999999999999999996532111 0000 00 000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+... . ..+.+++.++.+++.+|+..+|++||++.+++..
T Consensus 224 ~~~~----~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 DGDP----P--TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hcCC----C--CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0000 0 0111345668899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.28 Aligned_cols=195 Identities=22% Similarity=0.278 Sum_probs=159.7
Q ss_pred cccccccccEEEEEEEec---CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec--CCeeEEEEEccC
Q 005040 432 CNLLGTGGFGSVYKGTLS---DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN--LDFKALVLEFMP 506 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~ 506 (717)
.++||+|+||+||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 56789999886442 12456789999999999999999998854 456789999995
Q ss_pred CCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCcEEEeeecc
Q 005040 507 NGSLEKWLYSH--------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGI 574 (717)
Q Consensus 507 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl 574 (717)
++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||+ +..+.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5898887632 234889999999999999999999 6889999999999999 4667999999999
Q ss_pred ccccCCCCCc-eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 005040 575 SKLLGEGEDS-VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEM 633 (717)
Q Consensus 575 ~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~ 633 (717)
++........ .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876433211 11234568999999998876 45899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.07 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=202.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++++.||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46778889999999999999875 68899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++|+|.+++... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh----~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 9999999999764 3788999999999999999999 67899999999999999999999999999976543221
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......++..|+|||++.+..++.++|+||||+++|||++|+.||....+... ...+....+ +
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~--------~------ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LFLIPKNNP--------P------ 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hhhhhcCCC--------C------
Confidence 12334578899999999888899999999999999999999999875432111 000000000 0
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.....++..+.+++.+||+.+|++||++.++++.
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 ---TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0112355678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.35 Aligned_cols=256 Identities=21% Similarity=0.247 Sum_probs=201.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999976 67899999987553 233456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++++|.+++...+ .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999998754 4889999999999999999999 6789999999999999999999999999886421110
Q ss_pred C-------------ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC
Q 005040 583 D-------------SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649 (717)
Q Consensus 583 ~-------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 649 (717)
. ........++..|+|||++.+..++.++|+||||+++|||++|+.||.+.... ++......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~~~~~ 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQVIS 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh
Confidence 0 00111235788899999988888999999999999999999999998653211 11111000
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
.... .+ .....++.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 ~~~~---~~---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDIE---WP---------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccC---CC---------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000 00 0001245668899999999999999997766666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.90 Aligned_cols=251 Identities=26% Similarity=0.328 Sum_probs=206.3
Q ss_pred ccCCccccccccccEEEEEEEecC-CCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
+-|+++.-||.|+||.||+|..++ +-..|.|++.....+..++|.-|+++|+.+.||+||++++.|...+.+.+..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345677889999999999999874 3445778888777888899999999999999999999999988888899999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
.||.+...+-+-+..+.+.++.-+++|++.||.||| +..|+|||||+.|||++-+|.++|+|||.+..... ...
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH----s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH----SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ 185 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh----hcchhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence 999999999888888999999999999999999999 78999999999999999999999999999864321 112
Q ss_pred eeeccccCccccCCCc-----cCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 586 IQTMTMATIGYMAPEY-----GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~-----~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
....+.|||+|||||+ .+..+|+.++||||||++|.||..+.+|-....+ ++..++. -
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----MRVllKi-------------a 248 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKI-------------A 248 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----HHHHHHH-------------h
Confidence 2345689999999995 4567899999999999999999999999654221 1111111 1
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.+++....+...+..+.+++.+|+..+|..||++.++++
T Consensus 249 KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 249 KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1122233334455667889999999999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=305.04 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=202.3
Q ss_pred ccCCccccccccccEEEEEEEec------CCCeEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+.....+ ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999864 3467999988654433 4567889999999999999999999999989999
Q ss_pred EEEEccCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 005040 500 LVLEFMPNGSLEKWLYSHN--------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSD 571 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 571 (717)
+||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS----NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh----hcCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999998543 14899999999999999999999 67899999999999999999999999
Q ss_pred eccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCC
Q 005040 572 FGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 572 fgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........ .
T Consensus 161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~---~ 234 (275)
T cd05046 161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQA---G 234 (275)
T ss_pred cccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHc---C
Confidence 999875432221 11223345778999999888889999999999999999999 78888543211 11111110 0
Q ss_pred chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 651 RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
.... .....++..+.+++.+||+.+|++||++.|+++.|.
T Consensus 235 ~~~~-------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL-------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC-------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000 001134456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=305.69 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=200.5
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35667788999999999999865 68889999987443 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++... .+++..+..++.|+++|+.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH----~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 84 LGGGSALDLLKPG--PLEETYIATILREILKGLDYLH----SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred cCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh----cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999999998753 4789999999999999999999 67899999999999999999999999999876543221
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....... ...++....+ +.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~--------~~~---- 221 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKNSP--------PTL---- 221 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcCCC--------CCC----
Confidence 1123357889999999998889999999999999999999999986532211 1111111000 000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...++.++.+++.+|++.+|++||++.++++
T Consensus 222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 222 -----EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -----CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1123456889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.95 Aligned_cols=265 Identities=20% Similarity=0.210 Sum_probs=197.4
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC------
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL------ 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------ 495 (717)
..++|+..+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999865 68899999986532 23345677899999999999999999987543
Q ss_pred CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
...|+||||++ ++|.+++.. .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999996 478877754 2788899999999999999999 689999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC--chh
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH--RLT 653 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 653 (717)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... ............. ...
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 8654321 123346899999999999999999999999999999999999999753221 1111111110000 000
Q ss_pred hhccccchh---h------------hhh------hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 654 EVVDANLVR---E------------EQA------FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 654 ~~~~~~~~~---~------------~~~------~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+.+.... . .+. .........++.+++.+|++.||.+|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 0 000 00001123568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.69 Aligned_cols=248 Identities=21% Similarity=0.323 Sum_probs=201.6
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788999999999999999865 78999999987542 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+.+++|.+++... ...+++.++..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999999764 335789999999999999999999 67899999999999999999999999999976643221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
. .....+++.|+|||+..+..++.++|+||||+++|+|++|+.||..... ...+........
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~----------- 218 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGSY----------- 218 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCCC-----------
Confidence 1 1233578899999999888899999999999999999999999864211 111111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. .....++.++.+++.+||+.+|++||++.||++
T Consensus 219 -~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 -P--PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -C--CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 011234566889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.78 Aligned_cols=258 Identities=24% Similarity=0.306 Sum_probs=199.6
Q ss_pred HHHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeee----
Q 005040 420 LDIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCS---- 493 (717)
Q Consensus 420 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~---- 493 (717)
..+..+.++|++.+.||+|+||.||+|... +++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 344556789999999999999999999875 688999998764322 235677899999999 6999999999873
Q ss_pred -cCCeeEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 005040 494 -NLDFKALVLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV 569 (717)
Q Consensus 494 -~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl 569 (717)
..+..++||||+++++|.+++.. ....+++..+..++.|+++|+.||| +.+++||||||+||+++.++.++|
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH----VNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH----hCCccccCCCHHhEEECCCCCEEE
Confidence 44578999999999999998863 2345889999999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccC-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS-----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWV 644 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 644 (717)
+|||++........ ......|++.|+|||++. +..++.++||||+||++|||++|+.||...... ....
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~~~ 239 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RALF 239 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HHHh
Confidence 99999876643221 122346899999999864 345789999999999999999999998653211 1110
Q ss_pred HhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 645 KESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
. ......... ..+..++.++.+++.+||+.||++|||+.|+++.
T Consensus 240 ~-~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 K-IPRNPPPTL------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred h-ccccCCCcc------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000000000 0011233568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.13 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=199.3
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec-CCeeEEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN-LDFKALVLE 503 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e 503 (717)
+|++.+.||+|++|.||++..+ +++.||+|.+.... ....+.+.+|++++++++|||++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999865 67889999986543 3345668889999999999999999998764 446789999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 504 FMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 504 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|+++++|.+++... ...+++.++..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH----~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH----EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999864 345899999999999999999999 6789999999999999999999999999998664322
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. ......+++.|+|||+..+..++.++||||+|+++|||++|+.||..... .............
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~--------- 220 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGKLP--------- 220 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCCC---------
Confidence 1 12334578899999999999999999999999999999999999865221 1111111000000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......+..+.+++.+|++.+|++||++.++++
T Consensus 221 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 -----PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -----CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001134456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.71 Aligned_cols=256 Identities=27% Similarity=0.340 Sum_probs=205.1
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|||++++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999865 78899999986443 33557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSH--NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
+++++|.++++.. ...+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh----~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH----SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999864 245899999999999999999999 6889999999999999999999999999998765433
Q ss_pred Cce--eeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 583 DSV--IQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 583 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
... ......++..|+|||++... .++.++|+||||+++|||++|+.||...... .......... +..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~-------- 226 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQND-PPS-------- 226 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCC-CCC--------
Confidence 221 22334588999999988776 7899999999999999999999999754221 1111111110 000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.. ......++.++.+++.+|+..||++||+++++++
T Consensus 227 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LET----GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCC----ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0001234567889999999999999999999876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.37 Aligned_cols=238 Identities=24% Similarity=0.416 Sum_probs=189.7
Q ss_pred ccccccccEEEEEEEecCCC-----------eEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 433 NLLGTGGFGSVYKGTLSDGT-----------NVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
+.||+|+||.||+|...+.. .|++|++...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999976332 5788877655433 5778899999999999999999999887 778999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-------cEEEeeecc
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-------VAHVSDFGI 574 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfgl 574 (717)
|||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE----DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 9999999999999876656899999999999999999999 68899999999999999887 799999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCC--CcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCc
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEG--IVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHR 651 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 651 (717)
+..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...... ....+.... ..
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~~--~~ 224 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQDQ--HR 224 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhcC--CC
Confidence 986543 1223466789999998776 78999999999999999999 57777553211 111111100 00
Q ss_pred hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 652 LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
.. . .....+.+++.+||..+|.+|||+.++++.|+
T Consensus 225 --------~~-------~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 --------LP-------M--PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------CC-------C--CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 00145789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=302.85 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=198.8
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh---------HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---------ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF 497 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 497 (717)
+|.+...||+|+||.||+|... +++.||+|.+.... .+..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999864 68899999885432 1233568889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.++||||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH----~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH----NRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH----hcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999998753 4788999999999999999999 67899999999999999999999999999887
Q ss_pred cCCCCCc----eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchh
Q 005040 578 LGEGEDS----VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLT 653 (717)
Q Consensus 578 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 653 (717)
....... .......++..|+|||.+.+..++.++||||+|+++|||++|+.||....... ... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~-~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIF-KIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHH-HHhc-------
Confidence 6422111 11122357889999999998889999999999999999999999997531110 000 0000
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...+.+ +..++..+.+++.+||+.||.+||++.|+++
T Consensus 227 -~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -NASPEI---------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -cCCCcC---------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000000 1133466889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.87 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=203.1
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 68889999999999999999864 78899999987554445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++++|.+++.+.. +++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH----~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH----hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 9999999998643 788999999999999999999 68999999999999999999999999999876543322
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
......+++.|+|||+..+..++.++||||||+++||+++|+.||........ ... ... ...+
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~-~~~---------------~~~~ 233 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-IAT---------------NGTP 233 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eee-hhc---------------CCCC
Confidence 12334578899999998888899999999999999999999999965322110 000 000 0000
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
........+..+.+++.+||..+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112234568899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.51 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=198.2
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh----------HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL----------ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD 496 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 496 (717)
+|...+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999864 78999999875321 112346788999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..++||||+++++|.++++... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++++|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH----SKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh----hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999998764 4889999999999999999999 6789999999999999999999999999987
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCC--cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGI--VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
...............++..|+|||...... ++.++|+||||+++||+++|..||..... ...+... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~ 231 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFKL-GNKRSAP 231 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHHh-hccccCC
Confidence 654322111123345788999999876654 88999999999999999999999864211 1111110 0000000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+... ...+++.++.+++.+|+..+|++||++.++++
T Consensus 232 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PIPPD---------VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcc---------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000 01134567889999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.57 Aligned_cols=266 Identities=23% Similarity=0.271 Sum_probs=202.8
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999975 78999999987553 33346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+ +++|.+++......+++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH----ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 99999999876667999999999999999999999 67899999999999999999999999999987654321
Q ss_pred eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC----chhhhccc-
Q 005040 585 VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH----RLTEVVDA- 658 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~- 658 (717)
.......++..|+|||++.+ ..++.++||||+|+++|||++|++||....+. ..+ .++...... .+.+..+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQL-AIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHH-HHHHHHcCCCChHHHhhccCcc
Confidence 11233468899999998765 44689999999999999999998887653221 111 111111110 00000000
Q ss_pred -----cchhhhh-hh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 659 -----NLVREEQ-AF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 659 -----~~~~~~~-~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
....... .. ....+.+.++.+++.+|++.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00 0001334678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.41 Aligned_cols=265 Identities=22% Similarity=0.257 Sum_probs=200.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++|||++++++++.+....++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999976 68999999886442 1223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|++++.|..+..... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH----KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999988887765443 4899999999999999999999 67899999999999999999999999999987654321
Q ss_pred ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHH---hhCCCchhhhccc-
Q 005040 584 SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK---ESLPHRLTEVVDA- 658 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~- 658 (717)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+. ...... ...+ ...+..+.
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~ 231 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIP-RHQQIFSTN 231 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCh-HHhhhcccc
Confidence 1223357888999998765 5688999999999999999999999976432211 111111 0000 00000000
Q ss_pred ---------cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 659 ---------NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 659 ---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...............+..+.+++.+||+.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000001133567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=307.81 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=199.3
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
.|.....||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3344467999999999999865 688999999876555556778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+++|.+++... .+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||++........ .
T Consensus 103 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 174 (292)
T cd06658 103 GGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K 174 (292)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence 99999988654 3789999999999999999999 67899999999999999999999999999876532221 1
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (717)
.....++..|+|||+..+..++.++||||||+++|||++|+.||...... .....+....+ ...
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~--------~~~------ 238 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLP--------PRV------ 238 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCC--------Ccc------
Confidence 12345789999999998888999999999999999999999998652211 11111111111 110
Q ss_pred hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 667 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
......+..+.+++.+|+..||++|||++|+++.
T Consensus 239 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 -KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111234567899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=312.99 Aligned_cols=240 Identities=23% Similarity=0.212 Sum_probs=185.6
Q ss_pred ccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc---CCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 435 LGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV---RHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 435 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
||+|+||+||+|+.. +++.||+|++.... .........|..++... +||+|+++++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 68999999997543 22233445567777665 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+|||++........ ..
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~ 153 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH----KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TT 153 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Cc
Confidence 99999988654 4899999999999999999999 68899999999999999999999999999875432221 12
Q ss_pred eccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (717)
....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .+......... ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~------~~~~----- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGK------VRFP----- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCC------CCCC-----
Confidence 345689999999987654 489999999999999999999999865321 11111100000 0000
Q ss_pred hhhhHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 005040 667 FSDKMDCLFSIMDLALDCCMDTPHKRIH----MTDAAA 700 (717)
Q Consensus 667 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt----~~ev~~ 700 (717)
...++.++.+++.+||+.||.+||+ +.++++
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0123455779999999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.26 Aligned_cols=195 Identities=30% Similarity=0.363 Sum_probs=169.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-C-----CceeeEeeeeecCCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-H-----RNLLKILGSCSNLDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----pniv~~~~~~~~~~~~~ 499 (717)
-+|++.+.||+|.||.|-+|... +++.||||+++.... -.++...|+.+|..++ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 38899999999999999999864 799999999986643 3455677999999996 4 38999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC--cEEEeeecccc
Q 005040 500 LVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM--VAHVSDFGISK 576 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgl~~ 576 (717)
||+|.+. -+|+++++.+. ..++...++.++.||+.||.+|| +.+|||+||||+|||+.+.. .+||+|||+|+
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~----~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH----ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999995 59999999653 44899999999999999999999 67899999999999997433 79999999999
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDE 632 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 632 (717)
....... ...-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 8654433 23457789999999999999999999999999999999877765
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=296.93 Aligned_cols=250 Identities=32% Similarity=0.530 Sum_probs=201.3
Q ss_pred CCccccccccccEEEEEEEecC-----CCeEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 429 FNECNLLGTGGFGSVYKGTLSD-----GTNVAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
+++.+.||.|+||.||++...+ +..||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999753 378999999755432 5678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 503 EFMPNGSLEKWLYSHNYF-LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
||+++++|.+++...... +++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh----~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh----cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999865444 899999999999999999999 679999999999999999999999999999876544
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
..... ....+++.|+|||...+..++.++||||+|+++|||++ |+.||..... ....+.+......
T Consensus 157 ~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~---------- 223 (258)
T smart00219 157 DYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGYRL---------- 223 (258)
T ss_pred ccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCC----------
Confidence 22211 12236789999999988889999999999999999998 7888765211 1111111110000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
.....++.++.+++.+|+..+|++|||+.|+++.|
T Consensus 224 -------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00112456688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=298.81 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=209.6
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
+.+-|+..+.||+|.|+.|-+|++- +|..||||++.+.. .-....+.+|+++|+-++|||||++|++......+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 3467888899999999999999864 89999999998765 33446788899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeeccccccCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~ 580 (717)
.|.-.+|+|.+|+-++...+.+.-..+++.||+.|+.|+|+.| +|||||||+||.+- .-|-|||+|||++..+.+
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH----VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH----VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh----hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999999988777999999999999999999999655 99999999998775 688999999999987765
Q ss_pred CCCceeeeccccCccccCCCccCCCCcC-cccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVS-TKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
+.. -...+|+..|-|||.+.+..|+ ++.||||+|||+|-+++|+.||....+.+. +..++|=.
T Consensus 172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDCK 235 (864)
T KOG4717|consen 172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDCK 235 (864)
T ss_pred cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhccc
Confidence 443 3556899999999999888875 679999999999999999999987443321 22233322
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+ ..+...+.+..++|..|+.-||.+|.+.+|++.
T Consensus 236 Y-------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 Y-------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c-------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2 223345667789999999999999999998864
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=298.84 Aligned_cols=250 Identities=25% Similarity=0.316 Sum_probs=194.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCceeeEeeeeec--CCee
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-----ERAFRSFDSECEILRNVRHRNLLKILGSCSN--LDFK 498 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~ 498 (717)
.+|+..+.||+|+||.||+|... +++.||+|++.... .+....+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999865 68999999875331 2344568889999999999999999998865 3567
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++++||+++++|.+++..... +++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH----~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 899999999999999986543 789999999999999999999 678999999999999999999999999998765
Q ss_pred CCCCCc-eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 579 GEGEDS-VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 579 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
...... .......++..|+|||++.+..++.++||||+||++|||++|+.||...... .. +....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~-~~~~~~~~----~~ 227 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AA-IFKIATQP----TN 227 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HH-HHHHhcCC----CC
Confidence 432111 1112345788999999999888999999999999999999999999753211 11 11100000 00
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.+ +..+...+.+++ .||..+|++||+++|+++
T Consensus 228 ~~~---------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 PQL---------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC---------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 112234466777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=303.65 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=206.8
Q ss_pred HHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeE
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~ 499 (717)
......|++.++||.||.+.||++...+.+.+|+|.+.... .+....|..|+..|.+++ |.+||++++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 33456899999999999999999998888888888664332 556678999999999995 999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
|||||= ..||..++++.....+...+..+..|++.|+.++| ..||||.||||.|+|+-. |.+||+|||.|.-+.
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH----~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH----QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH----HhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 999986 45999999987665664478889999999999999 689999999999999865 589999999999988
Q ss_pred CCCCceeeeccccCccccCCCccCCC-----------CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEG-----------IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 648 (717)
.+..+......+||+.||+||.+... ..++++||||+|||+|+|+.|+.||..... .|.+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aK--- 581 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAK--- 581 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHH---
Confidence 87777777778999999999954332 256789999999999999999999975211 2222
Q ss_pred CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 649 PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+..+.++.-.-+++..+... ++.++++.||..||.+|||+.|+++.
T Consensus 582 ---l~aI~~P~~~Iefp~~~~~~----~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 ---LHAITDPNHEIEFPDIPEND----ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHhhcCCCccccccCCCCch----HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22333333222233333322 28899999999999999999999863
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.19 Aligned_cols=249 Identities=26% Similarity=0.338 Sum_probs=193.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHH-HHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEI-LRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|++.+.||+|+||.||+|... +|+.||+|+++... .+....+..|+.. ++.++||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999976 79999999987543 2222345556554 666789999999999999999999999
Q ss_pred ccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 504 FMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSA-PIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 504 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
|++ |+|.+++.. ....+++..+..++.|++.|++||| ++ +++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH----SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 688888764 2346899999999999999999999 44 89999999999999999999999999988653
Q ss_pred CCCCceeeeccccCccccCCCccCC----CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSE----GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (717)
... ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.........+.......
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 224 (283)
T cd06617 156 DSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-------- 224 (283)
T ss_pred ccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--------
Confidence 221 1223457889999998754 4568899999999999999999999864222111111111100
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+.+ ....++.++.+++.+||..+|++||++.++++
T Consensus 225 -~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 -SPQL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01124566889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=299.78 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=200.1
Q ss_pred cCCccccccccccEEEEEEEecC--CCeEEEEEechh----------hHHHHHHHHHHHHHHHh-cCCCceeeEeeeeec
Q 005040 428 EFNECNLLGTGGFGSVYKGTLSD--GTNVAIKIFNLQ----------LERAFRSFDSECEILRN-VRHRNLLKILGSCSN 494 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~ 494 (717)
+|++.+.||+|+||.||+|..+. ++.+|+|.+... .......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999764 688999987532 12334557778888875 699999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 005040 495 LDFKALVLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSD 571 (717)
Q Consensus 495 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 571 (717)
.+..++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+ ..+++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK---EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc---CCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998853 34568999999999999999999993 35799999999999999999999999
Q ss_pred eccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc
Q 005040 572 FGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR 651 (717)
Q Consensus 572 fgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 651 (717)
||.+....... ......++..|+|||+..+..++.++||||||+++|||++|+.||..... ......+.. ..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~---~~ 229 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSLATKIVE---AV 229 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--HHHHHHHhh---cc
Confidence 99998764432 22345688899999999888899999999999999999999999864211 111111110 00
Q ss_pred hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 652 LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
... .....++.++.+++.+||+.||++||++.|+.++++
T Consensus 230 ~~~-------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEP-------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCc-------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 001123456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=280.97 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=201.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 503 (717)
++.+.+..||.|..|.||++..+ +|...|||.+.... ++..+++...++++..-+ +|.||+.+|||.....+++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34455678999999999999976 68999999997654 445566777777777664 8999999999999888999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
.|. ..+...++.-..++++..+-++...+..||.||.+ .++|+|||+||+|||+|+.|++|+||||.+.++-+.
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe---KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-- 245 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-- 245 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH---hcceeecccCccceEEccCCCEEeecccccceeecc--
Confidence 984 36677777666779999889999999999999998 568999999999999999999999999999877543
Q ss_pred ceeeeccccCccccCCCccCC---CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 584 SVIQTMTMATIGYMAPEYGSE---GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
...+...|-+.|||||.+.. ..|+.++||||||+.++|+.||+.||..-.. ++....-+...
T Consensus 246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-dFe~ltkvln~------------- 310 (391)
T KOG0983|consen 246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-DFEVLTKVLNE------------- 310 (391)
T ss_pred -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-cHHHHHHHHhc-------------
Confidence 33455678899999997754 4689999999999999999999999986322 22222222211
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+.+..+....++..+.+++..|+..|+.+||...++++.
T Consensus 311 --ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 --EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 112223334467789999999999999999999988763
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.98 Aligned_cols=267 Identities=22% Similarity=0.311 Sum_probs=198.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|+..+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999976 789999999865432 1224467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+. ++|.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH----QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 97 4999999876667899999999999999999999 67899999999999999999999999999875432211
Q ss_pred eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-C--Cchhhhcc---
Q 005040 585 VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-P--HRLTEVVD--- 657 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~--- 657 (717)
......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.................. + ........
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122346788999998765 55889999999999999999999999653311111111111000 0 00000000
Q ss_pred ---cc---c-hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ---AN---L-VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ---~~---~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. . ...............++.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0 0000000000111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.82 Aligned_cols=246 Identities=30% Similarity=0.517 Sum_probs=198.3
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.+++.++|||++++++++...+ .++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence 5788999999999999999975 67889999986543 2357888999999999999999999987654 699999999
Q ss_pred CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 507 NGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 507 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
+++|.+++.... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999998653 35789999999999999999999 6789999999999999999999999999987643221
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
.....+..|+|||+..+..++.++|+||||+++|||++ |+.||...... .....+... ..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~------------~~--- 215 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEKG------------YR--- 215 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhCC------------CC---
Confidence 12234567999999988899999999999999999998 99998653221 111111110 00
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
......++..+.+++.+||+.+|++||+++++++.|++
T Consensus 216 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 --MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00112345668899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=301.60 Aligned_cols=254 Identities=28% Similarity=0.475 Sum_probs=198.2
Q ss_pred CCccccccccccEEEEEEEec----CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 005040 429 FNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD------ 496 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------ 496 (717)
|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 46889999886543 334567889999999999999999999875432
Q ss_pred eeEEEEEccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 005040 497 FKALVLEFMPNGSLEKWLYSH-----NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSD 571 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 571 (717)
..++++||+.+|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+|++|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS----SKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccchhhEEEcCCCCEEECc
Confidence 247889999999999887532 234788999999999999999999 67899999999999999999999999
Q ss_pred eccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCC
Q 005040 572 FGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 572 fgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
||+++...............++..|++||......++.++||||||+++|||++ |+.||..... .....++....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~-- 232 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGN-- 232 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCC--
Confidence 999987643322211222345678999999988889999999999999999999 8888865322 11122211100
Q ss_pred chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 651 RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
. . .....++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 233 ~--------~-------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 R--------L-------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred c--------C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 00112345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=297.06 Aligned_cols=252 Identities=20% Similarity=0.325 Sum_probs=186.5
Q ss_pred ccccccccEEEEEEEecCC---CeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 433 NLLGTGGFGSVYKGTLSDG---TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
+.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 345677665433 334567899999999999999999999999999999999999999
Q ss_pred CHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 509 SLEKWLYSHN---YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 509 ~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
+|.+++++.. ...++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH----KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999998542 33567778899999999999999 6789999999999999999999999999986432211111
Q ss_pred eeeccccCccccCCCccCC-------CCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 586 IQTMTMATIGYMAPEYGSE-------GIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~-------~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
......++..|+|||+... ..++.++||||||+++|||++ |..||...... ..+...... ......+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~----~~~~~~~ 231 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKD----QQVKLFK 231 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhh----cccccCC
Confidence 1234467889999998643 345789999999999999997 56677542211 111111111 1111111
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
+.+. ..+...+.+++..|| .+|++||+++++++.|.
T Consensus 232 ~~~~---------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE---------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC---------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111 113355778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=296.22 Aligned_cols=247 Identities=27% Similarity=0.359 Sum_probs=200.0
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-----ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+++++.++||||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999976 78999999886533 33456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
+||+++++|.+++.... .+++..+..++.|+++|++||| +.+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH----DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999998654 4789999999999999999999 678999999999999999999999999998765433
Q ss_pred CCceeeeccccCccccCCCccCCCC-cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGI-VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
. ......++..|+|||...... ++.++|+||||+++|+|++|+.||....... ....+.... ...
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~---~~~------- 221 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRSK---ELP------- 221 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhcc---cCC-------
Confidence 2 123445788999999887766 8999999999999999999999987532110 011100000 000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. .+..+..++.+++.+||+.+|.+||++.+++.
T Consensus 222 -----~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 -----P--IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----C--cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0 01123456789999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.94 Aligned_cols=266 Identities=25% Similarity=0.275 Sum_probs=200.0
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhhH-----HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-----RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
+|+..+.||+|+||.||+|... +++.||+|.+..... .....+..|+++++.++||||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999975 789999999875432 2334567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+ +|+|.+++......+++..+..++.|+++||.||| +.+|+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 89999999876546899999999999999999999 688999999999999999999999999999876543
Q ss_pred CCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-C--Cchh---h
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-P--HRLT---E 654 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~--~~~~---~ 654 (717)
... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||..... ...+........ + .... .
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Ccc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhccc
Confidence 221 123346788999998754 5678999999999999999999887764321 111111111100 0 0000 0
Q ss_pred hccccch---hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 655 VVDANLV---REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 655 ~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+.... ............+.++.+++.+||+.+|++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 0000000112335678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.70 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=198.8
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
|+....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999865 7899999998755444456788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
++|.+++... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........ ..
T Consensus 103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 174 (297)
T cd06659 103 GALTDIVSQT--RLNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR 174 (297)
T ss_pred CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence 9999988653 3889999999999999999999 67899999999999999999999999999875533221 12
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....++..|+|||+..+..++.++||||||+++|||++|+.||..... ...........+...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~--------------- 237 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPKL--------------- 237 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCCCc---------------
Confidence 334688999999999888899999999999999999999999864221 111111111100000
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
......+.++.+++.+|++.+|++||+++++++.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0011234557899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.40 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=199.9
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCC-----
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLD----- 496 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~----- 496 (717)
..+++|++.+.||+|+||.||+|..+ +++.+++|++..... ..+.+.+|+++++++ .||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999975 678999999875543 336788999999999 7999999999986543
Q ss_pred -eeEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 005040 497 -FKALVLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDF 572 (717)
Q Consensus 497 -~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 572 (717)
..++||||+++++|.+++... +..+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH----ENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEEccCCeEEECCC
Confidence 489999999999999998743 356899999999999999999999 688999999999999999999999999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCccCC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGSE-----GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES 647 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 647 (717)
|++....... .......++..|+|||++.. ..++.++||||||+++|+|++|+.||...... ........
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~-- 232 (275)
T cd06608 158 GVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPR-- 232 (275)
T ss_pred ccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhc--
Confidence 9987654322 11233458889999997643 45788999999999999999999999643211 11111100
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. .+ .......++.++.+++.+||..||++|||+.|+++
T Consensus 233 --~~-----~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 --NP-----PP-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --cC-----CC-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00 11112234567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=303.64 Aligned_cols=257 Identities=26% Similarity=0.318 Sum_probs=199.9
Q ss_pred HHHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC--
Q 005040 420 LDIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNL-- 495 (717)
Q Consensus 420 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~-- 495 (717)
.++..+.++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 445556789999999999999999999874 78899999986432 2235677899999999 899999999998643
Q ss_pred ---CeeEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 005040 496 ---DFKALVLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV 569 (717)
Q Consensus 496 ---~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl 569 (717)
+..++||||+++|+|.++++. ....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH----NNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEE
Confidence 357999999999999998863 3445899999999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccCCC-----CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG-----IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWV 644 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 644 (717)
+|||++........ ......++..|+|||++... .++.++|||||||++|||++|+.||...... ....++.
T Consensus 170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~ 246 (291)
T cd06639 170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIP 246 (291)
T ss_pred eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHh
Confidence 99999886543221 11234578899999986543 3688999999999999999999998753221 1111111
Q ss_pred HhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 645 KESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
... + ... .........+.+++.+||+.+|++||++.|+++
T Consensus 247 ~~~-~---~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RNP-P---PTL------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCC-C---CCC------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 100 0 000 011123345889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.89 Aligned_cols=257 Identities=23% Similarity=0.306 Sum_probs=200.5
Q ss_pred HHHHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeec--
Q 005040 419 YLDIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSN-- 494 (717)
Q Consensus 419 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~-- 494 (717)
..++....+.|++.+.||+|+||.||+|... +++.||+|++..... ....+..|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3445556789999999999999999999974 788999999865533 335678899999998 69999999999843
Q ss_pred ----CCeeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 005040 495 ----LDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV 569 (717)
Q Consensus 495 ----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl 569 (717)
....++||||+++|+|.+++... ...+++..+..++.|++.|++||| +.+++|+|++|+||+++.++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999999754 344788889999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccC-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS-----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWV 644 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 644 (717)
+|||++........ ......++..|+|||.+. ...++.++|||||||++|||++|+.||....+.. ...
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----~~~ 236 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR----ALF 236 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh----hhh
Confidence 99999876532211 123345888999999865 3568889999999999999999999986532111 000
Q ss_pred HhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 645 KESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ....... .....++.++.+++.+||+.||.+||++.|+++
T Consensus 237 ~~------~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LI------PRNPPPK--------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hH------hhCCCCC--------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 0000000 011134567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=299.16 Aligned_cols=255 Identities=25% Similarity=0.288 Sum_probs=200.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeec--CCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSN--LDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~ 502 (717)
++|+..+.||.|++|.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+ ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999975 68899999987543 2345678889999999999999999998854 34689999
Q ss_pred EccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
||+++++|.+++.. ....+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999988763 3445788999999999999999999 6789999999999999999999999999987653
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCcccc---CcchHHHHHHhhCCCchhhhc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFT---GEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 656 (717)
.... ....++..|+|||...+..++.++||||+|+++|||++|+.||..... .......+............
T Consensus 157 ~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (287)
T cd06621 157 NSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE- 231 (287)
T ss_pred cccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccC-
Confidence 2211 233568889999999988999999999999999999999999976421 11122222221110000000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.......+..+.+++.+||+.+|++|||+.|+++
T Consensus 232 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 ----------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ----------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0101123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=303.23 Aligned_cols=246 Identities=26% Similarity=0.311 Sum_probs=197.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
..|+..+.||+|+||.||+|... +++.||+|.+.... .+..+.+.+|+++++.++||||+++.+++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888899999999999999875 78999999886432 334467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||++ |++.+++......+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH----~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9996 6888888765556899999999999999999999 678999999999999999999999999998765322
Q ss_pred CceeeeccccCccccCCCccC---CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 583 DSVIQTMTMATIGYMAPEYGS---EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
....++..|+|||++. ...++.++||||||+++|||++|+.||....... .........+ +.
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~--------~~ 233 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNDS--------PT 233 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhcCCC--------CC
Confidence 2235788899999763 4668899999999999999999999986532111 0111110000 00
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.....++.++.+++.+||+.+|++||++.+++..
T Consensus 234 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 --------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0011345668999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.72 Aligned_cols=266 Identities=25% Similarity=0.300 Sum_probs=200.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999976 68999999886543 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++++|..+..... .+++..+..++.|+++|+.||| +.+++|+|++|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH----~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999988888766543 3899999999999999999999 67899999999999999999999999999886543321
Q ss_pred ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHH--hhCCCchhhhccc--
Q 005040 584 SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK--ESLPHRLTEVVDA-- 658 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-- 658 (717)
......++..|+|||+..+ ..++.++||||||+++|||++|+.||...... ....+... ...........+.
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccch
Confidence 1223457889999998765 45788999999999999999999998643211 11111000 0011111111110
Q ss_pred --------cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 659 --------NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 659 --------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..............++..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=296.76 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=202.6
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||+|+||.||+|... +++.||+|.++.... ...+.+..|+++++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999865 789999999875543 3567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++.... .+++..+..++.|+++|+.||| +.+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH----SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999998754 3788999999999999999999 678999999999999999999999999999876543322
Q ss_pred ee--eeccccCccccCCCccCCCC---cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 585 VI--QTMTMATIGYMAPEYGSEGI---VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 585 ~~--~~~~~~t~~y~aPE~~~~~~---~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.. .....++..|+|||++.+.. ++.++||||||+++||+++|+.||...... ......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~---------- 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGHK---------- 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhcCCC----------
Confidence 11 11345788999999987766 899999999999999999999999653211 111111111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...+....++..+.+++.+||+.+|.+||++.|++.
T Consensus 225 -----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 -----PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011111223556789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.47 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=200.0
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 78899999886542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~ 582 (717)
+++++|.+++... ...+++..+..++.++++|++||| +.+++|+||+|+||+++.+ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH----TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999864 345899999999999999999999 6799999999999999854 468999999998764332
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. .....++..|+|||...+..++.++||||||+++|+|++|+.||...... .....+.......
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~----------- 220 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGTFAP----------- 220 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHhcCCCC-----------
Confidence 1 12345788999999999888999999999999999999999998653211 1111111000000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....++.++.+++.+||+.+|++|||+.|+++
T Consensus 221 ------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=304.79 Aligned_cols=193 Identities=22% Similarity=0.289 Sum_probs=158.4
Q ss_pred ccccccccEEEEEEEec---CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeee--cCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS---DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS--NLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~~~~ 507 (717)
.+||+|+||.||+|..+ ++..||+|.+.... ....+.+|++++++++||||+++++++. .....++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999864 45789999886442 2245678999999999999999999884 3567799999986
Q ss_pred CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCcEEEeeeccc
Q 005040 508 GSLEKWLYSH--------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGIS 575 (717)
Q Consensus 508 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~ 575 (717)
++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5888887522 234788999999999999999999 6889999999999999 56779999999999
Q ss_pred cccCCCCCc-eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 005040 576 KLLGEGEDS-VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDE 632 (717)
Q Consensus 576 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~ 632 (717)
+........ .......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876433221 11233467999999998866 4589999999999999999999999965
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=300.49 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=199.3
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
.|...+.||+|++|.||+|... +++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555679999999999999864 788999998875544445668899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+++|.+++.. ..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.+........ .
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 9999999987 34889999999999999999999 67899999999999999999999999998875533211 1
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (717)
.....|++.|+|||...+..++.++||||||+++|||++|+.||..... ...........+.. .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~~~~~~~~~~--------~------ 235 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMKRIRDNLPPK--------L------ 235 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHhcCCCC--------C------
Confidence 2234588999999999888899999999999999999999999864211 11111111110000 0
Q ss_pred hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 667 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++..+.+++.+||+.+|++||++.++++
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 011123456889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=301.65 Aligned_cols=265 Identities=25% Similarity=0.319 Sum_probs=197.4
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||+|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 78999999886443 22335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+. ++|.+++... ...+++..+..++.|++.||+||| +.+++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh----~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 6899988753 345899999999999999999999 67899999999999999999999999999876543221
Q ss_pred ceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-CCc-h----hhhc
Q 005040 584 SVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-PHR-L----TEVV 656 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~-~----~~~~ 656 (717)
. .....++..|+|||+..+. .++.++||||||+++|||+||+.||...... ....+...... +.. . ....
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1 2233568899999977654 4688999999999999999999998653211 11122111111 000 0 0000
Q ss_pred c--ccchhhhh-hh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 657 D--ANLVREEQ-AF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 657 ~--~~~~~~~~-~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. ..+..... .. ......+.++.+++.+|++.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0 00000000 00 001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=300.04 Aligned_cols=252 Identities=25% Similarity=0.324 Sum_probs=205.2
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++.|+..+.||+|+||.||+|..+ +++.||+|++..... ..+.+.+|+++++.++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4467888899999999999999986 789999999976544 45678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 99999999999986546899999999999999999999 68999999999999999999999999999876543221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......++..|+|||+..+..++.++||||||+++|+|++|+.||...... .....+.....
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~~~--------------- 233 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTKGI--------------- 233 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCC---------------
Confidence 112334788999999988888999999999999999999999998653211 11111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
........++..+.+++.+|++.+|.+||++.++++
T Consensus 234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 234 -PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001111224566889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=301.01 Aligned_cols=244 Identities=26% Similarity=0.306 Sum_probs=199.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|+..+.||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999975 68999999987543 234467888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH----SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999998764 4899999999999999999999 678999999999999999999999999998876433
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
.....+++.|+|||...+..++.++||||||+++|+|++|+.||..... ....+.+. ....
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~-----------~~~~-- 215 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYEKIL-----------EGKV-- 215 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHh-----------cCCc--
Confidence 2234688999999998888899999999999999999999999865321 11111110 0000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
..+...+..+.+++.+||..+|.+|+ +++|+++
T Consensus 216 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 -----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 00012235678999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.89 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=206.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|++.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++.+++++|||++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999976 599999999876543 4457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++++|.+++... ..+++..+..++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh----~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH----TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh----ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999865 44899999999999999999999 6 8999999999999999999999999999987643322
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCcccc-CcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFT-GEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. .....++..|+|||...+..++.++|+||||+++|||++|+.||..... .......++... .. +
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~-----~---- 221 (264)
T cd06623 156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PP-----P---- 221 (264)
T ss_pred c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CC-----C----
Confidence 2 1234578899999999988999999999999999999999999976432 111111111110 00 0
Q ss_pred hhhhhhhhHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 663 EEQAFSDKMD-CLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 663 ~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..... ++..+.+++.+|++.+|++||++.|+++.
T Consensus 222 -----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 -----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00112 45678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.62 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=200.0
Q ss_pred cCCccccccccccEEEEEEEe-cCCCeEEEEEechhh------HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL------ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
+|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999986 478999999986432 2235678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeeccccccC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLG 579 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~ 579 (717)
||||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.+..+.
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH----~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH----ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999998654 4789999999999999999999 67999999999999998776 59999999998765
Q ss_pred CCCCc--eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 580 EGEDS--VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 580 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
..... .......++..|+|||+..+..++.++||||+|+++|+|++|+.||....... .... ........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~-~~~~~~~~----~~ 229 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLAL-IFKIASAT----TA 229 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHH-HHHHhccC----CC
Confidence 33211 11123357889999999988889999999999999999999999986422111 1111 11000000 00
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+ ..+...+.++.+++.+|+..+|++||++.|+++
T Consensus 230 ~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 P---------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred C---------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 011134466889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=293.34 Aligned_cols=249 Identities=29% Similarity=0.388 Sum_probs=204.7
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++||+++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999976 789999999976655456788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+++|.+++......+++..+..++.|+++|+.||| ..+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh----cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999999876556899999999999999999999 68899999999999999999999999999987654332
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (717)
.....++..|+|||+..+..++.++||||||+++|+|++|+.||....... ....... .... .
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~---~~~~------------~ 216 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALFKIAT---NGPP------------G 216 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHh---cCCC------------C
Confidence 233457889999999888889999999999999999999999986531110 0000000 0000 0
Q ss_pred hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 667 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++..+.+++.+|++.||++|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111123456889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=295.73 Aligned_cols=250 Identities=24% Similarity=0.280 Sum_probs=195.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--Cee
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-----ERAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFK 498 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~ 498 (717)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999875 68999999875321 23456788899999999999999999988663 467
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH----SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999998654 3788889999999999999999 678999999999999999999999999998765
Q ss_pred CCCCCc-eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 579 GEGEDS-VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 579 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
...... .......++..|+|||+..+..++.++||||||+++|||++|+.||...... ....+ .... . ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~---~~~~-~----~~ 227 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAIFK---IATQ-P----TN 227 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHHHH---HhcC-C----CC
Confidence 322111 1112335788999999988888999999999999999999999998653111 11111 0000 0 00
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+. .+......+.+++.+|+. +|++||+++|+++
T Consensus 228 ~~---------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 PV---------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CC---------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 011234557789999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.27 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=200.7
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec--CCeeEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN--LDFKALVL 502 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~ 502 (717)
+|++.+.||.|+||.||+|... +++.||+|++.... ....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 78899999886432 3345678889999999999999999997753 45679999
Q ss_pred EccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 503 EFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCH-SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 503 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
||+++++|.+++... ...+++..++.++.|++.||.|||..+ .+.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999753 456899999999999999999999321 1357999999999999999999999999999876
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
...... .....+++.|+|||+..+..++.++|+||||+++|+|++|+.||.... .....+.+..... +
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~--------~ 228 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGKF--------R 228 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCCC--------C
Confidence 543221 223457899999999998889999999999999999999999997532 1111111111000 0
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
. .....+.++.+++.+|++.+|++||++.++++.
T Consensus 229 ~---------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 R---------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C---------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 011334568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=300.58 Aligned_cols=266 Identities=23% Similarity=0.269 Sum_probs=200.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|+..+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 68899999886543 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|++++.+..+... ...+++..+..++.|++.|+.||| ..+++|+|++|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH----SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9988666655544 344899999999999999999999 67899999999999999999999999999987654332
Q ss_pred ceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh---CCCchhhhc--c
Q 005040 584 SVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES---LPHRLTEVV--D 657 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~ 657 (717)
.......++..|+|||+..+. .++.++||||||+++|||++|+.||...... ......... .+....... +
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccC
Confidence 122334578889999998887 8899999999999999999999998753221 111111100 000000000 0
Q ss_pred ccchh-----hh----hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVR-----EE----QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~-----~~----~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..... .. ........++.++.++|++||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00 000001123677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=294.66 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=200.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+-|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34677889999999999999864 78899999886443 33446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc----cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999998754 3789999999999999999999 68999999999999999999999999999876543221
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......++..|+|||...+..++.++|+|||||++|||++|..||...... .....+...... .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~--------~----- 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKNNPP--------T----- 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcCCCC--------C-----
Confidence 122345788999999998888999999999999999999999998653211 111111100000 0
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
....++.++.+++.+|++.+|.+||++.++++.
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 ----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011234567899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=296.91 Aligned_cols=246 Identities=27% Similarity=0.349 Sum_probs=204.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
+.|+.-++||+|+||.||-++.+ +|+-+|.|.+.+.. ++...-...|..+|++++.+.||.+-..|+..+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56778889999999999999865 79999999886553 233345678999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 503 EFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
..|.||||.-+|.+.+ ..++++.+.-++.+|+.||.+|| ..+||+||+||+|||+|+.|+++|+|.|+|..+..+
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH----~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH----RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH----hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 9999999998887653 45899999999999999999999 678999999999999999999999999999988655
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. ....+||.||||||++.++.|+...|+||+||++|||+.|+.||....... -.+-+|.+..
T Consensus 341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------------k~eEvdrr~~ 403 (591)
T KOG0986|consen 341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------------KREEVDRRTL 403 (591)
T ss_pred Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------------hHHHHHHHHh
Confidence 43 234589999999999999999999999999999999999999996532211 1122333333
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
.....++ ..+++++.++.+..|..||++|...
T Consensus 404 ~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 404 EDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cchhhcc--cccCHHHHHHHHHHHccCHHHhccC
Confidence 3322222 4667888999999999999999843
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=281.52 Aligned_cols=270 Identities=21% Similarity=0.329 Sum_probs=209.8
Q ss_pred CHHHHHHHhccCCccccccccccEEEEEEE-ecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeecC
Q 005040 418 SYLDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSNL 495 (717)
Q Consensus 418 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~ 495 (717)
+|.+..+-++ +.||+|+|+.|-.+. ..+|.++|||++.+.....+.++.+|++++.+.+ |+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4666666655 479999999999887 5689999999999887777888999999999995 99999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEEEeee
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM---VAHVSDF 572 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~---~~kl~Df 572 (717)
...|+|||-|.||+|..++++... +.+..+.+++++|+.||.||| .++|.|||+||+|||-.+.. -|||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH----~kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH----TKGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh----hcCcccccCCccceeecCCCCcCceeeecc
Confidence 999999999999999999998765 889999999999999999999 78999999999999997544 4899999
Q ss_pred ccccccCCCC-----CceeeeccccCccccCCCc-----cCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHH
Q 005040 573 GISKLLGEGE-----DSVIQTMTMATIGYMAPEY-----GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRR 642 (717)
Q Consensus 573 gl~~~~~~~~-----~~~~~~~~~~t~~y~aPE~-----~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~ 642 (717)
.+..-+.... .+..-...+|+..|||||+ -....|+.++|.||+|||+|=|++|.+||.++...+ --
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---CG 300 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---CG 300 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---CC
Confidence 8875432111 1222334578899999994 334568999999999999999999999998865421 11
Q ss_pred HHHhhCCCchhhhccccchhhhhhhh--hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 643 WVKESLPHRLTEVVDANLVREEQAFS--DKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
|-....-+...+.+-..+.+....++ ++...+.+..+++...+..|+.+|.++.+++.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 21111111111222222222222222 23466778899999999999999999998876
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=300.49 Aligned_cols=265 Identities=24% Similarity=0.260 Sum_probs=198.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeeEeeeeecC--CeeEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFKALV 501 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv 501 (717)
++|+..+.||+|+||.||+|..+ +++.+|+|.++.... .....+.+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999976 688999999865432 2223567899999999999999999998776 889999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||++ ++|.+++......+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH----DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 5999999876666899999999999999999999 678999999999999999999999999999876543
Q ss_pred CCceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-CC--chhhh--
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-PH--RLTEV-- 655 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~-- 655 (717)
.. ......+++.|+|||...+. .++.++|+||+|+++|||++|+.||...... ........... +. .+...
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhc
Confidence 21 12334578889999987654 4689999999999999999999998753211 11111110000 00 00000
Q ss_pred ---------ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 656 ---------VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 656 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...........++.. ..+..+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000001110 13566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.01 Aligned_cols=261 Identities=22% Similarity=0.245 Sum_probs=195.4
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecC--CeeEEEEE
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVR-HRNLLKILGSCSNL--DFKALVLE 503 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~e 503 (717)
|++.+.||+|+||.||+|... +++.||+|+++... ........+|+.+++++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999865 78999999987542 222233456888999885 99999999999887 88999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|++ |++.+++......+++..+..++.|++.||+||| +.+++||||+|+||+++. +.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH----RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 5898888876566899999999999999999999 678999999999999999 9999999999987643222
Q ss_pred ceeeeccccCccccCCCcc-CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh---cc--
Q 005040 584 SVIQTMTMATIGYMAPEYG-SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV---VD-- 657 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 657 (717)
. ....++..|+|||+. .++.++.++||||+||++|||++|..||..... .....+..........++ ..
T Consensus 155 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 Y---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred c---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhccc
Confidence 1 223578899999965 445678999999999999999999999965321 122222222111110000 00
Q ss_pred ----ccchhhhh--hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ----ANLVREEQ--AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ----~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+..... .......++.++.+++.+||+.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 00001234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=297.36 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=198.2
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcC---CCceeeEeeeeecCCeeEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVR---HRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~lv~ 502 (717)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999964 78999999986542 334456788999999996 999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++++|.++++.. .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH----KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998764 4899999999999999999999 6789999999999999999999999999998765433
Q ss_pred CceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 583 DSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
. ......|+..|+|||...+ ..++.++|+||||+++|+|++|+.||...... .+........ .+.+.
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~~-----~~~~~ 223 (277)
T cd06917 156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIPKSK-----PPRLE 223 (277)
T ss_pred c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccccCC-----CCCCC
Confidence 1 1233468889999998765 44689999999999999999999999753211 1111000000 00010
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...++.++.+++.+||+.||++||++.|+++
T Consensus 224 --------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 --------DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --------cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0114456889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=295.26 Aligned_cols=247 Identities=28% Similarity=0.330 Sum_probs=201.3
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
+|++.+.||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 68999999997543 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+.+++|.+++... ..+++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH----SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999876 45899999999999999999999 6789999999999999999999999999988764332
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......++..|+|||+..+..++.++|+||+|+++|+|++|+.||...... ...+........ . .
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~----~----- 219 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQETA-D----V----- 219 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhccc-c----c-----
Confidence 123345788999999988888999999999999999999999999753221 111111111100 0 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM--TDAA 699 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~--~ev~ 699 (717)
..+...+.++.+++.+||+.||.+||++ +|++
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 ----LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111234668899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=304.41 Aligned_cols=252 Identities=27% Similarity=0.346 Sum_probs=200.7
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+..|+++++.++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999976 58999999987543 224567888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 503 EFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 503 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
||+.+++|.+++... ...+++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH----LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999999854 355899999999999999999999 678999999999999999999999999998765322
Q ss_pred CCce---------------------------eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccc
Q 005040 582 EDSV---------------------------IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMF 634 (717)
Q Consensus 582 ~~~~---------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~ 634 (717)
.... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 0112357889999999988889999999999999999999999996532
Q ss_pred cCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 005040 635 TGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH----MTDAAA 700 (717)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt----~~ev~~ 700 (717)
.. ..+.. +.+... ..+.....+.++.+++.+|+..||++||+ ++|+++
T Consensus 237 ~~----~~~~~---------~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD----ETFSN---------ILKKEV-----TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH----HHHHH---------HhcCCc-----cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 11111 000000 01111124567899999999999999999 666555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.28 Aligned_cols=241 Identities=26% Similarity=0.427 Sum_probs=192.2
Q ss_pred ccccccccEEEEEEEec-CCCeEEE---EEechh-hHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe--eEEEEEcc
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAI---KIFNLQ-LERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF--KALVLEFM 505 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vav---K~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~--~~lv~e~~ 505 (717)
..||+|+|-+||+|.+. +|.+||= |.-+.. ..+..++|..|+++|+.|+|||||+++++|.+... ..+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 57999999999999975 6777753 322111 13445789999999999999999999999977655 67899999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
..|+|..|+++.+. .....+..|++||++||.|||.. .++|+|||||-+||+++ ..|.|||+|.|+|..+.....
T Consensus 126 TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a- 201 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA- 201 (632)
T ss_pred cCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence 99999999998765 88899999999999999999975 46899999999999998 678999999999998754322
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-CCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES-LPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 663 (717)
....|||.|||||+.. ..|.+.+||||||+.++||.|+..||.. +....++.+-+..- .|..+..+-|
T Consensus 202 ---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-C~n~AQIYKKV~SGiKP~sl~kV~d------ 270 (632)
T KOG0584|consen 202 ---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-CTNPAQIYKKVTSGIKPAALSKVKD------ 270 (632)
T ss_pred ---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-hCCHHHHHHHHHcCCCHHHhhccCC------
Confidence 2367999999999877 7899999999999999999999999975 22222222222211 1222222222
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+++.++|.+|+.. .++|||+.|+++
T Consensus 271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 -----------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 4577999999999 899999999875
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.40 Aligned_cols=247 Identities=26% Similarity=0.327 Sum_probs=198.1
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.|+..+.||+|+||.||+|... ++..||+|.+.... .+....+.+|++++++++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4677889999999999999965 78899999886432 3344678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+. |++.+++......+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 996 5888888766666899999999999999999999 678999999999999999999999999998754322
Q ss_pred ceeeeccccCccccCCCcc---CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 584 SVIQTMTMATIGYMAPEYG---SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~---~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
....+++.|+|||++ ..+.++.++|||||||++|||++|+.||..... ......+.....+.
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~~---------- 243 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPT---------- 243 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhccCCC----------
Confidence 223578899999986 346789999999999999999999999865311 11111111111000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
.....++..+.+++.+|++.+|.+||++.++++..-
T Consensus 244 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 244 -------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 011133456889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.71 Aligned_cols=273 Identities=27% Similarity=0.331 Sum_probs=205.9
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC------eeE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD------FKA 499 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------~~~ 499 (717)
-|...+.||+|+||.||+|+++ +|+.||||.+.... ....+...+|++++++++|||||+++++-++.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455678999999999999965 89999999997654 334566788999999999999999999865543 457
Q ss_pred EEEEccCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCC--cEEEeeec
Q 005040 500 LVLEFMPNGSLEKWLYS--HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD--ENM--VAHVSDFG 573 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg 573 (717)
+|||||.+|||...+++ +...+++.....+..+++.||.||| +++||||||||.||++- .+| ..||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr----En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR----ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH----HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999984 3456999999999999999999999 67999999999999985 333 47999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccC-CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcc-hHHHHHHh-hCCC
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGS-EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM-SLRRWVKE-SLPH 650 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~-~~~~~~~~-~~~~ 650 (717)
.|+.+.++. .....+||..|++||+.. .+.|+..+|.|||||++||+.||..||........ .-..|..- .-+.
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999886544 456678999999999888 48899999999999999999999999976433321 11122211 1111
Q ss_pred chhhhccccchhhh-------hhhhhhHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHhHH
Q 005040 651 RLTEVVDANLVREE-------QAFSDKMDCLFSIMDLALDCCMDTPHKRI--HMTDAAAKLRKIKA 707 (717)
Q Consensus 651 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~P~~Rp--t~~ev~~~L~~~~~ 707 (717)
.......+...+.. ............+..++..++..+|++|. .+.+..+.+..|.+
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 21111111111100 00111112234466788899999999999 88888888877755
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=282.28 Aligned_cols=202 Identities=24% Similarity=0.323 Sum_probs=168.9
Q ss_pred hccCCccccccccccEEEEEEEec---C--CCeEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeeEeeeeec-CCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS---D--GTNVAIKIFNLQLE--RAFRSFDSECEILRNVRHRNLLKILGSCSN-LDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~ 497 (717)
..+|+.+..||+|.||.||+|..+ + ...+|+|.++..++ ......-+|+..++.++|||++.++.++-. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 368999999999999999999643 3 23689999876542 223456779999999999999999999876 778
Q ss_pred eEEEEEccCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC----CcEEE
Q 005040 498 KALVLEFMPNGSLEKWLYSH----NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN----MVAHV 569 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~----~~~kl 569 (717)
+++++||.+. ||++.++-+ ...++...+..|+.||+.|+.||| ++-|+||||||.||++..+ |.|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH----~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH----SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh----hhheeeccCCcceEEEeccCCccCeeEe
Confidence 8999999987 999998732 356899999999999999999999 6679999999999999877 89999
Q ss_pred eeeccccccCCCCCce-eeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 005040 570 SDFGISKLLGEGEDSV-IQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDE 632 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~ 632 (717)
+|+|+++.+...-... .....+.|.+|+|||.+.+ ..||.+.||||.|||+.||+|-++-|.+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999886543322 2334567999999997665 5699999999999999999999887755
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.07 Aligned_cols=264 Identities=25% Similarity=0.304 Sum_probs=197.2
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
|+..+.||.|++|.||+|... +|+.||+|++.... ......+.+|+++++.++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999865 79999999987543 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+ ++|.+++.... ..+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH----~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH----SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 69999997654 35899999999999999999999 678999999999999999999999999999765432211
Q ss_pred eeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-CCch-----hhhcc
Q 005040 585 VIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-PHRL-----TEVVD 657 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~ 657 (717)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...... ........... +... ....+
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1223468889999987654 5789999999999999999999998653221 11111111100 0000 00000
Q ss_pred --ccchhhh--hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 --ANLVREE--QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 --~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+.... .........+.++.+++.+|++.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 000011233466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.30 Aligned_cols=267 Identities=24% Similarity=0.294 Sum_probs=197.8
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Cee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNL-----DFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~ 498 (717)
.++|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 78999999986432 33445678899999999999999999886543 357
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++|+||++ ++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 5888888654 4899999999999999999999 678999999999999999999999999999865
Q ss_pred CCCCCce-eeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC----Cch
Q 005040 579 GEGEDSV-IQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP----HRL 652 (717)
Q Consensus 579 ~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~ 652 (717)
....... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+... ............ +..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHH
Confidence 4322111 1123467899999997644 5689999999999999999999999965321 111111111111 111
Q ss_pred hhhccccchhhh------hh---hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 653 TEVVDANLVREE------QA---FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 653 ~~~~~~~~~~~~------~~---~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+.+....... .. .......+.++.+++.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111100000 00 00011235668899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.72 Aligned_cols=254 Identities=25% Similarity=0.303 Sum_probs=194.7
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35566788999999999999875 68999999987543 234456888999999996 9999999999998889999999
Q ss_pred ccCCCCHHHHHh---h-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 504 FMPNGSLEKWLY---S-HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 504 ~~~~g~L~~~l~---~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
|+. +++.++.. . ....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE---ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 986 46655432 2 23558999999999999999999994 3589999999999999999999999999997654
Q ss_pred CCCCceeeeccccCccccCCCccCCC---CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEG---IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
.... .....++..|+|||++.+. .++.++||||+|+++|||++|+.||.... .............
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~----- 227 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGD----- 227 (288)
T ss_pred cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCC-----
Confidence 3221 1233578899999988776 68999999999999999999999986532 1111111111000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.+.+.. .....++.++.+++.+|++.+|++|||+.++++.
T Consensus 228 ~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSN-----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCC-----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000100 0112355678999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=292.36 Aligned_cols=242 Identities=22% Similarity=0.280 Sum_probs=186.2
Q ss_pred cccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHH---hcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 434 LLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILR---NVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 434 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..+++ ..+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 68999999886532 111223344444433 3479999999999999899999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999999988654 4899999999999999999999 6789999999999999999999999999987654322
Q ss_pred eeccccCccccCCCccC-CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGS-EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....|+..|+|||... +..++.++||||+||++|||++|+.||......... ........ ....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~------~~~~------ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT------VNVE------ 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHhhc------CCcC------
Confidence 12346899999999876 456899999999999999999999999754322111 11000000 0000
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAAK 701 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~~ 701 (717)
.+..++.++.+++.+|+..||++|| |++|+++.
T Consensus 218 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 ---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1113456688999999999999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=323.25 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=191.1
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeee---------
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSC--------- 492 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~--------- 492 (717)
+-..+|+....||+||||.||+++.+ ||+.+|||++.... ......+.+|++++++|+|||||+++..+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34568999999999999999999988 99999999987553 44566788999999999999999997211
Q ss_pred ---------------------------------------------------e------c---------------------
Q 005040 493 ---------------------------------------------------S------N--------------------- 494 (717)
Q Consensus 493 ---------------------------------------------------~------~--------------------- 494 (717)
. .
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0 0
Q ss_pred ------------------------C--------CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 005040 495 ------------------------L--------DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542 (717)
Q Consensus 495 ------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~ 542 (717)
. -.+|+-||||+...+.++++.+...-.....++++.+|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH- 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH- 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence 0 1357889999987777777766532256778999999999999999
Q ss_pred cCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC----------------CCCCceeeeccccCccccCCCccCCC-
Q 005040 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG----------------EGEDSVIQTMTMATIGYMAPEYGSEG- 605 (717)
Q Consensus 543 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~----------------~~~~~~~~~~~~~t~~y~aPE~~~~~- 605 (717)
+.+||||||||.||++|++..|||+|||+++... .+......+..+||.-|+|||++.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 7889999999999999999999999999998721 00111234567899999999987654
Q ss_pred --CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhh
Q 005040 606 --IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALD 683 (717)
Q Consensus 606 --~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 683 (717)
.|+.|+|+||+||+++||+. ||....+.-..+....+..+|.. ....+++. ..-..+|+.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~--------------~~e~slI~~ 853 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPEH--------------PEEASLIRW 853 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccccc--------------hHHHHHHHH
Confidence 59999999999999999983 45442211111111111112211 12222222 234589999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 005040 684 CCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 684 cl~~~P~~Rpt~~ev~~ 700 (717)
+++.||.+||||.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.30 Aligned_cols=266 Identities=25% Similarity=0.288 Sum_probs=198.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeeEeeeeecC--CeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~l 500 (717)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999975 689999999864431 1223456799999999999999999998654 56899
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||++ ++|.+++......+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH----ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 5899998876566899999999999999999999 67899999999999999999999999999987653
Q ss_pred CCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh----
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV---- 655 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 655 (717)
.... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..... ......+...........
T Consensus 161 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhchhh
Confidence 3211 122345788999998765 5678999999999999999999999975322 111111111111000000
Q ss_pred cc----cc--chhhh-hhh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 656 VD----AN--LVREE-QAF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 656 ~~----~~--~~~~~-~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+ .. +.... ... ......+.++.++|.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00 00000 000 000113566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.02 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=198.8
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
+|+..+.||.|++|.||+|+.. +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999976 789999999875532 23356678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 506 PNGSLEKWLYSHN--YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 506 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
++ +|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH----ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 74 8999887543 45899999999999999999999 67899999999999999999999999999976543211
Q ss_pred ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-C--Cchhhhcc--
Q 005040 584 SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-P--HRLTEVVD-- 657 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~-- 657 (717)
......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.+.... ........... + ..+.....
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCc
Confidence 1123456889999998755 45788999999999999999999999753221 11111111100 0 00000000
Q ss_pred ---ccchh--hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ---ANLVR--EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ---~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..... ...........+.++.+++.+|++.||++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00000011134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=280.71 Aligned_cols=251 Identities=25% Similarity=0.271 Sum_probs=203.4
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
..++|+..++||+|.||.|..++-+ +++.+|+|++++.. +.....-..|-++|+..+||.+..+...|+..+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4578999999999999999999865 89999999998775 4445666789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+.||.|.-++..... +++....-.-..|+.||.||| +++||.||+|.+|.++|.+|++||+|||+++.--.
T Consensus 246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLH----s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLH----SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhh----hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999988876544 777777778889999999999 78999999999999999999999999999975322
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
........+|||.|+|||++....|+...|+|.+||++|||++|+.||....-+ .+-..+. +-|-++
T Consensus 321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--kLFeLIl---------~ed~kF 387 (516)
T KOG0690|consen 321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--KLFELIL---------MEDLKF 387 (516)
T ss_pred --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--HHHHHHH---------hhhccC
Confidence 223345679999999999999999999999999999999999999998652111 1111111 001111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC--HHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH--MTDAAAKL 702 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt--~~ev~~~L 702 (717)
+ ...+.++..++...+..||.+|.. ..++.+..
T Consensus 388 -------P--r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~ 422 (516)
T KOG0690|consen 388 -------P--RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIM 422 (516)
T ss_pred -------C--ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHH
Confidence 1 133456789999999999999983 44554443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=284.57 Aligned_cols=265 Identities=21% Similarity=0.327 Sum_probs=218.3
Q ss_pred HHHHhccCCccccccccccEEEEEEEec------CCCeEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeeEeeee-e
Q 005040 422 IRRATDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSC-S 493 (717)
Q Consensus 422 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~-~ 493 (717)
+.....+++....+.+|.||.||.|.|+ +.+.|-||.++....+ +...+..|.-.+..+.|||+.++.+++ +
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3444466777788999999999999764 3445677776655433 445678899999999999999999987 4
Q ss_pred cCCeeEEEEEccCCCCHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 005040 494 NLDFKALVLEFMPNGSLEKWLYSH-------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV 566 (717)
Q Consensus 494 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~ 566 (717)
+.+..++++.++.-|+|..|+... ...+...+...++.|++.|++||| .++|||.||.++|.++|+..+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh----~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH----NHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH----hcCcccchhhhhcceehhhee
Confidence 456778999999999999999822 344667788899999999999999 789999999999999999999
Q ss_pred EEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 005040 567 AHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVK 645 (717)
Q Consensus 567 ~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~ 645 (717)
+||+|-.+++++.+.+.+........+..||+||.+....|+.++|||||||++|||+| |+.||.+-.+- .+..+.+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--Em~~ylk 512 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--EMEHYLK 512 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--HHHHHHh
Confidence 99999999999988888777777788999999999999999999999999999999999 99998764332 2222222
Q ss_pred hhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 646 ESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
. ......+-.|+.++..++..||+.+|++||+++|++.-|.+...+.
T Consensus 513 d-----------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 513 D-----------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred c-----------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 1 1122344578999999999999999999999999999999987764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.88 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=210.5
Q ss_pred ccCCccccccccccEEEEEEEec----C----CCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS----D----GTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLD 496 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 496 (717)
++..+.+.+|+|.||.||+|... . ...||||.++... ....+.+..|+++|+.+ +||||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 44455669999999999999843 1 4569999987655 34567889999999999 6999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 005040 497 FKALVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL 561 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill 561 (717)
..++|+||+..|+|.+|++..+ ..++......++.|||.|++||+ +.++||||+.++|||+
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~----~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA----SVPCVHRDLAARNVLI 451 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh----hCCccchhhhhhhEEe
Confidence 9999999999999999999766 34888999999999999999999 7889999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCceeeecc-ccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 005040 562 DENMVAHVSDFGISKLLGEGEDSVIQTMT-MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639 (717)
Q Consensus 562 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 639 (717)
+.+..+||+|||+++.............. .-+..|||||.+....|+.|+|||||||++||++| |..||.+.. ....
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~ 530 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEE 530 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHH
Confidence 99999999999999976554433322111 13566999999999999999999999999999999 889987621 1111
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
+.+++++ ......+..|..++.++++.||+.+|++||++.|+++.++....
T Consensus 531 l~~~l~~-----------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 531 LLEFLKE-----------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHhc-----------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1222221 11223344677889999999999999999999999999998543
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.99 Aligned_cols=268 Identities=21% Similarity=0.280 Sum_probs=195.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD------ 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------ 496 (717)
.++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999975 78999999886443 222335567999999999999999999886544
Q ss_pred --eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecc
Q 005040 497 --FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574 (717)
Q Consensus 497 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 574 (717)
..++||||+. ++|.+++......+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH----RNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999996 5899888876656899999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCc--eeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh---hC
Q 005040 575 SKLLGEGEDS--VIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE---SL 648 (717)
Q Consensus 575 ~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~ 648 (717)
+......... .......++..|+|||+..+. .++.++||||||+++|||++|+.||...... .....+.. ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCC
Confidence 9866432211 111234568889999987654 4788999999999999999999998653221 11111111 01
Q ss_pred CCc-hhhh-----ccc-cchhhhh-hhh---hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 649 PHR-LTEV-----VDA-NLVREEQ-AFS---DKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 649 ~~~-~~~~-----~~~-~~~~~~~-~~~---~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.. .... .+. .+..... ... ...-....+.+++.+||..||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 100 0000 000 0000000 000 00011345779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=288.63 Aligned_cols=251 Identities=27% Similarity=0.346 Sum_probs=204.2
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--CeeEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFKALVL 502 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~ 502 (717)
+|+..+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 78999999987654 24557788999999999999999999999888 8899999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++++|.+++.+.. .+++..+..++.|+++|++||| +.+++|+|++|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh----~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998765 5899999999999999999999 6789999999999999999999999999998775443
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
.........++..|+|||...+..++.++||||||+++|+|++|+.||...... .............
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~---------- 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALYKIGSSGEP---------- 222 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHhccccCCC----------
Confidence 211123446788999999998888999999999999999999999999764311 1100000000000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. ..+...+..+.+++.+|+..+|++||++.|++.
T Consensus 223 --~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 --P--EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --c--CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0 011122466889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=290.59 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=199.8
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||+|+||.||+|..+ +|..||+|.+.... ....+.+.+|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999976 68899999987542 12345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~ 582 (717)
+++++|.+++.... ..+++..+..++.|+++|+.||| +.+++|+||||+||++++++ .++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999997643 35799999999999999999999 67899999999999999886 46999999998764332
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. ......|++.|+|||+..+..++.++|+||||+++|||++|+.||.... ..+++...........
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~------- 222 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAPI------- 222 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCCC-------
Confidence 1 1223457889999999888889999999999999999999999986532 1222222111111000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....+.++.+++.+|+..+|++|||+.|+++
T Consensus 223 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 -------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0123456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=288.41 Aligned_cols=245 Identities=22% Similarity=0.248 Sum_probs=192.4
Q ss_pred HHhccCCccccc--cccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeE
Q 005040 424 RATDEFNECNLL--GTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 424 ~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~ 499 (717)
...++|++.+.+ |+|+||.||++..+ +++.+|+|++....... .|+.....+ +||||+++++++...+..+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 334677777776 99999999999865 78889999986542111 122222222 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecccccc
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLL 578 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~ 578 (717)
+||||+++++|.+++.... .+++..+..++.|+++|+.||| +.+++||||||+||+++.++ .++|+|||++...
T Consensus 86 iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH----KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999998764 5899999999999999999999 67899999999999999988 9999999998765
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
.... ...++..|+|||++.+..++.++||||+|+++|||++|+.||............+.... ...
T Consensus 161 ~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~------- 226 (267)
T PHA03390 161 GTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK------- 226 (267)
T ss_pred CCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc-------
Confidence 4321 23578899999999988999999999999999999999999975433332233332211 000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-MTDAAA 700 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~ev~~ 700 (717)
.......+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 227 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 --------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0001134566889999999999999996 588874
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.03 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=211.2
Q ss_pred HHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 005040 421 DIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQ---LERAFRSFDSECEILRNVRHRNLLKILGSCSNLD 496 (717)
Q Consensus 421 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 496 (717)
.++-..++|++++.||+|+||.|..++++ +++.||.|++.+- .+.....|..|-.+|..-+.+.|+.+...|++..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 45666789999999999999999999976 7888999999763 2445567889999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
++|+|||||+||||-..+.+.. .+|+..+.-++..|+-||.-+| +.|+|||||||+|||+|..|++||+|||.+-
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH----~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH----SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH----hccceeccCCcceeEecccCcEeeccchhHH
Confidence 9999999999999999999887 6999999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccC----C-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGS----E-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR 651 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~----~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 651 (717)
.+... ........+|||.|.+||++. + +.|+..+|+||+||++|||+.|..||-.. .....+-+..
T Consensus 224 km~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----slveTY~KIm---- 294 (1317)
T KOG0612|consen 224 KMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----SLVETYGKIM---- 294 (1317)
T ss_pred hcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH----HHHHHHHHHh----
Confidence 87643 345567789999999999643 3 67999999999999999999999998642 1112221111
Q ss_pred hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 005040 652 LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH---MTDAAA 700 (717)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~ev~~ 700 (717)
+. .+.-.+|...+.+.++.+||.+.+. +|+.|.. +.++..
T Consensus 295 -----~h---k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 -----NH---KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred -----ch---hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 11 0111233334567778899998886 7888887 777654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=289.11 Aligned_cols=242 Identities=27% Similarity=0.310 Sum_probs=194.0
Q ss_pred ccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 435 LGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 435 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
||.|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 58999999987543 23446788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeecc
Q 005040 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590 (717)
Q Consensus 511 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 590 (717)
.+++.+.. .+++..+..++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH----~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH----NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 99998754 3789999999999999999999 6789999999999999999999999999998764432 12234
Q ss_pred ccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhh
Q 005040 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDK 670 (717)
Q Consensus 591 ~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
.++..|+|||...+..++.++|+||+|+++|||++|..||....... .+...... +.... ...+
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~--------~~~~~-----~~~~ 216 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDIL--------KGNGK-----LEFP 216 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHh--------ccCCC-----CCCC
Confidence 57889999999888889999999999999999999999997643211 11111111 00000 0001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 671 MDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
...+.++.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 122456889999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=299.10 Aligned_cols=268 Identities=21% Similarity=0.246 Sum_probs=196.9
Q ss_pred cCCccccccccccEEEEEEEec---CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--CeeE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS---DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFKA 499 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~ 499 (717)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999975 47899999987633 33345677899999999999999999999888 7899
Q ss_pred EEEEccCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC----CCcEEEee
Q 005040 500 LVLEFMPNGSLEKWLYSH----NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE----NMVAHVSD 571 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~----~~~~kl~D 571 (717)
+||||+++ ++.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH----SNWVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 99999974 777777532 235889999999999999999999 678999999999999999 99999999
Q ss_pred eccccccCCCCC-ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCc--------chHH
Q 005040 572 FGISKLLGEGED-SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE--------MSLR 641 (717)
Q Consensus 572 fgl~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~--------~~~~ 641 (717)
||++........ ........++..|+|||+..+ ..++.++||||||+++|||++|+.||....... ..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999987643322 111223457889999997665 458899999999999999999999997643322 0111
Q ss_pred HHHHhhCCC------------chhhhcc----ccchh--hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 642 RWVKESLPH------------RLTEVVD----ANLVR--EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 642 ~~~~~~~~~------------~~~~~~~----~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......... ......+ ..... ...........+.++.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111100000 0000000 00000 00000000133456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=302.35 Aligned_cols=265 Identities=22% Similarity=0.241 Sum_probs=197.8
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC------
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL------ 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------ 495 (717)
..++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 78999999986432 23345677899999999999999999987543
Q ss_pred CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
...|+||||+. ++|.+++... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999996 5898888653 788999999999999999999 679999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC--Cchh
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP--HRLT 653 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 653 (717)
........ .....++..|+|||.+.+..++.++||||+||++|+|++|+.||..... ............. ....
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence 87643221 2234578899999999999999999999999999999999999965321 1111111110000 0000
Q ss_pred hhcc--------ccch-------hhhhh--h-----hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 654 EVVD--------ANLV-------REEQA--F-----SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 654 ~~~~--------~~~~-------~~~~~--~-----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..++ .... ...+. . ......+.++.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0000 00000 0 0011235568899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=296.29 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=196.8
Q ss_pred cccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 432 CNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
...||+|+||.||+|..+ +++.||+|.+..........+.+|+.+++.++|||++++++++.+.+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999875 7899999988655445556788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeecc
Q 005040 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590 (717)
Q Consensus 511 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 590 (717)
.+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++........ .....
T Consensus 105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 9987654 3789999999999999999999 67899999999999999999999999999876543211 12334
Q ss_pred ccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhh
Q 005040 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDK 670 (717)
Q Consensus 591 ~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
.++..|+|||+..+..++.++|+||+|+++|||++|..||..... ...........+.... ..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~---------------~~ 239 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLK---------------NL 239 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcccC---------------Cc
Confidence 578999999998888889999999999999999999999864211 1111111111111110 01
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 671 MDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...+..+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 123345779999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=289.55 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=203.7
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 68999999987553 24556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 505 MPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 505 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
+++++|.+++... ...+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999999999865 366899999999999999999999 679999999999999999999999999999876443
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
. .......+++.|+|||...+..++.++|+||+|+++|+|++|+.||..... .+............
T Consensus 157 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~------- 222 (258)
T cd08215 157 V--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQYPP------- 222 (258)
T ss_pred c--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCCCC-------
Confidence 2 122334678899999998888899999999999999999999999865321 11111111100000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. +..++.++.+++.+||..+|++|||+.|+++
T Consensus 223 -----~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 -----I--PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -----C--CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 1133456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.03 Aligned_cols=263 Identities=25% Similarity=0.299 Sum_probs=201.3
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
|+..+.||+|++|.||+|... +++.+|+|.+..... .....+..|++++++++||||+++++++.+....++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 788999998865432 24467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++ ++.+++......+++..+..++.|+++||.||| +.+|+|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH----HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 75 999988876566899999999999999999999 6789999999999999999999999999998765433 1
Q ss_pred eeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc----hhhhcc---
Q 005040 586 IQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR----LTEVVD--- 657 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~--- 657 (717)
......++..|+|||...+. .++.++|+||+|+++|+|++|+.||...... ..+.... ...... .....+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIF-RTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HHcCCCchHhcccchhhhh
Confidence 12234578889999987766 7899999999999999999999998653221 1111111 111000 000000
Q ss_pred ---ccchhhh--hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ---ANLVREE--QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ---~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+.... ........++.++.++|.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 000111245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=296.16 Aligned_cols=266 Identities=22% Similarity=0.250 Sum_probs=194.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCe-----
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNVR-HRNLLKILGSCSNLDF----- 497 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~----- 497 (717)
++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999975 789999998865432 22356788999999995 6999999999876655
Q ss_pred eEEEEEccCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeee
Q 005040 498 KALVLEFMPNGSLEKWLYSH----NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVAHVSDF 572 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Df 572 (717)
.|+||||+++ +|.+++... ...+++..+..++.||++||.||| +.+|+||||+|+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH----KHGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999985 899988743 235799999999999999999999 678999999999999998 899999999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-CCC
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES-LPH 650 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~ 650 (717)
|++..+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||....... ......... .+.
T Consensus 156 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (295)
T cd07837 156 GLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPT 232 (295)
T ss_pred ccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 99876532211 1122356888999997754 557999999999999999999999986532111 111111100 000
Q ss_pred c--hhhhccccchhhhh-----hh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 651 R--LTEVVDANLVREEQ-----AF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 651 ~--~~~~~~~~~~~~~~-----~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. +............+ .. ......+.++.++|.+||..||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000000000000 00 001234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=291.03 Aligned_cols=243 Identities=24% Similarity=0.301 Sum_probs=191.9
Q ss_pred ccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 435 LGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 435 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
||+|+||+||+|... +|+.||+|.+.... ......+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 78999999987543 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeec
Q 005040 511 EKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589 (717)
Q Consensus 511 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 589 (717)
.+++.... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH----QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 99998644 35899999999999999999999 6789999999999999999999999999987654321 1223
Q ss_pred cccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhh
Q 005040 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSD 669 (717)
Q Consensus 590 ~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (717)
..++..|+|||+..+..++.++||||+|+++|+|++|+.||...... ............. . ...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-------------~--~~~ 217 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEM-------------A--VEY 217 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhccccc-------------c--ccC
Confidence 45788999999988888999999999999999999999999653221 1111111100000 0 001
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 670 KMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 670 ~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
...++..+.+++.+||+.+|++|| ++.+++.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 112356688999999999999999 5665653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=296.56 Aligned_cols=270 Identities=25% Similarity=0.285 Sum_probs=200.3
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC----
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD---- 496 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~---- 496 (717)
...++|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999976 68899999986543 223346678999999999999999999986654
Q ss_pred ------eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 005040 497 ------FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570 (717)
Q Consensus 497 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 570 (717)
..++|+||+++ ++.+++......+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH----KKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 888888766556899999999999999999999 6789999999999999999999999
Q ss_pred eeccccccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh--
Q 005040 571 DFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES-- 647 (717)
Q Consensus 571 Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-- 647 (717)
|||++........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.... ....+.......
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-~~~~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-ELAQLELISRLCGS 236 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCC
Confidence 9999987643321 11222345778999997654 457899999999999999999999996522 111111111111
Q ss_pred -CCCchhhhccccchh--------hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 648 -LPHRLTEVVDANLVR--------EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 648 -~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+.....+....... ...........+..+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 010011110000000 00000111123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=331.51 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=204.3
Q ss_pred HHHHhccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 422 IRRATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 422 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
++..+-++.....||.|.||.||.|.. .+|.-.|+|-++... ......+.+|+.++..++|||+|+++|+-...+.+
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 455667888899999999999999985 578889999765443 33445678899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++.||||++|+|.+.++..+ ..++.....+..|++.|++||| +++||||||||.||+++.+|.+|++|||.|..+
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH----~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH----EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH----hcCceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999999887543 3566667778899999999999 689999999999999999999999999999987
Q ss_pred CCCCCce--eeeccccCccccCCCccCCC---CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchh
Q 005040 579 GEGEDSV--IQTMTMATIGYMAPEYGSEG---IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLT 653 (717)
Q Consensus 579 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 653 (717)
....... .-....||+.|||||++.+. ....+.||||+||++.||+||+.||.... .+..+..-+.....
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-ne~aIMy~V~~gh~---- 1459 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-NEWAIMYHVAAGHK---- 1459 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-chhHHHhHHhccCC----
Confidence 6543221 12345799999999987653 35678999999999999999999997643 23222222222111
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+++++ ..+.+-.+++..|+..||++|+++.|+++.
T Consensus 1460 -----------Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 -----------PQIPE--RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----------CCCch--hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11122 245567799999999999999999877653
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.10 Aligned_cols=269 Identities=22% Similarity=0.279 Sum_probs=199.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeee----cCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCS----NLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~----~~~~~ 498 (717)
..+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999865 79999999987543 233456778999999999999999999875 33568
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+. |+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 699999876543 899999999999999999999 678999999999999999999999999999765
Q ss_pred CCCCCc--eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC--CCc-h
Q 005040 579 GEGEDS--VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL--PHR-L 652 (717)
Q Consensus 579 ~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~-~ 652 (717)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.... ..+........ +.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCChhHhh
Confidence 432211 11123467889999998755 56899999999999999999999999653211 11111111100 000 0
Q ss_pred hhhccccchhhh------hhh---hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 653 TEVVDANLVREE------QAF---SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 653 ~~~~~~~~~~~~------~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
............ ... ......+.++.+++.+||+.+|++||++++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000 000 0011345778999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.84 Aligned_cols=246 Identities=25% Similarity=0.315 Sum_probs=196.3
Q ss_pred ccccccEEEEEEEec-CCCeEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 435 LGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 435 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
||+|+||.||++... +|+.+|+|++..... ...+.+.+|++++++++||||+++++.+......|+|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 599999999865432 4456788899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC------c
Q 005040 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED------S 584 (717)
Q Consensus 511 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~------~ 584 (717)
.+++...+ .+++..+..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH----SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998755 5899999999999999999999 67899999999999999999999999999876533211 1
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
.......++..|+|||...+..++.++||||||+++||+++|+.||...... ........ .. .
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~---~~--------~---- 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EIFQNILN---GK--------I---- 218 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc---CC--------c----
Confidence 1223345788999999988888999999999999999999999999653211 11111100 00 0
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
..+.....+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00111112466889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=296.18 Aligned_cols=253 Identities=23% Similarity=0.279 Sum_probs=196.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 502 (717)
.++|++.+.||+|+||.||+|..+ +++.||||+++... ......+..|+.++.+.. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 367888999999999999999986 48999999987543 233345666777777664 999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||++ +++.+++......+++..+..++.|++.|++|||+ ..+|+||||+|+||+++.++.+||+|||++..+....
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE---KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9985 58888777655578999999999999999999994 2589999999999999999999999999987664322
Q ss_pred CceeeeccccCccccCCCccCCCC----cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGI----VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
. .....++..|+|||++.+.. ++.++||||||+++|||++|+.||.........+........+
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 237 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP--------- 237 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC---------
Confidence 1 12234778899999886553 7899999999999999999999986522111111111111000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+....++.++.+++.+||+.||++||++.++++.
T Consensus 238 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 -------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001111245668899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.12 Aligned_cols=248 Identities=26% Similarity=0.336 Sum_probs=205.0
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
....|.+...||+|.|+.|..|.+. ++..||+|++++.. ....+.+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3468899999999999999999975 79999999998765 23345588899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+.+|.+.+|+.+++. ..+..+..++.|+.+|++||| ++.|||||||++|||++.+.++||+|||++..+...
T Consensus 134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH----~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH----SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh----hcceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999998876 445888899999999999999 789999999999999999999999999999988533
Q ss_pred CCceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
......+|++.|.|||+..+..| ++.+|+||+|+++|-|+.|..||++..-.+ .-++.+
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------------Lr~rvl 268 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------------LRPRVL 268 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------------ccchhe
Confidence 33456789999999999888765 789999999999999999999998742211 111111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+.. ..+. -.+.+..+++++++-.+|.+|++.+++.+
T Consensus 269 ~gk~-rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 269 RGKY-RIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeee-cccc--eeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1111 0111 11223458999999999999999999875
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=288.49 Aligned_cols=244 Identities=23% Similarity=0.250 Sum_probs=189.0
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHH-hcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILR-NVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|... +++.||+|++.... ......+..|..++. ..+|||++++++++.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 68999999986543 222234445555444 45899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH----QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999998654 4789999999999999999999 67899999999999999999999999999875432 1
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
....++..|+|||...+..++.++||||+|+++|||++|..||....... .......... .. . .
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~--------~-----~ 214 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRI--NW--------P-----E 214 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhccc--CC--------C-----C
Confidence 23357889999999888889999999999999999999999996532211 0011000000 00 0 0
Q ss_pred hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 668 SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
.....++..+.+++.+||+.+|++||++.++.+.|.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 011134567889999999999999998876655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=294.05 Aligned_cols=264 Identities=25% Similarity=0.277 Sum_probs=199.2
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--CeeEEEEE
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFKALVLE 503 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 503 (717)
|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+++++.++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 58899999997653 33345688899999999999999999999887 88999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|++ ++|.+++......+++..+..++.|+++|++||| ..+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH----SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 4999998876556899999999999999999999 67899999999999999999999999999987654321
Q ss_pred ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC---CCchhhhcc--
Q 005040 584 SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL---PHRLTEVVD-- 657 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-- 657 (717)
.......++..|+|||...+ ..++.++||||||+++|||++|+.||...... ........... ...+....+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccch
Confidence 11233456788999997654 45789999999999999999999998753221 11111111000 000000000
Q ss_pred --------ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 --------ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 --------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.......... ....++.++.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREF-FKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHH-hcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000 00113567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=315.27 Aligned_cols=270 Identities=18% Similarity=0.187 Sum_probs=189.8
Q ss_pred HhccCCccccccccccEEEEEEEec--CCCeEEEEE--------------echh---hHHHHHHHHHHHHHHHhcCCCce
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS--DGTNVAIKI--------------FNLQ---LERAFRSFDSECEILRNVRHRNL 485 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~--------------~~~~---~~~~~~~~~~e~~~l~~l~hpni 485 (717)
..++|++.+.||+|+||+||++..+ ++..++.|. +.+. .......+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998754 222222221 1111 12234567889999999999999
Q ss_pred eeEeeeeecCCeeEEEEEccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 005040 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHN----YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL 561 (717)
Q Consensus 486 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill 561 (717)
+++++++.+.+..|+|+|++. ++|.+++.... .......+..++.|++.||.||| +.+|+||||||+|||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH----~~gIiHrDLKP~NILl 300 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH----DKKLIHRDIKLENIFL 300 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE
Confidence 999999999999999999985 58888876432 22345667789999999999999 6899999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCC-CCccccC-cch
Q 005040 562 DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP-TDEMFTG-EMS 639 (717)
Q Consensus 562 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p-~~~~~~~-~~~ 639 (717)
+.++.+||+|||++..+...... ......||..|+|||++.+..++.++|||||||++|||++|+.+ +...... ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876433221 12335689999999999999999999999999999999998854 4332111 112
Q ss_pred HHHHHHh------hCCCchhhhcc---cc-chh---hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 640 LRRWVKE------SLPHRLTEVVD---AN-LVR---EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 640 ~~~~~~~------~~~~~~~~~~~---~~-~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.+.+.. ..+.......+ .. +.. ..+........+.++.+++.+|++.||.+|||+.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 2221111 11111001100 00 000 00001111123455778899999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=288.19 Aligned_cols=246 Identities=28% Similarity=0.341 Sum_probs=201.6
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|++.+.||+|+||.||++... +++.+|+|.+.... ......+.+|+++++.++||||+++.+++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 78899999987543 33446678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 505 MPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 505 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
+++++|.+++... ...+++..++.++.|+++||+||| +.+++|+||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh----~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998752 345899999999999999999999 689999999999999999999999999999876543
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
......++..|+|||...+..++.++|+||+|+++|||++|+.||..... ......+... ...
T Consensus 157 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~---~~~-------- 219 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRYKVQRG---KYP-------- 219 (256)
T ss_pred ----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcC---CCC--------
Confidence 12234578899999999998999999999999999999999999975321 1111111110 000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. ....++.++.+++.+|++.+|++||++.|+++
T Consensus 220 ----~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 ----P--IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ----C--CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 01134566889999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=297.51 Aligned_cols=276 Identities=21% Similarity=0.285 Sum_probs=199.5
Q ss_pred cccccc--ccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTG--GFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
..||+| +||+||+|+.. +|+.||+|++.... .+..+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 89999999975 79999999986433 33456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce-
Q 005040 508 GSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV- 585 (717)
Q Consensus 508 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 585 (717)
+++.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH----QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999999864 234889999999999999999999 6789999999999999999999999998654332211110
Q ss_pred ----eeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC--C-------C
Q 005040 586 ----IQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL--P-------H 650 (717)
Q Consensus 586 ----~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~-------~ 650 (717)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||........ ......... + .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccch
Confidence 0111234567999998866 3478999999999999999999999976432211 111110000 0 0
Q ss_pred chhhh--------------ccc-----cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHhHHhh
Q 005040 651 RLTEV--------------VDA-----NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA--KLRKIKAKF 709 (717)
Q Consensus 651 ~~~~~--------------~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~--~L~~~~~~~ 709 (717)
..... ... .........+....++.++.+++++||+.||++|||+.|+++ .++.+.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~ 318 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT 318 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence 00000 000 000000011223356778999999999999999999999974 455555554
Q ss_pred ccch
Q 005040 710 LDDV 713 (717)
Q Consensus 710 ~~~~ 713 (717)
..++
T Consensus 319 ~~~~ 322 (328)
T cd08226 319 QGSI 322 (328)
T ss_pred ccch
Confidence 4443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=293.74 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=195.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|+..+.||+|++|.||+|..+ +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47888999999999999999975 78999999886442 2233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeeccccccCCC
Q 005040 504 FMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~ 581 (717)
|++ ++|.+++.... ...++..+..++.|++.||+||| +++++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 58888886543 33678888999999999999999 678999999999999985 567999999999765432
Q ss_pred CCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc----
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV---- 656 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 656 (717)
.. ......+++.|+|||++.+ ..++.++||||+|+++|+|+||+.||......+ ....... ..........
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFR-ILGTPNEETWPGVT 232 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCChhhccccc
Confidence 11 1123356889999998765 457899999999999999999999996532211 1111110 0000000000
Q ss_pred ---ccc--chh--hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 657 ---DAN--LVR--EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 657 ---~~~--~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.. ... ...........+.++.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 00000011223466889999999999999999999986
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=299.43 Aligned_cols=268 Identities=25% Similarity=0.318 Sum_probs=198.3
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC--Cee
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL--DFK 498 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~--~~~ 498 (717)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999975 68899999885421 22335567899999999 999999999988543 467
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||++ ++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5999998765 5789999999999999999999 679999999999999999999999999999866
Q ss_pred CCCCCc---eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc---
Q 005040 579 GEGEDS---VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR--- 651 (717)
Q Consensus 579 ~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 651 (717)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ...+ +.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~-~~~~~~~~~~~ 235 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEK-IIEVIGPPSAE 235 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhCCCCHH
Confidence 433221 11223457889999997654 567899999999999999999999996532211 1111 11100000
Q ss_pred -hh--------hhccccchhhhhhh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 652 -LT--------EVVDANLVREEQAF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 652 -~~--------~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+. ...+.......... .....++.++.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 00000000000000 0011245678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=274.00 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=197.1
Q ss_pred HhccCCcc-ccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeec----CCe
Q 005040 425 ATDEFNEC-NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSN----LDF 497 (717)
Q Consensus 425 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~----~~~ 497 (717)
++++|.+. ++||-|-.|.|-.+..+ +|+.+|+|++... ...++|++..-.. .|||||.++++|+. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35566654 56899999999998865 8999999988633 3345677765555 69999999998854 345
Q ss_pred eEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeec
Q 005040 498 KALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD---ENMVAHVSDFG 573 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg 573 (717)
+.+|||.|+||.|.+.+++++ ..+.+.++..|+.||+.|+.||| +.+|.||||||+|+|.. .+..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH----~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH----SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH----hcchhhccCChhheeeecCCCCcceEecccc
Confidence 679999999999999999664 45899999999999999999999 78899999999999997 45679999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchh
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLT 653 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 653 (717)
+|+.-.+ ...-...+-|+.|.|||++....|+..+|+||+||++|-|++|.+||-.+.... +.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--------------is 272 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------------IS 272 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--------------CC
Confidence 9986543 222345678999999999999999999999999999999999999996643211 00
Q ss_pred hhccccchhhhhhh--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 654 EVVDANLVREEQAF--SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 654 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.-...++...+..+ +++...+++..++|+.+|+.+|++|.|+.|++.
T Consensus 273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11111111111122 345567888999999999999999999999875
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=295.61 Aligned_cols=264 Identities=22% Similarity=0.223 Sum_probs=193.8
Q ss_pred ccccccccccEEEEEEEecCCCeEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 431 ECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQ--LERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 431 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
+.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334455555555555554 7999999998754 2445567899999999999999999999999999999999999999
Q ss_pred CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc---
Q 005040 509 SLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS--- 584 (717)
Q Consensus 509 ~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~--- 584 (717)
+|.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+|++|||.+..+......
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH----~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH----SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999999854 345889999999999999999999 678999999999999999999999999988755322211
Q ss_pred --eeeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC----------
Q 005040 585 --VIQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH---------- 650 (717)
Q Consensus 585 --~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------- 650 (717)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||............ .....+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhh
Confidence 11122346788999998765 45889999999999999999999999754322211111 1100000
Q ss_pred --chhh----hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 651 --RLTE----VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 651 --~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.... ..+.. ...............++.+++.+||..||++|||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 00111112223445678999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=283.80 Aligned_cols=247 Identities=27% Similarity=0.386 Sum_probs=202.0
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+|+..+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++|||++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 688999999876543 4557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH----EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999876 45899999999999999999999 689999999999999999999999999999876543321
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ....|.... ... ..+
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~--~~~-----~~~---- 219 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQ--DDH-----PPL---- 219 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhc--cCC-----CCC----
Confidence 2334578899999998888899999999999999999999999864221 111111100 000 000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....+..+.+++.+|+..+|++||++.|++.
T Consensus 220 -----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 -----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0122456789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.30 Aligned_cols=248 Identities=25% Similarity=0.317 Sum_probs=197.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQ---LERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
..|+..+.||+|+||.||+|... +++.||+|.+... .....+++.+|+++++.++|||++++.+++.+....++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777789999999999999975 6888999988642 2334466788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+. |++.+++......+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 6888888766666899999999999999999999 678999999999999999999999999998765432
Q ss_pred CceeeeccccCccccCCCccC---CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 583 DSVIQTMTMATIGYMAPEYGS---EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
....++..|+|||.+. ...++.++|||||||++|||++|+.||...... .....+.....+ .
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~---------~ 233 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP---------A 233 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCCC---------C
Confidence 2235788999999763 456888999999999999999999998652111 111111110000 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
.....++..+.+++.+||+.+|++||++.++++.--
T Consensus 234 --------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 001134456889999999999999999999887533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=292.89 Aligned_cols=259 Identities=21% Similarity=0.218 Sum_probs=185.8
Q ss_pred hccCCccccccccccEEEEEEEecC----CCeEEEEEechhhHHH-----------HHHHHHHHHHHHhcCCCceeeEee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSD----GTNVAIKIFNLQLERA-----------FRSFDSECEILRNVRHRNLLKILG 490 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpniv~~~~ 490 (717)
.++|.+.+.||+|+||.||+|...+ +..+|+|+........ ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3689999999999999999999753 4566777543221110 011223344556678999999999
Q ss_pred eeecCC----eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 005040 491 SCSNLD----FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV 566 (717)
Q Consensus 491 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~ 566 (717)
++.... ..++++|++. .++.+.+.... ..++..+..++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH----EHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCc
Confidence 765433 4478888874 46777666432 3578888999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCc-----eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHH
Q 005040 567 AHVSDFGISKLLGEGEDS-----VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR 641 (717)
Q Consensus 567 ~kl~Dfgl~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~ 641 (717)
++|+|||+++.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||....... ...
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HHH
Confidence 999999999876432211 11123468999999999999999999999999999999999999997642211 111
Q ss_pred HHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 642 RWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
..... +.. ..+.... .....++..+.+++..|++.+|++||+++++++.+
T Consensus 244 ~~~~~-------~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKC-------DFI-KRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHH-------HHH-HHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11100 000 0000000 01123456788999999999999999999999876
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=285.10 Aligned_cols=241 Identities=21% Similarity=0.290 Sum_probs=185.4
Q ss_pred cccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHH---HHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 434 LLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSEC---EILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 434 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~---~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
.||+|+||.||+|... +++.||+|.+.... ......+..|. +.++...||+|+.+.+++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 68899999886532 11112233343 34445579999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+|+|.+++.... .+++..+..++.|+++|+.||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 999999887654 5899999999999999999999 6789999999999999999999999999987653221
Q ss_pred eeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....|+..|+|||+..++ .++.++||||+|+++|||++|+.||................. ....+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~----- 218 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------MAVEL----- 218 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--------cCCCC-----
Confidence 1234689999999988754 689999999999999999999999976322111110000000 00000
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
+..++.++.+++.+|+..+|++|| ++.++++
T Consensus 219 ----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 112345688999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.01 Aligned_cols=244 Identities=27% Similarity=0.324 Sum_probs=194.2
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999865 78899999986432 23446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+. |++.+++......+++.++..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 6888888776666899999999999999999999 67899999999999999999999999998864322
Q ss_pred eeeeccccCccccCCCccC---CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 585 VIQTMTMATIGYMAPEYGS---EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.....++..|+|||++. .+.++.++||||||+++|||++|..||..... ............ ...
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~~---~~~------ 240 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNDS---PTL------ 240 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCC---CCC------
Confidence 12345788999999873 46688999999999999999999999865321 111111111000 000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
....++..+.+++.+||+.+|.+||++.+++..
T Consensus 241 -------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011233457899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=298.05 Aligned_cols=271 Identities=24% Similarity=0.260 Sum_probs=200.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Ce
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL-----DF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~ 497 (717)
..+|.+.+.||+|+||+||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467899999999999999999865 78999999886432 22345667899999999999999999987543 35
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+|+||+. ++|.+++...+ .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 69999887654 4899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh---CCCchh
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES---LPHRLT 653 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 653 (717)
..... .......++..|+|||.... ..++.++||||||+++|+|++|+.||..... ........... .+....
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhh
Confidence 64332 11223457889999997654 5689999999999999999999999965321 11111111000 000000
Q ss_pred hhccccchh--------hhhh-hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHh
Q 005040 654 EVVDANLVR--------EEQA-FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK--LRKI 705 (717)
Q Consensus 654 ~~~~~~~~~--------~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~--L~~~ 705 (717)
...+..... .... .....+++.++.+++.+||+.+|++|||++|+++. ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000 0000 00112456778999999999999999999999977 6554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.96 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=198.7
Q ss_pred HHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec-CCe
Q 005040 422 IRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN-LDF 497 (717)
Q Consensus 422 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~ 497 (717)
+..++++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999865 89999999875432 2234667789999999999999999998865 567
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.++|+||+ +++|.+++.... +++..+..++.|+++||.||| +.+++||||+|+||+++.++.++|+|||.+..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH----~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 89999998 569998887543 788888899999999999999 67899999999999999999999999999875
Q ss_pred cCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh--CCCchh-
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES--LPHRLT- 653 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~- 653 (717)
..... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+.... .++++.
T Consensus 158 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 158 QDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHH
Confidence 43211 22356888999998765 5689999999999999999999999965322 11111111100 000000
Q ss_pred hhcccc-------chhh-h-hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 654 EVVDAN-------LVRE-E-QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 654 ~~~~~~-------~~~~-~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
...+.. +... . +.......++.++.++|.+|++.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000 0 0000011245678999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=287.76 Aligned_cols=261 Identities=25% Similarity=0.298 Sum_probs=196.2
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhc---CCCceeeEeeeeecCCe-----
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNV---RHRNLLKILGSCSNLDF----- 497 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~----- 497 (717)
|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.+++++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999986 58999999986432 22234566788777766 59999999999987776
Q ss_pred eEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
.+++|||+. ++|.+++.... ..+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH----~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 48999887643 35899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC-Cchh--
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP-HRLT-- 653 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~-- 653 (717)
.+...... ....++..|+|||+..+..++.++|+||||+++|||++|+.||..... .....++...... ....
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcC
Confidence 76433211 223468889999999988999999999999999999999999875322 2222222221110 0000
Q ss_pred -------hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 654 -------EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 654 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
........... .....+.+..+.+++.+||+.||++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSF--KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccch--hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000 0111234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=282.70 Aligned_cols=250 Identities=23% Similarity=0.272 Sum_probs=196.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechh-----hHHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--Cee
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQ-----LERAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFK 498 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~ 498 (717)
.+|++.+.||+|+||.||+|... +++.||+|.+... ..+....+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999865 6899999987532 133456788999999999999999999998664 467
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++|+||+++++|.+++..... +++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999999986543 789999999999999999999 678999999999999999999999999999865
Q ss_pred CCCCC-ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 579 GEGED-SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 579 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
..... ........++..|+|||+..+..++.++|+||||+++|||++|+.||...... ....+.. .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~----~~~~~---- 227 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-AAIFKIA----TQPTK---- 227 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-HHHHHHH----cCCCC----
Confidence 32111 11112345788999999998888999999999999999999999999653111 1111100 00000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+. .+...+.++.+++.+|+. +|..||++.+++.
T Consensus 228 ~~---------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 PM---------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CC---------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00 011344668899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=289.11 Aligned_cols=255 Identities=25% Similarity=0.282 Sum_probs=199.1
Q ss_pred cCCccccccccccEEEEEEEe----cCCCeEEEEEechhh----HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCee
Q 005040 428 EFNECNLLGTGGFGSVYKGTL----SDGTNVAIKIFNLQL----ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 498 (717)
+|++.+.||+|+||.||+++. .+++.||||+++... ....+.+..|+++++++ +||||+++.+++......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477888999999999999974 257889999987542 22345678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+++|+|.+++.... .+++..+..++.|+++||.||| +.+++||||+|+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH----~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH----QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999987653 4789999999999999999999 678999999999999999999999999998765
Q ss_pred CCCCCceeeeccccCccccCCCccCCCC--cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGI--VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
...... ......++..|+|||...+.. .+.++||||||+++|||++|..||..... ...............
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~----- 228 (288)
T cd05583 156 LAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSK----- 228 (288)
T ss_pred cccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHccC-----
Confidence 433221 122345788999999876654 78899999999999999999999854211 111111111110000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
. +....++..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 229 -~---------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 -P---------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -C---------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 0111234567899999999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=294.30 Aligned_cols=270 Identities=22% Similarity=0.277 Sum_probs=199.2
Q ss_pred HHHHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 005040 419 YLDIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL 495 (717)
Q Consensus 419 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 495 (717)
-.++..++++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3456677899999999999999999999864 78999999986532 22345677899999999999999999987542
Q ss_pred ------CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 005040 496 ------DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV 569 (717)
Q Consensus 496 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl 569 (717)
...+++++++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEcCCCCEEE
Confidence 3467888887 78999888754 3899999999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 648 (717)
+|||++...... .....++..|+|||...+ ..++.++||||||+++|||++|+.||...... ...........
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~ 235 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVG 235 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence 999998765322 123457889999998765 56889999999999999999999998653211 11111111110
Q ss_pred --CCchhhhccccchhhh----h-----hhhh-hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 649 --PHRLTEVVDANLVREE----Q-----AFSD-KMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 649 --~~~~~~~~~~~~~~~~----~-----~~~~-~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+......+........ + .+.. ....+.++.+++.+|++.||.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000000 0 0000 00234568899999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=287.68 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=200.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv 501 (717)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.+..|++++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888999999999999999975 79999999987642 233466788999999998 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++++|.+++...+ .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh----~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999998764 4899999999999999999999 678999999999999999999999999998866433
Q ss_pred CCc------------------eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHH
Q 005040 582 EDS------------------VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRW 643 (717)
Q Consensus 582 ~~~------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~ 643 (717)
... .......++..|+|||......++.++|+||+|++++++++|+.||..... ....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHH
Confidence 211 112233578899999998888899999999999999999999999875321 111111
Q ss_pred HHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 005040 644 VKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM----TDAAA 700 (717)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~----~ev~~ 700 (717)
... . .. ..+...+..+.+++.+||+.+|.+||++ .|+++
T Consensus 234 ~~~---~------~~---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 ILK---L------EY---------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHh---c------CC---------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000 0 00 0011224567899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.91 Aligned_cols=271 Identities=25% Similarity=0.283 Sum_probs=203.8
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----eeE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD-----FKA 499 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~ 499 (717)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++.+++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999975 58999999887543 334467888999999999999999999987765 789
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||++ ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH----~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58999987654 6899999999999999999999 6899999999999999999999999999998765
Q ss_pred CCCCc-eeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC----chh
Q 005040 580 EGEDS-VIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH----RLT 653 (717)
Q Consensus 580 ~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 653 (717)
..... .......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||...... .....+...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhh
Confidence 43210 112234578899999998877 7899999999999999999999999764221 111111111000 000
Q ss_pred hhccccchh---------hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHhH
Q 005040 654 EVVDANLVR---------EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK--LRKIK 706 (717)
Q Consensus 654 ~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~--L~~~~ 706 (717)
......... ...-.......+.++.+++.+||+.+|++||++.++++. ++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 000000000 000000011245678899999999999999999999974 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=286.42 Aligned_cols=262 Identities=23% Similarity=0.256 Sum_probs=194.8
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhhH-HHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEEEcc
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-RAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
|++.+.||+|+||.||+|... +++.||+|.+..... .......+|+..+++++ |||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999976 588899998865432 12233456899999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+|+|.+++.... ..+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 789999988654 46899999999999999999999 67899999999999999999999999999986643221
Q ss_pred eeeeccccCccccCCCccC-CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc----h------h
Q 005040 585 VIQTMTMATIGYMAPEYGS-EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR----L------T 653 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~------~ 653 (717)
.....++..|+|||+.. ...++.++|+||||+++|||++|+.||......+ .... ........ + .
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYK-ICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHH-HHHhcCCCChhhhhhHhhhh
Confidence 12345788999999764 4568999999999999999999999986532111 1110 00000000 0 0
Q ss_pred hhccccchhhhhh--hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 654 EVVDANLVREEQA--FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 654 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...+..+...... .......+.++.+++.+||+.+|++|||++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000000 0000011456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=271.56 Aligned_cols=270 Identities=20% Similarity=0.284 Sum_probs=199.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec--------C
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN--------L 495 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------~ 495 (717)
..|+...+||+|.||.||+|+.+ +|+.||+|+.-... ........+|+++|+.++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666789999999999999865 68889998654322 2223456789999999999999999998743 2
Q ss_pred CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
...|+||++|+. +|...+.+....++..++.++++++..||.|+| ...|+|||+|+.|||++.+|.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH----r~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH----RNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH----HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 357999999986 999999887777999999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCC--ceeeeccccCccccCCCccC-CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcc--hHHHHHHhhCCC
Q 005040 576 KLLGEGED--SVIQTMTMATIGYMAPEYGS-EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM--SLRRWVKESLPH 650 (717)
Q Consensus 576 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~ 650 (717)
+.+..... ...++..+.|.+|++||.+. ...|+++.|||+.||++.||+||.+-+.+..+... .++.......++
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 76643322 22345567799999999654 47799999999999999999999998876432211 112222222222
Q ss_pred chhhhccccchhhh-------hhhhhhHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 651 RLTEVVDANLVREE-------QAFSDKMDC------LFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 651 ~~~~~~~~~~~~~~-------~~~~~~~~~------~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.+..+..-.+.... .+.....+. ..+..+++..++..||.+|+++++++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 22222211111000 001111111 2367899999999999999999998753
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=294.24 Aligned_cols=265 Identities=22% Similarity=0.253 Sum_probs=195.4
Q ss_pred ccCCc-cccccccccEEEEEEEec-CCCeEEEEEechhhHHH--------------HHHHHHHHHHHHhcCCCceeeEee
Q 005040 427 DEFNE-CNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERA--------------FRSFDSECEILRNVRHRNLLKILG 490 (717)
Q Consensus 427 ~~~~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~hpniv~~~~ 490 (717)
++|.. .+.||+|+||.||+|... +++.||+|++....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999865 78999999886442111 124678999999999999999999
Q ss_pred eeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 005040 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570 (717)
Q Consensus 491 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 570 (717)
++...+..++||||+. |+|.+++.... .+++.....++.|++.||+||| +.+++||||+|+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH----~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH----KWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 69999987543 4899999999999999999999 6789999999999999999999999
Q ss_pred eeccccccCCCCC------------ceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCc
Q 005040 571 DFGISKLLGEGED------------SVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637 (717)
Q Consensus 571 Dfgl~~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 637 (717)
|||.+........ ........++..|+|||++.+. .++.++||||+|+++|||++|+.||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 9999986641110 1111223468889999987664 4789999999999999999999999753221
Q ss_pred chHHHHHHhhC-CC--chhhhc--------cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 638 MSLRRWVKESL-PH--RLTEVV--------DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 638 ~~~~~~~~~~~-~~--~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+........ +. .+.... ........ ......++.++.+++.+|++.+|++||+++|++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL--KTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH--HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111000 00 000000 00000000 0011133567889999999999999999999986
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=285.33 Aligned_cols=251 Identities=25% Similarity=0.282 Sum_probs=194.7
Q ss_pred cCCccccccccccEEEEEEEe----cCCCeEEEEEechhh----HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCee
Q 005040 428 EFNECNLLGTGGFGSVYKGTL----SDGTNVAIKIFNLQL----ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 498 (717)
+|++.+.||+|+||.||.|.. .+|+.||+|++.... ....+.+..|+++++++ +||||+.+++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 377889999999999999986 368899999987543 22345678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+++++|.+++.... .+++..+..++.|+++||.||| +.+++||||+|+||+++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999998654 4788999999999999999999 688999999999999999999999999998765
Q ss_pred CCCCCceeeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
...... ......|+..|+|||+..+ ..++.++||||||+++|+|++|+.||..... ......+........
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~----- 228 (290)
T cd05613 156 HEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE----- 228 (290)
T ss_pred cccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC-----
Confidence 432211 1123457889999998765 3468899999999999999999999864211 111112111110000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
+ +.+..++..+.+++.+|++.||++|| ++.+++.
T Consensus 229 -~---------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -P---------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -C---------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 00112345678999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.42 Aligned_cols=267 Identities=23% Similarity=0.235 Sum_probs=195.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeeEeeeeecC-------
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNVRHRNLLKILGSCSNL------- 495 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------- 495 (717)
.++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999975 789999998864331 1224567899999999999999999987443
Q ss_pred -CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecc
Q 005040 496 -DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574 (717)
Q Consensus 496 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 574 (717)
...++|+||+. +++...+......+++..+..++.|+++||+||| +.+++|+||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH----ENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 34699999996 4788888766666999999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCce---------eeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 005040 575 SKLLGEGEDSV---------IQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWV 644 (717)
Q Consensus 575 ~~~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 644 (717)
+.......... ......+++.|+|||...+ ..++.++||||||+++|||++|+.||.+.... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 98654322111 1122346788999997654 45889999999999999999999998653221 1111111
Q ss_pred Hhh-C--CCch------hh----hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 645 KES-L--PHRL------TE----VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 645 ~~~-~--~~~~------~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
... . +... .. .......... ..........+.+++.+|+..||++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL--EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccH--HHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 100 0 0000 00 0000000000 0011123356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=293.27 Aligned_cols=264 Identities=23% Similarity=0.273 Sum_probs=196.5
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC----
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD---- 496 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~---- 496 (717)
...++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999864 78999999885432 223456788999999999999999999886543
Q ss_pred --eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecc
Q 005040 497 --FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574 (717)
Q Consensus 497 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 574 (717)
..++||||+ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++++|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH----~~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 458999999 77999888753 4899999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC--Cc
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP--HR 651 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~ 651 (717)
+....... ....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||...... ............ ..
T Consensus 165 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 165 ARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHH
Confidence 98653321 22356889999998765 45889999999999999999999999753211 111111110000 00
Q ss_pred hhhhcccc--------chhhh-hhh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 652 LTEVVDAN--------LVREE-QAF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 652 ~~~~~~~~--------~~~~~-~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+...+... +.... ... .....++.++.+++.+|++.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 00000 000 001234566889999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=293.70 Aligned_cols=268 Identities=22% Similarity=0.282 Sum_probs=195.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC------C
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL------D 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~ 496 (717)
..+|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999965 78999999886432 22335678899999999999999999988654 3
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..++|+||+. .+|.++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH----SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4689999996 47777653 24889999999999999999999 6789999999999999999999999999987
Q ss_pred ccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-CCC-chh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES-LPH-RLT 653 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~-~~~ 653 (717)
...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+....... .+. ...
T Consensus 166 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 653221 23356888999998766 46889999999999999999999999753211 1111111100 000 000
Q ss_pred hhccc-cch---hhhhhh------hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHhHH
Q 005040 654 EVVDA-NLV---REEQAF------SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK--LRKIKA 707 (717)
Q Consensus 654 ~~~~~-~~~---~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~--L~~~~~ 707 (717)
+.... ... ...+.. ......+.++.+++.+||+.||++||++++++.. ++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 000 000000 0001234568899999999999999999999854 665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=244.94 Aligned_cols=266 Identities=23% Similarity=0.273 Sum_probs=200.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.+|+..++||+|.||+||+|+.+ +++.||+|.++... +.......+|+-+++.++|.|||++++....+...-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35667789999999999999965 68889999886553 3334567889999999999999999999998899999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
||. .+|..|...-...++.+.+.+++.|+++||.++| ++.+.|||+||.|.++..+|+.|++|||+++-.+-..
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch----shnvlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH----SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh----hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 995 4999999988778999999999999999999999 7889999999999999999999999999999775332
Q ss_pred ceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCC-CCccccCcchHHHHHHhhC---CCchh---hh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKP-TDEMFTGEMSLRRWVKESL---PHRLT---EV 655 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p-~~~~~~~~~~~~~~~~~~~---~~~~~---~~ 655 (717)
.-.+..+.|.+|.+|.++.+. -|+...|+||.||++.|+.....| |.+.. -..++.+..+... ++.+. ..
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhCCCccccCCccccC
Confidence 223455789999999988775 489999999999999999985544 54422 2223333332211 11122 12
Q ss_pred ccccchhhhhhhhhhHH----HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 656 VDANLVREEQAFSDKMD----CLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
-|......++......+ ....-.+++++.+.-+|..|.+++++++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22111111111111111 1122457788888889999999998875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.52 Aligned_cols=265 Identities=20% Similarity=0.273 Sum_probs=194.5
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecC----------
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNL---------- 495 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~---------- 495 (717)
.+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 68899999999999999999875 7899999998765555567788899999999999999999876543
Q ss_pred ----CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEe
Q 005040 496 ----DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVS 570 (717)
Q Consensus 496 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~-~~~~~kl~ 570 (717)
...++||||++ ++|.+++... .+++..+..++.|+++||.||| +.+|+||||||+||+++ .++.++++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH----~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5999888654 3889999999999999999999 67899999999999998 45678999
Q ss_pred eeccccccCCCCCce-eeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC
Q 005040 571 DFGISKLLGEGEDSV-IQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 571 Dfgl~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 648 (717)
|||.+.......... ......++..|+|||+... ..++.++|||||||++|||++|+.||......+ ........ .
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~-~ 235 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILES-V 235 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-c
Confidence 999997654321111 1123357889999997544 568889999999999999999999996532211 11111111 0
Q ss_pred CCc----hhhh---ccccch----hhhhh-hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 649 PHR----LTEV---VDANLV----REEQA-FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 649 ~~~----~~~~---~~~~~~----~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.. .... ...... ..... .......+.++.+++.+|+..||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0000 000000 00000 0001124466889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=286.20 Aligned_cols=263 Identities=27% Similarity=0.286 Sum_probs=198.9
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+++++.++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999976 69999999987653 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
+ ++|.+++......+++..+..++.|++.||.||| +.+|+||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH----SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 5999999876556899999999999999999999 67899999999999999999999999999886643221
Q ss_pred eeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC----chhhh-----
Q 005040 586 IQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH----RLTEV----- 655 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~----- 655 (717)
......++..|+|||++.+. .++.++||||||+++||+++|+.||...... ..+.+ +...... .+...
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFK-IFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHH-HHHHhCCCcHHHHHhhccccc
Confidence 12233457789999987766 7899999999999999999999998653211 11111 1110000 00000
Q ss_pred ccccchhhhhh--hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 656 VDANLVREEQA--FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 656 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+..+...... .......+.++.+++.+||..+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 0001122467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.68 Aligned_cols=262 Identities=24% Similarity=0.290 Sum_probs=197.0
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe----
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF---- 497 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~---- 497 (717)
..++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999975 68899999886432 2234567789999999999999999998766554
Q ss_pred --eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 498 --KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 498 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
.++|+||+ +++|.+++... .+++..+..++.|+++||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 67999998763 4899999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
...... .....++..|+|||...+ ..++.++||||+|+++|||++|+.||...... ..+..... .......+
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~-~~~~~~~~ 238 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMN-LVGTPDEE 238 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH-hcCCCCHH
Confidence 865432 123357888999998754 46789999999999999999999999653221 11111111 11100000
Q ss_pred hc------------cccchhhhhhhh-hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VV------------DANLVREEQAFS-DKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~------------~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ..........+. .....+.++.+++.+|+..+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 000000000000 01123567899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=277.25 Aligned_cols=245 Identities=24% Similarity=0.267 Sum_probs=199.7
Q ss_pred HHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCe
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDF 497 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~ 497 (717)
+....+|..+.+||+|+||.|-+|..+ +.+.+|||++++.. ....+--+.|-++|+.. +-|.++++..+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 444568999999999999999999876 56779999998765 33334456688888866 57899999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
+|+||||+.||+|--.+++-++ +.+..+.-++..||-||-+|| +++|++||||..||++|.+|++||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh----~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh----cCCeeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999999988887665 667777889999999999999 79999999999999999999999999999975
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
---.. ......+|||.|+|||.+...+|+.++|+|||||+||||+.|++||++.. +..+-+.+.++
T Consensus 500 ni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD--E~elF~aI~eh---------- 565 (683)
T KOG0696|consen 500 NIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQAIMEH---------- 565 (683)
T ss_pred cccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHc----------
Confidence 32222 22345689999999999999999999999999999999999999998732 22222222211
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH 694 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt 694 (717)
+...+...+.++.++....+...|.+|..
T Consensus 566 --------nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 --------NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 12233355677889999999999999974
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=287.00 Aligned_cols=241 Identities=24% Similarity=0.362 Sum_probs=196.1
Q ss_pred ccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCC
Q 005040 433 NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGS 509 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 509 (717)
+.||.|.||+||-|+++ +|+.||||++.+-. .......++|+.+|++++||.||.+-..|+..+..|+|||.+. |+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence 68999999999999975 89999999997654 3334678899999999999999999999999999999999995 46
Q ss_pred HHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeeccccccCCCCCce
Q 005040 510 LEKWL-YSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN---MVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 510 L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
..+++ .....++++....-++.||+.||+||| -++|||+||||+|||+.+. .++||||||+|+.+++....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH----~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR- 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH----FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR- 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh----hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence 66555 455667999999999999999999999 5789999999999999743 47999999999999765433
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
...+||+.|+|||++..+.|...-|+||.||++|--++|..||.+.. ++.+.+.. ..+.-.
T Consensus 724 --rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----dIndQIQN-----------AaFMyP-- 784 (888)
T KOG4236|consen 724 --RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----DINDQIQN-----------AAFMYP-- 784 (888)
T ss_pred --hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----chhHHhhc-----------cccccC--
Confidence 35679999999999999999999999999999999999999997532 22222211 111000
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAA 699 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~ 699 (717)
-..+.+.+.+++++|...+++.=++|-|..+.+
T Consensus 785 -p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 785 -PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 012345567788999999999989998887654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=281.07 Aligned_cols=257 Identities=28% Similarity=0.418 Sum_probs=199.1
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh-------HHHHHHHHHHHHHHHhcCCCceeeEeeeee-cCC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL-------ERAFRSFDSECEILRNVRHRNLLKILGSCS-NLD 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~ 496 (717)
.++|-..++||+|+|+.||+|.+ ...+.||||+-.... ....+...+|.++.+.|.||.||++|+++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 46788889999999999999984 478889999764332 112345678999999999999999999985 456
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeec
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD---ENMVAHVSDFG 573 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg 573 (717)
..|-|.|||+|.+|.-|++.+.. +++..+..|++||+.||.||.+. +.+|+|-||||.|||+- .-|.+||+|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 67899999999999999987654 89999999999999999999976 57899999999999995 46789999999
Q ss_pred cccccCCCCCce-----eeeccccCccccCCCccC----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 005040 574 ISKLLGEGEDSV-----IQTMTMATIGYMAPEYGS----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWV 644 (717)
Q Consensus 574 l~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 644 (717)
+++.+....+.. ..+...||.+|++||++- ....+.|+||||.|||+|+++.|+.||+...... +..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----dIL 694 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----DIL 694 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH----HHH
Confidence 999987554432 223457999999999643 2357889999999999999999999998642211 111
Q ss_pred HhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 005040 645 KESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAA 699 (717)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~ 699 (717)
... .++. .....++.....+.++.++|++|+++.-++|....++.
T Consensus 695 qeN------TIlk----AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 QEN------TILK----ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhh------chhc----ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 110 0111 11112333334556788999999999999999887764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=312.37 Aligned_cols=145 Identities=27% Similarity=0.433 Sum_probs=131.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|.+.+.||+|+||.||+|... +++.||+|++.... ......+..|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999976 78999999987543 333467888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
||+.+++|.+++...+ .+++..++.++.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH----~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH----RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998654 3788999999999999999999 6789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.45 Aligned_cols=266 Identities=23% Similarity=0.261 Sum_probs=191.4
Q ss_pred cCCccccccccccEEEEEEEec-C--CCeEEEEEechhh--HHHHHHHHHHHHHHHhc-CCCceeeEeeeeec----CCe
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-D--GTNVAIKIFNLQL--ERAFRSFDSECEILRNV-RHRNLLKILGSCSN----LDF 497 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~----~~~ 497 (717)
+|++.+.||+|+||.||++... + +..||+|++.... ....+.+.+|+++++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999975 4 7789999886432 22345678899999999 59999999986532 245
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.++++||+. ++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 789999985 69999987544 4899999999999999999999 67899999999999999999999999999986
Q ss_pred cCCCCCc--eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-C-Cc-
Q 005040 578 LGEGEDS--VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-P-HR- 651 (717)
Q Consensus 578 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~-~~- 651 (717)
....... .......|+..|+|||+..+ ..++.++||||+|+++|+|++|+.||...... ......+.... + ..
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 6432211 11123468899999997655 56899999999999999999999998652211 11111110000 0 00
Q ss_pred hhhhcccc-------ch-hhhhhhh-hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 652 LTEVVDAN-------LV-REEQAFS-DKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 652 ~~~~~~~~-------~~-~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++. .. .....+. .....+..+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00 0000000 00112456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=279.96 Aligned_cols=247 Identities=21% Similarity=0.236 Sum_probs=192.3
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-----ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
+|.+.+.||+|+||.||++... .+..+++|+++... ......+..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999865 34556666654321 12234566789999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 502 LEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|||+++++|.+++.. ....+++..+..++.|+++|+.||| +.+++|+||+|+||+++. +.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH----QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH----HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999998874 3456899999999999999999999 679999999999999975 56999999998766
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
..... ......++..|+|||...+..++.++|+||||+++|+|++|..||..... ........... .+
T Consensus 156 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~-----~~ 223 (260)
T cd08222 156 MGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVEGP-----TP 223 (260)
T ss_pred CCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHcCC-----CC
Confidence 43222 12234578899999998888889999999999999999999999864211 11111110000 00
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. .+..++.++.+++.+|++.+|++||++.|+++
T Consensus 224 ~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 S---------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C---------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 01234567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=273.74 Aligned_cols=236 Identities=28% Similarity=0.289 Sum_probs=192.0
Q ss_pred ccccccEEEEEEEec-CCCeEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 435 LGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 435 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
||+|+||.||++... +++.+|+|++..... .....+..|++++++++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 689999999876542 2456788899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeecc
Q 005040 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590 (717)
Q Consensus 511 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 590 (717)
.+++.... .+++..+..++.|+++|+.||| +.+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh----~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH----SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTF 153 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCC
Confidence 99998764 3899999999999999999999 67899999999999999999999999999987643321 12344
Q ss_pred ccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhh
Q 005040 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDK 670 (717)
Q Consensus 591 ~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
.++..|+|||...+...+.++|+||||+++||+++|+.||..... ....+.+.. .. . ..+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~---~~--------~-------~~~ 213 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK---DP--------L-------RFP 213 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc---CC--------C-------CCC
Confidence 578899999998888889999999999999999999999965321 111111111 00 0 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHH
Q 005040 671 MDCLFSIMDLALDCCMDTPHKRIHMTD 697 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~P~~Rpt~~e 697 (717)
...+.++.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 112456789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=270.81 Aligned_cols=263 Identities=22% Similarity=0.272 Sum_probs=200.3
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-C-C----ceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-H-R----NLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-p----niv~~~~~~~~~~~~ 498 (717)
+.+|.++..+|+|.||.|-.+.+. .+..||||+++.- ....+..+-|+++++++. + | -++.+.+||+-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 679999999999999999999865 5788999998744 344566677999999993 2 2 378888999999999
Q ss_pred EEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--------------
Q 005040 499 ALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-------------- 563 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-------------- 563 (717)
++|+|.+ |.|+.+++.++ -.+++...+..|+.|++++++||| +.+++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh----~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH----DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH----hcceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 56999999975 456899999999999999999999 688999999999999932
Q ss_pred ------CCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc
Q 005040 564 ------NMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637 (717)
Q Consensus 564 ------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 637 (717)
+..++++|||.|+...+.. +..+.|..|+|||++.+-.++..+||||+||||+|++||..-|....+.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3468999999998765443 33457899999999999999999999999999999999999887643221
Q ss_pred -chHHHHHHhhCCCchh--------------------------hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCC
Q 005040 638 -MSLRRWVKESLPHRLT--------------------------EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPH 690 (717)
Q Consensus 638 -~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~ 690 (717)
..+.+-+-...|..+. .+.+.... .............++.+|+++|+..||.
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckp-l~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKP-LKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCcc-HHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 1122222212221110 00110000 0001111123346699999999999999
Q ss_pred CCCCHHHHHH
Q 005040 691 KRIHMTDAAA 700 (717)
Q Consensus 691 ~Rpt~~ev~~ 700 (717)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.83 Aligned_cols=252 Identities=25% Similarity=0.290 Sum_probs=191.3
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEcc
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.+....||.|+||+|++..++ .|+..|||++.... .....++..|.+...+- +.||||+++|.+..++...+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 344568999999999999876 89999999997654 24446677777765544 7999999999999899999999999
Q ss_pred CCCCHHHHHh----hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 506 PNGSLEKWLY----SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 506 ~~g~L~~~l~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
. .++..+-. -....+++...-.|+.-.+.||.||-+ ...|+|||+||+|||+|..|.+||||||.+..+.
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~---~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv-- 219 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE---ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV-- 219 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH---HhhhhhccCChhheEEecCCCEeeecccchHhHH--
Confidence 5 46654332 123458888888899999999999997 5579999999999999999999999999997763
Q ss_pred CCceeeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.+...+...|-..|||||.+.. ..|+.+|||||+|++|||+.||+.||.... +. -+.+.+.... |+.
T Consensus 220 -~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-sv---feql~~Vv~g------dpp 288 (361)
T KOG1006|consen 220 -DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-SV---FEQLCQVVIG------DPP 288 (361)
T ss_pred -HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-HH---HHHHHHHHcC------CCC
Confidence 2344556678888999997654 458999999999999999999999987622 11 1111111110 111
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.... -....+++..+..+|-.|+.+|-.+||...++++
T Consensus 289 ~l~~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 289 ILLF---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred eecC---cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 0000 0112346677899999999999999999998865
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.58 Aligned_cols=333 Identities=26% Similarity=0.372 Sum_probs=242.5
Q ss_pred CCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcc
Q 005040 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGG 82 (717)
Q Consensus 3 ~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 82 (717)
.||++++.+.+|++|.+++|++. .+-..++.|+.|+.+++.+|+++... .|..+-.+..|+.||||+|+++
T Consensus 46 ~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsG-------iP~diF~l~dLt~lDLShNqL~- 116 (1255)
T KOG0444|consen 46 QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSG-------IPTDIFRLKDLTILDLSHNQLR- 116 (1255)
T ss_pred hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCC-------CCchhcccccceeeecchhhhh-
Confidence 46777777777777777777776 45556777777777777777776533 2445667777888888888877
Q ss_pred cCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcccc
Q 005040 83 ILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC 162 (717)
Q Consensus 83 ~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~ 162 (717)
..|..+..- +++..|+|++|+|.++...-|-+|+.|-+||||+|++. .+|..+..|.+|++|.|++|.+...--..+.
T Consensus 117 EvP~~LE~A-Kn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLP 194 (1255)
T KOG0444|consen 117 EVPTNLEYA-KNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLP 194 (1255)
T ss_pred hcchhhhhh-cCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCc
Confidence 566666654 56777788888877655556777777778888888877 4566677777788888888777644333444
Q ss_pred CCCCCCEEeccCCcCc-ccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCe
Q 005040 163 HLERLNILNLSGNKLS-GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241 (717)
Q Consensus 163 ~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 241 (717)
.|++|++|.+++.+=+ ..+|..+..+.+|+.+|||.|.+. .+|+.+..+++|+.|+||+|+|+ .+......+.+|+.
T Consensus 195 smtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEt 272 (1255)
T KOG0444|consen 195 SMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLET 272 (1255)
T ss_pred cchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhh
Confidence 5566666777665432 346777778888888888888888 77888888888888888888888 55556677778888
Q ss_pred EEccCCCCCCCCcccccCCcccccccccCccccC-CCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCc
Q 005040 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG-PIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNR 320 (717)
Q Consensus 242 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~ 320 (717)
|+||.|+++ ..|.+++.+++|+.|.+.+|+++- -+|..++++.+|+.+..++|++. .+|..+..+..|+.|.|+.|.
T Consensus 273 LNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~Nr 350 (1255)
T KOG0444|consen 273 LNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNR 350 (1255)
T ss_pred hccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccc
Confidence 888888888 588888888888888888888752 35777888888888888888887 778888888888888888888
Q ss_pred ccccccccccccccccccccCCccccCCCC
Q 005040 321 LEGEIPVKGSFKDFSAQSYFGNYALCGPPR 350 (717)
Q Consensus 321 l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~ 350 (717)
+-..+...-.++.+..+.+-.|+.+.-||.
T Consensus 351 LiTLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 351 LITLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred eeechhhhhhcCCcceeeccCCcCccCCCC
Confidence 765444344455666666667776665554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=285.76 Aligned_cols=239 Identities=26% Similarity=0.293 Sum_probs=192.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 503 (717)
+++|.....+|.|+|+.|-.+... +++..+||++.... .+..+|+.++... .||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 456777778999999999888764 78899999997652 2234467666655 79999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee-CCCCcEEEeeeccccccCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL-DENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
.+.|+-+.+.+..... ....+..|+.+++.|+.||| +++|||||+||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH----~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH----EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH----hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988887776543 22677889999999999999 6899999999999999 69999999999999877543
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
....+-|..|.|||++....|++++||||+|++||+|++|+.||.....+ ..+...+. ...
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~---~~~----------- 530 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQ---MPK----------- 530 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhc---CCc-----------
Confidence 22335688999999999999999999999999999999999999764333 11111111 000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+. ...+.++.+|+..||+.||.+||+|.++..
T Consensus 531 ----~s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 ----FS--ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----cc--cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 00 244567889999999999999999999865
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=270.70 Aligned_cols=221 Identities=19% Similarity=0.147 Sum_probs=176.5
Q ss_pred cccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCHHHHHhh
Q 005040 438 GGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYS 516 (717)
Q Consensus 438 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 516 (717)
|.||.||++... +++.||+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999975 78999999987543 223345555566799999999999999999999999999999999976
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccc
Q 005040 517 HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596 (717)
Q Consensus 517 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y 596 (717)
.. .+++..+..++.|+++||.||| +.+++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH----REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 54 3899999999999999999999 6789999999999999999999999999876654321 223456779
Q ss_pred cCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHH
Q 005040 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFS 676 (717)
Q Consensus 597 ~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (717)
+|||...+..++.++||||+|+++|||++|+.|+...... ........+ +..++..
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~~~~~~~---------~~~~~~~ 204 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INTHTTLNI---------PEWVSEE 204 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------cccccccCC---------cccCCHH
Confidence 9999998888999999999999999999999887532110 000000000 1123456
Q ss_pred HHHHHhhccCCCCCCCCCHHH
Q 005040 677 IMDLALDCCMDTPHKRIHMTD 697 (717)
Q Consensus 677 l~~li~~cl~~~P~~Rpt~~e 697 (717)
+.+++.+|++.||++||++.+
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCc
Confidence 789999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-33 Score=281.94 Aligned_cols=242 Identities=25% Similarity=0.336 Sum_probs=199.0
Q ss_pred ccCCccccccccccEEEEEEEecCCC-eEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGT-NVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.+++.+..||-|+||.|-+++.+... .+|+|++++.. ..+.+.+..|-.+|.+.+.|.||++|-.|.+...+||.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999875433 48999887653 445567888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|-|-||.++..++..+. ++..+..-++.-+++|++||| +++||+|||||+|.++|.+|.+||.|||+|+.++.+.
T Consensus 500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH----~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH----RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH----hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999998765 777888888999999999999 7899999999999999999999999999999987655
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
.+ -..+|||.|.|||.+..+..+.++|.||+|+++||+++|.+||.+..+ +.....+-. -+|.
T Consensus 575 KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp--mktYn~ILk--------Gid~---- 637 (732)
T KOG0614|consen 575 KT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP--MKTYNLILK--------GIDK---- 637 (732)
T ss_pred ce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHh--------hhhh----
Confidence 43 456899999999999999999999999999999999999999976322 111111110 0110
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH 694 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt 694 (717)
..-+....+...++|++.++.+|.+|..
T Consensus 638 ----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 ----IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 0011233456789999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=279.69 Aligned_cols=220 Identities=24% Similarity=0.387 Sum_probs=184.4
Q ss_pred CCCCHHHHHHHh---ccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceee
Q 005040 415 RRTSYLDIRRAT---DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLK 487 (717)
Q Consensus 415 ~~~~~~~~~~~~---~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~ 487 (717)
....|..++++. .-|..++.||-|+||.|++++- ++...+|.|.+.+.. +.....+++|-.||+....+.||+
T Consensus 614 KESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVr 693 (1034)
T KOG0608|consen 614 KESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVR 693 (1034)
T ss_pred hhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEE
Confidence 445677777775 4577788999999999999974 456678999987664 556677899999999999999999
Q ss_pred EeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 005040 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVA 567 (717)
Q Consensus 488 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~ 567 (717)
+|..|.+.+.+|+||||++|||+-.+|.+-+- +++.-++-++..+..|+++.| ..|++||||||+|||||.+|++
T Consensus 694 LyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH----kmGFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 694 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEEEeccCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH----hccceecccCccceEEccCCce
Confidence 99999999999999999999999998887654 677777778889999999999 7899999999999999999999
Q ss_pred EEeeeccccc---------cCCCCCc-------------------------------eeeeccccCccccCCCccCCCCc
Q 005040 568 HVSDFGISKL---------LGEGEDS-------------------------------VIQTMTMATIGYMAPEYGSEGIV 607 (717)
Q Consensus 568 kl~Dfgl~~~---------~~~~~~~-------------------------------~~~~~~~~t~~y~aPE~~~~~~~ 607 (717)
||+|||++.- +..++-. ......+||+.|+|||++....|
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 9999999763 2211100 01122479999999999999999
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCccccCcch
Q 005040 608 STKCDVYSYGVLLMETFTEKKPTDEMFTGEMS 639 (717)
Q Consensus 608 ~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~ 639 (717)
+..+|+||.|||||||+.|+.||-+..+++.+
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcce
Confidence 99999999999999999999999887666543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=261.44 Aligned_cols=248 Identities=19% Similarity=0.256 Sum_probs=199.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l 500 (717)
.++|+..+.||+|.|+.|-.++++ +.+.+|+|++++.. .+...-...|..+..+. +||.+|.+..+|+....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 478999999999999999999975 77889999998765 34445566788888877 79999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
|.||++||+|--++++.++ ++++.+.-+...|+-||.||| ++||+.||+|..|||+|..|++|++|||+++.--.
T Consensus 329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh----~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh----hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999877776554 899999999999999999999 78999999999999999999999999999875332
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCc--cccCcchHHHHHHhhCCCchhhhccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDE--MFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
+.+ ..+..+|||.|.|||.+.+..|+...|+|++||+++||+.|+.||+. +...+....++.-+.+-+ +
T Consensus 404 ~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-------k 474 (593)
T KOG0695|consen 404 PGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-------K 474 (593)
T ss_pred CCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-------h
Confidence 222 23567899999999999999999999999999999999999999975 333333333333322111 1
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH 694 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt 694 (717)
.+ -.+...+..+..+++.-+.+||.+|..
T Consensus 475 qi-------riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 475 QI-------RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cc-------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11 011122344567888999999999873
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.80 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=204.5
Q ss_pred HHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeee-----cC
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCS-----NL 495 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~-----~~ 495 (717)
..-+..|++...||.|.+|.||+++.. +++..|+|+.....+. .+.+..|.++++.. .|||++.++|++. .+
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 334567888999999999999999854 8899999998766543 35677899999988 6999999999984 35
Q ss_pred CeeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecc
Q 005040 496 DFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 574 (717)
+.+.+|||||.+|+..++++.- +..+.|..+..|+..++.|+.+|| ...++|||+|-.|||++.++.||++|||.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH----~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH----NNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh----hcceeeecccCceEEEeccCcEEEeeeee
Confidence 6889999999999999999843 556899999999999999999999 67799999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSE-----GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 649 (717)
+..+... ........|||.|||||++.. ..|+..+|+||+|++..||-.|.+|+.++.+-...+ .++
T Consensus 170 SaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF------~Ip 241 (953)
T KOG0587|consen 170 SAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIP 241 (953)
T ss_pred eeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc------cCC
Confidence 9876432 223456689999999997643 347789999999999999999999988765421100 011
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. ...+....+..-..++.++|..|+..|-+.||++.++++
T Consensus 242 R-----------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 R-----------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred C-----------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1 111122223345677999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=262.16 Aligned_cols=238 Identities=31% Similarity=0.375 Sum_probs=192.7
Q ss_pred ccEEEEEEEec-CCCeEEEEEechhhHHH-HHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCHHHHHhh
Q 005040 439 GFGSVYKGTLS-DGTNVAIKIFNLQLERA-FRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYS 516 (717)
Q Consensus 439 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 516 (717)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 58999999997654333 57889999999999999999999999998999999999999999999986
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccc
Q 005040 517 HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596 (717)
Q Consensus 517 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y 596 (717)
... +++..+..++.++++++.||| ..+++|+||+|+||+++.++.++++|||.+....... ......++..|
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH----SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH----HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 544 889999999999999999999 5789999999999999999999999999998765432 22344578889
Q ss_pred cCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHH
Q 005040 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFS 676 (717)
Q Consensus 597 ~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (717)
+|||...+..++.++||||+|+++|++++|..||..... .....++........ ......++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-~~~~~~~~~~~~~~~---------------~~~~~~~~~~ 216 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-LLELFKKIGKPKPPF---------------PPPEWKISPE 216 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhccCCCC---------------ccccccCCHH
Confidence 999998888899999999999999999999999865211 111111111100000 0000014456
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH
Q 005040 677 IMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 677 l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=236.98 Aligned_cols=203 Identities=28% Similarity=0.351 Sum_probs=166.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.++......||+|+||.|-+.++. +|+..|+|.+.... .+..++..+|+.+..+. .+|.+|.++|.+.......+.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 345555678999999999888764 89999999987654 33345566777766554 7999999999998888999999
Q ss_pred EccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLY---SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
|.|. .||..|-+ ..+..+++...-+|+..+.+||.|||+ ...++|||+||+|||++.+|++|+||||.+..+.
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~---kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS---KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH---HhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9995 47776654 346668999999999999999999997 5679999999999999999999999999998774
Q ss_pred CCCCceeeeccccCccccCCCccC----CCCcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGS----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFT 635 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~ 635 (717)
. +...+...|--.|||||.+. ...|+.|+||||+|+.+.||.+++.||+....
T Consensus 201 d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 201 D---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred h---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 3 33334456777899999653 35799999999999999999999999987443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=239.96 Aligned_cols=261 Identities=20% Similarity=0.329 Sum_probs=198.5
Q ss_pred hccCCccccccccccEEEEEEE-ecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeecC--CeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSNL--DFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~--~~~~lv 501 (717)
.++|++++++|+|.|+.||.|. ..+.+.++||++++-.. +.+.+|+.+|+.|+ ||||+++++...+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3688999999999999999998 45788899999986543 56788999999997 99999999998765 466899
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeeccccccCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGE 580 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~ 580 (717)
+||+.+.+....-.. ++...+...+.+++.||.|+| +.||.|||+||.||++|. .-..+|+|+|+|.++.+
T Consensus 114 FE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH----S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH----SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH----hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999998877665443 566778889999999999999 899999999999999995 45799999999999866
Q ss_pred CCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC---------
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH--------- 650 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 650 (717)
+... ...+.+..|.-||.+-. ..|+.+-|+|||||++..|+..+.||-.......++.+.++-...+
T Consensus 186 ~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Ccee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 5433 33456777899997655 5688999999999999999999999865444444454444322222
Q ss_pred ------chhhhccccchhhhhhhhhh---HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 651 ------RLTEVVDANLVREEQAFSDK---MDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 651 ------~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+...++...-++....+... .-..+++.+++.+.+..|..+|+|++|+++
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 22222211111111111111 112367899999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=288.79 Aligned_cols=259 Identities=22% Similarity=0.232 Sum_probs=169.5
Q ss_pred HhccCCccccccccccEEEEEEEec-C----CCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeee------ee
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-D----GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGS------CS 493 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~------~~ 493 (717)
..++|+..+.||+|+||.||+|.+. + +..||+|++...... +....| .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999975 5 789999987643211 111111 1222222333222221 24
Q ss_pred cCCeeEEEEEccCCCCHHHHHhhCCCC-------------------CCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC
Q 005040 494 NLDFKALVLEFMPNGSLEKWLYSHNYF-------------------LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDL 554 (717)
Q Consensus 494 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dl 554 (717)
.....++|+||+.+++|.+++...... .....+..++.|++.||.||| +.+|+||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH----~~gIiHRDL 281 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH----STGIVHRDV 281 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH----HCCEEeCcC
Confidence 556789999999999999999754311 112345679999999999999 678999999
Q ss_pred CCCCeeeCC-CCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCC----------------------CcCccc
Q 005040 555 KPTNILLDE-NMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG----------------------IVSTKC 611 (717)
Q Consensus 555 k~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~ 611 (717)
||+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 689999999999866432221 22345689999999954221 234567
Q ss_pred chhhHHHHHHHHHhCCCCCCccc--------cCcchHHHHHHhhCCCchhhhccccchhhh-hhhhhhHHHHHHHHHHHh
Q 005040 612 DVYSYGVLLMETFTEKKPTDEMF--------TGEMSLRRWVKESLPHRLTEVVDANLVREE-QAFSDKMDCLFSIMDLAL 682 (717)
Q Consensus 612 Dvws~G~il~el~tg~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 682 (717)
||||+||++|||+++..|++... ........|... ..+...... ..+...........+|+.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL---------VEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh---------hccccchhhhhhhhhccccchHHHHHHH
Confidence 99999999999999777654310 001111222111 111100000 000000011233568999
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 005040 683 DCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 683 ~cl~~~P~~Rpt~~ev~~~ 701 (717)
+|++.||++|||++|+++.
T Consensus 432 ~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHccCCcccCCCHHHHhCC
Confidence 9999999999999999873
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=278.22 Aligned_cols=257 Identities=23% Similarity=0.254 Sum_probs=180.3
Q ss_pred HhccCCccccccccccEEEEEEEe-----------------cCCCeEEEEEechhhHHHH--------------HHHHHH
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTL-----------------SDGTNVAIKIFNLQLERAF--------------RSFDSE 473 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~--------------~~~~~e 473 (717)
..++|++.++||+|+||+||+|.. .+++.||||.+........ +....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999963 2456799999864432222 223447
Q ss_pred HHHHHhcCCCce-----eeEeeeeec--------CCeeEEEEEccCCCCHHHHHhhCC----------------------
Q 005040 474 CEILRNVRHRNL-----LKILGSCSN--------LDFKALVLEFMPNGSLEKWLYSHN---------------------- 518 (717)
Q Consensus 474 ~~~l~~l~hpni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------- 518 (717)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888866554 677777643 356799999999999999987421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCcccc
Q 005040 519 -YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597 (717)
Q Consensus 519 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~ 597 (717)
...++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++......... ......+|+.|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH----~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH----RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 12456788899999999999999 678999999999999999999999999999765432211 111223478999
Q ss_pred CCCccCCCC--------------------c--CcccchhhHHHHHHHHHhCCC-CCCccccCc-------chHHHHHHhh
Q 005040 598 APEYGSEGI--------------------V--STKCDVYSYGVLLMETFTEKK-PTDEMFTGE-------MSLRRWVKES 647 (717)
Q Consensus 598 aPE~~~~~~--------------------~--~~~~Dvws~G~il~el~tg~~-p~~~~~~~~-------~~~~~~~~~~ 647 (717)
|||.+.... + ..+.||||+||++|||++|.. |+.....-. .....|...
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~- 456 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY- 456 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-
Confidence 999765322 1 134799999999999999875 664321111 111112110
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTP---HKRIHMTDAAA 700 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~Rpt~~ev~~ 700 (717)
......++.....+....+++.+++..+| .+|+|++|+++
T Consensus 457 -------------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 -------------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -------------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00001112222344667899999999866 68999999985
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-33 Score=285.05 Aligned_cols=311 Identities=27% Similarity=0.382 Sum_probs=273.7
Q ss_pred CCCCccccCCCCCcEEECCCCcceec-CCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGH-IPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
.+|..+++.++.|+++++..|++... +|..+-.|..|+.||||+|+++.+|.+ +..-+++-.|+||+|+|
T Consensus 68 ~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~---------LE~AKn~iVLNLS~N~I 138 (1255)
T KOG0444|consen 68 ISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTN---------LEYAKNSIVLNLSYNNI 138 (1255)
T ss_pred HhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchh---------hhhhcCcEEEEcccCcc
Confidence 45677889999999999999998632 677788999999999999999987654 78889999999999999
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCccc-ccCCc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQ-GYVPH 159 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~-~~~~~ 159 (717)
.+++...|.++ ..|-.|+|++|++. .+|.....|.+|++|+|++|.+..-....+-.+++|+.|.+++.+-+ .-+|.
T Consensus 139 etIPn~lfinL-tDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Pt 216 (1255)
T KOG0444|consen 139 ETIPNSLFINL-TDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPT 216 (1255)
T ss_pred ccCCchHHHhh-HhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCC
Confidence 97766667676 56999999999999 77888999999999999999987544445556778888999987654 45788
Q ss_pred cccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCC
Q 005040 160 DLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVL 239 (717)
Q Consensus 160 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 239 (717)
.+..|.+|..+|||.|.+. ..|+.+-++++|+.|+||+|+|+ .+........+|++|+||.|+++ .+|++++.++.|
T Consensus 217 sld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL 293 (1255)
T KOG0444|consen 217 SLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKL 293 (1255)
T ss_pred chhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHH
Confidence 8999999999999999998 89999999999999999999999 55666777889999999999999 899999999999
Q ss_pred CeEEccCCCCCC-CCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccC
Q 005040 240 IDLDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSH 318 (717)
Q Consensus 240 ~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~ 318 (717)
+.|++.+|+++- -+|..++.+.+|+.++.++|.+. ..|+.++.+++|+.|.|+.|++. .+|+.+.-++.|+.|||..
T Consensus 294 ~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre 371 (1255)
T KOG0444|consen 294 TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE 371 (1255)
T ss_pred HHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence 999999999763 37889999999999999999998 89999999999999999999998 8999999999999999999
Q ss_pred Cccccccccc
Q 005040 319 NRLEGEIPVK 328 (717)
Q Consensus 319 N~l~~~~p~~ 328 (717)
|+=--.+|..
T Consensus 372 NpnLVMPPKP 381 (1255)
T KOG0444|consen 372 NPNLVMPPKP 381 (1255)
T ss_pred CcCccCCCCc
Confidence 9866555543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=281.80 Aligned_cols=242 Identities=27% Similarity=0.399 Sum_probs=187.3
Q ss_pred ccccccccccE-EEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 431 ECNLLGTGGFG-SVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 431 ~~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
..+.+|.|+.| .||+|.. +|+.||||++-.. ......+|+..|+.- +|||||++++.-.+..+.|++.|.|. .
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~ 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C 587 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence 34568999998 6799999 6899999987533 334567899999988 69999999999999999999999995 6
Q ss_pred CHHHHHhhCCCC---CCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---C--CcEEEeeeccccccCC
Q 005040 509 SLEKWLYSHNYF---LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---N--MVAHVSDFGISKLLGE 580 (717)
Q Consensus 509 ~L~~~l~~~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfgl~~~~~~ 580 (717)
+|.+++...... ......+.+..|++.||++|| +-+||||||||.|||++. + ..++|+|||+++.+..
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH----sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH----SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH----hcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 999999874111 111345678999999999999 678999999999999975 3 4799999999999875
Q ss_pred CCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhC-CCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 581 GEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTE-KKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 581 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
+..+. ......||-||+|||++....-+.++||||+||++|+.++| .+||++....+..+.. ....++
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L~-- 733 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTLV-- 733 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Ccccee--
Confidence 54332 24566799999999999998888899999999999999995 8999874322211110 000000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++ ++.+||.+|+.++|..||+|.+|+.
T Consensus 734 -------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 -------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00111122 6889999999999999999999974
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=247.64 Aligned_cols=130 Identities=27% Similarity=0.353 Sum_probs=111.4
Q ss_pred ccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-----C---CceeeEeeeee----
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-----H---RNLLKILGSCS---- 493 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---pniv~~~~~~~---- 493 (717)
.+|.+.++||.|-|++||+|.+ .+.+.||+|+.+.. ..-.+....|+++|++++ | ..||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999985 47889999998755 334466788999999994 3 47999999984
Q ss_pred cCCeeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 005040 494 NLDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL 561 (717)
Q Consensus 494 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill 561 (717)
.+.+++||+|++ |.+|..++... -+.++...+.+|++||+.||.|||..+ +|+|-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeee
Confidence 456899999999 66999999854 345899999999999999999999854 89999999999999
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-31 Score=242.95 Aligned_cols=265 Identities=23% Similarity=0.287 Sum_probs=192.7
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC-----CeeEE
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL-----DFKAL 500 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 500 (717)
.+..+.||.|+||.||.+.+. +|+.||+|++..-- -...+.+-+|++++...+|.|++..++...-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344578999999999999864 89999999886432 22345677899999999999999999876433 35678
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
++|.|. .+|...+-... .++...+.-+.+||++||+||| +-+|.||||||.|.|++++...||||||+++....
T Consensus 135 ~TELmQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH----sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH----TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh----hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 889885 48877766543 3777788889999999999999 78899999999999999999999999999987644
Q ss_pred CCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc-hhhh---
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR-LTEV--- 655 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~--- 655 (717)
.+ ....+..+.|..|+|||.+++ ..|+.+.||||.||++.|++.++.-|.... ..+..+.+.+..-.. .+.+
T Consensus 209 d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~--PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 209 RD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG--PIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred hh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC--hHHHHHHHHHHhCCCcHHHHHHH
Confidence 33 333445567999999998877 469999999999999999999888876532 222222222221111 1100
Q ss_pred --------ccc-----cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 656 --------VDA-----NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 656 --------~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
+.. .+..-+ ......+-..+...+...++..||++|.+..+++..+-
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLY-tlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLY-KIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCcccee-eecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000 000000 01111122345778999999999999999999877553
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=260.39 Aligned_cols=196 Identities=24% Similarity=0.361 Sum_probs=169.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHH-----HHHHHHHHHHhcC---CCceeeEeeeeec
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFR-----SFDSECEILRNVR---HRNLLKILGSCSN 494 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~-----~~~~e~~~l~~l~---hpniv~~~~~~~~ 494 (717)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.+.. ..+.+ .+..|+++|+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 56899999999999999999987 56779999887664 22222 3677999999997 9999999999999
Q ss_pred CCeeEEEEEcc-CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 005040 495 LDFKALVLEFM-PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573 (717)
Q Consensus 495 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 573 (717)
.+++|++||.. ++-+|.+++..... +++..+..|++||+.|+++|| +.+|||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh----~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH----DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc----ccCceecccccccEEEecCCeEEEeecc
Confidence 99999999985 45699999986544 899999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCC
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTD 631 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~ 631 (717)
.+.+...+. .....||.+|.|||++.+..| +..-|||++|+++|.++....||-
T Consensus 716 saa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998764433 234579999999999998877 566899999999999999888874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-31 Score=260.77 Aligned_cols=299 Identities=30% Similarity=0.444 Sum_probs=159.8
Q ss_pred CCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCccc
Q 005040 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGI 83 (717)
Q Consensus 4 iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 83 (717)
+|+..-+++.|++||...|-++ .+|..++.|.+|.-|+|.+|+|..+|. |.++..|++|+++.|+|. .
T Consensus 175 l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lPe----------f~gcs~L~Elh~g~N~i~-~ 242 (565)
T KOG0472|consen 175 LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLPE----------FPGCSLLKELHVGENQIE-M 242 (565)
T ss_pred CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCCC----------CCccHHHHHHHhcccHHH-h
Confidence 3444444555555555555554 445555555555555555555554432 455555555555555554 3
Q ss_pred CCcchh-ccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCccccc------
Q 005040 84 LPPLIG-NFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGY------ 156 (717)
Q Consensus 84 ~~~~~~-~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~------ 156 (717)
+|...+ ++ .++..|||.+|++. ..|+.+.-+++|.+||+|+|.|+ ..|..++++ +|+.|-+.+|.+..+
T Consensus 243 lpae~~~~L-~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~ 318 (565)
T KOG0472|consen 243 LPAEHLKHL-NSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIIS 318 (565)
T ss_pred hHHHHhccc-ccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHc
Confidence 333333 33 44555555555555 44555555555555555555555 344455555 555555555554311
Q ss_pred --------------------------------CCc---cccCCCCCCEEeccCCcCcc----------------------
Q 005040 157 --------------------------------VPH---DLCHLERLNILNLSGNKLSG---------------------- 179 (717)
Q Consensus 157 --------------------------------~~~---~~~~l~~L~~L~L~~n~l~~---------------------- 179 (717)
.+. +...+.+.+.|++++=+++.
T Consensus 319 ~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskN 398 (565)
T KOG0472|consen 319 KGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKN 398 (565)
T ss_pred ccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccc
Confidence 000 01112234444444444442
Q ss_pred ---cCCccccCCCCCCe-EEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcc
Q 005040 180 ---AIPQCLASLTSLRS-LYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPS 255 (717)
Q Consensus 180 ---~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 255 (717)
.+|..+..+..+.+ +.+++|.+. .+|..++.+++|+.|+|++|-+. .+|..++.+..|+.|+++.|.+. ..|.
T Consensus 399 qL~elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~ 475 (565)
T KOG0472|consen 399 QLCELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPE 475 (565)
T ss_pred hHhhhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchH
Confidence 34443333333222 233333333 55555666666666666666665 55666666666666666666665 4566
Q ss_pred cccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccc
Q 005040 256 TIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322 (717)
Q Consensus 256 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~ 322 (717)
++-.+..|+.+-.++|++....+..+.+|.+|.+|||.+|.+. .+|+.+++|.+|++|++.||++.
T Consensus 476 ~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 476 CLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 5555555666666666666555555666666666666666666 56666666666666666666666
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=233.38 Aligned_cols=210 Identities=37% Similarity=0.528 Sum_probs=182.9
Q ss_pred ccccccEEEEEEEec-CCCeEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCHHH
Q 005040 435 LGTGGFGSVYKGTLS-DGTNVAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEK 512 (717)
Q Consensus 435 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~ 512 (717)
||+|.+|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999986 4899999999766432 34678899999999999999999999999899999999999999999
Q ss_pred HHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeeccccccCCCCCceeeeccc
Q 005040 513 WLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEGEDSVIQTMTM 591 (717)
Q Consensus 513 ~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~ 591 (717)
++......+++..+..++.++++++.||| +.+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 99876445899999999999999999999 679999999999999999 89999999999987644321 122345
Q ss_pred cCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhh
Q 005040 592 ATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDK 670 (717)
Q Consensus 592 ~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
+...|++||..... .++.++|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 67889999988777 888999999999999998
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 671 MDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 236799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-32 Score=263.81 Aligned_cols=323 Identities=28% Similarity=0.430 Sum_probs=206.1
Q ss_pred CCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCc
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
.++|.++.++.++..|++.+|+++...|+.+ +++.|++||+..|.++.+|++ ++.+.+|..|+|..|+|.
T Consensus 150 ~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~tlP~~---------lg~l~~L~~LyL~~Nki~ 219 (565)
T KOG0472|consen 150 SSLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLETLPPE---------LGGLESLELLYLRRNKIR 219 (565)
T ss_pred ccCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhhcCChh---------hcchhhhHHHHhhhcccc
Confidence 3455555555555555555555553333322 255555555555555554432 556666666666666665
Q ss_pred ccCCcchhccccccceeeecCCcceecCCcc-ccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcc
Q 005040 82 GILPPLIGNFSASLQNIYAFECKLGGSIPKE-IGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD 160 (717)
Q Consensus 82 ~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 160 (717)
..| .|..- ..|++|++..|.|. .+|.. ..++++|..|||.+|+++ ..|+.+.-+.+|.+||+++|.|++ .|..
T Consensus 220 -~lP-ef~gc-s~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~s 293 (565)
T KOG0472|consen 220 -FLP-EFPGC-SLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYS 293 (565)
T ss_pred -cCC-CCCcc-HHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcc
Confidence 334 33322 34666666666666 33333 336666666666666666 556666666666666666666663 3445
Q ss_pred ccCCCCCCEEeccCCcCccc--------------------------------------CCccc---cCCCCCCeEEecCc
Q 005040 161 LCHLERLNILNLSGNKLSGA--------------------------------------IPQCL---ASLTSLRSLYLQSN 199 (717)
Q Consensus 161 ~~~l~~L~~L~L~~n~l~~~--------------------------------------~~~~~---~~l~~L~~L~L~~N 199 (717)
++++ +|+.|.+.+|.+..+ .+..| ..+-+.+.|++++-
T Consensus 294 Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ 372 (565)
T KOG0472|consen 294 LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDK 372 (565)
T ss_pred cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccc
Confidence 6666 666666666655310 00000 00112333333333
Q ss_pred cccC-------------------------CCChhhhcccCCCe-EEccCCcCcccCCccccCCCCCCeEEccCCCCCCCC
Q 005040 200 KLSS-------------------------SLPSSLWSLEYILR-INLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDI 253 (717)
Q Consensus 200 ~l~~-------------------------~~~~~~~~l~~L~~-L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 253 (717)
+++. .+|..+..++.+.+ +.+++|.+ +.+|..++.+++|..|+|++|.+. .+
T Consensus 373 qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~L 450 (565)
T KOG0472|consen 373 QLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DL 450 (565)
T ss_pred ccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hc
Confidence 3331 23333333333322 22333333 367777888999999999999998 48
Q ss_pred cccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccccccccc
Q 005040 254 PSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKD 333 (717)
Q Consensus 254 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 333 (717)
|..++.+..|+.|++|.|++. ..|..+..+..|+.+-.++|++..+.|..+.+|.+|.+|||.+|.+...+|..|.+..
T Consensus 451 P~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~Lgnmtn 529 (565)
T KOG0472|consen 451 PEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTN 529 (565)
T ss_pred chhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccc
Confidence 888999999999999999998 7888888888888888888999988888899999999999999999999998899999
Q ss_pred cccccccCCcc
Q 005040 334 FSAQSYFGNYA 344 (717)
Q Consensus 334 ~~~~~~~~n~~ 344 (717)
+..+.+.||+.
T Consensus 530 L~hLeL~gNpf 540 (565)
T KOG0472|consen 530 LRHLELDGNPF 540 (565)
T ss_pred eeEEEecCCcc
Confidence 99888888875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-29 Score=235.44 Aligned_cols=259 Identities=23% Similarity=0.274 Sum_probs=195.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC------C
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL------D 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~ 496 (717)
..+|.-.+.+|.|.- .|..|.+. .+++||+|.....- ....++..+|..++..++|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357777888999998 67777654 78899999774332 23345667899999999999999999998543 3
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..|+|||+|. .+|.+.+.. .++..++..+..|++.|++||| +.+|+||||||+||++..+..+||.|||+++
T Consensus 95 e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh----s~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLH----SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH----hcceeecccCcccceecchhheeeccchhhc
Confidence 5699999995 599998883 2788899999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC----CC-c
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL----PH-R 651 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~-~ 651 (717)
.-+.. ...+..+.|..|.|||++.+-.|.+.+||||.||++.||++|+.-|. ++..+.+|.+... +. .
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHH
Confidence 65433 23345568999999999888889999999999999999999998765 5566666754221 00 0
Q ss_pred h-hh-------hcc-----------ccchhhh--hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 652 L-TE-------VVD-----------ANLVREE--QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 652 ~-~~-------~~~-----------~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. .+ .+. ..++... .......--...+.+++.+||..+|++|.+++++++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 00 000 0000000 000000011245789999999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=227.14 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=189.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeee-eecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGS-CSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~-~~~~~~~~lv~ 502 (717)
.+.|++.+.+|+|.||.+-+++++ +.+.+++|.+...... .++|.+|...--.| .|.||+.-|+. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 368899999999999999999986 6788999988766433 36788887766666 59999998874 67778888999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCcEEEeeeccccccCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD--ENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~ 580 (717)
||++.|+|.+-+...+ +-+.....++.|++.|+.|+| ++++||||||.+|||+- +...+|+||||.++..+.
T Consensus 102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH----sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH----SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh----ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999888755 778888999999999999999 78999999999999994 345899999999986543
Q ss_pred CCCceeeeccccCccccCCCccCC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSE-----GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (717)
.. .....+..|-|||.... -...+.+|||.||+++|.++||+.||....-.+..+.+|.. +..+..
T Consensus 176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~--w~~rk~-- 246 (378)
T KOG1345|consen 176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ--WLKRKN-- 246 (378)
T ss_pred ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH--HhcccC--
Confidence 21 12223566899995332 23567899999999999999999999865545555554432 111111
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+++++... .+++.+..+.++-+..+|++|--..++.+.
T Consensus 247 --~~~P~~F~------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 --PALPKKFN------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred --ccCchhhc------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 12222111 234557789999999999999444444333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=259.47 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=203.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|+..+.+|.|.||.||+|++. .++..|+|+++......+.-+.+|+-+++..+||||+.++|.+...+...++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 468899999999999999999965 7899999999988888888888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
|.+|+|.+.=+- ...+++.++..+++...+|++||| +.+-+|||||-.||++++.|.+|++|||.+..+... -
T Consensus 94 cgggslQdiy~~-TgplselqiayvcRetl~gl~ylh----s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLH----SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--I 166 (829)
T ss_pred cCCCcccceeee-cccchhHHHHHHHhhhhccchhhh----cCCcccccccccceeecccCceeecccCchhhhhhh--h
Confidence 999999885443 345889999999999999999999 788999999999999999999999999998776432 2
Q ss_pred eeeeccccCccccCCCc---cCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 585 VIQTMTMATIGYMAPEY---GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~---~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.......||+.|||||+ ...+.|..++|||+.|+...|+-.-++|..+..+ ++...-+. +..+++.-.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr~l~LmT-----kS~~qpp~l 237 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MRALFLMT-----KSGFQPPTL 237 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----HHHHHHhh-----ccCCCCCcc
Confidence 23345679999999995 5677899999999999999999888888543221 11111100 011111111
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....-...+-++++.|+..+|++||+++.+++
T Consensus 238 ------kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 ------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ------cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111122345779999999999999999988664
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=230.74 Aligned_cols=199 Identities=29% Similarity=0.434 Sum_probs=172.5
Q ss_pred CCccccccccccEEEEEEEec-CCCeEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
|+..+.||+|++|.||++... +++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 556789999999999999986 4889999999765443 56788899999999999999999999998899999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+++|.+++......+++..+..++.+++.++.||| ..+++|+|++|+||+++.++.++|+|||.+......... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH----SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 99999999875443789999999999999999999 578999999999999999999999999999877543200 1
Q ss_pred eeccccCccccCCCcc-CCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 005040 587 QTMTMATIGYMAPEYG-SEGIVSTKCDVYSYGVLLMETFTEKKPTDE 632 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~-~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 632 (717)
.....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1233567889999987 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=242.62 Aligned_cols=266 Identities=23% Similarity=0.262 Sum_probs=200.7
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC------CCceeeEeeeeecCCe
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR------HRNLLKILGSCSNLDF 497 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------hpniv~~~~~~~~~~~ 497 (717)
-..+|.+....|+|-|++|.+|... .|..||||++.... -....=..|+++|++|+ .-++++++-.|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3478999999999999999999865 68899999997653 23345567999999995 3488999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeecc
Q 005040 498 KALVLEFMPNGSLEKWLYSHN--YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGI 574 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl 574 (717)
+|||||.+ ..+|.++++..+ ..+....+..+++|+.-||..|- .-+|+|.||||.|||+.+ ...+||||||.
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK----~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK----KCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH----hcCeeecccCccceEeccCcceeeeccCcc
Confidence 99999998 469999998653 34777889999999999999999 457999999999999985 45689999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcch---------------
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMS--------------- 639 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~--------------- 639 (717)
|........+ ....+..|.|||.+.+..|+...|+||.||.|||++||+..|.+.....+.
T Consensus 584 A~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 584 ASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 9887655432 234567799999999999999999999999999999999988774332210
Q ss_pred -HHHHHHhhCCCchh---hhccc---------------------cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC
Q 005040 640 -LRRWVKESLPHRLT---EVVDA---------------------NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH 694 (717)
Q Consensus 640 -~~~~~~~~~~~~~~---~~~~~---------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt 694 (717)
-.++..+++...+. .-+|+ .+...+............+.+|+.+|+..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 01122222221100 00010 000000011122344567899999999999999999
Q ss_pred HHHHHH
Q 005040 695 MTDAAA 700 (717)
Q Consensus 695 ~~ev~~ 700 (717)
..++++
T Consensus 740 ~nqAL~ 745 (752)
T KOG0670|consen 740 VNQALK 745 (752)
T ss_pred HHHHhc
Confidence 999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=233.09 Aligned_cols=269 Identities=24% Similarity=0.302 Sum_probs=198.9
Q ss_pred HHHHhccCCccccccccccEEEEEEEec----CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCC
Q 005040 422 IRRATDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLD 496 (717)
Q Consensus 422 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 496 (717)
.....+.|..+++||+|.|++||+|... ..+.||+|.+...... ..+..|+++|..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445578899999999999999999853 4678999988655433 5688899999999 5999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeeccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGIS 575 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~ 575 (717)
...+|+||++..+..++... ++...+...+..+..||.++| .+|||||||||+|++.+ ..+.-.|+|||++
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h----~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH----KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh----ccCccccCCCccccccccccCCceEEechhH
Confidence 99999999999998888776 567888899999999999999 78999999999999998 5667899999999
Q ss_pred cccCCCC------------------------------------------CceeeeccccCccccCCCccCC-CCcCcccc
Q 005040 576 KLLGEGE------------------------------------------DSVIQTMTMATIGYMAPEYGSE-GIVSTKCD 612 (717)
Q Consensus 576 ~~~~~~~------------------------------------------~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D 612 (717)
..+.... .........||+||.|||++.. +.-+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 8321100 0001122469999999997655 55788999
Q ss_pred hhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC----------CCc--hhh---------h------cc-ccchh-h
Q 005040 613 VYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL----------PHR--LTE---------V------VD-ANLVR-E 663 (717)
Q Consensus 613 vws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----------~~~--~~~---------~------~~-~~~~~-~ 663 (717)
|||.||++..+++++.||-....+-..+.+.+.... +.. +.+ . ++ ..+.. .
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999998654333333333322111 111 000 0 00 00000 0
Q ss_pred hh--hhhhh-HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 664 EQ--AFSDK-MDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 664 ~~--~~~~~-~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ..... ..++..+++++.+|+..||.+|.|++++++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00 00111 122347899999999999999999999885
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=210.37 Aligned_cols=169 Identities=22% Similarity=0.185 Sum_probs=129.9
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 587 (717)
|+|.++++..+..+++..++.++.|++.||+||| +.+ ||+||+++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH----RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----hcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6899999876667999999999999999999999 444 999999999999999 99988754321
Q ss_pred eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhh
Q 005040 588 TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAF 667 (717)
Q Consensus 588 ~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
..||+.|+|||++.+..++.++|||||||++|||+||+.||............+.....+.... + .
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---------~ 129 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---D---------R 129 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---c---------c
Confidence 2578999999999999999999999999999999999999965432222222222221111000 0 0
Q ss_pred hhhHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 668 SDKMDCL--FSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 668 ~~~~~~~--~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
....... .++.+++.+||..+|++||++.|+++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0111222 258899999999999999999999999887643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-27 Score=255.52 Aligned_cols=334 Identities=28% Similarity=0.361 Sum_probs=212.7
Q ss_pred CCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCccccccccc-----------cc-----
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS-----------LT----- 65 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~-----------l~----- 65 (717)
.++|.+++++.+|++|.|.+|.+. ..|..+..+++|++|+++.|++..+|...+....... ++
T Consensus 81 ~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik 159 (1081)
T KOG0618|consen 81 RSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAASNNEKIQRLGQTSIK 159 (1081)
T ss_pred hhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCCCchhHHhhhHHHHHhhhcchhhhhhccccch
Confidence 456777777777777777777776 5777777777777777777777766554322110000 00
Q ss_pred ---------------CccCCc-EEeccCCCCcccCCcchhcc----------------ccccceeeecCCcceecCCccc
Q 005040 66 ---------------NCRNLA-NLALASNPLGGILPPLIGNF----------------SASLQNIYAFECKLGGSIPKEI 113 (717)
Q Consensus 66 ---------------~l~~L~-~L~L~~N~l~~~~~~~~~~l----------------~~~L~~L~l~~n~l~~~~~~~~ 113 (717)
....|+ .|+|++|.+....-..+..+ .++|+.|+.++|.+....+ .+
T Consensus 160 ~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~-~p 238 (1081)
T KOG0618|consen 160 KLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDV-HP 238 (1081)
T ss_pred hhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeecc-cc
Confidence 111122 24555554441100000000 0123333444444442111 11
Q ss_pred cCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCe
Q 005040 114 GNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRS 193 (717)
Q Consensus 114 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 193 (717)
. -.+|+++++++|+++ .+|++++.+.+|+.|...+|++. ..|..+..+++|+.|++..|.++ -+|.....+.+|++
T Consensus 239 ~-p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~t 314 (1081)
T KOG0618|consen 239 V-PLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRT 314 (1081)
T ss_pred c-cccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeee
Confidence 1 146777777777777 34577777888888888888775 45566666677777777777776 45556667788888
Q ss_pred EEecCccccCCCChhh-h-------------------------cccCCCeEEccCCcCcccCCccccCCCCCCeEEccCC
Q 005040 194 LYLQSNKLSSSLPSSL-W-------------------------SLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRN 247 (717)
Q Consensus 194 L~L~~N~l~~~~~~~~-~-------------------------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 247 (717)
|+|..|+|.. .|+.+ . .++.|+.|.+.+|.++...-..+.++.+|+.|+|++|
T Consensus 315 LdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyN 393 (1081)
T KOG0618|consen 315 LDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYN 393 (1081)
T ss_pred eeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccc
Confidence 8888888873 33322 1 1233566777777777666667777888888888888
Q ss_pred CCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccc-cc
Q 005040 248 QLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGE-IP 326 (717)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p 326 (717)
++.......+.+++.|+.|+||+|+++ .+|+.+.+++.|++|...+|.+. ..| .+..++.|+.+|++.|+|+.. +|
T Consensus 394 rL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~ 470 (1081)
T KOG0618|consen 394 RLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLP 470 (1081)
T ss_pred ccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhh
Confidence 888655567778888888888888887 67778888888888888888887 556 777888888888888888653 34
Q ss_pred ccccccccccccccCCccc
Q 005040 327 VKGSFKDFSAQSYFGNYAL 345 (717)
Q Consensus 327 ~~~~~~~~~~~~~~~n~~~ 345 (717)
.....+.++.+.+.||.+.
T Consensus 471 ~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 471 EALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhCCCcccceeeccCCccc
Confidence 4444466777777777753
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-26 Score=262.69 Aligned_cols=195 Identities=19% Similarity=0.252 Sum_probs=138.2
Q ss_pred cCC-CceeeEeeee-------ecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 005040 480 VRH-RNLLKILGSC-------SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIH 551 (717)
Q Consensus 480 l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH 551 (717)
++| +||+.+++++ ...+..+.++||+ +++|.+++......+++..+..++.||++||+||| +++|+|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~gIvH 103 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH----SQGIVV 103 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH----hCCeee
Confidence 445 5788888877 2234567788987 56999999876666999999999999999999999 789999
Q ss_pred cCCCCCCeeeCCCC-------------------cEEEeeeccccccCCCCC--------------ceeeeccccCccccC
Q 005040 552 CDLKPTNILLDENM-------------------VAHVSDFGISKLLGEGED--------------SVIQTMTMATIGYMA 598 (717)
Q Consensus 552 ~dlk~~Nill~~~~-------------------~~kl~Dfgl~~~~~~~~~--------------~~~~~~~~~t~~y~a 598 (717)
|||||+|||++..+ .+|++|||+++....... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 455666666543211000 000112357889999
Q ss_pred CCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHH
Q 005040 599 PEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIM 678 (717)
Q Consensus 599 PE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (717)
||++.+..++.++|||||||++|||++|..|+.... .....+..... .+.. ........
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~--------~~~~----------~~~~~~~~ 242 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVL--------PPQI----------LLNWPKEA 242 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhc--------Chhh----------hhcCHHHH
Confidence 999999999999999999999999999988864311 01111111000 0000 01122345
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 005040 679 DLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 679 ~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+++..||+++|.+||++.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7888999999999999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=240.49 Aligned_cols=263 Identities=27% Similarity=0.363 Sum_probs=211.8
Q ss_pred CCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhcc
Q 005040 12 TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNF 91 (717)
Q Consensus 12 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 91 (717)
..-..|+|++|+++ .+|..+. ++|+.|++++|+|+.++. ..++|++|+|++|+|+. +|. +
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~------------lp~~Lk~LdLs~N~Lts-LP~----l 260 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA------------LPPELRTLEVSGNQLTS-LPV----L 260 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCC------------CCCCCcEEEecCCccCc-ccC----c
Confidence 34567999999999 5777775 489999999999998763 24789999999999995 453 3
Q ss_pred ccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEe
Q 005040 92 SASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILN 171 (717)
Q Consensus 92 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 171 (717)
+++|++|++++|.+. .+|..+ .+|+.|+|++|+++. +|. .+++|+.|+|++|+|+++ |.. ..+|+.|+
T Consensus 261 p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~ 328 (788)
T PRK15387 261 PPGLLELSIFSNPLT-HLPALP---SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASL-PAL---PSELCKLW 328 (788)
T ss_pred ccccceeeccCCchh-hhhhch---hhcCEEECcCCcccc-ccc---cccccceeECCCCccccC-CCC---cccccccc
Confidence 468999999999998 445433 578899999999994 454 357899999999999964 432 24688999
Q ss_pred ccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCC
Q 005040 172 LSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS 251 (717)
Q Consensus 172 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 251 (717)
+++|+|+. +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|.|++ +|.. ..+|+.|++++|.|++
T Consensus 329 Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~ 396 (788)
T PRK15387 329 AYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS 396 (788)
T ss_pred cccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC
Confidence 99999984 5532 2579999999999994 5543 3578899999999994 5543 3579999999999996
Q ss_pred CCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc
Q 005040 252 DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 252 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 327 (717)
+|.. .++|+.|++++|+++. +|... .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+.
T Consensus 397 -LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 397 -LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred -CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 5543 3689999999999984 66543 46889999999998 7899999999999999999999987765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-27 Score=229.39 Aligned_cols=318 Identities=19% Similarity=0.218 Sum_probs=201.1
Q ss_pred CCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccC-CCC
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALAS-NPL 80 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~-N~l 80 (717)
.+||..++.-+ +.++|..|.|+.+.+.+|+.+++|+.||||+|.|+.|.+.+ |.++++|.+|.+.+ |+|
T Consensus 59 ~eVP~~LP~~t--veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~A--------F~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 59 TEVPANLPPET--VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDA--------FKGLASLLSLVLYGNNKI 128 (498)
T ss_pred ccCcccCCCcc--eEEEeccCCcccCChhhccchhhhceecccccchhhcChHh--------hhhhHhhhHHHhhcCCch
Confidence 45566555544 44666666666666666666666666666666666665444 55666655555444 566
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD 160 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 160 (717)
+...-..|..+ .+|+.|.+.-|++.-+..+.|..|++|..|.+-+|.+..+--.+|..+..++++.+..|.+..
T Consensus 129 ~~l~k~~F~gL-~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic----- 202 (498)
T KOG4237|consen 129 TDLPKGAFGGL-SSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC----- 202 (498)
T ss_pred hhhhhhHhhhH-HHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----
Confidence 54444444444 345555555555554444555555555555555555543333345555555555555444321
Q ss_pred ccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcc-cCCCeEEccCCcCcccCC-ccccCCCC
Q 005040 161 LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSL-EYILRINLSSNSLKGTLP-SNIQKLNV 238 (717)
Q Consensus 161 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~-~~~~~l~~ 238 (717)
.++++.+.. +....|..++......-..|.++++..+.+..|... ..+..=-.+.+...+..| ..|..+++
T Consensus 203 dCnL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~ 275 (498)
T KOG4237|consen 203 DCNLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPN 275 (498)
T ss_pred ccccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhccc
Confidence 122222211 111233445556666666677777765555544322 222211122222332333 46899999
Q ss_pred CCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccC
Q 005040 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSH 318 (717)
Q Consensus 239 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~ 318 (717)
|+.|+|++|+|+++.+.+|.+...|++|.|..|+|..+-...|.++..|+.|+|.+|+|+...|..|..+..|.+|+|-.
T Consensus 276 L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~ 355 (498)
T KOG4237|consen 276 LRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLS 355 (498)
T ss_pred ceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehcc
Confidence 99999999999999899999999999999999999877777889999999999999999999999999999999999999
Q ss_pred CcccccccccccccccccccccCC
Q 005040 319 NRLEGEIPVKGSFKDFSAQSYFGN 342 (717)
Q Consensus 319 N~l~~~~p~~~~~~~~~~~~~~~n 342 (717)
|++.+.+...+..+++...+..|+
T Consensus 356 Np~~CnC~l~wl~~Wlr~~~~~~~ 379 (498)
T KOG4237|consen 356 NPFNCNCRLAWLGEWLRKKSVVGN 379 (498)
T ss_pred CcccCccchHHHHHHHhhCCCCCC
Confidence 999998877666666666554443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=236.38 Aligned_cols=256 Identities=28% Similarity=0.394 Sum_probs=206.2
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+++||..+.. +|+.|++++|+|+. +|. .+++|++|+|++|+|+.++. ..++|+.|+|++|.+
T Consensus 213 LtsLP~~l~~--~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsLP~------------lp~sL~~L~Ls~N~L 274 (788)
T PRK15387 213 LTTLPDCLPA--HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV------------LPPGLLELSIFSNPL 274 (788)
T ss_pred CCcCCcchhc--CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcccC------------cccccceeeccCCch
Confidence 4679998874 89999999999995 564 36899999999999998763 136899999999999
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD 160 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 160 (717)
+. +|. ++.+|+.|++++|+++. +|. .+++|++|+|++|+|+. +|.. ..+|+.|++++|+|+.+ |..
T Consensus 275 ~~-Lp~----lp~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~L-P~l 340 (788)
T PRK15387 275 TH-LPA----LPSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTSL-PTL 340 (788)
T ss_pred hh-hhh----chhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCC---cccccccccccCccccc-ccc
Confidence 84 443 33679999999999984 554 34789999999999995 4442 34688999999999954 432
Q ss_pred ccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCC
Q 005040 161 LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240 (717)
Q Consensus 161 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 240 (717)
..+|+.|+|++|+|+. +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.. .++|+
T Consensus 341 ---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~ 405 (788)
T PRK15387 341 ---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELK 405 (788)
T ss_pred ---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCC
Confidence 2589999999999995 5543 3578899999999994 5653 3579999999999994 5543 36799
Q ss_pred eEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCccccccc
Q 005040 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEAL 308 (717)
Q Consensus 241 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l 308 (717)
.|++++|.|++ +|.. ..+|+.|++++|+|+ .+|..+.++++|+.|+|++|++++..+..+..+
T Consensus 406 ~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 406 ELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred EEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 99999999996 5653 357899999999998 689999999999999999999998877766443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-26 Score=226.16 Aligned_cols=277 Identities=22% Similarity=0.239 Sum_probs=204.0
Q ss_pred CCCCC-ccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEccc-ccccCccCCcccccccccccCccCCcEEeccCC
Q 005040 1 MGTIP-NSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMM-NNLTTESSSADQWSFLSSLTNCRNLANLALASN 78 (717)
Q Consensus 1 ~~~iP-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N 78 (717)
|.+|| ..|+.+.+|+.||||+|+|+.+.|++|.+|++|.+|-+-+ |+|++++.++ |.+|..|+.|.+.-|
T Consensus 79 I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~--------F~gL~slqrLllNan 150 (498)
T KOG4237|consen 79 ISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGA--------FGGLSSLQRLLLNAN 150 (498)
T ss_pred cccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhH--------hhhHHHHHHHhcChh
Confidence 56787 7899999999999999999999999999999998886666 9999999877 999999999999999
Q ss_pred CCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCC
Q 005040 79 PLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVP 158 (717)
Q Consensus 79 ~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~ 158 (717)
++.-+..+.|.++ ++|..|.+.+|.+..+--.+|..+..++.+.+..|.+. ...+++.|..- +.. .|
T Consensus 151 ~i~Cir~~al~dL-~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~~-~a~------~~ 217 (498)
T KOG4237|consen 151 HINCIRQDALRDL-PSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLADD-LAM------NP 217 (498)
T ss_pred hhcchhHHHHHHh-hhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhhH-Hhh------ch
Confidence 9999999999998 67999999999999666669999999999999999854 22344433322 111 22
Q ss_pred ccccCCCCCCEEeccCCcCcccCCccccCC-CCCCeEEecCccccCC-CChhhhcccCCCeEEccCCcCcccCCccccCC
Q 005040 159 HDLCHLERLNILNLSGNKLSGAIPQCLASL-TSLRSLYLQSNKLSSS-LPSSLWSLEYILRINLSSNSLKGTLPSNIQKL 236 (717)
Q Consensus 159 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 236 (717)
..++...-..-..+.++++..+.+..|... .++..=..+.+...++ ....|..+++|+.|+|++|+|+.+-+.+|.++
T Consensus 218 ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~ 297 (498)
T KOG4237|consen 218 IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGA 297 (498)
T ss_pred hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcch
Confidence 233444444555555555554444433321 1221112222222223 33457777777777777777777777777777
Q ss_pred CCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCC
Q 005040 237 NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 237 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 298 (717)
..+++|.|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|++.
T Consensus 298 a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 298 AELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred hhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 77888888888777666667777788888888888887777777777777888888777765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-25 Score=204.67 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=189.0
Q ss_pred cCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
+.....+|.+...|..|+|+++ |..+++|++.... ....++|..|.-.++-..||||+.++|.|....+..++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3445567889999999999996 5567778876543 233467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe--eeccccccCCCC
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS--DFGISKLLGEGE 582 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~--Dfgl~~~~~~~~ 582 (717)
+.|+|+..+++. +...+..++.+++.++++|++|||... +-|-.--+.+..|++|++.+++|+ |--++
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfs------- 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFS------- 340 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceee-------
Confidence 999999999975 344678899999999999999999764 223334588999999999988875 22211
Q ss_pred CceeeeccccCccccCCCccCCCCc---CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIV---STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.......-.+.||+||.++.++- -.++|+|||++++||+.|...||.+..+-+--+.-. + ..
T Consensus 341 --fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------l-eg 405 (448)
T KOG0195|consen 341 --FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------L-EG 405 (448)
T ss_pred --eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------------h-cc
Confidence 11223345788999998887664 357999999999999999999998754322111100 0 00
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
+. ...+...+..+.+++.-|+..||.+||.+..++-.|+++.
T Consensus 406 lr-----v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LR-----VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cc-----ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 10 0112234566789999999999999999999999999864
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-23 Score=245.76 Aligned_cols=311 Identities=23% Similarity=0.279 Sum_probs=171.6
Q ss_pred cccCCCCCcEEECCCCc------ceecCCcCCCCCC-CCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCC
Q 005040 7 SITNATKLIGLDLGLNS------FSGHIPNTFGNLR-HLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNP 79 (717)
Q Consensus 7 ~~~~l~~L~~L~L~~n~------i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~ 79 (717)
.|..+.+|+.|.+..+. +...+|+.|..++ +|+.|.+.+|.++.+|.. | ...+|++|+|++|+
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~---------f-~~~~L~~L~L~~s~ 622 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSN---------F-RPENLVKLQMQGSK 622 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCc---------C-CccCCcEEECcCcc
Confidence 35556666666654332 2223455555543 355555555555554432 1 23455555555555
Q ss_pred CcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCc
Q 005040 80 LGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPH 159 (717)
Q Consensus 80 l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~ 159 (717)
+. .++..+..+ ++|+.|+|++|.....+| .++.+++|++|+|++|.....+|..+.++++|+.|++++|.....+|.
T Consensus 623 l~-~L~~~~~~l-~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~ 699 (1153)
T PLN03210 623 LE-KLWDGVHSL-TGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT 699 (1153)
T ss_pred cc-ccccccccC-CCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC
Confidence 54 334444443 345555555544333333 244555555555555443334455555555555555555432223333
Q ss_pred cccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCCh------------------------------hh
Q 005040 160 DLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPS------------------------------SL 209 (717)
Q Consensus 160 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~------------------------------~~ 209 (717)
.+ ++++|+.|+|++|......|.. .++|++|+|++|.+. .+|. .+
T Consensus 700 ~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~ 774 (1153)
T PLN03210 700 GI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMT 774 (1153)
T ss_pred cC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhh
Confidence 22 4455555555554433233321 234444445444443 2222 12
Q ss_pred hcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccce
Q 005040 210 WSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLES 289 (717)
Q Consensus 210 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 289 (717)
...++|+.|+|++|.....+|..++++++|+.|+|++|..-+.+|..+ .+++|+.|++++|.....+|.. ..+|+.
T Consensus 775 ~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~ 850 (1153)
T PLN03210 775 MLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISD 850 (1153)
T ss_pred hccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCE
Confidence 223577788888887666778888888888888888875433566554 6788888888887654444443 357888
Q ss_pred EeccCCCCCCCCcccccccccccEEEccCC-ccccccccccccccccccccc
Q 005040 290 LDFSNNNLSGKIPKSLEALSHLKQFNVSHN-RLEGEIPVKGSFKDFSAQSYF 340 (717)
Q Consensus 290 L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~~~~~~~~~~ 340 (717)
|+|++|.+. .+|.++..+++|+.|+|++| ++.+..+....++.+..+.+.
T Consensus 851 L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~ 901 (1153)
T PLN03210 851 LNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFS 901 (1153)
T ss_pred eECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecC
Confidence 888888887 67888888888888888884 455433333445555444443
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-23 Score=244.69 Aligned_cols=294 Identities=21% Similarity=0.266 Sum_probs=197.8
Q ss_pred CCccccCCC-CCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcc
Q 005040 4 IPNSITNAT-KLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGG 82 (717)
Q Consensus 4 iP~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 82 (717)
+|.+|..++ +|+.|++.++.++ .+|..| ...+|++|+|.+|+|..++.+ +..+++|+.|+|++|....
T Consensus 580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~---------~~~l~~Lk~L~Ls~~~~l~ 648 (1153)
T PLN03210 580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDG---------VHSLTGLRNIDLRGSKNLK 648 (1153)
T ss_pred cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccccccc---------cccCCCCCEEECCCCCCcC
Confidence 455555543 4666666666665 455555 356666666666666654322 4456666666666654333
Q ss_pred cCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcccc
Q 005040 83 ILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC 162 (717)
Q Consensus 83 ~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~ 162 (717)
.+|. +..+ ++|++|+|.+|.....+|..+.++++|+.|++++|..-..+|..+ ++++|+.|++++|......|..
T Consensus 649 ~ip~-ls~l-~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~-- 723 (1153)
T PLN03210 649 EIPD-LSMA-TNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI-- 723 (1153)
T ss_pred cCCc-cccC-CcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc--
Confidence 4443 3333 456666666665555666666666666666666643322444433 5666666666666444333321
Q ss_pred CCCCCCEEeccCCcCcccCCc------------------------------cccCCCCCCeEEecCccccCCCChhhhcc
Q 005040 163 HLERLNILNLSGNKLSGAIPQ------------------------------CLASLTSLRSLYLQSNKLSSSLPSSLWSL 212 (717)
Q Consensus 163 ~l~~L~~L~L~~n~l~~~~~~------------------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 212 (717)
..+|++|+|++|.+.. +|. .+...++|+.|+|++|.....+|..+.++
T Consensus 724 -~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L 801 (1153)
T PLN03210 724 -STNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNL 801 (1153)
T ss_pred -cCCcCeeecCCCcccc-ccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCC
Confidence 2355566666665542 222 11223578999999998877899999999
Q ss_pred cCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEec
Q 005040 213 EYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDF 292 (717)
Q Consensus 213 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 292 (717)
++|+.|+|++|..-+.+|..+ .+++|+.|++++|..-...|.. ..+|+.|+|++|.+. .+|..+..+++|+.|+|
T Consensus 802 ~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L 876 (1153)
T PLN03210 802 HKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDM 876 (1153)
T ss_pred CCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEEC
Confidence 999999999986444677666 7899999999998655445543 468999999999998 68889999999999999
Q ss_pred cCCCCCCCCcccccccccccEEEccCCc
Q 005040 293 SNNNLSGKIPKSLEALSHLKQFNVSHNR 320 (717)
Q Consensus 293 ~~N~~~~~~~~~~~~l~~L~~L~l~~N~ 320 (717)
++|+-...+|..+..+++|+.+++++|.
T Consensus 877 ~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 877 NGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCcCccCcccccccCCCeeecCCCc
Confidence 9964444678888999999999999985
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-26 Score=243.68 Aligned_cols=302 Identities=27% Similarity=0.388 Sum_probs=194.8
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
++..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|+|.+|.+...|. ++..+++|++|++++|++
T Consensus 57 ~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~~lP~---------~~~~lknl~~LdlS~N~f 126 (1081)
T KOG0618|consen 57 ISSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQSLPA---------SISELKNLQYLDLSFNHF 126 (1081)
T ss_pred cccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhhcCch---------hHHhhhcccccccchhcc
Confidence 3567888888888888888888888 677888888899999999988887654 378899999999999988
Q ss_pred cccCCcchhccc------------------cccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCcccccc--
Q 005040 81 GGILPPLIGNFS------------------ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTL-- 140 (717)
Q Consensus 81 ~~~~~~~~~~l~------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-- 140 (717)
. ..|..+..+. ..++.+++..|.+.+.++..+..+++ .|||.+|.+... .+..+
T Consensus 127 ~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~---dls~~~~ 200 (1081)
T KOG0618|consen 127 G-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVL---DLSNLAN 200 (1081)
T ss_pred C-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhh---hhhhccc
Confidence 7 4454443321 12555666666666666666666666 678888777621 12222
Q ss_pred ------------------CCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCcccc
Q 005040 141 ------------------QQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLS 202 (717)
Q Consensus 141 ------------------~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 202 (717)
++|+.|+.++|.++...+. + --.+|+++++++|+++ .+|.++..+.+|+.|...+|+++
T Consensus 201 l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~-p-~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~ 277 (1081)
T KOG0618|consen 201 LEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVH-P-VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV 277 (1081)
T ss_pred hhhhhhhhcccceEEecCcchheeeeccCcceeeccc-c-ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH
Confidence 3344444555554422111 1 1146788888888887 45577888888888888888885
Q ss_pred CCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccc-------------------------
Q 005040 203 SSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTI------------------------- 257 (717)
Q Consensus 203 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~------------------------- 257 (717)
.+|..+..+++|+.|.+..|.++ .+|....++..|+.|+|..|.|....+..+
T Consensus 278 -~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e 355 (1081)
T KOG0618|consen 278 -ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEE 355 (1081)
T ss_pred -hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccc
Confidence 56666666666666666666666 455556666666666666666653211111
Q ss_pred cCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccc
Q 005040 258 GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEG 323 (717)
Q Consensus 258 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~ 323 (717)
..++.|+.|++.+|.+++.....+.++++|+.|+|++|++.......+.++..|+.|+|+||+|+.
T Consensus 356 ~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~ 421 (1081)
T KOG0618|consen 356 NNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT 421 (1081)
T ss_pred hhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh
Confidence 113345666666666665555556666666666666666654444455666666666666666654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=213.25 Aligned_cols=167 Identities=23% Similarity=0.217 Sum_probs=129.8
Q ss_pred HHHhccCCccccccccccEEEEEEEec--CCCeEEEEEechh-----hHHHHHHHHHHHHHHHhcCCCceee-Eeeeeec
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS--DGTNVAIKIFNLQ-----LERAFRSFDSECEILRNVRHRNLLK-ILGSCSN 494 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~hpniv~-~~~~~~~ 494 (717)
+....+|+..+.||+|+||+||+|.++ +++.||||++... .....+.+.+|++++++++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 344578999999999999999999864 5777899986532 1223466899999999999999985 4432
Q ss_pred CCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC-CCCCeeeCCCCcEEEeeec
Q 005040 495 LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDL-KPTNILLDENMVAHVSDFG 573 (717)
Q Consensus 495 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg 573 (717)
+..|+||||++|++|... ... . ...++.++++||.||| +.+|+|||| ||+||+++.++.+||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH----~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH----RAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH----HCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999732 111 1 1457889999999999 689999999 9999999999999999999
Q ss_pred cccccCCCCCcee------eeccccCccccCCCccCCC
Q 005040 574 ISKLLGEGEDSVI------QTMTMATIGYMAPEYGSEG 605 (717)
Q Consensus 574 l~~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~ 605 (717)
+++.+........ .....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997754432211 1344678889999976543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=203.88 Aligned_cols=261 Identities=19% Similarity=0.192 Sum_probs=195.6
Q ss_pred cCCccccccccccEEEEEEEecCC--CeEEEEEechhhHHHHHHHHHHHHHHHhcCC----CceeeEeeee-ecCCeeEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLSDG--TNVAIKIFNLQLERAFRSFDSECEILRNVRH----RNLLKILGSC-SNLDFKAL 500 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----pniv~~~~~~-~~~~~~~l 500 (717)
+|.+.+.||+|+||.||.+..... ..+|+|.-..........+..|..++..+.. +++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997543 4788887765433222267778999998863 6899999988 57778899
Q ss_pred EEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-----CcEEEeeecc
Q 005040 501 VLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN-----MVAHVSDFGI 574 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfgl 574 (717)
||+.+ |.+|.++..... ..++..++..++.|++.+|+++| +.|++||||||.|+.+... -.+.+.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH----~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH----SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH----hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 779999886554 67999999999999999999999 7899999999999999865 4699999999
Q ss_pred cc--ccCCCCCc----e-e-eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh
Q 005040 575 SK--LLGEGEDS----V-I-QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 575 ~~--~~~~~~~~----~-~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 646 (717)
++ .+...... . . .....||..|.++....+...+.+.|+||++.++.|+..|..||........ .......
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~ 252 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKD 252 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHH
Confidence 98 33211110 1 1 1234599999999999999999999999999999999999999965332211 1111110
Q ss_pred hCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
..... ... .....+.++.++...+-..+..++|....+...+++....
T Consensus 253 ~~~~~----~~~----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 PRKLL----TDR----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhhc----ccc----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00000 000 0011234566666667678999999999999998877554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-23 Score=224.87 Aligned_cols=253 Identities=21% Similarity=0.212 Sum_probs=187.9
Q ss_pred ccccccccccEEEEEEEec-CCCeEEEEEec----hh-hHHH-HHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 431 ECNLLGTGGFGSVYKGTLS-DGTNVAIKIFN----LQ-LERA-FRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 431 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~-~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
....+|.|++|.|+.+... ....++.|.+. .. .... ...+..|+-+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988877643 44444554332 11 1111 1225667777888899999999888877776666699
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
||++ ||..++... .++....+..+++|+..|++|+| +.|+.|||+|++|++++.+|.+||+|||.+.....+..
T Consensus 402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h----~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH----SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH----hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999999875 34788889999999999999999 78999999999999999999999999999876654433
Q ss_pred c--eeeeccccCccccCCCccCCCCcCc-ccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 584 S--VIQTMTMATIGYMAPEYGSEGIVST-KCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 584 ~--~~~~~~~~t~~y~aPE~~~~~~~~~-~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
. ......+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+.++ ...........
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~~------ 546 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRNI------ 546 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhcccccccc------
Confidence 3 4455668999999999999988865 5999999999999999999997644333322 01111111000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...........+..-..++.++++++|.+|.|++++++
T Consensus 547 --~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 --FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00111122344566779999999999999999999875
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.8e-22 Score=222.23 Aligned_cols=247 Identities=24% Similarity=0.386 Sum_probs=152.7
Q ss_pred CCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhcc
Q 005040 12 TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNF 91 (717)
Q Consensus 12 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 91 (717)
.+.+.|+|+++.++ .+|..+. ++|+.|+|++|+|+.++... .++|++|+|++|+++ .+|..+.
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l-----------~~nL~~L~Ls~N~Lt-sLP~~l~-- 240 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENL-----------QGNIKTLYANSNQLT-SIPATLP-- 240 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhh-----------ccCCCEEECCCCccc-cCChhhh--
Confidence 34578888888888 4566553 47888888888888776432 247888888888887 4454432
Q ss_pred ccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEe
Q 005040 92 SASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILN 171 (717)
Q Consensus 92 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 171 (717)
.+|+.|+|++|++. .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|++++|+++.. |..+. ++|+.|+
T Consensus 241 -~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~ 310 (754)
T PRK15370 241 -DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLN 310 (754)
T ss_pred -ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccC-cccch--hhHHHHH
Confidence 46778888888777 5565554 46777788777777 3455443 4677777777777743 33332 3567777
Q ss_pred ccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCC
Q 005040 172 LSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS 251 (717)
Q Consensus 172 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 251 (717)
+++|+++. +|..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|.|++
T Consensus 311 Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~ 381 (754)
T PRK15370 311 VQSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN 381 (754)
T ss_pred hcCCcccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC
Confidence 77777763 34322 2567777777777763 444432 56666777777666 3444332 456666666666664
Q ss_pred CCcccccCCcccccccccCccccCCCCccc----cccCccceEeccCCCCC
Q 005040 252 DIPSTIGTLKNLETLSLAGNQFQGPIPESV----GNLISLESLDFSNNNLS 298 (717)
Q Consensus 252 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~----~~l~~L~~L~L~~N~~~ 298 (717)
+|..+. ..|+.|++++|++. .+|..+ +.++++..|+|.+|+++
T Consensus 382 -LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 382 -LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred -CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 343332 24666666666665 334332 22345555555555554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-20 Score=198.38 Aligned_cols=258 Identities=30% Similarity=0.397 Sum_probs=198.9
Q ss_pred CCccccccccccEEEEEEEecCCCeEEEEEechhhHH---HHHHHHHHHHHHHhcCCC-ceeeEeeeeecCCeeEEEEEc
Q 005040 429 FNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLER---AFRSFDSECEILRNVRHR-NLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e~ 504 (717)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999986 78899998766532 467789999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeeccccccCCC
Q 005040 505 MPNGSLEKWLYSHN--YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEG 581 (717)
Q Consensus 505 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 581 (717)
+.++++.+++.... ..++......++.|++.++.|+| +.+++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H----~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 99999997777654 25889999999999999999999 67899999999999999988 7999999999866543
Q ss_pred CCce----eeeccccCccccCCCccCC---CCcCcccchhhHHHHHHHHHhCCCCCCccccC--cchHHHHHHhhCCCch
Q 005040 582 EDSV----IQTMTMATIGYMAPEYGSE---GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG--EMSLRRWVKESLPHRL 652 (717)
Q Consensus 582 ~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~ 652 (717)
.... ......|+..|+|||...+ ..++...|+|++|++++++++|..||...... .......+........
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 3221 2355679999999998887 67899999999999999999999997653221 1122222221111100
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
......... ......+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNP---------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCcccc---------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 1223457799999999999999998887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=180.04 Aligned_cols=264 Identities=18% Similarity=0.191 Sum_probs=198.8
Q ss_pred HhccCCccccccccccEEEEEEE-ecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCC-CceeeEeeeeecCCeeEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRH-RNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~ 502 (717)
..++|..+++||.|+||.+|.|. ..+|..||+|+=...++. ..+..|.++++.+++ ..|..+..+..+..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35789999999999999999998 468999999986544432 456779999999964 67878888888888889999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~ 579 (717)
|.+ |.+|.+...-....++..++...+-|++.-++|+| .++++||||||+|.|..- ...+.++|||+|+.+.
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH----~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH----LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH----hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 998 77999999877777999999999999999999999 678999999999999963 4468999999999875
Q ss_pred CCCCc-----eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 580 EGEDS-----VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 580 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
..... .......||..|.+-....+..-+.+.|+=|+|.++.++.-|..||.+...... ..+ .+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-~QK---------yEk 235 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-KQK---------YEK 235 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-HHH---------HHH
Confidence 43322 122345689999988877777778899999999999999999999987533211 011 111
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
+.+..+..... .-...++.++.-.+..|-..--++-|...=+.+..+-+.+
T Consensus 236 I~EkK~s~~ie--~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 236 ISEKKMSTPIE--VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHhhcCCCHH--HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 11111111111 1122445667777788888788888887766666655544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-20 Score=179.73 Aligned_cols=262 Identities=16% Similarity=0.158 Sum_probs=199.9
Q ss_pred ccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
-.|.+.++||+|.||.++.|+. -++++||||.=.... ...++..|.+.++.| ..++|...+.+-.++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4788999999999999999984 489999999644332 224567799999988 579999999998888888999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-----cEEEeeeccccccC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-----VAHVSDFGISKLLG 579 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgl~~~~~ 579 (717)
+ |.+|+|...=+++.++.+++..+|.|++.-++|+| ++..|.|||||+|+||...+ .+.++|||+|+.+.
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH----~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH----EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH----hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 77999999988888999999999999999999999 67899999999999997543 58999999999887
Q ss_pred CCCCce-----eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 580 EGEDSV-----IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 580 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
...+.. ......||..||+--...+..-+.+-|+=|+|=++++.+-|..||.+..... .-.++-+.-...+...
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-nK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-NKEKYEKIGETKRSTP 259 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-hHHHHHHhccccccCC
Confidence 654321 2234469999999999889999999999999999999999999998853321 1112211111111000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
+ ..-...++.++..-+...-+.+-.+-|..+=+...+..+..
T Consensus 260 i-----------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 260 I-----------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred H-----------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 0 01112345556666666666677888887777666666544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-22 Score=221.11 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=197.2
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
++++|..+. +.|+.|+|++|+|+. +|..+. ++|++|+|++|+++.++.. + ..+|+.|+|++|.+
T Consensus 190 LtsLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~LtsLP~~---------l--~~~L~~L~Ls~N~L 253 (754)
T PRK15370 190 LTTIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTSIPAT---------L--PDTIQEMELSINRI 253 (754)
T ss_pred cCcCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccccCChh---------h--hccccEEECcCCcc
Confidence 467888775 479999999999994 566554 5899999999999987643 2 24799999999999
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD 160 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 160 (717)
. .+|..+. .+|+.|++++|++. .+|..+. ++|++|+|++|+++. +|..+. ++|+.|++++|+++.. |..
T Consensus 254 ~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~L-P~~ 322 (754)
T PRK15370 254 T-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTAL-PET 322 (754)
T ss_pred C-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccC-Ccc
Confidence 8 5666553 57999999999999 5677664 589999999999995 454443 5799999999999954 443
Q ss_pred ccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCC
Q 005040 161 LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240 (717)
Q Consensus 161 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 240 (717)
+. ++|+.|++++|.++. +|..+. ++|+.|+|++|+|+ .+|..+ .++|+.|+|++|.|+ .+|..+. ..|+
T Consensus 323 l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~ 391 (754)
T PRK15370 323 LP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALT-NLPENLP--AALQ 391 (754)
T ss_pred cc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCC-CCCHhHH--HHHH
Confidence 32 689999999999995 665553 79999999999998 566655 368999999999999 4565554 3699
Q ss_pred eEEccCCCCCCCCccc----ccCCcccccccccCccccCCCCccccccCccceEeccCCCCCC
Q 005040 241 DLDLSRNQLSSDIPST----IGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG 299 (717)
Q Consensus 241 ~L~l~~N~l~~~~~~~----~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~ 299 (717)
.|++++|+|++ +|.. ++.++++..|++.+|++.. ..+.+|+.| ++.+.+.|
T Consensus 392 ~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 392 IMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred HHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccC
Confidence 99999999985 5544 3446889999999999972 344556556 44555543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-21 Score=183.29 Aligned_cols=172 Identities=12% Similarity=0.134 Sum_probs=133.2
Q ss_pred HHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHH---HH------HHHHHHHHHHhcCCCceeeEeeeeec
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERA---FR------SFDSECEILRNVRHRNLLKILGSCSN 494 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~------~~~~e~~~l~~l~hpniv~~~~~~~~ 494 (717)
...++|...+.+|.|+||.||.+.. ++..+|+|++....... .. .+.+|++.++++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468999999999999999999766 57789999997553221 12 26789999999999999999988653
Q ss_pred C--------CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 005040 495 L--------DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV 566 (717)
Q Consensus 495 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~ 566 (717)
. ...++||||++|.+|.++.. ++. ....+++.++..+| ..+++|||++|+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH----~~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH----QHGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH----HcCCccCCCChHHEEEeCCC-
Confidence 3 35789999999999988732 222 24568999999999 68999999999999999998
Q ss_pred EEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHH
Q 005040 567 AHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETF 624 (717)
Q Consensus 567 ~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~ 624 (717)
++++|||........... ..+.....|..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987654221110 01334445668999999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=195.87 Aligned_cols=218 Identities=26% Similarity=0.352 Sum_probs=166.6
Q ss_pred HHhcCCCceeeEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 005040 477 LRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKP 556 (717)
Q Consensus 477 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~ 556 (717)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......+++.....++++++.||.|+|. +.--.|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence 356899999999999999999999999999999999999887789999999999999999999994 33349999999
Q ss_pred CCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCC-------CcCcccchhhHHHHHHHHHhCCCC
Q 005040 557 TNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG-------IVSTKCDVYSYGVLLMETFTEKKP 629 (717)
Q Consensus 557 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~Dvws~G~il~el~tg~~p 629 (717)
+|.++|....+|++|||+....................-|.|||.+... ..+.++||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876431111112222345569999976653 246789999999999999999999
Q ss_pred CCccccCcc--hHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 630 TDEMFTGEM--SLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 630 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
|+....... .+..++... ....+.+.+. ...+...++..++.+||..+|++||+++++...++.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~----~~~~~rP~i~-------~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKG----GSNPFRPSIE-------LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHhc----CCCCcCcchh-------hhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 987433322 222222220 0111111111 111334468899999999999999999999999988765
Q ss_pred h
Q 005040 708 K 708 (717)
Q Consensus 708 ~ 708 (717)
.
T Consensus 227 ~ 227 (484)
T KOG1023|consen 227 G 227 (484)
T ss_pred c
Confidence 4
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=177.08 Aligned_cols=141 Identities=18% Similarity=0.173 Sum_probs=108.4
Q ss_pred cccccccccEEEEEEEecCCCeEEEEEechhhHH--H------------------------HHHHHHHHHHHHhcCCCce
Q 005040 432 CNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLER--A------------------------FRSFDSECEILRNVRHRNL 485 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~hpni 485 (717)
...||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999888999999999754210 0 1122459999999987776
Q ss_pred eeEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 005040 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565 (717)
Q Consensus 486 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~ 565 (717)
.....+.. ...++||||++++++....... ..+++.....++.|++.+|.|+|+ +.+|+||||||+||+++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 43333222 2238999999988776553332 348899999999999999999942 56899999999999998 47
Q ss_pred cEEEeeeccccccC
Q 005040 566 VAHVSDFGISKLLG 579 (717)
Q Consensus 566 ~~kl~Dfgl~~~~~ 579 (717)
.++|+|||++....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=169.02 Aligned_cols=187 Identities=16% Similarity=0.085 Sum_probs=139.8
Q ss_pred CccccccccccEEEEEEEecCCCeEEEEEechhhH---H-HHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEEEc
Q 005040 430 NECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLE---R-AFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 430 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.....|++|+||+||.+.. ++.+++.+.+..... . ....+.+|+++|+++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998776 678888777654432 1 1235788999999995 5889999886 346999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC-CCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDL-KPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+.|.+|.+.... ....++.|+++++.++| ..||+|||| ||+||+++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH----~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH----RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH----HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998754321 11347789999999999 689999999 79999999999999999999986543321
Q ss_pred c----e-------eeeccccCccccCCCccCCC-CcC-cccchhhHHHHHHHHHhCCCCCCcc
Q 005040 584 S----V-------IQTMTMATIGYMAPEYGSEG-IVS-TKCDVYSYGVLLMETFTEKKPTDEM 633 (717)
Q Consensus 584 ~----~-------~~~~~~~t~~y~aPE~~~~~-~~~-~~~Dvws~G~il~el~tg~~p~~~~ 633 (717)
. . .......++.|++|+...-. ..+ ...++++-|..+|.++|++.|....
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 1 0 01223467888888832211 222 5679999999999999999986553
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-22 Score=207.48 Aligned_cols=283 Identities=25% Similarity=0.304 Sum_probs=172.2
Q ss_pred EEECCCCcce-ecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccc
Q 005040 16 GLDLGLNSFS-GHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSAS 94 (717)
Q Consensus 16 ~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~ 94 (717)
.|+|+++.++ ......|..+.+|+.|+|++|.++..... .+...+...++|++|+++++.+.. .+..+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~----~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~~----- 71 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAK----ALASALRPQPSLKELCLSLNETGR-IPRGLQ----- 71 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHH----HHHHHHhhCCCceEEeccccccCC-cchHHH-----
Confidence 4677777776 34445566677788888888887542211 123345566778888887777652 121111
Q ss_pred cceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCC---CCEEeccCCccccc----CCccccCC-CC
Q 005040 95 LQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQ---LQGFYVPENNLQGY----VPHDLCHL-ER 166 (717)
Q Consensus 95 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~l~~n~i~~~----~~~~~~~l-~~ 166 (717)
.++..+..+++|++|+|++|.+....+..+..+.+ |++|++++|.+.+. ....+..+ ++
T Consensus 72 -------------~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~ 138 (319)
T cd00116 72 -------------SLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPA 138 (319)
T ss_pred -------------HHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCC
Confidence 22344555677777777777776545555554444 77777777776631 22234455 67
Q ss_pred CCEEeccCCcCccc----CCccccCCCCCCeEEecCccccCC----CChhhhcccCCCeEEccCCcCccc----CCcccc
Q 005040 167 LNILNLSGNKLSGA----IPQCLASLTSLRSLYLQSNKLSSS----LPSSLWSLEYILRINLSSNSLKGT----LPSNIQ 234 (717)
Q Consensus 167 L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~ 234 (717)
|+.|+|++|.+++. .+..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++. +...+.
T Consensus 139 L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~ 218 (319)
T cd00116 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLA 218 (319)
T ss_pred ceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhc
Confidence 77777777777632 233455566777777777777632 223344556777777777777632 233455
Q ss_pred CCCCCCeEEccCCCCCCCCcccccC-----CcccccccccCccccCC----CCccccccCccceEeccCCCCCCC----C
Q 005040 235 KLNVLIDLDLSRNQLSSDIPSTIGT-----LKNLETLSLAGNQFQGP----IPESVGNLISLESLDFSNNNLSGK----I 301 (717)
Q Consensus 235 ~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~~~~~----~ 301 (717)
.+++|++|++++|.+++.....+.. .+.|+.|++++|.+++. ....+..+++|+.+++++|++... .
T Consensus 219 ~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~ 298 (319)
T cd00116 219 SLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLL 298 (319)
T ss_pred ccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHH
Confidence 6677888888887777532222221 36788888888877522 223445557788888888887744 3
Q ss_pred ccccccc-ccccEEEccCCcc
Q 005040 302 PKSLEAL-SHLKQFNVSHNRL 321 (717)
Q Consensus 302 ~~~~~~l-~~L~~L~l~~N~l 321 (717)
.+.+... +.|+.|++.+|++
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 299 AESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhhcCCchhhcccCCCCC
Confidence 3444444 6777777777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-21 Score=208.31 Aligned_cols=247 Identities=23% Similarity=0.285 Sum_probs=177.9
Q ss_pred cCCccccccccccEEEEEEEecCCCeEEEEEechhh-HHHHHHH---HHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 428 EFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL-ERAFRSF---DSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++...+.+|.+.|=.|.+|+++.|. |+||++-+.. .-..+.| ..|++ ...++|||.+++.-+.......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667789999999999999998887 8899986554 2222333 33444 555699999999988888888899999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc--cCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL--LGEG 581 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~--~~~~ 581 (717)
|+.+ +|+|.+..++ ++...+..-|+.|++.|+.-+| ..+|+|||||.+|||+++-..+.|+||..-+. +.++
T Consensus 102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH----~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH----KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH----HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9865 9999988654 3667777889999999999999 68999999999999999999999999987542 2222
Q ss_pred CC---ceeeeccccCccccCCCccCC----------CC-cCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHh
Q 005040 582 ED---SVIQTMTMATIGYMAPEYGSE----------GI-VSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 582 ~~---~~~~~~~~~t~~y~aPE~~~~----------~~-~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 646 (717)
+. .........-..|.|||.+-. .. .+++-||||+||++.|+++ |++||.- .++-.+...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLLAYRSG 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHHhHhcc
Confidence 21 111111122345999994322 12 5778999999999999998 6777753 112111111
Q ss_pred h--CCCc-hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 005040 647 S--LPHR-LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704 (717)
Q Consensus 647 ~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~ 704 (717)
. .++. ++.+-| ..+..++..|++-||++|.++++.++.-++
T Consensus 251 ~~~~~e~~Le~Ied-----------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 251 NADDPEQLLEKIED-----------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred CccCHHHHHHhCcC-----------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 0 0000 111111 237799999999999999999999887544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-20 Score=178.63 Aligned_cols=196 Identities=25% Similarity=0.293 Sum_probs=138.7
Q ss_pred CCCceeeEeeeeec---------------------------CCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHH
Q 005040 481 RHRNLLKILGSCSN---------------------------LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533 (717)
Q Consensus 481 ~hpniv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i 533 (717)
+|||||++.++|.+ ...+|+||..++ .+|.+|+..+. .+...+.-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999987633 235789999885 49999998655 4566777789999
Q ss_pred HHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCC--cEEEeeeccccccCCCC----CceeeeccccCccccCCCccCCC
Q 005040 534 GSALEYLHHCHSSAPIIHCDLKPTNILLD--ENM--VAHVSDFGISKLLGEGE----DSVIQTMTMATIGYMAPEYGSEG 605 (717)
Q Consensus 534 ~~~l~~LH~~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfgl~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~ 605 (717)
++|+.||| .++|.|||+|++|||+. +|+ ...++|||.+---.... .........|....||||+....
T Consensus 351 LEav~hL~----~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 351 LEAVTHLH----KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHH----HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999 78999999999999994 333 57899999764221110 11112223467779999975432
Q ss_pred C------cCcccchhhHHHHHHHHHhCCCCCCccccCcchH--HHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHH
Q 005040 606 I------VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL--RRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSI 677 (717)
Q Consensus 606 ~------~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (717)
. .-.|+|.|+.|.+.||+++...||-. .+++.+ +.+.....| .-+..++..+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r~Yqe~qLP------------------alp~~vpp~~ 486 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTRTYQESQLP------------------ALPSRVPPVA 486 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechhhhhhhhCC------------------CCcccCChHH
Confidence 2 12489999999999999999999965 232221 221111111 1123556778
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 678 MDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 678 ~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
.+++...++.||.+|++..=+...|.
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 89999999999999999765555443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=169.24 Aligned_cols=140 Identities=21% Similarity=0.216 Sum_probs=110.2
Q ss_pred cccccccccEEEEEEEecCCCeEEEEEechhhHH--------------------------HHHHHHHHHHHHHhcCCCce
Q 005040 432 CNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLER--------------------------AFRSFDSECEILRNVRHRNL 485 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~hpni 485 (717)
...||+|+||.||+|...+|+.||||++...... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754210 01224578999999999987
Q ss_pred eeEeeeeecCCeeEEEEEccCCCCHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC
Q 005040 486 LKILGSCSNLDFKALVLEFMPNGSLEKW-LYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN 564 (717)
Q Consensus 486 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~ 564 (717)
.....+.... .++||||++++++... +.. ..++......++.|++.++.++|+ ..+|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ---EAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCChhhEEEE-C
Confidence 5444433322 4899999998755433 333 336788899999999999999993 27999999999999999 8
Q ss_pred CcEEEeeeccccccC
Q 005040 565 MVAHVSDFGISKLLG 579 (717)
Q Consensus 565 ~~~kl~Dfgl~~~~~ 579 (717)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=176.85 Aligned_cols=231 Identities=21% Similarity=0.272 Sum_probs=146.9
Q ss_pred cCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcC----------CCceeeEeeee-
Q 005040 428 EFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVR----------HRNLLKILGSC- 492 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~----------hpniv~~~~~~- 492 (717)
.+.....||.|+++.||.+.+. +++++|||++.... ....+.+++|.-....+. |-.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455678999999999999986 68999999885332 334566666654444432 11222222211
Q ss_pred -----------ecCC-----eeEEEEEccCCCCHHHHHhh---CC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 005040 493 -----------SNLD-----FKALVLEFMPNGSLEKWLYS---HN---YFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550 (717)
Q Consensus 493 -----------~~~~-----~~~lv~e~~~~g~L~~~l~~---~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~iv 550 (717)
.+.. ..+++|+-+. +||.+++.. .. .......+..+..|+++.+++|| ..|+|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh----~~GlV 167 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH----SYGLV 167 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh----hcceE
Confidence 1111 2367888774 699888652 11 12344556778899999999999 68999
Q ss_pred ecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCC--------CCcCcccchhhHHHHHHH
Q 005040 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE--------GIVSTKCDVYSYGVLLME 622 (717)
Q Consensus 551 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Dvws~G~il~e 622 (717)
|+||+|+|++++.+|.+.|+||+.....+.. ......+..|.|||.... ..++.+.|.|++|+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999987765321 111345678999996433 357899999999999999
Q ss_pred HHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCC
Q 005040 623 TFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKR 692 (717)
Q Consensus 623 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 692 (717)
|++|+.||+....... +.. .+....+.++.+..+|..+|+.+|++|
T Consensus 243 lWC~~lPf~~~~~~~~------------------~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEAD------------------PEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGST------------------SGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCcccc------------------ccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999986422110 000 111222566778999999999999988
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.1e-21 Score=165.36 Aligned_cols=157 Identities=30% Similarity=0.540 Sum_probs=88.8
Q ss_pred ccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCC
Q 005040 113 IGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 192 (717)
+.++.+.+.|.||+|+++ .+|..+..+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 444555566666666666 44445666666666666666665 34555566666666666666655 4555566666666
Q ss_pred eEEecCccccC-CCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCc
Q 005040 193 SLYLQSNKLSS-SLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGN 271 (717)
Q Consensus 193 ~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 271 (717)
.|||.+|++.. .+|..|..|..|+.|+|++|.+. .+|..++.+++|+.|.+.+|.+- ..|..++.+..|++|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 66666655552 34555555555555555555555 45555555555555555555554 25555555555555555555
Q ss_pred ccc
Q 005040 272 QFQ 274 (717)
Q Consensus 272 ~l~ 274 (717)
+++
T Consensus 184 rl~ 186 (264)
T KOG0617|consen 184 RLT 186 (264)
T ss_pred eee
Confidence 555
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-20 Score=195.04 Aligned_cols=257 Identities=26% Similarity=0.302 Sum_probs=186.6
Q ss_pred EEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCC
Q 005040 40 VLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGL 119 (717)
Q Consensus 40 ~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L 119 (717)
.|+|+++.+++.. +...+..+.+|++|++++|.++..... .++..+...++|
T Consensus 2 ~l~L~~~~l~~~~-------~~~~~~~l~~L~~l~l~~~~l~~~~~~---------------------~i~~~l~~~~~l 53 (319)
T cd00116 2 QLSLKGELLKTER-------ATELLPKLLCLQVLRLEGNTLGEEAAK---------------------ALASALRPQPSL 53 (319)
T ss_pred ccccccCcccccc-------hHHHHHHHhhccEEeecCCCCcHHHHH---------------------HHHHHHhhCCCc
Confidence 4566666665322 122345555566666666666532111 233446667778
Q ss_pred cEEEccCCCCcc------cCCccccccCCCCEEeccCCcccccCCccccCCCC---CCEEeccCCcCcc----cCCcccc
Q 005040 120 IVLSLGFNDLNG------TIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLER---LNILNLSGNKLSG----AIPQCLA 186 (717)
Q Consensus 120 ~~L~L~~n~l~~------~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~---L~~L~L~~n~l~~----~~~~~~~ 186 (717)
++|+++++.+.. .++..+..+++|+.|++++|.+....+..+..+.+ |+.|++++|.+++ .+...+.
T Consensus 54 ~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~ 133 (319)
T cd00116 54 KELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK 133 (319)
T ss_pred eEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHH
Confidence 888888887762 23456778999999999999998766666666655 9999999999983 2233456
Q ss_pred CC-CCCCeEEecCccccCC----CChhhhcccCCCeEEccCCcCccc----CCccccCCCCCCeEEccCCCCCCCC----
Q 005040 187 SL-TSLRSLYLQSNKLSSS----LPSSLWSLEYILRINLSSNSLKGT----LPSNIQKLNVLIDLDLSRNQLSSDI---- 253 (717)
Q Consensus 187 ~l-~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~---- 253 (717)
.+ ++|+.|+|++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++..
T Consensus 134 ~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l 213 (319)
T cd00116 134 DLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASAL 213 (319)
T ss_pred hCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHH
Confidence 67 8999999999999842 344567778999999999999842 3345566789999999999998543
Q ss_pred cccccCCcccccccccCccccCCCCccccc-----cCccceEeccCCCCCC----CCcccccccccccEEEccCCccccc
Q 005040 254 PSTIGTLKNLETLSLAGNQFQGPIPESVGN-----LISLESLDFSNNNLSG----KIPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 254 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~~~~----~~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
+..+..+++|++|++++|++++.....+.. .+.|+.|++++|.++. .+...+..+++|+.+++++|+++..
T Consensus 214 ~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 214 AETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 334567889999999999998644444432 3799999999999973 2345566778999999999999865
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.2e-20 Score=191.73 Aligned_cols=225 Identities=25% Similarity=0.279 Sum_probs=176.1
Q ss_pred cccccccEEEEEEEe----cCCCeEEEEEechhhH--HHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEEEccC
Q 005040 434 LLGTGGFGSVYKGTL----SDGTNVAIKIFNLQLE--RAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 434 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
.+|+|.||.|+.+.. +.|..+|.|+.++... ........|..++...+ ||.++++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999997652 3577789888765431 11125566889999997 9999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+|+|...+..... +...........++-+++++| +.+|+|||+|++||+++.+|++++.|||+++..-...
T Consensus 81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh----~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH----KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc----hhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 9999888876654 455556667778888999999 6899999999999999999999999999998653322
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (717)
..+||.-|||||+.. .....+|.||||++++||+||..||.. .......+ . .
T Consensus 152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~------------~-------~ 203 (612)
T KOG0603|consen 152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILK------------A-------E 203 (612)
T ss_pred --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhh------------h-------c
Confidence 128999999999987 566789999999999999999999865 11111111 0 1
Q ss_pred hhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 667 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
...+.+.+..+.+++..++..+|..|...
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 12233556678889999999999999866
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.6e-18 Score=163.37 Aligned_cols=137 Identities=20% Similarity=0.272 Sum_probs=106.2
Q ss_pred CCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhc-----CCCceeeEeeeeecCC---eeE-
Q 005040 429 FNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV-----RHRNLLKILGSCSNLD---FKA- 499 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~~~~~~~~~~---~~~- 499 (717)
+.....||+|+||.||. ...++.. +||++........+.+.+|+++++.+ .||||++++|++++.. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 3234444 79988765444456789999999999 5799999999998763 434
Q ss_pred EEEEc--cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCCeEecCCCCCCeeeCC----CCcEEEeee
Q 005040 500 LVLEF--MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL-EYLHHCHSSAPIIHCDLKPTNILLDE----NMVAHVSDF 572 (717)
Q Consensus 500 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df 572 (717)
+|+|| +.+|+|.+++.+.. +++. ..++.+++.++ +||| +.+|+||||||+||+++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh----~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL----DNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 55799999997643 5555 35677888777 9999 688999999999999974 348999995
Q ss_pred ccc
Q 005040 573 GIS 575 (717)
Q Consensus 573 gl~ 575 (717)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-20 Score=161.31 Aligned_cols=161 Identities=32% Similarity=0.519 Sum_probs=96.1
Q ss_pred CCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEE
Q 005040 164 LERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLD 243 (717)
Q Consensus 164 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 243 (717)
+.+++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ .+|..++++++|+.|+++-|++. +.|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 344445555555555 33334455555555555555555 34445555555555555555555 5555555555555555
Q ss_pred ccCCCCCC-CCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccc
Q 005040 244 LSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322 (717)
Q Consensus 244 l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~ 322 (717)
|++|++.. ..|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+..|.+. ..|+.++.+..|++|++.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 55555543 34555666666777777777776 56666777777777777777766 56777777777777777777777
Q ss_pred ccccccc
Q 005040 323 GEIPVKG 329 (717)
Q Consensus 323 ~~~p~~~ 329 (717)
-.+|..+
T Consensus 187 vlppel~ 193 (264)
T KOG0617|consen 187 VLPPELA 193 (264)
T ss_pred ecChhhh
Confidence 6655543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=187.10 Aligned_cols=201 Identities=22% Similarity=0.246 Sum_probs=159.9
Q ss_pred HHHHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC---CCceeeEeeeeecCCe
Q 005040 421 DIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR---HRNLLKILGSCSNLDF 497 (717)
Q Consensus 421 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~ 497 (717)
+++...+.|.+.+.||+|+||.||+|...+|+.||+|+=+...... |.=-.+++.+|+ -+.|+.+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3444557888889999999999999998889999999865443210 111123333443 2455555555555667
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-------CCCcEEEe
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-------ENMVAHVS 570 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~-------~~~~~kl~ 570 (717)
.++|+||.+.|+|.+++.. ...++|.-+..++.|+++.+.+|| ..+||||||||+|.++. ...-++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH----~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLH----AMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHH----hcceecccCCcceeEeecccCCCCcccceEEE
Confidence 7899999999999999984 445999999999999999999999 67899999999999994 23468999
Q ss_pred eeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCC
Q 005040 571 DFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629 (717)
Q Consensus 571 Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p 629 (717)
|||.+.++........-....+|-.+-.+|+..+..++.++|.|.++.+++-|+.|+..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999988655444445566789999999999999999999999999999999999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-18 Score=188.11 Aligned_cols=216 Identities=24% Similarity=0.253 Sum_probs=149.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..+|+.++.|..|+||.||.++++ ..+.+|.|+=+ +. -+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence 368999999999999999999887 56778885422 10 01110 22222333333
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
||-...++.-+. ++.. ++.+++|+| +.+|+|||+||+|++++.-|++|++|||+++........
T Consensus 136 ---gDc~tllk~~g~-lPvd--------mvla~Eylh----~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP-LPVD--------MVLAVEYLH----SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC-Ccch--------hhHHhHhhc----cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 455555554332 3322 278899999 789999999999999999999999999998754222111
Q ss_pred e-------------eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc
Q 005040 585 V-------------IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR 651 (717)
Q Consensus 585 ~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 651 (717)
. .....+||+.|.|||++....|+..+|+|++|+++||.+-|+.||.+..+ +..+.+.+...+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~-- 276 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIE-- 276 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhcc--
Confidence 1 11234799999999999999999999999999999999999999987422 2223332222111
Q ss_pred hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 652 LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+. ..++....++.+++.+.++.+|.+|.-....++
T Consensus 277 wp--------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 277 WP--------------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred cc--------------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 00 112234466889999999999999986554443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=160.22 Aligned_cols=143 Identities=19% Similarity=0.142 Sum_probs=111.0
Q ss_pred ccCCccccccccccEEEEEEE--ecCCCeEEEEEechhhH------------------------HHHHHHHHHHHHHHhc
Q 005040 427 DEFNECNLLGTGGFGSVYKGT--LSDGTNVAIKIFNLQLE------------------------RAFRSFDSECEILRNV 480 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l 480 (717)
..|++.+.||+|+||.||+|. ..+|+.||+|++..... .....+..|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357788999999999999998 45899999999864321 0112356799999999
Q ss_pred CCC--ceeeEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCC-eEecCCCCC
Q 005040 481 RHR--NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP-IIHCDLKPT 557 (717)
Q Consensus 481 ~hp--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~-ivH~dlk~~ 557 (717)
.+. .+.+.+++ ...++||||++++++..+.... ..........++.|++.++.+|| ..+ ++|||+||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH----~~g~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY----KEGELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH----hcCCEEeCCCChh
Confidence 753 34444443 2348999999998887654332 23556667889999999999999 678 999999999
Q ss_pred CeeeCCCCcEEEeeeccccccC
Q 005040 558 NILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 558 Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
||+++ ++.++++|||.+...+
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-16 Score=154.70 Aligned_cols=134 Identities=22% Similarity=0.330 Sum_probs=112.7
Q ss_pred ccccccccEEEEEEEecCCCeEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--------ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+.||+|++|.||+|.. +|..|++|+..... ......+.+|++++..++|+++.....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 67789999765321 11224577899999999999988777777677788999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
++|++|.+++.... + .+..++.+++.++.++| +.+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH----~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH----SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH----hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999987532 2 78889999999999999 68899999999999999 78999999998764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.8e-16 Score=174.61 Aligned_cols=144 Identities=20% Similarity=0.268 Sum_probs=114.0
Q ss_pred HHHHHHHhccCCccccccccccEEEEEEEecCCCeEEEEEe-chhh-------HHHHHHHHHHHHHHHhcCCCceeeEee
Q 005040 419 YLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIF-NLQL-------ERAFRSFDSECEILRNVRHRNLLKILG 490 (717)
Q Consensus 419 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~e~~~l~~l~hpniv~~~~ 490 (717)
+...+.....|...+.||+|+||+||+|.+.+.. +++|+. .+.. ....+.+.+|+++++.++|++++....
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 3333444455667889999999999999875443 444432 1110 112356788999999999999988887
Q ss_pred eeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 005040 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570 (717)
Q Consensus 491 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 570 (717)
++.+....++||||+++++|.+++. ....++.++++++.||| +.+++|||+||+||++ .++.++|+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH----~~giiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH----KAGIVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH----hCCCccCCCChHHEEE-ECCcEEEE
Confidence 7777777899999999999999876 34678999999999999 6899999999999999 67899999
Q ss_pred eeccccc
Q 005040 571 DFGISKL 577 (717)
Q Consensus 571 Dfgl~~~ 577 (717)
|||+++.
T Consensus 470 DFGla~~ 476 (535)
T PRK09605 470 DFGLGKY 476 (535)
T ss_pred eCccccc
Confidence 9999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-16 Score=150.89 Aligned_cols=136 Identities=21% Similarity=0.186 Sum_probs=107.8
Q ss_pred cCCccccccccccEEEEEEEecCCCeEEEEEechhhH----------------------HHHHHHHHHHHHHHhcCCC--
Q 005040 428 EFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLE----------------------RAFRSFDSECEILRNVRHR-- 483 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~hp-- 483 (717)
-|...+.||+|+||.||+|..++|+.||||++..... .....+..|..++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4777889999999999999988899999998754210 0112356789999999877
Q ss_pred ceeeEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC
Q 005040 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE 563 (717)
Q Consensus 484 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~ 563 (717)
.+...++. ...++||||+++++|...... .....++.+++.++.++| ..+++||||+|+||++++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh----~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY----KHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH----HCCCCcCCCCcccEEEcC
Confidence 44444442 345899999999998765431 234568899999999999 678999999999999999
Q ss_pred CCcEEEeeecccccc
Q 005040 564 NMVAHVSDFGISKLL 578 (717)
Q Consensus 564 ~~~~kl~Dfgl~~~~ 578 (717)
++.++|+|||.+...
T Consensus 161 ~~~~~liDfg~~~~~ 175 (198)
T cd05144 161 DEKIYIIDWPQMVST 175 (198)
T ss_pred CCcEEEEECCccccC
Confidence 999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=150.71 Aligned_cols=130 Identities=23% Similarity=0.330 Sum_probs=105.6
Q ss_pred cccccccEEEEEEEecCCCeEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 434 LLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--------ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 434 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.||+|+||.||+|.+ ++..|++|+..... ......+.+|+++++.++|+++.....++.+....++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 57889999864321 112356778999999999887655555555566679999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
+|++|.+++..... .++.+++++|.++| +.+++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH----~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH----KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH----HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998765321 78899999999999 68999999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3e-17 Score=168.46 Aligned_cols=172 Identities=24% Similarity=0.365 Sum_probs=127.7
Q ss_pred CeeEEEEEccCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 005040 496 DFKALVLEFMPNGSLEKWLYS--HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 573 (717)
.+.|+.|++|...+|.+|+.. .....++.....++.|++.|+.| ++.+|+|+||.||+...+..+||+|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-------ccchhhhccccccccccchhhhhhhhh
Confidence 357899999999999999963 34457888899999999999998 368999999999999999999999999
Q ss_pred cccccCCCC----CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhC
Q 005040 574 ISKLLGEGE----DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 574 l~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 648 (717)
+........ .....+...||..||+||.+.+..|+.|+||||+|++++|++. =..+++.. .
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~---------- 467 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----A---------- 467 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----H----------
Confidence 988765444 1223455679999999999999999999999999999999997 33332210 0
Q ss_pred CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHH
Q 005040 649 PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMT 696 (717)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ 696 (717)
...++-|..+.... ..++ ++-..++..++.+.|.+||++.
T Consensus 468 --t~~d~r~g~ip~~~-----~~d~-p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 468 --TLTDIRDGIIPPEF-----LQDY-PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred --hhhhhhcCCCChHH-----hhcC-cHHHHHHHHhcCCCcccCchHH
Confidence 01111111111100 0011 1234799999999999999443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=139.26 Aligned_cols=137 Identities=22% Similarity=0.251 Sum_probs=97.6
Q ss_pred cccccccccEEEEEEEecCCCeEEEEEechhhHH--HHHH----------------------HHHHHHHHHhcCCCc--e
Q 005040 432 CNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLER--AFRS----------------------FDSECEILRNVRHRN--L 485 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~hpn--i 485 (717)
.+.||+|+||.||+|...+++.||||++...... .... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988653211 1111 134666666664432 4
Q ss_pred eeEeeeeecCCeeEEEEEccCCCCHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC
Q 005040 486 LKILGSCSNLDFKALVLEFMPNGSLEK-WLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN 564 (717)
Q Consensus 486 v~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~ 564 (717)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. +.+|+|||+||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~---~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR---EAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh---ccCcCcCCCChhhEEEE-C
Confidence 444443 23589999999854321 111111 11 5577899999999999993 27899999999999999 8
Q ss_pred CcEEEeeeccccccC
Q 005040 565 MVAHVSDFGISKLLG 579 (717)
Q Consensus 565 ~~~kl~Dfgl~~~~~ 579 (717)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-16 Score=175.86 Aligned_cols=256 Identities=21% Similarity=0.258 Sum_probs=196.1
Q ss_pred hccCCccccccccccEEEEEEEec--CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 500 (717)
...|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 356778888999999999888764 33446666554332 333344556777777776 9999999999999999999
Q ss_pred EEEccCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecccccc
Q 005040 501 VLEFMPNGSLEKWL-YSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLL 578 (717)
Q Consensus 501 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~ 578 (717)
+.+|..++++.+-+ .......+.......+.|+..++.|+|. ..+++|+|+||+|.+++..+ ..+++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~---~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP---ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc---ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999888 5443346667777899999999999994 46799999999999999999 9999999999988
Q ss_pred CC-CCCceeeecccc-CccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh
Q 005040 579 GE-GEDSVIQTMTMA-TIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655 (717)
Q Consensus 579 ~~-~~~~~~~~~~~~-t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (717)
.. ..........+| ++.|+|||...+ +...+..|+||.|+++.-+++|..|++........+..|........
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 251 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT---- 251 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc----
Confidence 76 444455556678 999999998777 45678899999999999999999999876555544444443321100
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 005040 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAA 699 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~ 699 (717)
............+++.+++..+|..|.+.+++.
T Consensus 252 -----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 -----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -----------cCccccCChhhhhcccccccCCchhcccccccc
Confidence 001112234467889999999999999988764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=133.25 Aligned_cols=135 Identities=22% Similarity=0.276 Sum_probs=113.6
Q ss_pred ccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCC--CceeeEeeeeecCCeeEEEEEccCCC
Q 005040 431 ECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRH--RNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 431 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
+++.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| +.+++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899999865533 4568889999999976 58999999888888899999999987
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 509 SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 509 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.+..+ +......++.+++++++++|..+ ..+++|+|++|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 45667778999999999999543 35799999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.1e-14 Score=138.29 Aligned_cols=136 Identities=19% Similarity=0.227 Sum_probs=104.6
Q ss_pred ccccc-ccccEEEEEEEecCCCeEEEEEechhh------H-------HHHHHHHHHHHHHHhcCCCce--eeEeeeeecC
Q 005040 432 CNLLG-TGGFGSVYKGTLSDGTNVAIKIFNLQL------E-------RAFRSFDSECEILRNVRHRNL--LKILGSCSNL 495 (717)
Q Consensus 432 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~------~-------~~~~~~~~e~~~l~~l~hpni--v~~~~~~~~~ 495 (717)
...|| .|+.|+||.+... +..++||.+.... . .....+.+|++++++++|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999884 7788999885311 1 122457789999999998775 6677664332
Q ss_pred -C---eeEEEEEccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 005040 496 -D---FKALVLEFMPN-GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570 (717)
Q Consensus 496 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 570 (717)
. ..++|||+++| .+|.+++.... ++.. .+.+++.++.+|| ..||+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH----~~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH----DAGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH----HCCCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 69999887532 4443 3568999999999 6899999999999999999999999
Q ss_pred eecccccc
Q 005040 571 DFGISKLL 578 (717)
Q Consensus 571 Dfgl~~~~ 578 (717)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-15 Score=155.88 Aligned_cols=176 Identities=32% Similarity=0.523 Sum_probs=112.7
Q ss_pred cCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEE
Q 005040 140 LQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRIN 219 (717)
Q Consensus 140 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 219 (717)
+..-...+|+.|++. ++|..++.+-.|+.|.|..|.+. .+|..+.++..|..|+|+.|+++ .+|..++.++ |+.|.
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 333445566666666 45555666666666666666666 55666666666666666666666 5555555555 66666
Q ss_pred ccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCC
Q 005040 220 LSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG 299 (717)
Q Consensus 220 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~ 299 (717)
+++|+++ .+|..++.+..|..||.+.|.+.. .|..++++.+|+.|++..|++. ..|..++.+ .|..||++.|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-
Confidence 6666666 566666666666677777776663 5556666777777777777766 455555544 3666777777776
Q ss_pred CCcccccccccccEEEccCCccccc
Q 005040 300 KIPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 300 ~~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
.+|-.|..|..|++|-|.+|+|+..
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCCCC
Confidence 6667777777777777777777643
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.6e-15 Score=154.29 Aligned_cols=194 Identities=29% Similarity=0.434 Sum_probs=108.0
Q ss_pred EEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCC
Q 005040 40 VLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGL 119 (717)
Q Consensus 40 ~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L 119 (717)
.|.|++-+++..+.++.. ..+..-...||+.|++. .+|..++.+ ..|+.|.|+.|.+. .+|..+.++..|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~-------~~ltdt~~aDlsrNR~~-elp~~~~~f-~~Le~liLy~n~~r-~ip~~i~~L~~l 123 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAAS-------YDLTDTVFADLSRNRFS-ELPEEACAF-VSLESLILYHNCIR-TIPEAICNLEAL 123 (722)
T ss_pred ccccccchhhcCCCcccc-------ccccchhhhhccccccc-cCchHHHHH-HHHHHHHHHhccce-ecchhhhhhhHH
Confidence 466677777776655411 35556667788888887 566666665 45666666666666 556666666666
Q ss_pred cEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCc
Q 005040 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSN 199 (717)
Q Consensus 120 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 199 (717)
++|||+.|++. ..|..++.|+ |+.|-+++|+++ .+|..++.++.|..||.+.|
T Consensus 124 t~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-------------------------~lp~~ig~~~tl~~ld~s~n 176 (722)
T KOG0532|consen 124 TFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-------------------------SLPEEIGLLPTLAHLDVSKN 176 (722)
T ss_pred HHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-------------------------cCCcccccchhHHHhhhhhh
Confidence 66666666666 4444444443 444555555554 34444444444445555555
Q ss_pred cccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCcccc
Q 005040 200 KLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274 (717)
Q Consensus 200 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 274 (717)
.+. .+|.-+..+.+|+.|.+..|++. .+|..+..++ |..||+|.|+++ .+|..|..|..|++|-|.+|+++
T Consensus 177 ei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 177 EIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 444 33444444555555555555544 3344444333 555555555555 35555555555555555555555
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.1e-14 Score=149.92 Aligned_cols=199 Identities=34% Similarity=0.480 Sum_probs=115.7
Q ss_pred EEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCC-CCcEEEccCCCCcccCCccccccCCCCEEeccC
Q 005040 72 NLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLR-GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPE 150 (717)
Q Consensus 72 ~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 150 (717)
.|++..|++... ...+..+ +.+..|++.+|++. .++.....+. +|+.|++++|.+. .+|..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~-~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLEL-TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccC-chhhhcc-cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 455555555312 1122222 34566666666665 3444444443 6666677766666 3445566666777777777
Q ss_pred CcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCC
Q 005040 151 NNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP 230 (717)
Q Consensus 151 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 230 (717)
|++... +.....+++|+.|++++|+++ .+|........|++|.+++|.+. ..+..+..+.++..|.+.+|++. ..+
T Consensus 173 N~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 173 NDLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred chhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 776633 333335666677777777776 34443334445667777777433 34455666666666666666666 335
Q ss_pred ccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCcc
Q 005040 231 SNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPES 280 (717)
Q Consensus 231 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 280 (717)
..++.+++|+.|++++|.++...+ ++.+.+|+.|++++|.+....+..
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred chhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 566666667777777777764333 666677777777777666544443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.2e-15 Score=145.36 Aligned_cols=200 Identities=21% Similarity=0.237 Sum_probs=127.9
Q ss_pred cccCCCCCcEEEccCCCCcccCCcc----ccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccC
Q 005040 112 EIGNLRGLIVLSLGFNDLNGTIPTS----IGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLAS 187 (717)
Q Consensus 112 ~~~~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 187 (717)
++-..++|++||||+|.+....+.. +.++..|++|+|.+|.+.......++. .|..|. .|+ ..+.
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~ 155 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAAS 155 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCC
Confidence 3444556777777777665333322 234555666666666655333222221 111111 111 1223
Q ss_pred CCCCCeEEecCccccCC----CChhhhcccCCCeEEccCCcCccc----CCccccCCCCCCeEEccCCCCCCCC----cc
Q 005040 188 LTSLRSLYLQSNKLSSS----LPSSLWSLEYILRINLSSNSLKGT----LPSNIQKLNVLIDLDLSRNQLSSDI----PS 255 (717)
Q Consensus 188 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~----~~ 255 (717)
-+.|+.+..++|++... +...|...+.|+.+.+++|.|... +...|..+++|+.|||.+|-++... ..
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 35678888888877743 234566677888888888887632 2346788889999999999887533 34
Q ss_pred cccCCcccccccccCccccCCCCcccc-----ccCccceEeccCCCCCC----CCcccccccccccEEEccCCccc
Q 005040 256 TIGTLKNLETLSLAGNQFQGPIPESVG-----NLISLESLDFSNNNLSG----KIPKSLEALSHLKQFNVSHNRLE 322 (717)
Q Consensus 256 ~~~~l~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~~~~----~~~~~~~~l~~L~~L~l~~N~l~ 322 (717)
.+..|++|++|++++|.+......+|. ..|+|+.|.|.+|.|+. .+.......+.|..|+|++|.+.
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 566788899999999988876665552 46889999999998874 22334556788999999999984
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.3e-15 Score=146.33 Aligned_cols=259 Identities=20% Similarity=0.237 Sum_probs=157.6
Q ss_pred ccCCCCCcEEECCCCcceec----CCcCCCCCCCCCEEEcccccccCccCCccc--ccccccccCccCCcEEeccCCCCc
Q 005040 8 ITNATKLIGLDLGLNSFSGH----IPNTFGNLRHLSVLSLMMNNLTTESSSADQ--WSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 8 ~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
+..+..++.|+||+|.+... +.+.+...++|+..++++=-..-....+.. -.+.+.+...++|++|+||.|.+.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 45667778888888877633 333455666777777765422221111100 012233556667888888888877
Q ss_pred ccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccc
Q 005040 82 GILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL 161 (717)
Q Consensus 82 ~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~ 161 (717)
...++.|..+ +.++..|+.|.|.+|.+.-..-..++. .|..|. .|+..
T Consensus 106 ~~g~~~l~~l---------------------l~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk~------- 153 (382)
T KOG1909|consen 106 PKGIRGLEEL---------------------LSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKKA------- 153 (382)
T ss_pred ccchHHHHHH---------------------HHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhcc-------
Confidence 6666666655 455789999999999987332222221 122222 12111
Q ss_pred cCCCCCCEEeccCCcCcccC----CccccCCCCCCeEEecCccccCC----CChhhhcccCCCeEEccCCcCccc----C
Q 005040 162 CHLERLNILNLSGNKLSGAI----PQCLASLTSLRSLYLQSNKLSSS----LPSSLWSLEYILRINLSSNSLKGT----L 229 (717)
Q Consensus 162 ~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~ 229 (717)
..-+.|+++...+|++.... ...|...+.|+.+.++.|.|... +...|..+++|+.|||.+|-++.. +
T Consensus 154 ~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~L 233 (382)
T KOG1909|consen 154 ASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVAL 233 (382)
T ss_pred CCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHH
Confidence 12246777777777765322 23455566777777777777622 234566777777777777777632 3
Q ss_pred CccccCCCCCCeEEccCCCCCCCCcccc-----cCCcccccccccCccccCCC----CccccccCccceEeccCCCCC
Q 005040 230 PSNIQKLNVLIDLDLSRNQLSSDIPSTI-----GTLKNLETLSLAGNQFQGPI----PESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 230 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~~~ 298 (717)
...++.+++|++|++++|.++......| ...++|+.|.|.+|.|+... ...+...+.|+.|+|++|.+.
T Consensus 234 akaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 234 AKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 3456777788888888888876554443 23678888888888876422 223445677888888888883
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-13 Score=147.63 Aligned_cols=264 Identities=29% Similarity=0.405 Sum_probs=186.9
Q ss_pred EEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCC
Q 005040 40 VLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGL 119 (717)
Q Consensus 40 ~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L 119 (717)
.|+++.|.+..... .+..++.++.|++.+|.++. +++.......+|+.|++++|++. .+|..+..+++|
T Consensus 97 ~l~~~~~~~~~~~~---------~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L 165 (394)
T COG4886 97 SLDLNLNRLRSNIS---------ELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNL 165 (394)
T ss_pred eeeccccccccCch---------hhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccc
Confidence 68888888733221 24566788899999998884 44444433126899999999988 555678999999
Q ss_pred cEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCc
Q 005040 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSN 199 (717)
Q Consensus 120 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 199 (717)
+.|++++|++. .++...+.+++|+.|++++|+++. +|.....+..|++|.+++|.+. ..+..+.++.++..|.+.+|
T Consensus 166 ~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n 242 (394)
T COG4886 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242 (394)
T ss_pred cccccCCchhh-hhhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCc
Confidence 99999999999 556556689999999999999995 4554456667999999999654 35667888999999999999
Q ss_pred cccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCc
Q 005040 200 KLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPE 279 (717)
Q Consensus 200 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 279 (717)
++. ..+..+..+++|++|++++|.++...+ +..+.+|+.|++++|.+....+...........+. . +.+. ..+.
T Consensus 243 ~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~~~~-~-~~~~-~~~~ 316 (394)
T COG4886 243 KLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL-N-LLLT-LKAL 316 (394)
T ss_pred eee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhccchhHHhhh-h-hhhh-cccc
Confidence 998 447788899999999999999995433 99999999999999999976666554433322222 2 3332 2222
Q ss_pred cccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccc
Q 005040 280 SVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 280 ~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
.+.....+....+..+... ..+..+.....+..++...+.....
T Consensus 317 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (394)
T COG4886 317 ELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNALDES 360 (394)
T ss_pred ccccccccccccccccccc-ccchhhcccccccCceecccccccc
Confidence 2233333444444555554 4455555555566666666555443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.8e-13 Score=141.92 Aligned_cols=144 Identities=21% Similarity=0.283 Sum_probs=100.7
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHH---------------------------------------
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAF--------------------------------------- 467 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------- 467 (717)
..|+ .+.||.|++|.||+|+.++|+.||||+.++...+..
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 367999999999999999999999999865421110
Q ss_pred -HHHHHHHHHHHhcC-----CCceeeEeeee-ecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHH
Q 005040 468 -RSFDSECEILRNVR-----HRNLLKILGSC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGS-ALEY 539 (717)
Q Consensus 468 -~~~~~e~~~l~~l~-----hpniv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~ 539 (717)
-+|..|.+.+.+++ ++++ .+-..+ ......++||||++|++|.++........+ +..++..++. .+..
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHH
Confidence 02444555555552 3433 222222 223446999999999999887754321122 3446666665 4677
Q ss_pred HhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 540 LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+| ..|++|+|++|.||+++.++.++++|||++..+.
T Consensus 273 l~----~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VL----RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HH----hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 78 6789999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.9e-12 Score=135.90 Aligned_cols=166 Identities=16% Similarity=0.182 Sum_probs=129.2
Q ss_pred cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHH
Q 005040 449 SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLN 528 (717)
Q Consensus 449 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 528 (717)
.++.+|.|..++...........+-++.|+.++||||+++++.++..+..|+|+|.+. .|..++.+.+ ...+.-
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~ 108 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCL 108 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHH
Confidence 4788888888765555555667778899999999999999999999999999999985 6888887643 455666
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcC
Q 005040 529 IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVS 608 (717)
Q Consensus 529 i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 608 (717)
.+.||+.||.|||+ ..+++|++|....|+++..|..||++|.++........ ......--..|..|+.+....
T Consensus 109 Gl~qIl~AL~FL~~---d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 109 GLFQILAALSFLND---DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHhc---cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 88999999999996 45799999999999999999999999998865432221 111122233466776543322
Q ss_pred cccchhhHHHHHHHHHhCC
Q 005040 609 TKCDVYSYGVLLMETFTEK 627 (717)
Q Consensus 609 ~~~Dvws~G~il~el~tg~ 627 (717)
-..|.|.||++++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.7e-13 Score=129.82 Aligned_cols=202 Identities=19% Similarity=0.291 Sum_probs=140.2
Q ss_pred HHHhcCCCceeeEeeeeecC-----CeeEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 005040 476 ILRNVRHRNLLKILGSCSNL-----DFKALVLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547 (717)
Q Consensus 476 ~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 547 (717)
-+-++-|.|++++..|+.+. ....+++|||..|++.++|++ ....+....-.+|+.||..||.|||.+ ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~--~P 197 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC--DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc--CC
Confidence 34455799999999998654 356889999999999999984 344577777888999999999999975 57
Q ss_pred CeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC--CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh
Q 005040 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE--DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625 (717)
Q Consensus 548 ~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t 625 (717)
+|+|+++.-+-|++..+|-+|++--.-........ .........+-++|.+||+...-..+..+|||+||+...||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 89999999999999999999886422211110000 0111122346788999999888888889999999999999988
Q ss_pred CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 626 EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 626 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+..--... ...... ...+..++.. ...+. -..++.+|+...|..||+|.+++..
T Consensus 278 lEiq~tns-eS~~~~--------ee~ia~~i~~--------len~l-----qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNS-ESKVEV--------EENIANVIIG--------LENGL-----QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCC-cceeeh--------hhhhhhheee--------ccCcc-----ccCcCcccccCCCCCCcchhhhhcC
Confidence 77542111 000000 0011111100 00100 1368899999999999999998654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.8e-13 Score=149.10 Aligned_cols=118 Identities=36% Similarity=0.661 Sum_probs=100.7
Q ss_pred CCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEcc
Q 005040 238 VLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVS 317 (717)
Q Consensus 238 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~ 317 (717)
.++.|+|++|.+++.+|..++.+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccccccc--ccccccccccccCCccccCCCCCCCCCCC
Q 005040 318 HNRLEGEIPVK--GSFKDFSAQSYFGNYALCGPPRLQVPPCK 357 (717)
Q Consensus 318 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~~~~~~~~c~ 357 (717)
+|+++|.+|.. ..+..+..+.+.+|+.+|+.+. ..+|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence 99999998864 1122344567889999998653 35674
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.1e-13 Score=139.97 Aligned_cols=248 Identities=22% Similarity=0.249 Sum_probs=183.4
Q ss_pred ccCCccccccc--cccEEEEEEEe--c-CCCeEEEEEechhhH--HHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCee
Q 005040 427 DEFNECNLLGT--GGFGSVYKGTL--S-DGTNVAIKIFNLQLE--RAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 427 ~~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 498 (717)
..|...+.+|. |.+|.||.+.. + ++..+|+|.-+..-. .....=.+|....+++ .|++.++....+.+.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999976 3 788899997433222 1222224466666666 499999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeec
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGS----ALEYLHHCHSSAPIIHCDLKPTNILLDEN-MVAHVSDFG 573 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg 573 (717)
|+-+|.+. .+|.++.+.....++....+....+..+ |+.++| +.+++|-|+||.||+...+ ...+++|||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h----s~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH----SNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC----CCcccccccchhheecccccceeecCCcc
Confidence 99999994 7999999987777888889999999999 999999 7889999999999999999 889999999
Q ss_pred cccccCCCCCceee---eccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCcc-ccCcchHHHHHHhhCC
Q 005040 574 ISKLLGEGEDSVIQ---TMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM-FTGEMSLRRWVKESLP 649 (717)
Q Consensus 574 l~~~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~ 649 (717)
+...++.+...... ....|...|++||... +.++.++|+|++|.+..+..++..+.... ...-.+++.+. .+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---ip 344 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---IP 344 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---Cc
Confidence 99988766533211 1225677899999754 56788999999999999999988764331 11111111111 00
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. +.++ ....++...+..|++.+|..|++++.+..
T Consensus 345 ~---e~~~--------------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 345 L---EFCE--------------GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred h---hhhc--------------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 0000 11233445888999999999999887654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3e-13 Score=128.54 Aligned_cols=134 Identities=28% Similarity=0.323 Sum_probs=106.2
Q ss_pred CCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCccccccc
Q 005040 188 LTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLS 267 (717)
Q Consensus 188 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 267 (717)
-..|++||||+|.|+ .+.+...-++.++.|++|+|.|... ..++.+++|+.||||+|.++. .-.+-..+.+.++|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCEeeee
Confidence 356888999999988 5566777788899999999998843 348888999999999999885 434445678889999
Q ss_pred ccCccccCCCCccccccCccceEeccCCCCCCCC-cccccccccccEEEccCCcccccccc
Q 005040 268 LAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI-PKSLEALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 268 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~ 327 (717)
|++|.|.. -..+.++-+|..||+++|+|.... ...++++|.|+.|.|.+|++.+.+..
T Consensus 359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 99998863 345777888999999999987533 35788999999999999999886654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.8e-13 Score=127.19 Aligned_cols=131 Identities=30% Similarity=0.396 Sum_probs=108.3
Q ss_pred CCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEE
Q 005040 164 LERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLD 243 (717)
Q Consensus 164 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 243 (717)
-+.|++||||+|.|+ .+.....-+|+++.|++|+|.|... ..+..+++|+.||||+|.++ ..-.+-..+-+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 356899999999998 5666677789999999999999844 33888999999999999998 4555667788899999
Q ss_pred ccCCCCCCCCcccccCCcccccccccCccccCCC-CccccccCccceEeccCCCCCCC
Q 005040 244 LSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI-PESVGNLISLESLDFSNNNLSGK 300 (717)
Q Consensus 244 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~~~~~ 300 (717)
|++|.|.+. ..+..+-+|..||+++|+|.... ...++++|-|+++.|.+|++.+.
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 999999752 44778889999999999997432 35689999999999999999854
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.4e-13 Score=135.99 Aligned_cols=212 Identities=22% Similarity=0.170 Sum_probs=106.1
Q ss_pred CCCCCcEEECCCCcceecCC-cCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcch
Q 005040 10 NATKLIGLDLGLNSFSGHIP-NTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLI 88 (717)
Q Consensus 10 ~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 88 (717)
++.+|+...|.++.+..... .....+++++.|||++|-+....+ ...-...|++|+.|+|+.|++........
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~------v~~i~eqLp~Le~LNls~Nrl~~~~~s~~ 192 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFP------VLKIAEQLPSLENLNLSSNRLSNFISSNT 192 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHH------HHHHHHhcccchhcccccccccCCccccc
Confidence 45556666666665552211 244556666666666665554332 12224456666666666666553222222
Q ss_pred hccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccC-CccccccCCCCEEeccCCcccccCCccccCCCCC
Q 005040 89 GNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTI-PTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167 (717)
Q Consensus 89 ~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L 167 (717)
.. .+++|+.|.|+.|.++... -..+..+|+|+.|+|..|.....-.....-+..|
T Consensus 193 ~~------------------------~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L 248 (505)
T KOG3207|consen 193 TL------------------------LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTL 248 (505)
T ss_pred hh------------------------hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHH
Confidence 22 3345555555555554111 1122345555555555553222222333444556
Q ss_pred CEEeccCCcCcccC-CccccCCCCCCeEEecCccccCC-CChh-----hhcccCCCeEEccCCcCccc-CCccccCCCCC
Q 005040 168 NILNLSGNKLSGAI-PQCLASLTSLRSLYLQSNKLSSS-LPSS-----LWSLEYILRINLSSNSLKGT-LPSNIQKLNVL 239 (717)
Q Consensus 168 ~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~-~~~~-----~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L 239 (717)
+.|||++|.+-... -...+.++.|+.|+++.|.+.++ .|+. ...+++|++|++..|+|... .-..+..+++|
T Consensus 249 ~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nl 328 (505)
T KOG3207|consen 249 QELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENL 328 (505)
T ss_pred hhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchh
Confidence 66666666554222 12344556666666666665532 1221 23456677777777776421 11244556667
Q ss_pred CeEEccCCCCCC
Q 005040 240 IDLDLSRNQLSS 251 (717)
Q Consensus 240 ~~L~l~~N~l~~ 251 (717)
+.|.+..|.++.
T Consensus 329 k~l~~~~n~ln~ 340 (505)
T KOG3207|consen 329 KHLRITLNYLNK 340 (505)
T ss_pred hhhhcccccccc
Confidence 777777777764
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.4e-13 Score=146.31 Aligned_cols=246 Identities=24% Similarity=0.320 Sum_probs=140.5
Q ss_pred CccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCE
Q 005040 66 NCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQG 145 (717)
Q Consensus 66 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 145 (717)
.+..++.+.+..|.+.. .-..+..+ .+|..|++.+|+|..+ ...+..+++|++|+|++|.|+.+ ..+..++.|+.
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~-~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~ 144 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKL-KSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE 144 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccc-cceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhh
Confidence 34444555555555552 11112222 3455555555555422 22256677777777777777644 34566666777
Q ss_pred EeccCCcccccCCccccCCCCCCEEeccCCcCcccCC-ccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCc
Q 005040 146 FYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP-QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNS 224 (717)
Q Consensus 146 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 224 (717)
|++++|.|..+ ..+..+..|+.+++++|++....+ . ...+.+|+.+++.+|.+... ..+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence 77777777744 334556777777777777774433 1 45667777777777777632 334455555555777777
Q ss_pred CcccCCccccCCCC--CCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCC--
Q 005040 225 LKGTLPSNIQKLNV--LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK-- 300 (717)
Q Consensus 225 l~~~~~~~~~~l~~--L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~-- 300 (717)
++..- .+..+.. |+.+++++|.+.. .+..+..+..+..|++.+|++... ..+.....+..+.+..|.+...
T Consensus 220 i~~~~--~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 294 (414)
T KOG0531|consen 220 ISKLE--GLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEA 294 (414)
T ss_pred ceecc--CcccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhh
Confidence 76332 2222222 6777777777763 334556667777777777776532 2344455566666666665521
Q ss_pred -Cccc-ccccccccEEEccCCccccccc
Q 005040 301 -IPKS-LEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 301 -~~~~-~~~l~~L~~L~l~~N~l~~~~p 326 (717)
.... ....+++..+.+..|+.....+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 295 ISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhccccccccccccccccccCccccccc
Confidence 1111 4455666777777776665444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.6e-12 Score=118.05 Aligned_cols=65 Identities=26% Similarity=0.450 Sum_probs=17.1
Q ss_pred ccCCCCCcEEEccCCCCcccCCccc-cccCCCCEEeccCCcccccCC-ccccCCCCCCEEeccCCcCc
Q 005040 113 IGNLRGLIVLSLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVP-HDLCHLERLNILNLSGNKLS 178 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~ 178 (717)
+..+++|++|++++|+|+.+ ...+ ..+++|++|+|++|+|..... ..+..+++|+.|+|.+|.++
T Consensus 60 l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 60 LPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp ----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 34445555555555555532 2222 234555555555555543211 22334444444444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.2e-12 Score=118.60 Aligned_cols=124 Identities=28% Similarity=0.322 Sum_probs=33.6
Q ss_pred CCCCCeEEecCccccCCCChhhh-cccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccc
Q 005040 188 LTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETL 266 (717)
Q Consensus 188 l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 266 (717)
..++++|+|++|+|+.+ +.+. .+.+|+.|+|++|.|+.. +.+..++.|+.|++++|.|++..+.....+++|++|
T Consensus 18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQEL 93 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EE
T ss_pred ccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEE
Confidence 34455555555555522 1233 345555555555555532 235555556666666666654322112345566666
Q ss_pred cccCccccCCC-CccccccCccceEeccCCCCCCCC---cccccccccccEEE
Q 005040 267 SLAGNQFQGPI-PESVGNLISLESLDFSNNNLSGKI---PKSLEALSHLKQFN 315 (717)
Q Consensus 267 ~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~~~~~~---~~~~~~l~~L~~L~ 315 (717)
++++|+|.... -..+..+++|+.|+|.+|++.... ...+..+|+|+.||
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 66666655321 133445566666666666665321 11345566666554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.7e-13 Score=144.06 Aligned_cols=250 Identities=25% Similarity=0.246 Sum_probs=165.5
Q ss_pred CCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCcc
Q 005040 33 GNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKE 112 (717)
Q Consensus 33 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~ 112 (717)
..+..++.+++..|.|..+. ..+..+++|+.|++.+|+|..+.. .+..+ .+|++|++++|.|+... .
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~---------~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~-~~L~~L~ls~N~I~~i~--~ 135 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKIL---------NHLSKLKSLEALDLYDNKIEKIEN-LLSSL-VNLQVLDLSFNKITKLE--G 135 (414)
T ss_pred HHhHhHHhhccchhhhhhhh---------cccccccceeeeeccccchhhccc-chhhh-hcchheecccccccccc--c
Confidence 34455555556666666521 124556666666666666663322 13333 45666666666666432 3
Q ss_pred ccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCC-ccccCCCCCCEEeccCCcCcccCCccccCCCCC
Q 005040 113 IGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVP-HDLCHLERLNILNLSGNKLSGAIPQCLASLTSL 191 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 191 (717)
+..++.|+.|++++|.|+.+ ..+..+++|+.+++++|++..+.+ . ...+.+|+.+++.+|.+... ..+..+..+
T Consensus 136 l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l 210 (414)
T KOG0531|consen 136 LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKL 210 (414)
T ss_pred hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHH
Confidence 56666688888888888733 456668888888888888886654 2 57778888888888888743 234555666
Q ss_pred CeEEecCccccCCCChhhhccc--CCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCccccccccc
Q 005040 192 RSLYLQSNKLSSSLPSSLWSLE--YILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLA 269 (717)
Q Consensus 192 ~~L~L~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 269 (717)
..+++..|.++...+ +..+. .|+.+++++|.+. ..+..+..+.++..|++.+|.+... ..+.....+..+.+.
T Consensus 211 ~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~ 285 (414)
T KOG0531|consen 211 VLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLN 285 (414)
T ss_pred HHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccC
Confidence 666888888874322 22333 3888889999888 4446777888889999999998753 335667788888888
Q ss_pred CccccCC---CCcc-ccccCccceEeccCCCCCCCCcccc
Q 005040 270 GNQFQGP---IPES-VGNLISLESLDFSNNNLSGKIPKSL 305 (717)
Q Consensus 270 ~N~l~~~---~~~~-~~~l~~L~~L~L~~N~~~~~~~~~~ 305 (717)
.|.+... .... .+..+.++.+.+..|.+....+...
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
T KOG0531|consen 286 DNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSLDL 325 (414)
T ss_pred cchhcchhhhhccccccccccccccccccCcccccccccH
Confidence 8887622 1121 4567788899999998886555433
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.1e-13 Score=132.28 Aligned_cols=210 Identities=27% Similarity=0.293 Sum_probs=113.4
Q ss_pred CCCCCcEEEccCCCCcccCC-ccccccCCCCEEeccCCccccc--CCccccCCCCCCEEeccCCcCcccCCc-cccCCCC
Q 005040 115 NLRGLIVLSLGFNDLNGTIP-TSIGTLQQLQGFYVPENNLQGY--VPHDLCHLERLNILNLSGNKLSGAIPQ-CLASLTS 190 (717)
Q Consensus 115 ~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~i~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~ 190 (717)
++.+|+...|.+..+..... .....|++++.|+|+.|-+... +......+++|+.|+|+.|++...... .-..++.
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 34455555555555542111 2344555666666666555422 112234556666666666665522211 1113456
Q ss_pred CCeEEecCccccCC-CChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCC-cccccCCcccccccc
Q 005040 191 LRSLYLQSNKLSSS-LPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDI-PSTIGTLKNLETLSL 268 (717)
Q Consensus 191 L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l 268 (717)
|+.|.|+.|.++.. +-..+..+++|..|+|..|.....-.....-+..|++|||++|++-... -...+.++.|+.|++
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl 278 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL 278 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence 66666666666611 1122335566777777776432233344455666777777777765421 134566777777777
Q ss_pred cCccccCCC-Ccc-----ccccCccceEeccCCCCCCC-CcccccccccccEEEccCCccccc
Q 005040 269 AGNQFQGPI-PES-----VGNLISLESLDFSNNNLSGK-IPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 269 ~~N~l~~~~-~~~-----~~~l~~L~~L~L~~N~~~~~-~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
+.+.+..+- |+. ...+++|++|+++.|+|..- .-+.+..+++|+.|....|+++-+
T Consensus 279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred cccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 777776422 222 24567777777777777521 123455566677777667766543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.9e-11 Score=132.43 Aligned_cols=144 Identities=19% Similarity=0.224 Sum_probs=93.7
Q ss_pred hccCCccccccccccEEEEEEEecC-CCeEEEEEechhhHH----------------------------------HHHH-
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLER----------------------------------AFRS- 469 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~- 469 (717)
-.+|+. +.||+|++|.||+|+.++ |+.||||+.++...+ ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 356776 789999999999999886 999999999754211 1111
Q ss_pred -----HHHHHHHHHhcC----CCceeeEeeeeec-CCeeEEEEEccCCCCHHHHH--hhCCC---CCCHHHHHHHHHHHH
Q 005040 470 -----FDSECEILRNVR----HRNLLKILGSCSN-LDFKALVLEFMPNGSLEKWL--YSHNY---FLDILQRLNIMIDVG 534 (717)
Q Consensus 470 -----~~~e~~~l~~l~----hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~---~~~~~~~~~i~~~i~ 534 (717)
+.+|...+.+++ +...+.+-.++.+ ....++||||++|+++.++- ...+. .+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 233444444432 3333333333322 33458999999999998753 33221 12222222233333
Q ss_pred HHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeeccccccCCC
Q 005040 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENM----VAHVSDFGISKLLGEG 581 (717)
Q Consensus 535 ~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl~~~~~~~ 581 (717)
. ..|++|+|++|.||+++.++ .+++.|||++..+.+.
T Consensus 277 ------f----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 ------F----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------H----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 2 45899999999999999888 9999999999877543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-11 Score=114.14 Aligned_cols=132 Identities=18% Similarity=0.183 Sum_probs=95.2
Q ss_pred cccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCcee-eEeeeeecCCeeEEEEEccCCCCH
Q 005040 432 CNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL-KILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
++.++.|.++.||+++.. ++.|++|+...... ....+..|+++++.+.+.+++ +++++.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 457899999999999874 77899998764432 123457799999998655543 4444433 335899999999887
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS-SAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 511 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.+. . ......+.+++++++.||.... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~----~-----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE----D-----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----c-----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 543 0 1122356789999999994321 12369999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.3e-10 Score=102.25 Aligned_cols=142 Identities=22% Similarity=0.279 Sum_probs=105.6
Q ss_pred ccccccccccEEEEEEEecCCCeEEEEE-echh----h---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 431 ECNLLGTGGFGSVYKGTLSDGTNVAIKI-FNLQ----L---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 431 ~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~----~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
....+.+|+-+.|+++.++ |+...||. +.+. . +-..++.++|++.+.+++--.|.-..-++.+...-+++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578899999999999984 66666663 3221 1 223456788999999997556655555566666678999
Q ss_pred EccCC-CCHHHHHhhCCCCC-CHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEEEeeeccccc
Q 005040 503 EFMPN-GSLEKWLYSHNYFL-DILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM---VAHVSDFGISKL 577 (717)
Q Consensus 503 e~~~~-g~L~~~l~~~~~~~-~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~ 577 (717)
||++| .++.+++......- ..+.....+..|-+.+.-|| ...|+||||+++||++.+++ .+.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH----~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH----DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh----hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 48889888543222 22333678899999999999 67899999999999997554 468999999865
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.5e-11 Score=133.18 Aligned_cols=113 Identities=38% Similarity=0.669 Sum_probs=104.0
Q ss_pred CCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEecc
Q 005040 214 YILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFS 293 (717)
Q Consensus 214 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 293 (717)
.++.|+|++|.+.+.+|..+..+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccc-ccccEEEccCCccccccc
Q 005040 294 NNNLSGKIPKSLEAL-SHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 294 ~N~~~~~~~~~~~~l-~~L~~L~l~~N~l~~~~p 326 (717)
+|++++.+|..+..+ .++..+++.+|+..|..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999988764 467889999998665444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.9e-10 Score=105.91 Aligned_cols=136 Identities=20% Similarity=0.201 Sum_probs=97.7
Q ss_pred ccccccccEEEEEEEecC-------CCeEEEEEechhh------------H----------HHHHH----HHHHHHHHHh
Q 005040 433 NLLGTGGFGSVYKGTLSD-------GTNVAIKIFNLQL------------E----------RAFRS----FDSECEILRN 479 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~----~~~e~~~l~~ 479 (717)
..||.|.-+.||.|...+ +..+|||+.+... + ..... ..+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999998543 4789999885321 0 01122 2379999999
Q ss_pred cCC--CceeeEeeeeecCCeeEEEEEccCCCCHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCCeEecCCC
Q 005040 480 VRH--RNLLKILGSCSNLDFKALVLEFMPNGSLEK-WLYSHNYFLDILQRLNIMIDVGSALEYL-HHCHSSAPIIHCDLK 555 (717)
Q Consensus 480 l~h--pniv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~~ivH~dlk 555 (717)
+.. -++...+++ ...++||||+.++.+.. .+++. .++......+..+++.++..+ | ..++||||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H----~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK----ECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH----hCCeecCCCC
Confidence 853 455666654 34589999997654321 22221 244556677889999999999 6 5689999999
Q ss_pred CCCeeeCCCCcEEEeeeccccccC
Q 005040 556 PTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 556 ~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+.||+++ ++.+.++|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.1e-11 Score=127.28 Aligned_cols=249 Identities=19% Similarity=0.169 Sum_probs=176.3
Q ss_pred HhccCCccccccccccEEEEEEEec--CCCeEEEEEechhhHHHHHH--HHHHHHHHHhc-CCCceeeEeeeeecCCeeE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS--DGTNVAIKIFNLQLERAFRS--FDSECEILRNV-RHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~ 499 (717)
-..+|..+..||.|.|+.|+....+ ++..+++|...........+ -..|+.+...+ .|.++++.+..+...+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3568889999999999999998744 67788988765443222222 24566666666 5899999888888888888
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecccccc
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLL 578 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~ 578 (717)
+--||++++++.....- ...+++..++++..|++.++.++| ++.++|+|+||+||++..+ +..+++|||.+..+
T Consensus 343 ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~----s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH----SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred CchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc----chhhhcccccccceeeccchhhhhcccccccccc
Confidence 99999999988776632 223677788889999999999999 7899999999999999886 88999999988643
Q ss_pred CCCCCceeeeccccCcccc--CCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 579 GEGEDSVIQTMTMATIGYM--APEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~--aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
.-. ......+-++. +|+......+..+.|+|+||.-+.|..+|..--... ..|.. +.
T Consensus 418 ~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------~~~~~---------i~ 476 (524)
T KOG0601|consen 418 AFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------VQSLT---------IR 476 (524)
T ss_pred cee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccc-------cccee---------ee
Confidence 111 11122233344 556666777889999999999999999887532110 01110 00
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
.... +........+..+...+...++..||.+.++....+-.+
T Consensus 477 ~~~~-------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 477 SGDT-------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cccc-------cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000 001111245678888999999999999988876655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.1e-10 Score=99.60 Aligned_cols=132 Identities=23% Similarity=0.298 Sum_probs=100.5
Q ss_pred ccccccccEEEEEEEecCCCeEEEEEechhh------H--HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL------E--RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..+++|+-+.+|.+.+. |.++++|.-.+.. . -.......|.+++++++--.|...+-+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999874 4446666432211 1 1234567899999999766665555566677778999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++|..|.+++... ...++..+-.-+.-|| ..+|+|+|++++||.+..+. +.++|||++...
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH----~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH----KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH----hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888865 2446677778888899 68999999999999998775 999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.5e-12 Score=137.95 Aligned_cols=253 Identities=22% Similarity=0.257 Sum_probs=175.1
Q ss_pred HHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe
Q 005040 422 IRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF 497 (717)
Q Consensus 422 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 497 (717)
.+...+.+.+.+.+.+|.++.++.+.-. .|...+.|+..... +...+....+-.++-..+||.++.....+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 3556678888889999999999988743 45444444432221 2223334444444444567888877776666777
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.++|++|+.+++|..-++..+. .+..........+.++.+||| +..+.|+|++|.|.+...+++.+++|||....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~----s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH----SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc----cchhhcccccccchhhcccCCcccCccccccc
Confidence 8999999999999999987653 444445556667888999999 56699999999999999999999999984332
Q ss_pred cCCC---------------------C--------CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCC
Q 005040 578 LGEG---------------------E--------DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKK 628 (717)
Q Consensus 578 ~~~~---------------------~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~ 628 (717)
.+.. . .........+|+.|.+||...+......+|+|+.|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2100 0 0011233468999999999999999999999999999999999999
Q ss_pred CCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHH
Q 005040 629 PTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMT 696 (717)
Q Consensus 629 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ 696 (717)
||....+... ++..+.+..+-...+...+....+++...+..+|.+|..|.
T Consensus 1034 p~na~tpq~~-----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI-----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhh-----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9976432211 11111110000111223345567888899999999998876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=7e-10 Score=109.19 Aligned_cols=143 Identities=20% Similarity=0.233 Sum_probs=109.7
Q ss_pred ccccccccEEEEEEEecCCCeEEEEEechhhH-HHHHHHHHHHHHHHhcCC--CceeeEeeeeecC---CeeEEEEEccC
Q 005040 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLE-RAFRSFDSECEILRNVRH--RNLLKILGSCSNL---DFKALVLEFMP 506 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~---~~~~lv~e~~~ 506 (717)
+.|+.|.++.||++...+|+.+++|+...... .....+..|.++++.+++ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999998765432 134567889999999975 3456777776654 25689999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH------------------------------------------ 544 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------ 544 (717)
|.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888765432 23677777788888888888888531
Q ss_pred ----------CCCCeEecCCCCCCeeeCC--CCcEEEeeeccccc
Q 005040 545 ----------SSAPIIHCDLKPTNILLDE--NMVAHVSDFGISKL 577 (717)
Q Consensus 545 ----------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~ 577 (717)
....++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245799999999999998 67789999997764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.6e-10 Score=130.95 Aligned_cols=275 Identities=23% Similarity=0.250 Sum_probs=171.2
Q ss_pred CCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCC--CcccCCcchhccccccceeeecCCcceecCCc
Q 005040 34 NLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNP--LGGILPPLIGNFSASLQNIYAFECKLGGSIPK 111 (717)
Q Consensus 34 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~ 111 (717)
+....+...+-+|.+..++... ..++|++|-+..|. +..+.++.|..+ +.|..|||++|.-.+.+|.
T Consensus 521 ~~~~~rr~s~~~~~~~~~~~~~----------~~~~L~tLll~~n~~~l~~is~~ff~~m-~~LrVLDLs~~~~l~~LP~ 589 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIEHIAGSS----------ENPKLRTLLLQRNSDWLLEISGEFFRSL-PLLRVLDLSGNSSLSKLPS 589 (889)
T ss_pred chhheeEEEEeccchhhccCCC----------CCCccceEEEeecchhhhhcCHHHHhhC-cceEEEECCCCCccCcCCh
Confidence 3466777788788777665432 44468888887775 553444444445 6688888887777778888
Q ss_pred cccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCc--ccCCccccCCC
Q 005040 112 EIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS--GAIPQCLASLT 189 (717)
Q Consensus 112 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~ 189 (717)
.++.|-+|++|+|++..+. .+|..+.+|+.|.+|++..+.-....+.....|++|++|.+..-... ...-..+.++.
T Consensus 590 ~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le 668 (889)
T KOG4658|consen 590 SIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLE 668 (889)
T ss_pred HHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhccc
Confidence 8888888888888888888 67888888888888888887766566777777888888888765422 11222334445
Q ss_pred CCCeEEecCccccCCCChhhhcccCCC----eEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccC------
Q 005040 190 SLRSLYLQSNKLSSSLPSSLWSLEYIL----RINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGT------ 259 (717)
Q Consensus 190 ~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~------ 259 (717)
.|+.+........ +-..+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++.+..........
T Consensus 669 ~L~~ls~~~~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~ 745 (889)
T KOG4658|consen 669 HLENLSITISSVL--LLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLC 745 (889)
T ss_pred chhhheeecchhH--hHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhh
Confidence 5555544333220 111223333333 3333333333 45567778888888888888886433222111
Q ss_pred CcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccc
Q 005040 260 LKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 260 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
+++|..+...++... ..+.+.--.++|+.|++..+.....+......+..++.+-+..+.+.+.
T Consensus 746 f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 746 FPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred HHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 334444444444332 2333334557888888888877766666677777777666666666554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.5e-10 Score=132.95 Aligned_cols=292 Identities=24% Similarity=0.261 Sum_probs=192.6
Q ss_pred CCCCCcEEECCCCcceecCCcCCCCCCCCCEEEccccc--ccCccCCcccccccccccCccCCcEEeccCCCCcccCCcc
Q 005040 10 NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNN--LTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPL 87 (717)
Q Consensus 10 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 87 (717)
+....+...+-+|.+. ..+....+ ++|++|-+..|. +..++.+ .|..++.|+.|||++|.=.+.+|..
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~--------ff~~m~~LrVLDLs~~~~l~~LP~~ 590 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGE--------FFRSLPLLRVLDLSGNSSLSKLPSS 590 (889)
T ss_pred chhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHH--------HHhhCcceEEEECCCCCccCcCChH
Confidence 4466778888888887 45554444 379999999996 6665543 2788999999999999877799999
Q ss_pred hhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcc--cccCCccccCCC
Q 005040 88 IGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNL--QGYVPHDLCHLE 165 (717)
Q Consensus 88 ~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i--~~~~~~~~~~l~ 165 (717)
++.+ -+|++|++++..+. .+|..+.+|+.|.+||+..+.-...++.....|.+|++|.+..... +...-..+.++.
T Consensus 591 I~~L-i~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le 668 (889)
T KOG4658|consen 591 IGEL-VHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLE 668 (889)
T ss_pred Hhhh-hhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhccc
Confidence 9998 68999999999999 8899999999999999998876556677777899999999877652 222333445555
Q ss_pred CCCEEeccCCcCcccCCccccCCCCCC----eEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccC------
Q 005040 166 RLNILNLSGNKLSGAIPQCLASLTSLR----SLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQK------ 235 (717)
Q Consensus 166 ~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~------ 235 (717)
+|+.|........ +-..+..++.|+ .+.+.++... ..+..+..+.+|+.|.+.++.+.......+..
T Consensus 669 ~L~~ls~~~~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~ 745 (889)
T KOG4658|consen 669 HLENLSITISSVL--LLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLC 745 (889)
T ss_pred chhhheeecchhH--hHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhh
Confidence 6666655443331 111123333333 4443333433 44566778889999999988886433322221
Q ss_pred CCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCC-CcccccccccccEE
Q 005040 236 LNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK-IPKSLEALSHLKQF 314 (717)
Q Consensus 236 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~-~~~~~~~l~~L~~L 314 (717)
++++..+.+.++..- ..+...--.++|+.|.+..++....+......+..+..+-+..+.+.+. .-.....++++..+
T Consensus 746 f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~ 824 (889)
T KOG4658|consen 746 FPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWL 824 (889)
T ss_pred HHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEec
Confidence 223333333333222 1233334468899999998887766666677777777766777777655 23444444444444
Q ss_pred Ecc
Q 005040 315 NVS 317 (717)
Q Consensus 315 ~l~ 317 (717)
.+.
T Consensus 825 ~l~ 827 (889)
T KOG4658|consen 825 PLS 827 (889)
T ss_pred ccC
Confidence 333
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.6e-11 Score=114.08 Aligned_cols=201 Identities=19% Similarity=0.152 Sum_probs=108.4
Q ss_pred cccCCCCCcEEEccCCCCcccCCc----cccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccC
Q 005040 112 EIGNLRGLIVLSLGFNDLNGTIPT----SIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLAS 187 (717)
Q Consensus 112 ~~~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 187 (717)
.+-.+++|+..+||+|.+....|. .+++-..|++|.|++|.+..+...-++.. |. .|..|+ -.++
T Consensus 87 aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigka--l~--~la~nK-------Kaa~ 155 (388)
T COG5238 87 ALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKA--LF--HLAYNK-------KAAD 155 (388)
T ss_pred HHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHH--HH--HHHHHh-------hhcc
Confidence 455566677777777666544433 33445556666666666553322222200 00 000000 0122
Q ss_pred CCCCCeEEecCccccCCCCh-----hhhcccCCCeEEccCCcCccc-----CCccccCCCCCCeEEccCCCCCCCC----
Q 005040 188 LTSLRSLYLQSNKLSSSLPS-----SLWSLEYILRINLSSNSLKGT-----LPSNIQKLNVLIDLDLSRNQLSSDI---- 253 (717)
Q Consensus 188 l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~~---- 253 (717)
-|.|+......|++.. .+. .+..-.+|+.+.+.+|.|.-. .--.+..+.+|+.|||.+|.++...
T Consensus 156 kp~Le~vicgrNRlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~L 234 (388)
T COG5238 156 KPKLEVVICGRNRLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYL 234 (388)
T ss_pred CCCceEEEeccchhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHH
Confidence 3556666666666552 222 222224666666666666521 1112355667778888888776432
Q ss_pred cccccCCcccccccccCccccCCCCccc------cccCccceEeccCCCCCCCCccc-----c--cccccccEEEccCCc
Q 005040 254 PSTIGTLKNLETLSLAGNQFQGPIPESV------GNLISLESLDFSNNNLSGKIPKS-----L--EALSHLKQFNVSHNR 320 (717)
Q Consensus 254 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~------~~l~~L~~L~L~~N~~~~~~~~~-----~--~~l~~L~~L~l~~N~ 320 (717)
...+..++.|++|.+..|-++.....++ ...|+|..|-+.+|-+.+-+-.. + .++|-|..|.++||+
T Consensus 235 a~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr 314 (388)
T COG5238 235 ADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNR 314 (388)
T ss_pred HHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCc
Confidence 3345667778888888887776555443 23577788888888665422111 1 246667777777777
Q ss_pred cccc
Q 005040 321 LEGE 324 (717)
Q Consensus 321 l~~~ 324 (717)
+...
T Consensus 315 ~~E~ 318 (388)
T COG5238 315 IKEL 318 (388)
T ss_pred chhH
Confidence 7654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.6e-10 Score=83.05 Aligned_cols=61 Identities=39% Similarity=0.516 Sum_probs=54.1
Q ss_pred CCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 12 TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 12 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
++|++|+|++|+|+.+.+..|.++++|++|++++|+|+.+++.+ |.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~--------f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDA--------FSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTT--------TTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHH--------HcCCCCCCEEeCcCCcC
Confidence 46889999999999888889999999999999999999888665 88999999999999975
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.3e-10 Score=83.13 Aligned_cols=57 Identities=33% Similarity=0.460 Sum_probs=22.2
Q ss_pred CcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCC
Q 005040 119 LIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGN 175 (717)
Q Consensus 119 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 175 (717)
|++|++++|+|+.+.++.|.++++|++|++++|.++.+.+..|.++++|++|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 333444444333333333333333333333333333333333333333333333333
|
... |
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-10 Score=109.71 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=160.9
Q ss_pred cCCCCCcEEECCCCcceecCC----cCCCCCCCCCEEEcccccccCccCCccc--ccccccccCccCCcEEeccCCCCcc
Q 005040 9 TNATKLIGLDLGLNSFSGHIP----NTFGNLRHLSVLSLMMNNLTTESSSADQ--WSFLSSLTNCRNLANLALASNPLGG 82 (717)
Q Consensus 9 ~~l~~L~~L~L~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~~~~~~l~~l~~L~~L~L~~N~l~~ 82 (717)
..+..++.+|||+|-|...-. +.+.+-.+|+..+++.-...-....... --++..+.++++|+..+||.|.++.
T Consensus 27 ~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~ 106 (388)
T COG5238 27 EMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGS 106 (388)
T ss_pred HhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCc
Confidence 346677777888887764433 3344556677776665433322111100 0123445677788888888887776
Q ss_pred cCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcccc
Q 005040 83 ILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC 162 (717)
Q Consensus 83 ~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~ 162 (717)
..|+.+..+ +++-+.|..|.|++|.+.-..-..++. .|. .|..|+- ..
T Consensus 107 ~~~e~L~d~---------------------is~~t~l~HL~l~NnGlGp~aG~rigk--al~--~la~nKK-------aa 154 (388)
T COG5238 107 EFPEELGDL---------------------ISSSTDLVHLKLNNNGLGPIAGGRIGK--ALF--HLAYNKK-------AA 154 (388)
T ss_pred ccchHHHHH---------------------HhcCCCceeEEeecCCCCccchhHHHH--HHH--HHHHHhh-------hc
Confidence 666555443 566789999999999987332222221 111 1222221 23
Q ss_pred CCCCCCEEeccCCcCcccCCc-----cccCCCCCCeEEecCccccCCC-----ChhhhcccCCCeEEccCCcCccc----
Q 005040 163 HLERLNILNLSGNKLSGAIPQ-----CLASLTSLRSLYLQSNKLSSSL-----PSSLWSLEYILRINLSSNSLKGT---- 228 (717)
Q Consensus 163 ~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~---- 228 (717)
+-+.|++..+..|++.. .+. .|..-.+|+++.+..|.|.... -..+..+.+|+.|||.+|-++..
T Consensus 155 ~kp~Le~vicgrNRlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~ 233 (388)
T COG5238 155 DKPKLEVVICGRNRLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRY 233 (388)
T ss_pred cCCCceEEEeccchhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHH
Confidence 44678888888888763 222 2333357888888888877221 11334567888889998888732
Q ss_pred CCccccCCCCCCeEEccCCCCCCCCcccc----c--CCcccccccccCccccCCCCcc-----c--cccCccceEeccCC
Q 005040 229 LPSNIQKLNVLIDLDLSRNQLSSDIPSTI----G--TLKNLETLSLAGNQFQGPIPES-----V--GNLISLESLDFSNN 295 (717)
Q Consensus 229 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~----~--~l~~L~~L~l~~N~l~~~~~~~-----~--~~l~~L~~L~L~~N 295 (717)
+...++.++.|++|.+.+|-++......+ . ..++|+.|-..+|.+.+.+... + .++|-|..|.+.+|
T Consensus 234 La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngN 313 (388)
T COG5238 234 LADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGN 313 (388)
T ss_pred HHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccC
Confidence 34466778889999999999886554433 1 2688999999999876543322 1 46788889999999
Q ss_pred CCC
Q 005040 296 NLS 298 (717)
Q Consensus 296 ~~~ 298 (717)
+|.
T Consensus 314 r~~ 316 (388)
T COG5238 314 RIK 316 (388)
T ss_pred cch
Confidence 987
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=6.7e-08 Score=97.29 Aligned_cols=265 Identities=11% Similarity=0.068 Sum_probs=162.1
Q ss_pred ccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeee------e-ecCCeeEEEE
Q 005040 431 ECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGS------C-SNLDFKALVL 502 (717)
Q Consensus 431 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~------~-~~~~~~~lv~ 502 (717)
..+.||+|+-+.+|-.--- +. .+.|++.........+ .++.|... .||-+-.-+.| - .......+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4567999999999964321 11 2457776443211111 23334443 46543321111 0 1123356777
Q ss_pred EccCCC-CHHHHHh-----hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 503 EFMPNG-SLEKWLY-----SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 503 e~~~~g-~L~~~l~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..+.+. ....+.. +.-....|....+.+..++.+.+.|| ..|.+-||+.++|+|+++++.|.|.|-..-.
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH----~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH----EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH----hcCCcccccCccceeeecCceEEEEccccee
Confidence 777653 2222222 11234689999999999999999999 6789999999999999999999999866544
Q ss_pred ccCCCCCceeeeccccCccccCCCc-----cCCCCcCcccchhhHHHHHHHHHhC-CCCCCccccCc---chHH-HHHHh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEY-----GSEGIVSTKCDVYSYGVLLMETFTE-KKPTDEMFTGE---MSLR-RWVKE 646 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~-----~~~~~~~~~~Dvws~G~il~el~tg-~~p~~~~~~~~---~~~~-~~~~~ 646 (717)
... ........+|...|.+||. ..+...+...|-|.+|+++++++.| ++||.+..... ..+. +....
T Consensus 166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 331 1223445678999999994 3344567789999999999999886 99997632110 0111 11100
Q ss_pred hCCCchhhhccccc-hhhhhhhhhhHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHHHHhHHhhcc
Q 005040 647 SLPHRLTEVVDANL-VREEQAFSDKMDCLFSIMDLALDCCMDT--PHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 647 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~--P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
.+ ...-+..- ....+..+...-.+.++..+..+|+... +.-|||++..+..|.+++++...
T Consensus 243 ~f----~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 243 RF----AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred ee----eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 00 00000000 0011112222344566778888888765 45799999999999999887654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.2e-11 Score=126.88 Aligned_cols=127 Identities=32% Similarity=0.338 Sum_probs=59.3
Q ss_pred CCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcc-cccCCccccccccc
Q 005040 191 LRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPS-TIGTLKNLETLSLA 269 (717)
Q Consensus 191 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~ 269 (717)
|...+.++|.+. ..-..+.-++.|+.|+|++|+++.. +.+..++.|++|||++|.+.. +|. ...++. |+.|+++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhhh-heeeeec
Confidence 444444455444 3333444444555555555555422 244555555555555555543 222 122222 5555555
Q ss_pred CccccCCCCccccccCccceEeccCCCCCCC-CcccccccccccEEEccCCccccc
Q 005040 270 GNQFQGPIPESVGNLISLESLDFSNNNLSGK-IPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 270 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~-~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
+|-++. -..+.++.+|+.||+++|-|.+- .-..+..+..|+.|+|.|||+++.
T Consensus 241 nN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 241 NNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 555542 12344555555555555554431 112234455556666666666553
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.2e-08 Score=91.96 Aligned_cols=125 Identities=23% Similarity=0.266 Sum_probs=81.7
Q ss_pred EEEEEEecCCCeEEEEEechhh--------------------------HHHHHHHHHHHHHHHhcCCC--ceeeEeeeee
Q 005040 442 SVYKGTLSDGTNVAIKIFNLQL--------------------------ERAFRSFDSECEILRNVRHR--NLLKILGSCS 493 (717)
Q Consensus 442 ~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~hp--niv~~~~~~~ 493 (717)
.||.|...+|..+|||+.+... ........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999875321 01123467899999999755 456666553
Q ss_pred cCCeeEEEEEccC--CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 005040 494 NLDFKALVLEFMP--NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY-LHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570 (717)
Q Consensus 494 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 570 (717)
..++||||++ |..+..+.... ++......++.+++..+.. +| ..+++|||+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~----~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH----KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH----CTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH----hcCceecCCChhhEEeecc-eEEEE
Confidence 2389999998 54554433221 1123345567777775555 46 6799999999999999988 99999
Q ss_pred eecccccc
Q 005040 571 DFGISKLL 578 (717)
Q Consensus 571 Dfgl~~~~ 578 (717)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.5e-07 Score=97.38 Aligned_cols=167 Identities=20% Similarity=0.217 Sum_probs=126.3
Q ss_pred cEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec----CCeeEEEEEccCC-CCHHHH
Q 005040 440 FGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN----LDFKALVLEFMPN-GSLEKW 513 (717)
Q Consensus 440 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~~~~-g~L~~~ 513 (717)
..+.|++... ||..|++|+++............-++.++++.|+|+|++.+++.. ...+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4588999865 899999999954433332233456888999999999999998752 3467899999876 466654
Q ss_pred Hhh--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 514 LYS--------------HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 514 l~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
--. .+...++...|.++.|+..||.++| +.|...+-|.+.+|+++.+.+++|+.-|....+.
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH----ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH----SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH----hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 321 1334788999999999999999999 6789999999999999999999998877766554
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCC
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p 629 (717)
.... |-+.+ -.+-|.=.+|.+++.|.||..-
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 3321 11111 2357999999999999999653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.2e-08 Score=95.72 Aligned_cols=138 Identities=14% Similarity=0.079 Sum_probs=96.7
Q ss_pred ccccccEEEEEEEecCCCeEEEEEechhh-HH----------HHHHHHHHHHHHHhcCCCc--eeeEeeeeec-----CC
Q 005040 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQL-ER----------AFRSFDSECEILRNVRHRN--LLKILGSCSN-----LD 496 (717)
Q Consensus 435 lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~----------~~~~~~~e~~~l~~l~hpn--iv~~~~~~~~-----~~ 496 (717)
+-......|++... +|+.|.||...... .+ ....+.+|.+.+.++..-+ ....+++.+. ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333345667666 57889999764322 11 1113678888888884332 2333444432 23
Q ss_pred eeEEEEEccCCC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-------CCcE
Q 005040 497 FKALVLEFMPNG-SLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-------NMVA 567 (717)
Q Consensus 497 ~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-------~~~~ 567 (717)
..++|+|++++. +|.+++... ....+...+..++.+++..+.-|| ..||+|+|++++|||++. ++.+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH----~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH----AAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCccCCCChhhEEEeccccCCCCCceE
Confidence 568999999876 899998642 223456677789999999999999 689999999999999985 4689
Q ss_pred EEeeeccccc
Q 005040 568 HVSDFGISKL 577 (717)
Q Consensus 568 kl~Dfgl~~~ 577 (717)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998754
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.8e-10 Score=119.76 Aligned_cols=127 Identities=29% Similarity=0.298 Sum_probs=74.0
Q ss_pred CCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEcc
Q 005040 166 RLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLS 245 (717)
Q Consensus 166 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 245 (717)
.|.+.+.+.|.+. .....+.-++.|+.|+|++|+++.. +.+..++.|++|||++|.+....--...++. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4566666666666 4445555566666667777766643 2566666666777777766632222222333 6666677
Q ss_pred CCCCCCCCcccccCCcccccccccCccccCCC-CccccccCccceEeccCCCCC
Q 005040 246 RNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI-PESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 246 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~~~ 298 (717)
+|.++.. ..+.++.+|+.||+++|-|.+.- -..++.+..|+.|+|.+|++-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 6666632 23556666666777776665422 122345566666677777664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-09 Score=92.65 Aligned_cols=134 Identities=24% Similarity=0.290 Sum_probs=91.0
Q ss_pred CCCeEEecCccccCCCChhhh---cccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccc
Q 005040 190 SLRSLYLQSNKLSSSLPSSLW---SLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETL 266 (717)
Q Consensus 190 ~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 266 (717)
.+..++|+.|++- .+++... ....|+.++|++|.+....+..-..++.++.|+|++|.|++ +|..+..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisd-vPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISD-VPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhh-chHHHhhhHHhhhc
Confidence 3556677777665 3344333 34456666788888875444444566678888888888884 77778888888888
Q ss_pred cccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc
Q 005040 267 SLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 267 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 327 (717)
++++|++. ..|..+..+.+|-.|+..+|.+. .+|..+-.-......++.+++|.+..+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 88888887 67777777888888888888777 4444333333444556677777776664
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.3e-09 Score=100.06 Aligned_cols=79 Identities=16% Similarity=0.227 Sum_probs=43.3
Q ss_pred CCCCeEEccCCCCCCCCc-ccccCCcccccccccCccccCCC-CccccccCccceEeccCCCCCCCCcc------ccccc
Q 005040 237 NVLIDLDLSRNQLSSDIP-STIGTLKNLETLSLAGNQFQGPI-PESVGNLISLESLDFSNNNLSGKIPK------SLEAL 308 (717)
Q Consensus 237 ~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~~~~~~~~------~~~~l 308 (717)
+++..+.+..|.+...-. ..+..++.+.-|+|+.|+|..-. .+++.+++.|..|.+++|++.+..-. .++.+
T Consensus 199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL 278 (418)
T KOG2982|consen 199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARL 278 (418)
T ss_pred ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeec
Confidence 445555555555543221 23344566666677777665321 24556667777777777776543221 24566
Q ss_pred ccccEEE
Q 005040 309 SHLKQFN 315 (717)
Q Consensus 309 ~~L~~L~ 315 (717)
++++.|+
T Consensus 279 ~~v~vLN 285 (418)
T KOG2982|consen 279 TKVQVLN 285 (418)
T ss_pred cceEEec
Confidence 7777654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.9e-07 Score=89.62 Aligned_cols=135 Identities=22% Similarity=0.212 Sum_probs=95.7
Q ss_pred CCccccccccccEEEEEEEecCCCeEEEEEechhh----------------------HHHHHHHHHHHHHHHhcCCC--c
Q 005040 429 FNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL----------------------ERAFRSFDSECEILRNVRHR--N 484 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~hp--n 484 (717)
..+...||-|.-+.||.|..+.|.++|||.=+... .-......+|.++|+.|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34567899999999999999999999999432110 11234567899999999655 6
Q ss_pred eeeEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC
Q 005040 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN 564 (717)
Q Consensus 485 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~ 564 (717)
+.+.+++ +...+|||+++|-.|...- ++......++..|++-+.-.- ..||||+|+.+-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~----~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY----RRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH----HcCccccCCchheEEEecC
Confidence 6666654 4458999999986665421 122333334444444444443 3579999999999999999
Q ss_pred CcEEEeeeccccc
Q 005040 565 MVAHVSDFGISKL 577 (717)
Q Consensus 565 ~~~kl~Dfgl~~~ 577 (717)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999975543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1e-08 Score=109.78 Aligned_cols=151 Identities=19% Similarity=0.268 Sum_probs=103.2
Q ss_pred HHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce-------eeeccccCccccCCCcc
Q 005040 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV-------IQTMTMATIGYMAPEYG 602 (717)
Q Consensus 530 ~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-------~~~~~~~t~~y~aPE~~ 602 (717)
+.+++.|+.|+|. +-++||++|.|++|.++.++..||+.|+++.-........ ..........|.|||++
T Consensus 105 l~~v~dgl~flh~---sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHR---SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhcc---CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3445699999996 6789999999999999999999999999987654422111 11112346679999999
Q ss_pred CCCCcCcccchhhHHHHHHHHHhCCCC-CCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHH
Q 005040 603 SEGIVSTKCDVYSYGVLLMETFTEKKP-TDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLA 681 (717)
Q Consensus 603 ~~~~~~~~~Dvws~G~il~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 681 (717)
.+...+.++|+||+|+++|.+..|..+ +.. ....... ..... ..+ . ..+......+.++.+-+
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~-~~~~~--~~~------~------~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSY-SFSRN--LLN------A------GAFGYSNNLPSELRESL 245 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhc-cCCcchh-hhhhc--ccc------c------ccccccccCcHHHHHHH
Confidence 998899999999999999999965554 332 1111111 10000 000 0 01111134567788999
Q ss_pred hhccCCCCCCCCCHHHHH
Q 005040 682 LDCCMDTPHKRIHMTDAA 699 (717)
Q Consensus 682 ~~cl~~~P~~Rpt~~ev~ 699 (717)
.+++..++..||++.++.
T Consensus 246 ~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHhcCCcccCcchhhhh
Confidence 999999999999776654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.5e-08 Score=95.58 Aligned_cols=187 Identities=22% Similarity=0.244 Sum_probs=99.9
Q ss_pred cCCCCEEeccCCcccc--cCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCcccc-CCCChhhhcccCCC
Q 005040 140 LQQLQGFYVPENNLQG--YVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLS-SSLPSSLWSLEYIL 216 (717)
Q Consensus 140 l~~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~ 216 (717)
.+.++.|+|.+|.|+. .+...+.+||.|++|+|+.|++...+...-..+.+|+.|-|.+..+. ......+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 4455666666666652 12223455666666666666665433222134456666666666554 22233445556666
Q ss_pred eEEccCCcCcccC--CccccCC-CCCCeEEccCCCCCC--CCcccccCCcccccccccCccccCCCC-ccccccCccceE
Q 005040 217 RINLSSNSLKGTL--PSNIQKL-NVLIDLDLSRNQLSS--DIPSTIGTLKNLETLSLAGNQFQGPIP-ESVGNLISLESL 290 (717)
Q Consensus 217 ~L~l~~N~l~~~~--~~~~~~l-~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L 290 (717)
.|.||.|.+.... .+..... +.++.|++..|.... ..-..-.-++++..+-+..|++..... ..+..++.+-.|
T Consensus 150 elHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~L 229 (418)
T KOG2982|consen 150 ELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCL 229 (418)
T ss_pred hhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhh
Confidence 6666666433110 0011111 123333333332210 000011235677788888888765443 234566777788
Q ss_pred eccCCCCCCC-CcccccccccccEEEccCCccccccc
Q 005040 291 DFSNNNLSGK-IPKSLEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 291 ~L~~N~~~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p 326 (717)
+|+.|+|..- --+.+.+++.|..|.+.+||+...+-
T Consensus 230 nL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~ 266 (418)
T KOG2982|consen 230 NLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLR 266 (418)
T ss_pred hhcccccccHHHHHHHcCCchhheeeccCCccccccc
Confidence 8888888642 23567788888888888888865443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 717 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-35 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-28 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-08 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-28 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-27 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-13 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 8e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 9e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 9e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-05 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-05 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 329 bits (847), Expect = e-102
Identities = 107/366 (29%), Positives = 162/366 (44%), Gaps = 18/366 (4%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G IP +++N ++L+ L L N SG IP++ G+L L L L +N L
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE--------GEIP 459
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
L + L L L N L G +P + N + +L I +L G IPK IG L L +
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L L N +G IP +G + L + N G +P + ++ N ++G
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKR 574
Query: 182 PQCLASLTSLRSLYLQSN--KLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVL 239
+ + + + N + L L N++S G +
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634
Query: 240 IDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG 299
+ LD+S N LS IP IG++ L L+L N G IP+ VG+L L LD S+N L G
Sbjct: 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDG 694
Query: 300 KIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQD 359
+IP+++ AL+ L + ++S+N L G IP G F+ F + N LCG P +P C
Sbjct: 695 RIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS 751
Query: 360 NRKRTN 365
N
Sbjct: 752 NADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 2e-82
Identities = 103/331 (31%), Positives = 151/331 (45%), Gaps = 20/331 (6%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNT-FGNLRHLSVLSLMMNNLTTESSSADQWSF 60
G IP L L L N F+G IP+ G L+ L L N+ +
Sbjct: 261 GPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG--------AV 310
Query: 61 LSSLTNCRNLANLALASNPLGGILPP-LIGNFSASLQNIYAFECKLGGSIPKEIGNLRG- 118
+C L +LAL+SN G LP + L+ + + G +P+ + NL
Sbjct: 311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMR-GLKVLDLSFNEFSGELPESLTNLSAS 369
Query: 119 LIVLSLGFNDLNGTIPTSIG--TLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNK 176
L+ L L N+ +G I ++ LQ Y+ N G +P L + L L+LS N
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429
Query: 177 LSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKL 236
LSG IP L SL+ LR L L N L +P L ++ + + L N L G +PS +
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 237 NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNN 296
L + LS N+L+ +IP IG L+NL L L+ N F G IP +G+ SL LD + N
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549
Query: 297 LSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327
+G IP ++ S ++ N + G+ V
Sbjct: 550 FNGTIPAAMFKQS----GKIAANFIAGKRYV 576
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 1e-80
Identities = 107/350 (30%), Positives = 153/350 (43%), Gaps = 29/350 (8%)
Query: 2 GTIP--NSITNATKLIGLDLGLNSFSGHIP-NTFGNLRHLSVLSLMMNNLTTE-SSSADQ 57
G + S+ + + L L++ N+ + L L VL L N+++
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173
Query: 58 WSFLSSLT----------------NCRNLANLALASNPLGGILPPLIGNFSASLQNIYAF 101
L C NL L ++SN +P +G+ S +LQ++
Sbjct: 174 SDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP-FLGDCS-ALQHLDIS 231
Query: 102 ECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL 161
KL G + I L +L++ N G IP L+ LQ + EN G +P L
Sbjct: 232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFL 289
Query: 162 CH-LERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLP-SSLWSLEYILRIN 219
+ L L+LSGN GA+P S + L SL L SN S LP +L + + ++
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349
Query: 220 LSSNSLKGTLPSNIQKLNV-LIDLDLSRNQLSSDIPSTIG--TLKNLETLSLAGNQFQGP 276
LS N G LP ++ L+ L+ LDLS N S I + L+ L L N F G
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 277 IPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
IP ++ N L SL S N LSG IP SL +LS L+ + N LEGEIP
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 4e-80
Identities = 101/330 (30%), Positives = 147/330 (44%), Gaps = 16/330 (4%)
Query: 2 GTIPNSIT-NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
G IP+ ++ L GLDL N F G +P FG+ L L+L NN + E
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM------ 336
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGN--LRG 118
+L R L L L+ N G LP + N SASL + G I +
Sbjct: 337 -DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 119 LIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS 178
L L L N G IP ++ +L ++ N L G +P L L +L L L N L
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV 238
G IPQ L + +L +L L N L+ +PS L + + I+LS+N L G +P I +L
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
L L LS N S +IP+ +G ++L L L N F G IP ++ S + N ++
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIA 571
Query: 299 GKIPKSLEALSHLKQFNVSHN--RLEGEIP 326
GK ++ K+ + + N +G
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRS 601
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 2e-76
Identities = 90/332 (27%), Positives = 151/332 (45%), Gaps = 20/332 (6%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
+ +S+ + T L L L + +G + F L+ L L N+L+ ++ L
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTT------L 119
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI---GNLRG 118
+SL +C L L ++SN L G SL+ + + G+
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179
Query: 119 LIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS 178
L L++ N ++G + + L+ V NN +P L L L++SGNKLS
Sbjct: 180 LKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLS 236
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKGTLPSNIQ-KL 236
G + +++ T L+ L + SN+ +P SL+Y ++L+ N G +P +
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQY---LSLAENKFTGEIPDFLSGAC 293
Query: 237 NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP-ESVGNLISLESLDFSNN 295
+ L LDLS N +P G+ LE+L+L+ N F G +P +++ + L+ LD S N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 296 NLSGKIPKSLEALS-HLKQFNVSHNRLEGEIP 326
SG++P+SL LS L ++S N G I
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-72
Identities = 87/329 (26%), Positives = 143/329 (43%), Gaps = 28/329 (8%)
Query: 10 NATKLIGLDL---GLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTN 66
K+ +DL LN + ++ +L L L L +++ +S
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN---------GSVSGFKC 98
Query: 67 CRNLANLALASNPLGGILPPL--IGNFSASLQNIYAFECKLGGSIPKEIG-NLRGLIVLS 123
+L +L L+ N L G + L +G+ S L+ + L G L L VL
Sbjct: 99 SASLTSLDLSRNSLSGPVTTLTSLGSCS-GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD 157
Query: 124 LGFNDLNGTIPTSI---GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L N ++G +L+ + N + G V + L L++S N S
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG 215
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP-SNIQKLNVL 239
IP L ++L+ L + NKLS ++ + + +N+SSN G +P ++ L
Sbjct: 216 IPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQY- 273
Query: 240 IDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
L L+ N+ + +IP + G L L L+GN F G +P G+ LESL S+NN S
Sbjct: 274 --LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331
Query: 299 GKIPK-SLEALSHLKQFNVSHNRLEGEIP 326
G++P +L + LK ++S N GE+P
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFNEFSGELP 360
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-33
Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 16/176 (9%)
Query: 162 CHLERLNILNLSGNKLS---GAIPQCLASLTSLRSLYLQSNKLSSSLPS--SLWSLEYIL 216
C +++ ++LS L+ A+ L SLT L SL+L ++ ++ S+ SL
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTS-- 104
Query: 217 RINLSSNSLKGTLPS--NIQKLNVLIDLDLSRNQLSSDIPSTIGT-LKNLETLSLAGNQF 273
++LS NSL G + + ++ + L L++S N L + G L +LE L L+ N
Sbjct: 105 -LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163
Query: 274 QGPIPESV---GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
G L+ L S N +SG + + +L+ +VS N IP
Sbjct: 164 SGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-16
Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 239 LIDLDLSRNQLSSD---IPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNN 295
+ +DLS L+ + S++ +L LE+L L+ + G + SL SLD S N
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRN 110
Query: 296 NLSGKIP--KSLEALSHLKQFNVSHNRLEGEIPVKGSFK 332
+LSG + SL + S LK NVS N L+ V G K
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK 149
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-08
Identities = 17/74 (22%), Positives = 34/74 (45%), Gaps = 1/74 (1%)
Query: 258 GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVS 317
+ +++ S N + S+ +L LESL SN++++G + + + L ++S
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 318 HNRLEGEIPVKGSF 331
N L G + S
Sbjct: 109 RNSLSGPVTTLTSL 122
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-89
Identities = 101/305 (33%), Positives = 150/305 (49%), Gaps = 14/305 (4%)
Query: 398 RSTKHLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIK 457
S +L P R +D+ AT+ F+ L+G G FG VYKG L DG VA+K
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 458 IFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLY-- 515
+ + F++E E L RH +L+ ++G C + L+ ++M NG+L++ LY
Sbjct: 70 RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 516 -SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574
+ QRL I I L YLH + IIH D+K NILLDEN V ++DFGI
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDFGI 185
Query: 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMF 634
SK E + + + T+ T+GY+ PEY +G ++ K DVYS+GV+L E + +
Sbjct: 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 635 -TGEMSLRRWVKESLPHR-LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKR 692
++L W ES + L ++VD NL + + L D A+ C + R
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADK---IR--PESLRKFGDTAVKCLALSSEDR 300
Query: 693 IHMTD 697
M D
Sbjct: 301 PSMGD 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 1e-88
Identities = 96/358 (26%), Positives = 139/358 (38%), Gaps = 64/358 (17%)
Query: 4 IPNSITNATKL----IGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWS 59
I + N T L D ++ G + +T ++ L L NL +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK------PYP 67
Query: 60 FLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGL 119
SSL N L L + L G IP I L L
Sbjct: 68 IPSSLANLPYLNFLYIGGIN------------------------NLVGPIPPAIAKLTQL 103
Query: 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
L + +++G IP + ++ L L+ S N LSG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLV------------------------TLDFSYNALSG 139
Query: 180 AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILR-INLSSNSLKGTLPSNIQKLNV 238
+P ++SL +L + N++S ++P S S + + +S N L G +P LN
Sbjct: 140 TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN- 198
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
L +DLSRN L D G+ KN + + LA N + VG +L LD NN +
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIY 257
Query: 299 GKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPC 356
G +P+ L L L NVS N L GEIP G+ + F +Y N LCG P +P C
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 5e-86
Identities = 106/295 (35%), Positives = 155/295 (52%), Gaps = 23/295 (7%)
Query: 415 RRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAF-----RS 469
+R S +++ A+D F+ N+LG GGFG VYKG L+DGT VA+K +L+
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK----RLKEERTQGGELQ 73
Query: 470 FDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLY---SHNYFLDILQR 526
F +E E++ HRNLL++ G C + LV +M NGS+ L LD +R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 527 LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586
I + L YLH H IIH D+K NILLDE A V DFG++KL+ D+ +
Sbjct: 134 QRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DTHV 191
Query: 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE---MSLRRW 643
T TIG++APEY S G S K DV+ YGV+L+E T ++ D + L W
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 644 VKESLPH-RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTD 697
VK L +L +VD +L + + D+ + ++ +AL C +P +R M++
Sbjct: 252 VKGLLKEKKLEALVDVDL---QGNYKDE--EVEQLIQVALLCTQSSPMERPKMSE 301
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 3e-76
Identities = 87/319 (27%), Positives = 148/319 (46%), Gaps = 28/319 (8%)
Query: 404 DHEDFLPPATRRRT-SYLDIRRATDEFNE------CNLLGTGGFGSVYKGTLSDGTNVAI 456
+++ TR + S+ +++ T+ F+E N +G GGFG VYKG + + T VA+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 457 KIFNLQLERA----FRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEK 512
K ++ + FD E +++ +H NL+++LG S+ D LV +MPNGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 513 WLYSHNYF--LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570
L + L R I + + +LH IH D+K NILLDE A +S
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHE----NHHIHRDIKSANILLDEAFTAKIS 175
Query: 571 DFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPT 630
DFG+++ + +V+ + + T YMAPE G ++ K D+YS+GV+L+E T
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 631 DEMFTGEMSLRRWVKESL--PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDT 688
DE L +E + + +D + + ++ +A C +
Sbjct: 235 DEHR-EPQLLLDIKEEIEDEEKTIEDYIDKKM----NDAD--STSVEAMYSVASQCLHEK 287
Query: 689 PHKRIHMTDAAAKLRKIKA 707
+KR + L+++ A
Sbjct: 288 KNKRPDIKKVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-65
Identities = 64/306 (20%), Positives = 117/306 (38%), Gaps = 22/306 (7%)
Query: 418 SYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEIL 477
++ + + G FG V+K L VA+KIF +Q +++++ + E L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYSL 72
Query: 478 RNVRHRNLLKILGSCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533
++H N+L+ +G+ L+ F GSL +L + + +I +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETM 130
Query: 534 GSALEYLHHCHSSA------PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587
L YLH I H D+K N+LL N+ A ++DFG++ G+ +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 588 TMTMATIGYMAPEYGSEGI-----VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRR 642
+ T YMAPE I + D+Y+ G++L E + D M
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 643 WVKESLP--HRLTEVVDANLVREE-QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAA 699
P + EVV R + + K + + + +C R+
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 700 AKLRKI 705
++ ++
Sbjct: 311 ERITQM 316
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-64
Identities = 57/349 (16%), Positives = 116/349 (33%), Gaps = 29/349 (8%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
T N L +++ +P L + ++++ N + D W L
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 62 SSLTNCRNLANLALASNPL-GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ + + + N L + + L + +L G +P G+ L
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK-KLGMLECLYNQLEGKLP-AFGSEIKLA 356
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPH-DLCHLERLNILNLSGNKLSG 179
L+L +N + G +Q++ N L+ D + ++ ++ S N++
Sbjct: 357 SLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS 416
Query: 180 -------AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG----- 227
+ ++ S+ L +N++S + + INL N L
Sbjct: 417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476
Query: 228 --TLPSNIQKLNVLIDLDLSRNQLSSDIPSTI--GTLKNLETLSLAGNQFQGPIPESVGN 283
N + +L +DL N+L+ + TL L + L+ N F P N
Sbjct: 477 LKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534
Query: 284 LISLESL------DFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
+L+ D N + P+ + L Q + N + +
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VN 582
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-57
Identities = 56/343 (16%), Positives = 117/343 (34%), Gaps = 51/343 (14%)
Query: 2 GTIPNSITNATKLIGLDLGLNSF-SGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
K+ + +G N+ + + + ++ L +L + N L
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE---------GK 345
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPK--EIGNLRG 118
L + + LA+L LA N + I G ++N+ KL IP + ++
Sbjct: 346 LPAFGSEIKLASLNLAYNQITEIPANFCGFTE-QVENLSFAHNKLK-YIPNIFDAKSVSV 403
Query: 119 LIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS 178
+ + +N++ + L ++ +NLS N++S
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPL-----------------DPTPFKGINVSSINLSNNQIS 446
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSS-------SLPSSLWSLEYILRINLSSNSLKGTLPS 231
+ ++ + L S+ L N L+ + + + I+L N L L
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSD 505
Query: 232 NIQ--KLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSL------AGNQFQGPIPESVGN 283
+ + L L+ +DLS N S P+ L+ + GN+ PE +
Sbjct: 506 DFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL 564
Query: 284 LISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
SL L +N++ + + + ++ ++ N
Sbjct: 565 CPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-57
Identities = 58/348 (16%), Positives = 122/348 (35%), Gaps = 44/348 (12%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
+I S K + N+ + + L L + + E+
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAEN--------- 222
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
C N N L ++ + C +P + L + +
Sbjct: 223 ----ICEAWENENSEYAQQYKTEDLKWDNLK-DLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 122 LSLGFNDL--------NGTIPTSIGTLQQLQGFYVPENNLQ-GYVPHDLCHLERLNILNL 172
+++ N + +++Q Y+ NNL+ V L +++L +L
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337
Query: 173 SGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWS-LEYILRINLSSNSLKGTLPS 231
N+L G +P S L SL L N++ + +P++ E + ++ + N LK +P+
Sbjct: 338 LYNQLEGKLP-AFGSEIKLASLNLAYNQI-TEIPANFCGFTEQVENLSFAHNKLK-YIPN 394
Query: 232 N--IQKLNVLIDLDLSRNQLSS-------DIPSTIGTLKNLETLSLAGNQFQGPIPESVG 282
+ ++V+ +D S N++ S + T N+ +++L+ NQ E
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 283 NLISLESLDFSNNNLSG-------KIPKSLEALSHLKQFNVSHNRLEG 323
L S++ N L+ ++ + L ++ N+L
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-55
Identities = 54/330 (16%), Positives = 110/330 (33%), Gaps = 22/330 (6%)
Query: 7 SITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTN 66
S+ + ++ GL L SG +P+ G L L VL+L + ++
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL----FGPKGISA 131
Query: 67 CRNLANLALASNPLGGILPPLIGNFSAS-LQNIYAFECKLGGSIPKEIGNLRGLIVLSLG 125
+ S L SI K +
Sbjct: 132 NMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQL 191
Query: 126 FNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCL 185
N++ + ++ L +L+ FY+ + E N +
Sbjct: 192 SNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKW 245
Query: 186 ASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK--------GTLPSNIQKLN 237
+L L + + + + LP+ L +L + IN++ N ++
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 238 VLIDLDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNN 296
+ + + N L + + +++ +K L L NQ +G +P G+ I L SL+ + N
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQ 364
Query: 297 LSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
++ ++ + +HN+L+ IP
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLK-YIP 393
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 4e-48
Identities = 45/294 (15%), Positives = 92/294 (31%), Gaps = 24/294 (8%)
Query: 50 TESSSADQWSFLS--SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIY----AFEC 103
+ D W SL + + L+L G +P IG + L+ + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT-ELEVLALGSHGEKV 119
Query: 104 KLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIG--TLQQLQGFYVPENNLQGYVPHDL 161
PK I T L + + Q +
Sbjct: 120 NERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
Query: 162 CHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLS 221
+ + N ++ + + + LT LR Y+ ++ + W E N
Sbjct: 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE-----NSE 233
Query: 222 SNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQF-------- 273
T L L D+++ + +P+ + L ++ +++A N+
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293
Query: 274 QGPIPESVGNLISLESLDFSNNNL-SGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
++ + NNL + + SL+ + L +N+LEG++P
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 7e-38
Identities = 36/239 (15%), Positives = 75/239 (31%), Gaps = 12/239 (5%)
Query: 103 CKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQG----YVP 158
G + + + LSL +G +P +IG L +L+ + + + + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 159 HDLCHLERLNILNLSGNKLSGAIPQCLA--SLTSLRSLYLQSNKLSSSLPSSLWSLEYIL 216
+ + L + S+ S+ S
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 217 RINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP 276
+I SN++ + + +L L + + ++ +N E
Sbjct: 187 QIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT----- 240
Query: 277 IPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFS 335
NL L ++ N K+P L+AL ++ NV+ NR +K ++ +
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 44/267 (16%), Positives = 82/267 (30%), Gaps = 26/267 (9%)
Query: 3 TIPNSI-TNATKLIGLDLGLNSFSGHIPNTF--GNLRHLSVLSLMMNNLTTESSSADQWS 59
IP + ++ L N IPN F ++ +S + N + +
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD-P 424
Query: 60 FLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGG-------SIPKE 112
+ N++++ L++N + L S L +I L +
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGS-PLSSINLMGNMLTEIPKNSLKDENEN 483
Query: 113 IGNLRGLIVLSLGFNDLNGTIPTSI--GTLQQLQGFYVPENNLQGYVPHDLCHLERL--- 167
N L + L FN L + TL L G + N+ P + L
Sbjct: 484 FKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGF 541
Query: 168 ---NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNS 224
N + GN+ P+ + SL L + SN + + + I +++ N
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNP 598
Query: 225 LKGTLPSNIQKLNVLIDLDLSRNQLSS 251
S + L ++
Sbjct: 599 NISIDLSYVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 29/198 (14%), Positives = 49/198 (24%), Gaps = 41/198 (20%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSG-------HIPNTFGNLRHLSVLSLMMNNLTTESSS 54
+ + L ++L N + F N L+ + L N LT S
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDD 506
Query: 55 ADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSA-----SLQNIYAFECKLGGSI 109
T L + L+ N P N S A +
Sbjct: 507 F-------RATTLPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558
Query: 110 PKEIGNLRGLIVLSLGFND---------------------LNGTIPTSIGTLQQLQGFYV 148
P+ I L L +G ND + + + + +
Sbjct: 559 PEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNPNISIDLSYVCPYIEAGMYML 618
Query: 149 PENNLQGYVPHDLCHLER 166
+ Q D ++R
Sbjct: 619 FYDKTQDIRGCDALDIKR 636
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-61
Identities = 75/301 (24%), Positives = 130/301 (43%), Gaps = 54/301 (17%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQ-------LERAFRSFDSECEILR 478
+E +G GGFG V+KG + D + VAIK L + F+ F E I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 479 NVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALE 538
N+ H N++K+ G + +V+EF+P G L L + + +L +M+D+ +E
Sbjct: 79 NLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDE-----NMVAHVSDFGISKLLGEGEDSVIQTMTMA- 592
Y+ + + PI+H DL+ NI L + A V+DFG+S+ + +++
Sbjct: 137 YMQNQNP--PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSVSGLL 187
Query: 593 -TIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE--- 646
+MAPE E + K D YS+ ++L T + P DE G++ ++E
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247
Query: 647 --SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704
++P DC + ++ C P KR H + +L +
Sbjct: 248 RPTIPE---------------------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
Query: 705 I 705
+
Sbjct: 287 L 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-60
Identities = 75/288 (26%), Positives = 112/288 (38%), Gaps = 35/288 (12%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
E ++G G FG V K +VAIK + ER ++F E L V H N++
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHN--YFLDILQRLNIMIDVGSALEYLHHCH 544
K+ G+C N LV+E+ GSL L+ + ++ + + YLH
Sbjct: 65 KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 545 SSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGEDSVIQTMTMA--TIGYMAPEY 601
+IH DLKP N+LL V + DFG + + MT + +MAPE
Sbjct: 123 PK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-------THMTNNKGSAAWMAPEV 174
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
S KCDV+S+G++L E T +KP DE+ + V R
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT--RPP-------- 224
Query: 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709
+ I L C P +R M + + + F
Sbjct: 225 -----LIK--NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-60
Identities = 81/334 (24%), Positives = 137/334 (41%), Gaps = 44/334 (13%)
Query: 401 KHLDHEDFLPPATRRRTSYLDIRRATD---------EFNECNLLGTGGFGSVYKGTLSDG 451
KH H + T L + A D + N +G G FG+V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 452 TNVAIKIFNLQ--LERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGS 509
++VA+KI Q F E I++ +RH N++ +G+ + ++V E++ GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 510 LEKWLYSHN--YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVA 567
L + L+ LD +RL++ DV + YLH+ + PI+H +LK N+L+D+
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP--PIVHRNLKSPNLLVDKKYTV 178
Query: 568 HVSDFGISKLLGEGEDSVIQTMTMA-TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTE 626
V DFG+S+L S + + A T +MAPE + + K DVYS+GV+L E T
Sbjct: 179 KVCDFGLSRLKASTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 627 KKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL---VREEQAFSDKMDCLFSIMDLALD 683
++P + ++ V + + + +
Sbjct: 236 QQPWGNLNPAQVVA-------------AVGFKCKRLEIPR--------NLNPQVAAIIEG 274
Query: 684 CCMDTPHKRIHMTDAAAKLRKIKAKFLDDVAASS 717
C + P KR LR + + S
Sbjct: 275 CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 4e-59
Identities = 69/304 (22%), Positives = 127/304 (41%), Gaps = 28/304 (9%)
Query: 410 PPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAF 467
+R +I + +G+G FG+VYKG +VA+K+ N+ +
Sbjct: 9 HHGSRDAADDWEIPD--GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQL 64
Query: 468 RSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL 527
++F +E +LR RH N+L +G + A+V ++ SL L++ ++ + +
Sbjct: 65 QAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLI 123
Query: 528 NIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587
+I ++YLH + IIH DLK NI L E+ + DFG++ S
Sbjct: 124 DIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 588 TMTMATIGYMAPE---YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWV 644
+I +MAPE S + DVY++G++L E T + P + + +
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239
Query: 645 KESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRK 704
+ SL L++V +C + L +C +R A++ +
Sbjct: 240 RGSLSPDLSKVRS--------------NCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
Query: 705 IKAK 708
+ +
Sbjct: 286 LARE 289
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 7e-58
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 18/215 (8%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRN 484
+ N L G ++KG G ++ +K+ ++ R R F+ EC LR H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 485 LLKILGSCSN--LDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLH 541
+L +LG+C + L+ +MP GSL L+ N+ +D Q + +D+ + +LH
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE- 600
I L ++++DE+M A +S + S M ++APE
Sbjct: 129 TL--EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179
Query: 601 --YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
E D++S+ VLL E T + P ++
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-56
Identities = 74/299 (24%), Positives = 116/299 (38%), Gaps = 42/299 (14%)
Query: 420 LDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQ----LERAFRSFDSECE 475
L+I E ++G GGFG VY+ G VA+K + + + E +
Sbjct: 2 LEIDF--AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 476 ILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGS 535
+ ++H N++ + G C LV+EF G L + L + +N + +
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIAR 116
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDE--------NMVAHVSDFGISKLLGEGEDSVIQ 587
+ YL H + PIIH DLK +NIL+ + N + ++DFG+++
Sbjct: 117 GMNYL-HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----- 170
Query: 588 TMTMA-TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE 646
M+ A +MAPE + S DV+SYGVLL E T + P + ++
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------ 224
Query: 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
V L C L DC PH R T+ +L I
Sbjct: 225 -------GVAMNKL-ALPIP----STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 8e-56
Identities = 69/300 (23%), Positives = 114/300 (38%), Gaps = 36/300 (12%)
Query: 422 IRRATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNV 480
R + E +LG G FG K T G + +K E R+F E +++R +
Sbjct: 7 FRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 481 RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
H N+LK +G + E++ G+L + S + QR++ D+ S + YL
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV---------IQTMTM 591
H + IIH DL N L+ EN V+DFG+++L+ + + +
Sbjct: 125 HSMN----IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 592 ATIG---YMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL 648
+G +MAPE + K DV+S+G++L E + M V+ L
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240
Query: 649 PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708
+C S + + CC P KR L ++
Sbjct: 241 --DRYCP---------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 58/296 (19%), Positives = 108/296 (36%), Gaps = 39/296 (13%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRN 484
++ L+G G FG VY G G VAI++ +++ E ++F E R RH N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++ +G+C + A++ +L + LD+ + I ++ + YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--- 147
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA---TIGYMAPE- 600
+ I+H DLK N+ D V ++DFG+ + G + + + ++APE
Sbjct: 148 -AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 601 --------YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652
+ S DV++ G + E + P +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--------------PAEAI 251
Query: 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708
+ + ++ I D+ L C +R T L K+ +
Sbjct: 252 IWQMGTGMKPNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 76/320 (23%), Positives = 132/320 (41%), Gaps = 37/320 (11%)
Query: 417 TSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEI 476
+ + D L+G G +G+VYKG+L D VA+K+F+ + +F +E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 477 --LRNVRHRNLLKILGSCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILQRLNI 529
+ + H N+ + + + LV+E+ PNGSL K+L H D + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116
Query: 530 MIDVGSALEYLH-----HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL------ 578
V L YLH H I H DL N+L+ + +SDFG+S L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 579 GEGEDSVIQTMTMATIGYMAPEYGSEGI-------VSTKCDVYSYGVLLMETF---TEKK 628
GE+ + TI YMAPE + + D+Y+ G++ E F T+
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 629 PTDEMFTGEMSLRRWVKESLP-HRLTEVVDANLVREE--QAFSDKMDCLFSIMDLALDCC 685
P + + +M+ + V + +V R + +A+ + + S+ + DC
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 686 MDTPHKRIHMTDAAAKLRKI 705
R+ A ++ ++
Sbjct: 297 DQDAEARLTAQXAEERMAEL 316
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 1e-55
Identities = 70/340 (20%), Positives = 117/340 (34%), Gaps = 27/340 (7%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P+ + + L+L N F L+ L + N ++
Sbjct: 18 QVPDDLPTNITV--LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL------- 68
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L L L N L + + +L ++ + + LI L
Sbjct: 69 -CQKLPMLKVLNLQHNELSQLSDKTFAFCT-NLTELHLMSNSIQKIKNNPFVKQKNLITL 126
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL--CHLERLNILNLSGNKLSGA 180
L N L+ T + L+ LQ + N +Q +L L L LS N++
Sbjct: 127 DLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEF 186
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSL---WSLEYILRINLSSNSLKGTLPSNIQKLN 237
P C ++ L L+L + +L SL L + I ++LS++ L T + L
Sbjct: 187 SPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246
Query: 238 V--LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNN 295
L LDLS N L+ + L LE L N Q S+ L ++ L+ +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 296 ---------NLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
+L S + L L+ N+ N + G
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-55
Identities = 72/353 (20%), Positives = 131/353 (37%), Gaps = 25/353 (7%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
+ T ++L LD+G N+ S P L L VL+L N L+ S
Sbjct: 39 RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDK------- 91
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+ C NL L L SN + I +L + L + L L
Sbjct: 92 -TFAFCTNLTELHLMSNSIQKIKNNPFVKQK-NLITLDLSHNGLSSTKLGTQVQLENLQE 149
Query: 122 LSLGFNDLNGTIPTSIGTLQ--QLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
L L N + + L+ + N ++ + P + RL L L+ +L
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP 209
Query: 180 AIPQCLA---SLTSLRSLYLQSNKLSSSLPSSLWSLEY--ILRINLSSNSLKGTLPSNIQ 234
++ + L + TS+R+L L +++LS++ ++ L++ + ++LS N+L +
Sbjct: 210 SLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA 269
Query: 235 KLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGN---------QFQGPIPESVGNLI 285
L L L N + ++ L N+ L+L + S L
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329
Query: 286 SLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQS 338
LE L+ +N++ G L +LK ++S++ +F +
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-53
Identities = 67/381 (17%), Positives = 126/381 (33%), Gaps = 38/381 (9%)
Query: 2 GTIPNSITNATKL---------IGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTES 52
+S+ + + L S +F L+ L L++ N++
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345
Query: 53 SSADQWSFLSSLTNCRNLANLALASNPLGGILPP---LIGNFSASLQNIYAFECKLGGSI 109
S+ T NL L+L+++ + + L + + K+
Sbjct: 346 SNM--------FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE 397
Query: 110 PKEIGNLRGLIVLSLGFNDLNGTIP-TSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLN 168
L L VL LG N++ + L+ + Y+ N + + L
Sbjct: 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 169 ILNLSGNKLSG--AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSL- 225
L L L + P L +L L L +N +++ L LE + ++L N+L
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 226 -------KGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP 278
G ++ L+ L L+L N L L+ + L N
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 279 ESVGNLISLESLDFSNNNLSGKIPKSLE-ALSHLKQFNVSHNRLEGEIPVKGSFKDF--- 334
N +SL+SL+ N ++ K A +L + ++ N + F ++
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637
Query: 335 --SAQSYFGNYALCG-PPRLQ 352
+ ++ LC PP
Sbjct: 638 THTNIPELSSHYLCNTPPHYH 658
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-48
Identities = 73/345 (21%), Positives = 120/345 (34%), Gaps = 29/345 (8%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
P L L+L N S TF +L+ L LM N++ ++
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP------ 116
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIG--NLRGL 119
+NL L L+ N L +LQ + K+ +E+ L
Sbjct: 117 --FVKQKNLITLDLSHNGLSSTKLGTQVQLE-NLQELLLSNNKIQALKSEELDIFANSSL 173
Query: 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC---HLERLNILNLSGNK 176
L L N + P + +L G ++ L + LC + L+LS ++
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 177 LSGAIPQCLASL--TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQ 234
LS L T+L L L N L+ S L + L N+++ ++
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
Query: 235 KLNVLIDLDLSRN---------QLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI 285
L + L+L R+ L + LK LE L++ N G LI
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353
Query: 286 SLESLDFSNNNLSGKIPKSLE----ALSHLKQFNVSHNRLEGEIP 326
+L+ L SN+ S + + A S L N++ N++
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-47
Identities = 66/317 (20%), Positives = 111/317 (35%), Gaps = 19/317 (5%)
Query: 17 LDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALA 76
D + + N+ L+L N L + ++ T L +L +
Sbjct: 9 ADCSHLKLTQVPDDLPTNITV---LNLTHNQLRRLPA--------ANFTRYSQLTSLDVG 57
Query: 77 SNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTS 136
N + + P L L+ + +L K L L L N +
Sbjct: 58 FNTISKLEPELCQKLP-MLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
Query: 137 IGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASL--TSLRSL 194
+ L + N L LE L L LS NK+ + L +SL+ L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176
Query: 195 YLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQ---KLNVLIDLDLSRNQLSS 251
L SN++ P ++ + + L++ L +L + + +L LS +QLS+
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236
Query: 252 DIPSTIGTLK--NLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALS 309
+T LK NL L L+ N +S L LE NN+ SL L
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296
Query: 310 HLKQFNVSHNRLEGEIP 326
+++ N+ + + I
Sbjct: 297 NVRYLNLKRSFTKQSIS 313
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 9e-42
Identities = 52/253 (20%), Positives = 88/253 (34%), Gaps = 9/253 (3%)
Query: 90 NFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVP 149
+ ++ + +L L L +GFN ++ P L L+ +
Sbjct: 22 DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81
Query: 150 ENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSL 209
N L L L+L N + +L +L L N LSS+ +
Sbjct: 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141
Query: 210 WSLEYILRINLSSNSLKGTLPSNIQKLN--VLIDLDLSRNQLSSDIPSTIGTLKNLETLS 267
LE + + LS+N ++ + L L+LS NQ+ P + L L
Sbjct: 142 VQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLF 201
Query: 268 LAGNQFQGPIPESVG---NLISLESLDFSNNNLSGKIPKSLEAL--SHLKQFNVSHNRLE 322
L Q + E + S+ +L SN+ LS + L ++L ++S+N L
Sbjct: 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261
Query: 323 GEIPVKGSFKDFS 335
SF
Sbjct: 262 VVGN--DSFAWLP 272
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 47/188 (25%), Positives = 71/188 (37%), Gaps = 7/188 (3%)
Query: 150 ENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSL 209
L VP DL + +LNL+ N+L + L SL + N +S P
Sbjct: 13 HLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC 69
Query: 210 WSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLA 269
L + +NL N L L +L L N + + KNL TL L+
Sbjct: 70 QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLS 129
Query: 270 GNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEAL--SHLKQFNVSHNRLEGEIPV 327
N + L +L+ L SNN + + L+ S LK+ +S N+++ P
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP- 188
Query: 328 KGSFKDFS 335
G F
Sbjct: 189 -GCFHAIG 195
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-19
Identities = 44/250 (17%), Positives = 74/250 (29%), Gaps = 55/250 (22%)
Query: 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
+ + P+ L LDL N+ + + L L +L L NNL A+
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ L +L L L SN I + +L L
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEI-------------------------PVEVFKDLFELK 563
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
++ LG N+LN + L+ LNL N ++
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLK------------------------SLNLQKNLITSV 599
Query: 181 IPQCLA-SLTSLRSLYLQSNKLSSSLPSSLWSLEYI----LRINLSSNSLKGTLPSNIQK 235
+ + +L L ++ N + S W + +I I S+ P +
Sbjct: 600 EKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHG 659
Query: 236 LNVLIDLDLS 245
+ D S
Sbjct: 660 FP-VRLFDTS 668
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-53
Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 32/296 (10%)
Query: 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEI--LRNVRHRNLLKILG 490
+G G +G V++G+ G NVA+KIF+ + E+ S+ E E+ +RH N+L +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69
Query: 491 SCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH----H 542
S + L+ + GSL +L LD + L I++ + S L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA--TIGYMAPE 600
I H DLK NIL+ +N ++D G++ + + + + T YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 601 ------YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654
+ D++++G++L E + + + E
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP---FYDVVPNDPSFE 244
Query: 655 VVDANLVREEQ-----AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+ + ++Q L S+ L +C P R+ L KI
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 7e-53
Identities = 63/303 (20%), Positives = 106/303 (34%), Gaps = 32/303 (10%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEI--LRNVRHRN 484
+ +G G +G V+ G G VA+K+F S+ E EI +RH N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHEN 92
Query: 485 LLKILGSCSNLDFK----ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
+L + + L+ ++ NGSL +L + LD L + S L +L
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHL 150
Query: 541 H----HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA--TI 594
H I H DLK NIL+ +N ++D G++ + V T
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 595 GYMAPE------YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL 648
YM PE + D+YS+G++L E + ++ +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP---YHDLVP 267
Query: 649 PHRLTEVVDANLVREEQ-----AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703
E + + ++ +CL + L +C P R+ L
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 704 KIK 706
K+
Sbjct: 328 KMS 330
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-51
Identities = 62/331 (18%), Positives = 114/331 (34%), Gaps = 25/331 (7%)
Query: 4 IPNSITNATKLIGLDLGLNS---FSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
+++ L + L + I + F L ++S SL+ +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER---------- 296
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ + +L L + G + + L G +L L
Sbjct: 297 VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK-RLTFTS-----NKGGNAFSEVDLPSLE 350
Query: 121 VLSLGFNDLN--GTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS 178
L L N L+ G S L+ + N + + + LE+L L+ + L
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409
Query: 179 GAIPQ-CLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKL 236
SL +L L + + L + + ++ NS + +I +L
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 237 NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNN 296
L LDLS+ QL P+ +L +L+ L+++ N F L SL+ LD+S N+
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 297 LSGKIPKSLEAL-SHLKQFNVSHNRLEGEIP 326
+ + L+ S L N++ N
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 5e-49
Identities = 68/356 (19%), Positives = 120/356 (33%), Gaps = 39/356 (10%)
Query: 1 MGTIPNSITNATKLIGLDLGLNSFSGHIP-NTFGNLRHLSVLSLMMNNLTT----ESSSA 55
M I +L L L N S ++ L L V L++ E
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 56 DQWSFLSSLT---------------------NCRNLANLALASNPLGGILPPLIGNFSAS 94
L +LT N+++ +L S + + +++
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD---FSYNFG 305
Query: 95 LQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQ 154
Q++ CK G ++ +L+ L F G S L L+ + N L
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360
Query: 155 --GYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW-S 211
G L L+LS N + + L L L Q + L S++ S
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 212 LEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPS-TIGTLKNLETLSLAG 270
L ++ +++S + L+ L L ++ N + L+NL L L+
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 271 NQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
Q + P + +L SL+ L+ S+NN + L+ L+ + S N +
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-43
Identities = 61/329 (18%), Positives = 105/329 (31%), Gaps = 42/329 (12%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+ L+L F +L+ L+ S N
Sbjct: 295 ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF------------- 341
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
S + +L L L+ N L G + L L
Sbjct: 342 SEVDLPSLEFLDLSRNGLSFK-----------------------GCCSQSDFGTTSLKYL 378
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD-LCHLERLNILNLSGNKLSGAI 181
L FN + T+ ++ L+QL+ +NL+ L L L++S A
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 182 PQCLASLTSLRSLYLQSNKLSSSL-PSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
L+SL L + N + P L + ++LS L+ P+ L+ L
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI-SLESLDFSNNNLSG 299
L++S N S L +L+ L + N + + + SL L+ + N+ +
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
Query: 300 KIPKS--LEALSHLKQFNVSHNRLEGEIP 326
L+ + +Q V R+E P
Sbjct: 558 TCEHQSFLQWIKDQRQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-41
Identities = 71/337 (21%), Positives = 121/337 (35%), Gaps = 29/337 (8%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
IP+++ +TK LDL N +F + L VL L + T A
Sbjct: 22 IPDNLPFSTKN--LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA-------- 71
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLS 123
+ +L+ L L NP+ + S SLQ + A E L IG+L+ L L+
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 124 LGFNDLNGT-IPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNI----LNLSGNKLS 178
+ N + +P L L+ + N +Q DL L ++ + L+LS N ++
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLP-------SSLWSLEYILRINLSSNSLKGTLPS 231
P + L L L++N S ++ + L +L + +L+ S
Sbjct: 191 FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 232 NIQKLNVLIDLDLSRNQLS---SDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLE 288
++ L L + L DI L N+ + SL + S +
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQ 307
Query: 289 SLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEI 325
L+ N L++L L + E+
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-38
Identities = 64/345 (18%), Positives = 108/345 (31%), Gaps = 32/345 (9%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
S + +L LDL + +L HLS L L N + + + A
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA------ 95
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKL-GGSIPKEIGNLRGLI 120
+ +L L L + IG+ +L+ + + +P+ NL L
Sbjct: 96 --FSGLSSLQKLVAVETNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVP----ENNLQGYVPHDLCHLERLNILNLSGNK 176
L L N + T + L Q+ + N + P + RL+ L L N
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNF 211
Query: 177 LSGAIPQ-CLASLTSLRSLYLQSNKLSSSL------PSSLWSLE--YILRINLSSNSLK- 226
S + + C+ L L L + + S+L L I L+
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 227 GTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLIS 286
+ L + L + + + L L +F L S
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPT---LKLKS 326
Query: 287 LESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSF 331
L+ L F++N S L L+ ++S N L + S
Sbjct: 327 LKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-36
Identities = 52/232 (22%), Positives = 87/232 (37%), Gaps = 9/232 (3%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
IP + L L FN L S + +LQ + +Q L L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
+ L L+GN + + L+SL+ L L+S + L+ + +N++ N ++
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 228 T-LPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLE----TLSLAGNQFQGPIPESVG 282
LP L L LDLS N++ S + + L + +L L+ N I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197
Query: 283 NLISLESLDFSNNNLSGKIPK-SLEALSHLKQFNVSHNRLEGEIPVKGSFKD 333
I L L NN S + K ++ L+ L+ + E ++ K
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 56/248 (22%), Positives = 89/248 (35%), Gaps = 14/248 (5%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
G S T L LDL N + + F L L L +NL S
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE-------F 414
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLI 120
S + RNL L ++ + S SL+ + + +I LR L
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLS-SLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L L L PT+ +L LQ + NN L L +L+ S N + +
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533
Query: 181 IPQCLASL-TSLRSLYLQSNKLSSSLPSS--LWSLEYILRINLSSNSLKGTLPSNIQKLN 237
Q L +SL L L N + + L ++ ++ + ++ PS+ Q +
Sbjct: 534 KKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
Query: 238 VLIDLDLS 245
VL L+++
Sbjct: 594 VL-SLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 34/167 (20%), Positives = 68/167 (40%), Gaps = 5/167 (2%)
Query: 161 LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINL 220
+ + + IP L S ++L L N L S +S + ++L
Sbjct: 4 VEVVPNI-TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 221 SSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPES 280
S ++ Q L+ L L L+ N + S L +L+ L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 281 VGNLISLESLDFSNNNL-SGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
+G+L +L+ L+ ++N + S K+P+ L++L+ ++S N+++
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-50
Identities = 64/390 (16%), Positives = 130/390 (33%), Gaps = 54/390 (13%)
Query: 1 MGTIPNSITNATKLIGLDLGLNSFSG---------HIPNTFGNLRHLSVLSLMMNNLTTE 51
M +P+ + + +L L++ N + + + + + NNL
Sbjct: 504 MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEF 563
Query: 52 SSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPK 111
+SA SL L L N + + G L ++ ++ IP+
Sbjct: 564 PASA-------SLQKMVKLGLLDCVHNKVRHL--EAFGTNV-KLTDLKLDYNQI-EEIPE 612
Query: 112 EIG-NLRGLIVLSLGFNDLNGTIP--TSIGTLQQLQGFYVPENNLQGYVPH-----DLCH 163
+ + L N L IP + ++ + N + + D
Sbjct: 613 DFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671
Query: 164 LERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSS-------SLPSSLWSLEYIL 216
+ + LS N++ + A+ + + ++ L +N ++S + + +
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731
Query: 217 RINLSSNSLKGTLPSNIQ--KLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSL------ 268
I+L N L +L + + L L ++D+S N SS P+ L+ +
Sbjct: 732 TIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA 789
Query: 269 AGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK 328
GN+ P + SL L +N++ K+ + L L +++ N I V
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNI-SIDVT 845
Query: 329 GSFKDFSAQSYF----GNYALCGPPRLQVP 354
A Y + G L +
Sbjct: 846 SVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-48
Identities = 54/349 (15%), Positives = 113/349 (32%), Gaps = 49/349 (14%)
Query: 6 NSITNATKLIGLDLGLNSFSGH------IPNTFGNLRHLSVLSLMMNNLTTESSSADQWS 59
+ K + L I L L ++ + T
Sbjct: 412 PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFT---------- 461
Query: 60 FLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGL 119
+ + N L ++ + C +P + +L L
Sbjct: 462 ---YDNIAVDWEDANSDYAKQYENEELSWSNLK-DLTDVELYNCPNMTQLPDFLYDLPEL 517
Query: 120 IVLSLGFNDLNG---------TIPTSIGTLQQLQGFYVPENNLQGY-VPHDLCHLERLNI 169
L++ N + T ++Q FY+ NNL+ + L + +L +
Sbjct: 518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
Query: 170 LNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWS-LEYILRINLSSNSLKGT 228
L+ NK+ + + L L L N++ +P + + + + S N LK
Sbjct: 578 LDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-Y 633
Query: 229 LPS--NIQKLNVLIDLDLSRNQLSSDIPST-----IGTLKNLETLSLAGNQFQGPIPESV 281
+P+ N + + V+ +D S N++ S+ + N T++L+ N+ Q E
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693
Query: 282 GNLISLESLDFSNNNLS-------GKIPKSLEALSHLKQFNVSHNRLEG 323
+ ++ SNN ++ + + L ++ N+L
Sbjct: 694 ATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 5e-48
Identities = 65/355 (18%), Positives = 114/355 (32%), Gaps = 50/355 (14%)
Query: 6 NSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLT 65
A + + ++ NL+ L+ + L T+ L
Sbjct: 461 TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD--------FLY 512
Query: 66 NCRNLANLALASNPLGGI---------LPPLIGNFSASLQNIYAFECKLGGSIPKE--IG 114
+ L +L +A N L +Q Y L P +
Sbjct: 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP-KIQIFYMGYNNLE-EFPASASLQ 570
Query: 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC-HLERLNILNLS 173
+ L +L N + + GT +L + N ++ +P D C +++ L S
Sbjct: 571 KMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFS 627
Query: 174 GNKLSGAIPQC--LASLTSLRSLYLQSNKLSSSLPSSLWSLEYIL-----RINLSSNSLK 226
NKL IP S+ + S+ NK+ S + S++ + LS N ++
Sbjct: 628 HNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686
Query: 227 GTLPSNIQKLNVLIDLDLSRNQLSS-------DIPSTIGTLKNLETLSLAGNQFQGPIPE 279
+ + + LS N ++S L T+ L N+ + +
Sbjct: 687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSD 745
Query: 280 S--VGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSH------NRLEGEIP 326
L L ++D S N S P S LK F + H NR+ + P
Sbjct: 746 DFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 7e-48
Identities = 68/359 (18%), Positives = 107/359 (29%), Gaps = 44/359 (12%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWS-- 59
+ N ++ GL L G +P+ G L L VLS ++ T
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELT 372
Query: 60 ------------------FLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAF 101
FL L A N + P + +
Sbjct: 373 PDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGN 432
Query: 102 ECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL 161
I K I L L ++ +
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-----YAKQYENEELSW 487
Query: 162 CHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSS---------SLPSSLWSL 212
+L+ L + L +P L L L+SL + N+ S L +
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547
Query: 213 EYILRINLSSNSLKGTLPSN--IQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAG 270
I + N+L+ P++ +QK+ L LD N++ GT L L L
Sbjct: 548 PKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTDLKLDY 604
Query: 271 NQFQGPIPESVG-NLISLESLDFSNNNLSGKIPKSLEA--LSHLKQFNVSHNRLEGEIP 326
NQ + IPE +E L FS+N L IP A + + + S+N++ E
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGR 661
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 2e-39
Identities = 44/325 (13%), Positives = 98/325 (30%), Gaps = 32/325 (9%)
Query: 17 LDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALA 76
+ L+ + N ++ LSL ++ L L+
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP--------DAIGQLTELKVLSFG 355
Query: 77 SNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIG----NLRGLIVLSLGFNDLNGT 132
++ L G+ + + ++ K L +L N
Sbjct: 356 THSETV-SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM 414
Query: 133 IPTSIGTLQQLQGFYV-PENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSL 191
P + L+ + N ++ + L +L I+ + + +
Sbjct: 415 KPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDW 469
Query: 192 RSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS 251
K + S +L+ + + L + LP + L L L+++ N+ S
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 252 ---------DIPSTIGTLKNLETLSLAGNQFQG-PIPESVGNLISLESLDFSNNNLSGKI 301
+ T ++ + N + P S+ ++ L LD +N +
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--H 587
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIP 326
++ L + +N++E EIP
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIE-EIP 611
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-32
Identities = 46/298 (15%), Positives = 105/298 (35%), Gaps = 24/298 (8%)
Query: 51 ESSSADQWSFLSSLTNCR-NLANLALASNP-LGGILPPLIGNFSASLQNIYAFECKLGGS 108
E+ W + S N + N + G P + + + + + G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 109 IPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD-LCHLERL 167
+P IG L L VLS G + + ++ ++ + L + +RL
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 168 NILNLSGNKLSG---AIPQCLASLTSLRSLYLQ--SNKLSSSLPSSLWSLEYILRINLSS 222
N+ +L + ++ P S SL+ + +N+++ + ++ L + I ++
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFAN 457
Query: 223 NSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVG 282
+ + + + + + + LK+L + L +P+ +
Sbjct: 458 SPFTY-DNIAVDWED----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY 512
Query: 283 NLISLESLDFSNNNLSG---------KIPKSLEALSHLKQFNVSHNRLEGEIPVKGSF 331
+L L+SL+ + N ++ + ++ F + +N LE E P S
Sbjct: 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL 569
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-49
Identities = 63/294 (21%), Positives = 112/294 (38%), Gaps = 26/294 (8%)
Query: 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEI--LRNVRHRNLLKILG 490
+G G FG V++G G VA+KIF+ + ER S+ E EI +RH N+L +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103
Query: 491 SCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH----H 542
+ + + LV ++ +GSL +L + Y + + + + + S L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA--TIGYMAPE 600
I H DLK NIL+ +N ++D G++ D++ T YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 601 ------YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP-HRLT 653
+ D+Y+ G++ E ++ V +
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 654 EVVDANLVR-EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706
+VV +R + L + + +C R+ L ++
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 58/333 (17%), Positives = 111/333 (33%), Gaps = 30/333 (9%)
Query: 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
MG+ + +++ L ++ + + ++W
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR------------NRWHS 48
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNF-SASLQNIYAFECKLGGSIPKEIGNLRGL 119
N N L L+ + + L P + L L
Sbjct: 49 AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106
Query: 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
+++ L +P ++ L+ + N L+ +P + L RL L++
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164
Query: 180 AIPQCLAS---------LTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP 230
+P+ LAS L +L+SL L+ + S LP+S+ +L+ + + + ++ L L
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALG 222
Query: 231 SNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAG-NQFQGPIPESVGNLISLES 289
I L L +LDL + P G L+ L L + +P + L LE
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEK 281
Query: 290 LDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
LD ++P + L V +
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 61/321 (19%), Positives = 109/321 (33%), Gaps = 35/321 (10%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+ ++ + D + N + + + L +
Sbjct: 27 PYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRTGRALK---------ATAD 73
Query: 63 SLTNCR--NLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
L + L L S PL P S LQ++ L +P + GL
Sbjct: 74 LLEDATQPGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLE 130
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC---------HLERLNILN 171
L+L N L +P SI +L +L+ + +P L L L L
Sbjct: 131 TLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLR 189
Query: 172 LSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPS 231
L + ++P +A+L +L+SL ++++ LS+ L ++ L + ++L + P
Sbjct: 190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP 247
Query: 232 NIQKLNVLIDLDLS-RNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESL 290
L L L + L + +P I L LE L L G +P + L + +
Sbjct: 248 IFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306
Query: 291 DFSNN---NLSGKIPKSLEAL 308
+ L P + A
Sbjct: 307 LVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-32
Identities = 44/246 (17%), Positives = 84/246 (34%), Gaps = 21/246 (8%)
Query: 92 SASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPEN 151
S+ +N+Y + + Q
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66
Query: 152 NLQGYVPHDL--CHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSL 209
L+ L L L L P L+ L+ + + + L LP ++
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTM 123
Query: 210 WSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIG---------TL 260
+ + L+ N L+ LP++I LN L +L + +++P + L
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 261 KNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNR 320
NL++L L + +P S+ NL +L+SL N+ LS + ++ L L++ ++
Sbjct: 183 VNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCT 240
Query: 321 LEGEIP 326
P
Sbjct: 241 ALRNYP 246
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-44
Identities = 66/335 (19%), Positives = 117/335 (34%), Gaps = 16/335 (4%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
+ + L LDL +TF + L L L N L + +A
Sbjct: 49 QNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETA-------- 100
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLS 123
L+ + L +L + I + N +L+++Y + + L VL
Sbjct: 101 LSGPKALKHLFFIQTGISSIDFIPLHNQK-TLESLYLGSNHISSIKLPKGFPTEKLKVLD 159
Query: 124 LGFNDLNGTIPTSIGTLQQLQGFYVPENNLQ-GYVPHDLCHLERLNILNLSGNKLSGAIP 182
N ++ + +LQQ + N + LN G + I
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIF 219
Query: 183 QCLA--SLTSLRSLYLQSNKLSSSLPSSLWSLE--YILRINLSSNSLKGTLPSNIQKLNV 238
+ L ++ SL + P+ L + INL + + +
Sbjct: 220 KGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG 279
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
L +LDL+ LS +PS + L L+ L L+ N+F+ S N SL L N
Sbjct: 280 LQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338
Query: 299 GKI-PKSLEALSHLKQFNVSHNRLEGEIPVKGSFK 332
++ LE L +L++ ++SH+ +E +
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-42
Identities = 67/359 (18%), Positives = 120/359 (33%), Gaps = 30/359 (8%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMM--NNLTTESSSADQWSFL 61
KL LD N+ +L+ + LSL + N++ A +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
Query: 62 SSL-----------------TNCRNLANLALASNPLGGILPPLIGNFSA-SLQNIYAFEC 103
SL + ++L I P + S+++I +
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 104 KLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCH 163
GL L L L+ +P+ + L L+ + N + +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 164 LERLNILNLSGNKLSGAI-PQCLASLTSLRSLYLQSNKLSSS--LPSSLWSLEYILRINL 220
L L++ GN + CL +L +LR L L + + +S L +L ++ +NL
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 221 SSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQGPIPE 279
S N ++ L LDL+ +L D S L L+ L+L+ + +
Sbjct: 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443
Query: 280 SVGNLISLESLDFSNNNLSGKI---PKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFS 335
L +L+ L+ N+ SL+ L L+ +S L +F
Sbjct: 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ--HAFTSLK 500
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-42
Identities = 57/338 (16%), Positives = 120/338 (35%), Gaps = 22/338 (6%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
IP ++ N+T+ L+ N TF L +L+ L L +
Sbjct: 26 EIPGTLPNSTEC--LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT------- 76
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
+ L L L +NPL + + +L++++ + + + N + L L
Sbjct: 77 -FQSQHRLDTLVLTANPLIFMAETALSGPK-ALKHLFFIQTGISSIDFIPLHNQKTLESL 134
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNI--LNLSGNKLSGA 180
LG N ++ ++L+ N + D+ L++ LNL+GN ++G
Sbjct: 135 YLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG- 193
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLP-----SSLWSLEYILRINLSSNSLKGTLPSNIQK 235
I +SL + + S++ SL ++ + + + +
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 236 LNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNN 295
++ + ++L ++ + +T L+ L L +P + L +L+ L S N
Sbjct: 254 MS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSAN 311
Query: 296 NLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKD 333
S L ++ N E+ G ++
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELG-TGCLEN 348
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-42
Identities = 66/337 (19%), Positives = 115/337 (34%), Gaps = 22/337 (6%)
Query: 1 MGTIPNSITNAT--KLIGLDLGLNSFSGHIPNTFGNLRHLSV--LSLMMNNLTTESSSAD 56
+ I + N+T L P F L +SV ++L + SS+
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT- 273
Query: 57 QWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNL 116
L L L + L + P + S +L+ + K N
Sbjct: 274 -------FHCFSGLQELDLTATHLSEL-PSGLVGLS-TLKKLVLSANKFENLCQISASNF 324
Query: 117 RGLIVLSLGFNDLNGTIPT-SIGTLQQLQGFYVPENNLQ--GYVPHDLCHLERLNILNLS 173
L LS+ N + T + L+ L+ + ++++ L +L L LNLS
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 174 GNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWS-LEYILRINLSSNSLKGTLPSN 232
N+ + L L L +L S + L + +NLS + L +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444
Query: 233 IQKLNVLIDLDLSRNQLSSDIPSTIGT---LKNLETLSLAGNQFQGPIPESVGNLISLES 289
L L L+L N + L LE L L+ + +L +
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504
Query: 290 LDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
+D S+N L+ ++L L + N++ N + +P
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP 540
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-37
Identities = 65/325 (20%), Positives = 113/325 (34%), Gaps = 59/325 (18%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P+ + + L L L N F + N L+ LS+ N E +
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT-------G 344
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L N NL L L+ + + ++ NL L L
Sbjct: 345 CLENLENLRELDLSHDDIETS-----------------------DCCNLQLRNLSHLQSL 381
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
+L +N+ + QL+ +L+L+ +L
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLE------------------------LLDLAFTRLKVKDA 417
Query: 183 Q-CLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGT---LPSNIQKLNV 238
Q +L L+ L L + L S L + +NL N +++Q L
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
L L LS LSS +LK + + L+ N+ E++ +L + L+ ++N++S
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHIS 536
Query: 299 GKIPKSLEALSHLKQFNVSHNRLEG 323
+P L LS + N+ N L+
Sbjct: 537 IILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-32
Identities = 46/253 (18%), Positives = 85/253 (33%), Gaps = 9/253 (3%)
Query: 89 GNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYV 148
G S + + L L L L L + + + +L +
Sbjct: 29 GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVL 88
Query: 149 PENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSS 208
N L L + L L +S L + +L SLYL SN +SS
Sbjct: 89 TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148
Query: 209 LWSLEYILRINLSSNSLKGTLPSNIQKLNVL--IDLDLSRNQLSSDIPSTIGTLKNLETL 266
+ E + ++ +N++ ++ L + L+L+ N ++ I ++L
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSL 207
Query: 267 SLAGNQFQGPIPESVGN--LISLESLDFSNNNLSGKIPKSLEALS--HLKQFNVSHNRLE 322
+ G Q I + + N + SL F + + P E L ++ N+ +
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267
Query: 323 GEIPVKGSFKDFS 335
+F FS
Sbjct: 268 NISS--NTFHCFS 278
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-26
Identities = 35/176 (19%), Positives = 59/176 (33%), Gaps = 5/176 (2%)
Query: 150 ENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSL 209
L +P L L S N L + L +L L L ++ +
Sbjct: 21 NLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77
Query: 210 WSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLA 269
S + + L++N L + + L L + +SS + K LE+L L
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 270 GNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQ--FNVSHNRLEG 323
N L+ LDF NN + + + +L N++ N + G
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-25
Identities = 32/166 (19%), Positives = 56/166 (33%), Gaps = 4/166 (2%)
Query: 162 CHLERLN-ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINL 220
C + +N N L+ IP L S L N L + ++ L + ++L
Sbjct: 8 CIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDL 64
Query: 221 SSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPES 280
+ + Q + L L L+ N L + + K L+ L
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
Query: 281 VGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
+ N +LESL +N++S LK + +N +
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-22
Identities = 59/298 (19%), Positives = 90/298 (30%), Gaps = 58/298 (19%)
Query: 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
+ N + L L+L N F L +L L L + +
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ------ 418
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
S N L L L+ + L + L L
Sbjct: 419 -SPFQNLHLLKVLNLSHSLLDIS-------------------------SEQLFDGLPALQ 452
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L+L N +LQ L RL IL LS LS
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQ---------------------TLGRLEILVLSFCDLSSI 491
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
SL + + L N+L+SS +L L+ + +NL+SN + LPS + L+
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK-GIYLNLASNHISIILPSLLPILSQQR 550
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
++L +N L + LE + + N L + S+ LS
Sbjct: 551 TINLRQNPLDCT----CSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 74/317 (23%), Positives = 136/317 (42%), Gaps = 32/317 (10%)
Query: 7 SITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTN 66
I T L L+L N + P NL L+ L + N +T +S+L N
Sbjct: 61 GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD----------ISALQN 108
Query: 67 CRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGF 126
NL L L + + I P + N + + ++ S + N+ GL L++
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLT-KMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTE 164
Query: 127 NDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLA 186
+ + P I L L + N ++ P L L L+ N+++ P +A
Sbjct: 165 SKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VA 218
Query: 187 SLTSLRSLYLQSNKLSSSLP-SSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLS 245
++T L SL + +NK++ P ++L L ++ + +N + + ++ L L L++
Sbjct: 219 NMTRLNSLKIGNNKITDLSPLANLSQLTWL---EIGTNQISD--INAVKDLTKLKMLNVG 273
Query: 246 RNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSL 305
NQ+S S + L L +L L NQ E +G L +L +L S N+++ P L
Sbjct: 274 SNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--L 329
Query: 306 EALSHLKQFNVSHNRLE 322
+LS + + ++ ++
Sbjct: 330 ASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 72/345 (20%), Positives = 144/345 (41%), Gaps = 38/345 (11%)
Query: 3 TIPNSIT------NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESS--- 53
T+P I + + I L S + + L ++ L + + +
Sbjct: 7 TLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQGIEY 64
Query: 54 ---------SADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECK 104
+ +Q + +S L+N L NL + +N + I + N + +L+ +Y E
Sbjct: 65 LTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDI--SALQNLT-NLRELYLNEDN 121
Query: 105 LGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHL 164
+ P + NL + L+LG N + + + + L V E+ ++ P + +L
Sbjct: 122 ISDISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANL 176
Query: 165 ERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNS 224
L L+L+ N++ P LASLTSL N+++ + + ++ + + + +N
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPVANMTRLNSLKIGNNK 232
Query: 225 LKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNL 284
+ S + L+ L L++ NQ+S + + L L+ L++ NQ + NL
Sbjct: 233 ITDL--SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNL 286
Query: 285 ISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKG 329
L SL +NN L + + + L++L +S N + P+
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 29/139 (20%), Positives = 59/139 (42%), Gaps = 10/139 (7%)
Query: 191 LRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLS 250
+L ++ P L +R L S+ ++L + L ++ +++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 251 SDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSH 310
S I L NLE L+L GNQ P + NL+ L +L N ++ +L+ L++
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 311 LKQFNVSHNRLEGEIPVKG 329
L++ ++ + + P+
Sbjct: 112 LRELYLNEDNISDISPLAN 130
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-42
Identities = 72/291 (24%), Positives = 123/291 (42%), Gaps = 38/291 (13%)
Query: 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRN 484
++ +G G FG V+ G L +D T VA+K L F E IL+ H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
+++++G C+ +V+E + G +L + L + L ++ D + +EYL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE--- 230
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE 604
S IH DL N L+ E V +SDFG+S+ +G + + + + APE +
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 605 GIVSTKCDVYSYGVLLMETFTE-KKPTDEMFTGEMSLRRWVKESLPH--RLTEVVDANLV 661
G S++ DV+S+G+LL ETF+ P + + +E + RL
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGGRL--------- 334
Query: 662 REEQAFSDK-MDC---LFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708
C +F +M C P +R + +L+ I+ +
Sbjct: 335 -------PCPELCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-42
Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 28/295 (9%)
Query: 428 EFNECNL-----LGTGGFGSVYKGTL-----SDGTNVAIKIFNLQLERAFRSFDSECEIL 477
+F E +L LG G FGSV + G VA+K E R F+ E EIL
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 478 RNVRHRNLLKILGSCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGS 535
++++H N++K G C + + L++E++P GSL +L H +D ++ L +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS-VIQTMTMATI 594
+EYL IH DL NIL++ + DFG++K+L + ++ ++ + I
Sbjct: 126 GMEYLGTKR----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLT 653
+ APE +E S DV+S+GV+L E FT +K + + +
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-- 239
Query: 654 EVVDANLVREEQAFSDKMDC---LFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+++ L++ C ++ IM +C + ++R D A ++ +I
Sbjct: 240 HLIE--LLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQI 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 82/331 (24%), Positives = 145/331 (43%), Gaps = 33/331 (9%)
Query: 401 KHLDHEDFLPPATRR---RTSYLDIRRATD--EFNECNL-----LGTGGFGSVYKGTL-- 448
H H D+ P T + + D +F E +L LG G FGSV
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 449 ---SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA--LVLE 503
+ G VA+K E R F+ E EIL++++H N++K G C + + L++E
Sbjct: 65 LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE 563
++P GSL +L H +D ++ L + +EYL IH DL NIL++
Sbjct: 125 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR----YIHRDLATRNILVEN 180
Query: 564 NMVAHVSDFGISKLLGEGEDS-VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLME 622
+ DFG++K+L + ++ ++ + I + APE +E S DV+S+GV+L E
Sbjct: 181 ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 240
Query: 623 TFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDC---LFSIM 678
FT +K + + + +++ L++ C ++ IM
Sbjct: 241 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVF--HLIE--LLKNNGRLPRPDGCPDEIYMIM 296
Query: 679 DLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709
+C + ++R D A ++ +I+ +
Sbjct: 297 ---TECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-41
Identities = 60/309 (19%), Positives = 100/309 (32%), Gaps = 21/309 (6%)
Query: 17 LDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALA 76
L + F L ++S +SL ++ L + +L++
Sbjct: 266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY----------LEDVPKHFKWQSLSII 315
Query: 77 SNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTS 136
L + L+++ K SI + L L L L N L+ + S
Sbjct: 316 RCQLKQFPT---LDLP-FLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCS 369
Query: 137 --IGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP-QCLASLTSLRS 193
L+ + N + + LE L L+ + L SL L
Sbjct: 370 YSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428
Query: 194 LYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRNQLSSD 252
L + L + + ++ NS K SN+ L LDLS+ QL
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 253 IPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLK 312
TL L+ L+++ N L SL +LD S N + L
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548
Query: 313 QFNVSHNRL 321
FN+++N +
Sbjct: 549 FFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-39
Identities = 71/330 (21%), Positives = 114/330 (34%), Gaps = 16/330 (4%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIP-NTFGNLRHLSVLSLMMNNLTTESSSAD-QWSF 60
I + KL L L N S +I NL L V L++ E + + S
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ L + L + ++ + + +++
Sbjct: 255 MEGLCDVTID-EFRLTYTNDFSDDIVKFHCLA-NVSAMSLAGVSI--KYLEDVPKHFKWQ 310
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
LS+ L + L+ L + N + L L+ L+LS N LS +
Sbjct: 311 SLSIIRCQLKQFPTLDLPFLKSL---TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFS 365
Query: 181 IPQCLASL--TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP-SNIQKLN 237
+ L SLR L L N + ++ LE + ++ ++LK S L
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424
Query: 238 VLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNN 296
L+ LD+S D L +L TL +AGN F+ +V N +L LD S
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 297 LSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
L + L L+ N+SHN L
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-38
Identities = 67/333 (20%), Positives = 108/333 (32%), Gaps = 25/333 (7%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHI------PNTFGNLRHLSVLSLMMNNLTTESSSADQ 57
+ + N L L L F P+ L +++ + S
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD--- 277
Query: 58 WSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLR 117
+ N++ ++LA + + Q++ C+L P +L
Sbjct: 278 ---IVKFHCLANVSAMSLAGVSIKYLED---VPKHFKWQSLSIIRCQLK-QFPT--LDLP 328
Query: 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLE--RLNILNLSGN 175
L L+L N G+I L L + N L L L L+LS N
Sbjct: 329 FLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386
Query: 176 KLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKGTLPSNIQ 234
+ L L+ L Q + L S + SLE +L +++S + K
Sbjct: 387 GAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 235 KLNVLIDLDLSRNQLSSDIPS-TIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFS 293
L L L ++ N + S NL L L+ Q + L L+ L+ S
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS 505
Query: 294 NNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
+NNL L L + S NR+E
Sbjct: 506 HNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-36
Identities = 77/333 (23%), Positives = 117/333 (35%), Gaps = 35/333 (10%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
IP+S N +DL N +F N L L L + T A
Sbjct: 30 IPSSTKN------IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA-------- 75
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLS 123
+L+NL L NP+ P + SL+N+ A E KL IG L L L+
Sbjct: 76 WHGLHHLSNLILTGNPIQSFSPGSFSGLT-SLENLVAVETKLASLESFPIGQLITLKKLN 134
Query: 124 LGFNDLNG-TIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNI----LNLSGNKLS 178
+ N ++ +P L L + N +Q +DL L L++S N +
Sbjct: 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLP-------SSLWSLEYILRINLSSNSLKGTLPS 231
Q + L L L+ N SS++ + L IL +L+ PS
Sbjct: 195 FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253
Query: 232 NIQKLNVL--IDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLES 289
++ L + + L+ SD L N+ +SLAG + E V +S
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQS 311
Query: 290 LDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
L L L LK ++ N+
Sbjct: 312 LSIIRCQLKQFPTLD---LPFLKSLTLTMNKGS 341
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-30
Identities = 46/234 (19%), Positives = 81/234 (34%), Gaps = 11/234 (4%)
Query: 107 GSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLER 166
GS+ I + + L+ +P I + + + N L+ + +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 167 LNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK 226
L L+LS ++ + L L +L L N + S P S L + + L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 227 GTLPSNIQKLNVLIDLDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNL- 284
I +L L L+++ N + S +P+ L NL + L+ N Q + L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 285 ---ISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFS 335
SLD S N + I L + + N I K ++ +
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIM-KTCLQNLA 229
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-29
Identities = 52/258 (20%), Positives = 87/258 (33%), Gaps = 13/258 (5%)
Query: 90 NFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVP 149
+ +S +NI L N L L L ++ + L L +
Sbjct: 29 DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88
Query: 150 ENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSS-SLPSS 208
N +Q + P L L L KL+ + L +L+ L + N + S LP+
Sbjct: 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
Query: 209 LWSLEYILRINLSSNSLKGTLPSNIQKL----NVLIDLDLSRNQLSSDIPSTIGTLKNLE 264
+L ++ ++LS N ++ +++Q L V + LD+S N + I L
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLH 207
Query: 265 TLSLAGNQFQGPIPESV-GNLISLESLD------FSNNNLSGKIPKSLEALSHLKQFNVS 317
L+L GN I ++ NL L NL P +E L +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 318 HNRLEGEIPVKGSFKDFS 335
F +
Sbjct: 268 LTYTNDFSDDIVKFHCLA 285
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-25
Identities = 45/243 (18%), Positives = 79/243 (32%), Gaps = 12/243 (4%)
Query: 12 TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLA 71
L L L +N S I L LS L L N L+ + +SL +
Sbjct: 328 PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH----- 380
Query: 72 NLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKE-IGNLRGLIVLSLGFNDLN 130
L L+ N I+ LQ++ L +L L+ L + + +
Sbjct: 381 -LDLSFNGAI-IMSANFMGLE-ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 131 GTIPTSIGTLQQLQGFYVPENNLQGYVPHD-LCHLERLNILNLSGNKLSGAIPQCLASLT 189
L L + N+ + + + L L+LS +L +L
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 190 SLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQL 249
L+ L + N L S L + ++ S N ++ + L +L+ N +
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
Query: 250 SSD 252
+
Sbjct: 558 ACI 560
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 40/239 (16%), Positives = 75/239 (31%), Gaps = 13/239 (5%)
Query: 10 NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRN 69
L LDL N + F L L L + L + S+ +
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTE-------FSAFLSLEK 425
Query: 70 LANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIVLSLGFND 128
L L ++ + + SL + + + N L L L
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLT-SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 129 LNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASL 188
L TL +LQ + NNL L L+ L+ S N++ +
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFP 544
Query: 189 TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLN--VLIDLDLS 245
SL L +N ++ L+++ +++ + ++N +++D + S
Sbjct: 545 KSLAFFNLTNNSVACI-CEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNS 602
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 23/98 (23%), Positives = 34/98 (34%), Gaps = 9/98 (9%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
T+ N N T L LDL F L L +L++ NNL SS
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH------ 516
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIY 99
+L+ L + N + ++ +F SL
Sbjct: 517 --YNQLYSLSTLDCSFNRIETS-KGILQHFPKSLAFFN 551
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 60/283 (21%), Positives = 114/283 (40%), Gaps = 23/283 (8%)
Query: 435 LGTGGFGSVYKGTL-----SDGTNVAIKIF-NLQLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FG V + G VA+K E EILRN+ H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 489 LGSCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
G C+ L++EF+P+GSL+++L + +++ Q+L + + ++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ-- 146
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS-VIQTMTMATIGYMAPEYGSEG 605
+H DL N+L++ + DFG++K + ++ ++ + + + APE +
Sbjct: 147 --YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 606 IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665
DV+S+GV L E T + + + +V+ ++E +
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT--RLVN--TLKEGK 260
Query: 666 AFSDKMDC---LFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+C ++ +M C P R + +
Sbjct: 261 RLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 31/296 (10%)
Query: 428 EFNECNL-----LGTGGFGSVYKGTL-----SDGTNVAIKIFNLQLERAFRSFDSECEIL 477
F E +L LG G FGSV + G VA+K R F E +IL
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 478 RNVRHRNLLKILGSCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGS 535
+ + ++K G ++ LV+E++P+G L +L H LD + L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS-VIQTMTMATI 594
+EYL +H DL NIL++ ++DFG++KLL +D V++ + I
Sbjct: 139 GMEYLGSRR----CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFTE-KKPTDEMFTGEMSLRRWVKESLP-HRL 652
+ APE S+ I S + DV+S+GV+L E FT K + R + L
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPAL 250
Query: 653 TEVVDANLVREEQAFSDKMDC---LFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+ +++ L+ E Q C + +M C +P R + +L +
Sbjct: 251 SRLLE--LLEEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQLDML 301
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 435 LGTGGFGSVYKGTLSDGTN----VAIKIFNL-QLERAFRSFDSECEILRNVRHRNLLKIL 489
+G+G G V G L VAIK ER R F SE I+ H N++++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
G + +V E+M NGSL+ +L +H+ I+Q + ++ VG+ + YL S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL----SDLGY 172
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM-TMATIGYMAPEYGSEGIVS 608
+H DL N+L+D N+V VSDFG+S++L + D+ T I + APE + S
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 609 TKCDVYSYGVLLMETFTE-KKPTDEM 633
+ DV+S+GV++ E ++P M
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNM 258
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 56/210 (26%), Positives = 82/210 (39%), Gaps = 18/210 (8%)
Query: 435 LGTGGFGSVYKGTL----SDGTNVAIKIFN---LQLERAFRSFDSECEILRNVRHRNLLK 487
LG G FG V +G +VA+K L A F E + ++ HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+ G K +V E P GSL L H + + V + YL
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--- 141
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT---IGYMAPEYGSE 604
IH DL N+LL + + DFG+ + L + +D M + APE
Sbjct: 142 -FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPESLKT 198
Query: 605 GIVSTKCDVYSYGVLLMETFTE-KKPTDEM 633
S D + +GV L E FT ++P +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-39
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 435 LGTGGFGSVYKGTLSDG-----TNVAIKIFNL-QLERAFRSFDSECEILRNVRHRNLLKI 488
LG+G FG+VYKG VAIK +A + E ++ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL--HHCHSS 546
LG C + L+ + MP G L ++ H + LN + + + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGI 606
+H DL N+L+ ++DFG++KLLG E I +MA E I
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 607 VSTKCDVYSYGVLLMETFTE-KKPTDEM 633
+ + DV+SYGV + E T KP D +
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-39
Identities = 73/321 (22%), Positives = 126/321 (39%), Gaps = 34/321 (10%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+ + L ++ N + P NL L + + N + ++
Sbjct: 59 KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD----------IT 106
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L N NL L L +N + I P + N + +L + + S + L L L
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLT-NLNRLELSSNTI--SDISALSGLTSLQQL 161
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
S G + + L L+ + N + L L L L + N++S P
Sbjct: 162 SFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP 216
Query: 183 QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL 242
L LT+L L L N+L +L SL + ++L++N + + + L L +L
Sbjct: 217 --LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTEL 270
Query: 243 DLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIP 302
L NQ+S+ P + L L L L NQ + P + NL +L L NN+S P
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
Query: 303 KSLEALSHLKQFNVSHNRLEG 323
+ +L+ L++ +N++
Sbjct: 327 --VSSLTKLQRLFFYNNKVSD 345
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-38
Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 34/323 (10%)
Query: 7 SITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTN 66
S T+ ++ L + L +L+ ++ N LT ++ L N
Sbjct: 41 SQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD----------ITPLKN 88
Query: 67 CRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGF 126
L ++ + +N + I P + N + +L + F ++ P + NL L L L
Sbjct: 89 LTKLVDILMNNNQIADITP--LANLT-NLTGLTLFNNQITDIDP--LKNLTNLNRLELSS 143
Query: 127 NDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLA 186
N ++ +++ L LQ N + P L +L L L++S NK+S LA
Sbjct: 144 NTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLA 196
Query: 187 SLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSR 246
LT+L SL +N++S + L L + ++L+ N LK + L L DLDL+
Sbjct: 197 KLTNLESLIATNNQISDI--TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 252
Query: 247 NQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLE 306
NQ+S+ P + L L L L NQ P + L +L +L+ + N L P +
Sbjct: 253 NQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--IS 306
Query: 307 ALSHLKQFNVSHNRLEGEIPVKG 329
L +L + N + PV
Sbjct: 307 NLKNLTYLTLYFNNISDISPVSS 329
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-37
Identities = 75/323 (23%), Positives = 128/323 (39%), Gaps = 34/323 (10%)
Query: 7 SITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTN 66
+ T + + LG + + + +L ++ L + + + +
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS----------IDGVEY 66
Query: 67 CRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGF 126
NL + ++N L I P + N + L +I ++ P + NL L L+L
Sbjct: 67 LNNLTQINFSNNQLTDITP--LKNLT-KLVDILMNNNQIADITP--LANLTNLTGLTLFN 121
Query: 127 NDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLA 186
N + P + L L + N + L L L L+ N+++ P LA
Sbjct: 122 NQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LA 174
Query: 187 SLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSR 246
+LT+L L + SNK+S S L L + + ++N + + + L L +L L+
Sbjct: 175 NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNG 230
Query: 247 NQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLE 306
NQL T+ +L NL L LA NQ P + L L L N +S P L
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LA 284
Query: 307 ALSHLKQFNVSHNRLEGEIPVKG 329
L+ L ++ N+LE P+
Sbjct: 285 GLTALTNLELNENQLEDISPISN 307
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 66/321 (20%), Positives = 119/321 (37%), Gaps = 34/321 (10%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+ ++++ T L L G N + P NL L L + N ++ +S
Sbjct: 147 SDISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD----------IS 193
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L NL +L +N + I P +G + +L + +L + +L L L
Sbjct: 194 VLAKLTNLESLIATNNQISDITP--LGILT-NLDELSLNGNQL--KDIGTLASLTNLTDL 248
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
L N ++ P + L +L + N + P L L L L L+ N+L P
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP 304
Query: 183 QCLASLTSLRSLYLQSNKLSSSLP-SSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
+++L +L L L N +S P SSL L+ + +N + S++ L +
Sbjct: 305 --ISNLKNLTYLTLYFNNISDISPVSSLTKLQRL---FFYNNKVSD--VSSLANLTNINW 357
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
L NQ+S P + L + L L + N+ ++ L
Sbjct: 358 LSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--A 413
Query: 302 PKSLEALSHLKQFNVSHNRLE 322
P ++ + +++ N
Sbjct: 414 PATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-33
Identities = 59/269 (21%), Positives = 108/269 (40%), Gaps = 22/269 (8%)
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ + T L + + + + + A + + L L
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVS--QTDLD-QVTTLQADRLGI--KSIDGVEYLNNLT 71
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
++ N L P + L +L + N + P L +L L L L N+++
Sbjct: 72 QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI 127
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
P L +LT+L L L SN +S S+L L + +++ + + L L
Sbjct: 128 DP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLE 180
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK 300
LD+S N++S S + L NLE+L NQ P +G L +L+ L + N L
Sbjct: 181 RLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD- 235
Query: 301 IPKSLEALSHLKQFNVSHNRLEGEIPVKG 329
+L +L++L ++++N++ P+ G
Sbjct: 236 -IGTLASLTNLTDLDLANNQISNLAPLSG 263
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 70/329 (21%), Positives = 123/329 (37%), Gaps = 54/329 (16%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
T + N T L LD+ N S + L +L L N ++ ++
Sbjct: 168 TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD----------IT 215
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L NL L+L N L I + + + +L ++ ++ P + L L L
Sbjct: 216 PLGILTNLDELSLNGNQLKDI--GTLASLT-NLTDLDLANNQISNLAP--LSGLTKLTEL 270
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
LG N ++ P + L L + EN L+ P + +L+ L L L N +S P
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
Query: 183 QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL 242
++SLT L+ L+ +NK+S SSL +L I ++ N + + + L + L
Sbjct: 327 --VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQL 380
Query: 243 DLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI-PESVGNLISLESLDFSNNNL---- 297
L+ ++ + N+ + N I P ++ + S D + N
Sbjct: 381 GLNDQAWTNAPVNY---KANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTN 437
Query: 298 -------------------SGKIPKSLEA 307
SG + + L+A
Sbjct: 438 EVSYTFSQPVTIGKGTTTFSGTVTQPLKA 466
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 12/223 (5%)
Query: 411 PATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDG----TNVAIKIFN-LQLER 465
A + I + ++G G FG VY G D AIK + + +
Sbjct: 5 SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64
Query: 466 AFRSFDSECEILRNVRHRNLLKILGSCSNLD-FKALVLEFMPNGSLEKWLYSHNYFLDIL 524
+F E ++R + H N+L ++G + ++L +M +G L +++ S +
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK 124
Query: 525 QRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584
++ + V +EYL + +H DL N +LDE+ V+DFG+++ + + E
Sbjct: 125 DLISFGLQVARGMEYL----AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180
Query: 585 VIQTMTMAT--IGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+Q A + + A E +TK DV+S+GVLL E T
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 9e-39
Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIF--NLQLERAFRSFDSECEILRNVRHRNLLKILGSC 492
+G+G FG V+ G + VAIK E F E E++ + H L+++ G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552
LV EFM +G L +L + L + +DV + YL A +IH
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL----EEACVIHR 128
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCD 612
DL N L+ EN V VSDFG+++ + + T T + + +PE S S+K D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 613 VYSYGVLLMETFTE-KKPTDEM 633
V+S+GVL+ E F+E K P +
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENR 209
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 13/232 (5%)
Query: 402 HLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDG----TNVAIK 457
H+D L P + ++ I ++ + ++G G FG VY GTL D + A+K
Sbjct: 1 HIDLSA-LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 59
Query: 458 IFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL-VLEFMPNGSLEKWLY 515
N F +E I+++ H N+L +LG C + L VL +M +G L ++
Sbjct: 60 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 119
Query: 516 SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575
+ + + + + V ++YL +S +H DL N +LDE V+DFG++
Sbjct: 120 NETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
Query: 576 KLLGEGEDSVIQTMTMAT--IGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ + + E + T A + +MA E +TK DV+S+GVLL E T
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 435 LGTGGFGSVYKGTLSDG---TNVAIKIF-NLQLERAFRSFDSECEILRNVRHRNLLKILG 490
LG G FGSV +G +VAIK+ + E +I+ + + +++++G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550
C LV+E G L K+L + + ++ V ++YL +
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKNFV 132
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS-VIQTMTMATIGYMAPEYGSEGIVST 609
H DL N+LL A +SDFG+SK LG + ++ + + APE + S+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 610 KCDVYSYGVLLMETFTE-KKPTDEM 633
+ DV+SYGV + E + +KP +M
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKM 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 435 LGTGGFGSVYKGTL----SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKIL 489
+G G FG V G L +VAIK + E+ R F E I+ H N++++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
G + +V E+M NGSL+ +L H+ ++Q + ++ + S ++YL S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDMGY 168
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM-TMATIGYMAPEYGSEGIVS 608
+H DL NIL++ N+V VSDFG+ ++L + ++ T I + +PE + +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 609 TKCDVYSYGVLLMETFTE-KKPTDEM 633
+ DV+SYG++L E + ++P EM
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEM 254
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 428 EFNECNL-----LGTGGFGSVYKGTL-----SDGTNVAIKIFNLQ---LERAFRSFDSEC 474
F++ L LG G FG V G VA+K L+ + + E
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEI 84
Query: 475 EILRNVRHRNLLKILGSCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMID 532
+ILR + H +++K G C + + LV+E++P GSL +L H+ + + Q L
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQ 142
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS-VIQTMTM 591
+ + YLH H IH DL N+LLD + + + DFG++K + EG + ++
Sbjct: 143 ICEGMAYLHAQH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 592 ATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ + + APE E DV+S+GV L E T
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 15/242 (6%)
Query: 393 VRCRNRSTKHLDHEDFLPPATRRRTSYL-DIRRATDEFNECNLLGTGGFGSVYKGTLSDG 451
+ + +T H+D P + + FNE ++G G FG VY GTL D
Sbjct: 56 LYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDN 113
Query: 452 ----TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL-VLEFM 505
+ A+K N F +E I+++ H N+L +LG C + L VL +M
Sbjct: 114 DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173
Query: 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565
+G L ++ + + + + + V +++L +S +H DL N +LDE
Sbjct: 174 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCMLDEKF 229
Query: 566 VAHVSDFGISKLLGEGEDSVIQTMTMAT--IGYMAPEYGSEGIVSTKCDVYSYGVLLMET 623
V+DFG+++ + + E + T A + +MA E +TK DV+S+GVLL E
Sbjct: 230 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289
Query: 624 FT 625
T
Sbjct: 290 MT 291
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 6/191 (3%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
LG+G FG V G +VA+K+ + + F E + + + H L+K G CS
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 495 LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDL 554
+V E++ NG L +L SH L+ Q L + DV + +L S IH DL
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL----ESHQFIHRDL 130
Query: 555 KPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVY 614
N L+D ++ VSDFG+++ + + V T + + APE S+K DV+
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 615 SYGVLLMETFT 625
++G+L+ E F+
Sbjct: 190 AFGILMWEVFS 200
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-38
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 8/200 (4%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
+ LG G FG V+ GT + T VAIK +F E ++++ +RH L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 242
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHS 545
++ S +V E+M GSL +L +L + Q +++ + S + Y+
Sbjct: 243 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV----E 297
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
+H DL+ NIL+ EN+V V+DFG+++L+ + E + I + APE G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYG 356
Query: 606 IVSTKCDVYSYGVLLMETFT 625
+ K DV+S+G+LL E T
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 55/191 (28%), Positives = 93/191 (48%), Gaps = 6/191 (3%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
LGTG FG V G +VAIK+ + F E +++ N+ H L+++ G C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 495 LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDL 554
++ E+M NG L +L + Q L + DV A+EYL S +H DL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHRDL 146
Query: 555 KPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVY 614
N L+++ V VSDFG+S+ + ++ + + + PE S+K D++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 615 SYGVLLMETFT 625
++GVL+ E ++
Sbjct: 206 AFGVLMWEIYS 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 435 LGTGGFGSVYKGTLSDGTN-----VAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKI 488
+G G FG VYKG L + VAIK E+ F E I+ H N++++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
G S ++ E+M NG+L+K+L + +LQ + ++ + + ++YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---- 167
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM-TMATIGYMAPEYGSEGIV 607
+H DL NIL++ N+V VSDFG+S++L + ++ T I + APE S
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 608 STKCDVYSYGVLLMETFTE-KKPTDEM 633
++ DV+S+G+++ E T ++P E+
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 9e-38
Identities = 51/200 (25%), Positives = 98/200 (49%), Gaps = 8/200 (4%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
+ LG G FG V+ T + T VA+K + +F +E +++ ++H L+
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNY-FLDILQRLNIMIDVGSALEYLHHCHS 545
K+ + + ++ EFM GSL +L S + + ++ + + ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI----E 301
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
IH DL+ NIL+ ++V ++DFG+++++ + E + + I + APE + G
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFG 360
Query: 606 IVSTKCDVYSYGVLLMETFT 625
+ K DV+S+G+LLME T
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-37
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 8/200 (4%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
+ LG G FG V+ GT + T VAIK +F E ++++ +RH L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 325
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHS 545
++ S +V E+M GSL +L +L + Q +++ + S + Y+
Sbjct: 326 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV----E 380
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
+H DL+ NIL+ EN+V V+DFG+++L+ + E + I + APE G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYG 439
Query: 606 IVSTKCDVYSYGVLLMETFT 625
+ K DV+S+G+LL E T
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 435 LGTGGFGSVYKGTL---SDGTNVAIKIF--NLQLERAFRSFDSECEILRNVRHRNLLKIL 489
LG+G FG+V KG VA+KI +E +++ + + +++++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
G C + LV+E G L K+L + + + + ++ V ++YL +
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL----EESNF 138
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS-VIQTMTMATIGYMAPEYGSEGIVS 608
+H DL N+LL A +SDFG+SK L E+ QT + + APE + S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 609 TKCDVYSYGVLLMETFTE-KKPTDEM 633
+K DV+S+GVL+ E F+ +KP M
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 435 LGTGGFGSVYKGTLSDG-----TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKI 488
LG+G FG+V+KG V IK+ + ++F++ + ++ H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
LG C + LV +++P GSL + H L LN + + + YL
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL----EEHG 135
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVS 608
++H +L N+LL V+DFG++ LL + ++ + I +MA E G +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 609 TKCDVYSYGVLLMETFTE-KKPTDEM 633
+ DV+SYGV + E T +P +
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPYAGL 221
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-37
Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 11/196 (5%)
Query: 435 LGTGGFGSVYKGTLSDGTN----VAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKIL 489
+G G FG V++G N VAIK + F E +R H +++K++
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
G + +++E G L +L Y LD+ + + +AL YL S
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL----ESKRF 137
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVST 609
+H D+ N+L+ N + DFG+S+ + E + I +MAPE + ++
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 610 KCDVYSYGVLLMETFT 625
DV+ +GV + E
Sbjct: 197 ASDVWMFGVCMWEILM 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 435 LGTGGFGSVYKGTLSDG-----TNVAIKIFNL-QLERAFRSFDSECEILRNVRHRNLLKI 488
LG+G FG+VYKG VAIK +A + E ++ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL--HHCHSS 546
LG C + L+ + MP G L ++ H + LN + + + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGI 606
+H DL N+L+ ++DFG++KLLG E I +MA E I
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 607 VSTKCDVYSYGVLLMETFTE-KKPTDEM 633
+ + DV+SYGV + E T KP D +
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 435 LGTGGFGSVYKGTLSDG----TNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKI 488
LG G FGSV +G L VA+K L +R F SE +++ H N++++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 489 LGSCSNLDFKA-----LVLEFMPNGSLEKWLYSH-----NYFLDILQRLNIMIDVGSALE 538
LG C + + ++L FM G L +L + + L M+D+ +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
YL S+ +H DL N +L ++M V+DFG+SK + G+ + + ++A
Sbjct: 162 YL----SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFT 625
E ++ + ++K DV+++GV + E T
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 435 LGTGGFGSVYKGTLSDG----TNVAIKIF--NLQLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FGSV + L VA+K+ ++ F E ++ H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 489 LGSCSNLDFKA------LVLEFMPNGSLEKWLYSH-----NYFLDILQRLNIMIDVGSAL 537
+G K ++L FM +G L +L + + L + + M+D+ +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597
EYL SS IH DL N +L E+M V+DFG+S+ + G+ + + ++
Sbjct: 151 EYL----SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 598 APEYGSEGIVSTKCDVYSYGVLLMETFT 625
A E ++ + + DV+++GV + E T
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-36
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 435 LGTGGFGSVYKGTLSDG---TNVAIKIF-NLQLERAFRSFDSECEILRNVRHRNLLKILG 490
LG G FGSV +G +VAIK+ + E +I+ + + +++++G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550
C LV+E G L K+L + + ++ V ++YL +
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKNFV 458
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS-VIQTMTMATIGYMAPEYGSEGIVST 609
H +L N+LL A +SDFG+SK LG + ++ + + APE + S+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 610 KCDVYSYGVLLMETFTE-KKPTDEM 633
+ DV+SYGV + E + +KP +M
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 65/193 (33%), Positives = 97/193 (50%), Gaps = 14/193 (7%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS- 493
+G G FG V G G VA+K ++ + ++F +E ++ +RH NL+++LG
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552
+V E+M GSL +L S L L +DV A+EYL +H
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EGNNFVHR 313
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCD 612
DL N+L+ E+ VA VSDFG++K E S Q + + APE E STK D
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 613 VYSYGVLLMETFT 625
V+S+G+LL E ++
Sbjct: 369 VWSFGILLWEIYS 381
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 435 LGTGGFGSVYKGTL----SDGTNVAIKIFNL-QLERAFRSFDSECEILRNVRHRNLLKIL 489
LG G FG VY+G + NVA+K F SE I++N+ H +++K++
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
G + +++E P G L +L + L +L + + + A+ YL +
Sbjct: 80 GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN----C 134
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVST 609
+H D+ NIL+ + DFG+S+ + E ED ++T I +M+PE + +T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 610 KCDVYSYGVLLMETFTE-KKPTDEM 633
DV+ + V + E + K+P +
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWL 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 51/200 (25%), Positives = 99/200 (49%), Gaps = 8/200 (4%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
+ LG G FG V+ G + T VA+K +F +E +++ ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHS 545
++ + + ++ E+M NGSL +L + + L I + L++ + + ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI----E 126
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
IH DL+ NIL+ + + ++DFG+++L+ E + + I + APE + G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 606 IVSTKCDVYSYGVLLMETFT 625
+ K DV+S+G+LL E T
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 44/232 (18%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRH 482
R +F E +LG G FG V K D AIK E + SE +L ++ H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61
Query: 483 RNLLKILGSCSNLDFKA-------------LVLEFMPNGSLEKWLYSHNYFLDILQRLNI 529
+ +++ + + +E+ NG+L ++S N + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
+ AL Y+H IIH DLKP NI +DE+ + DFG++K + D +
Sbjct: 122 FRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 590 TMAT---------IG---YMAPE-------YGSEGIVSTKCDVYSYGVLLME 622
IG Y+A E Y K D+YS G++ E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE------KIDMYSLGIIFFE 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-36
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 8/201 (3%)
Query: 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNL 485
+ + LG G +G VY+G VA+K F E +++ ++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 278
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCH 544
+++LG C+ ++ EFM G+L +L N + + L + + SA+EYL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---- 334
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE 604
IH +L N L+ EN + V+DFG+S+L+ + I + APE +
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAY 393
Query: 605 GIVSTKCDVYSYGVLLMETFT 625
S K DV+++GVLL E T
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 53/349 (15%), Positives = 111/349 (31%), Gaps = 49/349 (14%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
I N + + +S + + + ++ L L N L+ S++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAAD-------- 53
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLS 123
L L L L+SN L L + +L L L
Sbjct: 54 LAPFTKLELLNLSSNVLYETLD---------------------------LESLSTLRTLD 86
Query: 124 LGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQ 183
L N + + ++ + NN+ V + + L+ NK++
Sbjct: 87 LNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDL 138
Query: 184 CLASLTSLRSLYLQSNKLSS-SLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL 242
+ ++ L L+ N++ + + S + + +NL N + + + L L
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTL 196
Query: 243 DLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIP 302
DLS N+L+ + + + +SL N+ I +++ +LE D N
Sbjct: 197 DLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTL 254
Query: 303 KSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRL 351
+ + + V+ ++ ++G Y P
Sbjct: 255 RDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 41/216 (18%), Positives = 87/216 (40%), Gaps = 13/216 (6%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
+I + N + + + L + + + ++ + N L DL +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
+LNLS N L + L SL++LR+L L +N + L I ++ ++N++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG-PIPESVGNLIS 286
+ + ++ L+ N+++ G ++ L L N+ E + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 287 LESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
LE L+ N + + + + LK ++S N+L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 65/195 (33%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSC 492
+G G FG V G G VA+K ++ + ++F +E ++ +RH NL+++LG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 493 S-NLDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550
+V E+M GSL +L S L L +DV A+EYL +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EGNNFV 139
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTK 610
H DL N+L+ E+ VA VSDFG++K E S Q + + APE E STK
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 611 CDVYSYGVLLMETFT 625
DV+S+G+LL E ++
Sbjct: 195 SDVWSFGILLWEIYS 209
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 59/193 (30%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 435 LGTGGFGSVYKGTLSDG-TNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
LG G +G VY+G VA+K F E +++ ++H NL+++LG C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552
++ EFM G+L +L N + + L + + SA+EYL IH
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL----EKKNFIHR 135
Query: 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCD 612
DL N L+ EN + V+DFG+S+L+ + I + APE + S K D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSD 194
Query: 613 VYSYGVLLMETFT 625
V+++GVLL E T
Sbjct: 195 VWAFGVLLWEIAT 207
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-35
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 428 EFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLL 486
F ++LG G G++ + D +VA+K + F D E ++LR H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVI 81
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
+ + + F+ + +E +L++++ ++ L+ + ++ S L +LH +
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN-- 138
Query: 547 APIIHCDLKPTNILLDE-----NMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGYMAPE 600
I+H DLKP NIL+ + A +SDFG+ K L G S + + T G++APE
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 601 Y---GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+ + D++S G + +E
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-35
Identities = 53/240 (22%), Positives = 96/240 (40%), Gaps = 17/240 (7%)
Query: 396 RNRSTKHLDHEDFLPPATRRRTSYLDIRRATDEFNECNL-----LGTGGFGSVYKGTLSD 450
R+ + + +D+ T Y E + +G G FG V++G
Sbjct: 355 RSHTVSVSETDDYAEIIDEEDT-YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMS 413
Query: 451 GTN----VAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505
N VAIK + F E +R H +++K++G + + +++E
Sbjct: 414 PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELC 472
Query: 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565
G L +L + LD+ + + +AL YL S +H D+ N+L+ N
Sbjct: 473 TLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL----ESKRFVHRDIAARNVLVSSND 528
Query: 566 VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ DFG+S+ + E + I +MAPE + ++ DV+ +GV + E
Sbjct: 529 CVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 58/235 (24%), Positives = 94/235 (40%), Gaps = 16/235 (6%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNL--QLERAFRSFDSECEILRNVRHRNLLKILG 490
+G G F +VYKG VA + + F E E+L+ ++H N+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 491 SCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
S + LV E M +G+L+ +L I + + L++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM-KIKVLRSWCRQILKGLQFLHTRTP- 150
Query: 547 APIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
PIIH DLK NI + + D G++ L S + + + T +MAPE E
Sbjct: 151 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAV-IGTPEFMAPEMYEEK 205
Query: 606 IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660
DVY++G+ ++E T + P E RR P +V +
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNL--LKI 488
+G+GG V++ AIK NL+ + S+ +E L ++ + +++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
+ +V+E N L WL D +R + ++ A+ +H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE-------- 600
I+H DLKP N L+ + M+ + DFGI+ + SV++ + T+ YM PE
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 601 ---YGSEGIVSTKCDVYSYGVLL 620
S+ +S K DV+S G +L
Sbjct: 207 RENGKSKSKISPKSDVWSLGCIL 229
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 35/212 (16%)
Query: 435 LGTGGFGSVYKGTL--------SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
LG G F ++KG T V +K+ + SF ++ + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL--HHCH 544
G C D LV EF+ GSL+ +L + ++IL +L + + +A+ +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134
Query: 545 SSAPIIHCDLKPTNILLD--------ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
IH ++ NILL +SD GIS + + + I +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPW 183
Query: 597 MAPE---YGSEGIVSTKCDVYSYGVLLMETFT 625
+ PE ++ D +S+G L E +
Sbjct: 184 VPPECIENP--KNLNLATDKWSFGTTLWEICS 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 423 RRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
+R +F E L+G+GGFG V+K DG IK E+A R E + L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 482 HRNLLKILGSCSNLDFKA----------------LVLEFMPNGSLEKWLYSHN-YFLDIL 524
H N++ G D+ + +EF G+LE+W+ LD +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 525 QRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584
L + + ++Y+H +I+ DLKP+NI L + + DFG+ L
Sbjct: 123 LALELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK- 177
Query: 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
+T + T+ YM+PE S + D+Y+ G++L E E
Sbjct: 178 --RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNL--LKI 488
+G+GG V++ AIK NL+ + S+ +E L ++ + +++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
+ +V+E N L WL D +R + ++ A+ +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 128
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE-------- 600
I+H DLKP N L+ + M+ + DFGI+ + SV++ + T+ YM PE
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 601 ---YGSEGIVSTKCDVYSYGVLL 620
S+ +S K DV+S G +L
Sbjct: 188 RENGKSKSKISPKSDVWSLGCIL 210
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 435 LGTGGFGSVYKGTLSDG------TNVAIKIFN-LQLERAFRSFDSECEILRNVRHRNLLK 487
LG G FG VY+G +S VA+K + E+ F E I+ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSH------NYFLDILQRLNIMIDVGSALEYLH 541
+G + +++E M G L+ +L L +L L++ D+ +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 542 HCHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
IH D+ N LL VA + DFG+++ + M + +M
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFT 625
PE EGI ++K D +S+GVLL E F+
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 435 LGTGGFGSVYKGTL------SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FG V+ D VA+K A + F E E+L N++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILQRLNIMIDV 533
G C + D +V E+M +G L K+L +H L + Q L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT 593
S + YL +S +H DL N L+ N++ + DFG+S+ + + + TM
Sbjct: 143 ASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 594 IGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
I +M PE +T+ DV+S+GV+L E FT
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 435 LGTGGFGSVYKGTLSDG------TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLK 487
LG G FG VY+G T VAIK N R F +E +++ ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILQRLNIMIDVGSALE 538
+LG S +++E M G L+ +L S + + + + ++ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
YL ++ +H DL N ++ E+ + DFG+++ + E + + + +M+
Sbjct: 153 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFT 625
PE +G+ +T DV+S+GV+L E T
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNL--LKI 488
+G+GG V++ AIK NL+ + S+ +E L ++ + +++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP 548
+ +V+E N L WL D +R + ++ A+ +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 175
Query: 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE-------- 600
I+H DLKP N L+ + M+ + DFGI+ + SV++ + + YM PE
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 601 ---YGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
S+ +S K DV+S G +L K P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 435 LGTGGFGSVYKGTLSDG------TNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKI 488
LG G FG V+ + VA+K E A + F E E+L ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF--------------LDILQRLNIMIDVG 534
G C+ +V E+M +G L ++L SH L + Q L + V
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATI 594
+ + YL + +H DL N L+ + +V + DFG+S+ + + + TM I
Sbjct: 169 AGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+M PE +T+ DV+S+GV+L E FT
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 82/357 (22%), Positives = 133/357 (37%), Gaps = 69/357 (19%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESS-------SA 55
++P + L L NS + +P +L+ L V + + L+ S
Sbjct: 85 SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 140
Query: 56 DQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGN 115
+Q L L N L + + +N L LP L + L+ I A +L +P E+ N
Sbjct: 141 NQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS----LEFIAAGNNQLE-ELP-ELQN 193
Query: 116 LRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGN 175
L L + N L +P +L+ + N L+ +L +L L + N
Sbjct: 194 LPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPELQNLPFLTTIYADNN 247
Query: 176 KLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQK 235
L +P SL +L ++ N L + LP SL ++ + L LP N+
Sbjct: 248 LLK-TLPD---LPPSLEALNVRDNYL-TDLPELPQSLTFLDVSENIFSGLS-ELPPNLYY 301
Query: 236 LNV--------------LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV 281
LN L +L++S N+L +P+ LE L + N +PE
Sbjct: 302 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLAE-VPELP 356
Query: 282 GNLISLESLDFSNNNLSGKIPKSLEAL----------------SHLKQFNVSHNRLE 322
NL + L N L + P E++ +LKQ +V N L
Sbjct: 357 QNL---KQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-32
Identities = 72/349 (20%), Positives = 123/349 (35%), Gaps = 72/349 (20%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P N + + + P G R ++V L
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC---------------- 68
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
R L L + L LP L + L+++ A L +P+ +L+ L+V
Sbjct: 69 ---LDRQAHELELNNLGL-SSLPELPPH----LESLVASCNSL-TELPELPQSLKSLLVD 119
Query: 123 SLGFNDLNGTIPT---------------SIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
+ L+ P + L+ V N+L+ +P LE
Sbjct: 120 NNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEF- 177
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
+ N+L +P+ L +L L ++Y +N L LP SLE I +N L
Sbjct: 178 --IAAGNNQLE-ELPE-LQNLPFLTAIYADNNSL-KKLPDLPLSLE---SIVAGNNIL-- 227
Query: 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISL 287
+Q L L + N L + +P +LE L++ N +PE +L L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLKT-LPDLPP---SLEALNVRDNYLTD-LPELPQSLTFL 282
Query: 288 ESLDFSNNNLSGKIPKSLEAL--------------SHLKQFNVSHNRLE 322
+ + + LS ++P +L L L++ NVS+N+L
Sbjct: 283 DVSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-31
Identities = 73/373 (19%), Positives = 119/373 (31%), Gaps = 79/373 (21%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPN---------------TFGNLRHLSVLSLMMNN 47
+P + L+ + L + S P N L ++ + N+
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164
Query: 48 LTTESS----------SADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQN 97
L +Q L L N L + +N L LP L + L++
Sbjct: 165 LKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKK-LPDLPLS----LES 219
Query: 98 IYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYV 157
I A L E+ NL L + N L T+P +L+ L V +N L +
Sbjct: 220 IVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLTD-L 272
Query: 158 PHDLCHLERLNILNLSGNKLSGAIPQ-------------CLASLTSLRSLYLQSNKLSSS 204
P L L++ + LS P SL L + +NKL
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE- 331
Query: 205 LPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLK--- 261
LP+ LE R+ S N L +P Q L L + N L P +++
Sbjct: 332 LPALPPRLE---RLIASFNHLA-EVPELPQNLKQL---HVEYNPLRE-FPDIPESVEDLR 383
Query: 262 -------------NLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEAL 308
NL+ L + N + P+ ++ E L ++ + + E
Sbjct: 384 MNSHLAEVPELPQNLKQLHVETNPLRE-FPDIPESV---EDLRMNSERVVDPYEFAHETT 439
Query: 309 SHLKQFNVSHNRL 321
L+ H+
Sbjct: 440 DKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 62/301 (20%), Positives = 99/301 (32%), Gaps = 51/301 (16%)
Query: 34 NLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSA 93
+ L +NLT N ++ A + PP G
Sbjct: 9 SNTFLQEPLRHSSNLT---------EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59
Query: 94 ------------SLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQ 141
+ L S+P+ +L L N L +P +L+
Sbjct: 60 MAVSRLRDCLDRQAHELELNNLGL-SSLPELPPHLE---SLVASCNSLT-ELPELPQSLK 114
Query: 142 QLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKL 201
L L P L L +S N+L +P+ L + + L+ + + +N L
Sbjct: 115 SLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSL 165
Query: 202 SSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLK 261
LP SLE+ I +N L+ LP +Q L L + N L +P
Sbjct: 166 -KKLPDLPPSLEF---IAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LPDLPL--- 215
Query: 262 NLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRL 321
+LE++ N + + NL L ++ NN L +P L+ NV N L
Sbjct: 216 SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYL 269
Query: 322 E 322
Sbjct: 270 T 270
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-28
Identities = 63/319 (19%), Positives = 106/319 (33%), Gaps = 55/319 (17%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSAD------ 56
+P+ + L + G N +P NL L+ + N+L
Sbjct: 167 KLPDLPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKKLPDLPLSLESIV 221
Query: 57 ----QWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKE 112
L L N L + +N L LP L + L+ + + L +P+
Sbjct: 222 AGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPS----LEALNVRDNYLT-DLPEL 275
Query: 113 IGNLRGLIVLSLGFNDLNGTIP-------------TSIGTLQQLQGFYVPENNLQGYVPH 159
+L L V F+ L+ P + L+ V N L +P
Sbjct: 276 PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA 334
Query: 160 DLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRIN 219
LERL S N L+ +P +L+ L+++ N L P S+E +
Sbjct: 335 LPPRLERLI---ASFNHLA-EVP---ELPQNLKQLHVEYNPLRE-FPDIPESVE-----D 381
Query: 220 LSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPE 279
L NS +P Q L L + N L P ++++L + + P
Sbjct: 382 LRMNSHLAEVPELPQNLKQL---HVETNPLRE-FPDIPESVEDLR---MNSERVVDPYEF 434
Query: 280 SVGNLISLESLDFSNNNLS 298
+ LE F +++
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-33
Identities = 69/296 (23%), Positives = 116/296 (39%), Gaps = 51/296 (17%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
++P L L++ N + +P L LS+ S + +L S
Sbjct: 75 SLPALPPE---LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS--------- 121
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L L + N L LP L LQ + + +L S+P L L
Sbjct: 122 ------GLCKLWIFGNQLTS-LPVLPPG----LQELSVSDNQLA-SLPALPSELC---KL 166
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
N L ++P LQ+L V +N L +P L +L N N+L+ ++P
Sbjct: 167 WAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLP 217
Query: 183 QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL 242
A + L+ L + N+L+S LP L+ + +S N L +LP L L
Sbjct: 218 ---ALPSGLKELIVSGNRLTS-LPVLPSELKEL---MVSGNRLT-SLPMLPSGLLSL--- 266
Query: 243 DLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
+ RNQL+ +P ++ L + T++L GN +++ + S +S +
Sbjct: 267 SVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAP--GYSGPIIR 319
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-33
Identities = 74/324 (22%), Positives = 133/324 (41%), Gaps = 52/324 (16%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
T+P+ + + L + N+ + +P LR L V N LT S
Sbjct: 54 TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLEVSG---NQLT---------SLPV 98
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L+ + L P L L ++ F +L S+P L+ L
Sbjct: 99 LPPGLLELSIFSNPLTHL----PALPSG----LCKLWIFGNQLT-SLPVLPPGLQ---EL 146
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
S+ N L ++P L +L + N L +P L+ L+ +S N+L+ ++P
Sbjct: 147 SVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPSGLQELS---VSDNQLA-SLP 197
Query: 183 QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL 242
+ L L+ +N+L+S LP+ L+ + +S N L +LP +L L
Sbjct: 198 ---TLPSELYKLWAYNNRLTS-LPALPSGLK---ELIVSGNRLT-SLPVLPSELKEL--- 246
Query: 243 DLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIP 302
+S N+L+S +P L +LS+ NQ +PES+ +L S +++ N LS +
Sbjct: 247 MVSGNRLTS-LPMLPS---GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTL 301
Query: 303 KSLEALSHLKQFNVSHNRLEGEIP 326
++L ++ ++ R +
Sbjct: 302 QALREITSAPGYSGPIIRFDMAGA 325
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 3e-20
Identities = 47/183 (25%), Positives = 71/183 (38%), Gaps = 40/183 (21%)
Query: 162 CHLERLNILNLSGNKLSGAIPQCL------------------ASLTSLRSLYLQSNKLSS 203
C +LN+ + L+ +P CL A LR+L + N+L +
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQL-T 94
Query: 204 SLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNL 263
SLP L + + L LPS + K L + NQL+S +P L
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCK------LWIFGNQLTS-LPVLPP---GL 143
Query: 264 ETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEG 323
+ LS++ NQ +P L L NN L+ +P L L +VS N+L
Sbjct: 144 QELSVSDNQLAS-LPALPSE---LCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA- 194
Query: 324 EIP 326
+P
Sbjct: 195 SLP 197
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 52/291 (17%), Positives = 87/291 (29%), Gaps = 60/291 (20%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSG----------------HIPNTFGNLRHLSVLSLMMN 46
++P +L L +P L+ LSV N
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSD---N 151
Query: 47 NLTTESSSADQWSFLSSLTN--------CRNLANLALASNPLGGILPPLIGNFSASLQNI 98
L + + + L + N L L+++ N L LP L L +
Sbjct: 152 QLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLPTLPSE----LYKL 206
Query: 99 YAFECKLGGSIPKEIGNLRGLIV-----------------LSLGFNDLNGTIPTSIGTLQ 141
+A+ +L S+P L+ LIV L + N L ++P L
Sbjct: 207 WAYNNRLT-SLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPMLPSGLL 264
Query: 142 QLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKL 201
L V N L +P L HL +NL GN LS + S S +
Sbjct: 265 SL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQAL--REITSAPGYSGPI 317
Query: 202 SSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSD 252
+ + L + +P+ + + + ++D
Sbjct: 318 IRFDMAGASAPR--ETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNAD 366
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 435 LGTGGFGSVYKGTLSDG------TNVAIKIFN-LQLERAFRSFDSECEILRNVRHRNLLK 487
LG G FG VY+G +S VA+K + E+ F E I+ H+N+++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSH------NYFLDILQRLNIMIDVGSALEYLH 541
+G + ++LE M G L+ +L L +L L++ D+ +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 542 HCHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
IH D+ N LL VA + DFG+++ + M + +M
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFT 625
PE EGI ++K D +S+GVLL E F+
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 435 LGTGGFGSVYKGTLSDG------TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLK 487
LG FG VYKG L VAIK + F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILQRLNIMID 532
+LG + +++ + +G L ++L L+ ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 533 VGSALEYL--HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590
+ + +EYL HH +H DL N+L+ + + +SD G+ + + + + +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ I +MAPE G S D++SYGV+L E F+
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-33
Identities = 57/321 (17%), Positives = 114/321 (35%), Gaps = 27/321 (8%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
I N + + +S + + + ++ L L N L+ S++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAAD-------- 53
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLS 123
L L L L+SN L L + + S +L+ + + +E+ + L
Sbjct: 54 LAPFTKLELLNLSSNVLYETLD--LESLS-TLRTLDLNNNYV-----QELLVGPSIETLH 105
Query: 124 LGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG-AIP 182
N+++ + S Q + Y+ N + D R+ L+L N++
Sbjct: 106 AANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 183 QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL 242
+ AS +L L LQ N + + + + ++LSSN L + Q + +
Sbjct: 163 ELAASSDTLEHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 243 DLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ-GPIPESVGNLISLESLDFSNNNLSGKI 301
L N+L I + +NLE L GN F G + + ++++ +
Sbjct: 220 SLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLT 276
Query: 302 PKSLEALSHLKQFNVSHNRLE 322
++ E + + E
Sbjct: 277 GQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-29
Identities = 41/216 (18%), Positives = 87/216 (40%), Gaps = 13/216 (6%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
+I + N + + + L + + + ++ + N L DL +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
+LNLS N L + L SL++LR+L L +N + L I ++ ++N++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG-PIPESVGNLIS 286
+ + ++ L+ N+++ G ++ L L N+ E + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 287 LESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
LE L+ N + + + + LK ++S N+L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 48/358 (13%), Positives = 98/358 (27%), Gaps = 41/358 (11%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWS---- 59
+ + +A + LDL N S L +L+L N L +
Sbjct: 26 LASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTL 85
Query: 60 -----FLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIG 114
++ L ++ L A+N + + G +NIY K+ + G
Sbjct: 86 DLNNNYVQELLVGPSIETLHAANNNISRV-SCSRGQ---GKKNIYLANNKITMLRDLDEG 141
Query: 115 NLRGLIVLSLGFNDLNG-TIPTSIGTLQQLQGFYVPENNLQG------------------ 155
+ L L N+++ + L+ + N +
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
Query: 156 ---YVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSL 212
++ + + ++L NKL I + L +L L+ N +S
Sbjct: 202 KLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
Query: 213 EYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQ 272
++ ++ ++K N ++ V L L+ A
Sbjct: 261 NQRVQ-TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319
Query: 273 FQG----PIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
QG + N +D I + L+ ++
Sbjct: 320 GQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 44/315 (13%), Positives = 90/315 (28%), Gaps = 18/315 (5%)
Query: 12 TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLA 71
+ L N + G + L L +N + T + + + L
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE-------LAASSDTLE 172
Query: 72 NLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNG 131
+L L N + + + A L+ + KL + E + G+ +SL N L
Sbjct: 173 HLNLQYNFIYDV-KGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 132 TIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSL 191
I ++ Q L+ F + N D + + ++ + Q T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 192 RSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQK----LNVLIDLDLSRN 247
+ + L + R + S +G+ ++ ++D +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 248 QLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEA 307
Q + I + TL + L+ ++ + E
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEE 405
Query: 308 LSHLKQFNVSHNRLE 322
S L+ R E
Sbjct: 406 QSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 29/291 (9%), Positives = 64/291 (21%), Gaps = 15/291 (5%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+ +A + + L N I ++L L N + F S
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD----FFS 259
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
+ +A + L + L L
Sbjct: 260 KNQRVQTVAKQTVKK------LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRK 313
Query: 123 SLGFNDLNG----TIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS 178
G + + + + + + + L L
Sbjct: 314 EHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV 238
+ + L Q+ ++ L + + + + N
Sbjct: 374 EQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNA 433
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLES 289
+ D D+ +++ + K LA + E V +L S
Sbjct: 434 IRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 13/77 (16%), Positives = 28/77 (36%)
Query: 253 IPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLK 312
I + + + + + + +++ LD S N LS L + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 313 QFNVSHNRLEGEIPVKG 329
N+S N L + ++
Sbjct: 62 LLNLSSNVLYETLDLES 78
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-33
Identities = 74/326 (22%), Positives = 117/326 (35%), Gaps = 17/326 (5%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIP-NTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
I +L L L N S ++ L L V L++ + +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF--RNEGNLEKFDK 248
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFS--ASLQNIYAFECKLGGSIPKEIGNLRGL 119
S+L NL L L +I F+ ++ + + + N G
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI-ERVKDFSYN-FGW 306
Query: 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS- 178
L L + +L++L N L L L+LS N LS
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSF 361
Query: 179 -GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKL 236
G Q TSL+ L L N + ++ S+ LE + ++ ++LK ++ L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 237 NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNN 295
LI LD+S L +LE L +AGN FQ + L +L LD S
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 296 NLSGKIPKSLEALSHLKQFNVSHNRL 321
L P + +LS L+ N++ N+L
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-31
Identities = 60/327 (18%), Positives = 113/327 (34%), Gaps = 24/327 (7%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHI------PNTFGNLRHLSVLSLMMNNLTTESSSADQW 58
I L L L F + L +L++ + L
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD---- 273
Query: 59 SFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRG 118
+ N+++ +L S + + +++ Q++ CK G P L+
Sbjct: 274 -IIDLFNCLTNVSSFSLVSVTIERVKD---FSYNFGWQHLELVNCKFG-QFPT--LKLKS 326
Query: 119 LIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQ--GYVPHDLCHLERLNILNLSGNK 176
L L+ N + + L L+ + N L G L L+LS N
Sbjct: 327 LKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 177 LSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKGTLPSNIQK 235
+ + L L L Q + L S++ SL ++ +++S +
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 236 LNVLIDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSN 294
L+ L L ++ N + I L+NL L L+ Q + P + +L SL+ L+ ++
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503
Query: 295 NNLSGKIPKSLEALSHLKQFNVSHNRL 321
N L + L+ L++ + N
Sbjct: 504 NQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-31
Identities = 75/365 (20%), Positives = 120/365 (32%), Gaps = 45/365 (12%)
Query: 5 PNSITNATKLIGLDLGLNSF-SGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
I + L L++ N S +P F NL +L L L N + + + L
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD--LRVLHQ 174
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKE-IGNLRGLIVL 122
+ +L L+ NP+ I P L + ++ K I L GL V
Sbjct: 175 MPL--LNLSLDLSLNPMNFIQPGAFKEIR--LHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230
Query: 123 SL---GFNDLNGTIPTSIGTLQQLQGFYVPENNLQGY------VPHDLCHLERLNILNLS 173
L F + L+ L + E L + L ++ +L
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 174 GNKLSGAIPQ-------------------CLASLTSLRSLYLQSNKLSSSLP-SSLWSLE 213
+ L SL+ L SNK ++ L SLE
Sbjct: 291 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLE 350
Query: 214 YILRINLSSNSL--KGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGN 271
++ +LS N L KG + L LDLS N + + + S L+ LE L +
Sbjct: 351 FL---DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406
Query: 272 QFQGPIPESV-GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGS 330
+ SV +L +L LD S+ + LS L+ ++ N +
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDI 465
Query: 331 FKDFS 335
F +
Sbjct: 466 FTELR 470
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-29
Identities = 57/301 (18%), Positives = 105/301 (34%), Gaps = 24/301 (7%)
Query: 5 PNSITNATKLIGLDLGLNS---FSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
+++ L + L + I + F L ++S SL+ + +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER----------V 297
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
+ +L L + G SL+ + K G + + +L L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQ----FPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEF 351
Query: 122 LSLGFNDLN--GTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
L L N L+ G S L+ + N + + + LE+L L+ + L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 180 AIPQC-LASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLN 237
SL +L L + + L + + ++ NS + +I +L
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 238 VLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNL 297
L LDLS+ QL P+ +L +L+ L++A NQ + L SL+ + N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
Query: 298 S 298
Sbjct: 531 D 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 63/363 (17%), Positives = 116/363 (31%), Gaps = 48/363 (13%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
+ + + L L L N F L L L + NL + + +
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP--------I 120
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGL----I 120
+ + L L +A N + P + +L+++ K+ ++ L + +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCH-LERLNILNL------S 173
L L N +N I +L + N V L L + L +
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 174 GNKLSGAIPQCLASLTSLRSLYLQSNKL---SSSLPSSLWSLEYILRINLSSNSLKGTLP 230
L L L +L + L + L + +L S +++
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 231 ----SNIQKLNV---------------LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGN 271
Q L + L L + N+ + S + L +LE L L+ N
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-AFSEVD-LPSLEFLDLSRN 357
Query: 272 Q--FQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKG 329
F+G +S SL+ LD S N + + + L L+ + H+ L+ ++
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFS 415
Query: 330 SFK 332
F
Sbjct: 416 VFL 418
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 71/333 (21%), Positives = 123/333 (36%), Gaps = 32/333 (9%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
IP+++ +TK LDL N +F + L VL L + T A
Sbjct: 22 IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA-------- 71
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLS 123
+ +L+ L L NP+ + S SLQ + A E L IG+L+ L L+
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 124 LGFNDLN-GTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNI----LNLSGNKLS 178
+ N + +P L L+ + N +Q DL L ++ + L+LS N ++
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLP-------SSLWSLEYILRINLSSNSLKGTLPS 231
P + L L L++N S ++ + L +L + +L+ S
Sbjct: 191 FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 232 NIQKLNVLIDLDLSRNQL---SSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLE 288
++ L L + L DI L N+ + SL + + + N +
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQ 307
Query: 289 SLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRL 321
L+ N L++L L + N+
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRL---TFTSNKG 337
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-25
Identities = 41/199 (20%), Positives = 75/199 (37%), Gaps = 8/199 (4%)
Query: 133 IPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192
IP ++ + + N L+ + L +L+LS ++ SL+ L
Sbjct: 22 IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 193 SLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS- 251
+L L N + S + L + ++ +L I L L +L+++ N + S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 252 DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLE----SLDFSNNNLSGKIPKSLEA 307
+P L NLE L L+ N+ Q + L + SLD S N ++ I
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 308 LSHLKQFNVSHNRLEGEIP 326
L + + +N +
Sbjct: 199 EIRLHKLTLRNNFDSLNVM 217
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-22
Identities = 46/265 (17%), Positives = 91/265 (34%), Gaps = 15/265 (5%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTF-GNLRHLSVLSLMMNNLTTESS--------S 54
I + T + L + ++ +HL +++ T +
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT 333
Query: 55 ADQWSFLSSLTNCRNLANLALASNPLGGI-LPPLIGNFSASLQNIYAFECKLGGSIPKEI 113
+++ S + +L L L+ N L + SL+ + + ++
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 392
Query: 114 GNLRGLIVLSLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNL 172
L L L ++L S+ +L+ L + + + L L +L +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 173 SGNKLSGAIPQ-CLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPS 231
+GN L +L L L +L P++ SL + +N++SN LK ++P
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPD 511
Query: 232 NI-QKLNVLIDLDLSRNQLSSDIPS 255
I +L L + L N P
Sbjct: 512 GIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-21
Identities = 34/156 (21%), Positives = 65/156 (41%), Gaps = 4/156 (2%)
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
IP L S ++L L N L S +S + ++LS ++
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISL 287
Q L+ L L L+ N + S L +L+ L +G+L +L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 288 ESLDFSNNNL-SGKIPKSLEALSHLKQFNVSHNRLE 322
+ L+ ++N + S K+P+ L++L+ ++S N+++
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-15
Identities = 41/214 (19%), Positives = 70/214 (32%), Gaps = 14/214 (6%)
Query: 6 NSITNATKLIGLDLGLN--SFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
S + L LDL N SF G + L L L N + + S+
Sbjct: 341 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI---------TMSSN 391
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLS 123
L +L + L + + +L + + L L VL
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 124 LGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHD-LCHLERLNILNLSGNKLSGAI 181
+ N I L+ L + + L+ + L L +LN++ N+L
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVP 510
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYI 215
LTSL+ ++L +N S P + ++
Sbjct: 511 DGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 69/321 (21%), Positives = 110/321 (34%), Gaps = 37/321 (11%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P I T+L LDLG N + F + HL L L N ++ A
Sbjct: 25 AVPEGIPTETRL--LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA------- 75
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIV 121
N NL L L SN L IP + L L
Sbjct: 76 -FNNLFNLRTLGLRSNRL--------------------------KLIPLGVFTGLSNLTK 108
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L + N + + L L+ V +N+L L L L L L+
Sbjct: 109 LDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP 168
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
+ L+ L L L L+ +++ S L + + +S T+ N L
Sbjct: 169 TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
L ++ L++ + L L L+L+ N + L+ L+ + L+
Sbjct: 229 LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288
Query: 302 PKSLEALSHLKQFNVSHNRLE 322
P + L++L+ NVS N+L
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 64/296 (21%), Positives = 114/296 (38%), Gaps = 13/296 (4%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
+ + L L+L N S P F NL +L L L N L
Sbjct: 49 QDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGV--------F 100
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIVLS 123
T NL L ++ N + +L + + +L+++ + L I L L L+
Sbjct: 101 TGLSNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLV-YISHRAFSGLNSLEQLT 158
Query: 124 LGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQ 183
L +L ++ L L + N+ + L RL +L +S +
Sbjct: 159 LEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218
Query: 184 CLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDL 242
+L SL + L++ ++ L Y+ +NLS N + T+ ++ +L L ++
Sbjct: 219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEI 277
Query: 243 DLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
L QL+ P L L L+++GNQ ++ +LE+L +N L+
Sbjct: 278 QLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 61/320 (19%), Positives = 106/320 (33%), Gaps = 43/320 (13%)
Query: 18 DLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALAS 77
+ IP +L L N + T + + +L L L
Sbjct: 20 RKRFVAVPEGIP------TETRLLDLGKNRIKTLNQDE--------FASFPHLEELELNE 65
Query: 78 NPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSI 137
N + + P AF NL L L L N L IP +
Sbjct: 66 NIVSAVEP-------------GAFN------------NLFNLRTLGLRSNRLK-LIPLGV 99
Query: 138 -GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYL 196
L L + EN + + + L L L + N L + + L SL L L
Sbjct: 100 FTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTL 159
Query: 197 QSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPST 256
+ L+S +L L ++ + L ++ + ++L L L++S +
Sbjct: 160 EKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
Query: 257 IGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNV 316
NL +LS+ +V +L+ L L+ S N +S L L L++ +
Sbjct: 220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQL 279
Query: 317 SHNRLEGEIPVKGSFKDFSA 336
+L + +F+ +
Sbjct: 280 VGGQLA-VVE-PYAFRGLNY 297
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 433 NLLGTGGFGSVYKGTLSDG---TNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLK 487
+++G G FG V K + + AIK + R F E E+L + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILQRLNIMID 532
+LG+C + + L +E+ P+G+L +L L Q L+ D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
V ++YL S IH DL NIL+ EN VA ++DFG+S+ E V +TM
Sbjct: 151 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MA E + + +T DV+SYGVLL E +
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 435 LGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLL 486
LG G FG V + + VA+K+ R+ SE +IL ++ H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 487 KILGSCSNLDFKALV-LEFMPNGSLEKWLYSH---------------NYFLDILQRLNIM 530
+LG+C+ +V +EF G+L +L S FL + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590
V +E+L +S IH DL NILL E V + DFG+++ + + D V +
Sbjct: 155 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + + + DV+S+GVLL E F+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 70/292 (23%), Positives = 112/292 (38%), Gaps = 41/292 (14%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSC 492
LG GGF V L DG A+K ++ E ++ R H N+L+++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 493 SNLDFKA----LVLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHS 545
L+L F G+L + FL Q L +++ + LE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---- 151
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-------TIGYMA 598
+ H DLKPTNILL + + D G + Q +T+ TI Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 599 PE----YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654
PE I + DV+S G +L + P D +F S+ V+ L
Sbjct: 212 PELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS----- 265
Query: 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706
+ + S + L + M + +D PH+R H+ ++L ++
Sbjct: 266 ------IPQSPRHSSALWQLLNSM-MTVD-----PHQRPHIPLLLSQLEALQ 305
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSC 492
+LG G +G VY G LS+ +AIK + R + E + ++++H+N+++ LGS
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL--NIMIDVGSALEYLHHCHSSAPII 550
S F + +E +P GSL L S L ++ + L+YLH I+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ----IV 144
Query: 551 HCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--YGSEGIV 607
H D+K N+L++ + V +SDFG SK L G + +T T T+ YMAPE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFT-GTLQYMAPEIIDKGPRGY 202
Query: 608 STKCDVYSYGVLLMETFTEKKP 629
D++S G ++E T K P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 33/216 (15%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFN-LQLERAFRSFDSECEILRNVRHRN 484
+ ++LG G +V++G G AIK+FN + R E E+L+ + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 485 LLKILG--SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--LNIMIDVGSALEYL 540
++K+ + K L++EF P GSL L + + + L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 541 HHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGEDSVIQTMTMATI-- 594
I+H ++KP NI+ D V ++DFG ++ L + E ++
Sbjct: 129 RENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVSLYG 177
Query: 595 --GYMAPEYGSEGIVST--------KCDVYSYGVLL 620
Y+ P+ ++ D++S GV
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 30/225 (13%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNL-QLERAFRSFDSECEILRNVR 481
R +F LG GGFG V++ D N AIK L E A E + L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 482 HRNLLKILGSCSNLDFKA------------LVLEFMPNGSLEKWLYSHN--YFLDILQRL 527
H +++ + + + ++ +L+ W+ + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 528 NIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---- 583
+I + + A+E+LH ++H DLKP+NI + V V DFG+ + + E+
Sbjct: 122 HIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 584 ---SVIQTMTMATIG---YMAPEYGSEGIVSTKCDVYSYGVLLME 622
+G YM+PE S K D++S G++L E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 46/241 (19%), Positives = 82/241 (34%), Gaps = 16/241 (6%)
Query: 394 RCRNRSTKHLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGT 452
+ + + D+E L + Y + R +G G FG V++ G
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 453 NVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEK 512
A+K L+ E + ++ + G+ + + +E + GSL +
Sbjct: 85 QCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 513 WLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN-MVAHVSD 571
+ + + LEYLH I+H D+K N+LL + A + D
Sbjct: 140 LIKQMGCLPEDRAL-YYLGQALEGLEYLHTRR----ILHGDVKADNVLLSSDGSRAALCD 194
Query: 572 FGISKLLGEGEDSVIQTMTMATIG---YMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKK 628
FG + L G +MAPE K D++S +++
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
Query: 629 P 629
P
Sbjct: 255 P 255
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 67/343 (19%), Positives = 116/343 (33%), Gaps = 36/343 (10%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
+P + +L L N ++F L L +L L +
Sbjct: 19 VPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK-------EA 68
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSI--PKEIGNLRGLIV 121
N NL L L S+ + + P L + + C L ++ NL+ L
Sbjct: 69 FRNLPNLRILDLGSSKIYFLHPDAFQGLF-HLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
Query: 122 LSLGFNDLNG-TIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLE--RLNILNLSGNKLS 178
L L N + + S G L L+ N + H+L L+ L+ +L+ N L
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
Query: 179 GAIPQCLASL------TSLRSLYLQSNKLSSSLPS------------SLWSLEYILRINL 220
+ L L + N + + SL +I+
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247
Query: 221 SSNSLKGTLPSNIQKLNV--LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP 278
+++K + L + LDLS + S TLK+L+ L+LA N+
Sbjct: 248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD 307
Query: 279 ESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRL 321
E+ L +L+ L+ S N L + L + ++ N +
Sbjct: 308 EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 60/343 (17%), Positives = 113/343 (32%), Gaps = 33/343 (9%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHI-PNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
+S +L L+LG I F NL +L +L L + + A
Sbjct: 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA-------- 92
Query: 64 LTNCRNLANLALASNPL-GGILPPLIGNFSASLQNIYAFECKLGG-SIPKEIGNLRGLIV 121
+L L L L +L +L + + ++ + G L L
Sbjct: 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKS 152
Query: 122 LSLGFNDLNGTIPTSIGTLQQ--LQGFYVPENNLQGYVPHDLCHLE------RLNILNLS 173
+ N + + LQ L F + N+L V D L IL++S
Sbjct: 153 IDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS 212
Query: 174 GNKLSGAIP------------QCLASLTSLRSLYLQSNKLSSSLPSSLWSLE--YILRIN 219
GN + I L + + + ++ L + ++
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 220 LSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPE 279
LS + + L L L+L+ N+++ L NL+ L+L+ N
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332
Query: 280 SVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
+ L + +D N+++ ++ + L L+ ++ N L
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 63/319 (19%), Positives = 120/319 (37%), Gaps = 23/319 (7%)
Query: 10 NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRN 69
N + N+ S + H+ +N+ + SS+ +
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH--- 270
Query: 70 LANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDL 129
L L+ + + + L+ + K+ + L L VL+L +N L
Sbjct: 271 ---LDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 130 NGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLT 189
++ L ++ + +N++ LE+L L+L N L+ + +
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIP 381
Query: 190 SLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG-TLPSNIQKLNVLIDLDLSRNQ 248
S+ ++L NKL + LP + I +LS N L+ + + ++ L L L++N+
Sbjct: 382 SIPDIFLSGNKLVT-LPKINLTANLI---HLSENRLENLDILYFLLRVPHLQILILNQNR 437
Query: 249 LSS-DIPSTIGTLKNLETLSLAGNQFQGPIPESV-----GNLISLESLDFSNNNLSGKIP 302
SS T +LE L L N Q + L L+ L ++N L+ P
Sbjct: 438 FSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPP 497
Query: 303 KSLEALSHLKQFNVSHNRL 321
L+ L+ +++ NRL
Sbjct: 498 GVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 57/320 (17%), Positives = 101/320 (31%), Gaps = 45/320 (14%)
Query: 5 PNSITNATKLIGLDLGLNSFSG-HIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
N L LDL N ++ +FG L L + N + L
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE-----LEP 170
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLS 123
L + L+ +LA+N L + G +N+ L +L
Sbjct: 171 LQG-KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV-------------------LEILD 210
Query: 124 LGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQ 183
+ N I + N + L + + +
Sbjct: 211 VSGNGWTVDITGNF------------SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 184 CLASL--TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
A L +S+R L L + S +L+ + +NL+ N + L+ L
Sbjct: 259 TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQV 318
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
L+LS N L S L + + L N ++ L L++LD +N L+
Sbjct: 319 LNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT--- 375
Query: 302 PKSLEALSHLKQFNVSHNRL 321
++ + + +S N+L
Sbjct: 376 --TIHFIPSIPDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-28
Identities = 75/341 (21%), Positives = 128/341 (37%), Gaps = 29/341 (8%)
Query: 13 KLIGLDLGLNSFSGHIPNTFGNL------RHLSVLSLMMNNLTTE----SSSADQWSFLS 62
L L NS + +G L +L + N T + S+A S
Sbjct: 175 TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAF 234
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGN-FSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
SL ++ + + +S++++ + + L+ L V
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKV 294
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L+L +N +N + L LQ + N L + L ++ ++L N ++
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ 354
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
Q L L++L L+ N L++ + + I I LS N L TLP N++
Sbjct: 355 DQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLV-TLPKINLTANLI-- 406
Query: 242 LDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQG-PIPESVGNLISLESLDFSNNNLSG 299
LS N+L + DI + + +L+ L L N+F ++ SLE L N L
Sbjct: 407 -HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 300 KIPKSLEA-----LSHLKQFNVSHNRLEGEIPVKGSFKDFS 335
L LSHL+ ++HN L +P G F +
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLN-SLP-PGVFSHLT 504
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 54/331 (16%), Positives = 110/331 (33%), Gaps = 26/331 (7%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
+ S L +D N + L+ ++ + + S + W +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLS 123
L L ++ N + F + S + ++
Sbjct: 200 PFRNMVLEILDVSGNGWTVDIT-------------GNFSNAISKSQAFSLILAHHIMGAG 246
Query: 124 LGFNDLNGTIPTSIGTLQQ--LQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
GF+++ + L + ++ + + L+ L +LNL+ NK++
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA 306
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
+ L +L+ L L N L S+ + L + I+L N + + L L
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG-K 300
LDL N L +TI + ++ + L+GN+ + ++ + S N L
Sbjct: 367 LDLRDNAL-----TTIHFIPSIPDIFLSGNK----LVTLPKINLTANLIHLSENRLENLD 417
Query: 301 IPKSLEALSHLKQFNVSHNRLEGEIPVKGSF 331
I L + HL+ ++ NR +
Sbjct: 418 ILYFLLRVPHLQILILNQNRFS-SCSGDQTP 447
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-23
Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 16/218 (7%)
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
+ F +L +P + T ++L + N ++ LE+L +L L
Sbjct: 8 IAFYRFCNLT-QVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 181 I-PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTL--PSNIQKLN 237
I + +L +LR L L S+K+ P + L ++ + L L + + L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 238 VLIDLDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNL--ISLESLDFSN 294
L LDLS+NQ+ S + + G L +L+++ + NQ + L +L +
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 295 NNLSGKIPKSLEALS------HLKQFNVSHNRLEGEIP 326
N+L ++ L+ +VS N +I
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT 221
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 5e-17
Identities = 67/330 (20%), Positives = 124/330 (37%), Gaps = 33/330 (10%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQW------ 58
+ L L+L N + F L ++ + L N++ ++
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366
Query: 59 -----SFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGG-SIPKE 112
+ L+++ ++ ++ L+ N L + + + I+ E +L I
Sbjct: 367 LDLRDNALTTIHFIPSIPDIFLSGNKLVTL-----PKINLTANLIHLSENRLENLDILYF 421
Query: 113 IGNLRGLIVLSLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDLC-----HLER 166
+ + L +L L N + L+ ++ EN LQ +LC L
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 167 LNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK 226
L +L L+ N L+ P + LT+LR L L SN+L+ + L + IL ++S N L
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEIL--DISRNQLL 539
Query: 227 GTLPSNIQKLNVLIDLDLSRNQLSSDIP-STIGTLKNLETLSLAGNQFQ----GPIPESV 281
P L+V LD++ N+ + ST N +++AG P S
Sbjct: 540 APNPDVFVSLSV---LDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSG 596
Query: 282 GNLISLESLDFSNNNLSGKIPKSLEALSHL 311
+L SL + + + SL + +
Sbjct: 597 VSLFSLSTEGCDEEEVLKSLKFSLFIVCTV 626
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 31/145 (21%), Positives = 53/145 (36%), Gaps = 8/145 (5%)
Query: 190 SLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQL 249
R + + L+ +P L + E + LS N ++ S+ L L L+L
Sbjct: 5 DGRIAFYRFCNLTQ-VPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 250 SSDI-PSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI--PKSLE 306
I L NL L L ++ P++ L L L LS +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120
Query: 307 ALSHLKQFNVSHNRLEGEIPVKGSF 331
L L + ++S N++ + + SF
Sbjct: 121 NLKALTRLDLSKNQIR-SLYLHPSF 144
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 24/116 (20%), Positives = 44/116 (37%), Gaps = 5/116 (4%)
Query: 219 NLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP 278
+L +P + L LS N + + S+ L+ L+ L L I
Sbjct: 10 FYRFCNLT-QVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 279 ESV-GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKD 333
+ NL +L LD ++ + P + + L HL + + L + G F++
Sbjct: 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 435 LGTGGFGSVYKGTLSDG------TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLK 487
LG G FG V K T T VA+K+ R SE +L+ V H +++K
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSH-----------------------NYFLDIL 524
+ G+CS L++E+ GSL +L L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 525 QRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584
++ + ++YL + ++H DL NIL+ E +SDFG+S+ + E +
Sbjct: 151 DLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
V ++ + +MA E + I +T+ DV+S+GVLL E T
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 435 LGTGGFGSVYKGTLSD--------GTNVAIKIFN-LQLERAFRSFDSECEILRNV-RHRN 484
LG G FG V VA+K+ E+ SE E+++ + +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILQRLNI 529
++ +LG+C+ +++E+ G+L ++L + + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
+ +EYL +S IH DL N+L+ EN V ++DFG+++ + + T
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 29/216 (13%)
Query: 435 LGTGGFGSVYKGTLSD------GTNVAIKIFNLQ-LERAFRSFDSECEILRNV-RHRNLL 486
LG G FG V + T VA+K+ + SE ++L + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSH-----------------NYFLDILQRLNI 529
+LG+C+ ++ E+ G L +L LD+ L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
V + +L +S IH DL NILL + + DFG+++ + + V++
Sbjct: 151 SYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + + DV+SYG+ L E F+
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 34/221 (15%)
Query: 435 LGTGGFGSVYKGTLSDG------TNVAIKIFN-LQLERAFRSFDSECEILRNVRHRNLLK 487
+G G FG V++ T VA+K+ F E ++ + N++K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSH-----------------------NYFLDIL 524
+LG C+ L+ E+M G L ++L S L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 525 QRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584
++L I V + + YL S +H DL N L+ ENMV ++DFG+S+ + +
Sbjct: 175 EQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
I +M PE +T+ DV++YGV+L E F+
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFN-LQLERAFRSFDSECEILRNVRHRN 484
+ ++LG G +V++G G AIK+FN + R E E+L+ + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 485 LLKILG--SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--LNIMIDVGSALEYL 540
++K+ + K L++EF P GSL L + + + L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 541 HHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIG 595
I+H ++KP NI+ D V ++DFG ++ L + E Q +++ T
Sbjct: 129 RENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEE 180
Query: 596 YMAPEYGSEGIVST--------KCDVYSYGVLL 620
Y+ P+ ++ D++S GV
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 39/224 (17%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQ-LERAFRSFDSECEILR-NVRHRN 484
+ +LG G G+V G VA+K + + A E ++L + H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPN 70
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL------NIMIDVGSALE 538
+++ S + F + LE N +L+ + S N + L+ +++ + S +
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 539 YLHHCHSSAPIIHCDLKPTNILLD-------------ENMVAHVSDFGISKLLGEGEDSV 585
+LH IIH DLKP NIL+ EN+ +SDFG+ K L G+ S
Sbjct: 130 HLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 586 IQTMTMA--TIGYMAPE-------YGSEGIVSTKCDVYSYGVLL 620
+ T G+ APE ++ ++ D++S G +
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 433 NLLGTGGFGSVYKGTLSD------GTNVAIKIFNLQ-LERAFRSFDSECEILRNV-RHRN 484
LG G FG V + T VA+K+ + SE +I+ ++ +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH-------------NYFLDILQRLNIMI 531
++ +LG+C++ ++ E+ G L +L N L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 532 DVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM 591
V + +L +S IH D+ N+LL VA + DFG+++ + + +++
Sbjct: 172 QVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 592 ATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + + + DV+SYG+LL E F+
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 13/210 (6%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIK---IFNLQLERAFRSFDSECEILRNVRH 482
F +G G F VY+ L DG VA+K IF+L +A E ++L+ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEY 539
N++K S + +VLE G L + + + + + SALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
+H ++H D+KP N+ + V + D G+ + + + ++ T YM+P
Sbjct: 152 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSP 205
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
E E + K D++S G LL E + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-31
Identities = 63/321 (19%), Positives = 109/321 (33%), Gaps = 49/321 (15%)
Query: 17 LDLGLNSFSGHIPNT-------FGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRN 69
L NSF I T + ++ N +
Sbjct: 11 FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC----------LINQ 60
Query: 70 LANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDL 129
+ L L L LP + + + + L S+P+ +L L N L
Sbjct: 61 FSELQLNRLNLS-SLPDNLPP---QITVLEITQNALI-SLPELPASLE---YLDACDNRL 112
Query: 130 NGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLT 189
+ T+P +L+ L V N L +P LE +N N+L+ +P T
Sbjct: 113 S-TLPELPASLKHL---DVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLP---ELPT 160
Query: 190 SLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKL----NVLIDLDLS 245
SL L +++N+L+ LP SLE +++S+N L+ +LP+ + I
Sbjct: 161 SLEVLSVRNNQLTF-LPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCR 215
Query: 246 RNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSL 305
N+++ IP I +L T+ L N I ES+ + D+ + +
Sbjct: 216 ENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP--DYHGPRIYFSMSDGQ 272
Query: 306 EALSHLKQFNVSHNRLEGEIP 326
+ H +
Sbjct: 273 QNTLHRPLADAVTAWFPENKQ 293
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 1e-16
Identities = 53/311 (17%), Positives = 99/311 (31%), Gaps = 54/311 (17%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
++P + L LD N S +P +L+HL V + N LT L
Sbjct: 94 SLPELPAS---LEYLDACDNRLS-TLPELPASLKHLDVDN---NQLTM----------LP 136
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L L + +N L LP L + L+ + +L +P+ +L L
Sbjct: 137 ELPA--LLEYINADNNQLTM-LPELPTS----LEVLSVRNNQL-TFLPELPESLE---AL 185
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
+ N L ++P + E N+++ IP
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSE--------------------ETEIFFRCRENRIT-HIP 223
Query: 183 QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL 242
+ + SL ++ L+ N LSS + SL + ++ Q
Sbjct: 224 ENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLA 281
Query: 243 DLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIP 302
D + S + + + N F + + + +S + ++
Sbjct: 282 DAVTAWFPENKQSDVSQIWHAFEHEEHANTFSA-FLDRLSDTVSARNTSGFREQVA-AWL 339
Query: 303 KSLEALSHLKQ 313
+ L A + L+Q
Sbjct: 340 EKLSASAELRQ 350
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 20/101 (19%), Positives = 34/101 (33%), Gaps = 12/101 (11%)
Query: 229 LPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAG---NQFQGPIPESVGNLI 285
LP N N + + N +S E +L G N+ + E +
Sbjct: 5 LPINN---NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC--LIN 59
Query: 286 SLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
L + NLS +P +L + ++ N L +P
Sbjct: 60 QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLP 96
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 435 LGTGGFGSVYKGTLSD--------GTNVAIKIFN-LQLERAFRSFDSECEILRNV-RHRN 484
LG G FG V VA+K+ E+ SE E+++ + +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILQRLNI 529
++ +LG+C+ +++E+ G+L ++L + + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
+ +EYL +S IH DL N+L+ EN V ++DFG+++ + + T
Sbjct: 209 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + + + + DV+S+GVL+ E FT
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 435 LGTGGFGSVYKGTL--------SDGTNVAIKIFN-LQLERAFRSFDSECEILRNV-RHRN 484
LG G FG V + T VA+K+ E+ SE E+++ + +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILQRLNI 529
++ +LG+C+ +++E+ G+L ++L + L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM 589
V +EYL +S IH DL N+L+ E+ V ++DFG+++ + + T
Sbjct: 197 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 590 TMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ +MAPE + I + + DV+S+GVLL E FT
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 60/338 (17%), Positives = 124/338 (36%), Gaps = 36/338 (10%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
I +++ + + + + + L + +++ + + ++
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL------- 64
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIV 121
L + R + L L + I ++Q +Y + +P + N+ L V
Sbjct: 65 -LDSFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIR-YLPPHVFQNVPLLTV 121
Query: 122 LSLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS-- 178
L L NDL+ ++P I +L + NNL+ L L LS N+L+
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180
Query: 179 --GAIP------------QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNS 224
IP LA ++ L N ++ L + L N+
Sbjct: 181 DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNN 237
Query: 225 LKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNL 284
L T + + L+++DLS N+L + ++ LE L ++ N+ + +
Sbjct: 238 L--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPI 294
Query: 285 ISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
+L+ LD S+N+L + ++ L+ + HN +
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 57/270 (21%), Positives = 99/270 (36%), Gaps = 27/270 (10%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
P+ N L L L N S F N L+ LS+ NNL
Sbjct: 110 PHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT--------F 161
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSL 124
+L NL L+SN L + SL + + ++ + + L
Sbjct: 162 QATTSLQNLQLSSNRLTHVDL---SLIP-SLFHAN-----VSYNLLSTLAIPIAVEELDA 212
Query: 125 GFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQC 184
N +N + +L + NNL L + L ++LS N+L +
Sbjct: 213 SHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHP 267
Query: 185 LASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL 244
+ L LY+ +N+L +L + + ++LS N L + N + + L +L L
Sbjct: 268 FVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 245 SRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
N + + + + T L+ L+L+ N +
Sbjct: 326 DHNSIVT-LK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 14/120 (11%), Positives = 38/120 (31%)
Query: 203 SSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKN 262
+ S+L +++ + LN + + + + + + +
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 263 LETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
+E L+L Q + + +++ L N + P + + L + N L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 30/208 (14%), Positives = 49/208 (23%), Gaps = 66/208 (31%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
T + N L+ +DL N + + F ++ L L + N L +
Sbjct: 239 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALN---------L 289
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L L L+ N L + + L L
Sbjct: 290 YGQPIPTLKVLDLSHNHL--------------------------LHVERNQPQFDRLENL 323
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
L N + T+ S L L LS N
Sbjct: 324 YLDHNSIV-TLKLST--------------------------HHTLKNLTLSHNDWDCN-- 354
Query: 183 QCLASL-TSLRSLYLQSNKLSSSLPSSL 209
L +L ++ + + L
Sbjct: 355 -SLRALFRNVARPAVDDADQHCKIDYQL 381
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 17/221 (7%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHR 483
+++ +GTG +G K SDG + K + E + SE +LR ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 484 NLLKILGSCSNLDFKAL--VLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALE 538
N+++ + L V+E+ G L + +LD L +M + AL+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 539 YLHHCHSSA-PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGY 596
H ++H DLKP N+ LD + DFG++++L T T Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKTFVGTPYY 182
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
M+PE + + K D++S G LL E P FT
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHR 483
+++ +G G FG DG IK N+ + E +L N++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHH 542
N+++ S +V+++ G L K + + Q L+ + + AL+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGYMAPEY 601
I+H D+K NI L ++ + DFGI+++L + T Y++PE
Sbjct: 144 RK----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE---LARACIGTPYYLSPEI 196
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+ K D+++ G +L E T K
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-31
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLER--AFRS-FDSECEILRNVRHRNLLKI- 488
L+G GG G VY+ VA+K+ + L FR+ E ++ +++ I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 489 -LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
G + + + + L L L + + I+ +GSAL+ H
Sbjct: 101 DFGEIDGQLY--VDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--- 154
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT-MTMATIGYMAPEYGSEGI 606
H D+KP NIL+ + A++ DFGI+ + + Q T+ T+ YMAPE SE
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASATTDE--KLTQLGNTVGTLYYMAPERFSESH 211
Query: 607 VSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
+ + D+Y+ +L E T P + G+
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-30
Identities = 56/353 (15%), Positives = 110/353 (31%), Gaps = 30/353 (8%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
+ L L L + + + F +L L L L N+L++ SSS
Sbjct: 43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSW--------F 94
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKE-IGNLRGLIVLS 123
+L L L NP + + +LQ + + I + L L L
Sbjct: 95 GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE 154
Query: 124 LGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQ 183
+ L S+ +++ + + + + L + L L L+
Sbjct: 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS 214
Query: 184 CLASLTSLRSLYLQSNKLSS----------SLPSSLWSLEYILRINLSSNSLKGTLPSNI 233
L + + + S L + L + + + N L PS
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES 274
Query: 234 QKLN--------VLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI 285
++ + L + + L D+ + L+ ++ +++ ++ +L
Sbjct: 275 DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLK 334
Query: 286 SLESLDFSNNNLSGKIPKS---LEALSHLKQFNVSHNRLEGEIPVKGSFKDFS 335
SLE LD S N + + K+ A L+ +S N L
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 65/350 (18%), Positives = 121/350 (34%), Gaps = 38/350 (10%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
S+ + + L L L+ + + L + L L NL S +SS
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGG---------SIPKEIGN 115
L +L L L + +C L G + E+G
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILE--LSEVEFDDCTLNGLGDFNPSESDVVSELGK 282
Query: 116 LRGLI--VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLS 173
+ + L + L + T L++++ V + + HL+ L L+LS
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLS 342
Query: 174 GNKLSGAI---PQCLASLTSLRSLYLQSNKLSS--SLPSSLWSLEYILRINLSSNSLKGT 228
N + C + SL++L L N L S L +L+ + +++S N+
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-P 401
Query: 229 LPSNIQKLNVLIDLDLSRNQLSS---DIPSTIGTLK--------------NLETLSLAGN 271
+P + Q + L+LS + IP T+ L L+ L ++ N
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRN 461
Query: 272 QFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRL 321
+ + +P++ L + S N L + L+ L++ + N
Sbjct: 462 KLKT-LPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-29
Identities = 56/327 (17%), Positives = 116/327 (35%), Gaps = 24/327 (7%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIP-NTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
+ + N T L L +G I F L L+ L + +L S +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS------ 167
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
L + R++ +L L + + + + +S++ + + L +
Sbjct: 168 --LKSIRDIHHLTLHLSESAFL-LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
+ + S L +L + + + ++ + + + ++
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVS 278
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLI 240
++R L++ L L + LE + RI + ++ + +P + Q L L
Sbjct: 279 ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLE 337
Query: 241 DLDLSRNQLSSDIPST---IGTLKNLETLSLAGNQFQ--GPIPESVGNLISLESLDFSNN 295
LDLS N + + G +L+TL L+ N + E + L +L SLD S N
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN 397
Query: 296 NLSGKIPKSLEALSHLKQFNVSHNRLE 322
+P S + ++ N+S +
Sbjct: 398 TFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 38/168 (22%), Positives = 73/168 (43%), Gaps = 4/168 (2%)
Query: 157 VPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYIL 216
+P L + L+LS NK++ L + +L+ L L+S+++++ + +SL +
Sbjct: 20 IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77
Query: 217 RINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQG 275
++LS N L S L+ L L+L N + + S L NL+TL + +
Sbjct: 78 HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 276 PIPESV-GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
I L SL L+ +L +SL+++ + + +
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 53/262 (20%), Positives = 97/262 (37%), Gaps = 21/262 (8%)
Query: 19 LGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASN 78
GL F+ + L + +++ ++ D + S L + + + ++
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK---VKRITVENS 320
Query: 79 PLGGILPPLIGNFSASLQNIYAFECKLGGSIPKE---IGNLRGLIVLSLGFNDLNGTIPT 135
+ + + SL+ + E + K G L L L N L ++
Sbjct: 321 KVFLVPCSFSQHLK-SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQK 378
Query: 136 SIGT---LQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192
+ L+ L + N +P E++ LNLS + + C+ +L
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLE 434
Query: 193 SLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSD 252
L + +N L S L L+ + +S N LK TLP VL+ + +SRNQL S
Sbjct: 435 VLDVSNNNLDS-FSLFLPRLQ---ELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSV 488
Query: 253 IPSTIGTLKNLETLSLAGNQFQ 274
L +L+ + L N +
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-21
Identities = 42/177 (23%), Positives = 72/177 (40%), Gaps = 9/177 (5%)
Query: 162 CHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLS 221
+ + + + +IP L +++SL L NK++ L + + + L
Sbjct: 2 LSCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58
Query: 222 SNSLKGTLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG-PIPE 279
S+ + T+ + L L LDLS N LSS S G L +L+ L+L GN +Q +
Sbjct: 59 SSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 280 SVGNLISLESLDFSNNNLSGKIPK-SLEALSHLKQFNVSHNRLEGEIPVKGSFKDFS 335
NL +L++L N +I + L+ L + + L S K
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQ-SQSLKSIR 172
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 45/248 (18%), Positives = 88/248 (35%), Gaps = 24/248 (9%)
Query: 10 NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRN 69
+ L + + + L + +++ + + S + ++
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF--------SQHLKS 335
Query: 70 LANLALASNPLGGILPPLIGNFSA--SLQNIYAFECKLGGSIPKEIG---NLRGLIVLSL 124
L L L+ N + A SLQ + + L S+ K L+ L L +
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDI 394
Query: 125 GFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQC 184
N + +P S ++++ + ++ V C + L +L++S N L +
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFS-- 447
Query: 185 LASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL 244
L L+ LY+ NKL + LP + +L + +S N LK +L L + L
Sbjct: 448 -LFLPRLQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504
Query: 245 SRNQLSSD 252
N
Sbjct: 505 HTNPWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 39/227 (17%), Positives = 70/227 (30%), Gaps = 32/227 (14%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
+ K+ + + + + +L+ L L L N + E +
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS-----ACK 357
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFS--ASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
+L L L+ N L + +L ++ +P + L
Sbjct: 358 GAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNI------------- 169
+L + + T I Q L+ V NNL L L+ L I
Sbjct: 416 NLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELYISRNKLKTLPDASL 471
Query: 170 ------LNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW 210
+ +S N+L LTSL+ ++L +N S P +
Sbjct: 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 518
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKIL 489
LG GG +VY VAIK + E + F+ E + H+N++ ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 490 --GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
+ + LV+E++ +L +++ SH L + +N + +++ H
Sbjct: 78 DVDEEDDCYY--LVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMR--- 131
Query: 548 PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT-MTMATIGYMAPEYGSEGI 606
I+H D+KP NIL+D N + DFGI+K L E S+ QT + T+ Y +PE
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 607 VSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
D+YS G++L E + P F GE
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLER--AFRS-FDSECEILRNVRHRNLLKIL 489
+LG GG V+ L D +VA+K+ L R +F F E + + H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 490 ------GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
L + +V+E++ +L +++ + + + ++ D AL + H
Sbjct: 79 DTGEAETPAGPLPY--IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN 135
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT-MTMATIGYMAPEYG 602
IIH D+KP NI++ V DFGI++ + + +SV QT + T Y++PE
Sbjct: 136 G----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 603 SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
V + DVYS G +L E T + P FTG+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 42/225 (18%)
Query: 435 LGTGGFGSVYKGTLSDG------TNVAIKIFNLQL-----ERAFRSFDSECEILRNV-RH 482
LG+G FG V T VA+K L + SE +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK----MLKEKADSSEREALMSELKMMTQLGSH 108
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH----------------------NYF 520
N++ +LG+C+ L+ E+ G L +L S
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 521 LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580
L L V +E+L +H DL N+L+ V + DFG+++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT 625
+ V++ + +MAPE EGI + K DV+SYG+LL E F+
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 45/238 (18%), Positives = 90/238 (37%), Gaps = 30/238 (12%)
Query: 434 LLGTGGFGSVYKG--TLSDGTNVAIKIFNLQLERAFRS-FDSECEILRNVRHRNLLKIL- 489
+ GG G +Y +G V +K + ++ +E + L V H ++++I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 490 -GSCSNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
++ +V+E++ SL++ L + + + ++++ AL YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---- 199
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT-MTMATIGYMAPEYGSE 604
S +++ DLKP NI+L E + + D G + T G+ APE
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRIN-------SFGYLYGTPGFQAPEI-VR 250
Query: 605 GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662
+ D+Y+ G L + G + ++ + + L R
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT----RNGR-YVDGLPEDDPVLKTYDSYGRLLRR 303
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 50/215 (23%), Positives = 77/215 (35%), Gaps = 23/215 (10%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNV 480
F + LG G +G V+K DG A+K + +E V
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 481 -RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
+H +++ + L E SL++ + L Q + D AL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
LH ++H D+KP NI L + DFG+ L G + YMAP
Sbjct: 173 LHSQG----LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQE-GDPRYMAP 225
Query: 600 E-----YGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
E YG T DV+S G+ ++E +
Sbjct: 226 ELLQGSYG------TAADVFSLGLTILEVACNMEL 254
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFN---LQLERAFRSFDSECEILRNVRH 482
++F LG G FG+VY +A+K+ L+ E EI ++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
N+L++ G + L+LE+ P G++ + L + F + + ++ +AL Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHS 127
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEY 601
+IH D+KP N+LL ++DFG S + + T+ Y+ PE
Sbjct: 128 KR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPE- 177
Query: 602 GSEGIVSTK-----CDVYSYGVLLME 622
++ + D++S GVL E
Sbjct: 178 ----MIEGRMHDEKVDLWSLGVLCYE 199
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 40/220 (18%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVR 481
+ + LGTGGFG V + G VAIK +L + + E +I++ +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 482 HRNLLKIL------GSCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILQRLNIMIDV 533
H N++ + D L +E+ G L K+L L ++ D+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEGEDSVIQTMT 590
SAL YLH IIH DLKP NI+L + ++ + D G +K L +GE
Sbjct: 131 SSALRYLHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-------L 179
Query: 591 MATI----GYMAPE------YGSEGIVSTKCDVYSYGVLL 620
Y+APE Y D +S+G L
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTV------TVDYWSFGTLA 213
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 67/304 (22%), Positives = 118/304 (38%), Gaps = 30/304 (9%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P + T L LDL N + F NL++L L L+ N ++ S A
Sbjct: 45 KVPKDLPPDTAL--LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA------- 95
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIV 121
L L L+ N L + + +LQ + E ++ + K + L +IV
Sbjct: 96 -FAPLVKLERLYLSKNQLKELPEKM---PK-TLQELRVHENEIT-KVRKSVFNGLNQMIV 149
Query: 122 LSLGFNDL-NGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
+ LG N L + I +++L + + N+ +P L L L+L GNK++
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK 206
Query: 180 AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVL 239
L L +L L L N +S+ SL + ++ ++L++N L +P + +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265
Query: 240 IDLDLSRNQLSS------DIPSTIGTLKNLETLSLAGNQFQ-GPIPESV-GNLISLESLD 291
+ L N +S+ P + +SL N Q I S + ++
Sbjct: 266 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 325
Query: 292 FSNN 295
N
Sbjct: 326 LGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 50/221 (22%), Positives = 97/221 (43%), Gaps = 11/221 (4%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
+PK++ +L L N + L+ L + N + P L +L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK- 226
L LS N+L +P+ + +L+ L + N+++ S L ++ + L +N LK
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159
Query: 227 GTLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI 285
+ + Q + L + ++ +++ IP G +L L L GN+ S+ L
Sbjct: 160 SGIENGAFQGMKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKITKVDAASLKGLN 216
Query: 286 SLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
+L L S N++S SL HL++ ++++N+L ++P
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 36/207 (17%), Positives = 69/207 (33%), Gaps = 25/207 (12%)
Query: 5 PNSITNATKLIGLDLGLNSF-SGHIP-NTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+ ++I ++LG N S I F ++ LS + + N+TT
Sbjct: 138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL-----PP 192
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIV 121
SLT L L N + + + + +L + + ++ N L
Sbjct: 193 SLTE------LHLDGNKITKVDAASLKGLN-NLAKLGLSFNSIS-AVDNGSLANTPHLRE 244
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQG------YVPHDLCHLERLNILNLSGN 175
L L N L +P + + +Q Y+ NN+ P + ++L N
Sbjct: 245 LHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303
Query: 176 KLS-GAIPQCL-ASLTSLRSLYLQSNK 200
+ I + ++ L + K
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 21/85 (24%), Positives = 36/85 (42%), Gaps = 4/85 (4%)
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
+ S L +P + + L L N+ NL +L +L NN +S
Sbjct: 36 VQCSDLGLEK-VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIP 326
P + L L++ +S N+L+ E+P
Sbjct: 93 PGAFAPLVKLERLYLSKNQLK-ELP 116
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 34/212 (16%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFN---LQLERAFRSFDS--------------ECEIL 477
L G F + D A+K + L+ +R F ++ E +I+
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL-------NIM 530
++++ L G +N D ++ E+M N S+ K+ I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590
V ++ Y H+ I H D+KP+NIL+D+N +SDFG S+ + D I+ +
Sbjct: 158 KSVLNSFSY---IHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG-S 210
Query: 591 MATIGYMAPE--YGSEGIVSTKCDVYSYGVLL 620
T +M PE K D++S G+ L
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 421 DIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFN---LQLERAFRSFDSECEI 476
I ++F NLLG G F VY+ + G VAIK+ + + + +E +I
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 477 LRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSA 536
++H ++L++ + ++ LVLE NG + ++L + + + M + +
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM--TMATI 594
+ YLH I+H DL +N+LL NM ++DFG++ L + T+ T
Sbjct: 125 MLYLHSHG----ILHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLCGTPN-- 177
Query: 595 GYMAPE------YGSEGIVSTKCDVYSYGVLL 620
Y++PE +G E DV+S G +
Sbjct: 178 -YISPEIATRSAHGLE------SDVWSLGCMF 202
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 62/241 (25%), Positives = 97/241 (40%), Gaps = 59/241 (24%)
Query: 416 RTSYLDIRRATDEFNE----CNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSF 470
R + L +T F E +LG G V + A+KI ++ +F +
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 471 D---------SECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF 520
+ E +ILR V H N++++ + F LV + M G L F
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL---------F 112
Query: 521 LDILQR--------LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDF 572
+ ++ IM + + LH + I+H DLKP NILLD++M ++DF
Sbjct: 113 DYLTEKVTLSEKETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDF 168
Query: 573 GISKLLGEGEDSVIQTMTMA-TIGYMAPE------------YGSEGIVSTKCDVYSYGVL 619
G S L GE + + T Y+APE YG E D++S GV+
Sbjct: 169 GFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVI 218
Query: 620 L 620
+
Sbjct: 219 M 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 15/193 (7%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFN---LQLERAFRSFDSECEILRNVRHRNLLKIL 489
LG GGF ++ + A KI L E I R++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
G + DF +VLE SL + + R + + +YLH +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----V 136
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM--TMATIGYMAPEYGSEGIV 607
IH DLK N+ L+E++ + DFG++ + E + + + T Y+APE S+
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAPEVLSKKGH 192
Query: 608 STKCDVYSYGVLL 620
S + DV+S G ++
Sbjct: 193 SFEVDVWSIGCIM 205
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 42/248 (16%), Positives = 76/248 (30%), Gaps = 25/248 (10%)
Query: 420 LDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTN------VAIKIFNLQLERAFRSFDSE 473
+ + + +LLG G F VY+ T D + +K+ F
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 474 CEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL----EKWLYSHNYFLDILQRLNI 529
E L+ +K + + LV E G+L + + + ++
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 530 MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAH-----------VSDFGISKLL 578
+ + +E +H C IIH D+KP N +L + + D G S +
Sbjct: 178 AMRMLYMIEQVHDCE----IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM 638
I T T G+ E S + + D + + + GE
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 639 SLRRWVKE 646
+
Sbjct: 294 KPEGLFRR 301
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 35/266 (13%), Positives = 86/266 (32%), Gaps = 63/266 (23%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNL----------------QLERAFRSFDSECEI 476
+LG + + T G + + + R R ++ +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 477 LRNVR------------HRNLLKILGSCSNLDFKALVLEFM----PNGSLEKWLYSH--- 517
++R + ++++ ++ + + + + L SH
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 518 NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577
+ L RL + + V L LHH ++H L+P +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 578 LGEGEDSVIQTMTMATIGYMAPEY-----------GSEGIVSTKCDVYSYGVLLMETFTE 626
G + ++ + G+ PE +++ D ++ G+++ +
Sbjct: 256 DGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 627 KKPTDEMFTGE--MSLRRWVKESLPH 650
P T + + W+ S +
Sbjct: 310 DLP----ITKDAALGGSEWIFRSCKN 331
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 15/193 (7%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFN---LQLERAFRSFDSECEILRNVRHRNLLKIL 489
LG GGF ++ + A KI L E I R++ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 490 GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549
G + DF +VLE SL + + R + + +YLH +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----V 162
Query: 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTM--TMATIGYMAPEYGSEGIV 607
IH DLK N+ L+E++ + DFG++ + E + + + T Y+APE S+
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAPEVLSKKGH 218
Query: 608 STKCDVYSYGVLL 620
S + DV+S G ++
Sbjct: 219 SFEVDVWSIGCIM 231
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN 484
F +LG+G F V+ G A+K S ++E +L+ ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMIDVGSA 536
++ + + LV++ + G L F IL+R ++ V SA
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL---------FDRILERGVYTEKDASLVIQQVLSA 118
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMA- 592
++YLH I+H DLKP N+L +EN ++DFG+SK+ G T
Sbjct: 119 VKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACG 169
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLL 620
T GY+APE ++ S D +S GV+
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 31/304 (10%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P I+ T L LDL N S + F L+HL L L+ N ++ A
Sbjct: 47 AVPKEISPDTTL--LDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA------- 97
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIV 121
+ R L L ++ N L I P L S SL + + ++ +PK + LR +
Sbjct: 98 -FSPLRKLQKLYISKNHLVEIPPNL---PS-SLVELRIHDNRI-RKVPKGVFSGLRNMNC 151
Query: 122 LSLGFNDL-NGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
+ +G N L N +L + E L +P DL E LN L+L NK+
Sbjct: 152 IEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAI 208
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
+ L + L L L N++ SL L + ++L +N L +P+ + L +L
Sbjct: 209 ELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ 267
Query: 241 DLDLSRNQLSSDIPSTI-------GTLKNLETLSLAGNQFQ-GPIPESV-GNLISLESLD 291
+ L N ++ + +SL N + + + ++
Sbjct: 268 VVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQ 326
Query: 292 FSNN 295
F N
Sbjct: 327 FGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 51/221 (23%), Positives = 82/221 (37%), Gaps = 12/221 (5%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
++PKEI +L L ND++ LQ L + N + L +L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
L +S N L IP L +SL L + N++ L + I + N L+
Sbjct: 105 QKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN 161
Query: 228 T-LPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLI 285
+ L L +S +L+ IP + L L L N+ Q I
Sbjct: 162 SGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPETLNELHLDHNKIQA-IELEDLLRYS 217
Query: 286 SLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326
L L +N + SL L L++ ++ +N+L +P
Sbjct: 218 KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 55/280 (19%), Positives = 94/280 (33%), Gaps = 31/280 (11%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
+ L L L N S F LR L L + N+L +
Sbjct: 71 KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNL----P---- 122
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFS--ASLQNIYAFECKLG-GSIPKEIGNLRGLIV 121
+L L + N + + G FS ++ I L + L
Sbjct: 123 ---SSLVELRIHDNRIRKVPK---GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNY 176
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L + L IP + L ++ N +Q DL +L L L N++
Sbjct: 177 LRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIE 233
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-------Q 234
L+ L +LR L+L +NKL S +P+ L L+ + + L +N++ + N
Sbjct: 234 NGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGV 291
Query: 235 KLNVLIDLDLSRNQLSSDI--PSTIGTLKNLETLSLAGNQ 272
K + L N + P+T + + + +
Sbjct: 292 KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 67/296 (22%), Positives = 122/296 (41%), Gaps = 15/296 (5%)
Query: 401 KHLDHEDFLPPATRRRTSYLDIRRAT-----DEFNECNLLGTGGFGSVYKGTL-SDGTNV 454
K L+ + +R ++L ++ D+F + + LG G G V+K + G +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 455 AIKIFNLQLERAFRSF-DSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKW 513
A K+ +L+++ A R+ E ++L ++ G+ + ++ +E M GSL++
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ- 120
Query: 514 LYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573
+ + + I V L YL H I+H D+KP+NIL++ + DFG
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
+S G+ DS+ + T YM+PE S + D++S G+ L+E + P
Sbjct: 178 VS---GQLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233
Query: 634 FTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTP 689
E+ L + T R F +I +L + P
Sbjct: 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 427 DEFNECNLLGTGGFGSVYKG-TLSDGTNVAIKIFN---LQLERAFRSFDSECEILRNVRH 482
D+F+ LG G FG+VY + +A+K+ L+ E E EI ++RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
N+L++ + L+LEF P G L K L H F + M ++ AL Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHE 132
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGYMAPEY 601
+IH D+KP N+L+ ++DFG S + TM T+ Y+ PE
Sbjct: 133 RK----VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPE- 182
Query: 602 GSEGIVSTK-----CDVYSYGVLLME 622
++ K D++ GVL E
Sbjct: 183 ----MIEGKTHDEKVDLWCAGVLCYE 204
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 41/265 (15%), Positives = 82/265 (30%), Gaps = 62/265 (23%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRH------- 482
+LG + + T G + + + A + E LR +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 483 ---------RNLLKILGSCSNLDFKA----------LVLEFMPNGSLE---KWLYSH--- 517
+L+K + + L +L+ + L SH
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 518 NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577
+ L RL + + V L LHH ++H L+P +I+LD+ ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 578 LGEGEDSVIQTMTMATIGYMAPEY----------GSEGIVSTKCDVYSYGVLLMETFTEK 627
G ++ G+ PE +++ D ++ G+ + +
Sbjct: 261 DGAS------AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 628 KPTDEMFTGE--MSLRRWVKESLPH 650
P T + + W+ S +
Sbjct: 315 LP----NTDDAALGGSEWIFRSCKN 335
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 49/211 (23%), Positives = 79/211 (37%), Gaps = 26/211 (12%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGS 491
+L GGF VY+ + G A+K E R+ E ++ + H N+++ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 492 CSNL-------DFKALVLEFMPNGSLEKWL--YSHNYFLDILQRLNIMIDVGSALEYLHH 542
S + L+L + G L ++L L L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA---------- 592
PIIH DLK N+LL + DFG + + D A
Sbjct: 155 QKP--PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 593 TIGYMAPE---YGSEGIVSTKCDVYSYGVLL 620
T Y PE S + K D+++ G +L
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 44/216 (20%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRH 482
+D ++ LG G F V + + G A KI N + R F+ + E I R ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMIDVG 534
N++++ S F LV + + G L F DI+ R + + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 115
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTM 591
++ Y H I+H +LKP N+LL + ++DFG++ + + E
Sbjct: 116 ESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGF 167
Query: 592 A-TIGYMAPE------YGSEGIVSTKCDVYSYGVLL 620
A T GY++PE Y D+++ GV+L
Sbjct: 168 AGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 197
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 8e-27
Identities = 58/337 (17%), Positives = 113/337 (33%), Gaps = 57/337 (16%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
I +++ + + + + + L + +++ + + ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL------- 70
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIV 121
L + R + L L + I +
Sbjct: 71 -LDSFRQVELLNLNDLQI--------------------------EEIDTYAFAYAHTIQK 103
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L +GFN + P + L + N+L + +L L++S N L
Sbjct: 104 LYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 163
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG-TLPSNIQKLNV-- 238
+ TSL++L L SN+L+ S + SL N+S N L +P +++L+
Sbjct: 164 DDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF---HANVSYNLLSTLAIPIAVEELDASH 220
Query: 239 -------------LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI 285
L L L N L+ + + L + L+ N+ + + +
Sbjct: 221 NSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278
Query: 286 SLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
LE L SNN L + + + LK ++SHN L
Sbjct: 279 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 58/270 (21%), Positives = 97/270 (35%), Gaps = 27/270 (10%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
P+ N L L L N S F N L+ LS+ NNL
Sbjct: 116 PHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT--------F 167
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSL 124
+L NL L+SN L + SL + L + + L
Sbjct: 168 QATTSLQNLQLSSNRLTHVDL---SLIP-SLFHANVSYNLL-----STLAIPIAVEELDA 218
Query: 125 GFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQC 184
N +N + +L + NNL L + L ++LS N+L +
Sbjct: 219 SHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHP 273
Query: 185 LASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL 244
+ L LY+ +N+L +L + + ++LS N L + N + + L +L L
Sbjct: 274 FVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 331
Query: 245 SRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
N + + + + T L+ L+L+ N +
Sbjct: 332 DHNSIVT-LK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 38/222 (17%), Positives = 76/222 (34%), Gaps = 10/222 (4%)
Query: 102 ECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL 161
I + + + + TL + + ++ L
Sbjct: 12 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 71
Query: 162 CHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLS 221
++ +LNL+ ++ A +++ LY+ N + P ++ + + L
Sbjct: 72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131
Query: 222 SNSLKGTLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPES 280
N L +LP I L L +S N L T +L+ L L+ N+ +
Sbjct: 132 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL- 188
Query: 281 VGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
+ SL + S N LS +L +++ + SHN +
Sbjct: 189 -SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 8e-22
Identities = 46/281 (16%), Positives = 92/281 (32%), Gaps = 27/281 (9%)
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSA----SLQNIYAFECKLGGSIPKEI-GNLR 117
+ + + + F + + + + +P + + R
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFR 75
Query: 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKL 177
+ +L+L + + +Q Y+ N ++ PH ++ L +L L N L
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135
Query: 178 SGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK----GTLPS-- 231
S + L +L + +N L + + + + LSSN L +PS
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 195
Query: 232 ----------NIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV 281
+ + +LD S N ++ + L L L N +
Sbjct: 196 HANVSYNLLSTLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNNLT-DTA-WL 250
Query: 282 GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
N L +D S N L + + L++ +S+NRL
Sbjct: 251 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 14/127 (11%), Positives = 38/127 (29%)
Query: 196 LQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPS 255
+ S+L +++ + LN + + + +
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69
Query: 256 TIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFN 315
+ + + +E L+L Q + + +++ L N + P + + L
Sbjct: 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129
Query: 316 VSHNRLE 322
+ N L
Sbjct: 130 LERNDLS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 48/346 (13%), Positives = 111/346 (32%), Gaps = 39/346 (11%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
T + N L+ +DL N + + F ++ L L + N L +
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALN---------L 295
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L L L+ N L + F L+N+Y + ++ + L L
Sbjct: 296 YGQPIPTLKVLDLSHNHLLHV-ERNQPQFD-RLENLYLDHNSI-VTLK--LSTHHTLKNL 350
Query: 123 SLGFNDLNGTIPTSIGT-LQQLQGFYVPENNLQGY-VPHDLC------HLERLNILNLSG 174
+L ND + ++ + + ++ Y + H LC + ++
Sbjct: 351 TLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIAL 410
Query: 175 NKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPS--- 231
+ + + ++ ++ + L+ ++ N L+ +
Sbjct: 411 TSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTN 470
Query: 232 -------NIQKLNVLIDLDLSRNQLSSD-IPSTIGTLKNLETLSLAGNQFQGPIPESVGN 283
+Q L+ ID +L R +L D + + L + T F+ ++
Sbjct: 471 EQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRT 530
Query: 284 LIS-----LESLDFSNNNLSGKI-PKSLEALSHLKQFNVSHNRLEG 323
E L+ N L ++ K + ++ ++ +++
Sbjct: 531 EADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 25/255 (9%), Positives = 58/255 (22%), Gaps = 46/255 (18%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFN---LQLERAFRSFDSECEILRNVRHRNLLKIL 489
L G V+ + + A+K+F + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 490 GSCSNLDFKA--------------------------LVLEFM-----PNGSLEKWLYSHN 518
L L++ S ++Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 519 YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578
IL + + L ++H P N+ + + + D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 579 GEGEDSVIQTMTMATIGYMAPEY--GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG 636
G + + Y E+ S + + + G+ + + P + G
Sbjct: 245 GT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 637 EMSLRRWVKESLPHR 651
+ +P
Sbjct: 300 IKGSWKRPSLRVPGT 314
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 47/207 (22%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS 493
+G G +G V A K F E EI++++ H N++++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMIDVGSALEYLHHCHS 545
+ LV+E G L F ++ + IM DV SA+ Y H +
Sbjct: 77 DNTDIYLVMELCTGGEL---------FERVVHKRVFRESDAARIMKDVLSAVAYCHKLN- 126
Query: 546 SAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMATI----GYMA 598
+ H DLKP N L + + DFG++ G+ M T Y++
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-------MMRTKVGTPYYVS 176
Query: 599 PE-----YGSEGIVSTKCDVYSYGVLL 620
P+ YG +CD +S GV++
Sbjct: 177 PQVLEGLYG------PECDEWSAGVMM 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/240 (24%), Positives = 93/240 (38%), Gaps = 53/240 (22%)
Query: 405 HEDFLPPATRRRTSYL-DIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFN-- 460
H + R + + +N +LG G FG V K A+K+ N
Sbjct: 2 HHHHHHSSGRENLYFQGTFA---ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 461 LQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF 520
+ + E E+L+ + H N++K+ + +V E G L F
Sbjct: 59 SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---------F 109
Query: 521 LDILQR--------LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHV 569
+I++R I+ V S + Y+H + I+H DLKP NILL +++ +
Sbjct: 110 DEIIKRKRFSEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKI 165
Query: 570 SDFGISKLLGEGEDSVIQTMTMATI----GYMAPE-----YGSEGIVSTKCDVYSYGVLL 620
DFG+S + M Y+APE Y KCDV+S GV+L
Sbjct: 166 IDFGLSTCFQQNT-------KMKDRIGTAYYIAPEVLRGTYD------EKCDVWSAGVIL 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 44/216 (20%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRH 482
+D ++ LG G F V + + G A KI N + R F+ + E I R ++H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMIDVG 534
N++++ S F LV + + G L F DI+ R + + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 138
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTM 591
++ Y H I+H +LKP N+LL + ++DFG++ + + E
Sbjct: 139 ESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGF 190
Query: 592 A-TIGYMAPE------YGSEGIVSTKCDVYSYGVLL 620
A T GY++PE Y D+++ GV+L
Sbjct: 191 AGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 220
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 60/216 (27%), Positives = 88/216 (40%), Gaps = 54/216 (25%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFN--------LQLERAFRSFDSECEILRNVRHRNL 485
LG+G G V VAIKI + + + ++E EIL+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMIDVGSAL 537
+KI D+ +VLE M G L F ++ + A+
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGEL---------FDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 538 EYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMA-T 593
+YLH IIH DLKP N+LL +E+ + ++DFG SK+LGE T+ T
Sbjct: 128 QYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGT 179
Query: 594 IGYMAPE---------YGSEGIVSTKCDVYSYGVLL 620
Y+APE Y D +S GV+L
Sbjct: 180 PTYLAPEVLVSVGTAGYNRA------VDCWSLGVIL 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-26
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 38/208 (18%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFN--------LQLERAFRSFDSECEILRNVRHRNL 485
LG+G G V VAI+I + + + ++E EIL+ + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
+KI D+ +VLE M G L + + + + + A++YLH
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFYQMLLAVQYLHENG- 259
Query: 546 SAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGYMAPE- 600
IIH DLKP N+LL +E+ + ++DFG SK+LGE T+ T Y+APE
Sbjct: 260 ---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEV 312
Query: 601 --------YGSEGIVSTKCDVYSYGVLL 620
Y D +S GV+L
Sbjct: 313 LVSVGTAGYNRA------VDCWSLGVIL 334
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 48/214 (22%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNL--------QLERAFRSFDSECEILRNVR-HRN 484
+G G V + + G A+KI + QLE + E ILR V H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL--------NIMIDVGSA 536
++ ++ S + F LV + M G L F + +++ +IM + A
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL---------FDYLTEKVALSEKETRSIMRSLLEA 212
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATI-- 594
+ +LH + I+H DLKP NILLD+NM +SDFG S L GE + +
Sbjct: 213 VSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-------KLRELCG 261
Query: 595 --GYMAPE------YGSEGIVSTKCDVYSYGVLL 620
GY+APE + + D+++ GV+L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-26
Identities = 48/216 (22%), Positives = 88/216 (40%), Gaps = 5/216 (2%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
+P I +L+L N + S L+ L+ + N+++ L L
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
N L L N+L+ L+ L+ L+L++N + S + + + R++L
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 228 TLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLIS 286
+ + L+ L L+L+ L IP + L L+ L L+GN P S L+
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 287 LESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
L+ L + + + + L L + N++HN L
Sbjct: 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 66/274 (24%), Positives = 103/274 (37%), Gaps = 40/274 (14%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P+ I+ T+L L+L N N+F +LRHL +L L N++ T A
Sbjct: 57 EVPDGISTNTRL--LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGA------- 107
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
NL L L N L I G F L L L
Sbjct: 108 -FNGLANLNTLELFDNRLTTIPN---GAFV----------------------YLSKLKEL 141
Query: 123 SLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHD-LCHLERLNILNLSGNKLSGA 180
L N + +IP+ + L+ + E Y+ L L LNL+ L
Sbjct: 142 WLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
IP L L L L L N LS+ P S L ++ ++ + + ++ + L L+
Sbjct: 200 IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
+++L+ N L+ L +LE + L N +
Sbjct: 259 EINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 3/206 (1%)
Query: 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG 174
+LR L +L L N + + L L + +N L +L +L L L
Sbjct: 86 HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRN 145
Query: 175 NKLSGAIPQCLASLTSLRSLYLQS-NKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI 233
N + + SLR L L +LS + L + +NL+ +L+ +P+ +
Sbjct: 146 NPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-L 203
Query: 234 QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFS 293
L L +LDLS N LS+ P + L +L+ L + +Q Q + NL SL ++ +
Sbjct: 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263
Query: 294 NNNLSGKIPKSLEALSHLKQFNVSHN 319
+NNL+ L HL++ ++ HN
Sbjct: 264 HNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 43/181 (23%), Positives = 70/181 (38%), Gaps = 9/181 (4%)
Query: 157 VPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYIL 216
VP + +LNL N++ L L L L N + + + L +
Sbjct: 58 VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115
Query: 217 RINLSSNSLKGTLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAG-NQFQ 274
+ L N L T+P+ L+ L +L L N + S + +L L L +
Sbjct: 116 TLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 275 GPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDF 334
+ L +L L+ + NL +IP +L L L + ++S N L I GSF+
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIR-PGSFQGL 230
Query: 335 S 335
Sbjct: 231 M 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-26
Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 5/216 (2%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
+P+ I L+L N++ + L L+ + N+++ L L
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
N L L N L+ L+ LR L+L++N + S + + ++R++L
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 228 TLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLIS 286
+ + L L L+L + +P + L LE L ++GN F P S L S
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSS 243
Query: 287 LESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
L+ L N+ +S + + L+ L + N++HN L
Sbjct: 244 LKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 61/274 (22%), Positives = 94/274 (34%), Gaps = 40/274 (14%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P I + T+ L+L N+ +TF +L HL VL L N++ A
Sbjct: 68 EVPQGIPSNTRY--LNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGA------- 118
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
+L L L N L I G F L L L
Sbjct: 119 -FNGLASLNTLELFDNWLTVIPS---GAFE----------------------YLSKLREL 152
Query: 123 SLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHD-LCHLERLNILNLSGNKLSGA 180
L N + +IP+ + L + E Y+ L L LNL +
Sbjct: 153 WLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-D 210
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
+P L L L L + N P S L + ++ + ++ + + L L+
Sbjct: 211 MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV 269
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
+L+L+ N LSS L+ L L L N +
Sbjct: 270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 3/206 (1%)
Query: 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG 174
+L L VL LG N + + L L + +N L +L +L L L
Sbjct: 97 HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRN 156
Query: 175 NKLSGAIPQCLASLTSLRSLYLQS-NKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI 233
N + + SL L L KL + L + +NL ++K +P+ +
Sbjct: 157 NPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-L 214
Query: 234 QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFS 293
L L +L++S N P + L +L+ L + +Q + L SL L+ +
Sbjct: 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274
Query: 294 NNNLSGKIPKSLEALSHLKQFNVSHN 319
+NNLS L +L + ++ HN
Sbjct: 275 HNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 47/218 (21%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFD-----SECEILRN 479
T+E+ LG G F V + + G A I N + + D E I R
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN---TKKLSARDHQKLEREARICRL 66
Query: 480 VRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMI 531
++H N++++ S S L+ + + G L F DI+ R + +
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---------FEDIVAREYYSEADASHCIQ 117
Query: 532 DVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQT 588
+ A+ + H ++H +LKP N+LL + ++DFG++ + EGE
Sbjct: 118 QILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFG 172
Query: 589 MTMATIGYMAPE------YGSEGIVSTKCDVYSYGVLL 620
T GY++PE YG D+++ GV+L
Sbjct: 173 F-AGTPGYLSPEVLRKDPYGKP------VDLWACGVIL 203
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFN---LQLERAFRSFDSECEILRNVR 481
+D + +LG G FG V G A+K+ + ++ + S E ++L+ +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMIDV 533
H N++K+ + + LV E G L F +I+ R I+ V
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL---------FDEIISRKRFSEVDAARIIRQV 135
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMT 590
S + Y+H I+H DLKP N+LL ++ + DFG+S +
Sbjct: 136 LSGITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDK 188
Query: 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLL 620
+ T Y+APE G KCDV+S GV+L
Sbjct: 189 IGTAYYIAPEV-LHGTYDEKCDVWSTGVIL 217
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 45/216 (20%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQ--LERAFRSFDSECEILRNVRH 482
+ +N +LG G FG V K A+K+ N + + E E+L+ + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMIDVG 534
N++K+ + +V E G L F +I++R I+ V
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVF 131
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTM 591
S + Y+H + I+H DLKP NILL +++ + DFG+S + M
Sbjct: 132 SGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-----TKMKD 182
Query: 592 A--TIGYMAPE-----YGSEGIVSTKCDVYSYGVLL 620
T Y+APE Y KCDV+S GV+L
Sbjct: 183 RIGTAYYIAPEVLRGTYD------EKCDVWSAGVIL 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 56/242 (23%), Positives = 92/242 (38%), Gaps = 52/242 (21%)
Query: 410 PPATRRRTSYLDIRRATDEFNE----CNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLE 464
P + LD+ F + C ++G G F V + G A+KI ++
Sbjct: 3 PGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKF 62
Query: 465 RAFRSFD-----SECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNY 519
+ E I ++H +++++L + S+ +V EFM L
Sbjct: 63 TSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL--------- 113
Query: 520 FLDILQRLN------------IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DEN 564
+I++R + M + AL Y H + IIH D+KP +LL + +
Sbjct: 114 CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENS 169
Query: 565 MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE------YGSEGIVSTKCDVYSYGV 618
+ FG++ LGE V T +MAPE YG DV+ GV
Sbjct: 170 APVKLGGFGVAIQLGE-SGLVAGGRV-GTPHFMAPEVVKREPYGKP------VDVWGCGV 221
Query: 619 LL 620
+L
Sbjct: 222 IL 223
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL-ERAFRSFDSECEI-LRNVRHR 483
++ + +G G +GSV K G +A+K + E+ + + ++ +R+
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFL-------DILQRLNIMIDVGSA 536
+++ G+ + +E M + S +K Y + Y + +IL + I + A
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILGK--ITLATVKA 137
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
L +L IIH D+KP+NILLD + + DFGIS G+ DS+ +T Y
Sbjct: 138 LNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPY 191
Query: 597 MAPE----YGSEGIVSTKCDVYSYGVLLME 622
MAPE S + DV+S G+ L E
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 21/223 (9%)
Query: 412 ATRRRTSYLDIRRATD---EFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAF 467
+ R+ Y +RR D + LG G FG VYK G A K+ + E
Sbjct: 1 SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL 60
Query: 468 RSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL 527
+ E EIL H ++K+LG+ + +++EF P G+++ + + L Q
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 528 NIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ 587
+ + AL +LH IIH DLK N+L+ ++DFG+S + ++ +
Sbjct: 121 VVCRQMLEALNFLHSKR----IIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQK 173
Query: 588 TMTMATIG---YMAPE-----YGSEGIVSTKCDVYSYGVLLME 622
+ IG +MAPE + K D++S G+ L+E
Sbjct: 174 RDSF--IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 51/220 (23%), Positives = 83/220 (37%), Gaps = 9/220 (4%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNL--QGYVPHDLCHLE 165
S+P I L L N L L QL + N L +G
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 166 RLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSL-WSLEYILRINLSSNS 224
L L+LS N + + L L L Q + L S+ SL ++ +++S
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 225 LKGTLPSNI-QKLNVLIDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESVG 282
+ + I L+ L L ++ N + I L+NL L L+ Q + P +
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 283 NLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
+L SL+ L+ S+NN + L+ L+ + S N +
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 51/300 (17%), Positives = 93/300 (31%), Gaps = 63/300 (21%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
++P I ++ L+L N F L L+ LSL N L+ + + +
Sbjct: 21 SVPTGIPSSATR--LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
SL L L+ N + ++ L L L
Sbjct: 79 SLK------YLDLSFNGV--------------------------ITMSSNFLGLEQLEHL 106
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
+ ++ + + F L L L++S A
Sbjct: 107 DFQHS--------NLKQMSEFSVFL---------------SLRNLIYLDISHTHTRVAFN 143
Query: 183 QCLASLTSLRSLYLQSNKLSSSLPSSLWS-LEYILRINLSSNSLKGTLPSNI-QKLNVLI 240
L+SL L + N + +++ L + ++LS L+ L L+ L
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQ 202
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV--GNLISLESLDFSNNNLS 298
L++S N S L +L+ L + N + SL L+ + N+ +
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 41/214 (19%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQ--LERAFRSFDSECEILRNVRH 482
++ + LG+G +G V AIKI + E +L+ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMIDVG 534
N++K+ + LV+E G L F +I+ R I+ V
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL---------FDEIIHRMKFNEVDAAVIIKQVL 146
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTM 591
S + YLH + I+H DLKP N+LL +++ + + DFG+S + + +
Sbjct: 147 SGVTYLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERL 199
Query: 592 ATIGYMAPE-----YGSEGIVSTKCDVYSYGVLL 620
T Y+APE Y KCDV+S GV+L
Sbjct: 200 GTAYYIAPEVLRKKYDE------KCDVWSIGVIL 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 48/210 (22%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFN-LQLERAFRSFDSECEILRNVRHRNLLKILGSC 492
LG+G FG V+ S G IK N + + ++E E+L+++ H N++KI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL------------NIMIDVGSALEYL 540
+ +V+E G L I+ +M + +AL Y
Sbjct: 90 EDYHNMYIVMETCEGGEL---------LERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 541 HHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMA--TIG 595
H H ++H DLKP NIL + + DFG+++L + T A T
Sbjct: 141 HSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-----EHSTNAAGTAL 191
Query: 596 YMAPE-----YGSEGIVSTKCDVYSYGVLL 620
YMAPE KCD++S GV++
Sbjct: 192 YMAPEVFKRDVT------FKCDIWSAGVVM 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 59/270 (21%), Positives = 96/270 (35%), Gaps = 58/270 (21%)
Query: 402 HLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFN 460
H H + S L+++ +++ +G G +G V AIKI N
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQ---KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 461 LQLERAFRSFD-----SECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSL----- 510
R D +E +++ + H N+ ++ + + LV+E G L
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 511 ----------------------------------EKWLYSHNYFLDILQRLNIMIDVGSA 536
+ S ++ NIM + SA
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILL--DENMVAHVSDFGISKLLGEGEDSVIQTMTMA-- 592
L YLH+ I H D+KP N L +++ + DFG+SK + + MT
Sbjct: 181 LHYLHNQG----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 593 TIGYMAPE--YGSEGIVSTKCDVYSYGVLL 620
T ++APE + KCD +S GVLL
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN 484
+ +G G G V G VA+K+ +L+ ++ +E I+R+ +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQ--RLN------IMIDVGSA 536
++++ S + +++EF+ G+L DI+ RLN + V A
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQA 153
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG- 595
L YLH + +IH D+K +ILL + +SDFG + V + ++ +G
Sbjct: 154 LAYLH----AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGT 204
Query: 596 --YMAPEYGSEGIVSTKCDVYSYGVLLME 622
+MAPE S + +T+ D++S G++++E
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 14/226 (6%)
Query: 402 HLDHEDFLPPATRRRTSYLDIRRATDEFNE----CNLLGTGGFGSVYKGT-LSDGTNVAI 456
++ D ++ + + LG+G FG V++ + G
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81
Query: 457 KIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYS 516
K N + +E I+ + H L+ + + + L+LEF+ G L + +
Sbjct: 82 KFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA 141
Query: 517 HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGI 574
+Y + + +N M L+++H I+H D+KP NI+ + + V DFG+
Sbjct: 142 EDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLL 620
+ L E I +T AT + APE V D+++ GVL
Sbjct: 198 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 60/210 (28%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGS 491
+LG G V L A+KI Q E E+L + HRN+L+++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 492 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLN--------IMIDVGSALEYLHHC 543
D LV E M GS+ I +R + ++ DV SAL++LH+
Sbjct: 80 FEEEDRFYLVFEKMRGGSI---------LSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 544 HSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED-SVIQTMTMATI----G 595
I H DLKP NIL ++ + DF + + D S I T + T
Sbjct: 131 G----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 596 YMAPE-----YGSEGIVSTKCDVYSYGVLL 620
YMAPE I +CD++S GV+L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN 484
++ +G G G+VY ++ G VAI+ NLQ + +E ++R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQ--RLN------IMIDVGSA 536
++ L S D +V+E++ GSL D++ ++ + + A
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSL----------TDVVTETCMDEGQIAAVCRECLQA 128
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIG 595
LE+LH S +IH D+K NILL + ++DFG + + TM T
Sbjct: 129 LEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPY 181
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLLME 622
+MAPE + K D++S G++ +E
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 50/228 (21%), Positives = 92/228 (40%), Gaps = 10/228 (4%)
Query: 396 RNRSTKHLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNV 454
S+ + ++ + + + D ++ LGTG FG V++ T + G N
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185
Query: 455 AIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWL 514
A K E + E + + +RH L+ + + + + ++ EFM G L + +
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245
Query: 515 YSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDF 572
+ + + + M V L ++H + +H DLKP NI+ + DF
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNELKLIDF 301
Query: 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLL 620
G++ L + +T T + APE V D++S GVL
Sbjct: 302 GLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-25
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 56/233 (24%)
Query: 422 IRRATDEFNEC----NLLGTGGFGSVYKGT-LSDGTNVAIKI-------------FNLQL 463
+R+ + E LG+G +G V + + AIK+ N +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 464 ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 523
E+ +E +L+++ H N++K+ + + LV EF G L F I
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL---------FEQI 137
Query: 524 LQR--------LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDF 572
+ R NIM + S + YLH + I+H D+KP NILL + + + DF
Sbjct: 138 INRHKFDECDAANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 573 GISKLLGEGEDSVIQTMTMATIGYMAPE-----YGSEGIVSTKCDVYSYGVLL 620
G+S + + T Y+APE Y KCDV+S GV++
Sbjct: 194 GLSSFFSKDY---KLRDRLGTAYYIAPEVLKKKYN------EKCDVWSCGVIM 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 45/215 (20%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEIL-RNVRHR 483
TD + +G G + + + A+KI + E EIL R +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHP 76
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLN--------IMIDVGS 535
N++ + + + +V E M G L IL++ ++ +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL---------LDKILRQKFFSEREASAVLFTITK 127
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGEDSVIQTMTM 591
+EYLH ++H DLKP+NIL + DFG +K L E+ ++ T
Sbjct: 128 TVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTP-C 181
Query: 592 ATIGYMAPE------YGSEGIVSTKCDVYSYGVLL 620
T ++APE Y + CD++S GVLL
Sbjct: 182 YTANFVAPEVLERQGYDAA------CDIWSLGVLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 53/234 (22%), Positives = 90/234 (38%), Gaps = 48/234 (20%)
Query: 410 PPATRRRTSYLDIRRATDEFNEC----NLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLE 464
P Y D ++ + LG G VY+ A+K+ ++
Sbjct: 32 PGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD 91
Query: 465 RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL 524
+ +E +L + H N++K+ +LVLE + G L F I+
Sbjct: 92 KK--IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL---------FDRIV 140
Query: 525 QR--------LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFG 573
++ + + + A+ YLH I+H DLKP N+L + ++DFG
Sbjct: 141 EKGYYSERDAADAVKQILEAVAYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFG 196
Query: 574 ISKLLGEGEDSVIQTMTMA-TIGYMAPE------YGSEGIVSTKCDVYSYGVLL 620
+SK++ T+ T GY APE YG E D++S G++
Sbjct: 197 LSKIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPE------VDMWSVGIIT 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN 484
+ F+ LG G +GSVYK G VAIK + E + E I++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++K GS +V+E+ GS+ + N L + I+ LEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--- 142
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG---YMAPEY 601
IH D+K NILL+ A ++DFG++ L D++ + T+ IG +MAPE
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEV 196
Query: 602 GSEGIVSTKCDVYSYGVLLME 622
E + D++S G+ +E
Sbjct: 197 IQEIGYNCVADIWSLGITAIE 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 48/206 (23%), Positives = 90/206 (43%), Gaps = 30/206 (14%)
Query: 428 EFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
++ +LG G FG V+K + G +A KI + + +E ++ + H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR---------LNIMIDVGSAL 537
++ + + + LV+E++ G L F I+ + M + +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGEL---------FDRIIDESYNLTELDTILFMKQICEGI 200
Query: 538 EYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMATI 594
++H + I+H DLKP NIL D + + DFG+++ E ++ T
Sbjct: 201 RHMHQMY----ILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPRE--KLKVN-FGTP 252
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLL 620
++APE + VS D++S GV+
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERA-FRSFDSECEI-LRNVRHR 483
D+ LG G +G V K + G +A+K + + + +I +R V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFL------DILQRLNIMIDVGSAL 537
+ G+ + +E M + SL+K Y DIL + I + + AL
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGK--IAVSIVKAL 122
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597
E+LH S +IH D+KP+N+L++ + DFGIS G D V + + YM
Sbjct: 123 EHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPYM 176
Query: 598 APE----YGSEGIVSTKCDVYSYGVLLME 622
APE ++ S K D++S G+ ++E
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 43/205 (20%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSC 492
LG G F K A+KI + ++E + E L+ H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLN--------IMIDVGSALEYLHHCH 544
+ LV+E + G L F I ++ + IM + SA+ ++H
Sbjct: 76 HDQLHTFLVMELLNGGEL---------FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 545 SSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE- 600
++H DLKP N+L ++N+ + DFG ++L ++ ++T T+ Y APE
Sbjct: 127 ----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTP-CFTLHYAAPEL 180
Query: 601 -----YGSEGIVSTKCDVYSYGVLL 620
Y CD++S GV+L
Sbjct: 181 LNQNGYDES------CDLWSLGVIL 199
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 42/227 (18%), Positives = 88/227 (38%), Gaps = 25/227 (11%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNV 480
R T EF+E +G+G FGSV+K DG AIK L ++ E +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 481 -RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL---QRLNIMIDVGSA 536
+H ++++ + + D + E+ GSL + + + + ++++ VG
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQ--------- 587
L Y+H ++H D+KP+NI + + + + + + +
Sbjct: 128 LRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 588 -TMTMATIG---YMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKP 629
+ G ++A E E K D+++ + ++ +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 62/283 (21%), Positives = 111/283 (39%), Gaps = 24/283 (8%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+IP+ +T A K LDL N + + +L L L N + T + S
Sbjct: 45 SIPSGLTEAVKS--LDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS-----FS 97
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI--GNLRGLI 120
SL +L +L L+ N L + S SL + ++ + +L L
Sbjct: 98 SLG---SLEHLDLSYNYLSNLSSSWFKPLS-SLTFLNLLGNPY-KTLGETSLFSHLTKLQ 152
Query: 121 VLSLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
+L +G D I L L+ + ++LQ Y P L ++ ++ L L +
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212
Query: 180 AIPQCLASLTSLRSLYLQSNKLS----SSLPS----SLWSLEYILRINLSSNSLKGTLPS 231
+ + +S+ L L+ L S L + SL + ++ SL +
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMK 271
Query: 232 NIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
+ +++ L++L+ SRNQL S L +L+ + L N +
Sbjct: 272 LLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 44/230 (19%), Positives = 81/230 (35%), Gaps = 9/230 (3%)
Query: 132 TIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSL 191
+IP+ + ++ + N + DL L L L+ N ++ +SL SL
Sbjct: 45 SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 192 RSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRNQLS 250
L L N LS+ S L + +NL N K +++ L L L +
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 251 SDIPS-TIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALS 309
+ I L LE L + + Q P+S+ ++ ++ L + ++ S
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 310 HLKQFNVSHNRLEG----EIPVKGSFKDFSAQSYFGNYALCGPPRLQVPP 355
++ + L+ E+ G + F N + QV
Sbjct: 223 SVECLELRDTDLDTFHFSELS-TGETNSLIKKFTFRNVKITDESLFQVMK 271
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 53/214 (24%), Positives = 84/214 (39%), Gaps = 35/214 (16%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFD------SECEILR 478
D ++ LG+G F V K S G A K + RA R E ILR
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 479 NVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIM 530
V H N++ + N L+LE + G L F + Q+ + +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFI 121
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGEDSVI 586
+ + YLH I H DLKP NI+L + DFG++ + +G
Sbjct: 122 KQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EF 175
Query: 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLL 620
+ + T ++APE + + + D++S GV+
Sbjct: 176 KNI-FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 15/204 (7%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL-ERAFRSFDSECEIL-RNVRHR 483
++ +G+G G V+K G +A+K + + + +++ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
+++ G+ + +E M EK + + + + AL YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--- 600
H +IH D+KP+NILLDE + DFGIS G D + + YMAPE
Sbjct: 144 HG---VIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERID 197
Query: 601 --YGSEGIVSTKCDVYSYGVLLME 622
++ + DV+S G+ L+E
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVE 221
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 53/214 (24%), Positives = 84/214 (39%), Gaps = 35/214 (16%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFD------SECEILR 478
D ++ LG+G F V K S G A K + RA R E ILR
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 479 NVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIM 530
V H N++ + N L+LE + G L F + Q+ + +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFI 121
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGEDSVI 586
+ + YLH I H DLKP NI+L + DFG++ + +G
Sbjct: 122 KQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EF 175
Query: 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLL 620
+ + T ++APE + + + D++S GV+
Sbjct: 176 KNI-FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 70/349 (20%), Positives = 120/349 (34%), Gaps = 50/349 (14%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIP-NTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
S + L L + + I NTF L L +L L N + A
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGA-------- 98
Query: 64 LTNCRNLANLALASNPL-GGILPPLIGNFS--ASLQNIYAFECKLGGSIPKEI-GNLRGL 119
NL L L L G +L F SL+ + + + P N+R
Sbjct: 99 FNGLANLEVLTLTQCNLDGAVLSG--NFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRF 156
Query: 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
VL L FN + +I L QG + L + + +++ L
Sbjct: 157 HVLDLTFNKVK-SICE--EDLLNFQGKHFTLLRLS-----------SITLQDMNEYWLGW 202
Query: 180 AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRI-----NLSSNSLKGTLPSNIQ 234
TS+ +L L N S+ + +I + S N +N +
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262
Query: 235 KL----------NVLIDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-G 282
+ + DLS++++ + + ++ +LE L+LA N+ I ++
Sbjct: 263 DPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFW 320
Query: 283 NLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSF 331
L L L+ S N L + E L L+ ++S+N + + SF
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALG-DQSF 367
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 61/324 (18%), Positives = 105/324 (32%), Gaps = 37/324 (11%)
Query: 12 TKLIGLDLGLNSFSGHI--PNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRN 69
L L L + G + N F L L +L L NN+ SF ++
Sbjct: 103 ANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK----KIQPASFFLNMRR--- 155
Query: 70 LANLALASNPLGGILPPLIGNFSA------SLQNIYAFECKLGGSIPKEIGNLRGLI--- 120
L L N + I + NF L +I + ++ GN
Sbjct: 156 FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L L N ++ + + H + N + L
Sbjct: 216 TLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEA- 274
Query: 181 IPQCLASLTSLRSLYLQSNKLSS---SLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKL 236
+ +++ L +K+ + S+ S LE + L+ N + + N L
Sbjct: 275 --------SGVKTCDLSKSKIFALLKSVFSHFTDLEQL---TLAQNEIN-KIDDNAFWGL 322
Query: 237 NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNN 295
L+ L+LS+N L S L LE L L+ N + + + L +L+ L N
Sbjct: 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTN 381
Query: 296 NLSGKIPKSLEALSHLKQFNVSHN 319
L + L+ L++ + N
Sbjct: 382 QLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 49/271 (18%), Positives = 89/271 (32%), Gaps = 18/271 (6%)
Query: 9 TNATKLIGLDLGLNSFSGHIPNTFGNL--RHLSVLSLMMNNLTTESSSADQWSFLSSLTN 66
N + LDL N N +H ++L L L + W +
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 67 CRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGF 126
++ L L+ N + F ++ L + + S G
Sbjct: 211 NTSITTLDLSGNGFKESMA---KRFFDAIAGTKIQSLIL---------SNSYNMGSSFGH 258
Query: 127 NDLNGTIPTSIGTLQ--QLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQC 184
+ + L+ ++ + ++ + + H L L L+ N+++
Sbjct: 259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318
Query: 185 LASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLD 243
LT L L L N L S +L+ + ++LS N ++ L L L +L
Sbjct: 319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELA 377
Query: 244 LSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
L NQL S L +L+ + L N +
Sbjct: 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 7e-18
Identities = 50/293 (17%), Positives = 93/293 (31%), Gaps = 34/293 (11%)
Query: 69 NLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIVLSLGFN 127
++ + L+ N + + LQ + + G I L LI+L L +N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQD-LQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 128 DLNGTIPTSI-GTLQQLQGFYVPENNLQG-YVPHDL-CHLERLNILNLSGNKLSGAIPQC 184
+ T L L+ + + NL G + + L L +L L N + P
Sbjct: 90 QF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 185 L-ASLTSLRSLYLQSNKLSSSLPSSLWSLEYI------LRIN----LSSNSLKGTLPSNI 233
++ L L NK+ S L + + L ++ L N
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 234 QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETL-------------SLAGNQFQGPIPES 280
K + LDLS N + + S F+ P +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 281 VGNLI--SLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSF 331
L +++ D S + + + + L+Q ++ N + +I +F
Sbjct: 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KID-DNAF 319
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 29/137 (21%), Positives = 54/137 (39%), Gaps = 4/137 (2%)
Query: 189 TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRN 247
+ + L N ++ +S L+ + + + + + +N + L+ LI L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 248 QLSSDIPSTIGTLKNLETLSLAGNQFQG-PIPESV-GNLISLESLDFSNNNLSGKIPKSL 305
Q L NLE L+L G + + L SLE L +NN+ P S
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 306 -EALSHLKQFNVSHNRL 321
+ +++ N++
Sbjct: 150 FLNMRRFHVLDLTFNKV 166
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 21/107 (19%), Positives = 42/107 (39%), Gaps = 7/107 (6%)
Query: 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLIS 286
LP+++ + DLS N ++ ++ L++L+ L + I + L S
Sbjct: 27 ELPAHVNYV------DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 287 LESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKD 333
L L N + L++L+ ++ L+G + FK
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 38/209 (18%), Positives = 78/209 (37%), Gaps = 14/209 (6%)
Query: 12 TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNC---- 67
T + LDL N F + F + + + ++ + + S+ + N
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 68 ---RNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIVLS 123
+ L+ + + L + + L+ + + ++ I L L+ L+
Sbjct: 272 LEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLN 329
Query: 124 LGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDL-CHLERLNILNLSGNKLSGAI 181
L N L G+I + + L +L+ + N+++ + L L L L N+L
Sbjct: 330 LSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVP 387
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLW 210
LTSL+ ++L +N S P +
Sbjct: 388 DGIFDRLTSLQKIWLHTNPWDCSCPRIDY 416
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 51/205 (24%), Positives = 80/205 (39%), Gaps = 35/205 (17%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNL-QLERAFRSFD-----SECEILRNVRHRNLLK 487
LG+G F V K G A K +L + R E ILR +RH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMIDVGSALEY 539
+ N L+LE + G L F + ++ + + + Y
Sbjct: 73 LHDIFENKTDVVLILELVSGGEL---------FDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 540 LHHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
LH I H DLKP NI+L N + DFGI+ + G + + T
Sbjct: 124 LHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNI-FGTPE 176
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLL 620
++APE + + + D++S GV+
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 29/210 (13%)
Query: 423 RRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
+ +++ LG G FG V++ S K ++ E IL R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIAR 59
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR---------LNIMID 532
HRN+L + S +++ ++ EF+ + F I ++ +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDI---------FERINTSAFELNEREIVSYVHQ 110
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILL--DENMVAHVSDFGISKLLGEGEDSVIQTMT 590
V AL++LH + I H D++P NI+ + + +FG ++ L G+ +
Sbjct: 111 VCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLL 163
Query: 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLL 620
Y APE +VST D++S G L+
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 42/235 (17%), Positives = 86/235 (36%), Gaps = 20/235 (8%)
Query: 401 KHLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTG--GFGSVYKGT-LSDGTNVAIK 457
H H + +S+L + ++G G +V G V ++
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 458 IFNL--QLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLY 515
NL E + + H N++ + + +V FM GS + +
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 516 SH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574
+H ++ L I+ V AL+Y+HH +H +K ++IL+ + ++S
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHMG----YVHRSVKASHILISVDGKVYLSGLRS 174
Query: 575 SKLLGEGED--SVIQTMTMATIG---YMAPEYGSEGIV--STKCDVYSYGVLLME 622
+ + V+ ++ +++PE + + K D+YS G+ E
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 32/210 (15%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNL-QLERAFRSFDSECEILRNVRHR 483
+ F + +G G FG V+KG VAIKI +L + E E +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQ--RLN------IMIDVGS 535
+ K GS +++E++ GS LD+L+ L+ I+ ++
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILK 130
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
L+YLH S IH D+K N+LL E+ ++DFG++ L D+ I+ T +G
Sbjct: 131 GLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VG 181
Query: 596 ---YMAPEYGSEGIVSTKCDVYSYGVLLME 622
+MAPE + +K D++S G+ +E
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 44/195 (22%), Positives = 69/195 (35%), Gaps = 9/195 (4%)
Query: 132 TIPTSI-GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTS 190
+P I Q++ ++ N + L IL L N L+ L
Sbjct: 25 AVPVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 191 LRSLYLQSNKLSSSLPSSLWS-LEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRNQ 248
L L L N S+ + + L + ++L L+ L + + L L L L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 249 LSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEA 307
L + +P L NL L L GN+ + L SL+ L N ++ P +
Sbjct: 141 LQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 308 LSHLKQFNVSHNRLE 322
L L + N L
Sbjct: 200 LGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 53/232 (22%), Positives = 82/232 (35%), Gaps = 27/232 (11%)
Query: 90 NFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVP 149
A+ Q I+ ++ R L +L L N L + L L+ +
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 150 ENNLQGYVPHD-LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSS 208
+N V L RL+ L+L L P L +L+ LYLQ N L +LP
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-QALPDD 147
Query: 209 LWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSL 268
+ + L L L L N++SS L +L+ L L
Sbjct: 148 TF-----------------------RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 269 AGNQFQGPIPESV-GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHN 319
N+ + +L L +L NNLS ++L L L+ ++ N
Sbjct: 185 HQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 56/273 (20%), Positives = 87/273 (31%), Gaps = 60/273 (21%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P I A++ + L N S +F R+L++L L N L ++A
Sbjct: 25 AVPVGIPAASQR--IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA------- 75
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
T L L L+ N + P F L L L
Sbjct: 76 -FTGLALLEQLDLSDNAQLRSVDP--ATFH----------------------GLGRLHTL 110
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
L L + +G L L L L N L
Sbjct: 111 HLDRCGL-----QEL-----------GPGLFRG--------LAALQYLYLQDNALQALPD 146
Query: 183 QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLID 241
L +L L+L N++SS + L + R+ L N + + + + L L+
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMT 205
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
L L N LS+ + L+ L+ L L N +
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 35/205 (17%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFN-LQLERAFRSFD-----SECEILRNVRHRNLLK 487
LG+G F V K S G A K + + + R E IL+ ++H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR--------LNIMIDVGSALEY 539
+ N L+LE + G L F + ++ + + + + Y
Sbjct: 79 LHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 540 LHHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
LH I H DLKP NI+L + DFG++ + G + + T
Sbjct: 130 LHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNI-FGTPE 182
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLL 620
++APE + + + D++S GV+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 55/213 (25%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEIL-RNVRHRNLLKILGS 491
+LG G G V + G A+K+ +A + E + + +++ IL
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90
Query: 492 CSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILQRLN----------IMIDVGSAL 537
N+ +++E M G L F I +R + IM D+G+A+
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 538 EYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMA-T 593
++LH + I H D+KP N+L +++ V ++DFG +K + T T
Sbjct: 142 QFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYT 192
Query: 594 IGYMAPE------YGSEGIVSTKCDVYSYGVLL 620
Y+APE Y CD++S GV++
Sbjct: 193 PYYVAPEVLGPEKYD------KSCDMWSLGVIM 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 46/203 (22%), Positives = 79/203 (38%), Gaps = 33/203 (16%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFN--LQLERAFRSFDSECEILRNVRHR-NLLKILG 490
LG G F V + S G A K + + E +L + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRL----------NIMIDVGSALEYL 540
N L+LE+ G + F L L ++ + + YL
Sbjct: 97 VYENTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 541 HHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597
H + I+H DLKP NILL + DFG+S+ +G ++ + M T Y+
Sbjct: 148 HQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREI-MGTPEYL 200
Query: 598 APEYGSEGIVSTKCDVYSYGVLL 620
APE + ++T D+++ G++
Sbjct: 201 APEILNYDPITTATDMWNIGIIA 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 35/207 (16%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFN----LQLERAFRSFDSECEILRNVRHRNLLK- 487
LLG G +G V + A+KI ++ + E ++LR +RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 488 --ILGSCSNLDFKALVLEFMPNGSLEKWLY----------SHNYFLDILQRLNIMIDVGS 535
+L + +V+E+ G E +H YF ++
Sbjct: 72 VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI----------D 120
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
LEYLH I+H D+KP N+LL +S G+++ L + +
Sbjct: 121 GLEYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 596 YMAPE--YGSEGIVSTKCDVYSYGVLL 620
+ PE G + K D++S GV L
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 19/262 (7%)
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ L + + + S+ I A + S+ + I L +
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDIK-SV-QGIQYLPNVT 68
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L L N L P + L+ L ++ EN ++ L L++L L+L N +S
Sbjct: 69 KLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISDI 124
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
L L L SLYL +NK++ + L L + ++L N + + L L
Sbjct: 125 NG--LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQ 178
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK 300
+L LS+N +S D+ + LKNL+ L L + NL+ ++ ++ +L
Sbjct: 179 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--V 234
Query: 301 IPKSLEALSHLKQFNVSHNRLE 322
P+ + ++ NV + E
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPE 256
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 29/185 (15%), Positives = 72/185 (38%), Gaps = 10/185 (5%)
Query: 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG 174
+ + LG + T + + L + N+ + + + L ++
Sbjct: 21 TFKAYLNGLLG---QSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 175 NKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQ 234
+ P ++ L++L L + ++S +L L + +++S ++ ++ + I
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 235 KLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSN 294
L + +DLS N +DI + TL L++L++ + + + L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 295 NNLSG 299
+ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 27/166 (16%), Positives = 60/166 (36%), Gaps = 8/166 (4%)
Query: 164 LERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223
+ L + + A + SL + L + ++ + + I + +++
Sbjct: 22 FKAYLNGLLGQSSTANITE---AQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 224 SLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGN 283
+ I L+ L L + ++SD + L +L L ++ + I +
Sbjct: 77 HATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 284 LISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKG 329
L + S+D S N I L+ L LK N+ + + ++
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIED 179
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 33/195 (16%), Positives = 67/195 (34%), Gaps = 19/195 (9%)
Query: 9 TNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCR 68
+ + LG +S + T + L+ ++L N+T L+ +
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD----------LTGIEYAH 66
Query: 69 NLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFND 128
N+ +L + + P I S +L+ + + + L L +L + +
Sbjct: 67 NIKDLTINNIHATNYNP--ISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123
Query: 129 LNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASL 188
+ +I T I TL ++ + N + L L L LN+ + + +
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDF 180
Query: 189 TSLRSLYLQSNKLSS 203
L LY S +
Sbjct: 181 PKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 23/162 (14%), Positives = 48/162 (29%), Gaps = 29/162 (17%)
Query: 111 KEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNIL 170
I + L++ P I L L+ + ++ +L L L +L
Sbjct: 60 TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 171 NLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP 230
++S + +I + +L + S+ L N + +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI------------------------- 152
Query: 231 SNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQ 272
++ L L L++ + + D I L L
Sbjct: 153 MPLKTLPELKSLNIQFDGV-HDY-RGIEDFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/122 (13%), Positives = 36/122 (29%), Gaps = 12/122 (9%)
Query: 6 NSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLT 65
N I+ + L L + + L L++L + + L+ +
Sbjct: 82 NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI--------LTKIN 133
Query: 66 NCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLG 125
+ ++ L+ N + PL L+++ + I + L L
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTL--PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 126 FN 127
Sbjct: 190 SQ 191
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 40/226 (17%), Positives = 72/226 (31%), Gaps = 19/226 (8%)
Query: 112 EIGNLRGLIVLSLGFNDLNGTIPTSIG--TLQQLQGFYVPENNLQGYVPHDL----CHLE 165
+ + GL L+L ++ GT P + T L + +
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 166 RLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSL-------PSSLWSLEYILRI 218
L +L+++ + + +L +L L N P +L+ +
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 219 NLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGT-LKNLETLSLAGNQFQGPI 277
N + G + L LDLS N L + L +L+L+ + +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-V 268
Query: 278 PESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEG 323
P+ + L LD S N L P E L + ++ N
Sbjct: 269 PKGLPA--KLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 4e-22
Identities = 59/277 (21%), Positives = 89/277 (32%), Gaps = 28/277 (10%)
Query: 14 LIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANL 73
L +D + ++ LS+ L + S + L L
Sbjct: 49 LKRVDTEADLG-----QFTDIIKSLSLKRLTVRAARIPSRILFG---ALRVLGISGLQEL 100
Query: 74 ALASNPLGGILPPLIGNFS-ASLQNIYAFECKLGG--SIPKEIGNL--RGLIVLSLGFND 128
L + + G PP + + L + + E+ GL VLS+
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 129 LNGTIPTSIGTLQQLQGFYVPENNLQG-------YVPHDLCHLERLNILNLSGNKLSGAI 181
+ L + +N G P L+ L + N SG
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILR-INLSSNSLKGTLPSNI-QKLNVL 239
A+ L+ L L N L + + L +NLS LK +P + KL+V
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSV- 278
Query: 240 IDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP 276
LDLS N+L PS L + LSL GN F
Sbjct: 279 --LDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 41/240 (17%), Positives = 74/240 (30%), Gaps = 17/240 (7%)
Query: 100 AFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPH 159
AF C + G +L + + T I L+ V + +
Sbjct: 27 AFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILF 86
Query: 160 DLCHLE---RLNILNLSGNKLSGAIPQCLASLT--SLRSLYLQSNKLSSSLPS----SLW 210
+ L L L +++G P L T L L L++ ++ W
Sbjct: 87 GALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQW 146
Query: 211 SLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTI----GTLKNLETL 266
+ ++++ ++ L LDLS N + L+ L
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206
Query: 267 SLAGNQFQ---GPIPESVGNLISLESLDFSNNNLSGKIPKSL-EALSHLKQFNVSHNRLE 322
+L + G + L+ LD S+N+L + S L N+S L+
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 19/157 (12%), Positives = 50/157 (31%), Gaps = 10/157 (6%)
Query: 185 LASLTSLRSLYLQSNKLSSSLP-SSLWSLEYILRINLSSNSLKGTLPSNIQKL---NVLI 240
SL L + + + + + + R+ + + + + ++ + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 241 DLDLSRNQLSSDIPSTIG--TLKNLETLSLAGNQFQGPIPE----SVGNLISLESLDFSN 294
+L L +++ P + T +L L+L + L+ L +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 295 NNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSF 331
+ + + L ++S N GE + +
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 59/321 (18%), Positives = 101/321 (31%), Gaps = 42/321 (13%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
T S L LD +S + + L L+ L NN+TT
Sbjct: 32 ATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITTL---------- 79
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
L+ NL LA SN L + + L + KL + + L
Sbjct: 80 -DLSQNTNLTYLACDSNKLTNL--DVTPL--TKLTYLNCDTNKL-TKLD--VSQNPLLTY 131
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L+ N L I + QL N + D+ +L L+ S NK++ +
Sbjct: 132 LNCARNTLT-EID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT-EL 185
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241
++ L L +N ++ + L + ++ SSN L + + L L
Sbjct: 186 D--VSQNKLLNRLNCDTNNITKLDLNQNIQLTF---LDCSSNKLT-EID--VTPLTQLTY 237
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301
D S N L+ + + TL L TL + + L ++
Sbjct: 238 FDCSVNPLTE-LD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKEL 291
Query: 302 PKSLEALSHLKQFNVSHNRLE 322
+ + L + +
Sbjct: 292 D--VTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-22
Identities = 49/315 (15%), Positives = 98/315 (31%), Gaps = 42/315 (13%)
Query: 7 SITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTN 66
+T TKL L+ N + L+ L+ N LT +++
Sbjct: 101 DVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLTE-----------IDVSH 146
Query: 67 CRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGF 126
L L N I + + L + K+ + + + L L+
Sbjct: 147 NTQLTELDCHLNKK--ITKLDVTPQT-QLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDT 200
Query: 127 NDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLA 186
N++ + + QL N L D+ L +L + S N L+ + ++
Sbjct: 201 NNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELD--VS 251
Query: 187 SLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSR 246
+L+ L +L+ L + L Y + + ++ L LD
Sbjct: 252 TLSKLTTLHCIQTDLLEIDLTHNTQLIY-----FQAEGCRKIKELDVTHNTQLYLLDCQA 306
Query: 247 NQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLE 306
++ + L L L + + V + L+SL N ++ S+
Sbjct: 307 AGITEL---DLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ-DFS-SVG 358
Query: 307 ALSHLKQFNVSHNRL 321
+ L + +
Sbjct: 359 KIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 40/208 (19%), Positives = 75/208 (36%), Gaps = 22/208 (10%)
Query: 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG 174
N + + ++ T S L L +++ + L L L +
Sbjct: 19 NFASEVAAA---FEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTS 73
Query: 175 NKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQ 234
N ++ + L+ T+L L SNKL++ + L L Y +N +N L ++
Sbjct: 74 NNIT-TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTY---LNCDTNKLT---KLDVS 124
Query: 235 KLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSN 294
+ +L L+ +RN L+ + L L N+ + V L +LD S
Sbjct: 125 QNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 295 NNLSGKIPKSLEALSHLKQFNVSHNRLE 322
N ++ + L + N N +
Sbjct: 180 NKITE---LDVSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 36/259 (13%), Positives = 76/259 (29%), Gaps = 31/259 (11%)
Query: 7 SITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTN 66
+ +L LD N + I L L+ +N LT S
Sbjct: 207 DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVS-----------T 252
Query: 67 CRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGF 126
L L L I + + + Q IY ++ + L +L
Sbjct: 253 LSKLTTLHCIQTDLLEI------DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQA 306
Query: 127 NDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLA 186
+ + + +L Y+ L D+ H +L L+ + +
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHIQ-DFS-SVG 358
Query: 187 SLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL---D 243
+ +L + + + + +L + + ++ G + + D
Sbjct: 359 KIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNT 418
Query: 244 LSRNQLSSDIPSTIGTLKN 262
++ LS+D P+ T +
Sbjct: 419 ITWENLSTDNPAVTYTFTS 437
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 62/335 (18%), Positives = 114/335 (34%), Gaps = 59/335 (17%)
Query: 5 PNSIT------NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQW 58
P +I I + G ++ + T +L ++ LS +TT
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-------- 55
Query: 59 SFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRG 118
+ + NL L L N + + P + NL
Sbjct: 56 --IEGVQYLNNLIGLELKDNQITDLAP---------------------------LKNLTK 86
Query: 119 LIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS 178
+ L L N L ++I LQ ++ + + P L L L +L L N+++
Sbjct: 87 ITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT 142
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV 238
P LA LT+L+ L + + ++S + L +L + + N + S + L
Sbjct: 143 NISP--LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI--SPLASLPN 196
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
LI++ L NQ+S S + NL ++L NL+ + + +
Sbjct: 197 LIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV--KGPSGA 252
Query: 299 GKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKD 333
P ++ N++ N V +F
Sbjct: 253 PIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQ 287
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 8e-22
Identities = 50/329 (15%), Positives = 111/329 (33%), Gaps = 18/329 (5%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
L + + + ++ +V +L ++N+ FLS L
Sbjct: 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL 213
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFSA-----SLQNIYAFECKLGGSIPKEIG----- 114
+ L+ + ++ KL G +
Sbjct: 214 AKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
Query: 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG 174
+L+ L + + + + + + + L+ S
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333
Query: 175 NKLSGAIPQCLASLTSLRSLYLQSNKLSS--SLPSSLWSLEYILRINLSSNSLKGTLPSN 232
N L+ + + LT L +L LQ N+L + ++ + ++++S NS+
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 233 I-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLD 291
L+ L++S N L+ I + ++ L L N+ + IP+ V L +L+ L+
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELN 450
Query: 292 FSNNNLSGKIPK-SLEALSHLKQFNVSHN 319
++N L +P + L+ L++ + N
Sbjct: 451 VASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 7e-21
Identities = 61/343 (17%), Positives = 107/343 (31%), Gaps = 19/343 (5%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTT-ESSSADQWSFL 61
I N ++L L L +L VL ++ E Q
Sbjct: 106 PICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNT 165
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
SL + N + S + +C SI ++ L
Sbjct: 166 ESL-HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN 224
Query: 122 LSLGFNDLNGTIPTSIGTLQ---QLQGFYVPENNLQGYVPHDL-----CHLERLNILNLS 173
L+L + I L + F + LQG + L+ L+I +
Sbjct: 225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
Query: 174 GNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI 233
+ +++ + + L ++ S+N L T+ N
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344
Query: 234 QKLNVLIDLDLSRNQLSSDIPSTIG---TLKNLETLSLAGNQFQGPIPESV-GNLISLES 289
L L L L NQL + +K+L+ L ++ N + SL S
Sbjct: 345 GHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403
Query: 290 LDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFK 332
L+ S+N L+ I + L +K ++ N+++ IP K K
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIP-KQVVK 442
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 4e-20
Identities = 65/331 (19%), Positives = 105/331 (31%), Gaps = 20/331 (6%)
Query: 7 SITNATKLIGLDLGLNSF-SGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLT 65
S L LDL N+F + I FGN+ L L L +L SS + L+
Sbjct: 85 SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE--KSSVLPIAHLNISK 142
Query: 66 NCRNLANLALASNPLGGILPPLIGNFSASLQNIYAF----ECKLGGSIPKEIGNLRGLIV 121
L G+ + F + + E+ N++ +
Sbjct: 143 VLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV-- 200
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL------CHLERLNILNLS-- 173
L +I + T +L + + + +I N+
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 174 GNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI 233
G SL +L + S+ + N + + +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 234 QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ--GPIPESVGNLISLESLD 291
K++ + LD S N L+ + G L LETL L NQ + I E + SL+ LD
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 292 FSNNNLSGKIPKSL-EALSHLKQFNVSHNRL 321
S N++S K L N+S N L
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 6e-19
Identities = 57/305 (18%), Positives = 102/305 (33%), Gaps = 21/305 (6%)
Query: 6 NSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMN-NLTTESSSADQWSFLSSL 64
S+ L ++ L L + N L ++ + + + L
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQL 243
Query: 65 TNCRNLANLALASNPLGGIL----PPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ ++++ L G L G +L G +
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS-- 178
+ + + + N L V + HL L L L N+L
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL 363
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWS-LEYILRINLSSNSLK----GTLPSNI 233
I + + SL+ L + N +S S + +L +N+SSN L LP I
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRI 423
Query: 234 QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDF 292
+ L DL N++ S IP + L+ L+ L++A NQ + +P+ + L SL+ +
Sbjct: 424 KVL------DLHSNKIKS-IPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWL 475
Query: 293 SNNNL 297
N
Sbjct: 476 HTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 47/269 (17%), Positives = 92/269 (34%), Gaps = 36/269 (13%)
Query: 10 NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRN 69
T + + G + + S+ +L ++ + ++ Q +N
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN--- 301
Query: 70 LANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDL 129
+ + + S ++ L ++ + G+L L L L N L
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKIS-PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
Query: 130 NGTIPTSIG---TLQQLQGFYVPENNLQGYVPHDLC-HLERLNILNLSGNKLSGAIPQCL 185
+ ++ LQ + +N++ C + L LN+S N L+ I +CL
Sbjct: 361 K-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 186 ASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLS 245
++ L L SNK+ S +P + KL L +L+++
Sbjct: 420 --PPRIKVLDLHSNKIKS-------------------------IPKQVVKLEALQELNVA 452
Query: 246 RNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
NQL S L +L+ + L N +
Sbjct: 453 SNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 53/337 (15%), Positives = 104/337 (30%), Gaps = 32/337 (9%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
+ I + +KL L + N + F + L L L N L S
Sbjct: 38 TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--------PT 89
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFS--ASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
N L +L L+ N + P+ F + L+ + L S I +L VL
Sbjct: 90 VN---LKHLDLSFNAFDAL--PICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVL 144
Query: 123 SLGFNDLNGTIPT---SIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
+ + L + + + + L + N+
Sbjct: 145 LVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 180 AIPQCLASLTSL------RSLYLQSNKLSSSLPSSLWSLEY---ILRINLSSNSLKGTLP 230
L+ L L +L L + + + + + L + + ++S+ L+G L
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264
Query: 231 SNI-----QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI 285
L L + + N+ + + + +
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 286 SLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
LDFSNN L+ + ++ L+ L+ + N+L+
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 9e-16
Identities = 33/148 (22%), Positives = 56/148 (37%), Gaps = 5/148 (3%)
Query: 167 LNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK 226
ILN+S N +S + SL+ LR L + N++ S + + ++LS N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 227 GTLPSNIQKLNVLIDLDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI 285
+ L LDLS N + I G + L+ L L+ + + +L
Sbjct: 83 -KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 286 SLESLDFSNNNLSGKI-PKSLEALSHLK 312
+ L K P+ L+ +
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTES 167
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 38/228 (16%), Positives = 80/228 (35%), Gaps = 21/228 (9%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
S T+ L + + F + ++++ + ++ S +S
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC--PSKISP 325
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSA--SLQNIYAFECKLGGSIPKEIG---NLRG 118
+ L ++N L + N L+ + +L + K ++
Sbjct: 326 FLH------LDFSNNLLTDTVF---ENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKS 375
Query: 119 LIVLSLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKL 177
L L + N ++ + L + N L + L R+ +L+L NK+
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI 433
Query: 178 SGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSL 225
+IP+ + L +L+ L + SN+L S L + +I L +N
Sbjct: 434 K-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 34/207 (16%), Positives = 65/207 (31%), Gaps = 12/207 (5%)
Query: 133 IPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192
+ L + +N + D+ L +L IL +S N++ L
Sbjct: 19 LSQKTTIL------NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 193 SLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG-TLPSNIQKLNVLIDLDLSRNQLSS 251
L L NKL +L++ ++LS N+ + ++ L L LS L
Sbjct: 73 YLDLSHNKLVKISCHPTVNLKH---LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129
Query: 252 DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHL 311
I L + L + G + E L + + K + +S
Sbjct: 130 SSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187
Query: 312 KQFNVSHNRLEGEIPVKGSFKDFSAQS 338
N+ + ++ + S +
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILA 214
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 52/339 (15%), Positives = 108/339 (31%), Gaps = 38/339 (11%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
+P ++ T L++ N S + +L L +L + N + S
Sbjct: 15 VPKDLSQKTT--ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV-------- 64
Query: 64 LTNCRNLANLALASNPLGGI-LPPLIGNFSASLQNIYAFECKLGGSIP--KEIGNLRGLI 120
+ L L L+ N L I P +L+++ ++P KE GN+ L
Sbjct: 65 FKFNQELEYLDLSHNKLVKISCHPT-----VNLKHLDLSFNAF-DALPICKEFGNMSQLK 118
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL---CHLERLNILNLSGNKL 177
L L L + I L + V + + E L+I+ + +
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178
Query: 178 SGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYIL-----------RINLSSNS-- 224
+ + ++ +L ++ + L L + I + NS
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 225 --LKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVG 282
L+ + + + + ++ L D + +LK L + + F P
Sbjct: 239 RILQLVWHTTVWYFS-ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
Query: 283 NLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRL 321
++ +F+ + +S + S+N L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL 336
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 46/306 (15%), Positives = 82/306 (26%), Gaps = 38/306 (12%)
Query: 193 SLYLQSNKLSS---SLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQL 249
+ N L L L N+S N + S+I L+ L L +S N++
Sbjct: 4 LVDRSKNGLIHVPKDLSQKTTIL------NISQNYISELWTSDILSLSKLRILIISHNRI 57
Query: 250 SSDIPSTIGTLKNLETLSLAGNQFQG----------------------PIPESVGNLISL 287
S + LE L L+ N+ PI + GN+ L
Sbjct: 58 QYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 288 ESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCG 347
+ L S +L + L+ K V + +DF+ +S +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED-PEGLQDFNTESLHIVFPTNK 176
Query: 348 PPRLQVPPCKQDNRKRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHED 407
+ + VL+ S ++L + + +
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 408 F---LPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLE 464
F L Y I + S+ ++ V +F
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH---QVVSDVFGFPQS 293
Query: 465 RAFRSF 470
+ F
Sbjct: 294 YIYEIF 299
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDS---ECEILRNVR 481
F++ +G G FG+VY + + VAIK + +++ + E L+ +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
H N ++ G LV+E+ GS L H L ++ + L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG---YMA 598
S +IH D+K NILL E + + DFG + ++ + +G +MA
Sbjct: 172 ----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------PANSF--VGTPYWMA 218
Query: 599 PE---YGSEGIVSTKCDVYSYGVLLME 622
PE EG K DV+S G+ +E
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 40/182 (21%), Positives = 70/182 (38%), Gaps = 16/182 (8%)
Query: 464 ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNY--FL 521
+ + + +N + L S + + ++ +L+ W+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 522 DILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581
+ L+I I + A+E+LH ++H DLKP+NI + V V DFG+ + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 582 ED--------SVIQTMTMA--TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTD 631
E+ T T T YM+PE S K D++S G++L E
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277
Query: 632 EM 633
E
Sbjct: 278 ER 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 19/76 (25%), Positives = 29/76 (38%), Gaps = 2/76 (2%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNL-QLERAFRSFDSECEILRNVR 481
R +F +G GGFG V++ D N AIK L E A E + L +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 482 HRNLLKILGSCSNLDF 497
H +++ +
Sbjct: 63 HPGIVRYFNAWLETPP 78
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 60/215 (27%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSC 492
LG G G V + A+K+ +A R E E+ + ++++I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 493 SNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILQRLN----------IMIDVGSALE 538
NL +V+E + G L F I R + IM +G A++
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 539 YLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMATI- 594
YLH + I H D+KP N+L N + ++DFG +K ++ T
Sbjct: 176 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-------SLTTPC 224
Query: 595 ---GYMAPE------YGSEGIVSTKCDVYSYGVLL 620
Y+APE Y CD++S GV++
Sbjct: 225 YTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDS---ECEILRNVRH 482
D++ ++G+G V VAIK NL E+ S D E + + H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHH 72
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSL-------EKWLYSHNYFLDILQRLNIMIDVGS 535
N++ S D LV++ + GS+ + LD I+ +V
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
LEYLH IH D+K NILL E+ ++DFG+S L G D + +G
Sbjct: 133 GLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 596 ---YMAPE-------YGSEGIVSTKCDVYSYGVLLME 622
+MAPE Y K D++S+G+ +E
Sbjct: 189 TPCWMAPEVMEQVRGYDF------KADIWSFGITAIE 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFN-------LQLERAFRSFDSECE 475
++F +LG G F +V T AIKI ++ E +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVT----RERD 82
Query: 476 ILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGS 535
++ + H +K+ + + + L + NG L K++ F + R ++ S
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVS 141
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATI 594
ALEYLH IIH DLKP NILL+E+M ++DFG +K+L + + T
Sbjct: 142 ALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTA 196
Query: 595 GYMAPEYGSEGIVSTK-----CDVYSYGVLLME 622
Y++PE +++ K D+++ G ++ +
Sbjct: 197 QYVSPE-----LLTEKSACKSSDLWALGCIIYQ 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 50/242 (20%)
Query: 411 PATRRRTSYLDIRRATD---EFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERA 466
+ R +D+ D F L+G G +G VYKG + G AIK+ ++ +
Sbjct: 5 DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE- 63
Query: 467 FRSFDSECEILRNV-RHRNLLKILGS-----CSNLDFKA-LVLEFMPNGSLEKWLYSHNY 519
E +L+ HRN+ G+ +D + LV+EF GS+
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV--------- 114
Query: 520 FLDILQRLN-----------IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAH 568
D+++ I ++ L +LH +IH D+K N+LL EN
Sbjct: 115 -TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEVK 169
Query: 569 VSDFGISKLLGEGEDSVIQTMTMATIG---YMAPE-----YGSEGIVSTKCDVYSYGVLL 620
+ DFG+S L + +V + T IG +MAPE + K D++S G+
Sbjct: 170 LVDFGVSAQL---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224
Query: 621 ME 622
+E
Sbjct: 225 IE 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 51/229 (22%), Positives = 88/229 (38%), Gaps = 36/229 (15%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQ-----LERAFRSFDSECEILRNVRHRNLLK 487
LG G +G V VA+KI +++ E + E I + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILQRLNIMIDVGSALE 538
G + + L LE+ G L + +F ++ + +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVV 119
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDSVIQTMTMATIGYM 597
Y H I H D+KP N+LLDE +SDFG++ + + ++ T+ Y+
Sbjct: 120 Y---LHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYV 174
Query: 598 APE-YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK 645
APE + DV+S G++L + P D+ W +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 62/230 (26%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFN---LQLERAFRSFDS----------------- 472
+G G +G V +D T A+K+ + L + F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 473 ------ECEILRNVRHRNLLK---ILGSCSNLDFKALVLEFMPNGSL----------EKW 513
E IL+ + H N++K +L + D +V E + G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPVMEVPTLKPLSED- 137
Query: 514 LYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573
+ YF D++ +EYLH+ IIH D+KP+N+L+ E+ ++DFG
Sbjct: 138 -QARFYFQDLI----------KGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 574 ISKLLGEGEDSVIQTMTMATIGYMAPE--YGSEGIVS-TKCDVYSYGVLL 620
+S +G D+++ T+ T +MAPE + I S DV++ GV L
Sbjct: 183 VSNEF-KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 51/229 (22%), Positives = 88/229 (38%), Gaps = 36/229 (15%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQ-----LERAFRSFDSECEILRNVRHRNLLK 487
LG G +G V VA+KI +++ E + E I + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILQRLNIMIDVGSALE 538
G + + L LE+ G L + +F ++ + +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVV 119
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDSVIQTMTMATIGYM 597
Y H I H D+KP N+LLDE +SDFG++ + + ++ T+ Y+
Sbjct: 120 Y---LHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYV 174
Query: 598 APE-YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK 645
APE + DV+S G++L + P D+ W +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 56/284 (19%)
Query: 384 LLVIIIIMYVRCRNRSTKHLDH-EDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGS 442
LL I+I +Y C N + + ++L A + +R ++F ++G G FG
Sbjct: 30 LLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGE 89
Query: 443 VY----KGTLSDGTNVAIKIFN----LQL-ERAFRSFDSECEILRNVRHRNLLKILGSCS 493
V K A+KI N L+ E A F E ++L N + + + +
Sbjct: 90 VAVVKLKNA---DKVFAMKILNKWEMLKRAETAC--FREERDVLVNGDSKWITTLHYAFQ 144
Query: 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMID----------VGSALEYLHHC 543
+ + LV+++ G L + L + + + A++ +H
Sbjct: 145 DDNNLYLVMDYYVGGDL----LTL------LSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTM-ATIGYMAPE 600
H +H D+KP NIL+D N H+ +DFG L ED +Q+ T Y++PE
Sbjct: 195 H----YVHRDIKPDNILMDMN--GHIRLADFGSCLKL--MEDGTVQSSVAVGTPDYISPE 246
Query: 601 -----YGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
G +G +CD +S GV + E + P E +
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 56/255 (21%), Positives = 101/255 (39%), Gaps = 22/255 (8%)
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ S L + + + S+ I A + S+ + I L +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDIK-SV-QGIQYLPNVT 71
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L L N L P + L+ L ++ EN ++ L L++L L+L N +S
Sbjct: 72 KLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDI 127
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
L L L SLYL +NK++ + L L + ++L N + + + L L
Sbjct: 128 NG--LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQ 181
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK 300
+L LS+N +S D+ + LKNL+ L L + NL+ ++ ++ +L
Sbjct: 182 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-- 237
Query: 301 IPKSLEALSHLKQFN 315
+ E +S +
Sbjct: 238 ---TPEIISDDGDYE 249
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 36/162 (22%), Positives = 66/162 (40%), Gaps = 12/162 (7%)
Query: 161 LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINL 220
NL ++ A+ L S+ + ++ + S + L + ++ L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 75
Query: 221 SSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPES 280
+ N L + L L L L N++ D+ S++ LK L++LSL N
Sbjct: 76 NGNKLTDI--KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS--DING 129
Query: 281 VGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
+ +L LESL NN ++ I L L+ L ++ N++
Sbjct: 130 LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 54/305 (17%), Positives = 100/305 (32%), Gaps = 55/305 (18%)
Query: 3 TIPNSIT------NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSAD 56
T+P I + I +L S + T L + + +++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS------ 60
Query: 57 QWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNL 116
+ + N+ L L N L I P + NL
Sbjct: 61 ----VQGIQYLPNVTKLFLNGNKLTDIKP---------------------------LANL 89
Query: 117 RGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNK 176
+ L L L N + +S+ L++L+ + N + L HL +L L L NK
Sbjct: 90 KNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNK 145
Query: 177 LSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKL 236
++ L+ LT L +L L+ N++S L L + + LS N + + L
Sbjct: 146 ITDITV--LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISDL--RALAGL 199
Query: 237 NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNN 296
L L+L + + + L T+ P S ++ +
Sbjct: 200 KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 259
Query: 297 LSGKI 301
+ ++
Sbjct: 260 FTNEV 264
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 39/215 (18%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQL---ERAFRSFDSECEILRN 479
D F +G G FG V T A+K N Q R+ E +I++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 480 VRHRNLLKILGS---CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSA 536
+ H L+ + S ++ F +V++ + G L L + +F + +L I ++ A
Sbjct: 72 LEHPFLVNLWYSFQDEEDM-F--MVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMA 127
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIG 595
L+YL + IIH D+KP NILLDE+ H++DF I+ +L Q TMA T
Sbjct: 128 LDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKP 179
Query: 596 YMAPEYGSEGIVSTKC--------DVYSYGVLLME 622
YMAPE + S++ D +S GV E
Sbjct: 180 YMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYE 209
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 58/206 (28%), Positives = 87/206 (42%), Gaps = 37/206 (17%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFN------------LQLERAFRSFDSECEILRNVR 481
LG+G FG V+ V +K +L + E IL V
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL----EIAILSRVE 87
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLN------IMIDVGS 535
H N++K+L N F LV+E +G L+ L++ F+D RL+ I + S
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSG-LD--LFA---FIDRHPRLDEPLASYIFRQLVS 141
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
A+ YL IIH D+K NI++ E+ + DFG + L G+ + T TI
Sbjct: 142 AVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYT-FCGTIE 194
Query: 596 YMAPE-YGSEGIVSTKCDVYSYGVLL 620
Y APE + +++S GV L
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 38/203 (18%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFN------LQLERAFRSFDSECEILRNVRHRNLLK 487
+G G F V + G VAIKI + L++ FR E I++ + H N++K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 488 ILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILQRLNIMIDVGSALE 538
+ L++E+ G + +L +H + F I+ SA++
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----------SAVQ 128
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
Y H I+H DLK N+LLD +M ++DFG S G + Y A
Sbjct: 129 YCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDA-FCGAPPYAA 181
Query: 599 PE-YGSEGIVSTKCDVYSYGVLL 620
PE + + + DV+S GV+L
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVIL 204
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 45/208 (21%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQ-------LERAFRSFDSECEILRNVRHRNL 485
LG G FG V G G VA+KI N Q + + R E + L+ RH ++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHI 73
Query: 486 LK---ILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILQRLNIMIDV 533
+K ++ + ++ +V+E++ G L ++ H F IL
Sbjct: 74 IKLYQVISTPTDF---FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL--------- 121
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT 593
SA++Y CH ++H DLKP N+LLD +M A ++DFG+S ++ +GE ++T + +
Sbjct: 122 -SAVDY---CHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRT-SCGS 173
Query: 594 IGYMAPE-YGSEGIVSTKCDVYSYGVLL 620
Y APE + D++S GV+L
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVIL 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 65/241 (26%), Positives = 108/241 (44%), Gaps = 36/241 (14%)
Query: 410 PPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLER---- 465
++ R Y + +++ + +G G +G VYK S G VA+K L E
Sbjct: 6 HHSSGRENLYF--QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP 63
Query: 466 --AFRSFDSECEILRNVRHRN---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF 520
A R E +L+ + H N L+ ++ S L LV EFM L+K L +
Sbjct: 64 STAIR----EISLLKELHHPNIVSLIDVIHSERCL---TLVFEFMEK-DLKKVLDENKTG 115
Query: 521 LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580
L Q + + + + H I+H DLKP N+L++ + ++DFG+++ G
Sbjct: 116 LQDSQIKIYLYQLLRGVAHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLARAFG- 170
Query: 581 GEDSVIQTMT--MATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG 636
+++ T + T+ Y AP+ GS+ ST D++S G + E T KP +F G
Sbjct: 171 ---IPVRSYTHEVVTLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMIT-GKP---LFPG 222
Query: 637 E 637
Sbjct: 223 V 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 59/206 (28%), Positives = 85/206 (41%), Gaps = 35/206 (16%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFN----------LQLERAFRSFDSECEILRNVRH 482
LLG+GGFGSVY G +SD VAIK R E +L+ V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVSS 105
Query: 483 R--NLLKILGSCSNLDFKALVLEF-MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
++++L D L+LE P L ++ + L R + V A+ +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRH 164
Query: 540 LHHCHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
H+C ++H D+K NIL+D N + DFG LL +D+V T Y
Sbjct: 165 CHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSP 216
Query: 599 PEYGS----EGIVSTKCDVYSYGVLL 620
PE+ G V+S G+LL
Sbjct: 217 PEWIRYHRYHG---RSAAVWSLGILL 239
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLER------AFRSFDSECEILRN 479
++ + +G G +G+V+K VA+K L + A R E +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 480 VRHRN---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSA 536
++H+N L +L S L LV EF L+K+ S N LD + + +
Sbjct: 58 LKHKNIVRLHDVLHSDKKL---TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATI 594
L + H + ++H DLKP N+L++ N +++FG+++ G ++ + + T+
Sbjct: 114 LGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFG----IPVRCYSAEVVTL 165
Query: 595 GYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
Y P+ +G++ + ST D++S G + E +P +F G
Sbjct: 166 WYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 56/279 (20%), Positives = 113/279 (40%), Gaps = 49/279 (17%)
Query: 384 LLVIIIIMYVRCRNRSTKHLDH-EDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGS 442
LL + + + + + ++FL D+R +++ ++G G FG
Sbjct: 25 LLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGE 84
Query: 443 VY----KGTLSDGTNVAIKIFNLQ--LERA-FRSFDSECEILRNVRHRNLLKILGSCSNL 495
V K T A+K+ + ++R+ F E +I+ ++++ + +
Sbjct: 85 VQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141
Query: 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVG--------SALEYLHHCHSSA 547
+ +V+E+MP G L ++++ ++ AL+ +H
Sbjct: 142 RYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG--- 188
Query: 548 PIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTM-ATIGYMAPE---- 600
IH D+KP N+LLD++ H+ +DFG + ++ +++ T T Y++PE
Sbjct: 189 -FIHRDVKPDNMLLDKS--GHLKLADFGTCMKM--NKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 601 YGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
G +G +CD +S GV L E P +
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 282
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 30/231 (12%)
Query: 420 LDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFR-SFDS----E 473
LD++ + + + LG G F +VYK + VAIK L + + E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 474 CEILRNVRHRN---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIM 530
++L+ + H N LL G SN+ +LV +FM LE + ++ L M
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNI---SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590
+ LEYLH I+H DLKP N+LLDEN V ++DFG++K G S + T
Sbjct: 119 LMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFG----SPNRAYT 170
Query: 591 --MATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
+ T Y APE +G+ + D+++ G +L E + P G+
Sbjct: 171 HQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLL-RVP---FLPGD 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 53/205 (25%), Positives = 80/205 (39%), Gaps = 31/205 (15%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFN----------LQLERAFRSFDSECEILRNVR- 481
LLG GGFG+V+ G L+D VAIK+ E +L V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL----EVALLWKVGA 93
Query: 482 ---HRNLLKILGSCSNLDFKALVLEF-MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
H ++++L + LVLE +P L ++ + R V +A+
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAI 152
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
++ H ++H D+K NIL+D A + DFG LL D T Y
Sbjct: 153 QHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD-FDGTRVY 204
Query: 597 MAPEY-GSEGIVSTKCDVYSYGVLL 620
PE+ + V+S G+LL
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILL 229
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 45/208 (21%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQ-------LERAFRSFDSECEILRNVRHRNL 485
LG G FG V G G VA+KI N Q + + R E + L+ RH ++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHI 78
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILQRLNIMIDVGSA 536
+K+ S +V+E++ G L ++ + F IL S
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----------SG 128
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG- 595
++Y CH ++H DLKP N+LLD +M A ++DFG+S ++ +GE ++T + G
Sbjct: 129 VDY---CHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRT----SCGS 178
Query: 596 --YMAPE-YGSEGIVSTKCDVYSYGVLL 620
Y APE + D++S GV+L
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVIL 206
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 47/210 (22%), Positives = 81/210 (38%), Gaps = 18/210 (8%)
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC-HLERLNILNLSGNKLSG 179
L L FN L S + +LQ + +Q + L L+ L L+GN +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 180 AIPQCLASLTSLRSLYLQSNKLSSSLPS----SLWSLEYILRINLSSNSLKGTLPSN--I 233
+ L+SL+ L L +SL + L +L+ +N++ N ++ +
Sbjct: 91 LALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKE---LNVAHNLIQ-SFKLPEYF 145
Query: 234 QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLE----TLSLAGNQFQGPIPESVGNLISLES 289
L L LDLS N++ S + + L + +L L+ N I I L+
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKE 204
Query: 290 LDFSNNNLSGKIPKSLEALSHLKQFNVSHN 319
L N L + L+ L++ + N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 59/279 (21%), Positives = 97/279 (34%), Gaps = 75/279 (26%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
+P S N LDL N +F + L VL L + T A S
Sbjct: 26 LPFSTKN------LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA-----YQS 74
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIVL 122
L++ L+ L L NP+ S+ L L L
Sbjct: 75 LSH---LSTLILTGNPIQ--------------------------SLALGAFSGLSSLQKL 105
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKL-SGAI 181
+L ++ + HL+ L LN++ N + S +
Sbjct: 106 VAVETNLA-SLENFP-----------------------IGHLKTLKELNVAHNLIQSFKL 141
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLP----SSLWSLEYI-LRINLSSNSLKGTLPSNI-QK 235
P+ ++LT+L L L SNK+ S + L + + L ++LS N + + ++
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199
Query: 236 LNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
+ L +L L NQL S L +L+ + L N +
Sbjct: 200 IR-LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 65/256 (25%), Positives = 97/256 (37%), Gaps = 53/256 (20%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
+ F + +LG GGFG V + T G A K L+ +R + +IL
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKK--LEKKRIKKRKGEAMALNEKQIL 238
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMI-DVGSA 536
V R ++ + + D LVL M G L+ +Y R ++
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTMA-T 593
LE LH I++ DLKP NILLD++ H+ SD G++ + EG+ T
Sbjct: 299 LEDLH----RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQ----TIKGRVGT 348
Query: 594 IGYMAPE------YGSEGIVSTKCDVYSYGVLLMETFT---------EKKPTDEMFTGEM 638
+GYMAPE Y D ++ G LL E +K +E+
Sbjct: 349 VGYMAPEVVKNERYTFS------PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 639 SLRRWVKESLPHRLTE 654
V E R +
Sbjct: 403 E----VPEEYSERFSP 414
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 5e-19
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 41/232 (17%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC-------- 474
++F+ ++G GGFG VY T G A+K L +R
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKC--LDKKRIKMKQGETLALNERIML 243
Query: 475 EILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVG 534
++ ++ + + D + +L+ M G L L H F + R ++
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EII 302
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTMA 592
LE++H + +++ DLKP NILLDE+ HV SD G++ + +
Sbjct: 303 LGLEHMH----NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKK-----KPHASV 351
Query: 593 -TIGYMAPEYGSEGIVSTKC-DVYSYGVLLMETFT--------EKKPTDEMF 634
T GYMAPE +G+ D +S G +L + + K E+
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 43/206 (20%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFN---LQLERAFRSFDSECEILRNVRHRNLLK-- 487
+G+G FG VA+K E R E R++RH N+++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 488 -ILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILQRLNIMIDVGSAL 537
++ + ++L A+++E+ G L + + + +F +L S +
Sbjct: 83 EVILTPTHL---AIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----------SGV 129
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAH--VSDFGISKLLGEGEDSVIQTMTMATIG 595
Y CHS I H DLK N LLD + + DFG SK S ++ T+ T
Sbjct: 130 SY---CHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKS-TVGTPA 182
Query: 596 YMAPE-YGSEGIVSTKCDVYSYGVLL 620
Y+APE + DV+S GV L
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTL 208
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 67/315 (21%), Positives = 107/315 (33%), Gaps = 81/315 (25%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIK-IFNLQLE--------------RAFRSFDSECEILRN 479
+ +G +G+V G S+G VAIK +FN + R R E +L +
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR----EIRLLNH 85
Query: 480 VRHRN---LLKILGSCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVG 534
H N L I LV E M L + ++ + M +
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MA 592
L LH A ++H DL P NILL +N + DF +++ + T +
Sbjct: 145 LGLHVLH----EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-----KTHYVT 195
Query: 593 TIGYMAPEY-GSEGIVSTKCDVYSYGVLLMETFTEK--------------------KPTD 631
Y APE + D++S G ++ E F K P
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 632 E--MFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMD-LALD----- 683
E + S R +++ SL + +A++ + D +ALD
Sbjct: 256 EDVVMFSSPSARDYLRNSLSN-----------VPARAWTA----VVPTADPVALDLIAKM 300
Query: 684 CCMDTPHKRIHMTDA 698
+ P +RI A
Sbjct: 301 LEFN-PQRRISTEQA 314
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
+F LGTG FG V+ + G A+K+ L+ E R E +L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHN---GRYYAMKV--LKKEIVVRLKQVEHTNDERLML 60
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
V H ++++ G+ + ++++++ G L L F + + + +V AL
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLAL 119
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTM-ATI 594
EYLH II+ DLKP NILLD+N H+ +DFG +K + + T T+ T
Sbjct: 120 EYLHSKD----IIYRDLKPENILLDKN--GHIKITDFGFAKYVPD------VTYTLCGTP 167
Query: 595 GYMAPEYGSEGIVSTK-----CDVYSYGVLLME 622
Y+APE +VSTK D +S+G+L+ E
Sbjct: 168 DYIAPE-----VVSTKPYNKSIDWWSFGILIYE 195
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 44/234 (18%)
Query: 406 EDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNL 461
EDFL + + D+F+ LGTG FG V K + G + A+KI +
Sbjct: 24 EDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDK 76
Query: 462 -------QLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWL 514
Q+E +E IL+ V L+K+ S + +V+E++ G + L
Sbjct: 77 QKVVKLKQIEHTL----NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 515 YSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574
F + R + EYLH +I+ DLKP N+L+D+ V+DFG
Sbjct: 133 RRIGRFSEPHARFYAA-QIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 575 SKLLGEGEDSVIQTMTM-ATIGYMAPEYGSEGIVSTK-----CDVYSYGVLLME 622
+K + +T T+ T +APE I+ +K D ++ GVL+ E
Sbjct: 188 AKRVKG------RTWTLCGTPEALAPE-----IILSKGYNKAVDWWALGVLIYE 230
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 8e-19
Identities = 66/329 (20%), Positives = 115/329 (34%), Gaps = 32/329 (9%)
Query: 13 KLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLAN 72
L L + S ++ L L L L E+ +FLS LT L N
Sbjct: 195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ-RLMTFLSELTRGPTLLN 253
Query: 73 LALASNPLGGILPPLIGNF--SASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLN 130
+ L + F ++ + + + I +E + SL +
Sbjct: 254 VTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV- 312
Query: 131 GTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTS 190
+ Q F + L +NI LS + C S +S
Sbjct: 313 -----------KNQVFLFSKEALY-------SVFAEMNIKMLSISDTPFIHMVCPPSPSS 354
Query: 191 LRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPS---NIQKLNVLIDLDLSRN 247
L N + S+ +L+ + + L N LK + ++ L LD+S N
Sbjct: 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN 413
Query: 248 QLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLE 306
L+S +++ L+L+ N G + + ++ LD NN + IPK +
Sbjct: 414 SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVT 470
Query: 307 ALSHLKQFNVSHNRLEGEIPVKGSFKDFS 335
L L++ NV+ N+L+ +P G F +
Sbjct: 471 HLQALQELNVASNQLK-SVP-DGVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 46/272 (16%), Positives = 97/272 (35%), Gaps = 36/272 (13%)
Query: 7 SITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTN 66
+ L++ + + I ++ SLM+ ++ + + + S
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330
Query: 67 CRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGF 126
+ L+ + I + S S L+
Sbjct: 331 ---MNIKMLSISDTPFIHMVCPPSPS-SFTF------------------------LNFTQ 362
Query: 127 NDLNGTIPTSIGTLQQLQGFYVPENNLQ--GYVPHDLCHLERLNILNLSGNKLSGAIPQC 184
N ++ TL++LQ + N L+ V ++ L L++S N L+
Sbjct: 363 NVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422
Query: 185 LASL-TSLRSLYLQSNKLSSSLPSSL-WSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL 242
+ S+ L L SN L+ S+ L ++ + +L +N + ++P ++ L L +L
Sbjct: 423 TCAWAESILVLNLSSNMLTGSVFRCLPPKVKVL---DLHNNRIM-SIPKDVTHLQALQEL 478
Query: 243 DLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
+++ NQL S L +L+ + L N +
Sbjct: 479 NVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 5e-16
Identities = 61/329 (18%), Positives = 108/329 (32%), Gaps = 18/329 (5%)
Query: 7 SITNATKLIGLDLGLNSF-SGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLT 65
S L LDL N F + FGNL L+ L L + L
Sbjct: 116 SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR--QLDLLPVAHLHLSC 173
Query: 66 NCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSI----PKEIGNLR---- 117
+L + + + P F ++ S+ ++ N++
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233
Query: 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILN--LSGN 175
L ++L TLQ ++ + L + +E LNI N ++
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR--PVEYLNIYNLTITER 291
Query: 176 KLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQK 235
+L SL ++++ S + + LS +
Sbjct: 292 IDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPS 351
Query: 236 LNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ--GPIPESVGNLISLESLDFS 293
+ L+ ++N + + TLK L+TL L N + + N+ SLE+LD S
Sbjct: 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVS 411
Query: 294 NNNL-SGKIPKSLEALSHLKQFNVSHNRL 321
N+L S ++ + N+S N L
Sbjct: 412 LNSLNSHAYDRTCAWAESILVLNLSSNML 440
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 52/335 (15%), Positives = 102/335 (30%), Gaps = 30/335 (8%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64
I+ ++L L L N + F + L L + N L S ++SL
Sbjct: 69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCP-----MASL 123
Query: 65 TNCRNLANLALASNPLGGILPPLIGNFS--ASLQNIYAFECKLGGSIPKEIGNLR-GLIV 121
+L L+ N + P+ F L + K + +L I+
Sbjct: 124 R------HLDLSFNDFDVL--PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCIL 175
Query: 122 LSLGFNDLNGTIPTSIGTLQ--QLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
L L + G S+ L + P + V + L L + N+ N +
Sbjct: 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235
Query: 180 AIPQ----CLASLTSLRSLYLQSNKLSSSLPSSL------WSLEY--ILRINLSSNSLKG 227
L +L ++ LQ + + L +EY I + ++ +
Sbjct: 236 QRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295
Query: 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISL 287
+ L L+ + + + L+ + + S
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355
Query: 288 ESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
L+F+ N + + + L L+ + N L+
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 50/350 (14%), Positives = 116/350 (33%), Gaps = 38/350 (10%)
Query: 218 INLSSNSLK---GTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
++ S+ +L LP + L LS+N +S I L L L L+ N+ +
Sbjct: 36 VDYSNRNLTHVPKDLPPRTKAL------SLSQNSISELRMPDISFLSELRVLRLSHNRIR 89
Query: 275 GPIPESV-GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKD 333
+ V LE LD S+N L I ++ L+ ++S N + +PV F +
Sbjct: 90 S-LDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGN 144
Query: 334 FSAQSYFGNYALCGPPRLQ-VPPCKQDNRKRTNKVAPIVLQYILPSILSTVLLVIIIIMY 392
+ ++ G A + + + + + + +V +I ++ + +++
Sbjct: 145 LTKLTFLGLSA----AKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200
Query: 393 VRCRNRSTKHLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGT 452
+ S + + + S + + + T
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM---------------TFLSEL 245
Query: 453 NVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKI-LGSCSNLDFKALVLEFMPNGSLE 511
+ N+ L+ ++ ++ + R + + + + + + +L+
Sbjct: 246 TRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALK 305
Query: 512 KWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIH--CDLKPTNI 559
+ H L + V + + S P IH C P++
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 38/205 (18%), Positives = 65/205 (31%), Gaps = 35/205 (17%)
Query: 133 IPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192
+P L + +N++ D+ L L +L LS N++ L
Sbjct: 50 LPPRTKAL------SLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE 103
Query: 193 SLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS- 251
L + N+L ++ + L LDLS N
Sbjct: 104 YLDVSHNRL-QNISC--------------------------CPMASLRHLDLSFNDFDVL 136
Query: 252 DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNL-ISLESLDFSNNNLSGKIPKSLEALSH 310
+ G L L L L+ +F+ V +L +S LD + ++ G +SL+ +
Sbjct: 137 PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT 196
Query: 311 LKQFNVSHNRLEGEIPVKGSFKDFS 335
V H + V S
Sbjct: 197 TVLHLVFHPNSLFSVQVNMSVNALG 221
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 50/159 (31%), Positives = 74/159 (46%), Gaps = 9/159 (5%)
Query: 167 LNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK 226
IL+LS N L L T L L L +L + L +L + ++LS N L+
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHNQLQ 90
Query: 227 GTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGT-LKNLETLSLAGNQFQGPIPESV-GNL 284
+LP Q L L LD+S N+L+S +P L L+ L L GN+ + +P +
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKT-LPPGLLTPT 147
Query: 285 ISLESLDFSNNNLSGKIPKSL-EALSHLKQFNVSHNRLE 322
LE L +NNNL+ ++P L L +L + N L
Sbjct: 148 PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 45/166 (27%), Positives = 69/166 (41%), Gaps = 10/166 (6%)
Query: 167 LNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK 226
+N L+ A+P L L+L N L + ++L + ++NL L
Sbjct: 12 HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 227 GTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLI 285
L + L VL LDLS NQL S +P TL L L ++ N+ +P L
Sbjct: 69 -KLQVD-GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLG 124
Query: 286 SLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSF 331
L+ L N L P L L++ ++++N L E+P G
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELP-AGLL 168
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 52/225 (23%), Positives = 77/225 (34%), Gaps = 47/225 (20%)
Query: 3 TIPNSI-TNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
+P + + T L L N T L+ L+L LT L
Sbjct: 24 ALPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQLNLDRAELTK----------L 70
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
L L L+ N L S+P L L V
Sbjct: 71 QVDGTLPVLGTLDLSHNQL--------------------------QSLPLLGQTLPALTV 104
Query: 122 LSLGFNDLNGTIPTSIGT-LQQLQGFYVPENNLQGYVPHDLC-HLERLNILNLSGNKLSG 179
L + FN L ++P L +LQ Y+ N L+ +P L +L L+L+ N L+
Sbjct: 105 LDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT- 161
Query: 180 AIPQ-CLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223
+P L L +L +L LQ N L ++P + + L N
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 40/144 (27%), Positives = 58/144 (40%), Gaps = 13/144 (9%)
Query: 182 PQCLAS-LTSLRSLYLQSNKLSS---SLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLN 237
P C S + S + L++ LP L +LS N L + +
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTALPPDLPKDTTIL------HLSENLLYTFSLATLMPYT 55
Query: 238 VLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNL 297
L L+L R +L+ GTL L TL L+ NQ Q +P L +L LD S N L
Sbjct: 56 RLTQLNLDRAELTK--LQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRL 112
Query: 298 SGKIPKSLEALSHLKQFNVSHNRL 321
+ +L L L++ + N L
Sbjct: 113 TSLPLGALRGLGELQELYLKGNEL 136
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 67/290 (23%), Positives = 111/290 (38%), Gaps = 66/290 (22%)
Query: 384 LLVIIIIMYVRCRNRSTKHLDH-EDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGS 442
LL +++ ++ + DFL A ++R D+F ++G G F
Sbjct: 17 LLDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSE 76
Query: 443 VY----KGTLSDGTNVAIKIFNLQ--LERA-FRSFDSECEILRNVRHRNLLKILGSCSNL 495
V K T G A+KI N L+R F E ++L N R + ++ + +
Sbjct: 77 VAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133
Query: 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMID----------VGSALEYLHHCHS 545
++ LV+E+ G L + L + I + A++ +H
Sbjct: 134 NYLYLVMEYYVGGDL----LTL------LSKFGERIPAEMARFYLAEIVMAIDSVHRLG- 182
Query: 546 SAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTM-ATIGYMAPE-- 600
+H D+KP NILLD H+ +DFG L D ++++ T Y++PE
Sbjct: 183 ---YVHRDIKPDNILLDRC--GHIRLADFGSCLKL--RADGTVRSLVAVGTPDYLSPEIL 235
Query: 601 -----------YGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
YG E CD ++ GV E F + P T E +
Sbjct: 236 QAVGGGPGTGSYGPE------CDWWALGVFAYEMFYGQTPFYADSTAETY 279
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 34/224 (15%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLER------AFRSFDSECEILRNV 480
++++ +G G +G VYK + G A+K L+ E R E IL+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57
Query: 481 RHRN---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
+H N L ++ + L LV E + L+K L L+ + + ++ + + +
Sbjct: 58 KHSNIVKLYDVIHTKKRL---VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIG 595
Y H ++H DLKP N+L++ ++DFG+++ G ++ T + T+
Sbjct: 114 AYCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFG----IPVRKYTHEIVTLW 165
Query: 596 YMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
Y AP+ GS+ ST D++S G + E P +F G
Sbjct: 166 YRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVN-GTP---LFPGV 204
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 64/238 (26%), Positives = 94/238 (39%), Gaps = 50/238 (21%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
D F + +LG GGFG V+ K T G A K L +R + + +IL
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKK--LNKKRLKKRKGYQGAMVEKKIL 239
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL--QRLNIMI-DVG 534
V R ++ + + LV+ M G + +Y+ + R +
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTMA 592
S LE+LH II+ DLKP N+LLD++ +V SD G++ L G+ T A
Sbjct: 300 SGLEHLH----QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTK---TKGYA 350
Query: 593 -TIGYMAPE------YGSEGIVSTKCDVYSYGVLLMETFT---------EKKPTDEMF 634
T G+MAPE Y D ++ GV L E EK E+
Sbjct: 351 GTPGFMAPELLLGEEYDFS------VDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 53/230 (23%), Positives = 97/230 (42%), Gaps = 28/230 (12%)
Query: 423 RRATDEFNECNLLGTGGFGSVYKGTLSD-GTNVAIK-IFNLQLERAFRSFDSECEILRNV 480
R+ D F + G G FG+V G G +VAIK + R + L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNREL-QIMQDLAVL 76
Query: 481 RHRN---LLKILGSCSNLDFK----ALVLEFMPNGSLEKWLYSHNYFLDILQRLNI---M 530
H N L + D + +V+E++P+ +L + ++ + I +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDSVIQTM 589
+ ++ LH S + H D+KP N+L++ + + DFG +K L E +
Sbjct: 136 FQLIRSIGCLHL--PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VA 190
Query: 590 TMATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
+ + Y APE +G++ +T D++S G + E +P +F G+
Sbjct: 191 YICSRYYRAPELIFGNQH-YTTAVDIWSVGCIFAEMML-GEP---IFRGD 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 44/235 (18%)
Query: 423 RRATDEFNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
R + + ++G G FG VY+ L D G VAIK R E +I+R +
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLD 105
Query: 482 HRNLLKIL------GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNI---MID 532
H N++++ G + + LVL+++P ++ + ++ L + + M
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGEDSV--IQTM 589
+ +L Y+H S I H D+KP N+LLD + V + DFG +K L GE +V I
Sbjct: 165 LFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--- 217
Query: 590 TMATIGYMAPE-------YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
+ Y APE Y ++ DV+S G +L E +P +F G+
Sbjct: 218 --CSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLL-GQP---IFPGD 260
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 43/244 (17%)
Query: 413 TRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDS 472
+ + + C ++G G FG V++ L + VAIK R
Sbjct: 26 KVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR---- 81
Query: 473 ECEILRNVRHRNLLKIL------GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQR 526
E +I+R V+H N++ + G + F LVLE++P ++ + + +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140
Query: 527 LNI---MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGE 582
L I M + +L Y+H S I H D+KP N+LLD V + DFG +K+L GE
Sbjct: 141 LLIKLYMYQLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
Query: 583 DSVIQTMT--MATIGYMAPE-------YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633
+ + Y APE Y +T D++S G ++ E +P +
Sbjct: 197 -----PNVSYICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQ-GQP---L 241
Query: 634 FTGE 637
F GE
Sbjct: 242 FPGE 245
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 66/318 (20%), Positives = 124/318 (38%), Gaps = 65/318 (20%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLER------AFRSFDSECEI 476
++ + +G G FG V+K G VA+K ++ E+ A R E +I
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKI 69
Query: 477 LRNVRHRN---LLKILGSCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILQRLN 528
L+ ++H N L++I + ++ + LV +F + L L + + +
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128
Query: 529 IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT 588
+M + + L Y+H I+H D+K N+L+ + V ++DFG+++ ++S
Sbjct: 129 VMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 589 MT--MATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEK----------------- 627
T + T+ Y PE G D++ G ++ E +T
Sbjct: 185 YTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 628 ---KPTDEMFTGEMSLRRWVKESLPH----RLTEVVDANLVREEQAFSDKMDCLFSIMDL 680
T E++ + + K L ++ + + VR+ A L + L
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL-KAYVRDPYALD-----LIDKL-L 296
Query: 681 ALDCCMDTPHKRIHMTDA 698
LD P +RI DA
Sbjct: 297 VLD-----PAQRIDSDDA 309
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 46/208 (22%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQ-------LERAFRSFDSECEILRNVRHRNL 485
LG G FG V T VA+K + Q R R E L+ +RH ++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHI 71
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILQRLNIMIDVGSA 536
+K+ + +V+E+ G L ++ +F I+ A
Sbjct: 72 IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII----------CA 120
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG- 595
+EY CH I+H DLKP N+LLD+N+ ++DFG+S ++ +G ++T + G
Sbjct: 121 IEY---CHRHK-IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKT----SCGS 170
Query: 596 --YMAPE-YGSEGIVSTKCDVYSYGVLL 620
Y APE + + DV+S G++L
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVL 198
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 85.6 bits (211), Expect = 1e-17
Identities = 53/302 (17%), Positives = 103/302 (34%), Gaps = 17/302 (5%)
Query: 23 SFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGG 82
S P T G+ +L + L+ E + D + S + C A P
Sbjct: 258 SVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHT 317
Query: 83 ILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQ 142
G+ S + + ++ L L + + + + ++
Sbjct: 318 FRVIWTGSDSQKECVLLKDRPE---CWCRDSATDEQLFRCELSVEKST-VLQSELESCKE 373
Query: 143 LQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSL--YLQSNK 200
LQ + + L+ L + S L ++ +R+ +K
Sbjct: 374 LQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST-----LKAVDPMRAAYLDDLRSK 428
Query: 201 LSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTL 260
+ ++L+ L T+ ++++L ++ LDLS N+L + +P + L
Sbjct: 429 FLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAAL 485
Query: 261 KNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG-KIPKSLEALSHLKQFNVSHN 319
+ LE L + N + + V NL L+ L NN L + L + L N+ N
Sbjct: 486 RCLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
Query: 320 RL 321
L
Sbjct: 544 SL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 83.7 bits (206), Expect = 5e-17
Identities = 48/294 (16%), Positives = 91/294 (30%), Gaps = 25/294 (8%)
Query: 29 PNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLI 88
T S + L + + Q +F T + L
Sbjct: 287 WRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVL-LKDRPECWCRDS 345
Query: 89 GNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYV 148
+ + E + E+ + + L L + + T I ++ L
Sbjct: 346 ATDEQLFRCELSVEKST--VLQSELESCKELQELEP---ENKWCLLTIILLMRALDPLLY 400
Query: 149 PENNLQGYVPHDLCHLERLNILNLSG-----NKLSGAIPQCLASLTSLRSLYLQSNKLSS 203
+ LQ L+ ++ + + +K +R L+L L+
Sbjct: 401 EKETLQ-----YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV 455
Query: 204 SLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNL 263
L L + ++LS N L+ LP + L L L S N L + + + L L
Sbjct: 456 --LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRL 510
Query: 264 ETLSLAGNQFQG-PIPESVGNLISLESLDFSNNNLSGK---IPKSLEALSHLKQ 313
+ L L N+ Q + + + L L+ N+L + + E L +
Sbjct: 511 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 41/205 (20%), Positives = 74/205 (36%), Gaps = 15/205 (7%)
Query: 124 LGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC----HLERLNILNLSGNKLSG 179
L LN +P + E L P C E+L LS K +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST- 362
Query: 180 AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVL 239
+ L S L+ L ++ ++ + +L+ +L + S ++ ++ +
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF-----STLKAVDPM 417
Query: 240 --IDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNL 297
LD R++ + ++ L LA + + L+ + LD S+N L
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRL 475
Query: 298 SGKIPKSLEALSHLKQFNVSHNRLE 322
+P +L AL L+ S N LE
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 18/78 (23%), Positives = 27/78 (34%), Gaps = 9/78 (11%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P ++ L L N+ ++ NL L L L N L + +
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ-------SAAIQ 527
Query: 63 SLTNCRNLANLALASNPL 80
L +C L L L N L
Sbjct: 528 PLVSCPRLVLLNLQGNSL 545
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 47/200 (23%), Positives = 74/200 (37%), Gaps = 15/200 (7%)
Query: 113 IGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNL 172
L + +LG + T S L +Q F +N+Q + L L+L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70
Query: 173 SGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSN 232
S N++S P L LT L L + N+L + L + L +N L+ T +
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRDT--DS 123
Query: 233 IQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDF 292
+ L L L + N+L I +G L LE L L GN+ + L + +D
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179
Query: 293 SNNNLSGKIPKSLEALSHLK 312
+ + K L
Sbjct: 180 TGQKCVNEPVKYQPELYITN 199
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 42/240 (17%), Positives = 76/240 (31%), Gaps = 18/240 (7%)
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ N L + ++ S +QN + + L
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS--QKELS-GVQNFNGDNSNI--QSLAGMQFFTNLK 66
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L L N + + + + L +L+ V N L+ L RL L N+L
Sbjct: 67 ELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRDT 121
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
L L +L L +++NKL S L L + ++L N + T + +L +
Sbjct: 122 DS--LIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVN 175
Query: 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK 300
+DL+ + ++ L T+ ++ P S N S
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS--NGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 32/138 (23%), Positives = 58/138 (42%), Gaps = 11/138 (7%)
Query: 185 LASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL 244
L + L ++ S L + N +++++ + +Q L +L L
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 245 SRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKS 304
S NQ+S D+ S + L LE LS+ N+ + + L L NN L S
Sbjct: 71 SHNQIS-DL-SPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--TDS 123
Query: 305 LEALSHLKQFNVSHNRLE 322
L L +L+ ++ +N+L+
Sbjct: 124 LIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 46/270 (17%), Positives = 74/270 (27%), Gaps = 75/270 (27%)
Query: 8 ITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNC 67
+ T L L L N S + +L L LS+ N L L+ + +
Sbjct: 59 MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN----------LNGIPSA 106
Query: 68 RNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFN 127
L+ L L +N L + +L+ L +LS+ N
Sbjct: 107 -CLSRLFLDNNELRDTDS---------------------------LIHLKNLEILSIRNN 138
Query: 128 DLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLAS 187
L SI L L +L +L+L GN+++ L
Sbjct: 139 KL-----KSIVMLG---------------------FLSKLEVLDLHGNEITNTGG--LTR 170
Query: 188 LTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTL--PSNIQKLNVLIDLDLS 245
L + + L K + L I + G P I +D +
Sbjct: 171 LKKVNWIDLTGQKCVNEPVKYQ----PELYITNTVKDPDGRWISPYYISNGGSYVDGCVL 226
Query: 246 RNQLSSDIPSTIGTLKNLETLSLAGNQFQG 275
+L + F G
Sbjct: 227 -WELPVYTDEVSYKFSEYINVGETEAIFDG 255
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 56/182 (30%), Positives = 82/182 (45%), Gaps = 14/182 (7%)
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCH-LERLNILNLSGNKLSG 179
L L N L+ + L +L+ Y+ +N LQ +P + L+ L L ++ NKL
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ- 98
Query: 180 AIPQCL-ASLTSLRSLYLQSNKLSSSLPS----SLWSLEYILRINLSSNSLKGTLPSNI- 233
A+P + L +L L L N+L S LP SL L Y+ +L N L+ +LP +
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYL---SLGYNELQ-SLPKGVF 153
Query: 234 QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFS 293
KL L +L L NQL L L+TL L NQ + + +L L+ L
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 294 NN 295
N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 132 TIPTSI-GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCL-ASLT 189
IP++I ++L + N L L +L +L L+ NKL +P + L
Sbjct: 30 AIPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELK 85
Query: 190 SLRSLYLQSNKLSSSLPS----SLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDL 244
+L +L++ NKL + LP L +L + L N LK +LP + L L L L
Sbjct: 86 NLETLWVTDNKLQA-LPIGVFDQLVNLAEL---RLDRNQLK-SLPPRVFDSLTKLTYLSL 140
Query: 245 SRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNNLSGKIP 302
N+L S +P + L +L+ L L NQ + +PE L L++L NN L ++P
Sbjct: 141 GYNELQS-LPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLK-RVP 197
Query: 303 K----SLEALSHLKQFN 315
+ SLE L L+
Sbjct: 198 EGAFDSLEKLKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 171 NLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP 230
+ S KL+ AIP + + L LQSNKLSS + L + + L+ N L+ TLP
Sbjct: 22 DCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLP 77
Query: 231 SNI-QKLNVLIDLDLSRNQLSSDIPSTIGT-LKNLETLSLAGNQFQGPIPESV-GNLISL 287
+ I ++L L L ++ N+L + +P + L NL L L NQ + +P V +L L
Sbjct: 78 AGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKL 135
Query: 288 ESLDFSNNNLSGKIPKSLEA-----LSHLKQFNVSHNRL 321
L N L +SL L+ LK+ + +N+L
Sbjct: 136 TYLSLGYNEL-----QSLPKGVFDKLTSLKELRLYNNQL 169
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 56/225 (24%), Positives = 81/225 (36%), Gaps = 43/225 (19%)
Query: 3 TIPNSI-TNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
IP++I + KL DL N S F L L +L L N L T + F
Sbjct: 30 AIPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI----F- 81
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLI 120
L NL L + N L ++P + L L
Sbjct: 82 KELK---NLETLWVTDNKL--------------------------QALPIGVFDQLVNLA 112
Query: 121 VLSLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDLC-HLERLNILNLSGNKLS 178
L L N L ++P + +L +L + N LQ +P + L L L L N+L
Sbjct: 113 ELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223
LT L++L L +N+L + SLE + + L N
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 62/262 (23%), Positives = 103/262 (39%), Gaps = 45/262 (17%)
Query: 399 STKHLDHEDFLP----PATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTN 453
+ H H L S + D + LG G +G VYK
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET 61
Query: 454 VAIKIFNLQLER------AFRSFDSECEILRNVRHRN---LLKILGSCSNLDFKALVLEF 504
VAIK L+ E A R E +L+ ++HRN L ++ L L+ E+
Sbjct: 62 VAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIELKSVIHHNHRL---HLIFEY 114
Query: 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN 564
N L+K++ + + + + + + + + + H +H DLKP N+LL +
Sbjct: 115 AEN-DLKKYMDKNPDVSMRVIK-SFLYQLINGVNFCHSRR----CLHRDLKPQNLLLSVS 168
Query: 565 MVAH-----VSDFGISKLLGEGEDSVIQTMT--MATIGYMAPE--YGSEGIVSTKCDVYS 615
+ + DFG+++ G I+ T + T+ Y PE GS ST D++S
Sbjct: 169 DASETPVLKIGDFGLARAFG----IPIRQFTHEIITLWYRPPEILLGSR-HYSTSVDIWS 223
Query: 616 YGVLLMETFTEKKPTDEMFTGE 637
+ E K P +F G+
Sbjct: 224 IACIWAEMLM-KTP---LFPGD 241
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLE-----RAFRSFDSECEILRNV 480
+ + + + LG G + +VYKG VA+K L+ E A R E +L+++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 481 RHRN---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
+H N L I+ + +L LV E++ L+++L +++ + + L
Sbjct: 58 KHANIVTLHDIIHTEKSL---TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIG 595
Y H ++H DLKP N+L++E ++DFG+++ +T + T+
Sbjct: 114 AYCHRQK----VLHRDLKPQNLLINERGELKLADFGLARAKS----IPTKTYDNEVVTLW 165
Query: 596 YMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
Y P+ GS ST+ D++ G + E T +P +F G
Sbjct: 166 YRPPDILLGST-DYSTQIDMWGVGCIFYEMAT-GRP---LFPGS 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 35/122 (28%), Positives = 57/122 (46%), Gaps = 4/122 (3%)
Query: 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE 563
E + FL + + V +E+L +S IH DL NILL E
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSE 228
Query: 564 NMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMET 623
V + DFG+++ + + D V + + +MAPE + + + + DV+S+GVLL E
Sbjct: 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
Query: 624 FT 625
F+
Sbjct: 289 FS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 36/166 (21%), Positives = 59/166 (35%), Gaps = 18/166 (10%)
Query: 435 LGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLL 486
LG G FG V + + VA+K+ R+ SE +IL ++ H N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 487 KILGSCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
+LG+C+ +V +EF G+L +L S + G
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG------ 143
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM 591
I DLK + + + S F K L + E+
Sbjct: 144 ---AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 27/223 (12%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
+EF LLG G FG V K T G A+KI L+ E + +L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKI--LKKEVIVAKDEVAHTLTENRVL 202
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
+N RH L + S D V+E+ G L L F + R ++ SAL
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSAL 261
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM-ATIGY 596
+YLH + +++ DLK N++LD++ ++DFG+ K EG T T Y
Sbjct: 262 DYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEY 315
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
+APE + D + GV++ E + P +++F
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 2e-16
Identities = 81/414 (19%), Positives = 140/414 (33%), Gaps = 47/414 (11%)
Query: 245 SRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKS 304
R + + I + + + +L G V + + S
Sbjct: 161 GRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSL 220
Query: 305 LEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNRKRT 364
+ +F + + + + V+ D ++++ F G LQ + +
Sbjct: 221 NPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLS 280
Query: 365 NKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLDIRR 424
+ + P + + + R + E ++ + R
Sbjct: 281 QEEGEYFNVPVPPE--GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRM 338
Query: 425 ATDEFNECNLLGTGGFGSV----YKGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----E 475
+FN +LG G FG V KGT A+KI L+ + + D EC
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKR 393
Query: 476 ILRNVRHRNLLKILGSCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVG 534
+L L L SC + V+E++ G L + F + ++
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIA 452
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTMA 592
L +L S II+ DLK N++LD H+ +DFG+ K E + T T
Sbjct: 453 IGLFFLQ----SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGVTTKTFC 503
Query: 593 -TIGYMAPE------YGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
T Y+APE YG D +++GVLL E + P DE+F
Sbjct: 504 GTPDYIAPEIIAYQPYG------KSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 426 TDEFNECNLLGTGGFGSVYKGTLSD-GTNVAIK----IFNLQLE--RAFRSFDSECEILR 478
+ +G+G G V + NVAIK F Q RA+R E +++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 79
Query: 479 NVRHRNLLKILG----SCSNLDFKA--LVLEFMPNGSLEKWLYS------HNYFLDILQR 526
V H+N++ +L S +F+ +V+E M +L + + +Y L Q
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLL--YQM 136
Query: 527 LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586
L +++LH SA IIH DLKP+NI++ + + DFG+++ G
Sbjct: 137 LC-------GIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----- 180
Query: 587 QTMT--MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEK 627
MT + T Y APE D++S G ++ E
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 41/155 (26%), Positives = 62/155 (40%), Gaps = 8/155 (5%)
Query: 169 ILNLSGNKLSGAIPQC-LASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
+L+LS N LS + LT+L SL L N L+ + + + ++LSSN L
Sbjct: 43 LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH- 101
Query: 228 TLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV----G 282
TL + L L L L N + + + L+ L L+ NQ P +
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGN 160
Query: 283 NLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVS 317
L L LD S+N L L+ L + +
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 42/173 (24%), Positives = 65/173 (37%), Gaps = 16/173 (9%)
Query: 133 IPTSIGTLQQLQGFYVPENNLQGYVPH-DLCHLERLNILNLSGNKLSGAIPQCLASLTSL 191
+P+ L L NNL L L+ L LS N L+ + + +L
Sbjct: 37 LPSYTALLD-LSH-----NNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNL 90
Query: 192 RSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRNQLS 250
R L L SN L + L+ + + L +N + + N + + L L LS+NQ+S
Sbjct: 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 251 SDIP----STIGTLKNLETLSLAGNQFQGPIPESVGNLISL--ESLDFSNNNL 297
P L L L L+ N+ + + L + L NN L
Sbjct: 150 R-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 36/167 (21%), Positives = 64/167 (38%), Gaps = 20/167 (11%)
Query: 121 VLSLGFNDLNGTIPTSIGT------LQQLQGFYVPENNLQGYVPHD-LCHLERLNILNLS 173
+L L N+L + + L L + N+L ++ + + L L+LS
Sbjct: 43 LLDLSHNNL-----SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 174 GNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP--- 230
N L + L +L L L +N + ++ + + ++ LS N + P
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 231 -SNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNL--ETLSLAGNQFQ 274
+ KL L+ LDLS N+L + + L L L N +
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 38/153 (24%), Positives = 63/153 (41%), Gaps = 16/153 (10%)
Query: 190 SLRSLYLQSNKLSS---SLPSSLWSLEYILRINLSSNSLKGTLPSNI--QKLNVLIDLDL 244
+ L +L + SLPS L +LS N+L L + +L L L L
Sbjct: 19 ASNILSCSKQQLPNVPQSLPSYTALL------DLSHNNLS-RLRAEWTPTRLTNLHSLLL 71
Query: 245 SRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNNLSGKIPK 303
S N L+ + NL L L+ N + E + +L +LE L NN++
Sbjct: 72 SHNHLNFISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRN 130
Query: 304 SLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSA 336
+ E ++ L++ +S N++ P KD +
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFP-VELIKDGNK 161
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 45/217 (20%), Positives = 65/217 (29%), Gaps = 59/217 (27%)
Query: 12 TKLIGLDLGLNSFSGHIP-NTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNL 70
T L L L N + I F + +L L L N+L T ++ + L
Sbjct: 64 TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFL--------FSDLQAL 114
Query: 71 ANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLN 130
L L +N + + AFE ++ L L L N
Sbjct: 115 EVLLLYNNHIVVVDR-------------NAFE------------DMAQLQKLYLSQN--- 146
Query: 131 GTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTS 190
Q+ P + D L +L +L+LS NKL L L +
Sbjct: 147 -----------QIS--RFPVELI-----KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA 188
Query: 191 L--RSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSL 225
LYL +N L + LSS
Sbjct: 189 WVKNGLYLHNNPLECD-CKLYQLFSHWQYRQLSSVMD 224
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 32/251 (12%), Positives = 68/251 (27%), Gaps = 62/251 (24%)
Query: 434 LLGTGGFGSVYKGTLSD---GTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLK 487
G ++ D VA+ + Q + + S L + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 488 IL--GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
+L +V E++ GSL++ + + + M + +A + H
Sbjct: 96 VLDVVHTRAGGL--VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR--- 147
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
A + P+ + VS G L A M
Sbjct: 148 -AGVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPD------ 178
Query: 606 IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR-------------RWVKESLPHRL 652
+ + D+ G L + P E L + +P ++
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEA-GVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 653 TEVVDANLVRE 663
+ V ++ +
Sbjct: 237 SAVAARSVQGD 247
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 34/219 (15%), Positives = 69/219 (31%), Gaps = 10/219 (4%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVP----HDLCH 163
IP ++ R I L L + L+ + +N++ + +L
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 164 LERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223
L + I N L P+ +L +L+ L + + + + +++ N
Sbjct: 81 LHEIRIEK--ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138
Query: 224 SLKGTLPSN-IQKL-NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV 281
T+ N L + L L++N + S + E N + +
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 282 GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNR 320
LD S + LE L L+ + + +
Sbjct: 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 44/234 (18%), Positives = 84/234 (35%), Gaps = 13/234 (5%)
Query: 68 RNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIVLSL-G 125
RN L L I F L+ I + + I ++ NL L + +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 126 FNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQ- 183
N+L I L LQ + ++ H + +L++ N I +
Sbjct: 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN 147
Query: 184 CLASLTS-LRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLID 241
L+ L+L N + + +S ++ + +NLS N+ LP+++ + +
Sbjct: 148 SFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNN 295
LD+SR ++ S + LK L S + + L++L +
Sbjct: 207 LDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL----EKLVALMEASLTYP 256
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 45/216 (20%), Positives = 78/216 (36%), Gaps = 13/216 (6%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENN-LQGYVPHDLCHLER 166
IP L L L + L + YV + LQ H +L +
Sbjct: 25 RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81
Query: 167 LNILNLSGNKLSGAIP-QCLASLTSLRSLYLQSNKLSSSLP--SSLWSLEYILRINLSSN 223
+ + + + I L L L+ L + + L P + ++S + + ++ N
Sbjct: 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDN 140
Query: 224 SLKGTLPSNI-QKL-NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV 281
++P N Q L N + L L N +S + L+ + L N++ I +
Sbjct: 141 PYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDA 199
Query: 282 -GNLIS-LESLDFSNNNLSGKIPKSLEALSHLKQFN 315
G + S LD S +++ K LE L L N
Sbjct: 200 FGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 27/174 (15%), Positives = 59/174 (33%), Gaps = 10/174 (5%)
Query: 158 PHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILR 217
C + ++ + IP S +L L L + + +L I R
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISR 59
Query: 218 INLSSNSLKGTLPSNI-QKLNVLIDLDLSRNQLSSDIPS-TIGTLKNLETLSLAGNQFQG 275
I +S + L S+ L+ + +++ + + I + L L+ L + +
Sbjct: 60 IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119
Query: 276 -PIPESVGNLISLESLDFSNNNLSGKIPK-SLEAL-SHLKQFNVSHNRLEGEIP 326
P V + L+ ++N IP + + L + + +N +
Sbjct: 120 FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQ 172
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 42/271 (15%), Positives = 87/271 (32%), Gaps = 71/271 (26%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNN-LTTESSSADQWSFL 61
IP+ + L L + F NL ++S + + ++ L S +
Sbjct: 25 RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS------ 75
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIV 121
N + ++ + + + P A + L L
Sbjct: 76 --FYNLSKVTHIEIRNTRNLTYIDPD------------ALK------------ELPLLKF 109
Query: 122 LSLGFNDLNGTIP--TSIGTLQQLQGFYVPENNLQGYVPHD----LCHLERLNILNLSGN 175
L + L P T + + + +N +P + LC+ L L N
Sbjct: 110 LGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE--TLTLKLYNN 166
Query: 176 KLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQK 235
+ ++ + T L ++YL NK + + ++ G + S
Sbjct: 167 GFT-SVQGYAFNGTKLDAVYLNKNKYLTVID---------------KDAFGG-VYSGPS- 208
Query: 236 LNVLIDLDLSRNQLSSDIPSTIGTLKNLETL 266
LD+S+ +++ +PS L++L+ L
Sbjct: 209 -----LLDVSQTSVTA-LPS--KGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 32/195 (16%), Positives = 61/195 (31%), Gaps = 35/195 (17%)
Query: 167 LNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLP----SSLWSLEYIL------ 216
L L L ++L ++ +Y+ + L +L + +I
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 217 ----------------RINLSSNSLKGTLP--SNIQKLNVLIDLDLSRNQLSSDIPSTI- 257
+ + + LK P + + ++ L+++ N + IP
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 258 -GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSL--EALSHLKQF 314
G TL L N F + N L+++ + N I K S
Sbjct: 152 QGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 315 NVSHNRLEGEIPVKG 329
+VS + +P KG
Sbjct: 211 DVSQTSVT-ALPSKG 224
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 34/249 (13%)
Query: 400 TKHLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKI 458
H H + T ++ +++ L+G G +G V K G VAIK
Sbjct: 3 HHHHHHSSGVDLGTENLYF-----QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKK 57
Query: 459 FNLQLER------AFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEK 512
F + A R E ++L+ +RH NL+ +L C LV EF+ + ++
Sbjct: 58 FLESDDDKMVKKIAMR----EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILD 112
Query: 513 WLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDF 572
L LD + + + + + H + IIH D+KP NIL+ ++ V + DF
Sbjct: 113 DLELFPNGLDYQVVQKYLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDF 168
Query: 573 GISKLLGEGEDSVIQTMT--MATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKK 628
G ++ L + + +AT Y APE G DV++ G L+ E F +
Sbjct: 169 GFARTLA----APGEVYDDEVATRWYRAPELLVGDV-KYGKAVDVWAIGCLVTEMFM-GE 222
Query: 629 PTDEMFTGE 637
P +F G+
Sbjct: 223 P---LFPGD 228
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 35/225 (15%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLER------AFRSFDSECEILRN 479
+++ + +G G +G V+K G VAIK F + A R E +L+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQ 58
Query: 480 VRHRN---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSA 536
++H N LL++ L LV E+ + ++ L + + +I A
Sbjct: 59 LKHPNLVNLLEVFRRKRRL---HLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQA 114
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATI 594
+ + H IH D+KP NIL+ ++ V + DFG ++LL +AT
Sbjct: 115 VNFCH----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT----GPSDYYDDEVATR 166
Query: 595 GYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
Y +PE G DV++ G + E + P ++ G+
Sbjct: 167 WYRSPELLVGDT-QYGPPVDVWAIGCVFAELLS-GVP---LWPGK 206
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 6e-16
Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 22/191 (11%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIK-IFN-----LQLERAFRSFDSECEILR 478
D + +L+GTG +G V + + VAIK I + +R R E IL
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILN 107
Query: 479 NVRHRN---LLKILGSCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533
+ H + +L I+ F +VLE + +K + Y ++ + ++ ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNL 165
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT 593
++Y+H SA I+H DLKP N L++++ V DFG+++ + E+ Q
Sbjct: 166 LVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 594 IGYMAPEYGSE 604
M
Sbjct: 222 EDDMNLVTFPH 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 49/206 (23%), Positives = 78/206 (37%), Gaps = 63/206 (30%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEIL-RNVRHRNLLKILGSC 492
LG G G V + A+K+ +A R E E+ R + ++++I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 493 SNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILQRLN----------IMIDVGSALE 538
NL +V+E + G L F I R + IM +G A++
Sbjct: 81 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 539 YLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISK-LLGEGEDSVIQTMTMATI 594
YLH + I H D+KP N+L N + ++DFG +K GE
Sbjct: 132 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK------------- 174
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLL 620
Y CD++S GV++
Sbjct: 175 ------YDKS------CDMWSLGVIM 188
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 42/224 (18%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIK---IFNLQLE--RAFRSFDSECEILRN 479
+ + +G G +G V + VAIK F Q R R E +IL
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLR 81
Query: 480 VRHRN---LLKILGSCSNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFL-DILQR 526
RH N + I+ + + K +V + M L K L + YFL IL+
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR- 139
Query: 527 LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586
L+Y+H SA ++H DLKP+N+LL+ + DFG++++ + +
Sbjct: 140 ---------GLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHT 185
Query: 587 QTMT--MATIGYMAPEY-GSEGIVSTKCDVYSYGVLLMETFTEK 627
+T +AT Y APE + + D++S G +L E + +
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 46/232 (19%)
Query: 427 DEFNECNLLGTGGFGSV----YKGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
++F+ LLG G FG V K T G A+KI L+ E + +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKI--LRKEVIIAKDEVAHTVTESRVL 59
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
+N RH L + + D V+E+ G L L F + R ++ SAL
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSAL 118
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKL-LGEGEDSVIQTMTM-AT 593
EYLH S +++ D+K N++LD++ H+ +DFG+ K + +G T T
Sbjct: 119 EYLH----SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGA----TMKTFCGT 168
Query: 594 IGYMAPE------YGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
Y+APE YG D + GV++ E + P + +F
Sbjct: 169 PEYLAPEVLEDNDYG------RAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 45/237 (18%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGTLSDGTN--VAIKIFNLQLER------AFRSFDSECE 475
RA ++ +G G +G V+K VA+K +Q R E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61
Query: 476 I-----LRNVRHRNLLKIL----GSCSNLDFKA-LVLEFMPNGSLEKWLYSH-NYFLDIL 524
+ L H N++++ S ++ + K LV E + L +L +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 525 QRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584
++M + L++LH ++H DLKP NIL+ + ++DFG++++
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYS----- 171
Query: 585 VIQTMT--MATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
+T + T+ Y APE S +T D++S G + E F +KP +F G
Sbjct: 172 FQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFR-RKP---LFRGS 222
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 39/231 (16%)
Query: 425 ATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLER-----AFRSFDSECEILR 478
++ +F + LG G + +VYKG + G VA+K L E A R E +++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58
Query: 479 NVRHRN---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF-----LDILQRLNIM 530
++H N L ++ + + L LV EFM N L+K++ S L++
Sbjct: 59 ELKHENIVRLYDVIHTENKL---TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590
+ L + H I+H DLKP N+L+++ + DFG+++ G + T +
Sbjct: 115 WQLLQGLAFCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAFG----IPVNTFS 166
Query: 591 --MATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
+ T+ Y AP+ GS ST D++S G +L E T KP +F G
Sbjct: 167 SEVVTLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMIT-GKP---LFPGT 212
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 49/230 (21%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIK---IFNLQLE--RAFRSFDSECEILRNVRHRN---L 485
LG G +G V T G VAIK F+ L R R E +IL++ +H N +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 486 LKILGSCSNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDILQRLNIMIDVGSA 536
I S +F ++ E M L + + + YF I Q L A
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYF--IYQTLR-------A 124
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT------MT 590
++ LH + +IH DLKP+N+L++ N V DFG+++++ E + M
Sbjct: 125 VKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 591 --MATIGYMAPEY-GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
+AT Y APE + S DV+S G +L E F ++P +F G
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP---IFPGR 226
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 66/349 (18%), Positives = 98/349 (28%), Gaps = 65/349 (18%)
Query: 12 TKLIGLDLGLNSFS-GHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNL 70
+ LD+ S L+ V+ L LT S+L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD----ISSALRVNPAL 58
Query: 71 ANLALASNPLGG----ILPPLIGNFSASLQNIYAFECKLG----GSIPKEIGNLRGLIVL 122
A L L SN LG + + S +Q + C L G + + L L L
Sbjct: 59 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS---- 178
L N L + C LE+ L L LS
Sbjct: 119 HLSDNLLGDAGLQLLCEGLL----------------DPQCRLEK---LQLEYCSLSAASC 159
Query: 179 GAIPQCLASLTSLRSLYLQSNK--------LSSSLPSSLWSLEYILRINLSSNSLK---- 226
+ L + + L + +N L L S LE + L S +
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA---LKLESCGVTSDNC 216
Query: 227 GTLPSNIQKLNVLIDLDLSRNQLSSD-----IPSTIGTLKNLETLSLAGNQFQGP----I 277
L + L +L L N+L P + L TL + +
Sbjct: 217 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL 276
Query: 278 PESVGNLISLESLDFSNNNLSGKIPKSL-EALSH----LKQFNVSHNRL 321
+ SL+ L + N L + + L E L L+ V
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 65/361 (18%), Positives = 104/361 (28%), Gaps = 79/361 (21%)
Query: 12 TKLIGLDLGLNSFSG----------HIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
L L+L N P+ + LSL LT
Sbjct: 56 PALAELNLRSNELGDVGVHCVLQGLQTPSC-----KIQKLSLQNCCLTGAGCGV----LS 106
Query: 62 SSLTNCRNLANLALASNPLGG----ILPPLIGNFSASLQNIYAFECKLG----GSIPKEI 113
S+L L L L+ N LG +L + + L+ + C L + +
Sbjct: 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166
Query: 114 GNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLS 173
L++ ND+N G QG L+ L L
Sbjct: 167 RAKPDFKELTVSNNDINEA-----GVRVLCQGLKDSPCQLE--------------ALKLE 207
Query: 174 GNKLS----GAIPQCLASLTSLRSLYLQSNK--------LSSSLPSSLWSLEYILRINLS 221
++ + +AS SLR L L SNK L L L + +
Sbjct: 208 SCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT---LWIW 264
Query: 222 SNSLK----GTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIG-----TLKNLETLSLAGNQ 272
+ G L ++ L +L L+ N+L + + LE+L +
Sbjct: 265 ECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCS 324
Query: 273 FQG----PIPESVGNLISLESLDFSNNNLSGKIPKSL-EALSH----LKQFNVSHNRLEG 323
F + L L SNN L + L + L L+ ++ +
Sbjct: 325 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384
Query: 324 E 324
Sbjct: 385 S 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 59/326 (18%), Positives = 102/326 (31%), Gaps = 64/326 (19%)
Query: 37 HLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGG----ILPPLIGNFS 92
L L L +L+ S S L + L +++N + +L + +
Sbjct: 143 RLEKLQLEYCSLSAASCEP----LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198
Query: 93 ASLQNIYAFECKLG----GSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYV 148
L+ + C + + + + L L+LG N L G
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV------------GM-- 244
Query: 149 PENNLQGYVPHDLCHLERLNILNLSGNKLS----GAIPQCLASLTSLRSLYLQSNK---- 200
L + H L L + ++ G + + L + SL+ L L N+
Sbjct: 245 --AELCPGLLHPSSRLRTLW---IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
Query: 201 ----LSSSLPSSLWSLEYILRINLSSNSLKGT----LPSNIQKLNVLIDLDLSRNQLSSD 252
L +L LE + + S S S + + L++L +S N+L
Sbjct: 300 GARLLCETLLEPGCQLE---SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
Query: 253 IPSTIG-----TLKNLETLSLAGNQFQ----GPIPESVGNLISLESLDFSNNNLSGKIPK 303
+ L L LA + ++ SL LD SNN L
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 416
Query: 304 SL-EALSH----LKQFNVSHNRLEGE 324
L E++ L+Q + E
Sbjct: 417 QLVESVRQPGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 36/235 (15%), Positives = 77/235 (32%), Gaps = 45/235 (19%)
Query: 116 LRGLIVLSLGFNDLNGT----IPTSIGTLQQLQGFYVPENNLQGYVPHDLCHL-----ER 166
L+ V+ L L I +++ L + N L H + +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 167 LNILNLSGNKLS----GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSS 222
+ L+L L+ G + L +L +L+ L+L N L + L+ + L
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA------GLQLLCEGLLDP 140
Query: 223 NSLKGTLPSNIQKLNVLIDLDLSRNQLSS----DIPSTIGTLKNLETLSLAGNQFQGPIP 278
L L L LS+ + S + + + L+++ N
Sbjct: 141 QC-------------RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 187
Query: 279 ESVG-----NLISLESLDFSNNNLSGK----IPKSLEALSHLKQFNVSHNRLEGE 324
+ + LE+L + ++ + + + + L++ + N+L
Sbjct: 188 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 63/238 (26%), Positives = 99/238 (41%), Gaps = 46/238 (19%)
Query: 427 DEFNECNLLGTGGFGSVY---KGTLSDGTNV-AIKIFN----LQLERAFRSFDSECEILR 478
+ F +LGTG +G V+ K + D + A+K+ +Q + +E ++L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 479 NVRHRNLLKILGSC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVG 534
++R L L + L +L+++ G L L F + ++ + ++
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHL---ILDYINGGELFTHLSQRERFTEHEVQIYVG-EIV 169
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTMA 592
ALE+LH II+ D+K NILLD N HV +DFG+SK E
Sbjct: 170 LALEHLHKLG----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER--AYDFC 221
Query: 593 -TIGYMAPE------YGSEGIVSTKCDVYSYGVLLME---------TFTEKKPTDEMF 634
TI YMAP+ G + V D +S GVL+ E EK E+
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 43/197 (21%), Positives = 73/197 (37%), Gaps = 38/197 (19%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIK-IFN-----LQLERAFRSFDSECEILRNVRHRN--- 484
+G G +G VY + NVAIK + + +R R E IL ++
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 485 LLKILGSCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLD------ILQRLNIMIDVGSA 536
L ++ L F +VLE + L+K + + + + L
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL-------G 141
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
++H + IIH DLKP N LL+++ V DFG+++ + +D+ I
Sbjct: 142 ENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 597 MAPEYGSEGI----VST 609
+ V T
Sbjct: 198 GPHNKNLKKQLTSHVVT 214
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 29/127 (22%), Positives = 55/127 (43%), Gaps = 2/127 (1%)
Query: 170 LNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTL 229
+ L N + P + LR + L +N++S P + L + + L N + L
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 230 PSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLE 288
P ++ + L L L L+ N+++ L NL LSL N+ Q + L +++
Sbjct: 96 PKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155
Query: 289 SLDFSNN 295
++ + N
Sbjct: 156 TMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-14
Identities = 28/133 (21%), Positives = 56/133 (42%), Gaps = 4/133 (3%)
Query: 189 TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRN 247
++ + L+ N + P + + + RI+LS+N + L + Q L L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 248 QLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNNLSGKIPKSLE 306
+++ S L +L+ L L N+ + +L +L L +N L +
Sbjct: 91 KITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 307 ALSHLKQFNVSHN 319
L ++ +++ N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 36/155 (23%), Positives = 59/155 (38%), Gaps = 28/155 (18%)
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC-HLERLNILNLSGNKLSG 179
+ L N + P + ++L+ + N + + D L LN L L GNK++
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 180 AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNV 238
L SL+ L L +NK++ L + Q L+
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINC-------------------------LRVDAFQDLHN 129
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQF 273
L L L N+L + T L+ ++T+ LA N F
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 35/198 (17%), Positives = 62/198 (31%), Gaps = 67/198 (33%)
Query: 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSS 63
+P +IT + L N+ P F + L + L N ++ + A
Sbjct: 30 LPETITE------IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA-----FQG 78
Query: 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI-GNLRGLIVL 122
L +L +L L N + +PK + L L +L
Sbjct: 79 LR---SLNSLVLYGNKI--------------------------TELPKSLFEGLFSLQLL 109
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL-CHLERLNILNLSGNKLSGAI 181
L N ++ + D L LN+L+L NKL
Sbjct: 110 LLNAN--------------KIN-----------CLRVDAFQDLHNLNLLSLYDNKLQTIA 144
Query: 182 PQCLASLTSLRSLYLQSN 199
+ L ++++++L N
Sbjct: 145 KGTFSPLRAIQTMHLAQN 162
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 47/224 (20%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIK----IFNLQLE--RAFRSFDSECEILR 478
+ +G+G +GSV G VAIK F ++ RA+R E +L+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78
Query: 479 NVRHRN---LLKILGSCSNLD-FKA--LVLEFMPNGSLEKWLYS------HNYFLDILQR 526
+++H N LL + S+L F LV+ FM L+K + Y + Q
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYL--VYQM 135
Query: 527 LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586
L L+Y+H SA ++H DLKP N+ ++E+ + DFG+++
Sbjct: 136 LK-------GLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HAD 177
Query: 587 QTMT--MATIGYMAPE-YGSEGIVSTKCDVYSYGVLLMETFTEK 627
MT + T Y APE S + D++S G ++ E T K
Sbjct: 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 65/238 (27%)
Query: 435 LGTGGFGSVYKGTLSD-GTNVAIK--IFNLQLE--RAFRSFDSECEILRNVRHRNLLKIL 489
LG GG G V+ +D VAIK + A R E +I+R + H N++K+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 490 ------------GSCSNLDFKA--LVLEFMPNGSLEKWLYSHN-------YFLDILQRLN 528
S + + +V E+M L L F + Q L
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLF--MYQLLR 131
Query: 529 IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDSVIQ 587
L+Y+H SA ++H DLKP N+ ++ E++V + DFG+++++
Sbjct: 132 -------GLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK-G 179
Query: 588 TMT--MATIGYMAPE-------YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG 636
++ + T Y +P Y + D+++ G + E T K +F G
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLT-GKT---LFAG 227
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 46/234 (19%)
Query: 427 DEFNECNLLGTGGFGSVY---KGTLSDGTNV-AIKIFN----LQLERAFRSFDSECEILR 478
+ F +LG GG+G V+ K T ++ + A+K+ ++ + +E IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 479 NVRHRNLLKILGSC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVG 534
V+H ++ L L +LE++ G L L F++ + ++
Sbjct: 77 EVKHPFIVD-LIYAFQTGGKLYL---ILEYLSGGELFMQLEREGIFMEDTACFYLA-EIS 131
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTMA 592
AL +LH II+ DLKP NI+L+ HV +DFG+ K T T
Sbjct: 132 MALGHLHQKG----IIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTFC 182
Query: 593 -TIGYMAPE------YGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
TI YMAPE + D +S G L+ + T P +
Sbjct: 183 GTIEYMAPEILMRSGHNRA------VDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 9e-15
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 40/221 (18%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIK----IFNLQLE--RAFRSFDSECEILR 478
+ +G+G G V NVAIK F Q RA+R E +++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116
Query: 479 NVRHRNLLKIL------GSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMID 532
V H+N++ +L + LV+E M +L + + LD + ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQ 172
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT-- 590
+ +++LH SA IIH DLKP+NI++ + + DFG+++ G MT
Sbjct: 173 MLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-----FMMTPY 223
Query: 591 MATIGYMAPEYGSEGIVSTKC----DVYSYGVLLMETFTEK 627
+ T Y APE I+ D++S G ++ E K
Sbjct: 224 VVTRYYRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 47/239 (19%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLER---------AFRSFDSE 473
AT + +G G +G+VYK G VA+K + R
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR----- 60
Query: 474 CEI-----LRNVRHRNLLKIL----GSCSNLDFKA-LVLEFMPNGSLEKWLYSHN-YFLD 522
E+ L H N+++++ S ++ + K LV E + L +L L
Sbjct: 61 -EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 523 ILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582
++M L++LH I+H DLKP NIL+ ++DFG++++
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYS--- 171
Query: 583 DSVIQTMT--MATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637
+T + T+ Y APE S +T D++S G + E F +KP +F G
Sbjct: 172 --YQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFR-RKP---LFCGN 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 63/254 (24%)
Query: 413 TRRRTSYLDIRRATDEFNE------CNLLGTGGFGSVYKGT-LSDGTNVAIKIFNL-QLE 464
T R Y D E+ LG G + V++ +++ V +KI + +
Sbjct: 16 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK 75
Query: 465 RAFRSFDSECEILRNVR-HRNLLKIL----GSCSNLDFKALVLEFMPNGSLEKWLYSHN- 518
+ R E +IL N+R N++ + S ALV E + N ++ +
Sbjct: 76 KIKR----EIKILENLRGGPNIITLADIVKDPVSRTP--ALVFEHVNNTDFKQLYQTLTD 129
Query: 519 ----YFL-DILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDF 572
+++ +IL+ AL+Y H S I+H D+KP N+++D E+ + D+
Sbjct: 130 YDIRFYMYEILK----------ALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDW 175
Query: 573 GISKLLGEGEDSVIQTMT--MATIGYMAPE-------YGSEGIVSTKCDVYSYGVLLMET 623
G L E Q +A+ + PE Y D++S G +L
Sbjct: 176 G----LAEFYHPG-QEYNVRVASRYFKGPELLVDYQMY------DYSLDMWSLGCMLASM 224
Query: 624 FTEKKPTDEMFTGE 637
K+P F G
Sbjct: 225 IFRKEP---FFHGH 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 52/245 (21%)
Query: 410 PPATRRRTSYLDIRRA----TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIK-IFN--- 460
PP R ++ + + + +G+G +G+V G VAIK ++
Sbjct: 4 PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 63
Query: 461 --LQLERAFRSFDSECEILRNVRHRNLLKIL----GSCSNLDFKA--LVLEFMPNGSLEK 512
L +RA+R E +L+++RH N++ +L + DF LV+ FM L K
Sbjct: 64 SELFAKRAYR----ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGK 118
Query: 513 WLYS-------HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565
+ + + Q L L Y+H +A IIH DLKP N+ ++E+
Sbjct: 119 LMKHEKLGEDRIQFL--VYQMLK-------GLRYIH----AAGIIHRDLKPGNLAVNEDC 165
Query: 566 VAHVSDFGISKLLGEGEDSVIQTMT--MATIGYMAPEY-GSEGIVSTKCDVYSYGVLLME 622
+ DFG+++ MT + T Y APE + + D++S G ++ E
Sbjct: 166 ELKILDFGLAR-------QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 623 TFTEK 627
T K
Sbjct: 219 MITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 48/216 (22%)
Query: 435 LGTGGFGSVYKGTLSD-GTNVAIKIFNLQLE------RAFRSFDSECEILRNVRHRNLLK 487
+G+G +GSV + G VA+K + + R +R E +L++++H N++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 488 ILG----SCSNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDILQRLNIMIDVG 534
+L + S +F LV M L + + I Q L
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFL--IYQILR------ 143
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MA 592
L+Y+H SA IIH DLKP+N+ ++E+ + DFG+++ MT +A
Sbjct: 144 -GLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVA 191
Query: 593 TIGYMAPE-YGSEGIVSTKCDVYSYGVLLMETFTEK 627
T Y APE + + D++S G ++ E T +
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 66/235 (28%), Positives = 100/235 (42%), Gaps = 50/235 (21%)
Query: 427 DEFNECNLLGTGGFGSVY---KGTLSDGTNV-AIKIFNLQLERAFRSFDSECE------I 476
+F +LG G FG V+ K + SD + A+K+ L++A I
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV----LKKATLKVRDRVRTKMERDI 79
Query: 477 LRNVRHRNLLKILGSC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMID 532
L V H ++K L L +L+F+ G L L F + + + +
Sbjct: 80 LVEVNHPFIVK-LHYAFQTEGKLYL---ILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 134
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMT 590
+ AL++LH II+ DLKP NILLDE H+ +DFG+SK + E +
Sbjct: 135 LALALDHLHSLG----IIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYS 185
Query: 591 M-ATIGYMAPEYGSEGIVSTK-----CDVYSYGVLLMETFTEKKP-----TDEMF 634
T+ YMAPE +V+ + D +S+GVL+ E T P E
Sbjct: 186 FCGTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 47/157 (29%), Positives = 65/157 (41%), Gaps = 19/157 (12%)
Query: 170 LNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPS----SLWSLEYILRINLSSNSL 225
L+L L+ LT L L L N+L +L + L L + L++N L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELG---TLGLANNQL 95
Query: 226 KGTLPSNI-QKLNVLIDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-G 282
+LP + L L L L NQL S +PS + L L+ L L NQ Q IP
Sbjct: 96 A-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFD 152
Query: 283 NLISLESLDFSNNNLSGKIPK----SLEALSHLKQFN 315
L +L++L S N L +P L L + F
Sbjct: 153 KLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFG 188
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 52/166 (31%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 133 IPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192
IP L + L L +L LNL N+L LT L
Sbjct: 33 IPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86
Query: 193 SLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRNQLS 250
+L L +N+L+S LP ++ L + ++ L N LK +LPS + +L L +L L+ NQL
Sbjct: 87 TLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
Query: 251 SDIPSTI-GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNN 295
S IP+ L NL+TLSL+ NQ Q + L L+++ N
Sbjct: 145 S-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 189 TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRN 247
L LQS L++ ++ L + +NL N L+ TL + + L L L L+ N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93
Query: 248 QLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNNLSGKIPKSL 305
QL+S +P + L L+ L L GNQ + +P V L L+ L + N L IP
Sbjct: 94 QLAS-LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150
Query: 306 -EALSHLKQFNVSHNRLEGEIPVKGSF 331
+ L++L+ ++S N+L+ +P G+F
Sbjct: 151 FDKLTNLQTLSLSTNQLQS-VP-HGAF 175
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 49/154 (31%), Positives = 69/154 (44%), Gaps = 4/154 (2%)
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
L L L + L +L + N LQ L L L L+ N+L+
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKGTLPSNI-QKLNVL 239
LT L LYL N+L S LPS ++ L + + L++N L+ ++P+ KL L
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 240 IDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQF 273
L LS NQL S L L+T++L GNQF
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 53/201 (26%), Positives = 78/201 (38%), Gaps = 43/201 (21%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
++P+ I T+ LDL + TF L L+ L+L N L T S+
Sbjct: 28 SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD---- 81
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
LT L L LA+N L LP + F+ +L L L
Sbjct: 82 -LT---ELGTLGLANNQLAS-LPLGV------------FD------------HLTQLDKL 112
Query: 123 SLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPH---DLCHLERLNILNLSGNKLS 178
LG N L ++P+ + L +L+ + N LQ +P D L L L+LS N+L
Sbjct: 113 YLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFD--KLTNLQTLSLSTNQLQ 168
Query: 179 GAIPQCLASLTSLRSLYLQSN 199
L L+++ L N
Sbjct: 169 SVPHGAFDRLGKLQTITLFGN 189
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHR------NLL 486
++G G FG V K +VA+K+ +R R E IL ++R + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 487 KILGSCSNLDFKA---LVLEFMPNGSLEKWLYSHNYF---LDILQRLNIMIDVGSALEYL 540
+L + F+ + E + + +L + + + + L ++++ + L+ L
Sbjct: 163 HMLEN---FTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDAL 216
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAH--VSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
H IIHCDLKP NILL + + V DFG S + + IQ+ Y A
Sbjct: 217 HKNR----IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRA 267
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFT 625
PE D++S G +L E T
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 52/253 (20%), Positives = 92/253 (36%), Gaps = 54/253 (21%)
Query: 426 TDEFNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN 484
+ +++ LGTG FG V + + G A+K R E +I++ + H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61
Query: 485 ---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY-- 539
L+ + + + K N K +N+ ++ + + +EY
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 540 --------------------------------LHHCHSSAPIIHCDLKPTNILLD-ENMV 566
+ H S I H D+KP N+L++ ++
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDNT 180
Query: 567 AHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETF 624
+ DFG +K L E S + + Y APE G+ + D++S G + E
Sbjct: 181 LKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATE-YTPSIDLWSIGCVFGELI 236
Query: 625 TEKKPTDEMFTGE 637
KP +F+GE
Sbjct: 237 L-GKP---LFSGE 245
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 55/201 (27%), Positives = 83/201 (41%), Gaps = 17/201 (8%)
Query: 122 LSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAI 181
+L + T L + ++++ +L + L L GNKL I
Sbjct: 24 ANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLH-DI 78
Query: 182 PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLI 240
L LT+L L L N+L S L + + L N L+ +LP + KL L
Sbjct: 79 S-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLT 136
Query: 241 DLDLSRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNNLS 298
L+L+ NQL S +P + L NL L L+ NQ Q +PE V L L+ L N L
Sbjct: 137 YLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLK 194
Query: 299 GKIPK----SLEALSHLKQFN 315
+P L +L ++ +
Sbjct: 195 S-VPDGVFDRLTSLQYIWLHD 214
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 56/211 (26%), Positives = 79/211 (37%), Gaps = 27/211 (12%)
Query: 72 NLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNG 131
L + S + K I L + L+LG N L
Sbjct: 23 KANLKKKSVTD-AVTQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKL-- 75
Query: 132 TIPTSIG---TLQQLQGFYVPENNLQGYVPHDLCH-LERLNILNLSGNKLSGAIPQCLAS 187
I L L + N LQ +P+ + L L L L N+L
Sbjct: 76 ---HDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDK 131
Query: 188 LTSLRSLYLQSNKLSSSLPS----SLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDL 242
LT+L L L N+L S LP L +L + +LS N L+ +LP + KL L DL
Sbjct: 132 LTNLTYLNLAHNQLQS-LPKGVFDKLTNLTEL---DLSYNQLQ-SLPEGVFDKLTQLKDL 186
Query: 243 DLSRNQLSSDIPSTI-GTLKNLETLSLAGNQ 272
L +NQL S +P + L +L+ + L N
Sbjct: 187 RLYQNQLKS-VPDGVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 23/109 (21%), Positives = 46/109 (42%), Gaps = 12/109 (11%)
Query: 217 RINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP 276
+ NL S+ + + LN + + + + + S + I L N+ L+L GN+
Sbjct: 23 KANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKS-VQG-IQYLPNVRYLALGGNKLH-- 76
Query: 277 IPESVG---NLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
+ L +L L + N L + L++LK+ + N+L+
Sbjct: 77 ---DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ 122
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 66/236 (27%), Positives = 96/236 (40%), Gaps = 53/236 (22%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
+F+ ++G G FG V K A+K+ LQ + + + + +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKV--LQKKAILKKKEEKHIMSERNVL 92
Query: 478 -RNVRHRNLLKILGSC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMID 532
+NV+H L+ L L F VL+++ G L L FL+ R +
Sbjct: 93 LKNVKHPFLVG-LHFSFQTADKLYF---VLDYINGGELFYHLQRERCFLEPRARFYAA-E 147
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMT 590
+ SAL YLH S I++ DLKP NILLD H+ +DFG+ K E + T T
Sbjct: 148 IASALGYLH----SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TST 198
Query: 591 M-ATIGYMAPE------YGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
T Y+APE Y D + G +L E P T EM+
Sbjct: 199 FCGTPEYLAPEVLHKQPYD------RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 33/226 (14%)
Query: 427 DEFNECNLLGTGGFGSV----YKGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
++F +LG G FG V +K T AIK L+ + D EC +L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKA--LKKDVVLMDDDVECTMVEKRVL 71
Query: 478 -RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSA 536
H L + + + V+E++ G L + S + F ++
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILG 130
Query: 537 LEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTM-AT 593
L++LH S I++ DLK NILLD++ H+ +DFG+ K G+ T T T
Sbjct: 131 LQFLH----SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFCGT 181
Query: 594 IGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
Y+APE + D +S+GVLL E + P +E+F
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 77/346 (22%), Positives = 125/346 (36%), Gaps = 100/346 (28%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIK-IFN-----LQLERAFRSFDSECEILR 478
++ LG G +G V+K G VA+K IF+ +R FR E IL
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILT 63
Query: 479 NVR-HRNLLKILGSCSNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDILQRLN 528
+ H N++ +L + + LV ++M L + + Y + Q +
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV--VYQLIK 120
Query: 529 IMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG--------------- 573
++YLH S ++H D+KP+NILL+ V+DFG
Sbjct: 121 -------VIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 574 --ISKLLGEGEDSVIQTMT--MATIGYMAPE-------YGSEGIVSTKCDVYSYGVLLME 622
E D +T +AT Y APE Y ++GI D++S G +L E
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY-TKGI-----DMWSLGCILGE 223
Query: 623 TFTEK--------------------KPTDE--MFTGEMSLRRWVKESLPHRLTEVVDANL 660
K P++E + ++ SL + E+ +N
Sbjct: 224 ILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIE-SLKEK-VEIRQSNK 281
Query: 661 VREEQAFSDKMDCLFSIMD---LALD-----CCMDTPHKRIHMTDA 698
+ + + + D ALD + P+KRI DA
Sbjct: 282 RDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN-PNKRISANDA 326
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 66/236 (27%), Positives = 95/236 (40%), Gaps = 53/236 (22%)
Query: 427 DEFNECNLLGTGGFGSV----YKGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
+FN +LG G FG V KGT A+KI L+ + + D EC +L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVL 74
Query: 478 RNVRHRNLLKILGSC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533
L L SC L F V+E++ G L + F + ++
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDRLYF---VMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EI 130
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKL-LGEGEDSVIQTMT 590
L +L S II+ DLK N++LD H+ +DFG+ K + +G T T
Sbjct: 131 AIGLFFLQ----SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV----TTKT 180
Query: 591 M-ATIGYMAPE------YGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
T Y+APE YG D +++GVLL E + P DE+F
Sbjct: 181 FCGTPDYIAPEIIAYQPYG------KSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 49/223 (21%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR--------HRN 484
LG G F +V+ + + T+VA+KI + + + E ++L+ V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 485 LLKILGSCSNLDFKA-------LVLEFMPNGSLEKWLYSHNYF---LDILQRLNIMIDVG 534
IL + + K +V E + +L + + + L +++ I +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLL 141
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAH------VSDFGISKLLGEGEDSVIQT 588
L+Y+H IIH D+KP N+L++ ++D G + E + IQT
Sbjct: 142 LGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 589 MTMATIGYMAPE------YGSEGIVSTKCDVYSYGVLLMETFT 625
Y +PE +G D++S L+ E T
Sbjct: 199 RE-----YRSPEVLLGAPWG------CGADIWSTACLIFELIT 230
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 70/236 (29%), Positives = 94/236 (39%), Gaps = 53/236 (22%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
D F +LG G FG V K T G A+K+ L+ + + D EC IL
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKV--LKKDVILQDDDVECTMTEKRIL 77
Query: 478 RNVRHRNLLKILGSC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533
R+ L L C L F V+EF+ G L + F + R ++
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFF---VMEFVNGGDLMFHIQKSRRFDEARARF-YAAEI 133
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKL-LGEGEDSVIQTMT 590
SAL +LH II+ DLK N+LLD H +DFG+ K + G T T
Sbjct: 134 ISALMFLH----DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGV----TTAT 183
Query: 591 M-ATIGYMAPE------YGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMF 634
T Y+APE YG D ++ GVLL E P D++F
Sbjct: 184 FCGTPDYIAPEILQEMLYG------PAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 56/219 (25%), Positives = 86/219 (39%), Gaps = 48/219 (21%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
+F+ ++G G + V K T A+K+ ++ E D + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKV--VKKELVNDDEDIDWVQTEKHVF 63
Query: 478 RNVRHRNLLKILGSC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533
+ L L SC S L F V+E++ G L + + R ++
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFF---VIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EI 119
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKL-LGEGEDSVIQTMT 590
AL YLH II+ DLK N+LLD H+ +D+G+ K L G+ T T
Sbjct: 120 SLALNYLH----ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGD----TTST 169
Query: 591 M-ATIGYMAPE------YGSEGIVSTKCDVYSYGVLLME 622
T Y+APE YG D ++ GVL+ E
Sbjct: 170 FCGTPNYIAPEILRGEDYGFS------VDWWALGVLMFE 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 56/233 (24%), Positives = 88/233 (37%), Gaps = 56/233 (24%)
Query: 427 DEFNECNLLGTGGFGSVY----KGTLSDGTNVAIKIFNLQLERAFRSFDSEC-----EIL 477
+F+ ++G G + V K T A+++ ++ E D + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRV--VKKELVNDDEDIDWVQTEKHVF 106
Query: 478 RNVRHRNLLKILGSC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533
+ L L SC S L F V+E++ G L + + R ++
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFF---VIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EI 162
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKL-LGEGEDSVIQTMT 590
AL YLH II+ DLK N+LLD H+ +D+G+ K L G+ T T
Sbjct: 163 SLALNYLH----ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGD----TTST 212
Query: 591 M-ATIGYMAPEYGSEGIVS----TKC-DVYSYGVLLMETFTEKKPTDEMFTGE 637
T Y+APE I+ D ++ GVL+ EM G
Sbjct: 213 FCGTPNYIAPE-----ILRGEDYGFSVDWWALGVLMF----------EMMAGR 250
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPS----SLWSLEYILRINLSSNS 224
IL L N+++ P SL +L+ LYL SN+L +LP SL L ++L +N
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLT---VLDLGTNQ 99
Query: 225 LKGTLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGN 283
L LPS + +L L +L + N+L+ +P I L +L L+L NQ + +
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 284 LISLESLDFSNN 295
L SL N
Sbjct: 158 LSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 40/133 (30%), Positives = 59/133 (44%), Gaps = 10/133 (7%)
Query: 189 TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRN 247
T+ + LYL N+++ P SL + + L SN L LP + L L LDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 248 QLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPK--- 303
QL+ +PS + L +L+ L + N+ +P + L L L N L IP
Sbjct: 99 QLTV-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAF 155
Query: 304 -SLEALSHLKQFN 315
L +L+H F
Sbjct: 156 DRLSSLTHAYLFG 168
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 38/153 (24%), Positives = 58/153 (37%), Gaps = 27/153 (17%)
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC-HLERLNILNLSGNKLSG 179
+L L N + P +L L+ Y+ N L +P + L +L +L+L N+L+
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 180 AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVL 239
L L+ L++ NKL+ LP I++L L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLTE-------------------------LPRGIERLTHL 137
Query: 240 IDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQ 272
L L +NQL S L +L L GN
Sbjct: 138 THLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 29/91 (31%), Positives = 40/91 (43%), Gaps = 13/91 (14%)
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNNLSGK 300
L L NQ++ P +L NL+ L L NQ +P V +L L LD N L
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQL--- 100
Query: 301 IPKSLEA-----LSHLKQFNVSHNRLEGEIP 326
L + L HLK+ + N+L E+P
Sbjct: 101 --TVLPSAVFDRLVHLKELFMCCNKLT-ELP 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-12
Identities = 41/148 (27%), Positives = 65/148 (43%), Gaps = 20/148 (13%)
Query: 157 VPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLS--SSLPSSLWSLEY 214
+ L L+ L LS N + I L+ + +LR L L N + +L + +LE
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIENLDAVADTLEE 97
Query: 215 ILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQF 273
+ +S N + +L S I+KL L L +S N++++ + L LE L LAGN
Sbjct: 98 ---LWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152
Query: 274 QGPIPES----------VGNLISLESLD 291
E+ V L +L+ LD
Sbjct: 153 YNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 33/175 (18%), Positives = 62/175 (35%), Gaps = 32/175 (18%)
Query: 160 DLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRIN 219
E++ L+ + + L++L + + L L +N I +I
Sbjct: 21 VATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNN--------------IEKI- 63
Query: 220 LSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPE 279
S++ + L L L RN + I + LE L ++ NQ
Sbjct: 64 -----------SSLSGMENLRILSLGRNLI-KKIENLDAVADTLEELWISYNQIA--SLS 109
Query: 280 SVGNLISLESLDFSNNNLSG-KIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKD 333
+ L++L L SNN ++ L AL L+ ++ N L + + +
Sbjct: 110 GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 25/107 (23%), Positives = 44/107 (41%), Gaps = 4/107 (3%)
Query: 113 IGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNL 172
+ + L +LSLG N + I L+ ++ N + + L L +L +
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYM 122
Query: 173 SGNKLSGAIP-QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRI 218
S NK++ LA+L L L L N L + + + EY + +
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 55/243 (22%), Positives = 95/243 (39%), Gaps = 47/243 (19%)
Query: 423 RRATDEFNECNL-LGTGGFGSVYKGTLSDGTN---VAIKIFNLQLERAFRSFDSECEI-- 476
R D F +G G +G VYK DG + A+K Q+E S + EI
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK----QIEGTGISMSACREIAL 71
Query: 477 LRNVRHRN---LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNI---- 529
LR ++H N L K+ S ++ L+ ++ + L + H + + +
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGM 129
Query: 530 ----MIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAH----VSDFGISKLLGEG 581
+ + + YLH ++H DLKP NIL+ ++D G ++L
Sbjct: 130 VKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-- 183
Query: 582 EDSVIQTMTMA-----TIGYMAPE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMF 634
S ++ + T Y APE G+ + D+++ G + E T +P +F
Sbjct: 184 --SPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLT-SEP---IF 236
Query: 635 TGE 637
Sbjct: 237 HCR 239
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 6e-12
Identities = 36/200 (18%), Positives = 59/200 (29%), Gaps = 55/200 (27%)
Query: 425 ATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKI--------FNLQLERAFRSFDSECEI 476
T++ C +G G FG V++ D T VAIKI N ++ F E I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 477 LRNV---------RHRNLLKILGSC------------------------------SNLDF 497
+ + R + + D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 498 KALVLEFMPNG-SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKP 556
+VLEF G LE+ + +I+ + ++L H DL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR---FEHRDLHW 190
Query: 557 TNILLDENMVAHVSDFGISK 576
N+LL + + + K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 65/235 (27%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIF-NLQLERAFRSFDSECEILRNVRHR-----NLL 486
+G G FG V + + A+K+ N++ + RS E +IL+ +++ N++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 487 KILGSCSNLDFKA---LVLEFMPNGSLEKWLYSHNYF---LDILQRLNIMIDVGSALEYL 540
K G + L+ E + SL + + +NY ++ ++ I++ AL YL
Sbjct: 100 KYHGK---FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKL--YCIEILKALNYL 153
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVS-------------------------DFGIS 575
+ H DLKP NILLD+ DFG +
Sbjct: 154 RKMS----LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV-----STKCDVYSYGVLLMETFT 625
+ S+I T Y APE ++ D++S+G +L E +T
Sbjct: 210 TFKSDYHGSIINTRQ-----YRAPE-----VILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 25/131 (19%), Positives = 58/131 (44%), Gaps = 12/131 (9%)
Query: 189 TSLRSLYLQSNKLSSSLPSSLWS-LEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSR 246
L L +N+ + + ++ L + +IN S+N + + + + + ++ L+
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90
Query: 247 NQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNNLSGKIPK- 303
N+L + + + L++L+TL L N+ + L S+ L +N ++ +
Sbjct: 91 NRLEN-VQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147
Query: 304 ---SLEALSHL 311
+L +LS L
Sbjct: 148 AFDTLHSLSTL 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 34/156 (21%), Positives = 58/156 (37%), Gaps = 27/156 (17%)
Query: 121 VLSLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
L L N+ T I L QL+ N + +N + L+ N+L
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 180 AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNV 238
+ L SL++L L+SN+++ + ++ L+
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRITC-------------------------VGNDSFIGLSS 130
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274
+ L L NQ+++ P TL +L TL+L N F
Sbjct: 131 VRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 20/105 (19%), Positives = 38/105 (36%), Gaps = 11/105 (10%)
Query: 229 LPSNIQKLNVLIDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLIS 286
+P +L L+ N+ + + I L L ++ + N+ I E
Sbjct: 30 IPQYTAEL------RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASG 82
Query: 287 LESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSF 331
+ + ++N L K + L LK + NR+ + SF
Sbjct: 83 VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVG-NDSF 125
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 36/200 (18%), Positives = 57/200 (28%), Gaps = 64/200 (32%)
Query: 3 TIPNSI-TNATKLIGLDLGLNSFSGHIPN-TFGNLRHLSVLSLMMNNLTTESSSADQWSF 60
IP I +L L N F+ F L L ++ N +T A
Sbjct: 25 KIPEHIPQYTAEL---RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA----- 76
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLI 120
+ + + L SN L + F L L
Sbjct: 77 FEGAS---GVNEILLTSNRLEN-VQH--KMFK----------------------GLESLK 108
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL-CHLERLNILNLSGNKLSG 179
L L N + T + +D L + +L+L N+++
Sbjct: 109 TLMLRSNRI-----TCV--------------------GNDSFIGLSSVRLLSLYDNQITT 143
Query: 180 AIPQCLASLTSLRSLYLQSN 199
P +L SL +L L +N
Sbjct: 144 VAPGAFDTLHSLSTLNLLAN 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 36/151 (23%), Positives = 65/151 (43%), Gaps = 18/151 (11%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRH-RNLLKILGSC 492
+G G FG + G L VAIK+ ++ E + + + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 493 SNLDFKALVLEFMPNG-SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIH 551
+ A+VLE + G SLE + + L I I + S +EY+H + +I+
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN----LIY 128
Query: 552 CDLKPTNILL------DENMVAHVSDFGISK 576
D+KP N L+ + ++ H+ DF ++K
Sbjct: 129 RDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 46/231 (19%), Positives = 85/231 (36%), Gaps = 61/231 (26%)
Query: 434 LLGTGGFGSVYKG--TLSDGTNVAIKIF-NLQLERAFRSFDSECEILRNVRHR------N 484
LG G FG V + + VA+KI N+ + + E +L+ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFL 83
Query: 485 LLKILGSCSNLDFKA---LVLEFMPNGSLEKWLYSHNYF---LDILQRLNIMIDVGSALE 538
+ + +F + E + + ++L +N+ L ++ + + AL
Sbjct: 84 CVLMSDW---FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH--MAYQLCHALR 137
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAH-------------------VSDFGISKLLG 579
+LH + H DLKP NIL + V+DFG +
Sbjct: 138 FLHENQ----LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 580 EGEDSVIQTMTMATIGYMAPEYGSEGIV-----STKCDVYSYGVLLMETFT 625
E +++ T Y PE ++ + CDV+S G +L E +
Sbjct: 194 EHHTTIVATRH-----YRPPE-----VILELGWAQPCDVWSIGCILFEYYR 234
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 32/168 (19%), Positives = 66/168 (39%), Gaps = 32/168 (19%)
Query: 434 LLGTGGFGSVYKGTLSDGTNVAIKIFN-----------LQLERAFRSFDSECEILRNVRH 482
+G GGFG +Y ++ +V L E F ++ E ++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 483 RNLLKILG----------SCSNLDFKALVLEFMPNG-SLEKWLYSHNYFLDILQRLNIMI 531
LK LG + ++ ++++ G L+K ++ L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 532 DVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISK 576
+ LEY+H +H D+K +N+LL + + V ++ D+G++
Sbjct: 160 RILDILEYIHEHE----YVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 32/151 (21%), Positives = 61/151 (40%), Gaps = 18/151 (11%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRH-RNLLKILGSC 492
+G G FG +++GT L + VAIK + + E + + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 493 SNLDFKALVLEFMPNG-SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIH 551
LV++ + G SLE L + + + ++ +H +++
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVY 129
Query: 552 CDLKPTNILL------DENMVAHVSDFGISK 576
D+KP N L+ + NM+ +V DFG+ K
Sbjct: 130 RDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 49/231 (21%), Positives = 91/231 (39%), Gaps = 61/231 (26%)
Query: 434 LLGTGGFGSVYKG--TLSDGTNVAIKIF-NLQLERAFRSFDSECEILRNVRHR------N 484
LG G FG V + + G +VA+KI N+ +R + SE ++L ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 485 LLKILGSCSNLDFKA---LVLEFMPNGSLEKWLYSHNYF---LDILQRLNIMIDVGSALE 538
+++L + +V E + S ++ + + LD +++ + + ++
Sbjct: 79 CVQMLEW---FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK--MAYQICKSVN 132
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVS-------------------DFGISKLLG 579
+LH + H DLKP NIL ++ DFG +
Sbjct: 133 FLHSNK----LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 580 EGEDSVIQTMTMATIGYMAPEYGSEGIV-----STKCDVYSYGVLLMETFT 625
E +++ T Y APE ++ S CDV+S G +L+E +
Sbjct: 189 EHHSTLVSTRH-----YRAPE-----VILALGWSQPCDVWSIGCILIEYYL 229
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 7/110 (6%)
Query: 189 TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRN 247
+ LYL N+ + +P L + +++ I+LS+N + TL + + L+ L LS N
Sbjct: 31 RDVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
Query: 248 QLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNN 295
+L IP LK+L LSL GN +PE +L +L L N
Sbjct: 89 RLRC-IPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 8/100 (8%)
Query: 217 RINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP 276
+ L N +P + L +DLS N++S+ + + L TL L+ N+ +
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC- 92
Query: 277 IPESV-GNLISLESLDFSNNNLSGKIPK----SLEALSHL 311
IP L SL L N++S +P+ L ALSHL
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 25/100 (25%), Positives = 40/100 (40%), Gaps = 8/100 (8%)
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L L N +P + + L + N + ++ +L L LS N+L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 181 IPQ-CLASLTSLRSLYLQSNKLSSSLP----SSLWSLEYI 215
IP L SLR L L N + S +P + L +L ++
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 25/93 (26%), Positives = 45/93 (48%), Gaps = 2/93 (2%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
+PKE+ N + L ++ L N ++ S + QL + N L+ P L+ L
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSL 104
Query: 168 NILNLSGNKLSGAIPQ-CLASLTSLRSLYLQSN 199
+L+L GN +S +P+ L++L L + +N
Sbjct: 105 RLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 433 NLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHR------NL 485
+L+G G FG V K + VAIKI + + E +L + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 486 LKILGSCSNLDFKA---LVLEFMPNGSLEKWLYSHNYF---LDILQRLNIMIDVGSALEY 539
+ + F+ LV E + + +L L + N+ L++ ++ + +AL +
Sbjct: 119 VHLKRH---FMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTALLF 172
Query: 540 LHHCHSSAPIIHCDLKPTNILL--DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597
L IIHCDLKP NILL + + DFG S LG+ IQ+ Y
Sbjct: 173 LAT--PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YR 225
Query: 598 APEYGSEGIVSTKCDVYSYGVLLMETFT 625
+PE D++S G +L+E T
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 46/324 (14%), Positives = 99/324 (30%), Gaps = 77/324 (23%)
Query: 38 LSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQN 97
+ SL ++ +TTE + + L ++ + L+ N +G
Sbjct: 6 IEGKSLKLDAITTEDEKS----VFAVLLEDDSVKEIVLSGNTIG---------------- 45
Query: 98 IYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYV 157
+ +L + + IP ++ L Q
Sbjct: 46 --TEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA-------------- 89
Query: 158 PHDLCHLERLNILNLSGNKLSG----AIPQCLASLTSLRSLYLQSNKLS----------- 202
L +L+ + LS N + L+ T L LYL +N L
Sbjct: 90 ---LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146
Query: 203 --SSLPSSLWSLEYILRINLSSNSL--KGT--LPSNIQKLNVLIDLDLSRNQLSSD---- 252
++ + + I N L Q +L + + +N + +
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206
Query: 253 -IPSTIGTLKNLETLSLAGNQFQGP-----IPESVGNLISLESLDFSNNNLSGK----IP 302
+ + + L+ L L N F + ++ + +L L ++ LS + +
Sbjct: 207 LLLEGLAYCQELKVLDLQDNTF-THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265
Query: 303 KSLEALSH--LKQFNVSHNRLEGE 324
+ L + L+ + +N +E +
Sbjct: 266 DAFSKLENIGLQTLRLQYNEIELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 50/307 (16%), Positives = 98/307 (31%), Gaps = 58/307 (18%)
Query: 7 SITNATKLIGLDLGLNSFSG----HIPNTFGNLRHLSVLSLMMNNLTTESSSADQ--WSF 60
+ + + L N+ + + + L + +
Sbjct: 27 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL 86
Query: 61 LSSLTNCRNLANLALASNPLGGILPPLIGNF---SASLQNIYAFECKLG----------- 106
L +L C L + L+ N G + +F L+++Y LG
Sbjct: 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146
Query: 107 --GSIPKEIGNLRGLIVLSLGFNDLNG----TIPTSIGTLQQLQGFYVPENNL-----QG 155
++ K+ N L + G N L + + + L + +N + +
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206
Query: 156 YVPHDLCHLERLNILNLSGNKLSG----AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWS 211
+ L + + L +L+L N + A+ L S +LR L L LS+ +++
Sbjct: 207 LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV-- 264
Query: 212 LEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGT-----LKNLETL 266
++ L L L N++ D T+ T + +L L
Sbjct: 265 ----------VDAFSKLENIG------LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 308
Query: 267 SLAGNQF 273
L GN+F
Sbjct: 309 ELNGNRF 315
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 34/166 (20%), Positives = 67/166 (40%), Gaps = 31/166 (18%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNL------QLERAFRSFD--SECEILRNVRHRN 484
+G+GGFG +Y + A + + L + + ++ + ++ R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 485 LLKILG----------SCSNLDFKALVLEFMPNG-SLEKWLYSHNYFLDILQRLNIMIDV 533
L LG ++ +V+E + G L+K + N L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISK 576
LEY+H +H D+K N+LL + + V +++D+G+S
Sbjct: 161 LDVLEYIHENE----YVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 47/130 (36%), Positives = 69/130 (53%), Gaps = 8/130 (6%)
Query: 170 LNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKGT 228
L+L N L LTSL LYL NKL SLP+ ++ L + +NLS+N L+ +
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 229 LPSNI-QKLNVLIDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLI 285
LP+ + KL L +L L+ NQL S +P + L L+ L L NQ + +P+ V L
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLT 148
Query: 286 SLESLDFSNN 295
SL+ + +N
Sbjct: 149 SLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 11/134 (8%)
Query: 189 TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRN 247
L L++N L S L + ++ L N L+ +LP+ + KL L L+LS N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 248 QLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNNLSGKIPK-- 303
QL S +P+ + L L+ L+L NQ Q +P+ V L L+ L N L +P
Sbjct: 87 QLQS-LPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKS-VPDGV 143
Query: 304 --SLEALSHLKQFN 315
L +L ++ +
Sbjct: 144 FDRLTSLQYIWLHD 157
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 133 IPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192
+PT I Q + N+L+ L L L L GNKL LTSL
Sbjct: 22 VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79
Query: 193 SLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRNQLS 250
L L +N+L SLP+ ++ L + + L++N L+ +LP + KL L DL L +NQL
Sbjct: 80 YLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK 137
Query: 251 SDIPSTI-GTLKNLETLSLAGNQF 273
S +P + L +L+ + L N +
Sbjct: 138 S-VPDGVFDRLTSLQYIWLHDNPW 160
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 35/117 (29%), Positives = 54/117 (46%), Gaps = 6/117 (5%)
Query: 217 RINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP 276
++L +NSLK +L L L L N+L S L +L L+L+ NQ Q
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS- 90
Query: 277 IPESV-GNLISLESLDFSNNNLSGKIPKSL-EALSHLKQFNVSHNRLEGEIPVKGSF 331
+P V L L+ L + N L +P + + L+ LK + N+L+ +P G F
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VP-DGVF 144
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 40/149 (26%), Positives = 73/149 (48%), Gaps = 16/149 (10%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRH-RNLLKILGSC 492
+G+G FG +Y GT ++ G VAIK+ ++ + E +I + ++ + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 493 SNLDFKALVLEFMPNG-SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIH 551
+ D+ +V+E + G SLE + + L + + S +EY+H + IH
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN----FIH 128
Query: 552 CDLKPTNILL----DENMVAHVSDFGISK 576
D+KP N L+ N+V ++ DFG++K
Sbjct: 129 RDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 25/130 (19%), Positives = 47/130 (36%), Gaps = 10/130 (7%)
Query: 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSS--SLPSSLWSLEYILRINLSSNSLK 226
++ L+ + A + R L L+ K+ +L ++L + I + S N ++
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAI---DFSDNEIR 55
Query: 227 GTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP-IPESVGNLI 285
L L L ++ N++ L +L L L N + + +L
Sbjct: 56 KL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 113
Query: 286 SLESLDFSNN 295
SL L N
Sbjct: 114 SLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 28/141 (19%), Positives = 53/141 (37%), Gaps = 17/141 (12%)
Query: 161 LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINL 220
+ R L+L G K+ I A+L ++ N++ L + + +
Sbjct: 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLV 71
Query: 221 SSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS--DIPSTIGTLKNLETLSLAGNQFQGPIP 278
++N + Q L L +L L+ N L D+ + +LK+L L + N P+
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN----PVT 126
Query: 279 ES-------VGNLISLESLDF 292
+ + + LDF
Sbjct: 127 NKKHYRLYVIYKVPQVRVLDF 147
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 19/106 (17%), Positives = 42/106 (39%), Gaps = 9/106 (8%)
Query: 219 NLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP 278
L++ ++ + +LDL ++ I + TL + + + N+ I
Sbjct: 3 KLTAELIE--QAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNE----IR 55
Query: 279 --ESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
+ L L++L +NN + +AL L + +++N L
Sbjct: 56 KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 19/89 (21%), Positives = 29/89 (32%), Gaps = 3/89 (3%)
Query: 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG 174
N L L + I TL Q +N ++ L RL L ++
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNN 73
Query: 175 NKLSGAIPQCLASLTSLRSLYLQSNKLSS 203
N++ +L L L L +N L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLVE 102
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 28/167 (16%), Positives = 58/167 (34%), Gaps = 32/167 (19%)
Query: 435 LGTGGFGSVYKGT---------LSDGTNVAIKI--FNLQLERAFRSFDSECEI------- 476
G +Y+ ++K+ + +L F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 477 -LRNVRHRNLLKILGSCSNLD-FKALVLEFMPNG-SLEK-WLYSHNYFLDILQRLNIMID 532
L + + +G + D ++ LVL + G SL+ S + L L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISK 576
+ ALE+LH +H ++ NI + D++ V ++ +G +
Sbjct: 168 LLDALEFLHENE----YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 5e-10
Identities = 83/614 (13%), Positives = 168/614 (27%), Gaps = 205/614 (33%)
Query: 151 NNLQGYVPHDLCHLE-----RLNILNLSGNK------LSGAIPQCLASLTSLRSLYLQSN 199
N+ Q + +++ L+ R +L L K + G+ +A S
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV------CLSY 174
Query: 200 KLSSSLPSSL-WSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL-SRNQLSSDIPSTI 257
K+ + + W +NL + + T+ +QKL ID + SR+ SS+I I
Sbjct: 175 KVQCKMDFKIFW-------LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 258 GTLKN-LETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSH------ 310
+++ L L L + L+ L + N K+ A +
Sbjct: 228 HSIQAELRRL-LKSKPY----ENC---LLVLL--NVQN-------AKAWNAFNLSCKILL 270
Query: 311 ----------LKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDN 360
L +H L+ + +S Y C P L P
Sbjct: 271 TTRFKQVTDFLSAATTTHISLD---HHSMTLTPDEVKSLLLKYLDCRPQDL--PR----- 320
Query: 361 RKRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSY- 419
P L SI++ + + + KH++ + T +S
Sbjct: 321 --EVLTTNPRRL-----SIIAESIRDGL------ATWDNWKHVNCDKL---TTIIESSLN 364
Query: 420 -LDIRRATDEFNECNLLGTGGFGSVYK--GTLSDGTNVAIKIFNLQLERAFRSFDSECEI 476
L+ E+ + + ++ + L + +
Sbjct: 365 VLE----PAEYRKM-----------FDRLSVFPPSAHIPTIL----LSLIWFDVIKSDVM 405
Query: 477 LRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFL-DILQRLNIMIDVGS 535
+ ++ +L +EK + I L + ++
Sbjct: 406 V----------VVNKLHK---YSL---------VEKQPKESTISIPSIYLELKVKLE--- 440
Query: 536 ALEYLH------------HCHSSAPIIHCD----------LKPTNILLDENMVAHV-SDF 572
LH + D LK + V DF
Sbjct: 441 NEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF 500
Query: 573 GI--SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPT 630
K+ + S I++T + Y + P
Sbjct: 501 RFLEQKIRHDS----------------TAWNASGSILNTLQQLKFYK----PYICDNDPK 540
Query: 631 DEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPH 690
E + + LP ++ NL+ + ++D ++ +AL
Sbjct: 541 YERLVNA------ILDFLPK-----IEENLICSK--YTD-------LLRIAL----MAED 576
Query: 691 KRIHMTDAAAKLRK 704
+ I +A ++++
Sbjct: 577 EAIF-EEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 7e-10
Identities = 61/375 (16%), Positives = 122/375 (32%), Gaps = 112/375 (29%)
Query: 367 VAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPATRRRTSYLDIRRAT 426
++PI + PS+++ MY+ R+R + D++ F R YL +R+A
Sbjct: 95 MSPIKTEQRQPSMMTR--------MYIEQRDRL--YNDNQVFAKYNVSRLQPYLKLRQAL 144
Query: 427 DEFNECNLL---GTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSF---DSECEILRNV 480
E + G G G K + + +Q + F+ F C
Sbjct: 145 LELRPAKNVLIDGVLGSG---KTWV---ALDVCLSYKVQCKMDFKIFWLNLKNCN----- 193
Query: 481 RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
+L++L + L+ + PN + D NI + + S L
Sbjct: 194 SPETVLEML--------QKLLYQIDPNWTSR---------SDHSS--NIKLRIHSIQAEL 234
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS-KLLGEGED-SVIQTMTMATIGYMA 598
S P +C L +LL+ + F +S K+L V ++ AT +++
Sbjct: 235 RRLLKSKPYENCLL----VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK---ESLPHRLTEV 655
++ S T + + +++ + LP EV
Sbjct: 291 LDHHSMT------------------LTPDE-VKSLL------LKYLDCRPQDLPR---EV 322
Query: 656 VDAN---------LVRE--------EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
+ N +R+ + DK+ +I++ +L+ ++ R
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT---TIIESSLN-VLEPAEYRKMFDRL 378
Query: 699 AAKLRKIKAKFLDDV 713
+ + F
Sbjct: 379 S-----V---FPPSA 385
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 6e-06
Identities = 87/508 (17%), Positives = 138/508 (27%), Gaps = 175/508 (34%)
Query: 31 TFGNLRHLSVLSLMMNNLTTE-----SSSADQWSFLSSLTNC--RNLANLALASNPLGGI 83
N + M+ L + +S +D S + + L L L S P
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPYENC 246
Query: 84 LPPLIGNFSASLQNIY------AFE--CKLGGSIPKEIGNLRGLIV---LSLGFNDLNGT 132
L L+ L N+ AF CK+ L+ + + L+
Sbjct: 247 L--LV------LLNVQNAKAWNAFNLSCKI-------------LLTTRFKQV-TDFLSAA 284
Query: 133 IPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS----GAIPQCLASL 188
T I E L L L+ L P+ L+ +
Sbjct: 285 TTTHISLDHHSMTLTPDEVK-------SLL----LKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 189 -TSLRS--------LYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVL 239
S+R ++ +KL++ + SSL LE P+ +K+
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE----------------PAEYRKM--F 375
Query: 240 IDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESL-DFSNNNLS 298
L + S+ IP+ LSL V N + SL + +
Sbjct: 376 DRLSVFPP--SAHIPT--------ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425
Query: 299 GKIPK-SLEALSHLKQFNVSHNRL--EGEIPVKGSFKDFSAQ---SYFGNYALCGPPRLQ 352
IP LE L+ H + IP D YF ++
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH--------- 476
Query: 353 VPPCKQDNRKRTNKVAPIVLQYILPSILSTVLLVIIIIMYVRCRNRSTKHLDHEDFLPPA 412
I + HL + +
Sbjct: 477 -------------------------------------IGH---------HLKNIEHPERM 490
Query: 413 TRRRTSYLD-------IRRATDEFNEC----NLLGTGGFGSVYKGTLSDGTNVAIKIFNL 461
T R +LD IR + +N N L F YK + D
Sbjct: 491 TLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF---YKPYICDNDPK-----YE 542
Query: 462 QLERAFRSFDSECE-ILRNVRHRNLLKI 488
+L A F + E L ++ +LL+I
Sbjct: 543 RLVNAILDFLPKIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 8e-04
Identities = 50/305 (16%), Positives = 92/305 (30%), Gaps = 110/305 (36%)
Query: 460 NLQLERAFRSFDSECEIL---RNVR-----------------------HRNLLKILGSCS 493
N+Q +A+ +F+ C+IL R + + +L
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 494 NLDFK--------------ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
+ + +++ E + +G L W + D +L +I+ S+L
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDG-LATWDNWKHVNCD---KLTTIIE--SSLNV 365
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
L+P + + I T+ ++ I +
Sbjct: 366 --------------LEP------AEYRKMFDRLSVFP-----PSAHIPTILLSLIWFDVI 400
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP-----HRLTE 654
+ +V K YS L+ EK+P E S+ +K L HR
Sbjct: 401 KSDVMVVV-NKLHKYS---LV-----EKQP-KESTISIPSIYLELKVKLENEYALHR--S 448
Query: 655 VVDA-NLVREEQAFSDKMDCLFSIMD------LALDCCMDTPH-KRIHMTDAAAKLRKIK 706
+VD N+ + D D + +D + H K I + R +
Sbjct: 449 IVDHYNIPKT----FDSDDLIPPYLDQYFYSHIGH-------HLKNIEHPERMTLFRMV- 496
Query: 707 AKFLD 711
FLD
Sbjct: 497 --FLD 499
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 8e-04
Identities = 52/364 (14%), Positives = 99/364 (27%), Gaps = 118/364 (32%)
Query: 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGN----L---RHLSVLSLMMNNLTTESSSAD- 56
N L+ L N + N F L R V + TT S
Sbjct: 244 ENC------LLVLL---NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294
Query: 57 QWSF--------LSSLTNCR--NLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLG 106
+ L +CR +L L +NP + + S+++
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR------RLSIIAESIRDG-------- 340
Query: 107 GSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQ--QLQGFY-----------VPENNL 153
N + + + L I +S+ L+ + + + +P L
Sbjct: 341 ---LATWDNWK-----HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL 392
Query: 154 QGY--------VPHDLCHLERLNILNLSGNKLSGAIPQCLASL-------TSL-RSL--- 194
V + L + +++ + + +IP L +L RS+
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH 452
Query: 195 YLQSNKLSSSLPSSLWSLEYILR-----INLSSNSLKGTLPSNI--------QKL----- 236
Y S + +Y + + + TL + QK+
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 237 ---------NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISL 287
N L L + + + P + + F +P+ NLI
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILD-------F---LPKIEENLICS 562
Query: 288 ESLD 291
+ D
Sbjct: 563 KYTD 566
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 27/111 (24%), Positives = 50/111 (45%), Gaps = 7/111 (6%)
Query: 189 TSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSR 246
L L N+L L+ L +++++ L N L + N + + + +L L
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGE 87
Query: 247 NQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNN 295
N++ I + + L L+TL+L NQ + +L SL SL+ ++N
Sbjct: 88 NKIKE-ISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 5/108 (4%)
Query: 169 ILNLSGNKLSGAIPQCL-ASLTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLK 226
L L+ N+L L L L L L+ N+L+ + + + +I + L N +K
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK 91
Query: 227 GTLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQF 273
+ + + L+ L L+L NQ+S +P + L +L +L+LA N F
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 24/101 (23%), Positives = 46/101 (45%), Gaps = 8/101 (7%)
Query: 217 RINLSSNSLKGTLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG 275
+ L+ N L + +L L+ L+L RNQL+ P+ +++ L L N+ +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE 92
Query: 276 PIPESV-GNLISLESLDFSNNNLSGKIPK----SLEALSHL 311
I + L L++L+ +N +S + L +L+ L
Sbjct: 93 -ISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSL 131
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 29/105 (27%), Positives = 43/105 (40%), Gaps = 3/105 (2%)
Query: 121 VLSLGFNDLNGTIPTSI-GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
L L N+L + G L L + N L G P+ + L L NK+
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 180 AIPQ-CLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223
I L L++L L N++S +P S L + +NL+SN
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 37/148 (25%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 435 LGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSC 492
+G+G FG +Y GT + VAIK+ N++ + E +I R ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 493 SNLDFKALVLEFMPNG-SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIH 551
D+ LV++ + G SLE + L + L + + + +E++H +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS----FLH 126
Query: 552 CDLKPTNILLDENMVAH---VSDFGISK 576
D+KP N L+ A+ + DFG++K
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 19/95 (20%), Positives = 38/95 (40%), Gaps = 2/95 (2%)
Query: 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPS-TIGTLKNLETLSLAGNQFQGPIPESVGNLIS 286
++ L +L + Q + + L L L++ + + P++
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 287 LESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRL 321
L L+ S N L K+++ LS L++ +S N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 2/97 (2%)
Query: 157 VPHDLCHLERLNILNLSGNKLSGAIP-QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYI 215
H L E L L + + + + L L LR+L + + L P + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 216 LRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSD 252
R+NLS N+L+ +L + L +L LS N L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS 118
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 21/100 (21%), Positives = 30/100 (30%), Gaps = 2/100 (2%)
Query: 127 NDLNGTIPTSIGTLQQLQGFYVPENNLQGYVP-HDLCHLERLNILNLSGNKLSGAIPQCL 185
D + + L Y+ ++ DL L L L + + L P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 186 ASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSL 225
L L L N L SL + + LS N L
Sbjct: 77 HFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 2e-06
Identities = 15/76 (19%), Positives = 26/76 (34%), Gaps = 1/76 (1%)
Query: 247 NQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP-ESVGNLISLESLDFSNNNLSGKIPKSL 305
+ D + +NL L + Q + + L L +L + L P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 306 EALSHLKQFNVSHNRL 321
L + N+S N L
Sbjct: 77 HFTPRLSRLNLSFNAL 92
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-09
Identities = 31/135 (22%), Positives = 51/135 (37%), Gaps = 28/135 (20%)
Query: 163 HLERLNILNLSGNKLS-GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLS 221
+ L L ++ + G + L L + L+S I
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS--------------I--- 57
Query: 222 SNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP-IPES 280
+N+ KLN L L+LS N++S + NL L+L+GN+ + E
Sbjct: 58 ---------ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
Query: 281 VGNLISLESLDFSNN 295
+ L +L+SLD N
Sbjct: 109 LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-07
Identities = 22/99 (22%), Positives = 40/99 (40%), Gaps = 3/99 (3%)
Query: 222 SNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV 281
S S +G L + L L L+ I + + L L+ L L+ N+ G +
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLA 84
Query: 282 GNLISLESLDFSNNNLSG-KIPKSLEALSHLKQFNVSHN 319
+L L+ S N + + L+ L +LK ++ +
Sbjct: 85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 24/98 (24%), Positives = 44/98 (44%), Gaps = 7/98 (7%)
Query: 225 LKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNL 284
L+ PS++++L LD SR+ + + LE LS ++ L
Sbjct: 11 LRNRTPSDVKEL----VLDNSRSNEGK-LEGLTDEFEELEFLSTINVGLT--SIANLPKL 63
Query: 285 ISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
L+ L+ S+N +SG + E +L N+S N+++
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 19/89 (21%), Positives = 36/89 (40%), Gaps = 4/89 (4%)
Query: 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG 174
+++ L++ + N G + ++L+ L +L L +L L LS
Sbjct: 18 DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSD 73
Query: 175 NKLSGAIPQCLASLTSLRSLYLQSNKLSS 203
N++SG + +L L L NK+
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKD 102
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 6/110 (5%)
Query: 189 TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNVLIDLDLSRN 247
+S L L+SNKL S L + +++LS N ++ +LP + KL L L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 248 QLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNN 295
+L S +P+ + L L+ L+L NQ + +P+ + L SL+ + N
Sbjct: 87 KLQS-LPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 33/106 (31%), Positives = 47/106 (44%), Gaps = 4/106 (3%)
Query: 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKG 227
L L NKL LT L L L N++ SLP ++ L + + L N L+
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 228 TLPSNI-QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQ 272
+LP+ + KL L +L L NQL S L +L+ + L N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 64/334 (19%), Positives = 122/334 (36%), Gaps = 73/334 (21%)
Query: 34 NLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCR-NLANLALASNPLGGI----LPPLI 88
++ L L +NNL + S+ + + N ++ +L L+ N LG L ++
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVE----LIQAFANTPASVTSLNLSGNSLGFKNSDELVQIL 75
Query: 89 GNFSASLQNIYAFECKLGGSIPKEIGNL-----RGLIVLSLGFNDLNGTIPTSIGTLQQL 143
A++ ++ L E+ + VL LG+ND +S + +
Sbjct: 76 AAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF-----SSKSSSEFK 130
Query: 144 QGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG----AIPQCLASL-TSLRSLYLQS 198
Q F ++ LNL GN L + Q LA++ ++ SL L+
Sbjct: 131 QAFSNLPASIT--------------SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRG 176
Query: 199 NKLSS-----------SLPSSLWSLEYILRINLSSNSL--KG--TLPSNIQKLN-VLIDL 242
N L+S S+P+S+ SL +LS+N L K L + ++ L
Sbjct: 177 NNLASKNCAELAKFLASIPASVTSL------DLSANLLGLKSYAELAYIFSSIPNHVVSL 230
Query: 243 DLSRNQLSSD----IPSTIGTLKNLETLSLAGNQFQGP-------IPESVGNLISLESLD 291
+L N L + +LK+L+T+ L + + + + N+ + +D
Sbjct: 231 NLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVD 290
Query: 292 FSNNNLSGKIPKSL-EALSHLKQFNVSHNRLEGE 324
+ + + + L L +
Sbjct: 291 KNGKEIHPSHSIPISNLIREL-SGKADVPSLLNQ 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 54/333 (16%), Positives = 100/333 (30%), Gaps = 70/333 (21%)
Query: 34 NLRHLSVLSLMMNNLTTESSSADQWSFLSSLT-NCRNLANLALASNPLGGI----LPPLI 88
++ L+L N+L ++S + L N+ +L L+ N L L +
Sbjct: 49 TPASVTSLNLSGNSLGFKNSDE----LVQILAAIPANVTSLNLSGNFLSYKSSDELVKTL 104
Query: 89 GNFSASLQNIYAFECKLGGSIPKEIGNL-----RGLIVLSLGFNDLNGTIPTSIGTLQQL 143
++ + E + L+L NDL + + +
Sbjct: 105 AAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL-----GIKSSDELI 159
Query: 144 QGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS----GAIPQCLASL-TSLRSLYLQS 198
Q N+ LNL GN L+ + + LAS+ S+ SL L +
Sbjct: 160 QILAAIPANVN--------------SLNLRGNNLASKNCAELAKFLASIPASVTSLDLSA 205
Query: 199 NK--------LSSSLPSSLWSLEYILRINLSSNSLKGT----LPSNIQKLNVLIDLDLSR 246
N L+ S + +NL N L G L L L + L
Sbjct: 206 NLLGLKSYAELAYIFSSIPNHVV---SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDY 262
Query: 247 NQLSS-------DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI-----SLESLDFSN 294
+ + + + + ++ + + G + + NLI + N
Sbjct: 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
Query: 295 NNLS-----GKIPKSLEALSHLKQFNVSHNRLE 322
L + L L++ + L
Sbjct: 323 QCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 37/183 (20%), Positives = 63/183 (34%), Gaps = 37/183 (20%)
Query: 170 LNLSGNKLSGAIPQCLASLTSLRSLYLQSNK--------LSSSLPSSLWSLEYILRINLS 221
L+ + S + + + + SL L N L + ++ S+ +NLS
Sbjct: 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVT---SLNLS 59
Query: 222 SNSLKGT----LPSNIQKLNV-LIDLDLSRNQLSSDIPSTIGTL-----KNLETLSLAGN 271
NSL L + + + L+LS N LS + + L L N
Sbjct: 60 GNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWN 119
Query: 272 QFQGPIPESVGNLI--------SLESLDFSNNNLSGKIPKSL-EAL----SHLKQFNVSH 318
F +S S+ SL+ N+L K L + L +++ N+
Sbjct: 120 DFS---SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRG 176
Query: 319 NRL 321
N L
Sbjct: 177 NNL 179
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 8e-08
Identities = 33/134 (24%), Positives = 49/134 (36%), Gaps = 28/134 (20%)
Query: 164 LERLNILNLSGNKLS-GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSS 222
+ L L K + G I A +L L L + L S +
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS--------VS--------- 65
Query: 223 NSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP-IPESV 281
N+ KL L L+LS N++ + L NL L+L+GN+ + E +
Sbjct: 66 ---------NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116
Query: 282 GNLISLESLDFSNN 295
L L+SLD N
Sbjct: 117 KKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 10/116 (8%)
Query: 207 SSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETL 266
S ++ RI+L L+ P+ +++L LD ++ I NLE L
Sbjct: 3 SGSSGMDMKRRIHLE---LRNRTPAAVRELV----LDNCKSNDGK-IEGLTAEFVNLEFL 54
Query: 267 SLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
SL ++ L L+ L+ S N + G + E L +L N+S N+L+
Sbjct: 55 SLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 24/92 (26%), Positives = 36/92 (39%), Gaps = 4/92 (4%)
Query: 222 SNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV 281
S G + + L L L L S + S + L L+ L L+ N+ G +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V-SNLPKLPKLKKLELSENRIFGGLDMLA 91
Query: 282 GNLISLESLDFSNNNLSGKIPKSLEALSHLKQ 313
L +L L+ S N L +LE L L+
Sbjct: 92 EKLPNLTHLNLSGNKLKD--ISTLEPLKKLEC 121
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 34/149 (22%), Positives = 50/149 (33%), Gaps = 29/149 (19%)
Query: 122 LSLGFNDLN-GTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
L L N G I L+ + L +L L +L L LS N++ G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGG 86
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240
+ L +L L L NKL + +LE ++KL L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKL-----KDISTLEP------------------LKKLECLK 123
Query: 241 DLDLSRNQLSSDI---PSTIGTLKNLETL 266
LDL ++++ S L L L
Sbjct: 124 SLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.5 bits (122), Expect = 4e-07
Identities = 33/175 (18%), Positives = 62/175 (35%), Gaps = 34/175 (19%)
Query: 164 LERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223
L+ + +LN K + + +L+SL + S L +
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISG-------------------GLPDS 208
Query: 224 SLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTI-------GTLKNLETLSLAGNQFQGP 276
++ L S++ L L L + D + NL+ L + + Q
Sbjct: 209 VVEDILGSDLPNLEKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNV 267
Query: 277 IPESVGN---LISLESLDFSNNNLSGK----IPKSLEALSHLKQFNVSHNRLEGE 324
+ E L LE++D S L+ + + ++ + HLK N+ +N L E
Sbjct: 268 VVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.5 bits (122), Expect = 5e-07
Identities = 24/187 (12%), Positives = 55/187 (29%), Gaps = 27/187 (14%)
Query: 130 NGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLAS-- 187
+ + + L + N +L+ L + L ++ + +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE---IISGGLPDSVVEDILGSD 217
Query: 188 LTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRN 247
L +L L L + + K P+ L L +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFS--------KDRFPN-------LKWLGIVDA 262
Query: 248 QLSSDIPSTIGT---LKNLETLSLAGNQFQG----PIPESVGNLISLESLDFSNNNLSGK 300
+ + + L LET+ ++ + + V + L+ ++ N LS +
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
Query: 301 IPKSLEA 307
+ K L+
Sbjct: 323 MKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 9e-04
Identities = 20/138 (14%), Positives = 47/138 (34%), Gaps = 18/138 (13%)
Query: 92 SASLQNIYAFECKLGGSIPKEIG--NLRGLIVLSLGFNDLNGTIPTSIGTLQ-------- 141
+L+++ L S+ ++I +L L L L + + +
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251
Query: 142 -QLQGFYVPENNLQGYVPHDLCH---LERLNILNLSGNKLSG----AIPQCLASLTSLRS 193
L+ + + Q V L +L +++S L+ + + + L+
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 194 LYLQSNKLSSSLPSSLWS 211
+ ++ N LS + L
Sbjct: 312 INMKYNYLSDEMKKELQK 329
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 54/262 (20%), Positives = 88/262 (33%), Gaps = 89/262 (33%)
Query: 435 LGTGGFGSVYKG-TLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR--------HRNL 485
LG G F +V+ + VA+K+ E + E +L++VR +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 486 LKILGSCSNLDFK---------ALVLEFMPNG-SLEKWLYSHNYF---LDILQRLNIMID 532
+++L FK +V E + G L KW+ NY L +++ I+
Sbjct: 104 VQLLDD-----FKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK--IIQQ 154
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILL------------------------------- 561
V L+YLH + IIH D+KP NILL
Sbjct: 155 VLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 562 ------------------DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS 603
E + ++D G + + + IQT Y + E
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLI 266
Query: 604 EGIVSTKCDVYSYGVLLMETFT 625
+T D++S + E T
Sbjct: 267 GSGYNTPADIWSTACMAFELAT 288
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 31/170 (18%), Positives = 55/170 (32%), Gaps = 32/170 (18%)
Query: 165 ERLNILNLSGNKLSGAIPQCLAS-LTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223
L+ +NL+ +L A + L R L LQ N L P + L +L +
Sbjct: 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG---PEACKDLRDLLLHDQCQ- 156
Query: 224 SLKGTLPSNIQKLNVLIDLDLSRNQLSSD----IPSTIGTLKNLETLSLAGNQFQGP--- 276
+ L LS N L++ + + ++ LSL
Sbjct: 157 ---------------ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE 201
Query: 277 -IPESVGNLISLESLDFSNNNLSGKIPKSL-EALSH---LKQFNVSHNRL 321
+ + L+ L+ + N +L A L+ ++ N L
Sbjct: 202 LLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 32/198 (16%), Positives = 61/198 (30%), Gaps = 35/198 (17%)
Query: 164 LERLNILNLSGNKLSGAIPQCLASL-----TSLRSLYLQSNKLSSS----LPSSLWSLEY 214
R L L N L + L L + +L L +N L+++ L L
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 215 ILRINLSSNSLKGT--------LPSNIQKLNVLIDLDLSRNQLSS----DIPSTIGTLKN 262
+ ++L L L N Q L +L+++ N + +
Sbjct: 185 VTHLSLLHTGLGDEGLELLAAQLDRNRQ----LQELNVAYNGAGDTAALALARAAREHPS 240
Query: 263 LETLSLAGNQFQ-------GPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFN 315
LE L L N+ + + + +S LS +++
Sbjct: 241 LELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS---EYWSVILSEVQRNL 297
Query: 316 VSHNRLEGEIPVKGSFKD 333
S +R + ++ +D
Sbjct: 298 NSWDRARVQRHLELLLRD 315
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 26/150 (17%), Positives = 50/150 (33%), Gaps = 29/150 (19%)
Query: 185 LASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL 244
L+SLR L L +++ P + +L + L +++L
Sbjct: 68 AEVLSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHA----------------LDEVNL 108
Query: 245 SRNQLSSD-IPSTIGTLKNLETLSLAGNQFQGPIPESVG-----NLISLESLDFSNNNLS 298
+ QL + + + L L N + + + + +L SNN L+
Sbjct: 109 ASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLT 168
Query: 299 GKIPKSL-EALSH---LKQFNVSHNRLEGE 324
L E L+ + ++ H L E
Sbjct: 169 AAGVAVLMEGLAGNTSVTHLSLLHTGLGDE 198
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 35/119 (29%), Positives = 50/119 (42%), Gaps = 18/119 (15%)
Query: 183 QCLASLTSLRSLYLQSNKLSS---SLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNV 238
QC S T++ L+S +P++ L L N + L + +L
Sbjct: 6 QCSCSGTTV---DCSGKSLASVPTGIPTTTQVL------YLYDNQIT-KLEPGVFDRLTQ 55
Query: 239 LIDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNN 295
L LDL NQL+ +P+ + L L LSL NQ + IP NL SL + NN
Sbjct: 56 LTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 29/105 (27%), Positives = 41/105 (39%), Gaps = 28/105 (26%)
Query: 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGT 228
+L L N+++ P LT L L L +N+L+
Sbjct: 34 VLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV------------------------- 68
Query: 229 LPSNI-QKLNVLIDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGN 271
LP+ + KL L L L+ NQL S IP LK+L + L N
Sbjct: 69 LPAGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 29/105 (27%), Positives = 43/105 (40%), Gaps = 28/105 (26%)
Query: 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGT 228
L L+ N+++ P L +L+ LY SNKL++
Sbjct: 37 RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA------------------------- 71
Query: 229 LPSNI-QKLNVLIDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGN 271
+P+ + KL L LDL+ N L S IP LK+L + L N
Sbjct: 72 IPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 31/119 (26%), Positives = 49/119 (41%), Gaps = 18/119 (15%)
Query: 183 QCLASLTSLRSLYLQSNKLSS---SLPSSLWSLEYILRINLSSNSLKGTLPSNI-QKLNV 238
QC T + Q+ +L+S +P+ L L++N + L + L
Sbjct: 9 QCSCDQTLV---NCQNIRLASVPAGIPTDKQRL------WLNNNQIT-KLEPGVFDHLVN 58
Query: 239 LIDLDLSRNQLSSDIPSTI-GTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNN 295
L L + N+L++ IP+ + L L L L N + IP NL SL + NN
Sbjct: 59 LQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 32/171 (18%), Positives = 71/171 (41%), Gaps = 10/171 (5%)
Query: 161 LCHLERLNILNLSGNKLS-GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRIN 219
R+ ++LS + + + L+ + L++L L+ +LS + ++L ++R+N
Sbjct: 89 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148
Query: 220 LSSNSL--KGTLPSNIQKLNVLIDLDLSR-NQLSSDIPSTIGT--LKNLETLSLAGNQFQ 274
LS S + L + + + L +L+LS + + + L+L+G +
Sbjct: 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 208
Query: 275 ---GPIPESVGNLISLESLDFSN-NNLSGKIPKSLEALSHLKQFNVSHNRL 321
+ V +L LD S+ L + L++L+ ++S
Sbjct: 209 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 259
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 717 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.94 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.86 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.85 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.77 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.57 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.46 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.36 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.69 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.65 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.44 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.31 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.03 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.92 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.79 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.75 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.59 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.55 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.28 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.28 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.11 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.06 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.94 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.78 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.63 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.08 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.85 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.7 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=439.59 Aligned_cols=263 Identities=27% Similarity=0.439 Sum_probs=208.3
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
+++++.+.||+|+||+||+|++++ .||||+++... .+..+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 577888999999999999999753 59999986432 4456789999999999999999999998865 568999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
|++|+|.++++.....+++..+..|+.|||+||+||| +++||||||||+|||+++++.+||+|||+|+........
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH----~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH----AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999887777999999999999999999999 678999999999999999999999999999876544333
Q ss_pred eeeeccccCccccCCCccC---CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 585 VIQTMTMATIGYMAPEYGS---EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
......+||+.|||||++. .+.|+.++|||||||++|||+||+.||.+.... ......+..... .+.+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~~~~~~~~~~~~-------~p~~~ 260 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQIIFMVGRGYA-------SPDLS 260 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHTTCC-------CCCST
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcCCC-------CCCcc
Confidence 3344568999999999875 346899999999999999999999999763221 112222221111 01110
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
....+++.++.+++.+||+.||++||||+||++.|+.++..++
T Consensus 261 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 261 ------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred ------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 0112456778999999999999999999999999998876654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=441.30 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=217.5
Q ss_pred ccCCccccccccccEEEEEEEec------CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
++|.+.+.||+|+||.||+|++. +++.||||+++.......+.|.+|++++++++|||||+++|+|.+.+..|+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888899999999999999863 477899999987666667889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 005040 501 VLEFMPNGSLEKWLYSH------------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAH 568 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~k 568 (717)
|||||++|+|.++++.. ...++|.++..++.||++||+||| +++|+||||||+|||+++++.+|
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccCHhhEEECCCCcEE
Confidence 99999999999999854 246899999999999999999999 67899999999999999999999
Q ss_pred EeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhh
Q 005040 569 VSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKES 647 (717)
Q Consensus 569 l~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 647 (717)
|+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+.... .+...+...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~~ 246 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQG 246 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHHT
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC
Confidence 999999987654443333344568999999999999999999999999999999999 89999764321 222222211
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
.. .+.+..++.++.+++.+||+.||++||||+|+.+.|+++.+..+
T Consensus 247 ~~-----------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 247 RV-----------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp CC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred CC-----------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 00 01122456778999999999999999999999999999876544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=441.58 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=209.2
Q ss_pred ccCCccccccccccEEEEEEEec------CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
++|.+.+.||+|+||.||+|+++ +++.||||+++.......+.|.+|+++|++++|||||+++|+|.+.+..|+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56777889999999999999864 478899999987666667889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 005040 501 VLEFMPNGSLEKWLYSHN--------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV 566 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~ 566 (717)
|||||++|+|.++++... ..++|.++..++.||++||+||| +++|+||||||+|||+++++.
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA----GLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHhhEEECCCCc
Confidence 999999999999998542 35899999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 005040 567 AHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVK 645 (717)
Q Consensus 567 ~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~ 645 (717)
+||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... .....+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~ 274 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCIT 274 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence 99999999987755444334445679999999999999999999999999999999999 89999764221 1222222
Q ss_pred hhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 646 ESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.... .+.+..++.++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 275 ~g~~-----------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 QGRE-----------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HTCC-----------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCC-----------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1110 011224567789999999999999999999999999998664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=436.70 Aligned_cols=256 Identities=23% Similarity=0.393 Sum_probs=211.5
Q ss_pred ccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
.+++..+.||+|+||+||+|.+. +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45666789999999999999862 46789999997543 334567999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC
Q 005040 500 LVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN 564 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~ 564 (717)
+|||||++|+|.+++.... ..++|..+..++.|||+||+||| +++||||||||+|||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS----SHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCccccceEECCC
Confidence 9999999999999997432 35899999999999999999999 6789999999999999999
Q ss_pred CcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHH
Q 005040 565 MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRW 643 (717)
Q Consensus 565 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~ 643 (717)
+.+||+|||+++...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+... ..+...
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~~ 259 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEM 259 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHHH
Confidence 9999999999987654433333445679999999999999999999999999999999999 8999976432 222222
Q ss_pred HHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 644 VKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
+..... .+.+.+++.++.+++.+||+.||++||||+||++.|+++
T Consensus 260 i~~~~~-----------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRNRQV-----------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHcCCC-----------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 221100 011235667789999999999999999999999999865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=433.22 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=209.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
+.|+..+.||+|+||.||+|.++ +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56889999999999999999976 79999999997665545566889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
+||+|.+++.... +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~~--l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 154 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence 9999999998754 899999999999999999999 68899999999999999999999999999987754322
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. .......+....+..
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~-------------- 289 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPR-------------- 289 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCC--------------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCC--------------
Confidence 2345689999999999999999999999999999999999999997532 112222222211111
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++.++.+||.+||..||++|||++|+++
T Consensus 290 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112234567889999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=424.37 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=209.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 67999999999999999999975 79999999997653 234567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|||+||+|.+++++.+ .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999998754 4899999999999999999999 6899999999999999999999999999999876544
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
........+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ..+...+.... ..
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~---------~~--- 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFAKIIKLE---------YD--- 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC---------CC---
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCC---------CC---
Confidence 33344566899999999999999999999999999999999999999975321 11111111100 00
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAA 699 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~ 699 (717)
+ +..++.++.++|.+||..||++|||++|+.
T Consensus 253 ----~--p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 ----F--PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----C--CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----C--CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 0 112345688999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=431.94 Aligned_cols=248 Identities=21% Similarity=0.342 Sum_probs=202.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 79999999997543 3455778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 504 FMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 504 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+||+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999854 345789999999999999999999 6899999999999999999999999999998764211
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHH-HhhCCCchhhhccccch
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWV-KESLPHRLTEVVDANLV 661 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 661 (717)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+... ......+ ....+
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~~------------ 243 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--KNLVLKIISGSFP------------ 243 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCC------------
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC------------
Confidence 122345799999999999999999999999999999999999999976321 1111111 11111
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+....++.++.+||.+||+.||++|||++|+++
T Consensus 244 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 ------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011234566889999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=427.26 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=208.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.+.|+..++||+|+||.||+|+++ +|+.||||+++.... ..+|+.++++++|||||++++++.+.+..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999975 799999999975432 24699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~ 583 (717)
|+||+|.+++++.+ .+++..+..++.||+.||+||| +++|+||||||+|||++.+| ++||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH----TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999998754 4899999999999999999999 78999999999999999987 699999999987754322
Q ss_pred c---eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 584 S---VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 584 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+. ....... .+ . .
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~-~~-~--------~ 275 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASE-PP-P--------I 275 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHS-CC-G--------G
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcC-CC-C--------c
Confidence 1 122345799999999999999999999999999999999999999976433322 1111110 00 0 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
. ..+..++.++.++|.+||+.||++|||+.|+++.|....+.
T Consensus 276 ~------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 276 R------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp G------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 0 11124566788999999999999999999999998877554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=426.38 Aligned_cols=270 Identities=21% Similarity=0.304 Sum_probs=205.4
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC----eeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLD----FKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~lv~ 502 (717)
.+|.+.+.||+|+||+||+|++ +|+.||||++....... ..+..|+..+.+++|||||+++|++.+.+ .+|+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4677889999999999999998 58999999997654322 23345677777899999999999997643 579999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC----CCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH----SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|||++|+|.++++... ++|..+.+++.|+++||+|||+.. ...+|+||||||+|||++.++++||+|||+++..
T Consensus 81 Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999998754 899999999999999999999421 1238999999999999999999999999999877
Q ss_pred CCCCCce--eeeccccCccccCCCccCCC------CcCcccchhhHHHHHHHHHhCCCCCCccccCcc----------hH
Q 005040 579 GEGEDSV--IQTMTMATIGYMAPEYGSEG------IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM----------SL 640 (717)
Q Consensus 579 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~----------~~ 640 (717)
....... .....+||+.|||||++.+. .++.++|||||||++|||+||+.||......+. ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5443322 22345799999999987654 478899999999999999999887754322211 11
Q ss_pred HHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 641 RRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
....... .+..+....+......+++..+.+++.+||+.||++||||.||++.|+++.++
T Consensus 239 ~~~~~~~--------~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVV--------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHH--------TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHH--------hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111111 11111111111222345677899999999999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=427.56 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=216.5
Q ss_pred HhccCCccccccccccEEEEEEEecC------CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCC-CceeeEeeeeec-C
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSD------GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRH-RNLLKILGSCSN-L 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~-~ 495 (717)
..++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|++++++++| ||||+++|+|.+ .
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 45789999999999999999998642 3579999997654 3445779999999999965 999999999865 4
Q ss_pred CeeEEEEEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 496 DFKALVLEFMPNGSLEKWLYSH---------------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
+..++|||||++|+|.++++.. ...+++..+..++.|||+||+||| +++||||||||+|||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH----~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNIL 217 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh----hCCeecCccCcccee
Confidence 5689999999999999999853 234899999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 639 (717)
+++++.+||+|||+|+.+.............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....+ .
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-~ 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-H
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-H
Confidence 99999999999999998765554444556679999999999999999999999999999999998 899997643222 2
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
+...+..... ...+..++.++.+++.+||+.||++||||+|+++.|+++.+..
T Consensus 297 ~~~~i~~g~~-----------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 297 FCRRLKEGTR-----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHcCCC-----------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 2222221110 0111235567889999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=434.31 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=209.7
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
+.|+..+.||+|+||.||+|.++ +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999976 79999999997665444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
+||+|.++++... +++..+..++.||+.||+||| +++|+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH----~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence 9999999998654 899999999999999999999 68999999999999999999999999999987754322
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. .......+....+..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~-------------- 366 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPR-------------- 366 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCC--------------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCC--------------
Confidence 2345679999999999999999999999999999999999999997532 112222222221111
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++.++.+||.+||..||++|||++|+++
T Consensus 367 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111234566889999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=410.38 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=195.7
Q ss_pred CccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec----CCeeEEEE
Q 005040 430 NECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN----LDFKALVL 502 (717)
Q Consensus 430 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~ 502 (717)
+..+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+ ....|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999975 78999999997543 3445779999999999999999999999865 35689999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP--IIHCDLKPTNILLD-ENMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~ 579 (717)
|||++|+|.+++.+.+ .+++..+..++.||+.||+||| +++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH----~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999998754 4899999999999999999999 455 99999999999998 48999999999998643
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.... ..+...+...... .
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~~i~~~~~~-------~- 249 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTSGVKP-------A- 249 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHHHTTTCCC-------G-
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HHHHHHHHcCCCC-------C-
Confidence 22 1234579999999998865 6999999999999999999999999653211 1111111111000 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+..++.++.++|.+||+.||++|||++|+++
T Consensus 250 --------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 --------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011123456889999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=407.02 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=191.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||+||+|... +|+.||+|++.+.. ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 79999999996543 233467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+ +|+|.+++.+.+ .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 689999998765 4999999999999999999999 6899999999999999999999999999998764322
Q ss_pred CceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.....+||+.|||||++.+..| +.++||||+||++|||+||+.||.+... ..+.+.+.....
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i~~~~~------------ 229 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNISNGVY------------ 229 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCC------------
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCC------------
Confidence 2234679999999999988776 5899999999999999999999975311 111111111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+ +..++.++.+++.+||+.||++|||++|+++
T Consensus 230 ----~~--p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ----TL--PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----CC--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 1123456889999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=410.03 Aligned_cols=242 Identities=26% Similarity=0.267 Sum_probs=193.3
Q ss_pred ccCCccccccccccEEEEEEEec----CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
++|++.+.||+|+||+||+|+.. +++.||+|+++... ......+.+|++++++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 47889999986543 1223457789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
|||||+||+|.+++.+.+ .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999998754 4899999999999999999999 68999999999999999999999999999986543
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+... ......+.....
T Consensus 179 ~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~----------- 243 (304)
T 3ubd_A 179 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETMTMILKAKL----------- 243 (304)
T ss_dssp --C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-----------
T ss_pred CCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHHHHHHcCCC-----------
Confidence 221 22446799999999999999999999999999999999999999976321 111111111100
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
..+..++.++.+++.+||+.||++|||+
T Consensus 244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 0011345668899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=400.40 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=188.5
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC--------
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD-------- 496 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-------- 496 (717)
++|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 57999999999999999999975 79999999986543 334567899999999999999999999986543
Q ss_pred ----eeEEEEEccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 005040 497 ----FKALVLEFMPNGSLEKWLYSHNY--FLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570 (717)
Q Consensus 497 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 570 (717)
..|+|||||++|+|.+++..... ..++..+..++.||++||+||| +++|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH----~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH----HCcCccccCcHHHeEECCCCcEEEc
Confidence 46999999999999999986542 3566778899999999999999 6799999999999999999999999
Q ss_pred eeccccccCCCCCc----------eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchH
Q 005040 571 DFGISKLLGEGEDS----------VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL 640 (717)
Q Consensus 571 Dfgl~~~~~~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~ 640 (717)
|||+|+.+...... ......+||+.|||||++.+..|+.++||||+||++|||++ ||.... ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~ 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ER 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HH
Confidence 99999877543221 11234579999999999999999999999999999999996 775321 11
Q ss_pred HHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 641 RRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...... +....+. +...+..+.+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~--------~~~~~~p------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTD--------VRNLKFP------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHH--------HHTTCCC------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHH--------HhcCCCC------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 0011111 011223345678999999999999999999986
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=431.74 Aligned_cols=359 Identities=33% Similarity=0.564 Sum_probs=309.1
Q ss_pred CCCCccccCCCCCcEEECCCCcceecCCcC-CCCCCCCCEEEcccccccC-ccCCcccc----------------ccccc
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNT-FGNLRHLSVLSLMMNNLTT-ESSSADQW----------------SFLSS 63 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~-~~~~~~~~----------------~~~~~ 63 (717)
+.+|..|.++++|++|+|++|.+++.+|.. |.++++|++|+|++|+++. ++...... ..+..
T Consensus 308 ~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~ 387 (768)
T 3rgz_A 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387 (768)
T ss_dssp ECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTT
T ss_pred CccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChh
Confidence 367888888888888888888888777765 8888888888888888873 33221111 01222
Q ss_pred ccC--ccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccC
Q 005040 64 LTN--CRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQ 141 (717)
Q Consensus 64 l~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 141 (717)
+.. +++|++|+|++|.+++..|..+..+ ++|++|++++|++.+.+|..+.++++|++|+|++|.+++.+|..+..++
T Consensus 388 ~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 466 (768)
T 3rgz_A 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK 466 (768)
T ss_dssp TTCSTTCCCCEEECCSSEEEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred hhhcccCCccEEECCCCccccccCHHHhcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCC
Confidence 333 6778888888888888888888887 6799999999999989999999999999999999999988999999999
Q ss_pred CCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEcc
Q 005040 142 QLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLS 221 (717)
Q Consensus 142 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 221 (717)
+|++|++++|++++..|..+.++++|++|+|++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+++
T Consensus 467 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 546 (768)
T 3rgz_A 467 TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 546 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECC
T ss_pred CceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECC
Confidence 99999999999998899999999999999999999998999999999999999999999998999999999999999999
Q ss_pred CCcCcccCCcc---------------------------------------------------------------------
Q 005040 222 SNSLKGTLPSN--------------------------------------------------------------------- 232 (717)
Q Consensus 222 ~N~l~~~~~~~--------------------------------------------------------------------- 232 (717)
+|.+++.+|..
T Consensus 547 ~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~ 626 (768)
T 3rgz_A 547 TNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626 (768)
T ss_dssp SSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCC
T ss_pred CCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCch
Confidence 99988766653
Q ss_pred -ccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccc
Q 005040 233 -IQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHL 311 (717)
Q Consensus 233 -~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L 311 (717)
+..+++|+.|||++|.+++.+|..++.+++|+.|+|++|++++.+|..++++++|+.|+|++|++++.+|..+..+++|
T Consensus 627 ~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L 706 (768)
T 3rgz_A 627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 706 (768)
T ss_dssp SCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCC
T ss_pred hhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCC
Confidence 3345789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cEEEccCCcccccccccccccccccccccCCccccCCCCCCCCCCCCCCccCc
Q 005040 312 KQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPCKQDNRKRT 364 (717)
Q Consensus 312 ~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~c~~~~~~~~ 364 (717)
+.|++++|+++|.+|..+.+..+....+.||+++||+|. ++|........
T Consensus 707 ~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~~~~~~ 756 (768)
T 3rgz_A 707 TEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPSNADGY 756 (768)
T ss_dssp SEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSCC----
T ss_pred CEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCCccCCC
Confidence 999999999999999999999999999999999999874 37876654443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=397.56 Aligned_cols=267 Identities=23% Similarity=0.255 Sum_probs=201.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec------CCe
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN------LDF 497 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~ 497 (717)
++|++.+.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 79999999997543 3345678899999999999999999998753 467
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+|||||+ |+|.+++...+ .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999996 68999998654 4999999999999999999999 68999999999999999999999999999987
Q ss_pred cCCCCC--ceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc--h
Q 005040 578 LGEGED--SVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR--L 652 (717)
Q Consensus 578 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~ 652 (717)
+..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.... ..+........... .
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHH
Confidence 643221 1223456899999999987764 5799999999999999999999999763211 11222111111110 0
Q ss_pred -hhhccccchhhhhhh---------hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 653 -TEVVDANLVREEQAF---------SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 653 -~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
............... ......+.++.+|+.+||..||++|||++|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000000 000123467889999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=391.52 Aligned_cols=266 Identities=20% Similarity=0.243 Sum_probs=199.2
Q ss_pred HhccCCccccccccccEEEEEEEec----CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~ 499 (717)
..++|++.+.||+|+||+||+|+.+ +++.||+|++..... ...+.+|+++++.+ +||||+++++++.+.++.|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999853 467899998865432 24577899999998 6999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecccccc
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLL 578 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~ 578 (717)
+||||+++|+|.++++. +++..+..++.|++.||+||| +++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH----~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIH----QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHH----HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999853 899999999999999999999 6899999999999999876 79999999999865
Q ss_pred CCCCCc--------------------------eeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCC
Q 005040 579 GEGEDS--------------------------VIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTD 631 (717)
Q Consensus 579 ~~~~~~--------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~ 631 (717)
...... ......+||++|+|||++.+. .|+.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 432110 112334799999999988765 58999999999999999999999995
Q ss_pred ccccCcchHHHHHHhhC---------------------CC-chhhhcc------c---cc----hhhhhhhhhhHHHHHH
Q 005040 632 EMFTGEMSLRRWVKESL---------------------PH-RLTEVVD------A---NL----VREEQAFSDKMDCLFS 676 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~---------------------~~-~~~~~~~------~---~~----~~~~~~~~~~~~~~~~ 676 (717)
...+....+........ +. ....... . .. .............+.+
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 43322222222111000 00 0000000 0 00 0000001111234567
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH
Q 005040 677 IMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 677 l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.+|+.+||..||++|||++|+++
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHCcCChhHCcCHHHHhc
Confidence 899999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=401.58 Aligned_cols=248 Identities=20% Similarity=0.267 Sum_probs=200.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHH---HHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFD---SECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.+.. ......+. .++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999976 79999999997553 11122233 346677778999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|+|||||+||+|.+++.+.+ .+++..+..++.||+.||+||| +++||||||||+|||++.+|++||+|||+|+.+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH----~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999998764 3899999999999999999999 789999999999999999999999999999877
Q ss_pred CCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcc-hHHHHHHhhCCCchhhhc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM-SLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 656 (717)
.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.+...... .+.+.+... +.
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~------ 411 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AV------ 411 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CC------
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CC------
Confidence 5432 234589999999999864 5799999999999999999999999976332221 111111110 00
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
..+..++.++.+||.+||..||++|++ ++|+++
T Consensus 412 -----------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 -----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 011134566889999999999999998 677654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=405.94 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=210.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+....|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 7999999999766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC--CcEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN--MVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~~ 582 (717)
|+||+|.+++......+++..+..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH----~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999999876666999999999999999999999 6789999999999999854 899999999999875432
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .....+..... . +..
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~~~~-~--------~~~ 377 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSCDW-N--------MDD 377 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCC-C--------CCS
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHhCCC-C--------CCc
Confidence 234457999999999999999999999999999999999999999763221 11111111100 0 000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++.++.+||.+||..||++|||+.|+++
T Consensus 378 -----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111234566889999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=377.54 Aligned_cols=282 Identities=35% Similarity=0.572 Sum_probs=231.6
Q ss_pred CHHHHHHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe
Q 005040 418 SYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF 497 (717)
Q Consensus 418 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 497 (717)
.+.++..++++|+..+.||+|+||.||+|.+++++.||||++........+.+.+|+++++.++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 33445557789999999999999999999988899999999876655566788999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecc
Q 005040 498 KALVLEFMPNGSLEKWLYSHN---YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 574 (717)
.++||||+++|+|.+++.... ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc----CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999997543 35899999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccC-cchHHHHHHhhC-CCch
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG-EMSLRRWVKESL-PHRL 652 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~-~~~~ 652 (717)
+................||+.|+|||++.+..++.++||||||+++|||++|+.||....+. ......|..... ....
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98765433333334456899999999988889999999999999999999999999764433 234444543322 2223
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
...+++..... ...+++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 266 ~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTC-----SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccc-----cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 33344333221 1235678899999999999999999999999999988764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=367.05 Aligned_cols=266 Identities=25% Similarity=0.386 Sum_probs=218.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|...+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 368899999999999999999975 7899999988765566678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++|+|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999987777999999999999999999999 678999999999999999999999999999876433221
Q ss_pred e------------eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCch
Q 005040 585 V------------IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652 (717)
Q Consensus 585 ~------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 652 (717)
. ......||+.|+|||++.+..++.++||||||+++|||++|..|+........... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--------~~~ 236 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--------LNV 236 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--------BCH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--------hhh
Confidence 1 11145689999999999999999999999999999999999999865332211000 000
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
....+. ..+..++..+.+++.+||+.||++|||+.|+++.|+++++.....
T Consensus 237 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 237 RGFLDR---------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp HHHHHH---------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred hccccc---------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence 000000 011234456889999999999999999999999999998776543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=371.14 Aligned_cols=274 Identities=23% Similarity=0.323 Sum_probs=212.1
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC----eeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLD----FKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~lv 501 (717)
.++|++.+.||+|+||.||+|++. ++.||||++...... ......|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 478999999999999999999885 789999999765433 344566999999999999999999997744 46999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC----------CeEecCCCCCCeeeCCCCcEEEee
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA----------PIIHCDLKPTNILLDENMVAHVSD 571 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~----------~ivH~dlk~~Nill~~~~~~kl~D 571 (717)
|||+++|+|.++++... +++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH----~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH----EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT----CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999998754 899999999999999999999 56 999999999999999999999999
Q ss_pred eccccccCCCCCceeeeccccCccccCCCccCC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccCcc-hHHHHHH
Q 005040 572 FGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE-----GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM-SLRRWVK 645 (717)
Q Consensus 572 fgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~-~~~~~~~ 645 (717)
||+++...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ .......
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987755443333344578999999998876 4677889999999999999999999976433211 1111100
Q ss_pred hhCCC--chhh-hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 646 ESLPH--RLTE-VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 646 ~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
. .+. ...+ ..................++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 255 Q-HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp S-SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c-CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 000 0000 000011111111122234567799999999999999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=362.33 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=208.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|+..+.||+|+||+||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 368999999999999999999964 7999999999766655567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++|+|.+++.... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 99999999998754 899999999999999999999 67899999999999999999999999999987654332
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ..........+
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~--------------- 234 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP--------------- 234 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC---------------
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC---------------
Confidence 2344579999999999999999999999999999999999999997532211 11111111100
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....+..++..+.+++.+||+.||++|||++|+++
T Consensus 235 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 -ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01112234566889999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=371.25 Aligned_cols=263 Identities=24% Similarity=0.424 Sum_probs=215.7
Q ss_pred hccCCccccccccccEEEEEEEec--------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL 495 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 495 (717)
.++|++.+.||+|+||.||+|++. ++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999852 35579999997653 34456789999999999 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
+..|+||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVL 235 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchhhEE
Confidence 99999999999999999998643 34789999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 639 (717)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... .
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~ 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999987654433322334457889999999999999999999999999999999 99999763221 1
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
....+...... ..+..++.++.+++.+||+.||++|||+.|+++.|+++.....+
T Consensus 314 ~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 LFKLLKEGHRM-----------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp HHHHHHTTCCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHhcCCCC-----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 22222111100 11123456788999999999999999999999999999776554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=368.61 Aligned_cols=285 Identities=36% Similarity=0.559 Sum_probs=233.6
Q ss_pred cCCCCHHHHHHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeeEeeee
Q 005040 414 RRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLER-AFRSFDSECEILRNVRHRNLLKILGSC 492 (717)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~ 492 (717)
...+++.++..+.++|+..+.||+|+||.||+|..++++.||||++...... ....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4567888999999999999999999999999999888999999998755422 223688899999999999999999999
Q ss_pred ecCCeeEEEEEccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 005040 493 SNLDFKALVLEFMPNGSLEKWLYSHN---YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV 569 (717)
Q Consensus 493 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl 569 (717)
.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999998643 34899999999999999999999532 228999999999999999999999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCcc---ccCcchHHHHHHh
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM---FTGEMSLRRWVKE 646 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~---~~~~~~~~~~~~~ 646 (717)
+|||++......... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||+.. .........|...
T Consensus 176 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999876543322 234456899999999998888999999999999999999999999642 2334556666665
Q ss_pred hCCC-chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 647 SLPH-RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 647 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
.... ......+...... ...+.+..+.+++.+||+.||++|||++||++.|++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGN-----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTS-----CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccc-----cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 4433 2334444333221 2235667899999999999999999999999999853
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=379.21 Aligned_cols=261 Identities=27% Similarity=0.437 Sum_probs=215.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 468899999999999999999986 78999999987543 3344568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++|+|.++++..+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999999876666899999999999999999999 67899999999999999999999999999986543221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
........+++.|+|||.+.++.++.++|||||||++|||++ |+.||...... .....+.....
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~------------- 333 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGGR------------- 333 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTCC-------------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence 111122235778999999988899999999999999999998 99999764221 12222211110
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
.+.+..++.++.+++.+||+.||++|||++++++.|+++.++.
T Consensus 334 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 334 ----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 0111234567889999999999999999999999999997754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=364.87 Aligned_cols=276 Identities=26% Similarity=0.439 Sum_probs=212.5
Q ss_pred hccCCccccccccccEEEEEEEe-----cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec--CCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-----SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN--LDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~ 498 (717)
.++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 47899999999999999999984 2688999999987666666789999999999999999999999854 3568
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 9999999999999999987667999999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCc-eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchh--hh
Q 005040 579 GEGEDS-VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLT--EV 655 (717)
Q Consensus 579 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 655 (717)
...... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+..... ............... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH---HHHHHHCTTCCTHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH---HHHhhhcCccccchhHHHH
Confidence 543221 222334577889999999888999999999999999999999999865211 111111110000000 00
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
.+ .+ ......+.+..++.++.+++.+||+.||++|||++|+++.|+++++...
T Consensus 242 ~~-~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 242 IE-LL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HH-HH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HH-HH-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 00 00 0001112233566789999999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=362.24 Aligned_cols=262 Identities=27% Similarity=0.397 Sum_probs=204.8
Q ss_pred HHhccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
....+|++.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3457899999999999999999987 68899999986543 34456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 502 LEFMPNGSLEKWLYSHNY--FLDILQRLNIMIDVGSALEYLHHCHSSAP--IIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
|||+++|+|.+++..... .+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH----NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH----TSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH----cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999986542 3899999999999999999999 667 99999999999999999999999999986
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+......
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~~~~------- 257 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKCKR------- 257 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHSCCC-------
T ss_pred ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCC-------
Confidence 53321 1223456899999999999999999999999999999999999999763221 111111111000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
...+..++.++.+++.+||+.||++|||++|+++.|+.+.+...
T Consensus 258 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 258 ---------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred ---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 00112344568899999999999999999999999999876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=364.25 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=213.4
Q ss_pred hccCCccccccccccEEEEEEEec----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|.+. .+..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 368899999999999999999974 34469999997653 4445678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.++++.....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS----DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999877667999999999999999999999 67899999999999999999999999999987754
Q ss_pred CCCc-eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 581 GEDS-VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 581 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~--------- 272 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEEGYR--------- 272 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCC---------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCC---------
Confidence 3222 22233356788999999988899999999999999999999 99999763221 11111111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
.+....++.++.+++.+||+.||++|||+.|+++.|+++.+....
T Consensus 273 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 273 --------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred --------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 011123456788999999999999999999999999999775543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=353.46 Aligned_cols=281 Identities=30% Similarity=0.479 Sum_probs=228.5
Q ss_pred cCCCCHHHHHHHhccCCcc------ccccccccEEEEEEEecCCCeEEEEEechhh----HHHHHHHHHHHHHHHhcCCC
Q 005040 414 RRRTSYLDIRRATDEFNEC------NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL----ERAFRSFDSECEILRNVRHR 483 (717)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hp 483 (717)
...+++.++..++..|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4567889999999999887 8899999999999997 68899999986432 33456788999999999999
Q ss_pred ceeeEeeeeecCCeeEEEEEccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 005040 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL 561 (717)
Q Consensus 484 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill 561 (717)
||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH----ENHHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecCCCCHHHEEE
Confidence 9999999999999999999999999999999743 345899999999999999999999 6789999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHH
Q 005040 562 DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR 641 (717)
Q Consensus 562 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~ 641 (717)
+.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... ...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHH
Confidence 9999999999999987655443333445578999999998765 58899999999999999999999997643332 122
Q ss_pred HHHHh--hCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 642 RWVKE--SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 642 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.+... .....+.+.++..+.. ....++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMND------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSC------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhccccccc------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22221 1122233334433321 123556789999999999999999999999999998864
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=396.29 Aligned_cols=334 Identities=33% Similarity=0.533 Sum_probs=263.6
Q ss_pred CCCCccccCC-CCCcEEECCCCcceecCCcCCCCCCCCCEEEccccccc-CccCCcccccccccccCccCCcEEeccCCC
Q 005040 2 GTIPNSITNA-TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLT-TESSSADQWSFLSSLTNCRNLANLALASNP 79 (717)
Q Consensus 2 ~~iP~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~ 79 (717)
|.+|..+..+ ++|++|+|++|.+++..|..|+++++|++|+|++|+++ .++.. .+..+++|++|+|++|+
T Consensus 283 ~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~--------~l~~l~~L~~L~Ls~n~ 354 (768)
T 3rgz_A 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD--------TLLKMRGLKVLDLSFNE 354 (768)
T ss_dssp ESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHH--------HHTTCTTCCEEECCSSE
T ss_pred CccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHH--------HHhcCCCCCEEeCcCCc
Confidence 4789999886 99999999999999999999999999999999999998 44422 26677777777777777
Q ss_pred CcccCCcchhccc--------------------------cccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccC
Q 005040 80 LGGILPPLIGNFS--------------------------ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTI 133 (717)
Q Consensus 80 l~~~~~~~~~~l~--------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 133 (717)
+++..|..+..++ ++|++|++++|++.+.+|..+.++++|++|+|++|.+++..
T Consensus 355 l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 434 (768)
T 3rgz_A 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434 (768)
T ss_dssp EEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCC
T ss_pred cCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcc
Confidence 7766676666553 24555666666666666777777777777777777777777
Q ss_pred CccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhccc
Q 005040 134 PTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLE 213 (717)
Q Consensus 134 ~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 213 (717)
|..|.++++|+.|++++|.+.+..|..+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|.++..++
T Consensus 435 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 514 (768)
T 3rgz_A 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE 514 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred cHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCC
Confidence 77777777788888888877777777777788888888888888877777788888888888888888877888888888
Q ss_pred CCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccc------------------------------------
Q 005040 214 YILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTI------------------------------------ 257 (717)
Q Consensus 214 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~------------------------------------ 257 (717)
+|+.|+|++|++++.+|..+..+++|+.|++++|.+++.+|..+
T Consensus 515 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (768)
T 3rgz_A 515 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594 (768)
T ss_dssp TCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEE
T ss_pred CCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccc
Confidence 88888888888888888888888888888888888776555432
Q ss_pred ----------------------------------cCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcc
Q 005040 258 ----------------------------------GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPK 303 (717)
Q Consensus 258 ----------------------------------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~ 303 (717)
+.+++|++|+|++|++++.+|..++++++|+.|+|++|++++.+|.
T Consensus 595 ~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~ 674 (768)
T 3rgz_A 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674 (768)
T ss_dssp ECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred ccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCCh
Confidence 3346778888888888888888888888888888888888888888
Q ss_pred cccccccccEEEccCCccccccccc-ccccccccccccCCc
Q 005040 304 SLEALSHLKQFNVSHNRLEGEIPVK-GSFKDFSAQSYFGNY 343 (717)
Q Consensus 304 ~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~ 343 (717)
.+..+++|+.|||++|+++|.+|.. +.+..+..+.+..|+
T Consensus 675 ~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~ 715 (768)
T 3rgz_A 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715 (768)
T ss_dssp GGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE
T ss_pred HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc
Confidence 8888888888888888888888764 455556666666554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=358.58 Aligned_cols=262 Identities=22% Similarity=0.300 Sum_probs=213.8
Q ss_pred CCCCHHHHHHHhcc----------CCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCC
Q 005040 415 RRTSYLDIRRATDE----------FNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHR 483 (717)
Q Consensus 415 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp 483 (717)
..+++.+++.+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34666777776653 677789999999999999976 7999999999866655567788999999999999
Q ss_pred ceeeEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC
Q 005040 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE 563 (717)
Q Consensus 484 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~ 563 (717)
||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH----AQGVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECC
Confidence 9999999999999999999999999999998764 4899999999999999999999 678999999999999999
Q ss_pred CCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHH
Q 005040 564 NMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRW 643 (717)
Q Consensus 564 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~ 643 (717)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~ 252 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKR 252 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHH
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 99999999999987654322 12345789999999999999999999999999999999999999975321 111111
Q ss_pred HHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 644 VKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+....+.. + .....++..+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~--------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 LRDSPPPK--------L-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHSSCCC--------C-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhcCCCCC--------c-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 0 1112334568899999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=360.12 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=205.6
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.++|++.+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999997 489999999997553 344567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++...+. +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH----QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999986543 899999999999999999999 6789999999999999999999999999998765432
Q ss_pred CceeeeccccCccccCCCccCCCCcC-cccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVS-TKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
. ....+||+.|+|||++.+..+. .++||||+||++|||++|+.||.+.... .....+... ..
T Consensus 169 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~-----------~~- 231 (328)
T 3fe3_A 169 K---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLRG-----------KY- 231 (328)
T ss_dssp G---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-----------CC-
T ss_pred c---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----------CC-
Confidence 2 2445799999999998877764 8999999999999999999999763211 111111110 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+..++.++.+++.+||..||++|||++|+++.
T Consensus 232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011234567899999999999999999999763
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=366.46 Aligned_cols=271 Identities=27% Similarity=0.403 Sum_probs=218.4
Q ss_pred CCCHHHHHHHhccCCccccccccccEEEEEEEe------cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceee
Q 005040 416 RTSYLDIRRATDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLK 487 (717)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~ 487 (717)
...........++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 334445556678999999999999999999973 256789999997643 34456789999999999 7999999
Q ss_pred EeeeeecCC-eeEEEEEccCCCCHHHHHhhCCC-----------------------------------------------
Q 005040 488 ILGSCSNLD-FKALVLEFMPNGSLEKWLYSHNY----------------------------------------------- 519 (717)
Q Consensus 488 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 519 (717)
+++++.+.+ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999987754 48999999999999999986432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 520 ------------------FLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 520 ------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
.+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 2889999999999999999999 678999999999999999999999999999877554
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .....+.......
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~--------- 316 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMR--------- 316 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCCC---------
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCCC---------
Confidence 44444455678999999999988999999999999999999998 999997643222 1111111111100
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.+..++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 317 --------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 317 --------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 0112345688999999999999999999999999998764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=373.02 Aligned_cols=338 Identities=22% Similarity=0.228 Sum_probs=307.0
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+.+||..+. +++++|+|++|+|+++.+..|.++++|++|+|++|.|+.+.+.. |.++++|++|+|++|++
T Consensus 23 l~~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--------~~~l~~L~~L~L~~n~l 92 (477)
T 2id5_A 23 FVAVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA--------FNNLFNLRTLGLRSNRL 92 (477)
T ss_dssp CSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT--------TTTCTTCCEEECCSSCC
T ss_pred cCcCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhh--------hhCCccCCEEECCCCcC
Confidence 467898875 58899999999999999999999999999999999999987554 89999999999999999
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD 160 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 160 (717)
+...+..|..+ ++|++|+|++|++.+..+..|.++++|++|+|++|.++...+..|.++++|++|+|++|.+++..+..
T Consensus 93 ~~~~~~~~~~l-~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 93 KLIPLGVFTGL-SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CSCCTTSSTTC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CccCcccccCC-CCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 97777778877 68999999999999999999999999999999999999988999999999999999999999888888
Q ss_pred ccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCC
Q 005040 161 LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240 (717)
Q Consensus 161 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 240 (717)
|.++++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.++.......+|++|+|++|.+++..+..|..+++|+
T Consensus 172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 251 (477)
T 2id5_A 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR 251 (477)
T ss_dssp HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCC
T ss_pred hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccC
Confidence 99999999999999999988888999999999999999998877777777778999999999999966557899999999
Q ss_pred eEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCc
Q 005040 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNR 320 (717)
Q Consensus 241 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~ 320 (717)
.|+|++|.+++..+..|..+++|++|+|++|++.+..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 331 (477)
T 2id5_A 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP 331 (477)
T ss_dssp EEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSC
T ss_pred eeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCC
Confidence 99999999999888889999999999999999999999999999999999999999998888889999999999999999
Q ss_pred ccccccccccccccccccccCCccccCCC
Q 005040 321 LEGEIPVKGSFKDFSAQSYFGNYALCGPP 349 (717)
Q Consensus 321 l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 349 (717)
+.+.++..+.+.......+.++...|+.|
T Consensus 332 l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 332 LACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp EECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred ccCccchHhHHhhhhccccCccCceeCCc
Confidence 99988765544444445566677777643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=351.83 Aligned_cols=259 Identities=27% Similarity=0.374 Sum_probs=213.5
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|++.+.||+|+||.||+|..+++..||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 468999999999999999999998888999999975532 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++++|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE----SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-V 160 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-E
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-h
Confidence 999999999877666999999999999999999999 67899999999999999999999999999987654332 2
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......+|+.|+|||...+..++.++||||+|+++|||++ |+.||....... ....+......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~-------------- 224 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VVLKVSQGHRL-------------- 224 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTCCC--------------
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HHHHHHcCCCC--------------
Confidence 2334456788999999988889999999999999999999 999997532211 11111110000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
..+..++..+.+++.+||+.||++|||+.|+++.|++++++.
T Consensus 225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 225 ---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp ---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 001123456889999999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=349.48 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=213.4
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|+..+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 368899999999999999999998889999999975532 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 162 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH----hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence 999999999887777999999999999999999999 6789999999999999999999999999998764322 11
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~-------------- 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRL-------------- 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCC--------------
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCccC--------------
Confidence 2233456788999999988899999999999999999999 99999753221 111111111000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
..+..++.++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 227 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 ---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00112345688999999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.02 Aligned_cols=267 Identities=25% Similarity=0.301 Sum_probs=207.1
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||+||+|...+++.||+|++.... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 47899999999999999999999889999999987543 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|++ |+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH----QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 997 5899999887777999999999999999999999 67899999999999999999999999999987653322
Q ss_pred ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC---CCchhhhcccc
Q 005040 584 SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL---PHRLTEVVDAN 659 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 659 (717)
......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .......... +..+....+..
T Consensus 175 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 175 --SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred --cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhccc
Confidence 2234568999999998766 568999999999999999999999997643332 2222222111 11111111000
Q ss_pred c------h--hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 L------V--REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~------~--~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. . ...........++.++.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0 000000111234567889999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=367.18 Aligned_cols=261 Identities=27% Similarity=0.478 Sum_probs=203.0
Q ss_pred hccCCccccccccccEEEEEEEec----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
..+|++.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 368999999999999999999864 57789999997553 3445679999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.++++.....+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999987777999999999999999999999 57899999999999999999999999999987654
Q ss_pred CCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 581 GEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 581 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~~~----------- 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEG----------- 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHHTT-----------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC-----------
Confidence 32211 1122245778999999998999999999999999999998 99999753221 111111110
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
. ..+....++.++.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 267 -~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 -Y-----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -E-----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -C-----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0 00112244567889999999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=358.87 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=206.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 79999999986443 2233568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999987654 4899999999999999999999 67899999999999999999999999999987643333
Q ss_pred ceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............|.......
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 228 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------ 228 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS------------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC------------
Confidence 333345679999999999877665 7899999999999999999999976544333333333221110
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++.++.+++.+||+.||++|||+.|+++
T Consensus 229 -----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111234456789999999999999999999976
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.70 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=206.9
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHh--cCCCceeeEeeeeec----CCeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRN--VRHRNLLKILGSCSN----LDFKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~----~~~~~ 499 (717)
.++|++.+.||+|+||+||+|++ +++.||||++..... ..+..|.+++.. ++||||+++++++.+ ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 57899999999999999999998 689999999975532 345556777766 799999999998643 35679
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC----CCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH----SSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
+||||+++|+|.++++.. .+++..+..++.|++.||+|||... .+.+|+||||||+||+++.++.+||+|||++
T Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 999999999999999754 4899999999999999999999311 0368999999999999999999999999999
Q ss_pred cccCCCCCce--eeeccccCccccCCCccCCC------CcCcccchhhHHHHHHHHHhC----------CCCCCccccCc
Q 005040 576 KLLGEGEDSV--IQTMTMATIGYMAPEYGSEG------IVSTKCDVYSYGVLLMETFTE----------KKPTDEMFTGE 637 (717)
Q Consensus 576 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~Dvws~G~il~el~tg----------~~p~~~~~~~~ 637 (717)
+......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8765433221 12334789999999988776 566899999999999999999 88887654444
Q ss_pred chHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 638 MSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
............... .+... .......++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQ----RPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCC----CCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCC----CCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 444333332211110 00010 0111234667899999999999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.16 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=208.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999976 68899999987543 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--CCcEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE--NMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~ 582 (717)
+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999877667999999999999999999999 679999999999999997 7899999999998875433
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+...... ..
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~---------~~- 223 (321)
T 1tki_A 159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEYT---------FD- 223 (321)
T ss_dssp E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCC---------CC-
T ss_pred c---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHcCCCC---------CC-
Confidence 2 23456899999999999988999999999999999999999999763221 111111111000 00
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++.++.+++.+||..||++|||+.|+++
T Consensus 224 ----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 ----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111234567889999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.16 Aligned_cols=248 Identities=22% Similarity=0.265 Sum_probs=205.3
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++++.. ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999976 79999999997653 23456788899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++++||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999998654 4899999999999999999999 678999999999999999999999999999864322
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.... ..+
T Consensus 159 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~---------~~~- 224 (337)
T 1o6l_A 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILMEE---------IRF- 224 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC---------CCC-
T ss_pred CC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHHHcCC---------CCC-
Confidence 21 22345789999999999999999999999999999999999999965321 11111111100 000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
+..++.++.+++.+||+.||++|| +++|+++
T Consensus 225 --------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 225 --------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 112345688999999999999999 8988875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.50 Aligned_cols=264 Identities=26% Similarity=0.413 Sum_probs=217.2
Q ss_pred hccCCccccccccccEEEEEEEec--------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL 495 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 495 (717)
.++|.+.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999852 33579999997654 34457788999999999 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVL 223 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCcceEE
Confidence 99999999999999999998653 35899999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 639 (717)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~~ 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HH
Confidence 99999999999999987755443333344567889999999999999999999999999999999 9999875321 11
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
....+...... .....++.++.+++.+||+.||++|||++|+++.|+++.+...++
T Consensus 302 ~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 302 LFKLLKEGHRM-----------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHHHHTTCCC-----------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHHHHcCCCC-----------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 22222111100 011134566889999999999999999999999999998765443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=362.01 Aligned_cols=267 Identities=24% Similarity=0.384 Sum_probs=213.9
Q ss_pred HHhccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD 496 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 496 (717)
...++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999974 34789999997653 344567899999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecC
Q 005040 497 FKALVLEFMPNGSLEKWLYSHN-----------------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~d 553 (717)
..++||||+++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+|||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH----~~~ivH~D 199 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRD 199 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCC
Confidence 9999999999999999998642 45899999999999999999999 67899999
Q ss_pred CCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCc
Q 005040 554 LKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDE 632 (717)
Q Consensus 554 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~ 632 (717)
|||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987654332233344567899999999888889999999999999999999 9999975
Q ss_pred cccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 633 MFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
.... .....+...... ..+..++.++.+++.+||+.||++|||+.++++.|+++..++...
T Consensus 280 ~~~~--~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 280 MAHE--EVIYYVRDGNIL-----------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp SCHH--HHHHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred CChH--HHHHHHhCCCcC-----------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence 3221 111111111000 011134566889999999999999999999999999998776654
Q ss_pred h
Q 005040 713 V 713 (717)
Q Consensus 713 ~ 713 (717)
+
T Consensus 341 ~ 341 (343)
T 1luf_A 341 V 341 (343)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=352.58 Aligned_cols=266 Identities=23% Similarity=0.378 Sum_probs=218.9
Q ss_pred hccCCccccccccccEEEEEEEe------cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~ 497 (717)
.++|+..+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 256789999997554 23457789999999999 99999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 498 KALVLEFMPNGSLEKWLYSHNY-----------------FLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
.++||||+++|+|.+++..... .+++..+..++.|+++||.||| +.+|+||||||+||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNIL 177 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEE
Confidence 9999999999999999986542 4899999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 639 (717)
++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-K 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-H
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-H
Confidence 99999999999999988765544434445567889999999888899999999999999999999 999997643221 2
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccch
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 713 (717)
............ ....++.++.+++.+||+.||++|||+.|+++.|+++.....+++
T Consensus 257 ~~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~i 313 (313)
T 1t46_A 257 FYKMIKEGFRML-----------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI 313 (313)
T ss_dssp HHHHHHHTCCCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC--
T ss_pred HHHHhccCCCCC-----------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhcCC
Confidence 222222111100 011334568899999999999999999999999999988776653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=360.41 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=205.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCe----EEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTN----VAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
.++|+..+.||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|++++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 368999999999999999999964 4443 5888875443 334567899999999999999999999998755 68
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+|+||+.+|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999999987777999999999999999999999 6789999999999999999999999999999876
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~-------- 238 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERL-------- 238 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC--------
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCCCC--------
Confidence 5544433444567889999999999999999999999999999999 99999764322 222222211100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
+....++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1112344568899999999999999999999999998854
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=351.70 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=197.9
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|++. ..||+|+++... ....+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 478999999999999999999864 359999986443 44557789999999999999999999965 4556799999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999877777999999999999999999999 67899999999999999999999999999986654333
Q ss_pred ceeeeccccCccccCCCccC---CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-CCCchhhhcccc
Q 005040 584 SVIQTMTMATIGYMAPEYGS---EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES-LPHRLTEVVDAN 659 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 659 (717)
........||+.|+|||.+. +..++.++||||+|+++|||++|+.||....... .....+... .......
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~----- 249 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSLSPDLSK----- 249 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSCCCCTTS-----
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccccCcchhh-----
Confidence 33334456899999999876 6678899999999999999999999997643221 222222211 1111110
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
....++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 250 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 ---------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 011345678899999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=350.43 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=207.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 368999999999999999999965 78999999885332 34457789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++++|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH----DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999998754 4899999999999999999999 678999999999999999999999999999876433
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||....... ..... ....... ..
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~----~~~~~-~~~~~~~-----~~ 233 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS----IAIKH-IQDSVPN-----VT 233 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH----HHHHH-HSSCCCC-----HH
T ss_pred cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHH-hhccCCC-----cc
Confidence 21 12234568999999999999999999999999999999999999997632211 11111 0000000 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-HMTDAAAKLRKIKA 707 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ev~~~L~~~~~ 707 (717)
.....+++..+.+++.+|++.||++|| +++++.+.|+++..
T Consensus 234 -----~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 234 -----TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -----HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -----hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 001123456788999999999999999 89999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=356.23 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=205.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHH------HHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLER------AFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|..+ +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 468999999999999999999976 7999999999754321 246788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeecc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM----VAHVSDFGI 574 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl 574 (717)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999997654 4899999999999999999999 67899999999999998877 799999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
+........ .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.... .....+....
T Consensus 166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~~i~~~~------ 234 (361)
T 2yab_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITAVS------ 234 (361)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTC------
T ss_pred ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcC------
Confidence 987654322 23456999999999999999999999999999999999999999763211 1111111100
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+.. .....++.++.++|.+||..||++|||+.|+++
T Consensus 235 ---~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 ---YDFDE-----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ---CCCCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---CCCCc-----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 011234566889999999999999999999885
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=364.60 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=210.3
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 368899999999999999999853 46789999986442 34446788899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEEE
Q 005040 499 ALVLEFMPNGSLEKWLYSHN------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM---VAHV 569 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~---~~kl 569 (717)
++||||+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+|||++.++ .+||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999998542 45899999999999999999999 67899999999999999555 5999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhC
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 648 (717)
+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i~~~~ 303 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG 303 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC
Confidence 99999986533222222334567999999999988899999999999999999998 9999976321 11222221111
Q ss_pred CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 649 PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.. .....++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 304 ~~-----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 RM-----------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC-----------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 00 01123455688999999999999999999999999988653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=350.99 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=215.2
Q ss_pred hccCCccccccccccEEEEEEEe------cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 47899999999999999999986 245789999997543 34457788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC
Q 005040 499 ALVLEFMPNGSLEKWLYSHN-----------------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLK 555 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk 555 (717)
++||||+++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+|||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dik 177 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA----EMKLVHRDLA 177 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH----HTTEECCCCS
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH----HCCCcccccc
Confidence 99999999999999998643 23789999999999999999999 6789999999
Q ss_pred CCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccc
Q 005040 556 PTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMF 634 (717)
Q Consensus 556 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~ 634 (717)
|+||+++.++.+||+|||++................+|+.|+|||...+..++.++||||+|+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987755443333344567889999999988889999999999999999999 999997643
Q ss_pred cCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 635 TGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.. .....+...... .....++.++.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 258 ~~--~~~~~~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PE--RLFNLLKTGHRM-----------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG--GHHHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH--HHHHHhhcCCcC-----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 22 222222211100 01123456688999999999999999999999999998664
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=368.08 Aligned_cols=314 Identities=20% Similarity=0.282 Sum_probs=213.1
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEccccccc-CccCCcccccccccccCccCCcEEeccCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLT-TESSSADQWSFLSSLTNCRNLANLALASNP 79 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~ 79 (717)
+++||. +. ++|++|+|++|.|+++.|..|.++++|++|+|++|.+. .+++. .|.++++|++|+|++|+
T Consensus 22 l~~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~--------~~~~l~~L~~L~Ls~n~ 90 (455)
T 3v47_A 22 LHQVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN--------TFRGLSSLIILKLDYNQ 90 (455)
T ss_dssp CSSCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTT--------TTTTCTTCCEEECTTCT
T ss_pred cccCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcc--------cccccccCCEEeCCCCc
Confidence 457787 43 78999999999999999999999999999999999997 44433 38899999999999999
Q ss_pred CcccCCcchhccccccceeeecCCcceecCCcc--ccCCCCCcEEEccCCCCcccCCcc-ccccCCCCEEeccCCccccc
Q 005040 80 LGGILPPLIGNFSASLQNIYAFECKLGGSIPKE--IGNLRGLIVLSLGFNDLNGTIPTS-IGTLQQLQGFYVPENNLQGY 156 (717)
Q Consensus 80 l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~l~~n~i~~~ 156 (717)
+++..|..|..+ ++|++|++++|++.+..+.. |.++++|++|+|++|.+++..|.. |.++++|++|++++|.+++.
T Consensus 91 l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 169 (455)
T 3v47_A 91 FLQLETGAFNGL-ANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI 169 (455)
T ss_dssp TCEECTTTTTTC-TTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCC
T ss_pred cCccChhhccCc-ccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccccc
Confidence 998889999988 68999999999998755554 999999999999999999887776 89999999999999999988
Q ss_pred CCccccCC----------------------------------CCCCEEeccCCcCcccCCccccCC--------------
Q 005040 157 VPHDLCHL----------------------------------ERLNILNLSGNKLSGAIPQCLASL-------------- 188 (717)
Q Consensus 157 ~~~~~~~l----------------------------------~~L~~L~L~~n~l~~~~~~~~~~l-------------- 188 (717)
.+..+..+ ++|++|+|++|++++..+..+...
T Consensus 170 ~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~ 249 (455)
T 3v47_A 170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249 (455)
T ss_dssp CTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTC
T ss_pred ChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccc
Confidence 88777655 345555555555543333222111
Q ss_pred -------------------------CCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEE
Q 005040 189 -------------------------TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLD 243 (717)
Q Consensus 189 -------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 243 (717)
++|+.|++++|++++..|..+..+++|++|+|++|.+++..|..|.++++|+.|+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 329 (455)
T 3v47_A 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLN 329 (455)
T ss_dssp TTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEE
Confidence 3444555555555444444455555555555555555544444555555555555
Q ss_pred ccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccc
Q 005040 244 LSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEG 323 (717)
Q Consensus 244 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~ 323 (717)
|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..+..+++|+.|++++|++++
T Consensus 330 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 409 (455)
T 3v47_A 330 LSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 409 (455)
T ss_dssp CCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCccc
Confidence 55555554444445555555555555555554444455555555555555555554444444455555555555555555
Q ss_pred ccc
Q 005040 324 EIP 326 (717)
Q Consensus 324 ~~p 326 (717)
.+|
T Consensus 410 ~~~ 412 (455)
T 3v47_A 410 SCP 412 (455)
T ss_dssp CTT
T ss_pred CCC
Confidence 444
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=363.19 Aligned_cols=272 Identities=14% Similarity=0.149 Sum_probs=211.6
Q ss_pred HhccCCccccccccccEEEEEEEecC------CCeEEEEEechhhHHH-----------HHHHHHHHHHHHhcCCCceee
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSD------GTNVAIKIFNLQLERA-----------FRSFDSECEILRNVRHRNLLK 487 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpniv~ 487 (717)
..++|++.+.||+|+||.||+|.+.+ ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 4789999986543211 122445666778889999999
Q ss_pred EeeeeecC----CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-
Q 005040 488 ILGSCSNL----DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD- 562 (717)
Q Consensus 488 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~- 562 (717)
+++++... ...++||||+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH----~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH----EHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeEEecCCHHHEEEec
Confidence 99998664 4579999999 99999999987677999999999999999999999 67999999999999999
Q ss_pred -CCCcEEEeeeccccccCCCCCc-----eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccC
Q 005040 563 -ENMVAHVSDFGISKLLGEGEDS-----VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG 636 (717)
Q Consensus 563 -~~~~~kl~Dfgl~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~ 636 (717)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8999999999999876432211 1113345999999999999999999999999999999999999999863322
Q ss_pred cchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 637 EMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
.....+........+.+..+..+. ...++.++.+++..||+.||++||++.++++.|+++.....
T Consensus 268 -~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 268 -PKYVRDSKIRYRENIASLMDKCFP--------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp -HHHHHHHHHHHHHCHHHHHHHHSC--------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -HHHHHHHHHHhhhhHHHHHHHhcc--------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 222222222222222233222221 12346678999999999999999999999999999877543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.55 Aligned_cols=266 Identities=23% Similarity=0.376 Sum_probs=212.4
Q ss_pred HhccCCccccccccccEEEEEEEe------cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCC
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLD 496 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 496 (717)
..++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357899999999999999999986 245679999997543 33446788999999999 8999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNY----------------------FLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDL 554 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dl 554 (717)
..++||||+++|+|.+++..... .+++..+..++.|++.||.||| +.+|+||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Di 198 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDL 198 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTC
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCC
Confidence 99999999999999999986532 3789999999999999999999 679999999
Q ss_pred CCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCcc
Q 005040 555 KPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEM 633 (717)
Q Consensus 555 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~ 633 (717)
||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987755444444445567889999999988899999999999999999998 99999764
Q ss_pred ccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 634 FTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
... ............. ..+..++.++.+++.+||+.||++|||+.|+++.|+.+.+....+
T Consensus 279 ~~~-~~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 279 PVD-ANFYKLIQNGFKM-----------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp CCS-HHHHHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred CcH-HHHHHHHhcCCCC-----------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 322 1222222211110 011123466889999999999999999999999999987765544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=363.01 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=206.0
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 44678999999999999999999865 78999999986543 3345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeeccccc
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKL 577 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~ 577 (717)
||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++ .++.+||+|||++..
T Consensus 88 v~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH----~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH----QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999998764 4899999999999999999999 67899999999999998 567899999999987
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+... ......+.......
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~------ 232 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKAGAYDF------ 232 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCC------
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCCCC------
Confidence 654322 22345799999999999999999999999999999999999999965321 11111111110000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. .+....++.++.+++.+||+.||++|||+.|+++
T Consensus 233 ---~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 ---P-----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---C-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---C-----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0011234566889999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=346.47 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=210.4
Q ss_pred HhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..++|++.+.||+|+||.||+|.++++..||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3478999999999999999999998888999999975532 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 9999999999875566999999999999999999999 67899999999999999999999999999987643221
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....+.......
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~------------ 241 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLY------------ 241 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCCC------------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcccCCC------------
Confidence 11223346788999999988889999999999999999998 99999763221 1111111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.+..++..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 242 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 242 -----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0112235688999999999999999999999999988654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.16 Aligned_cols=273 Identities=26% Similarity=0.384 Sum_probs=209.9
Q ss_pred HHHHHHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhc--CCCceeeEeeeeecC-
Q 005040 419 YLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV--RHRNLLKILGSCSNL- 495 (717)
Q Consensus 419 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~hpniv~~~~~~~~~- 495 (717)
....+...++|++.+.||+|+||.||+|+.. ++.||||++..... ..+..|.+++... +||||+++++++.+.
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3344555689999999999999999999985 89999999865432 3344456666554 899999999998776
Q ss_pred ---CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--------CeEecCCCCCCeeeCCC
Q 005040 496 ---DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA--------PIIHCDLKPTNILLDEN 564 (717)
Q Consensus 496 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--------~ivH~dlk~~Nill~~~ 564 (717)
...++||||+++|+|.++++... +++..+..++.|++.||+||| +. +|+||||||+||+++.+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH----~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLH----TEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH----SCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCCceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH----HhhhhhccCCCEEecccchHHEEECCC
Confidence 67899999999999999998754 899999999999999999999 45 89999999999999999
Q ss_pred CcEEEeeeccccccCCCCCce--eeeccccCccccCCCccCCCCcCcc------cchhhHHHHHHHHHhC----------
Q 005040 565 MVAHVSDFGISKLLGEGEDSV--IQTMTMATIGYMAPEYGSEGIVSTK------CDVYSYGVLLMETFTE---------- 626 (717)
Q Consensus 565 ~~~kl~Dfgl~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~------~Dvws~G~il~el~tg---------- 626 (717)
+.+||+|||++.......... ......||+.|+|||++.+..++.+ +|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999998764332211 1234578999999999887766655 9999999999999999
Q ss_pred CCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 627 KKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 627 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
+.||....................... + ..+......+++.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~----~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCIKKLR----P----SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCC----C----CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccHhhhcCCCCchhhhHHHHhhhccC----c----cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 666655444333333332222111110 1 11111223467788999999999999999999999999999987
Q ss_pred Hhh
Q 005040 707 AKF 709 (717)
Q Consensus 707 ~~~ 709 (717)
+..
T Consensus 331 ~~~ 333 (337)
T 3mdy_A 331 ESQ 333 (337)
T ss_dssp HTT
T ss_pred hhc
Confidence 643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=370.74 Aligned_cols=261 Identities=22% Similarity=0.268 Sum_probs=208.7
Q ss_pred HHHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 005040 420 LDIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRHRNLLKILGSCSNL 495 (717)
Q Consensus 420 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 495 (717)
.+.+...++|++.+.||+|+||.||+|+.+ +++.||+|++.+... .....+.+|..+++.++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344556689999999999999999999986 588999999976432 1223478899999999999999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
+..|+||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 9999999999999999999986666999999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccC-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGS-----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
+....... ......+||+.|+|||++. .+.++.++|||||||++|||++|+.||.+....+ ..........
T Consensus 223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~-- 298 (437)
T 4aw2_A 223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKE-- 298 (437)
T ss_dssp EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHH--
T ss_pred hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhhccc--
Confidence 87654332 2234457999999999876 5679999999999999999999999997532111 1111110000
Q ss_pred chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 005040 651 RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHK--RIHMTDAAA 700 (717)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ev~~ 700 (717)
. ..+.. ....++.++.++|.+|+..+|++ ||+++|+++
T Consensus 299 ---~---~~~p~------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 ---R---FQFPT------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ---H---CCCCS------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ---c---ccCCc------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0 00000 00124566889999999988888 999999876
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=354.95 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=206.6
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3578999999999999999999975 78999999997543 34456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeecccccc
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN---MVAHVSDFGISKLL 578 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~~ 578 (717)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.+ +.+||+|||++...
T Consensus 107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999998654 4899999999999999999999 6789999999999999865 45999999999876
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......
T Consensus 182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~~------- 249 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDY------- 249 (362)
T ss_dssp TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCC-------
T ss_pred cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCCC-------
Confidence 53322 2345799999999999999999999999999999999999999975321 11111111111000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
. ......++.++.+++.+||+.||++|||+.|+++.
T Consensus 250 --~-----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 --P-----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --C-----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --C-----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 01112345668899999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=357.37 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=208.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999975 7899999999765544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--CCcEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE--NMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~ 582 (717)
+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999877667999999999999999999999 678999999999999974 5789999999998775432
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..... . .+.
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~-~----~~~---- 271 (387)
T 1kob_A 206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDW-E----FDE---- 271 (387)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCC-C----CCS----
T ss_pred c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-C----CCc----
Confidence 2 2334689999999999999999999999999999999999999976321 111111111000 0 000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++.++.+++.+||+.||++|||+.|+++
T Consensus 272 -----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001134466889999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=345.22 Aligned_cols=252 Identities=30% Similarity=0.467 Sum_probs=205.7
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH-------HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-------RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 68899999999999999999975 789999999854321 11267889999999999999999999997665
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeCCCCc-----EEEee
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP--IIHCDLKPTNILLDENMV-----AHVSD 571 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~D 571 (717)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+ |+||||||+||+++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ----NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH----hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999999999877777999999999999999999999 667 999999999999988776 99999
Q ss_pred eccccccCCCCCceeeeccccCccccCCCcc--CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC
Q 005040 572 FGISKLLGEGEDSVIQTMTMATIGYMAPEYG--SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649 (717)
Q Consensus 572 fgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 649 (717)
||+++.... ......||+.|+|||++ ....++.++||||+|+++|||++|+.||...................
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 999975432 22345689999999988 45668899999999999999999999997644333222222221110
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
. . .....++.++.+++.+||+.||++|||++|+++.|+++
T Consensus 248 ~-------~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 R-------P---------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp C-------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred C-------C---------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0 0 01113456688999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=352.03 Aligned_cols=263 Identities=24% Similarity=0.425 Sum_probs=214.5
Q ss_pred hccCCccccccccccEEEEEEEec--------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL 495 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 495 (717)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999863 56789999997553 34456788999999999 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
+..++||||+++|+|.+++.... ..+++..+..++.|+++||.||| +.+|+||||||+||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVL 189 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCccceEE
Confidence 99999999999999999998643 23889999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 639 (717)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~ 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EE 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--HH
Confidence 99999999999999987765443333344457889999999888889999999999999999999 9999975321 11
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
....+...... .....++.++.+++.+||+.||++|||+.|+++.|+++.....+
T Consensus 268 ~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 LFKLLKEGHRM-----------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHHTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHhcCCCC-----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 11211111100 01123456688999999999999999999999999999776543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=346.34 Aligned_cols=266 Identities=14% Similarity=0.106 Sum_probs=214.9
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++.+ +|++++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 479999999986443 224577899999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc-----EEEeeecccccc
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV-----AHVSDFGISKLL 578 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~~~~ 578 (717)
|+ +++|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 99999999987667999999999999999999999 789999999999999987776 999999999877
Q ss_pred CCCCCc-----eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcch-HHHHHHhhCCCch
Q 005040 579 GEGEDS-----VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMS-LRRWVKESLPHRL 652 (717)
Q Consensus 579 ~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~ 652 (717)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------ 235 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE------ 235 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH------
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh------
Confidence 543321 1224456899999999999999999999999999999999999999764322111 0000000
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
....... ......++.++.+++.+||+.||++||+++++++.|+++.++...
T Consensus 236 -----~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 236 -----KKQSTPL--RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp -----HHHHSCH--HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -----hccCccH--HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 0000000 001113456789999999999999999999999999999876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=353.97 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=204.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHH-----HHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLER-----AFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
.++|++.+.||+|+||.||+|..+ +++.||||++...... ..+.+.+|+++++.++||||+++++++.+.+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 368999999999999999999875 7899999999754321 3467889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc---EEEeeec
Q 005040 500 LVLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV---AHVSDFG 573 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 573 (717)
+||||+++|+|.+++... +..+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH----DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999888642 345899999999999999999999 678999999999999986654 9999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchh
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLT 653 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 653 (717)
++........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...............
T Consensus 179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~~~~~~~~-- 252 (351)
T 3c0i_A 179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMN-- 252 (351)
T ss_dssp TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHHHTCCCCC--
T ss_pred ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHHcCCCCCC--
Confidence 9987754322 2234579999999999999999999999999999999999999997631 111111111110000
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+ .....++.++.+++.+||+.||++|||+.|+++
T Consensus 253 ----~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 ----P---------RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ----H---------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----c---------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 011234567889999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.41 Aligned_cols=244 Identities=24% Similarity=0.289 Sum_probs=197.1
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~ 499 (717)
..++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+.+|.++++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999976 68999999998653 33446678899999998 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++++||+|||+++...
T Consensus 101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999998654 3899999999999999999999 6789999999999999999999999999998643
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+... .
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~-----------~ 240 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILND-----------E 240 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-----------C
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHHHHcC-----------C
Confidence 222 2234457999999999999889999999999999999999999999763221 111111110 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
. .+ +..++.++.+++.+||+.||++||++
T Consensus 241 ~-----~~--p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 V-----VY--PTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp C-----CC--CTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred C-----CC--CCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 0 00 11234567899999999999999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.57 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=202.5
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|++.+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999999889999999986443 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 975 999999877667999999999999999999999 67899999999999999999999999999987643221
Q ss_pred eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC---Cchhhh-----
Q 005040 585 VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP---HRLTEV----- 655 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~----- 655 (717)
......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ........... ..+...
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhcccc
Confidence 1234468999999998865 458999999999999999999999997642221 12221111110 001100
Q ss_pred ccccchhhh--hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 656 VDANLVREE--QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 656 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.++.+.... +.......++.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 000001134567889999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=347.67 Aligned_cols=273 Identities=22% Similarity=0.288 Sum_probs=211.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC--eeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD--FKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv 501 (717)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 368999999999999999999976 68999999997544 334566789999999999999999999987655 77999
Q ss_pred EEccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCcEEEeeeccc
Q 005040 502 LEFMPNGSLEKWLYSHN--YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGIS 575 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~ 575 (717)
|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999998643 33899999999999999999999 6789999999999999 78888999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccC--------CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcc---hHHHHH
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGS--------EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM---SLRRWV 644 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~---~~~~~~ 644 (717)
+....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ .+....
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 87754332 23456899999999765 57889999999999999999999999965332222 122222
Q ss_pred HhhCCCchhhhc---cccch---hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 645 KESLPHRLTEVV---DANLV---REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 645 ~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
....+..+..+. ...+. ............+..+.+++.+||+.||++|||++|+++.....
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 222211111110 00000 00011122345677899999999999999999999999988753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.66 Aligned_cols=248 Identities=25% Similarity=0.313 Sum_probs=202.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 68999999999999999999976 68899999997653 234467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+.+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ----NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999998754 4899999999999999999999 6789999999999999999999999999998764332
Q ss_pred CceeeeccccCccccCCCccCC---CCcCcccchhhHHHHHHHHHhCCCCCCccccCcc-hHHHHHHhhCCCchhhhccc
Q 005040 583 DSVIQTMTMATIGYMAPEYGSE---GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM-SLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 658 (717)
.....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ...........
T Consensus 170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------- 237 (384)
T 4fr4_A 170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--------- 237 (384)
T ss_dssp ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC---------
T ss_pred ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc---------
Confidence 2244579999999998863 4589999999999999999999999975322211 11111111000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-MTDAAA 700 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~ev~~ 700 (717)
..+..++.++.+++.+||+.||++||+ ++++.+
T Consensus 238 ---------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ---------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011133466889999999999999998 666543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.14 Aligned_cols=246 Identities=24% Similarity=0.367 Sum_probs=202.3
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+++++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999997 4889999999976532 2235688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+ +|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 689999987654 3899999999999999999999 578999999999999999999999999999876443
Q ss_pred CCceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
.. ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+...... ...+.....
T Consensus 162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~i~~~~~ 225 (336)
T 3h4j_B 162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKKVNSCVY 225 (336)
T ss_dssp BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCCCCSSCC
T ss_pred cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHHHHcCCC
Confidence 22 234579999999999988776 7899999999999999999999975322110 000000000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+..++.++.+++.+||+.||.+|||++|+++
T Consensus 226 -------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 -------VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -------CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 011123456889999999999999999999976
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=346.30 Aligned_cols=267 Identities=21% Similarity=0.258 Sum_probs=204.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 78999999986443 3344678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++ ++.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9975 777777766667999999999999999999999 67899999999999999999999999999987643222
Q ss_pred ceeeeccccCccccCCCccCCCC-cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC---chhhhcc--
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGI-VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH---RLTEVVD-- 657 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 657 (717)
......||+.|+|||++.+.. ++.++||||+||++|||++|+.||.........+.......... .+.....
T Consensus 157 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 224456899999999887665 89999999999999999999888643222222222222221111 1111000
Q ss_pred -c----cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 -A----NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 -~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. ..............++.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 000000000111234567889999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.98 Aligned_cols=260 Identities=24% Similarity=0.450 Sum_probs=195.6
Q ss_pred HhccCCccccccccccEEEEEEEecC-C---CeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSD-G---TNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
..++|++.+.||+|+||.||+|.+.. + ..||||++.... ....+.+.+|++++++++||||+++++++.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34689999999999999999998753 3 279999997652 34567789999999999999999999999776655
Q ss_pred ------EEEEEccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 005040 499 ------ALVLEFMPNGSLEKWLYSH-----NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVA 567 (717)
Q Consensus 499 ------~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~ 567 (717)
++||||+++|+|.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS----SRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH----cCCcccCCCCcceEEEcCCCCE
Confidence 9999999999999999743 225899999999999999999999 6789999999999999999999
Q ss_pred EEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHh
Q 005040 568 HVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 568 kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 646 (717)
||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~ 254 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNYLIG 254 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHHHhc
Confidence 9999999987654443333334457889999999998899999999999999999999 99999764322 11111111
Q ss_pred hCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
... ......++.++.+++.+||+.||++|||+.++++.|+++.+
T Consensus 255 ~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 255 GNR-----------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp TCC-----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-----------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 100 00112344668899999999999999999999999999865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=346.36 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=202.7
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
++|++.+.||+|+||.||+|++. ++.||+|++.... ..+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 67889999999999999999984 7889999986442 34678899999999999999999999874 4799999999
Q ss_pred CCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc-EEEeeeccccccCCCCC
Q 005040 507 NGSLEKWLYSHNY--FLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV-AHVSDFGISKLLGEGED 583 (717)
Q Consensus 507 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~~ 583 (717)
+|+|.+++..... .+++..+..++.|+++||+|||+.+ ..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 9999999986542 4788999999999999999999533 278999999999999998886 799999999765432
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.....................
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 224 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP------------ 224 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC------------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC------------
Confidence 12345899999999999999999999999999999999999999753322211111111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
....++..+.+++.+||+.||++|||+.|+++.|+++.+.+++
T Consensus 225 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 225 -----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp -----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred -----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 0113345688999999999999999999999999999877654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=358.61 Aligned_cols=249 Identities=18% Similarity=0.248 Sum_probs=199.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|+.+ +++.||+|++++.. ....+.+..|..+++++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 478999999999999999999976 68899999997653 22334578899999887 89999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++...+ .+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999998654 4899999999999999999999 67899999999999999999999999999986332
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcch---HHHHHHhhCCCchhhhcc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMS---LRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 657 (717)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ...+... .+..
T Consensus 206 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~-------~i~~ 276 (396)
T 4dc2_A 206 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------VILE 276 (396)
T ss_dssp TT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH-------HHHH
T ss_pred CC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH-------HHhc
Confidence 22 1234567999999999999999999999999999999999999999643211100 0000000 0000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
.. .. .+..++.++.+++.+||+.||++||++
T Consensus 277 ~~-----~~--~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 277 KQ-----IR--IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CC-----CC--CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cc-----cC--CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 00 00 111345668899999999999999996
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=348.82 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=205.3
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH------HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE------RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999976 789999999865431 1346788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeecc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM----VAHVSDFGI 574 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl 574 (717)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999997653 4899999999999999999999 67899999999999999887 899999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
+........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~----- 234 (326)
T 2y0a_A 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVNY----- 234 (326)
T ss_dssp CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHTCC-----
T ss_pred CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHhcCC-----
Confidence 987653322 23456899999999999999999999999999999999999999653211 11111111000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.... .....++..+.+++.+||+.||++|||+.|+++
T Consensus 235 ----~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 ----EFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ----CCCH-----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CcCc-----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 011234566889999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=353.07 Aligned_cols=264 Identities=18% Similarity=0.173 Sum_probs=211.9
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36799999999999999999996 4789999999875432 24578899999999 99999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc-----EEEeeecccccc
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV-----AHVSDFGISKLL 578 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~~~~ 578 (717)
|+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++.+
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 89999999976667999999999999999999999 678999999999999998887 999999999876
Q ss_pred CCCCCce-----eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchh
Q 005040 579 GEGEDSV-----IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLT 653 (717)
Q Consensus 579 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 653 (717)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~------- 231 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQK------- 231 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHH-------
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHH-------
Confidence 5433211 1234579999999999999999999999999999999999999997643221 1111100
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
+......... ......++ ++.+++..||+.||.+||++.++.+.|+++.+..
T Consensus 232 -i~~~~~~~~~--~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 232 -IGDTKRATPI--EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -HHHHHHHSCH--HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HHhhhccCCH--HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0000000000 00011234 7899999999999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=343.44 Aligned_cols=258 Identities=22% Similarity=0.358 Sum_probs=200.6
Q ss_pred hccCCccccccccccEEEEEEEec----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 468999999999999999999874 24569999987543 344567889999999999999999999985 456799
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999999977767999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+......
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~~~--------- 236 (281)
T 1mp8_A 169 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERL--------- 236 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC---------
T ss_pred cccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCCCC---------
Confidence 3221 2233456789999999988899999999999999999997 99999764322 122222111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
+....++..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01123456788999999999999999999999999998665
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=346.56 Aligned_cols=245 Identities=26% Similarity=0.324 Sum_probs=204.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++..... ...+.+.+|..+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 468999999999999999999976 799999999976532 2346678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999998754 4899999999999999999999 789999999999999999999999999999876432
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.. ....
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~-----------~~~~ 221 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILN-----------AELR 221 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH-----------CCCC
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-----------CCCC
Confidence 23457899999999999999999999999999999999999999653211 11111110 0000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
+ +..++.++.+++.+|+..||++|| +++|+++
T Consensus 222 -----~--p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 -----F--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----C--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----C--CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0 012345688999999999999999 7888774
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=350.14 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=205.6
Q ss_pred hccCCccccccccccEEEEEEEec-CC-------CeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DG-------TNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 497 (717)
.++|++.+.||+|+||.||+|... ++ ..||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 468999999999999999999865 33 4699999987766667889999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc--------EEE
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV--------AHV 569 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~--------~kl 569 (717)
.++||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE----ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh----hCCeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999987766999999999999999999999 678999999999999998887 999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 648 (717)
+|||++...... ....+|+.|+|||++.+ ..++.++||||||+++|||++|..|+........ ........
T Consensus 163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~- 234 (289)
T 4fvq_A 163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDR- 234 (289)
T ss_dssp CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTT-
T ss_pred ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhcc-
Confidence 999998765321 23357889999998877 7799999999999999999996555432211111 11111110
Q ss_pred CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 649 PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
.... ...+.++.+++.+||+.||++|||+.|+++.|+++...-.
T Consensus 235 -~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 235 -HQLP-----------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp -CCCC-----------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred -CCCC-----------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 0000 0112346799999999999999999999999998865433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=353.74 Aligned_cols=257 Identities=23% Similarity=0.409 Sum_probs=205.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCe----EEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTN----VAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence 57899999999999999999965 4554 7888775432 2233456789999999999999999999864 56799
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+.+|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE----EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH----HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH----hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999877667899999999999999999999 67899999999999999999999999999998765
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
...........+|..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~-------- 237 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGERLA-------- 237 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCBCC--------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCCC--------
Confidence 544444455668889999999998899999999999999999999 99999764222 2222222111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.+..++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 238 ---------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 238 ---------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011233457799999999999999999999999998854
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=340.50 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=213.1
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|+..+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 368899999999999999999998888999999976542 2357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++++|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++....... ..
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 999999999987777899999999999999999999 6789999999999999999999999999998764321 11
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
......+|+.|+|||+..+..++.++||||+|+++|||++ |+.||..... ......+.......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~i~~~~~~~------------- 225 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFRLY------------- 225 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCC-------------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHHHHHhcCCcCC-------------
Confidence 1223456788999999988889999999999999999999 8999875321 11111111111000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.+..++..+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 226 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 226 ----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0112345688999999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=349.82 Aligned_cols=272 Identities=26% Similarity=0.398 Sum_probs=219.0
Q ss_pred CCHHHHHHHhccCCccccccccccEEEEEEEe------cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeE
Q 005040 417 TSYLDIRRATDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKI 488 (717)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~ 488 (717)
..........++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34444555668999999999999999999984 256889999997654 33456788999999999 79999999
Q ss_pred eeeeecCC-eeEEEEEccCCCCHHHHHhhCCC---------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 005040 489 LGSCSNLD-FKALVLEFMPNGSLEKWLYSHNY---------------FLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552 (717)
Q Consensus 489 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~ 552 (717)
++++...+ ..++||||+++|+|.+++..... .+++..+..++.|+++||.||| +.+|+||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~ 172 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHR 172 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH----HTTCCCS
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH----hCCcccc
Confidence 99987654 58999999999999999986543 2789999999999999999999 6789999
Q ss_pred CCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCC
Q 005040 553 DLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTD 631 (717)
Q Consensus 553 dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~ 631 (717)
||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987755444444445567899999999988899999999999999999998 999997
Q ss_pred ccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 632 EMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
...... .....+....... ....++.++.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus 253 ~~~~~~-~~~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 253 GVKIDE-EFCRRLKEGTRMR-----------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TCCCSH-HHHHHHHHTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchhH-HHHHHhccCccCC-----------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 643222 1111111111100 011234568899999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=366.72 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=208.1
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC-eeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLD-FKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~ 504 (717)
.++|++.+.||+|+||.||+|.++ ++.||||+++... ..+.+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 468889999999999999999985 7899999997553 3467889999999999999999999986654 78999999
Q ss_pred cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSHNY-FLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++|+|.++++..+. .+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 999999999986543 4799999999999999999999 6789999999999999999999999999998643221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+.....
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~------------- 404 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYK------------- 404 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTCC-------------
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence 22356889999999999999999999999999999998 999997643221 1111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
...+..++.++.++|.+||+.||++|||+.++++.|+++...
T Consensus 405 ----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 405 ----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 011224567789999999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=349.63 Aligned_cols=269 Identities=25% Similarity=0.418 Sum_probs=213.0
Q ss_pred CCccccccccccEEEEEEEec-----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeec--CCeeEE
Q 005040 429 FNECNLLGTGGFGSVYKGTLS-----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSN--LDFKAL 500 (717)
Q Consensus 429 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~l 500 (717)
|++.+.||+|+||.||++.++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998753 68889999997654 3445678999999999999999999999977 467899
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH----AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999998765 899999999999999999999 67899999999999999999999999999988765
Q ss_pred CCCc-eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc------hh
Q 005040 581 GEDS-VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR------LT 653 (717)
Q Consensus 581 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~ 653 (717)
.... .......+|..|+|||++.+..++.++||||+|+++|||++|+.||........ .+. ..... ..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~---~~~--~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL---ELI--GIAQGQMTVLRLT 261 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH---HHH--CSCCHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh---hhh--cccccchhHHHHH
Confidence 4322 223344678889999999988999999999999999999999999865221100 000 00000 00
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccch
Q 005040 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 713 (717)
+.+.... .......++.++.+++.+||+.||++|||+.|+++.|+++.+++.++.
T Consensus 262 ~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 262 ELLERGE-----RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HHHhccc-----CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 1111100 111223456779999999999999999999999999999999887654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=348.90 Aligned_cols=269 Identities=23% Similarity=0.380 Sum_probs=209.5
Q ss_pred ccCCccccccccccEEEEEEEe-----cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--Cee
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-----SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFK 498 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~ 498 (717)
..|+..+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688999999999999999983 368899999997554 23446788999999999999999999999776 668
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh----cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 9999999999999999776666999999999999999999999 678999999999999999999999999999887
Q ss_pred CCCCCc-eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCch---hh
Q 005040 579 GEGEDS-VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL---TE 654 (717)
Q Consensus 579 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~ 654 (717)
...... .......+|..|+|||++.+..++.++||||+|+++|||++|+.|+.... ..+.....+... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHCSCCGGGHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccCCcccccCHH
Confidence 554322 22334567888999999988899999999999999999999999864321 111111111100 00
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
.+...+. ..........++.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 251 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHh-ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000000 00011112245577899999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=343.87 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=194.2
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhH----HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLE----RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|+..+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 368899999999999999999984 88999999875432 2346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCC---eEecCCCCCCeeeCC--------CCcEEEe
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP---IIHCDLKPTNILLDE--------NMVAHVS 570 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~---ivH~dlk~~Nill~~--------~~~~kl~ 570 (717)
|||+++++|.+++... .+++..+..++.|+++||.|||+ .+ |+||||||+||+++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~----~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHD----EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHH----SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh----CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999998754 48999999999999999999994 55 999999999999986 7789999
Q ss_pred eeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC
Q 005040 571 DFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 571 Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
|||++........ ....||+.|+|||...+..++.++||||+|+++|||++|+.||....... ........
T Consensus 159 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~--- 229 (271)
T 3dtc_A 159 DFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--VAYGVAMN--- 229 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHTS---
T ss_pred cCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHhhhcC---
Confidence 9999986643221 23468999999999988889999999999999999999999997632211 11111100
Q ss_pred chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 651 RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
. . ..+....++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 230 ~--------~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 K--------L-----ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C--------C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C--------C-----CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 0 0001123446688999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=362.39 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=207.3
Q ss_pred HHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 005040 421 DIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRHRNLLKILGSCSNLD 496 (717)
Q Consensus 421 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 496 (717)
+++...++|++.+.||+|+||.||+|+.+ +++.||+|++.+... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34455689999999999999999999976 688999999976431 12234778999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..|+||||+++|+|.++++... +++..+..++.|++.||+||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999998754 899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCC----cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCch
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGI----VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 652 (717)
...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.... ..........
T Consensus 217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~----- 289 (410)
T 3v8s_A 217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHK----- 289 (410)
T ss_dssp ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHH-----
T ss_pred eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHHHhcc-----
Confidence 765432 22234567999999999876654 889999999999999999999999753211 1111111100
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHK--RIHMTDAAAK 701 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ev~~~ 701 (717)
....++....++.++.++|.+||..+|.+ ||+++|+++.
T Consensus 290 ----------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 ----------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00011111234567889999999999988 9999998863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.01 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=196.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--------------------------HHHHHHHHHHHHHH
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--------------------------RAFRSFDSECEILR 478 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 478 (717)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999875 789999999864321 12346888999999
Q ss_pred hcCCCceeeEeeeeec--CCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 005040 479 NVRHRNLLKILGSCSN--LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKP 556 (717)
Q Consensus 479 ~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~ 556 (717)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..+..++.|+++||+||| +.+|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH----YQKIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCH
Confidence 9999999999999976 5688999999999999886543 34899999999999999999999 67899999999
Q ss_pred CCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCC---cCcccchhhHHHHHHHHHhCCCCCCcc
Q 005040 557 TNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGI---VSTKCDVYSYGVLLMETFTEKKPTDEM 633 (717)
Q Consensus 557 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Dvws~G~il~el~tg~~p~~~~ 633 (717)
+||+++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999987654322 234457899999999887655 478899999999999999999999753
Q ss_pred ccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 634 FTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ......+..... ..+....++.++.+++.+||+.||++|||+.|+++
T Consensus 244 ~~--~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RI--MCLHSKIKSQAL----------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SH--HHHHHHHHHCCC----------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cH--HHHHHHHhcccC----------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 111111111000 00111134456889999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.15 Aligned_cols=271 Identities=17% Similarity=0.231 Sum_probs=206.1
Q ss_pred hccCCcccccccc--ccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTG--GFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3689999999999 99999999976 79999999997654 4455678889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 501 VLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999864 345899999999999999999999 6789999999999999999999999999986543
Q ss_pred CCCC-----ceeeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc-
Q 005040 580 EGED-----SVIQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR- 651 (717)
Q Consensus 580 ~~~~-----~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 651 (717)
.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......... .....+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~ 258 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLL 258 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-hcCCCCccc
Confidence 2211 111223468999999998877 67999999999999999999999999764332221111 11100000
Q ss_pred ----------------------hhhhcc----ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 652 ----------------------LTEVVD----ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 652 ----------------------~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+... ..........+....++.++.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 00000000111223456779999999999999999999999854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=352.80 Aligned_cols=277 Identities=26% Similarity=0.418 Sum_probs=215.7
Q ss_pred hccCCccccccccccEEEEEEEe-----cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC--ee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-----SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLD--FK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~ 498 (717)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36789999999999999999984 368899999998766666678999999999999999999999886543 78
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+++++|.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999999987777999999999999999999999 678999999999999999999999999999887
Q ss_pred CCCCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCch-hhhc
Q 005040 579 GEGEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL-TEVV 656 (717)
Q Consensus 579 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 656 (717)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+..... ...+.......... ...+
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHHCTTCCTHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhhccccchhhhHHHH
Confidence 5443221 12234567889999999888899999999999999999999999754210 01111100000000 0000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
...+. .....+....++.++.+++.+||+.||++|||+.|+++.|+++++++.
T Consensus 273 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 273 IELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHH-TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhh-cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 00000 000011123456778999999999999999999999999999988753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=355.47 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=199.9
Q ss_pred CccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 430 NECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 430 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
...+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33567999999999999875 79999999998665555678899999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee--CCCCcEEEeeeccccccCCCCCcee
Q 005040 509 SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL--DENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 509 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+|.+++......+++..+..++.|+++||.||| +.+|+||||||+||++ +.++.+||+|||+++.+.....
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMH----QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 999999877667999999999999999999999 6789999999999999 6778999999999987754332
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+........... .
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~-----~--------- 309 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDLE-----D--------- 309 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCSC-----S---------
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCC-----h---------
Confidence 23346899999999999999999999999999999999999999763221 11111111111000 0
Q ss_pred hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 667 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++.++.+++.+||+.||++|||+.|+++
T Consensus 310 -~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 -EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011234567889999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=353.71 Aligned_cols=250 Identities=23% Similarity=0.292 Sum_probs=203.7
Q ss_pred HHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCe
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDF 497 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~ 497 (717)
....++|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+..|.++++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445689999999999999999999976 78999999998653 23445678899999987 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++++||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999998654 3899999999999999999999 67899999999999999999999999999986
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ......+....
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~--------- 234 (345)
T 1xjd_A 168 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDN--------- 234 (345)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC---------
T ss_pred cccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHhCC---------
Confidence 432221 22445799999999999999999999999999999999999999975321 11111111110
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMT-DAA 699 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ev~ 699 (717)
..+ +..++.++.+++.+||..||++||++. |++
T Consensus 235 ~~~---------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 PFY---------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCC---------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCC---------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 000 012345688999999999999999997 554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=345.77 Aligned_cols=280 Identities=23% Similarity=0.352 Sum_probs=220.4
Q ss_pred CCCHHHHHHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHh--cCCCceeeEeeeee
Q 005040 416 RTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRN--VRHRNLLKILGSCS 493 (717)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~ 493 (717)
......-+...++|++.+.||+|+||.||+|+. +++.||||++.... .+.+.+|.++++. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344555566778999999999999999999998 58999999997543 3456778888887 68999999999998
Q ss_pred cCC----eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc----CCCCCeEecCCCCCCeeeCCCC
Q 005040 494 NLD----FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC----HSSAPIIHCDLKPTNILLDENM 565 (717)
Q Consensus 494 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----~~~~~ivH~dlk~~Nill~~~~ 565 (717)
... ..++||||+++|+|.+++.... +++..++.++.|++.||.|||.. +.+.+|+||||||+||+++.++
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 765 7899999999999999998754 89999999999999999999931 0036899999999999999999
Q ss_pred cEEEeeeccccccCCCCCce--eeeccccCccccCCCccCCC------CcCcccchhhHHHHHHHHHhC----------C
Q 005040 566 VAHVSDFGISKLLGEGEDSV--IQTMTMATIGYMAPEYGSEG------IVSTKCDVYSYGVLLMETFTE----------K 627 (717)
Q Consensus 566 ~~kl~Dfgl~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~Dvws~G~il~el~tg----------~ 627 (717)
.+||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999998765443221 22345689999999987765 344789999999999999999 7
Q ss_pred CCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 628 KPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 628 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.||............+......... .+.+. ......+++..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKL----RPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCC----CCCCC----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHHh----CCCCc----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 7887654444444444333221111 11111 111223566789999999999999999999999999999987
Q ss_pred hh
Q 005040 708 KF 709 (717)
Q Consensus 708 ~~ 709 (717)
+.
T Consensus 337 ~~ 338 (342)
T 1b6c_B 337 QE 338 (342)
T ss_dssp TT
T ss_pred Hh
Confidence 64
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=341.49 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=205.4
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC--CeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL--DFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv 501 (717)
.++|++.+.||+|+||.||+|+++ ++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 368999999999999999999984 8899999997543 34456789999999999999999999999877 788999
Q ss_pred EEccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 502 LEFMPNGSLEKWLYSHNY-FLDILQRLNIMIDVGSALEYLHHCHSSAP--IIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|||+++|+|.+++..... .+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.++++|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH----TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT----TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999987543 5899999999999999999999 567 999999999999999999999999987643
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCc---ccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVST---KCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (717)
.. ....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||........ ............
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~---- 231 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEGLRPT---- 231 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHSCCCCC----
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhcCCCCC----
Confidence 22 2335799999999887765544 79999999999999999999976322111 111111100000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.+..++.++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 232 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 232 -------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011344568899999999999999999999999998854
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.77 Aligned_cols=276 Identities=27% Similarity=0.354 Sum_probs=213.5
Q ss_pred ccCCccccccccccEEEEEEEe-----cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeee--cCCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-----SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS--NLDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~ 499 (717)
++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999984 368899999998766666678999999999999999999999875 456789
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+++++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG----SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 999999999999999876556999999999999999999999 6789999999999999999999999999998775
Q ss_pred CCCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 580 EGEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 580 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
...... ......+|+.|+|||++.+..++.++||||+|+++|||++|+.||....... ...+.............+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC----CCHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhcccccccccHHHHHHH
Confidence 443322 2233457888999999988889999999999999999999999986421110 0000000000001111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
.. ..........++.++.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 257 ~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LE--EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hh--cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 00 000111223456778999999999999999999999999999866544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=352.53 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=196.4
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCC--CceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRH--RNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++| |||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 36799999999999999999998889999999986443 4445778899999999976 9999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
||+ .+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 995 5789999998754 4899999999999999999999 67899999999999997 678999999999877544
Q ss_pred CCceeeeccccCccccCCCccCC-----------CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSE-----------GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....................
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 43333445679999999998754 6789999999999999999999999975322211111111111100
Q ss_pred chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 651 RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.. +...+.++.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~-----------------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 241 EF-----------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CC-----------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC-----------------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 00 01123457899999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=372.36 Aligned_cols=263 Identities=22% Similarity=0.400 Sum_probs=214.2
Q ss_pred HhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..++|++.+.||+|+||.||+|.++++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346889999999999999999999888999999997653 23567899999999999999999999986 5678999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++|+|.++++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999999854 234889999999999999999999 67899999999999999999999999999987643211
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
.......+|+.|+|||++....++.++|||||||++|||+| |+.||.+.... .....+.....
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~------------- 403 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR------------- 403 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTCC-------------
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence 11223346788999999988899999999999999999999 99999764221 11111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccch
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 713 (717)
.+.+..++.++.++|.+||+.||++|||+.++++.|+++......++
T Consensus 404 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~ 450 (454)
T 1qcf_A 404 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQY 450 (454)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSS
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccccc
Confidence 01122456678999999999999999999999999999876554443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=344.17 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=209.3
Q ss_pred hccCCccccccccccEEEEEEEecC----CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeee-ecCCeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSD----GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSC-SNLDFKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~ 499 (717)
..+|+..+.||+|+||.||+|...+ ...||+|.+.... ....+.+.+|++++++++||||+++++++ ...+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3578888999999999999998642 2358999887543 34456788999999999999999999985 5566789
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999999877777899999999999999999999 6789999999999999999999999999998764
Q ss_pred CCCC--ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 580 EGED--SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 580 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
.... ........+|+.|+|||...+..++.++||||+|+++|||++ |.+||...... ............
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~------ 251 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRL------ 251 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHHTTCCC------
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhcCCCC------
Confidence 4321 122334467889999999988899999999999999999999 55556543221 122211111100
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
..+..++..+.+++.+||+.||++|||++|+++.|+++.+.+..+
T Consensus 252 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 252 -----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred -----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 001123456889999999999999999999999999998877654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=353.97 Aligned_cols=277 Identities=25% Similarity=0.351 Sum_probs=201.5
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHH--HHHHHhcCCCceeeEeeee-----ecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSE--CEILRNVRHRNLLKILGSC-----SNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e--~~~l~~l~hpniv~~~~~~-----~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|+. +++.||||++..... ..+..| +..+..++||||+++++++ ......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36899999999999999999987 689999999975543 233334 4445558999999999854 233467
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC---------CeEecCCCCCCeeeCCCCcEEE
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA---------PIIHCDLKPTNILLDENMVAHV 569 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---------~ivH~dlk~~Nill~~~~~~kl 569 (717)
++||||+++|+|.+++.... .++..+..++.|+++||+||| +. +|+||||||+||+++.++.+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH----~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH----TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH----CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH----hhhccccccccceeecccccceEEEcCCCcEEE
Confidence 89999999999999998765 589999999999999999999 56 9999999999999999999999
Q ss_pred eeeccccccCCCCC------ceeeeccccCccccCCCccCC-------CCcCcccchhhHHHHHHHHHhCCCCCCccccC
Q 005040 570 SDFGISKLLGEGED------SVIQTMTMATIGYMAPEYGSE-------GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG 636 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~ 636 (717)
+|||++..+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987653221 112234468999999998876 46778999999999999999998775432111
Q ss_pred cchHHHHHHhhC-CCch---hhhcc-ccc-hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 637 EMSLRRWVKESL-PHRL---TEVVD-ANL-VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 637 ~~~~~~~~~~~~-~~~~---~~~~~-~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
......+..... .... ...+. ... ............++.++.+++.+||+.||++|||++|+++.|+++...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 110000000000 0000 00000 000 00001112223466789999999999999999999999999999988776
Q ss_pred cc
Q 005040 711 DD 712 (717)
Q Consensus 711 ~~ 712 (717)
.+
T Consensus 322 ~~ 323 (336)
T 3g2f_A 322 RN 323 (336)
T ss_dssp C-
T ss_pred hc
Confidence 54
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=359.95 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=206.3
Q ss_pred HHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 005040 421 DIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD 496 (717)
Q Consensus 421 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 496 (717)
+.+...++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33445689999999999999999999975 79999999997643 223345788999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..|+||||+++|+|.+++.+.+..+++..+..++.|++.||.||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH----RLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 999999999999999999876656999999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccC-------CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGS-------EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 649 (717)
....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .........
T Consensus 211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~-- 286 (412)
T 2vd5_A 211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHYK-- 286 (412)
T ss_dssp ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHH--
T ss_pred eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhcc--
Confidence 7654322 2223457999999999876 4678999999999999999999999997632211 111111000
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKR---IHMTDAAA 700 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---pt~~ev~~ 700 (717)
... .+. .....++.++.++|.+||. +|++| |+++|+++
T Consensus 287 ----~~~--~~p------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 ----EHL--SLP------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ----HHC--CCC----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ----cCc--CCC------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000 000 0012345678899999999 99998 58888764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.57 Aligned_cols=249 Identities=19% Similarity=0.271 Sum_probs=200.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 368999999999999999999976 68899999997653 34456788899999988 89999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++++||+|||+++....
T Consensus 88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999998654 4899999999999999999999 67899999999999999999999999999986432
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcch---HHHHHHhhCCCchhhhcc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMS---LRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 657 (717)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......... ....... .+..
T Consensus 163 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------~i~~ 233 (345)
T 3a8x_A 163 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------VILE 233 (345)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH-------HHHH
T ss_pred CCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH-------HHHc
Confidence 221 224457999999999999999999999999999999999999999652211100 0000000 0000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
... .+ +..++.++.+++.+||+.||++||++
T Consensus 234 ~~~-----~~--p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 234 KQI-----RI--PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCC-----CC--CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCC-----CC--CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000 01 11345668899999999999999996
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.16 Aligned_cols=244 Identities=22% Similarity=0.216 Sum_probs=195.1
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|+..++||+|+||+||+|... +++.||||++.... .........|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 68999999999999999999986 79999999885432 22334455566666655 8999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+ +++|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH----SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 67999999877777999999999999999999999 5789999999999999999999999999998764332
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
......||++|+|||++.+ .++.++|||||||++|||++|..|+.... ..... .......
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~------------~~~~~~~ 271 (311)
T 3p1a_A 212 ---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQL------------RQGYLPP 271 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHH------------TTTCCCH
T ss_pred ---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHH------------hccCCCc
Confidence 2234568999999998876 78999999999999999999977754311 11110 0000000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++.++.+++.+||+.||++|||++|+++
T Consensus 272 -----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 -----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011234567899999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.31 Aligned_cols=267 Identities=25% Similarity=0.441 Sum_probs=203.0
Q ss_pred HHHHhccCCccccccccccEEEEEEEec----CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 005040 422 IRRATDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL 495 (717)
Q Consensus 422 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 495 (717)
.....++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3344578999999999999999999864 34579999987542 34456788999999999999999999998765
Q ss_pred C-----eeEEEEEccCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 005040 496 D-----FKALVLEFMPNGSLEKWLYS-----HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565 (717)
Q Consensus 496 ~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~ 565 (717)
. ..++||||+++|+|.+++.. ....+++..++.++.|+++||.||| +.+|+||||||+||+++.++
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS----NRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCSGGGEEECTTS
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCC
Confidence 4 35999999999999999953 2356899999999999999999999 78999999999999999999
Q ss_pred cEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHH
Q 005040 566 VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWV 644 (717)
Q Consensus 566 ~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 644 (717)
.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~ 262 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYL 262 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHH
Confidence 999999999987654433333344567889999999999999999999999999999999 88898763222 122211
Q ss_pred HhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 645 KESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
...... .....++.++.+++.+||+.||++|||+.++++.|+++.+..++
T Consensus 263 ~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 263 LHGHRL-----------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp HTTCCC-----------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HcCCCC-----------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 111100 01123456688999999999999999999999999999887765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=353.92 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=202.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCe----EEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTN----VAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 368999999999999999999964 5554 4777664332 334567889999999999999999999998765 78
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+|+||+.+|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999999987777999999999999999999999 6789999999999999999999999999998775
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~~-------- 238 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERL-------- 238 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC--------
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCC--------
Confidence 4443333344557889999999999999999999999999999999 99999764322 222222211100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
+....++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 239 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 ---------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1112344568899999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.16 Aligned_cols=244 Identities=24% Similarity=0.255 Sum_probs=203.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999976 79999999997653 234467888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999998754 3899999999999999999999 678999999999999999999999999999876432
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... ..
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~-----------~~-- 255 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSG-----------KV-- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC-----------CC--
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHHHHHcC-----------CC--
Confidence 1234689999999999999999999999999999999999999975321 1111111110 00
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
..+..++.++.+++.+||+.||++||+ ++|+++
T Consensus 256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 001123466889999999999999998 777764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=351.62 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=190.4
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467999999999999999999986 68899999997553 23567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeeccccccCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGE 580 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~ 580 (717)
|+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH----ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999998654 4899999999999999999999 678999999999999975 88999999999987643
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................... ..
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~-----~~--- 272 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF-----IS--- 272 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-----CT---
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-----CC---
Confidence 22 12345689999999999999999999999999999999999999965332221112111111000 00
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+...+++.++.+++.+||+.||++|||+.|+++
T Consensus 273 -------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 -------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001134566889999999999999999999886
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.97 Aligned_cols=263 Identities=24% Similarity=0.403 Sum_probs=213.7
Q ss_pred ccCCccc-cccccccEEEEEEEec---CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 427 DEFNECN-LLGTGGFGSVYKGTLS---DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 427 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
++|.+.. .||+|+||.||+|.+. +++.||+|+++... ....+.+.+|++++++++||||+++++++. .+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence 5666666 8999999999999853 67889999997643 345577899999999999999999999994 5568999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++++|.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999877667999999999999999999999 678999999999999999999999999999877543
Q ss_pred CCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 582 EDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 582 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~~~~~--------- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRM--------- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTCCC---------
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhcCCcC---------
Confidence 3221 1223356889999999988889999999999999999999 9999976322 1222222211100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccch
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 713 (717)
..+..++.++.+++.+||+.||++||++.|+++.|+++........
T Consensus 233 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 233 --------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp --------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred --------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 0112345678899999999999999999999999999977655443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.82 Aligned_cols=264 Identities=23% Similarity=0.369 Sum_probs=214.6
Q ss_pred HHhccCCccccccccccEEEEEEEec-CC-----CeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DG-----TNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL 495 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 495 (717)
...++|+..+.||+|+||.||+|... ++ ..||+|++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 34578999999999999999999964 23 479999997653 33456788999999999 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 005040 496 DFKALVLEFMPNGSLEKWLYSH-------------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD 562 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~ 562 (717)
+..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA----SKNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGCEEE
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCcccceEEEC
Confidence 9999999999999999999753 234799999999999999999999 67899999999999999
Q ss_pred CCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHH
Q 005040 563 ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLR 641 (717)
Q Consensus 563 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~ 641 (717)
.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHH
Confidence 999999999999987654443333444567889999999888889999999999999999999 99999764322 1222
Q ss_pred HHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 642 RWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
.......... .+..++..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 278 ~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 278 KLVKDGYQMA-----------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHHTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCC-----------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 2222211110 01123456889999999999999999999999999986654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=358.11 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=201.9
Q ss_pred ccCCccccccccccEEEEEEEec--CC--CeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeee-cCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS--DG--TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCS-NLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~l 500 (717)
..|+..+.||+|+||.||+|.+. ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 45677789999999999999864 22 358999886433 345577899999999999999999999864 4567899
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.++++.....+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999999987777899999999999999999999 67899999999999999999999999999987643
Q ss_pred CCCc--eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 581 GEDS--VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 581 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...... .....+......
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~~~~------- 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRL------- 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTTCCC-------
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcCCCC-------
Confidence 3211 12233457889999999988999999999999999999999 67777653222 222222211100
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
..+..++..+.+++.+||+.||++|||++|+++.|+++...+.++
T Consensus 316 ----------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 316 ----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 011234566889999999999999999999999999998877654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=342.47 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=202.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQ---LERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 368999999999999999999964 7999999998753 234556788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 502 LEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999974 3456899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
..... ......+++.|+|||++.+..++.++||||||+++|||++|+.||.............+... .. +
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-----~ 256 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DY-----P 256 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT---CS-----C
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc---cC-----C
Confidence 43221 12334689999999999999999999999999999999999999965322221222211110 00 0
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
.. ....++.++.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 257 ~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 PL--------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CC--------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 00 011344568899999999999999999999999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=347.47 Aligned_cols=267 Identities=24% Similarity=0.321 Sum_probs=190.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999975 78999999986543 2233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 504 FMPNGSLEKWLYSH-----NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 504 ~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|++ |+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH----ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 997 6999998743 235899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-C-Cc-hhh
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-P-HR-LTE 654 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~-~~-~~~ 654 (717)
..... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ........... + .. +..
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp TSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGG
T ss_pred CCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhh
Confidence 43221 1234468999999998876 46899999999999999999999999764321 11222211111 0 00 000
Q ss_pred hcc-----ccchh-------hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVD-----ANLVR-------EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~-----~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
... +.+.. ..........++.++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 00000 00000011134567899999999999999999999876
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.92 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=196.8
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcC--CCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVR--HRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv~ 502 (717)
.+|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 5699999999999999999998889999999986543 445577899999999996 599999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
| +.+++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56789999998765 4889999999999999999999 78999999999999996 5899999999998775443
Q ss_pred CceeeeccccCccccCCCccCC-----------CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc
Q 005040 583 DSVIQTMTMATIGYMAPEYGSE-----------GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR 651 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 651 (717)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~------- 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------- 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH-------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh-------
Confidence 3333345579999999998754 4689999999999999999999999975322111111111
Q ss_pred hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 652 LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+....... +...+.++.+++.+||+.||++|||+.|+++.
T Consensus 282 -----~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 -----DPNHEIEF-----PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----CTTSCCCC-----CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----CccccCCC-----CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11100000 00113457899999999999999999999853
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.71 Aligned_cols=264 Identities=23% Similarity=0.348 Sum_probs=210.5
Q ss_pred ccCCccccccccccEEEEEEEec-CC---CeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee-EE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DG---TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK-AL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~-~l 500 (717)
..|...+.||+|+||+||+|.+. ++ ..||+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35566789999999999999853 22 369999987543 34557788999999999999999999999776655 99
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+.+|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA----EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999999987777899999999999999999999 67899999999999999999999999999986643
Q ss_pred CCC--ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 581 GED--SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 581 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
... ........+|+.|+|||...+..++.++||||+|+++|||++|+.|+.... ........+.......
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~------- 248 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRLP------- 248 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTTCCCC-------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcCCCCC-------
Confidence 221 112234467899999999999999999999999999999999666543322 1222222222211110
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
....++..+.+++.+||+.||++|||+.++++.|+++..+...+
T Consensus 249 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 249 ----------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ----------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 11123456889999999999999999999999999998877644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=336.96 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=208.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 468999999999999999999976 78999999987543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999987543 4899999999999999999999 67899999999999999999999999999987643332
Q ss_pred ceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
........||+.|+|||...+..+ +.++||||+|+++|||++|+.||............|......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 227 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------- 227 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-------------
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-------------
Confidence 222344568999999999887665 789999999999999999999997654433333333321100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++..+.+++.+||+.||++|||++|+++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0011133456789999999999999999999876
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=355.10 Aligned_cols=270 Identities=26% Similarity=0.305 Sum_probs=194.8
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecC--Ce
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVR-HRNLLKILGSCSNL--DF 497 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~--~~ 497 (717)
...++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++++. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45679999999999999999999875 79999999885432 344566788999999997 99999999998654 37
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 6999999874 4899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCC-------------------CceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCc
Q 005040 578 LGEGE-------------------DSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637 (717)
Q Consensus 578 ~~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 637 (717)
+.... ........+||++|+|||++.+ ..++.++||||+||++|||++|+.||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~- 237 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM- 237 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 54311 1112234579999999998876 67999999999999999999999999763221
Q ss_pred chHHHHHHhhCCCchhhh--cccc--------c------------------hhhhhhhhhhHHHHHHHHHHHhhccCCCC
Q 005040 638 MSLRRWVKESLPHRLTEV--VDAN--------L------------------VREEQAFSDKMDCLFSIMDLALDCCMDTP 689 (717)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~--~~~~--------~------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P 689 (717)
..+..............+ +... + ............++.++.+++.+||..||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 112222211110000000 0000 0 00000000111345678999999999999
Q ss_pred CCCCCHHHHHHH
Q 005040 690 HKRIHMTDAAAK 701 (717)
Q Consensus 690 ~~Rpt~~ev~~~ 701 (717)
++|||++|+++.
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.04 Aligned_cols=249 Identities=22% Similarity=0.253 Sum_probs=203.1
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~ 499 (717)
..++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|..+++.+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999986 58899999998653 23446678899999988 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++++||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999998654 3899999999999999999999 6789999999999999999999999999998643
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+... .
T Consensus 173 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~-----------~ 237 (353)
T 2i0e_A 173 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEH-----------N 237 (353)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC-----------C
T ss_pred cCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHHHhC-----------C
Confidence 2221 23445799999999999999999999999999999999999999975321 1111111110 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
. .+ +..++.++.+++.+||+.||++||+ ++|+++
T Consensus 238 ~-----~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 V-----AY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp C-----CC--CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred C-----CC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 00 1123466889999999999999996 455553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=370.52 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=212.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..+|++.+.||+|+||.||+|.++ ++..||||+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 467889999999999999999986 588999999975432 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++|+|.++++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 9999999999864 345899999999999999999999 6789999999999999999999999999998764332
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~------------- 437 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYR------------- 437 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCC-------------
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence 222233456788999999988899999999999999999999 99999764322 22222211110
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
...+..++.++.++|.+||+.||++|||+.++++.|+++.
T Consensus 438 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 0112245567889999999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.84 Aligned_cols=266 Identities=24% Similarity=0.282 Sum_probs=210.2
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeee----cCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS----NLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~----~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999997 489999999987655566678899999999999999999999986 3457899
Q ss_pred EEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 501 VLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
||||+++|+|.+++.. ....+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH----AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999985 3556899999999999999999999 67899999999999999999999999999876
Q ss_pred cCCCCCce-------eeeccccCccccCCCccCCCC---cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 005040 578 LGEGEDSV-------IQTMTMATIGYMAPEYGSEGI---VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES 647 (717)
Q Consensus 578 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~---~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 647 (717)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.................
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 53211000 012235699999999887544 78999999999999999999999965322222222211110
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
. ..+....++.++.+++.+||+.||.+|||+.|+++.|+++....+++
T Consensus 264 ~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 264 L-----------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred C-----------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 0 00111234466889999999999999999999999999987665554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=336.51 Aligned_cols=251 Identities=21% Similarity=0.283 Sum_probs=205.9
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
..++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4578999999999999999999976 678899999987655556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeeeccccccCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~~ 580 (717)
|+++++|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH----KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999986543 899999999999999999999 6789999999999999 7889999999999987654
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
... .....||+.|+|||.+.+. ++.++||||+|+++|||++|+.||...... .....+...... .
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~---------~ 226 (277)
T 3f3z_A 162 GKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLKIREGTFT---------F 226 (277)
T ss_dssp TSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC---------C
T ss_pred ccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCCC---------C
Confidence 322 2344689999999987654 899999999999999999999999763221 111111111000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. .....++.++.+++.+||+.||++|||+.|+++
T Consensus 227 ~~-----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PE-----KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Cc-----hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 011134567889999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=352.20 Aligned_cols=266 Identities=23% Similarity=0.393 Sum_probs=214.2
Q ss_pred HHhccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD 496 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 496 (717)
...++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999864 36789999997543 334467889999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 005040 497 FKALVLEFMPNGSLEKWLYSHN---------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVA 567 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~ 567 (717)
..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCCccCCCccceEEEcCCCeE
Confidence 9999999999999999997531 34689999999999999999999 6789999999999999999999
Q ss_pred EEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHh
Q 005040 568 HVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 568 kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 646 (717)
||+|||++................+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... ......+..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~ 255 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRFVME 255 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHHHHHHT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--HHHHHHHHc
Confidence 9999999987644332222333456889999999988889999999999999999999 8899875321 111111111
Q ss_pred hCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
.. .. .....++..+.+++.+||+.||++|||+.|+++.|+++......+
T Consensus 256 ~~-----------~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~ 304 (322)
T 1p4o_A 256 GG-----------LL------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304 (322)
T ss_dssp TC-----------CC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred CC-----------cC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcc
Confidence 10 00 011234566889999999999999999999999999875544433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.21 Aligned_cols=260 Identities=27% Similarity=0.475 Sum_probs=204.9
Q ss_pred ccCCccccccccccEEEEEEEecC-----CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSD-----GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.+|+..+.||+|+||.||+|.... +..||||++.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567778999999999999998642 2359999997543 3345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999987677999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCc-eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 581 GEDS-VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 581 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~~--------- 268 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGFR--------- 268 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC---------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCCc---------
Confidence 3221 11223346788999999988899999999999999999999 99999653221 11111111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
.+....++..+.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 269 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 --------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0111234566889999999999999999999999999986643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=335.98 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=208.0
Q ss_pred hccCCccccccccccEEEEEEEecC----CCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSD----GTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|++++++++||||+++++++.+. ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4789999999999999999998642 3459999987653 34457789999999999999999999998754 5689
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE----SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999877667999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
... .......+|+.|+|||+..+..++.++||||||+++|||++ |+.||...... .....+......
T Consensus 166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~~--------- 233 (281)
T 3cc6_A 166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDRL--------- 233 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCCC---------
T ss_pred ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCCC---------
Confidence 322 12233457889999999988889999999999999999998 99999753222 122222111100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
+....++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 234 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 234 --------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 011123456889999999999999999999999999986643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=368.05 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=208.5
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|++.+.||+|+||.||+|.++++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 467889999999999999999998888899999975432 24678999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++|+|.++++.. +..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence 999999999853 345899999999999999999999 67899999999999999999999999999987643321
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.......+|+.|+|||.+.++.++.++||||||+++|||++ |+.||.+.... .....+.....
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~-------------- 399 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYR-------------- 399 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC--------------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--------------
Confidence 12233456889999999988899999999999999999999 99999764221 11111111100
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccch
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 713 (717)
.+.+..++..+.+++.+||+.||++|||++++++.|+++......++
T Consensus 400 ---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 01112456678899999999999999999999999999876554443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=337.82 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=186.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 468999999999999999999974 799999999975532 2246788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++++|.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH----SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999999987667999999999999999999999 678999999999999999999999999999876432
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. ......||+.|+|||...+..++.++||||+|+++|||++|+.||........ .. .......
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~--------~~~~~~~- 229 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LN--------KVVLADY- 229 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCC-
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HH--------HHhhccc-
Confidence 21 12234689999999999998999999999999999999999999975322110 00 0000000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+..++.++.+++.+||+.||++|||++++++
T Consensus 230 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 ------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 001123456889999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=334.66 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=205.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999975 68999999987553 344567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc---EEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV---AHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~~~ 579 (717)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999888654 4899999999999999999999 678999999999999986655 9999999998765
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.......
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~-------- 226 (284)
T 3kk8_A 160 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDY-------- 226 (284)
T ss_dssp SSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCC--------
T ss_pred cCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHhccccC--------
Confidence 4322 23456899999999999999999999999999999999999999653211 1111111110000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. .+....++.++.+++.+||+.||++|||+.|+++
T Consensus 227 -~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 -P-----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -C-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -C-----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 0011134456889999999999999999999987
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.96 Aligned_cols=259 Identities=23% Similarity=0.287 Sum_probs=202.7
Q ss_pred HHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 005040 422 IRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-----ERAFRSFDSECEILRNVRHRNLLKILGSCSNL 495 (717)
Q Consensus 422 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 495 (717)
+....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4566789999999999999999999975 78899999997653 23456789999999999999999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 005040 496 DFKALVLEFMPNGSLEKWLYSH---------------------------------------NYFLDILQRLNIMIDVGSA 536 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~ 536 (717)
+..++||||+++|+|.+++... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521 1123577888999999999
Q ss_pred HHHHhhcCCCCCeEecCCCCCCeeeCCCC--cEEEeeeccccccCCCCC--ceeeeccccCccccCCCccCC--CCcCcc
Q 005040 537 LEYLHHCHSSAPIIHCDLKPTNILLDENM--VAHVSDFGISKLLGEGED--SVIQTMTMATIGYMAPEYGSE--GIVSTK 610 (717)
Q Consensus 537 l~~LH~~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgl~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~--~~~~~~ 610 (717)
|+||| +.+|+||||||+||+++.++ .+||+|||++..+..... ........||+.|+|||++.+ ..++.+
T Consensus 181 l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 181 LHYLH----NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHH----HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHH----HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999 67899999999999998776 899999999986643221 112345578999999998765 678999
Q ss_pred cchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCC
Q 005040 611 CDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPH 690 (717)
Q Consensus 611 ~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~ 690 (717)
+||||||+++|||++|+.||......+ ........... .. .+....++.++.+++.+||+.||+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~------------~~---~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLC------------FE---NPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC------------TT---SGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcccc------------cC---CcccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999997632211 11111111100 00 011123456788999999999999
Q ss_pred CCCCHHHHHH
Q 005040 691 KRIHMTDAAA 700 (717)
Q Consensus 691 ~Rpt~~ev~~ 700 (717)
+|||+.|+++
T Consensus 321 ~Rps~~~~l~ 330 (345)
T 3hko_A 321 ERFDAMRALQ 330 (345)
T ss_dssp TSCCHHHHHH
T ss_pred HCCCHHHHhc
Confidence 9999999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.28 Aligned_cols=253 Identities=22% Similarity=0.263 Sum_probs=194.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999976 789999999975432 225677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc--EEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV--AHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~~~~~~ 582 (717)
+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH----~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999997654 3899999999999999999999 678999999999999987765 9999999997543221
Q ss_pred CceeeeccccCccccCCCccCCCCcCcc-cchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTK-CDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
......||+.|+|||++.+..++.+ +||||+||++|||++|+.||....... ............. .
T Consensus 173 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~--------~- 239 (361)
T 3uc3_A 173 ---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVK--------Y- 239 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTC--------C-
T ss_pred ---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCC--------C-
Confidence 2234468999999999877777655 999999999999999999997643222 1222211111100 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+....++.++.+++.+||+.||++|||+.|+++.
T Consensus 240 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 ----SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 011111234568899999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=350.45 Aligned_cols=261 Identities=22% Similarity=0.373 Sum_probs=198.4
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe----
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF---- 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~---- 497 (717)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999997 478999999997643 3345678899999999999999999999866543
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+||||+++|+|.++++..+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999998654 4899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCc-eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 578 LGEGEDS-VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 578 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........ ...
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~-~~~----- 238 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVRED-PIP----- 238 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCC-CCC-----
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcCC-CCC-----
Confidence 6543222 122344689999999999999999999999999999999999999976322111 01111100 000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHHHHHhHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMT-DAAAKLRKIKA 707 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ev~~~L~~~~~ 707 (717)
.......++.++.+++.+||+.||++||++. ++.+.+.++..
T Consensus 239 ---------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 239 ---------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp ---------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ---------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 0011123456788999999999999999654 55566665543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=338.79 Aligned_cols=265 Identities=19% Similarity=0.217 Sum_probs=207.5
Q ss_pred HhccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeee-ecCCeeEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSC-SNLDFKALVL 502 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~lv~ 502 (717)
..++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++.++|++++..++++ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 4789999998754432 24577899999999988777666655 6677889999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~ 579 (717)
||+ +++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 89999999976667999999999999999999999 6789999999999999 789999999999998775
Q ss_pred CCCCc-----eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc--chHHHHHHhhCCCch
Q 005040 580 EGEDS-----VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE--MSLRRWVKESLPHRL 652 (717)
Q Consensus 580 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~ 652 (717)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 234 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 234 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-----
Confidence 44321 12234578999999999999999999999999999999999999997643221 1111111110
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
..... ......++.++.+++.+||+.||++|||++++++.|+++.....
T Consensus 235 -------~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 235 -------MSTPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -------HHSCH--HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -------ccchh--hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00000 00012345678999999999999999999999999999977554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.99 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=214.9
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
...+|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999976 58899999987543 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 504 FMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 504 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|+++++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH----HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH----HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999864 345899999999999999999999 5789999999999999999999999999998765433
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
........+|+.|+|||.+.+..++.++||||+|+++|||++ |..||...... .....+......
T Consensus 166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~----------- 231 (288)
T 3kfa_A 166 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRM----------- 231 (288)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCC-----------
T ss_pred -cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccCCC-----------
Confidence 223344457889999999988899999999999999999999 99998763222 222222211110
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.....++..+.+++.+|++.||++|||+.|+++.|+++...
T Consensus 232 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 232 ------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11123456688999999999999999999999999998654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=336.86 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=202.0
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3478999999999999999999876 67899999997553 2234668899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999998654 3899999999999999999999 68999999999999999999999999999865433
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
.. .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .....+... ..
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-~~---------- 224 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRV-EF---------- 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT-CC----------
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHHHhC-CC----------
Confidence 22 23446899999999999999999999999999999999999999753211 111111100 00
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+..++..+.+++.+||+.||++|||+.|+++.
T Consensus 225 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 -------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011234567899999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.57 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=197.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC-------
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD------- 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------- 496 (717)
.++|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 468999999999999999999986 89999999986433 334577899999999999999999999885433
Q ss_pred --------------------------------------------------eeEEEEEccCCCCHHHHHhhCC--CCCCHH
Q 005040 497 --------------------------------------------------FKALVLEFMPNGSLEKWLYSHN--YFLDIL 524 (717)
Q Consensus 497 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~ 524 (717)
..++||||+++|+|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3799999999999999998653 235677
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc----------eeeeccccCc
Q 005040 525 QRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS----------VIQTMTMATI 594 (717)
Q Consensus 525 ~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~----------~~~~~~~~t~ 594 (717)
.+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........ .......||+
T Consensus 165 ~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHH----hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999 678999999999999999999999999999887544211 1223446899
Q ss_pred cccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHH
Q 005040 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCL 674 (717)
Q Consensus 595 ~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (717)
.|+|||++.+..++.++||||+|+++|||++|..|+... ....... ...... ......+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~--------~~~~~~------~~~~~~~ 299 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDV--------RNLKFP------LLFTQKY 299 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHH--------HTTCCC------HHHHHHC
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHh--------hccCCC------cccccCC
Confidence 999999999999999999999999999999987774321 0111100 000000 1112334
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 675 FSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 675 ~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.++.+++.+||+.||++|||+.|+++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 56789999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=344.67 Aligned_cols=248 Identities=23% Similarity=0.279 Sum_probs=193.5
Q ss_pred hccCCccccccccccEEEEEEEe----cCCCeEEEEEechhh----HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL----SDGTNVAIKIFNLQL----ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 497 (717)
.++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 47899999999999999999986 478999999997542 2234567889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+||||+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH----QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999998654 3889999999999999999999 67899999999999999999999999999876
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+...
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~---------- 236 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTIDKILKC---------- 236 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHT----------
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhC----------
Confidence 43222 1223457899999999999999999999999999999999999999753211 111111110
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
.. ..+..++.++.+++.+||+.||++|| ++.|+++
T Consensus 237 -~~-------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 -KL-------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -CC-------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CC-------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 00 00112345688999999999999999 6677764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.09 Aligned_cols=246 Identities=26% Similarity=0.342 Sum_probs=201.2
Q ss_pred ccCCccccccccccEEEEEEEe-cCCCeEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQ---LERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
+.|+..+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5688999999999999999996 47999999998643 2344567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+. |+|.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 6899988766667999999999999999999999 678999999999999999999999999999876432
Q ss_pred CceeeeccccCccccCCCcc---CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 583 DSVIQTMTMATIGYMAPEYG---SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
....||+.|+|||++ ..+.++.++|||||||++|||++|+.||....... ..........+.
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~--------- 272 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA--------- 272 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC---------
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCC---------
Confidence 234689999999986 46779999999999999999999999986532111 111111111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
. ....++..+.+++.+||+.||++|||+.++++.
T Consensus 273 ~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 L--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C--------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 011234567899999999999999999999763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.71 Aligned_cols=248 Identities=22% Similarity=0.282 Sum_probs=179.9
Q ss_pred cccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEEEccCCCC
Q 005040 432 CNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVLEFMPNGS 509 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~ 509 (717)
.+.||+|+||.||+|... +++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 78999999997543 345678999999997 9999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEEEeeeccccccCCCCCcee
Q 005040 510 LEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM---VAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 510 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||+++....... .
T Consensus 93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~ 165 (325)
T 3kn6_A 93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P 165 (325)
T ss_dssp HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence 999998764 4899999999999999999999 67899999999999998765 899999999987643322 2
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc--chHHHHHHhhCCCchhhhccccchhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE--MSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
.....||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ............... .+.
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~--- 236 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFE--- 236 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCC---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCC---
Confidence 234568999999999999999999999999999999999999997633211 111111111110000 000
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++.++.+++.+||+.||++|||++|+++
T Consensus 237 --~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 --GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp --SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred --cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0111234567899999999999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=342.05 Aligned_cols=265 Identities=22% Similarity=0.256 Sum_probs=201.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 78899999997553 23346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH----AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998654 4899999999999999999999 678999999999999999999999999999876433
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+....+..
T Consensus 188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~---------- 254 (309)
T 2h34_A 188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPRP---------- 254 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCCG----------
T ss_pred cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCCc----------
Confidence 21 1223456899999999999999999999999999999999999999763211 1111111111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhHHhhccch
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-HMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ev~~~L~~~~~~~~~~~ 713 (717)
......++.++.+++.+||+.||++|| +++++++.|++..+....+.
T Consensus 255 -----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 255 -----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp -----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred -----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 001123445688999999999999999 99999999998766554443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=337.49 Aligned_cols=264 Identities=19% Similarity=0.225 Sum_probs=209.9
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeee-ecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSC-SNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++.++|++++..++++ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999997 4899999999865432 24578899999999988866666655 66778899999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeeeccccccCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~~ 580 (717)
|+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 89999999866667999999999999999999999 6789999999999999 4889999999999987754
Q ss_pred CCCce-----eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc--chHHHHHHhhCCCchh
Q 005040 581 GEDSV-----IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE--MSLRRWVKESLPHRLT 653 (717)
Q Consensus 581 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 653 (717)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 234 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------ 234 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH------
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc------
Confidence 43211 1234578999999999999999999999999999999999999997643221 1111111110
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
...... .....++.++.+++.+||+.||++|||+.++++.|+++.....
T Consensus 235 ------~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 235 ------MSTPIE--VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ------HHSCHH--HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ------cCCchH--HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 000000 0112345678999999999999999999999999999876543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=355.51 Aligned_cols=276 Identities=22% Similarity=0.282 Sum_probs=213.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC--eeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD--FKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv 501 (717)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 368999999999999999999976 68999999997544 233566788999999999999999999987655 77999
Q ss_pred EEccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCcEEEeeeccc
Q 005040 502 LEFMPNGSLEKWLYSHN--YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL----DENMVAHVSDFGIS 575 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~ 575 (717)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999998543 33899999999999999999999 6789999999999999 78888999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCC--------CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchH---HHHH
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSE--------GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL---RRWV 644 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~---~~~~ 644 (717)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ....
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 87644321 234568999999998754 568889999999999999999999997543322222 2222
Q ss_pred HhhCCCchhhhc---cccc--h-hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 645 KESLPHRLTEVV---DANL--V-REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 645 ~~~~~~~~~~~~---~~~~--~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
....+..+.... ...+ . ............+..+.+++.+||+.||++||++.|+++.++++..+
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 211111111110 0000 0 00001112245677899999999999999999999999999988654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=357.21 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=205.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999976 799999999976532 23467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999998654 4899999999999999999999 7899999999999999999999999999998765432
Q ss_pred CceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
. ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+... ......+... ..
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~-----------~~- 233 (476)
T 2y94_A 171 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTLFKKICDG-----------IF- 233 (476)
T ss_dssp C---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHHHHHHHTT-----------CC-
T ss_pred c---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHHHHHHhcC-----------Cc-
Confidence 2 234579999999999888765 7899999999999999999999975321 1111111110 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+..++.++.+++.+||+.||++|||+.|+++
T Consensus 234 ------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 001123456889999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.42 Aligned_cols=206 Identities=26% Similarity=0.313 Sum_probs=178.5
Q ss_pred CCHHHHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-----CCceeeEee
Q 005040 417 TSYLDIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-----HRNLLKILG 490 (717)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~~~~ 490 (717)
+++.+-....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+..|+++++.++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 334344445689999999999999999999974 78999999997432 33456778999999996 999999999
Q ss_pred eeecCCeeEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC------
Q 005040 491 SCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE------ 563 (717)
Q Consensus 491 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~------ 563 (717)
++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR----KMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCcccEEEcccccccc
Confidence 999999999999999 899999998654 35899999999999999999999 678999999999999975
Q ss_pred -------------------CCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHH
Q 005040 564 -------------------NMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETF 624 (717)
Q Consensus 564 -------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~ 624 (717)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||+||++|||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 7899999999998754322 3446899999999999999999999999999999999
Q ss_pred hCCCCCCcc
Q 005040 625 TEKKPTDEM 633 (717)
Q Consensus 625 tg~~p~~~~ 633 (717)
+|+.||...
T Consensus 254 ~g~~pf~~~ 262 (360)
T 3llt_A 254 TGSLLFRTH 262 (360)
T ss_dssp HSSCSCCCS
T ss_pred HCCCCCCCC
Confidence 999999763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=335.30 Aligned_cols=262 Identities=23% Similarity=0.394 Sum_probs=210.7
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|++.+.||+|+||.||+|..++++.||+|++..... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 368899999999999999999988888999999875432 34678899999999999999999999874 4579999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 9999999997532 25899999999999999999999 67899999999999999999999999999987654321
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.......+++.|+|||...+..++.++||||||+++|||++ |+.||...... .....+......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~------------- 229 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRM------------- 229 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC-------------
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccCC-------------
Confidence 22233456788999999988889999999999999999999 89998753221 111111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccch
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 713 (717)
.....++.++.+++.+|++.||++|||+.++++.|+++......+.
T Consensus 230 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 230 ----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred ----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 0111345678899999999999999999999999999977665543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.29 Aligned_cols=267 Identities=15% Similarity=0.170 Sum_probs=202.5
Q ss_pred hccCCccccccccccEEEEEEEec----CCCeEEEEEechhhHH-----------HHHHHHHHHHHHHhcCCCceeeEee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQLER-----------AFRSFDSECEILRNVRHRNLLKILG 490 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~hpniv~~~~ 490 (717)
.++|++.+.||+|+||.||+|... ++..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 368999999999999999999975 5788999988644211 1134667889999999999999999
Q ss_pred eeec----CCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-
Q 005040 491 SCSN----LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM- 565 (717)
Q Consensus 491 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~- 565 (717)
++.+ ....++||||+ +++|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH----ENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCcCHHHEEEccCCC
Confidence 9877 77899999999 999999998665 5899999999999999999999 67899999999999999887
Q ss_pred -cEEEeeeccccccCCCCCc-----eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcch
Q 005040 566 -VAHVSDFGISKLLGEGEDS-----VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMS 639 (717)
Q Consensus 566 -~~kl~Dfgl~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~ 639 (717)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876432211 1113457899999999999989999999999999999999999999653322222
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
......... ..+............++.++.+++.+||+.||++|||++++++.|+++..
T Consensus 270 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAKTNLL---------DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHH---------HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHhhc---------ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 221111110 00000000001111455678999999999999999999999999998654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=361.53 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=206.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|+..+.||+|+||.||+|..+ +|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999975 79999999997653 22345678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 502 LEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
|||+++|+|.+++...+ ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|||++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH----~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH----RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999998653 34899999999999999999999 67899999999999999999999999999987754
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcc--hHHHHHHhhCCCchhhhccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM--SLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 658 (717)
... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||........ .+.+.+.. .+..
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~------- 407 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEE------- 407 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCC-------
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-cccc-------
Confidence 332 2345799999999999999999999999999999999999999976432211 11111111 1100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
+ +..++.++.++|.+||+.||++|| +++|+++
T Consensus 408 --------~--p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 408 --------Y--SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --------C--CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --------C--CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 112346688999999999999999 6788765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.24 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=199.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHH-HHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERA-FRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|++.+.||+|+||+||+|... +++.||+|++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999976 78999999987543221 12455799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++ |+|.+++...+..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH----RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 154 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--
Confidence 97 5999999987777999999999999999999999 6789999999999999999999999999998654322
Q ss_pred eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC---CCchhhhccccc
Q 005040 585 VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL---PHRLTEVVDANL 660 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 660 (717)
.......+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||.+.... ........... +..+........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcchh
Confidence 12234468999999998766 66899999999999999999999999764222 11111111111 111111111100
Q ss_pred hh--------hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VR--------EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~--------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ..........++.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 00001111234567889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=340.19 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=205.3
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHH------HHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLER------AFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 468999999999999999999976 7899999998754311 346788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeecc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM----VAHVSDFGI 574 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl 574 (717)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999998653 4899999999999999999999 67899999999999999888 799999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
+........ .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+..... .
T Consensus 166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~-~--- 236 (321)
T 2a2a_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITSVSY-D--- 236 (321)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCC-C---
T ss_pred ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhccc-c---
Confidence 987654322 23446899999999999999999999999999999999999999753211 11111111000 0
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
... .....++..+.+++.+||+.||++|||+.|+++
T Consensus 237 -----~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 237 -----FDE-----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -----CCH-----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -----cCh-----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 001134466889999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=347.09 Aligned_cols=255 Identities=17% Similarity=0.151 Sum_probs=207.8
Q ss_pred HhccCCccccccccccEEEEEEE------ecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC---CCceeeEeeeeecC
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGT------LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR---HRNLLKILGSCSNL 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~ 495 (717)
..++|.+.+.||+|+||+||+|. ..+++.||||++..... ..+..|+++++.++ |+||+.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45789999999999999999994 34788999999975533 45666777787776 99999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--------
Q 005040 496 DFKALVLEFMPNGSLEKWLYS----HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-------- 563 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-------- 563 (717)
+..++||||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECGGGTCC---
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999974 3456999999999999999999999 689999999999999998
Q ss_pred ---CCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchH
Q 005040 564 ---NMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL 640 (717)
Q Consensus 564 ---~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~ 640 (717)
++.+||+|||+++.+.............||++|+|||++.+..++.++|||||||++|||+||+.||.....+...
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 8999999999998765333344455667999999999999999999999999999999999999998653222110
Q ss_pred HHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHHhHHhhc
Q 005040 641 RRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKR-IHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-pt~~ev~~~L~~~~~~~~ 710 (717)
....+.. .+ ....+.+++..|+..+|.+| |+++++.+.|+++..+..
T Consensus 295 ---------------~~~~~~~----~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 295 ---------------PEGLFRR----LP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ---------------ECSCCTT----CS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ---------------echhccc----cC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0011110 01 12346689999999999998 578899999998866543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=371.98 Aligned_cols=262 Identities=23% Similarity=0.401 Sum_probs=208.1
Q ss_pred CCccc-cccccccEEEEEEEec---CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 429 FNECN-LLGTGGFGSVYKGTLS---DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 429 ~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
+.+.. .||+|+||.||+|.++ ++..||||+++... ....+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33344 7999999999999864 56679999997543 3345778999999999999999999999976 56899999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999877777999999999999999999999 67899999999999999999999999999987654322
Q ss_pred c-eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 584 S-VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 584 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
. .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.....
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~------------ 557 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR------------ 557 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTCC------------
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC------------
Confidence 1 11223345789999999988999999999999999999998 99999764322 22222221110
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccchh
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDVA 714 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~~ 714 (717)
...+..++.++.++|.+||+.||++||++.++++.|+.+.........
T Consensus 558 -----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 558 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred -----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 011124567789999999999999999999999999998776655444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=343.45 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=206.0
Q ss_pred hccCCccccccccccEEEEEEEe------cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 47899999999999999999984 257789999986432 34456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEE
Q 005040 499 ALVLEFMPNGSLEKWLYSHN------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVAHV 569 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~kl 569 (717)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++. +..+||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999998653 34889999999999999999999 678999999999999994 456999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhC
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 648 (717)
+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~ 262 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG 262 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcCC
Confidence 99999986644333333344567899999999888889999999999999999998 9999875321 11222222111
Q ss_pred CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 649 PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.. .....++..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 263 ~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 263 RM-----------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 00 0111344568899999999999999999999999998865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.91 Aligned_cols=250 Identities=25% Similarity=0.288 Sum_probs=194.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHH-HHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEI-LRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999976 68899999997654 2233456667776 567899999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++++||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999998654 3889999999999999999999 67899999999999999999999999999986432
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.. ...
T Consensus 192 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~-----------~~~ 256 (373)
T 2r5t_A 192 HNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILN-----------KPL 256 (373)
T ss_dssp CCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HHHHHHHH-----------SCC
T ss_pred CCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHh-----------ccc
Confidence 221 234557999999999999999999999999999999999999999753211 11111111 000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L 702 (717)
. + ...++.++.+++.+||+.||++||++.+..+.+
T Consensus 257 ~-----~--~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 257 Q-----L--KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp C-----C--CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred C-----C--CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 0 0 012345688999999999999999986544433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=344.30 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=197.5
Q ss_pred ccCCcc-ccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNEC-NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 503 (717)
+.|++. +.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 78999999999999965 7999999999765544456788999999985 79999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc---EEEeeeccccccCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV---AHVSDFGISKLLGE 580 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~~~~ 580 (717)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++.....
T Consensus 92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999998654 4899999999999999999999 678999999999999998776 99999999876542
Q ss_pred CCC-----ceeeeccccCccccCCCccCC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC
Q 005040 581 GED-----SVIQTMTMATIGYMAPEYGSE-----GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 581 ~~~-----~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.... ......
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~ 243 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD---RGEACP 243 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc---ccccch
Confidence 211 111223458999999998764 5689999999999999999999999976433221000 000000
Q ss_pred chhhhccccchhhhhhhh--hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 651 RLTEVVDANLVREEQAFS--DKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....+...+.......+ ....++.++.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000000000000000000 11234567899999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=339.56 Aligned_cols=265 Identities=21% Similarity=0.261 Sum_probs=199.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999976 68999999885443 3335668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999998877553 4899999999999999999999 67899999999999999999999999999987653322
Q ss_pred ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC---chhhhccc-
Q 005040 584 SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH---RLTEVVDA- 658 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~- 658 (717)
......+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+ ....+...... ........
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHTC
T ss_pred --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhcccccccccccccc
Confidence 1234568999999998765 678999999999999999999999997643221 11111111000 00000000
Q ss_pred ------cchh---hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 659 ------NLVR---EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 659 ------~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.... ..........++.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 00000011234567889999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=337.85 Aligned_cols=250 Identities=26% Similarity=0.332 Sum_probs=197.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 368999999999999999999975 78999999987654 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeeeccccc
Q 005040 504 FMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKL 577 (717)
Q Consensus 504 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~ 577 (717)
|+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH----SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999998642 356899999999999999999999 6789999999999999 4568899999999987
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
..... ......||+.|+|||.+. +.++.++||||+|+++|||++|+.||...... ..........+.
T Consensus 177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~------- 243 (285)
T 3is5_A 177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATYKEPN------- 243 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC-------
T ss_pred cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhccCCcc-------
Confidence 64322 123456899999999875 56899999999999999999999999763221 111111111000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
... ....++.++.+++.+||+.||++|||+.|+++
T Consensus 244 --~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 --YAV------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CCC--------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccc------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00112456789999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=361.32 Aligned_cols=249 Identities=22% Similarity=0.251 Sum_probs=196.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 478999999999999999999975 79999999998653 33345678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS---EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh---cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999998654 48999999999999999999993 178999999999999999999999999999864322
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .+
T Consensus 303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~---------~~- 368 (446)
T 4ejn_A 303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILMEEI---------RF- 368 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC---------CC-
T ss_pred C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHhCCC---------CC-
Confidence 2 123446799999999999999999999999999999999999999965321 111111111000 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
+..++.++.+++.+||+.||++|| +++|+++
T Consensus 369 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 --------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 112345688999999999999999 9999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.30 Aligned_cols=265 Identities=12% Similarity=0.119 Sum_probs=208.3
Q ss_pred ccCCccccccccccEEEEEEEecC---------CCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceee----------
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSD---------GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLK---------- 487 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~---------- 487 (717)
++|++.+.||+|+||.||+|.... ++.||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 689999999999999999999763 789999998754 45778999999999999988
Q ss_pred -----Eeeeeec-CCeeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 488 -----ILGSCSN-LDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 488 -----~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
+++++.. ....++||||+ +++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH----ENEYVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEE
Confidence 5666654 67889999999 99999999875 355999999999999999999999 679999999999999
Q ss_pred eCCCC--cEEEeeeccccccCCCCCc-----eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 005040 561 LDENM--VAHVSDFGISKLLGEGEDS-----VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633 (717)
Q Consensus 561 l~~~~--~~kl~Dfgl~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~ 633 (717)
++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876532211 1123347899999999999999999999999999999999999999765
Q ss_pred ccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 634 FTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
................ ......+.. .....++.++.+++.+||+.||++|||++++++.|+++.+...
T Consensus 272 ~~~~~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVD-KPGPFVGPC--------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTCHHHHHHHHHHHHH-SCCCEECTT--------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcCHHHHHHHHHhccC-Chhhhhhhc--------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 4333222222221100 000000000 0011234668899999999999999999999999999977654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=366.46 Aligned_cols=190 Identities=22% Similarity=0.201 Sum_probs=131.8
Q ss_pred ccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCC-hhhhcccCCCeEEccCCcCcccCCccccCCC
Q 005040 159 HDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLP-SSLWSLEYILRINLSSNSLKGTLPSNIQKLN 237 (717)
Q Consensus 159 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 237 (717)
..+..+++|++|+|++|.+++ +|..|..+++|+.|++++|++.+..+ ..+..+++|++|++++|.+++..|..+..++
T Consensus 370 ~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 448 (606)
T 3vq2_A 370 YSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448 (606)
T ss_dssp HHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred hhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCC
Confidence 334444445555555555442 33556666677777777777766555 5667777777777777777777777777777
Q ss_pred CCCeEEccCCCCCC-CCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEc
Q 005040 238 VLIDLDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNV 316 (717)
Q Consensus 238 ~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l 316 (717)
+|+.|++++|.+++ ..|..++.+++|++|++++|++++..|..+.++++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 449 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 528 (606)
T 3vq2_A 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDC 528 (606)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEEC
Confidence 77777777777776 35667777788888888888887777777778888888888888887777777888888888888
Q ss_pred cCCccccccccccccc-ccccccccCCccccCCC
Q 005040 317 SHNRLEGEIPVKGSFK-DFSAQSYFGNYALCGPP 349 (717)
Q Consensus 317 ~~N~l~~~~p~~~~~~-~~~~~~~~~n~~~c~~~ 349 (717)
++|+++...+....+. .+..+.+.+|++.|+.+
T Consensus 529 ~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 529 SFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 8888774333333343 36666777888777654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.02 Aligned_cols=243 Identities=26% Similarity=0.346 Sum_probs=202.5
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH--------HHHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE--------RAFRSFDSECEILRNVRHRNLLKILGSCSNL 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 495 (717)
..++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999865 789999999875431 1223567799999999999999999999999
Q ss_pred CeeEEEEEccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecc
Q 005040 496 DFKALVLEFMPNG-SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574 (717)
Q Consensus 496 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 574 (717)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR----LKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999998777 9999998754 3899999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchh
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLT 653 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 653 (717)
+........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 987754332 233568999999999888776 88999999999999999999999652110
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..... ..+..++.++.+++.+||+.||++|||+.|+++.
T Consensus 237 --~~~~~-------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --VEAAI-------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TTTCC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --Hhhcc-------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0011234568899999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.97 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=207.7
Q ss_pred hccCCccc-cccccccEEEEEEEec---CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 426 TDEFNECN-LLGTGGFGSVYKGTLS---DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 426 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
.++|++.+ .||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 36788877 9999999999999642 57889999997553 23356789999999999999999999999 556789
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH----hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999998754 4899999999999999999999 6789999999999999999999999999998775
Q ss_pred CCCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 580 EGEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 580 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.......
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~------ 240 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMG------ 240 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCC------
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCC------
Confidence 443322 1223346788999999988889999999999999999999 9999976322 11222221111000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
.+..++.++.+++.+||+.||++||++.++++.|+++.....
T Consensus 241 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 241 -----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp -----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred -----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 011345678899999999999999999999999999866544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.64 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=191.9
Q ss_pred ccCCcc-ccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHh-cCCCceeeEeeeeec----CCeeE
Q 005040 427 DEFNEC-NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRN-VRHRNLLKILGSCSN----LDFKA 499 (717)
Q Consensus 427 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~----~~~~~ 499 (717)
++|.+. +.||+|+||.||+|... +++.||||++... ..+.+|++++.+ .+||||+++++++.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 567666 68999999999999976 7899999998643 345678888754 489999999998865 56789
Q ss_pred EEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeeccc
Q 005040 500 LVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGIS 575 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~ 575 (717)
+||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999998653 45899999999999999999999 678999999999999997 789999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcc--hHHHHHHhhCCCchh
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM--SLRRWVKESLPHRLT 653 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 653 (717)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+......
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~--- 285 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE--- 285 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC---
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc---
Confidence 8754322 22345789999999999999999999999999999999999999976432211 111111110000
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+. ......++.++.++|.+||+.||++|||+.|+++.
T Consensus 286 ------~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 ------FP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ------CC-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CC-----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 01112345678899999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=339.53 Aligned_cols=267 Identities=25% Similarity=0.302 Sum_probs=199.2
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-----HHHHHHHHHHHHHHHhc---CCCceeeEeeeeecC
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-----ERAFRSFDSECEILRNV---RHRNLLKILGSCSNL 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~ 495 (717)
..++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.+ +||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4579999999999999999999964 78999999986432 11123455677777766 499999999998765
Q ss_pred C-----eeEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 005040 496 D-----FKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV 569 (717)
Q Consensus 496 ~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl 569 (717)
. ..++||||+. |+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEE
Confidence 4 5799999997 59999998654 34899999999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL- 648 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~- 648 (717)
+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus 162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~ 237 (308)
T 3g33_A 162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGL 237 (308)
T ss_dssp CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCC
T ss_pred eeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence 99999987643222 24457899999999998899999999999999999999999999763222 12222222111
Q ss_pred CC--chhhhc---cccchhh--hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 649 PH--RLTEVV---DANLVRE--EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 649 ~~--~~~~~~---~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+. .+.... ...+... ........+++.++.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 10 010000 0000000 0000111234567889999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=357.43 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=202.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368899999999999999999975 79999999997654 22346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 502 LEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|||++||+|.+++... ...+++..+..++.||+.||.||| +.+|+||||||+||+++.++++||+|||+++.+
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH----QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH----HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999854 345899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
...... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......... ..
T Consensus 340 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~--------~~ 408 (543)
T 3c4z_A 340 KAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVL--------EQ 408 (543)
T ss_dssp CTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHH--------HC
T ss_pred cCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHh--------hc
Confidence 543221 234579999999999999999999999999999999999999997642211 1111111100 00
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
.. ..+..++.++.+++.+||+.||++||++
T Consensus 409 ~~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 409 AV-------TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CC-------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred cc-------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 00 0011345668899999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.85 Aligned_cols=259 Identities=29% Similarity=0.475 Sum_probs=206.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCe--EEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTN--VAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv 501 (717)
++|++.+.||+|+||.||+|+.. ++.. ||+|++.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999875 5664 4999886432 33456788999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 005040 502 LEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV 566 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~ 566 (717)
|||+++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||||+||+++.++.
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCccceEEEcCCCe
Confidence 99999999999998653 46899999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 005040 567 AHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVK 645 (717)
Q Consensus 567 ~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~ 645 (717)
+||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.
T Consensus 181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~ 255 (327)
T 1fvr_A 181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLP 255 (327)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHGG
T ss_pred EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--HHHHHhh
Confidence 99999999874321 111233456889999999988889999999999999999998 99999753211 1111111
Q ss_pred hhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 646 ESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
.... ......++.++.+++.+||+.||++|||+.|+++.|+++......
T Consensus 256 ~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 256 QGYR-----------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp GTCC-----------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred cCCC-----------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 0000 001123456688999999999999999999999999998775543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=330.46 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=197.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec----CCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN----LDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~ 499 (717)
..|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 35777889999999999999875 78899999987543 4455778999999999999999999998754 45689
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeeecccc
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP--IIHCDLKPTNILLD-ENMVAHVSDFGISK 576 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl~~ 576 (717)
+||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+ |+||||||+||+++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH----cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999998653 3899999999999999999999 566 99999999999998 88999999999997
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
...... .....||+.|+|||++.+ .++.++||||+|+++|||++|+.||...... ..............
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~-- 249 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSGVKPA-- 249 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTTCCCG--
T ss_pred cccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHHHHHhccCCcc--
Confidence 654322 233468999999998764 5899999999999999999999999753221 11111111100000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++.++.+++.+||+.||++|||+.|+++
T Consensus 250 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 -----------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 001122356889999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=339.56 Aligned_cols=260 Identities=24% Similarity=0.393 Sum_probs=200.3
Q ss_pred hccCCccccccccccEEEEEEEec--CCC--eEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--DGT--NVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|.+. +++ .||+|+++... ....+.+.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 368999999999999999999863 333 68999987542 345577899999999999999999999998765 7
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+++++|.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999999876666899999999999999999999 678999999999999999999999999999877
Q ss_pred CCCCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 579 GEGEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 579 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
....... ......+|..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~------- 242 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGE------- 242 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCC-------
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccCC-------
Confidence 5443222 2234457889999999988889999999999999999999 99999763221 11111111000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
..+....++.++.+++.+||+.||++|||+.++++.|+++..+
T Consensus 243 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 ---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0011123456788999999999999999999999999987654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=344.87 Aligned_cols=271 Identities=26% Similarity=0.318 Sum_probs=200.9
Q ss_pred HHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHH-----HHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLER-----AFRSFDSECEILRNVRHRNLLKILGSCSNLD 496 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 496 (717)
....++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 445678999999999999999999975 6899999999754321 1246788999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..++||||+++ +|.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999975 999999887777899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-CC--ch
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-PH--RL 652 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~--~~ 652 (717)
....... ......+|+.|+|||++.+ ..++.++||||+||++|||++|.+||.+.... ..+........ +. .+
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhh
Confidence 7643322 2234568999999998865 45899999999999999999999998764221 12222222111 10 11
Q ss_pred hhhc---cccchhhhhh---hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 653 TEVV---DANLVREEQA---FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 653 ~~~~---~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.... +.......+. ......++.++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1100 0000000000 00112345678999999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.37 Aligned_cols=264 Identities=22% Similarity=0.227 Sum_probs=195.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC------C
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL------D 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~ 496 (717)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999865 78999999997542 34456788999999999999999999998654 4
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 57999999975 57776653 3889999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc-----
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR----- 651 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----- 651 (717)
...... ......||++|+|||++.+..|+.++||||+||++|||++|+.||.+.... ..+...+.......
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHT
T ss_pred ecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence 765322 224457899999999999999999999999999999999999999763211 11111111111000
Q ss_pred -----hhhhccc-------cchhhhh------hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 652 -----LTEVVDA-------NLVREEQ------AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 652 -----~~~~~~~-------~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
....+.. .+....+ ........+.++.+|+.+||..||++|||++|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000000 000112235678999999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.42 Aligned_cols=257 Identities=21% Similarity=0.253 Sum_probs=191.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeee--------ecC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSC--------SNL 495 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~--------~~~ 495 (717)
..+|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 358999999999999999999975 78999999987666666678899999999996 99999999998 334
Q ss_pred CeeEEEEEccCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeCCCCcEEEee
Q 005040 496 DFKALVLEFMPNGSLEKWLYS--HNYFLDILQRLNIMIDVGSALEYLHHCHSSAP--IIHCDLKPTNILLDENMVAHVSD 571 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--ivH~dlk~~Nill~~~~~~kl~D 571 (717)
...++||||+. |+|.+++.. ....+++..++.++.|++.||.||| +.+ |+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH----RQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCEEEccCCcccEEECCCCCEEEec
Confidence 55799999996 799999874 3455999999999999999999999 567 99999999999999999999999
Q ss_pred eccccccCCCCCce----------eeeccccCccccCCCcc---CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcc
Q 005040 572 FGISKLLGEGEDSV----------IQTMTMATIGYMAPEYG---SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM 638 (717)
Q Consensus 572 fgl~~~~~~~~~~~----------~~~~~~~t~~y~aPE~~---~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~ 638 (717)
||++.......... ......+|+.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 99998765432211 11134589999999987 5677899999999999999999999999652211
Q ss_pred hHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 639 SLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
......... +....++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 260 ---~~~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 260 ---RIVNGKYSI-----------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ---------CCC-----------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---HhhcCcccC-----------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111111000 000112233679999999999999999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.55 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=194.3
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCceeeEeeeeec
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--------ERAFRSFDSECEILRNVRHRNLLKILGSCSN 494 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 494 (717)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 44678999999999999999999875 78999999987543 1122347889999999999999999999864
Q ss_pred CCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEEEee
Q 005040 495 LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM---VAHVSD 571 (717)
Q Consensus 495 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 571 (717)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCCCcceEEEee
Confidence 45799999999999999887654 4899999999999999999999 57899999999999997544 599999
Q ss_pred eccccccCCCCCceeeeccccCccccCCCccC---CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC
Q 005040 572 FGISKLLGEGEDSVIQTMTMATIGYMAPEYGS---EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 572 fgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 648 (717)
||+++...... ......||+.|+|||++. ...++.++||||+||++|||++|+.||...... ......+....
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i~~~~ 361 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSGK 361 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHHHTTC
T ss_pred cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHHhcCC
Confidence 99998765322 223457899999999875 367889999999999999999999999763322 22222222111
Q ss_pred CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 649 PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..... .....++.++.+++.+||+.||++|||++|+++
T Consensus 362 ~~~~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 362 YNFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCCH--------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCc--------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 10000 011234566889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=340.42 Aligned_cols=258 Identities=26% Similarity=0.368 Sum_probs=207.7
Q ss_pred HHHHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--------HHHHHHHHHHHHHHHhc-CCCceeeE
Q 005040 419 YLDIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--------ERAFRSFDSECEILRNV-RHRNLLKI 488 (717)
Q Consensus 419 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~hpniv~~ 488 (717)
+.......++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3344556688999999999999999999986 79999999986542 23346688899999999 79999999
Q ss_pred eeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 005040 489 LGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAH 568 (717)
Q Consensus 489 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~k 568 (717)
++++......++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999998653 4899999999999999999999 67899999999999999999999
Q ss_pred EeeeccccccCCCCCceeeeccccCccccCCCccC------CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHH
Q 005040 569 VSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS------EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRR 642 (717)
Q Consensus 569 l~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~ 642 (717)
|+|||++..+..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... .....
T Consensus 241 l~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~ 315 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLR 315 (365)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH
T ss_pred EEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHH
Confidence 999999987754322 23457899999999764 34688999999999999999999999965321 11111
Q ss_pred HHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 643 WVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+....... ..+....++..+.+++.+||+.||++|||+.|+++
T Consensus 316 ~i~~~~~~~--------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIMEGQYQF--------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHTCCCC--------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCCCC--------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111110000 00111234566889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.34 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=205.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 468999999999999999999976 68899999987553 34456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++++|.+++.... .+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999987654 4899999999999999999999 678999999999999999999999999999876432
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. ......||+.|+|||...+..++.++||||+|+++|||++|+.||......+ ........ . .
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~----~--------~- 232 (294)
T 2rku_A 169 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKN----E--------Y- 232 (294)
T ss_dssp TC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTT----C--------C-
T ss_pred cc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhc----c--------C-
Confidence 22 1234568999999999999899999999999999999999999997632211 01110000 0 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+..++..+.+++.+||+.||++|||++|+++.
T Consensus 233 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0011234567899999999999999999999873
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=355.27 Aligned_cols=195 Identities=27% Similarity=0.389 Sum_probs=154.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeee-----cCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCS-----NLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~ 497 (717)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++. ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999875 78999999986532 334567889999999999999999999983 3357
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+||||+ +|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH----hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 479999998654 4899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCc-------------------------eeeeccccCccccCCCcc-CCCCcCcccchhhHHHHHHHHHhC
Q 005040 578 LGEGEDS-------------------------VIQTMTMATIGYMAPEYG-SEGIVSTKCDVYSYGVLLMETFTE 626 (717)
Q Consensus 578 ~~~~~~~-------------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~Dvws~G~il~el~tg 626 (717)
....... ......+||++|+|||++ ....++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6432211 122345789999999975 567799999999999999999993
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=341.98 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=200.1
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 502 (717)
..++|++.+.||+|+||.||+|..+ +++.||+|++..... ...+|++++.++ +||||+++++++.+.+..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3578999999999999999999976 789999999975532 234588888888 7999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC----CcEEEeeecccccc
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN----MVAHVSDFGISKLL 578 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~~ 578 (717)
||+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||++..+ +.+||+|||++...
T Consensus 96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999998654 4899999999999999999999 6789999999999998533 35999999999876
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc-chHHHHHHhhCCCchhhhcc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE-MSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 657 (717)
..... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+...+......
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~------- 241 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS------- 241 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC-------
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc-------
Confidence 54322 2234578999999999988889999999999999999999999997532111 1111111110000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.. .....++.++.+++.+||..||++|||+.|+++
T Consensus 242 --~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 --LSG-----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CCS-----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cCc-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 001134566889999999999999999999876
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.97 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=195.3
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD------ 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------ 496 (717)
.++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367999999999999999999975 79999999985432 334567889999999999999999999987653
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..|+||||+ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 78999999874 3899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC--chh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH--RLT 653 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 653 (717)
..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+.......... ...
T Consensus 177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 76432 234468999999998766 77999999999999999999999999763221 1111111111110 000
Q ss_pred hhcccc--------chhh-hhhh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 654 EVVDAN--------LVRE-EQAF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 654 ~~~~~~--------~~~~-~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+... +... ...+ .....++.++.+++.+||..||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000 0000 0000 001234567899999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=334.48 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=202.7
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
..++|.+.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3478999999999999999999976 799999999976544445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeeeccccccCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~~ 580 (717)
|+++++|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH----ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999997654 4899999999999999999999 6789999999999999 7889999999999876432
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
.. .....||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......+...... . ..
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~-~----~~-- 228 (304)
T 2jam_A 162 GI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGYYE-F----ES-- 228 (304)
T ss_dssp BT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHCCCC-C----CT--
T ss_pred Cc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCC-C----Cc--
Confidence 21 2334689999999999999999999999999999999999999975321 1111111111000 0 00
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+....++.++.+++.+||+.||++|||+.|+++
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 -------PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011134466889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=344.32 Aligned_cols=268 Identities=22% Similarity=0.281 Sum_probs=195.6
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
...++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999865 78999999996443 2234567789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee-----CCCCcEEEeeeccc
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL-----DENMVAHVSDFGIS 575 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Dfgl~ 575 (717)
||||++ |+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 111 v~e~~~-~~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH----SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEECCS-EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEecCC-CCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999997 599999987654 899999999999999999999 6789999999999999 45556999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-CCCc--
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES-LPHR-- 651 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~-- 651 (717)
........ ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+....... .+..
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhh
Confidence 87653322 22344679999999988764 58999999999999999999999997632211 122221111 1110
Q ss_pred hhhhcc--------ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 652 LTEVVD--------ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 652 ~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+..... +..............++.++.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 0000000000011124567889999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=329.73 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=206.3
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH------HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE------RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 367999999999999999999986 799999999865421 1356788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeecc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM----VAHVSDFGI 574 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl 574 (717)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999997643 4899999999999999999999 67899999999999999877 899999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
+........ .....+|+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..... .
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~--- 229 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTNISAVNY-D--- 229 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTTCC-C---
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHHhHhccc-C---
Confidence 987643321 23346899999999999999999999999999999999999999763211 11111110000 0
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHhHHh
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA--KLRKIKAK 708 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~--~L~~~~~~ 708 (717)
... .....++..+.+++.+||+.||++|||+.|+++ .+++++++
T Consensus 230 -----~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 230 -----FDE-----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp -----CCH-----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred -----Ccc-----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 000 011234566889999999999999999999997 46665443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=334.65 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=200.2
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec-CCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN-LDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||.||+|+. .|+.||||++.... ..+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46899999999999999999988 48899999987543 34678899999999999999999998654 4578999999
Q ss_pred cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++|+|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999998643 23789999999999999999999 6789999999999999999999999999988654321
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~------------- 232 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK------------- 232 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCC-------------
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCC-------------
Confidence 22357889999999988889999999999999999998 99999763221 11111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
......++..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 233 ----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 0111234567889999999999999999999999999987653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=348.85 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=205.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 368999999999999999999976 78999999987553 3445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999998654 38999999999999999999994 137999999999999999999999999999765321
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh----------------
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES---------------- 647 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~---------------- 647 (717)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .......
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH--HHHHC------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccCCCCCCCcccCC
Confidence 12334689999999999999999999999999999999999999975322111 0000000
Q ss_pred -----------CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 648 -----------LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 648 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+....+..+........ ......++.++.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000001111111100000 0111234567899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=342.66 Aligned_cols=267 Identities=25% Similarity=0.304 Sum_probs=200.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 368999999999999999999976 68999999885443 334466788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++++|.++..... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH----HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999988888766443 4899999999999999999999 6789999999999999999999999999998764322
Q ss_pred CceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC--Cchhh-----
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP--HRLTE----- 654 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~----- 654 (717)
. ......||+.|+|||++.+. .++.++||||+|+++|||++|+.||......+ ........... .....
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHC
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhc
Confidence 2 22345689999999988765 78999999999999999999999997643221 11111111000 00000
Q ss_pred -----hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 -----VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...+..............++.++.+++.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000001111245677999999999999999999999886
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.13 Aligned_cols=252 Identities=25% Similarity=0.315 Sum_probs=200.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999986 6899999999876655667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++++|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...... .
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH----SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L 171 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence 9999999999876666999999999999999999999 678999999999999999999999999987643211 1
Q ss_pred eeeeccccCccccCCCcc-----CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 585 VIQTMTMATIGYMAPEYG-----SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ..........+.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~--------- 241 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPPT--------- 241 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC---------
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCcc---------
Confidence 112234689999999986 46778999999999999999999999997632211 111111111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++.++.+++.+||+.||++|||+.|+++
T Consensus 242 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0111234566889999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=355.20 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=203.8
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
..++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3478999999999999999999976 79999999997553 23456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeecccccc
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLL 578 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~ 578 (717)
|||+.+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++ .++.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999987654 4899999999999999999999 67899999999999995 5668999999999876
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh-hCCCchhhhcc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE-SLPHRLTEVVD 657 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 657 (717)
.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+... ......+.. .....
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~------ 242 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFD------ 242 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCSC------
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCC------
Confidence 4432 2234579999999999875 589999999999999999999999976321 111111111 11000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.+....++.++.+++.+||+.||++|||+.|+++.
T Consensus 243 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 ---------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122345678899999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.29 Aligned_cols=260 Identities=20% Similarity=0.285 Sum_probs=201.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeec--CCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSN--LDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|... +++.||||++.... .+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 68999999999999999999864 78999999987443 356788999999997 9999999999987 66789999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeeccccccCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEG 581 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 581 (717)
||+++++|.++++. +++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999864 789999999999999999999 67899999999999999776 8999999999876543
Q ss_pred CCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc---------
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR--------- 651 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 651 (717)
.. .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||.........+...........
T Consensus 185 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 32 234568999999998776 67899999999999999999999999543322222222111111000
Q ss_pred ------hhhhccccch---hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 652 ------LTEVVDANLV---REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 652 ------~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+....... ...........++.++.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 000000111235677899999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.49 Aligned_cols=246 Identities=26% Similarity=0.341 Sum_probs=204.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 368999999999999999999976 68889999997553 22246788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999998654 4899999999999999999999 789999999999999999999999999998765432
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
. .....|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+... +..+
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~---------~~~~- 231 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETHRRIVNV---------DLKF- 231 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTT---------CCCC-
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHHHHHhcc---------ccCC-
Confidence 2 23456899999999999999999999999999999999999999753211 111111000 0000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+..++.++.+++.+|++.||++|||+.|+++
T Consensus 232 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 --------PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0123456789999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=370.14 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=213.0
Q ss_pred HhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..++|++.+.||+|+||.||+|.++++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3467889999999999999999998888899999975432 24678999999999999999999999876 678999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++|+|.++++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 417 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence 9999999999853 345899999999999999999999 6789999999999999999999999999998764321
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
........++..|+|||++.+..++.++|||||||++|||++ |+.||.+.... .....+.....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~------------- 482 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYR------------- 482 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTCC-------------
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence 111223356788999999988899999999999999999999 99999764221 11111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccch
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 713 (717)
......++.++.++|.+||+.||++|||+.++++.|+.+......++
T Consensus 483 ----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~ 529 (535)
T 2h8h_A 483 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529 (535)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence 01112455678899999999999999999999999998866544443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.26 Aligned_cols=248 Identities=23% Similarity=0.282 Sum_probs=205.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
..+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999976 68899999987553 34556788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++++|.+++.... .+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999987653 4899999999999999999999 678999999999999999999999999999876432
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..........
T Consensus 195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~------------- 258 (335)
T 2owb_A 195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEY------------- 258 (335)
T ss_dssp TC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC-------------
T ss_pred cc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCCC-------------
Confidence 22 1234568999999999988889999999999999999999999997532111 1111101000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++..+.+++.+||+.||++|||+.|+++
T Consensus 259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001123456789999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.29 Aligned_cols=250 Identities=24% Similarity=0.286 Sum_probs=189.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 478999999999999999999974 78999999997553 223344555666688889999999999999999999999
Q ss_pred EccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 503 EFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCHSSA-PIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 503 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
||++ |+|.+++.. ....+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|||++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH----SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9997 588888764 4556999999999999999999999 55 8999999999999999999999999999876
Q ss_pred CCCCCceeeeccccCccccCCCcc----CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYG----SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
.... ......||+.|+|||++ .+..++.++||||+|+++|||++|+.||..................+..
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 234 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL--- 234 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC---
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc---
Confidence 4332 12334689999999985 6677899999999999999999999999753222222222222111110
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....++.++.+++.+||+.||++|||+.|+++
T Consensus 235 --------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 --------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 01123456889999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=366.17 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=201.9
Q ss_pred ccccccccEEEEEEEec---CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS---DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 56789999997654 2345789999999999999999999999975 457899999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc-ee
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS-VI 586 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~ 586 (717)
|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH----~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999998654 4899999999999999999999 678999999999999999999999999999877543321 22
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... .....+.....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~---------------- 590 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER---------------- 590 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC----------------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC----------------
Confidence 233456889999999999999999999999999999998 99999764321 11111111100
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
...+..++.++.++|.+||+.||++||++.+|++.|+++.....
T Consensus 591 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 591 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 01112455678999999999999999999999999998876543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.84 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=201.1
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999976 68999999987543 23568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++++|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH----FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999999865566999999999999999999999 67899999999999999999999999999987643221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......||+.|+|||...+..++.++||||||+++|||++|+.||...... ..........+..
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~------------ 244 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--RAIFMIPTNPPPT------------ 244 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCC------------
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcCCCcc------------
Confidence 223456899999999999999999999999999999999999999753211 1111111111100
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++.++.+++.+||+.||++|||+.++++
T Consensus 245 ---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 ---FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111223456889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=353.34 Aligned_cols=247 Identities=14% Similarity=0.183 Sum_probs=191.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechh---hHHHHHHHHHHH---HHHHhcCCCceeeEe-------ee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQ---LERAFRSFDSEC---EILRNVRHRNLLKIL-------GS 491 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~hpniv~~~-------~~ 491 (717)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467889999999999999999964 7999999998733 234557788999 455555899999998 55
Q ss_pred eecCC-----------------eeEEEEEccCCCCHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHhhcCCCCC
Q 005040 492 CSNLD-----------------FKALVLEFMPNGSLEKWLYSHNY------FLDILQRLNIMIDVGSALEYLHHCHSSAP 548 (717)
Q Consensus 492 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ 548 (717)
+.+.+ ..|+||||+ +|+|.+++...+. .+++..+..++.|++.||+||| +.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ 226 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYG 226 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH----HTT
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH----hCC
Confidence 55443 278999999 6899999985422 2335888899999999999999 678
Q ss_pred eEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCC-----------CcCcccchhhHH
Q 005040 549 IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG-----------IVSTKCDVYSYG 617 (717)
Q Consensus 549 ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Dvws~G 617 (717)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999986432 2234467 999999998877 899999999999
Q ss_pred HHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 005040 618 VLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTD 697 (717)
Q Consensus 618 ~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e 697 (717)
|++|||++|+.||....... ....+... ...++.++.+++.+||+.||++|||+.|
T Consensus 301 ~il~elltg~~Pf~~~~~~~-------------~~~~~~~~-----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALG-------------GSEWIFRS-----------CKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHHSSCCC------C-------------CSGGGGSS-----------CCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred HHHHHHHHCCCCCccccccc-------------chhhhhhh-----------ccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 99999999999996532111 01111110 0133456889999999999999999999
Q ss_pred HHH--HHHHhHH
Q 005040 698 AAA--KLRKIKA 707 (717)
Q Consensus 698 v~~--~L~~~~~ 707 (717)
+++ .++++..
T Consensus 357 ~l~hp~f~~~~~ 368 (377)
T 3byv_A 357 AMETPEYEQLRT 368 (377)
T ss_dssp HHTSHHHHHHHH
T ss_pred HhhChHHHHHHH
Confidence 986 4555544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=331.88 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=206.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.+.|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 357899999999999999999865 78999999997553 3345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999999764 4899999999999999999999 67899999999999999999999999999987654321
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+....+.. +
T Consensus 175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~--------~--- 239 (303)
T 3a7i_A 175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPPT--------L--- 239 (303)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCC--------C---
T ss_pred --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCCC--------C---
Confidence 223456899999999999999999999999999999999999999753221 1111111111110 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
...++..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 ------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11234568899999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=350.32 Aligned_cols=263 Identities=19% Similarity=0.227 Sum_probs=209.9
Q ss_pred hccCCccccccccccEEEEEEEe-cCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCC-CceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNVRH-RNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+..|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 47999999987654322 357789999999976 566666666777888899999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeeeccccccCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~~ 580 (717)
|+ +++|.+++......+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 89999999976667999999999999999999999 6789999999999999 6889999999999987754
Q ss_pred CCCce-----eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcch--HHHHHHhhCCCchh
Q 005040 581 GEDSV-----IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMS--LRRWVKESLPHRLT 653 (717)
Q Consensus 581 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~ 653 (717)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... +.............
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 43211 122557899999999999999999999999999999999999999764332111 11111110000000
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
.....++.++.+++..||+.+|++||++.++++.|+++....
T Consensus 239 --------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 239 --------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp --------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 011234567899999999999999999999999999986643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=334.82 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=204.9
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec---------
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN--------- 494 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------- 494 (717)
...+|+..+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4578999999999999999999986 79999999987543 345679999999999999999998854
Q ss_pred -------CCeeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 005040 495 -------LDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV 566 (717)
Q Consensus 495 -------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~ 566 (717)
....++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHEEEcCCCC
Confidence 34579999999999999999854 345899999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh
Q 005040 567 AHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 567 ~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 646 (717)
+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|||++|..|+... ..+...
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFTD 230 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHHH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHHH
Confidence 99999999987654322 23346899999999998889999999999999999999999986421 111111
Q ss_pred hCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
... ..+. ..++.++.+++.+||+.||++|||+.|+++.|..+.+.-
T Consensus 231 ~~~--------~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 231 LRD--------GIIS---------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHT--------TCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred hhc--------cccc---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 000 0000 123355789999999999999999999999999886543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.70 Aligned_cols=200 Identities=26% Similarity=0.346 Sum_probs=167.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Ce
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL-----DF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~ 497 (717)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999975 78899999996532 34456788999999999999999999998665 57
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+||||++ |+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH----~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999996 59999998653 4899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCc--------------------eeeeccccCccccCCCcc-CCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 005040 578 LGEGEDS--------------------VIQTMTMATIGYMAPEYG-SEGIVSTKCDVYSYGVLLMETFTEKKPTD 631 (717)
Q Consensus 578 ~~~~~~~--------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~Dvws~G~il~el~tg~~p~~ 631 (717)
....... ......+||++|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 6543221 112456789999999975 66779999999999999999998666554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=330.79 Aligned_cols=251 Identities=27% Similarity=0.357 Sum_probs=198.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
++|.....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555668999999999999974 78899999987665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeeccccccCCCC
Q 005040 506 PNGSLEKWLYSHN--YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 506 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~ 582 (717)
++++|.+++.... ...++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH----DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH----hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999998653 34678899999999999999999 678999999999999987 8999999999998764322
Q ss_pred CceeeeccccCccccCCCccCCCC--cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGI--VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
. ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||................... +.+
T Consensus 178 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~ 247 (295)
T 2clq_A 178 P--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH--------PEI 247 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC--------CCC
T ss_pred C--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc--------ccc
Confidence 1 123456899999999876643 7899999999999999999999996532211111110000000 000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+..++.++.+++.+||+.||++|||+.|+++
T Consensus 248 ---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 ---------PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1134456889999999999999999999975
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=369.08 Aligned_cols=334 Identities=23% Similarity=0.248 Sum_probs=176.0
Q ss_pred CccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccC
Q 005040 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGIL 84 (717)
Q Consensus 5 P~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 84 (717)
|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|.+++..+.. ..|.++++|++|+|++|.+++..
T Consensus 66 ~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~------~~~~~L~~L~~L~Ls~N~l~~~~ 139 (844)
T 3j0a_A 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKD------GYFRNLKALTRLDLSKNQIRSLY 139 (844)
T ss_dssp TTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTT------CCCSSCSSCCEEEEESCCCCCCC
T ss_pred HHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccC------ccccccCCCCEEECCCCcccccc
Confidence 556666666666666666666666666666666666666666666522111 12566777777777777776554
Q ss_pred C-cchhccccccceeeecCCcceecCCccccCC-----------------------------------------------
Q 005040 85 P-PLIGNFSASLQNIYAFECKLGGSIPKEIGNL----------------------------------------------- 116 (717)
Q Consensus 85 ~-~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l----------------------------------------------- 116 (717)
+ ..|.++ ++|++|++++|.+.+..+..+..+
T Consensus 140 ~~~~~~~L-~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~ 218 (844)
T 3j0a_A 140 LHPSFGKL-NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTV 218 (844)
T ss_dssp CCGGGGTC-SSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSST
T ss_pred cchhHhhC-CCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCch
Confidence 4 355555 567777777776655444333221
Q ss_pred -----------------------------------------------CCCcEEEccCCCCcccCCccccccCCCCEEecc
Q 005040 117 -----------------------------------------------RGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVP 149 (717)
Q Consensus 117 -----------------------------------------------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 149 (717)
++|+.|+|++|.+.+..+..|..+++|+.|+|+
T Consensus 219 ~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 298 (844)
T 3j0a_A 219 DITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298 (844)
T ss_dssp TTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEE
T ss_pred hHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECC
Confidence 123333333333333333334444444444444
Q ss_pred CCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccC
Q 005040 150 ENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTL 229 (717)
Q Consensus 150 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 229 (717)
+|++++..+..|.++++|++|+|++|.+++..+..|..+++|+.|+|++|++.+..+..|..+++|++|+|++|.+++..
T Consensus 299 ~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~ 378 (844)
T 3j0a_A 299 YNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH 378 (844)
T ss_dssp SCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS
T ss_pred CCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc
Confidence 44444444444444444444444444444444444444444444444444444444444444444444444444443210
Q ss_pred C------------------c----------------------cccCCCCCCeEEccCCCCCCCC----------------
Q 005040 230 P------------------S----------------------NIQKLNVLIDLDLSRNQLSSDI---------------- 253 (717)
Q Consensus 230 ~------------------~----------------------~~~~l~~L~~L~l~~N~l~~~~---------------- 253 (717)
. . .+..+++|+.|+|++|.+++..
T Consensus 379 ~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L 458 (844)
T 3j0a_A 379 FIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458 (844)
T ss_dssp SCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEE
T ss_pred CCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccC
Confidence 0 0 0113334444444444443211
Q ss_pred --------------cccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCC
Q 005040 254 --------------PSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHN 319 (717)
Q Consensus 254 --------------~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N 319 (717)
+..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..+..+. ++|+.|+|++|
T Consensus 459 s~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N 536 (844)
T 3j0a_A 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRN 536 (844)
T ss_dssp ESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEE
T ss_pred CCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCC
Confidence 12244455566666666666655555566666666666666666655554444 56666666666
Q ss_pred cccccccccccccccccccccCCccccCCC
Q 005040 320 RLEGEIPVKGSFKDFSAQSYFGNYALCGPP 349 (717)
Q Consensus 320 ~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 349 (717)
++++..|. .+..+..+.+.+|++.|+.+
T Consensus 537 ~l~~~~~~--~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 537 QLLAPNPD--VFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp CCCCCCSC--CCSSCCEEEEEEECCCCSSS
T ss_pred cCCCCChh--HhCCcCEEEecCCCcccccc
Confidence 66665553 35566777788999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=355.88 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=198.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.++|++.+.||+|+||+||+|..+ +++.||+|++.... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 468999999999999999999976 78899999987543 223467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~ 579 (717)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||++....
T Consensus 116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999887654 3899999999999999999999 678999999999999976 4559999999998765
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-CCCchhhhccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES-LPHRLTEVVDA 658 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 658 (717)
... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||.+.... .....+... ....
T Consensus 191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~------- 257 (494)
T 3lij_A 191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGKYTFD------- 257 (494)
T ss_dssp TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCCC-------
T ss_pred CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCCC-------
Confidence 432 223456999999999876 46999999999999999999999999763221 111111111 1000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+....++.++.+++.+||+.||++|||+.|+++
T Consensus 258 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 --------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0111234566889999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=329.66 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=202.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeee--ecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSC--SNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~--~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++ ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999976 78999999987543 34456789999999999999999999987 44678899
Q ss_pred EEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCC-----eEecCCCCCCeeeCCCCcEEEeee
Q 005040 501 VLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHSSAP-----IIHCDLKPTNILLDENMVAHVSDF 572 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Df 572 (717)
||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~----~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR----RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH----HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc----ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999999753 3458999999999999999999994 55 999999999999999999999999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCch
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 652 (717)
|++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.......
T Consensus 161 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~~~- 235 (279)
T 2w5a_A 161 GLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRR- 235 (279)
T ss_dssp CHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCC-
T ss_pred chheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhccccc-
Confidence 99987643321 12234689999999999888999999999999999999999999976321 11111111111000
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
+ +..++.++.+++.+||+.||++|||+.|+++.+.
T Consensus 236 -------~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 -------I---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -------C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -------C---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 0 1134466889999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=339.76 Aligned_cols=269 Identities=21% Similarity=0.274 Sum_probs=202.8
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec--------
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN-------- 494 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-------- 494 (717)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999974 79999999885443 2223567789999999999999999999876
Q ss_pred CCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecc
Q 005040 495 LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574 (717)
Q Consensus 495 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 574 (717)
.+..++||||+++ +|.+.+......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 3468999999974 888888877667999999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCC--ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh--hCC
Q 005040 575 SKLLGEGED--SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE--SLP 649 (717)
Q Consensus 575 ~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~ 649 (717)
++.+..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..... ........ ..+
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSIT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence 987653222 122344568999999998765 568999999999999999999999997632221 11111111 111
Q ss_pred Cc-hhhhccccch----------hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 650 HR-LTEVVDANLV----------REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 650 ~~-~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ....-..... ............+..+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11 1111000000 000000011112456889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.97 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=201.3
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH-------------HHHHHHHHHHHHHHhcCCCceeeEee
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-------------RAFRSFDSECEILRNVRHRNLLKILG 490 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~hpniv~~~~ 490 (717)
..++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999976 688999999865431 23467889999999999999999999
Q ss_pred eeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cE
Q 005040 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM---VA 567 (717)
Q Consensus 491 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~---~~ 567 (717)
++.+....++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH----KHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999997654 3899999999999999999999 67899999999999999776 69
Q ss_pred EEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 005040 568 HVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES 647 (717)
Q Consensus 568 kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 647 (717)
||+|||++........ .....||+.|+|||++. +.++.++||||+||++|+|++|+.||.+.... .....+...
T Consensus 189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~ 262 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEKG 262 (504)
T ss_dssp EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC
Confidence 9999999987654322 23456999999999877 46899999999999999999999999763221 111111110
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. ... .......++.++.+++.+||+.||.+|||+.|+++
T Consensus 263 ~-----------~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 263 K-----------YYF---DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp C-----------CCC---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-----------CCC---CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 000 00111234567889999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=326.96 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=196.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE---RAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999976 799999999976532 2346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999998654 3899999999999999999999 578999999999999999999999999999876443
Q ss_pred CCceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
.. .....+|+.|+|||.+.+..+ +.++||||+|+++|||++|+.||..... ......+.....
T Consensus 165 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~----------- 228 (276)
T 2h6d_A 165 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFKKIRGGVF----------- 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-----------
T ss_pred cc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhcCcc-----------
Confidence 21 233468999999999887765 6899999999999999999999975321 111111111100
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+..++..+.+++.+||+.||++|||+.|+++.
T Consensus 229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011234568899999999999999999999873
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=347.78 Aligned_cols=254 Identities=11% Similarity=0.103 Sum_probs=183.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc--CCCceeeEe-------eee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV--RHRNLLKIL-------GSC 492 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~hpniv~~~-------~~~ 492 (717)
..+|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 356899999999999999999975 78999999997643 33456677786555555 699988855 333
Q ss_pred ecC-----------------CeeEEEEEccCCCCHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCCCe
Q 005040 493 SNL-----------------DFKALVLEFMPNGSLEKWLYSHNYFLDILQR------LNIMIDVGSALEYLHHCHSSAPI 549 (717)
Q Consensus 493 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~~i 549 (717)
... ...|+||||++ |+|.+++...+..+++..+ ..++.|++.||+||| +.+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH----~~~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ----SKGL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH----HTTE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH----HCCC
Confidence 222 34799999998 8999999865444566666 788899999999999 6789
Q ss_pred EecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCC
Q 005040 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEK 627 (717)
Q Consensus 550 vH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~ 627 (717)
+||||||+|||++.++.+||+|||+++..+.. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876421 124457799999999887 77999999999999999999999
Q ss_pred CCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 628 KPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 628 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.||......... .|... .......... ..+....++..+.+++.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~--~~~~~----~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKG--SWKRP----SLRVPGTDSL-----AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTT--CCCBC----CTTSCCCCSC-----CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCccccc--chhhh----hhhhcccccc-----chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999875332110 00000 0000000000 11111244567889999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=337.83 Aligned_cols=262 Identities=25% Similarity=0.323 Sum_probs=187.7
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999864 78999999987543 33456788899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecc
Q 005040 502 LEFMPNGSLEKWLYS-------HNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 574 (717)
|||+++++|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH----KNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999974 2445899999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCC---ceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC
Q 005040 575 SKLLGEGED---SVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 575 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
+........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ........+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~ 245 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLTLQNDPP 245 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHTSSCC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHHhccCCC
Confidence 987643321 111234468999999998765 5689999999999999999999999976433221 1111111111
Q ss_pred chh-hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 651 RLT-EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 651 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
... ...+... ...++.++.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEM---------LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CC---------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchh---------hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111 0011111 1123456889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=339.20 Aligned_cols=273 Identities=21% Similarity=0.234 Sum_probs=202.0
Q ss_pred HHHHHHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhh-----------HHHHHHHHHHHHHHHhcCCCceee
Q 005040 419 YLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL-----------ERAFRSFDSECEILRNVRHRNLLK 487 (717)
Q Consensus 419 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~hpniv~ 487 (717)
..++....++|++.+.||+|+||.||+|...+|+.||||++.... ....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456778889999999999999999999998889999999885421 223467899999999999999999
Q ss_pred Eeeeee-----cCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 005040 488 ILGSCS-----NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD 562 (717)
Q Consensus 488 ~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~ 562 (717)
+++++. .....++||||++ |+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH----EAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCEecCCChHHEEEc
Confidence 999983 3446899999997 6999999877777999999999999999999999 67899999999999999
Q ss_pred CCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHH
Q 005040 563 ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR 641 (717)
Q Consensus 563 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~ 641 (717)
.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~ 244 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLN 244 (362)
T ss_dssp TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHH
T ss_pred CCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 99999999999997543322 2234568999999998776 77999999999999999999999999763211 1111
Q ss_pred HHHHhhCCCchhhh-----------ccccchhhh--hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 642 RWVKESLPHRLTEV-----------VDANLVREE--QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 642 ~~~~~~~~~~~~~~-----------~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.............. ......... ........++..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111111100 000000000 000111233566889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=356.07 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=205.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999976 89999999986543 23456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeeecccccc
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLL 578 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~ 578 (717)
|||+.+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++..+
T Consensus 105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999998654 4899999999999999999999 6789999999999999 56789999999999877
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-CCCchhhhcc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES-LPHRLTEVVD 657 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 657 (717)
..... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+... ....
T Consensus 180 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~------ 247 (484)
T 3nyv_A 180 EASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTFE------ 247 (484)
T ss_dssp CCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCC------
T ss_pred ccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCCCC------
Confidence 54332 234568999999998865 689999999999999999999999976321 1112211111 0000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+....++.++.+++.+||+.||++|||+.|+++
T Consensus 248 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 ---------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ---------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1112234567889999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=339.04 Aligned_cols=267 Identities=23% Similarity=0.255 Sum_probs=202.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Cee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNL-----DFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~ 498 (717)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 358999999999999999999875 78899999987443 33446788999999999999999999998654 468
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||++ |+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 59999998754 899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCce-eeeccccCccccCCCccC-CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc---hh
Q 005040 579 GEGEDSV-IQTMTMATIGYMAPEYGS-EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR---LT 653 (717)
Q Consensus 579 ~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 653 (717)
....... ......||+.|+|||++. +..++.++||||+||++|||++|+.||......+ .+........... +.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence 4322111 123447899999999754 4558999999999999999999999997643221 2222221111110 00
Q ss_pred hhccccchhh---------hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 654 EVVDANLVRE---------EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 654 ~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...+...... .+.......++.++.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 0000001133567889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.91 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=206.3
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHH-----------------HHHHHHHHHHHHhcCCCceeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERA-----------------FRSFDSECEILRNVRHRNLLKI 488 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~hpniv~~ 488 (717)
.++|++.+.||+|+||.||+|.. +++.||+|++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999999 89999999997654221 1678899999999999999999
Q ss_pred eeeeecCCeeEEEEEccCCCCHHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 005040 489 LGSCSNLDFKALVLEFMPNGSLEKW------LYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL 561 (717)
Q Consensus 489 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill 561 (717)
++++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||.|||+ ..+|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN---EKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc---cCCEeecCCChHhEEE
Confidence 9999999999999999999999998 6542 4568999999999999999999993 2789999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCC-CcCc-ccchhhHHHHHHHHHhCCCCCCccccCcch
Q 005040 562 DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG-IVST-KCDVYSYGVLLMETFTEKKPTDEMFTGEMS 639 (717)
Q Consensus 562 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~Dvws~G~il~el~tg~~p~~~~~~~~~~ 639 (717)
+.++.+||+|||++...... ......||+.|+|||...+. .++. ++||||||+++|||++|+.||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HH
Confidence 99999999999999876432 23445789999999998877 6666 999999999999999999999764322 12
Q ss_pred HHHHHHhhC---CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 640 LRRWVKESL---PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 640 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....+.... +.............. .......++.++.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKK--STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCccchhhhhccccccc--cccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222221111 100000000000000 00111234567899999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=333.70 Aligned_cols=252 Identities=27% Similarity=0.333 Sum_probs=198.3
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--------ERAFRSFDSECEILRNVRHRNLLKILGSCSNL 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 495 (717)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999975 68899999986432 12234578899999999999999999998766
Q ss_pred CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc---EEEeee
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV---AHVSDF 572 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df 572 (717)
. .++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 5 799999999999999987654 4899999999999999999999 678999999999999987664 999999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCcc---CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYG---SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 649 (717)
|++....... ......||+.|+|||++ ....++.++||||||+++|||++|+.||....... .+...+.....
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 237 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKY 237 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCC
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCcc
Confidence 9998764321 12334689999999985 45678999999999999999999999997643222 22222221111
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.... .....++.++.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~--------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 NFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCH--------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCc--------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0000 001234567889999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.79 Aligned_cols=263 Identities=21% Similarity=0.222 Sum_probs=192.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD------ 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------ 496 (717)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999875 78999999986532 344567889999999999999999999987654
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..++||||++ |+|.+++.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999997 588888863 3889999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+..... .......+..
T Consensus 176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~-~~~~~~~~~~ 250 (371)
T 2xrw_A 176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIE-QLGTPCPEFM 250 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC--CCCCCHHHH
T ss_pred cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HhCCCCHHHH
Confidence 764321 223456899999999999999999999999999999999999999763211 11111111 0000000000
Q ss_pred ---ccc-------------------chhh--hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 657 ---DAN-------------------LVRE--EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 657 ---~~~-------------------~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.+. +... ..........+.++.+++.+||..||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 0000 00001112346779999999999999999999999873
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=361.57 Aligned_cols=332 Identities=17% Similarity=0.257 Sum_probs=288.9
Q ss_pred CCcccc--CCCCCcEEECCCCcceecCCcCCCCCCCCCEEEccccc-ccC--ccCCcccccccccccCccCCcEEeccCC
Q 005040 4 IPNSIT--NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNN-LTT--ESSSADQWSFLSSLTNCRNLANLALASN 78 (717)
Q Consensus 4 iP~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~--~~~~~~~~~~~~~l~~l~~L~~L~L~~N 78 (717)
||++++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++. ++..... +..+..+++|++|+|++|
T Consensus 239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~---L~~~~~l~~L~~L~L~~n 315 (636)
T 4eco_A 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA---LADAPVGEKIQIIYIGYN 315 (636)
T ss_dssp TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHH---HHHSGGGGTCCEEECCSS
T ss_pred CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHh---hhccccCCCCCEEECCCC
Confidence 999999 99999999999999999999999999999999999998 875 4422100 111234499999999999
Q ss_pred CCcccCCc--chhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCC-CCEEeccCCcccc
Q 005040 79 PLGGILPP--LIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQ-LQGFYVPENNLQG 155 (717)
Q Consensus 79 ~l~~~~~~--~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~l~~n~i~~ 155 (717)
+++ .+|. .+..+ ++|++|++++|++.+.+| .|..+++|++|+|++|+++ .+|..+.++++ |++|++++|.++
T Consensus 316 ~l~-~ip~~~~l~~l-~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~- 390 (636)
T 4eco_A 316 NLK-TFPVETSLQKM-KKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK- 390 (636)
T ss_dssp CCS-SCCCHHHHTTC-TTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-
T ss_pred cCC-ccCchhhhccC-CCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-
Confidence 999 7787 88888 689999999999999999 9999999999999999999 78888999999 999999999999
Q ss_pred cCCccccCCC--CCCEEeccCCcCcccCCcccc-------CCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCc
Q 005040 156 YVPHDLCHLE--RLNILNLSGNKLSGAIPQCLA-------SLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK 226 (717)
Q Consensus 156 ~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 226 (717)
.+|..+..+. +|++|+|++|.+++..|..|. .+++|+.|+|++|+++...+..+..+++|++|+|++|.++
T Consensus 391 ~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~ 470 (636)
T 4eco_A 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470 (636)
T ss_dssp SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS
T ss_pred ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC
Confidence 6777777755 899999999999998888888 7889999999999999665566677999999999999999
Q ss_pred ccCCccccCCC-------CCCeEEccCCCCCCCCccccc--CCcccccccccCccccCCCCccccccCccceEec-----
Q 005040 227 GTLPSNIQKLN-------VLIDLDLSRNQLSSDIPSTIG--TLKNLETLSLAGNQFQGPIPESVGNLISLESLDF----- 292 (717)
Q Consensus 227 ~~~~~~~~~l~-------~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L----- 292 (717)
...+..+.... +|+.|+|++|.++ .+|..+. .+++|+.|+|++|++++ +|..+.++++|+.|+|
T Consensus 471 ~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ 548 (636)
T 4eco_A 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD 548 (636)
T ss_dssp BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBC
T ss_pred CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcc
Confidence 44444454443 9999999999999 5777776 99999999999999997 8999999999999999
Q ss_pred -cCCCCCCCCcccccccccccEEEccCCcccccccccccccccccccccCCccccC
Q 005040 293 -SNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCG 347 (717)
Q Consensus 293 -~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~ 347 (717)
++|++.+.+|..+..+++|+.|+|++|++ +.+|.. ..+.+..+.+.+|+..|-
T Consensus 549 ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISI 602 (636)
T ss_dssp TTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEE
T ss_pred cccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCccc
Confidence 56888889999999999999999999999 667764 336777788888877663
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.03 Aligned_cols=261 Identities=19% Similarity=0.222 Sum_probs=205.3
Q ss_pred CCHHHHHHHhccCCcc-ccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhc-CCCceeeEeee
Q 005040 417 TSYLDIRRATDEFNEC-NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNV-RHRNLLKILGS 491 (717)
Q Consensus 417 ~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~~ 491 (717)
..|...+...++|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344455667788887 88999999999999976 79999999987543 22346788899999999 56999999999
Q ss_pred eecCCeeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcE
Q 005040 492 CSNLDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVA 567 (717)
Q Consensus 492 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~ 567 (717)
+.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH----~~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH----QNNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999998643 355899999999999999999999 678999999999999997 7899
Q ss_pred EEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 005040 568 HVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES 647 (717)
Q Consensus 568 kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 647 (717)
||+|||++........ .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ ....+...
T Consensus 174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~ 248 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNISQV 248 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT
T ss_pred EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHhc
Confidence 9999999987643322 233568999999999999999999999999999999999999997632211 11111111
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.... . ......++..+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~---------~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 NVDY---------S-----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CCCC---------C-----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccc---------C-----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0000 0 0011134466889999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=332.07 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=196.2
Q ss_pred HhccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcC--CCceeeEeeeeecCCeeEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVR--HRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~l 500 (717)
..++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++.+.+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 347899999999999999999998889999999986432 445577889999999997 5999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||| +.+++|.+++.... .+++..+..++.|+++||.||| +.+|+||||||+||++++ +.+||+|||++.....
T Consensus 106 v~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 999 55789999998754 4899999999999999999999 678999999999999965 8999999999987654
Q ss_pred CCCceeeeccccCccccCCCccCC-----------CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSE-----------GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 649 (717)
...........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...................
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 258 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence 433333344568999999998765 578899999999999999999999997533221111111111100
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.. + +..++.++.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~--------~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 259 IE--------F---------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CC--------C---------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cC--------C---------cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 00 0 01123567899999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.35 Aligned_cols=197 Identities=24% Similarity=0.303 Sum_probs=172.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc------CCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV------RHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~hpniv~~~~~~~~~~~~ 498 (717)
..+|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+++++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999875 68999999997543 3345677788888887 577999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc--EEEeeeccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV--AHVSDFGIS 575 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~ 575 (717)
++||||+. ++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 69999998654 44899999999999999999999 578999999999999999887 999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~ 633 (717)
+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7654322 2346899999999999999999999999999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.80 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=183.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC------C
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL------D 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~ 496 (717)
.++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999864 78999999986432 33456788999999999999999999998654 5
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..|+|+|++ +++|.+++... .+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 68999998763 4899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc---h
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR---L 652 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 652 (717)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... ...+........... +
T Consensus 181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 75432 234568999999998776 6799999999999999999999999976322 111111111111100 0
Q ss_pred hhhcccc-------chh-hhhhh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 653 TEVVDAN-------LVR-EEQAF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 653 ~~~~~~~-------~~~-~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+.... +.. ....+ .....++..+.+++.+||..||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 000 00000 0011235678899999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=364.58 Aligned_cols=245 Identities=22% Similarity=0.251 Sum_probs=201.6
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCee
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 498 (717)
...++|++.+.||+|+||.||+|+.+ +++.||||++++.. ....+.+..|..++..+ +||+|+.+++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999976 68899999998653 23345678899999988 799999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|+||||+++|+|.++++..+ .+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999998754 3899999999999999999999 678999999999999999999999999999864
Q ss_pred CCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+... ..+.+.+.. .
T Consensus 493 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~-----------~ 557 (674)
T 3pfq_A 493 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIME-----------H 557 (674)
T ss_dssp CCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHS-----------S
T ss_pred ccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHHHHHHh-----------C
Confidence 32222 23456799999999999999999999999999999999999999976321 111111111 0
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHM 695 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~ 695 (717)
.. .+ +..++.++.++|.+||+.||++||++
T Consensus 558 ~~-----~~--p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 558 NV-----AY--PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CC-----CC--CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CC-----CC--CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 00 00 11345668899999999999999997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.79 Aligned_cols=251 Identities=23% Similarity=0.281 Sum_probs=199.9
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh----HHHHHHHHHHHHHHHhcCCCceeeEeeee--ecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL----ERAFRSFDSECEILRNVRHRNLLKILGSC--SNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~--~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999975 78999999997654 23456789999999999999999999998 445678
Q ss_pred EEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
++||||++++ |.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH----SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 77777653 456899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCC--cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGI--VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (717)
..............||+.|+|||+..+.. ++.++||||+|+++|||++|+.||..... ......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~------ 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIGKGSY------ 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCCC------
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHhcCCC------
Confidence 75443333344557899999999877643 47899999999999999999999975321 111111111000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
.....++..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011344568899999999999999999999864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=360.49 Aligned_cols=327 Identities=20% Similarity=0.259 Sum_probs=289.9
Q ss_pred CCccccCCCCCcEEECCCCcceec-----------------CCcCCC--CCCCCCEEEcccccccCccCCcccccccccc
Q 005040 4 IPNSITNATKLIGLDLGLNSFSGH-----------------IPNTFG--NLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64 (717)
Q Consensus 4 iP~~~~~l~~L~~L~L~~n~i~~~-----------------~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l 64 (717)
||..|+++++|++|+|++|.+++. +|..++ ++++|++|+|++|++....+ ..|
T Consensus 198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p--------~~l 269 (636)
T 4eco_A 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP--------TFL 269 (636)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC--------TTT
T ss_pred CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh--------HHH
Confidence 899999999999999999999986 899999 99999999999999887543 448
Q ss_pred cCccCCcEEeccCCC-Ccc-cCCcchhccc-----cccceeeecCCcceecCCc--cccCCCCCcEEEccCCCCcccCCc
Q 005040 65 TNCRNLANLALASNP-LGG-ILPPLIGNFS-----ASLQNIYAFECKLGGSIPK--EIGNLRGLIVLSLGFNDLNGTIPT 135 (717)
Q Consensus 65 ~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-----~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~ 135 (717)
.++++|++|+|++|+ +++ .+|..+..+. ++|++|++++|+++ .+|. .++++++|++|+|++|.+++.+|
T Consensus 270 ~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip- 347 (636)
T 4eco_A 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP- 347 (636)
T ss_dssp TTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-
T ss_pred hcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-
Confidence 999999999999998 998 7898888762 67999999999999 8888 89999999999999999998888
Q ss_pred cccccCCCCEEeccCCcccccCCccccCCCC-CCEEeccCCcCcccCCccccCCC--CCCeEEecCccccCCCChhhh--
Q 005040 136 SIGTLQQLQGFYVPENNLQGYVPHDLCHLER-LNILNLSGNKLSGAIPQCLASLT--SLRSLYLQSNKLSSSLPSSLW-- 210 (717)
Q Consensus 136 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-- 210 (717)
.|..+++|++|+|++|+++ .+|..+.++++ |++|+|++|.++ .+|..+..++ +|+.|++++|++++..|..+.
T Consensus 348 ~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~ 425 (636)
T 4eco_A 348 AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425 (636)
T ss_dssp CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTT
T ss_pred hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccc
Confidence 9999999999999999999 67888999999 999999999999 6787777755 899999999999998898888
Q ss_pred -----cccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCC-------cccccccccCccccCCCC
Q 005040 211 -----SLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTL-------KNLETLSLAGNQFQGPIP 278 (717)
Q Consensus 211 -----~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-------~~L~~L~l~~N~l~~~~~ 278 (717)
.+++|++|+|++|.+++..+..+..+++|+.|+|++|.++...+..+... ++|++|+|++|+++ .+|
T Consensus 426 ~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp 504 (636)
T 4eco_A 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLS 504 (636)
T ss_dssp CSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCC
T ss_pred ccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccC
Confidence 88899999999999996555567789999999999999995444444433 39999999999999 678
Q ss_pred cccc--ccCccceEeccCCCCCCCCcccccccccccEEEc------cCCcccccccc-cccccccccccccCCcc
Q 005040 279 ESVG--NLISLESLDFSNNNLSGKIPKSLEALSHLKQFNV------SHNRLEGEIPV-KGSFKDFSAQSYFGNYA 344 (717)
Q Consensus 279 ~~~~--~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l------~~N~l~~~~p~-~~~~~~~~~~~~~~n~~ 344 (717)
..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|. .+.++.+..+.+.+|.-
T Consensus 505 ~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 578 (636)
T 4eco_A 505 DDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578 (636)
T ss_dssp GGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred hhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC
Confidence 8876 99999999999999997 8999999999999999 56778888875 35567777777777764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.61 Aligned_cols=252 Identities=26% Similarity=0.316 Sum_probs=204.2
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---------HHHHHHHHHHHHHHHhcC-CCceeeEeeeee
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---------ERAFRSFDSECEILRNVR-HRNLLKILGSCS 493 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~ 493 (717)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999976 78999999986432 234567889999999995 999999999999
Q ss_pred cCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 005040 494 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573 (717)
Q Consensus 494 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 573 (717)
+....++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999998653 4899999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccC------CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGS------EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES 647 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 647 (717)
++........ .....+++.|+|||++. ...++.++||||||+++|||++|+.||..... ......+...
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~ 244 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSG 244 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHHHhcC
Confidence 9987654322 23446899999999764 56689999999999999999999999965321 1111111111
Q ss_pred CCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 648 LPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.... . .+....++.++.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~---------~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQF---------G-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCC---------C-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Cccc---------C-----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0000 0 0111234567889999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=325.22 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=198.0
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l 500 (717)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3578999999999999999999976 79999999987532 33456778899999999 99999999999999999999
Q ss_pred EEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-------------
Q 005040 501 VLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN------------- 564 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~------------- 564 (717)
||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH----SMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999854 245899999999999999999999 6789999999999999844
Q ss_pred ------CcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCc
Q 005040 565 ------MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637 (717)
Q Consensus 565 ------~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 637 (717)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|||++|.+|+...
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---- 234 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---- 234 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----
T ss_pred cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----
Confidence 479999999998765432 23589999999988765 6678999999999999999999876431
Q ss_pred chHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 638 MSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...........+ .+ +..++.++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~---------~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 DQWHEIRQGRLP---------RI---------PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHHHTTCCC---------CC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHHHHHcCCCC---------CC---------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111111111100 00 0123456889999999999999999999975
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=344.49 Aligned_cols=323 Identities=20% Similarity=0.233 Sum_probs=282.7
Q ss_pred CcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCccc-CCcchhccc
Q 005040 14 LIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGI-LPPLIGNFS 92 (717)
Q Consensus 14 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~ 92 (717)
-+.++.++++++ .+|. + .++|++|+|++|.|+.+.+.. |.++++|++|+|++|.+.+. .+..|..+
T Consensus 12 ~~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~--------~~~l~~L~~L~L~~n~~~~~i~~~~~~~l- 78 (455)
T 3v47_A 12 GYNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETS--------FSRLQDLQFLKVEQQTPGLVIRNNTFRGL- 78 (455)
T ss_dssp TTEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTT--------TSSCTTCCEEECCCCSTTCEECTTTTTTC-
T ss_pred ccccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhH--------hccCccccEEECcCCcccceECccccccc-
Confidence 356899999998 4665 3 378999999999999886544 89999999999999999744 46677777
Q ss_pred cccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCcc--ccccCCCCEEeccCCcccccCCcc-ccCCCCCCE
Q 005040 93 ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTS--IGTLQQLQGFYVPENNLQGYVPHD-LCHLERLNI 169 (717)
Q Consensus 93 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~l~~n~i~~~~~~~-~~~l~~L~~ 169 (717)
++|++|+|++|++.+..|..|.++++|++|+|++|.+++..+.. |.++++|++|+|++|++++..|.. +.++++|++
T Consensus 79 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~ 158 (455)
T 3v47_A 79 SSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHV 158 (455)
T ss_dssp TTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCE
T ss_pred ccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccE
Confidence 78999999999999999999999999999999999998755444 999999999999999999887776 899999999
Q ss_pred EeccCCcCcccCCccccCC----------------------------------CCCCeEEecCccccCCCChhhhcc---
Q 005040 170 LNLSGNKLSGAIPQCLASL----------------------------------TSLRSLYLQSNKLSSSLPSSLWSL--- 212 (717)
Q Consensus 170 L~L~~n~l~~~~~~~~~~l----------------------------------~~L~~L~L~~N~l~~~~~~~~~~l--- 212 (717)
|+|++|.+++..+..+..+ ++|++|++++|++++..|..+..+
T Consensus 159 L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ 238 (455)
T 3v47_A 159 LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238 (455)
T ss_dssp EECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTT
T ss_pred EeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccc
Confidence 9999999998877666544 678899999998876555444322
Q ss_pred ------------------------------------cCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCccc
Q 005040 213 ------------------------------------EYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPST 256 (717)
Q Consensus 213 ------------------------------------~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 256 (717)
++|+.|++++|.+++..|..+..+++|+.|+|++|.+++..|..
T Consensus 239 ~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 318 (455)
T 3v47_A 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318 (455)
T ss_dssp CCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT
T ss_pred cceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhH
Confidence 58999999999999889999999999999999999999988889
Q ss_pred ccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccc-ccccccc
Q 005040 257 IGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK-GSFKDFS 335 (717)
Q Consensus 257 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~ 335 (717)
|..+++|++|+|++|.+++..+..+.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..+.. ..++.+.
T Consensus 319 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 398 (455)
T 3v47_A 319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQ 398 (455)
T ss_dssp TTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred hcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCccc
Confidence 999999999999999999888999999999999999999999888999999999999999999999866543 5677888
Q ss_pred cccccCCccccCCC
Q 005040 336 AQSYFGNYALCGPP 349 (717)
Q Consensus 336 ~~~~~~n~~~c~~~ 349 (717)
.+.+.+|+..|+.+
T Consensus 399 ~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 399 KIWLHTNPWDCSCP 412 (455)
T ss_dssp EEECCSSCBCCCTT
T ss_pred EEEccCCCcccCCC
Confidence 88899999988766
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.22 Aligned_cols=254 Identities=24% Similarity=0.276 Sum_probs=200.4
Q ss_pred hccCCccccccccccEEEEEEEe----cCCCeEEEEEechhh----HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL----SDGTNVAIKIFNLQL----ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLD 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 496 (717)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 378999999986432 12234567799999999 6999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999998654 4899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~---- 281 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS---- 281 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC----
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhcc----
Confidence 6543221 12234568999999998875 457899999999999999999999997532221 111111110000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAAK 701 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~~ 701 (717)
.+ ..+.+++..+.+++.+||..||++|| +++|+++.
T Consensus 282 --~~---------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 --EP---------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --CC---------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --CC---------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 00 01113345678999999999999999 89998764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=353.32 Aligned_cols=330 Identities=21% Similarity=0.265 Sum_probs=229.5
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+.+||..+.. ++++|+|++|.|+++.|..|.++++|++|+|++|+|+.+.+.+ |.++++|++|+|++|++
T Consensus 24 l~~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~--------~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 24 LNEIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT--------FQSQHRLDTLVLTANPL 93 (606)
T ss_dssp CSSCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTT--------TTTCTTCCEEECTTCCC
T ss_pred cccCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhh--------ccCccccCeeeCCCCcc
Confidence 3578877765 6788888888888888888888888888888888888876544 78888888888888888
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD 160 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 160 (717)
++..|..|..+ ++|++|++++|++.+..+..|.++++|++|+|++|.+++.....+..+++|++|++++|.+++..+..
T Consensus 94 ~~~~~~~~~~l-~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 94 IFMAETALSGP-KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp SEECTTTTSSC-TTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred cccChhhhccc-ccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 88878888777 67888888888888777777888888888888888888655455556888888888888888777777
Q ss_pred ccCCCCCC--EEeccCCcCcccCCccccCC--------------------------------------------------
Q 005040 161 LCHLERLN--ILNLSGNKLSGAIPQCLASL-------------------------------------------------- 188 (717)
Q Consensus 161 ~~~l~~L~--~L~L~~n~l~~~~~~~~~~l-------------------------------------------------- 188 (717)
|..+++|+ .|++++|.+++..+..|...
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~ 252 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhh
Confidence 88888888 77888887776555443221
Q ss_pred -CCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCccccccc
Q 005040 189 -TSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLS 267 (717)
Q Consensus 189 -~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 267 (717)
.+|+.|++++|.+++..+..|..+++|++|++++|.++ .+|..+..+++|++|++++|.+++..|..+..+++|++|+
T Consensus 253 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 331 (606)
T 3t6q_A 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331 (606)
T ss_dssp GSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEE
T ss_pred cCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEE
Confidence 04556666666666555555666666666666666666 4555666666666666666666655555666666666666
Q ss_pred ccCccccCCCCc-cccccCccceEeccCCCCCCCC--cccccccccccEEEccCCccccccccc-ccccccccccccCC
Q 005040 268 LAGNQFQGPIPE-SVGNLISLESLDFSNNNLSGKI--PKSLEALSHLKQFNVSHNRLEGEIPVK-GSFKDFSAQSYFGN 342 (717)
Q Consensus 268 l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~~~~~~--~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n 342 (717)
+++|.+.+.++. .+..+++|++|++++|++.+.. +..+..+++|+.|++++|++++..|.. ..++.+..+.+.+|
T Consensus 332 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 410 (606)
T 3t6q_A 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410 (606)
T ss_dssp CCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTC
T ss_pred CCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCC
Confidence 666666543332 3556666666666666665444 455566666666666666665544432 23344444444443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=341.88 Aligned_cols=271 Identities=21% Similarity=0.243 Sum_probs=200.0
Q ss_pred HHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec--------
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN-------- 494 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-------- 494 (717)
...++|++.+.||+|+||.||+|... +|+.||||++..... ...+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 45678999999999999999999864 899999998864432 23469999999999999999999843
Q ss_pred ------------------------------CCeeEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 005040 495 ------------------------------LDFKALVLEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLH 541 (717)
Q Consensus 495 ------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH 541 (717)
....++||||++ |+|.+.+.. ....+++..+..++.|+++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334789999997 588877763 3456999999999999999999999
Q ss_pred hcCCCCCeEecCCCCCCeeeC-CCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCC-CcCcccchhhHHHH
Q 005040 542 HCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVL 619 (717)
Q Consensus 542 ~~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~i 619 (717)
+.+|+||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||+||+
T Consensus 159 ----~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 159 ----SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp ----TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred ----HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 78999999999999998 689999999999987644332 2344679999999987764 58999999999999
Q ss_pred HHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc--c--------ccchhhhhhhhhhHHHHHHHHHHHhhccCCCC
Q 005040 620 LMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV--D--------ANLVREEQAFSDKMDCLFSIMDLALDCCMDTP 689 (717)
Q Consensus 620 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P 689 (717)
+|||++|+.||.+... ...+...+..........+. + +......-.......++.++.+++.+||+.||
T Consensus 232 l~ell~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 232 FGELILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999976322 12222222211111100000 0 00000000000112345678999999999999
Q ss_pred CCCCCHHHHHH--HHHHhHH
Q 005040 690 HKRIHMTDAAA--KLRKIKA 707 (717)
Q Consensus 690 ~~Rpt~~ev~~--~L~~~~~ 707 (717)
++|||+.|+++ .+++++.
T Consensus 311 ~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHHH
T ss_pred hhCCCHHHHhcCHHHHHHHh
Confidence 99999999984 3444444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=351.57 Aligned_cols=328 Identities=21% Similarity=0.229 Sum_probs=248.6
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
++.||..+. ++|++|+|++|.|+++.+..|.++++|++|+|++|+|+.+++.+ |.++++|++|+|++|++
T Consensus 43 L~~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~--------~~~l~~L~~L~Ls~N~l 112 (562)
T 3a79_B 43 LTHVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHV--------FLFNQDLEYLDVSHNRL 112 (562)
T ss_dssp CCSCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTT--------TTTCTTCCEEECTTSCC
T ss_pred CccCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHH--------hCCCCCCCEEECCCCcC
Confidence 457888775 78899999999999888888999999999999999999877544 88899999999999999
Q ss_pred cccCCcchhccccccceeeecCCcceec-CCccccCCCCCcEEEccCCCCcccCCccccccCCC--CEEeccCCcc--cc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGS-IPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQL--QGFYVPENNL--QG 155 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~l~~n~i--~~ 155 (717)
+. +|.. .+ ++|++|++++|++.+. .|..|+++++|++|+|++|.++.. .+..+++| ++|++++|.+ ++
T Consensus 113 ~~-lp~~--~l-~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~ 185 (562)
T 3a79_B 113 QN-ISCC--PM-ASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKG 185 (562)
T ss_dssp CE-ECSC--CC-TTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCS
T ss_pred Cc-cCcc--cc-ccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccc
Confidence 84 4444 44 6799999999998863 467899999999999999988753 45555555 8888888877 55
Q ss_pred cCCccccCCC----------------------------------------------------------------------
Q 005040 156 YVPHDLCHLE---------------------------------------------------------------------- 165 (717)
Q Consensus 156 ~~~~~~~~l~---------------------------------------------------------------------- 165 (717)
..|..+..+.
T Consensus 186 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~ 265 (562)
T 3a79_B 186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265 (562)
T ss_dssp SSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHH
T ss_pred cCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHH
Confidence 5555554433
Q ss_pred -----------CCCEEeccCCcCcccCCccc-------------------------------------------------
Q 005040 166 -----------RLNILNLSGNKLSGAIPQCL------------------------------------------------- 185 (717)
Q Consensus 166 -----------~L~~L~L~~n~l~~~~~~~~------------------------------------------------- 185 (717)
+|++|++++|.+++.+|..+
T Consensus 266 ~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~ 345 (562)
T 3a79_B 266 SVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345 (562)
T ss_dssp HHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCC
T ss_pred HHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccc
Confidence 56666666666665555433
Q ss_pred ----cCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCccc--CCccccCCCCCCeEEccCCCCCCCCc-cccc
Q 005040 186 ----ASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGT--LPSNIQKLNVLIDLDLSRNQLSSDIP-STIG 258 (717)
Q Consensus 186 ----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~ 258 (717)
..+++|++|++++|++++..|..+..+++|+.|++++|++++. .|..+..+++|+.|++++|.+++.+| ..+.
T Consensus 346 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 425 (562)
T 3a79_B 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA 425 (562)
T ss_dssp CCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCC
T ss_pred ccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhc
Confidence 5667888888888888877777888888888888888888853 24567888888888888888887343 4577
Q ss_pred CCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc-cccccccccc
Q 005040 259 TLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV-KGSFKDFSAQ 337 (717)
Q Consensus 259 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~~~ 337 (717)
.+++|++|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++..+. ...++.+..+
T Consensus 426 ~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 502 (562)
T 3a79_B 426 WAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYI 502 (562)
T ss_dssp CCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCE
T ss_pred CcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEE
Confidence 788888888888888766665544 67888888888887 5666666888888888888888854443 4556667777
Q ss_pred cccCCccccCC
Q 005040 338 SYFGNYALCGP 348 (717)
Q Consensus 338 ~~~~n~~~c~~ 348 (717)
.+.+|++.|+.
T Consensus 503 ~l~~N~~~c~c 513 (562)
T 3a79_B 503 WLHDNPWDCTC 513 (562)
T ss_dssp ECCSCCBCCCH
T ss_pred EecCCCcCCCc
Confidence 77888877753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=350.23 Aligned_cols=327 Identities=20% Similarity=0.237 Sum_probs=213.5
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+++||..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|+.+.+. .|.++++|++|+|++|++
T Consensus 12 l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--------~~~~l~~L~~L~Ls~N~l 81 (520)
T 2z7x_B 12 LIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS--------VFKFNQELEYLDLSHNKL 81 (520)
T ss_dssp CSSCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGG--------GGTTCTTCCEEECCSSCC
T ss_pred ccccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChH--------HhhcccCCCEEecCCCce
Confidence 457888776 8888999999998877778888889999999999988887543 378888888899988888
Q ss_pred cccCCcchhccccccceeeecCCccee-cCCccccCCCCCcEEEccCCCCcccCCccccccCCC--CEEeccCCcc--cc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGG-SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQL--QGFYVPENNL--QG 155 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~l~~n~i--~~ 155 (717)
+. +|.. .+ ++|++|++++|++.+ .+|..|+++++|++|+|++|.+++ ..+..+++| ++|++++|.+ .+
T Consensus 82 ~~-lp~~--~l-~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 82 VK-ISCH--PT-VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CE-EECC--CC-CCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred ee-cCcc--cc-CCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence 84 4443 34 678888888888886 467888888888888888888874 345566666 7777776666 44
Q ss_pred cCCccccCCC----------------------------------------------------------------------
Q 005040 156 YVPHDLCHLE---------------------------------------------------------------------- 165 (717)
Q Consensus 156 ~~~~~~~~l~---------------------------------------------------------------------- 165 (717)
..|..+..+.
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~ 234 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEH
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCH
Confidence 4444443322
Q ss_pred -------------CCCEEeccCCcCcccCCccc-----------------------------------------------
Q 005040 166 -------------RLNILNLSGNKLSGAIPQCL----------------------------------------------- 185 (717)
Q Consensus 166 -------------~L~~L~L~~n~l~~~~~~~~----------------------------------------------- 185 (717)
+|++|++++|++++.+|..+
T Consensus 235 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l 314 (520)
T 2z7x_B 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314 (520)
T ss_dssp HHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCC
T ss_pred HHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcc
Confidence 45555555555554444433
Q ss_pred ------cCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcc--cCCccccCCCCCCeEEccCCCCCCCCcc-c
Q 005040 186 ------ASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG--TLPSNIQKLNVLIDLDLSRNQLSSDIPS-T 256 (717)
Q Consensus 186 ------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~ 256 (717)
..+++|++|++++|++++..|..+..+++|++|++++|++++ .+|..+..+++|+.|++++|.+++.+|. .
T Consensus 315 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~ 394 (520)
T 2z7x_B 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394 (520)
T ss_dssp CCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCS
T ss_pred ccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccch
Confidence 345556666666666665555556666666666666666654 3334556666666666666666652333 3
Q ss_pred ccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc-cccccccc
Q 005040 257 IGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV-KGSFKDFS 335 (717)
Q Consensus 257 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~ 335 (717)
+..+++|++|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|++++..+. ...++.+.
T Consensus 395 ~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~ 471 (520)
T 2z7x_B 395 CSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQ 471 (520)
T ss_dssp CCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCccc
Confidence 55566666666666666555444443 46666666666666 5555555666666666666666643222 33445555
Q ss_pred cccccCCccccC
Q 005040 336 AQSYFGNYALCG 347 (717)
Q Consensus 336 ~~~~~~n~~~c~ 347 (717)
.+.+.+|++.|+
T Consensus 472 ~L~l~~N~~~c~ 483 (520)
T 2z7x_B 472 KIWLHTNPWDCS 483 (520)
T ss_dssp EEECCSSCBCCC
T ss_pred EEECcCCCCccc
Confidence 555666666554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=353.16 Aligned_cols=329 Identities=19% Similarity=0.208 Sum_probs=262.9
Q ss_pred CccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccC
Q 005040 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGIL 84 (717)
Q Consensus 5 P~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 84 (717)
|..|.++++|++|+|++|.|+++.|.+|.++++|++|+|++|+++.+.+.. |.++++|++|+|++|++++..
T Consensus 50 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~--------~~~l~~L~~L~L~~n~i~~l~ 121 (606)
T 3t6q_A 50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETA--------LSGPKALKHLFFIQTGISSID 121 (606)
T ss_dssp TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTT--------TSSCTTCCEEECTTSCCSCGG
T ss_pred hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhh--------hcccccccEeeccccCcccCC
Confidence 678999999999999999999999999999999999999999999876544 889999999999999999877
Q ss_pred CcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCC--EEeccCCcccccCCcccc
Q 005040 85 PPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQ--GFYVPENNLQGYVPHDLC 162 (717)
Q Consensus 85 ~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~l~~n~i~~~~~~~~~ 162 (717)
+..+..+ ++|++|++++|++.+.....+..+++|++|+|++|.+++..+..|..+++|+ .|++++|.+.+..+..+.
T Consensus 122 ~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~ 200 (606)
T 3t6q_A 122 FIPLHNQ-KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD 200 (606)
T ss_dssp GSCCTTC-TTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTT
T ss_pred cchhccC-CcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhh
Confidence 7778777 6799999999999876555666699999999999999988888899999998 889999988877665543
Q ss_pred CC---------------------------------------------------CCCCEEeccCCcCcccCCccccCCCCC
Q 005040 163 HL---------------------------------------------------ERLNILNLSGNKLSGAIPQCLASLTSL 191 (717)
Q Consensus 163 ~l---------------------------------------------------~~L~~L~L~~n~l~~~~~~~~~~l~~L 191 (717)
.. .+|+.|++++|.+++..+..|+.+++|
T Consensus 201 ~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 280 (606)
T 3t6q_A 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGL 280 (606)
T ss_dssp TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTC
T ss_pred hccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCC
Confidence 21 156777778888877767778888888
Q ss_pred CeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcc-cccCCcccccccccC
Q 005040 192 RSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPS-TIGTLKNLETLSLAG 270 (717)
Q Consensus 192 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~ 270 (717)
++|++++|+++ .+|..+..+++|++|++++|.+++..|..+..+++|+.|++++|.+.+.++. .+..+++|++|++++
T Consensus 281 ~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~ 359 (606)
T 3t6q_A 281 QELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359 (606)
T ss_dssp SEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCS
T ss_pred CEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCC
Confidence 88888888887 5677777888888888888888877777788888888888888877754443 477788888888888
Q ss_pred ccccCCC--CccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc--cccccccccccccCCc
Q 005040 271 NQFQGPI--PESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV--KGSFKDFSAQSYFGNY 343 (717)
Q Consensus 271 N~l~~~~--~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~~~~~~~~~~~n~ 343 (717)
|.+.+.. +..+..+++|++|+|++|++.+..|..+..+++|+.|++++|++++..|. ...++.+..+.+.+|.
T Consensus 360 n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~ 436 (606)
T 3t6q_A 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436 (606)
T ss_dssp SCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCC
T ss_pred CccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCc
Confidence 8877655 66777788888888888888777777777888888888888887766543 2445555555555543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=353.47 Aligned_cols=159 Identities=25% Similarity=0.266 Sum_probs=90.3
Q ss_pred cccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCC-ccccCCCCCCeEEccCCCCCCCCcccccCCcc
Q 005040 184 CLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP-SNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKN 262 (717)
Q Consensus 184 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 262 (717)
.+..+++|++|+|++|.+++ +|..+..+++|+.|++++|.+.+..+ ..+..+++|+.|++++|.+++..|..+..+++
T Consensus 371 ~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 449 (606)
T 3vq2_A 371 SDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449 (606)
T ss_dssp HHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTT
T ss_pred hhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCC
Confidence 33444444444444444442 23445555555555555555554444 45556666666666666666555566666666
Q ss_pred cccccccCccccC-CCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccc-cccccccccccc
Q 005040 263 LETLSLAGNQFQG-PIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK-GSFKDFSAQSYF 340 (717)
Q Consensus 263 L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~ 340 (717)
|++|++++|++.+ ..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..|.. ..++.+..+.+.
T Consensus 450 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 529 (606)
T 3vq2_A 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529 (606)
T ss_dssp CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECT
T ss_pred CCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECC
Confidence 6666666666665 24556666666666666666666666666666666666666666666654432 334445555554
Q ss_pred CCc
Q 005040 341 GNY 343 (717)
Q Consensus 341 ~n~ 343 (717)
+|.
T Consensus 530 ~N~ 532 (606)
T 3vq2_A 530 FNR 532 (606)
T ss_dssp TSC
T ss_pred CCc
Confidence 443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.10 Aligned_cols=325 Identities=18% Similarity=0.158 Sum_probs=296.5
Q ss_pred CCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccc
Q 005040 13 KLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFS 92 (717)
Q Consensus 13 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 92 (717)
.-+.++.++++++ .+|..+. ++|++|+|++|+|+.+++.. |.++++|++|+|++|.+++..|..|..+
T Consensus 12 ~~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~--------~~~l~~L~~L~L~~n~i~~~~~~~~~~l- 79 (477)
T 2id5_A 12 QDRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDE--------FASFPHLEELELNENIVSAVEPGAFNNL- 79 (477)
T ss_dssp TTTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTT--------TTTCTTCCEEECTTSCCCEECTTTTTTC-
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhH--------ccCCCCCCEEECCCCccCEeChhhhhCC-
Confidence 3467999999998 5676664 58999999999999987544 8999999999999999999989999998
Q ss_pred cccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEec
Q 005040 93 ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNL 172 (717)
Q Consensus 93 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 172 (717)
++|++|+|++|++....+..|.++++|++|+|++|.++...+..|.++++|++|+|++|.+....+..|.++++|++|+|
T Consensus 80 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 159 (477)
T 2id5_A 80 FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTL 159 (477)
T ss_dssp TTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEE
T ss_pred ccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEEC
Confidence 68999999999999877778999999999999999999988999999999999999999999999999999999999999
Q ss_pred cCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCC
Q 005040 173 SGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSD 252 (717)
Q Consensus 173 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 252 (717)
++|++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.++..+....+|+.|+|++|.+++.
T Consensus 160 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 239 (477)
T 2id5_A 160 EKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAV 239 (477)
T ss_dssp ESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSC
T ss_pred CCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccccc
Confidence 99999987777899999999999999999988888999999999999999998877777777777999999999999976
Q ss_pred CcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccc-ccc
Q 005040 253 IPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK-GSF 331 (717)
Q Consensus 253 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~ 331 (717)
.+..+..+++|+.|+|++|++++..+..|.++++|+.|+|++|++.+..|..|..+++|+.|+|++|.+++..+.. ..+
T Consensus 240 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 319 (477)
T 2id5_A 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV 319 (477)
T ss_dssp CHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCG
T ss_pred CHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCC
Confidence 6678999999999999999999888889999999999999999999999999999999999999999999866643 556
Q ss_pred cccccccccCCccccCCC
Q 005040 332 KDFSAQSYFGNYALCGPP 349 (717)
Q Consensus 332 ~~~~~~~~~~n~~~c~~~ 349 (717)
+.+..+.+.+|++.|+..
T Consensus 320 ~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 320 GNLETLILDSNPLACDCR 337 (477)
T ss_dssp GGCCEEECCSSCEECSGG
T ss_pred cccCEEEccCCCccCccc
Confidence 778888899999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.65 Aligned_cols=264 Identities=22% Similarity=0.253 Sum_probs=201.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC--------CCceeeEeeeee---
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR--------HRNLLKILGSCS--- 493 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------hpniv~~~~~~~--- 493 (717)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+++++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 368999999999999999999865 7889999999754 334467888999999995 788999999987
Q ss_pred -cCCeeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCC-----
Q 005040 494 -NLDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSA-PIIHCDLKPTNILLDENM----- 565 (717)
Q Consensus 494 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~ivH~dlk~~Nill~~~~----- 565 (717)
+....++||||+ ++++.+++... ...+++..+..++.|++.||.||| ++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH----TKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCCHHHeeEeccchhhhh
Confidence 566889999999 56777666644 356899999999999999999999 56 899999999999999775
Q ss_pred --------------------------------------------cEEEeeeccccccCCCCCceeeeccccCccccCCCc
Q 005040 566 --------------------------------------------VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601 (717)
Q Consensus 566 --------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~ 601 (717)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876432 233468999999999
Q ss_pred cCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcch-----HHHHHHhhC--CCch-------hhhccc---------
Q 005040 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMS-----LRRWVKESL--PHRL-------TEVVDA--------- 658 (717)
Q Consensus 602 ~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~-----~~~~~~~~~--~~~~-------~~~~~~--------- 658 (717)
+.+..++.++|||||||++|||++|+.||......... ......... +... .+.+..
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99989999999999999999999999999764332211 111111000 0000 000000
Q ss_pred ----cc-hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 659 ----NL-VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 659 ----~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+ .............+..+.+++.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 0000011123456678999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.28 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=197.0
Q ss_pred HHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeec----
Q 005040 421 DIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSN---- 494 (717)
Q Consensus 421 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~---- 494 (717)
++....++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33445688999999999999999999974 789999999865432 235688899999999 79999999999876
Q ss_pred --CCeeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 005040 495 --LDFKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSD 571 (717)
Q Consensus 495 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 571 (717)
.+..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999999864 345899999999999999999999 67899999999999999999999999
Q ss_pred eccccccCCCCCceeeeccccCccccCCCccC-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh
Q 005040 572 FGISKLLGEGEDSVIQTMTMATIGYMAPEYGS-----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 572 fgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 646 (717)
||++........ ......||+.|+|||++. +..++.++||||||+++|||++|+.||...... .....+..
T Consensus 173 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~ 248 (326)
T 2x7f_A 173 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--RALFLIPR 248 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHH
T ss_pred CcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhc
Confidence 999987643221 123446899999999876 567899999999999999999999999653221 11111111
Q ss_pred hCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..... . ....++..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~--------~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 249 NPAPR--------L--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SCCCC--------C--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Ccccc--------C--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 10000 0 01123456889999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=360.05 Aligned_cols=259 Identities=22% Similarity=0.359 Sum_probs=207.8
Q ss_pred HhccCCccccccccccEEEEEEEec----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
..++|++.+.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 3578889999999999999999874 24579999987543 3445678999999999999999999999854 5689
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+++|+|.++++.....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 999999999999999977767999999999999999999999 6789999999999999999999999999998764
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.... .....+......
T Consensus 543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~~-------- 611 (656)
T 2j0j_A 543 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERL-------- 611 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCCC--------
T ss_pred CCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCCC--------
Confidence 4322 12233456789999999988899999999999999999997 99999763221 111111111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
+.+..++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 612 ---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 612 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 01123456788999999999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.97 Aligned_cols=266 Identities=21% Similarity=0.287 Sum_probs=195.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeee-----------
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCS----------- 493 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~----------- 493 (717)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 368899999999999999999976 58999999987665666678899999999999999999999873
Q ss_pred ---cCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEE
Q 005040 494 ---NLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHV 569 (717)
Q Consensus 494 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~-~~~~~kl 569 (717)
+....++||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999997 6999999754 4899999999999999999999 67899999999999997 5779999
Q ss_pred eeeccccccCCCCCc-eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 005040 570 SDFGISKLLGEGEDS-VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES 647 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 647 (717)
+|||++......... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHh
Confidence 999999876432211 12233457999999997654 67899999999999999999999999764321 111111111
Q ss_pred CCCc----hhhhcc-------ccchhhh-hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 648 LPHR----LTEVVD-------ANLVREE-QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 648 ~~~~----~~~~~~-------~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+.. ..+... ....... +.......++.++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1110 000000 0000000 000011235677899999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.99 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=193.5
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec---------
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN--------- 494 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------- 494 (717)
..++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3568999999999999999999975 7999999998654 3345778899999999999999999998754
Q ss_pred ----CCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 005040 495 ----LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVS 570 (717)
Q Consensus 495 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 570 (717)
....++||||+++|+|.+++......+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH----hCCeecccCCHHhEEEcCCCCEEEe
Confidence 35679999999999999999987767889999999999999999999 6789999999999999999999999
Q ss_pred eeccccccCCCCC------------ceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCc
Q 005040 571 DFGISKLLGEGED------------SVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637 (717)
Q Consensus 571 Dfgl~~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 637 (717)
|||++........ ........||+.|+|||++.+. .++.++||||+|+++|||++ ||.......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 9999987643211 1122344689999999988754 78999999999999999998 553211111
Q ss_pred chHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 638 MSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....+... .... .+.+ ...++..+.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~~-~~~~----~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 -NILKKLRSV-SIEF----PPDF---------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHST-TCCC----CTTC---------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHhcccc-cccc----Cccc---------cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111100 0000 0000 1123456789999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=329.37 Aligned_cols=263 Identities=23% Similarity=0.280 Sum_probs=202.8
Q ss_pred hccCCccccccccccEEEEEEEe-c-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCC------ceeeEeeeeecCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL-S-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHR------NLLKILGSCSNLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp------niv~~~~~~~~~~~ 497 (717)
.++|++.+.||+|+||.||+|.. . +++.||||+++... ...+.+.+|+++++.++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999986 3 68899999997543 3446778899999998765 49999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-------------
Q 005040 498 KALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE------------- 563 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~------------- 563 (717)
.++||||+ +++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH----SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889999998654 35889999999999999999999 678999999999999987
Q ss_pred ------CCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc
Q 005040 564 ------NMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637 (717)
Q Consensus 564 ------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 637 (717)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6789999999998754322 33468999999999999999999999999999999999999997632211
Q ss_pred chHHHHHHhh--CCCchhhhc-----------------------cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCC
Q 005040 638 MSLRRWVKES--LPHRLTEVV-----------------------DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKR 692 (717)
Q Consensus 638 ~~~~~~~~~~--~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 692 (717)
......... .+....... ................++.++.+++.+||+.||++|
T Consensus 242 -~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 242 -HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp -HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred -HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 111111111 110000000 000000000011123456789999999999999999
Q ss_pred CCHHHHHH
Q 005040 693 IHMTDAAA 700 (717)
Q Consensus 693 pt~~ev~~ 700 (717)
||++|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=332.97 Aligned_cols=267 Identities=24% Similarity=0.243 Sum_probs=200.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Cee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNL-----DFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~ 498 (717)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999976 78999999986433 33446778999999999999999999987653 678
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+. |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 6999999874 4899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCce--------eeeccccCccccCCCccC-CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-
Q 005040 579 GEGEDSV--------IQTMTMATIGYMAPEYGS-EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL- 648 (717)
Q Consensus 579 ~~~~~~~--------~~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~- 648 (717)
....... ......||+.|+|||++. +..++.++||||+||++|||++|+.||.+..... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Confidence 5332111 112346899999999764 4778999999999999999999999997632211 1111111110
Q ss_pred CC---chhhhccccchhhh---------hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 649 PH---RLTEVVDANLVREE---------QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 649 ~~---~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+. .............. ........++.++.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 00000000000000 000011234567899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=340.73 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=199.8
Q ss_pred HhccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
..++|++.+.||+|+||.||+|..++ .||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 34789999999999999999999753 59999986542 222345677999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++++|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH----HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999999887767999999999999999999999 67899999999999998 6799999999987653221
Q ss_pred C---ceeeeccccCccccCCCccCC---------CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC
Q 005040 583 D---SVIQTMTMATIGYMAPEYGSE---------GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH 650 (717)
Q Consensus 583 ~---~~~~~~~~~t~~y~aPE~~~~---------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 650 (717)
. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+.....
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~- 260 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AIIWQMGTGMK- 260 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--HHHHHHHTTCC-
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhccCCC-
Confidence 1 112233458999999998764 45789999999999999999999999753221 11111111100
Q ss_pred chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 651 RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
+... ...++.++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 261 -------~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 261 -------PNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -------CCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -------CCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000 0123345789999999999999999999999999987654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=334.28 Aligned_cols=262 Identities=21% Similarity=0.238 Sum_probs=197.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee----
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK---- 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~---- 498 (717)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368899999999999999999875 78999999997542 33456788999999999999999999999877654
Q ss_pred --EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 499 --ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 499 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
++||||+. ++|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 689888743 3899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC--chh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH--RLT 653 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 653 (717)
..... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.+.... ..+.......... ...
T Consensus 193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHHHH
Confidence 65432 234568999999998876 78999999999999999999999999763221 1112211111110 000
Q ss_pred hhccccchhhh---------hh-hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 654 EVVDANLVREE---------QA-FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 654 ~~~~~~~~~~~---------~~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..+........ .. ......++.++.+++.+||+.||++|||++|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000 00 00112345678999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=321.41 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=203.7
Q ss_pred HHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 423 RRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 423 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 444579999999999999999999976 78999999987543 234567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeecccc
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN---MVAHVSDFGISK 576 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~ 576 (717)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.+ +.+||+|||++.
T Consensus 98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999987654 4899999999999999999999 6789999999999999754 479999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh-hCCCchhhh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE-SLPHRLTEV 655 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 655 (717)
....... .....+|+.|+|||.+.+ .++.++||||+|+++|+|++|+.||...... .....+.. .....
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~---- 242 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYAFD---- 242 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCCC----
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCCCC----
Confidence 7654322 123357899999998765 4899999999999999999999999763211 11111111 00000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+....++.++.+++.+||+.||++|||+.|+++
T Consensus 243 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 -----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0111234566889999999999999999999987
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=349.96 Aligned_cols=164 Identities=26% Similarity=0.307 Sum_probs=102.6
Q ss_pred ccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCC-ccccCCCCCCeEEccCCCCCCCCcccccCCccc
Q 005040 185 LASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP-SNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNL 263 (717)
Q Consensus 185 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 263 (717)
+..+++|++|++++|.+++..+ .+..+++|++|++++|.+++..+ ..+..+++|+.|++++|.+++..|..+..+++|
T Consensus 369 ~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 447 (570)
T 2z63_A 369 DFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447 (570)
T ss_dssp HHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC
T ss_pred ccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcC
Confidence 3344444444444444443222 25555555555555555554433 356666667777777776666666666777777
Q ss_pred ccccccCcccc-CCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc-cccccccccccccC
Q 005040 264 ETLSLAGNQFQ-GPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV-KGSFKDFSAQSYFG 341 (717)
Q Consensus 264 ~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~~~~~~~ 341 (717)
++|++++|++. +.+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++.+|. ...++.+..+.+.+
T Consensus 448 ~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 527 (570)
T 2z63_A 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHT 527 (570)
T ss_dssp CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred cEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecC
Confidence 77777777775 45666777777777777777777766677777777777777777777766553 24455666666677
Q ss_pred CccccCCC
Q 005040 342 NYALCGPP 349 (717)
Q Consensus 342 n~~~c~~~ 349 (717)
|++.|+.+
T Consensus 528 N~~~~~~~ 535 (570)
T 2z63_A 528 NPWDCSCP 535 (570)
T ss_dssp SCBCCCTT
T ss_pred CcccCCCc
Confidence 77666544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.10 Aligned_cols=267 Identities=21% Similarity=0.237 Sum_probs=183.4
Q ss_pred ccCCc-cccccccccEEEEEEEec---CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeee--ecCCeeEE
Q 005040 427 DEFNE-CNLLGTGGFGSVYKGTLS---DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSC--SNLDFKAL 500 (717)
Q Consensus 427 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~--~~~~~~~l 500 (717)
+.|++ .++||+|+||.||+|+++ +++.||+|++..... ...+.+|++++++++||||+++++++ ......++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45665 458999999999999965 578899999875432 24577899999999999999999999 44778999
Q ss_pred EEEccCCCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCcEE
Q 005040 501 VLEFMPNGSLEKWLYSH--------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL----DENMVAH 568 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill----~~~~~~k 568 (717)
||||++ |+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+|
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 999996 5888888632 224899999999999999999999 6789999999999999 7788999
Q ss_pred EeeeccccccCCCCCc-eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccC--------cc
Q 005040 569 VSDFGISKLLGEGEDS-VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG--------EM 638 (717)
Q Consensus 569 l~Dfgl~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~--------~~ 638 (717)
|+|||+++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 9999999876533211 22334578999999998877 45899999999999999999999999753221 01
Q ss_pred hHHHHHHhhC-CC--chhhhccc--------cchhh-hhhhh-------hhHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 005040 639 SLRRWVKESL-PH--RLTEVVDA--------NLVRE-EQAFS-------DKMDCLFSIMDLALDCCMDTPHKRIHMTDAA 699 (717)
Q Consensus 639 ~~~~~~~~~~-~~--~~~~~~~~--------~~~~~-~~~~~-------~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~ 699 (717)
.+........ +. .+..+... .+... ..... .....+.++.+|+.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1222221111 10 01111000 00000 00000 0001145688999999999999999999998
Q ss_pred H
Q 005040 700 A 700 (717)
Q Consensus 700 ~ 700 (717)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.07 Aligned_cols=200 Identities=26% Similarity=0.305 Sum_probs=171.8
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CC-----ceeeEeeeeecCCe
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HR-----NLLKILGSCSNLDF 497 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hp-----niv~~~~~~~~~~~ 497 (717)
..++|++.+.||+|+||.||+|... +++.||||++.... .....+..|+++++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999876 78899999997543 33456777889988884 54 49999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCcEEEeeecc
Q 005040 498 KALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD--ENMVAHVSDFGI 574 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl 574 (717)
.++||||++ |+|.+++.... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 59999998653 4589999999999999999999931 36899999999999995 578899999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEM 633 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~ 633 (717)
++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 208 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 98764322 3356899999999999999999999999999999999999999763
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.91 Aligned_cols=261 Identities=25% Similarity=0.286 Sum_probs=194.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec------CCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN------LDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~~~ 499 (717)
.+|+..+.||+|+||.||+|++. +++.||||++.... +...+|++++++++||||+++++++.. ....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 57899999999999999999985 69999999986442 223469999999999999999998843 22467
Q ss_pred EEEEccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeeccc
Q 005040 500 LVLEFMPNGSLEKWLY---SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGIS 575 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~ 575 (717)
+||||+++ ++.+.+. .....+++..+..++.|+++||.||| +.+|+||||||+|||++.+ +.+||+|||++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 99999975 6776665 34556999999999999999999999 7899999999999999965 67899999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc---
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR--- 651 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 651 (717)
+.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+...+.......
T Consensus 205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHH
T ss_pred hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 87644322 2335689999999988664 799999999999999999999999976322 222333322211110
Q ss_pred hhhh-------ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 652 LTEV-------VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 652 ~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+... ..+.+....-........+.++.+|+.+||..||++|||+.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000 000000000000001123567899999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=339.30 Aligned_cols=262 Identities=24% Similarity=0.299 Sum_probs=193.5
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC------eeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLD------FKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------~~~ 499 (717)
..+|+..+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999987777799998754322 2235999999999999999999984432 378
Q ss_pred EEEEccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeeccc
Q 005040 500 LVLEFMPNGSLEKWLY---SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGIS 575 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~ 575 (717)
+||||++++ +.+.+. .....+++..+..++.|+++||+||| +.+|+||||||+||+++ .++.+||+|||++
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 999999864 444333 23456899999999999999999999 67899999999999999 7999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
+....... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ...+...+..........
T Consensus 190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHH
T ss_pred ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 87644332 2344689999999987654 589999999999999999999999976322 122222222111111000
Q ss_pred --hccccc-----h---hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 --VVDANL-----V---REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 --~~~~~~-----~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...+.. . ...........++.++.+++.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000 0 000000001124567899999999999999999999986
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=356.51 Aligned_cols=324 Identities=22% Similarity=0.246 Sum_probs=231.5
Q ss_pred CCccccCCCCCcEEECCCCccee-----------------cCCcCCC--CCCCCCEEEcccccccCccCCcccccccccc
Q 005040 4 IPNSITNATKLIGLDLGLNSFSG-----------------HIPNTFG--NLRHLSVLSLMMNNLTTESSSADQWSFLSSL 64 (717)
Q Consensus 4 iP~~~~~l~~L~~L~L~~n~i~~-----------------~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l 64 (717)
||.+|+++++|++|+|++|.|++ .+|..++ ++++|++|+|++|++.... +..|
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~i--------P~~l 511 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL--------PDFL 511 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSC--------CGGG
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccC--------hHHH
Confidence 89999999999999999999997 3888877 9999999999999877644 3448
Q ss_pred cCccCCcEEeccCCC-Ccc-cCCcchhccc------cccceeeecCCcceecCCc--cccCCCCCcEEEccCCCCcccCC
Q 005040 65 TNCRNLANLALASNP-LGG-ILPPLIGNFS------ASLQNIYAFECKLGGSIPK--EIGNLRGLIVLSLGFNDLNGTIP 134 (717)
Q Consensus 65 ~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~------~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~ 134 (717)
.++++|++|+|++|+ +++ .+|..+..+. ++|++|+|++|++. .+|. .|.++++|++|+|++|+++ .+|
T Consensus 512 ~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp 589 (876)
T 4ecn_A 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE 589 (876)
T ss_dssp GGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC
T ss_pred hCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch
Confidence 889999999999998 887 7787777763 37999999999998 7787 8899999999999999988 666
Q ss_pred ccccccCCCCEEeccCCcccccCCccccCCCC-CCEEeccCCcCcccCCccccCCCC--CCeEEecCccccCCCChhh--
Q 005040 135 TSIGTLQQLQGFYVPENNLQGYVPHDLCHLER-LNILNLSGNKLSGAIPQCLASLTS--LRSLYLQSNKLSSSLPSSL-- 209 (717)
Q Consensus 135 ~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~-- 209 (717)
.|..+++|+.|+|++|+++ .+|..+.++++ |+.|+|++|.++ .+|..+..++. |+.|+|++|++++.+|...
T Consensus 590 -~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~ 666 (876)
T 4ecn_A 590 -AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666 (876)
T ss_dssp -CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSC
T ss_pred -hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhh
Confidence 8888899999999999988 67777888888 899999988888 56766666543 7777777777776544322
Q ss_pred -h--cccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCccc-ccC-------CcccccccccCccccCCCC
Q 005040 210 -W--SLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPST-IGT-------LKNLETLSLAGNQFQGPIP 278 (717)
Q Consensus 210 -~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-------l~~L~~L~l~~N~l~~~~~ 278 (717)
. .+++|+.|+|++|.++...+..+..+++|+.|+|++|.|+. +|.. +.. +++|+.|+|++|+++ .+|
T Consensus 667 l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~-ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp 744 (876)
T 4ecn_A 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLS 744 (876)
T ss_dssp TTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSC-CCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCC
T ss_pred hccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCc-cChHHhccccccccccCCccEEECCCCCCc-cch
Confidence 1 23366666666666663322233466666666666666663 3332 221 226666666666666 455
Q ss_pred cccc--ccCccceEeccCCCCCCCCcccccccccccEEEccC------Ccccccccc-cccccccccccccCCc
Q 005040 279 ESVG--NLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSH------NRLEGEIPV-KGSFKDFSAQSYFGNY 343 (717)
Q Consensus 279 ~~~~--~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~------N~l~~~~p~-~~~~~~~~~~~~~~n~ 343 (717)
..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |.+.+.+|. ...++.+..+.+.+|.
T Consensus 745 ~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~ 817 (876)
T 4ecn_A 745 DDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817 (876)
T ss_dssp GGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred HHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCC
Confidence 5554 66666666666666665 566666666666666654 555555553 2344555555555544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=328.39 Aligned_cols=267 Identities=24% Similarity=0.303 Sum_probs=200.2
Q ss_pred HhccCCccccccccccEEEEEEEe--cCCCeEEEEEechhhH--HHHHHHHHHHHHHHhc---CCCceeeEeeeee----
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTL--SDGTNVAIKIFNLQLE--RAFRSFDSECEILRNV---RHRNLLKILGSCS---- 493 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~~~~~~~---- 493 (717)
+.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 3688999999864431 1123455677777766 8999999999986
Q ss_pred -cCCeeEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 005040 494 -NLDFKALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSD 571 (717)
Q Consensus 494 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 571 (717)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHHHeEEcCCCCEEEec
Confidence 5667899999997 69999998653 34899999999999999999999 67899999999999999999999999
Q ss_pred eccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-CC
Q 005040 572 FGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-PH 650 (717)
Q Consensus 572 fgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~ 650 (717)
||++....... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...... ........... +.
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPG 239 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCC
Confidence 99998654221 223456899999999999999999999999999999999999999763221 11112111110 00
Q ss_pred c--hhhhcc---ccchh--hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 651 R--LTEVVD---ANLVR--EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 651 ~--~~~~~~---~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. +..... ..+.. ..........++..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 000000 00000 00000011234567889999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=326.32 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=182.5
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 368899999999999999999975 79999999997543 223344555666788889999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+ ++.+..+.......+++..+..++.|+++||.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 556666665545568999999999999999999993 1389999999999999999999999999997664322
Q ss_pred CceeeeccccCccccCCCccC-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 583 DSVIQTMTMATIGYMAPEYGS-----EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
......+|+.|+|||++. ...++.++||||||+++|||++|+.||................. +..
T Consensus 180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~------ 249 (318)
T 2dyl_A 180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPL------ 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCC------
T ss_pred ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCC------
Confidence 123346899999999874 56788999999999999999999999975322211111111111 000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+....++.++.+++.+||+.||++|||+.|+++
T Consensus 250 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 ---------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0111123456889999999999999999999986
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=346.86 Aligned_cols=338 Identities=23% Similarity=0.275 Sum_probs=256.3
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+++||..++ +++++|||++|+|+++.+.+|.++++|++|+|++|+|+.+++++ |.++++|++|+|++|+|
T Consensus 43 l~~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~--------f~~L~~L~~L~Ls~N~l 112 (635)
T 4g8a_A 43 FYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA--------YQSLSHLSTLILTGNPI 112 (635)
T ss_dssp CSSCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTT--------TTTCTTCCEEECTTCCC
T ss_pred cCccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhH--------hcCCCCCCEEEccCCcC
Confidence 468898876 47899999999999988899999999999999999999988765 88999999999999999
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCccc-CCccccccCCCCEEeccCCcccccCCc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGT-IPTSIGTLQQLQGFYVPENNLQGYVPH 159 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~ 159 (717)
++..+..|..+ ++|++|+|++|++++..+..|+++++|++|+|++|.++.. .|..++.+++|++|+|++|+|++..+.
T Consensus 113 ~~l~~~~f~~L-~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 113 QSLALGAFSGL-SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CEECGGGGTTC-TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCHHHhcCC-CCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 98777788887 6799999999999988888899999999999999999764 577889999999999999988765443
Q ss_pred cccCCC--------------------------------------------------------------------------
Q 005040 160 DLCHLE-------------------------------------------------------------------------- 165 (717)
Q Consensus 160 ~~~~l~-------------------------------------------------------------------------- 165 (717)
.|..+.
T Consensus 192 ~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~ 271 (635)
T 4g8a_A 192 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 271 (635)
T ss_dssp GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred cccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccc
Confidence 332111
Q ss_pred ---------------------------------------------------------CCCEEeccCCcCcccCCc-----
Q 005040 166 ---------------------------------------------------------RLNILNLSGNKLSGAIPQ----- 183 (717)
Q Consensus 166 ---------------------------------------------------------~L~~L~L~~n~l~~~~~~----- 183 (717)
.|+.|++.+|.+....+.
T Consensus 272 ~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L 351 (635)
T 4g8a_A 272 KSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 351 (635)
T ss_dssp TTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTC
T ss_pred ccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhh
Confidence 122233333222211100
Q ss_pred --------------cccCCCCCCeEEecCcccc-----------------------------------------------
Q 005040 184 --------------CLASLTSLRSLYLQSNKLS----------------------------------------------- 202 (717)
Q Consensus 184 --------------~~~~l~~L~~L~L~~N~l~----------------------------------------------- 202 (717)
....+++|+.|++++|.+.
T Consensus 352 ~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~ 431 (635)
T 4g8a_A 352 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 431 (635)
T ss_dssp CEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSE
T ss_pred hhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcc
Confidence 0112345555555555442
Q ss_pred --CC-CChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCC-CCCCcccccCCcccccccccCccccCCCC
Q 005040 203 --SS-LPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQL-SSDIPSTIGTLKNLETLSLAGNQFQGPIP 278 (717)
Q Consensus 203 --~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l-~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 278 (717)
.. .+..|..+++++.++++.|.+.+..+..+..+++|+.|++++|.+ .+..|..|..+++|++|+|++|++++..|
T Consensus 432 ~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~ 511 (635)
T 4g8a_A 432 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 511 (635)
T ss_dssp EESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcCh
Confidence 11 123455667788888888888877788888888888888888864 34566778888888888888888887778
Q ss_pred ccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccc-ccc-cccccccccCCccccCCC
Q 005040 279 ESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK-GSF-KDFSAQSYFGNYALCGPP 349 (717)
Q Consensus 279 ~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~-~~~~~~~~~~n~~~c~~~ 349 (717)
..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|.. ..+ ..+..+.+.+|++.|+..
T Consensus 512 ~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 512 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred HHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 88888888888888888888777888888888888888888888877653 223 456667778888888643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=349.08 Aligned_cols=345 Identities=22% Similarity=0.210 Sum_probs=268.5
Q ss_pred CCccccCCCC--CcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccc---------------------cc
Q 005040 4 IPNSITNATK--LIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQW---------------------SF 60 (717)
Q Consensus 4 iP~~~~~l~~--L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~---------------------~~ 60 (717)
.|..|.+++. |++|+|++|.+++..|..|.++++|++|+|++|+++.+.+..... .+
T Consensus 238 ~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~l 317 (680)
T 1ziw_A 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL 317 (680)
T ss_dssp CTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------C
T ss_pred ChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccc
Confidence 3556666644 888888888888777778888888888888888887765432100 00
Q ss_pred cc----cccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcce--ecCCccccCC--CCCcEEEccCCCCccc
Q 005040 61 LS----SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLG--GSIPKEIGNL--RGLIVLSLGFNDLNGT 132 (717)
Q Consensus 61 ~~----~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~--~~~~~~~~~l--~~L~~L~L~~n~l~~~ 132 (717)
+. .|..+++|++|+|++|++++..+..|..+ ++|++|++++|.+. ......|..+ ++|+.|++++|++++.
T Consensus 318 p~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~ 396 (680)
T 1ziw_A 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396 (680)
T ss_dssp CEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEE
T ss_pred cccChhhcccCCCCCEEECCCCccCCCChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeE
Confidence 00 35566667777777777766666666665 45777777766532 2222333332 4677777777888877
Q ss_pred CCccccccCCCCEEeccCCcccccCC-ccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCcccc--CCCChhh
Q 005040 133 IPTSIGTLQQLQGFYVPENNLQGYVP-HDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLS--SSLPSSL 209 (717)
Q Consensus 133 ~~~~~~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~ 209 (717)
.|..|..+++|+.|+|++|.+.+..+ ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+. +..|..|
T Consensus 397 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~ 476 (680)
T 1ziw_A 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476 (680)
T ss_dssp CTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTT
T ss_pred ChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCccc
Confidence 78888888899999999998876544 67888889999999999988777888888899999999999886 4678889
Q ss_pred hcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCC--------cccccCCcccccccccCccccCCCCccc
Q 005040 210 WSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDI--------PSTIGTLKNLETLSLAGNQFQGPIPESV 281 (717)
Q Consensus 210 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--------~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 281 (717)
..+++|+.|++++|+|++..+..|.++++|+.|++++|.+++.. +..|..+++|++|+|++|+++...+..|
T Consensus 477 ~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~ 556 (680)
T 1ziw_A 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF 556 (680)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred ccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHc
Confidence 99999999999999999888888999999999999999998642 2247889999999999999996666679
Q ss_pred cccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccc-c-cccccccccccCCccccCCC
Q 005040 282 GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK-G-SFKDFSAQSYFGNYALCGPP 349 (717)
Q Consensus 282 ~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~-~~~~~~~~~~~~n~~~c~~~ 349 (717)
.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|.. + .++.+..+.+.+|++.|+.+
T Consensus 557 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred ccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999999999999887888899999999999999999877653 2 46778888899999999866
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=344.18 Aligned_cols=152 Identities=20% Similarity=0.281 Sum_probs=111.7
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+++||..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+.+++.+ |.++++|++|+|++|++
T Consensus 17 l~~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~--------~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 17 FTSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA--------FYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp CSSCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTT--------TTTCTTCCEEECTTSCC
T ss_pred cccccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhh--------ccccccCCEEECCCCcc
Confidence 457787665 67888888888888777788888888888888888888776543 77788888888888888
Q ss_pred cccCCcchhccccccceeeecCCccee-cCCccccCCCCCcEEEccCCC-CcccCCccccccCCCCEEeccCCcccccCC
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGG-SIPKEIGNLRGLIVLSLGFND-LNGTIPTSIGTLQQLQGFYVPENNLQGYVP 158 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~ 158 (717)
++..+..+..+ ++|++|++++|++.+ ..|..+.++++|++|++++|. +....+..|.++++|++|++++|.+++..|
T Consensus 87 ~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 165 (549)
T 2z81_A 87 SSLSSSWFGPL-SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165 (549)
T ss_dssp CSCCHHHHTTC-TTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred CccCHHHhccC-CCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence 76666667766 568888888888775 345677777888888888777 443334567777777777777777776666
Q ss_pred ccccC
Q 005040 159 HDLCH 163 (717)
Q Consensus 159 ~~~~~ 163 (717)
..+..
T Consensus 166 ~~l~~ 170 (549)
T 2z81_A 166 QSLKS 170 (549)
T ss_dssp TTTTT
T ss_pred hhhhc
Confidence 55543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=329.76 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=177.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHH-HHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECE-ILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|+..+.||+|+||.||+|... +++.||||++.... ......+..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 68899999999999999999975 78999999987543 223344555555 7777899999999999999999999999
Q ss_pred ccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 504 FMPNGSLEKWLYS----HNYFLDILQRLNIMIDVGSALEYLHHCHSSA-PIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 504 ~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|+++ +|.+++.. ....+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK----ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH----HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh----ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9975 88888763 2456899999999999999999999 45 8999999999999999999999999999876
Q ss_pred CCCCCceeeeccccCccccCCCcc----CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 579 GEGEDSVIQTMTMATIGYMAPEYG----SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 579 ~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ..........
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~--- 246 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQVVKGD--- 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSC---
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHHHhcCC---
Confidence 4322 12334689999999988 56678999999999999999999999997532110 0000000000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+.+.. .....++.++.+++.+||+.||++|||+.|+++
T Consensus 247 --~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 --PPQLSN-----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCC-----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCC-----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000 001134566889999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.64 Aligned_cols=263 Identities=23% Similarity=0.279 Sum_probs=200.2
Q ss_pred hccCCccccccccccEEEEEEEec-CC-CeEEEEEechhhHHHHHHHHHHHHHHHhcCCCc------eeeEeeeeecCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DG-TNVAIKIFNLQLERAFRSFDSECEILRNVRHRN------LLKILGSCSNLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn------iv~~~~~~~~~~~ 497 (717)
.++|++.+.||+|+||.||+|... ++ +.||+|++.... ...+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 368999999999999999999975 44 689999997543 33466788999999997665 9999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---------------
Q 005040 498 KALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL--------------- 561 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill--------------- 561 (717)
.++||||+ ++++.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH----ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecccccccccccccc
Confidence 99999999 667777777543 46899999999999999999999 7899999999999999
Q ss_pred ----CCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc
Q 005040 562 ----DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE 637 (717)
Q Consensus 562 ----~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 637 (717)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++||||+|+++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999998754322 33468999999999999999999999999999999999999997632211
Q ss_pred chHHHHHHhh--CCCchhh-h------------ccc----------cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCC
Q 005040 638 MSLRRWVKES--LPHRLTE-V------------VDA----------NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKR 692 (717)
Q Consensus 638 ~~~~~~~~~~--~~~~~~~-~------------~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 692 (717)
......... .+..... . .+. ...............+.++.+++.+||+.||++|
T Consensus 247 -~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 -HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp -HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred -HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 111111111 1100000 0 000 0000000011122345678999999999999999
Q ss_pred CCHHHHHH
Q 005040 693 IHMTDAAA 700 (717)
Q Consensus 693 pt~~ev~~ 700 (717)
||+.|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.59 Aligned_cols=261 Identities=23% Similarity=0.266 Sum_probs=195.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe-----
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF----- 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~----- 497 (717)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367899999999999999999975 79999999986532 3345678899999999999999999999977654
Q ss_pred -eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 498 -KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 498 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
.++||||++ ++|.+++.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 588887653 3899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-CC-chh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-PH-RLT 653 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~-~~~ 653 (717)
..... .....+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||.+.... ..+........ +. ...
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 65322 233468999999998776 67899999999999999999999999763221 11111111110 00 000
Q ss_pred hhcccc--------chhh-hhhh-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 654 EVVDAN--------LVRE-EQAF-SDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 654 ~~~~~~--------~~~~-~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+... +... ...+ .....++.++.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000 0000 011234567899999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.79 Aligned_cols=273 Identities=20% Similarity=0.218 Sum_probs=191.1
Q ss_pred HHHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe-
Q 005040 420 LDIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF- 497 (717)
Q Consensus 420 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~- 497 (717)
.......++|++.+.||+|+||.||+|... +++.||||++..... ......+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 355677789999999999999999999975 789999998854432 22345668888899999999999999855332
Q ss_pred ------eEEEEEccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcE
Q 005040 498 ------KALVLEFMPNGSLEKWLY---SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVA 567 (717)
Q Consensus 498 ------~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-~~~~ 567 (717)
.++||||+++ +|.+.+. .....+++..+..++.|++.||.|||. + +.+|+||||||+||+++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~-~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-P-SVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-T-TTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-C-CCCeecCcCCHHHEEEeCCCCcE
Confidence 7899999976 6655554 234558999999999999999999993 2 468999999999999996 8999
Q ss_pred EEeeeccccccCCCCCceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh
Q 005040 568 HVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 568 kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 646 (717)
||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+......
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHH
Confidence 9999999987654332 2345689999999987654 489999999999999999999999976322 1222222221
Q ss_pred hCCCc--hhhhcccc-----------chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 647 SLPHR--LTEVVDAN-----------LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 647 ~~~~~--~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..... .....++. .............++.++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11110 00000000 00000000011124677999999999999999999999986
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=355.01 Aligned_cols=308 Identities=19% Similarity=0.232 Sum_probs=208.4
Q ss_pred CCcCCCCCCCCCEEEcccccccCccCCcccc---------ccccccc--CccCCcEEeccCCCCcccCCcchhccccccc
Q 005040 28 IPNTFGNLRHLSVLSLMMNNLTTESSSADQW---------SFLSSLT--NCRNLANLALASNPLGGILPPLIGNFSASLQ 96 (717)
Q Consensus 28 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~---------~~~~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~ 96 (717)
+|..|++|++|++|+|++|+|+......... .++..+. ++++|++|+|++|.+.+.+|..+.++ ++|+
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L-~~L~ 518 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL-PELQ 518 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC-SSCC
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC-CCCC
Confidence 5666777777777777777777610000000 0233345 77777777777777777777777776 5677
Q ss_pred eeeecCCc-cee-cCCccccCC-------CCCcEEEccCCCCcccCCc--cccccCCCCEEeccCCcccccCCccccCCC
Q 005040 97 NIYAFECK-LGG-SIPKEIGNL-------RGLIVLSLGFNDLNGTIPT--SIGTLQQLQGFYVPENNLQGYVPHDLCHLE 165 (717)
Q Consensus 97 ~L~l~~n~-l~~-~~~~~~~~l-------~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~ 165 (717)
.|+|++|+ +++ .+|..++++ ++|++|+|++|+++ .+|. .|.++++|+.|+|++|+++ .+| .|..++
T Consensus 519 ~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~ 595 (876)
T 4ecn_A 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV 595 (876)
T ss_dssp EEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTS
T ss_pred EEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCC
Confidence 77777776 666 566554444 37777777777777 5666 6777777777777777777 455 677777
Q ss_pred CCCEEeccCCcCcccCCccccCCCC-CCeEEecCccccCCCChhhhcccC--CCeEEccCCcCcccCCccc---c--CCC
Q 005040 166 RLNILNLSGNKLSGAIPQCLASLTS-LRSLYLQSNKLSSSLPSSLWSLEY--ILRINLSSNSLKGTLPSNI---Q--KLN 237 (717)
Q Consensus 166 ~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~l~~N~l~~~~~~~~---~--~l~ 237 (717)
+|+.|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|..+..+.. |+.|+|++|.+.+.+|... . .++
T Consensus 596 ~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~ 673 (876)
T 4ecn_A 596 KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGI 673 (876)
T ss_dssp EESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCC
T ss_pred cceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCC
Confidence 7777777777777 56666777777 777777777777 55666655543 7777777777776544322 2 334
Q ss_pred CCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccc--------cCccceEeccCCCCCCCCccccc--c
Q 005040 238 VLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGN--------LISLESLDFSNNNLSGKIPKSLE--A 307 (717)
Q Consensus 238 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~--------l~~L~~L~L~~N~~~~~~~~~~~--~ 307 (717)
+|+.|+|++|.++...+..+..+++|+.|+|++|++. .+|..+.. +++|+.|+|++|+++ .+|..+. .
T Consensus 674 ~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~ 751 (876)
T 4ecn_A 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATT 751 (876)
T ss_dssp CEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTT
T ss_pred CcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhcc
Confidence 7788888888887543334457788888888888888 44444332 238888888888888 6777776 8
Q ss_pred cccccEEEccCCcccccccccccccccccccccCCc
Q 005040 308 LSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNY 343 (717)
Q Consensus 308 l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 343 (717)
+++|+.|+|++|++++.+.....++.+..+.+..|+
T Consensus 752 l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~ 787 (876)
T 4ecn_A 752 LPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQR 787 (876)
T ss_dssp CTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCB
T ss_pred CCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCC
Confidence 888888888888888743344566666666666654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.65 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=173.9
Q ss_pred HhccCCccc-cccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec----CCee
Q 005040 425 ATDEFNECN-LLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN----LDFK 498 (717)
Q Consensus 425 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~ 498 (717)
..++|.+.+ .||+|+||.||+|... +++.||||++...... ..+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346888855 6999999999999976 7999999998654221 1222334566799999999999866 4558
Q ss_pred EEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecc
Q 005040 499 ALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGI 574 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl 574 (717)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH----~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999998653 46899999999999999999999 678999999999999986 45699999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
+....... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||........... . .......
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~-~~~~~~~--- 248 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-M-KRRIRLG--- 248 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-H-HHhhhcc---
Confidence 98654322 2344679999999999999999999999999999999999999965322211000 0 0000000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..... .+....++.++.+++.+||+.||++|||+.|+++
T Consensus 249 --~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 --QYGFP-----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----CCC-----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --ccccC-----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 0111234567889999999999999999999987
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.14 Aligned_cols=292 Identities=19% Similarity=0.204 Sum_probs=162.2
Q ss_pred CCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhc
Q 005040 11 ATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGN 90 (717)
Q Consensus 11 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 90 (717)
+.++++|++++|.++.+.+..|.++++|++|+|++|.|+.+++.. |..+++|++|+|++|.+++..|..+..
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~--------~~~l~~L~~L~L~~n~l~~~~~~~~~~ 115 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYA--------FAYAHTIQKLYMGFNAIRYLPPHVFQN 115 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTT--------TTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhh--------ccCCCCcCEEECCCCCCCcCCHHHhcC
Confidence 455556666666655444444555566666666666655554332 555566666666666665555555555
Q ss_pred cccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCC----
Q 005040 91 FSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLER---- 166 (717)
Q Consensus 91 l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~---- 166 (717)
+ ++|++|++++|++....+..|.++++|++|+|++|.+++..+..|.++++|++|++++|++++.. +..+++
T Consensus 116 l-~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L 191 (390)
T 3o6n_A 116 V-PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHA 191 (390)
T ss_dssp C-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEE
T ss_pred C-CCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---ccccccccee
Confidence 5 44666666666655433334455566666666666665555555555666666666666555432 333444
Q ss_pred ---------------CCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCc
Q 005040 167 ---------------LNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPS 231 (717)
Q Consensus 167 ---------------L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 231 (717)
|++|++++|.+... +. ...++|+.|++++|.+++. ..+..+++|++|++++|.+++..|.
T Consensus 192 ~l~~n~l~~~~~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~ 266 (390)
T 3o6n_A 192 NVSYNLLSTLAIPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH 266 (390)
T ss_dssp ECCSSCCSEEECCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESG
T ss_pred ecccccccccCCCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChh
Confidence 45555555555432 21 1134566666666666532 3455566666666666666655555
Q ss_pred cccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccc
Q 005040 232 NIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHL 311 (717)
Q Consensus 232 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L 311 (717)
.|..+++|+.|+|++|.+++ ++..+..+++|++|++++|++. .+|..+..+++|+.|+|++|+++.. + +..+++|
T Consensus 267 ~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L 341 (390)
T 3o6n_A 267 PFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTL 341 (390)
T ss_dssp GGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCC
T ss_pred HccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccC
Confidence 66666666666666666654 3444455566666666666665 3444555566666666666666533 2 4455566
Q ss_pred cEEEccCCccccc
Q 005040 312 KQFNVSHNRLEGE 324 (717)
Q Consensus 312 ~~L~l~~N~l~~~ 324 (717)
+.|++++|++++.
T Consensus 342 ~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 342 KNLTLSHNDWDCN 354 (390)
T ss_dssp SEEECCSSCEEHH
T ss_pred CEEEcCCCCccch
Confidence 6666666666554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=333.07 Aligned_cols=263 Identities=20% Similarity=0.227 Sum_probs=198.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-----------CCceeeEeeeeec
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-----------HRNLLKILGSCSN 494 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~~~~~~~~ 494 (717)
++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 68999999999999999999974 78999999997543 23456788999999886 8999999999875
Q ss_pred CC----eeEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeC------
Q 005040 495 LD----FKALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSA-PIIHCDLKPTNILLD------ 562 (717)
Q Consensus 495 ~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~ivH~dlk~~Nill~------ 562 (717)
.+ ..++||||+ +++|.+++... ...+++..+..++.|++.||+||| +. +|+||||||+||+++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH----RRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH----hcCCEEecCCChHHeEEeccCCCc
Confidence 44 789999999 88999999864 345899999999999999999999 56 899999999999994
Q ss_pred CCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc-----
Q 005040 563 ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE----- 637 (717)
Q Consensus 563 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~----- 637 (717)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876432 233468999999999999999999999999999999999999997643211
Q ss_pred chHHHHHHhhCCCc--h-------hhhccc----------c---chh-hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC
Q 005040 638 MSLRRWVKESLPHR--L-------TEVVDA----------N---LVR-EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH 694 (717)
Q Consensus 638 ~~~~~~~~~~~~~~--~-------~~~~~~----------~---~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt 694 (717)
..+........+.. . ...+.. . +.. ..........++.++.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 11111111110000 0 000000 0 000 00011122456788999999999999999999
Q ss_pred HHHHHH
Q 005040 695 MTDAAA 700 (717)
Q Consensus 695 ~~ev~~ 700 (717)
++|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999986
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=340.36 Aligned_cols=311 Identities=19% Similarity=0.209 Sum_probs=263.1
Q ss_pred CCCC-ccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 2 GTIP-NSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 2 ~~iP-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+.+| ..|.++++|++|+|++|.|+++.|+.|.++++|++|+|++|+|+.++. . .+++|++|+|++|++
T Consensus 65 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~----------~-~l~~L~~L~Ls~N~l 133 (562)
T 3a79_B 65 SELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISC----------C-PMASLRHLDLSFNDF 133 (562)
T ss_dssp CCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECS----------C-CCTTCSEEECCSSCC
T ss_pred cccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCc----------c-ccccCCEEECCCCCc
Confidence 4555 689999999999999999999999999999999999999999998763 2 789999999999999
Q ss_pred ccc-CCcchhccccccceeeecCCcceecCCccccCCCCC--cEEEccCCCC--cccCCccccccC--------------
Q 005040 81 GGI-LPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGL--IVLSLGFNDL--NGTIPTSIGTLQ-------------- 141 (717)
Q Consensus 81 ~~~-~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-------------- 141 (717)
++. .|..|.++ ++|++|++++|++... .+..+++| ++|+|++|.+ ++..|..|..+.
T Consensus 134 ~~l~~p~~~~~l-~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~ 209 (562)
T 3a79_B 134 DVLPVCKEFGNL-TKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF 209 (562)
T ss_dssp SBCCCCGGGGGC-TTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCC
T ss_pred cccCchHhhccc-CcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccch
Confidence 974 36788888 6799999999999853 45555555 9999999988 666666655533
Q ss_pred -------------------------------------------------------------------CCCEEeccCCccc
Q 005040 142 -------------------------------------------------------------------QLQGFYVPENNLQ 154 (717)
Q Consensus 142 -------------------------------------------------------------------~L~~L~l~~n~i~ 154 (717)
+|++|++++|.++
T Consensus 210 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 289 (562)
T 3a79_B 210 SVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289 (562)
T ss_dssp CCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEEC
T ss_pred hhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEee
Confidence 6777777777777
Q ss_pred ccCCccc-----------------------------------------------------cCCCCCCEEeccCCcCcccC
Q 005040 155 GYVPHDL-----------------------------------------------------CHLERLNILNLSGNKLSGAI 181 (717)
Q Consensus 155 ~~~~~~~-----------------------------------------------------~~l~~L~~L~L~~n~l~~~~ 181 (717)
+..|..+ ..+++|++|+|++|++++..
T Consensus 290 ~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 369 (562)
T 3a79_B 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369 (562)
T ss_dssp SCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTT
T ss_pred ccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccch
Confidence 6555544 67889999999999999888
Q ss_pred CccccCCCCCCeEEecCccccCCC--ChhhhcccCCCeEEccCCcCcc-cCCccccCCCCCCeEEccCCCCCCCCccccc
Q 005040 182 PQCLASLTSLRSLYLQSNKLSSSL--PSSLWSLEYILRINLSSNSLKG-TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIG 258 (717)
Q Consensus 182 ~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 258 (717)
|..+.++++|+.|+|++|++++.. |..+..+++|++|++++|.+++ ..+..+..+++|+.|++++|.+++..|..+.
T Consensus 370 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~ 449 (562)
T 3a79_B 370 FQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449 (562)
T ss_dssp TTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC
T ss_pred hhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc
Confidence 999999999999999999999633 4678999999999999999998 4445689999999999999999976665544
Q ss_pred CCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccccc
Q 005040 259 TLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGS 330 (717)
Q Consensus 259 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 330 (717)
++|++|++++|+++ .+|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++.|.++....
T Consensus 450 --~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~ 518 (562)
T 3a79_B 450 --PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRY 518 (562)
T ss_dssp --TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred --CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHHH
Confidence 79999999999999 6777777999999999999999954444499999999999999999999886543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=325.64 Aligned_cols=245 Identities=25% Similarity=0.313 Sum_probs=190.6
Q ss_pred HHHHHhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH------HHHHHHHHHHHHHHhc----CCCceeeEe
Q 005040 421 DIRRATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE------RAFRSFDSECEILRNV----RHRNLLKIL 489 (717)
Q Consensus 421 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~hpniv~~~ 489 (717)
+.....++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+++++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455688999999999999999999874 789999999965431 1223456799999999 899999999
Q ss_pred eeeecCCeeEEEEEc-cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcE
Q 005040 490 GSCSNLDFKALVLEF-MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVA 567 (717)
Q Consensus 490 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~-~~~~~ 567 (717)
+++.+.+..++|||| +.+++|.+++.... .+++..+..++.|+++||.||| +.+|+||||||+||+++ .++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH----SRGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHTEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChhhEEEeCCCCeE
Confidence 999999999999999 78999999998754 4899999999999999999999 57899999999999999 89999
Q ss_pred EEeeeccccccCCCCCceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHh
Q 005040 568 HVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE 646 (717)
Q Consensus 568 kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 646 (717)
||+|||++....... .....||..|+|||++.+..+ +.++||||+|+++|||++|+.||.... .....
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~ 248 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEA 248 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHT
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhh
Confidence 999999998765432 234468999999998776665 458999999999999999999996521 11110
Q ss_pred hCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. .+ ...++.++.+++.+||+.||++|||+.|+++
T Consensus 249 ~~----------~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 EL----------HF---------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CC----------CC---------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cc----------CC---------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00 0123456789999999999999999999986
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=344.49 Aligned_cols=191 Identities=21% Similarity=0.246 Sum_probs=163.1
Q ss_pred cCCCCEEeccCCcccccC--CccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCC-hhhhcccCCC
Q 005040 140 LQQLQGFYVPENNLQGYV--PHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLP-SSLWSLEYIL 216 (717)
Q Consensus 140 l~~L~~L~l~~n~i~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~ 216 (717)
+++|++|++++|.+++.. +..+.++++|++|++++|.+.+..+. +..+++|++|++++|.+.+..+ ..+..+++|+
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 344445555555554332 44566677778888888877754444 8999999999999999997665 5789999999
Q ss_pred eEEccCCcCcccCCccccCCCCCCeEEccCCCCC-CCCcccccCCcccccccccCccccCCCCccccccCccceEeccCC
Q 005040 217 RINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLS-SDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNN 295 (717)
Q Consensus 217 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 295 (717)
+|++++|.+.+..|..+.++++|+.|++++|.++ +.+|..+..+++|++|++++|++++..|..+.++++|++|+|++|
T Consensus 425 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 504 (570)
T 2z63_A 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504 (570)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence 9999999999999999999999999999999998 468889999999999999999999888999999999999999999
Q ss_pred CCCCCCcccccccccccEEEccCCcccccccccccc
Q 005040 296 NLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSF 331 (717)
Q Consensus 296 ~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 331 (717)
++++..+..+..+++|+.|++++|+++|.+|....+
T Consensus 505 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 540 (570)
T 2z63_A 505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 540 (570)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred cCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHH
Confidence 999988889999999999999999999999875443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.77 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=186.6
Q ss_pred cCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEccC
Q 005040 428 EFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 445567899999999987766689999999987543 24567899999987 89999999999999999999999996
Q ss_pred CCCHHHHHhhCCCC------CCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-------------CcE
Q 005040 507 NGSLEKWLYSHNYF------LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDEN-------------MVA 567 (717)
Q Consensus 507 ~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~-------------~~~ 567 (717)
|+|.+++...... .++..+..++.|++.||+||| +.+|+||||||+||+++.+ +.+
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6999999865321 123345779999999999999 6789999999999999754 489
Q ss_pred EEeeeccccccCCCCCce--eeeccccCccccCCCccCC-------CCcCcccchhhHHHHHHHHHh-CCCCCCccccCc
Q 005040 568 HVSDFGISKLLGEGEDSV--IQTMTMATIGYMAPEYGSE-------GIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGE 637 (717)
Q Consensus 568 kl~Dfgl~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~ 637 (717)
||+|||++.......... ......||++|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999998875433211 1234579999999998765 678999999999999999999 999997532221
Q ss_pred chHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 638 MSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
........... . . .......++.++.+++.+||+.||++|||+.|+++
T Consensus 248 ---~~i~~~~~~~~--~-----~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ---SNIIRGIFSLD--E-----M-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHTCCCCC--C-----C-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHhcCCCCcc--c-----c-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11211111100 0 0 00112245677899999999999999999999985
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.73 Aligned_cols=310 Identities=21% Similarity=0.244 Sum_probs=251.5
Q ss_pred CCCC-ccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 2 GTIP-NSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 2 ~~iP-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
..+| ..|.++++|++|+|++|+|++..|+.|.++++|++|+|++|+|+.++. . .+++|++|+|++|++
T Consensus 34 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~----------~-~l~~L~~L~L~~N~l 102 (520)
T 2z7x_B 34 SELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISC----------H-PTVNLKHLDLSFNAF 102 (520)
T ss_dssp CCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEEC----------C-CCCCCSEEECCSSCC
T ss_pred cccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCc----------c-ccCCccEEeccCCcc
Confidence 3455 689999999999999999999989999999999999999999998763 2 688899999999988
Q ss_pred ccc-CCcchhccccccceeeecCCcceecCCccccCCCCC--cEEEccCCCC--cccCCccccccC--------------
Q 005040 81 GGI-LPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGL--IVLSLGFNDL--NGTIPTSIGTLQ-------------- 141 (717)
Q Consensus 81 ~~~-~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-------------- 141 (717)
++. .|..+..+ ++|++|++++|++.+ ..+..+++| ++|+|++|.+ .+..|..+..+.
T Consensus 103 ~~~~~p~~~~~l-~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~ 178 (520)
T 2z7x_B 103 DALPICKEFGNM-SQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178 (520)
T ss_dssp SSCCCCGGGGGC-TTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCC
T ss_pred ccccchhhhccC-CcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcch
Confidence 873 57788877 578888888888764 344555555 6666666665 333443333321
Q ss_pred ---------------------------------------------------------------------CCCEEeccCCc
Q 005040 142 ---------------------------------------------------------------------QLQGFYVPENN 152 (717)
Q Consensus 142 ---------------------------------------------------------------------~L~~L~l~~n~ 152 (717)
+|++|++++|+
T Consensus 179 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 258 (520)
T 2z7x_B 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258 (520)
T ss_dssp CCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEE
T ss_pred hhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeeccc
Confidence 45555555555
Q ss_pred ccccCCccc-----------------------------------------------------cCCCCCCEEeccCCcCcc
Q 005040 153 LQGYVPHDL-----------------------------------------------------CHLERLNILNLSGNKLSG 179 (717)
Q Consensus 153 i~~~~~~~~-----------------------------------------------------~~l~~L~~L~L~~n~l~~ 179 (717)
+++..|..+ ..+++|++|+|++|++++
T Consensus 259 l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~ 338 (520)
T 2z7x_B 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338 (520)
T ss_dssp EESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCT
T ss_pred ccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccCh
Confidence 554444333 678899999999999998
Q ss_pred cCCccccCCCCCCeEEecCccccC--CCChhhhcccCCCeEEccCCcCcccCCc-cccCCCCCCeEEccCCCCCCCCccc
Q 005040 180 AIPQCLASLTSLRSLYLQSNKLSS--SLPSSLWSLEYILRINLSSNSLKGTLPS-NIQKLNVLIDLDLSRNQLSSDIPST 256 (717)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~ 256 (717)
..|..+..+++|++|+|++|++++ .+|..+..+++|++|++++|.+++.+|. .+..+++|+.|++++|.+++..|..
T Consensus 339 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 418 (520)
T 2z7x_B 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418 (520)
T ss_dssp TTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGS
T ss_pred hhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhh
Confidence 889999999999999999999996 4567899999999999999999974554 5899999999999999999877665
Q ss_pred ccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccccc
Q 005040 257 IGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKG 329 (717)
Q Consensus 257 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 329 (717)
+. ++|++|++++|+++ .+|..+..+++|++|+|++|+++...+..+..+++|+.|++++|+++|.++...
T Consensus 419 l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~ 488 (520)
T 2z7x_B 419 LP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 488 (520)
T ss_dssp CC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHH
T ss_pred hc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCchH
Confidence 54 79999999999999 788888899999999999999995444459999999999999999999887543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=354.76 Aligned_cols=312 Identities=20% Similarity=0.239 Sum_probs=270.8
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEccccc-ccCccCCcccccccccccCccCCcEEeccCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNN-LTTESSSADQWSFLSSLTNCRNLANLALASNP 79 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~ 79 (717)
++.||. -.++|++|||++|.|+++.|..|.++++|++|+|++|. +..+++. .|.++++|++|+|++|.
T Consensus 16 L~~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~--------~f~~L~~L~~L~Ls~N~ 84 (844)
T 3j0a_A 16 LTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE--------AFRNLPNLRILDLGSSK 84 (844)
T ss_dssp SSCCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTT--------TTSSCTTCCEEECTTCC
T ss_pred CCCCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHH--------HhcCCCCCCEEECCCCc
Confidence 467887 45789999999999999999999999999999999994 4444443 38999999999999999
Q ss_pred CcccCCcchhccccccceeeecCCcceecCCcc--ccCCCCCcEEEccCCCCcccCC-ccccccCCCCEEeccCCccccc
Q 005040 80 LGGILPPLIGNFSASLQNIYAFECKLGGSIPKE--IGNLRGLIVLSLGFNDLNGTIP-TSIGTLQQLQGFYVPENNLQGY 156 (717)
Q Consensus 80 l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~i~~~ 156 (717)
+.+..|..|..+ ++|++|+|++|++.+..|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++.
T Consensus 85 l~~~~p~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 85 IYFLHPDAFQGL-FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCEECTTSSCSC-SSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred CcccCHhHccCC-cccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999989999988 67999999999999866665 9999999999999999987655 5799999999999999999998
Q ss_pred CCccccCC--CCCCEEeccCCcCcccCCccccCCCC------CCeEEecCccccCCCChhhhc-----------------
Q 005040 157 VPHDLCHL--ERLNILNLSGNKLSGAIPQCLASLTS------LRSLYLQSNKLSSSLPSSLWS----------------- 211 (717)
Q Consensus 157 ~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~------L~~L~L~~N~l~~~~~~~~~~----------------- 211 (717)
.+..+..+ ++|+.|+|++|.+.+..+..++.+++ |+.|+|++|.+++..+..+..
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 88888877 89999999999998877776666655 899999999877655544432
Q ss_pred ---------------------ccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccC
Q 005040 212 ---------------------LEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAG 270 (717)
Q Consensus 212 ---------------------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 270 (717)
.++|+.|++++|.+.+..+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++
T Consensus 244 ~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~ 323 (844)
T 3j0a_A 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323 (844)
T ss_dssp BCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEES
T ss_pred cccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCC
Confidence 26789999999999988888899999999999999999988888899999999999999
Q ss_pred ccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccc
Q 005040 271 NQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 271 N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
|++++..+..|.++++|+.|+|++|++.+..+..|..+++|+.|+|++|.+++.
T Consensus 324 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i 377 (844)
T 3j0a_A 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377 (844)
T ss_dssp CCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC
T ss_pred CCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc
Confidence 999888888999999999999999999888888899999999999999998753
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=343.03 Aligned_cols=316 Identities=19% Similarity=0.210 Sum_probs=272.2
Q ss_pred CCccccCCCCCcEEECCCCcceecCCcCCCC---------------------------------CCCCCEEEcccccccC
Q 005040 4 IPNSITNATKLIGLDLGLNSFSGHIPNTFGN---------------------------------LRHLSVLSLMMNNLTT 50 (717)
Q Consensus 4 iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~---------------------------------l~~L~~L~L~~n~l~~ 50 (717)
.|..|..+++|++|+|++|++++..|..|.+ +++|++|+|++|+++.
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 3567888888888888888888777665554 4555555556666666
Q ss_pred ccCCcccccccccccCccCCcEEeccCCCCc--ccCCcchhccc-cccceeeecCCcceecCCccccCCCCCcEEEccCC
Q 005040 51 ESSSADQWSFLSSLTNCRNLANLALASNPLG--GILPPLIGNFS-ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFN 127 (717)
Q Consensus 51 ~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~--~~~~~~~~~l~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 127 (717)
+++. .|.++++|++|+|++|.+. ......+..+. .+|+.|++++|++.+..|..|..+++|++|+|++|
T Consensus 344 ~~~~--------~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 415 (680)
T 1ziw_A 344 IKSN--------MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415 (680)
T ss_dssp CCTT--------TTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CChh--------HhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCC
Confidence 5543 3889999999999999854 23333444332 47999999999999999999999999999999999
Q ss_pred CCcccCC-ccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCc--ccCCccccCCCCCCeEEecCccccCC
Q 005040 128 DLNGTIP-TSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS--GAIPQCLASLTSLRSLYLQSNKLSSS 204 (717)
Q Consensus 128 ~l~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~ 204 (717)
.+++.++ ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+. +..|..|.++++|+.|+|++|++++.
T Consensus 416 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i 495 (680)
T 1ziw_A 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495 (680)
T ss_dssp CCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCC
T ss_pred cCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcC
Confidence 9986555 78999999999999999999999999999999999999999987 46788899999999999999999988
Q ss_pred CChhhhcccCCCeEEccCCcCcccCC--------ccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCC
Q 005040 205 LPSSLWSLEYILRINLSSNSLKGTLP--------SNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP 276 (717)
Q Consensus 205 ~~~~~~~l~~L~~L~l~~N~l~~~~~--------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 276 (717)
.+..|.++++|++|++++|.+++..+ ..|.++++|+.|+|++|.++.+.+..|..+++|+.|+|++|++++.
T Consensus 496 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l 575 (680)
T 1ziw_A 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575 (680)
T ss_dssp CTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcC
Confidence 88889999999999999999986422 2478999999999999999976666899999999999999999988
Q ss_pred CCccccccCccceEeccCCCCCCCCccccc-ccccccEEEccCCcccccccc
Q 005040 277 IPESVGNLISLESLDFSNNNLSGKIPKSLE-ALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 277 ~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~ 327 (717)
.+..|.++++|+.|+|++|++++..+..+. .+++|+.|++++|++.|.++.
T Consensus 576 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 788889999999999999999988888887 899999999999999998875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=326.91 Aligned_cols=241 Identities=23% Similarity=0.264 Sum_probs=198.0
Q ss_pred HhccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHH------HHHHHHHHHHHHHhcC--CCceeeEeeeeecC
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLER------AFRSFDSECEILRNVR--HRNLLKILGSCSNL 495 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~ 495 (717)
..++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++ ||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4578999999999999999999864 7899999999765321 1234667999999996 59999999999999
Q ss_pred CeeEEEEEccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeec
Q 005040 496 DFKALVLEFMPN-GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFG 573 (717)
Q Consensus 496 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg 573 (717)
+..++|||++.+ ++|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++ .++.+||+|||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 999999999976 89999998654 4899999999999999999999 67899999999999999 78999999999
Q ss_pred cccccCCCCCceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCch
Q 005040 574 ISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652 (717)
Q Consensus 574 l~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 652 (717)
++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ........
T Consensus 196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~~--- 261 (320)
T 3a99_A 196 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQVF--- 261 (320)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCCC---
T ss_pred ccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhccccc---
Confidence 998765322 233468999999998876665 788999999999999999999996521 11110000
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....++.++.+++.+||+.||++|||++|+++
T Consensus 262 ----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 262 ----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00123456889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.82 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=188.0
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
..+|+..+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 457889999999999987655556899999999865432 2345799999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeeeccccccC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-----NMVAHVSDFGISKLLG 579 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~~~~ 579 (717)
+. |+|.+++.......++..+..++.|++.||.||| +.+|+||||||+||+++. ...+||+|||+++...
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH----HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH----HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 96 6999999877655666667889999999999999 678999999999999953 3368899999998765
Q ss_pred CCCCc-eeeeccccCccccCCCccC---CCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 580 EGEDS-VIQTMTMATIGYMAPEYGS---EGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 580 ~~~~~-~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
..... .......||++|+|||++. ...++.++||||+||++|||++ |..||...... .......... ..
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~~~~~~~~~~---~~ 248 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---QANILLGACS---LD 248 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---HHHHHTTCCC---CT
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---HHHHHhccCC---cc
Confidence 43221 2234457999999999887 4667889999999999999999 89998542211 1111100000 00
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.. ......+..+.+++.+||+.||++|||+.||++
T Consensus 249 ~~-----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CL-----------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TS-----------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-----------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 111233455789999999999999999999984
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=338.82 Aligned_cols=312 Identities=19% Similarity=0.169 Sum_probs=192.3
Q ss_pred cCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcch
Q 005040 9 TNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLI 88 (717)
Q Consensus 9 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 88 (717)
.++++|++|+|++|.|+++.|..|.++++|++|+|++|.|+.+++.. |.++++|++|+|++|.+++..+..|
T Consensus 72 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--------~~~l~~L~~L~L~~n~l~~l~~~~~ 143 (597)
T 3oja_B 72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV--------FQNVPLLTVLVLERNDLSSLPRGIF 143 (597)
T ss_dssp HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTT--------TTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred ccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHH--------HcCCCCCCEEEeeCCCCCCCCHHHh
Confidence 44555555555555555555555555555555555555555544332 4455555555555555554333334
Q ss_pred hccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCC
Q 005040 89 GNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLN 168 (717)
Q Consensus 89 ~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~ 168 (717)
..+ ++|++|+|++|.+.+..|..|.++++|++|+|++|.+++. .+..+++|+.|++++|.+++. ....+|+
T Consensus 144 ~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~l-----~~~~~L~ 214 (597)
T 3oja_B 144 HNT-PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVE 214 (597)
T ss_dssp TTC-TTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCTTCS
T ss_pred ccC-CCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccccc-----cCCchhh
Confidence 444 3455555555555555555555555555555555555533 134445555555555555432 2334566
Q ss_pred EEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCC
Q 005040 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQ 248 (717)
Q Consensus 169 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 248 (717)
.|++++|.+....+.. .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.
T Consensus 215 ~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 289 (597)
T 3oja_B 215 ELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289 (597)
T ss_dssp EEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSC
T ss_pred eeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCC
Confidence 6667776666433222 2577888888888775 3567778888888888888887777788888888888888888
Q ss_pred CCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccc
Q 005040 249 LSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK 328 (717)
Q Consensus 249 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~ 328 (717)
+++ +|..+..+++|+.|+|++|.+. .+|..+..+++|+.|+|++|++++.. +..+++|+.|++++|+++|....
T Consensus 290 l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~- 363 (597)
T 3oja_B 290 LVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR- 363 (597)
T ss_dssp CCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-
T ss_pred CCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH-
Confidence 875 5666667788888888888887 56666777888888888888877542 55677788888888888776433
Q ss_pred ccccccccccccCCccccCC
Q 005040 329 GSFKDFSAQSYFGNYALCGP 348 (717)
Q Consensus 329 ~~~~~~~~~~~~~n~~~c~~ 348 (717)
..+..+....+.++...|+.
T Consensus 364 ~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 364 ALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp HHTTTCCTTTBCCCCCCCCT
T ss_pred HHHHHHhhhccccccccCCc
Confidence 23444445555666666664
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.57 Aligned_cols=270 Identities=25% Similarity=0.294 Sum_probs=201.6
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeec------CCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSN------LDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~ 497 (717)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999975 78999999986542 3445678899999999999999999998765 677
Q ss_pred eEEEEEccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc---EEEeee
Q 005040 498 KALVLEFMPNGSLEKWLYSHN--YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV---AHVSDF 572 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df 572 (717)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH----s~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH----ENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH----HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999998643 35888999999999999999999 678999999999999997665 999999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCch
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 652 (717)
|++........ .....||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ....|.........
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC----
T ss_pred ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhcccc
Confidence 99987654332 234578999999999999999999999999999999999999996531 11222111110000
Q ss_pred h-----hhcccc--chhhh-hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHHHhH
Q 005040 653 T-----EVVDAN--LVREE-QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTD-----AAAKLRKIK 706 (717)
Q Consensus 653 ~-----~~~~~~--~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e-----v~~~L~~~~ 706 (717)
. +..... +.... ........++..+.+++.+||+.||++|||+.| ..+.++.+.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0 000000 00000 000112245678999999999999999999988 445555543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.57 Aligned_cols=294 Identities=20% Similarity=0.206 Sum_probs=232.2
Q ss_pred CCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccc
Q 005040 34 NLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI 113 (717)
Q Consensus 34 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~ 113 (717)
.+.+|++|++++|.++.++... |..+++|++|+|++|.+++..+..|..+ ++|++|++++|++.+..|..|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~--------~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~ 113 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAAL--------LDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMGFNAIRYLPPHVF 113 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHH--------HHHCCCCSEEECTTSCCCEECTTTTTTC-TTCCEEECCSSCCCCCCTTTT
T ss_pred ccCCceEEEecCCchhhCChhH--------hcccccCcEEECCCCcccccChhhccCC-CCcCEEECCCCCCCcCCHHHh
Confidence 4689999999999999988644 7889999999999999998888888888 689999999999999889999
Q ss_pred cCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCe
Q 005040 114 GNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRS 193 (717)
Q Consensus 114 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 193 (717)
.++++|++|+|++|.++...+..|.++++|++|++++|.+++..+..|.++++|++|++++|++++.. +..+++|+.
T Consensus 114 ~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~ 190 (390)
T 3o6n_A 114 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFH 190 (390)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSE
T ss_pred cCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccce
Confidence 99999999999999999766666899999999999999999998889999999999999999998653 444556666
Q ss_pred EEecCccccCC------------------CChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcc
Q 005040 194 LYLQSNKLSSS------------------LPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPS 255 (717)
Q Consensus 194 L~L~~N~l~~~------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 255 (717)
|++++|.+++. .|. ...++|+.|++++|.+++. ..+..+++|++|++++|.+++..|.
T Consensus 191 L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~ 266 (390)
T 3o6n_A 191 ANVSYNLLSTLAIPIAVEELDASHNSINVVRG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH 266 (390)
T ss_dssp EECCSSCCSEEECCSSCSEEECCSSCCCEEEC--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESG
T ss_pred eecccccccccCCCCcceEEECCCCeeeeccc--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChh
Confidence 55555555421 111 1235677777777777643 4677777888888888888776677
Q ss_pred cccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccccccccccc
Q 005040 256 TIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFS 335 (717)
Q Consensus 256 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~ 335 (717)
.|..+++|++|+|++|++++ ++..+..+++|+.|+|++|++. .+|..+..+++|+.|++++|+++... ...++.+.
T Consensus 267 ~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~ 342 (390)
T 3o6n_A 267 PFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLK 342 (390)
T ss_dssp GGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCS
T ss_pred HccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--chhhccCC
Confidence 77777888888888887774 4555667777888888888777 45666777778888888888877542 34566666
Q ss_pred cccccCCccccC
Q 005040 336 AQSYFGNYALCG 347 (717)
Q Consensus 336 ~~~~~~n~~~c~ 347 (717)
.+.+.+|++.|.
T Consensus 343 ~L~l~~N~~~~~ 354 (390)
T 3o6n_A 343 NLTLSHNDWDCN 354 (390)
T ss_dssp EEECCSSCEEHH
T ss_pred EEEcCCCCccch
Confidence 777777777664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=308.89 Aligned_cols=233 Identities=12% Similarity=0.070 Sum_probs=185.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+..+++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999976 58999999997553 344577889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++++|.++++.. .....+..++.|++.||+||| +.+|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH----~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH----RAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH----HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999653 355678889999999999999 6789999999999999999999998443
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
|++| ++.++|||||||++|||++|+.||.+....... . ............
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---------~-~~~~~~~~~~~~ 224 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---------A-PAERDTAGQPIE 224 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---------E-ECCBCTTSCBCC
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---------H-HHHHHhccCCCC
Confidence 3333 688999999999999999999999764322100 0 000000000000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
......+++.++.+++.+||+.||++| |+.|+++.|+++....
T Consensus 225 ---~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 225 ---PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp ---HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ---hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 001112345678999999999999999 9999999999986543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=308.50 Aligned_cols=306 Identities=24% Similarity=0.350 Sum_probs=260.4
Q ss_pred cccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCc
Q 005040 7 SITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPP 86 (717)
Q Consensus 7 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 86 (717)
.+..+++|++|++++|.++. .+ .|..+++|++|+|++|++++++. +..+++|++|+|++|.++.. +
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~----------~~~l~~L~~L~L~~n~i~~~--~ 104 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP----------LSNLVKLTNLYIGTNKITDI--S 104 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG----------GTTCTTCCEEECCSSCCCCC--G
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh----------hhcCCcCCEEEccCCcccCc--h
Confidence 34578899999999999985 34 48999999999999999998653 78899999999999999854 4
Q ss_pred chhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCC
Q 005040 87 LIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLER 166 (717)
Q Consensus 87 ~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~ 166 (717)
.+..+ ++|++|++++|++.+..+ +..+++|++|++++|..... +..+..+++|++|++++|.+.+..+ +..+++
T Consensus 105 ~~~~l-~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~ 178 (347)
T 4fmz_A 105 ALQNL-TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTD 178 (347)
T ss_dssp GGTTC-TTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG--GGGCTT
T ss_pred HHcCC-CcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh--hccCCC
Confidence 57776 679999999999986433 89999999999999966544 3458999999999999999986644 889999
Q ss_pred CCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccC
Q 005040 167 LNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSR 246 (717)
Q Consensus 167 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 246 (717)
|++|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+.|++++
T Consensus 179 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~ 252 (347)
T 4fmz_A 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGT 252 (347)
T ss_dssp CSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred CCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCC
Confidence 9999999999986443 8889999999999999986544 8899999999999999986543 89999999999999
Q ss_pred CCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccc
Q 005040 247 NQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 247 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 326 (717)
|.+++. ..+..+++|++|++++|++++. ..+..+++|+.|+|++|++.+..+..+..+++|+.|++++|++++..|
T Consensus 253 n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 253 NQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp SCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 999864 4688899999999999999864 468899999999999999998888999999999999999999998877
Q ss_pred ccccccccccccccCCc
Q 005040 327 VKGSFKDFSAQSYFGNY 343 (717)
Q Consensus 327 ~~~~~~~~~~~~~~~n~ 343 (717)
...++.+..+.+.+|+
T Consensus 329 -~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 329 -LASLSKMDSADFANQV 344 (347)
T ss_dssp -GGGCTTCSEESSSCC-
T ss_pred -hhhhhccceeehhhhc
Confidence 5567777777777664
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=332.55 Aligned_cols=326 Identities=23% Similarity=0.273 Sum_probs=208.6
Q ss_pred CccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCccc-
Q 005040 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGI- 83 (717)
Q Consensus 5 P~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~- 83 (717)
|..|.++++|++|+|++|+|++..|+.|.++++|++|+|++|+++.+++.. |.++++|++|+|++|++++.
T Consensus 43 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~--------~~~l~~L~~L~Ls~n~l~~~~ 114 (549)
T 2z81_A 43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSW--------FGPLSSLKYLNLMGNPYQTLG 114 (549)
T ss_dssp SSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHH--------HTTCTTCCEEECTTCCCSSSC
T ss_pred hhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHH--------hccCCCCcEEECCCCcccccc
Confidence 678999999999999999999888899999999999999999998876433 77888888888888888753
Q ss_pred CCcchhccccccceeeecCCc-ceecCCccccCCCCCcEEEccCCCCcccCCccccc-----------------------
Q 005040 84 LPPLIGNFSASLQNIYAFECK-LGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGT----------------------- 139 (717)
Q Consensus 84 ~~~~~~~l~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----------------------- 139 (717)
.|..+..+ ++|++|++++|. +....+..|.++++|++|++++|.+++..|..+..
T Consensus 115 ~~~~~~~l-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~ 193 (549)
T 2z81_A 115 VTSLFPNL-TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFAD 193 (549)
T ss_dssp SSCSCTTC-TTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHH
T ss_pred hhhhhhcc-CCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHh
Confidence 45566666 568888888877 44444457777777888888777777666655543
Q ss_pred -cCCCCEEeccCCcccccC-------------------------------------------------------------
Q 005040 140 -LQQLQGFYVPENNLQGYV------------------------------------------------------------- 157 (717)
Q Consensus 140 -l~~L~~L~l~~n~i~~~~------------------------------------------------------------- 157 (717)
+++|++|++++|++++..
T Consensus 194 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~ 273 (549)
T 2z81_A 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE 273 (549)
T ss_dssp STTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCT
T ss_pred hcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccc
Confidence 455666666666655421
Q ss_pred ----------------------------------------------------Cccc-cCCCCCCEEeccCCcCcccCC--
Q 005040 158 ----------------------------------------------------PHDL-CHLERLNILNLSGNKLSGAIP-- 182 (717)
Q Consensus 158 ----------------------------------------------------~~~~-~~l~~L~~L~L~~n~l~~~~~-- 182 (717)
|..+ ..+++|++|+|++|++++..|
T Consensus 274 ~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 353 (549)
T 2z81_A 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353 (549)
T ss_dssp TTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHH
T ss_pred hhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccc
Confidence 1111 123444444444444443321
Q ss_pred -ccccCCCCCCeEEecCccccCCCC--hhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccC
Q 005040 183 -QCLASLTSLRSLYLQSNKLSSSLP--SSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGT 259 (717)
Q Consensus 183 -~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 259 (717)
..++.+++|+.|+|++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|++|++++|.+++ +|..+
T Consensus 354 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~-- 429 (549)
T 2z81_A 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI-- 429 (549)
T ss_dssp HTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--
T ss_pred hhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--
Confidence 123344444444444444442211 23444444555555555444 334444444445555555554442 22211
Q ss_pred CcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc-ccccccccccc
Q 005040 260 LKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV-KGSFKDFSAQS 338 (717)
Q Consensus 260 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~~~~ 338 (717)
.++|++|++++|++++. +..+++|++|+|++|+++ .+|. ...+++|+.|+|++|++++.+|. ...+..+..+.
T Consensus 430 ~~~L~~L~Ls~N~l~~~----~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 503 (549)
T 2z81_A 430 PQTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503 (549)
T ss_dssp CTTCSEEECCSSCCSCC----CCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEE
T ss_pred cCCceEEECCCCChhhh----cccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEE
Confidence 13444555555544432 246888999999999998 5665 46789999999999999987775 35677788888
Q ss_pred ccCCccccCCC
Q 005040 339 YFGNYALCGPP 349 (717)
Q Consensus 339 ~~~n~~~c~~~ 349 (717)
+.+|++.|+.+
T Consensus 504 l~~N~~~~~~~ 514 (549)
T 2z81_A 504 LHTNPWDCSCP 514 (549)
T ss_dssp CCSSCBCCCHH
T ss_pred ecCCCccCCCc
Confidence 88999888654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=305.40 Aligned_cols=299 Identities=20% Similarity=0.296 Sum_probs=238.2
Q ss_pred CCCCccccCC------CCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEec
Q 005040 2 GTIPNSITNA------TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLAL 75 (717)
Q Consensus 2 ~~iP~~~~~l------~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L 75 (717)
+++|..+... .+++.++++++.++ .+|..+. ++|++|+|++|.|+.+++.. |.++++|++|+|
T Consensus 17 ~~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~--------~~~l~~L~~L~L 85 (332)
T 2ft3_A 17 DSLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDD--------FKGLQHLYALVL 85 (332)
T ss_dssp --------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTT--------TTTCTTCCEEEC
T ss_pred ccCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhH--------hhCCCCCcEEEC
Confidence 4566655443 36889999999988 5666563 68999999999998876543 788999999999
Q ss_pred cCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccc
Q 005040 76 ASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQG 155 (717)
Q Consensus 76 ~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~ 155 (717)
++|++++..|..|..+ ++|++|++++|++. .+|..+. ++|++|++++|.++...+..|.++++|++|++++|.++.
T Consensus 86 ~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~ 161 (332)
T 2ft3_A 86 VNNKISKIHEKAFSPL-RKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN 161 (332)
T ss_dssp CSSCCCEECGGGSTTC-TTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG
T ss_pred CCCccCccCHhHhhCc-CCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc
Confidence 9999998888888887 67999999999988 5555554 789999999999987777778899999999999999863
Q ss_pred --cCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccc
Q 005040 156 --YVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI 233 (717)
Q Consensus 156 --~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 233 (717)
..+..+..+ +|++|++++|++++ +|..+. ++|++|+|++|++++..+..|..+++|++|++++|.+++..+..+
T Consensus 162 ~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 237 (332)
T 2ft3_A 162 SGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSL 237 (332)
T ss_dssp GGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGG
T ss_pred CCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHh
Confidence 667778877 89999999999985 454443 689999999999988777888889999999999999988777788
Q ss_pred cCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccc------cCccceEeccCCCCC--CCCcccc
Q 005040 234 QKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGN------LISLESLDFSNNNLS--GKIPKSL 305 (717)
Q Consensus 234 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~------l~~L~~L~L~~N~~~--~~~~~~~ 305 (717)
..+++|+.|++++|.++ .+|..+..+++|++|++++|++++..+..|.. .+.|+.|++++|++. +..|..|
T Consensus 238 ~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~ 316 (332)
T 2ft3_A 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316 (332)
T ss_dssp GGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGG
T ss_pred hCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccc
Confidence 89999999999999998 57777888999999999999998777777754 367888999999887 6777888
Q ss_pred cccccccEEEccCCc
Q 005040 306 EALSHLKQFNVSHNR 320 (717)
Q Consensus 306 ~~l~~L~~L~l~~N~ 320 (717)
..+++|+.+++++|+
T Consensus 317 ~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 317 RCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTBCCSTTEEC----
T ss_pred cccchhhhhhccccc
Confidence 889999999998875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=345.37 Aligned_cols=241 Identities=22% Similarity=0.302 Sum_probs=195.1
Q ss_pred hccCCccccccccccEEEEEEEec--CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe-----
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF----- 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~----- 497 (717)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 68999999886433 3445678899999999999999999999977655
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+||||+++++|.+++.. .+++..+..++.||+.||.||| +.+|+||||||+||+++.+ .+||+|||++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH----~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH----SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH----HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999988765 4899999999999999999999 6789999999999999986 899999999987
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
.... ....||++|+|||++.++. +.++|||||||++|||++|..||........ +
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~-------- 285 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P-------- 285 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C--------
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------c--------
Confidence 6432 3346899999999876654 8899999999999999999998765321110 0
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHHHhHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-MTDAAAKLRKIKA 707 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~ev~~~L~~~~~ 707 (717)
. .......+..+.+++.+||+.||++||+ ++++.+.|..+.+
T Consensus 286 ----~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 ----E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ----T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ----c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0 0011123456889999999999999995 7777777777644
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=308.02 Aligned_cols=255 Identities=35% Similarity=0.560 Sum_probs=213.1
Q ss_pred ccceeeecCCccee--cCCccccCCCCCcEEEccC-CCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEE
Q 005040 94 SLQNIYAFECKLGG--SIPKEIGNLRGLIVLSLGF-NDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNIL 170 (717)
Q Consensus 94 ~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 170 (717)
+++.|+|++|++.+ .+|..|.++++|++|+|++ |.+.+.+|..|.++++|++|+|++|.+++..|..|.++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 46677777777776 6777788888888888884 77777778888888888888888888887778888888888888
Q ss_pred eccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhccc-CCCeEEccCCcCcccCCccccCCCCCCeEEccCCCC
Q 005040 171 NLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLE-YILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQL 249 (717)
Q Consensus 171 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 249 (717)
+|++|.+++..|..|..+++|++|+|++|++++.+|..+..++ +|++|++++|.+++..|..+..+. |+.|++++|.+
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 8888888877788888888888888888888877788888887 888888888888888888888887 88888888888
Q ss_pred CCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccccc
Q 005040 250 SSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKG 329 (717)
Q Consensus 250 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 329 (717)
++..|..+..+++|+.|++++|++++..+. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|..+
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 888888888888888888888888865554 7788899999999999988889999999999999999999999998888
Q ss_pred cccccccccccCCccccCCCC
Q 005040 330 SFKDFSAQSYFGNYALCGPPR 350 (717)
Q Consensus 330 ~~~~~~~~~~~~n~~~c~~~~ 350 (717)
.++.+..+.+.+|+++||.|.
T Consensus 289 ~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 289 NLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS
T ss_pred cccccChHHhcCCCCccCCCC
Confidence 888888888999999999764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.08 Aligned_cols=312 Identities=27% Similarity=0.386 Sum_probs=230.1
Q ss_pred CCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCc
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
..+|. +..+++|++|+|++|.+++..+ |.++++|++|+|++|.++.+++ +.++++|++|+|++|.++
T Consensus 59 ~~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~----------~~~l~~L~~L~L~~n~l~ 125 (466)
T 1o6v_A 59 KSIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP----------LANLTNLTGLTLFNNQIT 125 (466)
T ss_dssp CCCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG----------GTTCTTCCEEECCSSCCC
T ss_pred ccCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh----------hcCCCCCCEEECCCCCCC
Confidence 45664 7889999999999999986554 8899999999999999887653 678889999999999888
Q ss_pred ccCCcchhccccccceeeecCCcceecCC-------------------ccccCCCCCcEEEccCCCCcccCCccccccCC
Q 005040 82 GILPPLIGNFSASLQNIYAFECKLGGSIP-------------------KEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQ 142 (717)
Q Consensus 82 ~~~~~~~~~l~~~L~~L~l~~n~l~~~~~-------------------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 142 (717)
+..+ +..+ ++|++|++++|.+.+... ..+.++++|++|++++|.++.. ..+..+++
T Consensus 126 ~~~~--~~~l-~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~ 200 (466)
T 1o6v_A 126 DIDP--LKNL-TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTN 200 (466)
T ss_dssp CCGG--GTTC-TTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTT
T ss_pred CChH--HcCC-CCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCC
Confidence 6543 6666 678888888888775311 1255666777777777777643 34677777
Q ss_pred CCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccC
Q 005040 143 LQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSS 222 (717)
Q Consensus 143 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 222 (717)
|++|++++|.+.+..+ +..+++|++|++++|++++. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++
T Consensus 201 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~ 274 (466)
T 1o6v_A 201 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 274 (466)
T ss_dssp CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred CCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCC
Confidence 7777777777775544 66677777777777777743 346777778888888887775443 77777888888888
Q ss_pred CcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCc
Q 005040 223 NSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIP 302 (717)
Q Consensus 223 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~ 302 (717)
|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++.+..| +..+++|+.|++++|++++.
T Consensus 275 n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-- 346 (466)
T 1o6v_A 275 NQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-- 346 (466)
T ss_dssp SCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--
T ss_pred CccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--
Confidence 88775433 7777888888888888876443 6778888888888888876554 67788888888888888754
Q ss_pred ccccccccccEEEccCCcccccccccccccccccccccCCcccc
Q 005040 303 KSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALC 346 (717)
Q Consensus 303 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c 346 (717)
..+..+++|+.|++++|++++..| ...++.+..+.+.+|++..
T Consensus 347 ~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 347 SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEEC
T ss_pred hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccC
Confidence 467788888888888888887777 4566667767676666544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=330.99 Aligned_cols=312 Identities=17% Similarity=0.175 Sum_probs=278.6
Q ss_pred CCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchh
Q 005040 10 NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIG 89 (717)
Q Consensus 10 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 89 (717)
.+.+++.|++++|.++.+.+..|.++++|++|+|++|.|+.+++.. |..+++|++|+|++|.+++..|..|.
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~--------~~~l~~L~~L~L~~n~l~~~~~~~~~ 120 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYA--------FAYAHTIQKLYMGFNAIRYLPPHVFQ 120 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTT--------TTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHH--------hcCCCCCCEEECCCCcCCCCCHHHHc
Confidence 4688999999999999888888999999999999999999987544 89999999999999999998888888
Q ss_pred ccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCE
Q 005040 90 NFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNI 169 (717)
Q Consensus 90 ~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~ 169 (717)
.+ ++|++|+|++|.+.+..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++.. +..+++|+.
T Consensus 121 ~l-~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~ 196 (597)
T 3oja_B 121 NV-PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFH 196 (597)
T ss_dssp TC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSE
T ss_pred CC-CCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhh
Confidence 88 68999999999999777777899999999999999999999999999999999999999999763 567889999
Q ss_pred EeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCC
Q 005040 170 LNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQL 249 (717)
Q Consensus 170 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 249 (717)
|++++|.+++. ...++|+.|++++|.++...+. + .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+
T Consensus 197 L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l 266 (597)
T 3oja_B 197 ANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 266 (597)
T ss_dssp EECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCC
T ss_pred hhcccCccccc-----cCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCcc
Confidence 99999999853 4457899999999999854332 2 3689999999999996 47899999999999999999
Q ss_pred CCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccccc
Q 005040 250 SSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKG 329 (717)
Q Consensus 250 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 329 (717)
++..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++.. ..
T Consensus 267 ~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~ 342 (597)
T 3oja_B 267 EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LS 342 (597)
T ss_dssp CEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CC
T ss_pred CCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hh
Confidence 99889999999999999999999995 5777788999999999999999 67888899999999999999998763 34
Q ss_pred cccccccccccCCccccC
Q 005040 330 SFKDFSAQSYFGNYALCG 347 (717)
Q Consensus 330 ~~~~~~~~~~~~n~~~c~ 347 (717)
.++.+..+.+.+|++.|.
T Consensus 343 ~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 343 THHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp TTCCCSEEECCSSCEEHH
T ss_pred hcCCCCEEEeeCCCCCCh
Confidence 577888888999998875
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.34 Aligned_cols=290 Identities=26% Similarity=0.375 Sum_probs=254.2
Q ss_pred CCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCc
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
..+|. +..+++|++|+|++|.+++..+ |.++++|++|+|++|.++.++ .+..+++|++|+|++|.++
T Consensus 57 ~~~~~-~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~~----------~~~~l~~L~~L~l~~n~i~ 123 (347)
T 4fmz_A 57 ASIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDIS----------ALQNLTNLRELYLNEDNIS 123 (347)
T ss_dssp CCCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG----------GGTTCTTCSEEECTTSCCC
T ss_pred ccchh-hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCch----------HHcCCCcCCEEECcCCccc
Confidence 45664 8899999999999999996544 999999999999999999854 2889999999999999998
Q ss_pred ccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccc
Q 005040 82 GILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL 161 (717)
Q Consensus 82 ~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~ 161 (717)
+..+ +..+ ++|++|++++|.....+ ..+..+++|++|++++|.+....+ +..+++|++|++++|.+.+..+ +
T Consensus 124 ~~~~--~~~l-~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~ 195 (347)
T 4fmz_A 124 DISP--LANL-TKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--L 195 (347)
T ss_dssp CCGG--GTTC-TTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--G
T ss_pred Cchh--hccC-CceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--c
Confidence 6543 6666 67999999999766444 449999999999999999986544 8999999999999999996644 8
Q ss_pred cCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCe
Q 005040 162 CHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241 (717)
Q Consensus 162 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 241 (717)
..+++|+.|++++|.+++..+ +..+++|++|++++|++++..+ +..+++|++|++++|.+++. ..+..+++|+.
T Consensus 196 ~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~ 269 (347)
T 4fmz_A 196 ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKM 269 (347)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCE
T ss_pred cCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCE
Confidence 899999999999999996544 8899999999999999996544 88999999999999999964 57999999999
Q ss_pred EEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcc
Q 005040 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRL 321 (717)
Q Consensus 242 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l 321 (717)
|++++|.+++. ..+..+++|++|++++|++.+..+..+..+++|+.|+|++|++++..| +..+++|+.|++++|++
T Consensus 270 L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 270 LNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred EEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhcc
Confidence 99999999974 458899999999999999998888999999999999999999997766 88999999999999998
Q ss_pred c
Q 005040 322 E 322 (717)
Q Consensus 322 ~ 322 (717)
+
T Consensus 346 ~ 346 (347)
T 4fmz_A 346 K 346 (347)
T ss_dssp -
T ss_pred c
Confidence 6
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.16 Aligned_cols=230 Identities=21% Similarity=0.299 Sum_probs=179.2
Q ss_pred hccCCcc-ccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHH-HhcCCCceeeEeeeeec----CCee
Q 005040 426 TDEFNEC-NLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEIL-RNVRHRNLLKILGSCSN----LDFK 498 (717)
Q Consensus 426 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~hpniv~~~~~~~~----~~~~ 498 (717)
.++|.+. +.||+|+||.||+|... +++.||+|++... ..+.+|++++ +..+||||+++++++.+ ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 77999999999999974 7899999998643 3456788888 55589999999999876 6778
Q ss_pred EEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecc
Q 005040 499 ALVLEFMPNGSLEKWLYSHN-YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGI 574 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl 574 (717)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999998753 45899999999999999999999 678999999999999998 78999999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
+.... +..++.++||||+|+++|||++|+.||....... .........
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~------~~~~~~~~~-- 214 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------ISPGMKTRI-- 214 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCSCCSS--
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh------hhHHHHHHH--
Confidence 86532 2346789999999999999999999996532111 000000000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....... .......++.++.+++.+||+.||++|||+.|+++
T Consensus 215 -~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 215 -RMGQYEF---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -CTTCCSS---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -hhccccC---CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 00111245677899999999999999999999987
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.63 Aligned_cols=291 Identities=19% Similarity=0.275 Sum_probs=243.4
Q ss_pred CCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhc
Q 005040 11 ATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGN 90 (717)
Q Consensus 11 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 90 (717)
..+++.++++++.++ .+|..+. ++|++|+|++|+|+.++... |.++++|++|+|++|.+++..|..+..
T Consensus 30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~--------~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (330)
T 1xku_A 30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGD--------FKNLKNLHTLILINNKISKISPGAFAP 98 (330)
T ss_dssp EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTT--------TTTCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhh--------hccCCCCCEEECCCCcCCeeCHHHhcC
Confidence 347889999999998 4666554 68999999999999887544 888999999999999999888888888
Q ss_pred cccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccc--cCCccccCCCCCC
Q 005040 91 FSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQG--YVPHDLCHLERLN 168 (717)
Q Consensus 91 l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~--~~~~~~~~l~~L~ 168 (717)
+ ++|++|++++|++. .+|..+. ++|++|++++|.++...+..|.++++|+.|++++|.+.. ..+..+.++++|+
T Consensus 99 l-~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~ 174 (330)
T 1xku_A 99 L-VKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174 (330)
T ss_dssp C-TTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred C-CCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcC
Confidence 7 67999999999988 4565554 789999999999998777788999999999999999864 6777889999999
Q ss_pred EEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCC
Q 005040 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQ 248 (717)
Q Consensus 169 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 248 (717)
+|++++|.++. +|..+. ++|++|++++|++++..+..|..+++|++|++++|.+++..+..+..+++|+.|+|++|.
T Consensus 175 ~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 251 (330)
T 1xku_A 175 YIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251 (330)
T ss_dssp EEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred EEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCc
Confidence 99999999985 454433 789999999999998888889999999999999999998877889999999999999999
Q ss_pred CCCCCcccccCCcccccccccCccccCCCCccccc------cCccceEeccCCCCCC--CCcccccccccccEEEccCCc
Q 005040 249 LSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGN------LISLESLDFSNNNLSG--KIPKSLEALSHLKQFNVSHNR 320 (717)
Q Consensus 249 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~------l~~L~~L~L~~N~~~~--~~~~~~~~l~~L~~L~l~~N~ 320 (717)
++ .+|..+..+++|++|++++|++++..+..|.. .+.|+.|++++|++.. ..|..|..+++++.++|++|+
T Consensus 252 l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 252 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred Cc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 98 57778888999999999999999777777754 3678899999998864 667888899999999999885
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=302.83 Aligned_cols=253 Identities=28% Similarity=0.455 Sum_probs=234.5
Q ss_pred cCCcEEeccCCCCcc--cCCcchhccccccceeeecC-CcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCC
Q 005040 68 RNLANLALASNPLGG--ILPPLIGNFSASLQNIYAFE-CKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQ 144 (717)
Q Consensus 68 ~~L~~L~L~~N~l~~--~~~~~~~~l~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 144 (717)
.+++.|+|++|.+++ .+|..+..+ ++|++|++++ |++.+.+|..|.++++|++|+|++|.+++..|..|.++++|+
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l-~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 128 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANL-PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGC-TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred ceEEEEECCCCCccCCcccChhHhCC-CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence 578999999999988 788888888 6799999995 899989999999999999999999999988999999999999
Q ss_pred EEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCC-CCCeEEecCccccCCCChhhhcccCCCeEEccCC
Q 005040 145 GFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLT-SLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223 (717)
Q Consensus 145 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 223 (717)
+|+|++|.+++..|..+..+++|++|+|++|++++.+|..+..++ +|++|+|++|++++..|..+..++ |+.|++++|
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence 999999999999999999999999999999999988999999998 999999999999988999999987 999999999
Q ss_pred cCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcc
Q 005040 224 SLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPK 303 (717)
Q Consensus 224 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~ 303 (717)
.+++..|..|..+++|+.|+|++|.+++..|. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|.
T Consensus 208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred cccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence 99999999999999999999999999976655 88899999999999999999999999999999999999999998888
Q ss_pred cccccccccEEEccCCc-cccc
Q 005040 304 SLEALSHLKQFNVSHNR-LEGE 324 (717)
Q Consensus 304 ~~~~l~~L~~L~l~~N~-l~~~ 324 (717)
. ..+++|+.+++++|+ ++|.
T Consensus 287 ~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 287 G-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp S-TTGGGSCGGGTCSSSEEEST
T ss_pred C-ccccccChHHhcCCCCccCC
Confidence 6 889999999999999 5553
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=320.55 Aligned_cols=239 Identities=15% Similarity=0.164 Sum_probs=179.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCC-Cceee--------------
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRH-RNLLK-------------- 487 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-pniv~-------------- 487 (717)
..|...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++| ++...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45778889999999999999964 79999999987332 2234678899999999976 22111
Q ss_pred -------Eeeeeec-----CCeeEEEEEccCCCCHHHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 005040 488 -------ILGSCSN-----LDFKALVLEFMPNGSLEKWLY------SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPI 549 (717)
Q Consensus 488 -------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i 549 (717)
+..++.. ....+++|+++ +++|.++++ .....+++..+..++.|+++||+||| +.+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~i 232 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYGL 232 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH----hCCc
Confidence 1111111 22456777766 679999985 22445788899999999999999999 6789
Q ss_pred EecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCcc----------CCCCcCcccchhhHHHH
Q 005040 550 IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYG----------SEGIVSTKCDVYSYGVL 619 (717)
Q Consensus 550 vH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~Dvws~G~i 619 (717)
+||||||+|||++.++.+||+|||+++..+.. .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998865322 334467 999999988 66678999999999999
Q ss_pred HHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 005040 620 LMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAA 699 (717)
Q Consensus 620 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~ 699 (717)
+|||++|+.||......+. ...++. ....++.++.+++.+||+.||++||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~~-------------~~~~~~-----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG-------------SEWIFR-----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC-------------SGGGGS-----------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhh-------------HHHHHh-----------hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999976322110 001111 0012346688999999999999999977765
Q ss_pred H
Q 005040 700 A 700 (717)
Q Consensus 700 ~ 700 (717)
+
T Consensus 363 ~ 363 (413)
T 3dzo_A 363 E 363 (413)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.84 Aligned_cols=278 Identities=23% Similarity=0.288 Sum_probs=244.5
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+..+|..+. +++++|+|++|+|+++.+..|.++++|++|+|++|+++.+.+.. |..+++|++|+|++|++
T Consensus 43 l~~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--------~~~l~~L~~L~Ls~n~l 112 (330)
T 1xku_A 43 LEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA--------FAPLVKLERLYLSKNQL 112 (330)
T ss_dssp CCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT--------TTTCTTCCEEECCSSCC
T ss_pred ccccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHH--------hcCCCCCCEEECCCCcC
Confidence 357887775 68999999999999888889999999999999999999886544 88999999999999999
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcc--cCCccccccCCCCEEeccCCcccccCC
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNG--TIPTSIGTLQQLQGFYVPENNLQGYVP 158 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~l~~n~i~~~~~ 158 (717)
+. +|..+. ++|++|++++|++.+..+..|.++++|++|++++|.++. ..+..|.++++|++|++++|.++.. |
T Consensus 113 ~~-l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l-~ 187 (330)
T 1xku_A 113 KE-LPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-P 187 (330)
T ss_dssp SB-CCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC-C
T ss_pred Cc-cChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC-C
Confidence 84 555443 579999999999998888889999999999999999964 6778899999999999999999964 4
Q ss_pred ccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCC
Q 005040 159 HDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV 238 (717)
Q Consensus 159 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 238 (717)
..+. ++|++|+|++|++++..+..|..+++|+.|+|++|.+++..+..+..+++|++|+|++|.++ .+|..+..+++
T Consensus 188 ~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~ 264 (330)
T 1xku_A 188 QGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 264 (330)
T ss_dssp SSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSS
T ss_pred cccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCC
Confidence 4333 79999999999999888899999999999999999999888888999999999999999999 78888999999
Q ss_pred CCeEEccCCCCCCCCcccccC------CcccccccccCccccC--CCCccccccCccceEeccCCC
Q 005040 239 LIDLDLSRNQLSSDIPSTIGT------LKNLETLSLAGNQFQG--PIPESVGNLISLESLDFSNNN 296 (717)
Q Consensus 239 L~~L~l~~N~l~~~~~~~~~~------l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~L~~N~ 296 (717)
|++|++++|.|++..+..|.. .+.|+.|++++|++.. ..|..|..+.+|+.++|++|+
T Consensus 265 L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 999999999999877777754 3789999999999864 667889999999999999985
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.72 Aligned_cols=277 Identities=24% Similarity=0.314 Sum_probs=244.3
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+.+||..+. ++|++|+|++|.|+++.+..|.++++|++|+|++|+|+.+.+. .|.++++|++|+|++|++
T Consensus 45 l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--------~~~~l~~L~~L~L~~n~l 114 (332)
T 2ft3_A 45 LKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK--------AFSPLRKLQKLYISKNHL 114 (332)
T ss_dssp CSSCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGG--------GSTTCTTCCEEECCSSCC
T ss_pred ccccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHh--------HhhCcCCCCEEECCCCcC
Confidence 467888775 6899999999999998899999999999999999999987644 389999999999999999
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcc--cCCccccccCCCCEEeccCCcccccCC
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNG--TIPTSIGTLQQLQGFYVPENNLQGYVP 158 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~l~~n~i~~~~~ 158 (717)
+. +|..+. ++|++|++++|++....+..|.++++|++|++++|.++. ..+..+..+ +|++|++++|++++. |
T Consensus 115 ~~-l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l-~ 188 (332)
T 2ft3_A 115 VE-IPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGI-P 188 (332)
T ss_dssp CS-CCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSC-C
T ss_pred Cc-cCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCcc-C
Confidence 94 454443 679999999999998777889999999999999999963 677888888 999999999999964 4
Q ss_pred ccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCC
Q 005040 159 HDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV 238 (717)
Q Consensus 159 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 238 (717)
..+. ++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+..+++
T Consensus 189 ~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~ 265 (332)
T 2ft3_A 189 KDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265 (332)
T ss_dssp SSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTT
T ss_pred cccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCcc
Confidence 4443 79999999999999888889999999999999999999888889999999999999999999 78888999999
Q ss_pred CCeEEccCCCCCCCCcccccC------CcccccccccCcccc--CCCCccccccCccceEeccCCC
Q 005040 239 LIDLDLSRNQLSSDIPSTIGT------LKNLETLSLAGNQFQ--GPIPESVGNLISLESLDFSNNN 296 (717)
Q Consensus 239 L~~L~l~~N~l~~~~~~~~~~------l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~L~~N~ 296 (717)
|+.|++++|.|++..+..|.. ..+|+.|++++|++. +..|..|..+++|+.|+|++|+
T Consensus 266 L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 266 LQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 999999999999877777765 467999999999997 6778889999999999999985
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=321.78 Aligned_cols=331 Identities=24% Similarity=0.246 Sum_probs=260.3
Q ss_pred CCCCccccCCCC---CcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCC
Q 005040 2 GTIPNSITNATK---LIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASN 78 (717)
Q Consensus 2 ~~iP~~~~~l~~---L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N 78 (717)
+++|++...+.. -+..+.++.+++ .+|..+. +++++|+|++|+|+.+++.+ |.++++|++|+|++|
T Consensus 18 ~~~p~~~~~c~~~~~~~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~--------f~~l~~L~~L~Ls~N 86 (635)
T 4g8a_A 18 SSIPESWEPCVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYS--------FFSFPELQVLDLSRC 86 (635)
T ss_dssp -------CCSEEEETTTEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTT--------TTTCTTCCEEECTTC
T ss_pred CCCCCCCCCccccCCCCEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHH--------HhCCCCCCEEECCCC
Confidence 356776655432 245688888898 5676553 48999999999999998655 899999999999999
Q ss_pred CCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCccccc-C
Q 005040 79 PLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGY-V 157 (717)
Q Consensus 79 ~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~-~ 157 (717)
+|+++.+.+|..+ ++|++|+|++|++.+..+..|.++++|++|+|++|+++++.+..|+++++|++|+|++|.++.. .
T Consensus 87 ~i~~i~~~~f~~L-~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~ 165 (635)
T 4g8a_A 87 EIQTIEDGAYQSL-SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 165 (635)
T ss_dssp CCCEECTTTTTTC-TTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCC
T ss_pred cCCCcChhHhcCC-CCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCC
Confidence 9998888889988 6899999999999988888999999999999999999988888899999999999999999864 5
Q ss_pred CccccCCCCCCEEeccCCcCcccCCccccCC-------------------------------------------------
Q 005040 158 PHDLCHLERLNILNLSGNKLSGAIPQCLASL------------------------------------------------- 188 (717)
Q Consensus 158 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l------------------------------------------------- 188 (717)
|..+..+++|++|+|++|+|++..+..|..+
T Consensus 166 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~ 245 (635)
T 4g8a_A 166 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 245 (635)
T ss_dssp CGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHH
T ss_pred chhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhh
Confidence 7788999999999999999875544333221
Q ss_pred --------------------------------------------------------------------------------
Q 005040 189 -------------------------------------------------------------------------------- 188 (717)
Q Consensus 189 -------------------------------------------------------------------------------- 188 (717)
T Consensus 246 ~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~ 325 (635)
T 4g8a_A 246 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFS 325 (635)
T ss_dssp HTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGG
T ss_pred cCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccc
Confidence
Q ss_pred --CCCCeEEecCccccCCCCh-------------------hhhcccCCCeEEccCCcCccc-------------------
Q 005040 189 --TSLRSLYLQSNKLSSSLPS-------------------SLWSLEYILRINLSSNSLKGT------------------- 228 (717)
Q Consensus 189 --~~L~~L~L~~N~l~~~~~~-------------------~~~~l~~L~~L~l~~N~l~~~------------------- 228 (717)
.+|+.|++.+|.+....+. ....+++|+.|++++|.+...
T Consensus 326 ~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~ 405 (635)
T 4g8a_A 326 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLS 405 (635)
T ss_dssp SCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECC
T ss_pred cchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhcc
Confidence 1233444444443322111 112356677777777765310
Q ss_pred -------------------------------CCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCcccc-CC
Q 005040 229 -------------------------------LPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ-GP 276 (717)
Q Consensus 229 -------------------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~ 276 (717)
.+..|..+.+++.++++.|.+.+..+..+..+++|+.|++++|.+. +.
T Consensus 406 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~ 485 (635)
T 4g8a_A 406 FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 485 (635)
T ss_dssp SCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred ccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhccccccc
Confidence 1234567888999999999999988999999999999999999854 45
Q ss_pred CCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc-cccccccccccccCCcc
Q 005040 277 IPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV-KGSFKDFSAQSYFGNYA 344 (717)
Q Consensus 277 ~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~ 344 (717)
.|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|. ...++.+..+.+.+|.-
T Consensus 486 ~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l 554 (635)
T 4g8a_A 486 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 554 (635)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCC
T ss_pred CchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcC
Confidence 788999999999999999999999999999999999999999999987765 35566777777777654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.69 Aligned_cols=291 Identities=28% Similarity=0.402 Sum_probs=249.7
Q ss_pred CCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCc
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
+.+|. +.++++|++|+|++|.+++..+ |.++++|++|+|++|.++.+++ +..+++|++|+|++|.++
T Consensus 81 ~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~----------~~~l~~L~~L~l~~n~l~ 147 (466)
T 1o6v_A 81 TDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP----------LKNLTNLNRLELSSNTIS 147 (466)
T ss_dssp CCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG----------GTTCTTCSEEEEEEEEEC
T ss_pred CCchh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH----------HcCCCCCCEEECCCCccC
Confidence 45666 8888999999999999886554 8889999999999998887652 667788888888888776
Q ss_pred ccCC-------------------cchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCC
Q 005040 82 GILP-------------------PLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQ 142 (717)
Q Consensus 82 ~~~~-------------------~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 142 (717)
+... ..+..+ ++|++|++++|.+... ..+..+++|++|++++|.+++..+ ++.+++
T Consensus 148 ~~~~~~~l~~L~~L~l~~~~~~~~~~~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~ 222 (466)
T 1o6v_A 148 DISALSGLTSLQQLSFGNQVTDLKPLANL-TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTN 222 (466)
T ss_dssp CCGGGTTCTTCSEEEEEESCCCCGGGTTC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTT
T ss_pred CChhhccCCcccEeecCCcccCchhhccC-CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCC
Confidence 4311 124444 5799999999999854 458999999999999999997655 888999
Q ss_pred CCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccC
Q 005040 143 LQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSS 222 (717)
Q Consensus 143 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 222 (717)
|++|++++|++++. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++
T Consensus 223 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~ 296 (466)
T 1o6v_A 223 LDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 296 (466)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred CCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCC
Confidence 99999999999965 468899999999999999997654 8999999999999999996544 88999999999999
Q ss_pred CcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCc
Q 005040 223 NSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIP 302 (717)
Q Consensus 223 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~ 302 (717)
|++++..+ +..+++|+.|++++|.+++..| +..+++|++|++++|++++. ..+.++++|+.|++++|++++..|
T Consensus 297 n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 297 NQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp SCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred CcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence 99996544 8999999999999999998665 78999999999999999865 578999999999999999998777
Q ss_pred ccccccccccEEEccCCccccc
Q 005040 303 KSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 303 ~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
+..+++|+.|++++|++++.
T Consensus 371 --~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 371 --LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp --GTTCTTCCEEECCCEEEECC
T ss_pred --hhcCCCCCEEeccCCcccCC
Confidence 89999999999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.02 Aligned_cols=243 Identities=19% Similarity=0.233 Sum_probs=181.9
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhh--------HHHHHHHHHHHHHHHhcC---------CCceeeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--------ERAFRSFDSECEILRNVR---------HRNLLKI 488 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------hpniv~~ 488 (717)
.++|++.+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 47899999999999999999998 68999999997542 223367888999999886 5555555
Q ss_pred ee-----------------eeec-------------CCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 005040 489 LG-----------------SCSN-------------LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALE 538 (717)
Q Consensus 489 ~~-----------------~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 538 (717)
.+ ++.+ ....|+||||+++|++.+.+.+ ..+++..+..++.|++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 55 4433 6789999999999977666654 34899999999999999999
Q ss_pred HHhhcCCCCCeEecCCCCCCeeeCCCC--------------------cEEEeeeccccccCCCCCceeeeccccCccccC
Q 005040 539 YLHHCHSSAPIIHCDLKPTNILLDENM--------------------VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598 (717)
Q Consensus 539 ~LH~~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~a 598 (717)
|||+ +.+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 176 ~lH~---~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~a 245 (336)
T 2vuw_A 176 VAEA---SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMD 245 (336)
T ss_dssp HHHH---HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTC
T ss_pred HHHH---hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccC
Confidence 9992 25799999999999999887 9999999999876432 2368999999
Q ss_pred CCccCCCCcCcccchhhHHHH-HHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHH
Q 005040 599 PEYGSEGIVSTKCDVYSYGVL-LMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSI 677 (717)
Q Consensus 599 PE~~~~~~~~~~~Dvws~G~i-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (717)
||++.+.. +.++||||+|++ .+++++|..||... .|..... ..+.................++.++
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLT----DKMLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHH----HHHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHH----HhhhhhhccCcccchhhhhhcCHHH
Confidence 99988766 899999998777 77888999997431 1111000 0000000000000111233567889
Q ss_pred HHHHhhccCCCCCCCCCHHHHH
Q 005040 678 MDLALDCCMDTPHKRIHMTDAA 699 (717)
Q Consensus 678 ~~li~~cl~~~P~~Rpt~~ev~ 699 (717)
.+++.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999976 898887
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-33 Score=300.59 Aligned_cols=283 Identities=22% Similarity=0.180 Sum_probs=175.8
Q ss_pred CccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccC
Q 005040 5 PNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGIL 84 (717)
Q Consensus 5 P~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 84 (717)
|..++++++|++|+|++|.|++. | .|..+++|++|+|++|+|+.++ +..+++|++|+|++|++++.
T Consensus 35 ~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~-----------~~~l~~L~~L~Ls~N~l~~~- 100 (457)
T 3bz5_A 35 TISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLD-----------LSQNTNLTYLACDSNKLTNL- 100 (457)
T ss_dssp EEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCC-----------CTTCTTCSEEECCSSCCSCC-
T ss_pred ccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEc-----------cccCCCCCEEECcCCCCcee-
Confidence 44566778888888888888754 4 5777888888888888877753 56777778888888877754
Q ss_pred CcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCC
Q 005040 85 PPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHL 164 (717)
Q Consensus 85 ~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l 164 (717)
+ +..+ ++|++|++++|++++. + ++.+++|++|++++|++++. .++++++|++|++++|+..+.. .+..+
T Consensus 101 ~--~~~l-~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l 169 (457)
T 3bz5_A 101 D--VTPL-TKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQ 169 (457)
T ss_dssp C--CTTC-TTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTC
T ss_pred e--cCCC-CcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccC
Confidence 2 5555 5677778877777753 3 77777777777777777753 2667777777777777433333 35666
Q ss_pred CCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEc
Q 005040 165 ERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL 244 (717)
Q Consensus 165 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 244 (717)
++|++|++++|++++ +| +..+++|+.|++++|++++. .+..+++|+.|++++|++++ +| +..+++|+.|++
T Consensus 170 ~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l 240 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDC 240 (457)
T ss_dssp TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEEC
T ss_pred CcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEe
Confidence 777777777777765 33 56667777777777777643 26666777777777777765 33 666667777777
Q ss_pred cCCCCCCCCcccccCCc-------ccccccccCccccCCCCccccccCccceEeccCCCCCCCCcc--------cccccc
Q 005040 245 SRNQLSSDIPSTIGTLK-------NLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPK--------SLEALS 309 (717)
Q Consensus 245 ~~N~l~~~~~~~~~~l~-------~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~--------~~~~l~ 309 (717)
++|.+++..+..+..+. +|+.|++++|++.+.+| ++.+++|+.|+|++|+..+.+|. .+..++
T Consensus 241 ~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~ 318 (457)
T 3bz5_A 241 SVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNP 318 (457)
T ss_dssp CSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCT
T ss_pred eCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcc
Confidence 77777664443333332 33444444444433333 23444455555555443333222 123334
Q ss_pred cccEEEccCCcccc
Q 005040 310 HLKQFNVSHNRLEG 323 (717)
Q Consensus 310 ~L~~L~l~~N~l~~ 323 (717)
+|+.|++++|++++
T Consensus 319 ~L~~L~L~~N~l~~ 332 (457)
T 3bz5_A 319 KLVYLYLNNTELTE 332 (457)
T ss_dssp TCCEEECTTCCCSC
T ss_pred cCCEEECCCCcccc
Confidence 44444444444444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=297.01 Aligned_cols=285 Identities=19% Similarity=0.178 Sum_probs=242.8
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
++.+| ++..+++|++|+|++|+|+++ | |+.+++|++|+|++|+|+.++ +..+++|++|+|++|++
T Consensus 54 l~~~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~~-----------~~~l~~L~~L~L~~N~l 118 (457)
T 3bz5_A 54 ITDMT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNLD-----------VTPLTKLTYLNCDTNKL 118 (457)
T ss_dssp CCCCT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCC-----------CTTCTTCCEEECCSSCC
T ss_pred cccCh-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCceee-----------cCCCCcCCEEECCCCcC
Confidence 34577 699999999999999999975 3 999999999999999999863 77899999999999999
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD 160 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 160 (717)
++. + +..+ ++|++|++++|++++. .++++++|++|++++|...+.+ .+..+++|++|++++|++++. |
T Consensus 119 ~~l-~--~~~l-~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~-- 186 (457)
T 3bz5_A 119 TKL-D--VSQN-PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D-- 186 (457)
T ss_dssp SCC-C--CTTC-TTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--
T ss_pred Cee-c--CCCC-CcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--
Confidence 974 3 6666 6799999999999974 3899999999999999654444 588999999999999999975 3
Q ss_pred ccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCC---
Q 005040 161 LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLN--- 237 (717)
Q Consensus 161 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~--- 237 (717)
+..+++|+.|++++|++++. .++.+++|+.|++++|++++ +| +..+++|+.|++++|++++..+..+..+.
T Consensus 187 l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~ 260 (457)
T 3bz5_A 187 VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLH 260 (457)
T ss_dssp CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEE
T ss_pred cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEe
Confidence 88999999999999999975 38899999999999999997 55 88999999999999999987655555544
Q ss_pred ----CCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCc--------cccccCccceEeccCCCCCCCCcccc
Q 005040 238 ----VLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPE--------SVGNLISLESLDFSNNNLSGKIPKSL 305 (717)
Q Consensus 238 ----~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~--------~~~~l~~L~~L~L~~N~~~~~~~~~~ 305 (717)
+|+.|++++|.+.+.+| ++.+++|+.|++++|+..+.+|. .+.++++|+.|+|++|++++. + +
T Consensus 261 l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l 335 (457)
T 3bz5_A 261 CIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--V 335 (457)
T ss_dssp CTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--C
T ss_pred ccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--c
Confidence 45666666666655555 56789999999999987665553 356778999999999999984 3 8
Q ss_pred cccccccEEEccCCcccc
Q 005040 306 EALSHLKQFNVSHNRLEG 323 (717)
Q Consensus 306 ~~l~~L~~L~l~~N~l~~ 323 (717)
..+++|+.|++++|++++
T Consensus 336 ~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 336 SHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp TTCTTCSEEECCSSCCCB
T ss_pred ccCCcCcEEECCCCCCCC
Confidence 899999999999999997
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=284.14 Aligned_cols=278 Identities=18% Similarity=0.178 Sum_probs=190.2
Q ss_pred CCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCC
Q 005040 38 LSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLR 117 (717)
Q Consensus 38 L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~ 117 (717)
....++++|.++.+|... .++|++|+|++|.+++..+..+..+ ++|++|++++|++++..+..|.+++
T Consensus 33 ~~~c~~~~~~l~~iP~~~-----------~~~L~~L~l~~n~i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~ 100 (353)
T 2z80_A 33 NGICKGSSGSLNSIPSGL-----------TEAVKSLDLSNNRITYISNSDLQRC-VNLQALVLTSNGINTIEEDSFSSLG 100 (353)
T ss_dssp TSEEECCSTTCSSCCTTC-----------CTTCCEEECTTSCCCEECTTTTTTC-TTCCEEECTTSCCCEECTTTTTTCT
T ss_pred CeEeeCCCCCcccccccc-----------cccCcEEECCCCcCcccCHHHhccC-CCCCEEECCCCccCccCHhhcCCCC
Confidence 344555555555554321 1355555666665555444455554 4466666666666655566677777
Q ss_pred CCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCC-ccccCCCCCCEEeccCC-cCcccCCccccCCCCCCeEE
Q 005040 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVP-HDLCHLERLNILNLSGN-KLSGAIPQCLASLTSLRSLY 195 (717)
Q Consensus 118 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~ 195 (717)
+|++|+|++|+++...+..|.++++|++|++++|+++...+ ..|.++++|++|++++| .++...+..|.++++|++|+
T Consensus 101 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~ 180 (353)
T 2z80_A 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180 (353)
T ss_dssp TCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred CCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEE
Confidence 77777777777775555557777777777777777775544 46777777777777777 46655566777777777777
Q ss_pred ecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCccccc---CCcccccccccCcc
Q 005040 196 LQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIG---TLKNLETLSLAGNQ 272 (717)
Q Consensus 196 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~---~l~~L~~L~l~~N~ 272 (717)
+++|++++..|..+..+++|++|++++|.++......+..+++|+.|++++|.+++..+..+. ....++.+++++|.
T Consensus 181 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~ 260 (353)
T 2z80_A 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260 (353)
T ss_dssp EEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCB
T ss_pred CCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccccccc
Confidence 777777766677777777777777777777644433455677777788887777765444332 34556667777776
Q ss_pred ccC----CCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc
Q 005040 273 FQG----PIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 273 l~~----~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 327 (717)
+.+ .+|..+..+++|+.|+|++|+++...+..|..+++|+.|+|++|++.+.+|.
T Consensus 261 l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 261 ITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp CCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 654 4677788999999999999999954444568999999999999999998874
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=274.36 Aligned_cols=279 Identities=21% Similarity=0.243 Sum_probs=206.5
Q ss_pred cEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccc
Q 005040 15 IGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSAS 94 (717)
Q Consensus 15 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~ 94 (717)
+.++++++.++ .+|..+. ++|++|+|++|+|+.++... |.++++|++|+|++|+++...
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~--------~~~l~~L~~L~L~~n~l~~~~---------- 68 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGV--------FDKLTQLTKLSLSSNGLSFKG---------- 68 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTT--------TTTCTTCSEEECCSSCCCEEE----------
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhH--------hhccccCCEEECCCCccCccc----------
Confidence 56788888887 4555443 57888888888888776543 677788888888888776321
Q ss_pred cceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCC-ccccCCCCCCEEecc
Q 005040 95 LQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVP-HDLCHLERLNILNLS 173 (717)
Q Consensus 95 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~ 173 (717)
..+..+..+++|++|+|++|.++ .+|..+..+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 69 -------------~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~ 134 (306)
T 2z66_A 69 -------------CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134 (306)
T ss_dssp -------------EEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECT
T ss_pred -------------CcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECC
Confidence 11234455677777777777776 355567777777777777777776554 567777888888888
Q ss_pred CCcCcccCCccccCCCCCCeEEecCccccC-CCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCC
Q 005040 174 GNKLSGAIPQCLASLTSLRSLYLQSNKLSS-SLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSD 252 (717)
Q Consensus 174 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 252 (717)
+|.+++..+..|..+++|++|+|++|.+++ ..|..+..+++|++|++++|.+++..|..|..+++|+.|++++|.+++.
T Consensus 135 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (306)
T 2z66_A 135 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 214 (306)
T ss_dssp TSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred CCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence 888877777777788888888888888875 4677788888888888888888877778888888888888888888877
Q ss_pred CcccccCCcccccccccCccccCCCCccccccC-ccceEeccCCCCCCCCc--ccccccccccEEEccCCccccccccc
Q 005040 253 IPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI-SLESLDFSNNNLSGKIP--KSLEALSHLKQFNVSHNRLEGEIPVK 328 (717)
Q Consensus 253 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~N~~~~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~ 328 (717)
.+..+..+++|++|++++|++.+..+..+..++ +|++|+|++|++.+..+ .....+...+.+.+..+.+.+..|..
T Consensus 215 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~ 293 (306)
T 2z66_A 215 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 293 (306)
T ss_dssp CSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred ChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence 676788888888888888888888888888874 88889998888875422 22334555666677777887777653
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=283.76 Aligned_cols=240 Identities=25% Similarity=0.327 Sum_probs=123.8
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCC-------------CEEEcccccccCccCCcccccccccccCc
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHL-------------SVLSLMMNNLTTESSSADQWSFLSSLTNC 67 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-------------~~L~L~~n~l~~~~~~~~~~~~~~~l~~l 67 (717)
+|+||++|+++++|++|++++|.+++..|..++++++| ++|++++|.+++++.. .
T Consensus 23 l~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~------------~ 90 (454)
T 1jl5_A 23 LTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL------------P 90 (454)
T ss_dssp -----------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC------------C
T ss_pred hhhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC------------c
Confidence 47899999999999999999999998999999888764 8888888888876531 1
Q ss_pred cCCcEEeccCCCCcccCCcch----------------hccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcc
Q 005040 68 RNLANLALASNPLGGILPPLI----------------GNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNG 131 (717)
Q Consensus 68 ~~L~~L~L~~N~l~~~~~~~~----------------~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 131 (717)
++|++|++++|.+++ +|..+ ..++++|++|++++|++.+ +| .|+++++|++|++++|++++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~ 167 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK 167 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC
T ss_pred CCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc
Confidence 345555555555553 23211 0111345555555555553 34 35555555555555555553
Q ss_pred cCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhc
Q 005040 132 TIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWS 211 (717)
Q Consensus 132 ~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 211 (717)
+|..+ .+|++|++++|++++. | .+.++++|++|++++|++++ +|... ++|++|++++|.++ .+|. +..
T Consensus 168 -lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~ 235 (454)
T 1jl5_A 168 -LPDLP---PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQN 235 (454)
T ss_dssp -CCCCC---TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTT
T ss_pred -cCCCc---ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCC
Confidence 23221 3555555555555542 2 35555555555555555553 22211 35555555555555 3332 555
Q ss_pred ccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccC
Q 005040 212 LEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG 275 (717)
Q Consensus 212 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 275 (717)
+++|++|++++|++++ +|.. +++|+.|++++|.+++ +|.. +++|++|++++|++++
T Consensus 236 l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 236 LPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG 291 (454)
T ss_dssp CTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE
T ss_pred CCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc
Confidence 5555555555555553 2221 2445555555555553 2221 2445555555555543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=273.62 Aligned_cols=274 Identities=21% Similarity=0.199 Sum_probs=226.3
Q ss_pred cEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCccc--CCccccccCCCCEEec
Q 005040 71 ANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGT--IPTSIGTLQQLQGFYV 148 (717)
Q Consensus 71 ~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~l 148 (717)
+.++++++.++ .+|..+ +++|++|++++|++....+..|.++++|++|+|++|.++.. .+..+..+++|++|+|
T Consensus 10 ~~l~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcc-cCCCCC---CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 34555555555 233322 24566666666666644455688999999999999999843 2667888999999999
Q ss_pred cCCcccccCCccccCCCCCCEEeccCCcCcccCC-ccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcc
Q 005040 149 PENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP-QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227 (717)
Q Consensus 149 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 227 (717)
++|.+.. .+..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..+..+++|++|++++|.+++
T Consensus 86 s~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 9999995 56679999999999999999997655 579999999999999999998889999999999999999999986
Q ss_pred -cCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCccccc
Q 005040 228 -TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLE 306 (717)
Q Consensus 228 -~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~ 306 (717)
..|..+..+++|+.|++++|.+++..|..+..+++|++|++++|++++..+..+..+++|+.|+|++|++.+..|..+.
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 244 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence 6889999999999999999999998899999999999999999999988788899999999999999999999999999
Q ss_pred ccc-cccEEEccCCcccccccccccccc---cccccccCCccccCCC
Q 005040 307 ALS-HLKQFNVSHNRLEGEIPVKGSFKD---FSAQSYFGNYALCGPP 349 (717)
Q Consensus 307 ~l~-~L~~L~l~~N~l~~~~p~~~~~~~---~~~~~~~~n~~~c~~~ 349 (717)
.++ +|+.|+|++|++++.++......+ ........+...|..|
T Consensus 245 ~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 245 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp CCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred hhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 985 999999999999998765322222 2233334455556543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=281.61 Aligned_cols=253 Identities=23% Similarity=0.269 Sum_probs=203.6
Q ss_pred CCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEec
Q 005040 69 NLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYV 148 (717)
Q Consensus 69 ~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 148 (717)
....++.+++.++ .+|..+. ++++.|+|++|++....+..|.++++|++|+|++|.|+.+.+..|.++++|++|+|
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 3456667777666 4444332 45777777777777777778888888888888888888777788888888888888
Q ss_pred cCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecC-ccccCCCChhhhcccCCCeEEccCCcCcc
Q 005040 149 PENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQS-NKLSSSLPSSLWSLEYILRINLSSNSLKG 227 (717)
Q Consensus 149 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 227 (717)
++|+|+.+.+..|..+++|++|+|++|.|+...+..|..+++|++|+|++ |.+....+..|.++++|++|+|++|.++.
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 199 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE 199 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence 88888877777788888888888888888877777788888888888888 44554445578888888888888888883
Q ss_pred cCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccc
Q 005040 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEA 307 (717)
Q Consensus 228 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~ 307 (717)
+| .+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..+..|..
T Consensus 200 -~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 277 (440)
T 3zyj_A 200 -IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277 (440)
T ss_dssp -CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred -cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence 44 4788888999999999888887888888899999999999998888888888899999999999998877788888
Q ss_pred cccccEEEccCCcccccccc
Q 005040 308 LSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 308 l~~L~~L~l~~N~l~~~~p~ 327 (717)
+++|+.|+|++|++.+.+..
T Consensus 278 l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 278 LHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CTTCCEEECCSSCEECSSTT
T ss_pred ccCCCEEEcCCCCccCCCCc
Confidence 89999999999998877654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=282.61 Aligned_cols=253 Identities=21% Similarity=0.230 Sum_probs=212.5
Q ss_pred CCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEec
Q 005040 69 NLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYV 148 (717)
Q Consensus 69 ~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 148 (717)
....++.+++.++ .+|..+ ++++++|+|++|++.+..+..|.++++|++|+|++|.|+++.+..|.++++|++|+|
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCcC-ccCCCC---CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 4567777777777 445433 356888888888888888888888889999999999888888888888899999999
Q ss_pred cCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecC-ccccCCCChhhhcccCCCeEEccCCcCcc
Q 005040 149 PENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQS-NKLSSSLPSSLWSLEYILRINLSSNSLKG 227 (717)
Q Consensus 149 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 227 (717)
++|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.|+|++ |.+....+..|.++++|++|+|++|++++
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 99998887777788888999999999998877777888889999999988 45554555578888999999999999885
Q ss_pred cCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccc
Q 005040 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEA 307 (717)
Q Consensus 228 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~ 307 (717)
. | .+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..+..|..
T Consensus 211 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 211 M-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp C-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred c-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 4 3 5888889999999999999888888999999999999999999888888999999999999999999877888888
Q ss_pred cccccEEEccCCcccccccc
Q 005040 308 LSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 308 l~~L~~L~l~~N~l~~~~p~ 327 (717)
+++|+.|+|++|++.+.+..
T Consensus 289 l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 289 LRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CTTCCEEECCSSCEECSTTT
T ss_pred ccCCCEEEccCCCcCCCCCc
Confidence 99999999999999887664
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=280.94 Aligned_cols=281 Identities=19% Similarity=0.180 Sum_probs=234.5
Q ss_pred CCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchh
Q 005040 10 NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIG 89 (717)
Q Consensus 10 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 89 (717)
.+......+++++.++ .+|..+. ++|++|+|++|+|+.++... |.++++|++|+|++|++++..+..|.
T Consensus 29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~--------~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (353)
T 2z80_A 29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSD--------LQRCVNLQALVLTSNGINTIEEDSFS 97 (353)
T ss_dssp EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTT--------TTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHH--------hccCCCCCEEECCCCccCccCHhhcC
Confidence 4455566899999998 4666554 48999999999999877544 88899999999999999988888888
Q ss_pred ccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCC-ccccccCCCCEEeccCC-cccccCCccccCCCCC
Q 005040 90 NFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIP-TSIGTLQQLQGFYVPEN-NLQGYVPHDLCHLERL 167 (717)
Q Consensus 90 ~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n-~i~~~~~~~~~~l~~L 167 (717)
.+ ++|++|++++|++++..+..|.++++|++|+|++|+++...+ ..|.++++|++|++++| .++...+..|.++++|
T Consensus 98 ~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L 176 (353)
T 2z80_A 98 SL-GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFL 176 (353)
T ss_dssp TC-TTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEE
T ss_pred CC-CCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCC
Confidence 87 679999999999986656668999999999999999996554 57899999999999999 5787778889999999
Q ss_pred CEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccc---cCCCCCCeEEc
Q 005040 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI---QKLNVLIDLDL 244 (717)
Q Consensus 168 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L~l 244 (717)
++|++++|++++..|..|..+++|++|++++|+++......+..+++|+.|++++|.+++..+..+ .....++.+++
T Consensus 177 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L 256 (353)
T 2z80_A 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256 (353)
T ss_dssp EEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEE
T ss_pred CEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccc
Confidence 999999999998889999999999999999999985444455678999999999999997655544 34667889999
Q ss_pred cCCCCCC----CCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCc
Q 005040 245 SRNQLSS----DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIP 302 (717)
Q Consensus 245 ~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~ 302 (717)
++|.+++ .+|..+..+++|++|++++|+++...+..|.++++|++|+|++|++.+..|
T Consensus 257 ~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 257 RNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp ESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 9999886 356778899999999999999995444446899999999999999986443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=265.23 Aligned_cols=216 Identities=23% Similarity=0.272 Sum_probs=98.9
Q ss_pred ccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCc-ccccCCccccCCCCCCEEeccCCcCcccCCccccCCC
Q 005040 111 KEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENN-LQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLT 189 (717)
Q Consensus 111 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 189 (717)
..|.++++|++|+|++|.+++..+..|.++++|++|++++|. ++...+..|..+++|++|+|++|.+++..+..|.+++
T Consensus 50 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 129 (285)
T 1ozn_A 50 ASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCT
T ss_pred HHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCc
Confidence 334444444444444444444334444444444444444443 4433344444444444444444444444344444444
Q ss_pred CCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCccccccccc
Q 005040 190 SLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLA 269 (717)
Q Consensus 190 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 269 (717)
+|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+++..|..|..+++|+.|+++
T Consensus 130 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 209 (285)
T 1ozn_A 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209 (285)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCC
Confidence 44444444444444333344444444555555544444333344445555555555555554444445555555555555
Q ss_pred CccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc
Q 005040 270 GNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 270 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 327 (717)
+|++++..+..+..+++|+.|+|++|++....+. ...+..++.+....+.+.+..|.
T Consensus 210 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp SSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESG
T ss_pred CCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCch
Confidence 5555544444455555555555555555432111 11112233444455555555544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=264.93 Aligned_cols=251 Identities=21% Similarity=0.200 Sum_probs=220.4
Q ss_pred ceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCC
Q 005040 96 QNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGN 175 (717)
Q Consensus 96 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 175 (717)
..++.+++++. .+|..+ .++|++|+|++|.++...+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 34455555554 334433 368999999999999888889999999999999999999998999999999999999999
Q ss_pred c-CcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCc
Q 005040 176 K-LSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIP 254 (717)
Q Consensus 176 ~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 254 (717)
. ++...+..|..+++|++|+|++|.+++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|.+++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 7 887778899999999999999999998888999999999999999999998777889999999999999999998777
Q ss_pred ccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccccccccc
Q 005040 255 STIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDF 334 (717)
Q Consensus 255 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ 334 (717)
..|..+++|++|++++|++.+..|..+.++++|+.|+|++|++++..+..+..+++|+.|++++|++.+.++....+.++
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l 250 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL 250 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHH
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHH
Confidence 78999999999999999999888999999999999999999999888888999999999999999999988876555555
Q ss_pred ccccccCCccccCCC
Q 005040 335 SAQSYFGNYALCGPP 349 (717)
Q Consensus 335 ~~~~~~~n~~~c~~~ 349 (717)
.......+...|..|
T Consensus 251 ~~~~~~~~~~~c~~p 265 (285)
T 1ozn_A 251 QKFRGSSSEVPCSLP 265 (285)
T ss_dssp HHCCSEECCCBEEES
T ss_pred HhcccccCccccCCc
Confidence 555555555556533
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-29 Score=275.27 Aligned_cols=249 Identities=20% Similarity=0.196 Sum_probs=201.7
Q ss_pred CCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCC
Q 005040 37 HLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNL 116 (717)
Q Consensus 37 ~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l 116 (717)
..+.++.+++.++.+|... .++++.|+|++|+++...+..|..+ ++|++|+|++|++....+..|.++
T Consensus 44 ~~~~v~c~~~~l~~iP~~~-----------~~~l~~L~L~~n~i~~~~~~~~~~l-~~L~~L~Ls~n~i~~i~~~~~~~l 111 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGI-----------STNTRLLNLHENQIQIIKVNSFKHL-RHLEILQLSRNHIRTIEIGAFNGL 111 (440)
T ss_dssp TSCEEECCSCCCSSCCSCC-----------CTTCSEEECCSCCCCEECTTTTSSC-SSCCEEECCSSCCCEECGGGGTTC
T ss_pred CCCEEEeCCCCcCcCCCCC-----------CCCCcEEEccCCcCCeeCHHHhhCC-CCCCEEECCCCcCCccChhhccCC
Confidence 4567777777777766432 2567777777777777766777766 567777777777777777788888
Q ss_pred CCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccC-CcCcccCCccccCCCCCCeEE
Q 005040 117 RGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG-NKLSGAIPQCLASLTSLRSLY 195 (717)
Q Consensus 117 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 195 (717)
++|++|+|++|+++...+..|.++++|++|+|++|.|+...+..|.++++|++|+|++ |.+....+..|.++++|++|+
T Consensus 112 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 191 (440)
T 3zyj_A 112 ANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191 (440)
T ss_dssp SSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEE
T ss_pred ccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeec
Confidence 8888888888888877777888888888888888888888777888888888888888 455555555788888899999
Q ss_pred ecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccC
Q 005040 196 LQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG 275 (717)
Q Consensus 196 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 275 (717)
|++|+++. +| .+..+++|+.|+|++|.|++..|..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|++++
T Consensus 192 L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 192 LAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp CTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred CCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 99998884 44 47788889999999999988888888899999999999999988888888889999999999999987
Q ss_pred CCCccccccCccceEeccCCCCCC
Q 005040 276 PIPESVGNLISLESLDFSNNNLSG 299 (717)
Q Consensus 276 ~~~~~~~~l~~L~~L~L~~N~~~~ 299 (717)
..+..|..+++|+.|+|++|++..
T Consensus 270 ~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 270 LPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CCTTTTSSCTTCCEEECCSSCEEC
T ss_pred cChhHhccccCCCEEEcCCCCccC
Confidence 777788888999999999998863
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-29 Score=271.14 Aligned_cols=270 Identities=29% Similarity=0.330 Sum_probs=143.5
Q ss_pred CCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCccc----------ccccccccCccCCcEEeccCCCCc
Q 005040 12 TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQ----------WSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 12 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----------~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
++|++|+|++|.+++ +|.. +++|++|++++|+++.++..... +..+..|.++++|++|++++|+++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~lp~~~~l~~L~~L~l~~N~l~ 166 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK 166 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCCCcccCCCCCCCEEECCCCcCc
Confidence 566677777777765 4432 24555555555555543321000 000001455555555555555555
Q ss_pred ccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccc
Q 005040 82 GILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL 161 (717)
Q Consensus 82 ~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~ 161 (717)
+ +|..+ .+|++|++++|++.+ +| .++++++|++|++++|.+++ +|.. .++|++|++++|.++ ..| .+
T Consensus 167 ~-lp~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~ 233 (454)
T 1jl5_A 167 K-LPDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP-EL 233 (454)
T ss_dssp C-CCCCC----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CC
T ss_pred c-cCCCc----ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc-cc
Confidence 3 23221 245555555555554 33 35555555555555555553 2221 135555555555555 233 25
Q ss_pred cCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCe
Q 005040 162 CHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLID 241 (717)
Q Consensus 162 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 241 (717)
..+++|++|++++|++++ +|.. .++|+.|++++|++++ +|.. +++|++|++++|.+++. +.. .++|+.
T Consensus 234 ~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~ 301 (454)
T 1jl5_A 234 QNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYY 301 (454)
T ss_dssp TTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCE
T ss_pred CCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCE
Confidence 555666666666666553 2321 2455566666665553 2322 25566666666665542 110 134555
Q ss_pred EEccCCCCCCCCcccccCC-cccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCc
Q 005040 242 LDLSRNQLSSDIPSTIGTL-KNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNR 320 (717)
Q Consensus 242 L~l~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~ 320 (717)
|++++|.+++ +..+ ++|++|++++|++++ +|.. +++|+.|+|++|++++ +|. .+++|+.|++++|+
T Consensus 302 L~l~~N~l~~-----i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~ 368 (454)
T 1jl5_A 302 LNASSNEIRS-----LCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNP 368 (454)
T ss_dssp EECCSSCCSE-----ECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred EECcCCcCCc-----ccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCC
Confidence 5555555553 1122 477777777777774 4433 4677788888887773 444 46777888888888
Q ss_pred ccc
Q 005040 321 LEG 323 (717)
Q Consensus 321 l~~ 323 (717)
+++
T Consensus 369 l~~ 371 (454)
T 1jl5_A 369 LRE 371 (454)
T ss_dssp CSS
T ss_pred CCc
Confidence 777
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-29 Score=275.60 Aligned_cols=249 Identities=19% Similarity=0.154 Sum_probs=205.1
Q ss_pred CCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCC
Q 005040 37 HLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNL 116 (717)
Q Consensus 37 ~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l 116 (717)
..+.++.+++.++.+|... .++|++|+|++|.+++..+..|..+ ++|++|+|++|++.+..+..|.++
T Consensus 55 ~~~~v~c~~~~l~~iP~~~-----------~~~l~~L~L~~n~i~~~~~~~~~~l-~~L~~L~Ls~n~i~~~~~~~~~~l 122 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGI-----------PSNTRYLNLMENNIQMIQADTFRHL-HHLEVLQLGRNSIRQIEVGAFNGL 122 (452)
T ss_dssp SSCEEECCSSCCSSCCSCC-----------CTTCSEEECCSSCCCEECTTTTTTC-TTCCEEECCSSCCCEECTTTTTTC
T ss_pred CCcEEEECCCCcCccCCCC-----------CCCccEEECcCCcCceECHHHcCCC-CCCCEEECCCCccCCcChhhccCc
Confidence 4567777777777766432 2577778888888877777777776 568888888888877777888888
Q ss_pred CCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccC-CcCcccCCccccCCCCCCeEE
Q 005040 117 RGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG-NKLSGAIPQCLASLTSLRSLY 195 (717)
Q Consensus 117 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 195 (717)
++|++|+|++|+++...+..|.++++|++|+|++|+|+.+.+..|.++++|++|+|++ |.+....+..|.++++|+.|+
T Consensus 123 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 202 (452)
T 3zyi_A 123 ASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202 (452)
T ss_dssp TTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEE
Confidence 8899999999988877777788888999999999988888777888889999999988 556655556788889999999
Q ss_pred ecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccC
Q 005040 196 LQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG 275 (717)
Q Consensus 196 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 275 (717)
|++|++++. | .+..+++|+.|+|++|.|++..|..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|++++
T Consensus 203 L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 280 (452)
T 3zyi_A 203 LGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS 280 (452)
T ss_dssp CTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence 999998854 4 47788899999999999988888889999999999999999998888888889999999999999987
Q ss_pred CCCccccccCccceEeccCCCCCC
Q 005040 276 PIPESVGNLISLESLDFSNNNLSG 299 (717)
Q Consensus 276 ~~~~~~~~l~~L~~L~L~~N~~~~ 299 (717)
..+..|..+++|+.|+|++|++..
T Consensus 281 ~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 281 LPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CCTTSSTTCTTCCEEECCSSCEEC
T ss_pred cChHHhccccCCCEEEccCCCcCC
Confidence 777788889999999999998864
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-33 Score=304.26 Aligned_cols=315 Identities=19% Similarity=0.198 Sum_probs=168.8
Q ss_pred CccccCCCCCcEEECCCCcceecCCcCC-CCCC----CCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCC
Q 005040 5 PNSITNATKLIGLDLGLNSFSGHIPNTF-GNLR----HLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNP 79 (717)
Q Consensus 5 P~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~----~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~ 79 (717)
|..+..+++|++|+|++|.|++..+..+ ..++ +|++|+|++|+|++.... .++..+..+++|++|+|++|.
T Consensus 49 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~----~l~~~l~~~~~L~~L~Ls~n~ 124 (461)
T 1z7x_W 49 SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG----VLSSTLRTLPTLQELHLSDNL 124 (461)
T ss_dssp HHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH----HHHHHTTSCTTCCEEECCSSB
T ss_pred HHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH----HHHHHHccCCceeEEECCCCc
Confidence 3445555566666666665554333222 2233 466666666655532210 122335556666666666666
Q ss_pred CcccCCcchhcc----ccccceeeecCCcceec----CCccccCCCCCcEEEccCCCCcccCCcccc-----ccCCCCEE
Q 005040 80 LGGILPPLIGNF----SASLQNIYAFECKLGGS----IPKEIGNLRGLIVLSLGFNDLNGTIPTSIG-----TLQQLQGF 146 (717)
Q Consensus 80 l~~~~~~~~~~l----~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L 146 (717)
++...+..+... ..+|++|++++|+++.. ++..+..+++|++|+|++|.++...+..+. .+++|++|
T Consensus 125 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L 204 (461)
T 1z7x_W 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL 204 (461)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEE
T ss_pred CchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEE
Confidence 654433333321 12466666666666542 234445556666666666666543333332 24466666
Q ss_pred eccCCccccc----CCccccCCCCCCEEeccCCcCcccC-----CccccCCCCCCeEEecCccccCC----CChhhhccc
Q 005040 147 YVPENNLQGY----VPHDLCHLERLNILNLSGNKLSGAI-----PQCLASLTSLRSLYLQSNKLSSS----LPSSLWSLE 213 (717)
Q Consensus 147 ~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~ 213 (717)
++++|.++.. .+..+..+++|++|+|++|.+++.. +..+..+++|++|+|++|.+++. ++..+..++
T Consensus 205 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~ 284 (461)
T 1z7x_W 205 KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284 (461)
T ss_dssp ECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCT
T ss_pred EccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCC
Confidence 6666666543 2444555666666666666665432 12222456666666666666632 344555566
Q ss_pred CCCeEEccCCcCcccCCccccC-----CCCCCeEEccCCCCCCC----CcccccCCcccccccccCccccCCCCccccc-
Q 005040 214 YILRINLSSNSLKGTLPSNIQK-----LNVLIDLDLSRNQLSSD----IPSTIGTLKNLETLSLAGNQFQGPIPESVGN- 283 (717)
Q Consensus 214 ~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~- 283 (717)
+|++|++++|.+++..+..+.. .++|+.|++++|.+++. ++..+..+++|++|++++|++++..+..+..
T Consensus 285 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 364 (461)
T 1z7x_W 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364 (461)
T ss_dssp TCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHH
T ss_pred CcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHH
Confidence 6666666666665433333322 24666666666666643 2334455566666666666666544444432
Q ss_pred ----cCccceEeccCCCCCC----CCcccccccccccEEEccCCcccc
Q 005040 284 ----LISLESLDFSNNNLSG----KIPKSLEALSHLKQFNVSHNRLEG 323 (717)
Q Consensus 284 ----l~~L~~L~L~~N~~~~----~~~~~~~~l~~L~~L~l~~N~l~~ 323 (717)
.++|+.|+|++|++++ .+|..+..+++|+.|++++|++++
T Consensus 365 l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred HcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 4566666666666664 455566666666666666666654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=261.45 Aligned_cols=224 Identities=22% Similarity=0.288 Sum_probs=176.0
Q ss_pred ccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEecc
Q 005040 94 SLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLS 173 (717)
Q Consensus 94 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 173 (717)
.++.|+|++|++. .+|..+.++++|++|+|++|.++ .+|..|+++++|++|+|++|.++ .+|..+.++++|++|+|+
T Consensus 82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158 (328)
T ss_dssp TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence 4556666666655 45555666666777777777666 56666666777777777777666 456666667777777777
Q ss_pred CCcCcccCCcccc---------CCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEc
Q 005040 174 GNKLSGAIPQCLA---------SLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL 244 (717)
Q Consensus 174 ~n~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 244 (717)
+|.+.+.+|..+. ++++|++|+|++|+++ .+|..+..+++|++|+|++|.+++ +|..+..+++|+.|+|
T Consensus 159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L 236 (328)
T 4fcg_A 159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236 (328)
T ss_dssp EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence 7666556665544 4888999999999988 678888889999999999999884 5667888999999999
Q ss_pred cCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccc
Q 005040 245 SRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322 (717)
Q Consensus 245 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~ 322 (717)
++|.+.+.+|..++.+++|++|+|++|++.+.+|..+.++++|+.|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 999888888888899999999999999888888988999999999999999998899999999999999998877665
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-31 Score=271.57 Aligned_cols=250 Identities=19% Similarity=0.212 Sum_probs=202.3
Q ss_pred ccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcce-ecCCcccc-------CCCCCcEEEccCCCCcccCCc
Q 005040 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLG-GSIPKEIG-------NLRGLIVLSLGFNDLNGTIPT 135 (717)
Q Consensus 64 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~-~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~ 135 (717)
+...++|++|++++|.+ .+|..+... |+.|++++|++. ..+|..+. ++++|++|+|++|++++..|.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 56677888888888888 566655543 888888888884 45565555 788999999999999887887
Q ss_pred cc--cccCCCCEEeccCCcccccCCccccCC-----CCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCC--CC
Q 005040 136 SI--GTLQQLQGFYVPENNLQGYVPHDLCHL-----ERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSS--LP 206 (717)
Q Consensus 136 ~~--~~l~~L~~L~l~~n~i~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~ 206 (717)
.+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..+..|+.+++|++|+|++|++.+. .+
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 76 8899999999999999877 7777776 8899999999999887778899999999999999987643 23
Q ss_pred hhh--hcccCCCeEEccCCcCcc---cCCccccCCCCCCeEEccCCCCCCCCc-ccccCCcccccccccCccccCCCCcc
Q 005040 207 SSL--WSLEYILRINLSSNSLKG---TLPSNIQKLNVLIDLDLSRNQLSSDIP-STIGTLKNLETLSLAGNQFQGPIPES 280 (717)
Q Consensus 207 ~~~--~~l~~L~~L~l~~N~l~~---~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~ 280 (717)
..+ ..+++|++|+|++|+|++ .....+..+++|+.|++++|.+++..| ..+..+++|++|+|++|+++ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 334 788999999999999883 222345678899999999999998664 45667889999999999998 67776
Q ss_pred ccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccc
Q 005040 281 VGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 281 ~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
+. ++|++|+|++|+|++. |. +..+++|+.|+|++|++++.
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 66 7899999999999866 55 88999999999999998763
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=259.67 Aligned_cols=225 Identities=23% Similarity=0.284 Sum_probs=173.8
Q ss_pred cCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEe
Q 005040 68 RNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFY 147 (717)
Q Consensus 68 ~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 147 (717)
.+++.|+|++|.++ .+|..+..+ ++|++|+|++|.+. .+|..++++++|++|+|++|.++ .+|..|.++++|++|+
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l-~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRL-SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGG-TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred cceeEEEccCCCch-hcChhhhhC-CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 45555555555555 444445554 45666666666555 55666666666666666666666 4566666666666666
Q ss_pred ccCCcccccCCcccc---------CCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeE
Q 005040 148 VPENNLQGYVPHDLC---------HLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRI 218 (717)
Q Consensus 148 l~~n~i~~~~~~~~~---------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 218 (717)
|++|++.+..|..+. ++++|++|+|++|+++ .+|..+..+++|++|+|++|++++ +|..+..+++|++|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE
Confidence 666666555555544 4889999999999998 677888899999999999999984 56678889999999
Q ss_pred EccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCC
Q 005040 219 NLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 219 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 298 (717)
+|++|.+.+.+|..+..+++|+.|+|++|.+.+.+|..+..+++|++|+|++|++.+.+|..++++++|+.+++..|.+.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 99999988888999999999999999999888888988999999999999999998899999999999999998887665
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-32 Score=299.09 Aligned_cols=310 Identities=22% Similarity=0.193 Sum_probs=220.6
Q ss_pred CCCcEEECCCCcceecCCcC-CCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhc
Q 005040 12 TKLIGLDLGLNSFSGHIPNT-FGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGN 90 (717)
Q Consensus 12 ~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 90 (717)
++|++|||++|+++...... |..+++|++|+|++|++++.... .++..+..+++|++|+|++|.++...+..+..
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~----~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~ 78 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK----DISSALRVNPALAELNLRSNELGDVGVHCVLQ 78 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHH----HHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHH----HHHHHHHhCCCcCEEeCCCCcCChHHHHHHHH
Confidence 46788888888887554443 77788888888888888753211 12344667788888888888887655555554
Q ss_pred ccc----ccceeeecCCccee----cCCccccCCCCCcEEEccCCCCcccCCcccc-----ccCCCCEEeccCCcccccC
Q 005040 91 FSA----SLQNIYAFECKLGG----SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIG-----TLQQLQGFYVPENNLQGYV 157 (717)
Q Consensus 91 l~~----~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~l~~n~i~~~~ 157 (717)
..+ +|++|++++|+++. .++..+..+++|++|+|++|.++...+..+. ..++|++|+|++|++++..
T Consensus 79 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 158 (461)
T 1z7x_W 79 GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158 (461)
T ss_dssp TTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH
Confidence 333 58888888888874 4577788888888888888888754444333 2457888888888888643
Q ss_pred ----CccccCCCCCCEEeccCCcCcccCCcccc-----CCCCCCeEEecCccccCC----CChhhhcccCCCeEEccCCc
Q 005040 158 ----PHDLCHLERLNILNLSGNKLSGAIPQCLA-----SLTSLRSLYLQSNKLSSS----LPSSLWSLEYILRINLSSNS 224 (717)
Q Consensus 158 ----~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~ 224 (717)
+..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|.+++. ++..+..+++|++|++++|.
T Consensus 159 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 238 (461)
T 1z7x_W 159 CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSB
T ss_pred HHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCc
Confidence 44566678888888888888755444443 256888888888888753 46667778888888888888
Q ss_pred CcccC-----CccccCCCCCCeEEccCCCCCCC----CcccccCCcccccccccCccccCCCCcccccc-----CccceE
Q 005040 225 LKGTL-----PSNIQKLNVLIDLDLSRNQLSSD----IPSTIGTLKNLETLSLAGNQFQGPIPESVGNL-----ISLESL 290 (717)
Q Consensus 225 l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~L 290 (717)
+++.. +..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+.+..+..+... ++|+.|
T Consensus 239 l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L 318 (461)
T 1z7x_W 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318 (461)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred CChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceee
Confidence 77532 22334577888888888888753 45566678888888888888876555444432 588888
Q ss_pred eccCCCCCCC----CcccccccccccEEEccCCcccccc
Q 005040 291 DFSNNNLSGK----IPKSLEALSHLKQFNVSHNRLEGEI 325 (717)
Q Consensus 291 ~L~~N~~~~~----~~~~~~~l~~L~~L~l~~N~l~~~~ 325 (717)
+|++|.+++. ++..+..+++|+.|++++|++++..
T Consensus 319 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred EcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 8888888765 4556667788888888888877643
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-28 Score=269.57 Aligned_cols=263 Identities=27% Similarity=0.358 Sum_probs=222.3
Q ss_pred CCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhcc
Q 005040 12 TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNF 91 (717)
Q Consensus 12 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 91 (717)
.++++|++++|+|+ .+|..+. ++|++|+|++|+|+.++. .+++|++|+|++|++++ +|. .
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~------------~l~~L~~L~Ls~N~l~~-lp~----~ 99 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA------------LPPELRTLEVSGNQLTS-LPV----L 99 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC------------CCTTCCEEEECSCCCSC-CCC----C
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC------------cCCCCCEEEcCCCcCCc-CCC----C
Confidence 36899999999999 6777665 799999999999998763 46899999999999985 444 2
Q ss_pred ccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEe
Q 005040 92 SASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILN 171 (717)
Q Consensus 92 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 171 (717)
.++|++|++++|++++ +|. .+++|++|+|++|+++. +|.. +++|++|+|++|+++++ |. .+.+|+.|+
T Consensus 100 l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~ 167 (622)
T 3g06_A 100 PPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---LPSELCKLW 167 (622)
T ss_dssp CTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEE
T ss_pred CCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEE
Confidence 3689999999999985 444 67899999999999995 4543 58999999999999964 33 357899999
Q ss_pred ccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCC
Q 005040 172 LSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS 251 (717)
Q Consensus 172 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 251 (717)
+++|.|+. +| ..+++|+.|+|++|++++ +|. .+++|+.|++++|.++. +|. .+++|+.|+|++|.|++
T Consensus 168 L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~ 235 (622)
T 3g06_A 168 AYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS 235 (622)
T ss_dssp CCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC
T ss_pred CCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc
Confidence 99999995 55 456899999999999995 443 35899999999999994 443 35789999999999997
Q ss_pred CCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc
Q 005040 252 DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 252 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 327 (717)
+| ..+++|++|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|.
T Consensus 236 -lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 236 -LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp -CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred -CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 55 456899999999999984 555 6789999999999999 7788999999999999999999988775
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=270.15 Aligned_cols=246 Identities=19% Similarity=0.184 Sum_probs=169.3
Q ss_pred CccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCE
Q 005040 66 NCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQG 145 (717)
Q Consensus 66 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 145 (717)
.+++|++|+|++|++++..|..+..+ ++|++|++++|++.+..+ +..+++|++|+|++|.+++. ...++|++
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l-----~~~~~L~~ 103 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPF-TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-----LVGPSIET 103 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTC-TTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE-----EECTTCCE
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCC-CcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc-----cCCCCcCE
Confidence 34445555555555544444444444 345555555555544333 66777777777777777633 23377777
Q ss_pred EeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhh-cccCCCeEEccCCc
Q 005040 146 FYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNS 224 (717)
Q Consensus 146 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~ 224 (717)
|++++|++++..+. .+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+. .+++|++|+|++|.
T Consensus 104 L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 180 (317)
T 3o53_A 104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (317)
T ss_dssp EECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCc
Confidence 77777777765443 356788888888888876666777788888888888888766666553 67888888888888
Q ss_pred CcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCC-CCCcc
Q 005040 225 LKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS-GKIPK 303 (717)
Q Consensus 225 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~-~~~~~ 303 (717)
|++. + ....+++|++|+|++|.+++. |..+..+++|++|++++|+++ .+|..+..+++|+.|+|++|++. +.+|.
T Consensus 181 l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~ 256 (317)
T 3o53_A 181 IYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (317)
T ss_dssp CCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHH
T ss_pred Cccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHH
Confidence 8755 2 233478888888888888864 444778888888888888887 46777888888888888888887 66777
Q ss_pred cccccccccEEEccCC-ccccccc
Q 005040 304 SLEALSHLKQFNVSHN-RLEGEIP 326 (717)
Q Consensus 304 ~~~~l~~L~~L~l~~N-~l~~~~p 326 (717)
.+..+++|+.|++.+| .+++..|
T Consensus 257 ~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 257 FFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp HHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred HHhccccceEEECCCchhccCCch
Confidence 8888888888888844 4555443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=265.88 Aligned_cols=251 Identities=19% Similarity=0.239 Sum_probs=210.5
Q ss_pred CCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcc-cCCcchh-------ccccccceeeecC
Q 005040 31 TFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGG-ILPPLIG-------NFSASLQNIYAFE 102 (717)
Q Consensus 31 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~-------~l~~~L~~L~l~~ 102 (717)
.+...++|++|++++|.+ .++.. +... |+.|+|++|.++. ..|..+. .+ ++|++|++++
T Consensus 38 ~~~~~~~L~~l~l~~n~l-~~p~~---------~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l-~~L~~L~L~~ 104 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE-ADLGQ---------FTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGI-SGLQELTLEN 104 (312)
T ss_dssp EEEEEEECTTHHHHCCTT-CCCHH---------HHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTT-SCCCEEEEEE
T ss_pred EEccCCCceeEeeccccc-ccHHH---------HHHH--HhhcccccccccCCCcCHHHHHHHHHhcCc-CCccEEEccC
Confidence 356678899999999999 55432 2222 8899999999953 4454443 34 6799999999
Q ss_pred CcceecCCccc--cCCCCCcEEEccCCCCcccCCcccccc-----CCCCEEeccCCcccccCCccccCCCCCCEEeccCC
Q 005040 103 CKLGGSIPKEI--GNLRGLIVLSLGFNDLNGTIPTSIGTL-----QQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGN 175 (717)
Q Consensus 103 n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 175 (717)
|++++.+|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 105 n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 183 (312)
T 1wwl_A 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183 (312)
T ss_dssp EBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSC
T ss_pred CcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCC
Confidence 99998888886 8999999999999999977 8888888 99999999999999998899999999999999999
Q ss_pred cCcccC--Cccc--cCCCCCCeEEecCccccCC---CChhhhcccCCCeEEccCCcCcccCC-ccccCCCCCCeEEccCC
Q 005040 176 KLSGAI--PQCL--ASLTSLRSLYLQSNKLSSS---LPSSLWSLEYILRINLSSNSLKGTLP-SNIQKLNVLIDLDLSRN 247 (717)
Q Consensus 176 ~l~~~~--~~~~--~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N 247 (717)
++.+.. +..+ ..+++|++|+|++|++++. ....+..+++|++|+|++|.+++..| ..+..+++|+.|+|++|
T Consensus 184 ~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N 263 (312)
T 1wwl_A 184 PELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263 (312)
T ss_dssp TTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTS
T ss_pred CcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCC
Confidence 987542 3333 8899999999999999832 22445678999999999999998764 56778899999999999
Q ss_pred CCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCC
Q 005040 248 QLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK 300 (717)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~ 300 (717)
.|+ .+|..+. ++|++|+|++|+|++. |. +..+++|++|+|++|++++.
T Consensus 264 ~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 264 GLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred ccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 999 5777666 8999999999999966 65 99999999999999999853
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=262.87 Aligned_cols=268 Identities=20% Similarity=0.180 Sum_probs=180.5
Q ss_pred CCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccc
Q 005040 13 KLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFS 92 (717)
Q Consensus 13 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 92 (717)
+++.++++.+.+.......+..+++|++|+|++|+|+.+++. .|..+++|++|+|++|++++..+ +..+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~--------~~~~l~~L~~L~Ls~n~l~~~~~--~~~l- 79 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA--------DLAPFTKLELLNLSSNVLYETLD--LESL- 79 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHH--------HHTTCTTCCEEECTTSCCEEEEE--ETTC-
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHH--------HhhCCCcCCEEECCCCcCCcchh--hhhc-
Confidence 455566666666655555566666777777777777765432 36677777777777777765443 5555
Q ss_pred cccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEec
Q 005040 93 ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNL 172 (717)
Q Consensus 93 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 172 (717)
++|++|++++|++++.. ..++|++|++++|++++..+. .+++|++|++++|++++..+..+..+++|++|+|
T Consensus 80 ~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 151 (317)
T 3o53_A 80 STLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151 (317)
T ss_dssp TTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEEC
T ss_pred CCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEEC
Confidence 46777777777776432 236777777777777755433 3566777777777777766667777777777777
Q ss_pred cCCcCcccCCccc-cCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCC
Q 005040 173 SGNKLSGAIPQCL-ASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS 251 (717)
Q Consensus 173 ~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 251 (717)
++|.+++..+..+ ..+++|++|+|++|.+++. + ....+++|++|+|++|+|++. |..+..+++|+.|++++|.+++
T Consensus 152 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~ 228 (317)
T 3o53_A 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL 228 (317)
T ss_dssp TTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE
T ss_pred CCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccc
Confidence 7777776655555 3577777777777777744 2 233477777777777777743 4447777777777777777774
Q ss_pred CCcccccCCcccccccccCcccc-CCCCccccccCccceEeccC-CCCCCCCcc
Q 005040 252 DIPSTIGTLKNLETLSLAGNQFQ-GPIPESVGNLISLESLDFSN-NNLSGKIPK 303 (717)
Q Consensus 252 ~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~-N~~~~~~~~ 303 (717)
+|..+..+++|+.|++++|++. +..+..+..+++|+.|++++ +.+.+..|.
T Consensus 229 -l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 229 -IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp -ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred -hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 5666777777777777777777 56666777777777777774 344544443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=266.44 Aligned_cols=257 Identities=28% Similarity=0.392 Sum_probs=217.6
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+++||..+. ++|++|+|++|+|+. +|. .+++|++|+|++|+|+.++. .+++|++|+|++|++
T Consensus 52 L~~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~------------~l~~L~~L~Ls~N~l 113 (622)
T 3g06_A 52 LTTLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV------------LPPGLLELSIFSNPL 113 (622)
T ss_dssp CSCCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSCCCC------------CCTTCCEEEECSCCC
T ss_pred cCccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCcCCC------------CCCCCCEEECcCCcC
Confidence 468898887 899999999999995 554 57899999999999998763 578999999999999
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcc
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD 160 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 160 (717)
++. |. ..++|++|++++|+++. +|.. +++|++|+|++|++++. |. .+++|+.|++++|.|+.+ |
T Consensus 114 ~~l-~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~l-~-- 177 (622)
T 3g06_A 114 THL-PA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTSL-P-- 177 (622)
T ss_dssp CCC-CC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSCC-C--
T ss_pred CCC-CC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCCC-c--
Confidence 964 43 33679999999999985 5543 48999999999999953 43 457899999999999964 4
Q ss_pred ccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCC
Q 005040 161 LCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLI 240 (717)
Q Consensus 161 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 240 (717)
..+++|+.|+|++|.|++ +|. .+++|+.|++++|.++. +|. .+++|+.|+|++|.|++ +| ..+++|+
T Consensus 178 -~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~ 244 (622)
T 3g06_A 178 -MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP---VLPSELK 244 (622)
T ss_dssp -CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCC
T ss_pred -ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC---CCCCcCc
Confidence 557899999999999995 443 24899999999999994 454 35889999999999995 45 5668999
Q ss_pred eEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccc
Q 005040 241 DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALS 309 (717)
Q Consensus 241 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~ 309 (717)
.|+|++|.|++ +|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++..|..+..++
T Consensus 245 ~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 245 ELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp EEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred EEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 99999999996 554 6789999999999999 6788999999999999999999998888877665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-29 Score=271.84 Aligned_cols=234 Identities=19% Similarity=0.192 Sum_probs=117.7
Q ss_pred CCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEec
Q 005040 69 NLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYV 148 (717)
Q Consensus 69 ~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 148 (717)
+|++|+|++|.+++..|..|..+ ++|++|+|++|.+++..| |..+++|++|+|++|.|++.. ..++|++|++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L 106 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPF-TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHA 106 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTC-TTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEEC
T ss_pred CccEEEeeCCcCCCCCHHHHhCC-CCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEEC
Confidence 55555555555554444444444 334444444444443333 555555555555555555322 1255555555
Q ss_pred cCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhh-cccCCCeEEccCCcCcc
Q 005040 149 PENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLSSNSLKG 227 (717)
Q Consensus 149 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~ 227 (717)
++|.|++..+. .+++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++..|..+. .+++|++|+|++|.|++
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 55555544332 234555555555555555455555555555555555555554444443 45555555555555554
Q ss_pred cCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCC-CCCccccc
Q 005040 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS-GKIPKSLE 306 (717)
Q Consensus 228 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~-~~~~~~~~ 306 (717)
.. .+..+++|+.|+|++|.|++.+| .+..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|++. +.+|..+.
T Consensus 184 ~~--~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 184 VK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp EE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred cc--ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 31 12235555555555555554322 25555555555555555552 3444555555555555555554 33444445
Q ss_pred ccccccEEEcc
Q 005040 307 ALSHLKQFNVS 317 (717)
Q Consensus 307 ~l~~L~~L~l~ 317 (717)
.++.|+.+++.
T Consensus 260 ~l~~L~~l~~~ 270 (487)
T 3oja_A 260 KNQRVQTVAKQ 270 (487)
T ss_dssp TCHHHHHHHHH
T ss_pred hCCCCcEEecc
Confidence 55555544443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-29 Score=272.62 Aligned_cols=234 Identities=20% Similarity=0.173 Sum_probs=144.3
Q ss_pred CCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccc
Q 005040 13 KLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFS 92 (717)
Q Consensus 13 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 92 (717)
+|++|+|++|.|++..|..|.++++|++|+|++|.|+++++ |..+++|++|+|++|.+++..+.
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----------l~~l~~L~~L~Ls~N~l~~l~~~------ 98 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD----------LESLSTLRTLDLNNNYVQELLVG------ 98 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE----------CTTCTTCCEEECCSSEEEEEEEC------
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc----------cccCCCCCEEEecCCcCCCCCCC------
Confidence 67777777777777666777777777777777777765432 56777777777777777644321
Q ss_pred cccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcccc-CCCCCCEEe
Q 005040 93 ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC-HLERLNILN 171 (717)
Q Consensus 93 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~ 171 (717)
++|++|++++|.+.+..+. .+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..+. .+++|++|+
T Consensus 99 ~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 4566666666666654443 235666666666666666566666666666666666666665555554 566666666
Q ss_pred ccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCC-
Q 005040 172 LSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLS- 250 (717)
Q Consensus 172 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~- 250 (717)
|++|.|++..+ +..+++|+.|+|++|.+++.. ..+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.+.
T Consensus 176 Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp CTTSCCCEEEC--CCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred cCCCccccccc--cccCCCCCEEECCCCCCCCCC-HhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 66666664422 234566666666666666433 335566666666666666663 4445555666666666666655
Q ss_pred CCCcccccCCccccccccc
Q 005040 251 SDIPSTIGTLKNLETLSLA 269 (717)
Q Consensus 251 ~~~~~~~~~l~~L~~L~l~ 269 (717)
+.+|..+..++.|+.|+++
T Consensus 252 ~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 252 GTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHHHHHTTCHHHHHHHHH
T ss_pred cchHHHHHhCCCCcEEecc
Confidence 3344455555555555554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=240.87 Aligned_cols=210 Identities=23% Similarity=0.264 Sum_probs=142.9
Q ss_pred CCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEec
Q 005040 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQ 197 (717)
Q Consensus 118 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 197 (717)
+|++|+|++|.+++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 55566666666655555555566666666666666665555556666666666666666665555566666666666666
Q ss_pred CccccCCCChhhhcccCCCeEEccCCcCccc-CCccccCCCCCCeEEccCCCCCCCCcccccCCcccc----cccccCcc
Q 005040 198 SNKLSSSLPSSLWSLEYILRINLSSNSLKGT-LPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLE----TLSLAGNQ 272 (717)
Q Consensus 198 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~L~l~~N~ 272 (717)
+|.+++..+..+..+++|++|++++|.+++. +|..+..+++|+.|++++|.+++..+..+..+++|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 6666655554566666666667766666643 466777777777777777777766666666666666 77888888
Q ss_pred ccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccc
Q 005040 273 FQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK 328 (717)
Q Consensus 273 l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~ 328 (717)
+.+..+..+.. .+|+.|+|++|++++..+..+..+++|+.|+|++|++++.+|..
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 88655555544 47888899988888777777888899999999999999887743
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-29 Score=279.03 Aligned_cols=184 Identities=18% Similarity=0.087 Sum_probs=130.2
Q ss_pred ccccccEEEEEEEe-cCCCeEEEEEechh----------hHHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEEE
Q 005040 435 LGTGGFGSVYKGTL-SDGTNVAIKIFNLQ----------LERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 435 lg~G~~g~V~~~~~-~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 502 (717)
.+.|++|.+..++. --|+.||+|++.+. .....+.+.+|+++|+++ .|+||+++++++++.+..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45566666655543 25888999998643 233456799999999999 7999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||++|++|.+++.+.+. ++.. +|+.||+.||+|+| +++||||||||+|||++.+|.+||+|||+++......
T Consensus 322 Eyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH----~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALE----KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHH----HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHH----HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999987653 5554 48899999999999 6899999999999999999999999999998764432
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCC
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p 629 (717)
. .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 394 ~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred c--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 2244679999999998875 467789999999998887665544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-26 Score=230.90 Aligned_cols=206 Identities=23% Similarity=0.303 Sum_probs=157.1
Q ss_pred CCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEec
Q 005040 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQ 197 (717)
Q Consensus 118 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 197 (717)
+++++++++|.++. +|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++...+..|..+++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 45667777777763 444333 567777777777776666677777777777777777776555666777777777777
Q ss_pred CccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCC
Q 005040 198 SNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI 277 (717)
Q Consensus 198 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 277 (717)
+|++++..+..|..+++|++|++++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++|++|++++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 77777666666777788888888888887777777788888888888888888766666788888888888888888776
Q ss_pred CccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccc
Q 005040 278 PESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 278 ~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 326 (717)
+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|++.+.++
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 7778888888888888888887767778888888899999998887765
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=233.74 Aligned_cols=223 Identities=20% Similarity=0.187 Sum_probs=174.3
Q ss_pred EeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCc
Q 005040 73 LALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENN 152 (717)
Q Consensus 73 L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 152 (717)
++..+..+. .+|..+ +++|++|++++|++.+..+..|.++++|++|+|++|.++...+..|.++++|++|+|++|.
T Consensus 12 ~~c~~~~l~-~ip~~l---~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 12 YQCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EECTTSCCS-SCCSSS---CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEecCCCcc-ccCCCC---CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 444444444 333322 2456777777777766666678888888888888888887777778888888888888888
Q ss_pred ccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCC-CChhhhcccCCCeEEccCCcCcccCCc
Q 005040 153 LQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSS-LPSSLWSLEYILRINLSSNSLKGTLPS 231 (717)
Q Consensus 153 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~ 231 (717)
+++..+..|.++++|++|++++|.+++..+..+..+++|++|+|++|++++. +|..+..+++|++|++++|++++..+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 8877777888888888888888888876666788888888888888888864 578888888888888888888877777
Q ss_pred cccCCCCCC----eEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCC
Q 005040 232 NIQKLNVLI----DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGK 300 (717)
Q Consensus 232 ~~~~l~~L~----~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~ 300 (717)
.+..+++|+ .|++++|.+++..+..+.. .+|++|++++|++++..+..+..+++|+.|+|++|++.+.
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred HhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 777777776 8899999998765555544 4899999999999977777788999999999999999854
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=233.25 Aligned_cols=208 Identities=22% Similarity=0.210 Sum_probs=101.6
Q ss_pred ccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCC
Q 005040 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQL 143 (717)
Q Consensus 64 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 143 (717)
+..+++|+.|++++|.++.. +.+..+ ++|++|++++|++.+. ..+..+++|++|+|++|.+++..+..|.++++|
T Consensus 37 ~~~l~~L~~L~l~~~~i~~~--~~l~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 111 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKSV--QGIQYL-PNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111 (272)
T ss_dssp HHHHTTCCEEECTTSCCCCC--TTGGGC-TTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred cccccceeeeeeCCCCcccc--cccccC-CCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence 34555566666666555421 112222 2233333333332221 234455555555555555555444445555555
Q ss_pred CEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCC
Q 005040 144 QGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223 (717)
Q Consensus 144 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 223 (717)
++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|++++|
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 55555555555554444555555555555555555444444555555555555555555444444455555555555555
Q ss_pred cCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccc
Q 005040 224 SLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGN 283 (717)
Q Consensus 224 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 283 (717)
++++..+..+..+++|+.|++++|.+.+ .+++|+.|+++.|.+.|.+|..++.
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~ 244 (272)
T 3rfs_A 192 QLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGS 244 (272)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSC
T ss_pred cCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccc
Confidence 5554444444555555555555554442 1334444444445444444444443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-26 Score=230.01 Aligned_cols=207 Identities=24% Similarity=0.248 Sum_probs=172.1
Q ss_pred ccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCC
Q 005040 113 IGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 192 (717)
+.++++|+++++++|.++. +|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.|++..+ .+.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 5677788888888888884 444443 678888888888888877888888888888888888886543 36788889
Q ss_pred eEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCcc
Q 005040 193 SLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQ 272 (717)
Q Consensus 193 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 272 (717)
+|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999888 567778888899999999999987777888999999999999999988777778889999999999999
Q ss_pred ccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccc
Q 005040 273 FQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 273 l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 326 (717)
+++..+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++.+.+.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 98766677888999999999999998 677777788899999999999987654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=225.52 Aligned_cols=182 Identities=26% Similarity=0.286 Sum_probs=107.7
Q ss_pred CCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEec
Q 005040 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQ 197 (717)
Q Consensus 118 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 197 (717)
+|++|+|++|+++...+..|.++++|++|+|++|.++.+.+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 44555555555554444445555555555555555554444445555555555555555554444455555556666666
Q ss_pred CccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCC
Q 005040 198 SNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI 277 (717)
Q Consensus 198 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 277 (717)
+|++++..+..|..+++|++|+|++|.|++..+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 66665555555556666666666666666555555666666666666666666655555666666777777777666555
Q ss_pred CccccccCccceEeccCCCCCC
Q 005040 278 PESVGNLISLESLDFSNNNLSG 299 (717)
Q Consensus 278 ~~~~~~l~~L~~L~L~~N~~~~ 299 (717)
+..+..+++|+.|+|++|++..
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 198 EGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCBCC
T ss_pred HHHhccccCCCEEEecCCCeeC
Confidence 5556667777777777777654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.4e-26 Score=228.74 Aligned_cols=221 Identities=23% Similarity=0.230 Sum_probs=171.7
Q ss_pred cceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccC
Q 005040 95 LQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG 174 (717)
Q Consensus 95 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 174 (717)
+..+++..+.+... ..+..+++|+.|++++|.++.. ..+..+++|++|++++|.+++. ..+..+++|++|+|++
T Consensus 21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT
T ss_pred HHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC
Confidence 44445555544433 2355667788888888877632 3577788888888888888753 4677888888888888
Q ss_pred CcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCc
Q 005040 175 NKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIP 254 (717)
Q Consensus 175 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 254 (717)
|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|.+++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 88887777777888888888888888887777777888888888888888887777778888888888888888887777
Q ss_pred ccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccc
Q 005040 255 STIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK 328 (717)
Q Consensus 255 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~ 328 (717)
..+..+++|++|++++|++++..+..+..+++|+.|+|++|++.+. +++|+.|++..|.++|.+|..
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 7778888888888888888887777788888899999998888743 557888888999999888864
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-25 Score=222.94 Aligned_cols=203 Identities=24% Similarity=0.221 Sum_probs=113.5
Q ss_pred ccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCC
Q 005040 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQL 143 (717)
Q Consensus 64 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 143 (717)
+.++++|+++++++|.++. +|..+. ++++.|++++|++++..+..|.++++|++|+|++|.|+...+. ..+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 5677888888888888873 343322 3455666666665555555555555555555555555533221 444444
Q ss_pred CEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCC
Q 005040 144 QGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223 (717)
Q Consensus 144 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 223 (717)
++|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 80 ------------------------~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N 134 (290)
T 1p9a_G 80 ------------------------GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (290)
T ss_dssp ------------------------CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred ------------------------CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence 45555555444 33444444555555555555555444445555555555555555
Q ss_pred cCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCC
Q 005040 224 SLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 224 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 298 (717)
+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++ .+|..+..+.+|+.|+|++|++.
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 555444445555555555555555555544444555566666666666665 44555555556666666666665
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-26 Score=253.46 Aligned_cols=186 Identities=18% Similarity=0.189 Sum_probs=145.9
Q ss_pred CccccccccccEEEEEEEecCCCeEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 430 NECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--------ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 430 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
...+.||+|+||.||+|.. .++.+|+|+..... ....+.+.+|++++++++||||+++..++.+.+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4457899999999999965 57888998753221 12245689999999999999999666655567777999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++++|.+++.. +..++.|+++||.||| +.+|+||||||+|||++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH----~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH----KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH----HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH----HCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999876 4579999999999999 678999999999999999 9999999999987543
Q ss_pred CCce-----eeeccccCccccCCCccCC--CCcCcccchhhHHHHHHHHHhCCCCCC
Q 005040 582 EDSV-----IQTMTMATIGYMAPEYGSE--GIVSTKCDVYSYGVLLMETFTEKKPTD 631 (717)
Q Consensus 582 ~~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~ 631 (717)
.... ......||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2111 1234578999999998876 668889999999999999988888764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=218.05 Aligned_cols=197 Identities=18% Similarity=0.162 Sum_probs=140.6
Q ss_pred CCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCC-CcccCCcchhccccccceeeecC-CcceecCCcccc
Q 005040 37 HLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNP-LGGILPPLIGNFSASLQNIYAFE-CKLGGSIPKEIG 114 (717)
Q Consensus 37 ~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~~L~~L~l~~-n~l~~~~~~~~~ 114 (717)
+|++|+|++|+|+.+++.. |.++++|++|+|++|+ ++.+.+..|..+ ++|++|++++ |++....+..|.
T Consensus 32 ~l~~L~l~~n~l~~i~~~~--------~~~l~~L~~L~l~~n~~l~~i~~~~f~~l-~~L~~L~l~~~n~l~~i~~~~f~ 102 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHA--------FSNLPNISRIYVSIDVTLQQLESHSFYNL-SKVTHIEIRNTRNLTYIDPDALK 102 (239)
T ss_dssp TCCEEEEESCCCSEECTTT--------TTTCTTCCEEEEECCSSCCEECTTTEESC-TTCCEEEEEEETTCCEECTTSEE
T ss_pred cccEEEEeCCcceEECHHH--------ccCCCCCcEEeCCCCCCcceeCHhHcCCC-cCCcEEECCCCCCeeEcCHHHhC
Confidence 5666666666666655433 5566666666666665 655555555555 4566666666 666666666777
Q ss_pred CCCCCcEEEccCCCCcccCCccccccCCCC---EEeccCC-cccccCCccccCCCCCC-EEeccCCcCcccCCccccCCC
Q 005040 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQ---GFYVPEN-NLQGYVPHDLCHLERLN-ILNLSGNKLSGAIPQCLASLT 189 (717)
Q Consensus 115 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~---~L~l~~n-~i~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~ 189 (717)
++++|++|+|++|.+++ +|. |..+++|+ +|++++| .++.+.+..|.++++|+ +|++++|+++.+.+..|.. +
T Consensus 103 ~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~ 179 (239)
T 2xwt_C 103 ELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-T 179 (239)
T ss_dssp CCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-C
T ss_pred CCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-C
Confidence 88888888888888875 454 77777777 8888888 88877777788888888 8888888888544445555 7
Q ss_pred CCCeEEecCcc-ccCCCChhhhcc-cCCCeEEccCCcCcccCCccccCCCCCCeEEccCCC
Q 005040 190 SLRSLYLQSNK-LSSSLPSSLWSL-EYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQ 248 (717)
Q Consensus 190 ~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 248 (717)
+|+.|+|++|+ +++..+..|..+ ++|+.|++++|+|++..+. .+++|+.|+++++.
T Consensus 180 ~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 180 KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp EEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred CCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence 88888888884 886667778888 8888888888888854333 56778888887763
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-27 Score=255.91 Aligned_cols=253 Identities=15% Similarity=0.170 Sum_probs=161.7
Q ss_pred cCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC---cccCCcchhccccccceeeecCC
Q 005040 27 HIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL---GGILPPLIGNFSASLQNIYAFEC 103 (717)
Q Consensus 27 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l---~~~~~~~~~~l~~~L~~L~l~~n 103 (717)
.++..+..+++|++|+|++|.|+...... +...|..+++|++|+|++|.+ ++..|..+..+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~----l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l------------ 86 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARW----LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL------------ 86 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHH----HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHH------------
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHH----HHHHHHhCCCccEEeCcccccCccccchhHHHHHH------------
Confidence 45556667777888888888777643211 223366777788888877543 33344444332
Q ss_pred cceecCCccccCCCCCcEEEccCCCCcc----cCCccccccCCCCEEeccCCcccccCCccccC----C---------CC
Q 005040 104 KLGGSIPKEIGNLRGLIVLSLGFNDLNG----TIPTSIGTLQQLQGFYVPENNLQGYVPHDLCH----L---------ER 166 (717)
Q Consensus 104 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~----l---------~~ 166 (717)
...+..+++|++|+|++|.++. .++..+..+++|++|+|++|.++...+..+.. + ++
T Consensus 87 ------~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~ 160 (386)
T 2ca6_A 87 ------LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPP 160 (386)
T ss_dssp ------HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred ------HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCC
Confidence 2345677888888888888876 35667777888888888888876544433333 2 67
Q ss_pred CCEEeccCCcCcc-cCC---ccccCCCCCCeEEecCccccC-----CCChhhhcccCCCeEEccCCcCc----ccCCccc
Q 005040 167 LNILNLSGNKLSG-AIP---QCLASLTSLRSLYLQSNKLSS-----SLPSSLWSLEYILRINLSSNSLK----GTLPSNI 233 (717)
Q Consensus 167 L~~L~L~~n~l~~-~~~---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~l~~N~l~----~~~~~~~ 233 (717)
|++|+|++|+++. ..+ ..+..+++|++|+|++|+++. ..+..+..+++|++|+|++|.|+ ..+|..+
T Consensus 161 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l 240 (386)
T 2ca6_A 161 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240 (386)
T ss_dssp CCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred CcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHH
Confidence 7788888877762 233 355667777777777777762 22335666777777777777774 3456666
Q ss_pred cCCCCCCeEEccCCCCCCC----Ccccc--cCCcccccccccCccccC----CCCccc-cccCccceEeccCCCCCCCC
Q 005040 234 QKLNVLIDLDLSRNQLSSD----IPSTI--GTLKNLETLSLAGNQFQG----PIPESV-GNLISLESLDFSNNNLSGKI 301 (717)
Q Consensus 234 ~~l~~L~~L~l~~N~l~~~----~~~~~--~~l~~L~~L~l~~N~l~~----~~~~~~-~~l~~L~~L~L~~N~~~~~~ 301 (717)
..+++|+.|+|++|.+++. ++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|++|+|++|++++..
T Consensus 241 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp GGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred ccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 7777777777777777653 23444 226667777777777665 255554 44666777777777666554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=243.85 Aligned_cols=259 Identities=21% Similarity=0.212 Sum_probs=153.0
Q ss_pred EEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCcc-CCcEEeccCCCCcccCCcchhccccc
Q 005040 16 GLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCR-NLANLALASNPLGGILPPLIGNFSAS 94 (717)
Q Consensus 16 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~~ 94 (717)
.++|+.|++++..|..+...++|++|+|++|.|++++... +...|..++ +|++|+|++|.+++..+..+..+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~----l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~--- 74 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVE----LIQAFANTPASVTSLNLSGNSLGFKNSDELVQI--- 74 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHH----HHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHH---
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHH----HHHHHHhCCCceeEEECcCCCCCHHHHHHHHHH---
Confidence 4688999999888887777777999999999988766411 224467777 88999999998887666666554
Q ss_pred cceeeecCCcceecCCccccC-CCCCcEEEccCCCCcccCCccccc----c-CCCCEEeccCCcccccCCcccc----C-
Q 005040 95 LQNIYAFECKLGGSIPKEIGN-LRGLIVLSLGFNDLNGTIPTSIGT----L-QQLQGFYVPENNLQGYVPHDLC----H- 163 (717)
Q Consensus 95 L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~----l-~~L~~L~l~~n~i~~~~~~~~~----~- 163 (717)
+.. .++|++|+|++|.+++..+..+.. + ++|++|+|++|++++..+..+. .
T Consensus 75 ------------------l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~ 136 (362)
T 3goz_A 75 ------------------LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136 (362)
T ss_dssp ------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTS
T ss_pred ------------------HhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhC
Confidence 111 256666666666666544443332 2 5666666666666655444332 2
Q ss_pred CCCCCEEeccCCcCcccCC----ccccCCC-CCCeEEecCccccCCCChhhh----cc-cCCCeEEccCCcCccc----C
Q 005040 164 LERLNILNLSGNKLSGAIP----QCLASLT-SLRSLYLQSNKLSSSLPSSLW----SL-EYILRINLSSNSLKGT----L 229 (717)
Q Consensus 164 l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~l~~N~l~~~----~ 229 (717)
.++|++|+|++|.+++... ..+..++ +|++|+|++|++++..+..+. .+ ++|++|+|++|.|++. +
T Consensus 137 ~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l 216 (362)
T 3goz_A 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAEL 216 (362)
T ss_dssp CTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHH
Confidence 2466666666666664332 2233444 666666666666655544333 23 4666666666666642 2
Q ss_pred CccccC-CCCCCeEEccCCCCCCCCcc----cccCCcccccccccCccccCCCC-------ccccccCccceEeccCCCC
Q 005040 230 PSNIQK-LNVLIDLDLSRNQLSSDIPS----TIGTLKNLETLSLAGNQFQGPIP-------ESVGNLISLESLDFSNNNL 297 (717)
Q Consensus 230 ~~~~~~-l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~~~-------~~~~~l~~L~~L~L~~N~~ 297 (717)
+..+.. .++|+.|+|++|.+++..+. .+..+++|++|++++|.+.+..+ ..+..+++|+.|+|++|++
T Consensus 217 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l 296 (362)
T 3goz_A 217 AYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296 (362)
T ss_dssp HHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBC
T ss_pred HHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcC
Confidence 333333 33666666666666654432 23445666666666666443222 2334444555555555555
Q ss_pred CC
Q 005040 298 SG 299 (717)
Q Consensus 298 ~~ 299 (717)
..
T Consensus 297 ~~ 298 (362)
T 3goz_A 297 HP 298 (362)
T ss_dssp CG
T ss_pred CC
Confidence 43
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-26 Score=241.44 Aligned_cols=253 Identities=16% Similarity=0.180 Sum_probs=190.9
Q ss_pred EeccCCCCcccCCcchhccccccceeeecCCcceecCC----ccccCCC-CCcEEEccCCCCcccCCcccccc-----CC
Q 005040 73 LALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIP----KEIGNLR-GLIVLSLGFNDLNGTIPTSIGTL-----QQ 142 (717)
Q Consensus 73 L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~ 142 (717)
++|++|.+++.+|..+. .+.+|++|+|++|.+++..+ ..|.+++ +|++|+|++|.+++..+..|..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~~~-~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTS-IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHT-SCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHh-CCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 34555555544433322 22345555555555554444 5677888 89999999999998878788776 99
Q ss_pred CCEEeccCCcccccCCcccc----CC-CCCCEEeccCCcCcccCCcccc----C-CCCCCeEEecCccccCCCCh----h
Q 005040 143 LQGFYVPENNLQGYVPHDLC----HL-ERLNILNLSGNKLSGAIPQCLA----S-LTSLRSLYLQSNKLSSSLPS----S 208 (717)
Q Consensus 143 L~~L~l~~n~i~~~~~~~~~----~l-~~L~~L~L~~n~l~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~~~----~ 208 (717)
|++|+|++|++++..+..+. .+ ++|++|+|++|++++..+..+. . .++|++|+|++|.+++..+. .
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 99999999999987776544 44 8999999999999976665443 3 36999999999999965443 4
Q ss_pred hhccc-CCCeEEccCCcCcccCCccc----cCC-CCCCeEEccCCCCCCCC----cccccC-CcccccccccCccccCCC
Q 005040 209 LWSLE-YILRINLSSNSLKGTLPSNI----QKL-NVLIDLDLSRNQLSSDI----PSTIGT-LKNLETLSLAGNQFQGPI 277 (717)
Q Consensus 209 ~~~l~-~L~~L~l~~N~l~~~~~~~~----~~l-~~L~~L~l~~N~l~~~~----~~~~~~-l~~L~~L~l~~N~l~~~~ 277 (717)
+..++ +|++|+|++|+|++..+..+ ..+ ++|+.|+|++|.|++.. +..+.. .++|++|+|++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 99999999999997766544 445 59999999999999743 334444 459999999999999766
Q ss_pred Cc----cccccCccceEeccCCCCCCCCc-------ccccccccccEEEccCCccccccc
Q 005040 278 PE----SVGNLISLESLDFSNNNLSGKIP-------KSLEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 278 ~~----~~~~l~~L~~L~L~~N~~~~~~~-------~~~~~l~~L~~L~l~~N~l~~~~p 326 (717)
+. .+..+++|+.|+|++|.+.+..+ ..+..+++|+.|++++|++.+..+
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 53 34677999999999999664433 367788999999999999987644
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=214.50 Aligned_cols=196 Identities=19% Similarity=0.228 Sum_probs=114.0
Q ss_pred CCcEEEccCCCCcccCCccccccCCCCEEeccCCc-ccccCCccccCCCCCCEEeccC-CcCcccCCccccCCCCCCeEE
Q 005040 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENN-LQGYVPHDLCHLERLNILNLSG-NKLSGAIPQCLASLTSLRSLY 195 (717)
Q Consensus 118 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 195 (717)
+|++|+|++|+++++.+..|.++++|++|++++|+ ++.+.+..|.++++|++|+|++ |+++...+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444455555555555555554 5544444555555555555555 555544445555556666666
Q ss_pred ecCccccCCCChhhhcccCCC---eEEccCC-cCcccCCccccCCCCCC-eEEccCCCCCCCCcccccCCcccccccccC
Q 005040 196 LQSNKLSSSLPSSLWSLEYIL---RINLSSN-SLKGTLPSNIQKLNVLI-DLDLSRNQLSSDIPSTIGTLKNLETLSLAG 270 (717)
Q Consensus 196 L~~N~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 270 (717)
+++|++++ +|. |..+++|+ +|++++| .+++..+..|.++++|+ .|++++|.++...+..|.. ++|++|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 66666553 333 55555555 6666666 66655555566666666 6666666666433333444 6677777777
Q ss_pred cc-ccCCCCcccccc-CccceEeccCCCCCCCCcccccccccccEEEccCC
Q 005040 271 NQ-FQGPIPESVGNL-ISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHN 319 (717)
Q Consensus 271 N~-l~~~~~~~~~~l-~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N 319 (717)
|+ +++..+..|.++ ++|+.|+|++|++++..+. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 74 665555666666 6777777777777643332 4556666666655
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.4e-27 Score=248.69 Aligned_cols=244 Identities=19% Similarity=0.247 Sum_probs=193.9
Q ss_pred ccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCC---cccCCccc-
Q 005040 62 SSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDL---NGTIPTSI- 137 (717)
Q Consensus 62 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l---~~~~~~~~- 137 (717)
..+..+++|++|+|++|.++...+..+ +..+..+++|++|+|++|.+ ++.+|..+
T Consensus 26 ~~l~~~~~L~~L~L~~n~i~~~~~~~l---------------------~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~ 84 (386)
T 2ca6_A 26 AVLLEDDSVKEIVLSGNTIGTEAARWL---------------------SENIASKKDLEIAEFSDIFTGRVKDEIPEALR 84 (386)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHH---------------------HHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH
T ss_pred HHHhcCCCccEEECCCCCCCHHHHHHH---------------------HHHHHhCCCccEEeCcccccCccccchhHHHH
Confidence 345566667777777776664433222 23477889999999998644 44455544
Q ss_pred ------cccCCCCEEeccCCcccc----cCCccccCCCCCCEEeccCCcCcccCCccccC----C---------CCCCeE
Q 005040 138 ------GTLQQLQGFYVPENNLQG----YVPHDLCHLERLNILNLSGNKLSGAIPQCLAS----L---------TSLRSL 194 (717)
Q Consensus 138 ------~~l~~L~~L~l~~n~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----l---------~~L~~L 194 (717)
..+++|++|+|++|.++. .++..+..+++|++|+|++|.++...+..+.. + ++|++|
T Consensus 85 ~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L 164 (386)
T 2ca6_A 85 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164 (386)
T ss_dssp HHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred HHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEE
Confidence 789999999999999997 46668889999999999999997554444443 3 899999
Q ss_pred EecCcccc-CCCC---hhhhcccCCCeEEccCCcCcc-----cCCccccCCCCCCeEEccCCCCC----CCCcccccCCc
Q 005040 195 YLQSNKLS-SSLP---SSLWSLEYILRINLSSNSLKG-----TLPSNIQKLNVLIDLDLSRNQLS----SDIPSTIGTLK 261 (717)
Q Consensus 195 ~L~~N~l~-~~~~---~~~~~l~~L~~L~l~~N~l~~-----~~~~~~~~l~~L~~L~l~~N~l~----~~~~~~~~~l~ 261 (717)
+|++|+++ ...+ ..+..+++|++|+|++|.|+. ..+..+..+++|+.|+|++|.++ ..+|..+..++
T Consensus 165 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~ 244 (386)
T 2ca6_A 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244 (386)
T ss_dssp ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred ECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCC
Confidence 99999998 3334 467789999999999999983 34448889999999999999996 45777889999
Q ss_pred ccccccccCccccCC----CCccc--cccCccceEeccCCCCCC----CCcccc-cccccccEEEccCCccccccc
Q 005040 262 NLETLSLAGNQFQGP----IPESV--GNLISLESLDFSNNNLSG----KIPKSL-EALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 262 ~L~~L~l~~N~l~~~----~~~~~--~~l~~L~~L~L~~N~~~~----~~~~~~-~~l~~L~~L~l~~N~l~~~~p 326 (717)
+|++|+|++|++++. ++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|+.|++++|++++..+
T Consensus 245 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 999999999999865 45555 348999999999999997 477777 668999999999999997765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=222.08 Aligned_cols=223 Identities=17% Similarity=0.219 Sum_probs=111.7
Q ss_pred CCcEEeccCCCCcccCCcchh---ccccccceeeecCCcceecCCccc--cCCCCCcEEEccCCCCcccCC----ccccc
Q 005040 69 NLANLALASNPLGGILPPLIG---NFSASLQNIYAFECKLGGSIPKEI--GNLRGLIVLSLGFNDLNGTIP----TSIGT 139 (717)
Q Consensus 69 ~L~~L~L~~N~l~~~~~~~~~---~l~~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~ 139 (717)
.++.|.+.++.++......+. .. ++|++|++++|++.+..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAY-SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHH-SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhccc-CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 456666666665432111111 11 236666666666665666555 666666666666666664333 23345
Q ss_pred cCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCccc---C-CccccCCCCCCeEEecCccccCCCCh----hhhc
Q 005040 140 LQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA---I-PQCLASLTSLRSLYLQSNKLSSSLPS----SLWS 211 (717)
Q Consensus 140 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~---~-~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~ 211 (717)
+++|++|+|++|++.+..+..|..+++|++|+|++|++.+. . +..+..+++|++|+|++|+++. ++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence 56666666666666655555666666666666666665431 1 1223455566666666666542 222 1344
Q ss_pred ccCCCeEEccCCcCcccCCccccCC---CCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccc
Q 005040 212 LEYILRINLSSNSLKGTLPSNIQKL---NVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLE 288 (717)
Q Consensus 212 l~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 288 (717)
+++|++|+|++|.|++..|..+..+ ++|++|+|++|.|+. +|..+. ++|++|+|++|++++. |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 5555555555555554444444433 355555555555552 333332 3444444444444422 11 33444444
Q ss_pred eEeccCCCCC
Q 005040 289 SLDFSNNNLS 298 (717)
Q Consensus 289 ~L~L~~N~~~ 298 (717)
.|+|++|+++
T Consensus 298 ~L~L~~N~l~ 307 (310)
T 4glp_A 298 NLTLDGNPFL 307 (310)
T ss_dssp CEECSSTTTS
T ss_pred EEECcCCCCC
Confidence 4444444443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=224.05 Aligned_cols=228 Identities=20% Similarity=0.187 Sum_probs=187.0
Q ss_pred CCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcch--hccccccceeeecCCcceecCC---
Q 005040 36 RHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLI--GNFSASLQNIYAFECKLGGSIP--- 110 (717)
Q Consensus 36 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~--~~l~~~L~~L~l~~n~l~~~~~--- 110 (717)
..++.|.+.++.++..... ....+..+++|++|+|++|.+++..|..+ ..+ ++|++|++++|++.+..+
T Consensus 64 ~~l~~l~l~~~~~~~~~~~-----~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~-~~L~~L~Ls~n~i~~~~~~~~ 137 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLV-----GALRVLAYSRLKELTLEDLKITGTMPPLPLEATG-LALSSLRLRNVSWATGRSWLA 137 (310)
T ss_dssp CCCCEEEECSCCCBHHHHH-----HHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCC-BCCSSCEEESCCCSSTTSSHH
T ss_pred cceeEEEEeCCcCCHHHHH-----HHHHhcccCceeEEEeeCCEeccchhhhhhhccC-CCCCEEEeecccccchhhhhH
Confidence 3578888888877642210 01113355779999999999998888887 555 689999999999997555
Q ss_pred -ccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCccccc---C-CccccCCCCCCEEeccCCcCcccCCc--
Q 005040 111 -KEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGY---V-PHDLCHLERLNILNLSGNKLSGAIPQ-- 183 (717)
Q Consensus 111 -~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~---~-~~~~~~l~~L~~L~L~~n~l~~~~~~-- 183 (717)
..+..+++|++|+|++|.+++..+..|.++++|++|+|++|++.+. . +..+..+++|++|+|++|+++. .+.
T Consensus 138 ~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~ 216 (310)
T 4glp_A 138 ELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVC 216 (310)
T ss_dssp HHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHH
T ss_pred HHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHH
Confidence 4456799999999999999988889999999999999999998642 2 2335788999999999999973 333
Q ss_pred --cccCCCCCCeEEecCccccCCCChhhhcc---cCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCccccc
Q 005040 184 --CLASLTSLRSLYLQSNKLSSSLPSSLWSL---EYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIG 258 (717)
Q Consensus 184 --~~~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 258 (717)
.++.+++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|.|++. |. +.
T Consensus 217 ~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~ 291 (310)
T 4glp_A 217 AALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PD 291 (310)
T ss_dssp HHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TT
T ss_pred HHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hh
Confidence 35788999999999999998878777776 69999999999999 6677664 7999999999999974 44 68
Q ss_pred CCcccccccccCccccC
Q 005040 259 TLKNLETLSLAGNQFQG 275 (717)
Q Consensus 259 ~l~~L~~L~l~~N~l~~ 275 (717)
.+++|+.|++++|+++.
T Consensus 292 ~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 292 ELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp SCCCCSCEECSSTTTSC
T ss_pred hCCCccEEECcCCCCCC
Confidence 89999999999999974
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-25 Score=232.24 Aligned_cols=234 Identities=18% Similarity=0.197 Sum_probs=149.0
Q ss_pred cCCcEEeccCCCCcccCCcchhccccccceeeecCCcceec-CCccccCCCCCcEEEccCCCCcccCCccccccCCCCEE
Q 005040 68 RNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGS-IPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGF 146 (717)
Q Consensus 68 ~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 146 (717)
++++.|++++|.+.+..+.. ..+ ++|++|++++|.+.+. ++..+..+++|++|+|++|.+++..+..++.+++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~~-~~~-~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAEH-FSP-FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCSC-CCC-BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchhh-ccC-CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 44555555555554433332 222 3455555555555433 45556667777777777777776666677777777777
Q ss_pred eccCC-ccccc-CCccccCCCCCCEEeccCC-cCccc-CCccccCCC-CCCeEEecCc--ccc-CCCChhhhcccCCCeE
Q 005040 147 YVPEN-NLQGY-VPHDLCHLERLNILNLSGN-KLSGA-IPQCLASLT-SLRSLYLQSN--KLS-SSLPSSLWSLEYILRI 218 (717)
Q Consensus 147 ~l~~n-~i~~~-~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L 218 (717)
+|++| .+++. .+..+.++++|++|++++| .+++. .+..+..++ +|++|+|++| .++ +.++..+..+++|++|
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L 227 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE
Confidence 77777 56542 4445667777777777777 77643 355567777 7777777777 343 3445566677788888
Q ss_pred EccCCc-CcccCCccccCCCCCCeEEccCCC-CCCCCcccccCCcccccccccCccccCCCCcccccc-CccceEeccCC
Q 005040 219 NLSSNS-LKGTLPSNIQKLNVLIDLDLSRNQ-LSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNL-ISLESLDFSNN 295 (717)
Q Consensus 219 ~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~L~~N 295 (717)
++++|. +++..+..+..+++|+.|++++|. +.......+..+++|++|++++| +.. ..+..+ .+|..|++++|
T Consensus 228 ~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n 303 (336)
T 2ast_B 228 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCS 303 (336)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCC
T ss_pred eCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecc
Confidence 888877 665666677777888888888874 33222225677788888888877 332 233333 23666777888
Q ss_pred CCCCCCcccccc
Q 005040 296 NLSGKIPKSLEA 307 (717)
Q Consensus 296 ~~~~~~~~~~~~ 307 (717)
++++..|..+..
T Consensus 304 ~l~~~~~~~~~~ 315 (336)
T 2ast_B 304 HFTTIARPTIGN 315 (336)
T ss_dssp CSCCTTCSSCSS
T ss_pred cCccccCCcccc
Confidence 888777776554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-25 Score=231.80 Aligned_cols=253 Identities=19% Similarity=0.208 Sum_probs=207.9
Q ss_pred cCCcEEeccCCCCcccCCcchhcc-ccccceeeecCCcceecCCccccCCCCCcEEEccCCCCccc-CCccccccCCCCE
Q 005040 68 RNLANLALASNPLGGILPPLIGNF-SASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGT-IPTSIGTLQQLQG 145 (717)
Q Consensus 68 ~~L~~L~L~~N~l~~~~~~~~~~l-~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~ 145 (717)
..++.|++++|.+. +..+..+ .++++.|++++|.+.+..+. +..+++|++|+|++|.+++. .+..+..+++|++
T Consensus 47 ~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~ 122 (336)
T 2ast_B 47 SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 122 (336)
T ss_dssp TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence 34889999999887 3444443 25699999999999977665 66799999999999999865 7778899999999
Q ss_pred EeccCCcccccCCccccCCCCCCEEeccCC-cCccc-CCccccCCCCCCeEEecCc-cccCC-CChhhhccc-CCCeEEc
Q 005040 146 FYVPENNLQGYVPHDLCHLERLNILNLSGN-KLSGA-IPQCLASLTSLRSLYLQSN-KLSSS-LPSSLWSLE-YILRINL 220 (717)
Q Consensus 146 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~l 220 (717)
|+|++|.+++..+..+..+++|++|+|++| .+++. .+..+..+++|++|+|++| .+++. ++..+..++ +|++|++
T Consensus 123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l 202 (336)
T 2ast_B 123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202 (336)
T ss_dssp EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEe
Confidence 999999999888888999999999999999 68753 5666888999999999999 88854 567788999 9999999
Q ss_pred cCC--cCc-ccCCccccCCCCCCeEEccCCC-CCCCCcccccCCcccccccccCcc-ccCCCCccccccCccceEeccCC
Q 005040 221 SSN--SLK-GTLPSNIQKLNVLIDLDLSRNQ-LSSDIPSTIGTLKNLETLSLAGNQ-FQGPIPESVGNLISLESLDFSNN 295 (717)
Q Consensus 221 ~~N--~l~-~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~N 295 (717)
++| .++ +.++..+..+++|+.|++++|. +++..+..+..+++|++|++++|. +.......++++++|+.|+|++|
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 999 455 3566778889999999999999 777778889999999999999995 33333336888999999999999
Q ss_pred CCCCCCccccccc-ccccEEEccCCccccccccc
Q 005040 296 NLSGKIPKSLEAL-SHLKQFNVSHNRLEGEIPVK 328 (717)
Q Consensus 296 ~~~~~~~~~~~~l-~~L~~L~l~~N~l~~~~p~~ 328 (717)
+. ...+..+ ..++.|++++|++++..|..
T Consensus 283 -i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 283 -VP---DGTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp -SC---TTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred -cC---HHHHHHHHhhCcceEEecccCccccCCc
Confidence 43 2344444 34777889999999887754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=9.1e-24 Score=217.65 Aligned_cols=192 Identities=26% Similarity=0.376 Sum_probs=97.9
Q ss_pred CCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEE
Q 005040 116 LRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLY 195 (717)
Q Consensus 116 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 195 (717)
+++|++|++++|.++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++. ..+..+++|++|+
T Consensus 40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~ 113 (308)
T 1h6u_A 40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD 113 (308)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEE
Confidence 4444555555554442 22 34445555555555555543322 45555555555555555432 1345555555555
Q ss_pred ecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccC
Q 005040 196 LQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG 275 (717)
Q Consensus 196 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 275 (717)
|++|++++. + .+..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++
T Consensus 114 l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 114 LTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD 187 (308)
T ss_dssp CTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc
Confidence 555555532 2 24555555555555555553322 5555555555555555554222 5555555555555555553
Q ss_pred CCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccc
Q 005040 276 PIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEG 323 (717)
Q Consensus 276 ~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~ 323 (717)
..+ +..+++|++|+|++|++++.. .+..+++|+.|++++|++++
T Consensus 188 ~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 188 ISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred Chh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 322 555566666666666665433 25556666666666666654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=207.45 Aligned_cols=180 Identities=24% Similarity=0.288 Sum_probs=94.0
Q ss_pred CCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEec
Q 005040 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQ 197 (717)
Q Consensus 118 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 197 (717)
..++++++++.++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3455666666665 3333332 355555555555555555555555555555555555554444445555555555555
Q ss_pred CccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCC
Q 005040 198 SNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI 277 (717)
Q Consensus 198 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 277 (717)
+|++++..+.. |..+++|++|+|++|.|++..+..|..+++|++|+|++|++++..
T Consensus 92 ~n~l~~~~~~~------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 147 (251)
T 3m19_A 92 NNQLASLPLGV------------------------FDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIP 147 (251)
T ss_dssp TSCCCCCCTTT------------------------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCcccccChhH------------------------hcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccC
Confidence 55555444444 444445555555555554444444445555555555555555444
Q ss_pred CccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccc
Q 005040 278 PESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 278 ~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++.
T Consensus 148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 44455555555555555555554445555555555555555555554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=216.04 Aligned_cols=189 Identities=23% Similarity=0.379 Sum_probs=108.3
Q ss_pred cceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccC
Q 005040 95 LQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG 174 (717)
Q Consensus 95 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 174 (717)
|++|++++|++.. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|.+++. ..+..+++|++|+|++
T Consensus 43 L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 43 ITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTS 116 (308)
T ss_dssp CCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTT
T ss_pred cCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCC
Confidence 4444444444432 22 34555566666666666554332 55566666666666665543 2455666666666666
Q ss_pred CcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCc
Q 005040 175 NKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIP 254 (717)
Q Consensus 175 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 254 (717)
|++++. + .+..+++|++|+|++|++++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+
T Consensus 117 n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~ 190 (308)
T 1h6u_A 117 TQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP 190 (308)
T ss_dssp SCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG
T ss_pred CCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh
Confidence 666543 2 25666666666666666664322 5566666666666666664322 6666666666666666665332
Q ss_pred ccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCC
Q 005040 255 STIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG 299 (717)
Q Consensus 255 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~ 299 (717)
+..+++|++|++++|++.+.. .+..+++|+.|+|++|++++
T Consensus 191 --l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 191 --LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp --GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred --hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 566666666666666666433 25666667777777776653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-23 Score=206.06 Aligned_cols=180 Identities=27% Similarity=0.296 Sum_probs=152.5
Q ss_pred cccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEec
Q 005040 93 ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNL 172 (717)
Q Consensus 93 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 172 (717)
.+.++++++++.+. .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 45788999999998 5676665 69999999999999988889999999999999999999999989999999999999
Q ss_pred cCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCC
Q 005040 173 SGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSD 252 (717)
Q Consensus 173 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 252 (717)
++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999988888899999999999999999977777778888888888888888866666777777777777777777766
Q ss_pred CcccccCCcccccccccCccccC
Q 005040 253 IPSTIGTLKNLETLSLAGNQFQG 275 (717)
Q Consensus 253 ~~~~~~~l~~L~~L~l~~N~l~~ 275 (717)
.+..|..+++|+.|++++|++..
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCT
T ss_pred CHHHHhCCCCCCEEEeeCCceeC
Confidence 66666666777777777776653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=219.56 Aligned_cols=241 Identities=16% Similarity=0.135 Sum_probs=166.8
Q ss_pred cEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCC-cchhcccc
Q 005040 15 IGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILP-PLIGNFSA 93 (717)
Q Consensus 15 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~ 93 (717)
++++.++++++ .+|..+ .+++++|+|++|+|+.++.++ |.++++|++|+|++|++.+.++ ..|.+++.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~--------f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~ 80 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGA--------FSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTS--------STTCTTCCEEEEECCTTCCEECTTSBCSCTT
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHH--------HcCCCCCCEEECcCCCCCCccChhHhhcchh
Confidence 56888999998 567666 368999999999999888655 8899999999999999865444 45566644
Q ss_pred ccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccC-CcccccCCccccCCC-CCCEEe
Q 005040 94 SLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPE-NNLQGYVPHDLCHLE-RLNILN 171 (717)
Q Consensus 94 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~l~-~L~~L~ 171 (717)
.++.+.+..|++....|..|.++++|++|++++|+++...+..+....++..|++.+ |++..+.+..|..+. .++.|+
T Consensus 81 l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~ 160 (350)
T 4ay9_X 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW 160 (350)
T ss_dssp CCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEE
T ss_pred hhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhc
Confidence 344566667888877778888888888888888888866666666777777777754 567766666666664 577788
Q ss_pred ccCCcCcccCCccccCCCCCCeEEecC-ccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCC-CC
Q 005040 172 LSGNKLSGAIPQCLASLTSLRSLYLQS-NKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRN-QL 249 (717)
Q Consensus 172 L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l 249 (717)
|++|+|+.+.+..| ..++|++|++++ |.++...+..|.++++|+.|+|++|+|+...+..|. +|+.|.+.++ .+
T Consensus 161 L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l 236 (350)
T 4ay9_X 161 LNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNL 236 (350)
T ss_dssp CCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTC
T ss_pred cccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCc
Confidence 88888875444444 345677777764 566655455677777777777777777754443444 3444444333 33
Q ss_pred CCCCcccccCCcccccccccCcc
Q 005040 250 SSDIPSTIGTLKNLETLSLAGNQ 272 (717)
Q Consensus 250 ~~~~~~~~~~l~~L~~L~l~~N~ 272 (717)
+ ..| .+..+++|+.++++++.
T Consensus 237 ~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 237 K-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp C-CCC-CTTTCCSCCEEECSCHH
T ss_pred C-cCC-CchhCcChhhCcCCCCc
Confidence 3 344 26667777777776543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-25 Score=254.46 Aligned_cols=327 Identities=14% Similarity=0.104 Sum_probs=186.8
Q ss_pred cCCCCCcEEECCCCcceecC----CcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccC
Q 005040 9 TNATKLIGLDLGLNSFSGHI----PNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGIL 84 (717)
Q Consensus 9 ~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 84 (717)
..+++|++|+|++|.+++.. +..+..+++|++|+|++|.++.+.... +...+.++++|++|+|++|.+.+ .
T Consensus 161 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~----l~~~~~~~~~L~~L~L~~~~~~~-l 235 (592)
T 3ogk_B 161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKD----LETIARNCRSLVSVKVGDFEILE-L 235 (592)
T ss_dssp HHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHH----HHHHHHHCTTCCEEECSSCBGGG-G
T ss_pred hhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHH----HHHHHhhCCCCcEEeccCccHHH-H
Confidence 35677777777777776542 223456677777777777776432211 22334567778888888877764 4
Q ss_pred CcchhccccccceeeecCCcce---ecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCC-cc
Q 005040 85 PPLIGNFSASLQNIYAFECKLG---GSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVP-HD 160 (717)
Q Consensus 85 ~~~~~~l~~~L~~L~l~~n~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~ 160 (717)
+..+..+ ++|++|++..+... ...+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..
T Consensus 236 ~~~~~~~-~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~ 313 (592)
T 3ogk_B 236 VGFFKAA-ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTL 313 (592)
T ss_dssp HHHHHHC-TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHH
T ss_pred HHHHhhh-hHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHH
Confidence 4556655 56777777653322 233345666667777777665433 456666777788888888877654332 23
Q ss_pred ccCCCCCCEEeccCCcCcc-cCCccccCCCCCCeEEec-----------CccccCC-CChhhhcccCCCeEEccCCcCcc
Q 005040 161 LCHLERLNILNLSGNKLSG-AIPQCLASLTSLRSLYLQ-----------SNKLSSS-LPSSLWSLEYILRINLSSNSLKG 227 (717)
Q Consensus 161 ~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~-----------~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~ 227 (717)
+..+++|++|+++ |.+.+ ..+..+..+++|++|+|+ .|.+++. ++..+..+++|++|+++.|.+++
T Consensus 314 ~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~ 392 (592)
T 3ogk_B 314 IQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITN 392 (592)
T ss_dssp HTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCH
T ss_pred HHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccH
Confidence 4667777777777 33332 223334556677777777 2455432 12223446677777776666665
Q ss_pred cCCccccC-CCCCCeEEcc----CCCCCCC-----CcccccCCcccccccccCcc--ccCCCCccccc-cCccceEeccC
Q 005040 228 TLPSNIQK-LNVLIDLDLS----RNQLSSD-----IPSTIGTLKNLETLSLAGNQ--FQGPIPESVGN-LISLESLDFSN 294 (717)
Q Consensus 228 ~~~~~~~~-l~~L~~L~l~----~N~l~~~-----~~~~~~~l~~L~~L~l~~N~--l~~~~~~~~~~-l~~L~~L~L~~ 294 (717)
..+..+.. +++|+.|+++ .|.+++. ++..+..+++|+.|+++.|. +++..+..+.. +++|+.|+|++
T Consensus 393 ~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~ 472 (592)
T 3ogk_B 393 ESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGY 472 (592)
T ss_dssp HHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECS
T ss_pred HHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccC
Confidence 54444543 6667777774 5556542 22224456666666665432 44433333332 56666666666
Q ss_pred CCCCCC-CcccccccccccEEEccCCcccccc-cc-cccccccccccccCCc
Q 005040 295 NNLSGK-IPKSLEALSHLKQFNVSHNRLEGEI-PV-KGSFKDFSAQSYFGNY 343 (717)
Q Consensus 295 N~~~~~-~~~~~~~l~~L~~L~l~~N~l~~~~-p~-~~~~~~~~~~~~~~n~ 343 (717)
|++++. ++..+..+++|+.|++++|++++.. +. ...++.+..+.+.+|.
T Consensus 473 n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 473 VGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp CCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred CCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 666542 2334455666666666666664432 11 1234444444444443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.4e-23 Score=216.11 Aligned_cols=241 Identities=17% Similarity=0.117 Sum_probs=142.8
Q ss_pred EEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccC-CccccccCCCCE-Eecc
Q 005040 72 NLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTI-PTSIGTLQQLQG-FYVP 149 (717)
Q Consensus 72 ~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~-L~l~ 149 (717)
+++.++|+++ .+|..+ ++++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+ +.+|.++++|++ +.++
T Consensus 13 ~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred EEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 3444555554 233322 234555555555555444556677777777777777764433 345667766654 4555
Q ss_pred CCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecC-ccccCCCChhhhccc-CCCeEEccCCcCcc
Q 005040 150 ENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQS-NKLSSSLPSSLWSLE-YILRINLSSNSLKG 227 (717)
Q Consensus 150 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~ 227 (717)
.|+|+.+.+..|..+++|++|++++|+|+...+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 6777766667777777777777777777755555555566666677654 456544455555554 56677777777774
Q ss_pred cCCccccCCCCCCeEEccC-CCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCccccc
Q 005040 228 TLPSNIQKLNVLIDLDLSR-NQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLE 306 (717)
Q Consensus 228 ~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~ 306 (717)
+.+..| ...+|+.|++++ |.++.+.+..|..+++|++|+|++|+|+...+..+.+ |+.|.+.++.-...+| .+.
T Consensus 169 i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~~lP-~l~ 243 (350)
T 4ay9_X 169 IHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLKKLP-TLE 243 (350)
T ss_dssp ECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCCCCC-CTT
T ss_pred CChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcCcCC-Cch
Confidence 433333 345677777764 5566544556677777777777777777544444443 3344333332222445 366
Q ss_pred ccccccEEEccCCcc
Q 005040 307 ALSHLKQFNVSHNRL 321 (717)
Q Consensus 307 ~l~~L~~L~l~~N~l 321 (717)
.+++|+.+++.++.-
T Consensus 244 ~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 244 KLVALMEASLTYPSH 258 (350)
T ss_dssp TCCSCCEEECSCHHH
T ss_pred hCcChhhCcCCCCcc
Confidence 777777777765443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.7e-25 Score=249.67 Aligned_cols=307 Identities=14% Similarity=0.023 Sum_probs=230.4
Q ss_pred ccccCCCCCcEEECCCCcce----ecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCc
Q 005040 6 NSITNATKLIGLDLGLNSFS----GHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 6 ~~~~~l~~L~~L~L~~n~i~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
..+..+++|++|+|++|.++ +..+..+.++++|++|+|++|.+..++ ..+..+++|++|+++.+...
T Consensus 186 ~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~---------~~~~~~~~L~~L~l~~~~~~ 256 (592)
T 3ogk_B 186 ELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV---------GFFKAAANLEEFCGGSLNED 256 (592)
T ss_dssp HHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH---------HHHHHCTTCCEEEECBCCCC
T ss_pred HHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH---------HHHhhhhHHHhhcccccccc
Confidence 34557899999999999997 344555678899999999999988754 33788999999999864333
Q ss_pred ---ccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCC-ccccccCCCCEEeccCCccccc-
Q 005040 82 ---GILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIP-TSIGTLQQLQGFYVPENNLQGY- 156 (717)
Q Consensus 82 ---~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~i~~~- 156 (717)
...+..+..+ ++|+.|.+.++... .+|..+..+++|++|+|++|.++.... ..+..+++|++|+++ +.+...
T Consensus 257 ~~~~~~~~~l~~~-~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~ 333 (592)
T 3ogk_B 257 IGMPEKYMNLVFP-RKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRG 333 (592)
T ss_dssp TTCTTSSSCCCCC-TTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHH
T ss_pred cchHHHHHHhhcc-ccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHH
Confidence 1233344444 57999999886443 667778889999999999999875443 346789999999999 555433
Q ss_pred CCccccCCCCCCEEecc-----------CCcCcccCC-ccccCCCCCCeEEecCccccCCCChhhhc-ccCCCeEEcc--
Q 005040 157 VPHDLCHLERLNILNLS-----------GNKLSGAIP-QCLASLTSLRSLYLQSNKLSSSLPSSLWS-LEYILRINLS-- 221 (717)
Q Consensus 157 ~~~~~~~l~~L~~L~L~-----------~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~l~-- 221 (717)
.+..+..+++|++|+|+ .|.+++... ..+..+++|++|+++.|.+++..+..+.. +++|++|+++
T Consensus 334 l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~ 413 (592)
T 3ogk_B 334 LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLL 413 (592)
T ss_dssp HHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEEC
T ss_pred HHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeec
Confidence 33344678899999999 367764322 23456899999999999998766666665 8999999996
Q ss_pred --CCcCccc-----CCccccCCCCCCeEEccCCC--CCCCCccccc-CCcccccccccCccccCCC-CccccccCccceE
Q 005040 222 --SNSLKGT-----LPSNIQKLNVLIDLDLSRNQ--LSSDIPSTIG-TLKNLETLSLAGNQFQGPI-PESVGNLISLESL 290 (717)
Q Consensus 222 --~N~l~~~-----~~~~~~~l~~L~~L~l~~N~--l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L 290 (717)
.|.+++. ++..+.++++|+.|++++|. +++..+..+. .+++|++|++++|++++.. +..+..+++|+.|
T Consensus 414 ~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L 493 (592)
T 3ogk_B 414 DREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKL 493 (592)
T ss_dssp SCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEE
T ss_pred CCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCee
Confidence 6778753 23346779999999998543 6654444444 4889999999999987633 4455788999999
Q ss_pred eccCCCCCCC-CcccccccccccEEEccCCccccc
Q 005040 291 DFSNNNLSGK-IPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 291 ~L~~N~~~~~-~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
+|++|++++. ++..+..+++|+.|+|++|+++..
T Consensus 494 ~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 494 EMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp EEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred eccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 9999998754 344456789999999999998764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=9.6e-22 Score=190.38 Aligned_cols=163 Identities=26% Similarity=0.259 Sum_probs=106.9
Q ss_pred CCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEe
Q 005040 117 RGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYL 196 (717)
Q Consensus 117 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 196 (717)
++|++|+|++|+++...+..|.++++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 45666666666666555555666666666666666666555555666666777777777666555555666667777777
Q ss_pred cCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCC
Q 005040 197 QSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP 276 (717)
Q Consensus 197 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 276 (717)
++|++++..+..|..+++|++|+|++|.+++..+..|..+++|+.|++++|.+.+ .+++|++|+++.|++++.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTT
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCce
Confidence 7777765555556666777777777777765555556667777777777776553 345677777777777777
Q ss_pred CCccccccCc
Q 005040 277 IPESVGNLIS 286 (717)
Q Consensus 277 ~~~~~~~l~~ 286 (717)
+|..++.++.
T Consensus 181 ip~~~~~l~~ 190 (208)
T 2o6s_A 181 VRNSAGSVAP 190 (208)
T ss_dssp BBCTTSSBCT
T ss_pred eeccCccccC
Confidence 7766665543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-21 Score=190.14 Aligned_cols=179 Identities=26% Similarity=0.243 Sum_probs=108.3
Q ss_pred cEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCc
Q 005040 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSN 199 (717)
Q Consensus 120 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 199 (717)
+.++++++.++. +|..+ .++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 456666666663 33322 346777777777777666656666777777777777776555555666666666666666
Q ss_pred cccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCc
Q 005040 200 KLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPE 279 (717)
Q Consensus 200 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 279 (717)
++++..+..|..+++|++|++++|.|++..+..|..+++|+.|++++|.+++..+..+..+++|++|++++|++.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 6665555555666666666666666665555555666666666666666665444445556666666666665442
Q ss_pred cccccCccceEeccCCCCCCCCccccccc
Q 005040 280 SVGNLISLESLDFSNNNLSGKIPKSLEAL 308 (717)
Q Consensus 280 ~~~~l~~L~~L~L~~N~~~~~~~~~~~~l 308 (717)
.+++|+.|+++.|++++.+|..+..+
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCccc
Confidence 23455555555555555555554444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-22 Score=206.02 Aligned_cols=148 Identities=17% Similarity=0.122 Sum_probs=117.9
Q ss_pred HHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhH------------------HHHHHHHHHHHHHHhcCCCce
Q 005040 424 RATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLE------------------RAFRSFDSECEILRNVRHRNL 485 (717)
Q Consensus 424 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~hpni 485 (717)
.....|.+.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|++++++++|
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---
Confidence 33456667799999999999999997799999999864321 234668899999999994
Q ss_pred eeEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 005040 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM 565 (717)
Q Consensus 486 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~ 565 (717)
+++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.||| +.+|+||||||+||+++ ++
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH----~~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEE-TT
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH----HCCCEeCCCCHHHEEEE-CC
Confidence 555555443 55699999999999988 432 124469999999999999 67899999999999999 99
Q ss_pred cEEEeeeccccccCCCCCceeeeccccCccccCCCccC
Q 005040 566 VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS 603 (717)
Q Consensus 566 ~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 603 (717)
.+||+|||+++. +..|+|||++.
T Consensus 230 ~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 230 GIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred cEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999999999863 33478888754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-21 Score=190.00 Aligned_cols=159 Identities=20% Similarity=0.248 Sum_probs=126.2
Q ss_pred CEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCC-hhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccC
Q 005040 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLP-SSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSR 246 (717)
Q Consensus 168 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 246 (717)
+.+++++|.++. +|..+. ..+++|+|++|+|++..+ ..|..+++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 467777777763 444332 346777777777775533 4577788888888888888877777888888888888888
Q ss_pred CCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccc
Q 005040 247 NQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 247 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 326 (717)
|.+++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++.+.++
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 88888777778888888888888888888778888888899999999999988888888889999999999999988877
Q ss_pred ccc
Q 005040 327 VKG 329 (717)
Q Consensus 327 ~~~ 329 (717)
..+
T Consensus 171 l~~ 173 (220)
T 2v70_A 171 LAW 173 (220)
T ss_dssp GHH
T ss_pred hHH
Confidence 543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-21 Score=189.22 Aligned_cols=158 Identities=23% Similarity=0.325 Sum_probs=119.6
Q ss_pred CEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCC
Q 005040 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRN 247 (717)
Q Consensus 168 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 247 (717)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|.|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46677777776 3444332 56777777777777666667777777777777777777777777778888888888888
Q ss_pred CCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc
Q 005040 248 QLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 327 (717)
.|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 88766666677788888888888888877777888888888888888888877777788888888888888888876654
Q ss_pred c
Q 005040 328 K 328 (717)
Q Consensus 328 ~ 328 (717)
.
T Consensus 171 ~ 171 (220)
T 2v9t_B 171 K 171 (220)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.1e-21 Score=211.35 Aligned_cols=167 Identities=26% Similarity=0.345 Sum_probs=79.5
Q ss_pred CCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEe
Q 005040 117 RGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYL 196 (717)
Q Consensus 117 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 196 (717)
++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|++|.|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 34555555555554 233 234455555555555554 222 332 55555555555553 332 3455555555
Q ss_pred cCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCccc-------cccccc
Q 005040 197 QSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNL-------ETLSLA 269 (717)
Q Consensus 197 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-------~~L~l~ 269 (717)
++|+|++ +|. .+++|+.|+|++|.|++ +|. |. ++|+.|+|++|.|+. +|. +.. +| +.|+|+
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~-lp~-~~~--~L~~~~~~L~~L~Ls 215 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLES-LPA-VPV--RNHHSEETEIFFRCR 215 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSS-CCC-CC----------CCEEEECC
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCc-hhh-HHH--hhhcccccceEEecC
Confidence 5555553 232 34455555555555553 333 33 455555555555552 333 332 34 555555
Q ss_pred CccccCCCCccccccCccceEeccCCCCCCCCccccccc
Q 005040 270 GNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEAL 308 (717)
Q Consensus 270 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l 308 (717)
+|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 216 ~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp SSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred CCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 55555 344444445555555555555555555544443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.7e-23 Score=234.25 Aligned_cols=305 Identities=16% Similarity=0.178 Sum_probs=155.0
Q ss_pred cCCCCCcEEECCCCcceecCCcCCC-CCCCCCEEEcccc-cccCccCCcccccccccccCccCCcEEeccCCCCcccCCc
Q 005040 9 TNATKLIGLDLGLNSFSGHIPNTFG-NLRHLSVLSLMMN-NLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPP 86 (717)
Q Consensus 9 ~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n-~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 86 (717)
..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++... +...+.++++|++|+|++|.+++..+.
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~-------l~~~~~~~~~L~~L~L~~~~i~~~~~~ 174 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDG-------LAAIAATCRNLKELDLRESDVDDVSGH 174 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHH-------HHHHHHHCTTCCEEECTTCEEECCCGG
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHH-------HHHHHHhCCCCCEEeCcCCccCCcchH
Confidence 3567788888888877766666564 5777788877777 444311 111133667777777777776655444
Q ss_pred chhccc---cccceeeecCCc--cee-cCCccccCCCCCcEEEccCC-CCcccCCccccc--------------------
Q 005040 87 LIGNFS---ASLQNIYAFECK--LGG-SIPKEIGNLRGLIVLSLGFN-DLNGTIPTSIGT-------------------- 139 (717)
Q Consensus 87 ~~~~l~---~~L~~L~l~~n~--l~~-~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~-------------------- 139 (717)
.+..+. ++|++|++++|. +.. .++..+.++++|++|+|++| .+++ ++..+..
T Consensus 175 ~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~ 253 (594)
T 2p1m_B 175 WLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDV 253 (594)
T ss_dssp GGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHH
T ss_pred HHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhh
Confidence 444332 357777777665 211 11111234566777776666 2221 2333333
Q ss_pred ----------------------------------cCCCCEEeccCCcccccCCc-cccCCCCCCEEeccCCcCcccC-Cc
Q 005040 140 ----------------------------------LQQLQGFYVPENNLQGYVPH-DLCHLERLNILNLSGNKLSGAI-PQ 183 (717)
Q Consensus 140 ----------------------------------l~~L~~L~l~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~-~~ 183 (717)
+++|++|+|++|.+++.... .+..+++|++|++++| +.+.. +.
T Consensus 254 ~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~ 332 (594)
T 2p1m_B 254 YSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEV 332 (594)
T ss_dssp HHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHH
T ss_pred HHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHH
Confidence 44455555555544322111 1234445555555544 22111 11
Q ss_pred cccCCCCCCeEEec---------CccccCCCChhhh-cccCCCeEEccCCcCcccCCcccc-CCCCCCeEEcc--C----
Q 005040 184 CLASLTSLRSLYLQ---------SNKLSSSLPSSLW-SLEYILRINLSSNSLKGTLPSNIQ-KLNVLIDLDLS--R---- 246 (717)
Q Consensus 184 ~~~~l~~L~~L~L~---------~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~l~--~---- 246 (717)
....+++|++|+|+ .|.+++.....+. .+++|++|.+..|.+++.....+. .+++|+.|+++ +
T Consensus 333 l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~ 412 (594)
T 2p1m_B 333 LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAP 412 (594)
T ss_dssp HHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCC
T ss_pred HHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCc
Confidence 11234555555552 2233321111121 245555555555555543333332 35666666666 3
Q ss_pred CCCCCCC-----cccccCCcccccccccCccccCCCCccccc-cCccceEeccCCCCCCCCcccc-cccccccEEEccCC
Q 005040 247 NQLSSDI-----PSTIGTLKNLETLSLAGNQFQGPIPESVGN-LISLESLDFSNNNLSGKIPKSL-EALSHLKQFNVSHN 319 (717)
Q Consensus 247 N~l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~L~~N~~~~~~~~~~-~~l~~L~~L~l~~N 319 (717)
|.+++.. +..+..+++|+.|++++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|
T Consensus 413 ~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n 491 (594)
T 2p1m_B 413 DYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDC 491 (594)
T ss_dssp CTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESC
T ss_pred ccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCC
Confidence 4444211 11144556666666655 444444444443 6667777777777655444444 55677777777777
Q ss_pred cccc
Q 005040 320 RLEG 323 (717)
Q Consensus 320 ~l~~ 323 (717)
++++
T Consensus 492 ~~~~ 495 (594)
T 2p1m_B 492 PFGD 495 (594)
T ss_dssp SCCH
T ss_pred CCcH
Confidence 7643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.4e-20 Score=207.86 Aligned_cols=182 Identities=26% Similarity=0.375 Sum_probs=156.5
Q ss_pred CCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEec
Q 005040 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQ 197 (717)
Q Consensus 118 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 197 (717)
+|+.|+|++|.+++ +|..+ .++|++|+|++|+|+. +| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 89999999999996 56555 3889999999999994 45 457899999999999997 666 655 99999999
Q ss_pred CccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCC
Q 005040 198 SNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI 277 (717)
Q Consensus 198 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 277 (717)
+|+|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|.|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 999996 555 68999999999999996 555 67899999999999997 666 66 89999999999999 56
Q ss_pred CccccccCcc-------ceEeccCCCCCCCCcccccccccccEEEccCCcccccccc
Q 005040 278 PESVGNLISL-------ESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 278 ~~~~~~l~~L-------~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 327 (717)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 66 655 77 99999999999 5788888899999999999999998775
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-23 Score=234.29 Aligned_cols=208 Identities=16% Similarity=0.118 Sum_probs=155.9
Q ss_pred cCCCCCcEEEccCCCCcccCCc-cccccCCCCEEeccCCcccccCCcc-ccCCCCCCEEecc---------CCcCcccCC
Q 005040 114 GNLRGLIVLSLGFNDLNGTIPT-SIGTLQQLQGFYVPENNLQGYVPHD-LCHLERLNILNLS---------GNKLSGAIP 182 (717)
Q Consensus 114 ~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~n~i~~~~~~~-~~~l~~L~~L~L~---------~n~l~~~~~ 182 (717)
..+++|++|+|++|.++..... .+..+++|++|++++| ++...... ...+++|++|+++ .+.+++...
T Consensus 286 ~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l 364 (594)
T 2p1m_B 286 SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGL 364 (594)
T ss_dssp HHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHH
T ss_pred HhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHH
Confidence 3568999999999997744322 3568999999999998 54332222 3358999999993 456664433
Q ss_pred cccc-CCCCCCeEEecCccccCCCChhhh-cccCCCeEEcc--C----CcCcccC-----CccccCCCCCCeEEccCCCC
Q 005040 183 QCLA-SLTSLRSLYLQSNKLSSSLPSSLW-SLEYILRINLS--S----NSLKGTL-----PSNIQKLNVLIDLDLSRNQL 249 (717)
Q Consensus 183 ~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~--~----N~l~~~~-----~~~~~~l~~L~~L~l~~N~l 249 (717)
..+. .+++|+.|.++.|.+++.....+. .+++|+.|+++ + |.++... +..+..+++|+.|+|++ .+
T Consensus 365 ~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l 443 (594)
T 2p1m_B 365 VSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LL 443 (594)
T ss_dssp HHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SC
T ss_pred HHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cc
Confidence 3333 489999999999999865555554 58999999999 4 5666321 12367889999999987 77
Q ss_pred CCCCcccccC-CcccccccccCccccCCCCccc-cccCccceEeccCCCCCCCCcc-cccccccccEEEccCCcccc
Q 005040 250 SSDIPSTIGT-LKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNNLSGKIPK-SLEALSHLKQFNVSHNRLEG 323 (717)
Q Consensus 250 ~~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~L~~N~~~~~~~~-~~~~l~~L~~L~l~~N~l~~ 323 (717)
++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++.... .+..+++|+.|++++|+++.
T Consensus 444 ~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp CHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred cHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 7655555555 8999999999999987666555 6789999999999999654443 44568999999999999843
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.1e-21 Score=196.89 Aligned_cols=170 Identities=25% Similarity=0.369 Sum_probs=85.6
Q ss_pred CCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeE
Q 005040 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSL 194 (717)
Q Consensus 115 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 194 (717)
.+++|++|++++|.++.. + .+..+++|++|+|++|++++..+ +..+++|++|+|++|.+++. + .+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC-h-hhccCCCCCEE
Confidence 444555555555555532 2 24555555555555555554332 55555555555555555532 2 25555555555
Q ss_pred EecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCcccc
Q 005040 195 YLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274 (717)
Q Consensus 195 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 274 (717)
+|++|++++. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|+++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 5555555532 2344555555555555555532 345555555555555555554322 445555555555555554
Q ss_pred CCCCccccccCccceEeccCCCCC
Q 005040 275 GPIPESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 275 ~~~~~~~~~l~~L~~L~L~~N~~~ 298 (717)
+. + .+..+++|+.|+|++|++.
T Consensus 192 ~l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 192 DL-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp BC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred CC-h-hhccCCCCCEEECcCCccc
Confidence 32 2 2445555555555555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.5e-21 Score=200.16 Aligned_cols=183 Identities=25% Similarity=0.195 Sum_probs=105.5
Q ss_pred cEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcccc-CCCCCCEEeccCCcCcccCCccccCCCCCCeEEecC
Q 005040 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC-HLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQS 198 (717)
Q Consensus 120 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 198 (717)
+.+++++|.++. +|..+. +.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 467777777763 444332 3466667776666666665565 666666666666666655555566666666666666
Q ss_pred ccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCC
Q 005040 199 NKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP 278 (717)
Q Consensus 199 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 278 (717)
|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|.|++..+..|..
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~------------------- 158 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD------------------- 158 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC--------------------
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcC-------------------
Confidence 6666555555555566666666666655555555555555555555555555433322210
Q ss_pred ccccccCccceEeccCCCCCCCCccccccccc--ccEEEccCCccccccc
Q 005040 279 ESVGNLISLESLDFSNNNLSGKIPKSLEALSH--LKQFNVSHNRLEGEIP 326 (717)
Q Consensus 279 ~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~--L~~L~l~~N~l~~~~p 326 (717)
+..+++|+.|+|++|+|++..+..+..++. |+.|+|++|++.+.+.
T Consensus 159 --~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 159 --GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp -----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred --cccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 034555666666666666544455555555 3666677776666543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=210.97 Aligned_cols=191 Identities=26% Similarity=0.359 Sum_probs=106.6
Q ss_pred CCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEec
Q 005040 69 NLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYV 148 (717)
Q Consensus 69 ~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 148 (717)
.+..+.++.+.+....+ +..+ .+|+.|++++|.+... + .+..+++|+.|+|++|.|++..+ +..+++|+.|+|
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L-~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHH-TTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHhccCCCcccccc--hhcC-CCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 34444444444443322 2222 3455555555554422 2 35566666666666666664433 666666666666
Q ss_pred cCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCccc
Q 005040 149 PENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGT 228 (717)
Q Consensus 149 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 228 (717)
++|.|.+. ..+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.|++.
T Consensus 95 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 95 DENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred cCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 66666642 2456666666666666666642 2356666666666666666643 4455666666666666666644
Q ss_pred CCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCC
Q 005040 229 LPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP 276 (717)
Q Consensus 229 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 276 (717)
.| +..+++|+.|+|++|.|++. ..+..+++|+.|+|++|++.+.
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 33 56666666666666666642 2355566666666666666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-20 Score=191.84 Aligned_cols=169 Identities=28% Similarity=0.412 Sum_probs=113.1
Q ss_pred ccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEecc
Q 005040 94 SLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLS 173 (717)
Q Consensus 94 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 173 (717)
+|+.|++++|.+... + .+..+++|++|+|++|++++..+ +.++++|++|++++|.+++. ..+..+++|++|+|+
T Consensus 47 ~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLE 120 (291)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEECT
T ss_pred cccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEEECC
Confidence 345555555544422 2 35666677777777777765433 66777777777777777653 236777777777777
Q ss_pred CCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCC
Q 005040 174 GNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDI 253 (717)
Q Consensus 174 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 253 (717)
+|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++ +
T Consensus 121 ~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l 193 (291)
T 1h6t_A 121 HNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L 193 (291)
T ss_dssp TSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C
T ss_pred CCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-C
Confidence 7777743 3466777777777777777754 457777777777777777775443 7777778888888887775 3
Q ss_pred cccccCCcccccccccCccccCC
Q 005040 254 PSTIGTLKNLETLSLAGNQFQGP 276 (717)
Q Consensus 254 ~~~~~~l~~L~~L~l~~N~l~~~ 276 (717)
+ .+..+++|+.|++++|++...
T Consensus 194 ~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 194 R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp G-GGTTCTTCSEEEEEEEEEECC
T ss_pred h-hhccCCCCCEEECcCCcccCC
Confidence 3 377778888888888877753
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=9.1e-21 Score=211.80 Aligned_cols=190 Identities=25% Similarity=0.340 Sum_probs=99.9
Q ss_pred CCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccc
Q 005040 13 KLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFS 92 (717)
Q Consensus 13 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 92 (717)
.+..++|+.+.+.+..+ +..|.+|+.|+|++|.|+.++. +..+++|+.|+|++|++++..+ +
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~~----------l~~l~~L~~L~Ls~N~l~~~~~--l---- 83 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG----------IQYLPNVTKLFLNGNKLTDIKP--L---- 83 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCTT----------GGGCTTCCEEECTTSCCCCCGG--G----
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCChH----------HccCCCCCEEEeeCCCCCCChh--h----
Confidence 34445566666664433 5566777777777777766432 5667777777777777664432 3
Q ss_pred cccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEec
Q 005040 93 ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNL 172 (717)
Q Consensus 93 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 172 (717)
..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.|.+. ..+..+++|+.|+|
T Consensus 84 ---------------------~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 84 ---------------------TNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYL 138 (605)
T ss_dssp ---------------------GGCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEEC
T ss_pred ---------------------ccCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEEC
Confidence 4444444444444444421 1344444555555555544432 23444555555555
Q ss_pred cCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCC
Q 005040 173 SGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS 251 (717)
Q Consensus 173 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 251 (717)
++|.|++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.+.+
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 55555432 334555555555555555554333 45555555555555555532 235555555555555555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=2e-20 Score=197.30 Aligned_cols=176 Identities=22% Similarity=0.207 Sum_probs=91.3
Q ss_pred cEEeccCCCCcccCCcchhccccccceeeecCCcceecCCcccc-CCCCCcEEEccCCCCcccCCccccccCCCCEEecc
Q 005040 71 ANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIG-NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVP 149 (717)
Q Consensus 71 ~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 149 (717)
+.+++++|.++. +|..+. ..++.|+|++|++++..+..|. ++++|++|+|++|+|+.+.+..|.++++|++|+|+
T Consensus 21 ~~l~c~~~~l~~-iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcCc-cCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 567777777763 343322 3355555555555555555454 55555555555555554444455555555555555
Q ss_pred CCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccC
Q 005040 150 ENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTL 229 (717)
Q Consensus 150 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 229 (717)
+|+|+.+.+..|.++++|++|+|++|+|+...+..|.++++|+.|+|++|+| ++..
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l------------------------~~l~ 152 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI------------------------SRFP 152 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC------------------------CSCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcC------------------------CeeC
Confidence 5555544444455555555555555555544444444455555555555544 4332
Q ss_pred Cccc---cCCCCCCeEEccCCCCCCCCcccccCCcc--cccccccCcccc
Q 005040 230 PSNI---QKLNVLIDLDLSRNQLSSDIPSTIGTLKN--LETLSLAGNQFQ 274 (717)
Q Consensus 230 ~~~~---~~l~~L~~L~l~~N~l~~~~~~~~~~l~~--L~~L~l~~N~l~ 274 (717)
+..| ..+++|+.|+|++|.|++..+..+..++. |+.|+|++|++.
T Consensus 153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 2223 34555666666666666544445555554 255566665554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.82 E-value=4e-21 Score=200.09 Aligned_cols=296 Identities=11% Similarity=0.061 Sum_probs=179.1
Q ss_pred CCCCccccC--CCCCcEEECCCCcceecCCcCCCC-CCCCCEEEccccccc--CccCCcccccccccccCccCCcEEecc
Q 005040 2 GTIPNSITN--ATKLIGLDLGLNSFSGHIPNTFGN-LRHLSVLSLMMNNLT--TESSSADQWSFLSSLTNCRNLANLALA 76 (717)
Q Consensus 2 ~~iP~~~~~--l~~L~~L~L~~n~i~~~~~~~~~~-l~~L~~L~L~~n~l~--~~~~~~~~~~~~~~l~~l~~L~~L~L~ 76 (717)
|+++..+.. +.+|+.|.++++ +....-..+.. +++|++|||++|+|. ....+ .++.+..+.+.
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~-----------~~~~~~~~~~~ 80 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG-----------TYPNGKFYIYM 80 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS-----------SSGGGCCEEEC
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc-----------ccccccccccc
Confidence 444444443 556777777654 22122222333 666777777777776 22211 11223444444
Q ss_pred CCCCcccCCcchhc--------cccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEec
Q 005040 77 SNPLGGILPPLIGN--------FSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYV 148 (717)
Q Consensus 77 ~N~l~~~~~~~~~~--------l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 148 (717)
.|. +....|.. + .+|+.|+|.+ ++..+.+.+|.++++|+.|++++|.+..+.+.+|.++.++..+.+
T Consensus 81 ~~~---I~~~aF~~~~~~~~~g~-~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~ 155 (329)
T 3sb4_A 81 ANF---VPAYAFSNVVNGVTKGK-QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPL 155 (329)
T ss_dssp TTE---ECTTTTEEEETTEEEEC-TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECT
T ss_pred ccc---cCHHHhccccccccccc-CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecC
Confidence 442 22333333 3 4566666666 555555556666666666666666665555556666555555554
Q ss_pred cCCcc----cccCCccccCCCCCC-EEeccCCcC-cccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccC
Q 005040 149 PENNL----QGYVPHDLCHLERLN-ILNLSGNKL-SGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSS 222 (717)
Q Consensus 149 ~~n~i----~~~~~~~~~~l~~L~-~L~L~~n~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 222 (717)
..+.. ......+|.++.+|+ .+.+....- .......-....++..+.+.++-...........+++|+.|+|++
T Consensus 156 ~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~ 235 (329)
T 3sb4_A 156 GSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISK 235 (329)
T ss_dssp TCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTT
T ss_pred cchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCC
Confidence 44221 222333444555554 343332211 000000011234556666655432211111112478999999999
Q ss_pred CcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccc-cccccCccccCCCCccccccCccceEeccCCCCCCCC
Q 005040 223 NSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLE-TLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKI 301 (717)
Q Consensus 223 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~ 301 (717)
|+++.+....|.++.+|+.|+|.+| ++.+.+.+|.++++|+ .|++.+ .++.+.+.+|.++++|+.|+|++|.+..+.
T Consensus 236 n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~ 313 (329)
T 3sb4_A 236 TNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLG 313 (329)
T ss_dssp BCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEEC
T ss_pred CCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccc
Confidence 9999888888999999999999988 7777788899999999 999988 777677889999999999999999998888
Q ss_pred cccccccccccEEEc
Q 005040 302 PKSLEALSHLKQFNV 316 (717)
Q Consensus 302 ~~~~~~l~~L~~L~l 316 (717)
+..|.++++|+.++.
T Consensus 314 ~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 314 DELFGNGVPSKLIYK 328 (329)
T ss_dssp TTTTCTTCCCCEEEC
T ss_pred hhhhcCCcchhhhcc
Confidence 889999999998864
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=9.2e-20 Score=178.98 Aligned_cols=156 Identities=23% Similarity=0.302 Sum_probs=119.4
Q ss_pred CCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccC
Q 005040 167 LNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSR 246 (717)
Q Consensus 167 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 246 (717)
-+.+++++++++ .+|..+. ++|+.|+|++|++++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 456777777776 3444332 6777777777777777677777777788888888887766666677788888888888
Q ss_pred CCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccc
Q 005040 247 NQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 247 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 326 (717)
|.|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++.+.++
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 8888766667778888888888888887 667777888888888888888887766778888888888888888887765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=7.6e-20 Score=178.27 Aligned_cols=150 Identities=25% Similarity=0.335 Sum_probs=73.4
Q ss_pred EEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCcc
Q 005040 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNK 200 (717)
Q Consensus 121 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 200 (717)
.+++++|.++ .+|..+. ++|+.|+|++|+|+.+.+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4555555555 2333222 345555555555555444455555555555555555554445555555555555555555
Q ss_pred ccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccc
Q 005040 201 LSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQF 273 (717)
Q Consensus 201 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 273 (717)
|+...+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.|++..+..|..+++|++|+|++|++
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 5543333444445555555555554444444444444444444444444444333444444444444444444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-19 Score=177.03 Aligned_cols=151 Identities=24% Similarity=0.292 Sum_probs=70.7
Q ss_pred EEEccCCCCcccCCccccccCCCCEEeccCCcccccCC-ccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCc
Q 005040 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVP-HDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSN 199 (717)
Q Consensus 121 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 199 (717)
.+++++|.++. +|..+. ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 45555555552 333221 233455555555554422 23445555555555555555444444555555555555555
Q ss_pred cccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCcccc
Q 005040 200 KLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274 (717)
Q Consensus 200 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 274 (717)
++++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.|++..|..|..+++|++|+|++|++.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 554444444444444444444444444444444444444444444444444444444444444444444444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.6e-19 Score=173.35 Aligned_cols=133 Identities=27% Similarity=0.328 Sum_probs=60.9
Q ss_pred CCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEcc
Q 005040 166 RLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLS 245 (717)
Q Consensus 166 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 245 (717)
+|++|+|++|.|++..+..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|+
T Consensus 41 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls 120 (229)
T 3e6j_A 41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC 120 (229)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEecc
Confidence 33444444444443333334444444444444444433333333444444444444444443333344444445555555
Q ss_pred CCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCC
Q 005040 246 RNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG 299 (717)
Q Consensus 246 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~ 299 (717)
+|.|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 121 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 121 CNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 55554 244444555555555555555554444445555555555555555553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=182.42 Aligned_cols=150 Identities=22% Similarity=0.360 Sum_probs=79.2
Q ss_pred ccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCC
Q 005040 113 IGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 192 (717)
+..+++|++|++++|.++. ++ .+..+++|++|+|++|+|++..+ +..+++|++|+|++|++++. +. +.. ++|+
T Consensus 37 ~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l-~~-~~~-~~L~ 109 (263)
T 1xeu_A 37 QKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNL-NG-IPS-ACLS 109 (263)
T ss_dssp HHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCC-TT-CCC-SSCC
T ss_pred hhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCc-Cc-ccc-Cccc
Confidence 4444555555555555552 22 45555555555555555554433 55555555555555555532 22 122 5555
Q ss_pred eEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCcc
Q 005040 193 SLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQ 272 (717)
Q Consensus 193 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 272 (717)
.|+|++|++++. ..+..+++|+.|++++|+|++. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|+
T Consensus 110 ~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~ 183 (263)
T 1xeu_A 110 RLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK 183 (263)
T ss_dssp EEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred EEEccCCccCCC--hhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence 555555555532 2355555555555555555533 2455555566666666655543 345555556666666665
Q ss_pred ccC
Q 005040 273 FQG 275 (717)
Q Consensus 273 l~~ 275 (717)
+..
T Consensus 184 ~~~ 186 (263)
T 1xeu_A 184 CVN 186 (263)
T ss_dssp EEC
T ss_pred ccC
Confidence 553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=6.6e-22 Score=219.76 Aligned_cols=203 Identities=21% Similarity=0.190 Sum_probs=106.8
Q ss_pred CCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCC-------------CcccCCcchhccccccceee
Q 005040 33 GNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNP-------------LGGILPPLIGNFSASLQNIY 99 (717)
Q Consensus 33 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~~L~~L~ 99 (717)
...++|+.|+|++|+|+.+| ..++++++|++|++++|. +.+..|..+..+ ++|+.|+
T Consensus 346 ~~~~~L~~L~Ls~n~L~~Lp---------~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l-~~L~~L~ 415 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTVLQ---------SELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF-STLKAVD 415 (567)
T ss_dssp STTTTSSSCCCCHHHHHHHH---------HHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHH-HHHHHHC
T ss_pred ccCccceeccCChhhHHhhH---------HHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHH-HhcccCc
Confidence 44566666666666666543 235566666666665553 333444444444 3455554
Q ss_pred -ecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCc
Q 005040 100 -AFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS 178 (717)
Q Consensus 100 -l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~ 178 (717)
++.|.+. +|..+.+++|.++...+ ..|+.|+|++|.|+++ |. |..+++|+.|+|++|+|+
T Consensus 416 ~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~ 476 (567)
T 1dce_A 416 PMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR 476 (567)
T ss_dssp GGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC
T ss_pred chhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCccccc
Confidence 3333221 22233333344332111 1355566666666542 33 555666666666666665
Q ss_pred ccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccC-CccccCCCCCCeEEccCCCCCCCCccc-
Q 005040 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTL-PSNIQKLNVLIDLDLSRNQLSSDIPST- 256 (717)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~~- 256 (717)
.+|..|+.+++|+.|+|++|+|++ +| .+..+++|+.|+|++|.|++.. |..+..+++|+.|+|++|.+++.+|..
T Consensus 477 -~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 553 (567)
T 1dce_A 477 -ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 553 (567)
T ss_dssp -CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT
T ss_pred -ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH
Confidence 445556666666666666666654 34 5556666666666666666544 566666666666666666666533321
Q ss_pred --ccCCccccccc
Q 005040 257 --IGTLKNLETLS 267 (717)
Q Consensus 257 --~~~l~~L~~L~ 267 (717)
+..+++|+.|+
T Consensus 554 ~l~~~lp~L~~L~ 566 (567)
T 1dce_A 554 RLAEMLPSVSSIL 566 (567)
T ss_dssp HHHHHCTTCSEEE
T ss_pred HHHHHCcccCccC
Confidence 22355666554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=182.24 Aligned_cols=170 Identities=21% Similarity=0.276 Sum_probs=114.9
Q ss_pred ccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEE
Q 005040 67 CRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGF 146 (717)
Q Consensus 67 l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 146 (717)
+.++..+++++|.+++.. .+..+ ++|++|++++|++.. ++ .+..+++|++|+|++|++++..+ +.++++|++|
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l-~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKEL-SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHH-TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHhcCCCccccc--chhhc-CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 344444455555544322 23333 345555555555542 23 56667777888888887775443 7777888888
Q ss_pred eccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCc
Q 005040 147 YVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK 226 (717)
Q Consensus 147 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 226 (717)
+|++|++++..+ +.. ++|++|+|++|+|++. ..+..+++|+.|+|++|++++. + .+..+++|+.|++++|+|+
T Consensus 91 ~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 888888775433 223 7788888888888753 3477888888888888888754 3 5778888888888888888
Q ss_pred ccCCccccCCCCCCeEEccCCCCCCC
Q 005040 227 GTLPSNIQKLNVLIDLDLSRNQLSSD 252 (717)
Q Consensus 227 ~~~~~~~~~l~~L~~L~l~~N~l~~~ 252 (717)
+. ..+..+++|+.|++++|.++..
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 55 6678888888888888888764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=9e-22 Score=218.66 Aligned_cols=218 Identities=20% Similarity=0.151 Sum_probs=137.9
Q ss_pred ccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCC
Q 005040 64 LTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQL 143 (717)
Q Consensus 64 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 143 (717)
+..+++|+.|+|++|+++ .+|..+..+ ++|+.|++++|.....+|.. +..+.+.+..|..++++++|
T Consensus 345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l-~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L 411 (567)
T 1dce_A 345 SATDEQLFRCELSVEKST-VLQSELESC-KELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTL 411 (567)
T ss_dssp CSTTTTSSSCCCCHHHHH-HHHHHHHHH-HHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHH
T ss_pred cccCccceeccCChhhHH-hhHHHHHHH-HHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhc
Confidence 355667777777777776 556666666 45666666554321111100 11112344566677777777
Q ss_pred CEEe-ccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccC
Q 005040 144 QGFY-VPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSS 222 (717)
Q Consensus 144 ~~L~-l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 222 (717)
+.|+ ++.|.+. +|+.+.+++|.|+...+ ..|+.|+|++|+|++ +|. +..+++|+.|+|++
T Consensus 412 ~~L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~ 472 (567)
T 1dce_A 412 KAVDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSH 472 (567)
T ss_dssp HHHCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCS
T ss_pred ccCcchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCc
Confidence 7777 5655443 34455566666653222 246777777777774 454 77777777777777
Q ss_pred CcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCC-CccccccCccceEeccCCCCCCCC
Q 005040 223 NSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI-PESVGNLISLESLDFSNNNLSGKI 301 (717)
Q Consensus 223 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~~~~~~ 301 (717)
|.|+ .+|..|+.+++|+.|+|++|.|++ +| .++.+++|++|+|++|+|++.. |..++.+++|+.|+|++|++++.+
T Consensus 473 N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 473 NRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp SCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred cccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 7777 566777777777777777777775 45 6777777777777777777665 777777777777777777777554
Q ss_pred cc---cccccccccEEEc
Q 005040 302 PK---SLEALSHLKQFNV 316 (717)
Q Consensus 302 ~~---~~~~l~~L~~L~l 316 (717)
|. .+..+++|+.|++
T Consensus 550 ~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 550 GIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SCTTHHHHHCTTCSEEEC
T ss_pred cHHHHHHHHCcccCccCC
Confidence 42 2334677777754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.3e-19 Score=169.93 Aligned_cols=153 Identities=17% Similarity=0.257 Sum_probs=83.3
Q ss_pred cCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCe
Q 005040 114 GNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRS 193 (717)
Q Consensus 114 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 193 (717)
..+++|++|++++|.++ .++ .+..+++|++|++++|.++.. ..+..+++|++|++++|++++..+..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44556666666666666 233 456666666666666655422 34555666666666666665545555556666666
Q ss_pred EEecCccccCCCChhhhcccCCCeEEccCCc-CcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCcc
Q 005040 194 LYLQSNKLSSSLPSSLWSLEYILRINLSSNS-LKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQ 272 (717)
Q Consensus 194 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 272 (717)
|+|++|++++..+..+..+++|++|++++|. ++ .++ .+..+++|+.|++++|.+++. + .+..+++|++|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 6666666655455555555555555555555 44 222 455555555555555555532 2 34455555555555555
Q ss_pred cc
Q 005040 273 FQ 274 (717)
Q Consensus 273 l~ 274 (717)
|.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 43
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-19 Score=169.09 Aligned_cols=153 Identities=15% Similarity=0.230 Sum_probs=82.0
Q ss_pred cccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCe
Q 005040 138 GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILR 217 (717)
Q Consensus 138 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 217 (717)
..+++|++|++++|.++.. + .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDL-T-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCSCC-T-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCccCh-H-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 5566666666666666632 3 45666666666666665542 224555666666666666665544555555555666
Q ss_pred EEccCCcCcccCCccccCCCCCCeEEccCCC-CCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCC
Q 005040 218 INLSSNSLKGTLPSNIQKLNVLIDLDLSRNQ-LSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNN 296 (717)
Q Consensus 218 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 296 (717)
|++++|.+++..+..+..+++|++|++++|. ++. ++ .+..+++|++|++++|++++ ++ .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 6666555555445555555555555555555 442 22 34555555555555555543 22 34444555555555554
Q ss_pred CC
Q 005040 297 LS 298 (717)
Q Consensus 297 ~~ 298 (717)
|.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 43
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.77 E-value=8.5e-18 Score=178.53 Aligned_cols=267 Identities=11% Similarity=0.135 Sum_probs=205.5
Q ss_pred CCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccc
Q 005040 34 NLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEI 113 (717)
Q Consensus 34 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~ 113 (717)
....++.+.+-+ .++.++..+ |.+. +|+.+.|..| ++.+...+|.. .+|+.+.+.+ .+..+...+|
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~a--------F~~~-~L~~i~l~~~-i~~I~~~aF~~--~~L~~i~lp~-~l~~I~~~aF 176 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDA--------FRNS-QIAKVVLNEG-LKSIGDMAFFN--STVQEIVFPS-TLEQLKEDIF 176 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTT--------TTTC-CCSEEECCTT-CCEECTTTTTT--CCCCEEECCT-TCCEECSSTT
T ss_pred ecCCccEEEECC-ccCEehHhh--------cccC-CccEEEeCCC-ccEECHHhcCC--CCceEEEeCC-CccEehHHHh
Confidence 346677777743 466666554 5554 6888887766 66566666666 3578887775 6666777888
Q ss_pred cCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCe
Q 005040 114 GNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRS 193 (717)
Q Consensus 114 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 193 (717)
.++++|+.++|++|.++.+...+|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.
T Consensus 177 ~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~ 252 (401)
T 4fdw_A 177 YYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITT 252 (401)
T ss_dssp TTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSE
T ss_pred hCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccE
Confidence 8899999999998888877666776 588999998854 77788888889999999999875 56566777887 78999
Q ss_pred EEecCccccCCCChhhhcccCCCeEEccCCcCc-----ccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccc
Q 005040 194 LYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK-----GTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSL 268 (717)
Q Consensus 194 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-----~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 268 (717)
+.| .|.++.+....|.++++|+.+.+.+|.+. .+....|.++++|+.++|. +.++.+....|.+|.+|+.+.|
T Consensus 253 i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~l 330 (401)
T 4fdw_A 253 VKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTI 330 (401)
T ss_dssp EEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEE
T ss_pred EEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEE
Confidence 998 45566677788888999999998887765 4667788899999999998 4577777788888999999999
Q ss_pred cCccccCCCCccccccCccceEeccCCCCCCCCcccccccc-cccEEEccCCccc
Q 005040 269 AGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALS-HLKQFNVSHNRLE 322 (717)
Q Consensus 269 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~-~L~~L~l~~N~l~ 322 (717)
..| ++.+...+|.++ +|+.+++.+|.+....+..|.+++ +++.|++..+.+.
T Consensus 331 p~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 331 PAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred Ccc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 655 666777888888 899999999888877777788774 6788888776643
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.2e-19 Score=205.78 Aligned_cols=189 Identities=21% Similarity=0.200 Sum_probs=105.4
Q ss_pred EccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCcccc
Q 005040 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLS 202 (717)
Q Consensus 123 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 202 (717)
+++.|.+. ..++.|..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|+++++|+.|+|++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 44455555 55667777777777777777777 44555557778888888888887 66777788888888888888887
Q ss_pred CCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCc-ccccccccCccccCCCCccc
Q 005040 203 SSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLK-NLETLSLAGNQFQGPIPESV 281 (717)
Q Consensus 203 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~ 281 (717)
.+|..|.++++|++|+|++|.|+ .+|..|..+++|+.|+|++|.|++.+|..+..+. .+..|+|++|.+++.+|.
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~-- 359 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH-- 359 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC--
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc--
Confidence 56777888888888888888887 5677788888888888888888877777765543 233477888888877765
Q ss_pred cccCccceEeccCC--------CCCCCCcccccccccccEEEccCCccc
Q 005040 282 GNLISLESLDFSNN--------NLSGKIPKSLEALSHLKQFNVSHNRLE 322 (717)
Q Consensus 282 ~~l~~L~~L~L~~N--------~~~~~~~~~~~~l~~L~~L~l~~N~l~ 322 (717)
.|+.|+++.| .+.+..+..+..+..+....++.|-++
T Consensus 360 ----~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 360 ----ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ----C-----------------------------------------CCC
T ss_pred ----ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 3455566666 233333344445555555566666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=8.4e-20 Score=209.29 Aligned_cols=187 Identities=20% Similarity=0.244 Sum_probs=107.7
Q ss_pred cCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCccc
Q 005040 101 FECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180 (717)
Q Consensus 101 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 180 (717)
..|++. ..+..|..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+ .
T Consensus 209 ~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~ 284 (727)
T 4b8c_D 209 IENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-S 284 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-S
T ss_pred ccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-c
Confidence 334444 55677788888888888888887 55666668888888888888888 66777888888888888888888 5
Q ss_pred CCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCC-CCeEEccCCCCCCCCcccccC
Q 005040 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV-LIDLDLSRNQLSSDIPSTIGT 259 (717)
Q Consensus 181 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~ 259 (717)
+|..|+++++|++|+|++|.|+ .+|..|..+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus 285 lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~---- 359 (727)
T 4b8c_D 285 LPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH---- 359 (727)
T ss_dssp CCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC----
T ss_pred cChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc----
Confidence 6777888888888888888887 56667888888888888888888777776655422 23467888888876665
Q ss_pred CcccccccccCc--------cccCCCCccccccCccceEeccCCCCC
Q 005040 260 LKNLETLSLAGN--------QFQGPIPESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 260 l~~L~~L~l~~N--------~l~~~~~~~~~~l~~L~~L~L~~N~~~ 298 (717)
.|+.|+++.| .+.+..+..+.++.++....+++|.+.
T Consensus 360 --~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 360 --ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp --C-----------------------------------------CCC
T ss_pred --ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 3455566666 333333444455566666777777664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=7.8e-19 Score=167.23 Aligned_cols=128 Identities=25% Similarity=0.370 Sum_probs=62.2
Q ss_pred CEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCCh-hhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccC
Q 005040 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPS-SLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSR 246 (717)
Q Consensus 168 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 246 (717)
++|++++|+++ .+|..+. .+|++|+|++|++++..+. .|..+++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45666666665 3443332 2555555555555544332 244555555555555555544444555555555555555
Q ss_pred CCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCC
Q 005040 247 NQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 247 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 298 (717)
|.|++..+..|..+++|++|+|++|++++..|..+..+++|++|+|++|++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 139 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence 5554444444444444444444444444444444444444444444444444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-17 Score=176.45 Aligned_cols=267 Identities=11% Similarity=0.093 Sum_probs=212.9
Q ss_pred CCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchh
Q 005040 10 NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIG 89 (717)
Q Consensus 10 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 89 (717)
....++.+.+.++ ++.+...+|.+. +|+.+.|..| ++.+...+ |.+ .+|+.+.|.. .++.+...+|.
T Consensus 111 ~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~a--------F~~-~~L~~i~lp~-~l~~I~~~aF~ 177 (401)
T 4fdw_A 111 ILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMA--------FFN-STVQEIVFPS-TLEQLKEDIFY 177 (401)
T ss_dssp ECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTT--------TTT-CCCCEEECCT-TCCEECSSTTT
T ss_pred ecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHh--------cCC-CCceEEEeCC-CccEehHHHhh
Confidence 3466777777764 666788888884 7888888766 88877665 556 3688888885 67767777777
Q ss_pred ccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCE
Q 005040 90 NFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNI 169 (717)
Q Consensus 90 ~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~ 169 (717)
.. .+|+.+++.+|++..+....|. ..+|+.+.|.++ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.
T Consensus 178 ~c-~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~ 252 (401)
T 4fdw_A 178 YC-YNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITT 252 (401)
T ss_dssp TC-TTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSE
T ss_pred Cc-ccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccE
Confidence 76 6788899988888877777777 588999999854 77677888999999999999875 66677788888 78999
Q ss_pred EeccCCcCcccCCccccCCCCCCeEEecCcccc-----CCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEc
Q 005040 170 LNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLS-----SSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL 244 (717)
Q Consensus 170 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 244 (717)
+.| .+.++.+...+|.++++|+.+++.+|.+. .+.+..|.++++|+.+.|. +.++.+...+|.++++|+.+.|
T Consensus 253 i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~l 330 (401)
T 4fdw_A 253 VKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTI 330 (401)
T ss_dssp EEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEE
T ss_pred EEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEE
Confidence 999 45677677788999999999999888775 4667789999999999998 4588777889999999999999
Q ss_pred cCCCCCCCCcccccCCcccccccccCccccCCCCccccccC-ccceEeccCCCCC
Q 005040 245 SRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI-SLESLDFSNNNLS 298 (717)
Q Consensus 245 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~N~~~ 298 (717)
..| ++.+...+|.++ +|+.|++++|.+.......|.+++ +++.|++..+.+.
T Consensus 331 p~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 331 PAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred Ccc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 655 776777889999 999999999988877777888874 6888888777654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=181.21 Aligned_cols=263 Identities=16% Similarity=0.116 Sum_probs=197.6
Q ss_pred CCCCcEEECCCCcce--ecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccC--------ccCCcEEeccCCCC
Q 005040 11 ATKLIGLDLGLNSFS--GHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTN--------CRNLANLALASNPL 80 (717)
Q Consensus 11 l~~L~~L~L~~n~i~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~--------l~~L~~L~L~~N~l 80 (717)
+++|+.|||++|+|. ......+. .++.+.+..|.| +..+ |.+ +++|++|+|.+ .+
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~~I---~~~a--------F~~~~~~~~~g~~~L~~l~L~~-~i 112 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMANFV---PAYA--------FSNVVNGVTKGKQTLEKVILSE-KI 112 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTTEE---CTTT--------TEEEETTEEEECTTCCC-CBCT-TC
T ss_pred hccCeEEecCcceeEEecCcccccc---cccccccccccc---CHHH--------hcccccccccccCCCcEEECCc-cc
Confidence 788999999999998 44443333 356677777744 4343 667 99999999999 88
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCC----CCcccCCccccccCCCC-EEeccCCcc-c
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFN----DLNGTIPTSIGTLQQLQ-GFYVPENNL-Q 154 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n----~l~~~~~~~~~~l~~L~-~L~l~~n~i-~ 154 (717)
+.+...+|... ++|+.|++.+|.+..+.+.+|.++.++..+.+..+ ........+|.++.+|+ .+.+....- .
T Consensus 113 ~~I~~~aF~~~-~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~ 191 (329)
T 3sb4_A 113 KNIEDAAFKGC-DNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLE 191 (329)
T ss_dssp CEECTTTTTTC-TTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHH
T ss_pred cchhHHHhhcC-cccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHH
Confidence 87777888777 67999999999998888899999888888877763 23334556777888887 555543321 1
Q ss_pred ccCCccccCCCCCCEEeccCCcCcccCCccc-cCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccc
Q 005040 155 GYVPHDLCHLERLNILNLSGNKLSGAIPQCL-ASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI 233 (717)
Q Consensus 155 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 233 (717)
......-....++..+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+..|.++.+|+.|+|++| ++.+.+.+|
T Consensus 192 ~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF 269 (329)
T 3sb4_A 192 DEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVF 269 (329)
T ss_dssp HHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred HHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHh
Confidence 111111123456777877765333 222222 24789999999999999887888999999999999998 887888899
Q ss_pred cCCCCCC-eEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEec
Q 005040 234 QKLNVLI-DLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDF 292 (717)
Q Consensus 234 ~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 292 (717)
.++.+|+ .+++.+ .++.+.+..|.+|++|+.|++++|.+..+.+.+|.++++|+.++.
T Consensus 270 ~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 270 SNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred hCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 9999999 999988 787777889999999999999999999888889999999998874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.9e-18 Score=172.75 Aligned_cols=138 Identities=22% Similarity=0.263 Sum_probs=106.8
Q ss_pred cCCccccccccccEEEEEEEe-cCCCe--EEEEEechhhH------------------------HHHHHHHHHHHHHHhc
Q 005040 428 EFNECNLLGTGGFGSVYKGTL-SDGTN--VAIKIFNLQLE------------------------RAFRSFDSECEILRNV 480 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l 480 (717)
-|++.+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|+++++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999998 68989 99998753311 1123578899999999
Q ss_pred CCCce--eeEeeeeecCCeeEEEEEccCC-C----CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecC
Q 005040 481 RHRNL--LKILGSCSNLDFKALVLEFMPN-G----SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCD 553 (717)
Q Consensus 481 ~hpni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~d 553 (717)
+|+++ ...+++ ...++||||+.+ | +|.++... .++..+..++.|++.||.|||. +.+|+|||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~givHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ---EAELVHAD 196 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH---TSCEECSS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH---HCCEEeCC
Confidence 88754 344432 356899999942 3 77776543 2244567899999999999994 35899999
Q ss_pred CCCCCeeeCCCCcEEEeeecccccc
Q 005040 554 LKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 554 lk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
|||+|||++. .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=1.4e-17 Score=158.61 Aligned_cols=133 Identities=22% Similarity=0.309 Sum_probs=70.3
Q ss_pred CeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCc-cccCCCCCCeEEccCCCCCCCCcccccCCcccccccccC
Q 005040 192 RSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPS-NIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAG 270 (717)
Q Consensus 192 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 270 (717)
+.+++++|.++ .+|..+. .+|++|++++|.|++..+. .|..+++|+.|+|++|.|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 44555555554 3333322 1555555555555544332 255555555555555555555555555555555555555
Q ss_pred ccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc
Q 005040 271 NQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 271 N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 327 (717)
|+|++..+..|.++++|++|+|++|++++..|..+..+++|+.|+|++|++++.++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 555555555555555555555555555555555555555555555555555555443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=159.28 Aligned_cols=132 Identities=22% Similarity=0.310 Sum_probs=84.4
Q ss_pred eEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCcc
Q 005040 193 SLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQ 272 (717)
Q Consensus 193 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 272 (717)
.+++++|.++ .+|..+ .++|++|+|++|.|+ .+|..|.++++|+.|+|++|.|++..+..|..+++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 3444444444 223222 134555555555555 444556666666666666666666555666666667777777777
Q ss_pred ccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccc
Q 005040 273 FQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK 328 (717)
Q Consensus 273 l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~ 328 (717)
|++..+..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|++.+.+...
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~ 145 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQ 145 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGH
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCH
Confidence 76666666777777777777777777666666777888888888888887766543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=6.4e-17 Score=150.47 Aligned_cols=132 Identities=23% Similarity=0.205 Sum_probs=65.6
Q ss_pred CCCcEEEccCCCCc-ccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEE
Q 005040 117 RGLIVLSLGFNDLN-GTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLY 195 (717)
Q Consensus 117 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 195 (717)
++|++|+|++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45556666666555 34444555555555555555555543 4455555555555555555544444444455555555
Q ss_pred ecCccccCCC-ChhhhcccCCCeEEccCCcCcccCC---ccccCCCCCCeEEccCCCCC
Q 005040 196 LQSNKLSSSL-PSSLWSLEYILRINLSSNSLKGTLP---SNIQKLNVLIDLDLSRNQLS 250 (717)
Q Consensus 196 L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~ 250 (717)
|++|++++.. +..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 5555554321 1344444444444444444443222 23444444444444444444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=6.5e-17 Score=150.43 Aligned_cols=132 Identities=23% Similarity=0.224 Sum_probs=70.0
Q ss_pred CCCCEEeccCCccc-ccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEE
Q 005040 141 QQLQGFYVPENNLQ-GYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRIN 219 (717)
Q Consensus 141 ~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 219 (717)
++|++|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 34454555556666666666665543 4455555666666666665544555555555555555
Q ss_pred ccCCcCcccC-CccccCCCCCCeEEccCCCCCCCCc---ccccCCcccccccccCcccc
Q 005040 220 LSSNSLKGTL-PSNIQKLNVLIDLDLSRNQLSSDIP---STIGTLKNLETLSLAGNQFQ 274 (717)
Q Consensus 220 l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~ 274 (717)
|++|.|++.. +..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 5555555321 1344555555555555555554332 24444555555555555444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-15 Score=161.60 Aligned_cols=291 Identities=13% Similarity=0.090 Sum_probs=186.3
Q ss_pred ccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCC
Q 005040 6 NSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILP 85 (717)
Q Consensus 6 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 85 (717)
.+|.++++|+.+.|..+ ++.+...+|.++++|+.++|..+ ++.+...+ |.++.+|+.+.+..+ +..+..
T Consensus 65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~a--------F~~c~~L~~i~~p~~-l~~i~~ 133 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCT--------FSGCYALKSILLPLM-LKSIGV 133 (394)
T ss_dssp TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT--------TTTCTTCCCCCCCTT-CCEECT
T ss_pred HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchh--------hcccccchhhcccCc-eeeecc
Confidence 35778899999999754 77788889999999999999755 77777655 788888888877655 444555
Q ss_pred cchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCC
Q 005040 86 PLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLE 165 (717)
Q Consensus 86 ~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~ 165 (717)
.+|... .+..... ...+......+|.++++|+.+.+.++. ..+...+|.++.+|+.+.+..| ++.+...+|.++.
T Consensus 134 ~aF~~~--~~~~~~~-~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~ 208 (394)
T 4fs7_A 134 EAFKGC--DFKEITI-PEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECI 208 (394)
T ss_dssp TTTTTC--CCSEEEC-CTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCT
T ss_pred eeeecc--ccccccc-CccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhcccc
Confidence 555543 1222222 223333556778888888888887654 3366678888888888888776 5556667788887
Q ss_pred CCCEEeccCCcCc---------------------ccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCc
Q 005040 166 RLNILNLSGNKLS---------------------GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNS 224 (717)
Q Consensus 166 ~L~~L~L~~n~l~---------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 224 (717)
.|+.+.+..+... .+....|.++..|+.+.+..+... .....|..+..++.+....+.
T Consensus 209 ~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~ 287 (394)
T 4fs7_A 209 LLENMEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI 287 (394)
T ss_dssp TCCBCCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE
T ss_pred ccceeecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCcee
Confidence 7777777665432 111223334444444444444332 333444444555554444433
Q ss_pred CcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCccc
Q 005040 225 LKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKS 304 (717)
Q Consensus 225 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~ 304 (717)
+ ....|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.++|..| ++.+...+
T Consensus 288 i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~a 361 (394)
T 4fs7_A 288 V---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANA 361 (394)
T ss_dssp E---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred e---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHH
Confidence 2 2235666667777776554 55455566777777777777544 55555667777777777777665 55555667
Q ss_pred ccccccccEEEccCC
Q 005040 305 LEALSHLKQFNVSHN 319 (717)
Q Consensus 305 ~~~l~~L~~L~l~~N 319 (717)
|.++++|+.+++..+
T Consensus 362 F~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 362 FQGCINLKKVELPKR 376 (394)
T ss_dssp BTTCTTCCEEEEEGG
T ss_pred hhCCCCCCEEEECCC
Confidence 777777777776543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-16 Score=146.83 Aligned_cols=114 Identities=25% Similarity=0.301 Sum_probs=71.7
Q ss_pred cCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEec
Q 005040 213 EYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDF 292 (717)
Q Consensus 213 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 292 (717)
++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|++++..+..+..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 34555555555555444445555566666666666666544455566666666666666666555555666677777777
Q ss_pred cCCCCCCCCcccccccccccEEEccCCccccccc
Q 005040 293 SNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 293 ~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 326 (717)
++|++++..+..+..+++|+.|+|++|++++.+|
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 7777765555556667777777777777777665
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=9.9e-17 Score=145.94 Aligned_cols=83 Identities=24% Similarity=0.307 Sum_probs=31.8
Q ss_pred CCcEEEccCCCCc-ccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEe
Q 005040 118 GLIVLSLGFNDLN-GTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYL 196 (717)
Q Consensus 118 ~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 196 (717)
+|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 3344444444433 23333333333344444444333332 23333344444444444443333333333334444444
Q ss_pred cCcccc
Q 005040 197 QSNKLS 202 (717)
Q Consensus 197 ~~N~l~ 202 (717)
++|+++
T Consensus 96 s~N~i~ 101 (149)
T 2je0_A 96 SGNKIK 101 (149)
T ss_dssp TTSCCC
T ss_pred CCCcCC
Confidence 444433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-16 Score=144.29 Aligned_cols=128 Identities=19% Similarity=0.187 Sum_probs=96.5
Q ss_pred cccceeeecCCcce-ecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEe
Q 005040 93 ASLQNIYAFECKLG-GSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILN 171 (717)
Q Consensus 93 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 171 (717)
++|+.|++++|++. +.+|..+..+++|++|+|++|.+++. ..+..+++|++|++++|.+++..|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34556666666655 45666777788888888888888855 6788888888888888888876777777788888888
Q ss_pred ccCCcCccc-CCccccCCCCCCeEEecCccccCCCC---hhhhcccCCCeEEccC
Q 005040 172 LSGNKLSGA-IPQCLASLTSLRSLYLQSNKLSSSLP---SSLWSLEYILRINLSS 222 (717)
Q Consensus 172 L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~~ 222 (717)
+++|.+++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888888863 23667888888888888888886555 4677778888877753
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.8e-16 Score=147.22 Aligned_cols=128 Identities=27% Similarity=0.380 Sum_probs=91.2
Q ss_pred CEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCC
Q 005040 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRN 247 (717)
Q Consensus 168 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 247 (717)
+.+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|.|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45667777666 3443332 46777777777776 45566777777777777777777666667777777777777777
Q ss_pred CCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCC
Q 005040 248 QLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG 299 (717)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~ 299 (717)
.|++..+..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 7777666677777777777777777776656667777888888888887763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-15 Score=142.46 Aligned_cols=129 Identities=25% Similarity=0.277 Sum_probs=73.5
Q ss_pred cEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCc
Q 005040 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSN 199 (717)
Q Consensus 120 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 199 (717)
+.+++++|.++. +|..+ .++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 456666666653 23222 245666666666666555555566666666666666666544445556666666666666
Q ss_pred cccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCC
Q 005040 200 KLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS 251 (717)
Q Consensus 200 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 251 (717)
++++..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 6665544455556666666666666654444445555666666666665554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-16 Score=164.75 Aligned_cols=136 Identities=13% Similarity=0.153 Sum_probs=99.0
Q ss_pred cCCccccccccccEEEEEEEecCCCeEEEEEechhh------------------HH----HHHHHHHHHHHHHhcCCCce
Q 005040 428 EFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL------------------ER----AFRSFDSECEILRNVRHRNL 485 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~----~~~~~~~e~~~l~~l~hpni 485 (717)
-|++...||+|+||.||+|...+|+.||||+++... .. ..-...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999999899999999875321 00 00112346666666654443
Q ss_pred e--eEeeeeecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC
Q 005040 486 L--KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE 563 (717)
Q Consensus 486 v--~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~ 563 (717)
. ..+++ ...++||||++|++|.++... .....++.|++.+|.||| ..+||||||||.|||+++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH----~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA----KHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeC
Confidence 2 22222 123799999999888654321 123567899999999999 578999999999999987
Q ss_pred CC----------cEEEeeecccccc
Q 005040 564 NM----------VAHVSDFGISKLL 578 (717)
Q Consensus 564 ~~----------~~kl~Dfgl~~~~ 578 (717)
++ .+.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999977654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.5e-15 Score=142.34 Aligned_cols=131 Identities=21% Similarity=0.201 Sum_probs=68.5
Q ss_pred ccCCCCCcEEEccCCCCcccCCccccccC-CCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCC
Q 005040 113 IGNLRGLIVLSLGFNDLNGTIPTSIGTLQ-QLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSL 191 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 191 (717)
+.++++|++|+|++|+++.. +. +..+. +|++|++++|.|++. ..|..+++|++|+|++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 45556666666666666632 32 33333 666666666666644 345556666666666666654433444555556
Q ss_pred CeEEecCccccCCCCh--hhhcccCCCeEEccCCcCcccCCcc----ccCCCCCCeEEccCCCC
Q 005040 192 RSLYLQSNKLSSSLPS--SLWSLEYILRINLSSNSLKGTLPSN----IQKLNVLIDLDLSRNQL 249 (717)
Q Consensus 192 ~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~L~~L~l~~N~l 249 (717)
++|+|++|+++ .+|. .+..+++|+.|++++|.++ ..|.. +..+++|+.|++++|.+
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 66666555554 2332 4445555555555555554 22322 44444444444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=142.63 Aligned_cols=109 Identities=17% Similarity=0.191 Sum_probs=53.1
Q ss_pred ccccCCCCEEeccCCcccccCCccccCCC-CCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCC
Q 005040 137 IGTLQQLQGFYVPENNLQGYVPHDLCHLE-RLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYI 215 (717)
Q Consensus 137 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 215 (717)
+.++++|+.|++++|+++.. +. +..+. +|++|+|++|.|++. ..|..+++|+.|+|++|++++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 44555556666666655533 22 33222 555555555555543 345555555555555555554333333455555
Q ss_pred CeEEccCCcCcccCCc--cccCCCCCCeEEccCCCCC
Q 005040 216 LRINLSSNSLKGTLPS--NIQKLNVLIDLDLSRNQLS 250 (717)
Q Consensus 216 ~~L~l~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~ 250 (717)
++|++++|.|+ .+|. .+..+++|+.|++++|.++
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 55555555554 2222 3444444444444444444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.8e-14 Score=151.08 Aligned_cols=296 Identities=12% Similarity=0.087 Sum_probs=223.0
Q ss_pred CCCC-ccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccc--------------cccccccC
Q 005040 2 GTIP-NSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQW--------------SFLSSLTN 66 (717)
Q Consensus 2 ~~iP-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--------------~~~~~l~~ 66 (717)
.+|+ ..|.++++|+.++|.++ ++.+...+|.+..+|+.+.+..+ ++.+...++.. ..-..|.+
T Consensus 83 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~~~~~i~~~aF~~ 160 (394)
T 4fs7_A 83 REIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPEGVTVIGDEAFAT 160 (394)
T ss_dssp CEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCTTCCEECTTTTTT
T ss_pred cCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccCccccccchhhhcc
Confidence 3454 46888999999999866 77788999999999999887644 44444333110 01134677
Q ss_pred ccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEE
Q 005040 67 CRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGF 146 (717)
Q Consensus 67 l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 146 (717)
+++|+.+.+.++. ..+....|... .+|+.+.+..+ +..+....|.++..|+.+.+..+... +.+.+....+|+.+
T Consensus 161 c~~L~~i~l~~~~-~~I~~~~F~~c-~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i 235 (394)
T 4fs7_A 161 CESLEYVSLPDSM-ETLHNGLFSGC-GKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNI 235 (394)
T ss_dssp CTTCCEEECCTTC-CEECTTTTTTC-TTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEE
T ss_pred cCCCcEEecCCcc-ceeccccccCC-CCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceE
Confidence 7888888887654 33555555554 56888877765 55566677888888888877766543 23344455778888
Q ss_pred eccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCc
Q 005040 147 YVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK 226 (717)
Q Consensus 147 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 226 (717)
.+..+ ++.+....|.++..|+.+.+..+... +....|..+..++.+....+.+. ...|..+.+|+.+.+..+ ++
T Consensus 236 ~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~ 309 (394)
T 4fs7_A 236 IIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VK 309 (394)
T ss_dssp EECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CC
T ss_pred EECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cc
Confidence 88654 44466778899999999999988665 67778999999999999887654 356889999999999866 77
Q ss_pred ccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCccccc
Q 005040 227 GTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLE 306 (717)
Q Consensus 227 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~ 306 (717)
.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+++..| ++.+...+|.++.+|+.++|..+ +. .+...|.
T Consensus 310 ~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~ 385 (394)
T 4fs7_A 310 FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFE 385 (394)
T ss_dssp EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBC
T ss_pred eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-Ehhheec
Confidence 677889999999999999755 77777889999999999999887 77678889999999999999866 33 3456788
Q ss_pred ccccccEE
Q 005040 307 ALSHLKQF 314 (717)
Q Consensus 307 ~l~~L~~L 314 (717)
++++|+.+
T Consensus 386 ~c~~L~~I 393 (394)
T 4fs7_A 386 DTTKFKWI 393 (394)
T ss_dssp TTCEEEEE
T ss_pred CCCCCcEE
Confidence 88888865
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-17 Score=160.08 Aligned_cols=133 Identities=24% Similarity=0.315 Sum_probs=71.9
Q ss_pred cccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCccc
Q 005040 184 CLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNL 263 (717)
Q Consensus 184 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 263 (717)
.+..+++|++|+|++|.+++ +| .+..+++|++|++++|.|+ .+|..+..+++|+.|++++|.+++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 44555555555555555553 33 4555555555555555555 344444445555555555555554 22 35555666
Q ss_pred ccccccCccccCCCC-ccccccCccceEeccCCCCCCCCcc----------cccccccccEEEccCCcccc
Q 005040 264 ETLSLAGNQFQGPIP-ESVGNLISLESLDFSNNNLSGKIPK----------SLEALSHLKQFNVSHNRLEG 323 (717)
Q Consensus 264 ~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~~~~~~~~----------~~~~l~~L~~L~l~~N~l~~ 323 (717)
++|++++|++++..+ ..+..+++|++|++++|++.+..|. .+..+++|+.|| +|+++.
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 666666666653222 3455666666666666666544433 266677777665 566553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.4e-17 Score=156.82 Aligned_cols=132 Identities=28% Similarity=0.322 Sum_probs=70.2
Q ss_pred cccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCC
Q 005040 160 DLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVL 239 (717)
Q Consensus 160 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 239 (717)
.+..+++|++|+|++|.+++ +| .+..+++|+.|+|++|.++ .+|..+..+++|++|++++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 44455555555555555553 33 4555555555555555555 344444455555555555555553 22 45555555
Q ss_pred CeEEccCCCCCCCCc-ccccCCcccccccccCccccCCCCc----------cccccCccceEeccCCCCC
Q 005040 240 IDLDLSRNQLSSDIP-STIGTLKNLETLSLAGNQFQGPIPE----------SVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 240 ~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~----------~~~~l~~L~~L~L~~N~~~ 298 (717)
+.|++++|.+++..+ ..+..+++|++|++++|++.+..|. .+..+++|+.|+ +|.++
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 566666665554221 2455566666666666666544333 255666677665 55554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.57 E-value=9.1e-14 Score=148.15 Aligned_cols=296 Identities=10% Similarity=0.119 Sum_probs=207.8
Q ss_pred cccCC-CCCcEEECCCCcceecCCcCCCCCCCCCEEEccccc---ccCccCCcccccccccccCccCCcEEeccCCCCcc
Q 005040 7 SITNA-TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNN---LTTESSSADQWSFLSSLTNCRNLANLALASNPLGG 82 (717)
Q Consensus 7 ~~~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~---l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 82 (717)
.|.+. ..|+++.+..+ ++.+...+|.+..+|+.+.+..|. ++.+...+ |.++.+|+.+.+..+ ++.
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~a--------F~~c~~L~~i~~~~~-~~~ 127 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQA--------FMFCSELTDIPILDS-VTE 127 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTT--------TTTCTTCCBCGGGTT-CSE
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhh--------chhcccceeeccCCc-cce
Confidence 35555 35888888765 777888888888889988888774 66666554 778888888877655 444
Q ss_pred cCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCcccc
Q 005040 83 ILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC 162 (717)
Q Consensus 83 ~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~ 162 (717)
+....|... .+|+.+.+..+ +..+....|.++.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-.. ....+|.
T Consensus 128 I~~~aF~~c-~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~ 202 (394)
T 4gt6_A 128 IDSEAFHHC-EELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFS 202 (394)
T ss_dssp ECTTTTTTC-TTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTT
T ss_pred ehhhhhhhh-cccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhh
Confidence 555555554 56888888644 44466777888888888888765 44455556654 56888888765433 6667788
Q ss_pred CCCCCCEEeccCCcCcccCCcccc-------------CCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccC
Q 005040 163 HLERLNILNLSGNKLSGAIPQCLA-------------SLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTL 229 (717)
Q Consensus 163 ~l~~L~~L~L~~n~l~~~~~~~~~-------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 229 (717)
++.+|+......+.........+. ....+..+.+.. .++.....+|.++.+|+.+.+.++... +.
T Consensus 203 ~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~ 280 (394)
T 4gt6_A 203 ECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IG 280 (394)
T ss_dssp TCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-EC
T ss_pred hccccceecccccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce-ec
Confidence 888888877766554422111111 122333444332 233345567888889999998876554 67
Q ss_pred CccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccc
Q 005040 230 PSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALS 309 (717)
Q Consensus 230 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~ 309 (717)
..+|.++++|+.+.+. +.++.+....|.++.+|+.++|..+ ++.+...+|.++.+|+.+.|..+ ++.+...+|.+++
T Consensus 281 ~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~ 357 (394)
T 4gt6_A 281 TGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCT 357 (394)
T ss_dssp TTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCT
T ss_pred CcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCC
Confidence 7788889999999986 4566666778888999999999765 66567788889999999999655 6656778899999
Q ss_pred cccEEEccCCccc
Q 005040 310 HLKQFNVSHNRLE 322 (717)
Q Consensus 310 ~L~~L~l~~N~l~ 322 (717)
+|+.+++.+|...
T Consensus 358 ~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 358 ALNNIEYSGSRSQ 370 (394)
T ss_dssp TCCEEEESSCHHH
T ss_pred CCCEEEECCceee
Confidence 9999999887543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=3.1e-14 Score=132.26 Aligned_cols=109 Identities=22% Similarity=0.264 Sum_probs=79.0
Q ss_pred CCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccC
Q 005040 215 ILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSN 294 (717)
Q Consensus 215 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 294 (717)
.+.|++++|.++ .+|..+. ++|+.|+|++|.|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456667777666 3444442 5677777777777776677777777777777777777766666677777888888888
Q ss_pred CCCCCCCcccccccccccEEEccCCccccccc
Q 005040 295 NNLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 295 N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 326 (717)
|+|++..+..|..+++|+.|+|++|++++.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 88876666677778888888888888877765
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.8e-14 Score=129.97 Aligned_cols=108 Identities=22% Similarity=0.286 Sum_probs=63.9
Q ss_pred CeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCC
Q 005040 216 LRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNN 295 (717)
Q Consensus 216 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 295 (717)
+.+++++|.++ .+|..+. ++|+.|+|++|.|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 44555555554 3343332 45666666666666555556666666666666666666544445566666666666666
Q ss_pred CCCCCCcccccccccccEEEccCCccccccc
Q 005040 296 NLSGKIPKSLEALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 296 ~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 326 (717)
+|++..+..|..+++|+.|+|++|++.+.++
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 6665544556666666666666666665544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.7e-12 Score=136.73 Aligned_cols=300 Identities=12% Similarity=0.134 Sum_probs=220.9
Q ss_pred cceecCCcCCCCCC-CCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCC---CcccCCcchhcccccccee
Q 005040 23 SFSGHIPNTFGNLR-HLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNP---LGGILPPLIGNFSASLQNI 98 (717)
Q Consensus 23 ~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~~L~~L 98 (717)
.++.+...+|.+.+ .|+.+.+-.+ ++.|...+ |.++.+|+.+.+..|. ++.+...+|... .+|+.+
T Consensus 50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~A--------F~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c-~~L~~i 119 (394)
T 4gt6_A 50 PVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNA--------FYNCTSLKRVTIQDNKPSCVKKIGRQAFMFC-SELTDI 119 (394)
T ss_dssp EEEEECTTTTTTCCSCCCEEEECTT-CCEECTTT--------TTTCTTCCEEEEGGGCCCCCCEECTTTTTTC-TTCCBC
T ss_pred eeeEcCHhhccCCCCcCEEEEECCC-eeEEhHHH--------hhCCccCceEeecCCCCCeeeEechhhchhc-ccceee
Confidence 36677888999885 6999999754 88888766 8999999999998874 665666666654 568887
Q ss_pred eecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCc
Q 005040 99 YAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS 178 (717)
Q Consensus 99 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~ 178 (717)
.+.++ +..+....|.++.+|+.+.+..+ +..+...+|.++.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-..
T Consensus 120 ~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~ 195 (394)
T 4gt6_A 120 PILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR 195 (394)
T ss_dssp GGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE
T ss_pred ccCCc-cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc
Confidence 77654 55577788999999999999754 44467778999999999999765 55566777765 67999999876544
Q ss_pred ccCCccccCCCCCCeEEecCccccCCCChhh-------------hcccCCCeEEccCCcCcccCCccccCCCCCCeEEcc
Q 005040 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSL-------------WSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLS 245 (717)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 245 (717)
....+|.++.++.......+.........+ .....+..+.+. +.++.+...+|.++.+|+.+.+.
T Consensus 196 -i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp 273 (394)
T 4gt6_A 196 -IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMP 273 (394)
T ss_dssp -ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECC
T ss_pred -cccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecc
Confidence 666788888899988877665542211111 122344455554 33444666789999999999998
Q ss_pred CCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccc
Q 005040 246 RNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEI 325 (717)
Q Consensus 246 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 325 (717)
++..+ +....|.++++|+.+.+. +.+..+...+|.++.+|+.++|..+ ++.+....|.++.+|+.+.+..+ ++. +
T Consensus 274 ~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~-I 348 (394)
T 4gt6_A 274 DSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTK-I 348 (394)
T ss_dssp TTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCB-C
T ss_pred cccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCE-E
Confidence 76554 677889999999999996 4566677889999999999999865 66577789999999999999765 432 2
Q ss_pred cc--cccccccccccccCCc
Q 005040 326 PV--KGSFKDFSAQSYFGNY 343 (717)
Q Consensus 326 p~--~~~~~~~~~~~~~~n~ 343 (717)
.. ...+..+....+.++.
T Consensus 349 ~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 349 PESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp CGGGGTTCTTCCEEEESSCH
T ss_pred hHhHhhCCCCCCEEEECCce
Confidence 22 2334455555555543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=2.1e-13 Score=126.59 Aligned_cols=87 Identities=23% Similarity=0.288 Sum_probs=45.3
Q ss_pred CCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEc
Q 005040 165 ERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL 244 (717)
Q Consensus 165 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 244 (717)
++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 34444555555554444444555555555555555555444444455555555555555555444445555556666666
Q ss_pred cCCCCCC
Q 005040 245 SRNQLSS 251 (717)
Q Consensus 245 ~~N~l~~ 251 (717)
++|.++.
T Consensus 110 ~~N~~~c 116 (170)
T 3g39_A 110 LNNPWDC 116 (170)
T ss_dssp CSSCBCT
T ss_pred CCCCCCC
Confidence 6665553
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.7e-15 Score=159.22 Aligned_cols=183 Identities=15% Similarity=0.109 Sum_probs=97.4
Q ss_pred cCCcEEeccCCCCcccCCcchhcc----ccccceeeecCCcceecCCccc-cCCCCCcEEEccCCCCcccCCccc-----
Q 005040 68 RNLANLALASNPLGGILPPLIGNF----SASLQNIYAFECKLGGSIPKEI-GNLRGLIVLSLGFNDLNGTIPTSI----- 137 (717)
Q Consensus 68 ~~L~~L~L~~N~l~~~~~~~~~~l----~~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~----- 137 (717)
++|++|+|++|.++......+... ..+|++|+|++|.++......+ ..+++|++|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 344455555554443332222222 1234555555554443222222 223456667777776664433333
Q ss_pred cccCCCCEEeccCCcccccC----CccccCCCCCCEEeccCCcCcccC----CccccCCCCCCeEEecCccccCC----C
Q 005040 138 GTLQQLQGFYVPENNLQGYV----PHDLCHLERLNILNLSGNKLSGAI----PQCLASLTSLRSLYLQSNKLSSS----L 205 (717)
Q Consensus 138 ~~l~~L~~L~l~~n~i~~~~----~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~----~ 205 (717)
...++|++|+|++|.|+... +..+..+++|++|+|++|.|++.. +..+...++|++|+|++|.|++. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 23466777777777776432 233456677777777777776432 34556667788888888877743 2
Q ss_pred ChhhhcccCCCeEEccCCcCcccCCccccCCCC-----CCeEE--ccCCCCC
Q 005040 206 PSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV-----LIDLD--LSRNQLS 250 (717)
Q Consensus 206 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-----L~~L~--l~~N~l~ 250 (717)
+..+...++|++|+|++|.|+......+..+.. |+.+. +..|.++
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 334445677888888888887544444433321 55555 5555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.3e-15 Score=160.04 Aligned_cols=134 Identities=18% Similarity=0.155 Sum_probs=61.5
Q ss_pred CCCcEEEccCCCCcccCCcccccc-----CCCCEEeccCCcccccCCcccc-CCCCCCEEeccCCcCcccCCccc-----
Q 005040 117 RGLIVLSLGFNDLNGTIPTSIGTL-----QQLQGFYVPENNLQGYVPHDLC-HLERLNILNLSGNKLSGAIPQCL----- 185 (717)
Q Consensus 117 ~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~----- 185 (717)
++|++|+|++|.++......+... ++|++|+|++|.|+......+. .+++|+.|+|++|.|++.....+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 456666666666654333333222 4566666666655533222221 23455566666665553322222
Q ss_pred cCCCCCCeEEecCccccCC----CChhhhcccCCCeEEccCCcCcccC----CccccCCCCCCeEEccCCCCC
Q 005040 186 ASLTSLRSLYLQSNKLSSS----LPSSLWSLEYILRINLSSNSLKGTL----PSNIQKLNVLIDLDLSRNQLS 250 (717)
Q Consensus 186 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~ 250 (717)
...++|++|+|++|.|++. ++..+..+++|++|+|++|.|++.. +..+...++|+.|+|++|.|+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 1234555555555555421 2222334445555555555544211 223333444444444444444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.7e-13 Score=125.33 Aligned_cols=86 Identities=24% Similarity=0.337 Sum_probs=43.8
Q ss_pred CCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEc
Q 005040 165 ERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDL 244 (717)
Q Consensus 165 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 244 (717)
++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34444444444444444444444455555555555554443334445555555555555555444444555556666666
Q ss_pred cCCCCC
Q 005040 245 SRNQLS 250 (717)
Q Consensus 245 ~~N~l~ 250 (717)
++|.+.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 666655
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.36 E-value=5e-11 Score=126.25 Aligned_cols=290 Identities=8% Similarity=0.053 Sum_probs=188.1
Q ss_pred ccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcc
Q 005040 8 ITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPL 87 (717)
Q Consensus 8 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 87 (717)
+....+|+.+.+... ++.+...+|.++.+|+.++|..+ ++.+...+ |.++ +|+.+.+..+ +..+...+
T Consensus 42 ~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~a--------F~~c-~l~~i~~~~~-l~~I~~~a 109 (379)
T 4h09_A 42 YKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGA--------FADT-KLQSYTGMER-VKKFGDYV 109 (379)
T ss_dssp GGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTT--------TTTC-CCCEEEECTT-CCEECTTT
T ss_pred cccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhh--------hcCC-CCceEECCce-eeEeccce
Confidence 445677888888754 77788889999999999999654 88887665 6665 5777777644 55455555
Q ss_pred hhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCccccc-----------
Q 005040 88 IGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGY----------- 156 (717)
Q Consensus 88 ~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~----------- 156 (717)
|.. .+|+.+.+..+ +.......|.+. +|+.+.+..+ ++.+....|..+.+++.+.+..+.....
T Consensus 110 F~~--~~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (379)
T 4h09_A 110 FQG--TDLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNK 184 (379)
T ss_dssp TTT--CCCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTS
T ss_pred ecc--CCcccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceeccccc
Confidence 544 36888888654 333445556554 5666665543 4445566777777777777665433211
Q ss_pred -CCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccC
Q 005040 157 -VPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQK 235 (717)
Q Consensus 157 -~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 235 (717)
....+.....+..+.+..+... .....+....+|+.+.+..+ +.......|.++.+|+.+.+..+ ++.+...+|.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~ 261 (379)
T 4h09_A 185 TILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQN 261 (379)
T ss_dssp SEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTT
T ss_pred ceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccce
Confidence 1123344455556555544332 44455666777777777654 33355566777777777777665 55566667777
Q ss_pred CCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEE
Q 005040 236 LNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFN 315 (717)
Q Consensus 236 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~ 315 (717)
+.+|+.+.+..+ ++.+....|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.
T Consensus 262 ~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 339 (379)
T 4h09_A 262 CTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTIS 339 (379)
T ss_dssp CTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCC
T ss_pred eehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEE
Confidence 777777777544 44455566777777777777777776666677777777777777654 5545566777777777777
Q ss_pred ccCC
Q 005040 316 VSHN 319 (717)
Q Consensus 316 l~~N 319 (717)
+..+
T Consensus 340 ip~~ 343 (379)
T 4h09_A 340 YPKS 343 (379)
T ss_dssp CCTT
T ss_pred ECCc
Confidence 6543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=2.5e-12 Score=134.62 Aligned_cols=103 Identities=22% Similarity=0.238 Sum_probs=56.1
Q ss_pred eEEecCc-cccCCCChhhhcccCCCeEEccC-CcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccC
Q 005040 193 SLYLQSN-KLSSSLPSSLWSLEYILRINLSS-NSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAG 270 (717)
Q Consensus 193 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 270 (717)
.++++++ .|+ .+|. +..+++|+.|+|++ |.|++..+..|.++++|+.|+|++|.|++..|..|..+++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3455555 555 2444 55555566666654 555555555555555555555555555555555555555555555555
Q ss_pred ccccCCCCccccccCccceEeccCCCCC
Q 005040 271 NQFQGPIPESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 271 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 298 (717)
|+|++..+..|..++ |+.|+|++|++.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 555544444444433 555555555554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.8e-10 Score=121.87 Aligned_cols=131 Identities=10% Similarity=0.094 Sum_probs=58.0
Q ss_pred ccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCC
Q 005040 159 HDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV 238 (717)
Q Consensus 159 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 238 (717)
..+....+|+.+.+..+ +..+....|.++..|+.+.+..+ ++.+....|.++.+|+.+.+..+ ++......|.++.+
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~ 287 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN 287 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence 33444444444444433 22233334444444555544443 33233344444445555544332 33233344444455
Q ss_pred CCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEecc
Q 005040 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFS 293 (717)
Q Consensus 239 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 293 (717)
|+.+.+.++.++.+....|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+.
T Consensus 288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred cccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 555555444444444444444555555554332 333334444444455544443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=4.5e-12 Score=132.59 Aligned_cols=103 Identities=24% Similarity=0.296 Sum_probs=74.6
Q ss_pred EEeccCC-cCcccCCccccCCCCCCeEEecC-ccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccC
Q 005040 169 ILNLSGN-KLSGAIPQCLASLTSLRSLYLQS-NKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSR 246 (717)
Q Consensus 169 ~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 246 (717)
.++++++ +|+. +|. +..+++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4677776 7773 555 77777777777775 777766666777777777777777777777777777777777777777
Q ss_pred CCCCCCCcccccCCcccccccccCcccc
Q 005040 247 NQLSSDIPSTIGTLKNLETLSLAGNQFQ 274 (717)
Q Consensus 247 N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 274 (717)
|+|++..+..|..++ |+.|+|++|++.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 777765555555555 777777777776
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.6e-11 Score=121.43 Aligned_cols=148 Identities=14% Similarity=0.125 Sum_probs=115.0
Q ss_pred HHHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEE
Q 005040 422 IRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 422 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 500 (717)
++....+|+....++.|+.+.||++... ++.+++|+...........+.+|.++++.+. +..+.++++++.+.+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567888888888899999999864 6889999987533222345788999999984 6778899999988889999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH------------------------------------ 544 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 544 (717)
||||++|.+|.+.+.. ......++.++++++..||...
T Consensus 88 v~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999876321 1223467889999999999721
Q ss_pred -------------------CCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 545 -------------------SSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 545 -------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
....++|+|+++.||+++.+..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876667799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.4e-10 Score=115.93 Aligned_cols=139 Identities=14% Similarity=0.096 Sum_probs=100.7
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCc--eeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN--LLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~ 504 (717)
.++......+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+++.+ +.+++++..+.+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344443333456669999998777888999987643 2245677999999986444 55688888877888999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---------------------------------------
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS--------------------------------------- 545 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--------------------------------------- 545 (717)
++|.++. ... .+ ...++.++++.+..||....
T Consensus 97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 9998884 211 12 23567788888888885320
Q ss_pred ---------------CCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 546 ---------------SAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 546 ---------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
...++|+|++|.||+++.++.+.|+|||.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999997653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.05 E-value=5.6e-11 Score=123.62 Aligned_cols=154 Identities=21% Similarity=0.260 Sum_probs=70.4
Q ss_pred ccCCCCCCEEeccCCc-CcccCCccccCCCCCCeEEecCccccCCCChhhh--cccCCCeEEccC--CcCccc-----CC
Q 005040 161 LCHLERLNILNLSGNK-LSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW--SLEYILRINLSS--NSLKGT-----LP 230 (717)
Q Consensus 161 ~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~--N~l~~~-----~~ 230 (717)
+..+++|+.|+|++|. +. .+. +. +++|+.|+|..|.+.......+. .+++|++|+|+. |...+. +.
T Consensus 168 l~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~ 243 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243 (362)
T ss_dssp HHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG
T ss_pred HhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH
Confidence 3455566666665552 21 111 22 55666666666555432222232 455666666542 111100 00
Q ss_pred ccc--cCCCCCCeEEccCCCCCCCCcccc---cCCcccccccccCccccCCC----CccccccCccceEeccCCCCCCCC
Q 005040 231 SNI--QKLNVLIDLDLSRNQLSSDIPSTI---GTLKNLETLSLAGNQFQGPI----PESVGNLISLESLDFSNNNLSGKI 301 (717)
Q Consensus 231 ~~~--~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~~~~~~ 301 (717)
..+ ..+++|+.|+|++|.+.+..+..+ ..+++|++|+|+.|.+.+.. +..+..+++|+.|+|++|.|+...
T Consensus 244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~ 323 (362)
T 2ra8_A 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323 (362)
T ss_dssp GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH
T ss_pred HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH
Confidence 111 235566666666666553222222 13556666666666665432 222234556666666666555332
Q ss_pred cccccc-cccccEEEccCCc
Q 005040 302 PKSLEA-LSHLKQFNVSHNR 320 (717)
Q Consensus 302 ~~~~~~-l~~L~~L~l~~N~ 320 (717)
-..+.. + ...+++++++
T Consensus 324 ~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 324 KKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHC--CSEEECCSBC
T ss_pred HHHHHHHc--CCEEEecCCc
Confidence 222322 1 2345555554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.05 E-value=6.4e-11 Score=123.22 Aligned_cols=57 Identities=21% Similarity=0.189 Sum_probs=25.7
Q ss_pred ccCCCCCcEEEccCCC-CcccCCccccccCCCCEEeccCCcccccCCcccc--CCCCCCEEecc
Q 005040 113 IGNLRGLIVLSLGFND-LNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLC--HLERLNILNLS 173 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~--~l~~L~~L~L~ 173 (717)
+..+|+|+.|+|++|. +. .+. +. +++|++|+|..|.+.......++ .+++|+.|+|+
T Consensus 168 l~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred HhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 3445555555555542 21 111 22 45555555555555433222222 44555555553
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=3e-09 Score=111.57 Aligned_cols=143 Identities=14% Similarity=0.199 Sum_probs=106.3
Q ss_pred ccccccccccEEEEEEEecCCCeEEEEEec--hhh-HHHHHHHHHHHHHHHhcC--CCceeeEeeeeecC---CeeEEEE
Q 005040 431 ECNLLGTGGFGSVYKGTLSDGTNVAIKIFN--LQL-ERAFRSFDSECEILRNVR--HRNLLKILGSCSNL---DFKALVL 502 (717)
Q Consensus 431 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~---~~~~lv~ 502 (717)
.++.++.|.++.||+.... +..+++|+.. ... ......+.+|.++++.+. +..+.++++++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999999875 4678888876 332 123356788999999996 45678888888766 4579999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS------------------------------------- 545 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~------------------------------------- 545 (717)
||++|..+.+. .-..++...+..++.++++.|..||....
T Consensus 121 e~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99998777431 11226778888899999999999996310
Q ss_pred -----------------CCCeEecCCCCCCeeeCCCCc--EEEeeeccccc
Q 005040 546 -----------------SAPIIHCDLKPTNILLDENMV--AHVSDFGISKL 577 (717)
Q Consensus 546 -----------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~ 577 (717)
...++|||+++.||+++.++. +.+.||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=2.4e-09 Score=109.49 Aligned_cols=188 Identities=16% Similarity=0.156 Sum_probs=121.8
Q ss_pred cccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCc--eeeEeeeeecCC---eeEEEEEcc
Q 005040 432 CNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRN--LLKILGSCSNLD---FKALVLEFM 505 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpn--iv~~~~~~~~~~---~~~lv~e~~ 505 (717)
++.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+.+......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 56889986543 33467888999999883 322 344555443332 348999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH----------------------------------------- 544 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------- 544 (717)
+|.++.+.... .++..++..++.++++.+..||...
T Consensus 99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99888653332 2667777888888888888888521
Q ss_pred -------------CCCCeEecCCCCCCeeeCC--CCcEEEeeeccccccCCCCCceeeecc---ccC-------ccc--c
Q 005040 545 -------------SSAPIIHCDLKPTNILLDE--NMVAHVSDFGISKLLGEGEDSVIQTMT---MAT-------IGY--M 597 (717)
Q Consensus 545 -------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~---~~t-------~~y--~ 597 (717)
....++|+|+++.||+++. +..+.++||+.+..-....+-...... .+. .+| .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 1135899999999999998 556889999988754221110000000 000 001 1
Q ss_pred C-CCccCCCCcCcccchhhHHHHHHHHHhCCCCC
Q 005040 598 A-PEYGSEGIVSTKCDVYSYGVLLMETFTEKKPT 630 (717)
Q Consensus 598 a-PE~~~~~~~~~~~Dvws~G~il~el~tg~~p~ 630 (717)
. |+... ......+.|++|.++|.+.+|+.+|
T Consensus 256 ~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 11111 1112368999999999999998875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.69 E-value=1.3e-09 Score=102.25 Aligned_cols=87 Identities=15% Similarity=0.105 Sum_probs=43.5
Q ss_pred CCCCcEEEccCCCCccc----CCccccccCCCCEEeccCCccccc----CCccccCCCCCCEEec--cCCcCcccC----
Q 005040 116 LRGLIVLSLGFNDLNGT----IPTSIGTLQQLQGFYVPENNLQGY----VPHDLCHLERLNILNL--SGNKLSGAI---- 181 (717)
Q Consensus 116 l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L--~~n~l~~~~---- 181 (717)
.++|++|+|++|.|... +...+...++|++|+|++|.|+.. +...+...++|++|+| ++|.|+...
T Consensus 64 ~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l 143 (185)
T 1io0_A 64 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 143 (185)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHH
Confidence 34455555555555422 122233344555555555555533 1233444556666666 556665332
Q ss_pred CccccCCCCCCeEEecCcccc
Q 005040 182 PQCLASLTSLRSLYLQSNKLS 202 (717)
Q Consensus 182 ~~~~~~l~~L~~L~L~~N~l~ 202 (717)
...+...++|++|+|++|.+.
T Consensus 144 ~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 144 ANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeccCCCCC
Confidence 223444566667777666665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.65 E-value=3.8e-09 Score=99.07 Aligned_cols=92 Identities=24% Similarity=0.173 Sum_probs=47.2
Q ss_pred ccccCCCCCcEEEccCC-CCccc----CCccccccCCCCEEeccCCcccccCC----ccccCCCCCCEEeccCCcCcccC
Q 005040 111 KEIGNLRGLIVLSLGFN-DLNGT----IPTSIGTLQQLQGFYVPENNLQGYVP----HDLCHLERLNILNLSGNKLSGAI 181 (717)
Q Consensus 111 ~~~~~l~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l~~~~ 181 (717)
..+...++|++|+|++| .|... +...+...++|++|+|++|.|..... ..+...++|++|+|++|.|++..
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34556677777777777 66532 22334445566666666666654322 22333355555555555555321
Q ss_pred ----CccccCCCCCCeEEe--cCcccc
Q 005040 182 ----PQCLASLTSLRSLYL--QSNKLS 202 (717)
Q Consensus 182 ----~~~~~~l~~L~~L~L--~~N~l~ 202 (717)
...+...++|++|+| ++|.|+
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 223334444555555 445444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.45 E-value=1.9e-08 Score=99.01 Aligned_cols=78 Identities=26% Similarity=0.402 Sum_probs=34.7
Q ss_pred CCCCCeEEccCCCCCCC--CcccccCCcccccccccCccccCCCCccccccC--ccceEeccCCCCCCCCc-------cc
Q 005040 236 LNVLIDLDLSRNQLSSD--IPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI--SLESLDFSNNNLSGKIP-------KS 304 (717)
Q Consensus 236 l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~L~~N~~~~~~~-------~~ 304 (717)
+++|+.|+|++|.|++. ++..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|++.+..| ..
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 44444444444444431 123334444555555555554432 1122222 55555555555554333 12
Q ss_pred ccccccccEEE
Q 005040 305 LEALSHLKQFN 315 (717)
Q Consensus 305 ~~~l~~L~~L~ 315 (717)
+..+|+|+.||
T Consensus 247 l~~~P~L~~LD 257 (267)
T 3rw6_A 247 RERFPKLLRLD 257 (267)
T ss_dssp HHHCTTCCEES
T ss_pred HHHCcccCeEC
Confidence 44555555443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.44 E-value=3.3e-08 Score=97.31 Aligned_cols=79 Identities=27% Similarity=0.322 Sum_probs=41.2
Q ss_pred CCCCCCeEEecCccccC--CCChhhhcccCCCeEEccCCcCcccCCccccCCC--CCCeEEccCCCCCCCCcc-------
Q 005040 187 SLTSLRSLYLQSNKLSS--SLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLN--VLIDLDLSRNQLSSDIPS------- 255 (717)
Q Consensus 187 ~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~~------- 255 (717)
++++|+.|+|++|+|++ .++..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+..|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 44555555555555554 2234445555666666666665543 2222222 566666666666543331
Q ss_pred cccCCccccccc
Q 005040 256 TIGTLKNLETLS 267 (717)
Q Consensus 256 ~~~~l~~L~~L~ 267 (717)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 245566666654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3.3e-06 Score=85.94 Aligned_cols=137 Identities=14% Similarity=0.097 Sum_probs=94.1
Q ss_pred cccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCC---ceeeEeeeee-cCCeeEEEEEccCC
Q 005040 432 CNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHR---NLLKILGSCS-NLDFKALVLEFMPN 507 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp---niv~~~~~~~-~~~~~~lv~e~~~~ 507 (717)
++.++.|....||+. ++.+++|+.... .....+.+|.++++.+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899987 567889985422 3346788899999999642 3556666653 45567899999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH------------------------------------------- 544 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 544 (717)
.++.+..-. .++......++.++++.|..||...
T Consensus 98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 887653211 1344455555555555555555421
Q ss_pred -------------CCCCeEecCCCCCCeeeCC---CCc-EEEeeeccccc
Q 005040 545 -------------SSAPIIHCDLKPTNILLDE---NMV-AHVSDFGISKL 577 (717)
Q Consensus 545 -------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgl~~~ 577 (717)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335799999999999997 455 58999997653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.7e-06 Score=85.05 Aligned_cols=136 Identities=18% Similarity=0.114 Sum_probs=98.1
Q ss_pred cccccccE-EEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 434 LLGTGGFG-SVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 434 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68988765 5678999987644 2356778999999884 33467888888888999999999999888
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 005040 511 EKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH---------------------------------------------- 544 (717)
Q Consensus 511 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------- 544 (717)
.+...... .....+..+++..|..||...
T Consensus 108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 77654321 123345666777777777421
Q ss_pred --------CCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 545 --------SSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 545 --------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
....++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 011278999999999999887778999997653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.21 E-value=5e-07 Score=82.29 Aligned_cols=84 Identities=10% Similarity=0.057 Sum_probs=45.3
Q ss_pred CCCcEEEccCCCCcccCCccccccCCCCEEeccCCc-ccccCCccccCC----CCCCEEeccCCc-CcccCCccccCCCC
Q 005040 117 RGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENN-LQGYVPHDLCHL----ERLNILNLSGNK-LSGAIPQCLASLTS 190 (717)
Q Consensus 117 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~ 190 (717)
.+|+.|||+++.|+......+.++++|++|+|++|. |++..-..++.+ ++|++|+|++|. |++..-..++.+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666655544555556666666666653 554333344443 246666666653 55433344555556
Q ss_pred CCeEEecCcc
Q 005040 191 LRSLYLQSNK 200 (717)
Q Consensus 191 L~~L~L~~N~ 200 (717)
|++|+|++|.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666665553
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.11 E-value=8e-07 Score=80.92 Aligned_cols=83 Identities=12% Similarity=0.105 Sum_probs=36.5
Q ss_pred CCCEEeccCCcCcccCCccccCCCCCCeEEecCcc-ccCCCChhhhcc----cCCCeEEccCCc-CcccCCccccCCCCC
Q 005040 166 RLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNK-LSSSLPSSLWSL----EYILRINLSSNS-LKGTLPSNIQKLNVL 239 (717)
Q Consensus 166 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~l~~N~-l~~~~~~~~~~l~~L 239 (717)
.|+.|||++|.|+...-..+.++++|++|+|++|. |++..-..+..+ ++|++|+|++|. |+...-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 34444444444443333334444444444444442 332222223332 245555555543 443333344455555
Q ss_pred CeEEccCCC
Q 005040 240 IDLDLSRNQ 248 (717)
Q Consensus 240 ~~L~l~~N~ 248 (717)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 555555553
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=5.2e-06 Score=86.61 Aligned_cols=80 Identities=9% Similarity=-0.009 Sum_probs=55.2
Q ss_pred cccc-cccccEEEEEEEec-------CCCeEEEEEechhhH--H-HHHHHHHHHHHHHhcC-C--CceeeEeeeeecC--
Q 005040 432 CNLL-GTGGFGSVYKGTLS-------DGTNVAIKIFNLQLE--R-AFRSFDSECEILRNVR-H--RNLLKILGSCSNL-- 495 (717)
Q Consensus 432 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~--~-~~~~~~~e~~~l~~l~-h--pniv~~~~~~~~~-- 495 (717)
.+.| +.|....+|+.... +++.+++|+...... . ....+.+|.++++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998764 267789998754320 0 1245677888888884 3 3567778777654
Q ss_pred -CeeEEEEEccCCCCHH
Q 005040 496 -DFKALVLEFMPNGSLE 511 (717)
Q Consensus 496 -~~~~lv~e~~~~g~L~ 511 (717)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 4568999999886543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.92 E-value=1.9e-06 Score=80.07 Aligned_cols=54 Identities=11% Similarity=0.128 Sum_probs=32.3
Q ss_pred CCCCCCCCEEEcccc-cccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchh
Q 005040 32 FGNLRHLSVLSLMMN-NLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIG 89 (717)
Q Consensus 32 ~~~l~~L~~L~L~~n-~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 89 (717)
+.+-+.|++|+|++| +|.+... ..+.+.+...+.|++|+|++|+|+......+.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga----~~la~aL~~N~~L~~L~L~~n~igd~ga~alA 91 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERI----RSLIEAACNSKHIEKFSLANTAISDSEARGLI 91 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHH----HHHHHHHTTCSCCCEEECTTSCCBHHHHTTHH
T ss_pred HhcCCCccEEECCCCCCCCHHHH----HHHHHHHhhCCCcCEEEccCCCCChHHHHHHH
Confidence 344566777777764 6654321 12345566677777777777777755444443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.79 E-value=7.7e-06 Score=75.91 Aligned_cols=62 Identities=15% Similarity=0.041 Sum_probs=30.2
Q ss_pred ccCCCCCcEEEccCCCCcccC----CccccccCCCCEEeccCCcccccCCc----cccCCCCCCEEeccC
Q 005040 113 IGNLRGLIVLSLGFNDLNGTI----PTSIGTLQQLQGFYVPENNLQGYVPH----DLCHLERLNILNLSG 174 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~l~~n~i~~~~~~----~~~~l~~L~~L~L~~ 174 (717)
+..-+.|+.|+|++|+|.... ...+..-+.|++|+|++|.|+..... ++..-+.|++|+|++
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADN 135 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCC
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCC
Confidence 444456666666666665332 22233445566666666665543222 223334455555544
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00015 Score=74.86 Aligned_cols=139 Identities=17% Similarity=0.123 Sum_probs=78.6
Q ss_pred ccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-----CCceeeEe-e--eeecCCeeEEEEEc
Q 005040 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-----HRNLLKIL-G--SCSNLDFKALVLEF 504 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~~~-~--~~~~~~~~~lv~e~ 504 (717)
+.|+.|..+.||+....+| .+++|+..... ..+..|.++++.+. .|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987655 48899887532 22334555555553 34444311 1 11345677999999
Q ss_pred cCCCCHH--------------HHHhh--CCC-----------CCCHHHH-------------------------------
Q 005040 505 MPNGSLE--------------KWLYS--HNY-----------FLDILQR------------------------------- 526 (717)
Q Consensus 505 ~~~g~L~--------------~~l~~--~~~-----------~~~~~~~------------------------------- 526 (717)
++|..+. ..++. ... ...|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986431 11121 100 0123211
Q ss_pred HHHHHHHHHHHHHHhh--------c-CCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 527 LNIMIDVGSALEYLHH--------C-HSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 527 ~~i~~~i~~~l~~LH~--------~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
..+...+..++.+|+. . .....++|+|+.+.||+++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111123345666652 0 014679999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=6.4e-05 Score=79.54 Aligned_cols=75 Identities=15% Similarity=0.158 Sum_probs=48.9
Q ss_pred cccccccccEEEEEEEec-CCCeEEEEEechhhH-------HHHHHHHHHHHHHHhcCC--Cc-eeeEeeeeecCCeeEE
Q 005040 432 CNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-------RAFRSFDSECEILRNVRH--RN-LLKILGSCSNLDFKAL 500 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--pn-iv~~~~~~~~~~~~~l 500 (717)
.+.+|.|..+.||++... +++.++||....... .....+..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 568899997653221 112345678889888742 33 4455544 3345689
Q ss_pred EEEccCCC
Q 005040 501 VLEFMPNG 508 (717)
Q Consensus 501 v~e~~~~g 508 (717)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00016 Score=72.64 Aligned_cols=78 Identities=18% Similarity=0.156 Sum_probs=56.2
Q ss_pred cCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-C--CceeeEeeeeecCCeeEEEEEc
Q 005040 428 EFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-H--RNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 428 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--pniv~~~~~~~~~~~~~lv~e~ 504 (717)
+...+..+|.|..+.||+.+..||+.|++|+...........+..|.+.|+.+. . -.+.+.+++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 445567899999999999999999999999876443333345778999999884 2 1344555442 23799999
Q ss_pred cCCCC
Q 005040 505 MPNGS 509 (717)
Q Consensus 505 ~~~g~ 509 (717)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00051 Score=69.40 Aligned_cols=137 Identities=15% Similarity=0.095 Sum_probs=91.0
Q ss_pred cccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC---CCceeeEeeeeecCCeeEEEEEccCCC
Q 005040 432 CNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR---HRNLLKILGSCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~g 508 (717)
.+.|+.|....+|+... +++.+++|+.... ....+..|.+.|+.+. ...+.+.+++....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999986 4678889987643 2356778999888883 356888888887778899999999987
Q ss_pred CHH--------H---HHhhCCC---------------------CCCHHHHH---HHH----------------HHHHHHH
Q 005040 509 SLE--------K---WLYSHNY---------------------FLDILQRL---NIM----------------IDVGSAL 537 (717)
Q Consensus 509 ~L~--------~---~l~~~~~---------------------~~~~~~~~---~i~----------------~~i~~~l 537 (717)
.+. . .++.... .-+|.... ++. ..++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 541 1 1222110 11454322 111 1111111
Q ss_pred -HHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 005040 538 -EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573 (717)
Q Consensus 538 -~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 573 (717)
..|........++|+|+.+.|++++.++ +.+.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2332212245799999999999999887 8888874
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00024 Score=61.52 Aligned_cols=62 Identities=18% Similarity=0.286 Sum_probs=44.9
Q ss_pred cccccCcccc-CCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccc
Q 005040 265 TLSLAGNQFQ-GPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVK 328 (717)
Q Consensus 265 ~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~ 328 (717)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|+|.+.....
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~ 74 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLV 74 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGH
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccH
Confidence 5666777665 23444332 36888888888888777778888888889999999988766543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00079 Score=71.61 Aligned_cols=80 Identities=15% Similarity=0.114 Sum_probs=48.2
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCC---CCcCcccchhhHHHHHHH
Q 005040 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE---GIVSTKCDVYSYGVLLME 622 (717)
Q Consensus 546 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~G~il~e 622 (717)
...++|||+++.||+++.++ ++++||+.+..-....+-. .....-...|.+|+.... .......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 46799999999999999876 9999999887532111100 000001133555554321 112234555678888888
Q ss_pred HHhCC
Q 005040 623 TFTEK 627 (717)
Q Consensus 623 l~tg~ 627 (717)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0017 Score=66.67 Aligned_cols=140 Identities=12% Similarity=0.069 Sum_probs=73.6
Q ss_pred ccccccccEE-EEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-C-CceeeEeeeeecCCeeEEEEEccCCCC
Q 005040 433 NLLGTGGFGS-VYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-H-RNLLKILGSCSNLDFKALVLEFMPNGS 509 (717)
Q Consensus 433 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-pniv~~~~~~~~~~~~~lv~e~~~~g~ 509 (717)
+.|+.|.... +|+....+++.+++|....... ..+..|+++++.+. + -.+.+++.+..+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565565554 6677654477788887654321 23345677777663 2 23455666543333 78999997766
Q ss_pred HHHHHhhCC-------------------------CCCCHHHHH-------H-------------HHHHHHHHHHHHhh--
Q 005040 510 LEKWLYSHN-------------------------YFLDILQRL-------N-------------IMIDVGSALEYLHH-- 542 (717)
Q Consensus 510 L~~~l~~~~-------------------------~~~~~~~~~-------~-------------i~~~i~~~l~~LH~-- 542 (717)
+.+++.... ..++..... . ....+...+..+.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655443210 001111100 0 00011122222211
Q ss_pred cCCCCCeEecCCCCCCeeeCCC----CcEEEeeeccccc
Q 005040 543 CHSSAPIIHCDLKPTNILLDEN----MVAHVSDFGISKL 577 (717)
Q Consensus 543 ~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~ 577 (717)
......++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 0114579999999999999875 6899999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0014 Score=66.15 Aligned_cols=71 Identities=11% Similarity=0.096 Sum_probs=44.1
Q ss_pred cccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCce-eeEeeeeecCCeeEEEEEcc-CCCC
Q 005040 432 CNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNL-LKILGSCSNLDFKALVLEFM-PNGS 509 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~-~~g~ 509 (717)
++.|+.|....+|+. +.+++|+....... .....+|..+++.+...++ .+++++. .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 578888999999998 56889987643211 1123457888877742222 4555543 33347899999 5544
Q ss_pred H
Q 005040 510 L 510 (717)
Q Consensus 510 L 510 (717)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0034 Score=63.97 Aligned_cols=155 Identities=12% Similarity=0.128 Sum_probs=85.0
Q ss_pred HHHHHHHhccCCc-----cccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCc--eeeEeee
Q 005040 419 YLDIRRATDEFNE-----CNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN--LLKILGS 491 (717)
Q Consensus 419 ~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~ 491 (717)
..++.....+|.. .+.|+.|....+|+....+| .+++|+..... ....+..|.++++.+.... +.+++..
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 3445555455554 34566788889999987655 68899887531 1234556777777774212 2333321
Q ss_pred ------eecCCeeEEEEEccCCCCHH-----------H---HHhhC----CCC----C---CHHHHHH------------
Q 005040 492 ------CSNLDFKALVLEFMPNGSLE-----------K---WLYSH----NYF----L---DILQRLN------------ 528 (717)
Q Consensus 492 ------~~~~~~~~lv~e~~~~g~L~-----------~---~l~~~----~~~----~---~~~~~~~------------ 528 (717)
....+..+++++|++|..+. . .++.. ... . .|.....
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 11235568999999875431 1 11110 000 0 1222110
Q ss_pred HHHHHHHHHHHHhhcC---CCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 529 IMIDVGSALEYLHHCH---SSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 529 i~~~i~~~l~~LH~~~---~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
+...+.+.+.++++.. ....++|+|+.+.||+++.+..+.++||+.+.
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0112344555555321 13569999999999999987666899998765
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0016 Score=56.31 Aligned_cols=57 Identities=26% Similarity=0.326 Sum_probs=45.4
Q ss_pred cEEECCCCcce-ecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCc
Q 005040 15 IGLDLGLNSFS-GHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 15 ~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
+.++.++++++ ..+|..+. .+|++|+|++|+|+.++.+. |..+++|++|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~--------f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGL--------LDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTT--------GGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhh--------hhhccccCEEEecCCCee
Confidence 47889999887 24565432 36899999999999988765 788889999999999886
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0068 Score=56.37 Aligned_cols=102 Identities=14% Similarity=0.064 Sum_probs=68.9
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCceeee
Q 005040 509 SLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQT 588 (717)
Q Consensus 509 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 588 (717)
+|.+.|+..+.+++++++|.++.|.+.+|.-.-.. ..+ ..+=+.|..|++..+|.|...+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCC-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccC-CceecCCcceEEecCCceeccc-cccc------------
Confidence 89999998888899999999999999998776210 011 1223456899999999987764 1110
Q ss_pred ccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCC
Q 005040 589 MTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629 (717)
Q Consensus 589 ~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p 629 (717)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122366888753 3556788999999999998876555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0045 Score=64.21 Aligned_cols=140 Identities=14% Similarity=0.176 Sum_probs=82.4
Q ss_pred ccccccccEEEEEEEec--------CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEEE
Q 005040 433 NLLGTGGFGSVYKGTLS--------DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 503 (717)
+.+..|-...+|+.... +++.+++|+..... .......+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46766888889998864 35789999874321 22345567999998884 3323566666654 39999
Q ss_pred ccCCCCHH--------------HHH---hhC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 005040 504 FMPNGSLE--------------KWL---YSH----NYFLD--ILQRLNIMIDVGS-------------------ALEYL- 540 (717)
Q Consensus 504 ~~~~g~L~--------------~~l---~~~----~~~~~--~~~~~~i~~~i~~-------------------~l~~L- 540 (717)
|++|.++. +.+ +.- +.... +.++.++..++.. .+.+|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99875432 111 111 11122 3445555444322 22333
Q ss_pred ---hhcCCCCCeEecCCCCCCeeeCCC----CcEEEeeeccccc
Q 005040 541 ---HHCHSSAPIIHCDLKPTNILLDEN----MVAHVSDFGISKL 577 (717)
Q Consensus 541 ---H~~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~ 577 (717)
........++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222224568999999999999876 7899999997753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0023 Score=67.95 Aligned_cols=71 Identities=17% Similarity=0.216 Sum_probs=48.1
Q ss_pred cccccccccEEEEEEEecC--------CCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCc-eeeEeeeeecCCeeEEEE
Q 005040 432 CNLLGTGGFGSVYKGTLSD--------GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN-LLKILGSCSNLDFKALVL 502 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~ 502 (717)
++.|+.|....+|++...+ ++.+++|+...... ...+..|..+++.+...+ ..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998753 57899999843211 134456888888884333 3566666543 3899
Q ss_pred EccCCC
Q 005040 503 EFMPNG 508 (717)
Q Consensus 503 e~~~~g 508 (717)
||++|.
T Consensus 152 e~l~G~ 157 (429)
T 1nw1_A 152 EYIPSR 157 (429)
T ss_dssp CCCCEE
T ss_pred EEeCCc
Confidence 999763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0064 Score=62.05 Aligned_cols=141 Identities=11% Similarity=0.079 Sum_probs=79.8
Q ss_pred ccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCC--ceeeEeee-----eecCCeeEEEEEcc
Q 005040 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHR--NLLKILGS-----CSNLDFKALVLEFM 505 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~~~~-----~~~~~~~~lv~e~~ 505 (717)
..++ |....||+....+|+.+++|+..... .....+..|..+++.+... .+.+++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77889999887778789999986431 1224556688888877421 23344432 12244568899999
Q ss_pred CCCCHH-----------HH---Hhh----CC----CCCCHHHH----HHH---------------HHHHHHHHHHHhhcC
Q 005040 506 PNGSLE-----------KW---LYS----HN----YFLDILQR----LNI---------------MIDVGSALEYLHHCH 544 (717)
Q Consensus 506 ~~g~L~-----------~~---l~~----~~----~~~~~~~~----~~i---------------~~~i~~~l~~LH~~~ 544 (717)
+|..+. .. ++. .. ...++... ..+ ...+...+..+....
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874321 11 111 00 11222111 000 011112233332211
Q ss_pred ---CCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 545 ---SSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 545 ---~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
....++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 135689999999999999 4 899999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0031 Score=65.65 Aligned_cols=73 Identities=14% Similarity=0.251 Sum_probs=43.9
Q ss_pred cccccccccEEEEEEEecC---------CCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCc-eeeEeeeeecCCeeEEE
Q 005040 432 CNLLGTGGFGSVYKGTLSD---------GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN-LLKILGSCSNLDFKALV 501 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~lv 501 (717)
.+.++.|....+|+....+ ++.+++|+....... ......|.++++.+...+ ..++++... -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 3467778888999998753 268899987643221 112356888888874323 345665442 2689
Q ss_pred EEccCCCC
Q 005040 502 LEFMPNGS 509 (717)
Q Consensus 502 ~e~~~~g~ 509 (717)
|||++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0071 Score=64.52 Aligned_cols=73 Identities=16% Similarity=0.156 Sum_probs=46.9
Q ss_pred cccccccccEEEEEEEecC-CCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCce-eeEeeeeecCCeeEEEEEccCCCC
Q 005040 432 CNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNL-LKILGSCSNLDFKALVLEFMPNGS 509 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~ 509 (717)
++.|+.|-...+|+....+ +..+++|+........ -+...|..+++.+...++ .++++.+.. .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 4568888889999998764 4788899875432111 112468899998864444 566766632 35999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.94 E-value=0.02 Score=58.70 Aligned_cols=32 Identities=19% Similarity=0.312 Sum_probs=27.9
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 546 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.85 E-value=0.14 Score=53.79 Aligned_cols=140 Identities=14% Similarity=0.174 Sum_probs=82.8
Q ss_pred cccccccccEEEEEEEecC--------CCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEE
Q 005040 432 CNLLGTGGFGSVYKGTLSD--------GTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 502 (717)
++.+..|-...+|+....+ ++.+++|+..... +..-+..+|.++++.+. +.-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567778888999998753 5789999875432 11122356888888874 322345555432 27899
Q ss_pred EccCCCCHH--------------HHH---h---h---------CCCCCCHHHHHHHHHHH-------------------H
Q 005040 503 EFMPNGSLE--------------KWL---Y---S---------HNYFLDILQRLNIMIDV-------------------G 534 (717)
Q Consensus 503 e~~~~g~L~--------------~~l---~---~---------~~~~~~~~~~~~i~~~i-------------------~ 534 (717)
||++|.+|. +.+ + . ...+..+.++..+..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 999885431 111 1 0 00111244444433322 2
Q ss_pred HHHHHHhh--------------------cCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 535 SALEYLHH--------------------CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 535 ~~l~~LH~--------------------~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
..+.+|.+ ......++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 111345899999999999 8888999999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.70 E-value=0.35 Score=50.58 Aligned_cols=29 Identities=34% Similarity=0.406 Sum_probs=24.7
Q ss_pred eEecCCCCCCeee------CCCCcEEEeeeccccc
Q 005040 549 IIHCDLKPTNILL------DENMVAHVSDFGISKL 577 (717)
Q Consensus 549 ivH~dlk~~Nill------~~~~~~kl~Dfgl~~~ 577 (717)
++|+|+.+.||++ +++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 717 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 4e-66
Identities = 66/286 (23%), Positives = 121/286 (42%), Gaps = 26/286 (9%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRN 484
+ +G+G FG+VYKG VA+K+ N+ + ++F +E +LR RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
+L +G + A+V ++ SL L+ ++++ ++I ++YLH
Sbjct: 66 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY--- 601
IIH DLK NI L E++ + DFG++ + S +I +MAPE
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
+ S + DVY++G++L E T + P + + + + L L++V
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS---- 236
Query: 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707
+C ++ L +C +R A + +
Sbjct: 237 ----------NCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 9e-57
Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 24/279 (8%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
E +G+G FG V+ G + VAIK F E E++ + H L+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
++ G C LV EFM +G L +L + L + +DV + YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGI 606
+IH DL N L+ EN V VSDFG+++ + + + + T T + + +PE S
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSR 178
Query: 607 VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666
S+K DV+S+GVL+ E F+E K E + + + + ++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVY----- 232
Query: 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+ C + P R + +L +I
Sbjct: 233 ------------QIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 3e-56
Identities = 72/305 (23%), Positives = 124/305 (40%), Gaps = 39/305 (12%)
Query: 418 SYLDIRRATDEFNEC---------NLLGTGGFGSVYKGTL----SDGTNVAIKIFNLQL- 463
++ D A EF + ++G G FG V G L VAIK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 464 ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 523
E+ R F SE I+ H N++ + G + ++ EFM NGSL+ +L ++ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 524 LQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583
+Q + ++ + + ++YL + +H DL NIL++ N+V VSDFG+S+ L +
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 584 SVIQTMT---MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL 640
T I + APE ++ DV+SYG+++ E + + T + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 641 RRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700
+ ++ MDC ++ L LDC + R
Sbjct: 244 NA------------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 701 KLRKI 705
L K+
Sbjct: 286 TLDKM 290
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-56
Identities = 58/280 (20%), Positives = 117/280 (41%), Gaps = 26/280 (9%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
+ LG G FG V+ G + T VA+K + +F +E +++ ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF-LDILQRLNIMIDVGSALEYLHHCHS 545
++ + + ++ E+M NGSL +L + + L I + L++ + + ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
IH DL+ NIL+ + + ++DFG+++L+ + E + + I + APE + G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYG 185
Query: 606 IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665
+ K DV+S+G+LL E T + T ++ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN------------------LERGY 227
Query: 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+C + L C + P R + L
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-56
Identities = 61/290 (21%), Positives = 114/290 (39%), Gaps = 22/290 (7%)
Query: 435 LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN 494
+G G FG V++G G VA+KIF+ + ER++ ++E +RH N+L + + +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 495 LDFKA----LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH----HCHSS 546
+ LV ++ +GSL +L + Y + + + + + S L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT--MATIGYMAPEYGSE 604
I H DLK NIL+ +N ++D G++ D++ + T YMAPE +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 605 GI------VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE--SLPHRLTEVV 656
I + D+Y+ G++ E ++ V S+ V
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706
+ L + L + + +C R+ L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 7e-56
Identities = 62/274 (22%), Positives = 114/274 (41%), Gaps = 12/274 (4%)
Query: 420 LDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRS-FDSECEIL 477
++++ D+F + + LG G G V+K + G +A K+ +L+++ A R+ E ++L
Sbjct: 1 MELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 478 RNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
++ G+ + ++ +E M GSL++ L + + I V L
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597
YL H I+H D+KP+NIL++ + DFG+S L + + T YM
Sbjct: 118 TYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYM 170
Query: 598 APEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657
+PE S + D++S G+ L+E + P E+ L + T
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHK 691
R ++ +I +L + P K
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-55
Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 24/279 (8%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
+ LGTG FG V G +VAIK+ + F E +++ N+ H L+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
++ G C+ ++ E+M NG L +L + Q L + DV A+EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 120
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGI 606
+H DL N L+++ V VSDFG+S+ + + E + + + + PE
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSK 177
Query: 607 VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666
S+K D++++GVL+ E ++ K E FT + + +R +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE--------- 228
Query: 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+ + C + +R + + +
Sbjct: 229 ---------KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-55
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 28/284 (9%)
Query: 435 LGTGGFGSVYKGTL---SDGTNVAIKIFNLQLERAFR-SFDSECEILRNVRHRNLLKILG 490
LG G FGSV +G +VAIK+ E+A E +I+ + + +++++G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 491 SCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPII 550
C LV+E G L K+L + + ++ V ++YL +
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK----NFV 131
Query: 551 HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGYMAPEYGSEGIVST 609
H DL N+LL A +SDFG+SK LG + + + APE + S+
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 610 KCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSD 669
+ DV+SYGV + E + + + G + ++++
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRMECPP--------------- 235
Query: 670 KMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713
+C + L DC + R ++R V
Sbjct: 236 --ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 9e-55
Identities = 71/282 (25%), Positives = 116/282 (41%), Gaps = 32/282 (11%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
E +G G FG V G G VA+K ++ + ++F +E ++ +RH NL+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 487 KILGSCSNLDFK-ALVLEFMPNGSLEKWLYSHNY-FLDILQRLNIMIDVGSALEYLHHCH 544
++LG +V E+M GSL +L S L L +DV A+EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 122
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE 604
+H DL N+L+ E+ VA VSDFG++K +D+ + + APE E
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALRE 174
Query: 605 GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664
STK DV+S+G+LL E ++ + + V++ +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPD---------- 223
Query: 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706
C ++ ++ +C R +L IK
Sbjct: 224 -------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-54
Identities = 70/321 (21%), Positives = 132/321 (41%), Gaps = 31/321 (9%)
Query: 400 TKHLDHEDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGTLSDGTN----VA 455
T H+D L P + ++ I ++ + ++G G FG VY GTL D A
Sbjct: 1 TVHIDLSA-LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 59
Query: 456 IKIFNLQLERAFRS-FDSECEILRNVRHRNLLKILGSCSNLDFKA-LVLEFMPNGSLEKW 513
+K N + S F +E I+++ H N+L +LG C + +VL +M +G L +
Sbjct: 60 VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119
Query: 514 LYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFG 573
+ + + + + + V +++L +H DL N +LDE V+DFG
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKK----FVHRDLAARNCMLDEKFTVKVADFG 175
Query: 574 ISKLLGEGEDSVIQTMT--MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTD 631
+++ + + E + T + +MA E +TK DV+S+GVLL E T P
Sbjct: 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-- 233
Query: 632 EMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHK 691
+++ + + + C + ++ L C
Sbjct: 234 --PYPDVNTFDITVY--------------LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEM 277
Query: 692 RIHMTDAAAKLRKIKAKFLDD 712
R ++ +++ I + F+ +
Sbjct: 278 RPSFSELVSRISAIFSTFIGE 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-54
Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 26/280 (9%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLL 486
+ LG G FG V+ GT + T VAIK + +F E ++++ +RH L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL-QRLNIMIDVGSALEYLHHCHS 545
++ S + +V E+M GSL +L L Q +++ + S + Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 546 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEG 605
+H DL+ NIL+ EN+V V+DFG+++L+ + E + + I + APE G
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYG 189
Query: 606 IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665
+ K DV+S+G+LL E T+ + + V+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPP----------- 237
Query: 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+C S+ DL C P +R A L
Sbjct: 238 ------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-53
Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 29/286 (10%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTN-----VAIKIFNLQL-ERAFRSFDSECEILRNV 480
++G G FG VYKG L + VAIK E+ F E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 481 RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
H N++++ G S ++ E+M NG+L+K+L + +LQ + ++ + + ++YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGYMAP 599
+ + +H DL NIL++ N+V VSDFG+S++L + ++ T I + AP
Sbjct: 127 ANMN----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 600 EYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659
E S ++ DV+S+G+++ E T + E+S +K
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGER----PYWELSNHEVMK-------------- 224
Query: 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+ + MDC +I L + C +R D + L K+
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-52
Identities = 59/281 (20%), Positives = 105/281 (37%), Gaps = 30/281 (10%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHR 483
+++ +GTG +G K SDG + K + E + SE +LR ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 484 NLLKILGSCSNLDFKAL--VLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALE 538
N+++ + L V+E+ G L + +LD L +M + AL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 539 YLH-HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597
H ++H DLKP N+ LD + DFG++++L D+ + T YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYM 181
Query: 598 APEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657
+PE + + K D++S G LL E P + L ++E R+
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFRRIPYRYS 239
Query: 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
L ++ + R + +
Sbjct: 240 DELN-----------------EIITRMLNLKDYHRPSVEEI 263
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (452), Expect = 2e-51
Identities = 68/291 (23%), Positives = 116/291 (39%), Gaps = 28/291 (9%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNL 485
+ + LG G +G VY+G VA+K F E +++ ++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF-LDILQRLNIMIDVGSALEYLHHCH 544
+++LG C+ ++ EFM G+L +L N + + L + + SA+EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 134
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE 604
IH DL N L+ EN + V+DFG+S+L+ G+ I + APE +
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 605 GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664
S K DV+++GVLL E T ++ E+++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------------LSQVYELLEKDYR--- 234
Query: 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI--KAKFLDDV 713
C + +L C P R + + ++ D+V
Sbjct: 235 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 2e-51
Identities = 67/293 (22%), Positives = 117/293 (39%), Gaps = 33/293 (11%)
Query: 419 YLDIRRATDEFNECNLLGTGGFGSVYKGTLSD---GTNVAIKIFNLQL--ERAFRSFDSE 473
YLD + T E E LG+G FG+V KG VA+KI + +E
Sbjct: 2 YLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 58
Query: 474 CEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533
+++ + + +++++G C + LV+E G L K+L + + + + ++ V
Sbjct: 59 ANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQV 116
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA- 592
++YL + +H DL N+LL A +SDFG+SK L E+
Sbjct: 117 SMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652
+ + APE + S+K DV+S+GVL+ E F+ + + G +
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK---PYRG---------------M 214
Query: 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
++ + + C + DL C R +LR
Sbjct: 215 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (451), Expect = 4e-51
Identities = 64/316 (20%), Positives = 115/316 (36%), Gaps = 54/316 (17%)
Query: 420 LDIRRATDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQLERAFRS-FDS 472
L+ R + +G G FG V++ T VA+K+ + ++ F
Sbjct: 8 LEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 473 ECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF------------ 520
E ++ + N++K+LG C+ L+ E+M G L ++L S +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 521 -----------LDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV 569
L ++L I V + + YL +H DL N L+ ENMV +
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKI 181
Query: 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+DFG+S+ + + I +M PE +T+ DV++YGV+L E F+
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 630 TDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTP 689
E + ++ + +C + +L C P
Sbjct: 242 PYYGMAHEEVIYYVRDGNIL------------------ACPENCPLELYNLMRLCWSKLP 283
Query: 690 HKRIHMTDAAAKLRKI 705
R L+++
Sbjct: 284 ADRPSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 60/304 (19%), Positives = 106/304 (34%), Gaps = 46/304 (15%)
Query: 427 DEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQLERAFR-SFDSECEILRN 479
+ + LG G FG V + T VA+K+ R + SE ++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 480 V-RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH-----------------NYFL 521
+ H N++ +LG+C+ ++ E+ G L +L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 522 DILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581
D+ L+ V + +L + IH DL NILL + + DFG+++ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR 641
+ V++ + +MAPE + + + DV+SYG+ L E F+ +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 642 RWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701
+ +KE + D+ C P KR
Sbjct: 259 KMIKEGFR-----------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 702 LRKI 705
+ K
Sbjct: 302 IEKQ 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-50
Identities = 66/288 (22%), Positives = 99/288 (34%), Gaps = 30/288 (10%)
Query: 427 DEFNECNLLGTGGFGSVYKGTL----SDGTNVAIKIFNLQL---ERAFRSFDSECEILRN 479
+ LG G FG V +G +VA+K + A F E + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 480 VRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
+ HRNL+++ G K +V E P GSL L H + + V + Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS-VIQTMTMATIGYMA 598
L IH DL N+LL + + DFG+ + L + +D V+Q + A
Sbjct: 127 LESKR----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658
PE S D + +GV L E FT + G L + KE
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--------- 233
Query: 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706
DC I ++ + C P R L + +
Sbjct: 234 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-50
Identities = 61/306 (19%), Positives = 110/306 (35%), Gaps = 51/306 (16%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTN------VAIKIFNLQLERAFR-SFDSECEILRN 479
+ +LG+G FG V T + VA+K+ + + + R + SE +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 480 V-RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHN-------------------- 518
+ H N++ +LG+C+ L+ E+ G L +L S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 519 --YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576
L L V +E+L +H DL N+L+ V + DFG+++
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 577 LLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTG 636
+ + V++ + +MAPE EGI + K DV+SYG+LL E F+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 637 EMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMT 696
+ + + ++ I + C KR
Sbjct: 273 DANFYKLIQNGFK-----------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 697 DAAAKL 702
+ + L
Sbjct: 316 NLTSFL 321
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (444), Expect = 5e-50
Identities = 61/280 (21%), Positives = 96/280 (34%), Gaps = 36/280 (12%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNL---QLERAFRSFDSECEILRNVR 481
F++ +G G FG+VY + + VAIK + Q ++ E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
H N ++ G LV+E+ + + H L ++ + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
S +IH D+K NILL E + + DFG + ++ + T +MAPE
Sbjct: 133 ----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEV 182
Query: 602 ---GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658
EG K DV+S G+ +E K P M L + P +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSE 241
Query: 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
+ C P R
Sbjct: 242 YFR-----------------NFVDSCLQKIPQDRPTSEVL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-50
Identities = 64/289 (22%), Positives = 103/289 (35%), Gaps = 32/289 (11%)
Query: 419 YLDIRR---ATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSEC 474
Y + R D + LG G FG VYK A K+ + + E + E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 475 EILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVG 534
+IL + H N++K+L + + +++EF G+++ + L Q +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 535 SALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATI 594
AL YLH IIH DLK NIL + ++DFG+S + + T
Sbjct: 121 DALNYLHDNK----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTP 174
Query: 595 GYMAPEY-----GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649
+MAPE + K DV+S G+ L+E + P E+ + L + K P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPP 233
Query: 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
+ + D C R +
Sbjct: 234 T----------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-49
Identities = 56/275 (20%), Positives = 101/275 (36%), Gaps = 25/275 (9%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNL-QLERAFRSFDSECEILRNVRHRN 484
++++ LG G +G V VA+KI ++ + + E I + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++K G + + L LE+ G L + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLHGIG 123
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY-GS 603
I H D+KP N+LLDE +SDFG++ + + T+ Y+APE
Sbjct: 124 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663
+ DV+S G++L + P D+ W ++ + +D+ +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL-- 237
Query: 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
L ++ P RI + D
Sbjct: 238 ---------------ALLHKILVENPSARITIPDI 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-49
Identities = 64/293 (21%), Positives = 117/293 (39%), Gaps = 30/293 (10%)
Query: 420 LDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL-----ERAFRSFDSE 473
L I + T+ F + +LG+G FG+VYKG + +G V I + +L +A + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 474 CEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDV 533
++ +V + ++ ++LG C + L+ + MP G L ++ H + LN + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMAT 593
+ YL ++H DL N+L+ ++DFG++KLLG E
Sbjct: 121 AKGMNYLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 594 IGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLT 653
I +MA E I + + DV+SYGV + E T +
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------------ 224
Query: 654 EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706
++ + + C + + + C M R + + K+
Sbjct: 225 ------ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 7e-49
Identities = 60/272 (22%), Positives = 102/272 (37%), Gaps = 33/272 (12%)
Query: 435 LGTGGFGSVYKGTLSD-GTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGS 491
+G G F +VYKG ++ VA + + + F E E+L+ ++H N+++ S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 492 C----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSA 547
LV E M +G+L+ +L + I + + L++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTP-- 133
Query: 548 PIIHCDLKPTNILL-DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGI 606
PIIH DLK NI + + D G++ L + + T +MAPE E
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYEEK- 188
Query: 607 VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQA 666
DVY++G+ ++E T + P E RR P +V +
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK----- 243
Query: 667 FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
++ C +R + D
Sbjct: 244 ------------EIIEGCIRQNKDERYSIKDL 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-48
Identities = 58/284 (20%), Positives = 101/284 (35%), Gaps = 29/284 (10%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTN----VAIKIFNLQLERAFRS-FDSECEILRNVR 481
+ +G G FG V++G N VAIK + R F E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
H +++K++G + + +++E G L +L Y LD+ + + +AL YL
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
+H D+ N+L+ N + DFG+S+ + E + I +MAPE
Sbjct: 126 SKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPES 180
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661
+ ++ DV+ +GV + E + + R
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT--- 237
Query: 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+ L C P +R T+ A+L I
Sbjct: 238 ---------------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 45/299 (15%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDG---TNVAIKIFNLQLER-AFRSFDSECEILRNV-R 481
++ +++G G FG V K + + AIK + R F E E+L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILQR 526
H N++ +LG+C + + L +E+ P+G+L +L L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 527 LNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586
L+ DV ++YL IH DL NIL+ EN VA ++DFG+S+ E V
Sbjct: 130 LHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVK 182
Query: 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKE 646
+TM + +MA E + + +T DV+SYGVLL E + M+ +
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC----GMTCAELYE- 237
Query: 647 SLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+ + ++C + DL C + P++R L ++
Sbjct: 238 -------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 7e-48
Identities = 67/276 (24%), Positives = 109/276 (39%), Gaps = 33/276 (11%)
Query: 427 DEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFN---LQLERAFRSFDSECEILRNVRH 482
++F LG G FG+VY +A+K+ L+ E EI ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
N+L++ G + L+LE+ P G++ + L + F D + + ++ +AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH- 123
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYG 602
S +IH D+KP N+LL ++DFG S +T T+ Y+ PE
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMI 176
Query: 603 SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662
+ K D++S GVL E K P F + + + R
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKR--------------ISR 218
Query: 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
E F D + DL P +R + +
Sbjct: 219 VEFTFPDFVT--EGARDLISRLLKHNPSQRPMLREV 252
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-47
Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 29/295 (9%)
Query: 423 RRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL---ERAFRSFDSECEILR 478
++ ++F +LG G F +V L+ AIKI + E E +++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 479 NVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALE 538
+ H +K+ + + + L + NG L K++ F D ++ SALE
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALE 122
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
YLH IIH DLKP NILL+E+M ++DFG +K+L + T Y++
Sbjct: 123 YLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658
PE +E D+++ G ++ + P F ++
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNE--------------YLIFQ 220
Query: 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713
+++ E F +K DL + KR+ + F + V
Sbjct: 221 KIIKLEYDFPEKFF--PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 2e-47
Identities = 60/304 (19%), Positives = 120/304 (39%), Gaps = 38/304 (12%)
Query: 427 DEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNL-QLERAFRSFDSECEILRN 479
++ LG G FG VY+G T VAIK N R F +E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 480 VRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------LDILQRLNIM 530
+++++LG S +++E M G L+ +L S + + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 531 IDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT 590
++ + YL+ +H DL N ++ E+ + DFG+++ + E +
Sbjct: 140 GEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 591 MATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH 650
+ + +M+PE +G+ +T DV+S+GV+L E T + + + E LR ++ L
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255
Query: 651 RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710
+ D + +L C P R + + +++
Sbjct: 256 KPDNCPDM------------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 711 DDVA 714
+V+
Sbjct: 298 REVS 301
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-47
Identities = 58/274 (21%), Positives = 102/274 (37%), Gaps = 26/274 (9%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN 484
++ +G G G+VY ++ G VAI+ NLQ + +E ++R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++ L S D +V+E++ GSL + Q + + ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLH--- 133
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSE 604
S +IH D+K NILL + ++DFG + + ++ + T +MAPE +
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTR 190
Query: 605 GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664
K D++S G++ +E + P +L P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPE-------------- 235
Query: 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
+ D C KR +
Sbjct: 236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 165 bits (419), Expect = 4e-46
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 26/275 (9%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNL 485
D ++ LGTG FG V++ T + G N A K E + E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
+ + + + + ++ EFM G L + + + + + + M V L ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 546 SAPIIHCDLKPTNILL--DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS 603
+H DLKP NI+ + + DFG++ L + +T T + APE
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAE 198
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663
V D++S GVL + P + E+ L V + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSP-------------FGGENDDETLRNVKSCDWNMD 245
Query: 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
+ AFS D + P+ R+ + A
Sbjct: 246 DSAFS---GISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (411), Expect = 5e-45
Identities = 64/275 (23%), Positives = 108/275 (39%), Gaps = 26/275 (9%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNL 485
D ++ LG+G FG V++ + G K N + +E I+ + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
+ + + + L+LEF+ G L + + +Y + + +N M L+++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS- 147
Query: 546 SAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS 603
I+H D+KP NI+ + + V DFG++ L E I +T AT + APE
Sbjct: 148 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVD 201
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663
V D+++ GVL + P + E L V + +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSP-------------FAGEDDLETLQNVKRCDWEFD 248
Query: 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
E AFS D + P KR+ + DA
Sbjct: 249 EDAFS---SVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 67/306 (21%), Positives = 118/306 (38%), Gaps = 47/306 (15%)
Query: 427 DEFNECNLLGTGGFGSVYKGTL--------SDGTNVAIKIFNLQL-ERAFRSFDSECEIL 477
D LG G FG V + T VA+K+ E+ SE E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 478 RNV-RHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------L 521
+ + +H+N++ +LG+C+ +++E+ G+L ++L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 522 DILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581
++ V +EYL IH DL N+L+ E+ V ++DFG+++ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR 641
+ T + +MAPE + I + + DV+S+GVLL E FT E +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 642 RWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701
L++E +C + + DC P +R
Sbjct: 249 ------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 702 LRKIKA 707
L +I A
Sbjct: 291 LDRIVA 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (387), Expect = 1e-42
Identities = 60/290 (20%), Positives = 114/290 (39%), Gaps = 31/290 (10%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL---ERAFRSFDSECEILRNVR 481
+D + +LG GG V+ L +VA+K+ L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 482 HRNLLKILGSCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
H ++ + + +V+E++ +L +++ + + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-TIGY 596
+ H IIH D+KP NI++ V DFGI++ + + +SV QT + T Y
Sbjct: 125 NFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656
++PE V + DVYS G +L E T + P ++ + ++ +P
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA---- 236
Query: 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-MTDAAAKLRKI 705
+ S +D + L P R + A L ++
Sbjct: 237 ------RHEGLSADLD------AVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 69/303 (22%), Positives = 113/303 (37%), Gaps = 45/303 (14%)
Query: 427 DEFNECNLLGTGGFGSVYKGT------LSDGTNVAIKIFNL-QLERAFRSFDSECEIL-R 478
D LG G FG V + + VA+K+ R+ SE +IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 479 NVRHRNLLKILGSCSNLDFK-ALVLEFMPNGSLEKWLYSHNY---------------FLD 522
H N++ +LG+C+ +++EF G+L +L S FL
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 523 ILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582
+ + V +E+L IH DL NILL E V + DFG+++ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRR 642
D V + + +MAPE + + + + DV+S+GVLL E F+ + R
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 643 WVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKL 702
+KE R + + LDC P +R ++ L
Sbjct: 249 RLKEGTRMRAPDYTTPEMY-----------------QTMLDCWHGEPSQRPTFSELVEHL 291
Query: 703 RKI 705
+
Sbjct: 292 GNL 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (386), Expect = 2e-41
Identities = 57/283 (20%), Positives = 108/283 (38%), Gaps = 34/283 (12%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSD-GTNVAIKIFNL------QLERAFRSFDSECEILRN 479
++F+ ++G GGFG VY +D G A+K + Q E + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 480 VRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
++ + + D + +L+ M G L L H F + ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEH 122
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAP 599
+H+ +++ DLKP NILLDE+ +SD G++ + + ++ T GYMAP
Sbjct: 123 MHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAP 174
Query: 600 EYGSEGI-VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658
E +G+ + D +S G +L + P + T + + ++ L +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701
L L ++R+ A+
Sbjct: 235 ELR-----------------SLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 56/275 (20%), Positives = 114/275 (41%), Gaps = 27/275 (9%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNL 485
+++ LG G FG V++ S K ++ E IL RHRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNI 63
Query: 486 LKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHS 545
L + S +++ ++ EF+ + + + + + L+ + ++ + V AL++LH +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 546 SAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS 603
I H D++P NI+ + + +FG ++ L G++ + Y APE
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQ 176
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663
+VST D++S G L+ + P ++ E+ + +++A +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP-------------FLAETNQQIIENIMNAEYTFD 223
Query: 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
E+AF + MD + R+ ++A
Sbjct: 224 EEAFKEISIEA---MDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 5e-40
Identities = 66/283 (23%), Positives = 113/283 (39%), Gaps = 32/283 (11%)
Query: 421 DIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQ-LERAFRSFDSECEILR 478
DIR D ++ ++LGTG F V VAIK + LE S ++E +L
Sbjct: 6 DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 479 NVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALE 538
++H N++ + + L+++ + G L + F ++ V A++
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVK 121
Query: 539 YLHHCHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
YLH I+H DLKP N+L DE+ +SDFG+SK+ G + + T G
Sbjct: 122 YLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPG 174
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655
Y+APE ++ S D +S GV+ P + ++ + +K +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKA--EYEFDSP 231
Query: 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
++ + F + + D P KR A
Sbjct: 232 YWDDISDSAKDFIRHL--------MEKD-----PEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (370), Expect = 1e-39
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 14/216 (6%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRH 482
+F LGTG FG V+ +G A+K+ ++ + + E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
++++ G+ + ++++++ G L + +V ALEYLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYG 602
II+ DLKP NILLD+N ++DFG +K + + ++ T Y+APE
Sbjct: 123 KD----IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVV 173
Query: 603 SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEM 638
S + D +S+G+L+ E P + T +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (361), Expect = 6e-39
Identities = 65/289 (22%), Positives = 108/289 (37%), Gaps = 41/289 (14%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNL---------QLERAFRSFDSECEI 476
+ + +LG G V + A+KI ++ +++ + E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 477 LRNVR-HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGS 535
LR V H N++++ + F LV + M G L +L L + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLE 121
Query: 536 ALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIG 595
+ LH + I+H DLKP NILLD++M ++DFG S L GE T
Sbjct: 122 VICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPS 174
Query: 596 YMAPEY------GSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649
Y+APE + + D++S GV++ P +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-------------FWHRKQM 221
Query: 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
L ++ N + D D ++ DL + P KR +A
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSD---TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-38
Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 17/247 (6%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFN---LQLERAFRSFDSECEIL-RNVR 481
++F +LG G FG V+ AIK + ++ E +L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 482 HRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLH 541
H L + + + V+E++ G L + S + F D+ + ++ L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY 601
I++ DLK NILLD++ ++DFG+ K G+ T Y+APE
Sbjct: 121 SKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEI 174
Query: 602 GSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMFTGEMSLRRWVKESLPHRLTEVV 656
+ D +S+GVLL E + P +E+F + L +++
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 234
Query: 657 DANLVRE 663
VRE
Sbjct: 235 VKLFVRE 241
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 26/294 (8%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT--LSDGTNVAIKIFNLQL--ERAFRSFDSECEILR- 478
RA ++ +G G +G V+K + G VA+K +Q E S E +LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 479 --NVRHRNLLKILGSCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMI 531
H N++++ C+ LV E + + ++M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 532 DVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTM 591
+ L++LH ++H DLKP NIL+ + ++DFG++++ + T +
Sbjct: 124 QLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 176
Query: 592 ATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR 651
T+ Y APE + +T D++S G + E F K + + LP
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 652 LTEVVDANLVREEQAFSDKM-------DCLFSIMDLALDCCMDTPHKRIHMTDA 698
D L R+ D DL L C P KRI A
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 62/290 (21%), Positives = 107/290 (36%), Gaps = 21/290 (7%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFN-LQLERAFRSFDSECEILRNVRHR 483
+ + +G G +G V + VAIK + + + + E +IL RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYS--HNYFLDILQRLNIMIDVGSALEYLH 541
N++ I + + ++ + LY L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 542 HCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT-MATIGYMAPE 600
SA ++H DLKP+N+LL+ + DFG++++ D +AT Y APE
Sbjct: 127 ----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 601 YGSEGIVST-KCDVYSYGVLLMETFTEKKP------TDEMFTGEMSLRRWVKESLPHRLT 653
T D++S G +L E + + D++ L +E L +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 654 EVVDANLVREEQAFSDKMDCLFS-----IMDLALDCCMDTPHKRIHMTDA 698
L+ + LF +DL PHKRI + A
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (354), Expect = 7e-38
Identities = 57/284 (20%), Positives = 112/284 (39%), Gaps = 19/284 (6%)
Query: 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRN 484
++++ +G G +G VYK + G A+K L+ E + E IL+ ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++K+ LV E + + L+K L L+ + + ++ + + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 545 SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE-YGS 603
++H DLKP N+L++ ++DFG+++ G + + Y AP+
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMG 174
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663
ST D++S G + E + + +R + P+ L +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 664 EQAFSDKMDCLF---------SIMDLALDCCMDTPHKRIHMTDA 698
+ F+ + S +DL P++RI A
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 2e-37
Identities = 61/285 (21%), Positives = 106/285 (37%), Gaps = 19/285 (6%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHR 483
+ F + +G G +G VYK G VA+K L E + E +L+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
N++K+L + LV EF+ + S + + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE-YG 602
++H DLKP N+L++ ++DFG+++ G T + T+ Y APE
Sbjct: 122 R----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILL 175
Query: 603 SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662
ST D++S G + E T + + R + P + ++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 663 EEQAFSDKMDCLFS---------IMDLALDCCMDTPHKRIHMTDA 698
+ +F FS L P+KRI A
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 67/281 (23%), Positives = 110/281 (39%), Gaps = 22/281 (7%)
Query: 433 NLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL-----ERAFRSFDSECEILRNVRHRNLL 486
+ LG G F +VYK + VAIK L + R+ E ++L+ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 487 KILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSS 546
+L + + +LV +FM + ++ L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 547 APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE-YGSEG 605
I+H DLKP N+LLDEN V ++DFG++K G + T + T Y APE
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGAR 176
Query: 606 IVSTKCDVYSYGVLLMETFTEKKP---TDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662
+ D+++ G +L E ++ + + V
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 663 EEQAFSDKMDCLFS-----IMDLALDCCMDTPHKRIHMTDA 698
+ + +FS ++DL + P RI T A
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 6e-37
Identities = 46/291 (15%), Positives = 97/291 (33%), Gaps = 27/291 (9%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRH 482
R + + +G+G FG +Y GT ++ G VAIK+ ++ + E +I + ++
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQG 61
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
+ + C +++ + SLE + + L + + S +EY+H
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 543 CHSSAPIIHCDLKPTNIL---LDENMVAHVSDFGISKLLGEGEDSVIQTMTMA-----TI 594
+ IH D+KP N L + + ++ DFG++K + T
Sbjct: 122 KN----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 595 GYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654
Y + S + D+ S G +LM G + + + +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLM----------YFNLGSLPWQGLKAATKRQKYER 227
Query: 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705
+ + + + C + + R +
Sbjct: 228 ISEKKMSTPIEVLCK--GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 6e-36
Identities = 60/283 (21%), Positives = 108/283 (38%), Gaps = 35/283 (12%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL------ERAFRSFDSECEILRN 479
D ++ LG+G F V K S G A K + + + E IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 480 VRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEY 539
++H N++ + N L+LE + G L +L + + + + + + Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128
Query: 540 LHHCHSSAPIIHCDLKPTNILLDENMVA----HVSDFGISKLLGEGEDSVIQTMTMATIG 595
LH I H DLKP NI+L + V + DFG++ + G + T
Sbjct: 129 LHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 596 YMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655
++APE + + + D++S GV+ + P ++ ++ L V
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDTKQETLANV 228
Query: 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDA 698
N E++ FS + D + P KR+ + D+
Sbjct: 229 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-35
Identities = 58/229 (25%), Positives = 89/229 (38%), Gaps = 22/229 (9%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRS------FDSECEILRNVR--HRN 484
LLG+GGFGSVY G +SD VAIK + E +L+ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 485 LLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH 544
++++L D L+LE + L + V A+ + H+C
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 545 SSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEY-G 602
++H D+K NIL+D N + DFG LL + + T T Y PE+
Sbjct: 131 ----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIR 182
Query: 603 SEGIVSTKCDVYSYGVLLMETFTEKKP---TDEMFTGEMSLRRWVKESL 648
V+S G+LL + P +E+ G++ R+ V
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-35
Identities = 57/277 (20%), Positives = 102/277 (36%), Gaps = 38/277 (13%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEIL-RNVRHRNLLKILGS 491
+LG G G V + A+K+ +A R E E+ R + ++++I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDV 73
Query: 492 CSNLDFKA----LVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSS 546
NL +V+E + G L + + + IM +G A++YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 547 APIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGS 603
I H D+KP N+L N + ++DFG +K T T Y+APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLG 186
Query: 604 EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663
CD++S GV++ P F ++ + +
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPP----FYSNH----------GLAISPGMKTRIRMG 232
Query: 664 EQAFSDKMDCLFS--IMDLALDCCMDTPHKRIHMTDA 698
+ F + S + L + P +R+ +T+
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 53/286 (18%), Positives = 110/286 (38%), Gaps = 21/286 (7%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHR 483
++ + +G G +G+V+K VA+K L E S E +L+ ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC 543
N++++ + LV EF + + + + + + L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLKGLGFCHSR 120
Query: 544 HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE-YG 602
+ ++H DLKP N+L++ N +++FG+++ G + + T+ Y P+
Sbjct: 121 N----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLF 174
Query: 603 SEGIVSTKCDVYSYGVLLMETFTEKKP------TDEMFTGEMSLRRWVKESLPHRLTEVV 656
+ ST D++S G + E +P D+ L E +T++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 657 DANLVREEQAFSDKMDCLFSIMDLALD----CCMDTPHKRIHMTDA 698
D A + ++ + + D P +RI +A
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-35
Identities = 61/296 (20%), Positives = 107/296 (36%), Gaps = 31/296 (10%)
Query: 423 RRATDEFNECNLLGTGGFGSVYKGTL-SDGTNVAIKIFNLQLERAFRSFDSECEILRNVR 481
R + + ++G G FG VY+ L G VAIK + E +I+R +
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLD 71
Query: 482 HRNLLKILGSC------SNLDFKALVLEFMPNGSLEKWLY--SHNYFLDILQRLNIMIDV 533
H N++++ + + LVL+++P + L ++ M +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 534 GSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDSVIQTMTMA 592
+L Y+H S I H D+KP N+LLD + V + DFG +K L GE + +
Sbjct: 132 FRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICS 185
Query: 593 TIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRL 652
++ DV+S G +L E + + L +K
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTR 244
Query: 653 TEVVDANLVREEQAFSDKMDCLFS----------IMDLALDCCMDTPHKRIHMTDA 698
++ + N E F ++ + L TP R+ +A
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (333), Expect = 5e-35
Identities = 37/292 (12%), Positives = 81/292 (27%), Gaps = 31/292 (10%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSC 492
+G G FG +++GT L + VAIK + + E + + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 493 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHC 552
+++ + SLE L + + + ++ +H +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVYR 125
Query: 553 DLKPTNILLDENMVAH-----VSDFGISKLLGEGEDSVIQTMTMA-----TIGYMAPEYG 602
D+KP N L+ + V DFG+ K + T YM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 603 SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662
S + D+ + G + M G + + + + + +
Sbjct: 186 LGREQSRRDDLEALGHVFM----------YFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI--KAKFLDD 712
+ K+ + +D
Sbjct: 236 PLRELCA--GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 7e-34
Identities = 68/300 (22%), Positives = 106/300 (35%), Gaps = 38/300 (12%)
Query: 406 EDFLPPATRRRTSYLDIRRATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL- 463
EDFL + + D+F+ LGTG FG V G + A+KI + Q
Sbjct: 24 EDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 464 --ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFL 521
+ +E IL+ V L+K+ S + +V+E++ G + L F
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF- 138
Query: 522 DILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581
+ EYLH +I+ DLKP N+L+D+ V+DFG +K
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR 641
T +APE + D ++ GVL+ E P F +
Sbjct: 190 RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----FFADQ--- 242
Query: 642 RWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701
P ++ E + + VR FS + DL + KR
Sbjct: 243 -------PIQIYEKIVSGKVRFPSHFSS------DLKDLLRNLLQVDLTKRFGNLKNGVN 289
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 8e-34
Identities = 58/301 (19%), Positives = 113/301 (37%), Gaps = 31/301 (10%)
Query: 424 RATDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNV 480
++ + +G G FG V+K G VA+K ++ E + E +IL+ +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 481 RHRNLLKILGSCSNLDFKA--------LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMID 532
+H N++ ++ C LV +F + F + + +M
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQM 125
Query: 533 VGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMT-- 590
+ + L Y+H I+H D+K N+L+ + V ++DFG+++ ++S T
Sbjct: 126 LLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 591 MATIGYMAPE-YGSEGIVSTKCDVYSYGVLLMETFTEKKP-TDEMFTGEMSLRRWVKESL 648
+ T+ Y PE E D++ G ++ E +T +++L + S+
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 649 PHRLTEVVDANLVREEQAFSDKMDCLFS-----------IMDLALDCCMDTPHKRIHMTD 697
+ VD + E+ +DL + P +RI D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 698 A 698
A
Sbjct: 302 A 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 11/207 (5%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRH 482
++F+ LLG G FG V + G A+KI ++ + +E +L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 483 RNLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHH 542
L + + D V+E+ G L L F + + ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHS 123
Query: 543 CHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYG 602
+++ D+K N++LD++ ++DFG+ K ++ T Y+APE
Sbjct: 124 RD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVL 177
Query: 603 SEGIVSTKCDVYSYGVLLMETFTEKKP 629
+ D + GV++ E + P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 1e-31
Identities = 61/316 (19%), Positives = 120/316 (37%), Gaps = 44/316 (13%)
Query: 413 TRRRTSYLDIRRAT------DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLER 465
T R Y D D++ LG G + V++ +++ V +KI ++
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK 74
Query: 466 AFRSFDSECEILRNVR-HRNLLKILGSCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLD 522
+ E +IL N+R N++ + + + ALV E + N ++ + L
Sbjct: 75 KIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LT 127
Query: 523 ILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEG 581
M ++ AL+Y H I+H D+KP N+++D E+ + D+G+++ G
Sbjct: 128 DYDIRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183
Query: 582 EDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL 640
++ + +A+ + PE + + D++S G +L K+P L
Sbjct: 184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240
Query: 641 RRWVKESLPHRLTEVVDANLVREEQAFSDKM--------------DCLFSIMDLALD--- 683
R K L + +D + + F+D + + + ALD
Sbjct: 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300
Query: 684 -CCMDTPHKRIHMTDA 698
R+ +A
Sbjct: 301 KLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-30
Identities = 70/286 (24%), Positives = 110/286 (38%), Gaps = 33/286 (11%)
Query: 427 DEFNECNLLGTGGFGSVYKGTL----SDGTNVAIKIFN----LQLERAFRSFDSECEILR 478
+ F +LGTG +G V+ G A+K+ +Q + +E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 479 NVRHR-NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
++R L+ + + L+L+++ G L L F + + I VG +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 139
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597
L H H II+ D+K NILLD N ++DFG+SK E TI YM
Sbjct: 140 LALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYM 197
Query: 598 APE--YGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655
AP+ G + D +S GVL+ E T P FT +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDG----------EKNSQAE 243
Query: 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701
+ +++ E + +M L DL M P KR+ A
Sbjct: 244 ISRRILKSEPPYPQEMSALA--KDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 8e-30
Identities = 51/289 (17%), Positives = 101/289 (34%), Gaps = 25/289 (8%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHR 483
+ + +G+G +G+V G VAIK E + E +L+++RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 484 NLLKILGSCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILQRLNIMIDVGSALEYL 540
N++ +L + + +F + L + ++ + L Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPE 600
H IIH DLKP N+ ++E+ + DFG+++ DS + +
Sbjct: 138 HAAG----IIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEV 189
Query: 601 YGSEGIVSTKCDVYSYGVLLMETFTEKKP-----TDEMFTGEMSLRRWVKESLPHRLTEV 655
+ + D++S G ++ E T K + M + RL
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 656 VDANLVREEQAFSDK--MDCLFSIMDLALD----CCMDTPHKRIHMTDA 698
N ++ K L + LA++ + +R+ +A
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 7e-28
Identities = 53/291 (18%), Positives = 107/291 (36%), Gaps = 27/291 (9%)
Query: 426 TDEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRH 482
+ + + +G+G +GSV G VA+K + + E +L++++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 483 RNLLKILGSC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALE 538
N++ +L S +F + L G+ + D ++ + L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLIYQILRGLK 135
Query: 539 YLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMA 598
Y+H IIH DLKP+N+ ++E+ + DFG+++ D +
Sbjct: 136 YIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAP 187
Query: 599 PEYGSEGIVSTKCDVYSYGVLLMETFTEKKP---TDEMFTGEMSLRRWVK--ESLPHRLT 653
+ + D++S G ++ E T + TD + ++ LR L +++
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 654 EVVDANLVREEQAFSDK--MDCLFSIMDLALD----CCMDTPHKRIHMTDA 698
N ++ + LA+D + KRI A
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 9e-28
Identities = 59/303 (19%), Positives = 102/303 (33%), Gaps = 42/303 (13%)
Query: 427 DEFNECNLLGTGGFGSVYKGT-LSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHR 483
+ +G+G G V NVAIK + + + E +++ V H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 484 NLLKILGSCSNLDFK------ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
N++ +L + LV+E M + D + ++ + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGI 132
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYM 597
++LH IIH DLKP+NI++ + + DFG+++ G + T + T Y
Sbjct: 133 KHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYR 185
Query: 598 APEYGSEGIVSTKCDVYSYGVLLMETFTEK--------------------KPTDEMFTGE 637
APE D++S G ++ E K P E
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 638 MSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFS--IMDLALDCCMDTPHKRIHM 695
R E+ P + + L + DL + P KRI +
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 696 TDA 698
DA
Sbjct: 306 DDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (266), Expect = 1e-25
Identities = 43/213 (20%), Positives = 80/213 (37%), Gaps = 21/213 (9%)
Query: 434 LLGTGGFGSVYKGT-LSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSC 492
LG G F +V+ + + T+VA+KI + + + E ++L+ V + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 493 SNLDFK---------------ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSAL 537
+N K +V E + L + + ++ I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 538 EYLHHCHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGY 596
+Y+H IIH D+KP N+L++ + ++ I+ L T ++ T Y
Sbjct: 139 DYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 597 MAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKP 629
+PE D++S L+ E T
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.8 bits (237), Expect = 9e-22
Identities = 67/341 (19%), Positives = 113/341 (33%), Gaps = 46/341 (13%)
Query: 7 SITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTN 66
+ L ++ N + P NL L + + N + + A+ +
Sbjct: 61 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 118
Query: 67 CRNLANLALASNPLGGILPPLIGN----------------------------FSASLQNI 98
+ ++ N L N +
Sbjct: 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178
Query: 99 YAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVP 158
S + L L L N ++ P I T L + N L+
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--I 234
Query: 159 HDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRI 218
L L L L+L+ N++S P L+ LT L L L +N++S+ P L L + +
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 290
Query: 219 NLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP 278
L+ N + S I L L L L N +S P + +L L+ L A N+
Sbjct: 291 ELNEN--QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-- 344
Query: 279 ESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHN 319
S+ NL ++ L +N +S P L L+ + Q ++
Sbjct: 345 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 2e-11
Identities = 68/345 (19%), Positives = 121/345 (35%), Gaps = 50/345 (14%)
Query: 9 TNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCR 68
T + + LG + + + + +L ++ L + + + +
Sbjct: 19 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS----------IDGVEYLN 66
Query: 69 NLANLALASNPLGGILP---------PLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGL 119
NL + ++N L I P L+ N + A L G
Sbjct: 67 NLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 126
Query: 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS- 178
+ +L + +I + L G + G DL L L L +
Sbjct: 127 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186
Query: 179 GAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV 238
+ LA LT+L SL +N++S P + + + ++L+ N LK + L
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTN 242
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP-------------------- 278
L DLDL+ NQ+S+ P + L L L L NQ P
Sbjct: 243 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI 300
Query: 279 ESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEG 323
+ NL +L L NN+S P + +L+ L++ ++N++
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 5e-08
Identities = 36/161 (22%), Positives = 63/161 (39%), Gaps = 21/161 (13%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNL------------TT 50
++ + T L LDL N S P L L+ L L N + T
Sbjct: 232 KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTN 289
Query: 51 ESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIP 110
+ +Q +S ++N +NL L L N + I P + + + LQ ++ K+ S
Sbjct: 290 LELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT-KLQRLFFANNKV--SDV 344
Query: 111 KEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPEN 151
+ NL + LS G N ++ P + L ++ + +
Sbjct: 345 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 3e-07
Identities = 48/228 (21%), Positives = 82/228 (35%), Gaps = 17/228 (7%)
Query: 113 IGNLRGLIVLSLGFNDLNGTIP----TSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLN 168
+ L L ++ N L P T + + L L
Sbjct: 62 VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 121
Query: 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGT 228
I ++ K + + S ++ + S S S + + + + +
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181
Query: 229 LPSNIQ-------KLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV 281
+ SN KL L L + NQ+S P I T NL+ LSL GNQ + ++
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTL 237
Query: 282 GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKG 329
+L +L LD +NN +S P L L+ L + + N++ P+ G
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAG 283
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.4 bits (88), Expect = 0.002
Identities = 14/70 (20%), Positives = 27/70 (38%), Gaps = 4/70 (5%)
Query: 260 LKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHN 319
L L + ++ +L + +L + +E L++L Q N S+N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 320 RLEGEIPVKG 329
+L P+K
Sbjct: 77 QLTDITPLKN 86
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 2e-20
Identities = 25/160 (15%), Positives = 49/160 (30%), Gaps = 23/160 (14%)
Query: 433 NLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL----------ERAFRSFDSECEILRNVRH 482
L+G G +V+ +K + + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 483 RNLLKILGSC--SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYL 540
R L K+ G ++ + +E Y + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAV------LMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 541 HHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580
+H I+H DL N+L+ E + + DF S +GE
Sbjct: 120 YHRG----IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGE 154
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.2 bits (217), Expect = 9e-20
Identities = 50/271 (18%), Positives = 97/271 (35%), Gaps = 12/271 (4%)
Query: 68 RNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFN 127
+ A L L +N + I N +L + K+ P L L L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 128 DLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLAS 187
L TLQ+L+ ++ V + L + + L + K SG
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQG 148
Query: 188 LTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRN 247
+ L + + +++ SL + +L N + ++++ LN L L LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 248 QLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG------KI 301
+S+ ++ +L L L N+ +P + + ++ + NNN+S
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 302 PKSLEALSHLKQFNVSHNRLEGEIPVKGSFK 332
P + ++ N ++ +F+
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.2 bits (204), Expect = 5e-18
Identities = 58/297 (19%), Positives = 107/297 (36%), Gaps = 24/297 (8%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P + T L LDL N + F NL++L L L+ N ++ S A
Sbjct: 24 KVPKDLPPDTAL--LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA------- 74
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L L L+ N L + P + L+ K+ S+ + N ++ L
Sbjct: 75 -FAPLVKLERLYLSKNQLKEL-PEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVEL 131
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
+G + +++L + + N+ L L+L GNK++
Sbjct: 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDA 188
Query: 183 QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL 242
L L +L L L N +S+ SL + ++ ++L++N L P + + +
Sbjct: 189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVV 247
Query: 243 DLSRNQLSS------DIPSTIGTLKNLETLSLAGNQFQ--GPIPESVGNLISLESLD 291
L N +S+ P + +SL N Q P + + ++
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.4 bits (202), Expect = 9e-18
Identities = 46/214 (21%), Positives = 86/214 (40%), Gaps = 6/214 (2%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
+PK++ +L L N + L+ L + N + P L +L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
L LS N+L + +L LR + K+ S+ + L ++ + + G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSG 140
Query: 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISL 287
Q + L + ++ +++ IP G +L L L GN+ S+ L +L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 288 ESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRL 321
L S N++S SL HL++ ++++N+L
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.9 bits (193), Expect = 1e-16
Identities = 45/218 (20%), Positives = 80/218 (36%), Gaps = 6/218 (2%)
Query: 132 TIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSL 191
+P + + N + D +L+ L+ L L NK+S P A L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 192 RSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS 251
LYL N+L LP + LR++ + + N ++++L + + S
Sbjct: 82 ERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140
Query: 252 DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHL 311
+K L + +A IP+ G SL L N ++ SL+ L++L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 312 KQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPP 349
+ +S N + + + + N L P
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 76.6 bits (187), Expect = 9e-16
Identities = 55/276 (19%), Positives = 86/276 (31%), Gaps = 24/276 (8%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFL 61
N L L L N S P F L L L L N L +
Sbjct: 45 EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQ- 103
Query: 62 SSLTNCRNLANLALASNPLGGILPPLIGNFS-ASLQNIYAFECKLGGSIPKEIGNLRGLI 120
L + N + + + + + + K G ++ L
Sbjct: 104 ----------ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 153
Query: 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA 180
+ + ++ TIP + L ++ N + L L L L LS N +S
Sbjct: 154 YIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 210
Query: 181 IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG------TLPSNIQ 234
LA+ LR L+L +NKL P L +YI + L +N++ P
Sbjct: 211 DNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 269
Query: 235 KLNVLIDLDLSRNQLSSD--IPSTIGTLKNLETLSL 268
K + L N + PST + + L
Sbjct: 270 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.4 bits (132), Expect = 7e-09
Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 3/108 (2%)
Query: 218 INLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI 277
+ S L+ +P ++ LDL N+++ LKNL TL L N+
Sbjct: 15 VQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 278 PESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEI 325
P + L+ LE L S N L K + L L+ ++ +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.2 bits (121), Expect = 2e-07
Identities = 27/153 (17%), Positives = 46/153 (30%), Gaps = 3/153 (1%)
Query: 190 SLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQL 249
LR + L +P L ++L +N + + + L L L L N++
Sbjct: 11 HLRVVQCSDLGLEK-VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 250 SSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALS 309
S P L LE L L+ NQ + + L L + + + L +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 310 HLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGN 342
++ E K S
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (201), Expect = 8e-18
Identities = 63/282 (22%), Positives = 98/282 (34%), Gaps = 18/282 (6%)
Query: 18 DLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALAS 77
GL + IP + L N ++ ++ S CRNL L L S
Sbjct: 20 QQGLQAVPVGIPAA------SQRIFLHGNRISHVPAA--------SFRACRNLTILWLHS 65
Query: 78 NPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSI 137
N L I + Q + +L P L L L L L P
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 138 GTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQ 197
L LQ Y+ +N LQ L L L L GN++S + L SL L L
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 198 SNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTI 257
N+++ P + L ++ + L +N+L + L L L L+ N D +
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-R 244
Query: 258 GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSG 299
L+ + ++ +P+ L + + N+L G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (187), Expect = 6e-16
Identities = 47/256 (18%), Positives = 80/256 (31%), Gaps = 4/256 (1%)
Query: 68 RNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFN 127
+ L N + + G +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 128 DLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLAS 187
L P + L +L ++ LQ P L L L L N L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 188 LTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRN 247
L +L L+L N++SS + L + R+ L N + P + L L+ L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 248 QLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEA 307
LS+ + L+ L+ L L N + + L+ S++ + +P+ L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 308 LSHLKQFNVSHNRLEG 323
++ N L+G
Sbjct: 271 RDLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (174), Expect = 2e-14
Identities = 53/247 (21%), Positives = 88/247 (35%), Gaps = 4/247 (1%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
++P I + L N ++ S + L ++ N L L L
Sbjct: 25 AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 168 NILNLSGNKLSGAI-PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLK 226
L+LS N ++ P L L +L+L L P L + + L N+L+
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 227 GTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLIS 286
+ L L L L N++SS L +L+ L L N+ P + +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 287 LESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALC 346
L +L NNLS ++L L L+ ++ N + + + + C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262
Query: 347 -GPPRLQ 352
P RL
Sbjct: 263 SLPQRLA 269
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.3 bits (199), Expect = 3e-17
Identities = 70/298 (23%), Positives = 112/298 (37%), Gaps = 32/298 (10%)
Query: 62 SSLTNCRNLANLALASNPLGGI--LPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGL 119
+ T + NL L+ L +P + N L G IP I L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSG 179
L + +++G IP + ++ L N L G +P + L L + GN++SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 180 AIPQCLASLTSLRS-LYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNV 238
AIP S + L + + + N+L+ +P + L S ++ S + +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA--NLNLAFVDLSRNMLEGDASVLFGSDK 221
Query: 239 LIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLS 298
+ +G KNL L L N+ G +P+ + L L SL+ S NNL
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 299 GKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALCGPPRLQVPPC 356
G+IP+ G+ + F +Y N LCG P +P C
Sbjct: 282 GEIPQG------------------------GNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.7 bits (117), Expect = 5e-07
Identities = 19/71 (26%), Positives = 26/71 (36%), Gaps = 11/71 (15%)
Query: 18 DLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALAS 77
DL N G +P L+ L L++ NNL E + N + A A+
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE---------IPQGGNLQRFDVSAYAN 300
Query: 78 NPL--GGILPP 86
N G LP
Sbjct: 301 NKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 47.8 bits (112), Expect = 2e-06
Identities = 15/47 (31%), Positives = 22/47 (46%), Gaps = 1/47 (2%)
Query: 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNL 48
GT+P +T L L++ N+ G IP GNL+ V + N
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.0 bits (133), Expect = 7e-09
Identities = 25/93 (26%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 171 NLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP 230
N S I SL L + +NKL LP+ LE R+ S N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLE---RLIASFNHLA-EVP 320
Query: 231 SNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNL 263
Q L L + N L P ++++L
Sbjct: 321 ELPQNLKQ---LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 23/103 (22%), Positives = 39/103 (37%), Gaps = 9/103 (8%)
Query: 210 WSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLA 269
L + N+ + S L +L++S N+L +P+ LE L +
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIAS 312
Query: 270 GNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLK 312
N +PE N L+ L N L + P E++ L+
Sbjct: 313 FNHLAE-VPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 4e-08
Identities = 20/90 (22%), Positives = 36/90 (40%), Gaps = 10/90 (11%)
Query: 151 NNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLW 210
N + L LN+S NKL +P A L L N L + +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL-AEVPELPQ 324
Query: 211 SLEYILRINLSSNSLKG--TLPSNIQKLNV 238
+L+ +++ N L+ +P +++ L +
Sbjct: 325 NLKQ---LHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 9/83 (10%)
Query: 244 LSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPK 303
N S++I S +LE L+++ N+ +P LE L S N+L+ ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVP- 320
Query: 304 SLEALSHLKQFNVSHNRLEGEIP 326
E +LKQ +V +N L E P
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 9e-04
Identities = 19/70 (27%), Positives = 30/70 (42%), Gaps = 5/70 (7%)
Query: 162 CHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLS 221
C + + L L+ LS ++P+ L SL N L + LP SL+ +L N +
Sbjct: 35 CLDRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSL-TELPELPQSLKSLLVDNNN 89
Query: 222 SNSLKGTLPS 231
+L P
Sbjct: 90 LKALSDLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.004
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 8/63 (12%)
Query: 261 KNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNR 320
+ L L +PE +L ESL S N+L+ ++P E LK V +N
Sbjct: 38 RQAHELELNNLGLSS-LPELPPHL---ESLVASCNSLT-ELP---ELPQSLKSLLVDNNN 89
Query: 321 LEG 323
L+
Sbjct: 90 LKA 92
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 8e-09
Identities = 39/190 (20%), Positives = 66/190 (34%), Gaps = 6/190 (3%)
Query: 108 SIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERL 167
++P ++ + +L L N L ++ +L + + + L L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLT--QLNLDRAELTKLQVDGTLPVL 79
Query: 168 NILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
L+LS N+L + N+L+S +L L + + L N LK
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 228 TLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISL 287
P + L L L+ N L+ + L+NL+TL L N IP+ L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 288 ESLDFSNNNL 297
N
Sbjct: 198 PFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 3e-08
Identities = 41/185 (22%), Positives = 67/185 (36%), Gaps = 4/185 (2%)
Query: 90 NFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVP 149
+ ++ E L + L L+L + T GTL L +
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVLGTLDLS 85
Query: 150 ENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSL 209
N LQ + ++S N+L+ L L L+ LYL+ N+L + P L
Sbjct: 86 HNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL 144
Query: 210 WSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLA 269
+ +++L++N+L + L L L L N L + IP L L
Sbjct: 145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLH 203
Query: 270 GNQFQ 274
GN +
Sbjct: 204 GNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 5e-08
Identities = 47/210 (22%), Positives = 78/210 (37%), Gaps = 7/210 (3%)
Query: 112 EIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILN 171
E+ + + ++ +L +P + ++ EN L + L RL LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 172 LSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPS 231
L +L+ +L L +L L N+L S +++S N L
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALT-VLDVSFNRLTSLPLG 118
Query: 232 NIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLD 291
++ L L +L L N+L + P + LE LSLA N + L +L++L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 292 FSNNNLSGKIPKSLEALSHLKQFNVSHNRL 321
N+L IPK L + N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 4e-07
Identities = 41/199 (20%), Positives = 60/199 (30%), Gaps = 15/199 (7%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
+P + T + L L N T L+ L+L LT L
Sbjct: 24 ALPPDLPKDTTI--LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL----QVDGTLP 77
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVL 122
L N + +G +L + +L + L L L
Sbjct: 78 VLGTLDLSHNQLQSLPL--------LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129
Query: 123 SLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIP 182
L N+L P + +L+ + NNL L LE L+ L L N L IP
Sbjct: 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 183 QCLASLTSLRSLYLQSNKL 201
+ L +L N
Sbjct: 189 KGFFGSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 3e-08
Identities = 29/114 (25%), Positives = 52/114 (45%), Gaps = 6/114 (5%)
Query: 218 INLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI 277
++L+ L T+ ++++L ++ LDLS N+L + P+ + L+ LE L +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNALEN 57
Query: 278 PESVGNLISLESLDFSNNNL-SGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGS 330
+ V NL L+ L NN L + L + L N+ N L E ++
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 2e-07
Identities = 28/126 (22%), Positives = 48/126 (38%), Gaps = 9/126 (7%)
Query: 192 RSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSS 251
R L+L L+ L L + ++LS N L+ P+ + L L L S N
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--L 55
Query: 252 DIPSTIGTLKNLETLSLAGNQFQG-PIPESVGNLISLESLDFSNNNLSGK---IPKSLEA 307
+ + L L+ L L N+ Q + + + L L+ N+L + + E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 308 LSHLKQ 313
L +
Sbjct: 116 LPSVSS 121
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 5e-08
Identities = 14/85 (16%), Positives = 30/85 (35%), Gaps = 7/85 (8%)
Query: 242 LDLSRNQLS-SDIPSTIGTLKNLETLSLAGNQFQG----PIPESVGNLISLESLDFSNNN 296
LD+ +LS + + L+ + + L I ++ +L L+ +N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 297 LSGKIPKSLEALSHLKQFNVSHNRL 321
L + L L+ + +L
Sbjct: 67 LGDVGVHCV--LQGLQTPSCKIQKL 89
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 1e-07
Identities = 19/88 (21%), Positives = 33/88 (37%), Gaps = 9/88 (10%)
Query: 230 PSNIQKLNVLIDLDLSRNQLS----SDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLI 285
Q +VL L L+ +S S + +T+ +L L L+ N + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 286 -----SLESLDFSNNNLSGKIPKSLEAL 308
LE L + S ++ L+AL
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 7e-06
Identities = 22/120 (18%), Positives = 39/120 (32%), Gaps = 27/120 (22%)
Query: 156 YVPHDLCHLERLNILNLSGNKLSG----AIPQCLASLTSLRSLYLQSNKLSSSLPSSLWS 211
L +L L+ +S ++ L + SLR L L +N L + L
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-- 417
Query: 212 LEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLK----NLETLS 267
S++ Q +L L L S ++ + L+ +L +S
Sbjct: 418 ----------VESVR-------QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 9e-06
Identities = 16/90 (17%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 167 LNILNLSGNKLSGA-IPQCLASLTSLRSLYLQSNKLS----SSLPSSLWSLEYILRINLS 221
+ L++ +LS A + L L + + L L+ + S+L + +NL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 222 SNSLKGTLPSNIQKLNVLIDLDLSRNQLSS 251
SN L + + + + L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 3e-05
Identities = 15/92 (16%), Positives = 26/92 (28%), Gaps = 10/92 (10%)
Query: 215 ILRINLSSNSLKGT-LPSNIQKLNVLIDLDLSRNQLS----SDIPSTIGTLKNLETLSLA 269
I +++ L + L + L L+ DI S + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 270 GNQFQGPIPESVG-----NLISLESLDFSNNN 296
N+ V ++ L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 143 LQGFYVPENNLQGYVPHDLC-HLERLNILNLSGNKLSG----AIPQCLASLTSLRSLYLQ 197
+Q + L +L L++ ++ L L+ I L +L L L+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 198 SNKLSSSLPSSLWSLEYILRINLSSNSLKG 227
SN+L + + SL+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 3e-04
Identities = 18/75 (24%), Positives = 24/75 (32%), Gaps = 5/75 (6%)
Query: 17 LDLGLNSFS-GHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLAL 75
LD+ S L+ V+ L LT S+L LA L L
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD----ISSALRVNPALAELNL 62
Query: 76 ASNPLGGILPPLIGN 90
SN LG + +
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.001
Identities = 18/90 (20%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 119 LIVLSLGFNDLNGT-IPTSIGTLQQLQGFYVPENNLQG----YVPHDLCHLERLNILNLS 173
+ L + +L+ + LQQ Q + + L + L L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 174 GNKLSGAIPQCLASLTSLRSLYLQSNKLSS 203
N+L C+ S +Q L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 15/104 (14%), Positives = 40/104 (38%), Gaps = 3/104 (2%)
Query: 217 RINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG- 275
++L+ +L + + V+ R+ + + + ++ + L+ + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 276 PIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHN 319
+ + L++L LS I +L S+L + N+S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 8e-05
Identities = 47/298 (15%), Positives = 93/298 (31%), Gaps = 52/298 (17%)
Query: 17 LDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALA 76
LDL + P+ G L V++ + A+ +S + ++ L+
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-------RVQHMDLS 54
Query: 77 SNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTS 136
++ + I + + LQN+ +L I + L+ L+
Sbjct: 55 NSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN------------- 101
Query: 137 IGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYL 196
+ + L RL+ LNLS
Sbjct: 102 ---------LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ------------ 140
Query: 197 QSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSD-IPS 255
++ ++ + N K L + +++ L+ LDLS + + +
Sbjct: 141 ------VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194
Query: 256 TIGTLKNLETLSLAG-NQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLK 312
L L+ LSL+ +G + +L++L G + EAL HL+
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 9e-05
Identities = 37/262 (14%), Positives = 73/262 (27%), Gaps = 22/262 (8%)
Query: 13 KLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLAN 72
+I + + F R + + L + + + L+ C L N
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST-------LHGILSQCSKLQN 75
Query: 73 LALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGT 132
L+L L + + S +L + C + + L +
Sbjct: 76 LSLEGLRLSDPIVNTLAKNS-NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDF 134
Query: 133 IPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLER---------LNILNLSGNKLSGAIPQ 183
+ + + NL GY + +++ L Q
Sbjct: 135 TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194
Query: 184 CLASLTSLRSLYLQS-NKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDL 242
L L+ L L + L + + + + GTL + L L
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HL 251
Query: 243 DLSRNQLSSDIPSTIGTLKNLE 264
++ + ++ TIG KN E
Sbjct: 252 QINCSHFTTIARPTIGNKKNQE 273
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 35/218 (16%), Positives = 73/218 (33%), Gaps = 22/218 (10%)
Query: 115 NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSG 174
L I ++ G +++ T+ + L + + + +L L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 175 NKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQ 234
N+++ P + + L K S++ L ++ SN+Q
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 235 KLNVLIDLDLSRNQL--------------SSDIPSTIGTLKNLETLSLAGNQFQGPIPES 280
L + ++ + + L + + L L TL N+ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 281 VGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSH 318
+ +L +L + NN +S P L S+L +++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 7e-06
Identities = 37/225 (16%), Positives = 76/225 (33%), Gaps = 29/225 (12%)
Query: 10 NATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRN 69
I + G ++ + + T +L ++ LS +TT + + N
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT----------IEGVQYLNN 64
Query: 70 LANLALASNPL------GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLS 123
L L L N + + S + + L ++ + + V
Sbjct: 65 LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 124 LGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHD-------LCHLERLNILNLSGNK 176
L + + + + N + + L +L +L L NK
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 177 LSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLS 221
+S P LASL +L ++L++N++S P L + + + L+
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 1e-06
Identities = 30/143 (20%), Positives = 55/143 (38%), Gaps = 6/143 (4%)
Query: 171 NLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLP 230
L ++ + ++ L L S L + + +N S+ TL
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLR 58
Query: 231 SNIQKLNVLIDLDLSRNQLS--SDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLE 288
+ + L+ L+LS N+L D+ S + NL+ L+L+GN+ + + LE
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 289 SLDFSNNNLSGKIPKSLEALSHL 311
L N+LS +S +
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAI 141
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 8e-06
Identities = 45/216 (20%), Positives = 86/216 (39%), Gaps = 22/216 (10%)
Query: 108 SIPKEIG------NLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDL 161
++P I I +L + + + L + ++++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGI 64
Query: 162 CHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLS 221
+L + L L+GNKL+ + LA+L +L L+L NK + + +LS
Sbjct: 65 QYLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENK----VKDLSSLKDLKKLKSLS 118
Query: 222 SNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV 281
+ + + L L L L N+++ + L L+TLSL NQ +P +
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--L 174
Query: 282 GNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVS 317
L L++L S N++S ++L L +L +
Sbjct: 175 AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 42/226 (18%), Positives = 78/226 (34%), Gaps = 31/226 (13%)
Query: 3 TIPNSI------TNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSAD 56
T+P I + I +L S + + L + + +++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS------ 60
Query: 57 QWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNL 116
+ + N+ L L N L I P L N+ + +
Sbjct: 61 ----VQGIQYLPNVTKLFLNGNKLTDIKP---------LANLKNLGWLFLDENKVKDLSS 107
Query: 117 RGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNK 176
+ + + I G + Q + N + L L +L+ L+L N+
Sbjct: 108 LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQ 167
Query: 177 LSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSS 222
+S +P LA LT L++LYL N +S +L L+ + + L S
Sbjct: 168 ISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 2e-05
Identities = 48/335 (14%), Positives = 111/335 (33%), Gaps = 34/335 (10%)
Query: 38 LSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQN 97
+ SL ++ +TTE D+ S + L ++ + L+ N +G + AS ++
Sbjct: 5 IEGKSLKLDAITTE----DEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 98 I------YAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPEN 151
+ F ++ IP+ + L ++ + + + T Q+ ++ ++
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 152 NLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWS 211
++ L ++ A+ + + LRS+ N+L +
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 212 LEYILRINLSSNSLKGTLPSNIQKLNVLIDLD-------------LSRNQLSSDIPSTIG 258
R+ + ++ + + +L L + SS + +
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 259 TLKNLETLSLAGNQFQGPIPESVGN------LISLESLDFSNNNLSGKIPKSL-----EA 307
+ NL L L +V + I L++L N + ++L E
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 308 LSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGN 342
+ L ++ NR E V ++ + G
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 9e-04
Identities = 39/314 (12%), Positives = 92/314 (29%), Gaps = 28/314 (8%)
Query: 4 IPNSITNATKLIGLDLGLNSFSG----HIPNTFGNLRHLSVLSLMMNNLTTESSSADQWS 59
+ + + + L N+ + + + L + +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 60 --FLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLR 117
L +L C L + L+ N G + +F + ++ L + +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS--KHTPLEHLYLHNNGLGPQAGAK 140
Query: 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKL 177
L + + ++ + + + L + +G +
Sbjct: 141 IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200
Query: 178 SGAIPQCLASLTSLRSLYLQSNKLS-------SSLPSSLWSLEYILRINLSSNSLKGTLP 230
G L L + L + + + S+L +L S + + L+ L
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260
Query: 231 SNI------QKLNVLIDLDLSRNQLSSDIPSTIGT-----LKNLETLSLAGNQF--QGPI 277
+ + + L L L N++ D T+ T + +L L L GN+F + +
Sbjct: 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 320
Query: 278 PESVGNLISLESLD 291
+ + + S
Sbjct: 321 VDEIREVFSTRGRG 334
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 4e-05
Identities = 20/106 (18%), Positives = 31/106 (29%), Gaps = 2/106 (1%)
Query: 242 LDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESV-GNLISLESLDFSNNNLSGK 300
L +R+ + +NL L + Q + L L +L + L
Sbjct: 13 LRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 301 IPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALC 346
P + L + N+S N LE GN C
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 25/151 (16%), Positives = 45/151 (29%), Gaps = 4/151 (2%)
Query: 160 DLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWS-LEYILRI 218
D C + L + + L +L LY+++ + L L + +
Sbjct: 3 DACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 219 NLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPI- 277
+ + L+ P L L+LS N L S + +L+ L L+GN
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 278 PESVGNLISLESLDFSNNNLSGKIPKSLEAL 308
+ L L +
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 4e-05
Identities = 34/224 (15%), Positives = 58/224 (25%), Gaps = 24/224 (10%)
Query: 3 TIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLS 62
IP+ + I L L F L + + N++ + +
Sbjct: 22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 63 SLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAF-------------------EC 103
AN L NP P + S I
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 104 KLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCH 163
+G ++L L N + + Q + NNL+
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 164 LERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPS 207
IL++S ++ L +L LR+ + K LP+
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 11/54 (20%), Positives = 18/54 (33%), Gaps = 4/54 (7%)
Query: 253 IPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLE 306
L ++ + + NL L + S NL K+P +LE
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR--STYNLK-KLP-TLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.003
Identities = 11/63 (17%), Positives = 21/63 (33%), Gaps = 4/63 (6%)
Query: 158 PHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILR 217
H +CH + +K++ IP L + L KL + + +
Sbjct: 2 HHRICHCS-NRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 218 INL 220
I +
Sbjct: 58 IEI 60
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.003
Identities = 7/44 (15%), Positives = 13/44 (29%)
Query: 277 IPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNR 320
+ LD S + LE L L+ + + +
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 1e-04
Identities = 26/134 (19%), Positives = 48/134 (35%), Gaps = 7/134 (5%)
Query: 164 LERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223
R L+L G K+ I A+L ++ N++ L + + +++N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNNN 73
Query: 224 SLKGTLPSNIQKLNVLIDLDLSRNQLSS-DIPSTIGTLKNLETLSLAGNQFQ---GPIPE 279
+ Q L L +L L+ N L + +LK+L L + N
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 280 SVGNLISLESLDFS 293
+ + + LDF
Sbjct: 134 VIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.001
Identities = 20/107 (18%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 216 LRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG 275
L L + + T ++L DL ++ I + TL + + + N+ +
Sbjct: 3 LTAELIEQAAQYTNAVRDREL------DLRGYKIPV-IENLGATLDQFDAIDFSDNEIR- 54
Query: 276 PIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLE 322
+ L L++L +NN + +AL L + +++N L
Sbjct: 55 -KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 34/193 (17%), Positives = 63/193 (32%), Gaps = 15/193 (7%)
Query: 9 TNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCR 68
T + + LG + + + + +L ++ L + S D +L++LT
Sbjct: 15 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK----SIDGVEYLNNLTQIN 68
Query: 69 NLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFND 128
N PL + + + + L + N + + L
Sbjct: 69 FSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128
Query: 129 LNGTIPTSIGTLQQLQGFYVPENNLQGYVPH-------DLCHLERLNILNLSGNKLSGAI 181
+ S T+ + + Q L +L L L++S NK+S
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-- 186
Query: 182 PQCLASLTSLRSL 194
LA LT+L SL
Sbjct: 187 ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 717 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.82 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.68 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.65 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.65 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.63 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.63 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.6 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.38 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.65 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.45 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.1 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.01 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.64 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.96 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=420.35 Aligned_cols=264 Identities=25% Similarity=0.423 Sum_probs=208.8
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||+||+|+++ ..||||+++... ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367899999999999999999874 359999986442 4456789999999999999999999998765 56799999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++|+|.+++...+..+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh----cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999877777999999999999999999999 67899999999999999999999999999987654443
Q ss_pred ceeeeccccCccccCCCccCC---CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 584 SVIQTMTMATIGYMAPEYGSE---GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+..... .....+...... +..
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~-------p~~ 231 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLS-------PDL 231 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSCC-------CCG
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCC-------Ccc
Confidence 333445679999999998754 458999999999999999999999997642221 222222211110 000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
. ....+++.++.+++.+||+.||++||||+|+++.|+.+.+..+
T Consensus 232 ~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 232 S------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp G------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred h------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 0 1112456678999999999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=412.27 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=206.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|++.+.||+|+||+||+|+++ +|+.||||++.... .+..+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 58999999999999999999975 79999999986543 33446688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+++|+|.+++.... .+++..+..++.|+++||+||| +++|+||||||+|||+++++.+||+|||+|+........
T Consensus 85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH----~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999997654 4899999999999999999999 678999999999999999999999999999877544433
Q ss_pred eeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||............+......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence 33455679999999999887775 678999999999999999999997643332222222111100
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++.++.+++.+||+.||++|||++|+++
T Consensus 226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111233456789999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=412.60 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=209.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
++|+..+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999975 79999999998766555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++|+|.+++.+.. +++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~~~--l~~~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 171 (293)
T d1yhwa1 100 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (293)
T ss_dssp TTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH----HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence 9999999887653 899999999999999999999 67899999999999999999999999999987754322
Q ss_pred eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 586 IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..... .+........+
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~---------------- 234 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP---------------- 234 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC----------------
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCC----------------
Confidence 2345579999999999999999999999999999999999999996532111 11111111111
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....+..++.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112234567889999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=410.06 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=203.5
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
++|+..+.||+|+||+||+|.+.+++.||||+++.... ..+.+.+|++++++++||||++++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 57888999999999999999998889999999975432 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+|+|.+++......+++..+..++.|+++||+||| +++|+||||||+|||++.++.+||+|||+++........ .
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S 158 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh----ccceeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence 99999999887777999999999999999999999 678999999999999999999999999999876543322 2
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCC-CCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEK-KPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....||+.|+|||++.+..|+.++|||||||++|||+|++ +||... ......+.+......
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~--------------- 221 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRL--------------- 221 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHTCCC---------------
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhcCCC---------------
Confidence 23456899999999999999999999999999999999965 444432 112222222221110
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
..+..++.++.+++.+||+.||++||||+|+++.|+++.+
T Consensus 222 --~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 222 --YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 0112345668899999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-50 Score=410.14 Aligned_cols=258 Identities=27% Similarity=0.453 Sum_probs=201.9
Q ss_pred ccCCccccccccccEEEEEEEec-CC---CeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DG---TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
++|++.+.||+|+||+||+|.++ ++ ..||||.+.... ....+.|.+|++++++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45666789999999999999975 33 258999886543 44557799999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++|+|.+++......+++.++..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh----hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999999987777999999999999999999999 678999999999999999999999999999877543
Q ss_pred CCce---eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 582 EDSV---IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 582 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
.... ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+... ......+.....
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~~~~-------- 251 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQDYR-------- 251 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCC--------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC--------
Confidence 2221 1223457999999999999999999999999999999998 8999976322 122222221110
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.+.+.+++.++.+++.+||+.||++||||.|+++.|+++.+
T Consensus 252 ---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 ---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11122456778899999999999999999999999998865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=401.67 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=206.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+.. ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999985 78999999997543 233567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++...+ .+++..+..++.|+++||+||| +++|+||||||+|||++.++.+||+|||++.......
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999998654 3899999999999999999999 6789999999999999999999999999998764322
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .....+... . .
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~---~------~---- 221 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRV---E------F---- 221 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTT---C------C----
T ss_pred ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHHHHHHcC---C------C----
Confidence 23457999999999999999999999999999999999999999753211 111111110 0 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..+..++.++.+++.+||+.||++|||++|+++
T Consensus 222 -----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 001124566889999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=412.62 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=207.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
+.|++.+.||+|+||+||+|++. +++.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999975 78999999997665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV 585 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 585 (717)
++|+|.+++.+....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH----~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH----DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 165 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--cc
Confidence 999999998876667999999999999999999999 678999999999999999999999999999765321 11
Q ss_pred eeeccccCccccCCCcc-----CCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 586 IQTMTMATIGYMAPEYG-----SEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 586 ~~~~~~~t~~y~aPE~~-----~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
......||+.|+|||++ .+..|+.++||||+||++|||+||+.||.+....+ .+........+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~----------- 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPP----------- 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCC-----------
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCC-----------
Confidence 22345799999999986 45668999999999999999999999997643221 11111111110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
....+..++.++.+++.+||+.||++|||++|+++
T Consensus 234 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 -----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112244567889999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=396.17 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=214.1
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMP 506 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 506 (717)
++|+..+.||+|+||+||+|++++++.||||+++.... ..+.+.+|++++++++||||++++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 58899999999999999999998888999999976532 33678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCcee
Q 005040 507 NGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSVI 586 (717)
Q Consensus 507 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 586 (717)
+|+|.+++......+++..+.+++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++........ .
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH----~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S 157 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh----hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence 99999998877677999999999999999999999 678999999999999999999999999999876544332 2
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .....+......
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~~~--------------- 220 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRL--------------- 220 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCCC---------------
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCCCC---------------
Confidence 334568999999999999999999999999999999998 89999764322 122212211100
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
..+..++.++.++|.+||+.||++|||++|+++.|.+|
T Consensus 221 --~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 --YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11123456788999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=401.58 Aligned_cols=260 Identities=24% Similarity=0.410 Sum_probs=212.4
Q ss_pred ccCCcccc-ccccccEEEEEEEec---CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 427 DEFNECNL-LGTGGFGSVYKGTLS---DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 427 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
++|.+.+. ||+|+||+||+|.++ ++..||||+++... ....+.+.+|++++++++|||||+++|++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999864 45579999997543 3455789999999999999999999999875 457999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++|+|.+++......+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999999877677999999999999999999999 678999999999999999999999999999987654
Q ss_pred CCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 582 EDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 582 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
.... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+... ......+......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~~~~~--------- 231 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRM--------- 231 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTCCC---------
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC---------
Confidence 3322 2234468999999999999999999999999999999998 8999976432 2222222211100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
+.+..++.++.++|.+||+.||++||||.+|++.|+.+.....
T Consensus 232 --------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 232 --------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp --------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 1112456678899999999999999999999999998755443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=402.89 Aligned_cols=256 Identities=23% Similarity=0.397 Sum_probs=208.0
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|++.+.||+|+||.||+|.+++++.||||+++.... ..+.+.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 368889999999999999999998889999999975432 34678999999999999999999998865 5579999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++|+|.+++... ...+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH----~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y 164 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccchhheeeecccceeeccccceEEccCCc-c
Confidence 999999988643 334899999999999999999999 6789999999999999999999999999999875432 2
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
.......||+.|+|||++.++.++.++|||||||++|||+||+.|+..... .....+.+......
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i~~~~~~-------------- 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRM-------------- 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCCC--------------
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCC--------------
Confidence 223445689999999999989999999999999999999997666533221 11122222111100
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
..+..++.++.+++.+||+.||++||||+||++.|+.+-
T Consensus 230 ---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 230 ---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 111234567889999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=401.01 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=194.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec--CCeeEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN--LDFKALV 501 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv 501 (717)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... +...+.+.+|++++++++|||||++++++.+ ....|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 68999999999999999999975 79999999986543 3445678899999999999999999999865 4568999
Q ss_pred EEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 502 LEFMPNGSLEKWLYS---HNYFLDILQRLNIMIDVGSALEYLHHCH-SSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
|||+++|+|.+++.+ ....+++..++.++.|++.||+|||+.. ...+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999974 3456999999999999999999999632 123599999999999999999999999999988
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcc
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVD 657 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (717)
+..... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+... ..+...+.......
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~~~~~~------ 233 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRR------ 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCC------
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCCC------
Confidence 754322 22345789999999999999999999999999999999999999976322 11111111110000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 ANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.+..++.++.+++.+||+.||++|||++|+++
T Consensus 234 -----------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -----------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 01134567889999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=406.04 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=204.5
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999975 79999999997543 234467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.+....
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc----cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999988654 3899999999999999999999 6789999999999999999999999999999875444
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
.........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+... ......+... . ..+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~~---~------~~~-- 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQKIIKL---E------YDF-- 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHTT---C------CCC--
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHHHHcC---C------CCC--
Confidence 33334456799999999999999999999999999999999999999975321 1111111110 0 000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+..++.++.++|.+||+.||++|||++|+++.
T Consensus 230 -------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 -------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11244568899999999999999999997543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-50 Score=404.63 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=213.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||+||+|.++ +++.||||+++.... ..+.+.+|++++++++|||||+++|++.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 468889999999999999999976 688999999975533 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++|+|.+++... ...+++..+..++.|+++||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~- 169 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 169 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH----HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-
Confidence 9999999999754 456899999999999999999999 5789999999999999999999999999998765433
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
........||+.|+|||++.+..|+.++|||||||++|||++|+.|+..... .....+.+......
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~~------------- 235 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRM------------- 235 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCC-------------
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCCC-------------
Confidence 2233445689999999999999999999999999999999998777643211 11122222211110
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
+.+..++.++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 236 ----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112345678899999999999999999999999998744
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=400.51 Aligned_cols=259 Identities=26% Similarity=0.464 Sum_probs=204.7
Q ss_pred ccCCccccccccccEEEEEEEecCC-----CeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDG-----TNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
+.|+..+.||+|+||.||+|.+++. ..||||++.... ......|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688889999999999999987532 369999986544 3344578999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+.+|++.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc----ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999999887777999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCC-ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GED-SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
... ........||+.|+|||++.++.++.++|||||||++|||++|+.|+..... .....+.+.....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~~---------- 231 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFR---------- 231 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTTCC----------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHHHHHhccCC----------
Confidence 322 1223344689999999999999999999999999999999997666543221 1122222221110
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.+.+.+++.++.+++.+||+.||++||||.||++.|+++.+
T Consensus 232 -------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 01112355678899999999999999999999999998865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=390.86 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=195.3
Q ss_pred CccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec----CCeeEEEE
Q 005040 430 NECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN----LDFKALVL 502 (717)
Q Consensus 430 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~ 502 (717)
+..+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+ ....|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999975 78899999987543 3445678999999999999999999999854 45679999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeeeccccccC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAP--IIHCDLKPTNILLD-ENMVAHVSDFGISKLLG 579 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~ 579 (717)
||+++|+|.+++.+.. .+++..+..++.||++||+||| +++ |+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH----~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH----HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999998654 4899999999999999999999 455 99999999999996 58899999999998653
Q ss_pred CCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||.+.... ..+.+.+...... .
T Consensus 167 ~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~~~~~~i~~~~~~-------~- 232 (270)
T d1t4ha_ 167 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTSGVKP-------A- 232 (270)
T ss_dssp TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHHHTTTCCC-------G-
T ss_pred CCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-HHHHHHHHcCCCC-------c-
Confidence 321 234579999999998865 5999999999999999999999999653221 1111111111000 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++.++.+++.+||+.||++|||++|+++
T Consensus 233 --------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 --------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 011123456889999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=406.47 Aligned_cols=255 Identities=24% Similarity=0.407 Sum_probs=208.5
Q ss_pred ccCCccccccccccEEEEEEEecC-C-----CeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCee
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSD-G-----TNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 498 (717)
++|++.+.||+|+||+||+|++.. + ..||+|++.... ......+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 688999999999999999998642 2 369999886543 33446788999999998 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 005040 499 ALVLEFMPNGSLEKWLYSHN----------------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKP 556 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~ 556 (717)
++||||+++|+|.++++... ..+++..+..++.|+++||+||| +++|+||||||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH----~~~IiHRDlKp 192 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAA 192 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCSG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCch
Confidence 99999999999999997543 24789999999999999999999 67899999999
Q ss_pred CCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 005040 557 TNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFT 635 (717)
Q Consensus 557 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~ 635 (717)
+||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987765554444455678999999999999999999999999999999998 8999976432
Q ss_pred CcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 005040 636 GEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLR 703 (717)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~ 703 (717)
. ..+.+.+..... .+.+..++.++.++|.+||+.||++|||++||++.|.
T Consensus 273 ~-~~~~~~~~~~~~-----------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D-ANFYKLIQNGFK-----------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S-HHHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H-HHHHHHHhcCCC-----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 222222222111 0111234567899999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=395.58 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=201.3
Q ss_pred ccccccccEEEEEEEec---CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEccCC
Q 005040 433 NLLGTGGFGSVYKGTLS---DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFMPN 507 (717)
Q Consensus 433 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 507 (717)
++||+|+||+||+|.++ .++.||||+++... ....+.+.+|++++++++|||||+++|++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999864 35679999996543 33456799999999999999999999998654 56899999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCce-e
Q 005040 508 GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDSV-I 586 (717)
Q Consensus 508 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~ 586 (717)
|+|.++++... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......... .
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH----~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH----hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999998754 4899999999999999999999 6789999999999999999999999999998775443322 2
Q ss_pred eeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhhh
Q 005040 587 QTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREEQ 665 (717)
Q Consensus 587 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+... ......+.....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~~~---------------- 228 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGER---------------- 228 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCC----------------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcCCC----------------
Confidence 234568999999999999999999999999999999998 8999976322 122222221100
Q ss_pred hhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 666 AFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.+.+..++.++.+++.+||+.||++|||+++|++.|+..-.
T Consensus 229 -~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 01112456678899999999999999999999999887643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-50 Score=411.03 Aligned_cols=270 Identities=22% Similarity=0.307 Sum_probs=208.0
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||+||+|... +|+.||+|+++... ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999975 78999999987543 3344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
|+++|+|.+++.+.+ .+++..+..++.|+++||.|||+ .++|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH---hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 999999999998654 38999999999999999999994 2479999999999999999999999999998764221
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHH--hhC-------------
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK--ESL------------- 648 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~------------- 648 (717)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+............. ...
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 23457999999999999999999999999999999999999999763322111100000 000
Q ss_pred ----------CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHH
Q 005040 649 ----------PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA--KLRK 704 (717)
Q Consensus 649 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~--~L~~ 704 (717)
+....+..+.......+. ......+.++.+++.+||..||++|||++|+++ .+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPK-LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCC-CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCcc-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000000000000000000 001123567889999999999999999999987 3544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-48 Score=404.17 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=209.8
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999975 7999999999766555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCcEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD--ENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~~~ 582 (717)
+++|+|.+++.+....+++..+..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+++.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999766666999999999999999999999 68999999999999996 46889999999998875433
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. .....||+.|||||++.+..++.++||||+||++|||++|+.||.+... ....+.+..... .. ..
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~-~~----~~---- 246 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKSCDW-NM----DD---- 246 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCC-CS----CC----
T ss_pred c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-CC----Cc----
Confidence 2 3445789999999999999999999999999999999999999975321 111111111100 00 00
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++.++.++|.+||+.||++|||++|+++
T Consensus 247 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 247 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp -----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011234566889999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.7e-49 Score=399.35 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=191.3
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
.+.|++.+.||+|+||+||+|+.+ +++.||||++.... ......+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 78999999997554 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeeccccccCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~~~ 580 (717)
|++||+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||++. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh----hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999998654 4999999999999999999999 67899999999999995 578999999999987643
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANL 660 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (717)
... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .....+...... .
T Consensus 163 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~~~~---------~ 228 (307)
T d1a06a_ 163 GSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQILKAEYE---------F 228 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHTTCCC---------C
T ss_pred CCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCC---------C
Confidence 322 23457999999999999999999999999999999999999999763221 121211111000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 661 VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. .+...+++.++.+++.+||+.||++|||++|+++
T Consensus 229 ~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 D-----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp C-----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 0111234567889999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-48 Score=402.46 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=210.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 7999999999766555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCcEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLD--ENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||++..+....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999999998877767999999999999999999999 67999999999999998 67899999999999875433
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... .....+...... ...
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~---------~~~ 249 (352)
T d1koba_ 184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCDWE---------FDE 249 (352)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCCCC---------CCS
T ss_pred c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC---------CCc
Confidence 2 34457899999999999999999999999999999999999999753221 111111111000 000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++.++.++|.+||+.||++|||++|+++
T Consensus 250 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011134566889999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-49 Score=400.56 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=200.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
+.|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999965 78999999986542 344567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|||++|+|..++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++......
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 999999997766654 45899999999999999999999 678999999999999999999999999999865432
Q ss_pred CceeeeccccCccccCCCccCC---CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 583 DSVIQTMTMATIGYMAPEYGSE---GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||.+....+ .+........+ .
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~---------~ 233 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP---------A 233 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC---------C
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCC---------C
Confidence 23469999999998753 568999999999999999999999996532111 11111111000 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.....++.++.+++.+||+.||++|||++|+++
T Consensus 234 --------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 011134566889999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=400.31 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=206.9
Q ss_pred ccCCccccccccccEEEEEEEec-CCC----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGT----NVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.+|+..+.||+|+||+||+|.+. +|+ .||+|.++... .+..+.+.+|++++++++|||||+++|++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 47999999999999999999874 444 58999886443 34457799999999999999999999999875 4678
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
++||+.+|+|.+++......+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH----HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999999988888999999999999999999999 67899999999999999999999999999998765
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
...........||+.|+|||++.++.++.++|||||||++|||+| |+.||++.... .+...+.....
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~~~~---------- 231 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER---------- 231 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHHTCC----------
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC----------
Confidence 544443444568999999999999999999999999999999999 78888764322 22222221110
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.+.+..++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 232 -------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 01112455678899999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=389.73 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=206.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh------HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL------ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999975 79999999986432 12356789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeecc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM----VAHVSDFGI 574 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl 574 (717)
|+|||||++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH----~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh----hcceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999998654 4899999999999999999999 67899999999999998776 599999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
+........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .....+.....
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~~~----- 233 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVNY----- 233 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHTTCC-----
T ss_pred hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHHHHHHhcCC-----
Confidence 987754322 23457899999999999999999999999999999999999999753211 11111111000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
.... .....++.++.++|.+||+.||++|||++|+++
T Consensus 234 ----~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 ----EFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----CCCH-----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCCc-----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 111234567889999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=392.52 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=205.9
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEcc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEFM 505 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 505 (717)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 36899999999999999999999888889999997553 234678999999999999999999999865 4579999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 506 PNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 506 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
++|+|..++... ...++|.++..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH----~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh----hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 999999998743 345899999999999999999999 57899999999999999999999999999987654332
Q ss_pred eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhhh
Q 005040 585 VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVREE 664 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
.......||+.|+|||++.++.++.++|||||||++|||++|+.|+...... ......+......
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~~-------------- 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRM-------------- 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCC--------------
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCC--------------
Confidence 2234456899999999999999999999999999999999977765442221 1222222211110
Q ss_pred hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhcc
Q 005040 665 QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLD 711 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 711 (717)
+....++.++.++|.+||+.||++|||+++|++.|+.+.....+
T Consensus 234 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 234 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 11123456788999999999999999999999999887544433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=387.22 Aligned_cols=258 Identities=22% Similarity=0.364 Sum_probs=202.1
Q ss_pred hccCCccccccccccEEEEEEEec----CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 500 (717)
.++|++.+.||+|+||.||+|.+. .+..||||+++... ....+.+.+|++++++++||||++++|++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 368999999999999999999864 24568999886543 4445679999999999999999999999964 56899
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCC
Q 005040 501 VLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 580 (717)
Q Consensus 501 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 580 (717)
||||+++|+|.+++......+++..+..++.|+++||.||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc----ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999999998887777999999999999999999999 67899999999999999999999999999987643
Q ss_pred CCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhcccc
Q 005040 581 GEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDAN 659 (717)
Q Consensus 581 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||...... .....+......
T Consensus 161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~~~~--------- 228 (273)
T d1mp8a_ 161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERL--------- 228 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC---------
T ss_pred Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCC---------
Confidence 322 22344568999999999999999999999999999999998 88998764332 222222211100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 660 LVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
+.+..++.++.++|.+||+.||++|||++|+++.|+++.++
T Consensus 229 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11123556789999999999999999999999999998654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-48 Score=394.92 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=211.5
Q ss_pred HhccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCe
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDF 497 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 497 (717)
..++|++.+.||+|+||+||+|+++ +++.||||+++... .+..+.+.+|++++++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999864 45789999997554 3345679999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC
Q 005040 498 KALVLEFMPNGSLEKWLYSHN-----------------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDL 554 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dl 554 (717)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH----~~~ivHrDl 166 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDL 166 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCC
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc----cCCeEeeEE
Confidence 999999999999999997432 24789999999999999999999 678999999
Q ss_pred CCCCeeeCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCC-CCCCcc
Q 005040 555 KPTNILLDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEK-KPTDEM 633 (717)
Q Consensus 555 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~-~p~~~~ 633 (717)
||+|||++.++.+||+|||+++...............+|+.|+|||++.+..|+.++|||||||++|||++|. +||.+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999998765444334445567899999999999999999999999999999999986 567653
Q ss_pred ccCcchHHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 005040 634 FTGEMSLRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIK 706 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~ 706 (717)
.. ......+...... ..+..++.++.+++.+||+.||++||||.||++.|++|.
T Consensus 247 ~~--~e~~~~v~~~~~~-----------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AH--EEVIYYVRDGNIL-----------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CH--HHHHHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CH--HHHHHHHHcCCCC-----------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22 1222222211100 011234567889999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=393.07 Aligned_cols=248 Identities=22% Similarity=0.251 Sum_probs=207.2
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 501 (717)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++++.. ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 468999999999999999999975 89999999997653 23456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++|+|.+++...+. +++..++.++.|++.||+||| +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh----hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999987654 899999999999999999999 689999999999999999999999999999876433
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.... .+.+.+.....
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~i~~~~~------------ 222 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILMEEI------------ 222 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC------------
T ss_pred Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HHHHHHhcCCC------------
Confidence 22 234467999999999999999999999999999999999999999763221 11111111000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
..+..++.++.++|.+||+.||++||+ ++|+++
T Consensus 223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 001134566889999999999999995 778775
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=392.25 Aligned_cols=278 Identities=21% Similarity=0.291 Sum_probs=204.8
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC----eeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLD----FKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~lv~ 502 (717)
++|...+.||+|+||+||+|++ +|+.||||+++..... ......|+..+.+++||||+++++++.+.+ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5677888999999999999997 6889999999755332 122334555666789999999999986543 679999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc----CCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHC----HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
||+++|+|.+++++.. ++|..+..++.|++.||+|+|.. ..+++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999998764 89999999999999999999952 11368999999999999999999999999999877
Q ss_pred CCCCCce--eeeccccCccccCCCccCCC------CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC-
Q 005040 579 GEGEDSV--IQTMTMATIGYMAPEYGSEG------IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP- 649 (717)
Q Consensus 579 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~- 649 (717)
....... ......||+.|+|||++.+. .++.++|||||||++|||+||..||...................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 5443322 23445799999999987654 36789999999999999999998875432221111000000000
Q ss_pred Cc-hhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 650 HR-LTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 650 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.. .....+..+....+......++...+.+++.+||+.||++|||+.||++.|+++.++
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00 001111111111111222345667799999999999999999999999999999765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=389.53 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=200.4
Q ss_pred hccCCccccccccccEEEEEEEec--CC--CeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--DG--TNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|++.+.||+|+||.||+|++. ++ ..||||++.... .+..+.|.+|++++++++||||++++|++.+. ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 367999999999999999999863 22 368999987543 34456799999999999999999999999764 67
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccccc
Q 005040 499 ALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 578 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 578 (717)
++||||+++|++.+++......+++..+..++.|+++||.||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh----hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 8999999999999998877667999999999999999999999 678999999999999999999999999999987
Q ss_pred CCCCCce-eeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 579 GEGEDSV-IQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 579 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
....... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||.+... .....++..... +
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--~~~~~~i~~~~~-~----- 233 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILHKIDKEGE-R----- 233 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTSCC-C-----
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--HHHHHHHHhCCC-C-----
Confidence 5544332 2334467889999999999999999999999999999998 8999975322 122222211100 0
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKI 705 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~ 705 (717)
.+....++.++.+++.+||+.||++||||+||++.|++.
T Consensus 234 ----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 ----------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 011123456788999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=383.29 Aligned_cols=251 Identities=29% Similarity=0.427 Sum_probs=199.7
Q ss_pred hccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec-CCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN-LDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~ 504 (717)
.++|+..+.||+|+||.||+|+++ |+.||||+++... ..+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 357888999999999999999984 7889999997543 34678999999999999999999998854 4668999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 505 MPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 505 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
+++|+|.+++... ...+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc----cCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999999754 234899999999999999999999 678999999999999999999999999999865432
Q ss_pred ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
.....+|+.|+|||++.++.++.++|||||||++|||+| |+.||..... .+...++.......
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~~~~~----------- 220 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMD----------- 220 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTCCCC-----------
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCC-----------
Confidence 233457899999999999999999999999999999998 6777765322 23333332211111
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
.+..++.++.+++.+||+.||++||||.|+++.|++++.
T Consensus 221 ------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 ------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 111344568899999999999999999999999998864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=387.26 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=216.1
Q ss_pred hccCCccccccccccEEEEEEEe------cCCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCe
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTL------SDGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~ 497 (717)
.++|++.+.||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +|||||+++|++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 36889999999999999999985 246689999997654 33456788999999999 69999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 498 KALVLEFMPNGSLEKWLYSHN-----------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
.++||||+++|+|.++++... ..+++..+..++.||++||+||| +++|+||||||+||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH----~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNIL 177 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccccccccc
Confidence 999999999999999997542 25889999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchH
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL 640 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~ 640 (717)
++.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|++.|+.........+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999998766555555566789999999999999999999999999999999999555543323333333
Q ss_pred HHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 641 RRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
.+.+....... .+..++.++.+||.+||+.||++||||+|+++.|+++...
T Consensus 258 ~~~i~~~~~~~-----------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGFRML-----------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTCCCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCC-----------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 33333222111 0112345688999999999999999999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-47 Score=387.68 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=204.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 67999999999999999999975 79999999997653 233567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||++||+|..++..... +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc----cCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 99999999998887654 788899999999999999999 7899999999999999999999999999998865332
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
...+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.... ....-+... ..
T Consensus 159 -----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~~-----------~~-- 218 (316)
T d1fota_ 159 -----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILNA-----------EL-- 218 (316)
T ss_dssp -----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHC-----------CC--
T ss_pred -----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHHHHHHcC-----------CC--
Confidence 3457999999999999999999999999999999999999999763211 111111100 00
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
..+..++.++.+++.+||..||++|+ |++|+++
T Consensus 219 -----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 00112345688999999999999996 8888875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=387.56 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=201.6
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeec-CC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSN-LD 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~-~~ 496 (717)
.++|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|..++.++ +||||+.+++++.+ ..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 368999999999999999999863 34689999997544 34456678888888887 68999999998765 45
Q ss_pred eeEEEEEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 005040 497 FKALVLEFMPNGSLEKWLYSH---------------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILL 561 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill 561 (717)
..++||||+++|+|.++++.. ...+++..+..++.||++||+||| +++|+||||||+|||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILL 167 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEE
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH----hCCCcCCcCCccceeE
Confidence 689999999999999999753 234889999999999999999999 6789999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCC-CCCCccccCcchH
Q 005040 562 DENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEK-KPTDEMFTGEMSL 640 (717)
Q Consensus 562 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~-~p~~~~~~~~~~~ 640 (717)
+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||...... ..+
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEF 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HHH
Confidence 999999999999998765544444444567999999999999999999999999999999999975 567553222 222
Q ss_pred HHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 641 RRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
...+...... ..+..++.++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 247 ~~~~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 247 CRRLKEGTRM-----------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCC-----------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 2222221111 11123456688999999999999999999999999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=386.94 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=209.0
Q ss_pred cccccccccEEEEEEEecC----CCeEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeeEeeeeec-CCeeEEEEEcc
Q 005040 432 CNLLGTGGFGSVYKGTLSD----GTNVAIKIFNLQ-LERAFRSFDSECEILRNVRHRNLLKILGSCSN-LDFKALVLEFM 505 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~ 505 (717)
.++||+|+||+||+|.+.+ ...||||+++.. .....+++.+|++++++++||||++++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 3679999999999998743 235899998643 34456789999999999999999999999765 56889999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc-
Q 005040 506 PNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS- 584 (717)
Q Consensus 506 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 584 (717)
++|+|.+++.......++..+.+++.|+++||.|+| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH----~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc----ccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999987777889999999999999999999 678999999999999999999999999999876543322
Q ss_pred -eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchhh
Q 005040 585 -VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVRE 663 (717)
Q Consensus 585 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .....++......
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~~~------------- 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRL------------- 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC-------------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCC-------------
Confidence 1223346899999999999999999999999999999999988887653221 1222222211100
Q ss_pred hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccc
Q 005040 664 EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDD 712 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 712 (717)
..+..++.++.++|.+||+.||++||+|.||++.|+++.+++..+
T Consensus 254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 011234566889999999999999999999999999998877654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.8e-47 Score=384.79 Aligned_cols=260 Identities=21% Similarity=0.359 Sum_probs=202.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC----e
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD----F 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~ 497 (717)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999974 79999999997543 344567899999999999999999999986543 4
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+||||++||+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH----hCCccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999987654 4899999999999999999999 67899999999999999999999999999876
Q ss_pred cCCCCC-ceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhc
Q 005040 578 LGEGED-SVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVV 656 (717)
Q Consensus 578 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (717)
...... ........||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+ ...+.+... +.. .
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~~-~~~-~--- 234 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVRED-PIP-P--- 234 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCC-CCC-G---
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhcC-CCC-C---
Confidence 543322 223344579999999999999999999999999999999999999997532211 111111110 000 0
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhH
Q 005040 657 DANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-HMTDAAAKLRKIK 706 (717)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ev~~~L~~~~ 706 (717)
.....+++.++.+++.+||+.||++|| |++++++.|.+++
T Consensus 235 ----------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 ----------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 011123456788999999999999999 8999999998775
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-46 Score=377.41 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=204.5
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---------HHHHHHHHHHHHHHHhcC-CCceeeEeeeeecC
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---------ERAFRSFDSECEILRNVR-HRNLLKILGSCSNL 495 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~ 495 (717)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999974 79999999986432 233456889999999997 99999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccc
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS 575 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 575 (717)
+..|+||||+++|+|.++++..+ .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HcCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999998654 4899999999999999999999 578999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccC------CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCC
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGS------EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLP 649 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 649 (717)
+....... .....||+.|+|||.+. ...++.++||||+||++|||++|+.||.+... ....+.+.....
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--~~~~~~i~~~~~ 232 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSGNY 232 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCC
T ss_pred eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--HHHHHHHHhCCC
Confidence 98754332 23457999999999754 34578899999999999999999999976322 111111111100
Q ss_pred CchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 650 HRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
. . ..+....++.++.+++.+||+.||++|||++||++
T Consensus 233 ~---------~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 Q---------F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C---------C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C---------C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0 00112245567889999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=385.12 Aligned_cols=251 Identities=20% Similarity=0.291 Sum_probs=207.1
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.++|++.+.||+|+||+||+|.+. +++.||||+++....+ ...+.+|+++|+.++||||+++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999975 7889999999765433 35678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--CCcEEEeeeccccccCCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE--NMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~ 582 (717)
|+||+|.+++...+..+++..+..++.||++||+||| +.+|+||||||+|||++. ...+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH----~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999999999877667999999999999999999999 679999999999999985 4589999999998764432
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
......+|+.|+|||...+..|+.++||||+||++|||++|+.||...... .....+..... . +.
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i~~~~~-~--------~~- 223 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEY-T--------FD- 223 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCC-C--------CC-
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC-C--------CC-
Confidence 233456899999999999999999999999999999999999999763211 11111111000 0 00
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
......++.++.+++.+||..||++|||++|+++
T Consensus 224 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 ----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111234566889999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=384.83 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=209.2
Q ss_pred hccCCccccccccccEEEEEEEec--------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecC
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS--------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNL 495 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 495 (717)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ......+.+|...+.++ +|||||++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 368899999999999999999853 23479999997655 34456788899999888 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 005040 496 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNIL 560 (717)
Q Consensus 496 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nil 560 (717)
+..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+|||
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH----~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVL 167 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh----hCCEEeeeeccccee
Confidence 99999999999999999997543 34899999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 005040 561 LDENMVAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFT-EKKPTDEMFTGEMS 639 (717)
Q Consensus 561 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 639 (717)
++.++.+||+|||+++...............+|+.|+|||++.++.|+.++|||||||++|||++ |..||.+... ..
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--~~ 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--HH
Confidence 99999999999999987765444444455678999999999999999999999999999999998 6888865322 12
Q ss_pred HHHHHHhhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHh
Q 005040 640 LRRWVKESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAK 708 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 708 (717)
..+.+...... ..+..++.++.++|.+||+.||++||||.||++.|+++.+.
T Consensus 246 ~~~~i~~~~~~-----------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 LFKLLKEGHRM-----------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHTTCCC-----------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCC-----------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 22222211110 11113456688999999999999999999999999998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-46 Score=388.33 Aligned_cols=248 Identities=20% Similarity=0.269 Sum_probs=199.1
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHH---HHHHHHHhcCCCceeeEeeeeecCCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFD---SECEILRNVRHRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~hpniv~~~~~~~~~~~~~ 499 (717)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+. .|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999975 79999999997543 11122233 4567777778999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
+||||+++|+|.+++.+.. .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH----~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH----HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999998754 3789999999999999999999 6899999999999999999999999999998775
Q ss_pred CCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccc
Q 005040 580 EGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDA 658 (717)
Q Consensus 580 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (717)
... .....||+.|+|||++.+ ..|+.++||||+||++|||+||+.||........ ............
T Consensus 159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~~~~------ 226 (364)
T d1omwa3 159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAV------ 226 (364)
T ss_dssp SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSSCCC------
T ss_pred CCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcccCCC------
Confidence 432 234579999999998864 5689999999999999999999999976432221 111111111000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 659 NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
..+..++.++.++|.+||+.||++||| ++|+++
T Consensus 227 ---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ---------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 001124456889999999999999999 677764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-46 Score=389.09 Aligned_cols=244 Identities=24% Similarity=0.246 Sum_probs=205.2
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 502 (717)
++|++++.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999975 79999999997543 233467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
||+.+|+|.+++...+ .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH----~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 9999999999998664 3899999999999999999999 6789999999999999999999999999998774322
Q ss_pred CceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccchh
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLVR 662 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (717)
....||+.|||||++.+..++.++||||+||++|||+||+.||.+... ......+.....
T Consensus 196 -----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~~~~------------- 255 (350)
T d1rdqe_ 196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSGKV------------- 255 (350)
T ss_dssp -----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-------------
T ss_pred -----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHHHhcCCC-------------
Confidence 345799999999999999999999999999999999999999975321 111111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 005040 663 EEQAFSDKMDCLFSIMDLALDCCMDTPHKRI-----HMTDAAA 700 (717)
Q Consensus 663 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ev~~ 700 (717)
..+..++.++.+++.+||..||++|+ |++|+++
T Consensus 256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 00113456688999999999999994 8999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=385.73 Aligned_cols=261 Identities=29% Similarity=0.456 Sum_probs=207.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCC--eEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeeEeeeeecCCeeEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGT--NVAIKIFNLQL-ERAFRSFDSECEILRNV-RHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv 501 (717)
++|++.+.||+|+||+||+|.++ ++. .||||++.... .+..+.+.+|+++++++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 78889999999999999999976 444 47888875432 34556799999999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 005040 502 LEFMPNGSLEKWLYSH---------------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMV 566 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~ 566 (717)
|||+++|+|.++++.. ...+++..+..++.||++||.|+| +++|+||||||+|||++.++.
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH----~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh----cCCccccccccceEEEcCCCc
Confidence 9999999999999753 356899999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCC-CCCccccCcchHHHHHH
Q 005040 567 AHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKK-PTDEMFTGEMSLRRWVK 645 (717)
Q Consensus 567 ~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~-p~~~~~~~~~~~~~~~~ 645 (717)
+||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.+.. ...+...+.
T Consensus 166 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i~ 240 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLP 240 (309)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHGG
T ss_pred eEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHHHH
Confidence 9999999997653222 1234468999999999999999999999999999999999765 565421 111222111
Q ss_pred hhCCCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhccch
Q 005040 646 ESLPHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFLDDV 713 (717)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 713 (717)
.... ...+..++.++.++|.+||+.||++||||+||++.|+++.++....+
T Consensus 241 ~~~~-----------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~ 291 (309)
T d1fvra_ 241 QGYR-----------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291 (309)
T ss_dssp GTCC-----------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred hcCC-----------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCC
Confidence 1100 01112345678999999999999999999999999999987655443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=385.62 Aligned_cols=247 Identities=24% Similarity=0.304 Sum_probs=202.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh---HHHHHHHHHHHHHHH-hcCCCceeeEeeeeecCCeeEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL---ERAFRSFDSECEILR-NVRHRNLLKILGSCSNLDFKALV 501 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~hpniv~~~~~~~~~~~~~lv 501 (717)
++|++.+.||+|+||+||+|+.+ +++.||||++++.. ....+.+..|..++. .++|||||++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999976 79999999997643 233455667777765 68999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCC
Q 005040 502 LEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 502 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 581 (717)
|||+++|+|.++++.... +++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH----~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999986543 899999999999999999999 678999999999999999999999999999876433
Q ss_pred CCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhhccccch
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEVVDANLV 661 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (717)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ..+...+....+ .
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~---------~-- 221 (320)
T d1xjda_ 157 DA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNP---------F-- 221 (320)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC---------C--
T ss_pred cc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCC---------C--
Confidence 22 23445799999999999999999999999999999999999999976321 111111111100 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 005040 662 REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMT-DAAA 700 (717)
Q Consensus 662 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ev~~ 700 (717)
.+..++.++.+++.+||..||++|||+. |+++
T Consensus 222 -------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 -------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0112456688999999999999999995 6753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=383.75 Aligned_cols=251 Identities=21% Similarity=0.284 Sum_probs=198.7
Q ss_pred hccCCccc-cccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeeEeeeeec----CCee
Q 005040 426 TDEFNECN-LLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNV-RHRNLLKILGSCSN----LDFK 498 (717)
Q Consensus 426 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~----~~~~ 498 (717)
.++|.+.. .||+|+||.||+|++. +++.||||+++.. ..+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46888875 5999999999999974 7999999998643 3466799887655 89999999999865 4678
Q ss_pred EEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecc
Q 005040 499 ALVLEFMPNGSLEKWLYSH-NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGI 574 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl 574 (717)
|+|||||+||+|.+++.+. ...+++..+..++.|++.||+||| +.+|+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH----~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH----HcCCccccccccccccccccccccccccccce
Confidence 9999999999999999865 346999999999999999999999 689999999999999985 56799999999
Q ss_pred ccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 575 SKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
++....... .....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+..... ............
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~i~~~--- 232 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRMG--- 232 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC---
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHHHHhcC---
Confidence 987654332 244579999999999999999999999999999999999999996532211 111111110000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
...+. .+....++.++.+++.+||+.||++|||+.|+++
T Consensus 233 --~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 --QYEFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --SSSCC-----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --CCCCC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000 0122345677899999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=384.42 Aligned_cols=262 Identities=23% Similarity=0.394 Sum_probs=212.6
Q ss_pred hccCCccccccccccEEEEEEEec------CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCee
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS------DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFK 498 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 498 (717)
.++|+..+.||+|+||+||+|.+. +++.||||+++... .+....+.+|++++++++||||++++|++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 378899999999999999999863 35789999997543 44456789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 005040 499 ALVLEFMPNGSLEKWLYSH---------NYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHV 569 (717)
Q Consensus 499 ~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl 569 (717)
++||||+++|+|.+++... ...+++..+..++.|+++||.||| +.+|+||||||+|||++.++++||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH----~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCEEE
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeeceEcCCceeecCCceEEE
Confidence 9999999999999998742 134689999999999999999999 578999999999999999999999
Q ss_pred eeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCC-CCCCccccCcchHHHHHHhhC
Q 005040 570 SDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEK-KPTDEMFTGEMSLRRWVKESL 648 (717)
Q Consensus 570 ~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~ 648 (717)
+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||+||+ .||.+.... .....+..
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~--~~~~~i~~-- 250 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRFVME-- 250 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHHHHT--
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHh--
Confidence 9999998775544433344456899999999999999999999999999999999985 666542111 11111111
Q ss_pred CCchhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhhc
Q 005040 649 PHRLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKFL 710 (717)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 710 (717)
... .+.+..++..+.++|.+||+.+|++|||++||++.|++..+...
T Consensus 251 ---------~~~------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 251 ---------GGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp ---------TCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred ---------CCC------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 000 01112345678999999999999999999999999998755443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=378.96 Aligned_cols=267 Identities=24% Similarity=0.297 Sum_probs=201.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|++++.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+....|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999974 79999999997553 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCC
Q 005040 504 FMPNGSLEKWL-YSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 582 (717)
Q Consensus 504 ~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 582 (717)
|+.+ ++.+++ ......+++..+..++.|++.||+||| +.+||||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH----~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh----cCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9976 444444 445566999999999999999999999 6789999999999999999999999999998775433
Q ss_pred CceeeeccccCccccCCCccCCCC-cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-CCCc--hhhhcc-
Q 005040 583 DSVIQTMTMATIGYMAPEYGSEGI-VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES-LPHR--LTEVVD- 657 (717)
Q Consensus 583 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~- 657 (717)
. ......||+.|+|||...... ++.++||||+||++|||++|+.||.+....+ .+....... .+.. ......
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccccc
Confidence 2 233457899999999766554 5889999999999999999999997632221 122111111 1111 000000
Q ss_pred ccchhhh------hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 658 ANLVREE------QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 658 ~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
+...... .........+.++.+++.+||..||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000 0000112344678899999999999999999999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=376.31 Aligned_cols=262 Identities=25% Similarity=0.292 Sum_probs=194.4
Q ss_pred ccccccccccEEEEEEEec-CCCeEEEEEechhhHH-----HHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 431 ECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLER-----AFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 431 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
.+++||+|+||+||+|..+ +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 7999999998754321 124688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+.++++..+. .....+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh----ccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9887666554 44455889999999999999999999 688999999999999999999999999999876543322
Q ss_pred eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC---chhhhcc---
Q 005040 585 VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH---RLTEVVD--- 657 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 657 (717)
.....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+....+ .+.......... .+.....
T Consensus 157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred --ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccch
Confidence 234578999999998764 568999999999999999999999997532211 111111111100 0000000
Q ss_pred -ccchh--hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 -ANLVR--EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 -~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..... ..+........+.++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 00000001123467889999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=371.06 Aligned_cols=239 Identities=23% Similarity=0.269 Sum_probs=195.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhH------HHHHHHHHHHHHHHhcC--CCceeeEeeeeecCCe
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE------RAFRSFDSECEILRNVR--HRNLLKILGSCSNLDF 497 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~ 497 (717)
++|++.+.||+|+||+||+|... +|+.||||++..... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 799999999875431 11233567999999996 8999999999999999
Q ss_pred eEEEEEccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeeccc
Q 005040 498 KALVLEFMPN-GSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGIS 575 (717)
Q Consensus 498 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~ 575 (717)
.++||||+.+ +++.+++.... .+++..+..++.|+++||+||| +++|+||||||+||+++. ++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 68888887654 4899999999999999999999 689999999999999985 579999999999
Q ss_pred cccCCCCCceeeeccccCccccCCCccCCCCc-CcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhh
Q 005040 576 KLLGEGEDSVIQTMTMATIGYMAPEYGSEGIV-STKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTE 654 (717)
Q Consensus 576 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (717)
+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ....... .
T Consensus 159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~--~--- 222 (273)
T d1xwsa_ 159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV--F--- 222 (273)
T ss_dssp EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC--C---
T ss_pred eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhccc--C---
Confidence 8754322 234579999999998876655 678999999999999999999996521 0111000 0
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+ ...++.++.+++.+||+.||++|||++|+++
T Consensus 223 -~-------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 -F-------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -C-------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -C-------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 0123456889999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-45 Score=370.30 Aligned_cols=266 Identities=22% Similarity=0.275 Sum_probs=200.2
Q ss_pred ccCCccccccccccEEEEEEEecCCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 504 (717)
++|++.+.||+|+||+||+|++++|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999999999999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCCc
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDS 584 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 584 (717)
+.++.+..+. .....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc----cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 9876555554 44456999999999999999999999 57899999999999999999999999999987654322
Q ss_pred eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhC-CC--chhhhcc---
Q 005040 585 VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESL-PH--RLTEVVD--- 657 (717)
Q Consensus 585 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~--- 657 (717)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+. +.+...... +. .+.....
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhh
Confidence 2234468999999998765 5579999999999999999999999976432221 111111111 10 0110000
Q ss_pred --ccchh--hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 658 --ANLVR--EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 658 --~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..... ..+........+.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00000111234467889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=372.10 Aligned_cols=266 Identities=23% Similarity=0.281 Sum_probs=199.5
Q ss_pred HhccCCccccccccccEEEEEEEec-C-CCeEEEEEechhh--HHHHHHHHHHHHHHHhc---CCCceeeEeeeeec---
Q 005040 425 ATDEFNECNLLGTGGFGSVYKGTLS-D-GTNVAIKIFNLQL--ERAFRSFDSECEILRNV---RHRNLLKILGSCSN--- 494 (717)
Q Consensus 425 ~~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~--- 494 (717)
+.++|++++.||+|+||+||+|++. + ++.||||+++... ......+.+|+++++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3578999999999999999999974 4 6679999986543 11223455677777766 79999999998843
Q ss_pred --CCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 005040 495 --LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDF 572 (717)
Q Consensus 495 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 572 (717)
....+++|||+.++++..........+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH----~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecCCCccEEEEcCCCCeeecch
Confidence 35679999999988777666666667999999999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC-c
Q 005040 573 GISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH-R 651 (717)
Q Consensus 573 gl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~ 651 (717)
|++...... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.... ..+.......... .
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGE 236 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCG
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCch
Confidence 998765322 2234567999999999999999999999999999999999999999763221 1122221111110 0
Q ss_pred --hh-------hhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 652 --LT-------EVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 652 --~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+. ............ ......+..+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIE--KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGG--GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhccccccchh--hccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 000000000000 011234566889999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=365.17 Aligned_cols=269 Identities=22% Similarity=0.244 Sum_probs=196.7
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC----eeE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL-ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD----FKA 499 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~ 499 (717)
..+|++++.||+|+||+||+|... +|+.||||++.+.. ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999864 89999999997543 444567889999999999999999999986543 234
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccC
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 579 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 579 (717)
++++|+.+|+|.+++.... +++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 87 ~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH----~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 4556667899999998754 899999999999999999999 6799999999999999999999999999998764
Q ss_pred CCCCc-eeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh--
Q 005040 580 EGEDS-VIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV-- 655 (717)
Q Consensus 580 ~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 655 (717)
..... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+. ................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhhhh
Confidence 33221 12234568999999998744 5678999999999999999999999976332211 1111111111000000
Q ss_pred -ccccchhh---------hhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 656 -VDANLVRE---------EQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 656 -~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
........ .+........+.++.+++.+||..||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00000011234568899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-42 Score=352.14 Aligned_cols=264 Identities=14% Similarity=0.132 Sum_probs=210.8
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCC-CceeeEeeeeecCCeeEEEEE
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRH-RNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 503 (717)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367999999999999999999975 789999998864432 2346778999999965 899999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeeecccccc
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE-----NMVAHVSDFGISKLL 578 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~~~ 578 (717)
|+ +++|.+++...+..+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+|+.+
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH----~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH----HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 68999999887777999999999999999999999 789999999999999974 678999999999876
Q ss_pred CCCCCc-----eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHH-HHHHhhCCCch
Q 005040 579 GEGEDS-----VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLR-RWVKESLPHRL 652 (717)
Q Consensus 579 ~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~ 652 (717)
...... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.+......... ..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~----- 231 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK----- 231 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-----
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-----
Confidence 543221 122345799999999999999999999999999999999999999976433221111 111100
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHhh
Q 005040 653 TEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKAKF 709 (717)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 709 (717)
....... .....+++++.+++..|++.+|++||+++.+.+.|+++.++.
T Consensus 232 ------~~~~~~~--~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 232 ------KQSTPLR--ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp ------HHHSCHH--HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ------cCCCChH--HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0000000 001234567889999999999999999999999999876554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-43 Score=355.99 Aligned_cols=260 Identities=19% Similarity=0.202 Sum_probs=202.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCc-eeeEeeeeecCCeeEEEEEc
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRN-LLKILGSCSNLDFKALVLEF 504 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e~ 504 (717)
++|++.+.||+|+||+||+|.+. +|+.||||++..... ...+..|+++++.++|++ |+.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999874 789999998865432 245778999999998766 45555666778888999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeeccccccCCC
Q 005040 505 MPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGEG 581 (717)
Q Consensus 505 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~ 581 (717)
+ ++++.+.+......+++..+..++.|++.||+||| +++|+||||||+||+++. +..+|++|||+|+.+...
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 56888888777777999999999999999999999 688999999999999864 557999999999987543
Q ss_pred CCc-----eeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchH--HHHHHhhCCCchhh
Q 005040 582 EDS-----VIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSL--RRWVKESLPHRLTE 654 (717)
Q Consensus 582 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~ 654 (717)
... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......... ..+....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~------- 232 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------- 232 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-------
Confidence 322 12234579999999999999999999999999999999999999997643222111 1111100
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 005040 655 VVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAKLRKIKA 707 (717)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~L~~~~~ 707 (717)
..... ......++.++.+++..||+.+|++||+++++.+.|+.+..
T Consensus 233 -----~~~~~--~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 233 -----MSTPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -----HHSCH--HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----CCCCh--hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00000 00112456778999999999999999999999999988743
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=362.35 Aligned_cols=263 Identities=23% Similarity=0.273 Sum_probs=195.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLD------ 496 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------ 496 (717)
.++|++++.||+|+||+||+|... +|+.||||+++... ....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 79999999997543 344567889999999999999999999987654
Q ss_pred eeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 497 FKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 497 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
+.|+||||+ +++|..+++... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH----~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHH----hCCCcccccCcchhhccccccccccccccee
Confidence 569999999 568888877643 899999999999999999999 6899999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC--chh
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH--RLT 653 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 653 (717)
...... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... ...+.......... ...
T Consensus 170 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred ccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHHHH
Confidence 764322 34578999999998765 5679999999999999999999999976321 11122211111110 000
Q ss_pred hhccc--------cchhhh--hhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 654 EVVDA--------NLVREE--QAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 654 ~~~~~--------~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
..... .+.... .........+.++.+|+.+||..||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000000 0000011334568899999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-43 Score=359.69 Aligned_cols=268 Identities=21% Similarity=0.266 Sum_probs=196.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec--------
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN-------- 494 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-------- 494 (717)
.++|++++.||+|+||+||+|++. +|+.||||++.... +.....+.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 379999999999999999999975 89999999986543 2334668899999999999999999998754
Q ss_pred CCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecc
Q 005040 495 LDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 574 (717)
Q Consensus 495 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 574 (717)
....++||||++++.+. ........+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|++|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH----~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhc----cCCEEecCcCchheeecCCCcEEeeecce
Confidence 34679999999876555 44444556899999999999999999999 67999999999999999999999999999
Q ss_pred ccccCCCCCc--eeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhh---C
Q 005040 575 SKLLGEGEDS--VIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKES---L 648 (717)
Q Consensus 575 ~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~ 648 (717)
+......... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... .....+... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~i~~~~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSI 241 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHHHHHHHhcCCC
Confidence 9876543322 122335689999999987654 6899999999999999999999999753221 111111111 1
Q ss_pred CCc-hhhhccccch----------hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 649 PHR-LTEVVDANLV----------REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 649 ~~~-~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+.. .......... ..............++.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 111 1110000000 000001111233456789999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=362.37 Aligned_cols=262 Identities=24% Similarity=0.272 Sum_probs=192.8
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeeEeeeeec------CCeeE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNLLKILGSCSN------LDFKA 499 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~~~ 499 (717)
.+|+..++||+|+||+||+|++. +|+.||||++..... ...+|++++++++||||+++++++.. ..+.+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 37888999999999999999975 799999999865432 23469999999999999999999843 34578
Q ss_pred EEEEccCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecccc
Q 005040 500 LVLEFMPNGSLEKWLY--SHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISK 576 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~ 576 (717)
+||||++++.+..+.. .....+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH----~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH----hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 9999997654333322 34556999999999999999999999 78999999999999999775 89999999998
Q ss_pred ccCCCCCceeeeccccCccccCCCccC-CCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCc---h
Q 005040 577 LLGEGEDSVIQTMTMATIGYMAPEYGS-EGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHR---L 652 (717)
Q Consensus 577 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 652 (717)
....... .....||+.|+|||.+. ...++.++||||+||++|||++|+.||...... ..+........... +
T Consensus 172 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 172 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp ECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred hccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhh
Confidence 7654332 23457899999999765 457899999999999999999999999753221 11211111110000 0
Q ss_pred hhh----ccccch---hhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 653 TEV----VDANLV---REEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 653 ~~~----~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
... .+..+. ............+.++.+|+.+||..||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000 000000011134566889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=353.31 Aligned_cols=267 Identities=20% Similarity=0.234 Sum_probs=204.4
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecCCeeEEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNLDFKALVLE 503 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 503 (717)
++|++++.||+|+||+||+|++. +++.||||+++... ......+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 78999999986443 3445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccccCCCCC
Q 005040 504 FMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 583 (717)
Q Consensus 504 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 583 (717)
++.++++..++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH----~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh----cCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99998888877654 45899999999999999999999 67899999999999999999999999999988754332
Q ss_pred ceeeeccccCccccCCCccCCCC-cCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC---chhh---hc
Q 005040 584 SVIQTMTMATIGYMAPEYGSEGI-VSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH---RLTE---VV 656 (717)
Q Consensus 584 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~---~~ 656 (717)
. .....+++.|+|||.+.... ++.++||||+||++|||++|+.||.................... .... ..
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred c--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2 23445788899999876654 69999999999999999999999744222222222211111110 0000 00
Q ss_pred cc----cchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 657 DA----NLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 657 ~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
+. ...............+..+.+|+.+||+.||.+||||+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000001111234466889999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-42 Score=357.42 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=197.3
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeec--CCeeEEEE
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSN--LDFKALVL 502 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~ 502 (717)
++|++++.||+|+||+||+|+.. +|+.||||+++... .+.+.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 58999999999999999999974 79999999987543 356788999999995 9999999999864 45689999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeeccccccCCC
Q 005040 503 EFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEG 581 (717)
Q Consensus 503 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 581 (717)
||+.+++|..+. ..+++..+..++.||+.||.||| +++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH----~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh----hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999987654 34899999999999999999999 68999999999999998655 6999999999876543
Q ss_pred CCceeeeccccCccccCCCccCCC-CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHH------------HHHhh-
Q 005040 582 EDSVIQTMTMATIGYMAPEYGSEG-IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRR------------WVKES- 647 (717)
Q Consensus 582 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~------------~~~~~- 647 (717)
.. .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||............ |....
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 2445789999999986654 5799999999999999999999998653322111111 11110
Q ss_pred CCC--chhhhccccc---hhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 648 LPH--RLTEVVDANL---VREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 648 ~~~--~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
... .......... ............++.++.+||.+||..||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0111110000 0000011122334567899999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=356.95 Aligned_cols=252 Identities=25% Similarity=0.283 Sum_probs=200.0
Q ss_pred ccCCccccccccccEEEEEEEec----CCCeEEEEEechhh----HHHHHHHHHHHHHHHhcCC-CceeeEeeeeecCCe
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS----DGTNVAIKIFNLQL----ERAFRSFDSECEILRNVRH-RNLLKILGSCSNLDF 497 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~ 497 (717)
++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 58899999986432 2233567789999999966 899999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.++||||+.+|+|.+++...+. +++..+..++.|++.||+|+| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh----cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999987654 678899999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCceeeeccccCccccCCCccCCC--CcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCCchhhh
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEG--IVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPHRLTEV 655 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (717)
+...... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||........... ......
T Consensus 179 ~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~-i~~~~~------- 249 (322)
T d1vzoa_ 179 FVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-ISRRIL------- 249 (322)
T ss_dssp CCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-HHHHHH-------
T ss_pred hcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcc-------
Confidence 6433222 23445789999999987654 478899999999999999999999976433222111 111100
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 005040 656 VDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIH-----MTDAAA 700 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ev~~ 700 (717)
.. ....+..++.++.+++.+||++||++||| ++|+++
T Consensus 250 -~~-------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 -KS-------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -HC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -cC-------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00 00111235677899999999999999994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=354.75 Aligned_cols=261 Identities=22% Similarity=0.245 Sum_probs=190.6
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeec------CCe
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSN------LDF 497 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~ 497 (717)
++|++++.||+|+||+||+|.+. +|+.||||++.... ......+.+|+.++++++||||+++++++.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999976 79999999997543 3445678899999999999999999999853 468
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.|+||||+.++ +.+.+. ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH----~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhh----hcccccccCCccccccccccceeeechhhhhc
Confidence 89999999764 544443 23899999999999999999999 67999999999999999999999999999886
Q ss_pred cCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHHhhCCC-------
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVKESLPH------- 650 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 650 (717)
..... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .............
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHH
Confidence 54322 234557899999999999999999999999999999999999999653211 1111111100000
Q ss_pred ------------------chhhhccccchhhhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 005040 651 ------------------RLTEVVDANLVREEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAAK 701 (717)
Q Consensus 651 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~~ 701 (717)
............ .........+.++.+|+.+||..||++||||+|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFP--ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSC--CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCcccccccccccccccccc--ccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 0111223456789999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=353.50 Aligned_cols=262 Identities=21% Similarity=0.261 Sum_probs=194.4
Q ss_pred hccCCccccccccccEEEEEEEec-CCCeEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Ce
Q 005040 426 TDEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQL--ERAFRSFDSECEILRNVRHRNLLKILGSCSNL-----DF 497 (717)
Q Consensus 426 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~ 497 (717)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999964 79999999997543 33446788999999999999999999998532 34
Q ss_pred eEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 498 KALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 498 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
.+++++|+.+|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH----~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCCccccccccccccccccchhcc
Confidence 46677788899999999754 4899999999999999999999 67999999999999999999999999999976
Q ss_pred cCCCCCceeeeccccCccccCCCccCC-CCcCcccchhhHHHHHHHHHhCCCCCCccccCcchHHHHHH-hhCCCc--hh
Q 005040 578 LGEGEDSVIQTMTMATIGYMAPEYGSE-GIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGEMSLRRWVK-ESLPHR--LT 653 (717)
Q Consensus 578 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~--~~ 653 (717)
.... .....||+.|+|||...+ ..++.++||||+||++|||++|+.||.+... ......+. ...... ..
T Consensus 171 ~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 171 TDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCHHHH
T ss_pred cCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChHHh
Confidence 5322 234568999999997555 4568999999999999999999999975321 11111111 111100 00
Q ss_pred hhccc--------cchhh-hhh-hhhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 005040 654 EVVDA--------NLVRE-EQA-FSDKMDCLFSIMDLALDCCMDTPHKRIHMTDAAA 700 (717)
Q Consensus 654 ~~~~~--------~~~~~-~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev~~ 700 (717)
..... .+... ... .......+.++.+||.+||..||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000 00000 000 0001134566889999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-36 Score=317.85 Aligned_cols=265 Identities=19% Similarity=0.193 Sum_probs=189.0
Q ss_pred ccCCccccccccccEEEEEEEec-CCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-----------CCceeeEeeeeec
Q 005040 427 DEFNECNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLERAFRSFDSECEILRNVR-----------HRNLLKILGSCSN 494 (717)
Q Consensus 427 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~~~~~~~~ 494 (717)
++|++++.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999975 799999999976532 2356778898888875 5789999988754
Q ss_pred --CCeeEEEEEccCCCCH-HHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-----
Q 005040 495 --LDFKALVLEFMPNGSL-EKWL-YSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENM----- 565 (717)
Q Consensus 495 --~~~~~lv~e~~~~g~L-~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~----- 565 (717)
....+++++++..+.. .... ......+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh---hcCcccccCChhHeeeeccCccccc
Confidence 3455667776554432 2222 2344568999999999999999999995 36899999999999998665
Q ss_pred -cEEEeeeccccccCCCCCceeeeccccCccccCCCccCCCCcCcccchhhHHHHHHHHHhCCCCCCccccCc-----ch
Q 005040 566 -VAHVSDFGISKLLGEGEDSVIQTMTMATIGYMAPEYGSEGIVSTKCDVYSYGVLLMETFTEKKPTDEMFTGE-----MS 639 (717)
Q Consensus 566 -~~kl~Dfgl~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~-----~~ 639 (717)
.++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||....... ..
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 3999999999865322 234579999999999999999999999999999999999999997532211 11
Q ss_pred HHHHHHhhCC--Cc-------hhhhccc-------------cchh-hhhhhhhhHHHHHHHHHHHhhccCCCCCCCCCHH
Q 005040 640 LRRWVKESLP--HR-------LTEVVDA-------------NLVR-EEQAFSDKMDCLFSIMDLALDCCMDTPHKRIHMT 696 (717)
Q Consensus 640 ~~~~~~~~~~--~~-------~~~~~~~-------------~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ 696 (717)
+...+..... .. .....+. .... ...........+.++.+|+.+||..||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111111000 00 0000000 0000 0001112245677899999999999999999999
Q ss_pred HHHH
Q 005040 697 DAAA 700 (717)
Q Consensus 697 ev~~ 700 (717)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9976
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=6.8e-32 Score=277.36 Aligned_cols=255 Identities=35% Similarity=0.555 Sum_probs=223.4
Q ss_pred ccceeeecCCccee--cCCccccCCCCCcEEEccC-CCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEE
Q 005040 94 SLQNIYAFECKLGG--SIPKEIGNLRGLIVLSLGF-NDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNIL 170 (717)
Q Consensus 94 ~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 170 (717)
.++.|+|++|++.+ .+|..++++++|++|+|++ |++++.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 36666666666655 4778888999999999986 78888888889999999999999999998888888889999999
Q ss_pred eccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCC-CeEEccCCcCcccCCccccCCCCCCeEEccCCCC
Q 005040 171 NLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYI-LRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQL 249 (717)
Q Consensus 171 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 249 (717)
++++|.+.+.+|..+.+++.|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 999999888888889999999999999999988888888888776 788999999998888888887654 799999999
Q ss_pred CCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccccc
Q 005040 250 SSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKG 329 (717)
Q Consensus 250 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 329 (717)
.+.+|..+..+++|+.+++++|.+.+.++ .++.+++|+.|+|++|++++.+|..|.++++|++|+|++|+++|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 98899999999999999999999986544 68888999999999999999999999999999999999999999999888
Q ss_pred cccccccccccCCccccCCCC
Q 005040 330 SFKDFSAQSYFGNYALCGPPR 350 (717)
Q Consensus 330 ~~~~~~~~~~~~n~~~c~~~~ 350 (717)
.++.++.+.+.+|+.+||.|.
T Consensus 289 ~L~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS
T ss_pred cCCCCCHHHhCCCccccCCCC
Confidence 888899999999999999774
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=7.1e-31 Score=269.70 Aligned_cols=253 Identities=29% Similarity=0.453 Sum_probs=225.1
Q ss_pred cCCcEEeccCCCCcc--cCCcchhccccccceeeecC-CcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCC
Q 005040 68 RNLANLALASNPLGG--ILPPLIGNFSASLQNIYAFE-CKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQ 144 (717)
Q Consensus 68 ~~L~~L~L~~N~l~~--~~~~~~~~l~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 144 (717)
.+++.|+|++|.+.+ .+|..++++ ++|++|+|++ |++.+.+|..|+++++|++|+|++|++.+..+..+..+.+|+
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L-~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANL-PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGC-TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcC-ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 468888888888876 467888888 6799999986 788888999999999999999999999988888899999999
Q ss_pred EEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCC-CeEEecCccccCCCChhhhcccCCCeEEccCC
Q 005040 145 GFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSL-RSLYLQSNKLSSSLPSSLWSLEYILRINLSSN 223 (717)
Q Consensus 145 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 223 (717)
.+++++|.+....|..+.+++.|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~ 207 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRN 207 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSS
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 99999999999999999999999999999999998899888888776 889999999998888888777654 7999999
Q ss_pred cCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcc
Q 005040 224 SLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPK 303 (717)
Q Consensus 224 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~ 303 (717)
...+.+|..+..+++|+.+++++|.+.+.+ ..+..+++|+.|+|++|++++.+|..++++++|++|+|++|+|+|.+|.
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred cccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 999999999999999999999999998754 4688899999999999999999999999999999999999999988885
Q ss_pred cccccccccEEEccCCc-cccc
Q 005040 304 SLEALSHLKQFNVSHNR-LEGE 324 (717)
Q Consensus 304 ~~~~l~~L~~L~l~~N~-l~~~ 324 (717)
+.++++|+.+++++|+ ++|.
T Consensus 287 -~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 287 -GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp -STTGGGSCGGGTCSSSEEEST
T ss_pred -cccCCCCCHHHhCCCccccCC
Confidence 5789999999999998 5654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=3.8e-28 Score=256.91 Aligned_cols=302 Identities=26% Similarity=0.383 Sum_probs=219.9
Q ss_pred cCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcch
Q 005040 9 TNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLI 88 (717)
Q Consensus 9 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 88 (717)
..+.+|++|++++|+|+.+ +.+..|++|++|+|++|+|+++++ +.++++|++|++++|++.+..+ +
T Consensus 41 ~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~----------l~~L~~L~~L~L~~n~i~~i~~--l 106 (384)
T d2omza2 41 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP----------LKNLTKLVDILMNNNQIADITP--L 106 (384)
T ss_dssp HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG----------GTTCTTCCEEECCSSCCCCCGG--G
T ss_pred HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc----------ccCCcccccccccccccccccc--c
Confidence 3567888899999988853 468888899999999999888653 7788899999999998885432 5
Q ss_pred hccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcc-------------------------------------
Q 005040 89 GNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNG------------------------------------- 131 (717)
Q Consensus 89 ~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~------------------------------------- 131 (717)
..+ ++|+.|++.+|.+++..+ ......+..+....|.+..
T Consensus 107 ~~l-~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (384)
T d2omza2 107 ANL-TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS 183 (384)
T ss_dssp TTC-TTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECC
T ss_pred ccc-cccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccc
Confidence 555 578888888888764322 2233344444443333211
Q ss_pred ----cCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCCh
Q 005040 132 ----TIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPS 207 (717)
Q Consensus 132 ----~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 207 (717)
.....+..+++++.|++++|.+++..+ +..+++|++|++++|+++.. ..+..+++|+.|++++|.+++..
T Consensus 184 ~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~-- 257 (384)
T d2omza2 184 SNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA-- 257 (384)
T ss_dssp SSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--
T ss_pred ccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--
Confidence 123456677888888888888886644 45667888888888888743 35778888888888888888543
Q ss_pred hhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCcc
Q 005040 208 SLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISL 287 (717)
Q Consensus 208 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 287 (717)
.+..+++|++|++++|++++.. .+..++.++.+++++|.+++. ..+..+++++.|++++|++++.. .+..+++|
T Consensus 258 ~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L 331 (384)
T d2omza2 258 PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKL 331 (384)
T ss_dssp GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTC
T ss_pred cccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCC
Confidence 3777888888888888887542 477788888888888888752 34777888888888888887643 37788888
Q ss_pred ceEeccCCCCCCCCcccccccccccEEEccCCcccccccccccccccccccccCC
Q 005040 288 ESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGN 342 (717)
Q Consensus 288 ~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n 342 (717)
+.|+|++|++++ ++ .+..+++|++|++++|++++..| ...++.+..+.+.+|
T Consensus 332 ~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 332 QRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 888888888874 33 57888888888888888887655 345666666655544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=1.3e-27 Score=244.13 Aligned_cols=284 Identities=20% Similarity=0.286 Sum_probs=188.9
Q ss_pred CCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccc
Q 005040 13 KLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFS 92 (717)
Q Consensus 13 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 92 (717)
..+.+|-++++++ .+|..+. ++|++|+|++|+|+.+++.+ |.++++|++|++++|.+....|..|..+
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~--------f~~l~~L~~L~l~~n~~~~i~~~~f~~l- 78 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGD--------FKNLKNLHTLILINNKISKISPGAFAPL- 78 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTT--------TTTCTTCCEEECCSSCCCCBCTTTTTTC-
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhH--------hhccccccccccccccccccchhhhhCC-
Confidence 3455666666666 3444442 45666666666666665433 5666666666666666665556666655
Q ss_pred cccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCccc--ccCCccccCCCCCCEE
Q 005040 93 ASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQ--GYVPHDLCHLERLNIL 170 (717)
Q Consensus 93 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~--~~~~~~~~~l~~L~~L 170 (717)
++|++|++++|++.. +|..+ ...|..|++.+|.+....+..+.....+..++...|... ...+..+..+++|+.+
T Consensus 79 ~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l 155 (305)
T d1xkua_ 79 VKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 155 (305)
T ss_dssp TTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEE
T ss_pred CccCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCcc
Confidence 456666666666663 33322 246677777777777665556666667777777666443 3344566777777777
Q ss_pred eccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCC
Q 005040 171 NLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLS 250 (717)
Q Consensus 171 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 250 (717)
++++|.+.. ++..+ .++|+.|++++|.++...+..|..++.++.|++++|.+++..+..+.++++|++|+|++|.|+
T Consensus 156 ~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 156 RIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp ECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred ccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc
Confidence 777777763 33322 467778888888777777777777778888888888887777777778888888888888887
Q ss_pred CCCcccccCCcccccccccCccccCCCCccc------cccCccceEeccCCCCC--CCCcccccccccccEEE
Q 005040 251 SDIPSTIGTLKNLETLSLAGNQFQGPIPESV------GNLISLESLDFSNNNLS--GKIPKSLEALSHLKQFN 315 (717)
Q Consensus 251 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~------~~l~~L~~L~L~~N~~~--~~~~~~~~~l~~L~~L~ 315 (717)
. +|..|..+++|++|+|++|+|+......| ..+++|+.|+|++|++. ...|..|..+.....++
T Consensus 233 ~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~~ 304 (305)
T d1xkua_ 233 K-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304 (305)
T ss_dssp S-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEE
T ss_pred c-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCcccc
Confidence 4 56677778888888888888775443333 45677888899888875 35666776665554443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=2.1e-27 Score=251.13 Aligned_cols=286 Identities=25% Similarity=0.340 Sum_probs=235.8
Q ss_pred CCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCc
Q 005040 2 GTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLG 81 (717)
Q Consensus 2 ~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 81 (717)
.+| ++++.+++|++|+|++|+|+++. .|+++++|++|+|++|+|+++++ +..+++|+.|++++|.++
T Consensus 57 ~~l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~~----------l~~l~~L~~L~~~~~~~~ 123 (384)
T d2omza2 57 KSI-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITP----------LANLTNLTGLTLFNNQIT 123 (384)
T ss_dssp CCC-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG----------GTTCTTCCEEECCSSCCC
T ss_pred CCc-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccccccc----------cccccccccccccccccc
Confidence 345 46889999999999999999654 39999999999999999998653 789999999999999998
Q ss_pred ccCCcchhccccccceeeecCCcce-----------------------------------------ecCCccccCCCCCc
Q 005040 82 GILPPLIGNFSASLQNIYAFECKLG-----------------------------------------GSIPKEIGNLRGLI 120 (717)
Q Consensus 82 ~~~~~~~~~l~~~L~~L~l~~n~l~-----------------------------------------~~~~~~~~~l~~L~ 120 (717)
+..+.... ..+..+....|.+. ......+..+++++
T Consensus 124 ~~~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 200 (384)
T d2omza2 124 DIDPLKNL---TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200 (384)
T ss_dssp CCGGGTTC---TTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCS
T ss_pred cccccccc---ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccc
Confidence 65433222 23444444333321 12234567788999
Q ss_pred EEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCcc
Q 005040 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNK 200 (717)
Q Consensus 121 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 200 (717)
.|++++|.+++..+ +...++|++|++++|+++.. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|+
T Consensus 201 ~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~ 274 (384)
T d2omza2 201 SLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274 (384)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred eeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcc
Confidence 99999999996644 57789999999999999864 468899999999999999996543 8889999999999999
Q ss_pred ccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCcc
Q 005040 201 LSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPES 280 (717)
Q Consensus 201 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 280 (717)
+++.. .+..++.++.+.++.|.+++. ..+..+++++.|++++|.+++.. .+..+++|++|++++|++++ ++ .
T Consensus 275 l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~ 346 (384)
T d2omza2 275 ISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-S 346 (384)
T ss_dssp CCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-G
T ss_pred cCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-h
Confidence 98543 478899999999999999853 46899999999999999999753 38899999999999999985 34 6
Q ss_pred ccccCccceEeccCCCCCCCCcccccccccccEEEccCC
Q 005040 281 VGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHN 319 (717)
Q Consensus 281 ~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N 319 (717)
++++++|++|+|++|++++..| +.++++|+.|+|++|
T Consensus 347 l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred HcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 8999999999999999997654 889999999999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=4.8e-27 Score=239.95 Aligned_cols=268 Identities=20% Similarity=0.252 Sum_probs=214.1
Q ss_pred CCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCC
Q 005040 37 HLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNL 116 (717)
Q Consensus 37 ~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l 116 (717)
.+++++.++++++.+|.. + .+++++|+|++|+|+...+..|.++ ++|++|++++|.+....|..|.++
T Consensus 11 ~~~~~~C~~~~L~~lP~~---------l--~~~l~~L~Ls~N~i~~l~~~~f~~l-~~L~~L~l~~n~~~~i~~~~f~~l 78 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKD---------L--PPDTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPL 78 (305)
T ss_dssp ETTEEECTTSCCCSCCCS---------C--CTTCCEEECCSSCCCCBCTTTTTTC-TTCCEEECCSSCCCCBCTTTTTTC
T ss_pred cCCEEEecCCCCCccCCC---------C--CCCCCEEECcCCcCCCcChhHhhcc-ccccccccccccccccchhhhhCC
Confidence 567888888888888753 2 2578899999999986666678777 579999999999988888889999
Q ss_pred CCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCc--ccCCccccCCCCCCeE
Q 005040 117 RGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLS--GAIPQCLASLTSLRSL 194 (717)
Q Consensus 117 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L 194 (717)
++|++|++++|+++.+ |.. ....|..|++.+|.+..+.+..+.....+..++...|... ...+..|..+++|+.+
T Consensus 79 ~~L~~L~l~~n~l~~l-~~~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l 155 (305)
T d1xkua_ 79 VKLERLYLSKNQLKEL-PEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 155 (305)
T ss_dssp TTCCEEECCSSCCSBC-CSS--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEE
T ss_pred CccCEecccCCccCcC-ccc--hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCcc
Confidence 9999999999988844 433 3357888899999888877777888888888888887654 2335578888889999
Q ss_pred EecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCcccc
Q 005040 195 YLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQ 274 (717)
Q Consensus 195 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 274 (717)
++++|.++. +|..+ +++|++|++++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+
T Consensus 156 ~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 156 RIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp ECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred ccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc
Confidence 999998874 44433 578889999999888888888888889999999999998887888888899999999999888
Q ss_pred CCCCccccccCccceEeccCCCCCCCCccc------ccccccccEEEccCCcccc
Q 005040 275 GPIPESVGNLISLESLDFSNNNLSGKIPKS------LEALSHLKQFNVSHNRLEG 323 (717)
Q Consensus 275 ~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~------~~~l~~L~~L~l~~N~l~~ 323 (717)
.+|..+.++++|++|+|++|+|+...... +..+++|+.|+|++|+++.
T Consensus 233 -~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 233 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp -SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred -ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 56778888899999999999888654433 3456788899999998863
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.4e-27 Score=239.35 Aligned_cols=229 Identities=21% Similarity=0.201 Sum_probs=146.8
Q ss_pred CCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEecc-CCcCcccCCccccCCCCCCeEEe
Q 005040 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLS-GNKLSGAIPQCLASLTSLRSLYL 196 (717)
Q Consensus 118 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~-~n~l~~~~~~~~~~l~~L~~L~L 196 (717)
++++|+|++|+|+.+.+.+|.++++|++|++++|++..+.+..+..+..++.+... .|.++...+..|+++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 45566666666655555556666666666666666665555555666666665543 44555555556666666666666
Q ss_pred cCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCC
Q 005040 197 QSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGP 276 (717)
Q Consensus 197 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 276 (717)
++|.+....+..+..+.+|+.+++++|.|+++.+..|..+++|+.|++++|.+++..+..|.++++|+.+++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 66666655555566666666777777776655566666677777777777777766666677777777777777777766
Q ss_pred CCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccccccccccccccccCCcccc
Q 005040 277 IPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQSYFGNYALC 346 (717)
Q Consensus 277 ~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c 346 (717)
.|..|.++++|++|++++|++.+..+..|..+++|+.|+|++|++.+.++..+...++.......+...|
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C 262 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBE
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEe
Confidence 6777777777777777777777666677777777777777777777766543333334433333344444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.3e-27 Score=236.27 Aligned_cols=224 Identities=24% Similarity=0.283 Sum_probs=118.9
Q ss_pred cEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccc
Q 005040 15 IGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSAS 94 (717)
Q Consensus 15 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~ 94 (717)
..++.++++++ .+|..+. +++++|+|++|+|+.+++.+ |.++++|++|++++|++..+.+..+... ..
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~--------f~~l~~L~~L~ls~n~l~~i~~~~~~~~-~~ 81 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAAS--------FRACRNLTILWLHSNVLARIDAAAFTGL-AL 81 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTT--------TTTCTTCCEEECCSSCCCEECTTTTTTC-TT
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHH--------hhcccccccccccccccccccccccccc-cc
Confidence 34567777777 4565443 46778888888887776544 6777777777777777776555444433 23
Q ss_pred cceeee-cCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEecc
Q 005040 95 LQNIYA-FECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLS 173 (717)
Q Consensus 95 L~~L~l-~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 173 (717)
+..+.. ..|.+....+..|.++++|++|++++|.+....+..+..+.+|+.+++++|+|+.+.+..|..+++|+.|+|+
T Consensus 82 ~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~ 161 (284)
T d1ozna_ 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH 161 (284)
T ss_dssp CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred ccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccc
Confidence 333332 2334444444445555555555555555544444444445555555555555554444444444455555555
Q ss_pred CCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCC
Q 005040 174 GNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLS 250 (717)
Q Consensus 174 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 250 (717)
+|+++...+..|.++++|+.|++++|++++..|..|..+++|++|++++|.+.+..+..|..+++|++|++++|.+.
T Consensus 162 ~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred cCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 55554444444444444555555544444444444444444444444444444444444444444444444444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.8e-25 Score=219.18 Aligned_cols=207 Identities=24% Similarity=0.253 Sum_probs=161.2
Q ss_pred cCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCe
Q 005040 114 GNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRS 193 (717)
Q Consensus 114 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 193 (717)
.+...+.+++.+++.++. +|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.. + .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence 344556667777777773 454443 4677777777777776667777778888888888877743 2 3567788888
Q ss_pred EEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccc
Q 005040 194 LYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQF 273 (717)
Q Consensus 194 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 273 (717)
|+|++|+++. .+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|++
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 8888888873 456677888888888888888877777788888888888888888877777788888888999999988
Q ss_pred cCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccCCcccccccc
Q 005040 274 QGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPV 327 (717)
Q Consensus 274 ~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 327 (717)
++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|.+.+..
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 8777788888899999999999988 6777788888999999999999876543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=6.2e-24 Score=211.64 Aligned_cols=202 Identities=26% Similarity=0.254 Sum_probs=122.8
Q ss_pred cCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcch
Q 005040 9 TNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLI 88 (717)
Q Consensus 9 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 88 (717)
.+...+.++|.++++++ .+|..+. ++|++|+|++|+|+.++..+ |.++++|++|+|++|+|+..
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~--------f~~l~~L~~L~L~~N~l~~l----- 70 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLAT--------LMPYTRLTQLNLDRAELTKL----- 70 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGG--------GTTCTTCCEEECTTSCCCEE-----
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHH--------hhcccccccccccccccccc-----
Confidence 34555556667776666 3455443 35666777777666655332 56666666666666666522
Q ss_pred hccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCC
Q 005040 89 GNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLN 168 (717)
Q Consensus 89 ~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~ 168 (717)
+ .++.+++|++|+|++|+++ ..+..+.++++|+.|++++|.+....+..+..+.+++
T Consensus 71 ---------------------~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~ 127 (266)
T d1p9ag_ 71 ---------------------Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127 (266)
T ss_dssp ---------------------E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCC
T ss_pred ---------------------c-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccc
Confidence 1 2345566777777777766 3455566666666666666666666666666666666
Q ss_pred EEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCC
Q 005040 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQ 248 (717)
Q Consensus 169 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 248 (717)
+|++++|.++...+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.
T Consensus 128 ~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np 206 (266)
T d1p9ag_ 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (266)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred cccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCC
Confidence 6666666666555555666666666666666666555555666666666666666666 445555555566666666655
Q ss_pred CC
Q 005040 249 LS 250 (717)
Q Consensus 249 l~ 250 (717)
+.
T Consensus 207 ~~ 208 (266)
T d1p9ag_ 207 WL 208 (266)
T ss_dssp BC
T ss_pred CC
Confidence 54
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=8.9e-23 Score=192.09 Aligned_cols=163 Identities=18% Similarity=0.186 Sum_probs=121.0
Q ss_pred CccccccccccEEEEEEEecCCCeEEEEEechhh------------------HHHHHHHHHHHHHHHhcCCCceeeEeee
Q 005040 430 NECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQL------------------ERAFRSFDSECEILRNVRHRNLLKILGS 491 (717)
Q Consensus 430 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~hpniv~~~~~ 491 (717)
.+.++||+|+||+||+|...+|+.||||+++... .........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4568999999999999998899999999875321 1112345568899999999999988876
Q ss_pred eecCCeeEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 005040 492 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSD 571 (717)
Q Consensus 492 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 571 (717)
.. .+++|||++++.+.+ ++......++.|++++++||| +.+|+||||||+|||+++++ ++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH----~~giiHrDiKP~NILv~~~~-~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVSEEG-IWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEETTE-EEECC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh----hCCEEEccCChhheeeeCCC-EEEEE
Confidence 43 379999998765432 344456679999999999999 67899999999999999654 89999
Q ss_pred eccccccCCCCCceeeeccccCccccCC------CccCCCCcCcccchhhHHHHH
Q 005040 572 FGISKLLGEGEDSVIQTMTMATIGYMAP------EYGSEGIVSTKCDVYSYGVLL 620 (717)
Q Consensus 572 fgl~~~~~~~~~~~~~~~~~~t~~y~aP------E~~~~~~~~~~~Dvws~G~il 620 (717)
||.|......... .|... +. ..+.|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999765432211 01110 11 135678899999976544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=8e-20 Score=189.71 Aligned_cols=267 Identities=25% Similarity=0.295 Sum_probs=172.6
Q ss_pred CCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhcc
Q 005040 12 TKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNF 91 (717)
Q Consensus 12 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 91 (717)
.++++|||++|.++ .+|+. +++|++|+|++|+|+.++. ...+|+.|++++|+++.+ + .+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~------------~~~~L~~L~l~~n~l~~l-~----~l 96 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPE------------LPQSLKSLLVDNNNLKAL-S----DL 96 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCC------------CCTTCCEEECCSSCCSCC-C----SC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccccc------------chhhhhhhhhhhcccchh-h----hh
Confidence 46889999999998 56753 5789999999999998763 246899999999999843 2 35
Q ss_pred ccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEe
Q 005040 92 SASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILN 171 (717)
Q Consensus 92 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 171 (717)
+++|++|++++|.+. .+|. ++.+++|++|++++|.+... +. ....+..+.+.++.... ...+..++.++.|+
T Consensus 97 p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~ 168 (353)
T d1jl5a_ 97 PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIY 168 (353)
T ss_dssp CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEE
T ss_pred ccccccccccccccc-cccc-hhhhccceeecccccccccc-cc---ccccccchhhccccccc--cccccccccceecc
Confidence 567999999999998 4553 68899999999999988733 22 23445556555554442 23455566666666
Q ss_pred ccCCcCcccC------------------CccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccc
Q 005040 172 LSGNKLSGAI------------------PQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNI 233 (717)
Q Consensus 172 L~~n~l~~~~------------------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 233 (717)
+++|.+.... ...+..++.|+.+++++|.... .+. ...++..+.+.+|.+... +.
T Consensus 169 l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~~-- 241 (353)
T d1jl5a_ 169 ADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-PE-- 241 (353)
T ss_dssp CCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-CC--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-ccc---cccccccccccccccccc-cc--
Confidence 6666554211 1123455667777777766652 222 234556666666665521 11
Q ss_pred cCCCCCCeEEccCCCCCC----------------CCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCC
Q 005040 234 QKLNVLIDLDLSRNQLSS----------------DIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNL 297 (717)
Q Consensus 234 ~~l~~L~~L~l~~N~l~~----------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 297 (717)
....+..+++..|.+.+ .++.....+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|
T Consensus 242 -~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L 316 (353)
T d1jl5a_ 242 -LPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHL 316 (353)
T ss_dssp -CCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCC
T ss_pred -ccccccccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcC
Confidence 12223333333333221 01111233578888888888887 45543 56788888888888
Q ss_pred CCCCcccccccccccEEEccCCcccc
Q 005040 298 SGKIPKSLEALSHLKQFNVSHNRLEG 323 (717)
Q Consensus 298 ~~~~~~~~~~l~~L~~L~l~~N~l~~ 323 (717)
+ .+|.. +++|+.|++++|+++.
T Consensus 317 ~-~l~~~---~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 317 A-EVPEL---PQNLKQLHVEYNPLRE 338 (353)
T ss_dssp S-CCCCC---CTTCCEEECCSSCCSS
T ss_pred C-ccccc---cCCCCEEECcCCcCCC
Confidence 7 45543 4578888888888874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=5.9e-20 Score=179.97 Aligned_cols=201 Identities=14% Similarity=0.124 Sum_probs=107.6
Q ss_pred CCcEEEccCCCCcccCCccccccCCCCEEeccCCccccc-CCccccCCCCCCEEeccC-CcCcccCCccccCCCCCCeEE
Q 005040 118 GLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGY-VPHDLCHLERLNILNLSG-NKLSGAIPQCLASLTSLRSLY 195 (717)
Q Consensus 118 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 195 (717)
++++|+|++|+|+.+.+.+|.++++|++|++++|.+... .+..|.+++++++|.+.+ |.+....+..|.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 445555555555544444455555555555555554432 233455555555555432 444444445555555555555
Q ss_pred ecCccccCCCC-hhhhcccCCCeEEccCCcCcccCCccccCCC-CCCeEEccCCCCCCCCcccccCCcccccccccCccc
Q 005040 196 LQSNKLSSSLP-SSLWSLEYILRINLSSNSLKGTLPSNIQKLN-VLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQF 273 (717)
Q Consensus 196 L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 273 (717)
+++|++....+ ..+..+..+..+...++.+....+..|.+++ .++.|++++|.++...+..+.....++.+.+++|++
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l 189 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTC
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhcccccccccc
Confidence 55555543222 1223344444445555555555555555543 566667777776654443333322233345566667
Q ss_pred cCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEccC
Q 005040 274 QGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSH 318 (717)
Q Consensus 274 ~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~ 318 (717)
+...+..|.++++|+.|+|++|+|+...+..|.++++|+.+++.+
T Consensus 190 ~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 654455567777777777777777755555667777666666543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.82 E-value=4e-20 Score=179.16 Aligned_cols=167 Identities=23% Similarity=0.343 Sum_probs=73.3
Q ss_pred ccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCC
Q 005040 113 IGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 192 (717)
+..+++|++|++++|.+++.. .+..+++|++|++++|.++.+ ..+.++++|+.+++++|...+. ..+...+.++
T Consensus 59 l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~ 132 (227)
T d1h6ua2 59 VQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQ 132 (227)
T ss_dssp GGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCC
T ss_pred HhcCCCCcEeecCCceeeccc--ccccccccccccccccccccc--cccccccccccccccccccccc--chhccccchh
Confidence 444455555555555544322 144444444444444444422 2344444444444444444322 1133344444
Q ss_pred eEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCcc
Q 005040 193 SLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQ 272 (717)
Q Consensus 193 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 272 (717)
.+.++.+.+... ..+..+++|+.|++++|.+++.. .++++++|++|+|++|+
T Consensus 133 ~l~~~~~~~~~~--------------------------~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~ 184 (227)
T d1h6ua2 133 VLYLDLNQITNI--------------------------SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNK 184 (227)
T ss_dssp EEECCSSCCCCC--------------------------GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred hhhchhhhhchh--------------------------hhhccccccccccccccccccch--hhcccccceecccCCCc
Confidence 444444444321 12334444444444444444221 14444455555555555
Q ss_pred ccCCCCccccccCccceEeccCCCCCCCCcccccccccccEEEcc
Q 005040 273 FQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVS 317 (717)
Q Consensus 273 l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~ 317 (717)
+++. + .++++++|++|+|++|++++.. .+.++++|+.|+++
T Consensus 185 l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 185 ISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp CCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred cCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 4432 1 2444555555555555554322 24455555555544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=6.5e-20 Score=179.69 Aligned_cols=220 Identities=15% Similarity=0.168 Sum_probs=122.7
Q ss_pred cEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccc
Q 005040 15 IGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSAS 94 (717)
Q Consensus 15 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~ 94 (717)
+.++.++++++ .+|..+. +++++|+|++|+|+.++..+ |.++++|++|+|++|.+...++
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~--------f~~l~~L~~L~ls~n~~~~~i~--------- 70 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGA--------FSGFGDLEKIEISQNDVLEVIE--------- 70 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTT--------TTTCTTCCEEEEESCTTCCEEC---------
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhH--------hhccchhhhhhhccccccceee---------
Confidence 45667777766 4554442 46777777777777666543 6667777777777776653322
Q ss_pred cceeeecCCcceecCCccccCCCCCcEEEcc-CCCCcccCCccccccCCCCEEeccCCcccccCCc-cccCCCCCCEEec
Q 005040 95 LQNIYAFECKLGGSIPKEIGNLRGLIVLSLG-FNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPH-DLCHLERLNILNL 172 (717)
Q Consensus 95 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~-~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~-~~~~l~~L~~L~L 172 (717)
+..|.+++++++|.+. .|++....+..|.++++|++|++++|.+....+. .+..++.+..+..
T Consensus 71 ---------------~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~ 135 (242)
T d1xwdc1 71 ---------------ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135 (242)
T ss_dssp ---------------SSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEE
T ss_pred ---------------ccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccc
Confidence 2334555555555544 2445545555555556666666666555533221 2233444555555
Q ss_pred cCCcCcccCCccccCCC-CCCeEEecCccccCCCChhhhcccCCCeE-EccCCcCcccCCccccCCCCCCeEEccCCCCC
Q 005040 173 SGNKLSGAIPQCLASLT-SLRSLYLQSNKLSSSLPSSLWSLEYILRI-NLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLS 250 (717)
Q Consensus 173 ~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 250 (717)
+++.+....+..|.+++ .++.|++++|+++...+..+ ...+++.+ ++++|.|+...+..|.++++|++|+|++|+|+
T Consensus 136 ~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp SCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred cccccccccccccccccccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC
Confidence 55555544444554443 56666666666664333333 33343333 35556666444455666667777777777766
Q ss_pred CCCcccccCCcccccccccC
Q 005040 251 SDIPSTIGTLKNLETLSLAG 270 (717)
Q Consensus 251 ~~~~~~~~~l~~L~~L~l~~ 270 (717)
...+..|.++++|+.|++.+
T Consensus 215 ~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 215 SLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCCSSSCTTCCEEESSSEES
T ss_pred ccCHHHHcCCcccccCcCCC
Confidence 55555566666666666543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.82 E-value=5e-20 Score=178.47 Aligned_cols=201 Identities=22% Similarity=0.319 Sum_probs=147.0
Q ss_pred EEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCcc
Q 005040 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNK 200 (717)
Q Consensus 121 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 200 (717)
.++++.+++++.. .+..+.+|++|++.+|.|+.. ..+..+++|++|++++|++++..+ +..+++|+.+++++|.
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 3455555555432 445666777777777777644 246677777777777777775433 6777777788887777
Q ss_pred ccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCcc
Q 005040 201 LSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPES 280 (717)
Q Consensus 201 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 280 (717)
++.. ..+.++++|+.+++++|...+. ..+...+.++.+.++++.+... ..+..+++|+.|++++|.+.+. ..
T Consensus 97 ~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~ 168 (227)
T d1h6ua2 97 LKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TP 168 (227)
T ss_dssp CSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GG
T ss_pred cccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hh
Confidence 7632 3467788888888888877643 4567788899999999999853 3477889999999999999743 34
Q ss_pred ccccCccceEeccCCCCCCCCcccccccccccEEEccCCccccccccccccccccccc
Q 005040 281 VGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVSHNRLEGEIPVKGSFKDFSAQS 338 (717)
Q Consensus 281 ~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~ 338 (717)
++++++|+.|+|++|++++. + .+.++++|++|+|++|++++..| ...++.+..+.
T Consensus 169 l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ 223 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVT 223 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEE
T ss_pred hcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEE
Confidence 88999999999999999864 3 48899999999999999997544 34555555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=4.6e-18 Score=176.22 Aligned_cols=265 Identities=25% Similarity=0.309 Sum_probs=180.0
Q ss_pred CCCCCccccCCCCCcEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCC
Q 005040 1 MGTIPNSITNATKLIGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPL 80 (717)
Q Consensus 1 ~~~iP~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 80 (717)
+++||+. .++|++|+|++|+|+ .+|+. +.+|+.|++++|+++.++. + .+.|++|++++|.+
T Consensus 50 L~~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~~----------l--p~~L~~L~L~~n~l 110 (353)
T d1jl5a_ 50 LSSLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALSD----------L--PPLLEYLGVSNNQL 110 (353)
T ss_dssp CSCCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCCS----------C--CTTCCEEECCSSCC
T ss_pred CCCCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhhh----------h--cccccccccccccc
Confidence 4788864 467899999999999 56765 4579999999999998652 1 14699999999999
Q ss_pred cccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCccccc----
Q 005040 81 GGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGY---- 156 (717)
Q Consensus 81 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~---- 156 (717)
.. +|. +..+ ++|++|++++|.+... + .....+..|.+.++... ....+..++.++.|++++|.+...
T Consensus 111 ~~-lp~-~~~l-~~L~~L~l~~~~~~~~-~---~~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~~~ 181 (353)
T d1jl5a_ 111 EK-LPE-LQNS-SFLKIIDVDNNSLKKL-P---DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLP 181 (353)
T ss_dssp SS-CCC-CTTC-TTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCCCC
T ss_pred cc-ccc-hhhh-ccceeecccccccccc-c---cccccccchhhcccccc--ccccccccccceeccccccccccccccc
Confidence 84 443 4555 6799999999988632 2 22345555666555543 233455566666666665554421
Q ss_pred --------------CCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEE---
Q 005040 157 --------------VPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRIN--- 219 (717)
Q Consensus 157 --------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~--- 219 (717)
....+..++.|+.+++++|.... .+. ...++..+.+.+|.+... +.. ...+..++
T Consensus 182 ~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~~~---~~~l~~~~~~~ 253 (353)
T d1jl5a_ 182 LSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-PEL---PQSLTFLDVSE 253 (353)
T ss_dssp TTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCS
T ss_pred ccccccccccccccccccccccccccccccccccccc-ccc---cccccccccccccccccc-ccc---ccccccccccc
Confidence 11235667889999999988773 332 346678888888877632 221 22333333
Q ss_pred -----------------ccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCcccc
Q 005040 220 -----------------LSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVG 282 (717)
Q Consensus 220 -----------------l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 282 (717)
+..|.+. .....+++|++|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|..
T Consensus 254 ~~~~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~~-- 322 (353)
T d1jl5a_ 254 NIFSGLSELPPNLYYLNASSNEIR----SLCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPEL-- 322 (353)
T ss_dssp SCCSEESCCCTTCCEEECCSSCCS----EECCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCCC--
T ss_pred ccccccccccchhcccccccCccc----cccccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-ccccc--
Confidence 3333333 223446799999999999995 554 3678999999999998 45643
Q ss_pred ccCccceEeccCCCCCCCCcccccccccccEEEcc
Q 005040 283 NLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVS 317 (717)
Q Consensus 283 ~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~ 317 (717)
+.+|++|+|++|+++ .+|.... .|+.|.++
T Consensus 323 -~~~L~~L~L~~N~L~-~lp~~~~---~L~~L~~~ 352 (353)
T d1jl5a_ 323 -PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRMN 352 (353)
T ss_dssp -CTTCCEEECCSSCCS-SCCCCCT---TCCEEECC
T ss_pred -cCCCCEEECcCCcCC-CCCcccc---ccCeeECc
Confidence 468999999999998 5666433 45566554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=4.7e-19 Score=166.40 Aligned_cols=172 Identities=21% Similarity=0.287 Sum_probs=95.4
Q ss_pred cEEEccCCCCcccCCccccccCCCCEEeccCCcccc-cCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecC
Q 005040 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQG-YVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQS 198 (717)
Q Consensus 120 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 198 (717)
++++.++|+++ .+|..+. +++++|+|++|+|+. ..+..|.++++|+.|+|++|.+....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 35666666666 3343332 456666666666653 3344556666666666666666655566666666666666666
Q ss_pred ccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCC
Q 005040 199 NKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIP 278 (717)
Q Consensus 199 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 278 (717)
|+|+...+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+..... ...-...|+.+.+..|.+....|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCC
Confidence 66665555566666666666666666666666666666666666666666653221 11112234555555555544333
Q ss_pred ccccccCccceEeccCCCCC
Q 005040 279 ESVGNLISLESLDFSNNNLS 298 (717)
Q Consensus 279 ~~~~~l~~L~~L~L~~N~~~ 298 (717)
..+ ..++.++|+.|.+.
T Consensus 167 ~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 167 SKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp TTT---TTSBGGGSCTTTCC
T ss_pred hhh---cCCEeeecCHhhCc
Confidence 322 22334444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=1e-18 Score=166.48 Aligned_cols=164 Identities=26% Similarity=0.383 Sum_probs=78.4
Q ss_pred CCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEE
Q 005040 116 LRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLY 195 (717)
Q Consensus 116 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 195 (717)
+.+|++|++++|.++... .+..+++|++|+|++|+|++.. .++.+++|++|++++|+|++ ++ .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 445555555555555321 2455555555555555555432 24455555555555555553 22 244455555555
Q ss_pred ecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccC
Q 005040 196 LQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQG 275 (717)
Q Consensus 196 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 275 (717)
+++|.+... ..+.++++|+.+++++|.+++ +..+..+++|+.+++++|++.+
T Consensus 119 l~~~~~~~~--------------------------~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 119 LEHNGISDI--------------------------NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp CTTSCCCCC--------------------------GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred ccccccccc--------------------------ccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 555554421 234444444444454444442 1223444555555555555543
Q ss_pred CCCccccccCccceEeccCCCCCCCCcccccccccccEEEcc
Q 005040 276 PIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQFNVS 317 (717)
Q Consensus 276 ~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~L~l~ 317 (717)
. + .++++++|+.|+|++|+|++ ++ .+.++++|+.|+|+
T Consensus 171 i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 171 I-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp C-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred c-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 2 1 24455555555555555542 22 35555555555554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=2.8e-19 Score=167.95 Aligned_cols=173 Identities=21% Similarity=0.246 Sum_probs=89.3
Q ss_pred CEEeccCCcccccCCccccCCCCCCEEeccCCcCccc-CCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccC
Q 005040 144 QGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGA-IPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSS 222 (717)
Q Consensus 144 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 222 (717)
+.++.++++++. +|..+. +++++|+|++|+|+.. .+..|.++++|+.|+|++|++....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 455666666663 333322 3556666666666532 234455566666666666666655555555566666666666
Q ss_pred CcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCc
Q 005040 223 NSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIP 302 (717)
Q Consensus 223 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~ 302 (717)
|+|++..+..|.++++|++|+|++|.|+++.+..|..+++|++|+|++|++..... ...-...++.+.+..|.+....|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCC
Confidence 66665555555666666666666666665555555555555555555555542211 11111123444444444444334
Q ss_pred ccccccccccEEEccCCcccc
Q 005040 303 KSLEALSHLKQFNVSHNRLEG 323 (717)
Q Consensus 303 ~~~~~l~~L~~L~l~~N~l~~ 323 (717)
..+ ..++.++|+.|.+.+
T Consensus 167 ~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 167 SKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp TTT---TTSBGGGSCTTTCCC
T ss_pred hhh---cCCEeeecCHhhCcC
Confidence 322 233344455555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.5e-18 Score=165.45 Aligned_cols=188 Identities=25% Similarity=0.339 Sum_probs=151.0
Q ss_pred CccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCE
Q 005040 66 NCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQG 145 (717)
Q Consensus 66 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 145 (717)
.+.++....++.+.+++.++. ..+ .+|++|++++|.+.... .+..+++|++|+|++|+|++.. .++.+++|++
T Consensus 22 ~l~~~i~~~l~~~~~~~~~~~--~~L-~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~ 94 (210)
T d1h6ta2 22 AFAETIKDNLKKKSVTDAVTQ--NEL-NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGW 94 (210)
T ss_dssp HHHHHHHHHTTCSCTTSEECH--HHH-HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCE
T ss_pred HHHHHHHHHhCcCccCCccCH--HHh-cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccc
Confidence 344555567888888866553 234 57999999999998543 4889999999999999999643 4789999999
Q ss_pred EeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcC
Q 005040 146 FYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSL 225 (717)
Q Consensus 146 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 225 (717)
|++++|+|+++ + .+.++++|+.|++++|.+... ..+..+++|+.+++++|.+++ +..+..+++|+.+++++|++
T Consensus 95 L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l 168 (210)
T d1h6ta2 95 LFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 168 (210)
T ss_dssp EECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCC
T ss_pred ccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccc--cccccccccccccccccccc
Confidence 99999999965 3 589999999999999999843 458899999999999999984 34577888999999999988
Q ss_pred cccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccccccccC
Q 005040 226 KGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLETLSLAG 270 (717)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 270 (717)
++. + .+.++++|+.|+|++|.|++ ++ .+..+++|++|+|++
T Consensus 169 ~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 169 SDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 853 2 47888888888888888875 43 477888888888764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=3.2e-18 Score=161.67 Aligned_cols=141 Identities=30% Similarity=0.442 Sum_probs=68.4
Q ss_pred ccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCC
Q 005040 113 IGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 192 (717)
+..+++|++|+|++|++++..+ ++++++|++|++++|.+.... .+.++++|+.|++++|.+... ..+..+++|+
T Consensus 58 l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~ 131 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLN 131 (199)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCS
T ss_pred cccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--ccccccccccccccccccccc--cccchhhhhH
Confidence 4445555555555555553321 555555555555555554321 245555555555555555432 2244555555
Q ss_pred eEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCccccc
Q 005040 193 SLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLET 265 (717)
Q Consensus 193 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 265 (717)
.|++++|++.. + ..+..+++|+.|++++|++++. ..++++++|+.|++++|++++ ++ .++.+++|++
T Consensus 132 ~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~ 198 (199)
T d2omxa2 132 RLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLES 198 (199)
T ss_dssp EEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred Hhhhhhhhhcc-c-ccccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCc
Confidence 55555555542 1 2344555555555555555432 124455555555555555543 21 2444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=3.9e-18 Score=161.06 Aligned_cols=176 Identities=26% Similarity=0.367 Sum_probs=81.1
Q ss_pred eeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcC
Q 005040 98 IYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKL 177 (717)
Q Consensus 98 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 177 (717)
+.+..+.+++.++ ...+.+|++|++++|.++.. +.+..+++|++|++++|++++..+ +.++++|++|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 3444444443222 23345555555555555532 234455555555555555553321 44555555555555554
Q ss_pred cccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccc
Q 005040 178 SGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTI 257 (717)
Q Consensus 178 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 257 (717)
... + .+.+++.|+.|++++|.+... ..+..+++|+.|++++|.+.. + ..+
T Consensus 97 ~~~-~-~l~~l~~L~~L~l~~~~~~~~--------------------------~~~~~l~~L~~L~l~~n~l~~-~-~~l 146 (199)
T d2omxa2 97 ADI-T-PLANLTNLTGLTLFNNQITDI--------------------------DPLKNLTNLNRLELSSNTISD-I-SAL 146 (199)
T ss_dssp CCC-G-GGTTCTTCSEEECCSSCCCCC--------------------------GGGTTCTTCSEEECCSSCCCC-C-GGG
T ss_pred ccc-c-ccccccccccccccccccccc--------------------------cccchhhhhHHhhhhhhhhcc-c-ccc
Confidence 422 1 244445555555554444421 224444445555555554442 1 124
Q ss_pred cCCcccccccccCccccCCCCccccccCccceEeccCCCCCCCCcccccccccccE
Q 005040 258 GTLKNLETLSLAGNQFQGPIPESVGNLISLESLDFSNNNLSGKIPKSLEALSHLKQ 313 (717)
Q Consensus 258 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~~~~~~~~~~l~~L~~ 313 (717)
..+++|++|++++|++++. ..++++++|++|++++|++++. ..+.++++|++
T Consensus 147 ~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~ 198 (199)
T d2omxa2 147 SGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSDI--SVLAKLTNLES 198 (199)
T ss_dssp TTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred cccccccccccccccccCC--ccccCCCCCCEEECCCCCCCCC--ccccCCCCCCc
Confidence 4445555555555555432 1244555555555555555432 13445555544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3.5e-21 Score=207.75 Aligned_cols=308 Identities=21% Similarity=0.214 Sum_probs=203.2
Q ss_pred CCCcEEECCCCcceecC-CcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhc
Q 005040 12 TKLIGLDLGLNSFSGHI-PNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGN 90 (717)
Q Consensus 12 ~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 90 (717)
.+|++||+++|+|++.. .+-+..+++|++|+|++|.|++.... .+...+..+++|++|+|++|+|+......+..
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~----~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~ 77 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK----DISSALRVNPALAELNLRSNELGDVGVHCVLQ 77 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHH----HHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHH----HHHHHHhcCCCCCEEECcCCcCChHHHHHHHH
Confidence 36789999999998643 33466788999999999988753321 13344678899999999999987543333332
Q ss_pred ----cccccceeeecCCcceec----CCccccCCCCCcEEEccCCCCcccCC----------------------------
Q 005040 91 ----FSASLQNIYAFECKLGGS----IPKEIGNLRGLIVLSLGFNDLNGTIP---------------------------- 134 (717)
Q Consensus 91 ----l~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~---------------------------- 134 (717)
...+|++|+|++|+++.. ++..+..+++|++|+|++|.++....
T Consensus 78 ~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 157 (460)
T d1z7xw1 78 GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 157 (460)
T ss_dssp TTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhh
Confidence 224699999999998753 45667888999999999998753110
Q ss_pred -----ccccccCCCCEEeccCCcccccC---------------------------------CccccCCCCCCEEeccCCc
Q 005040 135 -----TSIGTLQQLQGFYVPENNLQGYV---------------------------------PHDLCHLERLNILNLSGNK 176 (717)
Q Consensus 135 -----~~~~~l~~L~~L~l~~n~i~~~~---------------------------------~~~~~~l~~L~~L~L~~n~ 176 (717)
..+.....++.++++++.+.... ...+...+.++.+++++|.
T Consensus 158 ~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~ 237 (460)
T d1z7xw1 158 CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 237 (460)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSB
T ss_pred hcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcc
Confidence 01122345666666655443110 0112234567777777776
Q ss_pred Cccc-----CCccccCCCCCCeEEecCccccCC----CChhhhcccCCCeEEccCCcCcccCCccc-----cCCCCCCeE
Q 005040 177 LSGA-----IPQCLASLTSLRSLYLQSNKLSSS----LPSSLWSLEYILRINLSSNSLKGTLPSNI-----QKLNVLIDL 242 (717)
Q Consensus 177 l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L 242 (717)
+... ....+.....|+.|++++|.+... ....+...+.++.+++++|.++......+ .....|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l 317 (460)
T d1z7xw1 238 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 317 (460)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred ccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccc
Confidence 6421 122334466788888888887632 22345567788888888888864322221 234578899
Q ss_pred EccCCCCCCCCcccc----cCCcccccccccCccccCCCCcc----cc-ccCccceEeccCCCCCCC----Ccccccccc
Q 005040 243 DLSRNQLSSDIPSTI----GTLKNLETLSLAGNQFQGPIPES----VG-NLISLESLDFSNNNLSGK----IPKSLEALS 309 (717)
Q Consensus 243 ~l~~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~~~~~----~~-~l~~L~~L~L~~N~~~~~----~~~~~~~l~ 309 (717)
++++|.++......+ ...++|++|+|++|++++..... +. ..+.|++|+|++|+|+.. ++..+..++
T Consensus 318 ~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 397 (460)
T d1z7xw1 318 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 397 (460)
T ss_dssp ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCC
T ss_pred cccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCC
Confidence 999998876443333 44568999999999887543322 22 356799999999998753 344566778
Q ss_pred cccEEEccCCcccc
Q 005040 310 HLKQFNVSHNRLEG 323 (717)
Q Consensus 310 ~L~~L~l~~N~l~~ 323 (717)
+|++|+|++|+++.
T Consensus 398 ~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 398 SLRELDLSNNCLGD 411 (460)
T ss_dssp CCCEEECCSSSCCH
T ss_pred CCCEEECCCCcCCH
Confidence 99999999998875
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2.6e-19 Score=192.76 Aligned_cols=314 Identities=19% Similarity=0.153 Sum_probs=197.7
Q ss_pred ccCCCCCcEEECCCCcceec----CCcCCCCCCCCCEEEcccccccCccCCccccccccccc-CccCCcEEeccCCCCcc
Q 005040 8 ITNATKLIGLDLGLNSFSGH----IPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLT-NCRNLANLALASNPLGG 82 (717)
Q Consensus 8 ~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~-~l~~L~~L~L~~N~l~~ 82 (717)
++.+++++.|+|++|.|+.. +...+..+++|++|+|++|.|++..... +...+. ...+|++|+|++|+++.
T Consensus 23 ~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~----l~~~l~~~~~~L~~L~L~~n~it~ 98 (460)
T d1z7xw1 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHC----VLQGLQTPSCKIQKLSLQNCCLTG 98 (460)
T ss_dssp HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHH----HHHTTCSTTCCCCEEECTTSCCBG
T ss_pred HHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHH----HHHHHhcCCCCCCEEECCCCCccc
Confidence 34556677777777766632 2344556677777777777765422110 111122 23467777777777664
Q ss_pred cC----CcchhccccccceeeecCCcceecCC---------------------------------ccccCCCCCcEEEcc
Q 005040 83 IL----PPLIGNFSASLQNIYAFECKLGGSIP---------------------------------KEIGNLRGLIVLSLG 125 (717)
Q Consensus 83 ~~----~~~~~~l~~~L~~L~l~~n~l~~~~~---------------------------------~~~~~l~~L~~L~L~ 125 (717)
.. +..+... ++|++|++++|.++.... ..+.....++.++++
T Consensus 99 ~~~~~l~~~l~~~-~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls 177 (460)
T d1z7xw1 99 AGCGVLSSTLRTL-PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 177 (460)
T ss_dssp GGHHHHHHHTTSC-TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECC
T ss_pred cccccccchhhcc-ccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccc
Confidence 42 2223333 457777777766542100 001122345555555
Q ss_pred CCCC-----------------------------ccc----CCccccccCCCCEEeccCCccccc-----CCccccCCCCC
Q 005040 126 FNDL-----------------------------NGT----IPTSIGTLQQLQGFYVPENNLQGY-----VPHDLCHLERL 167 (717)
Q Consensus 126 ~n~l-----------------------------~~~----~~~~~~~l~~L~~L~l~~n~i~~~-----~~~~~~~l~~L 167 (717)
++.+ ... ....+...+.++.+++.+|.+... ..........|
T Consensus 178 ~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l 257 (460)
T d1z7xw1 178 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 257 (460)
T ss_dssp SSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCC
T ss_pred ccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccc
Confidence 4433 211 012234567899999999987532 22334556789
Q ss_pred CEEeccCCcCcccC----CccccCCCCCCeEEecCccccCCCChhh-----hcccCCCeEEccCCcCcccCCc----ccc
Q 005040 168 NILNLSGNKLSGAI----PQCLASLTSLRSLYLQSNKLSSSLPSSL-----WSLEYILRINLSSNSLKGTLPS----NIQ 234 (717)
Q Consensus 168 ~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~~~----~~~ 234 (717)
+.|++++|.+.... ...+...+.++.+++++|.++......+ .....|+.+++++|.++..... .+.
T Consensus 258 ~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~ 337 (460)
T d1z7xw1 258 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLA 337 (460)
T ss_dssp CEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccc
Confidence 99999999987432 2345668899999999999974322222 2346899999999998854333 345
Q ss_pred CCCCCCeEEccCCCCCCCCc----cccc-CCcccccccccCccccCCC----CccccccCccceEeccCCCCCCCCcccc
Q 005040 235 KLNVLIDLDLSRNQLSSDIP----STIG-TLKNLETLSLAGNQFQGPI----PESVGNLISLESLDFSNNNLSGKIPKSL 305 (717)
Q Consensus 235 ~l~~L~~L~l~~N~l~~~~~----~~~~-~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~~~~~~~~~~ 305 (717)
..++|++|+|++|.|++... ..+. ..+.|++|+|++|+|++.. +..+..+++|++|+|++|+|+......+
T Consensus 338 ~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l 417 (460)
T d1z7xw1 338 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417 (460)
T ss_dssp HCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHH
T ss_pred cccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHH
Confidence 56789999999999975322 2232 4677999999999998543 3445667999999999999986443333
Q ss_pred ----c-ccccccEEEccCCccccccc
Q 005040 306 ----E-ALSHLKQFNVSHNRLEGEIP 326 (717)
Q Consensus 306 ----~-~l~~L~~L~l~~N~l~~~~p 326 (717)
. ....|+.|++.+|.+..+..
T Consensus 418 ~~~l~~~~~~L~~l~l~~~~~~~~~~ 443 (460)
T d1z7xw1 418 VESVRQPGCLLEQLVLYDIYWSEEME 443 (460)
T ss_dssp HHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred HHHHHhCCCccCEEECCCCCCCHHHH
Confidence 2 23479999999999976543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.65 E-value=6.3e-18 Score=174.57 Aligned_cols=248 Identities=16% Similarity=0.172 Sum_probs=138.1
Q ss_pred cCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCccc---CCcchhccccccceeeecCCcce
Q 005040 30 NTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGI---LPPLIGNFSASLQNIYAFECKLG 106 (717)
Q Consensus 30 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~~L~~L~l~~n~l~ 106 (717)
..+.+...|+.|+|++|.|....... +...+...++|+.|+++++..... .+..+..+
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~----l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l--------------- 85 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARW----LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL--------------- 85 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHH----HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHH---------------
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHH----HHHHHHhCCCCCEEECCCCcccccccccchHHHHH---------------
Confidence 34455666777777776665432111 223355666677777766544321 12222111
Q ss_pred ecCCccccCCCCCcEEEccCCCCccc----CCccccccCCCCEEeccCCcccccCCcc-------------ccCCCCCCE
Q 005040 107 GSIPKEIGNLRGLIVLSLGFNDLNGT----IPTSIGTLQQLQGFYVPENNLQGYVPHD-------------LCHLERLNI 169 (717)
Q Consensus 107 ~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~-------------~~~l~~L~~ 169 (717)
...+...++|+.|+|++|.++.. +...+...++|++|++++|.+....... ....+.|+.
T Consensus 86 ---~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~ 162 (344)
T d2ca6a1 86 ---LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 162 (344)
T ss_dssp ---HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCE
T ss_pred ---HHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccce
Confidence 12344455566666666655532 2233455566666666666554221111 123456777
Q ss_pred EeccCCcCcccC----CccccCCCCCCeEEecCccccCC-----CChhhhcccCCCeEEccCCcCccc----CCccccCC
Q 005040 170 LNLSGNKLSGAI----PQCLASLTSLRSLYLQSNKLSSS-----LPSSLWSLEYILRINLSSNSLKGT----LPSNIQKL 236 (717)
Q Consensus 170 L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l 236 (717)
|++++|.++... ...+...+.|++|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+
T Consensus 163 l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~ 242 (344)
T d2ca6a1 163 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242 (344)
T ss_dssp EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred eecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccccc
Confidence 777777665322 22344566777777777776532 223455667777777777776532 33455677
Q ss_pred CCCCeEEccCCCCCCCCcccc----c--CCcccccccccCccccCCCCccc-----cccCccceEeccCCCCCC
Q 005040 237 NVLIDLDLSRNQLSSDIPSTI----G--TLKNLETLSLAGNQFQGPIPESV-----GNLISLESLDFSNNNLSG 299 (717)
Q Consensus 237 ~~L~~L~l~~N~l~~~~~~~~----~--~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~~~~ 299 (717)
++|++|+|++|.|++.....+ . ..+.|++|++++|+|+......+ .++++|+.|+|++|.+..
T Consensus 243 ~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 778888888887775333322 2 23568888888888764332222 246778888888888863
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.65 E-value=5.6e-18 Score=174.97 Aligned_cols=245 Identities=16% Similarity=0.196 Sum_probs=179.4
Q ss_pred ccccccCccCCcEEeccCCCCcccCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCccc-------
Q 005040 60 FLSSLTNCRNLANLALASNPLGGILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGT------- 132 (717)
Q Consensus 60 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------- 132 (717)
+...+....+|++|+|++|.++......++ ..+...++|+.|+++++.....
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~---------------------~~l~~~~~L~~l~l~~~~~~~~~~~~~~~ 81 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLS---------------------ENIASKKDLEIAEFSDIFTGRVKDEIPEA 81 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHH---------------------HTTTTCTTCCEEECCSCCTTSCGGGSHHH
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHH---------------------HHHHhCCCCCEEECCCCcccccccccchH
Confidence 345567778888888888887654333332 3466778888999887765422
Q ss_pred ---CCccccccCCCCEEeccCCcccccCC----ccccCCCCCCEEeccCCcCcccCCcc-------------ccCCCCCC
Q 005040 133 ---IPTSIGTLQQLQGFYVPENNLQGYVP----HDLCHLERLNILNLSGNKLSGAIPQC-------------LASLTSLR 192 (717)
Q Consensus 133 ---~~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~-------------~~~l~~L~ 192 (717)
+...+..+++|+.|+|++|.++.... ..+...++|+.|++++|.++...... ....+.|+
T Consensus 82 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~ 161 (344)
T d2ca6a1 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 161 (344)
T ss_dssp HHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred HHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccc
Confidence 22345668899999999999986533 34456789999999999986322111 13467899
Q ss_pred eEEecCccccCCC----ChhhhcccCCCeEEccCCcCccc-----CCccccCCCCCCeEEccCCCCCCC----CcccccC
Q 005040 193 SLYLQSNKLSSSL----PSSLWSLEYILRINLSSNSLKGT-----LPSNIQKLNVLIDLDLSRNQLSSD----IPSTIGT 259 (717)
Q Consensus 193 ~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~ 259 (717)
.|++++|.++... ...+...+.|+.|+|++|.|+.. +...+..+++|+.|+|++|.++.. +...+..
T Consensus 162 ~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~ 241 (344)
T d2ca6a1 162 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241 (344)
T ss_dssp EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred eeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccc
Confidence 9999999987432 33456778999999999998742 334578889999999999998753 3345678
Q ss_pred CcccccccccCccccCCCCcccc------ccCccceEeccCCCCCCCC----ccccc-ccccccEEEccCCcccccc
Q 005040 260 LKNLETLSLAGNQFQGPIPESVG------NLISLESLDFSNNNLSGKI----PKSLE-ALSHLKQFNVSHNRLEGEI 325 (717)
Q Consensus 260 l~~L~~L~l~~N~l~~~~~~~~~------~l~~L~~L~L~~N~~~~~~----~~~~~-~l~~L~~L~l~~N~l~~~~ 325 (717)
+++|++|+|++|.|++.....++ ..+.|++|+|++|+|.... ...+. ++++|+.|+|++|++..+.
T Consensus 242 ~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~ 318 (344)
T d2ca6a1 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318 (344)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred cccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence 89999999999999865444442 2467999999999987532 33343 5789999999999997654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=7.1e-17 Score=161.27 Aligned_cols=207 Identities=21% Similarity=0.223 Sum_probs=132.2
Q ss_pred cCCCCCcEEEccCCCCccc-CCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCC-cCcccC-CccccCCCC
Q 005040 114 GNLRGLIVLSLGFNDLNGT-IPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGN-KLSGAI-PQCLASLTS 190 (717)
Q Consensus 114 ~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n-~l~~~~-~~~~~~l~~ 190 (717)
....+|++|||++|.++.. +...+.++++|++|+|++|.+++..+..+..+++|++|+|++| .+++.. ...+.++++
T Consensus 43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~ 122 (284)
T d2astb2 43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122 (284)
T ss_dssp CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHh
Confidence 3445788888888877643 2344677888888888888887766677778888888888884 555322 222456788
Q ss_pred CCeEEecCc-cccCC-CChhhhc-ccCCCeEEccCC--cCccc-CCccccCCCCCCeEEccCC-CCCCCCcccccCCccc
Q 005040 191 LRSLYLQSN-KLSSS-LPSSLWS-LEYILRINLSSN--SLKGT-LPSNIQKLNVLIDLDLSRN-QLSSDIPSTIGTLKNL 263 (717)
Q Consensus 191 L~~L~L~~N-~l~~~-~~~~~~~-l~~L~~L~l~~N--~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L 263 (717)
|++|++++| .+++. ....+.. .++|+.|+++++ .++.. +...+.++++|++|++++| .+++.....+..+++|
T Consensus 123 L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L 202 (284)
T d2astb2 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202 (284)
T ss_dssp CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred ccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcC
Confidence 888888875 34321 1122333 467888888765 33322 2223456778888888875 4666666677778888
Q ss_pred ccccccCc-cccCCCCccccccCccceEeccCCCCCC-CCcccccccccccEEEccCCccccc
Q 005040 264 ETLSLAGN-QFQGPIPESVGNLISLESLDFSNNNLSG-KIPKSLEALSHLKQFNVSHNRLEGE 324 (717)
Q Consensus 264 ~~L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~N~~~~-~~~~~~~~l~~L~~L~l~~N~l~~~ 324 (717)
++|++++| .+++.....++++++|+.|+++++ ++. ..+.....+|+| .++.++++..
T Consensus 203 ~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~ls~~ 261 (284)
T d2astb2 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSHFTTI 261 (284)
T ss_dssp CEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCCSCCT
T ss_pred CEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCccCCCC
Confidence 88888884 566666667777888888888877 332 222222344444 3555666543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=7.7e-17 Score=161.01 Aligned_cols=223 Identities=18% Similarity=0.170 Sum_probs=107.1
Q ss_pred cEEECCCCcceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchhccccc
Q 005040 15 IGLDLGLNSFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIGNFSAS 94 (717)
Q Consensus 15 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~ 94 (717)
+.|||+++.+.......+.. ..+..+.++.+.+...... .....+|++|+|++|.++......
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~---------~~~~~~L~~LdLs~~~i~~~~l~~------- 65 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE---------HFSPFRVQHMDLSNSVIEVSTLHG------- 65 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS---------CCCCBCCCEEECTTCEECHHHHHH-------
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh---------hccCCCCCEEECCCCccCHHHHHH-------
Confidence 46788877665222111111 2345666666555432211 234456777777777665432222
Q ss_pred cceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCC-cccccCC-ccccCCCCCCEEec
Q 005040 95 LQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPEN-NLQGYVP-HDLCHLERLNILNL 172 (717)
Q Consensus 95 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n-~i~~~~~-~~~~~l~~L~~L~L 172 (717)
.+.++++|++|+|++|.+++..+..+..+++|++|++++| .+++..- ..+.++++|++|++
T Consensus 66 -----------------l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~l 128 (284)
T d2astb2 66 -----------------ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 128 (284)
T ss_dssp -----------------HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEEC
T ss_pred -----------------HHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccc
Confidence 2344445555555555544444444445555555555553 3332111 11234455555555
Q ss_pred cCC-cCcccC-CccccC-CCCCCeEEecCc--cccCC-CChhhhcccCCCeEEccCC-cCcccCCccccCCCCCCeEEcc
Q 005040 173 SGN-KLSGAI-PQCLAS-LTSLRSLYLQSN--KLSSS-LPSSLWSLEYILRINLSSN-SLKGTLPSNIQKLNVLIDLDLS 245 (717)
Q Consensus 173 ~~n-~l~~~~-~~~~~~-l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~ 245 (717)
++| .+++.. ...+.. .++|+.|+++++ .+++. +...+.++++|++|++++| .+++.....+..+++|++|+|+
T Consensus 129 s~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~ 208 (284)
T d2astb2 129 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 208 (284)
T ss_dssp CCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred ccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECC
Confidence 553 232111 111222 245566665543 22211 1222344566666666654 3554455555666666666666
Q ss_pred CC-CCCCCCcccccCCcccccccccCc
Q 005040 246 RN-QLSSDIPSTIGTLKNLETLSLAGN 271 (717)
Q Consensus 246 ~N-~l~~~~~~~~~~l~~L~~L~l~~N 271 (717)
++ .+++.....++.+++|+.|+++++
T Consensus 209 ~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 209 RCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 63 455544445566666666666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=9.8e-16 Score=138.38 Aligned_cols=111 Identities=21% Similarity=0.161 Sum_probs=64.4
Q ss_pred ccCCCCCcEEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCC
Q 005040 113 IGNLRGLIVLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLR 192 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 192 (717)
|.+..+|++|+|++|+|+. ++..+..+++|+.|+|++|+|+.+ +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 4555566666666666663 344555666666666666666644 2356666666666666666654444455566666
Q ss_pred eEEecCccccCCCC-hhhhcccCCCeEEccCCcCc
Q 005040 193 SLYLQSNKLSSSLP-SSLWSLEYILRINLSSNSLK 226 (717)
Q Consensus 193 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~ 226 (717)
.|+|++|+|+.... ..+..+++|++|++++|.++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCccc
Confidence 66666666653211 23445555555555555554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=7.1e-16 Score=139.32 Aligned_cols=128 Identities=18% Similarity=0.171 Sum_probs=65.8
Q ss_pred ccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcccc
Q 005040 185 LASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKNLE 264 (717)
Q Consensus 185 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 264 (717)
|.+..+|++|+|++|+|+. ++..+..+++|+.|+|++|+|+.. +.|..+++|++|++++|.+++..+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 3344455555555555552 233444455555555555555532 2355555555555555555544444444555555
Q ss_pred cccccCccccCCCC-ccccccCccceEeccCCCCCCCC---cccccccccccEEE
Q 005040 265 TLSLAGNQFQGPIP-ESVGNLISLESLDFSNNNLSGKI---PKSLEALSHLKQFN 315 (717)
Q Consensus 265 ~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~~~~~~---~~~~~~l~~L~~L~ 315 (717)
.|++++|+|..... ..+..+++|++|++++|+++... +..+..+|+|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 55555555553211 34555666666666666665322 12455666666654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=7.7e-15 Score=125.79 Aligned_cols=77 Identities=29% Similarity=0.399 Sum_probs=32.2
Q ss_pred EEeccCCcCcccCCccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCC
Q 005040 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQ 248 (717)
Q Consensus 169 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 248 (717)
.|+|++|+|+. ++ .+..+++|++|++++|+|+ .+|..+..+++|+.|++++|.|++. + .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 34444444442 22 2444444444444444444 2333344444444444444444421 1 23444444444444444
Q ss_pred CC
Q 005040 249 LS 250 (717)
Q Consensus 249 l~ 250 (717)
|+
T Consensus 77 i~ 78 (124)
T d1dcea3 77 LQ 78 (124)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=1.9e-14 Score=123.23 Aligned_cols=101 Identities=31% Similarity=0.390 Sum_probs=43.8
Q ss_pred EEEccCCCCcccCCccccccCCCCEEeccCCcccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecCcc
Q 005040 121 VLSLGFNDLNGTIPTSIGTLQQLQGFYVPENNLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQSNK 200 (717)
Q Consensus 121 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 200 (717)
.|+|++|+|+. ++ .+.++++|++|++++|+|+. +|..|..+++|++|++++|+|+.. + .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 34444444442 12 24444444444444444442 233344444444444444444422 2 24444444444444444
Q ss_pred ccCCC-ChhhhcccCCCeEEccCCcCc
Q 005040 201 LSSSL-PSSLWSLEYILRINLSSNSLK 226 (717)
Q Consensus 201 l~~~~-~~~~~~l~~L~~L~l~~N~l~ 226 (717)
|++.. ...+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 44221 123444444555555555444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.45 E-value=1.1e-15 Score=143.30 Aligned_cols=129 Identities=22% Similarity=0.259 Sum_probs=78.9
Q ss_pred CCCcEEECCCC--cceecCCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcccCCcchh
Q 005040 12 TKLIGLDLGLN--SFSGHIPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGGILPPLIG 89 (717)
Q Consensus 12 ~~L~~L~L~~n--~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 89 (717)
..++.++++++ .++ .++..|..|++|++|+|++|+|+.++. |..+++|++|+|++|.|+. ++..+.
T Consensus 23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i~~----------l~~l~~L~~L~Ls~N~i~~-i~~~~~ 90 (198)
T d1m9la_ 23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS----------LSGMENLRILSLGRNLIKK-IENLDA 90 (198)
T ss_dssp TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCCCC----------HHHHTTCCEEECCEEEECS-CSSHHH
T ss_pred cccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCccc----------ccCCccccChhhccccccc-cccccc
Confidence 34556666654 343 455678888888888888888887642 6788888888888888874 333332
Q ss_pred ccccccceeeecCCcceecCCccccCCCCCcEEEccCCCCcccCC-ccccccCCCCEEeccCCcccc
Q 005040 90 NFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSLGFNDLNGTIP-TSIGTLQQLQGFYVPENNLQG 155 (717)
Q Consensus 90 ~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~i~~ 155 (717)
. .++|+.|++++|+++.. ..+..+++|++|+|++|+|+.... ..|..+++|+.|+|++|.+..
T Consensus 91 ~-~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 91 V-ADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp H-HHHCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred c-ccccccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 2 24566666666666532 235555566666666666553211 345555555555555555543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.42 E-value=2e-15 Score=141.36 Aligned_cols=133 Identities=25% Similarity=0.299 Sum_probs=64.3
Q ss_pred ccccCCCCCCeEEecCccccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCCCCCCCCcccccCCcc
Q 005040 183 QCLASLTSLRSLYLQSNKLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRNQLSSDIPSTIGTLKN 262 (717)
Q Consensus 183 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 262 (717)
..+..+++|++|+|++|+|+.. + .+..+++|++|+|++|.|+ .++..+..+++|+.|++++|.|+.. ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccc
Confidence 3444455555555555555422 2 2445555555555555554 2333333344455555555555532 22445555
Q ss_pred cccccccCccccCCCC-ccccccCccceEeccCCCCCCCCcc----------cccccccccEEEccCCccc
Q 005040 263 LETLSLAGNQFQGPIP-ESVGNLISLESLDFSNNNLSGKIPK----------SLEALSHLKQFNVSHNRLE 322 (717)
Q Consensus 263 L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~~~~~~~~----------~~~~l~~L~~L~l~~N~l~ 322 (717)
|+.|++++|+|+.... ..+..+++|+.|+|++|++....+. .+..+|+|+.|| +.+++
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 5555555555543211 2345555555555555555432221 145667777654 44443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=3.2e-13 Score=120.69 Aligned_cols=81 Identities=20% Similarity=0.201 Sum_probs=31.2
Q ss_pred EEeccCCcCcccCCccccCCCCCCeEEecCc-cccCCCChhhhcccCCCeEEccCCcCcccCCccccCCCCCCeEEccCC
Q 005040 169 ILNLSGNKLSGAIPQCLASLTSLRSLYLQSN-KLSSSLPSSLWSLEYILRINLSSNSLKGTLPSNIQKLNVLIDLDLSRN 247 (717)
Q Consensus 169 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 247 (717)
.++++++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3444444443 22333333344444444322 233333333334444444444444444333333444444444444444
Q ss_pred CCC
Q 005040 248 QLS 250 (717)
Q Consensus 248 ~l~ 250 (717)
+|+
T Consensus 91 ~l~ 93 (156)
T d2ifga3 91 ALE 93 (156)
T ss_dssp CCS
T ss_pred CCc
Confidence 443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=5.6e-13 Score=119.08 Aligned_cols=82 Identities=21% Similarity=0.173 Sum_probs=37.7
Q ss_pred cEEEccCCCCcccCCccccccCCCCEEeccCC-cccccCCccccCCCCCCEEeccCCcCcccCCccccCCCCCCeEEecC
Q 005040 120 IVLSLGFNDLNGTIPTSIGTLQQLQGFYVPEN-NLQGYVPHDLCHLERLNILNLSGNKLSGAIPQCLASLTSLRSLYLQS 198 (717)
Q Consensus 120 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n-~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 198 (717)
+.++++++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34444444444 23334444444455544433 24444444444444444444444444444444444444444444444
Q ss_pred cccc
Q 005040 199 NKLS 202 (717)
Q Consensus 199 N~l~ 202 (717)
|+|+
T Consensus 90 N~l~ 93 (156)
T d2ifga3 90 NALE 93 (156)
T ss_dssp SCCS
T ss_pred CCCc
Confidence 4444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.65 E-value=1.4e-09 Score=97.27 Aligned_cols=13 Identities=46% Similarity=0.527 Sum_probs=5.7
Q ss_pred ccceEeccCCCCC
Q 005040 286 SLESLDFSNNNLS 298 (717)
Q Consensus 286 ~L~~L~L~~N~~~ 298 (717)
+|+.|++++|++.
T Consensus 116 ~L~~L~L~~Npl~ 128 (162)
T d1koha1 116 KLEELWLDGNSLS 128 (162)
T ss_dssp CCSSCCCTTSTTS
T ss_pred ccceeecCCCCcC
Confidence 3444444444443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=1.6e-09 Score=96.97 Aligned_cols=40 Identities=30% Similarity=0.395 Sum_probs=16.4
Q ss_pred ccCCCCEEeccCCcccccC--CccccCCCCCCEEeccCCcCc
Q 005040 139 TLQQLQGFYVPENNLQGYV--PHDLCHLERLNILNLSGNKLS 178 (717)
Q Consensus 139 ~l~~L~~L~l~~n~i~~~~--~~~~~~l~~L~~L~L~~n~l~ 178 (717)
++++|++|+|++|+|+... +..+..+++|+.|+|++|.|+
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 3444444444444444321 122333444444444444444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.45 E-value=3.9e-07 Score=88.26 Aligned_cols=149 Identities=13% Similarity=0.147 Sum_probs=103.6
Q ss_pred HHHHHhccCCccccccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeE
Q 005040 421 DIRRATDEFNECNLLGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKA 499 (717)
Q Consensus 421 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~ 499 (717)
++++.-+.|+.++..+.++.+.||+... +++.+++|+...........+.+|..+++.+. +--+.+++.+..+.+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 5566667787766655455578999875 56667889887655444455677888888774 434667778888888899
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 005040 500 LVLEFMPNGSLEKWLYSHNYFLDILQRLNIMIDVGSALEYLHHCH----------------------------------- 544 (717)
Q Consensus 500 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 544 (717)
+||++++|.++.+...... ....++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999999988765443211 12234555666666666421
Q ss_pred --------------------CCCCeEecCCCCCCeeeCCCCcEEEeeecccc
Q 005040 545 --------------------SSAPIIHCDLKPTNILLDENMVAHVSDFGISK 576 (717)
Q Consensus 545 --------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 576 (717)
....++|+|+.+.||++++++.+-|.||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11237899999999999987777899998765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.10 E-value=3.4e-07 Score=81.73 Aligned_cols=19 Identities=16% Similarity=0.426 Sum_probs=10.0
Q ss_pred ccCccCCcEEeccCCCCcc
Q 005040 64 LTNCRNLANLALASNPLGG 82 (717)
Q Consensus 64 l~~l~~L~~L~L~~N~l~~ 82 (717)
+...++|++|+|++|.++.
T Consensus 40 L~~n~~L~~L~Ls~n~l~~ 58 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISD 58 (167)
T ss_dssp HTTCSCCCEEECTTSCCBH
T ss_pred HhhCCccceeeccccccch
Confidence 4444555555555555543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.01 E-value=5.2e-07 Score=80.53 Aligned_cols=89 Identities=13% Similarity=0.047 Sum_probs=49.5
Q ss_pred ccCCCCCcEEEccCCCCcccC----CccccccCCCCEEeccCCcccccCC----ccccCCCCCCEEeccCCcCccc----
Q 005040 113 IGNLRGLIVLSLGFNDLNGTI----PTSIGTLQQLQGFYVPENNLQGYVP----HDLCHLERLNILNLSGNKLSGA---- 180 (717)
Q Consensus 113 ~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l~~~---- 180 (717)
+...++|++|+|++|.++... ...+...+.|++|+|++|.|+.... ..+...++|++|+|++|++...
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~ 119 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 119 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence 444456666666666665321 2233445667777777776664322 2344556677777776655422
Q ss_pred ---CCccccCCCCCCeEEecCccc
Q 005040 181 ---IPQCLASLTSLRSLYLQSNKL 201 (717)
Q Consensus 181 ---~~~~~~~l~~L~~L~L~~N~l 201 (717)
+...+...++|+.|+++.+..
T Consensus 120 ~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 120 EMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHHhCCCccEeeCcCCCc
Confidence 223344456777777766543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=3e-05 Score=73.99 Aligned_cols=74 Identities=14% Similarity=0.058 Sum_probs=53.4
Q ss_pred ccccccc-EEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcC--CCceeeEeeeeecCCeeEEEEEccCCCCH
Q 005040 434 LLGTGGF-GSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVR--HRNLLKILGSCSNLDFKALVLEFMPNGSL 510 (717)
Q Consensus 434 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~g~L 510 (717)
.+..|.. +.||+...+++..+++|....... ..+..|.+.++.+. .-.+.+++++..+.+..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4445554 689999988888899998764432 34566888887774 23356778887888888999999987654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.64 E-value=1.4e-06 Score=77.53 Aligned_cols=18 Identities=6% Similarity=0.145 Sum_probs=9.2
Q ss_pred ccCccCCcEEeccCCCCc
Q 005040 64 LTNCRNLANLALASNPLG 81 (717)
Q Consensus 64 l~~l~~L~~L~L~~N~l~ 81 (717)
+...++|++|+|++|.++
T Consensus 42 l~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HTTCCSCCEEECTTSCCC
T ss_pred HhcCCccCeeeccCCccc
Confidence 444455555555555554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.53 E-value=4.6e-06 Score=74.13 Aligned_cols=121 Identities=14% Similarity=0.081 Sum_probs=78.3
Q ss_pred ccCCCCCcEEECCC-Ccceec----CCcCCCCCCCCCEEEcccccccCccCCcccccccccccCccCCcEEeccCCCCcc
Q 005040 8 ITNATKLIGLDLGL-NSFSGH----IPNTFGNLRHLSVLSLMMNNLTTESSSADQWSFLSSLTNCRNLANLALASNPLGG 82 (717)
Q Consensus 8 ~~~l~~L~~L~L~~-n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 82 (717)
..+.++|++|+|++ +.|+.. +..++...++|++|+|++|.++..... .+...+...++|+.|++++|.++.
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~----~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAF----ALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHH----HHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHH----HHHHHHhhcccchhhhhccccccc
Confidence 35779999999998 557633 334566789999999999999864322 234456778899999999998875
Q ss_pred cCCcchhccccccceeeecCCcceecCCccccCCCCCcEEEc--cCCCCccc----CCccccccCCCCEEeccCCcc
Q 005040 83 ILPPLIGNFSASLQNIYAFECKLGGSIPKEIGNLRGLIVLSL--GFNDLNGT----IPTSIGTLQQLQGFYVPENNL 153 (717)
Q Consensus 83 ~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L--~~n~l~~~----~~~~~~~l~~L~~L~l~~n~i 153 (717)
.....+. ..+...++|+.++| ++|.+... +...+...++|++|+++.+..
T Consensus 89 ~g~~~l~---------------------~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 89 SGILALV---------------------EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHH---------------------HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred hhHHHHH---------------------HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 4332222 23455566766544 45566532 233444566666666655543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.28 E-value=0.00027 Score=71.77 Aligned_cols=76 Identities=16% Similarity=0.169 Sum_probs=48.0
Q ss_pred cccccccccEEEEEEEec-CCCeEEEEEechhhH-------HHHHHHHHHHHHHHhcC-C--CceeeEeeeeecCCeeEE
Q 005040 432 CNLLGTGGFGSVYKGTLS-DGTNVAIKIFNLQLE-------RAFRSFDSECEILRNVR-H--RNLLKILGSCSNLDFKAL 500 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~-h--pniv~~~~~~~~~~~~~l 500 (717)
.+.||.|....||+.... +++.|+||.-....+ ....+...|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 456899999999999865 467899996543211 01223455888887763 2 345566654 3445589
Q ss_pred EEEccCCCC
Q 005040 501 VLEFMPNGS 509 (717)
Q Consensus 501 v~e~~~~g~ 509 (717)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.71 E-value=0.0025 Score=62.62 Aligned_cols=68 Identities=10% Similarity=0.058 Sum_probs=45.3
Q ss_pred cEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCCCce--eeEee-----eeecCCeeEEEEEccCCC
Q 005040 440 FGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRHRNL--LKILG-----SCSNLDFKALVLEFMPNG 508 (717)
Q Consensus 440 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni--v~~~~-----~~~~~~~~~lv~e~~~~g 508 (717)
--.||++..++|+.|++|+..... ...+.+..|.+.+..|....+ +..+. .+...+..+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 348999999999999999987542 233557778888888742221 11111 223456678999998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.13 E-value=0.0085 Score=58.28 Aligned_cols=158 Identities=12% Similarity=0.045 Sum_probs=84.2
Q ss_pred CCHHHHHHHhccCCcccc-----ccccccEEEEEEEecCCCeEEEEEechhhHHHHHHHHHHHHHHHhcCC-----Ccee
Q 005040 417 TSYLDIRRATDEFNECNL-----LGTGGFGSVYKGTLSDGTNVAIKIFNLQLERAFRSFDSECEILRNVRH-----RNLL 486 (717)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----pniv 486 (717)
.+..+++....+|.+.+. |..|.--+.|+.+.++|+ +++|++.... ..+.+..|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 345567777778876544 345656788999886654 8899986432 22345557777777742 2222
Q ss_pred eEee---eeecCCeeEEEEEccCCCCHH-----------HH---Hhh----CC----CCC------------------CH
Q 005040 487 KILG---SCSNLDFKALVLEFMPNGSLE-----------KW---LYS----HN----YFL------------------DI 523 (717)
Q Consensus 487 ~~~~---~~~~~~~~~lv~e~~~~g~L~-----------~~---l~~----~~----~~~------------------~~ 523 (717)
...+ +.......+.++.++.+.... .. ++. .. ... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1111 112234456667776653221 01 110 00 000 00
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeeccccc
Q 005040 524 LQRLNIMIDVGSALEYLHHCHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 577 (717)
Q Consensus 524 ~~~~~i~~~i~~~l~~LH~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 577 (717)
......+......+.-.+...-..++||+|+.+.||+++.+...-+.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 011122223333333333222356799999999999999988789999997753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.96 E-value=0.0049 Score=62.22 Aligned_cols=72 Identities=15% Similarity=0.181 Sum_probs=48.8
Q ss_pred cccccccccEEEEEEEecC--------CCeEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeeEeeeeecCCeeEEEE
Q 005040 432 CNLLGTGGFGSVYKGTLSD--------GTNVAIKIFNLQLERAFRSFDSECEILRNVR-HRNLLKILGSCSNLDFKALVL 502 (717)
Q Consensus 432 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 502 (717)
++.|+.|-.-.+|++..++ .+.|.+++..... ......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4568878888999998653 3457777765322 2234557888888884 4334577777654 6899
Q ss_pred EccCCCC
Q 005040 503 EFMPNGS 509 (717)
Q Consensus 503 e~~~~g~ 509 (717)
||++|..
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEecccc
Confidence 9998743
|